Citrus Sinensis ID: 018275

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------36
Protein Sequence
MENQNIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIMLYV
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHcccccccccEEEEEEcccEEEEEEEEEcccccEEEEEEccHHHHHHHHHHHHHHHHHHHHHHccccEEEEEEEEEEccccEEEEEEccccHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccccEEEcccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccHHHHHcccccccccHHHHHHHHHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHcccccEEEEEEEEEEccEEEEEEEEcccccEEEEEEEEHHHHHccccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEEEcccccEEEccccccEcccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHccEcHHHccHHHHccccEccHHHHHHHHHHHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
menqnikveeqgddegapmaGEVLEeegeigssLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERklassdvpeeEQINILKDLERKETEYMRLKRhkisvddfdlltiigrgafgevRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKhnyihrdikpdnllldqnghmklsdfglckpldctnlsainenevlddenlnesmdvdgrfpesgcgrrwksplEQLQHWQINRRKlaystvgtpdyiapevllkkgygmecdWLAYWNETLSCNYLSDIMLYV
Flexible Loop (DISEMBL)
menqnikveeqgddegapmAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLErklassdvpeeeqinilkdlerKETEYMRLkrhkisvddfdllTIIGRgafgevrlcqekksgniyAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINenevlddenlneSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKlaystvgtpdyIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIMLYV
Low Complexity Region (SEG)
MENQNIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVmtllmreetltetVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAInenevlddenlneSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIMLYV
Disordered region (IsUnstruct)
********************************************************************************************TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK***********VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL*******************CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIMLY*
Disordered Region (DISOPRED)
****************************************AAKQFIESHYKAQM********************************DLERKETEYM****H***VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT************************************************************DYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIMLYV
Disordered Region (DISEMBL)
********EEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYK****************************EQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIMLYV
Disordered Region (DISPRO)
********************************SLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN***************************KSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIMLYV
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MENQNIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIMLYV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	358	2.2.26 [Sep-21-2011]
Q5AP53	732	Serine/threonine-protein	N/A	no	0.935	0.457	0.463	5e-84
Q9NBK5	463	Serine/threonine-protein	yes	no	0.835	0.645	0.496	4e-81
Q54Y26	530	Probable serine/threonine	yes	no	0.821	0.554	0.503	4e-81
Q6BLJ9	716	Serine/threonine-protein	yes	no	0.946	0.473	0.442	1e-80
A2VDV2	465	Serine/threonine-protein	yes	no	0.824	0.634	0.501	1e-80
Q6TGC6	507	Serine/threonine-protein	N/A	no	0.849	0.599	0.490	2e-80
Q2LZZ7	458	Serine/threonine-protein	yes	no	0.826	0.646	0.493	2e-80
Q91VJ4	465	Serine/threonine-protein	yes	no	0.824	0.634	0.498	3e-80
Q5R8M1	465	Serine/threonine-protein	yes	no	0.824	0.634	0.498	4e-80
Q15208	465	Serine/threonine-protein	yes	no	0.824	0.634	0.498	4e-80

>sp|Q5AP53|CBK1_CANAL Serine/threonine-protein kinase CBK1 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) GN=CBK1 PE=1 SV=1

 Score =  311 bits (797), Expect = 5e-84,   Method: Compositional matrix adjust.
 Identities = 163/352 (46%), Positives = 232/352 (65%), Gaps = 17/352 (4%)

Query: 1   MENQNIKVEEQGDD-EGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQE 59
           + NQ++  E    D  G+       E +  + S  T ++ A+ K  +E++Y + + H  E
Sbjct: 225 VANQSVSTEAANSDMTGSNTKYVYFERKPNLLSKTTQDKAASIKLTLENYYTSSVSHAIE 284

Query: 60  RKQRRSVLERKLASSDV--PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRG 117
           R QRR  LE K+A+ D+   EE +   L++L +KE++++RLKR K++++DF  + +IG+G
Sbjct: 285 RNQRRLELENKIANEDIGSSEERKNRQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKG 344

Query: 118 AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177
           AFGEVRL Q+K +G IYAMK L KSEM ++ Q+ HV+AER++LA   S  IV LYYSFQD
Sbjct: 345 AFGEVRLVQKKDTGKIYAMKTLLKSEMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQD 404

Query: 178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237
           ++YLYLIME+LPGGD+MT+L+R E  TE + RFYIA+ VLAIE+IHK  +IHRDIKPDN+
Sbjct: 405 SQYLYLIMEFLPGGDLMTMLIRWEVFTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNI 464

Query: 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR---- 293
           L+D  GH+KLSDFGL      T+ S    N++L+ E  N  +  +    +   GR     
Sbjct: 465 LIDNRGHVKLSDFGLSTGFHKTHDSNY-YNKLLEKEPSNTHLQPN----QLTSGRNSVMV 519

Query: 294 -----WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                  S  + +Q W+ +RR +AYSTVGTPDYIAPE+ + +GYG ECDW +
Sbjct: 520 DAIHLTMSNRQTMQTWRKSRRLMAYSTVGTPDYIAPEIFIHQGYGQECDWWS 571

Serine/threonine-protein kinase required for wild-type hyphal growth and transcriptional regulation of cell-wall-associated genes. Involved in the biofilm formation through phosphorylation of the master regulator of biofilm formation BCR1.
Candida albicans (strain SC5314 / ATCC MYA-2876) (taxid: 237561)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9NBK5|TRC_DROME Serine/threonine-protein kinase tricorner OS=Drosophila melanogaster GN=trc PE=1 SV=1

 Score =  301 bits (772), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 155/312 (49%), Positives = 210/312 (67%), Gaps = 13/312 (4%)

Query: 32  SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
           S  T+++   AK  +E++Y   +    ERKQR + LE +L    + E ++        +K
Sbjct: 17  SDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLSEAQRQEKRLQHAQK 76

Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           ETEY+RLKR ++ V+DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV 
Sbjct: 77  ETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQVA 136

Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
           HVRAER++L E     +VK+YYSFQD   LYLIME+LPGGD+MTLLM+++TL+E   +FY
Sbjct: 137 HVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQFY 196

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
           I+++ LAI+SIHK  +IHRDIKPDNLLLD  GH+KLSDFGL     CT L   +  +   
Sbjct: 197 ISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGL-----CTGLKKSHRTDFYR 251

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLE---QLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
           D +  +  D  G      C     SP++   + + W+ NRR LAYSTVGTPDYIAPEV L
Sbjct: 252 DLSQAKPSDFIGTCASLSC-----SPMDSKRRAESWKRNRRALAYSTVGTPDYIAPEVFL 306

Query: 329 KKGYGMECDWLA 340
           + GYG  CDW +
Sbjct: 307 QTGYGPACDWWS 318

Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54Y26|NDRA_DICDI Probable serine/threonine-protein kinase ndrA OS=Dictyostelium discoideum GN=ndrA PE=3 SV=1

 Score =  301 bits (772), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 156/310 (50%), Positives = 210/310 (67%), Gaps = 16/310 (5%)

Query: 32  SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
           S  TM+R  AAK +IE +Y    + ++ER QRR  LE KL +  +  +E  ++ K+L++K
Sbjct: 36  SRPTMDRSLAAKMYIEQYYINAQQSVKERGQRRKDLELKLENMKLSSKESNDLRKELDKK 95

Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           E++YMR+KR K+   DF+++ IIGRGAFGEV L + ++S ++YAMK+LKKSEML + Q  
Sbjct: 96  ESDYMRIKRLKLKRSDFEVIRIIGRGAFGEVSLVRHRESNDLYAMKRLKKSEMLKKEQAA 155

Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
           HVRAER++LA   ++ +VKLYYSFQD  YLYLIMEYLPGGD+M+LL++ +  TE  ARFY
Sbjct: 156 HVRAERDVLASANTNWVVKLYYSFQDDNYLYLIMEYLPGGDMMSLLIKYDIFTENQARFY 215

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
           IA+++LAIES+H   YIHRDIKPDNLLLD  GH+KL D GLC      + S   +  V D
Sbjct: 216 IAETILAIESVHTLGYIHRDIKPDNLLLDSKGHVKLCDLGLCTGFHRLHSSEFYQMLVGD 275

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPL---EQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
                 +M +  +  E+       +PL   E++  W+  RR LAYS VGTPDY APEV L
Sbjct: 276 ------AMTIKMKLIEA-------TPLTQTERIASWKKARRALAYSAVGTPDYTAPEVFL 322

Query: 329 KKGYGMECDW 338
           + GY  E DW
Sbjct: 323 QIGYNKEVDW 332

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6BLJ9|CBK1_DEBHA Serine/threonine-protein kinase CBK1 OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) GN=CBK1 PE=3 SV=2

 Score =  300 bits (767), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 157/355 (44%), Positives = 230/355 (64%), Gaps = 16/355 (4%)

Query: 1   MENQNIKVEEQGDDEGAPMAGEV-LEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQE 59
           + N NI      +D  A  +  +    +    + +  ++ ++ K  +E++Y+  + H  E
Sbjct: 205 LPNSNIPPAGASNDPNAQKSNYIYFNRQPNSLNKIAQDKASSIKLKLENYYQMSVAHAIE 264

Query: 60  RKQRRSVLERKLAS--SDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRG 117
           R QRR  LE KL +  S   EE +   L++L +KE++++RL+R K+S++DF+ + +IG+G
Sbjct: 265 RNQRRLDLEHKLLNEESGSSEERKNRQLQNLGKKESQFLRLRRTKLSLEDFNTVKVIGKG 324

Query: 118 AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177
           AFGEVRL Q++ +G IYAMK L KSEM  + Q+ HV+AER++LA   S  +V LYYSFQD
Sbjct: 325 AFGEVRLVQKRDTGKIYAMKTLLKSEMYKKDQLAHVKAERDVLAGSDSPWVVSLYYSFQD 384

Query: 178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237
           A+YLYLIME+LPGGD+MT+L+R +  TE + RFY+A+ VLAIE+IHK  +IHRDIKPDN+
Sbjct: 385 AQYLYLIMEFLPGGDLMTMLIRWQIFTEDITRFYMAECVLAIEAIHKLGFIHRDIKPDNI 444

Query: 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF--PESGCGRRWK 295
           L+D  GH+KLSDFGL      T+ S   + ++L+ EN + +   +G    P      R  
Sbjct: 445 LIDIRGHIKLSDFGLSTGFHKTHDSNYYK-KLLEKENPHHTNPQNGNLQAPSMATNNRNS 503

Query: 296 ----------SPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                     S  +Q+Q W+ +RR +AYSTVGTPDYIAPE+ + +GYG ECDW +
Sbjct: 504 MMVDAIHLTMSNRQQMQTWRKSRRLMAYSTVGTPDYIAPEIFVHQGYGQECDWWS 558

Protein kinase that seems to play a role in the regulation of cell morphogenesis and proliferation.

Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) (taxid: 284592)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2VDV2|STK38_BOVIN Serine/threonine-protein kinase 38 OS=Bos taurus GN=STK38 PE=1 SV=1

 Score =  300 bits (767), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 155/309 (50%), Positives = 210/309 (67%), Gaps = 14/309 (4%)

Query: 32  SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
           SS T ERV   K  +E+ Y   +   +ER+ R+  LE+ +    + +EE+        RK
Sbjct: 13  SSHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72

Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           ETE++RLKR ++ ++DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV 
Sbjct: 73  ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132

Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
           H+RAER++L E  S  +VK++YSFQD   LYLIME+LPGGD+MTLLM+++TLTE   +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
           IA++VLAI+SIH+  +IHRDIKPDNLLLD  GH+KLSDFGL     CT L   +  E   
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL-----CTGLKKAHRTEFY- 246

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
             NLN S+  D  F      R+        + W+ NRR+LA+STVGTPDYIAPEV ++ G
Sbjct: 247 -RNLNHSLPSDFTFQNMNSKRK-------AETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298

Query: 332 YGMECDWLA 340
           Y   CDW +
Sbjct: 299 YNKLCDWWS 307

Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6TGC6|CBK1_PNECA Serine/threonine-protein kinase CBK1 OS=Pneumocystis carinii GN=CBK1 PE=2 SV=1

 Score =  300 bits (767), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 150/306 (49%), Positives = 206/306 (67%), Gaps = 2/306 (0%)

Query: 35  TMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETE 94
           T ER A+ K  +E  YK  ++   ER QRR   E KLA     EE +   L  L +KE++
Sbjct: 53  THERAASVKLKLEHLYKVTVEQTVERNQRRMDFEAKLAQDRGSEERKKRQLNSLGQKESQ 112

Query: 95  YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           ++RL+R K+S++DF  + +IG+GAFGEVRL Q+  +G IYAMK L KSEM  + Q+ HV+
Sbjct: 113 FLRLRRTKLSLNDFHTVKVIGKGAFGEVRLVQKIDTGKIYAMKTLLKSEMFKKDQLAHVK 172

Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
           AER++LAE  S  +V LYYSFQD++YLYLIME+LPGGD+MT+L++ +T +E V RFYIA+
Sbjct: 173 AERDVLAESDSPWVVSLYYSFQDSQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYIAE 232

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
            +LAIE++HK  +IHRDIKPDN+L+D+ GH+KLSDFGL      T+ +A  +   L +  
Sbjct: 233 CILAIEAVHKLGFIHRDIKPDNILIDKTGHIKLSDFGLSMGFHKTHDNAYYQR--LFESK 290

Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
           +N S                 S  +++  W+ NRR +AYSTVGTPDYIAPE+  + GYG 
Sbjct: 291 INTSTSSTQNSLMVDTISLTMSSKDKIATWKKNRRIMAYSTVGTPDYIAPEIFTQHGYGQ 350

Query: 335 ECDWLA 340
           ECDW +
Sbjct: 351 ECDWWS 356

Protein kinase that seems to play a role in signaling pathways necessary for cell growth and mating.

Pneumocystis carinii (taxid: 4754)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2LZZ7|TRC_DROPS Serine/threonine-protein kinase tricorner OS=Drosophila pseudoobscura pseudoobscura GN=trc PE=3 SV=1

 Score =  299 bits (766), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 157/318 (49%), Positives = 213/318 (66%), Gaps = 22/318 (6%)

Query: 31  GSSL-----TMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINIL 85
           GSS+     T+++   AK  +E++Y   +    ERKQR + LE +L    + E ++    
Sbjct: 10  GSSIRFSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLTESQRQEKR 69

Query: 86  KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
               +KETEY+RLKR ++ V+DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML
Sbjct: 70  LQHAQKETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADML 129

Query: 146 SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTE 205
            + QV HVRAER++L E     +VK+YYSFQD   LYLIME+LPGGD+MTLLM+++TL+E
Sbjct: 130 EKEQVAHVRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLMKKDTLSE 189

Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265
              +FYI+++ LAI+SIHK  +IHRDIKPDNLLLD  GH+KLSDFGL     CT L   +
Sbjct: 190 EGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGL-----CTGLKKSH 244

Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLE---QLQHWQINRRKLAYSTVGTPDYI 322
             +   D +  +  D  G      C     SP++   + + W+ NRR LAYSTVGTPDYI
Sbjct: 245 RTDFYRDLSQAKPSDFIG-----TCA----SPMDSKRRAESWKRNRRALAYSTVGTPDYI 295

Query: 323 APEVLLKKGYGMECDWLA 340
           APEV L+ GYG  CDW +
Sbjct: 296 APEVFLQTGYGPACDWWS 313

Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons.

Drosophila pseudoobscura pseudoobscura (taxid: 46245)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q91VJ4|STK38_MOUSE Serine/threonine-protein kinase 38 OS=Mus musculus GN=Stk38 PE=1 SV=1

 Score =  298 bits (764), Expect = 3e-80,   Method: Compositional matrix adjust.
 Identities = 154/309 (49%), Positives = 210/309 (67%), Gaps = 14/309 (4%)

Query: 32  SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
           S+ T ERV   K  +E+ Y   +   +ER+ R+  LE+ +    + +EE+        RK
Sbjct: 13  SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72

Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           ETE++RLKR ++ ++DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV 
Sbjct: 73  ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132

Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
           H+RAER++L E  S  +VK++YSFQD   LYLIME+LPGGD+MTLLM+++TLTE   +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
           IA++VLAI+SIH+  +IHRDIKPDNLLLD  GH+KLSDFGL     CT L   +  E   
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL-----CTGLKKAHRTEFY- 246

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
             NLN S+  D  F      R+        + W+ NRR+LA+STVGTPDYIAPEV ++ G
Sbjct: 247 -RNLNHSLPSDFTFQNMNSKRK-------AETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298

Query: 332 YGMECDWLA 340
           Y   CDW +
Sbjct: 299 YNKLCDWWS 307

Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5R8M1|STK38_PONAB Serine/threonine-protein kinase 38 OS=Pongo abelii GN=STK38 PE=1 SV=1

 Score =  298 bits (763), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 154/309 (49%), Positives = 210/309 (67%), Gaps = 14/309 (4%)

Query: 32  SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
           S+ T ERV   K  +E+ Y   +   +ER+ R+  LE+ +    + +EE+        RK
Sbjct: 13  SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72

Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           ETE++RLKR ++ ++DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV 
Sbjct: 73  ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132

Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
           H+RAER++L E  S  +VK++YSFQD   LYLIME+LPGGD+MTLLM+++TLTE   +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
           IA++VLAI+SIH+  +IHRDIKPDNLLLD  GH+KLSDFGL     CT L   +  E   
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL-----CTGLKKAHRTEFY- 246

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
             NLN S+  D  F      R+        + W+ NRR+LA+STVGTPDYIAPEV ++ G
Sbjct: 247 -RNLNHSLPSDFTFQNMNSKRK-------AETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298

Query: 332 YGMECDWLA 340
           Y   CDW +
Sbjct: 299 YNKLCDWWS 307

Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2.

Pongo abelii (taxid: 9601)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q15208|STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1

 Score =  298 bits (763), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 154/309 (49%), Positives = 210/309 (67%), Gaps = 14/309 (4%)

Query: 32  SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
           S+ T ERV   K  +E+ Y   +   +ER+ R+  LE+ +    + +EE+        RK
Sbjct: 13  SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72

Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           ETE++RLKR ++ ++DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV 
Sbjct: 73  ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132

Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
           H+RAER++L E  S  +VK++YSFQD   LYLIME+LPGGD+MTLLM+++TLTE   +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
           IA++VLAI+SIH+  +IHRDIKPDNLLLD  GH+KLSDFGL     CT L   +  E   
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL-----CTGLKKAHRTEFY- 246

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
             NLN S+  D  F      R+        + W+ NRR+LA+STVGTPDYIAPEV ++ G
Sbjct: 247 -RNLNHSLPSDFTFQNMNSKRK-------AETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 298

Query: 332 YGMECDWLA 340
           Y   CDW +
Sbjct: 299 YNKLCDWWS 307

Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	358
444436616	538	serine/threonine protein kinase [Carica	0.896	0.596	0.900	1e-169
255546075	492	serine/threonine-protein kinase, putativ	0.860	0.626	0.902	1e-164
449452743	533	PREDICTED: serine/threonine-protein kina	0.944	0.634	0.838	1e-164
224091216	486	predicted protein [Populus trichocarpa]	0.868	0.639	0.891	1e-163
449500536	533	PREDICTED: LOW QUALITY PROTEIN: serine/t	0.944	0.634	0.829	1e-162
356558379	519	PREDICTED: serine/threonine-protein kina	0.938	0.647	0.811	1e-161
357449949	676	Serine/threonine protein kinase [Medicag	0.882	0.467	0.844	1e-158
356532738	511	PREDICTED: probable serine/threonine-pro	0.871	0.610	0.855	1e-158
255550097	623	serine/threonine-protein kinase, putativ	0.868	0.499	0.855	1e-157
359476253	503	PREDICTED: serine/threonine-protein kina	0.879	0.626	0.847	1e-157

>gi|444436616|gb|AGE09676.1| serine/threonine protein kinase [Carica papaya]

 Score =  600 bits (1547), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 291/323 (90%), Positives = 306/323 (94%), Gaps = 2/323 (0%)

Query: 18  PMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVP 77
           P+A  V EEEG++GSSLTMERVAAAKQFIESHYKA MKHIQERK+RRS+LER+ A SDVP
Sbjct: 21  PIA--VDEEEGQVGSSLTMERVAAAKQFIESHYKAHMKHIQERKERRSILERRFACSDVP 78

Query: 78  EEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK 137
           +EEQIN+LKDLERKETEYMRLKRHKI VDDFDLLTIIGRGAFGEVRLC+EKKSGNIYAMK
Sbjct: 79  QEEQINMLKDLERKETEYMRLKRHKICVDDFDLLTIIGRGAFGEVRLCREKKSGNIYAMK 138

Query: 138 KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL 197
           KLKKSEMLSRGQVEHVRAERNLLAEV SHCIVKLYYSFQDA+YLYLIMEYLPGGD+MTLL
Sbjct: 139 KLKKSEMLSRGQVEHVRAERNLLAEVGSHCIVKLYYSFQDADYLYLIMEYLPGGDMMTLL 198

Query: 198 MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD++GHMKLSDFGLCKPLD
Sbjct: 199 IREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKSGHMKLSDFGLCKPLD 258

Query: 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317
           C NLSAINENE L DENLNESMDVDG  P S  GRRWKSPLEQLQHWQINRRKLAYSTVG
Sbjct: 259 CRNLSAINENEPLHDENLNESMDVDGSLPGSRGGRRWKSPLEQLQHWQINRRKLAYSTVG 318

Query: 318 TPDYIAPEVLLKKGYGMECDWLA 340
           TPDYIAPEVLLKKGYGMECDW +
Sbjct: 319 TPDYIAPEVLLKKGYGMECDWWS 341

Source: Carica papaya

Species: Carica papaya

Genus: Carica

Family: Caricaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255546075|ref|XP_002514097.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223546553|gb|EEF48051.1| serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  583 bits (1504), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 279/309 (90%), Positives = 300/309 (97%), Gaps = 1/309 (0%)

Query: 32  SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
           SSLT+ERVAAAK FIE+HY+AQMKHIQ+RK+RRS L+++LASSDV +EEQ N+LKDLERK
Sbjct: 25  SSLTLERVAAAKLFIENHYRAQMKHIQQRKERRSELQKQLASSDVSQEEQTNLLKDLERK 84

Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           ETEYMRLKR+KI VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE
Sbjct: 85  ETEYMRLKRNKICVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 144

Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
           HV+AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD+MTLLMREETLTETVARFY
Sbjct: 145 HVKAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDIMTLLMREETLTETVARFY 204

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
           IAQSVLAIESIH+HNYIHRDIKPDNLLLD+NGHMKLSDFGLCKPLDC+NLSAINENEVLD
Sbjct: 205 IAQSVLAIESIHRHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSNLSAINENEVLD 264

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
           DENL ESMDV+GRFP++G GRRWKSPLEQLQHWQ+NRR LAYSTVGTPDYIAPEVLLKKG
Sbjct: 265 DENLKESMDVNGRFPDTG-GRRWKSPLEQLQHWQMNRRTLAYSTVGTPDYIAPEVLLKKG 323

Query: 332 YGMECDWLA 340
           YGMECDW +
Sbjct: 324 YGMECDWWS 332

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452743|ref|XP_004144118.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Cucumis sativus]

 Score =  583 bits (1502), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 285/340 (83%), Positives = 312/340 (91%), Gaps = 2/340 (0%)

Query: 1   MENQNIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQER 60
           MEN   +VE + DD+  P   E  EE G +GSSLT+E+VAAAKQ+IE+HYKAQ KHIQER
Sbjct: 1   MENHQ-EVEGEEDDDMGPTTVEE-EEIGFVGSSLTLEKVAAAKQYIENHYKAQRKHIQER 58

Query: 61  KQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFG 120
           K+RRSVLER+LASSDV EEEQIN+LKDLER ET+Y+RLKRHKI V+DF LLTIIGRGAFG
Sbjct: 59  KERRSVLERRLASSDVSEEEQINLLKDLERTETQYIRLKRHKICVEDFYLLTIIGRGAFG 118

Query: 121 EVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180
           EVRLC+EKK+GNIYAMKKL+KSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY
Sbjct: 119 EVRLCREKKTGNIYAMKKLRKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 178

Query: 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 240
           LYLIMEYLPGGD+MTLL+REETLTETVARFYIAQSVLAIESIH HNYIHRDIKPDNLLLD
Sbjct: 179 LYLIMEYLPGGDMMTLLIREETLTETVARFYIAQSVLAIESIHIHNYIHRDIKPDNLLLD 238

Query: 241 QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQ 300
           + GHMKLSDFGLCKPLDCTNLSAINE+EVLDDENLN+++DVD  FP    GRRWKSPLEQ
Sbjct: 239 KRGHMKLSDFGLCKPLDCTNLSAINEHEVLDDENLNDTVDVDESFPGKKSGRRWKSPLEQ 298

Query: 301 LQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
           LQHWQINRRKLA+STVGTPDYIAPEVLLKKGYG+ECDW +
Sbjct: 299 LQHWQINRRKLAFSTVGTPDYIAPEVLLKKGYGVECDWWS 338

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224091216|ref|XP_002309207.1| predicted protein [Populus trichocarpa] gi|222855183|gb|EEE92730.1| predicted protein [Populus trichocarpa]

 Score =  580 bits (1495), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 278/312 (89%), Positives = 299/312 (95%), Gaps = 1/312 (0%)

Query: 29  EIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDL 88
           ++GSSLT+ERVAAAK FIE+HYKAQMKHIQ+RK+RR  L+++LASS V EEEQINILKDL
Sbjct: 25  QVGSSLTLERVAAAKIFIENHYKAQMKHIQQRKERRLELKKQLASSQVSEEEQINILKDL 84

Query: 89  ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
           E KET+YMRLKRHKI VDDFDLLTIIGRGAFGEVRLC+EKKSG+IYAMKKLKKSEMLSRG
Sbjct: 85  EHKETQYMRLKRHKICVDDFDLLTIIGRGAFGEVRLCREKKSGDIYAMKKLKKSEMLSRG 144

Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVA 208
           QVEHV+AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD+MTLL+REETLTET+A
Sbjct: 145 QVEHVKAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDIMTLLIREETLTETMA 204

Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268
           RFYI+QSVLAIESIHKHNYIHRDIKPDNLLLD+NGHMKLSDFGLCKPLDCTNLSAINENE
Sbjct: 205 RFYISQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCTNLSAINENE 264

Query: 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
            LDDENL ESMD DG FPE+G GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL
Sbjct: 265 ALDDENLKESMDADGHFPEAG-GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 323

Query: 329 KKGYGMECDWLA 340
           KKGYG+ECDW +
Sbjct: 324 KKGYGIECDWWS 335

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449500536|ref|XP_004161124.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase CBK1-like [Cucumis sativus]

 Score =  575 bits (1483), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 282/340 (82%), Positives = 309/340 (90%), Gaps = 2/340 (0%)

Query: 1   MENQNIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQER 60
           MEN   +VE + DD+  P   E  EE G +GSSLT+E+VAAAKQ+IE+HYKAQ KHIQER
Sbjct: 1   MENHQ-EVEGEEDDDMGPTTVEE-EEIGFVGSSLTLEKVAAAKQYIENHYKAQRKHIQER 58

Query: 61  KQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFG 120
           K+RRSVLER+LASSDV EEEQIN+LKDLER ET+Y+RLKRHKI V+DF LLTIIGRGAFG
Sbjct: 59  KERRSVLERRLASSDVSEEEQINLLKDLERTETQYIRLKRHKICVEDFYLLTIIGRGAFG 118

Query: 121 EVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180
           EVRLC+EKK+GNIYAMKKL+KSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY
Sbjct: 119 EVRLCREKKTGNIYAMKKLRKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 178

Query: 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 240
           LYLIMEYLPGGD+MTLL+REETLTETVARFYIAQSVLAIESIH HNYIHRDIKPDNLLLD
Sbjct: 179 LYLIMEYLPGGDMMTLLIREETLTETVARFYIAQSVLAIESIHIHNYIHRDIKPDNLLLD 238

Query: 241 QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQ 300
           + GHMKLSDFGLCKPLDCTNLSAINE+EVLDDENLN+++DVD        GRRWKSPLEQ
Sbjct: 239 KRGHMKLSDFGLCKPLDCTNLSAINEHEVLDDENLNDTVDVDESXSRXKSGRRWKSPLEQ 298

Query: 301 LQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
           LQHWQINRRKLA+STVGTPDYIAPEVL KKGYG+ECDW +
Sbjct: 299 LQHWQINRRKLAFSTVGTPDYIAPEVLXKKGYGVECDWWS 338

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558379|ref|XP_003547484.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max]

 Score =  573 bits (1478), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 279/344 (81%), Positives = 311/344 (90%), Gaps = 8/344 (2%)

Query: 1   MENQ----NIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKH 56
           MENQ    ++ V E+ DD    +A E  E+ G++GSS+T+ERVAAAK+FIE+HYK+Q KH
Sbjct: 1   MENQKVGESVHVREEEDD----VAVEKEEDHGDVGSSMTLERVAAAKKFIENHYKSQRKH 56

Query: 57  IQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGR 116
           IQERK+RR +LE+KLASS  PEEEQIN+LKDLE KETEYMRLKRHKI VDDFDLLTIIGR
Sbjct: 57  IQERKERRLMLEKKLASSQAPEEEQINLLKDLELKETEYMRLKRHKICVDDFDLLTIIGR 116

Query: 117 GAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176
           GAFGEVRLC+EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN+LAEVA  CIVKLYYSFQ
Sbjct: 117 GAFGEVRLCREKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNVLAEVACDCIVKLYYSFQ 176

Query: 177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN 236
           DAE+LYLIMEYLPGGD+MTLLMREETLTETVARFY+AQSV+AIESIHKHNYIHRDIKPDN
Sbjct: 177 DAEHLYLIMEYLPGGDIMTLLMREETLTETVARFYVAQSVIAIESIHKHNYIHRDIKPDN 236

Query: 237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKS 296
           LLLDQ GHMKLSDFGLCKPLDC++LS+I+ENE+LDDENLN++ DVDG       GRRWKS
Sbjct: 237 LLLDQYGHMKLSDFGLCKPLDCSSLSSISENEILDDENLNDTTDVDGALSNGRNGRRWKS 296

Query: 297 PLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
           PLEQLQHWQINRRKLA+STVGTPDYIAPEVLLKKGYG+ECDW +
Sbjct: 297 PLEQLQHWQINRRKLAFSTVGTPDYIAPEVLLKKGYGVECDWWS 340

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357449949|ref|XP_003595251.1| Serine/threonine protein kinase [Medicago truncatula] gi|355484299|gb|AES65502.1| Serine/threonine protein kinase [Medicago truncatula]

 Score =  565 bits (1456), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 267/316 (84%), Positives = 299/316 (94%)

Query: 25  EEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINI 84
           E++ ++ S+LTMERVAAAK+FIESHYK+QMKHIQERK+RRSVL+++L SS VPEEEQIN+
Sbjct: 183 EDDEDVVSTLTMERVAAAKKFIESHYKSQMKHIQERKERRSVLQKELESSHVPEEEQINL 242

Query: 85  LKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM 144
           LKDLE KETEYMRLKRHKI VDDFDLLTIIGRGAFGEVRLC+EKKSGNIYAMKKLKKSEM
Sbjct: 243 LKDLESKETEYMRLKRHKICVDDFDLLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM 302

Query: 145 LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLT 204
           LSRGQVEHVRAERN+LAEVA+ CIVKLYYSFQD E+LYLIMEYLPGGD+MTLLMREETLT
Sbjct: 303 LSRGQVEHVRAERNVLAEVANDCIVKLYYSFQDPEFLYLIMEYLPGGDIMTLLMREETLT 362

Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
           E+VARFYIAQ+VLAIESIHKHNY+HRDIKPDNLLLD NGHMKLSDFGLCKPL+ +NLS I
Sbjct: 363 ESVARFYIAQTVLAIESIHKHNYVHRDIKPDNLLLDINGHMKLSDFGLCKPLEVSNLSPI 422

Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
           +E E+LDD+NLN++MDVDG +P S  GRRWKSPLEQLQHWQ+NRRKLA+STVGTPDYIAP
Sbjct: 423 SEKEILDDDNLNDTMDVDGNYPNSRNGRRWKSPLEQLQHWQMNRRKLAFSTVGTPDYIAP 482

Query: 325 EVLLKKGYGMECDWLA 340
           EVLLKKGYG+ECDW +
Sbjct: 483 EVLLKKGYGVECDWWS 498

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356532738|ref|XP_003534928.1| PREDICTED: probable serine/threonine-protein kinase ndrB-like [Glycine max]

 Score =  563 bits (1451), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 267/312 (85%), Positives = 296/312 (94%)

Query: 29  EIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDL 88
           ++GSS+T+ERVAAAK+FIE+HY++Q KHIQERK+RR +LE+KLASS VPE+EQIN+LKDL
Sbjct: 32  DVGSSMTLERVAAAKKFIENHYRSQRKHIQERKERRLMLEKKLASSQVPEDEQINLLKDL 91

Query: 89  ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
           E KETEYMRLKRHKI VDDFDLLTIIGRGAFGEVRLC+EKKSGNIYAMKKLKKSEMLSRG
Sbjct: 92  ELKETEYMRLKRHKICVDDFDLLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLSRG 151

Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVA 208
           QVEHVRAERN+LAEVA   IVKLYYSFQDAE+LYLIMEYLPGGD+MTLLMREETLTETVA
Sbjct: 152 QVEHVRAERNVLAEVACDFIVKLYYSFQDAEHLYLIMEYLPGGDIMTLLMREETLTETVA 211

Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268
           RFYIA+SV+AIESIHKHNYIHRDIKPDNLLLDQ GHMKLSDFGLCKPLDC++LS+I+ENE
Sbjct: 212 RFYIAESVIAIESIHKHNYIHRDIKPDNLLLDQYGHMKLSDFGLCKPLDCSSLSSISENE 271

Query: 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
           +LDDENLN++MDVDG  P    GRRWKSPLEQLQHWQINRRKLA+STVGTPDYIAPEVLL
Sbjct: 272 ILDDENLNDTMDVDGALPNGRNGRRWKSPLEQLQHWQINRRKLAFSTVGTPDYIAPEVLL 331

Query: 329 KKGYGMECDWLA 340
           KKGYG+ECDW +
Sbjct: 332 KKGYGVECDWWS 343

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255550097|ref|XP_002516099.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223544585|gb|EEF46101.1| serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  561 bits (1447), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 266/311 (85%), Positives = 292/311 (93%)

Query: 30  IGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLE 89
           +GSSLTME+VAAAKQFIE+HY+AQMK+IQERK+RR VLERKLASSDVP+EEQI+++KDLE
Sbjct: 14  LGSSLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPKEEQISLIKDLE 73

Query: 90  RKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ 149
           RKETE+MRLKRHKI VDDF+LLTIIGRGAFGEVRLC+EKKSGNIYAMKKLKKSEML RGQ
Sbjct: 74  RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLMRGQ 133

Query: 150 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVAR 209
           VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD+MTLLMRE+TLTE VAR
Sbjct: 134 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMREDTLTENVAR 193

Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269
           FYIAQSVLAIESIHKHNYIHRDIKPDNLLLD+NGHMKLSDFGLCKPLDCT LS I EN+ 
Sbjct: 194 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCTTLSVIPENKT 253

Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
           +DD+N NE MD+DG  P++     W+SP EQLQHWQ+NRRKLA+STVGTPDYIAPEVLLK
Sbjct: 254 IDDKNSNEPMDIDGGIPDADNKSNWRSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 313

Query: 330 KGYGMECDWLA 340
           KGYGMECDW +
Sbjct: 314 KGYGMECDWWS 324

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359476253|ref|XP_002280119.2| PREDICTED: serine/threonine-protein kinase CBK1 [Vitis vinifera]

 Score =  560 bits (1442), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 267/315 (84%), Positives = 294/315 (93%)

Query: 26  EEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINIL 85
           EE  +GSSLTME+VAAAKQFIE+HY+ QMK IQERK+RR VLER+LASSDVP+EEQIN++
Sbjct: 7   EEEVLGSSLTMEKVAAAKQFIENHYRTQMKTIQERKERRWVLERRLASSDVPKEEQINLI 66

Query: 86  KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
           KDLERKETE+MRLKRHKI VDDF+LLTIIGRGAFGEVRLC+EKKS NIYAMKKLKKSEML
Sbjct: 67  KDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSENIYAMKKLKKSEML 126

Query: 146 SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTE 205
            RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD+MTLLMRE+TL+E
Sbjct: 127 IRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMREDTLSE 186

Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265
           +VA+FYIAQSVLAIESIHKHNYIHRDIKPDNLLLD+NGHMKLSDFGLCKPLDC  LSA+ 
Sbjct: 187 SVAKFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCRTLSALK 246

Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
           E+EV+DDEN  ESMD+DG FP++     WKSP EQLQHWQ+NRRKLA+STVGTPDYIAPE
Sbjct: 247 EDEVMDDENSRESMDIDGGFPDADNRSSWKSPREQLQHWQMNRRKLAFSTVGTPDYIAPE 306

Query: 326 VLLKKGYGMECDWLA 340
           VLLKKGYGMECDW +
Sbjct: 307 VLLKKGYGMECDWWS 321

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	358
TAIR|locus:2125894	519	AT4G33080 [Arabidopsis thalian	0.902	0.622	0.740	6.8e-127
TAIR|locus:2047590	527	AT2G19400 [Arabidopsis thalian	0.921	0.626	0.708	2.4e-122
TAIR|locus:2090925	568	AT3G23310 [Arabidopsis thalian	0.910	0.573	0.636	3e-108
TAIR|locus:2129650	551	AT4G14350 [Arabidopsis thalian	0.835	0.542	0.677	1.2e-106
TAIR|locus:2054784	569	AT2G20470 [Arabidopsis thalian	0.851	0.536	0.644	9.5e-105
TAIR|locus:2024167	569	AT1G03920 [Arabidopsis thalian	0.899	0.565	0.628	2.9e-103
TAIR|locus:2204574	562	AT1G30640 [Arabidopsis thalian	0.846	0.539	0.625	3.5e-98
TAIR|locus:2178208	516	AT5G09890 [Arabidopsis thalian	0.879	0.610	0.580	2.9e-96
CGD|CAL0006211	732	CBK1 [Candida albicans (taxid:	0.698	0.341	0.482	9.7e-74
UNIPROTKB|Q5AP53	732	CBK1 "Serine/threonine-protein	0.698	0.341	0.482	9.7e-74

TAIR|locus:2125894 AT4G33080 [Arabidopsis thaliana (taxid:3702)]

 Score = 1246 (443.7 bits), Expect = 6.8e-127, P = 6.8e-127
 Identities = 248/335 (74%), Positives = 277/335 (82%)

Query:     4 QNIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQR 63
             ++I+ EE G DE      EVL      GSSLTME+VAAAKQ+IE+HYKAQ K+IQERK+R
Sbjct:     2 EDIQEEENGTDE------EVL------GSSLTMEKVAAAKQYIENHYKAQNKNIQERKER 49

Query:    64 RSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVR 123
             R +LERKLASS VP+EEQIN++KDLERKETE+MRLKR+KISVDDF+LLTIIGRGAFGEVR
Sbjct:    50 RWILERKLASSGVPKEEQINMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVR 109

Query:   124 LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183
             LC+E+KSGNIYAMKKLKKSEM+ RGQVEHVRAERNLLAEV SH IVKLYYSFQD EYLYL
Sbjct:   110 LCRERKSGNIYAMKKLKKSEMVMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYL 169

Query:   184 IMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243
             IMEYLPGGD+             VARFYIAQSVLAIESIH++NYIHRDIKPDNLLLD++G
Sbjct:   170 IMEYLPGGDMMTLLMREDTLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDG 229

Query:   244 HMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQH 303
             HMKLSDFGLCKPLDC NL +I              MDVD  FP++   R W+SP EQLQH
Sbjct:   230 HMKLSDFGLCKPLDCRNLPSIQENRATDDETMSEPMDVDRCFPDTDNKRSWRSPQEQLQH 289

Query:   304 WQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
             WQ+NRRKLA+STVGTPDYIAPEVLLKKGYGMECDW
Sbjct:   290 WQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDW 324

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047590 AT2G19400 [Arabidopsis thaliana (taxid:3702)]

 Score = 1203 (428.5 bits), Expect = 2.4e-122, P = 2.4e-122
 Identities = 238/336 (70%), Positives = 272/336 (80%)

Query:     8 VEEQGDDEG--APMAGEV---LEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQ 62
             +E Q +DE   A +  EV    E+EG + +S T+E+VAAAK++IE+HY  +M+HIQ+RK+
Sbjct:     1 MENQEEDEVVLAKVTSEVEDNFEDEGLVSNS-TLEKVAAAKKYIENHYNRRMRHIQQRKE 59

Query:    63 RRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEV 122
             RR VLE+K+AS DV E+EQ+ +L+DL+RKETEY RL R+++ VDDFDLL+IIGRGAFGEV
Sbjct:    60 RRWVLEQKIASLDVSEKEQLELLEDLQRKETEYTRLMRNRLCVDDFDLLSIIGRGAFGEV 119

Query:   123 RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182
             RLC+EKK+GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS CIVKLYYSFQD EYLY
Sbjct:   120 RLCREKKTGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASDCIVKLYYSFQDPEYLY 179

Query:   183 LIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN 242
             LIMEYL GGDV             VARFYIAQSVLAIESIHKHNY+HRDIKPDNLLLD+ 
Sbjct:   180 LIMEYLSGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYVHRDIKPDNLLLDKY 239

Query:   243 GHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQ 302
             GHMKLSDFGLCKPLDC N+SA+             S+D D        GRRWKSPLEQLQ
Sbjct:   240 GHMKLSDFGLCKPLDCRNISAMNVNEPLNDENINESIDGDENCSIGRRGRRWKSPLEQLQ 299

Query:   303 HWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
             HWQINRRKLAYSTVGTPDYIAPEVLLKKGYG+ECDW
Sbjct:   300 HWQINRRKLAYSTVGTPDYIAPEVLLKKGYGVECDW 335

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2090925 AT3G23310 [Arabidopsis thaliana (taxid:3702)]

 Score = 1070 (381.7 bits), Expect = 3.0e-108, P = 3.0e-108
 Identities = 215/338 (63%), Positives = 260/338 (76%)

Query:     2 ENQNIKVEEQGD-DEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQER 60
             ++ N K   +G+  EG+  AG    EE    S++T ++ AAAKQ+IE+HYK Q++  Q+R
Sbjct:    18 KSSNKKETSRGNVKEGSKTAGG---EEAV--SNVTKQKAAAAKQYIENHYKKQVQSQQQR 72

Query:    61 KQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFG 120
             K+RR +LE KLA+++V EEEQ N+LKDLE+KETEYMR +RHK+  DDF+ LT+IG+GAFG
Sbjct:    73 KERRDMLENKLAAAEVSEEEQKNLLKDLEKKETEYMRRQRHKMGTDDFEPLTMIGKGAFG 132

Query:   121 EVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180
             EVR+C+EK +GN+YAMKKLKKSEML RGQVEHV+AERNLLAEV S+CIVKLY SFQD EY
Sbjct:   133 EVRICREKTTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDEEY 192

Query:   181 LYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 240
             LYLIMEYLPGGD+              ARFY+ ++VLAIESIHKHNYIHRDIKPDNLLLD
Sbjct:   193 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD 252

Query:   241 QNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQ 300
             ++GHMKLSDFGLCKPLDC   S +             ++  DGR P +   RR +S +EQ
Sbjct:   253 RSGHMKLSDFGLCKPLDC---SILQEKDFVVAHNLSGALQSDGR-PVAP--RRTRSQMEQ 306

Query:   301 LQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
             LQ+WQ NRR LAYSTVGTPDYIAPEVLLKKGYGMECDW
Sbjct:   307 LQNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 344

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2129650 AT4G14350 [Arabidopsis thaliana (taxid:3702)]

 Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
 Identities = 208/307 (67%), Positives = 244/307 (79%)

Query:    32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
             S++T E+ AAAK +IE+HYK QM+ +QERK+RR +LE+KLA+++V EEEQ N+LKDLE K
Sbjct:    43 SNITKEKAAAAKLYIENHYKMQMQSLQERKERRKMLEKKLAAAEVSEEEQNNLLKDLEMK 102

Query:    92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
             ETEYMR +RHK+  DDF+ LT+IG+GAFGEVR+C+EK +GN+YAMKKLKKSEML RGQVE
Sbjct:   103 ETEYMRRQRHKMGADDFEPLTMIGKGAFGEVRICREKGTGNVYAMKKLKKSEMLRRGQVE 162

Query:   152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY 211
             HV+AERNLLAEV S+CIVKLY SFQD EYLYLIMEYLPGGD+              ARFY
Sbjct:   163 HVKAERNLLAEVDSNCIVKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 222

Query:   212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXX 271
             I ++VLAIESIHKHNYIHRDIKPDNLLLD++GHMKLSDFGLCKPLDC+NL          
Sbjct:   223 IGETVLAIESIHKHNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCSNLQE---KDFTV 279

Query:   272 XXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
                   ++  DGR P +   RR +   EQL +WQ NRR LAYSTVGTPDYIAPEVLLKKG
Sbjct:   280 ARNVSGALQSDGR-PVAT--RRTQQ--EQLLNWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334

Query:   332 YGMECDW 338
             YGMECDW
Sbjct:   335 YGMECDW 341

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2054784 AT2G20470 [Arabidopsis thaliana (taxid:3702)]

 Score = 1037 (370.1 bits), Expect = 9.5e-105, P = 9.5e-105
 Identities = 203/315 (64%), Positives = 245/315 (77%)

Query:    24 LEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQIN 83
             +E + E  S+ T ++VAAAKQ+IE+HYK QMK +QERK+RRS+LE+KLA +DV EE+Q N
Sbjct:    40 VETDEEAVSNTTKQKVAAAKQYIENHYKEQMKILQERKERRSMLEQKLADADVSEEDQNN 99

Query:    84 ILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE 143
             +LK LE+KETEYMRL+RHK+ V DFDLLT+IG+GAFGEVR+C+EK +G +YAMKKLKK+E
Sbjct:   100 LLKFLEKKETEYMRLQRHKLGVADFDLLTMIGKGAFGEVRVCREKTTGQVYAMKKLKKAE 159

Query:   144 MLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXX 203
             ML RGQVEHVRAERNLLAEV S+ IVKLY SFQD ++LYL+MEYLPGGD+          
Sbjct:   160 MLRRGQVEHVRAERNLLAEVDSNYIVKLYCSFQDDDHLYLVMEYLPGGDMMTLLMRKDTL 219

Query:   204 XXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
                 A+FY+A++VLAIESIH+HNYIHRDIKPDNLLLD+ GH++LSDFGLCKPLDC   SA
Sbjct:   220 TEEEAKFYVAETVLAIESIHRHNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDC---SA 276

Query:   264 IXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA 323
             I               +     P+       ++  EQL+HWQ NRR LAYSTVGTPDYIA
Sbjct:   277 IGENDFSNNSNGSTEQEAGSTAPK-------RTQQEQLEHWQRNRRTLAYSTVGTPDYIA 329

Query:   324 PEVLLKKGYGMECDW 338
             PEVLLKKGYGMECDW
Sbjct:   330 PEVLLKKGYGMECDW 344

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009827 "plant-type cell wall modification" evidence=RCA

TAIR|locus:2024167 AT1G03920 [Arabidopsis thaliana (taxid:3702)]

 Score = 1023 (365.2 bits), Expect = 2.9e-103, P = 2.9e-103
 Identities = 208/331 (62%), Positives = 246/331 (74%)

Query:     8 VEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVL 67
             V + G+D         L  +GE  S+ T ++VAAAKQ+IE+HYK QMK++ ERK+RR+ L
Sbjct:    37 VPDGGNDTETATKLPPLGGDGEALSNSTKQKVAAAKQYIENHYKEQMKNLNERKERRTTL 96

Query:    68 ERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE 127
             E+KLA +DV EE+Q N++K LE+KETEYMRL+RHK+  DDF+LLT+IG+GAFGEVR+ +E
Sbjct:    97 EKKLADADVCEEDQTNLMKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVVRE 156

Query:   128 KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187
               +G+++AMKKLKKSEML RGQVEHVRAERNLLAEV S+CIVKLY SFQD EYLYLIMEY
Sbjct:   157 INTGHVFAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDNEYLYLIMEY 216

Query:   188 LPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247
             LPGGD+              A+FYIA+SVLAIESIH  NYIHRDIKPDNLLLD+ GH++L
Sbjct:   217 LPGGDMMTLLMRKDTLSEDEAKFYIAESVLAIESIHNRNYIHRDIKPDNLLLDRYGHLRL 276

Query:   248 SDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQIN 307
             SDFGLCKPLDC   S I                  G   ES      +S  EQL+HWQ N
Sbjct:   277 SDFGLCKPLDC---SVIDGEDFTVGNAGS------GGGSESVSTTPKRSQQEQLEHWQKN 327

Query:   308 RRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
             RR LAYSTVGTPDYIAPEVLLKKGYGMECDW
Sbjct:   328 RRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)]

 Score = 975 (348.3 bits), Expect = 3.5e-98, P = 3.5e-98
 Identities = 192/307 (62%), Positives = 233/307 (75%)

Query:    32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
             S+ T ++VAAAKQ+IE+HYK Q K +QERK+RRS+LE+ LA +DV  E++++ILK+ E+K
Sbjct:    44 SNATKQKVAAAKQYIENHYKIQKKSLQERKERRSILEQNLADADVTVEDKMDILKNFEKK 103

Query:    92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
             E EYMRL+R K+ VDDF+LL+IIGRGAFGEVR+C+EK +G++YAMKKLKKSEML RGQVE
Sbjct:   104 EMEYMRLQRQKMGVDDFELLSIIGRGAFGEVRICKEKSTGSVYAMKKLKKSEMLRRGQVE 163

Query:   152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY 211
             HV+AERN+LAEV S  IVKL YSFQD E+LYLIMEYLPGGD+               RFY
Sbjct:   164 HVKAERNVLAEVDSPFIVKLCYSFQDDEHLYLIMEYLPGGDMMTLLMRKDTLREDETRFY 223

Query:   212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXX 271
             +AQ++LAIESIHKHNY+HRDIKPDNLL+ +NGH+KLSDFGL K L+  N           
Sbjct:   224 VAQTILAIESIHKHNYVHRDIKPDNLLITRNGHIKLSDFGLSKSLESKNFPDFKAELVDR 283

Query:   272 XXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
                     D   + P +   RR +   EQL HWQ NRR LA+STVGTPDYIAPEVLLKKG
Sbjct:   284 STKPAAEHDRLSKPPSAP--RRTQQ--EQLLHWQQNRRTLAFSTVGTPDYIAPEVLLKKG 339

Query:   332 YGMECDW 338
             YGMECDW
Sbjct:   340 YGMECDW 346

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

TAIR|locus:2178208 AT5G09890 [Arabidopsis thaliana (taxid:3702)]

 Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
 Identities = 187/322 (58%), Positives = 236/322 (73%)

Query:    18 PMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVP 77
             P  G   E +  + S +T ++ AAAKQFIE+HYK  ++ + ER +RR   +RK+  + +P
Sbjct:    12 PGRGFETETDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHERMERRREFQRKVQEAQLP 71

Query:    78 EEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK 137
              EEQ  ++++L R+ETEYMRL+R KI +DDF+LLT+IG+GAFGEVRLC+ + +  +YAMK
Sbjct:    72 VEEQDEMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLCRLRSTSEVYAMK 131

Query:   138 KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXX 197
             KLKK+EMLSRGQVEHVR+ERNLLAEV S  IVKL+YSFQD+E LYLIMEYLPGGD+    
Sbjct:   132 KLKKTEMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIMEYLPGGDIMTLL 191

Query:   198 XXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
                      VARFYIA+S+LAI SIH+HNY+HRDIKPDNL+LD++GH+KLSDFGLCKPLD
Sbjct:   192 MREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKSGHLKLSDFGLCKPLD 251

Query:   258 CTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRR-WKSPLEQLQHWQINRRKLAYSTV 316
                 S +             S D + +  +S   +  W+ P EQL  W+ NRR LAYSTV
Sbjct:   252 DKYSSLLLEDDEML------SQDSENQSGKSDADKAPWQMPKEQLLQWKRNRRALAYSTV 305

Query:   317 GTPDYIAPEVLLKKGYGMECDW 338
             GT DY+APEVLLKKGYGMECDW
Sbjct:   306 GTLDYMAPEVLLKKGYGMECDW 327

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

CGD|CAL0006211 CBK1 [Candida albicans (taxid:5476)]

 Score = 607 (218.7 bits), Expect = 9.7e-74, Sum P(2) = 9.7e-74
 Identities = 122/253 (48%), Positives = 172/253 (67%)

Query:     3 NQNIKVEEQGDD-EGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERK 61
             NQ++  E    D  G+       E +  + S  T ++ A+ K  +E++Y + + H  ER 
Sbjct:   227 NQSVSTEAANSDMTGSNTKYVYFERKPNLLSKTTQDKAASIKLTLENYYTSSVSHAIERN 286

Query:    62 QRRSVLERKLASSDV--PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAF 119
             QRR  LE K+A+ D+   EE +   L++L +KE++++RLKR K++++DF  + +IG+GAF
Sbjct:   287 QRRLELENKIANEDIGSSEERKNRQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKGAF 346

Query:   120 GEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179
             GEVRL Q+K +G IYAMK L KSEM ++ Q+ HV+AER++LA   S  IV LYYSFQD++
Sbjct:   347 GEVRLVQKKDTGKIYAMKTLLKSEMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQDSQ 406

Query:   180 YLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 239
             YLYLIME+LPGGD+             + RFYIA+ VLAIE+IHK  +IHRDIKPDN+L+
Sbjct:   407 YLYLIMEFLPGGDLMTMLIRWEVFTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNILI 466

Query:   240 DQNGHMKLSDFGL 252
             D  GH+KLSDFGL
Sbjct:   467 DNRGHVKLSDFGL 479

GO:0031505 "fungal-type cell wall organization" evidence=IMP

GO:0006357 "regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IGI;ISS

GO:0005935 "cellular bud neck" evidence=IDA

GO:0005938 "cell cortex" evidence=IDA

GO:0001411 "hyphal tip" evidence=IDA

GO:0030428 "cell septum" evidence=IDA

GO:0036178 "filamentous growth of a population of unicellular organisms in response to neutral pH" evidence=IMP

GO:1900442 "positive regulation of filamentous growth of a population of unicellular organisms in response to neutral pH" evidence=IMP

GO:0036168 "filamentous growth of a population of unicellular organisms in response to heat" evidence=IMP

GO:1900433 "positive regulation of filamentous growth of a population of unicellular organisms in response to heat" evidence=IMP

GO:0000902 "cell morphogenesis" evidence=IMP

GO:0031579 "membrane raft organization" evidence=IMP

GO:0000920 "cytokinetic cell separation" evidence=IMP

GO:0007163 "establishment or maintenance of cell polarity" evidence=IMP

GO:0030447 "filamentous growth" evidence=IMP

GO:0071216 "cellular response to biotic stimulus" evidence=IMP

GO:0036244 "cellular response to neutral pH" evidence=IMP

GO:0034605 "cellular response to heat" evidence=IMP

GO:0035690 "cellular response to drug" evidence=IMP

GO:0005634 "nucleus" evidence=IEA

GO:0005934 "cellular bud tip" evidence=IEA

GO:0043332 "mating projection tip" evidence=IEA

GO:0051285 "cell cortex of cell tip" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0000131 "incipient cellular bud site" evidence=IEA

GO:0007346 "regulation of mitotic cell cycle" evidence=IEA

GO:0010590 "regulation of cytokinetic cell separation" evidence=IEA

GO:2000695 "cytokinetic cell separation involved in cell cycle cytokinesis" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0030950 "establishment or maintenance of actin cytoskeleton polarity" evidence=IEA

GO:0007118 "budding cell apical bud growth" evidence=IEA

GO:2000100 "regulation of establishment or maintenance of bipolar cell polarity regulating cell shape" evidence=IEA

GO:0060237 "regulation of fungal-type cell wall organization" evidence=IEA

GO:0071470 "cellular response to osmotic stress" evidence=IEA

GO:0009267 "cellular response to starvation" evidence=IMP

GO:0044011 "single-species biofilm formation on inanimate substrate" evidence=IMP

GO:1900233 "positive regulation of single-species biofilm formation on inanimate substrate" evidence=IMP

GO:0036180 "filamentous growth of a population of unicellular organisms in response to biotic stimulus" evidence=IMP

GO:0036170 "filamentous growth of a population of unicellular organisms in response to starvation" evidence=IMP

UNIPROTKB|Q5AP53 CBK1 "Serine/threonine-protein kinase CBK1" [Candida albicans SC5314 (taxid:237561)]

 Score = 607 (218.7 bits), Expect = 9.7e-74, Sum P(2) = 9.7e-74
 Identities = 122/253 (48%), Positives = 172/253 (67%)

Query:     3 NQNIKVEEQGDD-EGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERK 61
             NQ++  E    D  G+       E +  + S  T ++ A+ K  +E++Y + + H  ER 
Sbjct:   227 NQSVSTEAANSDMTGSNTKYVYFERKPNLLSKTTQDKAASIKLTLENYYTSSVSHAIERN 286

Query:    62 QRRSVLERKLASSDV--PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAF 119
             QRR  LE K+A+ D+   EE +   L++L +KE++++RLKR K++++DF  + +IG+GAF
Sbjct:   287 QRRLELENKIANEDIGSSEERKNRQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKGAF 346

Query:   120 GEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179
             GEVRL Q+K +G IYAMK L KSEM ++ Q+ HV+AER++LA   S  IV LYYSFQD++
Sbjct:   347 GEVRLVQKKDTGKIYAMKTLLKSEMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQDSQ 406

Query:   180 YLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 239
             YLYLIME+LPGGD+             + RFYIA+ VLAIE+IHK  +IHRDIKPDN+L+
Sbjct:   407 YLYLIMEFLPGGDLMTMLIRWEVFTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNILI 466

Query:   240 DQNGHMKLSDFGL 252
             D  GH+KLSDFGL
Sbjct:   467 DNRGHVKLSDFGL 479

GO:0000902 "cell morphogenesis" evidence=IMP

GO:0000920 "cytokinetic cell separation" evidence=IMP

GO:0001411 "hyphal tip" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IGI;ISS

GO:0005935 "cellular bud neck" evidence=IDA

GO:0005938 "cell cortex" evidence=IDA

GO:0006357 "regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0007163 "establishment or maintenance of cell polarity" evidence=IMP

GO:0009267 "cellular response to starvation" evidence=IMP

GO:0030428 "cell septum" evidence=IDA

GO:0030447 "filamentous growth" evidence=IMP

GO:0031505 "fungal-type cell wall organization" evidence=IMP

GO:0031579 "membrane raft organization" evidence=IMP

GO:0034605 "cellular response to heat" evidence=IMP

GO:0035690 "cellular response to drug" evidence=IMP

GO:0036168 "filamentous growth of a population of unicellular organisms in response to heat" evidence=IMP

GO:0036170 "filamentous growth of a population of unicellular organisms in response to starvation" evidence=IMP

GO:0036178 "filamentous growth of a population of unicellular organisms in response to neutral pH" evidence=IMP

GO:0036180 "filamentous growth of a population of unicellular organisms in response to biotic stimulus" evidence=IMP

GO:0036244 "cellular response to neutral pH" evidence=IMP

GO:0044011 "single-species biofilm formation on inanimate substrate" evidence=IMP

GO:0071216 "cellular response to biotic stimulus" evidence=IMP

GO:1900233 "positive regulation of single-species biofilm formation on inanimate substrate" evidence=IMP

GO:1900433 "positive regulation of filamentous growth of a population of unicellular organisms in response to heat" evidence=IMP

GO:1900442 "positive regulation of filamentous growth of a population of unicellular organisms in response to neutral pH" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
A2VDV2	STK38_BOVIN	2, ., 7, ., 1, 1, ., 1	0.5016	0.8240	0.6344	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	358
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-130
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-102
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-96
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-86
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-85
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-82
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-78
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-74
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-73
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-71
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-69
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-69
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-67
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-64
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-62
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-58
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-56
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-56
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-56
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-54
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-53
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-53
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-52
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-51
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-51
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-51
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-50
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-50
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-49
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-46
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-46
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-45
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-44
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-44
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-43
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-43
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-43
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-41
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-41
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-41
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-41
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-39
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-39
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-39
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-37
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-37
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-37
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-37
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-36
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-36
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-35
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-35
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-34
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-33
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-33
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-33
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-33
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-32
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-32
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-31
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-31
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-30
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-29
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-28
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-28
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-27
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-26
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-26
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-26
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-24
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-24
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-24
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-23
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-22
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-22
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-22
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-21
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-20
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-20
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-19
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-18
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-17
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-17
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-13
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-11
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-11
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-08
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-05
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-05
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-05
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-04
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	6e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-04
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-04
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	0.001
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	0.002
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.002
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	0.002
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.002
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.003
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	0.003
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.003

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  377 bits (970), Expect = e-130
 Identities = 137/233 (58%), Positives = 170/233 (72%), Gaps = 11/233 (4%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ + +IGRGAFGEVRL Q+K +G+IYAMKKL+KSEML + QV HVRAER++LAE  +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             +VKLYYSFQD  YLYLIMEYLPGGD+MTLLM+++T TE   RFYIA+++LAI+SIHK 
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
            YIHRDIKPDNLLLD  GH+KLSDFGLC  L  ++ +            L+ ++  +   
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE-------FYRILSHALPSNFLD 173

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
             S    +  S   + + W+ NRR LAYSTVGTPDYIAPEV L+ GY  ECDW
Sbjct: 174 FIS----KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  304 bits (780), Expect = e-102
 Identities = 121/233 (51%), Positives = 160/233 (68%), Gaps = 20/233 (8%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+++ +IGRGAFGEV L ++K +G +YAMK L+KS+M+ R Q+ HVRAER++LA+  S
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IVKLYYSFQD E+LYL+MEY+PGGD+M LL+R++   E  ARFYIA+ VLA++S+HK 
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
            +IHRDIKPDN+L+D +GH+KL+DFGLCK         +N+     D     +   +  F
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK--------KMNKA---KDREYYLNDSHNLLF 169

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
            ++   RR              RR  A STVGTPDYIAPEVL    YG+ECDW
Sbjct: 170 RDNVLVRRR---------DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW 213

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  291 bits (747), Expect = 1e-96
 Identities = 126/238 (52%), Positives = 167/238 (70%), Gaps = 12/238 (5%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF  + +IG+GAFGEVRL Q+K +G IYAMK L KSEM  + Q+ HV+AER++LAE  S
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             +V LYYSFQDA+YLYLIME+LPGGD+MT+L++ +T +E V RFY+A+ VLAIE++HK 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA-----INENEVLDDENLNESMD 280
            +IHRDIKPDN+L+D+ GH+KLSDFGL       + SA     +      +  +   S+ 
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
           VD             S  +Q+  W+ NRR +AYSTVGTPDYIAPE+ L++GYG ECDW
Sbjct: 181 VDSINLTM-------SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  263 bits (673), Expect = 8e-86
 Identities = 128/233 (54%), Positives = 166/233 (71%), Gaps = 14/233 (6%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ L +IGRGAFGEVRL Q+K +G+IYAMK L+K++ML + QV H+RAER++L E   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             +VK++YSFQD   LYLIME+LPGGD+MTLLM+++TL+E   +FYIA++VLAI++IH+ 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
            +IHRDIKPDNLLLD  GH+KLSDFGL     CT L   +  E     NL  +   D  F
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGL-----CTGLKKAHRTEFY--RNLTHNPPSDFSF 173

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                 R+ ++       W+ NRR+LAYSTVGTPDYIAPEV ++ GY   CDW
Sbjct: 174 QNMNSKRKAET-------WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDW 219

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  262 bits (671), Expect = 2e-85
 Identities = 130/233 (55%), Positives = 169/233 (72%), Gaps = 14/233 (6%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV H+RAER++L E  S
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             +VK++YSFQD   LYLIME+LPGGD+MTLLM+++TLTE   +FYIA++VLAI+SIH+ 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
            +IHRDIKPDNLLLD  GH+KLSDFGL     CT L   +  E     NLN S+  D  F
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGL-----CTGLKKAHRTEFY--RNLNHSLPSDFTF 173

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                 R+ ++       W+ NRR+LA+STVGTPDYIAPEV ++ GY   CDW
Sbjct: 174 QNMNSKRKAET-------WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDW 219

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  253 bits (648), Expect = 8e-82
 Identities = 113/231 (48%), Positives = 157/231 (67%), Gaps = 6/231 (2%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  +  IG GAFGEV L ++  +  +YAMK L+K+++L R Q  HV+AER++LAE  +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           +VKLYYSFQD + LY +M+Y+PGGD+M+LL+R     E +ARFYIA+   AIES+HK  +
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           IHRDIKPDN+L+D++GH+KL+DFGLC     T+ S   +     D +  +SM+    + E
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK---GDHHRQDSMEPSEEWSE 179

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
               R    PLE+ +  Q ++R LA+S VGTP+YIAPEVLL+ GY   CDW
Sbjct: 180 I--DRCRLKPLERRRKRQ-HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  240 bits (616), Expect = 2e-78
 Identities = 87/225 (38%), Positives = 125/225 (55%), Gaps = 49/225 (21%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G+G+FG+V L ++K +G +YAMK LKK +++ R +VEH   ERN+L+ +    IVKL+Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
           +FQ  E LYL++EY PGG++ + L +E   +E  ARFY A+ VLA+E +H    I+RD+K
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
           P+N+LLD +GH+KL+DFGL K L                                     
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL------------------------------------- 143

Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                        +      +  GTP+Y+APEVLL KGYG   DW
Sbjct: 144 ------------SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  235 bits (601), Expect = 1e-74
 Identities = 117/231 (50%), Positives = 158/231 (68%), Gaps = 2/231 (0%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  +  +G GAFGEV L  +  +  +YAMK L+K ++L+R QV HV+AER++LAE  +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           +VKLYYSFQD + LY +M+Y+PGGD+M+LL+R E   E +ARFYIA+  LAIES+HK  +
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           IHRDIKPDN+L+D +GH+KL+DFGLC     T+ S   +      ++  E  D+      
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
             CG R K+ LEQ    Q ++R LA+S VGTP+YIAPEVLL+KGY   CDW
Sbjct: 183 CRCGDRLKT-LEQRATKQ-HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  230 bits (588), Expect = 8e-73
 Identities = 114/234 (48%), Positives = 159/234 (67%), Gaps = 8/234 (3%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  +  +G GAFGEV L ++  +  +YAMK L+K ++L R QV HV+AER++LAE  +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           +V+LYYSFQD + LY +M+Y+PGGD+M+LL+R     E +ARFYIA+   A+ES+HK  +
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           IHRDIKPDN+L+D++GH+KL+DFGLC     T+ S   ++    D    +SMD    + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS---GDHVRQDSMDFSNEWGD 179

Query: 288 SG---CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                CG R K PLE+    Q ++R LA+S VGTP+YIAPEVLL+ GY   CDW
Sbjct: 180 PANCRCGDRLK-PLERRAARQ-HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  222 bits (567), Expect = 5e-71
 Identities = 96/227 (42%), Positives = 133/227 (58%), Gaps = 41/227 (18%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           I +GA+G V L ++K +G+IYA+K +KK++M+ + QV+ V  ER++L++  S  +VKLYY
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
           SFQ  + LYL+MEYLPGGD+ +LL    +L E VAR YIA+ VLA+E +H +  IHRD+K
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
           PDN+L+D NGH+KL+DFGL K                                  G  RR
Sbjct: 121 PDNILIDSNGHLKLTDFGLSK---------------------------------VGLVRR 147

Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                   Q    +  K     VGTPDYIAPEV+L +G+    DW +
Sbjct: 148 --------QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS 186

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  217 bits (556), Expect = 2e-69
 Identities = 78/231 (33%), Positives = 123/231 (53%), Gaps = 52/231 (22%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           +++L  +G G+FG+V L ++KK+G + A+K +KK ++  +   E +  E  +L ++    
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           IV+LY  F+D + LYL+MEY  GGD+  LL +   L+E  ARFY+ Q + A+E +H    
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           +HRD+KP+N+LLD++GH+KL+DFGL +                                 
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR--------------------------------- 145

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                            Q++  +   + VGTP+Y+APEVLL KGYG   D 
Sbjct: 146 -----------------QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  218 bits (559), Expect = 2e-69
 Identities = 88/235 (37%), Positives = 125/235 (53%), Gaps = 52/235 (22%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ +  +G G+FG V L + K SG  YA+K L K++++   QVEHV  E+ +L  +  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             +V LY SFQD   LYL+MEY+PGG++ + L +     E VARFY AQ VLA+E +H  
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
           + ++RD+KP+NLLLD +G++K++DFG  K                          V GR 
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAK-------------------------RVKGR- 154

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                      Y+  GTP+Y+APE++L KGYG   DW A
Sbjct: 155 --------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWA 183

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  216 bits (553), Expect = 1e-67
 Identities = 103/260 (39%), Positives = 144/260 (55%), Gaps = 53/260 (20%)

Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           NI   L R E    ++ + ++  +DFD++ +IGRGAFGEV+L + K S  +YAMK L K 
Sbjct: 20  NIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF 79

Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET 202
           EM+ R        ER+++A   S  IV+L+Y+FQD +YLY++MEY+PGGD++  LM    
Sbjct: 80  EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYD 138

Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
           + E  ARFY A+ VLA+++IH   +IHRD+KPDN+LLD++GH+KL+DFG C         
Sbjct: 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-------- 190

Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
                           MD +G                              + VGTPDYI
Sbjct: 191 ---------------KMDANGMVRCD-------------------------TAVGTPDYI 210

Query: 323 APEVLLKKG----YGMECDW 338
           +PEVL  +G    YG ECDW
Sbjct: 211 SPEVLKSQGGDGYYGRECDW 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  205 bits (524), Expect = 9e-64
 Identities = 99/239 (41%), Positives = 133/239 (55%), Gaps = 54/239 (22%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF++L +IGRGAFGEV + + K +G +YAMK L K EML R +    R ER++L     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
             I  L+Y+FQD   LYL+M+Y  GGD++TLL + E+ L E +ARFY+A+ VLAI+S+H+
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
             Y+HRDIKPDN+LLD+NGH++L+DFG C                         +  DG 
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCL-----------------------RLLADGT 157

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 338
              +                           VGTPDYI+PE+L      K  YG ECDW
Sbjct: 158 VQSN-------------------------VAVGTPDYISPEILQAMEDGKGRYGPECDW 191

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  202 bits (516), Expect = 1e-62
 Identities = 96/240 (40%), Positives = 136/240 (56%), Gaps = 55/240 (22%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
            DFD+ +++GRG FGEV++ +EK +G+IYAMK +KKS +L++  V     ER++L+   S
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
             I +L Y+FQD + LYL+MEY PGGD+++LL R E+   E +A+FY+A+ VLAI S+H+
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
             Y+HRDIKP+N+L+D+ GH+KL+DFG    L                            
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--------------------------- 153

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------KKGYGMECDW 338
                                 N+   +   VGTPDYIAPEVL       K  YG+ECDW
Sbjct: 154 ---------------------ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  188 bits (480), Expect = 9e-58
 Identities = 86/237 (36%), Positives = 132/237 (55%), Gaps = 30/237 (12%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF    IIG G+F  V L +EK++   YA+K L K +++   +V++V+ E+ +L  +  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
           H  I+KLYY+FQD E LY ++EY P G+++  + +  +L E   RFY A+ +LA+E +H 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
              IHRD+KP+N+LLD++ H+K++DFG  K              VLD  +  ES   D  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAK--------------VLDPNSSPESNKGDAT 166

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
             +S                + NRR+ A S VGT +Y++PE+L +K  G   D  A 
Sbjct: 167 NIDS--------------QIEKNRRRFA-SFVGTAEYVSPELLNEKPAGKSSDLWAL 208

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  184 bits (469), Expect = 2e-56
 Identities = 78/227 (34%), Positives = 114/227 (50%), Gaps = 50/227 (22%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G FG V L + K     +A+K +KK  ++  GQ EH+ +E+ +L E     IVKLY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
           +F+D +Y+Y++MEY  GG++ T+L       E  ARFYIA  VLA E +H    I+RD+K
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
           P+NLLLD NG++KL DFG  K L                                  G++
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKL--------------------------------KSGQK 148

Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                              ++  GTP+Y+APE++L KGY    D+ +
Sbjct: 149 ------------------TWTFCGTPEYVAPEIILNKGYDFSVDYWS 177

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  186 bits (473), Expect = 3e-56
 Identities = 74/148 (50%), Positives = 106/148 (71%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           DF +LT +G+G +G+V L ++K +G I A+K++KKS +    +V HV  ER++L    S 
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN 226
            +VKL Y+FQD EYLYL MEY+PGGD  TLL     L+E  ARFY+A+   A++++H+  
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           YIHRD+KP+N L+D +GH+KL+DFGL K
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  185 bits (470), Expect = 7e-56
 Identities = 104/239 (43%), Positives = 135/239 (56%), Gaps = 54/239 (22%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+++ +IGRGAFGEV + + K +  IYAMK L K EML R +    R ERN+L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
             I  L+Y+FQD  YLYL+M+Y  GGD++TLL + E+ L E +ARFYIA+ VLAI SIH+
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
            +Y+HRDIKPDN+LLD NGH++L+DFG C                         M+ DG 
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCL-----------------------KMNQDGT 157

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL--LKKG---YGMECDW 338
              S                           VGTPDYI+PE+L  ++ G   YG ECDW
Sbjct: 158 VQSS-------------------------VAVGTPDYISPEILQAMEDGMGKYGPECDW 191

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  180 bits (459), Expect = 8e-54
 Identities = 98/260 (37%), Positives = 144/260 (55%), Gaps = 53/260 (20%)

Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           NI   L R E    ++++ ++  +D+D++ +IGRGAFGEV+L + K S  +YAMK L K 
Sbjct: 20  NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79

Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET 202
           EM+ R        ER+++A   S  +V+L+ +FQD +YLY++MEY+PGGD++  LM    
Sbjct: 80  EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYD 138

Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
           + E  A+FY A+ VLA+++IH    IHRD+KPDN+LLD++GH+KL+DFG C  +D T + 
Sbjct: 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198

Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
             +                                                + VGTPDYI
Sbjct: 199 RCD------------------------------------------------TAVGTPDYI 210

Query: 323 APEVLLKKG----YGMECDW 338
           +PEVL  +G    YG ECDW
Sbjct: 211 SPEVLKSQGGDGYYGRECDW 230

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  175 bits (446), Expect = 4e-53
 Identities = 85/228 (37%), Positives = 123/228 (53%), Gaps = 54/228 (23%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER-NLLAEVASHCIVKLY 172
           I +GAFG V L +++ +G+ +A+K LKKS+M+++ QV +V+AER  ++ +  S  + KLY
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
           YSFQ  +YLYL+MEYL GGD  +L+     L E  A+ YIA+ VL +E +H+   IHRDI
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123

Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
           KP+NLL+DQ GH+KL+DFG                       L+ +   + +F       
Sbjct: 124 KPENLLIDQTGHLKLTDFG-----------------------LSRNGLENKKF------- 153

Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                  VGTPDY+APE +L  G     DW +
Sbjct: 154 -----------------------VGTPDYLAPETILGVGDDKMSDWWS 178

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  174 bits (444), Expect = 8e-53
 Identities = 79/233 (33%), Positives = 123/233 (52%), Gaps = 50/233 (21%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F+LL +IG+GAFG+V + Q++ +  ++AMK + K + + +G V +V  ER +L E+    
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           +V L+YSFQD E +YL+++ L GGD+   L ++   +E   +F+I + VLA+E +H    
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           IHRDIKPDN+LLD+ GH+ ++DF         N++      V  D               
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDF---------NIATK----VTPDTLTT----------- 157

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                     ST GTP Y+APEVL ++GY +  DW +
Sbjct: 158 --------------------------STSGTPGYMAPEVLCRQGYSVAVDWWS 184

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  172 bits (439), Expect = 6e-52
 Identities = 75/232 (32%), Positives = 111/232 (47%), Gaps = 51/232 (21%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           ++LL  +G G+FG V   + K +G I A+K LKK    S+      R E  +L  ++   
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           IV+L  +F+D ++LYL+MEY  GGD+   L R   L+E  A+    Q +  +E +H +  
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           IHRD+KP+N+LLD+NG +K++DFGL K L  ++                           
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS--------------------------- 152

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW 338
                                     + VGTP Y+APEVLL   GYG + D 
Sbjct: 153 ----------------------SSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182

Length = 260

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  173 bits (441), Expect = 1e-51
 Identities = 80/243 (32%), Positives = 119/243 (48%), Gaps = 34/243 (13%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
             F  + ++G+G  G V L + K +G ++A+K L K EM+ R +V+ V  E+ +LA +  
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIH 223
             +  LY SFQ   YL L+M+Y PGG++  LL R+    L+E VARFY A+ +LA+E +H
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
               ++RD+KP+N+LL ++GH+ LSDF L K  D                          
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP--------------------- 159

Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYST------VGTPDYIAPEVLLKKGYGMECD 337
                  G R  S          +       +      VGT +YIAPEV+   G+G   D
Sbjct: 160 VSKALRKGSRRSSVNSIP-----SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVD 214

Query: 338 WLA 340
           W  
Sbjct: 215 WWT 217

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  172 bits (438), Expect = 4e-51
 Identities = 95/239 (39%), Positives = 136/239 (56%), Gaps = 54/239 (22%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF++L +IGRGAFGEV + + K +  ++AMK L K EML R +    R ER++L    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
             I  L+Y+FQD   LYL+M+Y  GGD++TLL + E+ L E +ARFY+A+ V+AI+S+H+
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
            +Y+HRDIKPDN+L+D NGH++L+DFG C  L             ++D  +  S+     
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-------------MEDGTVQSSV----- 162

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 338
                                          VGTPDYI+PE+L      K  YG ECDW
Sbjct: 163 ------------------------------AVGTPDYISPEILQAMEDGKGKYGPECDW 191

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  173 bits (439), Expect = 7e-51
 Identities = 97/260 (37%), Positives = 143/260 (55%), Gaps = 53/260 (20%)

Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           NI   L R +    +++  ++  +D++++ +IGRGAFGEV+L + K +  +YAMK L K 
Sbjct: 20  NIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 79

Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET 202
           EM+ R        ER+++A   S  +V+L+Y+FQD  YLY++MEY+PGGD++  LM    
Sbjct: 80  EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD 138

Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
           + E  ARFY A+ VLA+++IH   +IHRD+KPDN+LLD++GH+KL+DFG C         
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-------- 190

Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
                           M+ +G                      + R   A  T   PDYI
Sbjct: 191 ---------------KMNKEG----------------------MVRCDTAVGT---PDYI 210

Query: 323 APEVLLKKG----YGMECDW 338
           +PEVL  +G    YG ECDW
Sbjct: 211 SPEVLKSQGGDGYYGRECDW 230

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  169 bits (430), Expect = 3e-50
 Identities = 70/235 (29%), Positives = 118/235 (50%), Gaps = 52/235 (22%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DD + +  +G G FG V L +++ S + YA+K +   E++   Q +HV  E+ +L EV+ 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             I++L+++  D  +LY++MEY+PGG++ + L      + +   FY ++ V A+E +H  
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
             ++RD+KP+N+LLD+ GH+KL+DFG  K             ++ D              
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-------------KLRD-------------- 153

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 R W                   +  GTP+Y+APEV+  KG+    DW A
Sbjct: 154 ------RTW-------------------TLCGTPEYLAPEVIQSKGHNKAVDWWA 183

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  168 bits (428), Expect = 9e-50
 Identities = 84/236 (35%), Positives = 131/236 (55%), Gaps = 36/236 (15%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF+ + +I  GA+G V L + K++   +AMKK+ K  ++ R Q++ V  ER++L    +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             +V ++ SF+   +L ++MEY+ GGD  TLL     L   +AR Y A++VLA+E +H +
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE-SMDVDGR 284
             +HRD+KPDNLL+   GH+KL+DFGL K +   +L+           NL E  ++ D R
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSK-IGLMSLTT----------NLYEGHIEKDTR 169

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                          +    Q+          GTP+YIAPEV+L++GYG   DW A
Sbjct: 170 ---------------EFLDKQV---------CGTPEYIAPEVILRQGYGKPVDWWA 201

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  174 bits (442), Expect = 6e-49
 Identities = 71/151 (47%), Positives = 105/151 (69%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F ++  I RGAFG+V L ++K +  +YA+K +KK++M+++  V  V+AER+ LA  
Sbjct: 2   SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
            S  IV LYYS Q A  +YL+MEYL GGDV +LL       E +A  YI++  LA++ +H
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           +H  IHRD+KPDN+L+   GH+KL+DFGL K
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  159 bits (405), Expect = 4e-46
 Identities = 80/253 (31%), Positives = 125/253 (49%), Gaps = 59/253 (23%)

Query: 88  LERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
             + +T   +L        DF++   +G G+FG VR+ + K +G  YA+K LKK E+L  
Sbjct: 7   FTKPDTSSWKLS-------DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59

Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
            QV+HV  E+++L E++   IV +  SFQD   +Y ++E++ GG++ T L +       V
Sbjct: 60  KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119

Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
           A+FY A+ VLA E +H  + I+RD+KP+NLLLD  GH+K++DFG  K             
Sbjct: 120 AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------------- 166

Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
                           + P+                         ++  GTP+Y+APEV+
Sbjct: 167 ----------------KVPDR-----------------------TFTLCGTPEYLAPEVI 187

Query: 328 LKKGYGMECDWLA 340
             KG+G   DW  
Sbjct: 188 QSKGHGKAVDWWT 200

Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  158 bits (401), Expect = 9e-46
 Identities = 82/233 (35%), Positives = 120/233 (51%), Gaps = 55/233 (23%)

Query: 111 LTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVE--HVRAERNLLAEVAS 165
           L ++G+G +G+V   R      +G I+AMK LKK+  + R Q +  H +AERN+L  V  
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA-TIVRNQKDTAHTKAERNILEAVKH 59

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IV L Y+FQ    LYLI+EYL GG++   L RE    E  A FY+++  LA+E +H+ 
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
             I+RD+KP+N+LLD  GH+KL+DFGLCK        +I+E  V                
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTV---------------- 156

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                      ++  GT +Y+APE+L++ G+G   DW
Sbjct: 157 --------------------------THTFCGTIEYMAPEILMRSGHGKAVDW 183

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  157 bits (398), Expect = 3e-45
 Identities = 80/228 (35%), Positives = 117/228 (51%), Gaps = 50/228 (21%)

Query: 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVK 170
            +IG+G+FG+V L + K  G  YA+K L+K  +L + + +H+ AERN+L +   H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
           L+YSFQ A+ LY +++Y+ GG++   L RE +  E  ARFY A+   A+  +H  N I+R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
           D+KP+N+LLD  GH+ L+DFGLCK           E                        
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-----------EG----------------------- 146

Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                          I   K   +  GTP+Y+APEVL K+ Y    DW
Sbjct: 147 ---------------IEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  154 bits (392), Expect = 2e-44
 Identities = 84/234 (35%), Positives = 128/234 (54%), Gaps = 53/234 (22%)

Query: 111 LTIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           L ++G+G+FG+V L ++     +G +YAMK LKK+ +  R +V   + ER++LAEV    
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           IVKL+Y+FQ    LYLI+++L GGD+ T L +E   TE   +FY+A+  LA++ +H    
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           I+RD+KP+N+LLD+ GH+KL+DFGL K             E +D E              
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK-------------ESIDHE-------------- 152

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                 K AYS  GT +Y+APEV+ ++G+    DW ++
Sbjct: 153 ----------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 184

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  154 bits (391), Expect = 4e-44
 Identities = 78/238 (32%), Positives = 119/238 (50%), Gaps = 55/238 (23%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL--AEVAS 165
           F  L ++GRG FG+V L + KK+G +YA+K LKK ++++R +VE +  E+ +   A    
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
           H  +V L+  FQ  +++  +MEY  GGD+M + +  +  +E  A FY A  VL ++ +H+
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
           +  ++RD+K DNLLLD  G +K++DFGLCK                      E M     
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK----------------------EGM----- 152

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIAPEVLLKKGYGMECDWLAY 341
               G G R                    ST  GTP+++APEVL +  Y    DW   
Sbjct: 153 ----GFGDR-------------------TSTFCGTPEFLAPEVLTETSYTRAVDWWGL 187

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  153 bits (387), Expect = 1e-43
 Identities = 81/234 (34%), Positives = 119/234 (50%), Gaps = 56/234 (23%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVK 170
           IG+G FG+V   ++K +  IYAMK L K E++++ +V H   ERN+L       S  IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
           L +SFQ    LYL+ +Y+ GG++   L +E   +E  A+FYIA+ VLA+E +HK++ ++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
           D+KP+N+LLD  GH+ L DFGL K     NL+                            
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA----NLTD--------------------------- 149

Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWLAYWN 343
                              K   +  GT +Y+APEVLL +KGY    D   +W+
Sbjct: 150 ------------------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVD---FWS 182

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  152 bits (385), Expect = 2e-43
 Identities = 81/225 (36%), Positives = 121/225 (53%), Gaps = 49/225 (21%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG+G+FG+V   +++ +  IYA+K ++K+ ++SR +V H  AER +LA+V    IV L +
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
           SFQ  E LYL++ ++ GG++   L RE     + ARFY A+ + A+E++HK N I+RD+K
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
           P+N+LLD  GH+ L DFGLCK     N+         DD+  N                 
Sbjct: 121 PENILLDYQGHIALCDFGLCK----LNMK--------DDDKTN----------------- 151

Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                               +  GTP+Y+APE+LL  GY    DW
Sbjct: 152 --------------------TFCGTPEYLAPELLLGHGYTKAVDW 176

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  148 bits (375), Expect = 6e-43
 Identities = 75/227 (33%), Positives = 107/227 (47%), Gaps = 54/227 (23%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G FG V L ++KK+G   A+K +KK +  S   +E +  E  +L ++    IVKLY 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
            F+D  +LYL+MEY  GG +  LL   E  L+E      + Q +  +E +H +  IHRD+
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 233 KPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           KP+N+LLD  NG +KL+DFGL K L                                   
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLT---------------------------------- 144

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECD 337
                          + + L  + VGTP Y+APEVLL K  Y  + D
Sbjct: 145 ---------------SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  147 bits (373), Expect = 1e-41
 Identities = 76/226 (33%), Positives = 114/226 (50%), Gaps = 49/226 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G FG+V L +EK +G  YAMK LKK  ++++ +V H   E  +L       +  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
           YSFQ  + L  +MEY  GG++   L RE   +E  ARFY A+ V A+  +H  + ++RD+
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121

Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
           K +NL+LD++GH+K++DFGLCK                  E ++     DG   ++ C  
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK------------------EGIS-----DGATMKTFC-- 156

Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                   GTP+Y+APEVL    YG   DW
Sbjct: 157 ------------------------GTPEYLAPEVLEDNDYGRAVDW 178

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  147 bits (372), Expect = 2e-41
 Identities = 82/227 (36%), Positives = 117/227 (51%), Gaps = 50/227 (22%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           +IG+G+FG+V L + K  G+ YA+K L+K  +L + +  H+ AERN+L +   H  +V L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           +YSFQ AE LY +++Y+ GG++   L RE    E  ARFY A+   AI  +H  N I+RD
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +KP+N+LLD  GH+ L+DFGLCK                           +G  PE    
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK---------------------------EGVEPEETTS 154

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                 +  GTP+Y+APEVL K+ Y    DW
Sbjct: 155 ----------------------TFCGTPEYLAPEVLRKEPYDRTVDW 179

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  145 bits (368), Expect = 2e-41
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 51/229 (22%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++GRG+FG V L  +K +G + A+K ++ S      ++E +  E  +L+ +    IV+ Y
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYY 65

Query: 173 YSFQDAE--YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
            S +D E   L + +EY+ GG + +LL +   L E V R Y  Q +  +  +H +  +HR
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
           DIK  N+L+D +G +KL+DFG  K L                                  
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT------------------------- 160

Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                  S  GTP ++APEV+  + YG   D W
Sbjct: 161 ----------------------GSVRGTPYWMAPEVIRGEEYGRAADIW 187

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  147 bits (372), Expect = 2e-41
 Identities = 76/230 (33%), Positives = 114/230 (49%), Gaps = 50/230 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           ++G+G+FG+V L + K +  +YA+K LKK  +L    VE    E+ +LA    H  + +L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           +  FQ  + L+ +MEY+ GGD+M  + R     E  ARFY A+ VL ++ +H+   I+RD
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +K DN+LLD  GH+K++DFG+CK                  E +     + G    + CG
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCK------------------EGI-----LGGVTTSTFCG 158

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                     TPDYIAPE+L  + YG   DW A 
Sbjct: 159 --------------------------TPDYIAPEILSYQPYGPAVDWWAL 182

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  145 bits (368), Expect = 7e-41
 Identities = 75/229 (32%), Positives = 111/229 (48%), Gaps = 50/229 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           ++G+G+FG+V L + K +  +YA+K LKK  +L    V+    E+ +LA  A H  +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           +  FQ  + L+ +MEY+ GGD+M  + R     E  +RFY A+  LA+  +H+H  I+RD
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +K DN+LLD  GH KL+DFG+CK                  E +   +            
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCK------------------EGILNGV------------ 151

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                 +  GTPDYIAPE+L +  YG   DW A
Sbjct: 152 -------------------TTTTFCGTPDYIAPEILQELEYGPSVDWWA 181

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  140 bits (354), Expect = 4e-39
 Identities = 81/239 (33%), Positives = 123/239 (51%), Gaps = 55/239 (23%)

Query: 107 DFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQV-EHVRAERNLLAE 162
           +F+LL ++G GA+G+V L ++     +G +YAMK LKK+ ++ + +  EH R ER +L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 163 V-ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
           V     +V L+Y+FQ    L+LI++Y+ GG++ T L + E  TE+  R YIA+ VLA++ 
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +H+   I+RDIK +N+LLD  GH+ L+DFGL K                  E L E  + 
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK------------------EFLAEEEE- 161

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK--GYGMECDW 338
                                         AYS  GT +Y+APEV+     G+    DW
Sbjct: 162 -----------------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  140 bits (355), Expect = 5e-39
 Identities = 80/227 (35%), Positives = 120/227 (52%), Gaps = 50/227 (22%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           +IG+G+FG+V L + K  G  YA+K L+K  +L+R + +H+ AERN+L +   H  +V L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           +YSFQ  E LY +++++ GG++   L RE +  E  ARFY A+   A+  +H  N ++RD
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +KP+N+LLD  GH+ L+DFGLCK                  E + +S D    F    CG
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK------------------EGIAQS-DTTTTF----CG 158

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                     TP+Y+APEV+ K+ Y    DW
Sbjct: 159 --------------------------TPEYLAPEVIRKQPYDNTVDW 179

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  140 bits (355), Expect = 6e-39
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 50/236 (21%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA-EVAS 165
           DF+ L ++G+G+FG+V L + K +  +YA+K LKK  ++    VE    E+ +LA     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             + +L+  FQ  + LY +MEY+ GGD+M  + +     E  A FY A+  + +  +H  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
             I+RD+K DN++LD  GH+K++DFG+CK                  EN+       G+ 
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK------------------ENIF-----GGKT 157

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
             + C                          GTPDYIAPE++  + YG   DW A+
Sbjct: 158 TRTFC--------------------------GTPDYIAPEIIAYQPYGKSVDWWAF 187

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  139 bits (352), Expect = 1e-38
 Identities = 73/231 (31%), Positives = 113/231 (48%), Gaps = 52/231 (22%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVK 170
           ++G+G+FG+V L + K +   +A+K LKK  +L    VE    ER +LA +A     +  
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLA-LAWEHPFLTH 60

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
           L+ +FQ  E+L+ +MEYL GGD+M  +       E  ARFY A+ +  ++ +HK   I+R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
           D+K DN+LLD++GH+K++DFG+CK                                    
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKE----------------------------------- 145

Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                          +N    A +  GTPDYIAPE+L  + Y    DW ++
Sbjct: 146 --------------NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSF 182

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  134 bits (339), Expect = 3e-37
 Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 63/238 (26%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
            F++L  IG+G FGEV   + K++G   A+K +K      +   E +  E  +L +    
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLTET-VARFYIAQSVL-AIES 221
            IVK Y S+   + L+++ME+  GG   D++    +  TLTE+ +A  Y+ + +L  +E 
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIA--YVCKELLKGLEY 113

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +H +  IHRDIK  N+LL  +G +KL DFGL                             
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA--------------------------- 146

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                  Q++  K   + VGTP ++APEV+  K Y  + D W
Sbjct: 147 -----------------------QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIW 181

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  134 bits (339), Expect = 3e-37
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 54/231 (23%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
            ++++  IG+G+FG+V L + K  G +Y +K++  S M S  + E    E  +L ++   
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL----MREETLTETVARFYIAQSVLAIESI 222
            I+K Y SF++   L ++MEY  GGD+   +       +   E     +  Q  LA++ +
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
           H    +HRDIKP N+ L  NG +KL DFG+ K                    L+ ++D  
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISK-------------------VLSSTVD-- 158

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333
                                       LA + VGTP Y++PE+   K Y 
Sbjct: 159 ----------------------------LAKTVVGTPYYLSPELCQNKPYN 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  136 bits (343), Expect = 4e-37
 Identities = 79/242 (32%), Positives = 122/242 (50%), Gaps = 55/242 (22%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI--YAMKKLKKSEMLSRGQVEHVRAE 156
           +++K+  +DF+ +  +G G+FG V L    K+ +    A+K+ +KS+++ + QV+HV +E
Sbjct: 23  RKNKMKYEDFNFIRTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81

Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
           R +L  +     V LY SF+D  YLYL++E++ GG+  T L R +     V  FY AQ V
Sbjct: 82  RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
           L  E +   N ++RD+KP+NLLLD++G +K++DFG  K                      
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------------------- 180

Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
               VD R                            Y+  GTP+YIAPE+LL  G+G   
Sbjct: 181 ----VDTR---------------------------TYTLCGTPEYIAPEILLNVGHGKAA 209

Query: 337 DW 338
           DW
Sbjct: 210 DW 211

Length = 340

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  135 bits (340), Expect = 7e-37
 Identities = 75/229 (32%), Positives = 112/229 (48%), Gaps = 50/229 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           ++G+G+FG+V L + K+SG +YA+K LKK  +L    VE    E+ +L+   +H  + +L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           Y  FQ  + L+ +ME++ GGD+M  + +     E  ARFY A+   A+  +H    I+RD
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +K DN+LLD  GH KL+DFG+CK                           +G+   + C 
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIF-----------------------NGKTTSTFC- 157

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                    GTPDYIAPE+L +  YG   DW A
Sbjct: 158 -------------------------GTPDYIAPEILQEMLYGPSVDWWA 181

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  134 bits (338), Expect = 2e-36
 Identities = 76/227 (33%), Positives = 115/227 (50%), Gaps = 50/227 (22%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           +IG+G+FG+V L + K     YA+K L+K  +L + + +H+ +ERN+L +   H  +V L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           ++SFQ A+ LY +++Y+ GG++   L RE    E  ARFY A+   A+  +H  N ++RD
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +KP+N+LLD  GH+ L+DFGLCK           EN                        
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCK-----------EN------------------------ 146

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                         I       +  GTP+Y+APEVL K+ Y    DW
Sbjct: 147 --------------IEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  132 bits (333), Expect = 9e-36
 Identities = 80/238 (33%), Positives = 127/238 (53%), Gaps = 54/238 (22%)

Query: 107 DFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLAE 162
           +F+LL ++G GA+G+V L ++     +G +YAMK L+K+ ++ + + VEH R ERN+L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 163 V-ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
           V  S  +V L+Y+FQ    L+LI++Y+ GG++ T L + +  +E   RFY  + +LA+E 
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +HK   ++RDIK +N+LLD  GH+ L+DFGL K             E L +E        
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-------------EFLSEE-------- 159

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDW 338
                                      ++  YS  GT +Y+APE++  K G+G   DW
Sbjct: 160 ---------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDW 190

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  132 bits (332), Expect = 1e-35
 Identities = 76/226 (33%), Positives = 113/226 (50%), Gaps = 49/226 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G FG+V L +EK +G  YAMK L+K  ++++ +V H   E  +L       +  L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
           Y+FQ  + L  +MEY  GG++   L RE   TE  ARFY A+ V A+E +H  + ++RDI
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121

Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
           K +NL+LD++GH+K++DFGLCK             E + D    ++           CG 
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK-------------EGISDGATMKTF----------CG- 157

Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                    TP+Y+APEVL    YG   DW
Sbjct: 158 -------------------------TPEYLAPEVLEDNDYGRAVDW 178

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  129 bits (327), Expect = 6e-35
 Identities = 73/230 (31%), Positives = 115/230 (50%), Gaps = 50/230 (21%)

Query: 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVK 170
            +IGRG++ +V L + KK+  IYAMK +KK  +     ++ V+ E+++    ++H  +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
           L+  FQ    L+ ++E++ GGD+M  + R+  L E  ARFY A+  LA+  +H+   I+R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
           D+K DN+LLD  GH+KL+D+G+CK                  E +       G    + C
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK------------------EGIR-----PGDTTSTFC 157

Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                     GTP+YIAPE+L  + YG   DW A
Sbjct: 158 --------------------------GTPNYIAPEILRGEDYGFSVDWWA 181

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  128 bits (322), Expect = 3e-34
 Identities = 76/236 (32%), Positives = 116/236 (49%), Gaps = 50/236 (21%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-AS 165
           DF+ L ++G+G+FG+V L + K +  +YA+K LKK  ++    VE    E+ +LA     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             + +L+  FQ  + LY +MEY+ GGD+M  + +     E  A FY A+  + +  +H+ 
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
             I+RD+K DN++LD  GH+K++DFG+CK                      E M VDG  
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK----------------------EHM-VDGVT 157

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
             + C                          GTPDYIAPE++  + YG   DW AY
Sbjct: 158 TRTFC--------------------------GTPDYIAPEIIAYQPYGKSVDWWAY 187

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  125 bits (315), Expect = 2e-33
 Identities = 70/230 (30%), Positives = 110/230 (47%), Gaps = 50/230 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           ++G+G+FG+V L + K +   +A+K LKK  +L    VE    E+ +L+    H  +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           Y +FQ  E L+ +MEYL GGD+M  +          A FY A+ +  ++ +H    ++RD
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +K DN+LLD +GH+K++DFG+CK                      E+M  D +       
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK----------------------ENMLGDAK------- 152

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                 +  GTPDYIAPE+LL + Y    DW ++
Sbjct: 153 --------------------TCTFCGTPDYIAPEILLGQKYNTSVDWWSF 182

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  125 bits (316), Expect = 3e-33
 Identities = 74/226 (32%), Positives = 114/226 (50%), Gaps = 49/226 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G FG+V L +EK SG  YAMK LKK  ++++ +V H   E  +L       +  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
           YSFQ  + L  +MEY+ GG++   L RE   +E   RFY A+ V A++ +H    ++RD+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
           K +NL+LD++GH+K++DFGLCK                  E + ++  +     ++ CG 
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK------------------EGITDAATM-----KTFCG- 157

Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                    TP+Y+APEVL    YG   DW
Sbjct: 158 -------------------------TPEYLAPEVLEDNDYGRAVDW 178

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  124 bits (313), Expect = 3e-33
 Identities = 79/239 (33%), Positives = 122/239 (51%), Gaps = 55/239 (23%)

Query: 107 DFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQV-EHVRAERNLLAE 162
           +F+LL ++G GA+G+V L ++     SG +YAMK LKK+ ++ + +  EH R ER +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 163 V-ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
           +  S  +V L+Y+FQ    L+LI++Y+ GG++ T L + E   E   + Y  + VLA+E 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +HK   I+RDIK +N+LLD NGH+ L+DFGL K             E  +DE        
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-------------EFHEDEV------- 160

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL--KKGYGMECDW 338
                                       + AYS  GT +Y+AP+++     G+    DW
Sbjct: 161 ----------------------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW 191

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  124 bits (312), Expect = 9e-33
 Identities = 77/227 (33%), Positives = 115/227 (50%), Gaps = 50/227 (22%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G FG+V L +EK +G  YAMK LKK  ++++ +V H   E  +L       +  L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH-KHNYIHRD 231
           YSFQ  + L  +MEY  GG++   L RE   +E  ARFY A+ V A++ +H + N ++RD
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +K +NL+LD++GH+K++DFGLCK                  E +      DG   ++ C 
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCK------------------EGIK-----DGATMKTFC- 157

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                    GTP+Y+APEVL    YG   DW
Sbjct: 158 -------------------------GTPEYLAPEVLEDNDYGRAVDW 179

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  123 bits (311), Expect = 1e-32
 Identities = 75/229 (32%), Positives = 118/229 (51%), Gaps = 50/229 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           +IGRG++ +V L + KK+  IYAMK +KK  +     ++ V+ E+++  + +S+  +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           +  FQ    L+L++EY+ GGD+M  + R+  L E  ARFY A+  +A+  +H+   I+RD
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +K DN+LLD +GH+KL+D+G+CK                  E L       G    + CG
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK------------------EGLGP-----GDTTSTFCG 158

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                     TP+YIAPE+L  + YG   DW A
Sbjct: 159 --------------------------TPNYIAPEILRGEEYGFSVDWWA 181

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  124 bits (310), Expect = 3e-32
 Identities = 66/164 (40%), Positives = 95/164 (57%), Gaps = 8/164 (4%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
            + +L  +G G+FGEV L +++K   + A+K L K       +VE    E  +LA +   
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 167 -CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLAIESI 222
             IVKLY  FQD   LYL+MEY+ GG +  LL    R+  L+E+ A F +AQ + A+E +
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 223 HKHNYIHRDIKPDNLLLDQNGHM-KLSDFGLCKPLDCTNLSAIN 265
           H    IHRDIKP+N+LLD++G + KL DFGL K L     ++  
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161

Length = 384

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  122 bits (306), Expect = 6e-32
 Identities = 76/229 (33%), Positives = 116/229 (50%), Gaps = 50/229 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           +IGRG++ +V L + KK+  IYAMK +KK  +     ++ V+ E+++  + ++H  +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           +  FQ    L+ ++EY+ GGD+M  + R+  L E  ARFY A+  LA+  +H+   I+RD
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +K DN+LLD  GH+KL+D+G+CK                  E L    D    F    CG
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK------------------EGLRPG-DTTSTF----CG 158

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                     TP+YIAPE+L  + YG   DW A
Sbjct: 159 --------------------------TPNYIAPEILRGEDYGFSVDWWA 181

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (302), Expect = 9e-32
 Identities = 51/157 (32%), Positives = 87/157 (55%), Gaps = 7/157 (4%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH-VRAERNLLAEVA 164
            D + + ++G+G+ G V   + K +G IYA+KK+    +    +    +  E   L    
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCE 57

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIH 223
           S  +VK Y +F     + +++EY+ GG +  LL +   + E V   YIA+ +L  ++ +H
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-YIARQILKGLDYLH 116

Query: 224 -KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
            K + IHRDIKP NLL++  G +K++DFG+ K L+ T
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  121 bits (304), Expect = 1e-31
 Identities = 74/236 (31%), Positives = 116/236 (49%), Gaps = 50/236 (21%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           DF+ L ++G+G+FG+V L + K +  +YA+K LKK  ++    VE    E+ +LA     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 167 -CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             + +L+  FQ  + LY +MEY+ GGD+M  + +     E  A FY A+  + +  +H  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
             I+RD+K DN++LD  GH+K++DFG+CK                  EN+      DG  
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK------------------ENM-----WDGVT 157

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
            ++ C                          GTPDYIAPE++  + YG   DW A+
Sbjct: 158 TKTFC--------------------------GTPDYIAPEIIAYQPYGKSVDWWAF 187

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  117 bits (296), Expect = 7e-31
 Identities = 54/141 (38%), Positives = 86/141 (60%), Gaps = 2/141 (1%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G+G FGEV  CQ K +G +YA KKL K  +  R   +    E+ +L +V+S  IV L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           +F+  + L L+M  + GGD+   +  + E    E  A FY AQ +  +E +H+   ++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 232 IKPDNLLLDQNGHMKLSDFGL 252
           +KP+N+LLD +G++++SD GL
Sbjct: 121 LKPENVLLDDHGNVRISDLGL 141

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  117 bits (295), Expect = 2e-30
 Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 50/230 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           ++G+G+FG+V L + K  G  +A+K LKK  +L    VE    E+ +LA    +  +  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           Y +FQ  E+L+ +ME+L GGD+M  +  +       A FY A+ V  ++ +H    I+RD
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +K DN++LD++GH+K++DFG+CK           EN   D+                   
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK-----------ENVFGDNR------------------ 152

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                               A +  GTPDYIAPE+L    Y    DW ++
Sbjct: 153 --------------------ASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  116 bits (291), Expect = 4e-30
 Identities = 58/143 (40%), Positives = 86/143 (60%), Gaps = 4/143 (2%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G+G FGEV  CQ + +G +YA KKL K  +  R   E    E+ +LA+V S  IV L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLL--MREET--LTETVARFYIAQSVLAIESIHKHNYIH 229
           +FQ    L L+M  + GGD+   +  + EE     E  A FY AQ +  +E +H+   I+
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 230 RDIKPDNLLLDQNGHMKLSDFGL 252
           RD+KP+N+LLD +G++++SD GL
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGL 143

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  114 bits (287), Expect = 2e-29
 Identities = 65/243 (26%), Positives = 105/243 (43%), Gaps = 75/243 (30%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           +  L  IG GA GEV    ++ +G   A+KK++    L +   E +  E  ++ +     
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF----------YIAQSVL 217
           IV  Y S+   + L+++MEY+ GG          +LT+ + +           Y+ + VL
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGG----------SLTDIITQNFVRMNEPQIAYVCREVL 126

Query: 218 -AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
             +E +H  N IHRDIK DN+LL ++G +KL+DFG         L+              
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGF-----AAQLTK------------- 168

Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
                                       + ++R    S VGTP ++APEV+ +K YG + 
Sbjct: 169 ----------------------------EKSKRN---SVVGTPYWMAPEVIKRKDYGPKV 197

Query: 337 D-W 338
           D W
Sbjct: 198 DIW 200

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 7e-29
 Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 22/156 (14%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK-----SEMLSRGQVEHVRAERNLLAE 162
           + ++  +G G FG V L + K++G + A+KK+KK      E +    +  V++    L +
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM---NLREVKS----LRK 53

Query: 163 VASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTL--LMREET---LTETVARFYIAQSV 216
           +  H  IVKL   F++ + LY + EY+ G     L  LM++      +E+V R  I Q +
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             +  IHKH + HRD+KP+NLL+     +K++DFGL
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGL 145

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 4e-28
 Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 51/233 (21%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           ++ L  +IGRGAFG V      ++G+  A+K++   + +    ++ +  E +LL  +   
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN 226
            IVK   S + ++ LY+I+EY   G +  ++ +     E++   Y+ Q +  +  +H+  
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFP 286
            IHRDIK  N+L  ++G +KL+DFG+      T L+ +++++                  
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGV-----ATKLNDVSKDD------------------ 156

Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                      S VGTP ++APEV+   G     D W
Sbjct: 157 --------------------------ASVVGTPYWMAPEVIEMSGASTASDIW 183

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 5e-28
 Identities = 69/227 (30%), Positives = 101/227 (44%), Gaps = 48/227 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK--KSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           ++G+GAFG V LC +  +G   A+K++        ++ +V  +  E  LL  +    IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
            Y   +D E L + MEY+PGG V   L     LTETV R Y  Q +  +E +H +  +HR
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
           DIK  N+L D  G++KL DFG  K L                               SG 
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICS--------------------------SGT 162

Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
           G +                    S  GTP +++PEV+  +GYG + D
Sbjct: 163 GMK--------------------SVTGTPYWMSPEVISGEGYGRKAD 189

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  109 bits (274), Expect = 7e-28
 Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 56/235 (23%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + FD+L  +G G++G V     K++G + A+K      +     ++ +  E ++L +  S
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKV-----VPVEEDLQEIIKEISILKQCDS 57

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHK 224
             IVK Y S+     L+++MEY   G V  ++ +  +TLTE      + Q++  +E +H 
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
           +  IHRDIK  N+LL++ G  KL+DFG+                                
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGV-------------------------------- 145

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
              SG          QL      R     + +GTP ++APEV+ + GY  + D W
Sbjct: 146 ---SG----------QLTDTMAKRN----TVIGTPFWMAPEVIQEIGYNNKADIW 183

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 1e-27
 Identities = 72/236 (30%), Positives = 109/236 (46%), Gaps = 57/236 (24%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK--LKKSEMLSRGQVEHVRAERNLLAEV 163
           + F LL  IG+G+FGEV    +K++  + A+K   L+++E     ++E ++ E   L++ 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
            S  I K Y SF     L++IMEY  GG  + LL +   L ET   F + + +L +E +H
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
           +   IHRDIK  N+LL + G +KL+DFG                             V G
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFG-----------------------------VSG 146

Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                           QL      R     + VGTP ++APEV+ + GY  + D W
Sbjct: 147 ----------------QLTSTMSKRN----TFVGTPFWMAPEVIKQSGYDEKADIW 182

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  108 bits (271), Expect = 3e-27
 Identities = 70/233 (30%), Positives = 107/233 (45%), Gaps = 55/233 (23%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HC--IV 169
           IIGRG FGEV  C++  +G +YAMK L K  +  +        ER +L+ V++  C  IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
            + Y+F   + L  I++ + GGD+   L +    +E   RFY A+ +L +E +H    ++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
           RD+KP N+LLD++GH+++SD GL                                     
Sbjct: 121 RDLKPANILLDEHGHVRISDLGL------------------------------------A 144

Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAY 341
           C    K P               +++VGT  Y+APEVL K   Y    DW + 
Sbjct: 145 CDFSKKKP---------------HASVGTHGYMAPEVLQKGVAYDSSADWFSL 182

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  105 bits (264), Expect = 2e-26
 Identities = 66/186 (35%), Positives = 96/186 (51%), Gaps = 13/186 (6%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           DF++L  IG+G+FG V     K    +YAMK++  S+M  R + E +  E  +LA++ S 
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTET-VARFYIAQSVLAIESIH 223
            I++ Y SF D   L ++MEY   GD+  LL   R   L E  V RF+I Q +L +  +H
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN--------ENEVLDDENL 275
               +HRDIK  NL LD   ++K+ D G+ K L      A            E+ +D+  
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178

Query: 276 NESMDV 281
           NE  DV
Sbjct: 179 NEKSDV 184

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  105 bits (263), Expect = 3e-26
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 54/229 (23%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKL 171
           +G G+FG V        G+ +A+K   L       +  V+ +  E  LL+++    IV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
             + ++ + LY+ +E +PGG +  LL +  +  E V R Y  Q +L +E +H  N +HRD
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           IK  N+L+D NG +KL+DFG+ K                                     
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK------------------------------------- 150

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECD-W 338
                        Q+     A S  G+P ++APEV+ ++G YG+  D W
Sbjct: 151 -------------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIW 186

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 3e-26
 Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 52/233 (22%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F    ++G+G FGEV  CQ + +G +YA KKL+K  +  R        E+ +L +V S  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKH 225
           +V L Y+++  + L L++  + GGD+   +  M      E  A FY A+    +E +H+ 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
             ++RD+KP+N+LLD  GH+++SD GL           I E E            + GR 
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA--------VEIPEGET-----------IRGR- 161

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                         VGT  Y+APEV+  + Y    DW
Sbjct: 162 ------------------------------VGTVGYMAPEVVKNERYTFSPDW 184

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  104 bits (262), Expect = 4e-26
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 62/244 (25%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           D+++L  IG+G+FG VR  + K  G I   K++    M +  + + + +E N+L E+   
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHP 59

Query: 167 CIVKLYYSFQD--AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI----AQSVLAIE 220
            IV+ Y    D   + LY++MEY  GGD+  L+ + +   + +   +I     Q +LA+ 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 221 SIH-----KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
             H      +  +HRD+KP N+ LD N ++KL DFGL K L                   
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG------------------ 161

Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
                                          +    A + VGTP Y++PE L    Y  +
Sbjct: 162 -------------------------------HDSSFAKTYVGTPYYMSPEQLNHMSYDEK 190

Query: 336 CD-W 338
            D W
Sbjct: 191 SDIW 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 8e-26
 Identities = 49/147 (33%), Positives = 79/147 (53%), Gaps = 7/147 (4%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN--LLAEVASHCIVKL 171
           IG G +G V   ++K +G I A+KK+K        +     A R   LL E+    I+KL
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
              F+    LYL+ E++   D+  L+  R+  L E++ + Y+ Q +  +   H H  +HR
Sbjct: 64  LDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           D+KP+NLL++  G +KL+DFGL +   
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFG 149

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  100 bits (251), Expect = 1e-24
 Identities = 69/232 (29%), Positives = 106/232 (45%), Gaps = 55/232 (23%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HC--IV 169
           IIGRG FGEV  C++  +G +YAMK L K  +  +        ER +L+ V++  C  IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
            + Y+F   + L  I++ + GGD+   L +    +E   RFY  + +L +E +H    ++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
           RD+KP N+LLD++GH+++SD GL                                     
Sbjct: 121 RDLKPANILLDEHGHVRISDLGL------------------------------------A 144

Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLA 340
           C    K P               +++VGT  Y+APEVL K   Y    DW +
Sbjct: 145 CDFSKKKP---------------HASVGTHGYMAPEVLQKGTAYDSSADWFS 181

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  100 bits (249), Expect = 2e-24
 Identities = 55/147 (37%), Positives = 80/147 (54%), Gaps = 4/147 (2%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
            +++L ++G G+FG   L Q   S   YAMK+++  +  S   VE  R E  LLA++   
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTL--LMREETLTETVARFYIAQSVLAIESIHK 224
            IV    SF+   +LY++MEY  GGD+M    L R +   E     +  Q  L ++ IH+
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFG 251
              +HRDIK  N+ L QNG +KL DFG
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFG 145

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  100 bits (250), Expect = 2e-24
 Identities = 51/142 (35%), Positives = 85/142 (59%), Gaps = 2/142 (1%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G FGEV  CQ + +G +YA KKL+K  +  R        E+ +L +V S  +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
           Y+++  + L L++  + GGD+   +  M E    E  A FY A+    +E +H+   ++R
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126

Query: 231 DIKPDNLLLDQNGHMKLSDFGL 252
           D+KP+N+LLD +GH+++SD GL
Sbjct: 127 DLKPENILLDDHGHIRISDLGL 148

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 99.5 bits (248), Expect = 3e-24
 Identities = 55/159 (34%), Positives = 86/159 (54%), Gaps = 6/159 (3%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK------KSEMLSRGQVEHVRAERNLLAEVASH 166
           +IG G+FG V L     SG + A+K+++       S+   R  ++ +  E  LL E+   
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN 226
            IV+   S  DA++L + +EY+PGG V  LL       ET+ R ++ Q +  +  +H   
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265
            IHRDIK  N+L+D  G +K+SDFG+ K L+  +LS   
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 99.3 bits (247), Expect = 6e-24
 Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 52/228 (22%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G FGEV  CQ + +G +YA K+L+K  +  R        E+ +L +V S  +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
           Y+++  + L L++  + GGD+   +  M      E  A FY A+ +  +E +H+ N ++R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
           D+KP+N+LLD  GH+++SD GL          A+          + E   + GR      
Sbjct: 127 DLKPENILLDDYGHIRISDLGL----------AV---------KIPEGESIRGR------ 161

Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                    VGT  Y+APEVL  + Y +  D+
Sbjct: 162 -------------------------VGTVGYMAPEVLNNQRYTLSPDY 184

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.4 bits (243), Expect = 2e-23
 Identities = 64/230 (27%), Positives = 94/230 (40%), Gaps = 52/230 (22%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G FG+V       +G + A+K+++  +      ++ +  E  +L E+  H  +  YY
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVL-ELLKHPNLVKYY 65

Query: 174 SFQ-DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
             +   E +Y+ MEY  GG +  LL     L E V R Y  Q +  +  +H H  +HRDI
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125

Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
           KP N+ LD NG +KL DFG    L                                    
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKL----------------------------------KN 151

Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMECD-W 338
              +  E++Q              GTP Y+APEV+     KG+G   D W
Sbjct: 152 NTTTMGEEVQSL-----------AGTPAYMAPEVITGGKGKGHGRAADIW 190

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 97.0 bits (241), Expect = 4e-23
 Identities = 49/142 (34%), Positives = 82/142 (57%), Gaps = 2/142 (1%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G FGEV  CQ + +G +YA KKL+K  +  R        E+ +L +V S  +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
           Y+++  + L L++  + GGD+   +  M      E  A FY A+    +E + +   ++R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126

Query: 231 DIKPDNLLLDQNGHMKLSDFGL 252
           D+KP+N+LLD  GH+++SD GL
Sbjct: 127 DLKPENILLDDRGHIRISDLGL 148

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 9e-23
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 19/169 (11%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLLAE 162
              F+L+ +IG G +G+V   + KK+G + A+K   + + E       E ++ E N+L +
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE------EEEIKEEYNILRK 58

Query: 163 VASH-CIVKLYYSF------QDAEYLYLIMEYLPGGDVM----TLLMREETLTETVARFY 211
            ++H  I   Y +F       + + L+L+ME   GG V      L  + + L E    + 
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           + +++  +  +H++  IHRDIK  N+LL +N  +KL DFG+   LD T 
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 95.2 bits (237), Expect = 1e-22
 Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 58/236 (24%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           DF +L  +G+G++G V   +       YA+K++    M S+ + E    E  +LA V   
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHP 59

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETL-----TETVARFYIAQSVLAIES 221
            I+    +F D   L ++MEY P GD+   + + +        + + R +I Q +  +++
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQA 118

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +H+   +HRD+K  N+LL  N  +K+ D G+ K L                         
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVL------------------------- 153

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                                     ++ +A + +GTP Y+APEV   + Y  + D
Sbjct: 154 --------------------------KKNMAKTQIGTPHYMAPEVWKGRPYSYKSD 183

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 52/238 (21%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DD++L+ +IG GA   V       +    A+K++   +   +  V+ +R E   +++   
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLTETVARFYIAQSVLAIESI 222
             +VK Y SF   + L+L+M YL GG   D+M        L E +    + + +  +E +
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
           H +  IHRDIK  N+LL ++G +K++DFG                             V 
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFG-----------------------------VS 149

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-LKKGYGMECD-W 338
               + G                   RK+  + VGTP ++APEV+    GY  + D W
Sbjct: 150 ASLADGGD----------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIW 191

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 57/156 (36%), Positives = 85/156 (54%), Gaps = 11/156 (7%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA----ERNLLAEV 163
           +++L ++G GA+G V  C+ K +G I A+KK K+SE       E V+     E  +L ++
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-----DDEDVKKTALREVKVLRQL 57

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIESI 222
               IV L  +F+    LYL+ EY+    ++ LL      L     R YI Q + AI   
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258
           H HN IHRDIKP+N+L+ ++G +KL DFG  + L  
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 93.4 bits (233), Expect = 5e-22
 Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 9/154 (5%)

Query: 110 LLTIIGRGAFGEVRLCQ-EKKSGNIY---AMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           L   +G GAFGEV   + + K G      A+K LK+       Q+E    E  ++ ++  
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKL-D 59

Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQSVLAIESIH 223
           H  +VKL     + E LY++MEY+ GGD+++ L      L+ +    +  Q    +E + 
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
             N+IHRD+   N L+ +N  +K+SDFGL + L 
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 153

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 6e-22
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 57/238 (23%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +D++L+  IG G +G+V   ++  +G + A+K +K          E ++ E ++L E   
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRH 59

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDV-MTLLMREETLTETVARFYIAQSVLAIESIHK 224
             IV  + S+   + L+++MEY  GG +     +    L+E    +   +++  +  +H+
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
              IHRDIK  N+LL ++G +KL+DFG+   L  T                         
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT------------------------- 154

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGYGMECD-W 338
                                I +RK   S +GTP ++APEV     K GY  +CD W
Sbjct: 155 ---------------------IAKRK---SFIGTPYWMAPEVAAVERKGGYDGKCDIW 188

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 93.4 bits (233), Expect = 6e-22
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)

Query: 110 LLTIIGRGAFGEVRLCQ-EKKSGNIY---AMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           L   +G GAFGEV     + K        A+K LK+       Q+E    E  ++ ++  
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKL-D 59

Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIESI 222
           H  IVKL     + E L ++MEY+PGGD++  L +      +++    +  Q    +E +
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              N+IHRD+   N L+ +N  +K+SDFGL + L 
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 93.5 bits (233), Expect = 7e-22
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 7/154 (4%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK--LKKSEMLSRGQVEHVRA-ERNLLAEV 163
            + +L  IG GA G V   +++++G   A+KK  L++ E    G + +    E   L   
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE----GGIPNQALREIKALQAC 56

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
               +VKL   F       L+MEY+P      L   E  L E   + Y+   +  +  +H
Sbjct: 57  QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            +  +HRD+KP NLL+  +G +K++DFGL +   
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFS 150

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 91.6 bits (227), Expect = 2e-21
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 53/233 (22%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           ++++  IG G+FG++ L + K       +K++  ++M  + + E  + E  LLA++    
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKH 225
           IV  + SFQ+   L+++MEY  GGD+M  + R+     +E     +  Q  L ++ IH  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 226 NYIHRDIKPDNLLLDQNGHM-KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
             +HRDIK  N+ L +NG + KL DFG+ +                    LN+SM+    
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-------------------QLNDSME---- 157

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                                     LAY+ VGTP Y++PE+   + Y  + D
Sbjct: 158 --------------------------LAYTCVGTPYYLSPEICQNRPYNNKTD 184

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 91.5 bits (227), Expect = 4e-21
 Identities = 50/141 (35%), Positives = 77/141 (54%), Gaps = 2/141 (1%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G+G FGEV   Q K +G +YA KKL K  +  +   +    E+ +L +V S  IV L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVAR--FYIAQSVLAIESIHKHNYIHRD 231
           +F+   +L L+M  + GGD+   +         + R   Y AQ    I  +H  + ++RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 232 IKPDNLLLDQNGHMKLSDFGL 252
           +KP+N+LLD  G+ +LSD GL
Sbjct: 121 MKPENVLLDDQGNCRLSDLGL 141

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 91.0 bits (227), Expect = 4e-21
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 7/150 (4%)

Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIY----AMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           L   +G GAFGEV     K  G       A+K LK+       + E    E +++ +++ 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKLSH 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV-LAIESIHK 224
             IV+L       E LY++ EY+PGGD++  L +            +A  +   +E +  
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            N++HRD+   N L+ +N  +K+SDFGL +
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 49/163 (30%), Positives = 85/163 (52%), Gaps = 13/163 (7%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           ++ +  IG G +G+V   + KK+G + A+KK++         +  +R E  LL ++    
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59

Query: 168 IVKLY---YSFQDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIESIH 223
           IV+L     S       Y++ EY+   D+  LL   E   TE+  + Y+ Q +  ++ +H
Sbjct: 60  IVRLKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL------DCTN 260
            +  +HRDIK  N+L++ +G +KL+DFGL +P       D TN
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 2e-20
 Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 7/145 (4%)

Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG-QVEHVRAERNLLAEVASH-CI 168
           L  +G G +G V   ++KK+G I A+KK++  +    G     +R E +LL E+  H  I
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTALR-EISLLKEL-KHPNI 60

Query: 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHKHNY 227
           VKL         LYL+ EY    D+   L  R   L+  + +  + Q +  +   H H  
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGL 252
           +HRD+KP N+L++++G +KL+DFGL
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGL 144

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 89.1 bits (221), Expect = 2e-20
 Identities = 47/150 (31%), Positives = 82/150 (54%), Gaps = 9/150 (6%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK-------KSEMLSRGQVEHVRAERNLLAEVAS 165
           +IG+G +G V L     +G + A+K+++       + +   +  V+ +R+E   L ++  
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 166 HCIVKLYYSFQDAE-YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
             IV+ Y  F+  E YL + +EY+PGG + + L       E + RF+  Q +  +  +H 
Sbjct: 68  LNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
              +HRD+K DNLL+D +G  K+SDFG+ K
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 51/159 (32%), Positives = 85/159 (53%), Gaps = 14/159 (8%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           + +L  IG G F EV   Q +K+G  YA+K +KK    S  QV ++R E   L  ++ H 
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH-FKSLEQVNNLR-EIQALRRLSPHP 58

Query: 168 -IVKLYYSFQDAEY--LYLIMEYLPGGDVMTL--LM--REETLTETVARFYIAQSVLAIE 220
            I++L     D +   L L+ E +     M L  L+  R+  L E   + Y+ Q + +++
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSLD 114

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
            +H++   HRDIKP+N+L+  +  +KL+DFG C+ +   
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSK 152

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.2 bits (218), Expect = 5e-20
 Identities = 68/230 (29%), Positives = 103/230 (44%), Gaps = 52/230 (22%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           ++GRGAFGEV LC +  +G   A+K++     S+  S+ +V  +  E  LL  +    IV
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSK-EVNALECEIQLLKNLRHDRIV 67

Query: 170 KLYYSFQDAEY--LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           + Y   +D E   L + +EY+PGG +   L     LTE V R Y  Q +  +  +H +  
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           +HRDIK  N+L D  G++KL DFG  K +    +                          
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICM-------------------------- 161

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
           SG G +                    S  GTP +++PEV+  +GYG + D
Sbjct: 162 SGTGIK--------------------SVTGTPYWMSPEVISGEGYGRKAD 191

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 87.8 bits (217), Expect = 7e-20
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 52/230 (22%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           ++G+GAFG V LC +  +G   A K+++   +S   S+ +V  +  E  LL  +    IV
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSK-EVSALECEIQLLKNLQHERIV 67

Query: 170 KLYYSFQD--AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           + Y   +D   + L + MEY+PGG V   L     LTE+V R Y  Q +  +  +H +  
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           +HRDIK  N+L D  G++KL DFG  K L    +                          
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICM-------------------------- 161

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
           SG G R                    S  GTP +++PEV+  +GYG + D
Sbjct: 162 SGTGIR--------------------SVTGTPYWMSPEVISGEGYGRKAD 191

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.0 bits (219), Expect = 8e-20
 Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 2/143 (1%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER--NLLAEVASHCIVKL 171
           +G G +  V   ++K++G I A+KK+K  E        +  A R   LL E+    I+ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
              F     + L+ E++       +  +   LT    + Y+  ++  +E +H +  +HRD
Sbjct: 68  LDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRD 127

Query: 232 IKPDNLLLDQNGHMKLSDFGLCK 254
           +KP+NLL+  +G +KL+DFGL +
Sbjct: 128 LKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 52/152 (34%), Positives = 86/152 (56%), Gaps = 7/152 (4%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE---MLSRGQVEHVRAERNLLAEVA 164
           ++ L ++G G++G V  C+ K++G I A+KK  +SE   M+ +  +  +R    +L ++ 
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLR 58

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
              +V L   F+  + LYL+ E++    +  L      L E+  R Y+ Q +  IE  H 
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           HN IHRDIKP+N+L+ Q+G +KL DFG  + L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 65/232 (28%), Positives = 102/232 (43%), Gaps = 55/232 (23%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
             D    IG G+ G V +  +K +G   A+KK+   +   R   E +  E  ++ +    
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHP 76

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKH 225
            IV++Y S+   + L+++ME+L GG +  ++       E +A   +  +VL A+  +H  
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALSFLHAQ 134

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
             IHRDIK D++LL  +G +KLSDFG C  +                     S +V    
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV---------------------SKEVP--- 170

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                                 RRK   S VGTP ++APEV+ +  YG E D
Sbjct: 171 ----------------------RRK---SLVGTPYWMAPEVISRLPYGTEVD 197

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 55/225 (24%), Positives = 89/225 (39%), Gaps = 39/225 (17%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA---E 162
           DD + L  +G G  G V     + +G I A+K +         ++E   A +  +    +
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---------RLEINEAIQKQILRELD 51

Query: 163 VASHC----IVKLYYSFQDAEYLYLIMEYLPGG--DVMTLLMREETLTETVARFYIAQSV 216
           +   C    IV  Y +F +   + + MEY+ GG  D +   ++       + +  IA +V
Sbjct: 52  ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAV 109

Query: 217 LA--IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL------DCTNLSAINENE 268
           L        KH  IHRD+KP N+L++  G +KL DFG+   L           S+    E
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE 169

Query: 269 VLDDENLNESMDV-----------DGRFPESGCGRRWKSPLEQLQ 302
            +   + +   D+            GRFP            E LQ
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ 214

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 86.2 bits (213), Expect = 2e-19
 Identities = 67/230 (29%), Positives = 102/230 (44%), Gaps = 52/230 (22%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           ++G+GAFG V LC +  +G   A+K+++   +S   S+ +V  +  E  LL  +    IV
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSK-EVNALECEIQLLKNLLHERIV 67

Query: 170 KLYYSFQDA--EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           + Y   +D     L + ME++PGG +   L     LTE V R Y  Q +  +  +H +  
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           +HRDIK  N+L D  G++KL DFG  K L    L                          
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICL-------------------------- 161

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
           SG G +                    S  GTP +++PEV+  +GYG + D
Sbjct: 162 SGTGMK--------------------SVTGTPYWMSPEVISGEGYGRKAD 191

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 85.7 bits (212), Expect = 3e-19
 Identities = 44/147 (29%), Positives = 80/147 (54%), Gaps = 4/147 (2%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++GRGAFG V LC+ K    +  +K++   +M ++ +    + E  +L  ++   I++ Y
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVLAIESIHKHNYIHR 230
            +F + + L ++MEY PGG +   +       L E     +  Q +LA+  +H    +HR
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125

Query: 231 DIKPDNLLLDQNGH-MKLSDFGLCKPL 256
           D+K  N+LLD++   +K+ DFG+ K L
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKIL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.8 bits (210), Expect = 6e-19
 Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 53/237 (22%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + +F +   IG+G F  V        G + A+KK++  EM+     +    E +LL ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIE 220
              ++K   SF +   L +++E    GD+  ++     ++  + E     Y  Q   A+E
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
            +H    +HRDIKP N+ +   G +KL D GL                            
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGL---------------------------- 152

Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
             GRF  S                   +   A+S VGTP Y++PE + + GY  + D
Sbjct: 153 --GRFFSS-------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSD 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 9e-19
 Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 6/148 (4%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---A 164
           +  L +IGRGA+G V   +   +G + A+K +          V  ++ E  LL+++    
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
              I K Y S+     L++IMEY  GG V TL M+   + E      I + ++A++ IHK
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHK 119

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
              IHRDIK  N+L+   G++KL DFG+
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGV 147

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 53/151 (35%), Positives = 82/151 (54%), Gaps = 1/151 (0%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + F++L ++G GA+G V  C+ K++  I A+KK K SE     +   +R E  +L  +  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IV+L  +F+    LYL+ EY+    +  L      +     R YI Q + AI   HK+
Sbjct: 60  ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           + +HRDIKP+NLL+  N  +KL DFG  + L
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 83.3 bits (206), Expect = 2e-18
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 3/148 (2%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG+  L + K+ G  Y +K++  S+M  + + E  R E  +L+ +    IV+   
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQE 66

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           SF++   LY++M+Y  GGD+   +   R     E     +  Q  LA++ +H    +HRD
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
           IK  N+ L ++G +KL DFG+ + L+ T
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVLNST 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.7 bits (204), Expect = 5e-18
 Identities = 52/166 (31%), Positives = 88/166 (53%), Gaps = 14/166 (8%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++++  IG+G +G+V     KK G++ A+K L     +     E + AE N+L  + +
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEAEYNILQSLPN 77

Query: 166 H-CIVKLYYSFQDAEY-----LYLIMEYLPGGDVMTL----LMREETLTETVARFYIAQS 215
           H  +VK Y  F  A+      L+L++E   GG V  L    L+  + L E +  + +  +
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261
           +L ++ +H +  IHRD+K +N+LL   G +KL DFG+   L  T L
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.8 bits (202), Expect = 9e-18
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 49/229 (21%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVRAERNLLAEVASHCIV 169
            +G GAF      ++ K+G + A+K++      S  Q   VE +R E  L+A +    I+
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
           ++  +  +  +  L +E++ GG V  LL +     E V   Y  Q +  +  +H++  IH
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126

Query: 230 RDIKPDNLLLDQNGH-MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPES 288
           RD+K  NLL+D  G  ++++DFG          +A           L       G F   
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFG----------AAA---------RLAAKGTGAGEF--- 164

Query: 289 GCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                      Q Q             +GT  ++APEVL  + YG  CD
Sbjct: 165 -----------QGQ------------LLGTIAFMAPEVLRGEQYGRSCD 190

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 81.0 bits (201), Expect = 1e-17
 Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 16/158 (10%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIY---AMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
            +G GAFGEV   + K         A+K LK+    S  + +    E  ++ ++    +V
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLGHPNVV 59

Query: 170 KLY-YSFQDAEYLYLIMEYLPGGDVMTLL---------MREETLTETVARFYIAQSVLAI 219
           +L     ++ E LYL++EY+ GGD++  L           + TL+      +  Q    +
Sbjct: 60  RLLGVCTEE-EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           E +    ++HRD+   N L+ ++  +K+SDFGL + + 
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 48/146 (32%), Positives = 73/146 (50%), Gaps = 22/146 (15%)

Query: 117 GAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-------V 169
           G FG+V + + K +  ++  K +K          ++  A      E   H +       +
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKA---------KNFNA-----IEPMVHQLMKDNPNFI 72

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
           KLYYS    +   LIM+Y+  GD+  LL +E  L+E   +  I Q V A+  +HKHN IH
Sbjct: 73  KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIH 132

Query: 230 RDIKPDNLLLDQN-GHMKLSDFGLCK 254
            DIK +N+L D+    + L D+GLCK
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.9 bits (199), Expect = 2e-17
 Identities = 65/233 (27%), Positives = 102/233 (43%), Gaps = 58/233 (24%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG+G+FGEV    + ++  + A+K +   E  +  ++E ++ E  +L++  S  
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR---EETLTETVARFYIAQSVLAIESIHK 224
           I + Y S+     L++IMEYL GG  + LL     EET   T+ R    + +  ++ +H 
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR----EILKGLDYLHS 119

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
              IHRDIK  N+LL + G +KL+DFG+                                
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAG------------------------------ 149

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                          QL   QI R       VGTP ++APEV+ +  Y  + D
Sbjct: 150 ---------------QLTDTQIKRNTF----VGTPFWMAPEVIKQSAYDFKAD 183

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 80.3 bits (198), Expect = 3e-17
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 47/228 (20%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKK--LKKSEMLS-RGQVEHVRAERNLLAEVASHCIV 169
           ++G+GA+G V  C     G + A+K+  L  S +L+   + E ++ E +LL  +    IV
Sbjct: 7   VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
           +   +  D   + + ME++PGG + ++L R   L E V   Y  Q +  +  +H +  +H
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125

Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
           RDIK +N++L  NG +KL DFG  + L    L   + N                      
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN---------------------- 163

Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                                +  S  GTP ++APEV+ + GYG + D
Sbjct: 164 ---------------------MLKSMHGTPYWMAPEVINESGYGRKSD 190

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 79.7 bits (196), Expect = 5e-17
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 52/230 (22%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG+G+FGEV    + ++  + A+K +   E  +  ++E ++ E  +L++  S  
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           + K Y S+     L++IMEYL GG  + LL R     E      + + +  ++ +H    
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           IHRDIK  N+LL + G +KL+DFG+                                   
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG--------------------------------- 149

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                       QL   QI R       VGTP ++APEV+ +  Y  + D
Sbjct: 150 ------------QLTDTQIKRNTF----VGTPFWMAPEVIQQSAYDSKAD 183

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 79.7 bits (196), Expect = 5e-17
 Identities = 50/166 (30%), Positives = 90/166 (54%), Gaps = 14/166 (8%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++++  IG+G +G+V     KK+G+  A+K L     +     E + AE N+L  ++ 
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73

Query: 166 H-CIVKLYYSF-----QDAEYLYLIMEYLPGGDVMTL----LMREETLTETVARFYIAQS 215
           H  +VK Y  +     ++ + L+L++E   GG V  L    L R E + E +  + + ++
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261
           ++ ++ +H +  IHRD+K +N+LL   G +KL DFG+   L  T L
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 52/150 (34%), Positives = 77/150 (51%), Gaps = 7/150 (4%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAERNLLAEVAS 165
           D+  +  IG G +G V   + KK+G I AMKK++ +SE    G       E +LL E+  
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQH 58

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDV---MTLLMREETLTETVARFYIAQSVLAIESI 222
             IV L         LYLI E+L   D+   +  L + + +   + + Y+ Q +  I   
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           H    +HRD+KP NLL+D  G +KL+DFGL
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGL 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 47/139 (33%), Positives = 80/139 (57%), Gaps = 4/139 (2%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G GAFG+V   Q K++G   A K +   ++ S  ++E    E ++L+E     IV LY 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKHPNIVGLYE 69

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
           ++     L++++E+  GG + ++++  E  LTE   R+   Q + A+  +H H  IHRD+
Sbjct: 70  AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129

Query: 233 KPDNLLLDQNGHMKLSDFG 251
           K  N+LL  +G +KL+DFG
Sbjct: 130 KAGNILLTLDGDVKLADFG 148

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 55/225 (24%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+ G V + +EK SG   A+K +   +   R   E +  E  ++ +     +V++Y 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHQNVVEMYK 85

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKHNYIHRDI 232
           S+   E L+++ME+L GG +  ++ +     E +A   + +SVL A+  +H    IHRDI
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT--VCESVLQALCYLHSQGVIHRDI 143

Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
           K D++LL  +G +KLSDFG C  +                     S DV  R        
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQI---------------------SKDVPKR-------- 174

Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                                S VGTP ++APEV+ +  YG E D
Sbjct: 175 --------------------KSLVGTPYWMAPEVISRTPYGTEVD 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 50/154 (32%), Positives = 84/154 (54%), Gaps = 3/154 (1%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG+G+FGEV    + ++  + A+K +   E  +  ++E ++ E  +L++  S  
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           + K Y S+     L++IMEYL GG  + LL     L ET     + + +  ++ +H    
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261
           IHRDIK  N+LL ++G +KL+DFG+   L  T +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 77.6 bits (191), Expect = 3e-16
 Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 59/227 (25%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG+GA G V    +  +G   A+K++   +   +   E +  E  ++ E     IV    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83

Query: 174 SFQDAEYLYLIMEYLPGG---DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
           S+   + L+++MEYL GG   DV+T    +E     V R    + + A+E +H +  IHR
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFLHSNQVIHR 139

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
           DIK DN+LL  +G +KL+DFG C  +                             PE   
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQIT----------------------------PEQ-- 169

Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                           ++R    + VGTP ++APEV+ +K YG + D
Sbjct: 170 ----------------SKRS---TMVGTPYWMAPEVVTRKAYGPKVD 197

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 51/163 (31%), Positives = 84/163 (51%), Gaps = 17/163 (10%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F+L+ ++G G +G+V   +  K+G + A+K +  +E     + E ++ E N+L + + H 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73

Query: 168 IVKLYYSF--------QDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVL 217
            +  YY           D + L+L+ME+   G V  L+   +   L E     YI + +L
Sbjct: 74  NIATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-YICREIL 131

Query: 218 -AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
             +  +H H  IHRDIK  N+LL +N  +KL DFG+   LD T
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 76.3 bits (188), Expect = 8e-16
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 14/155 (9%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE--MLSRGQVEHVRAERNLLAEV 163
           +    L+ +G GA G V  C+ K +G I+A+K +       L + Q+  +R E  +    
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK-QI--LR-ELEINKSC 56

Query: 164 ASHCIVKLYYSFQDAE--YLYLIMEYLPGGDVMTLL--MREET--LTETVARFYIAQSVL 217
            S  IVK Y +F D     + + MEY  GG + ++   +++    + E V    IA+SVL
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-KIAESVL 115

Query: 218 -AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
             +  +H    IHRDIKP N+LL + G +KL DFG
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.8 bits (190), Expect = 9e-16
 Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 17/155 (10%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN--LLAEVAS 165
           ++LL  IG GA+G V    +K++G   A+KK+     +    ++  R  R   LL  +  
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI---SNVFDDLIDAKRILREIKLLRHLRH 58

Query: 166 HCIVKL--------YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
             I+ L           F D   +Y++ E +   D+  ++   + LT+   ++++ Q + 
Sbjct: 59  ENIIGLLDILRPPSPEDFND---VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILR 114

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            ++ +H  N IHRD+KP N+L++ N  +K+ DFGL
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL 149

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 76.6 bits (188), Expect = 9e-16
 Identities = 50/159 (31%), Positives = 86/159 (54%), Gaps = 4/159 (2%)

Query: 95  YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           Y  ++R     + ++++  +G GAFG+V   + K++G + A K +   E  S  ++E   
Sbjct: 1   YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYM 57

Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV-MTLLMREETLTETVARFYIA 213
            E  +LA      IVKL  +F     L++++E+ PGG V   +L  +  LTE   +    
Sbjct: 58  VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR 117

Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           Q + A++ +H    IHRD+K  N+LL  +G +KL+DFG+
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGV 156

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 47/154 (30%), Positives = 85/154 (55%), Gaps = 7/154 (4%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE---MLSRGQVEHVRAERNLLAE 162
           + ++ L+ IG G++G V  C+ +++G I A+KK  +SE   ++ +  +  +R    +L +
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQ 56

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
           +    +V L   F+    L+L+ EY     +  L      + E + +  I Q++ A+   
Sbjct: 57  LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           HKHN IHRD+KP+N+L+ + G +KL DFG  + L
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 22/158 (13%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+    
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60

Query: 168 IVKLYYSFQDAEYLYLIMEYL-----------PGGDVMTLLMREETLTETVARFYIAQSV 216
           IVKL         LYL+ E+L           P   +   L++           Y+ Q +
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS----------YLFQLL 110

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             +   H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 55/225 (24%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+ G V +   K SG + A+KK+   +   R   E +  E  ++ +     +V++Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 84

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKHNYIHRDI 232
           S+   + L+++ME+L GG +  ++       E +A   +  +VL A+  +H    IHRDI
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLAVLKALSVLHAQGVIHRDI 142

Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
           K D++LL  +G +KLSDFG C        + +++                          
Sbjct: 143 KSDSILLTHDGRVKLSDFGFC--------AQVSK-------------------------- 168

Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                       ++ RRK   S VGTP ++APE++ +  YG E D
Sbjct: 169 ------------EVPRRK---SLVGTPYWMAPELISRLPYGPEVD 198

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 75.1 bits (184), Expect = 2e-15
 Identities = 48/161 (29%), Positives = 85/161 (52%), Gaps = 13/161 (8%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F+L+ ++G G +G+V   +  K+G + A+K +     ++  + E ++ E N+L + + H 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63

Query: 168 IVKLYY-SFQDA------EYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLA 218
            +  YY +F         + L+L+ME+   G V  L+   +  TL E    +   + +  
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
           +  +H+H  IHRDIK  N+LL +N  +KL DFG+   LD T
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 55/225 (24%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+ G V +  EK +G   A+KK+   +   R   E +  E  ++ +     +V +Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYHHENVVDMYN 86

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKHNYIHRDI 232
           S+   + L+++ME+L GG +  ++       E +A   +  SVL A+  +H    IHRDI
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--VCLSVLRALSYLHNQGVIHRDI 144

Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
           K D++LL  +G +KLSDFG C  +                                    
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVS----------------------------------- 169

Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                       ++ +RK   S VGTP ++APEV+ +  YG E D
Sbjct: 170 -----------KEVPKRK---SLVGTPYWMAPEVISRLPYGTEVD 200

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 46/146 (31%), Positives = 76/146 (52%), Gaps = 3/146 (2%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+GAFGE  L +  +  ++   K++  +  LS  +      E  +L+ +    I+  Y
Sbjct: 7   VLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIHKHNYIHR 230
             F D   L + MEY  GG +   ++R++     E +  +Y+ Q V A+  IHK   +HR
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPL 256
           DIK  N+ L + G +KL DFG+ K L
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKIL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 62/243 (25%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           SVD+++ L  I  G +G V   ++KK+G I A+KKLK  +      +  +R E N+L ++
Sbjct: 3   SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKL 61

Query: 164 ASHCIVKLYY----SFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVL 217
               IV +      S  D   +Y++MEY+   D+ +L+  M++  L   V +  + Q + 
Sbjct: 62  QHPNIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEV-KCLMLQLLS 117

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
            +  +H +  +HRD+K  NLLL+  G +K+ DFGL                         
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL------------------------- 152

Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMEC 336
                         R + SPL+                V T  Y APE+LL  K Y    
Sbjct: 153 -------------AREYGSPLKPYTQ-----------LVVTLWYRAPELLLGAKEYSTAI 188

Query: 337 D-W 338
           D W
Sbjct: 189 DMW 191

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.9 bits (185), Expect = 4e-15
 Identities = 57/174 (32%), Positives = 91/174 (52%), Gaps = 20/174 (11%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN--LLAEVAS 165
           +++L  +G+GA+G V    ++++  + A+KK+  +    R   +  R  R    L E+  
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA---FRNATDAQRTFREIMFLQELGD 65

Query: 166 H-CIVKLYYSFQDAEY---LYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLA 218
           H  IVKL    + AE    +YL+ EY+      T L   +R   L +   R+ + Q + A
Sbjct: 66  HPNIVKLLNVIK-AENDKDIYLVFEYME-----TDLHAVIRANILEDVHKRYIMYQLLKA 119

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
           ++ IH  N IHRD+KP N+LL+ +  +KL+DFGL + L    L    EN VL D
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE--LEENPENPVLTD 171

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 16/159 (10%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQV--EHVRAERNLLAEVAS 165
           ++ L  IG GA+G V   ++  +G   A+KK++    LS   +    +R E  LL ++ S
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP--LSEEGIPLSTLR-EIALLKQLES 57

Query: 166 HC---IVKLYYSFQDAEY-----LYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQS 215
                IV+L              L L+ E++   D+ T L +  +  L     +  + Q 
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           +  ++ +H H  +HRD+KP N+L+  +G +K++DFGL +
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 5e-15
 Identities = 49/144 (34%), Positives = 72/144 (50%), Gaps = 10/144 (6%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G +G V   ++K +G I A+KK++  E    G       E +LL E+    IV+L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 174 SFQDAEYLYLIMEYLPGGDVMTL--LMR---EETLTETVARFYIAQSVLAIESIHKHNYI 228
                  LYL+ E+L     + L   M       L   + + Y+ Q +  I   H H  +
Sbjct: 66  VVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121

Query: 229 HRDIKPDNLLLDQNGHMKLSDFGL 252
           HRD+KP NLL+D+ G +KL+DFGL
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGL 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 6e-15
 Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 10/164 (6%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D+ ++L  +G+G +G V     + +G   AMK+++    L   +   +  E ++L +  S
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLAIESI 222
             IV  Y +F     +Y+ MEY+  G +  L    +  E + E V R      V  ++ +
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 223 -HKHNYIHRDIKPDNLLLDQNGHMKLSDFG----LCKPLDCTNL 261
             +HN IHRD+KP N+L++ NG +KL DFG    L   L  TN+
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI 162

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 48/165 (29%), Positives = 85/165 (51%), Gaps = 15/165 (9%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER--NLLA 161
            + D+++L  +G G FGEV   ++ K+G + A+KK+    M +      + A R   +L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILK 62

Query: 162 EVASHCIVKL---YYSFQDAEY-----LYLIMEYLPGGDVMTLLMREE-TLTETVARFYI 212
           ++    +V L        D        +Y++  Y+   D+  LL      LTE+  + Y+
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYM 121

Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            Q +  I  +H+++ +HRDIK  N+L+D  G +K++DFGL +P D
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 47/148 (31%), Positives = 83/148 (56%), Gaps = 4/148 (2%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + ++++  +G GAFG+V   Q K++G + A K +      S  ++E    E ++LA    
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 61

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
             IVKL  +F     L++++E+  GG V  +++  E  LTE   R    Q++ A+  +H+
Sbjct: 62  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +  IHRD+K  N+L   +G +KL+DFG+
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGV 149

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 57/239 (23%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLAEVA 164
           +DF+L+  IG G +G+V   +   +G + A+K +K    L  G+    V+ E  ++ +  
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQEIIMMKDCK 64

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
              IV  + S+   + L++ ME+  GG +  +      L+E+   +   +++  +  +H 
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
              +HRDIK  N+LL  NGH+KL+DFG+   +  T                         
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT------------------------- 159

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWLA 340
                                I +RK   S +GTP ++APEV     K GY   CD  A
Sbjct: 160 ---------------------IAKRK---SFIGTPYWMAPEVAAVERKGGYNQLCDIWA 194

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 52/166 (31%), Positives = 87/166 (52%), Gaps = 17/166 (10%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERN 158
           K  VD FD++  IG G +G+V   ++K +G + A+KK++   + E      +  ++  R 
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 159 L-------LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETL---TETVA 208
           L       L E+ +     L +  +D    YL+ EY+   D+M LL  E  L   +E   
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFK-KDKGAFYLVFEYM-DHDLMGLL--ESGLVHFSEDHI 118

Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           + ++ Q +  +   HK N++HRDIK  N+LL+  G +KL+DFGL +
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 14/161 (8%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSG-NIYAMKK-------LKKSEMLSRGQVEHVRAERNL 159
           + +L  +G GAFG V   ++K +G N+ A+K+         K +      +  + +E  +
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 160 LAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDV----MTLLMREETLTETVARFYIAQ 214
           + E   H  IV+ Y +F + + LY++M+ + G  +     +L  +++  TE        Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 215 SVLAIESIHKHNYI-HRDIKPDNLLLDQNGHMKLSDFGLCK 254
            VLA+  +HK   I HRD+ P+N++L ++  + ++DFGL K
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 48/155 (30%), Positives = 82/155 (52%), Gaps = 5/155 (3%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           SV +F+ L  IG G +G V   ++  SG I A+KK++         +  +R E  LL  +
Sbjct: 5   SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNL 63

Query: 164 ASHCIVKLYYSF--QDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIE 220
               IV+L      +  + ++L+MEY    D+ +LL    T  +E+  +  + Q +  ++
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255
            +H++  IHRD+K  NLLL   G +K++DFGL + 
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 16/161 (9%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-----L 160
             +  +  IG GA+G V    + +SG   A+KK+               A+R L     L
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI------PHAFDVPTLAKRTLRELKIL 58

Query: 161 AEVASHCIVKLYYSFQ----DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
                  I+ +    +    D + +Y++M+ L   D+  ++  ++ LTE   R+++ Q +
Sbjct: 59  RHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLL 117

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
             ++ IH  N IHRD+KP NLL++++  +++ DFG+ + L 
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.9 bits (173), Expect = 7e-14
 Identities = 70/254 (27%), Positives = 109/254 (42%), Gaps = 65/254 (25%)

Query: 92  ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
           + E M   R  +S+ D    +     IG+GA G V    +  +G   A+K++    +  +
Sbjct: 1   DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQ 57

Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLT 204
            + E +  E  ++ E+ +  IV    SF   + L+++MEYL GG   DV+T    +E   
Sbjct: 58  PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI 117

Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
             V R    + + A+E +H +  IHRDIK DN+LL  +G +KL+DFG C           
Sbjct: 118 AAVCR----ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA---------- 163

Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIA 323
                                                   QI   +   ST VGTP ++A
Sbjct: 164 ----------------------------------------QITPEQSKRSTMVGTPYWMA 183

Query: 324 PEVLLKKGYGMECD 337
           PEV+ +K YG + D
Sbjct: 184 PEVVTRKAYGPKVD 197

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 5/154 (3%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLAEVAS 165
           D++L+  +G G +G+V   +   +G + A+K +K    L  G     ++ E  ++ E   
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK----LEPGDDFSLIQQEIFMVKECKH 65

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IV  + S+   E L++ MEY  GG +  +      L+E    +   +++  +  +H  
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
             +HRDIK  N+LL  NG +KL+DFG+   +  T
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 67/253 (26%), Positives = 107/253 (42%), Gaps = 63/253 (24%)

Query: 92  ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
           + E +   R  +SV D    +     IG+GA G V    +  +G   A++++   +   +
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61

Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLT 204
              E +  E  ++ E  +  IV    S+   + L+++MEYL GG   DV+T    +E   
Sbjct: 62  ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118

Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
             V R    + + A+E +H +  IHRDIK DN+LL  +G +KL+DFG C           
Sbjct: 119 AAVCR----ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---------- 164

Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
                                              Q+   Q  R  +    VGTP ++AP
Sbjct: 165 -----------------------------------QITPEQSKRSTM----VGTPYWMAP 185

Query: 325 EVLLKKGYGMECD 337
           EV+ +K YG + D
Sbjct: 186 EVVTRKAYGPKVD 198

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 64/258 (24%), Positives = 100/258 (38%), Gaps = 58/258 (22%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           +F +   IGRG F EV            A+KK++  EM+     +    E +LL ++   
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIESI 222
            ++K   SF +   L +++E    GD+  ++     ++  + E     Y  Q   A+E +
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
           H    +HRDIKP N+ +   G +KL D GL                              
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGL------------------------------ 152

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W--- 338
           GRF  S                   +   A+S VGTP Y++PE + + GY  + D W   
Sbjct: 153 GRFFSS-------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLG 193

Query: 339 -LAYWNETLSCNYLSDIM 355
            L Y    L   +  D M
Sbjct: 194 CLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 58/235 (24%), Positives = 94/235 (40%), Gaps = 53/235 (22%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           +F +   IGRG F EV        G   A+KK++  +++          E +LL ++   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIESI 222
            ++K Y SF +   L +++E    GD+  ++     ++  + E     Y  Q   A+E +
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
           H    +HRDIKP N+ +   G +KL D GL                              
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGL------------------------------ 152

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
           GRF  S                   +   A+S VGTP Y++PE + + GY  + D
Sbjct: 153 GRFFSS-------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSD 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 32/138 (23%), Positives = 72/138 (52%), Gaps = 14/138 (10%)

Query: 117 GAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI---VKLYY 173
           G   +V L  + ++   + +K L+KS   SR ++            +  HC+   V L+ 
Sbjct: 4   GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLT-----------IIPHCVPNMVCLHK 52

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
                + ++L++++  GG + + + +   + E   + + A+ V+A++++H+   + RD+ 
Sbjct: 53  YIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN 112

Query: 234 PDNLLLDQNGHMKLSDFG 251
           P+N+LLD  GH++L+ F 
Sbjct: 113 PNNILLDDRGHIQLTYFS 130

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.4 bits (169), Expect = 3e-13
 Identities = 68/254 (26%), Positives = 107/254 (42%), Gaps = 65/254 (25%)

Query: 92  ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
           + E +   R  +SV D    +     IG+GA G V    +  +G   A+K++   +   +
Sbjct: 1   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60

Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLT 204
              E +  E  ++ E  +  IV    S+   + L+++MEYL GG   DV+T    +E   
Sbjct: 61  ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117

Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
             V R    + + A++ +H +  IHRDIK DN+LL  +G +KL+DFG C           
Sbjct: 118 AAVCR----ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---------- 163

Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIA 323
                                                   QI   +   ST VGTP ++A
Sbjct: 164 ----------------------------------------QITPEQSKRSTMVGTPYWMA 183

Query: 324 PEVLLKKGYGMECD 337
           PEV+ +K YG + D
Sbjct: 184 PEVVTRKAYGPKVD 197

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 24/164 (14%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++ L  IG G +G+V   ++K +G + A+KK  + EM   G       E +LL  + S
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQML-S 58

Query: 166 HC--IVKLYYSFQDAEY---------LYLIMEYLPGGDVMTLLMRE-----ETLTETVAR 209
               IV+L     D E+         LYL+ EYL   D+   +          L     +
Sbjct: 59  ESIYIVRLL----DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113

Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGL 252
            ++ Q +  +   HKH  +HRD+KP NLL+D Q G +K++D GL
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 7/158 (4%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L+  +G G FGEV +     S  + A+K LK   M     V+    E NL+ 
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMK 56

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAI 219
            +    +V+LY      E +Y+I EY+  G ++  L  +E     + +   + AQ    +
Sbjct: 57  TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 116

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
             I + NYIHRD++  N+L+ ++   K++DFGL + ++
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 56/230 (24%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHCIVKL 171
           +G+G+FG V L ++KK+     +K LK+  +  L+  +      E  LL+++    IVK 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 172 YYSFQDAEYLYLIMEYLPGGD----VMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           + SF + +   +I EY  G D    +  L    +TL+E     +  Q +L +  +H+   
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           +HRD+K  N+ L +N  +K+ DFG+                               R   
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGV------------------------------SRLLM 156

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
             C                    LA +  GTP Y++PE L  +GY  + D
Sbjct: 157 GSC-------------------DLATTFTGTPYYMSPEALKHQGYDSKSD 187

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 1/148 (0%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           ++ L  IG G +G V   + +++  I A+K+++  +    G       E  LL E+    
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKN 60

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           IV+LY      + L L+ EY               +   + + ++ Q +  +   H HN 
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKP 255
           +HRD+KP NLL+++NG +KL+DFGL + 
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 49/149 (32%), Positives = 74/149 (49%), Gaps = 7/149 (4%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RGQVEHVRAERNLLAEV 163
           DDF+ L  +G G  G V     + SG I A +KL   E+    R Q+  +R E  +L E 
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIKPAIRNQI--IR-ELKVLHEC 56

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV-ARFYIAQSVLAIESI 222
            S  IV  Y +F     + + ME++ GG +  +L +   + E +  +  IA         
Sbjct: 57  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLR 116

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
            KH  +HRD+KP N+L++  G +KL DFG
Sbjct: 117 EKHKIMHRDVKPSNILVNSRGEIKLCDFG 145

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 40/152 (26%), Positives = 78/152 (51%), Gaps = 12/152 (7%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-----LSRGQVE----HVRAERNL--LAE 162
           +G G +G+V    +  +G I A+KK+K  E+       R  V     H    R L  + E
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
           +    I+ L   + + +++ L+M+ +   D+  ++ R+  LTE+  +  + Q +  +  +
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           HK  ++HRD+ P N+ ++  G  K++DFGL +
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 41/151 (27%), Positives = 80/151 (52%), Gaps = 4/151 (2%)

Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
            + ++G+G++GEV L + +  G  Y +KKL      SR + +    E  LL+++    IV
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIV 62

Query: 170 KLYYSFQDAE-YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHN 226
               S++  +  LY++M +  GGD+   L  +  + L E     +  Q  +A++ +H+ +
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122

Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            +HRD+K  N+ L +   +K+ D G+ + L+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 6/143 (4%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
                   Y+I E++  G+++  L     + +   V  +   Q   A+E + K N+IHRD
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129

Query: 232 IKPDNLLLDQNGHMKLSDFGLCK 254
           +   N L+ +N  +K++DFGL +
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR 152

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 64/237 (27%), Positives = 92/237 (38%), Gaps = 63/237 (26%)

Query: 110 LLTIIGR----GAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEVA 164
           L T++GR     AF   R       G+    K + K  ML+   Q  + R+E + LA   
Sbjct: 71  LTTLVGRNPTTAAFVATR-------GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD 123

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGD----VMTLLMREETLTETVARFYIAQSVLAIE 220
              IVK +  F+  + L LIMEY  GGD    +   L       E        Q VLA++
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
            +H    +HRD+K  N+ L   G +KL DFG  K                     ++S+ 
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-------------------QYSDSVS 224

Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
           +D                            +A S  GTP Y+APE+  +K Y  + D
Sbjct: 225 LD----------------------------VASSFCGTPYYLAPELWERKRYSKKAD 253

Length = 478

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 25/160 (15%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK-------------LKKSEMLSRGQVEH 152
             +  L+ IG GA+G V     K +G   A+KK             L++ ++L R + E+
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI 212
           +    +++           + SF D   +Y++ E +   D+  L+ + + L+    ++++
Sbjct: 65  IIGILDII-------RPPSFESFND---VYIVQELMET-DLYKLI-KTQHLSNDHIQYFL 112

Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            Q +  ++ IH  N +HRD+KP NLLL+ N  +K+ DFGL
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGL 152

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 49/162 (30%), Positives = 89/162 (54%), Gaps = 16/162 (9%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           +++   ++D + L  IG G  G+V   + KK+G++ A+K+++++      + E+ R   +
Sbjct: 8   QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMD 63

Query: 159 LLAEVASH-C--IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ- 214
           L   + SH C  IVK Y  F     +++ ME L    +  LL R   +   +    + + 
Sbjct: 64  LDVVLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKR---IQGPIPEDILGKM 119

Query: 215 SVLAIESIH----KHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +V  ++++H    KH  IHRD+KP N+LLD +G++KL DFG+
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI 161

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 3/151 (1%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG G+FG V   ++ ++  + A+KK+  S   S  + + +  E   L ++    
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
            ++    +      +L+MEY  G     L + ++ L E         ++  +  +H H  
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFG---LCKP 255
           IHRDIK  N+LL + G +KL+DFG   L  P
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSP 167

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 17/159 (10%)

Query: 109 DLLTIIGRGAFGE--VRLCQEKKSGNIYAMKKL----KKSEMLSRGQVEHVRAERNLLAE 162
           +LLT+IG+       V L + K +  + A+KK+       E L   Q E +   R L   
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQE-IITSRQL--- 56

Query: 163 VASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLA 218
              H  I+    SF     LY++   +  G     L++    E L E    F +   + A
Sbjct: 57  --QHPNILPYVTSFIVDSELYVVSPLMAYGSC-EDLLKTHFPEGLPELAIAFILKDVLNA 113

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           ++ IH   +IHR +K  ++LL  +G + LS       + 
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 42/171 (24%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-- 163
           +D   L  IGRGAFG V     K SG I A+K+++ S +  + Q       + LL ++  
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQ-------KRLLMDLDV 55

Query: 164 ---ASHC--IVKLY---YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV---ARFYI 212
              +S C  IVK Y   +   D    ++ ME      +M + +  +   + V    +  I
Sbjct: 56  VMRSSDCPYIVKFYGALFREGDC---WICME------LMDISL--DKFYKYVYEVLKSVI 104

Query: 213 AQSVLA------IESIH----KHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
            + +L       +++++    +   IHRD+KP N+LLD+NG++KL DFG+ 
Sbjct: 105 PEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 15/162 (9%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL---KKSEMLSRGQVEHVRAERNL-- 159
           V  ++ L  IG+G FGEV   + KK+  I A+KK+    + E      +  ++  + L  
Sbjct: 11  VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70

Query: 160 -----LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIA 213
                L E+   C  K     +     YL+ E+    D+  LL  +    T +  +  + 
Sbjct: 71  ENVVNLIEI---CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMK 126

Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255
             +  +  IH++  +HRD+K  N+L+ ++G +KL+DFGL + 
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 11/156 (7%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D ++ +  IG G +G V   +++ +    A+KK++  E    G       E +LL E+ 
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQ 59

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYL-----PGGDVMTLLMREETLTETVARFYIAQSVLAI 219
              IV+L       + LYL+ EYL        D      +   L +T    Y+ Q +  I
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT----YLYQILRGI 115

Query: 220 ESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCK 254
              H H  +HRD+KP NLL+D+    +KL+DFGL +
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 64.0 bits (155), Expect = 2e-11
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 5/175 (2%)

Query: 77  PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
           P   +   LKD E  E  + +    K+  D    L  IG G+FG V   ++ ++  + A+
Sbjct: 1   PSTSRAGSLKDPEIAEL-FFKEDPEKLFTD----LREIGHGSFGAVYFARDVRTNEVVAI 55

Query: 137 KKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL 196
           KK+  S   S  + + +  E   L  +     ++    +      +L+MEY  G     L
Sbjct: 56  KKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLL 115

Query: 197 LMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
            + ++ L E         ++  +  +H HN IHRDIK  N+LL + G +KL+DFG
Sbjct: 116 EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG 170

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 66/243 (27%), Positives = 106/243 (43%), Gaps = 64/243 (26%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR--AERNLLAEVAS 165
           +D++ +IG+G  GEV L  +       A+KK+++   LS   +   R   E  + A++  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED--LSENPLLKKRFLREAKIAADLIH 61

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM---REETLTETVARFYIAQSVLA---- 218
             IV +Y    D + +Y  M Y+ G  + +LL    ++E+L++ +A      SV A    
Sbjct: 62  PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFLSI 118

Query: 219 -------IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
                  IE +H    +HRD+KPDN+LL   G + + D+G         +    E E L 
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA-------IFKKLEEEDLL 171

Query: 272 DENLNE------SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
           D +++E      SM + G+                               VGTPDY+APE
Sbjct: 172 DIDVDERNICYSSMTIPGKI------------------------------VGTPDYMAPE 201

Query: 326 VLL 328
            LL
Sbjct: 202 RLL 204

Length = 932

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 8/164 (4%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      E   AE NL+ 
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMK 56

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G ++  L   E +  T+ +     AQ    +
Sbjct: 57  QLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+ +    K++DFGL + ++    +A
Sbjct: 116 AFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 8/157 (5%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL-KKSEMLSRGQVEHVRAERNLLAE 162
           S+ + + +  IG GA G V     + +G +YA+K +    E   R Q+     E  +L +
Sbjct: 72  SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR---EIEILRD 128

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
           V    +VK +  F     + +++E++ GG +    + +E     VAR    Q +  I  +
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYL 184

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
           H+ + +HRDIKP NLL++   ++K++DFG+ + L  T
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221

Length = 353

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 12/156 (7%)

Query: 111 LTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           +  +G+G FG V LC+    +  +G + A+KKL+ S   +   +     E  +L  +   
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHD 65

Query: 167 CIVK---LYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESI 222
            IVK   + YS      L L+MEYLP G +   L +  E L       Y +Q    +E +
Sbjct: 66  NIVKYKGVCYSAGRRN-LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258
               Y+HRD+   N+L++    +K+ DFGL K L  
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 68/260 (26%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I+  +  L   IG+G FG+V L   +  G   A+K LK          +   A +  LAE
Sbjct: 3   INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK----------DDSTAAQAFLAE 50

Query: 163 VA-----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQS 215
            +      H  +V+L         LY++ EY+  G ++  L  R   +     +   A  
Sbjct: 51  ASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD 110

Query: 216 VL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
           V   +E + + N++HRD+   N+L+ ++   K+SDFGL K                 + +
Sbjct: 111 VCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----------------EAS 153

Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQH----------------WQINRRKLAYSTVGT 318
             +     G+ P      +W +P E L+                 W+I     ++  V  
Sbjct: 154 QGQDS---GKLP-----VKWTAP-EALREKKFSTKSDVWSFGILLWEI----YSFGRVPY 200

Query: 319 PDYIAPEVL--LKKGYGMEC 336
           P     +V+  ++KGY ME 
Sbjct: 201 PRIPLKDVVPHVEKGYRMEA 220

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.0 bits (153), Expect = 4e-11
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 15/156 (9%)

Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNLLAEVASHC 167
           L  +G GA+G V    ++++G   A+KKL +   SE+ ++     +R    LL  +    
Sbjct: 20  LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKHMKHEN 75

Query: 168 IVKLYYSFQDAEYL------YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
           ++ L   F     L      YL+M ++  G  +  LM+ E L+E   +F + Q +  ++ 
Sbjct: 76  VIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKY 133

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           IH    IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 29/162 (17%)

Query: 108 FDLLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKL----KKSEMLSRGQVE-----HVR 154
           ++L+  +G+GA+G V  C     E       A+KK+     K  +  R   E     H R
Sbjct: 2   YELIKELGQGAYGIV--CSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59

Query: 155 AERNLLAEVASHCIVKL---YYSFQDAEYLYL-IMEYLPGGDVMTLLMREETLTETVARF 210
             +N+       C+  +   +    +  YLY  +ME     D+  ++   + LT+   + 
Sbjct: 60  GHKNIT------CLYDMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQPLTDAHFQS 109

Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +I Q +  ++ IH  N +HRD+KP NLL++ +  +K+ DFGL
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGL 151

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 62.0 bits (150), Expect = 7e-11
 Identities = 40/144 (27%), Positives = 69/144 (47%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG G+FG V   ++ ++  + A+KK+  S   S  + + +  E   L ++    
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
            ++    +      +L+MEY  G     L + ++ L E         ++  +  +H HN 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFG 251
           IHRD+K  N+LL + G +KL DFG
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFG 160

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 26/161 (16%)

Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNL--LAEVAS 165
           L  +G GA+G V    +K++G   A+KKL +   SE+ ++      RA R L  L  +  
Sbjct: 20  LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAK------RAYRELTLLKHMQH 73

Query: 166 HCIVKL---------YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
             ++ L            FQD    YL+M Y+   D+  ++     L+E   ++ + Q +
Sbjct: 74  ENVIGLLDVFTSAVSGDEFQD---FYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQML 127

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
             ++ IH    IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           +G GAFG V   +++ +G   A+KK+ K   + +L++        E  LL  +    I+ 
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK----RTYRELKLLKHLRHENIIS 73

Query: 171 LYYSF-QDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
           L   F    E +Y + E L G D+  LL     L +   ++++ Q +  ++ +H    +H
Sbjct: 74  LSDIFISPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSAGVVH 131

Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           RD+KP N+L+++N  +K+ DFGL +  D
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQD 159

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 61.4 bits (149), Expect = 8e-11
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 19/154 (12%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC----- 167
           ++G+G +G V   ++  +    A+K++ + +          R  + L  E+A H      
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---------RYVQPLHEEIALHSYLKHR 65

Query: 168 -IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIH 223
            IV+   S  +  +  + ME +PGG +  LL  +       E    FY  Q +  ++ +H
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 224 KHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPL 256
            +  +HRDIK DN+L++  +G +K+SDFG  K L
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 47/155 (30%), Positives = 69/155 (44%), Gaps = 23/155 (14%)

Query: 114 IGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRA----ERNLLAEVAS 165
           +G G FG+V LC        +G   A+K L  S        E  R+    E  +L  +  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS------GEEQHRSDFEREIEILRTLDH 65

Query: 166 HCIVKLYYSFQDAEY--LYLIMEYLPGGDVMTLL--MREETLTETVARF--YIAQSVLAI 219
             IVK     +      L LIMEYLP G +   L   R++   + +  F   I + +  +
Sbjct: 66  ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            S     YIHRD+   N+L++    +K+SDFGL K
Sbjct: 126 GSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 11/152 (7%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL---KKSEMLSRGQVEHVRAERNLLAE 162
           +D + ++ +G G  G V   +   +G + A K +    KS +  R Q+  +R E  ++ E
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV--RKQI--LR-ELQIMHE 59

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA--IE 220
             S  IV  Y +F +   + + ME++  G +  +  +   +   +    IA +V+     
Sbjct: 60  CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-KIAVAVVEGLTY 118

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             + H  +HRDIKP N+L++  G +KL DFG+
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGV 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 15/156 (9%)

Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNLLAEVASHC 167
           L+ +G GA+G+V    + K+G   A+KKL +   S + ++     +R    LL  +    
Sbjct: 20  LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR----LLKHMDHEN 75

Query: 168 IVKLYYSFQDAEYL------YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
           ++ L   F  A  L      YL+   L G D+   +++ + L++   +F + Q +  ++ 
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNN-IVKCQKLSDDHIQFLVYQILRGLKY 133

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           IH    IHRD+KP N+ ++++  +K+ DFGL +  D
Sbjct: 134 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 2/161 (1%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++ L  +G G++  V   + K +G + A+K ++  E    G       E +LL  +  
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IV L+      E L L+ EY+       +      L     + ++ Q +  +  IH+ 
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266
             +HRD+KP NLL+   G +KL+DFGL +     + +  NE
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 3/152 (1%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ ++ +G G  G V   Q K SG I A +KL   E+    + + +R E  +L E  S
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 62

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV-ARFYIAQSVLAIESIHK 224
             IV  Y +F     + + ME++ GG +  +L   + + E +  +  IA          K
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           H  +HRD+KP N+L++  G +KL DFG+   L
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 38/138 (27%), Positives = 65/138 (47%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V       +  + A+KK+  S   +  + + +  E   L ++     ++   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
            +      +L+MEY  G     L + ++ L E         ++  +  +H HN IHRDIK
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148

Query: 234 PDNLLLDQNGHMKLSDFG 251
             N+LL + G +KL+DFG
Sbjct: 149 AGNILLTEPGQVKLADFG 166

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 9/155 (5%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ ++ +G G  G V     K SG I A +KL   E+    + + +R E  +L E  S
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 62

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI--- 222
             IV  Y +F     + + ME++ GG +  +L +   + E +       S+  I+ +   
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYL 119

Query: 223 -HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             KH  +HRD+KP N+L++  G +KL DFG+   L
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 75/245 (30%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-- 163
           DD +++  +GRGA+G V   +   +G I A+K++       R  V   + ++ LL ++  
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVN-SQEQKRLLMDLDI 52

Query: 164 ---ASHC--IVKLYYS-FQDAEYLYLIME-------------YLPGGDVMTLLMREETLT 204
              +  C   V  Y + F++ + +++ ME             Y  G     L + E+ L 
Sbjct: 53  SMRSVDCPYTVTFYGALFREGD-VWICMEVMDTSLDKFYKKVYDKG-----LTIPEDILG 106

Query: 205 ETVARFYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFG--------LCK 254
           +      IA S++ A+E +H K + IHRD+KP N+L+++NG +KL DFG        + K
Sbjct: 107 K------IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160

Query: 255 PLD--CTNLSAINENEVLDDENLNESMDVD---------------GRFPESGCGRRWKSP 297
            +D  C    A    E ++ E   +  DV                GRFP       WK+P
Sbjct: 161 TIDAGCKPYMA---PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD----SWKTP 213

Query: 298 LEQLQ 302
            +QL+
Sbjct: 214 FQQLK 218

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 6/146 (4%)

Query: 114 IGRGAFGEVR--LCQEKKSGNI-YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           +G G FG V   +   K    +  A+K LK+  + + G+ E +R E +++A++   CIV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLR-EASVMAQLDHPCIVR 60

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
           L    +  E L L+ME  P G ++  L +   +  +  +    Q  + +  +   +++HR
Sbjct: 61  LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPL 256
           D+   N+LL      K+SDFG+ + L
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 58.4 bits (141), Expect = 8e-10
 Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 27/196 (13%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I   D   L  +G G FG V+  + +   ++ A+K +K+  M     +E  +    L  E
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHE 59

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIES 221
                +V+LY        +Y++ EY+  G ++  L       +      + + V   +  
Sbjct: 60  K----LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +    +IHRD+   N L+D  G +K+SDFGL +              VLDDE  +    V
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR-------------YVLDDEYTSS---V 159

Query: 282 DGRFPESGCGRRWKSP 297
             +FP      RW  P
Sbjct: 160 GSKFPV-----RWSPP 170

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 6/150 (4%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAERNLLAEVASH 166
           F  L  +G G +  V   + + +G I A+K++   +E    G       E +L+ E+   
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHE 58

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGG--DVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
            IV+L+        L L+ EY+       M        L     + +  Q +  I   H+
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           +  +HRD+KP NLL+++ G +KL+DFGL +
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 64/260 (24%), Positives = 110/260 (42%), Gaps = 53/260 (20%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G FGEV +    K   + A+K +K   M     VE   AE N++  +    +VKL+ 
Sbjct: 14  LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 67

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIESIHKHNYIHRD 231
           +    E +Y+I E++  G ++  L  +E   + + +   + AQ    +  I + NYIHRD
Sbjct: 68  AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           ++  N+L+  +   K++DFGL +         I +NE    E          +FP     
Sbjct: 128 LRAANILVSASLVCKIADFGLAR--------VIEDNEYTAREG--------AKFP----- 166

Query: 292 RRWKSPLEQLQHWQINRRK------------LAYSTVGTPDYIAPEVL--LKKGYGMECD 337
            +W +P E +       +             + Y  +  P    PEV+  L++GY M   
Sbjct: 167 IKWTAP-EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-- 223

Query: 338 WLAYWNETLSC-NYLSDIML 356
                    +C   L +IM+
Sbjct: 224 ------RPENCPEELYNIMM 237

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 9/158 (5%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + +  L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +  
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKH 75

Query: 166 HCIVKLYYSFQDAEYL------YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
             ++ L   F  A  L      YL+  +L G D+  ++ + + LT+   +F I Q +  +
Sbjct: 76  ENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQILRGL 133

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           + IH  + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 25/156 (16%)

Query: 114 IGRGAFGEV-----RLCQE----KKSGNIY-----AMKKLKKSEMLSRGQVEHVRAERNL 159
           IGRGA+G V         E    KK  N +     A + L++ ++L     E+V A +++
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
           +             +F D   +Y +M+     D+  ++   +TL++   ++++ Q +  +
Sbjct: 73  MPPPHRE-------AFNDVYIVYELMD----TDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255
           + IH  N +HRD+KP NLLL+ N  +K+ DFGL + 
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 14/145 (9%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG+G FG+V     K +  + A+K  +    L          E  +L +     IVKL  
Sbjct: 3   IGKGNFGDVYKGVLKGNTEV-AVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREE------TLTETVARFYIAQSVLAIESIHKHNY 227
                + +Y++ME +PGG ++T L +++       L +       A  +  +ES    N 
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD--AAAGMEYLES---KNC 114

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGL 252
           IHRD+   N L+ +N  +K+SDFG+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGM 139

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 14/151 (9%)

Query: 113 IIGRGAFGEVR--LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           ++G+G FGEV     ++K    +   K+    E+  +       +E  +L +     IVK
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYI--AQSVLAIESIHKHN 226
           L       + +Y++ME +PGGD ++ L +  +E  T+ + +F +  A  +  +ES    N
Sbjct: 57  LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KN 113

Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            IHRD+   N L+ +N  +K+SDFG+ +  D
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQED 144

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 18/159 (11%)

Query: 111 LTIIGRGAFGEVRLCQEKKS--GNIYAMKKLKKSEMLSRGQVEHV----RAERNLLAEVA 164
           +T +GRG FGEV L + K         +  +K    L + + E++    R E ++  +++
Sbjct: 10  ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRRELDMFRKLS 66

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM----REETL----TETVARFYIA-QS 215
              +V+L    ++AE  Y+I+EY   GD+   L     ++E L      T  +  +  Q 
Sbjct: 67  HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            L ++ +    ++HRD+   N L+     +K+S   L K
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 13/153 (8%)

Query: 114 IGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRG-QVEHVRAERNLLAEVASHCI 168
           +G G FG+V LC    +   +G   A+K LK     S G  +  ++ E  +L  +    I
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE---SGGNHIADLKKEIEILRNLYHENI 68

Query: 169 VKLYYSFQDAEY---LYLIMEYLPGGDVMTLLMREETLTETVARF-YIAQSVLAIESIHK 224
           VK Y      +    + LIME+LP G +   L R +       +  Y  Q    ++ +  
Sbjct: 69  VK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
             Y+HRD+   N+L++    +K+ DFGL K ++
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 25/162 (15%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA--- 164
           + +  +IG+G++G V    +  +G   A+KK+           EHV     +L E+    
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKLLR 54

Query: 165 --SHC-IVKLYY--------SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIA 213
              H  IV++ +         F+D   +Y++ E L   D+  ++   + LT    +F++ 
Sbjct: 55  LLRHPDIVEIKHIMLPPSRREFKD---IYVVFE-LMESDLHQVIKANDDLTPEHHQFFLY 110

Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255
           Q + A++ IH  N  HRD+KP N+L + +  +K+ DFGL + 
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 11/148 (7%)

Query: 114 IGRGAFGEVRL-CQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +G G FG+V L C +     +G + A+K LK+     +      + E N+L  +    IV
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIV 69

Query: 170 KLY--YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKHN 226
           K     S Q  + L LIMEY+P G +   L + +     +  F  AQ +   +  +H  +
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF--AQQICEGMAYLHSQH 127

Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           YIHRD+   N+LLD +  +K+ DFGL K
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 21/169 (12%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           +   L  +G G FG V L + +   ++ A+K +++  M     +E  +    L     SH
Sbjct: 5   ELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEAKVMMKL-----SH 58

Query: 167 C-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHK 224
             +V+LY        ++++ EY+  G ++  L   +    T     +   V  A+E +  
Sbjct: 59  PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES 118

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273
           + +IHRD+   N L+ ++  +K+SDFGL +              VLDD+
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLAR-------------YVLDDQ 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 26/165 (15%)

Query: 113 IIGRGAFGEVRLCQEKK-----SGNI-YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
            +G GAFGEV            SG I  A+K L+K       + E +  E +L++     
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFL-KEAHLMSNFNHP 59

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE---------TLTETVAR-FYIAQSV 216
            IVKL       E  Y+IME + GGD+++ L             TL E +     +A+  
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGH-----MKLSDFGLCKPL 256
           + +E +H   +IHRD+   N L+ + G+     +K+ DFGL + +
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 23/160 (14%)

Query: 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKL 171
            ++G GA G V   +    G  +A+K +   E +S       +AE   L       IVK 
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96

Query: 172 YYSF--------QDAEYLYLIMEYLPGGDVMTLLMREE---------TLTETVARFYIAQ 214
           +  F        ++   + L+++Y   GD     +R+E         T  E  A     Q
Sbjct: 97  HEDFAKKDPRNPENVLMIALVLDYANAGD-----LRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +LA+  +H  + IHRDIK  N+LL  NG +KL DFG  K
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191

Length = 496

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 23/169 (13%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSG--NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +D     +IG G FG+V   + KK G     A+K++K  E  S+        E  +L ++
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKL 64

Query: 164 ASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES- 221
             H  I+ L  + +   YLYL +EY P G+++  L R+  + ET   F IA S  +  S 
Sbjct: 65  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 123

Query: 222 ----------------IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                           + +  +IHRD+   N+L+ +N   K++DFGL +
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.4 bits (133), Expect = 9e-09
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 20/153 (13%)

Query: 114 IGRGAFGEVR--LCQEKKSGNIYAMKKLK--------KSEMLSRGQVEHVRAERNLLAEV 163
           +G G FG V+  + + KKS    A+K LK        K E+L          E N++ ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELL---------REANVMQQL 53

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
            +  IV++     +AE   L+ME    G +   L + + +TE      + Q  + ++ + 
Sbjct: 54  DNPYIVRMI-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           + N++HRD+   N+LL    + K+SDFGL K L
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 23/169 (13%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIY--AMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +D     +IG G FG+V     KK G     A+K LK  E  S         E  +L ++
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59

Query: 164 ASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF------------ 210
             H  I+ L  + ++  YLY+ +EY P G+++  L R+  + ET   F            
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118

Query: 211 -----YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                + +     ++ + +  +IHRD+   N+L+ +N   K++DFGL +
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 17/157 (10%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I  +   L   +G G FGEV +     +  + A+K LK   M      E    E  ++ +
Sbjct: 3   IPRESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKK 57

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-------MREETLTETVARFYIAQS 215
           +    +V+LY    + E +Y++ EY+  G ++  L       +R   L +  A+  IA+ 
Sbjct: 58  LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ--IAEG 115

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +  +ES    NYIHRD+   N+L+ +N   K++DFGL
Sbjct: 116 MAYLES---RNYIHRDLAARNILVGENLVCKIADFGL 149

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 17/154 (11%)

Query: 114 IGRGAFGEVRLCQE-KKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASH-CI 168
           IG GA+G+V   ++ K  G   A+K+++     E +    +  V   R+L  E   H  +
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL--ETFEHPNV 66

Query: 169 VKLY----YSFQDAEY-LYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIE 220
           V+L+     S  D E  L L+ E++   D+ T L +       TET+    + Q +  ++
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM-MFQLLRGLD 124

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +H H  +HRD+KP N+L+  +G +KL+DFGL +
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 2/141 (1%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +  V   + K + N+ A+K+++       G       E +LL  +    IV L+ 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
                  L L+ EYL       L      ++    + ++ Q +  +   HK   +HRD+K
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130

Query: 234 PDNLLLDQNGHMKLSDFGLCK 254
           P NLL+++ G +KL+DFGL +
Sbjct: 131 PQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 20/153 (13%)

Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L  +G G +  V   + K + N+ A+K+++       G       E +LL ++    IV 
Sbjct: 11  LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68

Query: 171 LYYSFQDAEYLYLIMEYLPG---------GDVMTLLMREETLTETVARFYIAQSVLAIES 221
           L+      + L L+ EYL           G++M++            + ++ Q +  +  
Sbjct: 69  LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM---------HNVKIFLYQILRGLAY 119

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H+   +HRD+KP NLL+++ G +KL+DFGL +
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 10/148 (6%)

Query: 114 IGRGAFGEVR---LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           +G G FG V+       KK  ++ A+K LK      +   + +  E  ++ ++ +  IV+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVLAIESIHKHNYI 228
           +     +AE L L+ME   GG +   L   ++E     V    + Q  + ++ +   N++
Sbjct: 60  MI-GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYLEGKNFV 117

Query: 229 HRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           HRD+   N+LL    + K+SDFGL K L
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKAL 145

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 2/144 (1%)

Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L  +G G +  V   + K + N+ A+K+++       G       E +LL ++    IV 
Sbjct: 11  LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
           L+      + L L+ EYL       L     ++     + ++ Q +  +   H+   +HR
Sbjct: 69  LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 231 DIKPDNLLLDQNGHMKLSDFGLCK 254
           D+KP NLL+++ G +KL+DFGL +
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 32/110 (29%), Positives = 51/110 (46%), Gaps = 2/110 (1%)

Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
           E +LL  +    IV L+      E L  + EY+       ++     L     R ++ Q 
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL 112

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC--KPLDCTNLSA 263
           +  +  IH  + +HRD+KP NLL+   G +KL+DFGL   K +     S+
Sbjct: 113 LRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 44/185 (23%), Positives = 84/185 (45%), Gaps = 27/185 (14%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G FG V L + +    + A+K + +  M     +E    E  ++ +++   +V+LY 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYG 66

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKHNYIHRDI 232
                + LY++ E++  G ++  L + +          + Q V   +E + ++++IHRD+
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126

Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
              N L+   G +K+SDFG+ +              VLDDE  + S     +FP      
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTR-------------YVLDDEYTSSS---GAKFP-----V 165

Query: 293 RWKSP 297
           +W  P
Sbjct: 166 KWSPP 170

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 8/155 (5%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L+  +G G FGEV +     +  + A+K LK   M     +E    E  ++ 
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMK 56

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAI 219
           ++    +V+LY +    E +Y++ EY+  G ++  L   E     +       AQ    +
Sbjct: 57  KLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             I + NYIHRD++  N+L+      K++DFGL +
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 21/169 (12%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRL--CQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAER 157
           +  D   L   +G GAFG+V L  C   +  N   + A+K LK  E  S    +    E 
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREA 59

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR--------------EETL 203
            LL       IVK Y    + +   ++ EY+  GD+   L                   L
Sbjct: 60  ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 204 TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           T +       Q    +  +   +++HRD+   N L+  +  +K+ DFG+
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 9/153 (5%)

Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           LT +G GA+G V    + +     A+KKL +    S         E  LL  +    ++ 
Sbjct: 20  LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHMKHENVIG 78

Query: 171 LY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
           L        S ++   +YL+   L G D+  ++ + + L++   +F I Q +  ++ IH 
Sbjct: 79  LLDVFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              IHRD+KP N+ ++++  +++ DFGL +  D
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 7/159 (4%)

Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNI-YAMKKLKKSEMLSRGQVEHVRAERNL 159
           I  +D  L   IG G FG+V   +    ++  I  A+K  K     S    E    E  +
Sbjct: 3   IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYI 60

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV-MTLLMREETLTETVARFYIAQSVLA 218
           + +     IVKL     +   ++++ME  P G++   L + + +L       Y  Q   A
Sbjct: 61  MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +  +    ++HRDI   N+L+     +KL DFGL + L+
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 14/155 (9%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G+G FGEV +     +  + A+K LK   M     ++  +  + L  E     +V+LY 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEK----LVQLYA 68

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF-----YIAQSVLAIESIHKHNYI 228
              + E +Y++ EY+  G ++  L  E        R        AQ    +  + + NY+
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYV 124

Query: 229 HRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           HRD++  N+L+ +N   K++DFGL + ++    +A
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 3/142 (2%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IGRG FGEV   + +      A+K  +  E L          E  +L + +   IV+L  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA-IESIHKHNYIHRDI 232
                + +Y++ME + GGD +T L  E    +      + ++  A +E +   + IHRD+
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 233 KPDNLLLDQNGHMKLSDFGLCK 254
              N L+ +   +K+SDFG+ +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 42/164 (25%), Positives = 81/164 (49%), Gaps = 10/164 (6%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +++ +  LL  IG+G FG+V L   +  GN  A+K +K          +   AE +++ +
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQ 55

Query: 163 VASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVL-AI 219
           +    +V+L     ++   LY++ EY+  G ++  L  R  ++         +  V  A+
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           E +  +N++HRD+   N+L+ ++   K+SDFGL K    T  + 
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 19/160 (11%)

Query: 113 IIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVK 170
           +IG G FG+V   + KK G  + A  K  K E  S+        E  +L ++  H  I+ 
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTE--TVARFYIAQSVLA---------- 218
           L  + +   YLYL +EY P G+++  L +   L      A      S L+          
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 219 ----IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
               ++ + +  +IHRD+   N+L+ +N   K++DFGL +
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 12/165 (7%)

Query: 103 ISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
           I      +  +IG G FGEV   RL    K     A+K LK     S  Q      E ++
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASI 58

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE---TLTETVARFY-IAQS 215
           + +     I++L      +  + +I EY+  G +   L   +   T+ + V     IA  
Sbjct: 59  MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIAS- 117

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
              ++ + + NY+HRD+   N+L++ N   K+SDFGL + L+ + 
Sbjct: 118 --GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 50.1 bits (119), Expect = 5e-07
 Identities = 37/152 (24%), Positives = 76/152 (50%), Gaps = 8/152 (5%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G+G FGEV +     +  + A+K LK   M+    ++    E  ++ ++    +V LY 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPLYA 68

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA--IESIHKHNYIHRD 231
              + E +Y++ E++  G ++  L   +     + +     + +A  +  I + NYIHRD
Sbjct: 69  VVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           ++  N+L+  N   K++DFGL + ++    +A
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 20/38 (52%), Positives = 23/38 (60%), Gaps = 5/38 (13%)

Query: 311 LAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSC 348
            A S VG+PDY+APEVL  KGY    D   YW  +L C
Sbjct: 154 YANSVVGSPDYMAPEVLRGKGYDFTVD---YW--SLGC 186

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 11/156 (7%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I      LL  +G G FGEV       +  + A+K LK   M      +   AE  ++ +
Sbjct: 3   IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKK 57

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE----TLTETVARFYIAQSVLA 218
           +    +++LY      E +Y++ E +  G ++  L         L + +     AQ    
Sbjct: 58  LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID--MAAQVASG 115

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           +  +   NYIHRD+   N+L+ +N   K++DFGL +
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 30/193 (15%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV------RLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           +KRH I      L   +G GAFG+V       LC E+    + A+K LK +   +R    
Sbjct: 2   IKRHNIV-----LKRELGEGAFGKVFLAECYNLCPEQDK-ILVAVKTLKDASDNARKDF- 54

Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVM---------TLLMRE-- 200
           H  AE  LL  +    IVK Y    + + L ++ EY+  GD+           +LM E  
Sbjct: 55  HREAE--LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 112

Query: 201 --ETLTETVARFYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
               LT++    +IAQ + A +  +   +++HRD+   N L+ +N  +K+ DFG+ + + 
Sbjct: 113 RPAELTQS-QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171

Query: 258 CTNLSAINENEVL 270
            T+   +  + +L
Sbjct: 172 STDYYRVGGHTML 184

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 18/163 (11%)

Query: 108 FDLLTIIGRGAFGEVR---LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           F L  ++G+G FG VR   L  E  S    A+K LK +++ S   +E    E   + E  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59

Query: 165 SHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMR----EETLT---ETVARFY 211
              ++KL        +        +I+ ++  GD+ T L+     EE  T   +T+ RF 
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           I      +E +   N+IHRD+   N +L++N  + ++DFGL K
Sbjct: 120 I-DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 14/156 (8%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASH-CIV 169
           IG GA+G V   ++  SG+  A+K ++     + L    V  V   + L  E   H  IV
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRL--EAFDHPNIV 65

Query: 170 KLY----YSFQDAEY-LYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESI 222
           +L      S  D E  + L+ E++   D+ T L +     L     +  + Q +  ++ +
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258
           H +  +HRD+KP+N+L+   G +KL+DFGL +   C
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 27/165 (16%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL------KKSEMLSRGQVEHVRAERNLLA 161
           + L  IIG G+FG V       +    A+KK+      K  E+L    + H+    N++ 
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NII- 122

Query: 162 EVASHCIVKLYY---SFQDAE---YLYLIMEYLPGG--DVMTLLMRE-ETLTETVARFYI 212
                  +K YY    F+  E   +L ++ME++P      M    R    L   + + Y 
Sbjct: 123 ------FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS 176

Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH-MKLSDFGLCKPL 256
            Q   A+  IH     HRD+KP NLL+D N H +KL DFG  K L
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Length = 440

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 40/182 (21%)

Query: 109 DLLTI---IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ--------VEHVRAER 157
             LT    +G G FGEV LC+ +       M+K    +              V+ +R + 
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAE------GMEKFMDKDFSLDVSGNQPVLVAVKMLREDA 58

Query: 158 N------------LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE---- 201
           N            +++ +    I++L      ++ L +I EY+  GD+   L R E    
Sbjct: 59  NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118

Query: 202 -------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                  T++ +   F   Q    ++ +   N++HRD+   N L+ +N  +K++DFG+ +
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 255 PL 256
            L
Sbjct: 179 NL 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 23/78 (29%), Positives = 46/78 (58%), Gaps = 3/78 (3%)

Query: 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 240
           +Y++ EY+     +  ++ +  L+E  AR ++ Q +  ++ IH  N +HRD+KP N+ ++
Sbjct: 91  VYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148

Query: 241 QNGHM-KLSDFGLCKPLD 257
               + K+ DFGL + +D
Sbjct: 149 TEDLVLKIGDFGLARIVD 166

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 18/155 (11%)

Query: 113 IIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +IG G FGEV     K  G      A+K LK     +  Q +   +E +++ + + H I+
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNII 69

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI------- 222
           +L       +   +I EY+  G +      ++ L +    F   Q V  +  I       
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGAL------DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              NY+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 25/155 (16%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKL--------------KKSEMLSRGQVEHVRAERNL 159
           IG GAFG V    + + G   A+KK+              ++ +ML   + ++V +  ++
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
           L                  E +Y++ E L   D+  +++  + L+    + ++ Q +  +
Sbjct: 68  LQPPHIDPF----------EEIYVVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGL 116

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           + +H    +HRDIKP NLL++ N  +K+ DFGL +
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 24/155 (15%)

Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR--GQVEHV-RAERNL-LAEVASH 166
           L  IG GA G V    +  +G   A+KKL      SR    V H  RA R L L ++ +H
Sbjct: 21  LKPIGSGAQGIVCAAYDTVTGQNVAIKKL------SRPFQNVTHAKRAYRELVLMKLVNH 74

Query: 167 -CIVKLYYSF------QDAEYLYLIMEYLPGG--DVMTLLMREETLTETVARFYIAQSVL 217
             I+ L   F      ++ + +YL+ME +      V+ + +  E ++     + + Q + 
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLC 129

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            I+ +H    IHRD+KP N+++  +  +K+ DFGL
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 26/159 (16%)

Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR----AERNLLAEVAS 165
           +IG G FGEV   RL    K     A+K LK       G  E  R    +E +++ +   
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS------GYTEKQRRDFLSEASIMGQFDH 64

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI--- 222
             I+ L      +  + +I E++  G + + L + +       +F + Q V  +  I   
Sbjct: 65  PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAG 118

Query: 223 ----HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
                + NY+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 40/167 (23%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH--------VRAE 156
           ++ +  L  +G G++  V   + K +G + A+K+++         +EH        +R E
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR---------LEHEEGAPFTAIR-E 53

Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL-----------PGGDVMTLLMREETLTE 205
            +LL ++    IV L+      + L L+ EYL            GG    L M       
Sbjct: 54  ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG----LSMHN----- 104

Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
              R ++ Q +  +   H+   +HRD+KP NLL+ + G +KL+DFGL
Sbjct: 105 --VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGL 149

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 15/162 (9%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL--LAEVAS 165
           +  L  IG GA G V    +   G   A+KKL +     + Q    RA R L  L  V  
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLLKCVNH 79

Query: 166 HCIVKLYYSF------QDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
             I+ L   F      ++ + +YL+ME +       + M    L      + + Q +  I
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQMLCGI 136

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261
           + +H    IHRD+KP N+++  +  +K+ DFGL +   CTN 
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-CTNF 177

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 9e-06
 Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 14/157 (8%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           +++L+ +  G+ GEV +C   K G+    K + K+    +     +   + +     SH 
Sbjct: 94  YNILSSLTPGSEGEVFVCT--KHGDEQRKKVIVKAVTGGKTPGREIDILKTI-----SHR 146

Query: 168 -IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLT-ETVARFYIAQSVL-AIESIHK 224
            I+ L ++++    + ++M      D+ T + R   L  E      I + +L A+  +H 
Sbjct: 147 AIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA--ITIQRRLLEALAYLHG 203

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFG-LCKPLDCTN 260
              IHRD+K +N+ LD+  +  L DFG  CK     +
Sbjct: 204 RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240

Length = 392

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 18/155 (11%)

Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +IG G FGEV   RL    K     A+K LK        Q     +E +++ +     I+
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNII 68

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI------- 222
            L      ++ + ++ EY+  G +   L + +       +F + Q V  +  I       
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYL 122

Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
               Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 10/152 (6%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLLAEVA 164
           D     I+G G  G V       +  I A+K   L  +  L +     + +E  +L +  
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK----QIMSELEILYKCD 57

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
           S  I+  Y +F     + +  E++ GG   +L +  +     + R  +A  V  +  +  
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGG---SLDVYRKIPEHVLGRIAVA-VVKGLTYLWS 113

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
              +HRD+KP N+L++  G +KL DFG+   L
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 41/181 (22%), Positives = 77/181 (42%), Gaps = 24/181 (13%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE-----RN-------LLA 161
           +G G FGEV LC+ +           +         V+ +RA+     RN       +++
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTE--------TVARFYIA 213
            + +  I++L       + L +I EY+  GD+   L + E  +         +V+   + 
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 214 QSVLAIESIHKH----NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269
              + I S  K+    N++HRD+   N L+  +  +K++DFG+ + L   +   I    V
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAV 192

Query: 270 L 270
           L
Sbjct: 193 L 193

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 66/269 (24%), Positives = 102/269 (37%), Gaps = 66/269 (24%)

Query: 110 LLTIIGRGAFGEV------RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           L   +G G FG+V      RL + +      A+K LK++   S  ++  + +E NLL +V
Sbjct: 4   LGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQV 60

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR------------------------ 199
               ++KLY +      L LI+EY   G + + L                          
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 200 EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
           E  LT      +  Q    ++ + +   +HRD+   N+L+ +   MK+SDFGL + +   
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV--- 177

Query: 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQH--------WQINRRKL 311
                      +D  +  S    GR P      +W +      H        W       
Sbjct: 178 ---------YEEDSYVKRS---KGRIPV-----KWMAIESLFDHIYTTQSDVWSFGVLLW 220

Query: 312 AYSTVGTPDY--IAPE---VLLKKGYGME 335
              T+G   Y  IAPE    LLK GY ME
Sbjct: 221 EIVTLGGNPYPGIAPERLFNLLKTGYRME 249

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 8/110 (7%)

Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQ-DAEYLYLIMEYLPGGDVMTLLMREETLT--E 205
           Q    R E  L A +    IV L  S +     L+ + EY+PG  +  +L  +  L   E
Sbjct: 21  QRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGE 80

Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGL 252
           T     + Q + A+   H    +HRD+KP N+++ Q G   H K+ DFG+
Sbjct: 81  TGR--LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 12/151 (7%)

Query: 113 IIGRGAFGEVR------LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
            +G GAFG+V       L +      + A+K LK +   S  + E + +E  +++ + +H
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTAHSS--EREALMSELKIMSHLGNH 98

Query: 167 C-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIH 223
             IV L  +      + +I EY   GD++  L R  E  LT      +  Q    +  + 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             N IHRD+   N+LL     +K+ DFGL +
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 40/163 (24%), Positives = 77/163 (47%), Gaps = 18/163 (11%)

Query: 108 FDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
             L  I+G G FG V   +L Q+  S    A+K +K  ++ +  ++E   +E   + +  
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFD 59

Query: 165 SHCIVKLY-YSFQDAEYLYL-----IMEYLPGGDVMTLL--MREETL-----TETVARFY 211
              ++KL    F+ +    +     I+ ++  GD+ + L   R   L      +T+ +F 
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF- 118

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           +    L +E +   N+IHRD+   N +L ++  + ++DFGL K
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 23/172 (13%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
           +I +     L  +G GAFG+V   +     E+ S    A+K LK++        +  R E
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQE 58

Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE--------ETLTETVA 208
             L++++    IV L       +   ++ EYL  GD+   L+R         E+  ETV 
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 209 R-------FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                    +IA  + A +E +  H+++HRD+   N L+ +   +K+SDFGL
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.2 bits (102), Expect = 3e-05
 Identities = 22/113 (19%), Positives = 44/113 (38%), Gaps = 12/113 (10%)

Query: 146 SRGQVEHVRAERNLLAEVASHCIV--KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETL 203
           SR +      E  +L  +A   +   K+  S +   + YL+ME++ G      L      
Sbjct: 31  SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG----ETLDEVSEE 86

Query: 204 TETVARFYIAQSVLAIESIHKHNY---IHRDIKPDNLLLDQNGHMKLSDFGLC 253
            +      +A+    +  +H+       H D+ P N+L+D    + + D+   
Sbjct: 87  EKEDIAEQLAE---LLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 21/180 (11%)

Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 53

Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSF------QDAEYLYLIMEYLPGGDVM 194
               + Q    RA R L L +  +H  I+ L   F      ++ + +YL+ME +      
Sbjct: 54  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ 110

Query: 195 TLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            + M    L      + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 111 VIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 22/50 (44%), Positives = 33/50 (66%), Gaps = 2/50 (4%)

Query: 212 IAQSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG-LCKPLDCT 259
           I +SVL AI+ +H++  IHRDIK +N+ ++  G + L DFG  C P+D  
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236

Length = 391

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 48/186 (25%), Positives = 85/186 (45%), Gaps = 33/186 (17%)

Query: 114 IGRGAFGEVRLCQEKKSG-------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           IG+GAFG  R+ Q +  G        + A+K LK+ E  +  Q +  R E  L+AE    
Sbjct: 13  IGQGAFG--RVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQR-EAALMAEFDHP 68

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-----EETLTETVAR------------ 209
            IVKL       + + L+ EY+  GD+   L       + +L+ + +             
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 210 ----FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
                 IA+ V A +  + +  ++HRD+   N L+ +N  +K++DFGL + +   +    
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 265 NENEVL 270
           +EN+ +
Sbjct: 189 SENDAI 194

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 27/173 (15%)

Query: 102 KISVDDFDLLTIIGRGAFGEV-----RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
           ++  D   LL  +G GAFGEV     R           A+K L   E  S         E
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLME 59

Query: 157 RNLLAEVASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMTLLMREE----------TLTE 205
             ++++     IV+L   SF+     ++++E + GGD+ + L RE           T+ +
Sbjct: 60  ALIMSKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFL-RENRPRPERPSSLTMKD 117

Query: 206 TV-ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCK 254
            +     +A+    +E  H   +IHRDI   N LL   G     K++DFG+ +
Sbjct: 118 LLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 29/170 (17%)

Query: 114 IGRGAFGEVRLCQ----------------EKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           +G G FGEV LC+                   +  + A+K L+     S    E    E 
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEV 70

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVA--RFYIAQS 215
            +L+ ++   I +L         L +IMEY+  GD+   L +    T  +A     ++ S
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 216 VL-----AIESIHKH----NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
            L      I S  ++    N++HRD+   N L+ +N  +K++DFG+ + L
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 20/66 (30%), Positives = 37/66 (56%)

Query: 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM 245
           E++  G  +   M ++     V +  + Q +  +  +H+   +HRDIKP+NLL+  +G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348

Query: 246 KLSDFG 251
           K+ DFG
Sbjct: 349 KIIDFG 354

Length = 507

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 6/148 (4%)

Query: 114 IGRGAFGEVRLCQEKKSGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKL 171
           +G G+FG VR  +   SG   I    K  KS+ LS    + ++ E  ++  +    +++L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK-EAAIMHSLDHENLIRL 61

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIESIHKHNYIH 229
           Y        L ++ E  P G ++  L ++      ++    Y  Q    +  +    +IH
Sbjct: 62  YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120

Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           RD+   N+LL  +  +K+ DFGL + L 
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALP 148

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 30/171 (17%)

Query: 114 IGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168
           +G GAFG+V L +       K   + A+K LK   + +R   +    E  LL  +    I
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQHEHI 69

Query: 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR------------------EETLTETV-AR 209
           VK Y    D + L ++ EY+  GD+   L                    E  L++ +   
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
             IA  ++ + S H   ++HRD+   N L+  N  +K+ DFG+ + +  T+
Sbjct: 130 SQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 8/151 (5%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLAEVAS 165
           +F L   +G G FGEV     K    + A+K LK  ++L +    + V+A + L  +   
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKH-- 63

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF-YIAQSVL-AIESIH 223
             ++ L+      E +Y+I E +  G ++  L   E     VA    +A  V   +  + 
Sbjct: 64  --LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           + N IHRD+   N+L+ ++   K++DFGL +
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLAR 152

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 15/25 (60%), Positives = 19/25 (76%)

Query: 316 VGTPDYIAPEVLLKKGYGMECDWLA 340
           +GTPDY+APE+LL K +G   DW A
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWA 565

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 29/170 (17%)

Query: 114 IGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168
           +G GAFG+V L +      ++   + A+K LK++   +R   +  + E  LL  +    I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69

Query: 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLL-----------------MREETLTETVA-RF 210
           V+ Y    +   L ++ EY+  GD+   L                   + TL + +A   
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
            IA  ++ + S+H   ++HRD+   N L+ Q   +K+ DFG+ + +  T+
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 3/81 (3%)

Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
           S ++ + +Y++ME +       + M    L      + + Q +  I+ +H    IHRD+K
Sbjct: 97  SLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 153

Query: 234 PDNLLLDQNGHMKLSDFGLCK 254
           P N+++  +  +K+ DFGL +
Sbjct: 154 PSNIVVKSDCTLKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 42/172 (24%)

Query: 108 FDLLTIIGRGAFGEVRLCQEK--KSGNIYAMKKLK--KSEM--LSRGQVEHVRAERNL-- 159
           +++   IGRG +G V   + K  K G  YA+KK K  K +   +S+     +   R L  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 160 -----LAEV-ASHCIVKLYYSFQDAEY-LYLIMEY--------LPGGDVMTLLMREETLT 204
                L EV   H    +Y  F  AE+ L+ I+++        +P   V +LL       
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW------ 115

Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGL 252
                    Q +  +  +H +  +HRD+KP N+L+     + G +K+ D GL
Sbjct: 116 ---------QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 47/157 (29%), Positives = 67/157 (42%), Gaps = 31/157 (19%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYA---MKKLKKS-------EMLSRGQVEHVRAERNLLAEV 163
           IG G FG+V L  E  SG   A   +K+L+ S       + L   Q        NLL + 
Sbjct: 3   IGNGWFGKVIL-GEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL-QC 60

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--------MREETLTETVARFYIAQS 215
              C        +   YL L+ME+ P GD+   L        M  +  T       IA  
Sbjct: 61  LGQCT-------EVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALG 112

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +L    +HK+N+IH D+   N LL  +  +K+ D+GL
Sbjct: 113 LL---HLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 31/180 (17%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++++++  IG G FGEV L + K++   +  K +    +  R + + V  E N++ E+ 
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK 70

Query: 165 SHCIVKLYYSFQDA--EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIA----QSVLA 218
              IV+    F +   + LY++ME+   GD+   + +   +   +    I     Q + A
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 219 IESIHK-------HNYIHRDIKPDNLLL---------------DQNGH--MKLSDFGLCK 254
           +   H           +HRD+KP N+ L               + NG    K+ DFGL K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Length = 1021

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 49/171 (28%), Positives = 86/171 (50%), Gaps = 26/171 (15%)

Query: 109 DLLTIIGRG--AFGEVRLCQEKKSGNIYAMKKLK----KSEMLSRGQVE-HVRAERNLLA 161
           +LLT+IGRG      V L + K +G    ++++      +EM++  Q E HV       +
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHV-------S 53

Query: 162 EVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVL- 217
           ++ +H  IV    +F     L+++  ++  G    L+     + ++E +A  YI Q VL 
Sbjct: 54  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSE-LAIAYILQGVLK 112

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268
           A++ IH   Y+HR +K  ++L+  +G + LS  GL      +NLS IN  +
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISVDGKVYLS--GL-----RSNLSMINHGQ 156

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 27/105 (25%), Positives = 54/105 (51%), Gaps = 9/105 (8%)

Query: 151 EHVRAERNLLAEVASHC-----IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR--EETL 203
           EH++A +N    V SH      I+  +  F    +L++I  ++  G   +LL     E +
Sbjct: 41  EHLKALQN--EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM 98

Query: 204 TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLS 248
           +E +    +  ++  +  +H++ YIHR+IK  ++L+  +G + LS
Sbjct: 99  SEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS 143

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 42/178 (23%), Positives = 82/178 (46%), Gaps = 23/178 (12%)

Query: 114 IGRGAFGEVRLCQEKKSG----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +G  AFG++        G     + A+K LK  ++ +  Q    + E +L+AE+    IV
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMT-LLMR------------EETLTETVAR---FYIA 213
            L       + + ++ EYL  GD+   L+MR            + T+  ++      +IA
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 214 QSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
             + A +E +  H ++H+D+   N+L+ +  H+K+SD GL + +   +   +    +L
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 35/168 (20%), Positives = 72/168 (42%), Gaps = 23/168 (13%)

Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY---AMKKLKKSEMLSRGQVEHVRAER 157
           +  +   L+  +G+G+FG V   L +    G      A+K +  +E  S  +      E 
Sbjct: 3   LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV--NENASMRERIEFLNEA 60

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL---MREETLTE-----TVAR 209
           +++ E   H +V+L       +   ++ME +  GD+ + L     E          T+ +
Sbjct: 61  SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120

Query: 210 FY-----IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           F      IA  +  + +     ++HRD+   N ++ ++  +K+ DFG+
Sbjct: 121 FIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGM 165

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 9/148 (6%)

Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +IG+G FG V    L          A+K L +   L   +VE    E  ++ + +   ++
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVL 59

Query: 170 KLYYSFQDAEYLYLI-MEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIESIHKHN 226
            L      +E   L+ + Y+  GD+   + R ET   TV     +  Q    +E +    
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK 118

Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           ++HRD+   N +LD++  +K++DFGL +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 30/184 (16%)

Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQ-------EKKSGNIYAMKKLKKSEMLSRGQVEH 152
           R + S D   L   +G G FG+V + +       + K     A+K LK     +   +  
Sbjct: 9   RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSD 66

Query: 153 VRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-------------- 197
           + +E  ++  +  H  I+ L  +      LY+I+EY   G++   L              
Sbjct: 67  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 126

Query: 198 --MREETLT--ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
             + +E +T  + V+  Y  Q    +E +     IHRD+   N+L+ +N  MK++DFGL 
Sbjct: 127 ARVPDEQMTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 184

Query: 254 KPLD 257
           + ++
Sbjct: 185 RDVN 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 35/157 (22%), Positives = 72/157 (45%), Gaps = 15/157 (9%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMK-KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           +G G FG V   Q  +  +I  +  K  K  + +R ++E   +E   + E     +++L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 173 -YSFQDAE-----YLYLIMEYLPGGDVMTLLMREET-------LTETVARFYIAQSVLAI 219
               Q  E        +I+ ++  GD+ + L+            T+ + +F +      +
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF-MTDIASGM 125

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           E +   ++IHRD+   N +L++N ++ ++DFGL K +
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 20/49 (40%), Positives = 29/49 (59%)

Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           R  + Q + A+E IH    IHRDIK +N+ L+ +G + L DFG   P +
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318

Length = 501

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 22/76 (28%), Positives = 40/76 (52%), Gaps = 2/76 (2%)

Query: 181 LYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVL-AIESIHKHNYIHRDIKPDNLL 238
           LY++ME +  G+++  L  R   L   +     +  V   +E +     +HRD+   N+L
Sbjct: 73  LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132

Query: 239 LDQNGHMKLSDFGLCK 254
           + ++G  K+SDFGL +
Sbjct: 133 VSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 42/188 (22%)

Query: 97  RLKRHKISVDDFDLLTIIGRGAFGEVR----LCQEKKSGNIYAMKKLKKSEMLSRGQVE- 151
            L R     DDF L   +G GAFG V     + ++ K    Y +KK  +      G VE 
Sbjct: 123 GLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY-----GAVEI 177

Query: 152 --HVRAERNLLAEVASHC----------------IV-------KLYYSFQDAEYLYLIME 186
             + R  R      A                   +V        L    Q  E+ Y +  
Sbjct: 178 WMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEP 237

Query: 187 YLPG--GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NG 243
           YL G   D+   L RE  + +T+ R    Q + A++ +H    +HRD+KP N++  + +G
Sbjct: 238 YLLGKVQDLPKGLERENKIIQTIMR----QILFALDGLHSTGIVHRDVKPQNIIFSEGSG 293

Query: 244 HMKLSDFG 251
             K+ D G
Sbjct: 294 SFKIIDLG 301

Length = 566

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 40/176 (22%), Positives = 75/176 (42%), Gaps = 33/176 (18%)

Query: 114 IGRGAFGEVRLCQEKKSGNI------YAMKK----LKKSEMLSRGQVEHVRA----ERNL 159
           +G G FGEV LC+     ++      + ++K    L   ++L     ++ R     E  +
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTE-------------- 205
           L+ +    I++L     D + L +I EY+  GD+   L       +              
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 206 -TVARFYIAQSVLAIESIHKH----NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             ++   +    L I S  K+    N++HRD+   N L+ +N  +K++DFG+ + L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 31/198 (15%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRL--CQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
           I   +  L+  IG G FG V L    EK+   I  +++   SE       E    E  ++
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-------EDFIEEAQVM 53

Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AI 219
            +++   +V+LY    +   + L+ E++  G +   L  +           +   V   +
Sbjct: 54  MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
             +   N IHRD+   N L+ +N  +K+SDFG+ +              VLDD+  + + 
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR-------------FVLDDQYTSST- 159

Query: 280 DVDGRFPESGCGRRWKSP 297
               +FP      +W SP
Sbjct: 160 --GTKFPV-----KWSSP 170

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 4/45 (8%)

Query: 207 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           VAR    Q + AI+ IH    IHRDIK +N+L++    + L DFG
Sbjct: 265 VAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG 305

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	358
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.98
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PRK10345	210	hypothetical protein; Provisional	99.87
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.86
smart00090	237	RIO RIO-like kinase.	99.86
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.83
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.63
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.59
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.54
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.51
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.4
KOG3087	229	consensus Serine/threonine protein kinase [General	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
KOG1243	690	consensus Protein kinase [General function predict	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.08
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.01
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.96
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.9
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.83
PRK09902	216	hypothetical protein; Provisional	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.71
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.68
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.58
COG4248	637	Uncharacterized protein with protein kinase and he	98.55
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.52
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.51
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.48
PF01636	239	APH: Phosphotransferase enzyme family This family	98.44
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.26
PLN02876	822	acyl-CoA dehydrogenase	98.25
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.21
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.18
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.04
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.91
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.81
PRK10593	297	hypothetical protein; Provisional	97.78
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.76
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.75
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.51
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.45
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.42
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.4
KOG2270	520	consensus Serine/threonine protein kinase involved	97.39
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.29
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.24
PRK05231	319	homoserine kinase; Provisional	97.21
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.19
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.01
PLN02236	344	choline kinase	96.93
PLN02756	418	S-methyl-5-thioribose kinase	96.77
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.66
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.43
PRK12396	409	5-methylribose kinase; Reviewed	96.31
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.27
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.19
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.99
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.47
PTZ00384	383	choline kinase; Provisional	95.14
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.12
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.99
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.84
PRK10271	188	thiK thiamine kinase; Provisional	94.18
PTZ00296	442	choline kinase; Provisional	94.1
PHA03111	444	Ser/Thr kinase; Provisional	94.06
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	93.71
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	93.61

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-72  Score=531.96  Aligned_cols=325  Identities=61%  Similarity=0.902  Sum_probs=293.5

Q ss_pred             CCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHhHhHHHHhHhhccCccCCCce
Q 018275           30 IGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFD  109 (358)
Q Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (358)
                      ..++.|..++.+|+.++++||..+.+...+|++|+..+++.+...+.+++++...++.+..++.+++|+++..+..++|+
T Consensus        65 ~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~~~DFe  144 (550)
T KOG0605|consen   65 LVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLSLDDFE  144 (550)
T ss_pred             ccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhHHHHHHHhccccCCcccch
Confidence            55666999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecC
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      +++.||+|+||.||+|+.+.||..+|+|+++++.+....++.+++.|.++|...++||||+||.+|+|..++||||||+|
T Consensus       145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP  224 (550)
T KOG0605|consen  145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP  224 (550)
T ss_pred             hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccc
Q 018275          190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV  269 (358)
Q Consensus       190 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  269 (358)
                      |||+..+|...+.+++..+++|+++++.|+..||+.|+|||||||+|+|||.+|++||+|||||+.+...+....+....
T Consensus       225 GGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~  304 (550)
T KOG0605|consen  225 GGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDE  304 (550)
T ss_pred             CccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchh
Confidence            99999999999999999999999999999999999999999999999999999999999999998887665543322111


Q ss_pred             cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhc
Q 018275          270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCN  349 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l  349 (358)
                      .....+...  ....++.....+.++...+++.+|+.+++.+++|+||||+||||||+++++|+..||||||||||||||
T Consensus       305 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmL  382 (550)
T KOG0605|consen  305 QMQINLSEA--KPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEML  382 (550)
T ss_pred             hhhhhhccC--CCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHH
Confidence            111111111  111122112346677899999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc
Q 018275          350 YLSDIML  356 (358)
Q Consensus       350 ~~~~~~~  356 (358)
                      .|..+|-
T Consensus       383 vGyPPF~  389 (550)
T KOG0605|consen  383 VGYPPFC  389 (550)
T ss_pred             hCCCCCC
Confidence            9998874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-57  Score=434.15  Aligned_cols=307  Identities=43%  Similarity=0.709  Sum_probs=274.1

Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHhHhHHHHhHhhccCccCCCceeeeeEeeeeeE
Q 018275           41 AAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFG  120 (358)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~IG~G~fG  120 (358)
                      +-|-++|+|..+.++.-++|..|+..||+.+....+++..+.+..+-+..+|++|.++++......-|..++.||-|+||
T Consensus       564 afkFfMEQHVEnvlksyqqr~~Rk~QLEkEM~kagLpd~~q~qMrkmL~QKESnYiRLkRaKMdKSmFvkik~iGvGAFG  643 (1034)
T KOG0608|consen  564 AFKFFMEQHVENVLKSYQQREKRKKQLEKEMVKAGLPDIMQNQMRKMLQQKESNYIRLKRAKMDKSMFVKIKTIGVGAFG  643 (1034)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHhhhhhHHHHHHhhccccceEEEeeecccccc
Confidence            55788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCHHHHHhhc
Q 018275          121 EVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE  200 (358)
Q Consensus       121 ~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~  200 (358)
                      +|.+++..++...+|+|.+++.+...++++.++..|.+||+..+++|||+||..|+|.+++|+||+|++|||++++|.+-
T Consensus       644 eV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm  723 (1034)
T KOG0608|consen  644 EVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM  723 (1034)
T ss_pred             eeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCC
Q 018275          201 ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD  280 (358)
Q Consensus       201 ~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      +.|.+.++++||+++..|+++.|+.|+|||||||+|||||.+|++||+|||||+.+.+.+.+.++.+.   +..-.+++.
T Consensus       724 gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~g---dH~RqDSme  800 (1034)
T KOG0608|consen  724 GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEG---DHHRQDSME  800 (1034)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCC---CccccccCC
Confidence            99999999999999999999999999999999999999999999999999999999999988877532   111112222


Q ss_pred             CCCCCCCCCCCCCCCCchHHHHHH--hhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          281 VDGRFPESGCGRRWKSPLEQLQHW--QINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ...  -+.+    ...+...|...  +.-+|-++.+.|||+.||||||+...+|+..|||||+||||||||+|.-.|+
T Consensus       801 p~~--e~~d----~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~  872 (1034)
T KOG0608|consen  801 PSP--EWAD----ISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFL  872 (1034)
T ss_pred             Cch--hhcc----ccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCcc
Confidence            111  1111    11123333333  4456788899999999999999999999999999999999999999988775

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-55  Score=400.27  Aligned_cols=206  Identities=43%  Similarity=0.746  Sum_probs=192.9

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ....++|++++.||+|+||+|+.++.+.+++.+|+|++++..+.......+..+|+.||..++||.||.++..||+...+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            45579999999999999999999999999999999999999998888999999999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |||+||+.||.|...|.+.+.+++..+++|+++|+.||.|||++|||||||||+|||||.+|+++|+|||||+.....+.
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999986532221


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                       ...+.|||+.|||||++.+.+|+..+|||||
T Consensus       181 -------------------------------------------------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL  211 (357)
T KOG0598|consen  181 -------------------------------------------------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSL  211 (357)
T ss_pred             -------------------------------------------------ccccccCCccccChHHHhcCCCCcccchHhH
Confidence                                                             1225699999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      |+++||||++..+|.
T Consensus       212 GillYeML~G~pPF~  226 (357)
T KOG0598|consen  212 GILLYEMLTGKPPFY  226 (357)
T ss_pred             HHHHHHHhhCCCCCc
Confidence            999999999988774

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-52  Score=368.65  Aligned_cols=201  Identities=43%  Similarity=0.747  Sum_probs=192.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...++|++++.||.|+||.|.+++.+.+|..+|+|++.+.....-.++++..+|..+|+.+.||+++.+++.|.|..++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            66789999999999999999999999999999999999999989999999999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||++||.|.+++.+.+++++..++++++||+.||+|||+.+|++|||||+|||||.+|++||+|||.|+.+.     
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-----  195 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-----  195 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998764     


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                     ...++.||||.|+|||++..++|+.++||||||
T Consensus       196 -----------------------------------------------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalG  228 (355)
T KOG0616|consen  196 -----------------------------------------------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALG  228 (355)
T ss_pred             -----------------------------------------------CcEEEecCCccccChHHhhcCCCCcchhHHHHH
Confidence                                                           125678999999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|||+.|..+|
T Consensus       229 VLIYEMlaG~pPF  241 (355)
T KOG0616|consen  229 VLIYEMLAGYPPF  241 (355)
T ss_pred             HHHHHHHcCCCCC
Confidence            9999999998776

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1e-51  Score=379.50  Aligned_cols=202  Identities=33%  Similarity=0.541  Sum_probs=187.4

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|.+.+.||+|+||+||+|+++.++..||||.+.+... .....+.+..|+.+|+.++|||||.+++++.+++++||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            35899999999999999999999999999999999988754 55667778899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC------CcEEEEecCCCccCC
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN------GHMKLSDFGLCKPLD  257 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~------~~vkl~DFGla~~~~  257 (358)
                      |||||.||||.+++...+.+++..++.++.||+.||.+||+++||||||||.||||+.+      -.+||+|||+|+.+.
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999865      568999999999875


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      .                                                  ..++.+.||+|-||||||++.+.|+.++|
T Consensus       167 ~--------------------------------------------------~~~a~tlcGSplYMAPEV~~~~~YdAKAD  196 (429)
T KOG0595|consen  167 P--------------------------------------------------GSMAETLCGSPLYMAPEVIMSQQYDAKAD  196 (429)
T ss_pred             c--------------------------------------------------hhHHHHhhCCccccCHHHHHhccccchhh
Confidence            2                                                  23455789999999999999999999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      +||+|+|||+|+++.-+|.
T Consensus       197 LWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  197 LWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             HHHHHHHHHHHHhCCCCcc
Confidence            9999999999999998886

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-51  Score=410.61  Aligned_cols=210  Identities=48%  Similarity=0.833  Sum_probs=192.8

Q ss_pred             hhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275           98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus        98 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      .+...+..++|.+++.||+|+||.|.+++++.++++||+|++.+..+..+.....|..|.++|...+.+|||.++.+|+|
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            34455667999999999999999999999999999999999999988888888999999999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ++++|+|||||+||||..++....++++..+++|+++|+.||+.||+.|+|||||||+|||||..|++||+|||.|-.++
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999998876


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc----C-CCC
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL----K-KGY  332 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~----~-~~y  332 (358)
                      ..+.                                                ....+.||||+|++|||+.    + +.|
T Consensus       227 ~dG~------------------------------------------------V~s~~aVGTPDYISPEvLqs~~~~~g~y  258 (1317)
T KOG0612|consen  227 ADGT------------------------------------------------VRSSVAVGTPDYISPEVLQSQGDGKGEY  258 (1317)
T ss_pred             CCCc------------------------------------------------EEeccccCCCCccCHHHHHhhcCCcccc
Confidence            3321                                                1122569999999999996    2 459


Q ss_pred             CccchhhhhhHHHHhhccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +..|||||+||++||||||+-+|
T Consensus       259 G~ecDwWSlGV~~YEMlyG~TPF  281 (1317)
T KOG0612|consen  259 GRECDWWSLGVFMYEMLYGETPF  281 (1317)
T ss_pred             CCccchhhhHHHHHHHHcCCCcc
Confidence            99999999999999999998877

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-49  Score=379.32  Aligned_cols=202  Identities=30%  Similarity=0.463  Sum_probs=191.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ..|...+.||+|||+.||.+.+..+|..||+|++.+..+....+.+.+.+|+.|.+.++|||||+++++|+|.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999999999889999999999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      |+|+.++|..+++...+++|..++.++.||+.||.|||+++|||||||..|++|+.+.+|||+|||||..+...+     
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-----  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-----  172 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-----
Confidence            999999999999999999999999999999999999999999999999999999999999999999999876332     


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                  .+..+.||||.|+||||+...++++.+||||+||+|
T Consensus       173 --------------------------------------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvm  208 (592)
T KOG0575|consen  173 --------------------------------------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVM  208 (592)
T ss_pred             --------------------------------------------cccceecCCCcccChhHhccCCCCCchhhhhhhhHH
Confidence                                                        122367999999999999999999999999999999


Q ss_pred             Hhhcccccccc
Q 018275          346 LSCNYLSDIML  356 (358)
Q Consensus       346 ~e~l~~~~~~~  356 (358)
                      |-+|.|..+|.
T Consensus       209 YtLL~G~PPFe  219 (592)
T KOG0575|consen  209 YTLLVGRPPFE  219 (592)
T ss_pred             HhhhhCCCCcc
Confidence            99999998885

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-49  Score=364.67  Aligned_cols=202  Identities=30%  Similarity=0.491  Sum_probs=180.1

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhch----hhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR----GQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+......    .....+++|++||++++|||||+++++|..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34778899999999999999999999999999999998765442    23445789999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC---CcEEEEecCCCccC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPL  256 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~vkl~DFGla~~~  256 (358)
                      +.|+||||+.||+|.+++..++.+.+..-+.++.|++.||.|||++||+||||||+|||+..+   ..+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999876   78999999999976


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC---
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG---  333 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~---  333 (358)
                      ...                                                  ....+.||||.|.||||+.++++.   
T Consensus       330 g~~--------------------------------------------------sfm~TlCGTpsYvAPEVl~~kg~~~~~  359 (475)
T KOG0615|consen  330 GEG--------------------------------------------------SFMKTLCGTPSYVAPEVLASKGVEYYP  359 (475)
T ss_pred             ccc--------------------------------------------------eehhhhcCCccccChhheecCCeeccc
Confidence            511                                                  112367999999999999987744   


Q ss_pred             ccchhhhhhHHHHhhccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .++|+||+||+||-||.+..+|
T Consensus       360 ~kVDiWSlGcvLfvcLsG~pPF  381 (475)
T KOG0615|consen  360 SKVDIWSLGCVLFVCLSGYPPF  381 (475)
T ss_pred             chheeeeccceEEEEeccCCCc
Confidence            4679999999999999988776

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-49  Score=372.61  Aligned_cols=217  Identities=36%  Similarity=0.572  Sum_probs=195.2

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~  182 (358)
                      ..++|.+++.||.|+|++|++|+.+.+++.||||++.+..+.......-+..|.++|..| .||.||+||..|+|+..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            458999999999999999999999999999999999999988888888899999999999 8999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +|+||+++|+|.+++.+.+.|++..+++++++|+.||+|||+.|||||||||+|||||.||++||+|||.|+.+.....+
T Consensus       151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998755433


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                      .....              +...                      ......|+|||-.|++||++.....+++||+|+||
T Consensus       231 ~~~~~--------------~~~~----------------------a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlG  274 (604)
T KOG0592|consen  231 QENPV--------------DPNQ----------------------ASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALG  274 (604)
T ss_pred             ccCcc--------------Cccc----------------------ccCcccceeeeecccCHHHhcCCCCCcccchHHHH
Confidence            21100              0000                      00113478999999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      ||||+||.|...|.
T Consensus       275 CilyQmlaG~PPFr  288 (604)
T KOG0592|consen  275 CILYQMLAGQPPFR  288 (604)
T ss_pred             HHHHHHhcCCCCCc
Confidence            99999999998874

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-49  Score=358.62  Aligned_cols=202  Identities=28%  Similarity=0.432  Sum_probs=184.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE-E
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY-L  181 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~-~  181 (358)
                      +..++.+.++.||+|..|+||+|.|+.+++.+|+|++...  ..+...+.+.+|+.++..++||+||.+||+|.++.. +
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            4556888899999999999999999999999999999543  245566778999999999999999999999999984 9


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++|+|.+++...+.+++.....++.+++.||.|||. ++||||||||+|||++..|.|||||||.++.+... 
T Consensus       154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999999999988999999999999999999999995 89999999999999999999999999999877522 


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                                                                        ++.+++||..|||||.+.+..|+.++||||
T Consensus       233 --------------------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWS  262 (364)
T KOG0581|consen  233 --------------------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIWS  262 (364)
T ss_pred             --------------------------------------------------hcccccccccccChhhhcCCcCCcccceec
Confidence                                                              355789999999999999999999999999


Q ss_pred             hhHHHHhhccccccccc
Q 018275          341 YWNETLSCNYLSDIMLY  357 (358)
Q Consensus       341 lGvil~e~l~~~~~~~~  357 (358)
                      ||++++||..|.+.++-
T Consensus       263 LGLsllE~a~GrfP~~~  279 (364)
T KOG0581|consen  263 LGLSLLELAIGRFPYPP  279 (364)
T ss_pred             ccHHHHHHhhCCCCCCC
Confidence            99999999999887763

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=376.47  Aligned_cols=206  Identities=36%  Similarity=0.645  Sum_probs=189.7

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCC
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE  179 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~  179 (358)
                      ..+..++|.++++||+|+||+|+++..+.+++.+|||++++..+...+.++....|..|+.... ||.++.|+.+|++.+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            4677899999999999999999999999999999999999999999999999999999988775 999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ++|+||||+.||| ...+...+.+++..+++|+++++.||.|||++|||+||||.+|||||.+|++||+|||+|+..-..
T Consensus       443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            9999999999999 444445688999999999999999999999999999999999999999999999999999864322


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .                                                 .++.++||||.|||||++.++.|+.++|||
T Consensus       522 g-------------------------------------------------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW  552 (694)
T KOG0694|consen  522 G-------------------------------------------------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWW  552 (694)
T ss_pred             C-------------------------------------------------CccccccCChhhcChhhhccCcccchhhHH
Confidence            1                                                 123478999999999999999999999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||+|||||.|.++|+
T Consensus       553 ~lGVLlyeML~Gq~PF~  569 (694)
T KOG0694|consen  553 GLGVLLYEMLVGESPFP  569 (694)
T ss_pred             HHHHHHHHHHcCCCCCC
Confidence            99999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-50  Score=350.93  Aligned_cols=205  Identities=31%  Similarity=0.473  Sum_probs=182.2

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEE-EeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY-SFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~-~~~~~~~  180 (358)
                      ..+..+|+++++||+|+||+||++.+..+|..||.|.+.-.. ......+....|+.+|+.++|||||++++ .|..++.
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            345578999999999999999999999999999999998544 45666777889999999999999999998 5655555


Q ss_pred             -EEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeCCCCCCCEEEcCCCcEEEEecC
Q 018275          181 -LYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHK--HN--YIHRDIKPDNLLLDQNGHMKLSDFG  251 (358)
Q Consensus       181 -~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~--~~--iiHrDikp~NILl~~~~~vkl~DFG  251 (358)
                       ++|||||+.+|||..+++.    ...+++..+..++.|++.||..+|+  ..  |+||||||.||+|+.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence             8999999999999999864    3579999999999999999999998  45  9999999999999999999999999


Q ss_pred             CCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC
Q 018275          252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG  331 (358)
Q Consensus       252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~  331 (358)
                      +++.+...                                                 ...+.|.||||.||+||++.+.+
T Consensus       174 L~r~l~s~-------------------------------------------------~tfA~S~VGTPyYMSPE~i~~~~  204 (375)
T KOG0591|consen  174 LGRFLSSK-------------------------------------------------TTFAHSLVGTPYYMSPERIHESG  204 (375)
T ss_pred             hHhHhcch-------------------------------------------------hHHHHhhcCCCcccCHHHHhcCC
Confidence            99987522                                                 23455889999999999999999


Q ss_pred             CCccchhhhhhHHHHhhcccccccc
Q 018275          332 YGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      |++++||||+||++|||..+..+|.
T Consensus       205 Y~~kSDiWslGCllyEMcaL~~PF~  229 (375)
T KOG0591|consen  205 YNFKSDIWSLGCLLYEMCALQSPFY  229 (375)
T ss_pred             CCcchhHHHHHHHHHHHHhcCCCcc
Confidence            9999999999999999999887763

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-46  Score=345.88  Aligned_cols=253  Identities=29%  Similarity=0.489  Sum_probs=195.8

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      +...+..++|++++.||.|.-|+||+|..+.++..+|+|++.+..+..+....++..|.+||+.++||.++.||..|+.+
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            33456678999999999999999999999999999999999999988888999999999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ++.|||||||+||+|..+++++  ..+++..+++|+++++.||+|||.+|||.|||||+||||.++|++.|+||.|+...
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999999999999999765  57999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccccCCC------CCCCCCCCCC-C-CCC---CchHHHHHHhhhhccccccccCCCCCchhh
Q 018275          257 DCTNLSAINENEVLDDENLNESMDV------DGRFPESGCG-R-RWK---SPLEQLQHWQINRRKLAYSTVGTPDYIAPE  325 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~-~-~~~---~~~~~~~~~~~~~~~~~~s~~gt~~Y~APE  325 (358)
                      ... .+.+.......... +.+...      ..+....... + ...   .+...+-.  -....+..|+|||-.|+|||
T Consensus       230 ~~~-Pt~~~s~~~~~~~~-~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~a--ep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  230 PVS-PTLVKSSSPRSSGS-QPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVA--EPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             CCC-CeeeccCCCCCCCC-Ccccccccccccccchhccccccccccccccccchhhhc--CCCCccccccccccccccce
Confidence            211 11110000000000 000000      0000000000 0 000   00000000  01123456899999999999


Q ss_pred             hhcCCCCCccchhhhhhHHHHhhccccccc
Q 018275          326 VLLKKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       326 v~~~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      |+.|.+++.++|||+||+.|||||||.-.|
T Consensus       306 vI~G~GHgsAVDWWtfGIflYEmLyG~TPF  335 (459)
T KOG0610|consen  306 VIRGEGHGSAVDWWTFGIFLYEMLYGTTPF  335 (459)
T ss_pred             eeecCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            999999999999999999999999998766

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.5e-44  Score=344.00  Aligned_cols=237  Identities=53%  Similarity=0.880  Sum_probs=192.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+...........+..|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998766555566677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||++||+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+.+.........
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999999876533221111


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                      ....       .....+..+..       .........|..++.....+.+||+.|+|||++.+.+|+.++|||||||++
T Consensus       161 ~~~~-------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         161 RNLN-------HSLPSDFTFQN-------MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             cccc-------ccccccccccc-------cccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            1000       00000000000       001111223333444455677999999999999999999999999999999


Q ss_pred             Hhhcccccccc
Q 018275          346 LSCNYLSDIML  356 (358)
Q Consensus       346 ~e~l~~~~~~~  356 (358)
                      |||+++..+|.
T Consensus       227 ~ell~G~~Pf~  237 (363)
T cd05628         227 YEMLIGYPPFC  237 (363)
T ss_pred             HHHHhCCCCCC
Confidence            99999887763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-45  Score=327.73  Aligned_cols=201  Identities=30%  Similarity=0.404  Sum_probs=176.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +.|+.+.++|+|+||+||+|+++.||+.||||++..+.. .+.-.+...+|+.+|+.++|+|+|.|+.+|.....++||+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            568889999999999999999999999999999987642 3555667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      |||+..-|.++-.....+++..++.++.|++.|++|+|++++|||||||+||||+.+|.+||||||+|+.+......   
T Consensus        81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~---  157 (396)
T KOG0593|consen   81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN---  157 (396)
T ss_pred             eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch---
Confidence            99976444444444568999999999999999999999999999999999999999999999999999987632210   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlGvi  344 (358)
                                                                    ....|.|.+|+|||.+.| ..|+.++|||++||+
T Consensus       158 ----------------------------------------------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv  191 (396)
T KOG0593|consen  158 ----------------------------------------------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCV  191 (396)
T ss_pred             ----------------------------------------------hhhhhhhhhccChhhhcccCcCCCcccchhhhHH
Confidence                                                          113488999999999998 789999999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +.||+.|..++|
T Consensus       192 ~aEl~~G~pL~P  203 (396)
T KOG0593|consen  192 FAELLTGEPLWP  203 (396)
T ss_pred             HHHHhcCCcCCC
Confidence            999999998876

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=341.38  Aligned_cols=206  Identities=31%  Similarity=0.502  Sum_probs=183.0

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhch--hhHHHHHHHHHHHHHhc-CcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR--GQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~  179 (358)
                      ...+.|.+.+.||+|+||.|++|.+..++..||+|++.+......  .....+.+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            445899999999999999999999999999999998776532211  34456778999999999 999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-CcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~vkl~DFGla~~~~~  258 (358)
                      .+|+||||+.||+|.+++...+++.+..++.++.|++.||+|||++||+||||||+|||++.+ +++||+|||++.....
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999999999999998999999999999999999999999999999999999999999 9999999999987630


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC-CC-ccc
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YG-MEC  336 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~-y~-~~~  336 (358)
                      .                                                 .....+.||||.|+|||++.+.+ |+ .++
T Consensus       174 ~-------------------------------------------------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~a  204 (370)
T KOG0583|consen  174 E-------------------------------------------------DGLLKTFCGSPAYAAPEVLSGKGTYSGKAA  204 (370)
T ss_pred             C-------------------------------------------------CCcccCCCCCcccCCHHHhCCCCCcCCchh
Confidence            0                                                 01122569999999999999988 97 789


Q ss_pred             hhhhhhHHHHhhccccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIMLY  357 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~~~  357 (358)
                      |+||+||+||-|++|...|..
T Consensus       205 DvWS~GViLy~ml~G~~PF~d  225 (370)
T KOG0583|consen  205 DVWSLGVILYVLLCGRLPFDD  225 (370)
T ss_pred             hhhhhHHHHHHHHhCCCCCCC
Confidence            999999999999999998863

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-45  Score=342.47  Aligned_cols=203  Identities=29%  Similarity=0.411  Sum_probs=179.4

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC--CEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYL  181 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~  181 (358)
                      ..+.|+.+.+||+|+||.||+|++..+|+.||+|+++.+.. .........+|+.||++++||||++|.+...+.  ..+
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            34789999999999999999999999999999999987753 344555678899999999999999999988766  689


Q ss_pred             EEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      |||+|||+. ||..++... -.|++.+++.++.|++.||+|||++||+|||||.+|||||.+|.+||+|||||+.+....
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999999975 999998764 479999999999999999999999999999999999999999999999999999876443


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Diw  339 (358)
                      ...                                                ..+.|-|.+|+|||.++| ..|+.++|+|
T Consensus       273 ~~~------------------------------------------------~T~rVvTLWYRpPELLLG~t~Yg~aVDlW  304 (560)
T KOG0600|consen  273 SAP------------------------------------------------YTSRVVTLWYRPPELLLGATSYGTAVDLW  304 (560)
T ss_pred             Ccc------------------------------------------------cccceEEeeccChHHhcCCcccccceeeh
Confidence            221                                                124589999999999997 4699999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      |+||||.||+.+..+|.
T Consensus       305 S~GCIl~El~~gkPI~~  321 (560)
T KOG0600|consen  305 SVGCILAELFLGKPILQ  321 (560)
T ss_pred             hhhHHHHHHHcCCCCcC
Confidence            99999999999988874

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-44  Score=342.57  Aligned_cols=249  Identities=51%  Similarity=0.859  Sum_probs=195.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++|||||+++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999998765555566777889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++|+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.........
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999999765432221111


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                      ......... .......... ..............+..|...+..+..+.+||+.|+|||++.+..|+.++|||||||++
T Consensus       161 ~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         161 QKLLQGKSN-KNRIDNRNSV-AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             ccccccccc-cccccccccc-ccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence            100000000 0000000000 00001111223344455555555556678999999999999999999999999999999


Q ss_pred             Hhhcccccccc
Q 018275          346 LSCNYLSDIML  356 (358)
Q Consensus       346 ~e~l~~~~~~~  356 (358)
                      |||+++..+|.
T Consensus       239 ~elltG~~Pf~  249 (377)
T cd05629         239 FECLIGWPPFC  249 (377)
T ss_pred             hhhhcCCCCCC
Confidence            99999887763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-44  Score=341.10  Aligned_cols=240  Identities=57%  Similarity=0.909  Sum_probs=194.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998765555566677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++|+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.........
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999999876433221111


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                      ......       .  ....+  ...............|...++....+.+||+.|+|||++.+.+|+.++|||||||++
T Consensus       161 ~~~~~~-------~--~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  229 (364)
T cd05599         161 RILSHA-------L--PSNFL--DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM  229 (364)
T ss_pred             cccccc-------c--ccccc--ccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence            100000       0  00000  000111112223334555555566788999999999999999999999999999999


Q ss_pred             Hhhcccccccc
Q 018275          346 LSCNYLSDIML  356 (358)
Q Consensus       346 ~e~l~~~~~~~  356 (358)
                      |||+++..+|.
T Consensus       230 ~el~~G~~Pf~  240 (364)
T cd05599         230 YEMLVGYPPFC  240 (364)
T ss_pred             HHhhcCCCCCC
Confidence            99999877653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.1e-45  Score=346.50  Aligned_cols=199  Identities=28%  Similarity=0.474  Sum_probs=183.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+... ....+..+++|+.|++.++|||||.++++|....++|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            578899999999999999999999999999999987653 4566788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+.| +|..+|...+.++++.++.++.+++.||.|||+.+|+|||+||.|||++.+|++|+||||+|+.+....     
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-----  154 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-----  154 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence            99976 999999999999999999999999999999999999999999999999999999999999999775211     


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                  ....++-|||.|||||++.+++|+..+|.||||||+
T Consensus       155 --------------------------------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcil  190 (808)
T KOG0597|consen  155 --------------------------------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCIL  190 (808)
T ss_pred             --------------------------------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHH
Confidence                                                        122366799999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |||..|...|
T Consensus       191 YE~~~G~PPF  200 (808)
T KOG0597|consen  191 YELYVGQPPF  200 (808)
T ss_pred             HHHhcCCCCc
Confidence            9999988776

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-43  Score=340.66  Aligned_cols=246  Identities=46%  Similarity=0.795  Sum_probs=189.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +.|.+++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++|||||++++.|.+.+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            36899999999999999999999999999999998776555666778999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..+.........
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998765433222111


Q ss_pred             cccccccccccccCCCCCCCCC---CCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          266 ENEVLDDENLNESMDVDGRFPE---SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                      ...   +.........+.....   ..++.... +.+. .......+....+.+||+.|+|||++.+.+|+.++||||||
T Consensus       161 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         161 QSG---DHVRQDSMDFSNEWGDPANCRCGDRLK-PLER-RAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             ccc---ccccccccccccccccccccccccccc-chhh-hhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            100   0000000000000000   00000000 0000 00111122334567999999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |+||||+++..+|.
T Consensus       236 vil~elltG~~Pf~  249 (382)
T cd05625         236 VILYEMLVGQPPFL  249 (382)
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999999887764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4e-43  Score=338.88  Aligned_cols=246  Identities=46%  Similarity=0.778  Sum_probs=188.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ..|.+++.||+|+||+||+|.+..++..||||++.............+..|+.++..++|||||+++++|.+.+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            36899999999999999999999999999999998876556666778999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||++||+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++++||+|||+++.+.........
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999999765433222111


Q ss_pred             cccc-cccccccccCCCCCCCCCCCCCCCCCCchHHHH--HHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          266 ENEV-LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQ--HWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       266 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                      .... ...+.... ............+.    ....+.  .........+.+.+||+.|+|||++.+.+|+.++||||||
T Consensus       161 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         161 QKGSHIRQDSMEP-SDLWDDVSNCRCGD----RLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             cccccccccccCc-cccccccccccccc----ccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            1000 00000000 00000000000000    000000  0011122334567999999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|||+++..+|.
T Consensus       236 ~il~elltG~~Pf~  249 (381)
T cd05626         236 VILFEMLVGQPPFL  249 (381)
T ss_pred             hHHHHHHhCCCCCc
Confidence            99999999887763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.8e-43  Score=337.36  Aligned_cols=237  Identities=52%  Similarity=0.880  Sum_probs=191.7

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||.||+|.+..+++.||||+++............+..|+.++..++||||+++++.|.+.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998766555666778899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||++||+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.........
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999999876433221111


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                      ......       .+.+..+       ...........+..++.....+.+||+.|+|||++.+.+|+.++|||||||++
T Consensus       161 ~~~~~~-------~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         161 RNLTHN-------PPSDFSF-------QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             cccccC-------Ccccccc-------cccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            100000       0000000       00001111122333444555678999999999999999999999999999999


Q ss_pred             Hhhcccccccc
Q 018275          346 LSCNYLSDIML  356 (358)
Q Consensus       346 ~e~l~~~~~~~  356 (358)
                      |||+++..+|.
T Consensus       227 yel~tG~~Pf~  237 (360)
T cd05627         227 YEMLIGYPPFC  237 (360)
T ss_pred             eecccCCCCCC
Confidence            99999887663

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.3e-44  Score=311.59  Aligned_cols=200  Identities=27%  Similarity=0.416  Sum_probs=177.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|...++||+|.||.||+|++..+|+.||||+++...... .--....+|+..|+.++|+||+.++++|.+...+.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            46888899999999999999999999999999998875422 22334778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+ .||...+... ..+++..++.|+.+++.||+|||.+.|+||||||.|+|++++|.+||+|||+|+.+...+... 
T Consensus        81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-  158 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-  158 (318)
T ss_pred             Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence            9996 5999999765 579999999999999999999999999999999999999999999999999999886443211 


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlGv  343 (358)
                                                                      ...|-|.+|+|||.+.| +.|+..+|+||+||
T Consensus       159 ------------------------------------------------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGC  190 (318)
T KOG0659|consen  159 ------------------------------------------------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGC  190 (318)
T ss_pred             ------------------------------------------------ccceeeeeccChHHhccchhcCCcchhhhHHH
Confidence                                                            12278999999999886 56999999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      |+.|++++..+|+
T Consensus       191 I~AELllr~P~fp  203 (318)
T KOG0659|consen  191 IFAELLLRVPFFP  203 (318)
T ss_pred             HHHHHHccCCCCC
Confidence            9999999998885

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=335.08  Aligned_cols=202  Identities=28%  Similarity=0.417  Sum_probs=175.0

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCE-EEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI-YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-  179 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~-vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-  179 (358)
                      .+..+.+.+...||+|+||+||+|.+.  |.. ||+|++......... ...+.+|+.+|.+++|||||+++|+|.++. 
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            344456666777999999999999876  445 999999877643333 778999999999999999999999999887 


Q ss_pred             EEEEEEeecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCCEEEcCCC-cEEEEecCCCcc
Q 018275          180 YLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHN-YIHRDIKPDNLLLDQNG-HMKLSDFGLCKP  255 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~-iiHrDikp~NILl~~~~-~vkl~DFGla~~  255 (358)
                      .+++|||||++|+|..++..  ...++...+..++.+|+.||.|||+.+ ||||||||+|||++.++ ++||+|||+++.
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            79999999999999999988  578999999999999999999999999 99999999999999998 999999999987


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc--CCCCC
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL--KKGYG  333 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~--~~~y~  333 (358)
                      .......                                                 ..+..||+.|||||++.  ...|+
T Consensus       194 ~~~~~~~-------------------------------------------------~~~~~GT~~wMAPEv~~~~~~~~~  224 (362)
T KOG0192|consen  194 KVISKTS-------------------------------------------------MTSVAGTYRWMAPEVLRGEKSPYT  224 (362)
T ss_pred             ecccccc-------------------------------------------------ccCCCCCccccChhhhcCCCCcCC
Confidence            6532100                                                 01247999999999999  66999


Q ss_pred             ccchhhhhhHHHHhhccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .++|+||||++||||+++.-+|
T Consensus       225 ~K~DvySFgIvlWEl~t~~~Pf  246 (362)
T KOG0192|consen  225 EKSDVYSFGIVLWELLTGEIPF  246 (362)
T ss_pred             ccchhhhHHHHHHHHHHCCCCC
Confidence            9999999999999999987554

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.5e-43  Score=336.22  Aligned_cols=245  Identities=46%  Similarity=0.756  Sum_probs=188.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++.|.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998765545556677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|..+.........
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999999766433222211


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                      ....   .....+...........  ......... .......+....+.+||+.|||||++.+.+|+.++|||||||++
T Consensus       161 ~~~~---~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         161 QKGD---HHRQDSMEPSEEWSEID--RCRLKPLER-RRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             cccc---ccccccccccccccccc--cccccchhh-hhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            1100   00000000000000000  000000000 00011112223467899999999999999999999999999999


Q ss_pred             Hhhcccccccc
Q 018275          346 LSCNYLSDIML  356 (358)
Q Consensus       346 ~e~l~~~~~~~  356 (358)
                      |||+++..+|.
T Consensus       235 yell~G~~Pf~  245 (376)
T cd05598         235 YEMLVGQPPFL  245 (376)
T ss_pred             eehhhCCCCCC
Confidence            99999888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-42  Score=328.55  Aligned_cols=202  Identities=38%  Similarity=0.678  Sum_probs=183.5

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+.+
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            34568999999999999999999999999999999999877655555667788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||+++|+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....  
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence            999999999999999988889999999999999999999999999999999999999999999999999998755311  


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                        ..+.+||+.|+|||++.+..++.++|||||
T Consensus       172 --------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  201 (329)
T PTZ00263        172 --------------------------------------------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTM  201 (329)
T ss_pred             --------------------------------------------------cceecCChhhcCHHHHcCCCCCCcceeech
Confidence                                                              013479999999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|||+++...|
T Consensus       202 G~il~elltg~~pf  215 (329)
T PTZ00263        202 GVLLYEFIAGYPPF  215 (329)
T ss_pred             HHHHHHHHcCCCCC
Confidence            99999999987765

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.7e-44  Score=325.85  Aligned_cols=201  Identities=28%  Similarity=0.523  Sum_probs=188.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      .+|++.+.||+|.||.|-+|.....|+.||||.|+++.+......-++++|+.||+.++||||+++|.+|...+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            67999999999999999999999999999999999999988999999999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||..+|.|.+++...+.+++..++.++.||++|++|+|.++++|||||.+|||+|.|+++||+|||++-.+..       
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-------  205 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-------  205 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-------
Confidence            9999999999999999999999999999999999999999999999999999999999999999999876531       


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC-ccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG-MECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~-~~~DiwSlGvi  344 (358)
                                                                 .++.-++||+|-|.+||++.|.+|. ..+|.|||||+
T Consensus       206 -------------------------------------------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvL  242 (668)
T KOG0611|consen  206 -------------------------------------------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVL  242 (668)
T ss_pred             -------------------------------------------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHH
Confidence                                                       1223377999999999999999996 67999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      ||-+.||+-.|+
T Consensus       243 LYtLVyGtMPFD  254 (668)
T KOG0611|consen  243 LYTLVYGTMPFD  254 (668)
T ss_pred             HHHHhhcccccC
Confidence            999999987664

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.8e-42  Score=329.49  Aligned_cols=209  Identities=44%  Similarity=0.810  Sum_probs=181.3

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      .......++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            34455668999999999999999999999999999999999876544455566688899999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|..+..
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999999999999854 4688999999999999999999999999999999999999999999999999976532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC----CCc
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG----YGM  334 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~----y~~  334 (358)
                      ....                                                ...+.+||+.|||||++.+.+    |+.
T Consensus       195 ~~~~------------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~  226 (370)
T cd05621         195 TGMV------------------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGR  226 (370)
T ss_pred             CCce------------------------------------------------ecccCCCCcccCCHHHHhccCCCCCCCc
Confidence            1100                                                011447999999999998654    789


Q ss_pred             cchhhhhhHHHHhhcccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ++|||||||++|||+++..+|.
T Consensus       227 ~~DiwSlG~ilyell~G~~Pf~  248 (370)
T cd05621         227 ECDWWSVGVFLFEMLVGDTPFY  248 (370)
T ss_pred             ccCEEeehHHHHHHHhCCCCCC
Confidence            9999999999999999887763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.5e-42  Score=327.40  Aligned_cols=203  Identities=38%  Similarity=0.678  Sum_probs=182.0

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCC-CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..++ ..||+|++.............+.+|+.+++.++|||||++++++.+.+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            3456689999999999999999999876654 689999998766555556677889999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+|+||||+++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999998765311


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                                                                          ..+.+||+.|||||++.+..++.++|||
T Consensus       185 ----------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diw  212 (340)
T PTZ00426        185 ----------------------------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWW  212 (340)
T ss_pred             ----------------------------------------------------cceecCChhhcCHHHHhCCCCCcccccc
Confidence                                                                0134799999999999999999999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      ||||++|||+++..+|
T Consensus       213 SlGvil~ell~G~~Pf  228 (340)
T PTZ00426        213 TLGIFIYEILVGCPPF  228 (340)
T ss_pred             chhhHHHHHhcCCCCC
Confidence            9999999999987765

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.5e-42  Score=324.96  Aligned_cols=195  Identities=37%  Similarity=0.621  Sum_probs=174.5

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g  191 (358)
                      +.||+|+||.||+|.+..+|+.||||++.+...........+..|+.+++.++||||++++++|.+.+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765555566677888999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccc
Q 018275          192 DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD  271 (358)
Q Consensus       192 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~  271 (358)
                      +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......          
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----------  150 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----------  150 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC----------
Confidence            9999998888999999999999999999999999999999999999999999999999999874321110          


Q ss_pred             cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccc
Q 018275          272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                                                             .....+||+.|+|||++.+..|+.++|+|||||++|||+++
T Consensus       151 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg  191 (323)
T cd05571         151 ---------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG  191 (323)
T ss_pred             ---------------------------------------cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcC
Confidence                                                   01134799999999999999999999999999999999998


Q ss_pred             cccc
Q 018275          352 SDIM  355 (358)
Q Consensus       352 ~~~~  355 (358)
                      ...|
T Consensus       192 ~~Pf  195 (323)
T cd05571         192 RLPF  195 (323)
T ss_pred             CCCC
Confidence            7665

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-42  Score=325.16  Aligned_cols=199  Identities=45%  Similarity=0.765  Sum_probs=181.3

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||.||+|.+..+++.||||++.+...........+..|+.++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998775544556677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++|+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....       
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-------  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-------  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence            9999999999998888899999999999999999999999999999999999999999999999999875532       


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                   ...+.+||+.|+|||++.+..|+.++|||||||++
T Consensus       154 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il  188 (333)
T cd05600         154 ---------------------------------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCML  188 (333)
T ss_pred             ---------------------------------------------ccCCcccCccccChhHhcCCCCCCccceecchHHH
Confidence                                                         01134799999999999999999999999999999


Q ss_pred             Hhhcccccccc
Q 018275          346 LSCNYLSDIML  356 (358)
Q Consensus       346 ~e~l~~~~~~~  356 (358)
                      |||+++..+|.
T Consensus       189 ~ell~g~~pf~  199 (333)
T cd05600         189 YEFLCGFPPFS  199 (333)
T ss_pred             hhhhhCCCCCC
Confidence            99999877663

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-42  Score=321.38  Aligned_cols=198  Identities=34%  Similarity=0.669  Sum_probs=179.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999999999999999998765444455667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....      
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------  154 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------  154 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------
Confidence            99999999999988889999999999999999999999999999999999999999999999999998754311      


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                    ....+||+.|+|||++.+..++.++|||||||++
T Consensus       155 ----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  188 (291)
T cd05612         155 ----------------------------------------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILI  188 (291)
T ss_pred             ----------------------------------------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence                                                          0134799999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |+|+++...|
T Consensus       189 ~~l~~g~~pf  198 (291)
T cd05612         189 YEMLVGYPPF  198 (291)
T ss_pred             HHHHhCCCCC
Confidence            9999987665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-44  Score=318.06  Aligned_cols=207  Identities=38%  Similarity=0.667  Sum_probs=191.7

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ...+..++|..++.||+|.||.|.+|+.+.+++.+|||++++..+...+.+.+-..|-.+|..++||.+..|-.+|+..+
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD  241 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence            34567799999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+|+||||..||.|.-.|.+...+++..++++-++|++||.|||+++||.||||.+|.|+|++|++||+|||+|+.-...
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999854322


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ..                                                 ...++||||.|.||||+....|+.++|||
T Consensus       322 g~-------------------------------------------------t~kTFCGTPEYLAPEVleDnDYgraVDWW  352 (516)
T KOG0690|consen  322 GD-------------------------------------------------TTKTFCGTPEYLAPEVLEDNDYGRAVDWW  352 (516)
T ss_pred             cc-------------------------------------------------eeccccCChhhcCchhhccccccceeehh
Confidence            11                                                 12367999999999999999999999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      .+||+||||..+.-.|
T Consensus       353 G~GVVMYEMmCGRLPF  368 (516)
T KOG0690|consen  353 GVGVVMYEMMCGRLPF  368 (516)
T ss_pred             hhhHHHHHHHhccCcc
Confidence            9999999999987554

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-43  Score=314.23  Aligned_cols=202  Identities=26%  Similarity=0.364  Sum_probs=174.3

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee--cCCEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEYL  181 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~  181 (358)
                      +.++|+.++.|++|+||.||+|.++.++..||+|.++.......-.+ ...+|+.+|.+++|||||.+-.+..  +-+.+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            45789999999999999999999999999999999987653222222 3567999999999999999976664  34569


Q ss_pred             EEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      |+|||||+. ||.+++..- ++|....++.++.|++.||.|||.+.|+||||||+|+|++..|.+||+|||+|+.+...-
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999999964 999999764 599999999999999999999999999999999999999999999999999999876331


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~Diw  339 (358)
                                                                       +.....|.|.+|+|||.++|. .|+++.|+|
T Consensus       232 -------------------------------------------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMW  262 (419)
T KOG0663|consen  232 -------------------------------------------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMW  262 (419)
T ss_pred             -------------------------------------------------ccCcceEEEeeecCHHHhcCCcccCcchhhh
Confidence                                                             111245899999999999874 599999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      |+|||+.|+|....+|+
T Consensus       263 SvGCI~aE~l~~kPlf~  279 (419)
T KOG0663|consen  263 SVGCIFAELLTQKPLFP  279 (419)
T ss_pred             hHHHHHHHHHhcCCCCC
Confidence            99999999999988875

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-43  Score=324.17  Aligned_cols=208  Identities=31%  Similarity=0.560  Sum_probs=189.0

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ....+..+.|..-++||+|+||.|+-|+.+.||+-+|+|.+.+..+..+.......+|..+|..++.+.||.+-.+|.+.
T Consensus       178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk  257 (591)
T KOG0986|consen  178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK  257 (591)
T ss_pred             HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence            34566779999999999999999999999999999999999888777777777788999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      +.+|||+..|.||||.-+|...+  .+++..+++|+++|+.||.+||+.+||.||+||+|||||++|+++|+|.|||..+
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999999998886654  7999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      ....                                                  ...+.|||.+||||||+.+..|+++.
T Consensus       338 ~~g~--------------------------------------------------~~~~rvGT~GYMAPEvl~ne~Y~~s~  367 (591)
T KOG0986|consen  338 PEGK--------------------------------------------------PIRGRVGTVGYMAPEVLQNEVYDFSP  367 (591)
T ss_pred             CCCC--------------------------------------------------ccccccCcccccCHHHHcCCcccCCc
Confidence            4221                                                  11244899999999999999999999


Q ss_pred             hhhhhhHHHHhhcccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~~  356 (358)
                      |||||||+||||+-+..+|.
T Consensus       368 Dwf~lGCllYemi~G~sPFr  387 (591)
T KOG0986|consen  368 DWFSLGCLLYEMIAGHSPFR  387 (591)
T ss_pred             cHHHHHhHHHHHHcccCchh
Confidence            99999999999999888774

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-41  Score=326.70  Aligned_cols=210  Identities=43%  Similarity=0.815  Sum_probs=181.5

Q ss_pred             hhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275           98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus        98 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      +....+..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            33455667999999999999999999999999999999999987554445555668889999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ...+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            9999999999999999999854 468899999999999999999999999999999999999999999999999997653


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC----CC
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG----YG  333 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~----y~  333 (358)
                      .....                                                ...+.+||+.|||||++.+..    |+
T Consensus       194 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~  225 (371)
T cd05622         194 KEGMV------------------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYG  225 (371)
T ss_pred             cCCcc------------------------------------------------cccCcccCccccCHHHHhccCCCccCC
Confidence            21100                                                011347999999999997643    88


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|||||||++|||+++..+|.
T Consensus       226 ~~~DiwSlGvilyell~G~~Pf~  248 (371)
T cd05622         226 RECDWWSVGVFLYEMLVGDTPFY  248 (371)
T ss_pred             CccceeehhHHHHHHHhCCCCCC
Confidence            99999999999999999887663

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=328.30  Aligned_cols=200  Identities=29%  Similarity=0.455  Sum_probs=175.5

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCC-EE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE-YL  181 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~-~~  181 (358)
                      ..++|.++++||.|+||.||+|..+.++..||||.+++.-. ..++.- -.+|+..|+++. |||||+|.+++.+.+ .+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            34789999999999999999999999999999999987642 333322 456999999998 999999999999888 99


Q ss_pred             EEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      |+|||||+ .+|..+++.+ ..|++..++.|+.||+.||+|+|.+|+.|||+||+|||+..+..+||+|||+|+.+....
T Consensus        86 ~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp  164 (538)
T KOG0661|consen   86 YFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP  164 (538)
T ss_pred             eeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence            99999995 5999999765 689999999999999999999999999999999999999999999999999999876432


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Diw  339 (358)
                      .-+                                                  ..|-|.+|+|||+++. .-|+.+.|+|
T Consensus       165 PYT--------------------------------------------------eYVSTRWYRAPEvLLrs~~Ys~pvD~w  194 (538)
T KOG0661|consen  165 PYT--------------------------------------------------EYVSTRWYRAPEVLLRSGYYSSPVDMW  194 (538)
T ss_pred             Ccc--------------------------------------------------hhhhcccccchHHhhhccccCCchHHH
Confidence            111                                                  2378999999999986 5599999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ++|||++|+..+..+|+
T Consensus       195 A~GcI~aEl~sLrPLFP  211 (538)
T KOG0661|consen  195 AVGCIMAELYSLRPLFP  211 (538)
T ss_pred             HHHHHHHHHHHhcccCC
Confidence            99999999999988886

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=316.44  Aligned_cols=201  Identities=32%  Similarity=0.497  Sum_probs=170.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC--EEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE--YLY  182 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~~~  182 (358)
                      ..++...+.||+|+||.||++.+..+|..+|||.+.....  . ..+.+.+|+.+|++++|||||+++|......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--P-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            3568888999999999999999999999999999876532  1 1666889999999999999999999754444  699


Q ss_pred             EEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-CCcEEEEecCCCccCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~vkl~DFGla~~~~~~~  260 (358)
                      +.|||+++|+|.+++...+ .+++..++.+..||+.||.|||++|||||||||+|||++. ++.+||+|||+++......
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999998876 7999999999999999999999999999999999999999 7999999999998775310


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~Diw  339 (358)
                      ..                                              .....+..|||.|||||++.++ .-+.++|||
T Consensus       173 ~~----------------------------------------------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiW  206 (313)
T KOG0198|consen  173 TK----------------------------------------------SDSELSVQGTPNYMAPEVIRNGEVARRESDIW  206 (313)
T ss_pred             cc----------------------------------------------ccccccccCCccccCchhhcCCCcCCccchhh
Confidence            00                                              0011245899999999999963 233599999


Q ss_pred             hhhHHHHhhcccccc
Q 018275          340 AYWNETLSCNYLSDI  354 (358)
Q Consensus       340 SlGvil~e~l~~~~~  354 (358)
                      ||||++.||+++...
T Consensus       207 SlGCtVvEM~Tg~~P  221 (313)
T KOG0198|consen  207 SLGCTVVEMLTGKPP  221 (313)
T ss_pred             hcCCEEEeccCCCCc
Confidence            999999999997544

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-42  Score=320.60  Aligned_cols=210  Identities=33%  Similarity=0.534  Sum_probs=174.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh-----------chhhHHHHHHHHHHHHHhcCcceEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----------SRGQVEHVRAERNLLAEVASHCIVKL  171 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-----------~~~~~~~~~~E~~il~~l~h~~iv~l  171 (358)
                      ...|+|++++.||+|.||.|.+|++..+++.||||++.+....           ....++.+++|+.||++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            4569999999999999999999999999999999999875422           12335689999999999999999999


Q ss_pred             EEEeecC--CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEe
Q 018275          172 YYSFQDA--EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSD  249 (358)
Q Consensus       172 ~~~~~~~--~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~D  249 (358)
                      +.+..|+  +.+|||+|||..|.+...=.....+++..++.|+..++.||+|||.+|||||||||+|+||+.+|++||+|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence            9999765  57999999999888765443333389999999999999999999999999999999999999999999999


Q ss_pred             cCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC
Q 018275          250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK  329 (358)
Q Consensus       250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~  329 (358)
                      ||.+.........                                 ...++|.           .++|||.|||||...+
T Consensus       254 FGVs~~~~~~~~~---------------------------------~~d~~L~-----------~tvGTPAF~APE~c~~  289 (576)
T KOG0585|consen  254 FGVSNEFPQGSDE---------------------------------GSDDQLS-----------RTVGTPAFFAPELCSG  289 (576)
T ss_pred             cceeeecccCCcc---------------------------------ccHHHHh-----------hcCCCccccchHhhcC
Confidence            9998765322111                                 0111222           2699999999999987


Q ss_pred             C---CC-CccchhhhhhHHHHhhcccccccc
Q 018275          330 K---GY-GMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       330 ~---~y-~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .   .| +++.||||+||+||.+||+...|.
T Consensus       290 ~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  290 GNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             CCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            3   33 478999999999999999988773

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=322.57  Aligned_cols=230  Identities=52%  Similarity=0.853  Sum_probs=187.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++.............+..|+.++..++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998876555566778899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..+.........
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999999876543311111


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                      .........      ..              ...........+.......+||+.|+|||++.+..++.++|+|||||++
T Consensus       161 ~~~~~~~~~------~~--------------~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  220 (350)
T cd05573         161 LNDSHNLLF------RD--------------NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL  220 (350)
T ss_pred             ccccccccc------cc--------------cccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhh
Confidence            110000000      00              0000000001112223456899999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |||+++..+|
T Consensus       221 ~ell~g~~Pf  230 (350)
T cd05573         221 YEMLYGFPPF  230 (350)
T ss_pred             hhhccCCCCC
Confidence            9999988765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.7e-41  Score=311.57  Aligned_cols=200  Identities=30%  Similarity=0.534  Sum_probs=175.2

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      .|...+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|++|++++++|.+.+.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            37889999999999999999999999999999987654444444567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       187 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |+++|+|...+...  ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++........   
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---
Confidence            99999999887543  4688999999999999999999999999999999999999999999999999875431100   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                     ....+||+.|+|||++.+..|+.++|||||||+
T Consensus       158 -----------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvi  190 (285)
T cd05631         158 -----------------------------------------------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCL  190 (285)
T ss_pred             -----------------------------------------------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHH
Confidence                                                           013479999999999999999999999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +|||+++..+|.
T Consensus       191 l~el~~g~~pf~  202 (285)
T cd05631         191 IYEMIQGQSPFR  202 (285)
T ss_pred             HHHHHhCCCCCC
Confidence            999999887663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.6e-41  Score=323.31  Aligned_cols=208  Identities=45%  Similarity=0.823  Sum_probs=179.8

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ...+..++|++.+.||+|+||.||+|.+..++..||+|++.+...........+..|+.+++.++||||+++++++.+.+
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~  116 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK  116 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            34556789999999999999999999999999999999998765444555566788999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999999998854 46889999999999999999999999999999999999999999999999998765321


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC----CCCcc
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK----GYGME  335 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~----~y~~~  335 (358)
                      ...                                                .....+||+.|+|||++.+.    .++.+
T Consensus       196 ~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  227 (370)
T cd05596         196 GMV------------------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRE  227 (370)
T ss_pred             Ccc------------------------------------------------cCCCCCCCcCeECHHHhccCCCCCCCCCc
Confidence            100                                                01134799999999999764    38899


Q ss_pred             chhhhhhHHHHhhcccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +|||||||++|||+++..+|.
T Consensus       228 ~DiwSlGvilyelltG~~Pf~  248 (370)
T cd05596         228 CDWWSVGVFLYEMLVGDTPFY  248 (370)
T ss_pred             eeeeehhHHHHHHHhCCCCcC
Confidence            999999999999999877653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.4e-41  Score=319.35  Aligned_cols=195  Identities=37%  Similarity=0.632  Sum_probs=173.8

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g  191 (358)
                      +.||+|+||.||++.+..+|..||+|++.............+..|+.+++.++||||++++++|.+.+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765545556667888999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccc
Q 018275          192 DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD  271 (358)
Q Consensus       192 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~  271 (358)
                      +|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......          
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----------  150 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----------  150 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----------
Confidence            9999998888899999999999999999999999999999999999999999999999999874321110          


Q ss_pred             cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccc
Q 018275          272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                                                             .....+||+.|+|||++.+..|+.++|+|||||++|||+++
T Consensus       151 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g  191 (323)
T cd05595         151 ---------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG  191 (323)
T ss_pred             ---------------------------------------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC
Confidence                                                   01134799999999999999999999999999999999998


Q ss_pred             cccc
Q 018275          352 SDIM  355 (358)
Q Consensus       352 ~~~~  355 (358)
                      ..+|
T Consensus       192 ~~Pf  195 (323)
T cd05595         192 RLPF  195 (323)
T ss_pred             CCCC
Confidence            7665

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.4e-41  Score=316.95  Aligned_cols=200  Identities=35%  Similarity=0.600  Sum_probs=176.4

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCc-ceEEEEEEeecCCEEEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~-~iv~l~~~~~~~~~~~lV~  185 (358)
                      +|.+++.||+|+||.||+|.+..+++.||||++.+...........+..|..++..+.|+ +|+.+++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            588999999999999999999999999999999876554455667788899999999775 5888999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......    
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~----  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----  156 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC----
Confidence            9999999999998888899999999999999999999999999999999999999999999999999864321110    


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                   .....+||+.|+|||++.+..|+.++|||||||++
T Consensus       157 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil  191 (324)
T cd05587         157 ---------------------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL  191 (324)
T ss_pred             ---------------------------------------------ceeeecCCccccChhhhcCCCCCcccchhhhHHHH
Confidence                                                         01134799999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |||+++..+|
T Consensus       192 ~elltG~~pf  201 (324)
T cd05587         192 YEMLAGQPPF  201 (324)
T ss_pred             HHHHhCCCCC
Confidence            9999987765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5e-41  Score=317.03  Aligned_cols=201  Identities=34%  Similarity=0.602  Sum_probs=175.8

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +|.+.+.||+|+||.||+|.+..++..||||++.+..............|..++..+ +|++|+.+++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            588999999999999999999999999999999876544445555667788888776 5788999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++|+|...+.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......    
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~----  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV----  156 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC----
Confidence            9999999999998888899999999999999999999999999999999999999999999999999874321110    


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                   .....+||+.|+|||++.+..|+.++|||||||++
T Consensus       157 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  191 (323)
T cd05616         157 ---------------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL  191 (323)
T ss_pred             ---------------------------------------------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHH
Confidence                                                         01134799999999999999999999999999999


Q ss_pred             Hhhcccccccc
Q 018275          346 LSCNYLSDIML  356 (358)
Q Consensus       346 ~e~l~~~~~~~  356 (358)
                      |||+++..+|.
T Consensus       192 ~elltg~~Pf~  202 (323)
T cd05616         192 YEMLAGQAPFE  202 (323)
T ss_pred             HHHHhCCCCCC
Confidence            99999877663

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=316.68  Aligned_cols=193  Identities=40%  Similarity=0.676  Sum_probs=173.3

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCH
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV  193 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L  193 (358)
                      ||+|+||.||+|.+..++..||+|++.............+..|+.++..++||||++++++|.+.+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999999876555556667788999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccc
Q 018275          194 MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE  273 (358)
Q Consensus       194 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......            
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------------  148 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------------  148 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------------
Confidence            99998888899999999999999999999999999999999999999999999999999875321110            


Q ss_pred             cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccccc
Q 018275          274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                                                           .....+||+.|+|||++.+..|+.++|+|||||++|||+++..
T Consensus       149 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~  191 (312)
T cd05585         149 -------------------------------------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP  191 (312)
T ss_pred             -------------------------------------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCC
Confidence                                                 0113479999999999999999999999999999999999877


Q ss_pred             cc
Q 018275          354 IM  355 (358)
Q Consensus       354 ~~  355 (358)
                      +|
T Consensus       192 pf  193 (312)
T cd05585         192 PF  193 (312)
T ss_pred             Cc
Confidence            65

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.9e-41  Score=318.66  Aligned_cols=195  Identities=37%  Similarity=0.627  Sum_probs=174.3

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g  191 (358)
                      +.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765555566677888999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccc
Q 018275          192 DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD  271 (358)
Q Consensus       192 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~  271 (358)
                      +|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......          
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~----------  150 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA----------  150 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc----------
Confidence            9999998888899999999999999999999999999999999999999999999999999875321100          


Q ss_pred             cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccc
Q 018275          272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                                                             .....+||+.|+|||++.+..++.++|||||||++|||+++
T Consensus       151 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG  191 (328)
T cd05593         151 ---------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG  191 (328)
T ss_pred             ---------------------------------------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC
Confidence                                                   01134799999999999999999999999999999999998


Q ss_pred             cccc
Q 018275          352 SDIM  355 (358)
Q Consensus       352 ~~~~  355 (358)
                      ..+|
T Consensus       192 ~~Pf  195 (328)
T cd05593         192 RLPF  195 (328)
T ss_pred             CCCC
Confidence            7765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=328.84  Aligned_cols=202  Identities=26%  Similarity=0.410  Sum_probs=181.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      .....|....+||+|+.|.||.|....+++.||||.+....   ....+-+.+|+.+|+..+|+|||.++..|.-.+.+|
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            34467888899999999999999999999999999998764   333445889999999999999999999999889999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      .|||||+||+|.+.+ ....+++.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+..... 
T Consensus       347 VVMEym~ggsLTDvV-t~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVV-TKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             EEEeecCCCchhhhh-hcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            999999999999988 445699999999999999999999999999999999999999999999999999987753321 


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                      ...+.||||.||||||+..+.|++++||||||
T Consensus       425 ------------------------------------------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLG  456 (550)
T KOG0578|consen  425 ------------------------------------------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLG  456 (550)
T ss_pred             ------------------------------------------------ccccccCCCCccchhhhhhcccCccccchhhh
Confidence                                                            12256999999999999999999999999999


Q ss_pred             HHHHhhccccccccc
Q 018275          343 NETLSCNYLSDIMLY  357 (358)
Q Consensus       343 vil~e~l~~~~~~~~  357 (358)
                      ++++||.-|+..|++
T Consensus       457 IMaIEMveGEPPYln  471 (550)
T KOG0578|consen  457 IMAIEMVEGEPPYLN  471 (550)
T ss_pred             hHHHHHhcCCCCccC
Confidence            999999999988874

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5e-41  Score=318.27  Aligned_cols=202  Identities=50%  Similarity=0.853  Sum_probs=177.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++.+...........+.+|..++..++|++|+.+++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999998755444555666888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......... 
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-  159 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-  159 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee-
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999987653211000 


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-----CCCCccchhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KGYGMECDWL  339 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-----~~y~~~~Diw  339 (358)
                                                                     ....+||+.|+|||++.+     ..++.++|||
T Consensus       160 -----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  192 (331)
T cd05624         160 -----------------------------------------------SSVAVGTPDYISPEILQAMEDGMGKYGPECDWW  192 (331)
T ss_pred             -----------------------------------------------eccccCCcccCCHHHHhccccCCCCCCCcccEE
Confidence                                                           012369999999999976     5688999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      ||||++|||+++...|
T Consensus       193 SlGvil~ell~g~~Pf  208 (331)
T cd05624         193 SLGVCMYEMLYGETPF  208 (331)
T ss_pred             eeehhhhhhhhCCCCc
Confidence            9999999999988766

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-41  Score=309.78  Aligned_cols=200  Identities=27%  Similarity=0.392  Sum_probs=172.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc-eEEEEEEeecCC-----
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAE-----  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~-iv~l~~~~~~~~-----  179 (358)
                      ..|..+++||+|+||+||+|+.+.+|+.||+|+++..... +..-....+|+.+++.++|+| ||.|++++.+.+     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            5677788999999999999999999999999999876431 223334678999999999999 999999998877     


Q ss_pred             -EEEEEEeecCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          180 -YLYLIMEYLPGGDVMTLLMREE----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       180 -~~~lV~E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                       .+++|+||++ .+|..++....    .++...++.++.||+.||+|||+++|+||||||.||||+++|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             8999999995 69999997644    57778999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCC
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYG  333 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~  333 (358)
                      .......                                                 ...+-++|.+|+|||++.|. .|+
T Consensus       169 a~~ip~~-------------------------------------------------~yt~evvTlWYRaPEvLlGs~~Ys  199 (323)
T KOG0594|consen  169 AFSIPMR-------------------------------------------------TYTPEVVTLWYRAPEVLLGSTSYS  199 (323)
T ss_pred             HhcCCcc-------------------------------------------------cccccEEEeeccCHHHhcCCCcCC
Confidence            5431110                                                 01234899999999999986 799


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ...|+||+|||+.||..+..+|+
T Consensus       200 ~~vDiWs~GcIfaEm~~~~~LFp  222 (323)
T KOG0594|consen  200 TSVDIWSLGCIFAEMFTRRPLFP  222 (323)
T ss_pred             CCcchHhHHHHHHHHHhCCCCCC
Confidence            99999999999999999888875

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-42  Score=299.29  Aligned_cols=205  Identities=33%  Similarity=0.456  Sum_probs=188.1

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ...+.++|++.+.||+|-||.||+|+.+.++..||+|++.++.+........+++|++|-+.++||||.++|++|.|...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            35677999999999999999999999999999999999999987777777789999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 LYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      +||++||.++|+|...|.  ....+++..+..++.|++.||.|+|..+||||||||+|+|++.++.+||+|||.+..-..
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            999999999999999998  557899999999999999999999999999999999999999999999999998764321


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                                                                         .+..+.|||.+|.+||+..+.+++..+|+
T Consensus       177 ---------------------------------------------------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~  205 (281)
T KOG0580|consen  177 ---------------------------------------------------NKRKTLCGTLDYLPPEMVEGRGHDKFVDL  205 (281)
T ss_pred             ---------------------------------------------------CCceeeecccccCCHhhcCCCCccchhhH
Confidence                                                               11226699999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |++|++.||+|.+-..|.
T Consensus       206 w~lgvl~yeflvg~ppFe  223 (281)
T KOG0580|consen  206 WSLGVLCYEFLVGLPPFE  223 (281)
T ss_pred             HHHHHHHHHHHhcCCchh
Confidence            999999999999887774

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=311.55  Aligned_cols=209  Identities=24%  Similarity=0.437  Sum_probs=184.1

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ...+..++|++...||.|.-++||+|+...++..||||++.....  ....+.++.|+..++.++||||++++.+|..+.
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            345667999999999999999999999999999999999998874  344788999999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      .+|+||.||.+|++.++++..  ..++|..+..++.+++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            999999999999999999764  569999999999999999999999999999999999999999999999999887665


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCcc
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGME  335 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~  335 (358)
                      .....                                            ++.+. .+++|||.||||||++.  .+|+++
T Consensus       178 ~~G~R--------------------------------------------~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfK  212 (516)
T KOG0582|consen  178 DSGDR--------------------------------------------QVTRF-NTFVGTPCWMAPEVLMQQLHGYDFK  212 (516)
T ss_pred             ccCce--------------------------------------------eeEee-ccccCcccccChHHhhhcccCccch
Confidence            32210                                            11111 47799999999999764  689999


Q ss_pred             chhhhhhHHHHhhccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~  355 (358)
                      +||||||++..|+-.|.-+|
T Consensus       213 aDIwSfGITA~ELA~G~aPf  232 (516)
T KOG0582|consen  213 ADIWSFGITACELAHGHAPF  232 (516)
T ss_pred             hhhhhhhHHHHHHhcCCCCc
Confidence            99999999999988776544

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-42  Score=326.42  Aligned_cols=202  Identities=30%  Similarity=0.502  Sum_probs=182.9

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE-EEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY-LYL  183 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~-~~l  183 (358)
                      .++|..++.||+|+||.+++++++.++..+++|.+.......+ ..+...+|+.+++++.|||||.+.+.|..++. +||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            4789999999999999999999999999999999987764333 34468899999999999999999999998887 999


Q ss_pred             EEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          184 IMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ||+|++||+|.+.+...  ..+++..+..|+.|++.|+.|||+.+|+|||||+.||++++++.|||.|||+|+.+.... 
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-  160 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-  160 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence            99999999999999765  479999999999999999999999999999999999999999999999999999886332 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                      .++.+.+|||.||.||++.+.+|+.++|+|||
T Consensus       161 ------------------------------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsL  192 (426)
T KOG0589|consen  161 ------------------------------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSL  192 (426)
T ss_pred             ------------------------------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhh
Confidence                                                            24557899999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|||+....-|.
T Consensus       193 GC~~yEm~~lk~aF~  207 (426)
T KOG0589|consen  193 GCCLYEMCTLKPAFK  207 (426)
T ss_pred             cchHHHHHhcccccC
Confidence            999999999877663

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=315.83  Aligned_cols=202  Identities=49%  Similarity=0.849  Sum_probs=176.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..++|+||++++++|.+.+++|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765555556677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||+++|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+....... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  159 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-  159 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc-
Confidence            99999999999976 4678999999999999999999999999999999999999999999999999987553211100 


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-----CCCCccchhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KGYGMECDWL  339 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-----~~y~~~~Diw  339 (358)
                                                                     ....+||+.|||||++.+     ..++.++|||
T Consensus       160 -----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  192 (331)
T cd05597         160 -----------------------------------------------SNVAVGTPDYISPEILQAMEDGKGRYGPECDWW  192 (331)
T ss_pred             -----------------------------------------------ccceeccccccCHHHHhhccccccCCCCcceee
Confidence                                                           012369999999999973     4578899999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      ||||++|||+++...|
T Consensus       193 slG~~l~el~~g~~Pf  208 (331)
T cd05597         193 SLGVCMYEMLYGETPF  208 (331)
T ss_pred             hhhhHHHHHhhCCCCC
Confidence            9999999999987665

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.9e-41  Score=315.94  Aligned_cols=195  Identities=37%  Similarity=0.625  Sum_probs=172.9

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g  191 (358)
                      +.||+|+||.||+|.+..++..||+|++.+...........+..|+.++..++||||++++++|.+...+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765545555667788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          192 DVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       192 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      +|..++.....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---------  151 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---------  151 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---------
Confidence            999999888889999999999999999999997 7999999999999999999999999999874321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|+|||||++|||++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t  191 (325)
T cd05594         152 ----------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC  191 (325)
T ss_pred             ----------------------------------------ccccccCCcccCCHHHHccCCCCCccccccccceeeeecc
Confidence                                                    0113469999999999999999999999999999999999


Q ss_pred             ccccc
Q 018275          351 LSDIM  355 (358)
Q Consensus       351 ~~~~~  355 (358)
                      +..+|
T Consensus       192 G~~Pf  196 (325)
T cd05594         192 GRLPF  196 (325)
T ss_pred             CCCCC
Confidence            87765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-40  Score=314.94  Aligned_cols=202  Identities=47%  Similarity=0.824  Sum_probs=176.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++|++|+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999998755445555666888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+......  
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~--  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc--
Confidence            99999999999976 467899999999999999999999999999999999999999999999999998754311100  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----CCCCCccchhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWL  339 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----~~~y~~~~Diw  339 (358)
                                                                    .....+||+.|+|||++.     ...|+.++|||
T Consensus       159 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvw  192 (332)
T cd05623         159 ----------------------------------------------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW  192 (332)
T ss_pred             ----------------------------------------------eecccccCccccCHHHHhccccCCCCCCCcCCEE
Confidence                                                          011247999999999996     35689999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      ||||++|||+++..+|
T Consensus       193 SlGvil~ell~g~~Pf  208 (332)
T cd05623         193 SLGVCMYEMLYGETPF  208 (332)
T ss_pred             eeHHHHHHHhcCCCCC
Confidence            9999999999987765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-40  Score=315.53  Aligned_cols=196  Identities=35%  Similarity=0.589  Sum_probs=173.9

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876554555667788899999888 799999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---------  151 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---------  151 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---------
Confidence            99999998888999999999999999999999999999999999999999999999999999874221110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|+|||||++||+++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~  191 (329)
T cd05588         152 ----------------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA  191 (329)
T ss_pred             ----------------------------------------ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             cccccc
Q 018275          351 LSDIML  356 (358)
Q Consensus       351 ~~~~~~  356 (358)
                      +..+|.
T Consensus       192 g~~Pf~  197 (329)
T cd05588         192 GRSPFD  197 (329)
T ss_pred             CCCCcc
Confidence            887764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-40  Score=313.52  Aligned_cols=200  Identities=35%  Similarity=0.619  Sum_probs=175.4

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC-cceEEEEEEeecCCEEEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +|++.+.||+|+||.||+|.+..+++.||||++.+...........+..|..++..+.| ++|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47889999999999999999999999999999987654445556667788888888865 67888999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......    
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~----  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV----  156 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc----
Confidence            9999999999998888999999999999999999999999999999999999999999999999999874321110    


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                   ...+.+||+.|+|||++.+..++.++|||||||++
T Consensus       157 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil  191 (323)
T cd05615         157 ---------------------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL  191 (323)
T ss_pred             ---------------------------------------------cccCccCCccccCHHHHcCCCCCCccchhhhHHHH
Confidence                                                         01134699999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |||+++..+|
T Consensus       192 ~elltG~~pf  201 (323)
T cd05615         192 YEMLAGQPPF  201 (323)
T ss_pred             HHHHhCCCCC
Confidence            9999987765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.7e-41  Score=316.15  Aligned_cols=202  Identities=47%  Similarity=0.831  Sum_probs=178.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|+++............+..|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998776545556677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||+++|+|.+++... ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+......  
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV--  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--
Confidence            999999999999776 68999999999999999999999999999999999999999999999999999765422110  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc------CCCCCccchh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------KKGYGMECDW  338 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~------~~~y~~~~Di  338 (358)
                                                                    .....+||+.|+|||++.      +..|+.++||
T Consensus       159 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di  192 (330)
T cd05601         159 ----------------------------------------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW  192 (330)
T ss_pred             ----------------------------------------------eeecccCCccccCHHHhccccccccCCCCCccee
Confidence                                                          011237999999999997      5678899999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      |||||++|||+++..+|
T Consensus       193 wslG~il~el~~g~~Pf  209 (330)
T cd05601         193 WSLGVIAYEMIYGRSPF  209 (330)
T ss_pred             ecccceeeeeccCCCCC
Confidence            99999999999988765

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=305.28  Aligned_cols=209  Identities=36%  Similarity=0.612  Sum_probs=190.6

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCC
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE  179 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~  179 (358)
                      ..+..++|.+++.||+|+|..|.+++++.+.+.+|+|++++.-......++.++.|..+.... +||.+|.|+.+|+...
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            456679999999999999999999999999999999999998777778888899998887665 7999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+++|.||++||+|.-.+.++..+++..++++.++|+.||+|||++|||.||||.+|||+|..|++||+|+|.++.--..
T Consensus       325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999754322


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .+                                                 .+.++||||.|+|||++.|..|++++|||
T Consensus       405 gd-------------------------------------------------~tstfcgtpnyiapeilrgeeygfsvdww  435 (593)
T KOG0695|consen  405 GD-------------------------------------------------TTSTFCGTPNYIAPEILRGEEYGFSVDWW  435 (593)
T ss_pred             Cc-------------------------------------------------ccccccCCCcccchhhhcccccCceehHH
Confidence            11                                                 12367999999999999999999999999


Q ss_pred             hhhHHHHhhcccccccccC
Q 018275          340 AYWNETLSCNYLSDIMLYV  358 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~~~  358 (358)
                      +|||+||||..+...|+-|
T Consensus       436 algvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  436 ALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             HHHHHHHHHHcCCCCccee
Confidence            9999999999999988753

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.7e-40  Score=313.25  Aligned_cols=196  Identities=37%  Similarity=0.606  Sum_probs=172.3

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.++.+++.||||++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999999999999999999876544455666677888888776 699999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---------  151 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---------  151 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---------
Confidence            99999998888999999999999999999999999999999999999999999999999999875321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  191 (320)
T cd05590         152 ----------------------------------------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC  191 (320)
T ss_pred             ----------------------------------------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             cccccc
Q 018275          351 LSDIML  356 (358)
Q Consensus       351 ~~~~~~  356 (358)
                      +..+|.
T Consensus       192 g~~Pf~  197 (320)
T cd05590         192 GHAPFE  197 (320)
T ss_pred             CCCCCC
Confidence            887663

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-40  Score=312.34  Aligned_cols=196  Identities=36%  Similarity=0.613  Sum_probs=170.0

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHH-hcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE-VASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~-l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..+++.||||+++...............|..++.. .+||||+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999987654444445555667777664 4899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++......          
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----------  150 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----------  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----------
Confidence            9999999888889999999999999999999999999999999999999999999999999987542111          


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                             ......+||+.|+|||++.+..|+.++|+|||||++|||++
T Consensus       151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~  191 (316)
T cd05592         151 ---------------------------------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI  191 (316)
T ss_pred             ---------------------------------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh
Confidence                                                   00113479999999999999999999999999999999999


Q ss_pred             cccccc
Q 018275          351 LSDIML  356 (358)
Q Consensus       351 ~~~~~~  356 (358)
                      +..+|.
T Consensus       192 G~~Pf~  197 (316)
T cd05592         192 GQSPFH  197 (316)
T ss_pred             CCCCCC
Confidence            877663

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-41  Score=309.11  Aligned_cols=193  Identities=25%  Similarity=0.414  Sum_probs=167.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC-----CE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----EY  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~  180 (358)
                      -.|...+.+|+|+||.||.|....++..||||+...+...       -.+|+.+|+.++|||||+|..+|...     -+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            3577889999999999999999999999999998766422       23689999999999999999888632     25


Q ss_pred             EEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-CcEEEEecCCCcc
Q 018275          181 LYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKP  255 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~vkl~DFGla~~  255 (358)
                      +.|||||||. +|...+..    +..++.-.++.+..||+.||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            6799999975 89988864    5678888999999999999999999999999999999999987 9999999999998


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGM  334 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~  334 (358)
                      +.....+.                                                  |..-|..|+|||.+.| ..|+.
T Consensus       176 L~~~epni--------------------------------------------------SYicSRyYRaPELifga~~Yt~  205 (364)
T KOG0658|consen  176 LVKGEPNI--------------------------------------------------SYICSRYYRAPELIFGATEYTT  205 (364)
T ss_pred             eccCCCce--------------------------------------------------eEEEeccccCHHHHcCccccCc
Confidence            86443221                                                  3367889999999987 67999


Q ss_pred             cchhhhhhHHHHhhcccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +.|+||.||++.|||.+..+|+
T Consensus       206 ~IDiWSaGCV~aELl~g~plFp  227 (364)
T KOG0658|consen  206 SIDIWSAGCVMAELLKGQPLFP  227 (364)
T ss_pred             eeEEhhhhHHHHHHhcCCcccC
Confidence            9999999999999999999886

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-40  Score=313.15  Aligned_cols=196  Identities=36%  Similarity=0.606  Sum_probs=174.3

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ +||+|+.+++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999887655556667788999998888 699999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---------  151 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---------  151 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---------
Confidence            99999998888999999999999999999999999999999999999999999999999999874321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~  191 (327)
T cd05617         152 ----------------------------------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA  191 (327)
T ss_pred             ----------------------------------------ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHh
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             cccccc
Q 018275          351 LSDIML  356 (358)
Q Consensus       351 ~~~~~~  356 (358)
                      +..+|.
T Consensus       192 g~~pf~  197 (327)
T cd05617         192 GRSPFD  197 (327)
T ss_pred             CCCCCC
Confidence            888773

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=317.62  Aligned_cols=207  Identities=35%  Similarity=0.602  Sum_probs=187.8

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCC
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE  179 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~  179 (358)
                      ..+...+|.++..||+|+||.|-+|..+.+...+|||+++++.++..+..+--..|..+|+... -|.+++++..|+.-+
T Consensus       344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            3556688999999999999999999999999999999999998888888777778888888764 568999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+|+||||+.||+|+..+..-+.+-+..+.+|+++|+.||-+||++|||.||||.+||+|+.+|++||+|||+++.-...
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999743211


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .                                                 ....+.||||+|||||++..++|+.++|||
T Consensus       504 ~-------------------------------------------------~TTkTFCGTPdYiAPEIi~YqPYgksvDWW  534 (683)
T KOG0696|consen  504 G-------------------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWW  534 (683)
T ss_pred             C-------------------------------------------------cceeeecCCCcccccceEEecccccchhHH
Confidence            1                                                 223477999999999999999999999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      |+||+|||||.+...|+
T Consensus       535 a~GVLLyEmlaGQpPFd  551 (683)
T KOG0696|consen  535 AFGVLLYEMLAGQPPFD  551 (683)
T ss_pred             HHHHHHHHHHcCCCCCC
Confidence            99999999999988775

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.2e-40  Score=313.65  Aligned_cols=195  Identities=36%  Similarity=0.604  Sum_probs=172.5

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876544455566788888888776 799999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---------  151 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---------  151 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---------
Confidence            99999998888999999999999999999999999999999999999999999999999999874321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  191 (329)
T cd05618         152 ----------------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA  191 (329)
T ss_pred             ----------------------------------------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             ccccc
Q 018275          351 LSDIM  355 (358)
Q Consensus       351 ~~~~~  355 (358)
                      +..+|
T Consensus       192 g~~Pf  196 (329)
T cd05618         192 GRSPF  196 (329)
T ss_pred             CCCCC
Confidence            87776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=320.34  Aligned_cols=200  Identities=31%  Similarity=0.487  Sum_probs=183.2

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ...|..+..||+|+||.||+|.+..+++.||+|++....  ....++.+++|+.+|+.++++||..+|++|.....++++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            356888899999999999999999999999999999875  567788899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||||.||++.+.+.....+.+..+..++.+++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+....    
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~----  165 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV----  165 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh----
Confidence            9999999999999888888999999999999999999999999999999999999999999999999997664221    


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                   .+..+++|||.||||||+.+.+|+.++||||||++
T Consensus       166 ---------------------------------------------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGIT  200 (467)
T KOG0201|consen  166 ---------------------------------------------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGIT  200 (467)
T ss_pred             ---------------------------------------------hccccccccccccchhhhccccccchhhhhhhhHH
Confidence                                                         11247899999999999999999999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      ++||..|+.++
T Consensus       201 aiEla~GePP~  211 (467)
T KOG0201|consen  201 AIELAKGEPPH  211 (467)
T ss_pred             HHHHhcCCCCC
Confidence            99999987653

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-41  Score=325.44  Aligned_cols=203  Identities=28%  Similarity=0.471  Sum_probs=184.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..+-|++.+.||.|+-|.|.+|.+..||+.+|||++.+...........+.+|+.||+.+.||||+++|++|.+..++||
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            34779999999999999999999999999999999998754555666678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |.||++||.|.+++...+++++..++.++.||+.|+.|+|..+|+||||||+|+|||.++++||+|||+|..-..     
T Consensus        90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-----  164 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-----  164 (786)
T ss_pred             EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC-----
Confidence            999999999999999999999999999999999999999999999999999999999999999999999975421     


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC-ccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG-MECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~-~~~DiwSlG  342 (358)
                                                                   .++..+.||+|.|.|||+++|.+|+ .++||||.|
T Consensus       165 ---------------------------------------------gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCG  199 (786)
T KOG0588|consen  165 ---------------------------------------------GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCG  199 (786)
T ss_pred             ---------------------------------------------CccccccCCCcccCCchhhcCCCCCCCccccchhH
Confidence                                                         1233467999999999999999997 689999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      ||||.+|.|.=.|+
T Consensus       200 VILfALLtG~LPFd  213 (786)
T KOG0588|consen  200 VILFALLTGKLPFD  213 (786)
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999888876664

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2e-40  Score=312.64  Aligned_cols=196  Identities=37%  Similarity=0.613  Sum_probs=172.5

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            3699999999999999999999999999876554555666677888888865 799999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|...+.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---------  151 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---------  151 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---------
Confidence            99999998888899999999999999999999999999999999999999999999999999875321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t  191 (321)
T cd05591         152 ----------------------------------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA  191 (321)
T ss_pred             ----------------------------------------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             cccccc
Q 018275          351 LSDIML  356 (358)
Q Consensus       351 ~~~~~~  356 (358)
                      +..+|.
T Consensus       192 g~~Pf~  197 (321)
T cd05591         192 GQPPFE  197 (321)
T ss_pred             CCCCCC
Confidence            887664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=306.02  Aligned_cols=203  Identities=28%  Similarity=0.407  Sum_probs=177.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec-----CCE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-----AEY  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~  180 (358)
                      ..|..++.||+|+||.|..|.++.+|..||||++... +......++..+|+.+|+.++|+||+.+++.+..     -+.
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            5566689999999999999999999999999999744 2345566778899999999999999999999865     356


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+|+|+| +.||...++.++.+++..+.+++.|++.||.|+|+.+|+||||||+|+|++.+..+||||||+|+..+.. 
T Consensus       101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-  178 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-  178 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence            89999999 6799999988888999999999999999999999999999999999999999999999999999987533 


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-CCCCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-~~~y~~~~Diw  339 (358)
                      ....                                              .-...|-|.+|+|||++. ...|+.+.|+|
T Consensus       179 ~~~~----------------------------------------------~mTeYVaTRWYRAPElll~~~~Yt~aiDiW  212 (359)
T KOG0660|consen  179 FEDG----------------------------------------------FMTEYVATRWYRAPELLLNSSEYTKAIDIW  212 (359)
T ss_pred             Cccc----------------------------------------------chhcceeeeeecCHHHHhccccccchhhhh
Confidence            0000                                              001348899999999986 47799999999


Q ss_pred             hhhHHHHhhccccccccc
Q 018275          340 AYWNETLSCNYLSDIMLY  357 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~~  357 (358)
                      |+|||+.|||.+..+|+.
T Consensus       213 SvGCI~AEmL~gkplFpG  230 (359)
T KOG0660|consen  213 SVGCILAEMLTGKPLFPG  230 (359)
T ss_pred             hhhHHHHHHHcCCCCCCC
Confidence            999999999999999974

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.7e-40  Score=312.16  Aligned_cols=199  Identities=35%  Similarity=0.606  Sum_probs=172.7

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHH---HHhcCcceEEEEEEeecCCEEEEE
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL---AEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il---~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      |.+++.||+|+||.||+|.+..+++.||||++++.........+.+..|..++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67899999999999999999999999999999876544455566677776665   466899999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++++|...+. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......   
T Consensus        81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---  156 (324)
T cd05589          81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---  156 (324)
T ss_pred             EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC---
Confidence            99999999998874 45789999999999999999999999999999999999999999999999999864321110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                    .....+||+.|+|||++.+..++.++|||||||+
T Consensus       157 ----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i  190 (324)
T cd05589         157 ----------------------------------------------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVL  190 (324)
T ss_pred             ----------------------------------------------cccccccCccccCHhHhcCCCCCcccchhhHHHH
Confidence                                                          0113479999999999999999999999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +|||+++..+|.
T Consensus       191 l~el~~G~~pf~  202 (324)
T cd05589         191 IYEMLVGESPFP  202 (324)
T ss_pred             HHHHHhCCCCCC
Confidence            999999887764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-40  Score=312.25  Aligned_cols=195  Identities=41%  Similarity=0.683  Sum_probs=168.9

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHH-HHHHhcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||+||+|.+..+|+.||||++.+...........+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999998765433444445555555 56789999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---------  151 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---------  151 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---------
Confidence            99999998888999999999999999999999999999999999999999999999999999864321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~  191 (323)
T cd05575         152 ----------------------------------------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY  191 (323)
T ss_pred             ----------------------------------------ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhc
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             ccccc
Q 018275          351 LSDIM  355 (358)
Q Consensus       351 ~~~~~  355 (358)
                      +...|
T Consensus       192 g~~pf  196 (323)
T cd05575         192 GLPPF  196 (323)
T ss_pred             CCCCC
Confidence            87765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3e-40  Score=312.01  Aligned_cols=195  Identities=38%  Similarity=0.653  Sum_probs=167.9

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHH-HHHHHhcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER-NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|. .+++.++||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999876443333333444444 456789999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---------  151 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---------  151 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---------
Confidence            99999998888899999999999999999999999999999999999999999999999999875321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  191 (325)
T cd05602         152 ----------------------------------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY  191 (325)
T ss_pred             ----------------------------------------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             ccccc
Q 018275          351 LSDIM  355 (358)
Q Consensus       351 ~~~~~  355 (358)
                      +...|
T Consensus       192 g~~pf  196 (325)
T cd05602         192 GLPPF  196 (325)
T ss_pred             CCCCC
Confidence            88765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.1e-40  Score=311.29  Aligned_cols=195  Identities=41%  Similarity=0.680  Sum_probs=168.4

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHH-HHHHhcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..++..||+|++.+...........+..|.. +++.++||||+++++.|.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998765433334444555554 67889999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      ++|...+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---------  151 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---------  151 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---------
Confidence            99999998888899999999999999999999999999999999999999999999999999874321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|+|||||++|||++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  191 (321)
T cd05603         152 ----------------------------------------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY  191 (321)
T ss_pred             ----------------------------------------ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             ccccc
Q 018275          351 LSDIM  355 (358)
Q Consensus       351 ~~~~~  355 (358)
                      +...|
T Consensus       192 g~~pf  196 (321)
T cd05603         192 GLPPF  196 (321)
T ss_pred             CCCCC
Confidence            87765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.7e-40  Score=312.36  Aligned_cols=195  Identities=39%  Similarity=0.667  Sum_probs=169.0

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHH-HHHHhcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999998764433444445555655 46789999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|...+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---------  151 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---------  151 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---------
Confidence            99999998888999999999999999999999999999999999999999999999999999874321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  191 (325)
T cd05604         152 ----------------------------------------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY  191 (325)
T ss_pred             ----------------------------------------CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             ccccc
Q 018275          351 LSDIM  355 (358)
Q Consensus       351 ~~~~~  355 (358)
                      +...|
T Consensus       192 G~~pf  196 (325)
T cd05604         192 GLPPF  196 (325)
T ss_pred             CCCCC
Confidence            87665

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.3e-40  Score=309.91  Aligned_cols=196  Identities=35%  Similarity=0.588  Sum_probs=170.3

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHH-hcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE-VASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~-l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..+|..||+|++++..............|..++.. .+||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999987654334445556777777765 4899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......          
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----------  150 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----------  150 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----------
Confidence            9999999888889999999999999999999999999999999999999999999999999986421110          


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                             ......+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus       151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~  191 (316)
T cd05620         151 ---------------------------------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI  191 (316)
T ss_pred             ---------------------------------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh
Confidence                                                   00113479999999999999999999999999999999999


Q ss_pred             cccccc
Q 018275          351 LSDIML  356 (358)
Q Consensus       351 ~~~~~~  356 (358)
                      +..+|.
T Consensus       192 g~~Pf~  197 (316)
T cd05620         192 GQSPFH  197 (316)
T ss_pred             CCCCCC
Confidence            887663

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.8e-40  Score=321.55  Aligned_cols=194  Identities=25%  Similarity=0.367  Sum_probs=171.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-C-----cceEEEEEEeecCC
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-S-----HCIVKLYYSFQDAE  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h-----~~iv~l~~~~~~~~  179 (358)
                      .+|.+++.||+|+||.|-+|.+..+++.||||+++...    ........|+.+|..++ |     .|+|+++++|...+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            37899999999999999999999999999999998764    33445677999999987 3     38999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC--CcEEEEecCCCcc
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN--GHMKLSDFGLCKP  255 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~--~~vkl~DFGla~~  255 (358)
                      ++|||+|.+ .-+|.++++.+  .+++...++.++.||+.||.+||..+|||+||||+||||..-  ..|||+|||.|..
T Consensus       262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999999999 56999999876  478899999999999999999999999999999999999644  4799999999976


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      ....                                                    .++.+.+..|+||||++|.+|+.+
T Consensus       341 ~~q~----------------------------------------------------vytYiQSRfYRAPEVILGlpY~~~  368 (586)
T KOG0667|consen  341 ESQR----------------------------------------------------VYTYIQSRFYRAPEVILGLPYDTA  368 (586)
T ss_pred             cCCc----------------------------------------------------ceeeeeccccccchhhccCCCCCc
Confidence            5422                                                    224578999999999999999999


Q ss_pred             chhhhhhHHHHhhcccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +|+||||||+.||.+|..+|+
T Consensus       369 IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  369 IDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             cceeehhhhHHhHhcCccccC
Confidence            999999999999999988875

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=316.29  Aligned_cols=205  Identities=25%  Similarity=0.309  Sum_probs=173.6

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      .....++++|.....||+|+||.||+|.... |..||||.+.......   ...|.+|+.++.+++|||+|+|+|+|.+.
T Consensus        68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~  143 (361)
T KOG1187|consen   68 DELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEG  143 (361)
T ss_pred             HHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence            3344456999999999999999999998654 4899999877653211   44499999999999999999999999988


Q ss_pred             C-EEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          179 E-YLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKH---NYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       179 ~-~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                      + ..+||+|||++|+|.++|....  ++++.....|+.+++.||+|||..   .||||||||+|||||.++.+||+|||+
T Consensus       144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL  223 (361)
T KOG1187|consen  144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL  223 (361)
T ss_pred             CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence            8 5999999999999999998765  889999999999999999999975   499999999999999999999999999


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccc-cCCCCCchhhhhcCCC
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIAPEVLLKKG  331 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~gt~~Y~APEv~~~~~  331 (358)
                      |+...... ..                                                ..+. .||.+|+|||++..+.
T Consensus       224 a~~~~~~~-~~------------------------------------------------~~~~~~gt~gY~~PEy~~~g~  254 (361)
T KOG1187|consen  224 AKLGPEGD-TS------------------------------------------------VSTTVMGTFGYLAPEYASTGK  254 (361)
T ss_pred             cccCCccc-cc------------------------------------------------eeeecCCCCccCChhhhccCC
Confidence            96553210 00                                                0011 6999999999999988


Q ss_pred             CCccchhhhhhHHHHhhcccccccc
Q 018275          332 YGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .+.++|||||||+|+|++.+...++
T Consensus       255 lt~KsDVySFGVvllElitgr~~~d  279 (361)
T KOG1187|consen  255 LTEKSDVYSFGVVLLELITGRKAVD  279 (361)
T ss_pred             cCcccccccchHHHHHHHhCCcccC
Confidence            9999999999999999998875543

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9e-40  Score=309.44  Aligned_cols=201  Identities=38%  Similarity=0.667  Sum_probs=173.5

Q ss_pred             CceeeeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhh-chhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEML-SRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~  181 (358)
                      +|++++.||+|+||.||+|.+.   .++..||+|++.+.... .....+.+..|+.++..+ +||+|+.+++++.+.+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5889999999999999998763   47899999999865432 233455678899999999 589999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ++||||+++|+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999876432110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLA  340 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwS  340 (358)
                      .                                                ...+.+||+.|+|||++.+. .++.++||||
T Consensus       161 ~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws  192 (332)
T cd05614         161 E------------------------------------------------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS  192 (332)
T ss_pred             C------------------------------------------------ccccccCCccccCHHHhcCCCCCCCcccccc
Confidence            0                                                11245799999999999875 4889999999


Q ss_pred             hhHHHHhhccccccc
Q 018275          341 YWNETLSCNYLSDIM  355 (358)
Q Consensus       341 lGvil~e~l~~~~~~  355 (358)
                      |||++|||+++..+|
T Consensus       193 lG~il~elltg~~pf  207 (332)
T cd05614         193 LGILIFELLTGASPF  207 (332)
T ss_pred             chhhhhhhhcCCCCC
Confidence            999999999988776

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7e-40  Score=308.51  Aligned_cols=195  Identities=34%  Similarity=0.597  Sum_probs=169.4

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHH-hcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE-VASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~-l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..++..||||+++...............|..++.. ++||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999987654333444556677777775 4899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---------  151 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---------  151 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---------
Confidence            99999998878899999999999999999999999999999999999999999999999999864321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              ...+.+||+.|+|||++.+..|+.++|+|||||++|||++
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  191 (316)
T cd05619         152 ----------------------------------------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI  191 (316)
T ss_pred             ----------------------------------------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             ccccc
Q 018275          351 LSDIM  355 (358)
Q Consensus       351 ~~~~~  355 (358)
                      +..+|
T Consensus       192 G~~pf  196 (316)
T cd05619         192 GQSPF  196 (316)
T ss_pred             CCCCC
Confidence            87765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.6e-40  Score=304.54  Aligned_cols=202  Identities=31%  Similarity=0.436  Sum_probs=175.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||++++++|.+.+..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            479999999999999999999999999999999976532 2334556788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||++++++..+......+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++..+.......  
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--  157 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--  157 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc--
Confidence            999987776665555679999999999999999999999999999999999999999999999999998653211000  


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                    ....+||+.|+|||++.+..++.++|+|||||++
T Consensus       158 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil  191 (287)
T cd07848         158 ----------------------------------------------YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCIL  191 (287)
T ss_pred             ----------------------------------------------ccccccccccCCcHHHcCCCCCCchhHHhHHHHH
Confidence                                                          0124699999999999999999999999999999


Q ss_pred             Hhhcccccccc
Q 018275          346 LSCNYLSDIML  356 (358)
Q Consensus       346 ~e~l~~~~~~~  356 (358)
                      |||+++..+|.
T Consensus       192 ~el~~g~~pf~  202 (287)
T cd07848         192 GELSDGQPLFP  202 (287)
T ss_pred             HHHHhCCCCCC
Confidence            99999887663

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=313.43  Aligned_cols=202  Identities=34%  Similarity=0.509  Sum_probs=182.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~  182 (358)
                      ....|.+.+.||+|.||.||+|..+.+|..+|+|++.+...........+.+|+.+|+.+. |||||.++++|.+...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3467999999999999999999999999999999999887665556678999999999998 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC----CcEEEEecCCCccCCC
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN----GHMKLSDFGLCKPLDC  258 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~----~~vkl~DFGla~~~~~  258 (358)
                      +|||++.||.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+...    +.+|++|||+|.....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999999999999777 49999999999999999999999999999999999999643    4799999999987653


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                                                                        .......||||.|+|||++...+|+..+|+
T Consensus       192 --------------------------------------------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~Di  221 (382)
T KOG0032|consen  192 --------------------------------------------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDV  221 (382)
T ss_pred             --------------------------------------------------CceEeeecCCccccCchhhcCCCCCcccch
Confidence                                                              112336799999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      ||+||++|.+|.+...|.
T Consensus       222 WS~Gvi~yiLL~G~~PF~  239 (382)
T KOG0032|consen  222 WSIGVILYILLSGVPPFW  239 (382)
T ss_pred             hHHHHHHHHHhhCCCCCc
Confidence            999999999998877763

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.7e-40  Score=305.59  Aligned_cols=200  Identities=26%  Similarity=0.358  Sum_probs=170.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999875532  22233467899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||++ ++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  158 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--  158 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence            99995 6787777554 5788999999999999999999999999999999999999999999999999875421110  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                     ...+.+||+.|+|||++.+ ..|+.++||||||
T Consensus       159 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  191 (303)
T cd07869         159 -----------------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVG  191 (303)
T ss_pred             -----------------------------------------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHH
Confidence                                                           0113468999999999876 4589999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|||+++..+|.
T Consensus       192 ~il~~l~~g~~pf~  205 (303)
T cd07869         192 CIFVEMIQGVAAFP  205 (303)
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999999887763

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.6e-40  Score=308.36  Aligned_cols=197  Identities=39%  Similarity=0.687  Sum_probs=170.7

Q ss_pred             eeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhh-chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          111 LTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEML-SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      ++.||+|+||.||+|.+.   .+++.||+|++...... .......+..|+.+++.++||||++++++|.+++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999863   47889999999875432 22344567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......     
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----  155 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-----  155 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-----
Confidence            999999999998888899999999999999999999999999999999999999999999999999874321110     


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETL  346 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~  346 (358)
                                                                  .....+||+.|+|||++.+..++.++|+|||||++|
T Consensus       156 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  191 (323)
T cd05584         156 --------------------------------------------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMY  191 (323)
T ss_pred             --------------------------------------------cccccCCCccccChhhccCCCCCCcceecccHHHHH
Confidence                                                        011347999999999999999999999999999999


Q ss_pred             hhcccccccc
Q 018275          347 SCNYLSDIML  356 (358)
Q Consensus       347 e~l~~~~~~~  356 (358)
                      ||+++..+|.
T Consensus       192 ell~G~~pf~  201 (323)
T cd05584         192 DMLTGAPPFT  201 (323)
T ss_pred             HHhcCCCCCC
Confidence            9999887663

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-39  Score=315.49  Aligned_cols=194  Identities=23%  Similarity=0.295  Sum_probs=170.9

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .+..++|.+++.||+|+||.||+|.+..+++.||+|.....         .+.+|+.+++.++|||||+++++|......
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~---------~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG---------GTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh---------hhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            45568899999999999999999999999999999975422         266899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ++|||++. ++|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+.......
T Consensus       159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            99999994 78999988878899999999999999999999999999999999999999999999999999865321110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                      ......+||+.|+|||++.+..|+.++|||||
T Consensus       238 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  269 (391)
T PHA03212        238 ------------------------------------------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSA  269 (391)
T ss_pred             ------------------------------------------------cccccccCccCCCChhhhcCCCCCcHHHHHHH
Confidence                                                            01123479999999999999999999999999


Q ss_pred             hHHHHhhccccc
Q 018275          342 WNETLSCNYLSD  353 (358)
Q Consensus       342 Gvil~e~l~~~~  353 (358)
                      ||++|||+++..
T Consensus       270 Gvil~elltg~~  281 (391)
T PHA03212        270 GIVLFEMATCHD  281 (391)
T ss_pred             HHHHHHHHHCCC
Confidence            999999998764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.5e-40  Score=310.25  Aligned_cols=206  Identities=23%  Similarity=0.285  Sum_probs=168.6

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~  174 (358)
                      +.++.++|.+.+.||+|+||.||+|.+.     .++..||||++....  .......+..|+.++..+ +|||||+++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            3456689999999999999999999752     345789999987542  233456688999999999 89999999998


Q ss_pred             eecC-CEEEEEEeecCCCCHHHHHhhc-----------------------------------------------------
Q 018275          175 FQDA-EYLYLIMEYLPGGDVMTLLMRE-----------------------------------------------------  200 (358)
Q Consensus       175 ~~~~-~~~~lV~E~~~~g~L~~~l~~~-----------------------------------------------------  200 (358)
                      |... ..+++||||+++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            8754 4689999999999999998642                                                     


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccc
Q 018275          201 ---------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD  271 (358)
Q Consensus       201 ---------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~  271 (358)
                               .+++...+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.........        
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~--------  231 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--------  231 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh--------
Confidence                     236677888899999999999999999999999999999999999999999997653111000        


Q ss_pred             cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-
Q 018275          272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-  350 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-  350 (358)
                                                             ...+..+|+.|+|||++.+..|+.++|||||||++|||+. 
T Consensus       232 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~  272 (338)
T cd05102         232 ---------------------------------------RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL  272 (338)
T ss_pred             ---------------------------------------cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhC
Confidence                                                   0012346788999999999999999999999999999985 


Q ss_pred             ccccc
Q 018275          351 LSDIM  355 (358)
Q Consensus       351 ~~~~~  355 (358)
                      +..+|
T Consensus       273 g~~pf  277 (338)
T cd05102         273 GASPY  277 (338)
T ss_pred             CCCCC
Confidence            65554

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.5e-39  Score=306.55  Aligned_cols=201  Identities=26%  Similarity=0.362  Sum_probs=179.0

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++++.||+|+||.||++.+..++..||+|.+....  .......+.+|+.+++.++||||+++++++.+.+.++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            34589999999999999999999999999999999987642  2344566889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+.... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            9999999999999998888899999999999999999999986 69999999999999999999999999987543111 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                        ....+||+.|+|||++.+..++.++|+|||
T Consensus       159 --------------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  188 (331)
T cd06649         159 --------------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSM  188 (331)
T ss_pred             --------------------------------------------------cccCCCCcCcCCHhHhcCCCCCchHhHHHH
Confidence                                                              013369999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|||+++...|.
T Consensus       189 G~il~el~tg~~p~~  203 (331)
T cd06649         189 GLSLVELAIGRYPIP  203 (331)
T ss_pred             HHHHHHHHhCCCCCC
Confidence            999999999887764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-39  Score=302.10  Aligned_cols=200  Identities=25%  Similarity=0.360  Sum_probs=171.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||.|+||.||+|.+..++..||+|+++...  .......+.+|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            468999999999999999999999999999999987543  122334577899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........ 
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~-  159 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-  159 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-
Confidence            999975 899888654 45788899999999999999999999999999999999999999999999998754311100 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                      ....+||+.|+|||++.+ ..|+.++|+||||
T Consensus       160 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  191 (288)
T cd07871         160 ------------------------------------------------YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG  191 (288)
T ss_pred             ------------------------------------------------ccCceecccccChHHhcCCcccCcHHHHHHHH
Confidence                                                            112368999999999876 5689999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|||+++..+|.
T Consensus       192 ~~l~~l~~g~~pf~  205 (288)
T cd07871         192 CILYEMATGRPMFP  205 (288)
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999999887663

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-39  Score=306.24  Aligned_cols=196  Identities=37%  Similarity=0.604  Sum_probs=173.0

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+||.||+|.+..++..||||++++...........+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999887654555666677888888877 699999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---------  151 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---------  151 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---------
Confidence            99999998888899999999999999999999999999999999999999999999999999864321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              .....+||+.|+|||++.+..|+.++|+|||||++|++++
T Consensus       152 ----------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~  191 (318)
T cd05570         152 ----------------------------------------TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA  191 (318)
T ss_pred             ----------------------------------------cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh
Confidence                                                    0113479999999999999999999999999999999999


Q ss_pred             cccccc
Q 018275          351 LSDIML  356 (358)
Q Consensus       351 ~~~~~~  356 (358)
                      +..+|.
T Consensus       192 G~~pf~  197 (318)
T cd05570         192 GQSPFE  197 (318)
T ss_pred             CCCCCC
Confidence            887764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.9e-39  Score=298.85  Aligned_cols=193  Identities=35%  Similarity=0.581  Sum_probs=168.8

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCH
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV  193 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L  193 (358)
                      ||+|+||+||+|.+..+++.||+|.+.............+..|+.+++.++||||++++++|.+....|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999999876544444556678899999999999999999999999999999999999999


Q ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccc
Q 018275          194 MTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV  269 (358)
Q Consensus       194 ~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  269 (358)
                      ...+..    ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+......       
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-------  153 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-------  153 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-------
Confidence            887743    356899999999999999999999999999999999999999999999999998755321100       


Q ss_pred             cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhc
Q 018275          270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCN  349 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l  349 (358)
                                                                .....||+.|+|||++.+..++.++|+|||||++|||+
T Consensus       154 ------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  191 (280)
T cd05608         154 ------------------------------------------TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI  191 (280)
T ss_pred             ------------------------------------------ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHH
Confidence                                                      11336999999999999999999999999999999999


Q ss_pred             cccccc
Q 018275          350 YLSDIM  355 (358)
Q Consensus       350 ~~~~~~  355 (358)
                      ++...|
T Consensus       192 ~g~~pf  197 (280)
T cd05608         192 AARGPF  197 (280)
T ss_pred             hCCCCC
Confidence            987665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-39  Score=305.69  Aligned_cols=201  Identities=23%  Similarity=0.328  Sum_probs=170.2

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC-----CEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----EYL  181 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~  181 (358)
                      +|++.+.||+|+||.||+|.+..++..||||.+..... .......+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            58899999999999999999999999999999875321 223344578899999999999999999988543     358


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||++ ++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999995 69999998888899999999999999999999999999999999999999999999999999975432111


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCccchhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWL  339 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~~Diw  339 (358)
                      ..                                              ......+||+.|+|||++.+  ..|+.++|||
T Consensus       159 ~~----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Dvw  192 (338)
T cd07859         159 TA----------------------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIW  192 (338)
T ss_pred             cc----------------------------------------------ccccCCCCCCCcCCHHHHhccccccCchhHHH
Confidence            00                                              00113479999999999976  6799999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      ||||++|||+++..+|
T Consensus       193 SlGvvl~el~tg~~pf  208 (338)
T cd07859         193 SIGCIFAEVLTGKPLF  208 (338)
T ss_pred             HHHHHHHHHHcCCCCC
Confidence            9999999999988766

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=297.92  Aligned_cols=199  Identities=31%  Similarity=0.544  Sum_probs=174.1

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||+|+||.||++.+..++..||+|++.............+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48899999999999999999998999999999987554333344556789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       187 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++........   
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---
Confidence            99999999888653  4689999999999999999999999999999999999999999999999999875431110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                     ..+.+||+.|+|||++.+..++.++|+||+||+
T Consensus       158 -----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~  190 (285)
T cd05605         158 -----------------------------------------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCL  190 (285)
T ss_pred             -----------------------------------------------cccccCCCCccCcHHhcCCCCCccccchhHHHH
Confidence                                                           013479999999999999999999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|||+.+..+|
T Consensus       191 l~el~~g~~pf  201 (285)
T cd05605         191 IYEMIEGKSPF  201 (285)
T ss_pred             HHHHHHCCCCC
Confidence            99999987765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=307.73  Aligned_cols=193  Identities=40%  Similarity=0.655  Sum_probs=166.7

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh---cCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      ||+|+||+||+|.+..+++.||||++.+..............|..++...   .||+|+.++..+.+...+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999999999999999999876544444455566677777665   699999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      |+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......         
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---------  151 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---------  151 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---------
Confidence            99999998888999999999999999999999999999999999999999999999999999875321110         


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhHHHHhhc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWNETLSCN  349 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGvil~e~l  349 (358)
                                                              .....+||+.|+|||++.+. .|+.++|+|||||++|||+
T Consensus       152 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell  191 (330)
T cd05586         152 ----------------------------------------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC  191 (330)
T ss_pred             ----------------------------------------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEec
Confidence                                                    01134799999999999764 5899999999999999999


Q ss_pred             cccccc
Q 018275          350 YLSDIM  355 (358)
Q Consensus       350 ~~~~~~  355 (358)
                      ++..+|
T Consensus       192 tG~~Pf  197 (330)
T cd05586         192 CGWSPF  197 (330)
T ss_pred             cCCCCC
Confidence            987765

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.1e-39  Score=299.06  Aligned_cols=204  Identities=21%  Similarity=0.312  Sum_probs=168.8

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEec----------------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKK----------------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC  167 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~  167 (358)
                      ..++|.+.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++..++|||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence            45789999999999999999997532                34479999987643  2344566889999999999999


Q ss_pred             eEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 018275          168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-------------------TLTETVARFYIAQSVLAIESIHKHNYI  228 (358)
Q Consensus       168 iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~qi~~aL~~LH~~~ii  228 (358)
                      |+++++++.+.+..++||||+++|+|.+++....                   .++...+..++.|++.||.|||+.||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999985431                   356677888999999999999999999


Q ss_pred             eCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhh
Q 018275          229 HRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR  308 (358)
Q Consensus       229 HrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (358)
                      ||||||+|||++.++.+||+|||+++.+.......                                             
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~---------------------------------------------  195 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR---------------------------------------------  195 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeE---------------------------------------------
Confidence            99999999999999999999999997653221000                                             


Q ss_pred             ccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          309 RKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       309 ~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                        ......+++.|||||++.+..++.++|||||||++|||+.+...++
T Consensus       196 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         196 --IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             --ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence              0012356889999999999999999999999999999987554444

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.4e-39  Score=303.29  Aligned_cols=201  Identities=26%  Similarity=0.357  Sum_probs=177.6

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++.+.||+|+||.||+|.+..++..+|+|.+....  .......+.+|+.+++.++||||++++++|.+.+.+|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            34589999999999999999999999999999999887542  2334456889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      +||||+++++|.+++.....+++..+..++.+++.||.|||+. +|+||||||+|||++.++.+||+|||++..+.... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            9999999999999998888899999999999999999999975 79999999999999999999999999987542110 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                        ....+||+.|+|||++.+..++.++|+|||
T Consensus       159 --------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  188 (333)
T cd06650         159 --------------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSM  188 (333)
T ss_pred             --------------------------------------------------cccCCCCccccCHHHhcCCCCCcHHHHHHH
Confidence                                                              012369999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++||++++...|.
T Consensus       189 G~il~~l~~g~~p~~  203 (333)
T cd06650         189 GLSLVEMAIGRYPIP  203 (333)
T ss_pred             HHHHHHHHHCCCCCC
Confidence            999999999877654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.8e-39  Score=303.51  Aligned_cols=195  Identities=41%  Similarity=0.662  Sum_probs=169.9

Q ss_pred             eeEeeeeeEEEEEEEE---ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeec
Q 018275          112 TIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL  188 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~  188 (358)
                      +.||+|+||.||++.+   ..+|+.||+|++...... ......+..|+.+++.++||||++++++|.+...+|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            6799999999999876   357899999999876432 223345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccc
Q 018275          189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE  268 (358)
Q Consensus       189 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~  268 (358)
                      ++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++......        
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--------  152 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--------  152 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--------
Confidence            999999999888889999999999999999999999999999999999999999999999999987543111        


Q ss_pred             ccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhh
Q 018275          269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSC  348 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~  348 (358)
                                                               ....+.+||+.|+|||++.+..++.++|+|||||++|||
T Consensus       153 -----------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el  191 (318)
T cd05582         153 -----------------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEM  191 (318)
T ss_pred             -----------------------------------------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeee
Confidence                                                     011245799999999999999999999999999999999


Q ss_pred             cccccccc
Q 018275          349 NYLSDIML  356 (358)
Q Consensus       349 l~~~~~~~  356 (358)
                      +++..+|.
T Consensus       192 ~tg~~p~~  199 (318)
T cd05582         192 LTGSLPFQ  199 (318)
T ss_pred             ccCCCCCC
Confidence            99876653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=315.57  Aligned_cols=200  Identities=28%  Similarity=0.370  Sum_probs=173.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecC-CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKS-GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ..|.+.+.||+|+||.||+|....+ +..||+|.+...   .......++.|+.+++.++|||||+++++|.+.+.+|||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            4599999999999999999998777 788999977544   233445678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          185 MEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      |||+++|+|.+++..    ..++++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999999987753    3578999999999999999999999999999999999999999999999999998654211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ..                                               ....+.+||+.|+|||++.+..|+.++||||
T Consensus       224 ~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s  256 (478)
T PTZ00267        224 SL-----------------------------------------------DVASSFCGTPYYLAPELWERKRYSKKADMWS  256 (478)
T ss_pred             cc-----------------------------------------------ccccccCCCccccCHhHhCCCCCCcHHhHHH
Confidence            00                                               0112457999999999999999999999999


Q ss_pred             hhHHHHhhccccccc
Q 018275          341 YWNETLSCNYLSDIM  355 (358)
Q Consensus       341 lGvil~e~l~~~~~~  355 (358)
                      |||++|||+++...|
T Consensus       257 lG~~l~el~tg~~Pf  271 (478)
T PTZ00267        257 LGVILYELLTLHRPF  271 (478)
T ss_pred             HHHHHHHHHhCCCCC
Confidence            999999999987665

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=308.46  Aligned_cols=201  Identities=25%  Similarity=0.369  Sum_probs=169.2

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      .+.+....+.+++.||+|-||.||+|.+..+ ..||+|.++...+.    .+.+.+|+.+|++++|++||+++++|..++
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            3445556677889999999999999987643 37999999876432    234779999999999999999999999988


Q ss_pred             EEEEEEeecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      .+|||||||+.|+|.++|..  ...+.......++.|||.|++||+++++|||||...|||++.+..+||+|||+|+...
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999999986  4578888899999999999999999999999999999999999999999999999544


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ........                                                +.--.-.|.|||.+....++.+||
T Consensus       355 d~~Y~~~~------------------------------------------------~~kfPIkWtAPEa~~~~~FS~kSD  386 (468)
T KOG0197|consen  355 DDEYTASE------------------------------------------------GGKFPIKWTAPEALNYGKFSSKSD  386 (468)
T ss_pred             CCceeecC------------------------------------------------CCCCCceecCHHHHhhCCcccccc
Confidence            22211100                                                001234599999999999999999


Q ss_pred             hhhhhHHHHhhccccc
Q 018275          338 WLAYWNETLSCNYLSD  353 (358)
Q Consensus       338 iwSlGvil~e~l~~~~  353 (358)
                      ||||||+|||++....
T Consensus       387 VWSFGVlL~E~fT~G~  402 (468)
T KOG0197|consen  387 VWSFGVLLWELFTYGR  402 (468)
T ss_pred             eeehhhhHHHHhccCC
Confidence            9999999999987643

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-41  Score=314.66  Aligned_cols=204  Identities=36%  Similarity=0.619  Sum_probs=191.3

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +...+++.+..||-|+||.|-++........+|+|++++..+....+.+++..|..||..+++|+||++|..|.+.+++|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            45578888999999999999999877666679999999999999999999999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ++||-|-||.|+..|...+.|.+..++++++.++.|++|||++|||.|||||+|++++.+|-+||.|||+|+.+...   
T Consensus       497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g---  573 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG---  573 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987522   


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                     ..+|++||||.|.|||++++++++.++|+||||
T Consensus       574 -----------------------------------------------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLG  606 (732)
T KOG0614|consen  574 -----------------------------------------------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALG  606 (732)
T ss_pred             -----------------------------------------------CceeeecCCcccccchhhhccCcchhhHHHHHH
Confidence                                                           346788999999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      +++||+|+|+.+|.
T Consensus       607 Ili~ELL~G~pPFs  620 (732)
T KOG0614|consen  607 ILIYELLTGSPPFS  620 (732)
T ss_pred             HHHHHHHcCCCCCC
Confidence            99999999998875

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.6e-38  Score=291.65  Aligned_cols=199  Identities=31%  Similarity=0.546  Sum_probs=173.6

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+.............+..|+.+++.++|++++.+++.+.+.+.+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            37788999999999999999999999999999887654444444557789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       187 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.......    
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~----  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence            99999999988543  368899999999999999999999999999999999999999999999999986542110    


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                    ...+.+||+.|+|||++.+..++.++|+|||||+
T Consensus       157 ----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~  190 (285)
T cd05630         157 ----------------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL  190 (285)
T ss_pred             ----------------------------------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHH
Confidence                                                          0012369999999999999999999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|+|+++..+|
T Consensus       191 l~~l~~g~~Pf  201 (285)
T cd05630         191 LYEMIAGQSPF  201 (285)
T ss_pred             HHHHHhCCCCC
Confidence            99999987765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-41  Score=289.16  Aligned_cols=200  Identities=29%  Similarity=0.458  Sum_probs=178.5

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .+.|++...||+|.|+.||+|.+..+|+.+|+|++....+.. ...+.+.+|+.|-+.++|||||+|...+......|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            478889999999999999999999999999999998776543 4677899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC---CcEEEEecCCCccCCCCCC
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~vkl~DFGla~~~~~~~~  261 (358)
                      +|+|.|++|..-+-....+++..+..++.||+.||.|+|.+||||||+||.|+|+.+.   .-+||+|||+|..+.  + 
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~-  165 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D-  165 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--C-
Confidence            9999999998777677788999999999999999999999999999999999999643   469999999998765  1 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                     ..++...+|||+||||||+...+|+.++|+|+.
T Consensus       166 -----------------------------------------------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~c  198 (355)
T KOG0033|consen  166 -----------------------------------------------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC  198 (355)
T ss_pred             -----------------------------------------------ccccccccCCCcccCHHHhhcCCCCCcchhhhh
Confidence                                                           122346699999999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      |||||=+|.|.-+|
T Consensus       199 GViLfiLL~G~~PF  212 (355)
T KOG0033|consen  199 GVILYILLVGYPPF  212 (355)
T ss_pred             hHHHHHHHhCCCCC
Confidence            99999988766554

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.5e-38  Score=324.09  Aligned_cols=219  Identities=25%  Similarity=0.327  Sum_probs=175.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999997654333444567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          186 EYLPGGDVMTLLMRE-----------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       186 E~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                      ||++|++|.+++...           ..++...+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||+++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999999998541           234455677888999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCc
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM  334 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~  334 (358)
                      .............           ....+..                    ..........+||+.|||||++.+..++.
T Consensus       162 ~i~~~~~~~~~l~-----------~~~~~s~--------------------~s~~t~~g~~vGT~~YmAPE~l~g~~~S~  210 (932)
T PRK13184        162 FKKLEEEDLLDID-----------VDERNIC--------------------YSSMTIPGKIVGTPDYMAPERLLGVPASE  210 (932)
T ss_pred             ecccccccccccc-----------ccccccc--------------------ccccccCCCCCCCCCCCCHHHhcCCCCCc
Confidence            7632211000000           0000000                    00000112357999999999999999999


Q ss_pred             cchhhhhhHHHHhhccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ++|+|||||++|||+++..+|
T Consensus       211 kSDIWSLGVILyELLTG~~PF  231 (932)
T PRK13184        211 STDIYALGVILYQMLTLSFPY  231 (932)
T ss_pred             HhHHHHHHHHHHHHHHCCCCC
Confidence            999999999999999988765

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.4e-38  Score=313.90  Aligned_cols=206  Identities=28%  Similarity=0.400  Sum_probs=175.4

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC---
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE---  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~---  179 (358)
                      ...++|.+.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..++|+||++++..+....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            345899999999999999999999999999999999976543 3445566888999999999999999988775322   


Q ss_pred             -----EEEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEec
Q 018275          180 -----YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF  250 (358)
Q Consensus       180 -----~~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DF  250 (358)
                           .+++||||+++|+|.+++..    ..++++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence                 37899999999999998864    246899999999999999999999999999999999999999999999999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK  330 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~  330 (358)
                      |+++.+.......                                               .....+||+.|+|||++.+.
T Consensus       188 Gls~~~~~~~~~~-----------------------------------------------~~~~~~Gt~~Y~aPE~~~~~  220 (496)
T PTZ00283        188 GFSKMYAATVSDD-----------------------------------------------VGRTFCGTPYYVAPEIWRRK  220 (496)
T ss_pred             ccCeecccccccc-----------------------------------------------ccccccCCcceeCHHHhCCC
Confidence            9998654221100                                               01135799999999999999


Q ss_pred             CCCccchhhhhhHHHHhhcccccccc
Q 018275          331 GYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .|+.++|||||||++||++++..+|.
T Consensus       221 ~~s~k~DVwSlGvilyeLltG~~Pf~  246 (496)
T PTZ00283        221 PYSKKADMFSLGVLLYELLTLKRPFD  246 (496)
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999999877653

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.6e-38  Score=290.38  Aligned_cols=192  Identities=32%  Similarity=0.508  Sum_probs=166.5

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCH
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV  193 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L  193 (358)
                      ||+|+||.||++.++.+|+.||+|.+.............+..|+.+++.++||||+++++.+.+....|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999999765543333444566799999999999999999999999999999999999999


Q ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccc
Q 018275          194 MTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD  271 (358)
Q Consensus       194 ~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~  271 (358)
                      .+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........          
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----------  150 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----------  150 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----------
Confidence            9888543  3588888889999999999999999999999999999999999999999999876532110          


Q ss_pred             cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccc
Q 018275          272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                                                              .....||+.|+|||++.+..++.++|+|||||++|||+++
T Consensus       151 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g  190 (277)
T cd05607         151 ----------------------------------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG  190 (277)
T ss_pred             ----------------------------------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC
Confidence                                                    0023689999999999999999999999999999999998


Q ss_pred             cccc
Q 018275          352 SDIM  355 (358)
Q Consensus       352 ~~~~  355 (358)
                      ...|
T Consensus       191 ~~p~  194 (277)
T cd05607         191 RTPF  194 (277)
T ss_pred             CCCC
Confidence            7665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.6e-38  Score=289.71  Aligned_cols=199  Identities=31%  Similarity=0.538  Sum_probs=173.8

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      .|...+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|++|+.+++.+.+.+..|+|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            37788999999999999999999999999999977654334444557789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       187 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |+++++|.+++...  .++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........   
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---
Confidence            99999999888643  4689999999999999999999999999999999999999999999999999865431100   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                     ..+..|++.|+|||++.+..++.++|+|||||+
T Consensus       158 -----------------------------------------------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~  190 (285)
T cd05632         158 -----------------------------------------------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCL  190 (285)
T ss_pred             -----------------------------------------------ccCCCCCcCccChHHhcCCCCCcccchHHHHHH
Confidence                                                           013369999999999999999999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +||++++..+|
T Consensus       191 l~~l~~g~~P~  201 (285)
T cd05632         191 IYEMIEGQSPF  201 (285)
T ss_pred             HHHHHhCCCCC
Confidence            99999987765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=302.48  Aligned_cols=192  Identities=30%  Similarity=0.494  Sum_probs=170.4

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g  191 (358)
                      +.||+|-||+||-|.++.+|+.||||+|.+-.+. ..+...+++|+.||..++||.||.+--.|.+.+.+++|||-+ .|
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp-~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP-TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCC-CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            6899999999999999999999999999887653 445578999999999999999999999999999999999999 56


Q ss_pred             CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC---CcEEEEecCCCccCCCCCCccccc
Q 018275          192 DVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       192 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      |..+++..  .+.+++...++++.||+.||.|||.++|+|+||||+|||+...   ..+||||||.|+.+....      
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks------  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS------  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh------
Confidence            77777644  4789999999999999999999999999999999999999755   479999999999876322      


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETL  346 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~  346 (358)
                                                                  ...++||||.|.||||+.+++|+.+-|+||+|||+|
T Consensus       722 --------------------------------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiY  757 (888)
T KOG4236|consen  722 --------------------------------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIY  757 (888)
T ss_pred             --------------------------------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEE
Confidence                                                        234889999999999999999999999999999999


Q ss_pred             hhccccccc
Q 018275          347 SCNYLSDIM  355 (358)
Q Consensus       347 e~l~~~~~~  355 (358)
                      --|-++-.|
T Consensus       758 VsLSGTFPF  766 (888)
T KOG4236|consen  758 VSLSGTFPF  766 (888)
T ss_pred             EEecccccC
Confidence            966555443

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.1e-38  Score=302.26  Aligned_cols=199  Identities=23%  Similarity=0.319  Sum_probs=170.5

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----EE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----YL  181 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~~  181 (358)
                      +|++.+.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+++.++||||+++++++.+..     .+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            4788999999999999999999999999999986532 12234456888999999999999999999998776     79


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||+. ++|...+.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999996 68988887788899999999999999999999999999999999999999999999999999875432110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLA  340 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwS  340 (358)
                      .                                                .....++|+.|+|||++.+. .|+.++||||
T Consensus       159 ~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  190 (372)
T cd07853         159 K------------------------------------------------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWS  190 (372)
T ss_pred             c------------------------------------------------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHh
Confidence            0                                                00123689999999999874 5899999999


Q ss_pred             hhHHHHhhccccccc
Q 018275          341 YWNETLSCNYLSDIM  355 (358)
Q Consensus       341 lGvil~e~l~~~~~~  355 (358)
                      |||++|||+++..+|
T Consensus       191 lG~il~el~~g~~pf  205 (372)
T cd07853         191 VGCIFAELLGRRILF  205 (372)
T ss_pred             HHHHHHHHHcCCCCC
Confidence            999999999987765

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.8e-38  Score=307.31  Aligned_cols=195  Identities=26%  Similarity=0.339  Sum_probs=162.4

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec-----
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-----  177 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----  177 (358)
                      ....+|.+.+.||+|+||.||+|.+..++..||||++....       ....+|+.+++.++|||||+++++|..     
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            34578999999999999999999999999999999886432       113469999999999999999887643     


Q ss_pred             ---CCEEEEEEeecCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-cEEEEe
Q 018275          178 ---AEYLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSD  249 (358)
Q Consensus       178 ---~~~~~lV~E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~vkl~D  249 (358)
                         ...+++||||+++ +|.+++.    ....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence               2357899999975 6766654    346789999999999999999999999999999999999999765 799999


Q ss_pred             cCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC
Q 018275          250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK  329 (358)
Q Consensus       250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~  329 (358)
                      ||+|+.+.....                                                  ..+.+||+.|+|||++.+
T Consensus       215 FGla~~~~~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~  244 (440)
T PTZ00036        215 FGSAKNLLAGQR--------------------------------------------------SVSYICSRFYRAPELMLG  244 (440)
T ss_pred             cccchhccCCCC--------------------------------------------------cccCCCCcCccCHHHhcC
Confidence            999986532110                                                  113478999999999876


Q ss_pred             C-CCCccchhhhhhHHHHhhccccccc
Q 018275          330 K-GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       330 ~-~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      . .|+.++|||||||+||||+++..+|
T Consensus       245 ~~~~~~~~DiwSlGvil~elltG~~pf  271 (440)
T PTZ00036        245 ATNYTTHIDLWSLGCIIAEMILGYPIF  271 (440)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            4 6999999999999999999987665

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1e-37  Score=298.66  Aligned_cols=197  Identities=26%  Similarity=0.343  Sum_probs=167.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----  179 (358)
                      .++|.+.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||++++++|....     
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4889999999999999999999999999999999875422 2334456778999999999999999999986543     


Q ss_pred             -EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 -~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                       .+|+||||+++ +|...+.  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence             57999999965 6666653  3578888999999999999999999999999999999999999999999999875421


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ...                                                  ....+||+.|+|||++.+..|+.++|+
T Consensus       176 ~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di  205 (359)
T cd07876         176 NFM--------------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDI  205 (359)
T ss_pred             Ccc--------------------------------------------------CCCCcccCCCCCchhccCCCCCcchhh
Confidence            110                                                  012368999999999999999999999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      |||||++|+|+++..+|
T Consensus       206 wSlG~il~el~tg~~pf  222 (359)
T cd07876         206 WSVGCIMGELVKGSVIF  222 (359)
T ss_pred             HHHHHHHHHHHhCCCCC
Confidence            99999999999987766

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.8e-38  Score=302.75  Aligned_cols=205  Identities=22%  Similarity=0.257  Sum_probs=169.6

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecC-----CCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEe
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF  175 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~  175 (358)
                      .+..++|++.+.||+|+||.||+|.+..+     +..||+|++....  .......+.+|+.+++.+ +|+|||+++++|
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            34557899999999999999999986543     3579999997653  233456688899999999 899999999999


Q ss_pred             ecCCEEEEEEeecCCCCHHHHHhhc-------------------------------------------------------
Q 018275          176 QDAEYLYLIMEYLPGGDVMTLLMRE-------------------------------------------------------  200 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~g~L~~~l~~~-------------------------------------------------------  200 (358)
                      .+....|+||||+++|+|.+++...                                                       
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            9999999999999999999988532                                                       


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          201 ---------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       201 ---------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                                     .+++...+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.......  
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~--  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV--  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee--
Confidence                           236777888999999999999999999999999999999999999999999987653211000  


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                   ......+++.|||||++.+..|+.++|||||||++
T Consensus       270 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil  304 (374)
T cd05106         270 ---------------------------------------------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL  304 (374)
T ss_pred             ---------------------------------------------eccCCCCccceeCHHHhcCCCCCccccHHHHHHHH
Confidence                                                         00012356789999999999999999999999999


Q ss_pred             Hhhcc-ccccc
Q 018275          346 LSCNY-LSDIM  355 (358)
Q Consensus       346 ~e~l~-~~~~~  355 (358)
                      |||+. +..+|
T Consensus       305 ~ellt~G~~Pf  315 (374)
T cd05106         305 WEIFSLGKSPY  315 (374)
T ss_pred             HHHHhCCCCCC
Confidence            99985 66544

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.4e-38  Score=301.42  Aligned_cols=197  Identities=24%  Similarity=0.341  Sum_probs=166.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|+.++.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            467888999999999999999999999999999986542  233455688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++++|...    ....+..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+......  
T Consensus       151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--  224 (353)
T PLN00034        151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--  224 (353)
T ss_pred             EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--
Confidence            999999998653    34567778889999999999999999999999999999999999999999998765321100  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-----CCCCccchhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KGYGMECDWL  339 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-----~~y~~~~Diw  339 (358)
                                                                     ....+||+.|+|||++..     ..++.++|||
T Consensus       225 -----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvw  257 (353)
T PLN00034        225 -----------------------------------------------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIW  257 (353)
T ss_pred             -----------------------------------------------ccccccCccccCccccccccccCcCCCcchhHH
Confidence                                                           013479999999999853     3345789999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||++|||+++...|.
T Consensus       258 slGvil~el~~g~~pf~  274 (353)
T PLN00034        258 SLGVSILEFYLGRFPFG  274 (353)
T ss_pred             HHHHHHHHHHhCCCCCC
Confidence            99999999999887663

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-38  Score=302.66  Aligned_cols=204  Identities=29%  Similarity=0.462  Sum_probs=183.5

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ....+.|.+.+.||+|.|++|.+|.+..++..||||.+.+... .......+.+|+.+|..+.|||||+++.+......+
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            3456889999999999999999999999999999999988764 334445588999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||+.+|.+.+++...+...+..++.++.|++.|++|||+++|+|||||++||||+.+.++||+|||++..+.....
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987763321


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC-ccchhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG-MECDWLA  340 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~-~~~DiwS  340 (358)
                                                                        ..+.||+|.|.|||++.+..|+ +.+|+||
T Consensus       211 --------------------------------------------------lqt~cgsppyAaPEl~~g~~y~gpe~D~Ws  240 (596)
T KOG0586|consen  211 --------------------------------------------------LQTFCGSPPYAAPELFNGKKYDGPEVDIWS  240 (596)
T ss_pred             --------------------------------------------------ccccCCCCCccChHhhcCcccCCcceehhh
Confidence                                                              2266999999999999999987 6799999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      +|++||-++.++=.|+
T Consensus       241 lgvvly~LV~GsLPFD  256 (596)
T KOG0586|consen  241 LGVVLYALVEGSLPFD  256 (596)
T ss_pred             hhhhheeeeecccccC
Confidence            9999999777665543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=306.06  Aligned_cols=191  Identities=23%  Similarity=0.312  Sum_probs=168.3

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      +++..+...-+.-||.|+.|.||+|+..  +..||||+++.-.          ..++.-|++|+||||+.+.|+|.....
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPc  186 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPC  186 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCce
Confidence            4455555566778999999999999765  6799999876432          135666899999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|||||||+.|-|...|....++++.....|..+|+.|++|||.+.|||||||.-||||..+..|||+|||.++.+....
T Consensus       187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S  266 (904)
T KOG4721|consen  187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS  266 (904)
T ss_pred             eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999988664321


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .                                                  .-+++||..||||||+.+.+-+.++||||
T Consensus       267 T--------------------------------------------------kMSFaGTVaWMAPEvIrnePcsEKVDIwS  296 (904)
T KOG4721|consen  267 T--------------------------------------------------KMSFAGTVAWMAPEVIRNEPCSEKVDIWS  296 (904)
T ss_pred             h--------------------------------------------------hhhhhhhHhhhCHHHhhcCCcccccceeh
Confidence            1                                                  12679999999999999999999999999


Q ss_pred             hhHHHHhhccccc
Q 018275          341 YWNETLSCNYLSD  353 (358)
Q Consensus       341 lGvil~e~l~~~~  353 (358)
                      |||+|||||+++-
T Consensus       297 fGVVLWEmLT~Ei  309 (904)
T KOG4721|consen  297 FGVVLWEMLTGEI  309 (904)
T ss_pred             hHHHHHHHHhcCC
Confidence            9999999998764

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.8e-37  Score=286.69  Aligned_cols=198  Identities=43%  Similarity=0.759  Sum_probs=179.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998766555566777889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+|||++.++.+||+|||+++.....      
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------  154 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------  154 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence            99999999999988889999999999999999999999999999999999999999999999999998765311      


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                    ....+|++.|+|||.+.+..++.++|+||||+++
T Consensus       155 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  188 (290)
T cd05580         155 ----------------------------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILI  188 (290)
T ss_pred             ----------------------------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHH
Confidence                                                          0123689999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |+|+++..+|
T Consensus       189 ~~l~~g~~p~  198 (290)
T cd05580         189 YEMLAGYPPF  198 (290)
T ss_pred             HHHHhCCCCC
Confidence            9999887654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-37  Score=288.52  Aligned_cols=198  Identities=25%  Similarity=0.367  Sum_probs=163.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEec-CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh---cCcceEEEEEEee-----
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQ-----  176 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~~iv~l~~~~~-----  176 (358)
                      ++|.+.+.||+|+||.||+|.+.. ++..||+|.++..... ......+.+|+.+++.+   +||||++++++|.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            368999999999999999999854 4788999998754321 22233455677777665   6999999999885     


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                      ....+++||||++ ++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            3456899999996 6899988653  458899999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCc
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM  334 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~  334 (358)
                      ......                                                  ......||+.|+|||++.+..++.
T Consensus       159 ~~~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~  188 (290)
T cd07862         159 IYSFQM--------------------------------------------------ALTSVVVTLWYRAPEVLLQSSYAT  188 (290)
T ss_pred             eccCCc--------------------------------------------------ccccccccccccChHHHhCCCCCC
Confidence            543110                                                  011346999999999999999999


Q ss_pred             cchhhhhhHHHHhhccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ++|+|||||++|||+.+..+|
T Consensus       189 ~~DiwslG~il~el~~g~~~f  209 (290)
T cd07862         189 PVDLWSVGCIFAEMFRRKPLF  209 (290)
T ss_pred             ccchHHHHHHHHHHHcCCCCc
Confidence            999999999999999887665

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-37  Score=287.03  Aligned_cols=197  Identities=26%  Similarity=0.362  Sum_probs=163.8

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh---cCcceEEEEEEeec-----C
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQD-----A  178 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~~iv~l~~~~~~-----~  178 (358)
                      +|++.+.||+|+||.||+|.++.+++.||+|.++..... ......+.+|+.+++.+   +||||+++++++.+     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            588999999999999999999999999999998764321 11222345677766655   79999999998864     3


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ..+++||||++ ++|.+++...  ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            45899999997 4888888653  35899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      .....                                                  ....+||+.|+|||++.+..++.++
T Consensus       159 ~~~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~  188 (288)
T cd07863         159 SCQMA--------------------------------------------------LTPVVVTLWYRAPEVLLQSTYATPV  188 (288)
T ss_pred             cCccc--------------------------------------------------CCCccccccccCchHhhCCCCCCcc
Confidence            32110                                                  0123689999999999999999999


Q ss_pred             hhhhhhHHHHhhccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~  355 (358)
                      |||||||++|+|+.+..+|
T Consensus       189 DiwslG~~l~~l~~g~~~f  207 (288)
T cd07863         189 DMWSVGCIFAEMFRRKPLF  207 (288)
T ss_pred             hhhhHHHHHHHHHhCCcCc
Confidence            9999999999999887765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-37  Score=307.01  Aligned_cols=197  Identities=21%  Similarity=0.358  Sum_probs=165.6

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCc------ceEEEEEEee
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH------CIVKLYYSFQ  176 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~------~iv~l~~~~~  176 (358)
                      ...++|.+++.||+|+||+||+|.+..+++.||||+++...    ........|+.++..+.|.      +++.++++|.
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34588999999999999999999999999999999986532    1223355677777777554      5888998887


Q ss_pred             cC-CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCC-----------
Q 018275          177 DA-EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNG-----------  243 (358)
Q Consensus       177 ~~-~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~-----------  243 (358)
                      .. .++|+|||++ +++|.+++...+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++           
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            54 5789999998 78999999888899999999999999999999998 5999999999999998765           


Q ss_pred             -----cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCC
Q 018275          244 -----HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT  318 (358)
Q Consensus       244 -----~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt  318 (358)
                           .+||+|||++......                                                    ....+||
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~~----------------------------------------------------~~~~~gt  308 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERHS----------------------------------------------------RTAIVST  308 (467)
T ss_pred             CCCCceEEECCCCccccCccc----------------------------------------------------cccccCC
Confidence                 4999999987532110                                                    1134799


Q ss_pred             CCCchhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          319 PDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       319 ~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +.|||||++.+..|+.++|||||||++|||+++..+|.
T Consensus       309 ~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        309 RHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             ccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999999999999887764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.3e-38  Score=301.22  Aligned_cols=203  Identities=23%  Similarity=0.271  Sum_probs=167.9

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEE-----ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEe
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQE-----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF  175 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~  175 (358)
                      .+..++|.+.+.||+|+||.||+|.+     ..++..||||+++...  .....+.+.+|+.++..+ +|||||+++++|
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            34456899999999999999999974     3456789999997543  223445688899999999 899999999999


Q ss_pred             ecCCEEEEEEeecCCCCHHHHHhhcC------------------------------------------------------
Q 018275          176 QDAEYLYLIMEYLPGGDVMTLLMREE------------------------------------------------------  201 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~g~L~~~l~~~~------------------------------------------------------  201 (358)
                      .+....++||||+++|+|.+++....                                                      
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            99999999999999999999985421                                                      


Q ss_pred             ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          202 ---------------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       202 ---------------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                                           .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                                 36677788899999999999999999999999999999999999999999997653211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ...                                               ......+++.|+|||++.+..++.++||||
T Consensus       269 ~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~s  301 (375)
T cd05104         269 NYV-----------------------------------------------VKGNARLPVKWMAPESIFNCVYTFESDVWS  301 (375)
T ss_pred             ccc-----------------------------------------------ccCCCCCCcceeChhHhcCCCCCCCCCHHH
Confidence            000                                               000124567899999999999999999999


Q ss_pred             hhHHHHhhcc-ccc
Q 018275          341 YWNETLSCNY-LSD  353 (358)
Q Consensus       341 lGvil~e~l~-~~~  353 (358)
                      |||++|||+. +..
T Consensus       302 lG~~l~ellt~g~~  315 (375)
T cd05104         302 YGILLWEIFSLGSS  315 (375)
T ss_pred             HHHHHHHHHhcCCC
Confidence            9999999986 443

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-37  Score=284.94  Aligned_cols=203  Identities=17%  Similarity=0.193  Sum_probs=170.1

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      +..++|++.+.||+|+||.||+|.+.   ..+..||+|.++...  .......+.+|+.++..++||||+++++++...+
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            34578999999999999999999765   346789999998653  2334456888999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++++|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999999764 5789999999999999999999999999999999999999999999999997754321


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ....                                                ......+++.|+|||++.+..++.++|+
T Consensus       160 ~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di  191 (266)
T cd05064         160 EAIY------------------------------------------------TTMSGKSPVLWAAPEAIQYHHFSSASDV  191 (266)
T ss_pred             cchh------------------------------------------------cccCCCCceeecCHHHHhhCCccchhHH
Confidence            1000                                                0002246678999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      |||||++||++. +..+|
T Consensus       192 ~slG~~l~ell~~g~~p~  209 (266)
T cd05064         192 WSFGIVMWEVMSYGERPY  209 (266)
T ss_pred             HHHHHHHHHHhcCCCCCc
Confidence            999999999664 65544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-37  Score=288.24  Aligned_cols=191  Identities=17%  Similarity=0.137  Sum_probs=166.2

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec----CCEEEEEEee
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----AEYLYLIMEY  187 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~~~~~lV~E~  187 (358)
                      ..||+|++|.||+|..  +|+.||||.+...........+.+.+|+.++..++|||||++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999976  688999999987643333445778899999999999999999999876    4578999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       188 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      +++|+|.+++.....++......++.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+....      
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------  177 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------  177 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------
Confidence            9999999999888889999999999999999999998 499999999999999999999999999987553110      


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCccchhhhhhHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWLAYWNE  344 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~~DiwSlGvi  344 (358)
                                                                    ...+||+.|+|||++.+  ..|+.++|||||||+
T Consensus       178 ----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvi  211 (283)
T PHA02988        178 ----------------------------------------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVV  211 (283)
T ss_pred             ----------------------------------------------ccccCcccccCHHHhhhccccccchhhhhHHHHH
Confidence                                                          02368999999999986  789999999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +|||+++..+|.
T Consensus       212 l~el~~g~~Pf~  223 (283)
T PHA02988        212 LWEIFTGKIPFE  223 (283)
T ss_pred             HHHHHHCCCCCC
Confidence            999999876653

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=308.27  Aligned_cols=199  Identities=29%  Similarity=0.419  Sum_probs=171.7

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC------
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE------  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~------  179 (358)
                      ..+...+.||+|+||.||+++++.+|..||||.+++..  .....+....|+++|++++|||||+++++-.+..      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            44566789999999999999999999999999998754  3444566778999999999999999998765433      


Q ss_pred             EEEEEEeecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC--C--cEEEEecCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN--G--HMKLSDFGL  252 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~--~--~vkl~DFGl  252 (358)
                      ...+|||||+||||...|...   ..+++...+.++..++.||.|||.+||+||||||.||++...  |  .-||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            467999999999999999764   469999999999999999999999999999999999999533  3  469999999


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-CCC
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKG  331 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-~~~  331 (358)
                      |+.++...                                                  ...|.+||+.|.+||++. .+.
T Consensus       171 Arel~d~s--------------------------------------------------~~~S~vGT~~YLhPel~E~q~~  200 (732)
T KOG4250|consen  171 ARELDDNS--------------------------------------------------LFTSLVGTEEYLHPELYERQKK  200 (732)
T ss_pred             cccCCCCC--------------------------------------------------eeeeecCchhhcChHHHhhccC
Confidence            99876322                                                  234789999999999999 488


Q ss_pred             CCccchhhhhhHHHHhhcccccccc
Q 018275          332 YGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      |+..+|.|||||++|+|.+|+-+|.
T Consensus       201 y~~tVDLWS~GvtlY~caTG~lPF~  225 (732)
T KOG4250|consen  201 YTATVDLWSFGVTLYECATGELPFI  225 (732)
T ss_pred             cCceeehhhhhhHHHHHhccCCCCC
Confidence            9999999999999999999987774

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.1e-37  Score=295.96  Aligned_cols=198  Identities=24%  Similarity=0.336  Sum_probs=167.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC------
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------  178 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||++++++|...      
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4789999999999999999999999999999999875432 233445677899999999999999999988644      


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ...|+||||+++ +|...+.  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            357999999965 6766664  3578888899999999999999999999999999999999999999999999975432


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ...                                                  ....+||+.|+|||++.+..|+.++|+
T Consensus       172 ~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di  201 (355)
T cd07874         172 SFM--------------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDI  201 (355)
T ss_pred             ccc--------------------------------------------------cCCccccCCccCHHHHcCCCCCchhhH
Confidence            110                                                  012379999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||++|+|+++..+|.
T Consensus       202 wslG~il~el~~g~~pf~  219 (355)
T cd07874         202 WSVGCIMGEMVRHKILFP  219 (355)
T ss_pred             HHHHHHHHHHHhCCCCCC
Confidence            999999999999877653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.7e-37  Score=296.26  Aligned_cols=198  Identities=24%  Similarity=0.326  Sum_probs=168.5

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC------
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------  178 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...      
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4899999999999999999999999999999999875432 233445677899999999999999999988643      


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..+|+||||+++ +|...+.  ..++...+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            357999999965 7777664  3477888899999999999999999999999999999999999999999999975432


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ...                                                  ....+||+.|+|||++.+..|+.++|+
T Consensus       179 ~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di  208 (364)
T cd07875         179 SFM--------------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDI  208 (364)
T ss_pred             CCc--------------------------------------------------ccCCcccCCcCCHHHHhCCCCCchhhH
Confidence            110                                                  113379999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||++|||+++..+|.
T Consensus       209 wSlG~il~ell~g~~pf~  226 (364)
T cd07875         209 WSVGCIMGEMIKGGVLFP  226 (364)
T ss_pred             HhHHHHHHHHHhCCCCCC
Confidence            999999999999887763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-37  Score=289.82  Aligned_cols=200  Identities=24%  Similarity=0.355  Sum_probs=170.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||+|+||.||+|.+..++..||+|.++....  ......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            4789999999999999999999999999999999875532  22233467899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++ +|.+++... ..++...+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++........ 
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  160 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-  160 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence            999975 888877654 45788899999999999999999999999999999999999999999999998754311100 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                      ....++|+.|+|||++.+ ..++.++|+||||
T Consensus       161 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  192 (309)
T cd07872         161 ------------------------------------------------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVG  192 (309)
T ss_pred             ------------------------------------------------cccccccccccCCHHHhCCCCCCcHHHHHHHH
Confidence                                                            012368999999999875 5689999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|+|+++..+|.
T Consensus       193 ~il~el~tg~~pf~  206 (309)
T cd07872         193 CIFFEMASGRPLFP  206 (309)
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999999887764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-37  Score=319.08  Aligned_cols=206  Identities=26%  Similarity=0.422  Sum_probs=173.6

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--  177 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--  177 (358)
                      ..+...++|.+++.||+|+||+||+|.+..++..||+|++..... .......+..|+.++..++|||||+++++|.+  
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            345667899999999999999999999999999999999876543 33445668889999999999999999999854  


Q ss_pred             CCEEEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeCCCCCCCEEEcC-----
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKH-------NYIHRDIKPDNLLLDQ-----  241 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-------~iiHrDikp~NILl~~-----  241 (358)
                      ...+||||||+++|+|.++|..    ...+++..++.++.||+.||.|||+.       +||||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            4579999999999999999865    35799999999999999999999984       4999999999999964     


Q ss_pred             ------------CCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhc
Q 018275          242 ------------NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRR  309 (358)
Q Consensus       242 ------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (358)
                                  .+.+||+|||++..+....                                                 
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-------------------------------------------------  196 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES-------------------------------------------------  196 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc-------------------------------------------------
Confidence                        2358999999997653211                                                 


Q ss_pred             cccccccCCCCCchhhhhcC--CCCCccchhhhhhHHHHhhcccccccc
Q 018275          310 KLAYSTVGTPDYIAPEVLLK--KGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       310 ~~~~s~~gt~~Y~APEv~~~--~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                       .....+||+.|+|||++.+  ..|+.++||||||||||||+++..+|.
T Consensus       197 -~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        197 -MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             -cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence             0113479999999999965  458999999999999999999887763

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.6e-37  Score=283.70  Aligned_cols=193  Identities=24%  Similarity=0.344  Sum_probs=169.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.++||||+++++.|.+.+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            36888999999999999999999999999999987542  2334456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..+....     
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-----  149 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-----  149 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----
Confidence            99999998654    356788889999999999999999999999999999999999999999999987553111     


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                    ....+||+.|+|||++.+..++.++|+|||||++
T Consensus       150 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l  183 (279)
T cd06619         150 ----------------------------------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF  183 (279)
T ss_pred             ----------------------------------------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHH
Confidence                                                          0123799999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |+|+++...|
T Consensus       184 ~~l~~g~~pf  193 (279)
T cd06619         184 MELALGRFPY  193 (279)
T ss_pred             HHHHhCCCCc
Confidence            9999887665

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-37  Score=283.57  Aligned_cols=199  Identities=29%  Similarity=0.490  Sum_probs=173.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|+++...   ......+.+|+.+++.++||||+++++.+.+.+..|+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            368899999999999999999999999999999987552   23344577899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........  
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~--  162 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--  162 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc--
Confidence            999999999999988889999999999999999999999999999999999999999999999999998755311100  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCccchhhhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWLAY  341 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~~~DiwSl  341 (358)
                                                                     .....||+.|+|||++.   +..++.++|+|||
T Consensus       163 -----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSl  195 (267)
T cd06645         163 -----------------------------------------------RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAV  195 (267)
T ss_pred             -----------------------------------------------cccccCcccccChhhhccccCCCCCchhhhHHH
Confidence                                                           01236999999999985   5668999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|+|+.+...|
T Consensus       196 G~il~~l~~~~~p~  209 (267)
T cd06645         196 GITAIELAELQPPM  209 (267)
T ss_pred             HHHHHHHhcCCCCc
Confidence            99999999876654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.8e-37  Score=298.61  Aligned_cols=206  Identities=25%  Similarity=0.277  Sum_probs=170.6

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecC-----CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEE
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYY  173 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~  173 (358)
                      +..+..++|.+++.||+|+||.||+|.+...     +..||||++....  .....+.+.+|+.+++.+. |||||++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            4556678999999999999999999986433     3469999997543  2344567889999999996 999999999


Q ss_pred             EeecCCEEEEEEeecCCCCHHHHHhhc-----------------------------------------------------
Q 018275          174 SFQDAEYLYLIMEYLPGGDVMTLLMRE-----------------------------------------------------  200 (358)
Q Consensus       174 ~~~~~~~~~lV~E~~~~g~L~~~l~~~-----------------------------------------------------  200 (358)
                      +|.+...+||||||+++|+|.+++...                                                     
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            999999999999999999999987542                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 018275          201 -------------------------------------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL  237 (358)
Q Consensus       201 -------------------------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NI  237 (358)
                                                                 ..+++..+..++.|++.||.|||+.+|+||||||+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni  268 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV  268 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence                                                       1366777788999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC
Q 018275          238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG  317 (358)
Q Consensus       238 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g  317 (358)
                      |++.++.+||+|||+++........                                               ....+..+
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~-----------------------------------------------~~~~~~~~  301 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNY-----------------------------------------------VSKGSTFL  301 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccc-----------------------------------------------cccCCcCC
Confidence            9999999999999998765321100                                               00113367


Q ss_pred             CCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-cccc
Q 018275          318 TPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       318 t~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~  354 (358)
                      ++.|+|||++.+..++.++|||||||++|||+. +...
T Consensus       302 ~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P  339 (400)
T cd05105         302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP  339 (400)
T ss_pred             CcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            889999999999999999999999999999985 5443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1e-36  Score=278.94  Aligned_cols=204  Identities=31%  Similarity=0.477  Sum_probs=174.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh--hchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC--CEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYL  181 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~  181 (358)
                      .+|.+.+.||+|+||.||.|.+..++..||||.+.....  ........+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            689999999999999999999999999999998864321  1234456788899999999999999999998763  568


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++..+.....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            89999999999999998777889999999999999999999999999999999999999999999999999876532110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      ...                                              ......|+..|+|||++.+..++.++|+|||
T Consensus       162 ~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  195 (265)
T cd06652         162 SGT----------------------------------------------GMKSVTGTPYWMSPEVISGEGYGRKADIWSV  195 (265)
T ss_pred             ccc----------------------------------------------ccccCCCCccccChhhhcCCCCCcchhHHHH
Confidence            000                                              0112368999999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++||++++..+|
T Consensus       196 G~il~el~~g~~p~  209 (265)
T cd06652         196 GCTVVEMLTEKPPW  209 (265)
T ss_pred             HHHHHHHhhCCCCC
Confidence            99999999987765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.2e-37  Score=280.97  Aligned_cols=199  Identities=28%  Similarity=0.472  Sum_probs=172.9

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++.+.||+|+||.||+|.+..++..||+|++....   ......+.+|+.+++.++||||+++++++......|+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            368999999999999999999999999999999987542   23345578899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++++|.+++....++++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+......  
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--  162 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--  162 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc--
Confidence            999999999999988888999999999999999999999999999999999999999999999999999765311100  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCccchhhhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWLAY  341 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~~~DiwSl  341 (358)
                                                                     .....|++.|+|||++.   ...++.++|+|||
T Consensus       163 -----------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~  195 (267)
T cd06646         163 -----------------------------------------------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV  195 (267)
T ss_pred             -----------------------------------------------cCccccCccccCHhHcccccCCCCcchhhHHHH
Confidence                                                           01236899999999985   4558889999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|||+++...|
T Consensus       196 G~il~el~~g~~p~  209 (267)
T cd06646         196 GITAIELAELQPPM  209 (267)
T ss_pred             HHHHHHHHhCCCCc
Confidence            99999998876543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-37  Score=280.15  Aligned_cols=199  Identities=35%  Similarity=0.501  Sum_probs=174.3

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEee
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      |++.+.||+|+||+||++.+..+++.||+|++........ .......|+.+++.++||||+++++++.+....++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence            7889999999999999999999999999999987754322 223345599999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccc
Q 018275          188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN  267 (358)
Q Consensus       188 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  267 (358)
                      +++++|.+++.....+++..+..++.|++.||.+||+.+|+|+||||+||+++.++.++|+|||++.......       
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-------  152 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-------  152 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence            9999999999878899999999999999999999999999999999999999999999999999987541110       


Q ss_pred             cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-CCCCCccchhhhhhHHHH
Q 018275          268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWLAYWNETL  346 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-~~~y~~~~DiwSlGvil~  346 (358)
                                                                .......+|+.|+|||++. +..++.++|+||||+++|
T Consensus       153 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~  190 (260)
T PF00069_consen  153 ------------------------------------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILY  190 (260)
T ss_dssp             ------------------------------------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHH
T ss_pred             ------------------------------------------cccccccccccccccccccccccccccccccccccccc
Confidence                                                      0111347899999999998 888999999999999999


Q ss_pred             hhcccccccc
Q 018275          347 SCNYLSDIML  356 (358)
Q Consensus       347 e~l~~~~~~~  356 (358)
                      +|+.+..++.
T Consensus       191 ~l~~~~~p~~  200 (260)
T PF00069_consen  191 ELLTGKLPFE  200 (260)
T ss_dssp             HHHHSSSSST
T ss_pred             cccccccccc
Confidence            9999877653

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.3e-37  Score=286.68  Aligned_cols=198  Identities=27%  Similarity=0.368  Sum_probs=175.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....  .......+.+|+.++..++||||+++++.|.+++.+|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999987542  2334456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++.......    
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----  154 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----  154 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence            999999999999888889999999999999999999997 699999999999999999999999999986542110    


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                     ..+.+|++.|+|||++.+..++.++|+|||||+
T Consensus       155 -----------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~  187 (308)
T cd06615         155 -----------------------------------------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS  187 (308)
T ss_pred             -----------------------------------------------cccCCCCcCccChhHhcCCCCCccchHHHHHHH
Confidence                                                           013478999999999999889999999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +|+|+++..+|.
T Consensus       188 l~~l~~g~~p~~  199 (308)
T cd06615         188 LVEMAIGRYPIP  199 (308)
T ss_pred             HHHHHhCCCCCC
Confidence            999999887653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-38  Score=278.50  Aligned_cols=200  Identities=29%  Similarity=0.480  Sum_probs=175.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh-----chhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCC
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----SRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~  179 (358)
                      +.|...+.||.|..++|.+|.++.+|..+|+|++......     .....+.-+.|+.||+++ .||+|+++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            5677788999999999999999999999999998643211     223344566799999987 6999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+++|+|.|+.|.|.++|...-.+++..++.++.|+..|+.|||..+|+||||||+|||++++.++||+|||+|+.+...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G  176 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG  176 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999876521


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc------CCCCC
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------KKGYG  333 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~------~~~y~  333 (358)
                                                                        ......||||+|.|||.+.      ..+|+
T Consensus       177 --------------------------------------------------ekLrelCGTPgYLAPEtikC~m~e~~pGYs  206 (411)
T KOG0599|consen  177 --------------------------------------------------EKLRELCGTPGYLAPETIKCSMYENHPGYS  206 (411)
T ss_pred             --------------------------------------------------hhHHHhcCCCcccChhheeeecccCCCCcc
Confidence                                                              1223569999999999996      35799


Q ss_pred             ccchhhhhhHHHHhhccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ..+|.|++|||||-+|.|...|
T Consensus       207 ~EVD~Wa~GVImyTLLaGcpPF  228 (411)
T KOG0599|consen  207 KEVDEWACGVIMYTLLAGCPPF  228 (411)
T ss_pred             chhhHHHHHHHHHHHHcCCCch
Confidence            9999999999999999988765

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-37  Score=298.81  Aligned_cols=195  Identities=21%  Similarity=0.298  Sum_probs=169.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEe--cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ..+|.+++.||+|+||.||+|...  .++..||+|.+....        ...+|+.+++.++|||||+++++|......|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            467999999999999999999754  356789999886542        1457999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +|||++. ++|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||+++.+......
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            9999995 689999877788999999999999999999999999999999999999999999999999999765422110


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                     ......+||+.|+|||++.+..|+.++||||||
T Consensus       242 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  274 (392)
T PHA03207        242 -----------------------------------------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAG  274 (392)
T ss_pred             -----------------------------------------------ccccccccccCccCHhHhcCCCCCchhhHHHHH
Confidence                                                           011235799999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|||+++...|
T Consensus       275 vil~el~~g~~pf  287 (392)
T PHA03207        275 LVLFEMSVKNVTL  287 (392)
T ss_pred             HHHHHHHHCCCCC
Confidence            9999999877655

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-37  Score=278.77  Aligned_cols=204  Identities=33%  Similarity=0.490  Sum_probs=176.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh--chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ++|.+.+.||+|++|.||.|.+..++..||+|.+......  .......+.+|+.+++.++||||+++++++.+...+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5799999999999999999999999999999998754321  22344568889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++.........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987653211000


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                    .......|++.|+|||++.+..++.++|+||||+
T Consensus       162 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  195 (263)
T cd06625         162 ----------------------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGC  195 (263)
T ss_pred             ----------------------------------------------ccccCCCcCccccCcceeccCCCCchhhhHHHHH
Confidence                                                          0001236889999999999999999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++||++++...|
T Consensus       196 il~el~~g~~p~  207 (263)
T cd06625         196 TVVEMLTEKPPW  207 (263)
T ss_pred             HHHHHHhCCCCc
Confidence            999999987654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=308.75  Aligned_cols=198  Identities=28%  Similarity=0.469  Sum_probs=175.7

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      +.+.|.++..||.|+||.||+|..+.++...|.|+|...   +....+.+..|++||+.++||+||+|+++|...+.+++
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            346788999999999999999999999988999998654   56778889999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +.|||+||....++.. ..++++.++..++.|++.||.|||+++|||||||..|||++-+|.++|+|||.+....     
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-----  181 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-----  181 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-----
Confidence            9999999998887754 5689999999999999999999999999999999999999999999999999875432     


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----CCCCCccch
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECD  337 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----~~~y~~~~D  337 (358)
                                                                  ..+....+++|||+||||||.+     ..+|++++|
T Consensus       182 --------------------------------------------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaD  217 (1187)
T KOG0579|consen  182 --------------------------------------------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKAD  217 (1187)
T ss_pred             --------------------------------------------hHHhhhccccCCcccccchheeeccccCCCchhhhh
Confidence                                                        1123345789999999999986     578999999


Q ss_pred             hhhhhHHHHhhccccc
Q 018275          338 WLAYWNETLSCNYLSD  353 (358)
Q Consensus       338 iwSlGvil~e~l~~~~  353 (358)
                      |||||++|.||.-+..
T Consensus       218 iWSlGITLIEMAqiEP  233 (1187)
T KOG0579|consen  218 IWSLGITLIEMAQIEP  233 (1187)
T ss_pred             HHhhhhHHHHHhccCC
Confidence            9999999999976543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=294.35  Aligned_cols=199  Identities=31%  Similarity=0.448  Sum_probs=178.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +-|.+.+.||+|.|.+|-+|++..+|..||||++.+..+ ......++.+|+..|+.++|||||+||.+......+|||+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            668899999999999999999999999999999998775 3445567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-CCcEEEEecCCCccCCCCCCcc
Q 018275          186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       186 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |+=++|+|.+++.+. ..+++..++.|++||+.|+.|+|+..+|||||||+||++.+ -|-|||+|||++-.+...    
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG----  172 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG----  172 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc----
Confidence            999999999999765 68999999999999999999999999999999999998764 589999999998765421    


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC-ccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG-MECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~-~~~DiwSlG  342 (358)
                                                                    +...+.||+..|-|||+++|..|+ .++||||||
T Consensus       173 ----------------------------------------------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLG  206 (864)
T KOG4717|consen  173 ----------------------------------------------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLG  206 (864)
T ss_pred             ----------------------------------------------chhhcccchhhccCchhhhcCccCCcchhhhHHH
Confidence                                                          123366999999999999999999 568999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      ||||.+..|...|
T Consensus       207 VILyMLVCGq~PF  219 (864)
T KOG4717|consen  207 VILYMLVCGQPPF  219 (864)
T ss_pred             HHHHHHHhCCCcc
Confidence            9999998887766

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-36  Score=283.31  Aligned_cols=217  Identities=37%  Similarity=0.627  Sum_probs=179.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+...+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999998765444455667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||++|++|.+++....++++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++...........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998743211111100


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                      ....                ..                  ...........|++.|+|||.+.+..++.++|+|||||++
T Consensus       161 ~~~~----------------~~------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl  206 (305)
T cd05609         161 EGHI----------------EK------------------DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL  206 (305)
T ss_pred             cccc----------------cc------------------chhhccccCCccCccccCchhccCCCCCchhhHHHHHHHH
Confidence            0000                00                  0000001124688999999999999999999999999999


Q ss_pred             Hhhcccccccc
Q 018275          346 LSCNYLSDIML  356 (358)
Q Consensus       346 ~e~l~~~~~~~  356 (358)
                      ||++++..+|.
T Consensus       207 ~el~~g~~pf~  217 (305)
T cd05609         207 YEFLVGCVPFF  217 (305)
T ss_pred             HHHHhCCCCCC
Confidence            99999887653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-37  Score=294.34  Aligned_cols=197  Identities=25%  Similarity=0.365  Sum_probs=168.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC------
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------  178 (358)
                      .++|.+++.||.|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||++++++|...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3789999999999999999999999999999999876432 223345577899999999999999999887543      


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ...|++++++ +++|..++. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            3579999998 789988774 45789999999999999999999999999999999999999999999999999875431


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~D  337 (358)
                      ..                                                    .+.+||+.|+|||++.+ ..|+.++|
T Consensus       171 ~~----------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~D  198 (343)
T cd07878         171 EM----------------------------------------------------TGYVATRWYRAPEIMLNWMHYNQTVD  198 (343)
T ss_pred             Cc----------------------------------------------------CCccccccccCchHhcCCccCCchhh
Confidence            10                                                    12369999999999987 57899999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|+|+++..+|.
T Consensus       199 iwslG~il~el~~g~~pf~  217 (343)
T cd07878         199 IWSVGCIMAELLKGKALFP  217 (343)
T ss_pred             hHhHHHHHHHHHHCCCCCC
Confidence            9999999999999877663

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8e-37  Score=279.53  Aligned_cols=201  Identities=27%  Similarity=0.419  Sum_probs=175.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            68999999999999999999999999999999887654444555666888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          186 EYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       186 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            99999999988853    34588889999999999999999999999999999999999999999999999876532110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                       ......|++.|+|||++.+..++.++|+|||
T Consensus       162 -------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl  192 (267)
T cd08228         162 -------------------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSL  192 (267)
T ss_pred             -------------------------------------------------HHhcCCCCccccChhhhccCCCCchhhHHHH
Confidence                                                             0113368899999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      |+++|||+++..+|
T Consensus       193 G~~l~el~~g~~p~  206 (267)
T cd08228         193 GCLLYEMAALQSPF  206 (267)
T ss_pred             HHHHHHHhcCCCCC
Confidence            99999999877654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=303.38  Aligned_cols=190  Identities=29%  Similarity=0.421  Sum_probs=168.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      .-|.-++.||.|+||.||.|++..+...||||++.-+.-.+...-..+..|+..|..+.|||+|.+-|+|..+...||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            34667788999999999999999999999999998665555555667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||- |+-.+++.. ..++-+..+..++.+.+.||.|||+++.||||||..|||++..|.|||+|||.|.....      
T Consensus       106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------  178 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------  178 (948)
T ss_pred             HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------
Confidence            9994 577777765 46888999999999999999999999999999999999999999999999999876542      


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC---CCCCccchhhhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMECDWLAY  341 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~---~~y~~~~DiwSl  341 (358)
                                                                     +.|+||||.||||||++.   +-|+-++|||||
T Consensus       179 -----------------------------------------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSL  211 (948)
T KOG0577|consen  179 -----------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  211 (948)
T ss_pred             -----------------------------------------------hhcccCCccccchhHheeccccccCCccceeec
Confidence                                                           347899999999999973   569999999999


Q ss_pred             hHHHHhhc
Q 018275          342 WNETLSCN  349 (358)
Q Consensus       342 Gvil~e~l  349 (358)
                      |++-.|+-
T Consensus       212 GITCIELA  219 (948)
T KOG0577|consen  212 GITCIELA  219 (948)
T ss_pred             cchhhhhh
Confidence            99988853

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-37  Score=301.00  Aligned_cols=191  Identities=22%  Similarity=0.189  Sum_probs=165.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ...|.+.+.||+|+||.||+|.+..+++.||||.....         .+.+|+.+++.++|+|||++++++......++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~---------~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA---------SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc---------CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            45799999999999999999999999999999964322         256799999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||++. ++|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            99994 6888888654 578999999999999999999999999999999999999999999999999997653211100


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                     .....+||+.|+|||++.+..|+.++|||||||
T Consensus       318 -----------------------------------------------~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGv  350 (461)
T PHA03211        318 -----------------------------------------------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGL  350 (461)
T ss_pred             -----------------------------------------------cccccCCCcCCcCHHHHcCCCCCchHHHHHHHH
Confidence                                                           011347999999999999999999999999999


Q ss_pred             HHHhhcccc
Q 018275          344 ETLSCNYLS  352 (358)
Q Consensus       344 il~e~l~~~  352 (358)
                      +||||+++.
T Consensus       351 iL~El~~g~  359 (461)
T PHA03211        351 VIFEAAVHT  359 (461)
T ss_pred             HHHHHHHcC
Confidence            999998654

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-37  Score=294.42  Aligned_cols=188  Identities=18%  Similarity=0.239  Sum_probs=164.2

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ..+|.+++.||+|+||.||+|.+..++..||+|+.....         ...|+.+++.++||||+++++++.+....++|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            467999999999999999999999999999999865432         34688999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||++. ++|.+++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......   
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---  211 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---
Confidence            99995 688888755 4678999999999999999999999999999999999999999999999999986432110   


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                     ...+..||+.|+|||++.+..|+.++|+|||||
T Consensus       212 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  244 (357)
T PHA03209        212 -----------------------------------------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGI  244 (357)
T ss_pred             -----------------------------------------------ccccccccccccCCeecCCCCCCchhhHHHHHH
Confidence                                                           011346999999999999999999999999999


Q ss_pred             HHHhhcccc
Q 018275          344 ETLSCNYLS  352 (358)
Q Consensus       344 il~e~l~~~  352 (358)
                      ++|||+.+.
T Consensus       245 vl~ell~~~  253 (357)
T PHA03209        245 VLFEMLAYP  253 (357)
T ss_pred             HHHHHHHcC
Confidence            999998643

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.5e-37  Score=282.67  Aligned_cols=199  Identities=23%  Similarity=0.349  Sum_probs=168.8

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCC-----CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSG-----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      +..++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.++..++||||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            34568999999999999999999876554     689999987543  23445568899999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ  241 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~  241 (358)
                      ....|++|||+++++|.+++...                ..++...+..++.|++.||.|||+.+++|+||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999999754                34777888899999999999999999999999999999999


Q ss_pred             CCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCC
Q 018275          242 NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY  321 (358)
Q Consensus       242 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y  321 (358)
                      ++.++|+|||+++.........                                               ......+++.|
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y  192 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYR-----------------------------------------------VQSKSLLPVRW  192 (283)
T ss_pred             CCcEEECCCcceeecccccccc-----------------------------------------------ccCCCcccccc
Confidence            9999999999987553211000                                               01123578899


Q ss_pred             chhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          322 IAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       322 ~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                      +|||++.+..++.++|+|||||++|||+.
T Consensus       193 ~aPE~~~~~~~~~~sDv~slG~il~el~~  221 (283)
T cd05048         193 MPPEAILYGKFTTESDIWSFGVVLWEIFS  221 (283)
T ss_pred             cCHHHhccCcCchhhhHHHHHHHHHHHHc
Confidence            99999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6e-37  Score=287.93  Aligned_cols=194  Identities=24%  Similarity=0.327  Sum_probs=158.0

Q ss_pred             eeeEeeeeeEEEEEEEEe--cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--CCEEEEEEe
Q 018275          111 LTIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEYLYLIME  186 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lV~E  186 (358)
                      .++||+|+||.||+|.++  .+++.||+|.+.....     ...+.+|+.+++.++||||++++++|.+  ...+|+|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999865  3678999999875421     2236789999999999999999999854  567899999


Q ss_pred             ecCCCCHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE----cCCCcEEEEecCCC
Q 018275          187 YLPGGDVMTLLMRE---------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLC  253 (358)
Q Consensus       187 ~~~~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl----~~~~~vkl~DFGla  253 (358)
                      |++ ++|.+++...         ..+++..++.++.|++.||.|||+.||+||||||+|||+    +.++.+||+|||+|
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            995 5888877432         258899999999999999999999999999999999999    46689999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGY  332 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y  332 (358)
                      +.........                                              ......+||+.|+|||++.+ ..|
T Consensus       160 ~~~~~~~~~~----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~  193 (317)
T cd07868         160 RLFNSPLKPL----------------------------------------------ADLDPVVVTFWYRAPELLLGARHY  193 (317)
T ss_pred             eccCCCCccc----------------------------------------------cccCCccccccccCCHHHcCCCCc
Confidence            8654221100                                              00113479999999999987 458


Q ss_pred             CccchhhhhhHHHHhhcccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +.++|+||+||++|||+++..+|.
T Consensus       194 ~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         194 TKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcc
Confidence            999999999999999999887763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.3e-36  Score=276.12  Aligned_cols=201  Identities=27%  Similarity=0.431  Sum_probs=176.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+.+++.++|++++++++.+.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999899999999987655444555677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          186 EYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       186 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ||+++++|..++..    ...+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999998854    34588999999999999999999999999999999999999999999999999876532211


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      .                                                 .....|++.|+|||++.+..++.++|+|||
T Consensus       162 ~-------------------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  192 (267)
T cd08224         162 A-------------------------------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSL  192 (267)
T ss_pred             c-------------------------------------------------cceecCCccccCHHHhccCCCCchhcHHHH
Confidence            0                                                 113368999999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|+++.+...|
T Consensus       193 G~il~~l~~g~~p~  206 (267)
T cd08224         193 GCLLYEMAALQSPF  206 (267)
T ss_pred             HHHHHHHHHCCCCc
Confidence            99999999876654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.5e-37  Score=286.84  Aligned_cols=202  Identities=21%  Similarity=0.288  Sum_probs=167.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCE----EEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNI----YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ...+|++.+.||+|+||.||+|.+..++..    ||+|++....  .......+..|+.+++.++||||++++++|... 
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            457899999999999999999988766654    8999987542  233455688899999999999999999999865 


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..++|+||+++|+|.+++... ..++...+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            578999999999999999764 4678888889999999999999999999999999999999999999999999987642


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .....                                               ......+++.|+|||++.+..++.++||
T Consensus       162 ~~~~~-----------------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di  194 (316)
T cd05108         162 DEKEY-----------------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDV  194 (316)
T ss_pred             CCcce-----------------------------------------------eccCCccceeecChHHhccCCCCchhhh
Confidence            21100                                               0001235678999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      |||||++||+++ +..+|
T Consensus       195 ~slGv~l~el~t~g~~p~  212 (316)
T cd05108         195 WSYGVTVWELMTFGSKPY  212 (316)
T ss_pred             HHHHHHHHHHHcCCCCCC
Confidence            999999999875 55443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-36  Score=274.22  Aligned_cols=200  Identities=34%  Similarity=0.509  Sum_probs=175.4

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|.+.+.||+|+||.||+|.+..++..|++|.+..... .......+..|+.+++.++|||++++++.+.+.+..|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            58889999999999999999999999999999876543 24455668889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       187 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |+++++|.+++...  ..+++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+.....   
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~---  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence            99999999999764  5788889999999999999999999999999999999999999999999999876542110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                    ......|++.|+|||++.+..++.++|+|||||+
T Consensus       157 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  190 (256)
T cd08529         157 ----------------------------------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVV  190 (256)
T ss_pred             ----------------------------------------------hhhccccCccccCHHHhcCCCCCCccchHHHHHH
Confidence                                                          0113368999999999999999999999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +|+|+.+...|.
T Consensus       191 l~~l~~g~~p~~  202 (256)
T cd08529         191 LYECCTGKHPFD  202 (256)
T ss_pred             HHHHHhCCCCCC
Confidence            999999877653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-36  Score=274.84  Aligned_cols=198  Identities=33%  Similarity=0.524  Sum_probs=173.2

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||.|+||.||++.+..++..+|+|.++...  .....+.+..|+.+++.++||||+++++.+.+...+|+|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            5889999999999999999999999999999986543  23345667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          187 YLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       187 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..+.....   
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---  155 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA---  155 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---
Confidence            9999999998864  34688999999999999999999999999999999999999999999999999875532110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                    ......|++.|+|||++.+..++.++|+||||++
T Consensus       156 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i  189 (255)
T cd08219         156 ----------------------------------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCI  189 (255)
T ss_pred             ----------------------------------------------ccccccCCccccCHHHHccCCcCchhhhhhhchh
Confidence                                                          0113468999999999999999999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|+|+++...|
T Consensus       190 ~~~l~~g~~p~  200 (255)
T cd08219         190 LYELCTLKHPF  200 (255)
T ss_pred             heehhhccCCC
Confidence            99999887665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-36  Score=279.40  Aligned_cols=200  Identities=17%  Similarity=0.245  Sum_probs=166.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      +..++|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            45678999999999999999999764     245689999986542  22334557889999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEE
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREE----------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL  247 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl  247 (358)
                      ....++||||+++++|.+++....          .++...+..++.|++.||.|||+.+++|+||||+|||++.++.++|
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999999986522          3466778889999999999999999999999999999999999999


Q ss_pred             EecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh
Q 018275          248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL  327 (358)
Q Consensus       248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~  327 (358)
                      +|||+++..........                                               .....+++.|+|||++
T Consensus       161 ~dfg~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~y~aPE~~  193 (277)
T cd05062         161 GDFGMTRDIYETDYYRK-----------------------------------------------GGKGLLPVRWMSPESL  193 (277)
T ss_pred             CCCCCccccCCcceeec-----------------------------------------------CCCCccCHhhcChhHh
Confidence            99999876532111000                                               0012467889999999


Q ss_pred             cCCCCCccchhhhhhHHHHhhccc
Q 018275          328 LKKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       328 ~~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                      .+..++.++|+|||||++||++.+
T Consensus       194 ~~~~~~~~~Di~slG~~l~el~~~  217 (277)
T cd05062         194 KDGVFTTYSDVWSFGVVLWEIATL  217 (277)
T ss_pred             hcCCcCchhHHHHHHHHHHHHHcC
Confidence            999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=284.84  Aligned_cols=195  Identities=27%  Similarity=0.475  Sum_probs=174.7

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      .-|.++.+||+|+||.||+|.++.+|+.||||.++...     ..+.+..|+.|+..++.|++|++||.+.....+|+||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            44788899999999999999999999999999988653     4566888999999999999999999999889999999


Q ss_pred             eecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||..|++.+.+.. +.++++..+..++...+.||.|||...-||||||..|||++-+|+.||+|||.|..+...-    
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM----  183 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM----  183 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH----
Confidence            99999999999864 5789999999999999999999999999999999999999999999999999997653110    


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                   ...++++|||.||||||+..-+|+..+||||||++
T Consensus       184 ---------------------------------------------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGIT  218 (502)
T KOG0574|consen  184 ---------------------------------------------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGIT  218 (502)
T ss_pred             ---------------------------------------------HhhCccccCcccccHHHHHHhccchhhhHhhhcch
Confidence                                                         11236799999999999999999999999999999


Q ss_pred             HHhhcccccc
Q 018275          345 TLSCNYLSDI  354 (358)
Q Consensus       345 l~e~l~~~~~  354 (358)
                      ..||.-+...
T Consensus       219 aIEMAEG~PP  228 (502)
T KOG0574|consen  219 AIEMAEGRPP  228 (502)
T ss_pred             hhhhhcCCCC
Confidence            9999876543

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-36  Score=279.74  Aligned_cols=202  Identities=19%  Similarity=0.301  Sum_probs=168.8

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEe----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEK----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ..++|++.+.||+|+||.||+|...    .++..||+|.+....  .......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            4578999999999999999999853    456789999987542  2344466888999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN  242 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-----------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~  242 (358)
                      ..|+||||+++++|.+++...                 ..+++..+..++.|++.||.|||+.+|+||||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            999999999999999998532                 236778888899999999999999999999999999999999


Q ss_pred             CcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCc
Q 018275          243 GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI  322 (358)
Q Consensus       243 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~  322 (358)
                      +.+||+|||+++.........                                               ...+..++..|+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~  193 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYR-----------------------------------------------VQPKSLLPIRWM  193 (283)
T ss_pred             CcEEeccccccccccCCccee-----------------------------------------------cccCCCccceec
Confidence            999999999998654221100                                               011235677899


Q ss_pred             hhhhhcCCCCCccchhhhhhHHHHhhcc-cccc
Q 018275          323 APEVLLKKGYGMECDWLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       323 APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~  354 (358)
                      |||++.+..++.++|+|||||++|||+. +...
T Consensus       194 aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p  226 (283)
T cd05090         194 PPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP  226 (283)
T ss_pred             ChHHhccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999999997 5433

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=286.01  Aligned_cols=217  Identities=28%  Similarity=0.386  Sum_probs=182.4

Q ss_pred             HhhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc----hhhHHHHHHHHHHHHHhcCcceEEEE
Q 018275           97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS----RGQVEHVRAERNLLAEVASHCIVKLY  172 (358)
Q Consensus        97 ~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~----~~~~~~~~~E~~il~~l~h~~iv~l~  172 (358)
                      .+..+..--++|-++..||+|||+.||+|.+....+.||+|+-.....+.    .....+..+|..|.+.++||.||++|
T Consensus       454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY  533 (775)
T KOG1151|consen  454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY  533 (775)
T ss_pred             hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence            45556666688999999999999999999999999999999876654443    34556788999999999999999999


Q ss_pred             EEee-cCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCCEEEcC---CCcEE
Q 018275          173 YSFQ-DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH--NYIHRDIKPDNLLLDQ---NGHMK  246 (358)
Q Consensus       173 ~~~~-~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~iiHrDikp~NILl~~---~~~vk  246 (358)
                      ++|. |...+|-|+|||+|.+|.-+|+.+..+++..++.|+.||+.||.||...  .|||-||||.||||-.   -|.+|
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence            9996 6677999999999999999999999999999999999999999999854  7999999999999954   47899


Q ss_pred             EEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhh
Q 018275          247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV  326 (358)
Q Consensus       247 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv  326 (358)
                      |+||||++.++...+......                                          .+.....||.+|.+||.
T Consensus       614 ITDFGLSKIMdddSy~~vdGm------------------------------------------eLTSQgAGTYWYLPPEc  651 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGM------------------------------------------ELTSQGAGTYWYLPPEC  651 (775)
T ss_pred             eeecchhhhccCCccCcccce------------------------------------------eeecccCceeeecCcce
Confidence            999999999875543322111                                          11223479999999999


Q ss_pred             hcCC----CCCccchhhhhhHHHHhhccccccc
Q 018275          327 LLKK----GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       327 ~~~~----~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      |.-.    ..+.++||||+|||+|.|||+.-.|
T Consensus       652 FvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF  684 (775)
T KOG1151|consen  652 FVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF  684 (775)
T ss_pred             eecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence            8632    3678999999999999999998776

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=295.37  Aligned_cols=202  Identities=25%  Similarity=0.327  Sum_probs=171.9

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCC---E-EEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---I-YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~-vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      +++.-++-.+.++||+|+||.||+|..+..+.   . ||+|..+........++..+.+|..+++.++|||||++||++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34444666677999999999999998765422   3 8999988755457888899999999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      +...+++|||+|+||+|.++|...+ .++......++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++.
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            9999999999999999999998876 489999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      .........                                                 ..--...|+|||.+....|+++
T Consensus       312 ~~~~~~~~~-------------------------------------------------~~klPirWLAPEtl~~~~~s~k  342 (474)
T KOG0194|consen  312 GSQYVMKKF-------------------------------------------------LKKLPIRWLAPETLNTGIFSFK  342 (474)
T ss_pred             Ccceeeccc-------------------------------------------------cccCcceecChhhhccCccccc
Confidence            431100000                                                 0013456999999999999999


Q ss_pred             chhhhhhHHHHhhccc
Q 018275          336 CDWLAYWNETLSCNYL  351 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~  351 (358)
                      +|||||||++||+...
T Consensus       343 TDV~sfGV~~~Eif~~  358 (474)
T KOG0194|consen  343 TDVWSFGVLLWEIFEN  358 (474)
T ss_pred             cchhheeeeEEeeecc
Confidence            9999999999998763

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.2e-36  Score=280.97  Aligned_cols=204  Identities=22%  Similarity=0.328  Sum_probs=172.0

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCC----------------CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSG----------------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC  167 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~----------------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~  167 (358)
                      ..++|.+.+.||+|+||.||+|.+...+                ..||+|.+....  .......+.+|+.+++.++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence            4578999999999999999998876533                568999987653  2345567889999999999999


Q ss_pred             eEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 018275          168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-----------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN  236 (358)
Q Consensus       168 iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~N  236 (358)
                      |++++++|.+....++||||+++++|.+++....           .+++..+..++.|++.||.|||+.+|+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999997655           68899999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccccc
Q 018275          237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV  316 (358)
Q Consensus       237 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  316 (358)
                      |+++.++.++|+|||+++.........                                               ......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~  193 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYR-----------------------------------------------VQGRAP  193 (296)
T ss_pred             eeecCCCceEEccccceeecccCccee-----------------------------------------------ecCcCC
Confidence            999999999999999987653221100                                               011235


Q ss_pred             CCCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          317 GTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       317 gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +|+.|+|||++.+..++.++|+|||||++||++.+....+
T Consensus       194 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  233 (296)
T cd05051         194 LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP  233 (296)
T ss_pred             CCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence            7889999999999899999999999999999987543333

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-36  Score=280.42  Aligned_cols=203  Identities=22%  Similarity=0.301  Sum_probs=170.2

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ..++|.+.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            34678999999999999999998743     46789999987653  233456788999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE--------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH  244 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~  244 (358)
                      ...++||||+++++|.+++...+              .+++..+..++.|++.||.|||+.|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999996542              3678888999999999999999999999999999999999999


Q ss_pred             EEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchh
Q 018275          245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP  324 (358)
Q Consensus       245 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~AP  324 (358)
                      +||+|||+++.........                                               ......+++.|+||
T Consensus       161 ~kl~d~g~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aP  193 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYR-----------------------------------------------VGGHTMLPIRWMPP  193 (280)
T ss_pred             EEECCcccceecccCccee-----------------------------------------------cCCCCcccceecCh
Confidence            9999999987543211000                                               00122567899999


Q ss_pred             hhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          325 EVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       325 Ev~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      |++.+..++.++|||||||++|||+. +...|
T Consensus       194 E~~~~~~~~~~~Di~slG~il~e~~~~g~~p~  225 (280)
T cd05049         194 ESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW  225 (280)
T ss_pred             hhhccCCcchhhhHHHHHHHHHHHHhcCCCCC
Confidence            99999999999999999999999996 55443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=297.29  Aligned_cols=202  Identities=20%  Similarity=0.253  Sum_probs=173.6

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ..+++..+.+.+...||+|.||+||+|.+..   .||||++..... .+.+.+.|++|+.++++.+|-||+-+.|+|..+
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            4467778889999999999999999998864   599999988765 556889999999999999999999999999988


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      .. .||+-+|+|.+|+.+++.. ..|.....+.|+.||+.|+.|||.++|||||||..||+|.+++.|||+||||+..-.
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            76 9999999999999999764 468888899999999999999999999999999999999999999999999987542


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCc
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGM  334 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~  334 (358)
                      .-..                                               ..-.....|...||||||+.   ..+|++
T Consensus       540 ~w~g-----------------------------------------------~~q~~qp~gsilwmAPEvIRmqd~nPfS~  572 (678)
T KOG0193|consen  540 RWSG-----------------------------------------------EQQLEQPHGSLLWMAPEVIRMQDDNPFSF  572 (678)
T ss_pred             eecc-----------------------------------------------ccccCCCccchhhhcHHHHhhcccCCCCc
Confidence            1100                                               00111235778899999997   467999


Q ss_pred             cchhhhhhHHHHhhcccc
Q 018275          335 ECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~  352 (358)
                      ++||||||+++||++.+.
T Consensus       573 qSDVYaFGiV~YELltg~  590 (678)
T KOG0193|consen  573 QSDVYAFGIVWYELLTGE  590 (678)
T ss_pred             ccchhhhhHHHHHHHhCc
Confidence            999999999999988764

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-36  Score=281.14  Aligned_cols=229  Identities=36%  Similarity=0.585  Sum_probs=181.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+.............+..|+.+++.++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998765444446667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          186 EYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       186 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998754  578999999999999999999999999999999999999999999999999987654322111


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchH-HHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLE-QLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                      ......                     .+...+... ................+||+.|+|||++.+..++.++||||||
T Consensus       161 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG  219 (316)
T cd05574         161 SKALRK---------------------GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG  219 (316)
T ss_pred             cccccc---------------------ccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHH
Confidence            000000                     000000000 0000000011122345899999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|+++++...|
T Consensus       220 ~ll~~l~~g~~pf  232 (316)
T cd05574         220 ILLYEMLYGTTPF  232 (316)
T ss_pred             HHHHHHhhCCCCC
Confidence            9999999887665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.1e-36  Score=275.59  Aligned_cols=201  Identities=24%  Similarity=0.321  Sum_probs=172.0

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +...+|.+.+.||+|+||.||+|.+..++..||+|.+....    .....+.+|+.+++.++||||+++++++.....++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            45577999999999999999999999999999999987542    23456788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999998653  358888899999999999999999999999999999999999999999999987654211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ...                                                .....+++.|+|||++.+..++.++|+||
T Consensus       159 ~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  190 (263)
T cd05052         159 YTA------------------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWA  190 (263)
T ss_pred             eec------------------------------------------------cCCCCCccccCCHHHhccCCCCchhHHHH
Confidence            000                                                00123567899999999999999999999


Q ss_pred             hhHHHHhhcc-ccccc
Q 018275          341 YWNETLSCNY-LSDIM  355 (358)
Q Consensus       341 lGvil~e~l~-~~~~~  355 (358)
                      |||++|||+. +...|
T Consensus       191 lG~il~el~t~g~~p~  206 (263)
T cd05052         191 FGVLLWEIATYGMSPY  206 (263)
T ss_pred             HHHHHHHHHcCCCCCC
Confidence            9999999986 55444

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.1e-36  Score=282.88  Aligned_cols=201  Identities=24%  Similarity=0.358  Sum_probs=166.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCE--EEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI--YAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~  179 (358)
                      +..++|++.+.||+|+||.||+|.+..++..  +|+|.+...  ........+.+|+.++..+ +||||+++++++.+.+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            4458999999999999999999998877754  577766532  2344556788899999999 8999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG  243 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  243 (358)
                      ..|+||||+++++|.+++....                .+++..+..++.|++.||.|||+.||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            9999999999999999996432                478889999999999999999999999999999999999999


Q ss_pred             cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCch
Q 018275          244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA  323 (358)
Q Consensus       244 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~A  323 (358)
                      .+||+|||++........                                                  .....+++.|+|
T Consensus       162 ~~kl~dfg~~~~~~~~~~--------------------------------------------------~~~~~~~~~y~a  191 (303)
T cd05088         162 VAKIADFGLSRGQEVYVK--------------------------------------------------KTMGRLPVRWMA  191 (303)
T ss_pred             cEEeCccccCcccchhhh--------------------------------------------------cccCCCcccccC
Confidence            999999999853210000                                                  001134678999


Q ss_pred             hhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          324 PEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       324 PEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ||++.+..++.++|+|||||++||++. +...|
T Consensus       192 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  224 (303)
T cd05088         192 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY  224 (303)
T ss_pred             HHHHhccCCcccccchhhhhHHHHHHhcCCCCc
Confidence            999999999999999999999999986 44433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-36  Score=288.66  Aligned_cols=206  Identities=24%  Similarity=0.276  Sum_probs=168.2

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~  174 (358)
                      +.++.++|++.+.||+|+||.||+|.+..     +++.||+|+++...  .......+..|+.++..+ +|+||++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            34556789999999999999999997533     45789999987542  233445677899999999 89999999998


Q ss_pred             eec-CCEEEEEEeecCCCCHHHHHhhc-----------------------------------------------------
Q 018275          175 FQD-AEYLYLIMEYLPGGDVMTLLMRE-----------------------------------------------------  200 (358)
Q Consensus       175 ~~~-~~~~~lV~E~~~~g~L~~~l~~~-----------------------------------------------------  200 (358)
                      |.. ...++++|||+++++|.+++...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            864 45789999999999999998542                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccccc
Q 018275          201 --------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD  272 (358)
Q Consensus       201 --------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~  272 (358)
                              .+++...+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||+++.+.......         
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~---------  230 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---------  230 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh---------
Confidence                    257888899999999999999999999999999999999999999999999998653211000         


Q ss_pred             ccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-c
Q 018275          273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-L  351 (358)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~  351 (358)
                                                            ...+..+++.|+|||++.+..|+.++|||||||++|||+. +
T Consensus       231 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g  272 (337)
T cd05054         231 --------------------------------------RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG  272 (337)
T ss_pred             --------------------------------------hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcC
Confidence                                                  0012356778999999999999999999999999999985 6


Q ss_pred             cccc
Q 018275          352 SDIM  355 (358)
Q Consensus       352 ~~~~  355 (358)
                      ..+|
T Consensus       273 ~~p~  276 (337)
T cd05054         273 ASPY  276 (337)
T ss_pred             CCCC
Confidence            5443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.9e-36  Score=281.41  Aligned_cols=200  Identities=24%  Similarity=0.361  Sum_probs=170.5

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||.|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999875432  22234467899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||++ ++|..++... ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++........  
T Consensus        83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            99997 5888888653 5688999999999999999999999999999999999999999999999999875431110  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                     ......+++.|+|||++.+ ..++.++|+||||
T Consensus       160 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG  192 (301)
T cd07873         160 -----------------------------------------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVG  192 (301)
T ss_pred             -----------------------------------------------cccccceeecccCcHHHhCCCCCccHHHHHHHH
Confidence                                                           0012357899999999876 4588999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|||+++..+|.
T Consensus       193 ~~l~el~tg~~~f~  206 (301)
T cd07873         193 CIFYEMSTGRPLFP  206 (301)
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999999887664

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-36  Score=276.88  Aligned_cols=201  Identities=27%  Similarity=0.438  Sum_probs=175.3

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||.|+||.||+|.+..++..||||.+.............+.+|+.+++.++||||+++++.|.+++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57889999999999999999999999999999887654444455567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          186 EYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       186 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99999999998863    34688999999999999999999999999999999999999999999999999876532110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      .                                                 ....+|++.|+|||++.+..++.++|+|||
T Consensus       162 ~-------------------------------------------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl  192 (267)
T cd08229         162 A-------------------------------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSL  192 (267)
T ss_pred             c-------------------------------------------------cccccCCcCccCHHHhcCCCccchhhHHHH
Confidence            0                                                 012368999999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      |+++|+++++...|
T Consensus       193 G~il~~l~~g~~p~  206 (267)
T cd08229         193 GCLLYEMAALQSPF  206 (267)
T ss_pred             HHHHHHHHhCCCCc
Confidence            99999999876544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.1e-36  Score=273.62  Aligned_cols=204  Identities=31%  Similarity=0.475  Sum_probs=174.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh--hchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--CCEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEYL  181 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~  181 (358)
                      .+|...+.||+|+||.||+|.+..++..||+|.+.....  ........+.+|+.+++.++||||+++++.+.+  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            579999999999999999999999999999999865431  123345668889999999999999999998875  4678


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      +++|||+++++|.+++.....+++.....++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||+++.+.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            99999999999999998878899999999999999999999999999999999999999999999999999876532110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      ...                                              ......|+..|+|||++.+..++.++|+|||
T Consensus       162 ~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  195 (266)
T cd06651         162 SGT----------------------------------------------GIRSVTGTPYWMSPEVISGEGYGRKADVWSL  195 (266)
T ss_pred             cCC----------------------------------------------ccccCCccccccCHHHhCCCCCCchhhhHHH
Confidence            000                                              0012358899999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++||++++...|
T Consensus       196 G~i~~el~~g~~pf  209 (266)
T cd06651         196 GCTVVEMLTEKPPW  209 (266)
T ss_pred             HHHHHHHHHCCCCc
Confidence            99999999987765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-36  Score=272.78  Aligned_cols=199  Identities=30%  Similarity=0.505  Sum_probs=175.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++.+.||.|+||.||+|.+..++..+++|++....   ......+.+|+.+++.++||||+++++.+.+...+|++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            478999999999999999999998899999999997653   23556788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++++|.+++... .++++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++..+.....  
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  156 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--  156 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence            9999999999998776 7899999999999999999999999999999999999999999999999999875532110  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC---CCCccchhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK---GYGMECDWLA  340 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~---~y~~~~DiwS  340 (358)
                                                                     ......|++.|+|||++.+.   .++.++|+||
T Consensus       157 -----------------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~s  189 (262)
T cd06613         157 -----------------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWA  189 (262)
T ss_pred             -----------------------------------------------ccccccCCccccCchhhcccccCCcCchhhhHH
Confidence                                                           00123688999999999877   8999999999


Q ss_pred             hhHHHHhhccccccc
Q 018275          341 YWNETLSCNYLSDIM  355 (358)
Q Consensus       341 lGvil~e~l~~~~~~  355 (358)
                      |||++|||+.+...|
T Consensus       190 lG~~l~~~~tg~~p~  204 (262)
T cd06613         190 LGITAIELAELQPPM  204 (262)
T ss_pred             HHHHHHHHHhCCCCC
Confidence            999999999876554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.9e-36  Score=277.23  Aligned_cols=202  Identities=19%  Similarity=0.279  Sum_probs=168.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCC----EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      +..++|++.+.||+|+||+||+|.+..++.    .||+|++....  .......+.+|+.++..+.||||+++++.+.+.
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence            345789999999999999999999877766    48999987543  233445688899999999999999999999754


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                       ..+++|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence             578999999999999999764 568999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      .......                                               .....+++.|+|||++.+..++.++|
T Consensus       161 ~~~~~~~-----------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~D  193 (279)
T cd05109         161 IDETEYH-----------------------------------------------ADGGKVPIKWMALESILHRRFTHQSD  193 (279)
T ss_pred             cccceee-----------------------------------------------cCCCccchhhCCHHHhccCCCCchhH
Confidence            2211000                                               00123567899999999999999999


Q ss_pred             hhhhhHHHHhhcc-cccc
Q 018275          338 WLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~  354 (358)
                      ||||||++||+++ +...
T Consensus       194 i~slG~~l~el~t~g~~p  211 (279)
T cd05109         194 VWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             HHHHHHHHHHHHcCCCCC
Confidence            9999999999886 4443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.8e-36  Score=270.95  Aligned_cols=200  Identities=27%  Similarity=0.486  Sum_probs=172.0

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec-CCEEEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-AEYLYLIM  185 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lV~  185 (358)
                      .|++.+.||+|++|.||++.+..+++.||+|.+..... .......+.+|+.+++.++|+|++++++.+.. +..+|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            48899999999999999999999999999999876432 33445668889999999999999999998864 45689999


Q ss_pred             eecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          186 EYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       186 E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||+++++|.+++..  ...+++..+..++.+++.||.+||+.||+|+||||+||+++.++.++|+|||++........  
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--  157 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--  157 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence            99999999999875  34689999999999999999999999999999999999999999999999999876532110  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                     ......|++.|+|||++.+..++.++|+|||||
T Consensus       158 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~  190 (257)
T cd08223         158 -----------------------------------------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGC  190 (257)
T ss_pred             -----------------------------------------------ccccccCCcCccChhHhcCCCCCchhhhHHHHH
Confidence                                                           011236899999999999999999999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|+++.+...|.
T Consensus       191 il~~l~~g~~~~~  203 (257)
T cd08223         191 CVYEMATLKHAFN  203 (257)
T ss_pred             HHHHHHcCCCCCC
Confidence            9999999876653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.5e-36  Score=278.20  Aligned_cols=200  Identities=29%  Similarity=0.450  Sum_probs=172.4

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..+.|++++.||.|+||.||+|.+..++..|++|.+...   .......+.+|+.+++.++||||+++++.+..+...|+
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            346799999999999999999999999999999998754   34456668889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||||+++++|..++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++........ 
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-  165 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-  165 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence            9999999999888754 45789999999999999999999999999999999999999999999999998864321100 


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----CCCCCccch
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECD  337 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----~~~y~~~~D  337 (358)
                                                                      ......|++.|+|||++.     ...++.++|
T Consensus       166 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D  197 (292)
T cd06644         166 ------------------------------------------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD  197 (292)
T ss_pred             ------------------------------------------------ccceecCCccccCceeeccccccCCCCCchhh
Confidence                                                            011346889999999985     455788999


Q ss_pred             hhhhhHHHHhhccccccc
Q 018275          338 WLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~  355 (358)
                      +|||||++|||+++..+|
T Consensus       198 v~slG~il~el~~g~~p~  215 (292)
T cd06644         198 IWSLGITLIEMAQIEPPH  215 (292)
T ss_pred             hHhHHHHHHHHhcCCCCC
Confidence            999999999999987654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6e-36  Score=276.44  Aligned_cols=196  Identities=29%  Similarity=0.480  Sum_probs=169.5

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEee
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      |++.+.||.|+||.||+|.+..++..+++|.+....   ......+.+|+.+++.++|||++++++.|...+..|+||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            677889999999999999999999999999986542   34456688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          188 LPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       188 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      +++++|..++.. ..++++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........     
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-----  158 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-----  158 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-----
Confidence            999999988765 46789999999999999999999999999999999999999999999999999875431110     


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----CCCCCccchhhhh
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWLAY  341 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----~~~y~~~~DiwSl  341 (358)
                                                                  ......||+.|+|||++.     +..++.++|+|||
T Consensus       159 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  194 (282)
T cd06643         159 --------------------------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL  194 (282)
T ss_pred             --------------------------------------------ccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence                                                        011346899999999984     4568889999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|||+++..+|
T Consensus       195 Gvil~el~~g~~p~  208 (282)
T cd06643         195 GITLIEMAQIEPPH  208 (282)
T ss_pred             HHHHHHHccCCCCc
Confidence            99999999887665

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.6e-36  Score=278.30  Aligned_cols=201  Identities=22%  Similarity=0.321  Sum_probs=169.1

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ..++|.+.+.||+|+||.||++.+.     .++..+|+|.+....   ......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4578999999999999999999752     345679999887542   33455688999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcE
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE-------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM  245 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~v  245 (358)
                      ...++||||+++++|.+++....             .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999986443             48899999999999999999999999999999999999999999


Q ss_pred             EEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhh
Q 018275          246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE  325 (358)
Q Consensus       246 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APE  325 (358)
                      ||+|||+++.........                                               ......+++.|+|||
T Consensus       160 kl~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE  192 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYR-----------------------------------------------VGGHTMLPIRWMPPE  192 (288)
T ss_pred             EeccCCccccccCCceee-----------------------------------------------cCCCCCccccccCHH
Confidence            999999987653211000                                               001224678899999


Q ss_pred             hhcCCCCCccchhhhhhHHHHhhcc-cccc
Q 018275          326 VLLKKGYGMECDWLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       326 v~~~~~y~~~~DiwSlGvil~e~l~-~~~~  354 (358)
                      ++.+..++.++|+|||||++|+|++ +...
T Consensus       193 ~~~~~~~~~~sDiwslG~il~~l~t~g~~p  222 (288)
T cd05093         193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQP  222 (288)
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999987 4433

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6e-36  Score=276.63  Aligned_cols=192  Identities=33%  Similarity=0.570  Sum_probs=161.2

Q ss_pred             eEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHH---HhcCcceEEEEEEeecCCEEEEEEeecC
Q 018275          113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA---EVASHCIVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~---~l~h~~iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      .||+|+||.||++.+..++..||+|.+.+.............+|..++.   ..+||+|+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999987654322222233344444333   3479999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccc
Q 018275          190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV  269 (358)
Q Consensus       190 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  269 (358)
                      +++|.+++...+.+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++.......         
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---------  151 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---------  151 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999986543110         


Q ss_pred             cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-CCCCCccchhhhhhHHHHhh
Q 018275          270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWLAYWNETLSC  348 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-~~~y~~~~DiwSlGvil~e~  348 (358)
                                                                .....||+.|+|||++. +..++.++|+||+||++||+
T Consensus       152 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l  189 (279)
T cd05633         152 ------------------------------------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKL  189 (279)
T ss_pred             ------------------------------------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHH
Confidence                                                      00236999999999987 46789999999999999999


Q ss_pred             ccccccc
Q 018275          349 NYLSDIM  355 (358)
Q Consensus       349 l~~~~~~  355 (358)
                      +++..+|
T Consensus       190 ~~g~~pf  196 (279)
T cd05633         190 LRGHSPF  196 (279)
T ss_pred             HhCCCCc
Confidence            9987765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.2e-36  Score=275.42  Aligned_cols=200  Identities=39%  Similarity=0.729  Sum_probs=178.7

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||.|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58899999999999999999998999999999987655454567788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      |+++++|..++....++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----  155 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-----  155 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-----
Confidence            999999999998777899999999999999999999999999999999999999999999999999876532210     


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETL  346 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~  346 (358)
                                                                   .....|+..|+|||++.+..++.++|+||||+++|
T Consensus       156 ---------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  190 (258)
T cd05578         156 ---------------------------------------------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAY  190 (258)
T ss_pred             ---------------------------------------------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHH
Confidence                                                         00235888999999999999999999999999999


Q ss_pred             hhcccccccc
Q 018275          347 SCNYLSDIML  356 (358)
Q Consensus       347 e~l~~~~~~~  356 (358)
                      +++++..+|.
T Consensus       191 ~l~~g~~p~~  200 (258)
T cd05578         191 ECLRGKRPYR  200 (258)
T ss_pred             HHHhCCCCCC
Confidence            9998876654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=277.80  Aligned_cols=199  Identities=29%  Similarity=0.461  Sum_probs=172.9

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++++.||.|+||.||+|.+..++..||+|.+...   .......+..|+.+++.++||||+++++.+.++...|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            46799999999999999999999889999999998754   234456688899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++++|.+++... .++++..++.++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++........  
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--  158 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--  158 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence            9999999999998664 5799999999999999999999999999999999999999999999999998865431110  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----CCCCCccchh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDW  338 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----~~~y~~~~Di  338 (358)
                                                                     ......||+.|+|||++.     +.+++.++|+
T Consensus       159 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi  191 (280)
T cd06611         159 -----------------------------------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADI  191 (280)
T ss_pred             -----------------------------------------------ccceeecchhhcCHHHHhhcccCCCCCCccccH
Confidence                                                           011346899999999985     4567889999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      |||||++|+|+++..+|
T Consensus       192 ~slG~il~~l~~g~~p~  208 (280)
T cd06611         192 WSLGITLIELAQMEPPH  208 (280)
T ss_pred             HHHHHHHHHHHhCCCCc
Confidence            99999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.1e-36  Score=278.42  Aligned_cols=199  Identities=28%  Similarity=0.437  Sum_probs=173.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ...+|.+.+.||+|+||.||+|.+..++..||+|.+.....   .....+.+|+.+++.++||||+++++.|.+....|+
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l   94 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence            34789999999999999999999999999999999876532   234568889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||||+++++|.+++. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......... 
T Consensus        95 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-  172 (296)
T cd06654          95 VMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (296)
T ss_pred             eecccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence            999999999999885 456788899999999999999999999999999999999999999999999998754321100 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      .....|++.|+|||.+.+..++.++|+|||||
T Consensus       173 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gv  204 (296)
T cd06654         173 ------------------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI  204 (296)
T ss_pred             ------------------------------------------------cCcccCCccccCHHHHcCCCCCccchHHHHHH
Confidence                                                            01236899999999999999999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|+|+++..+|
T Consensus       205 il~~l~~g~~pf  216 (296)
T cd06654         205 MAIEMIEGEPPY  216 (296)
T ss_pred             HHHHHHhCCCCC
Confidence            999999987765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.9e-36  Score=275.49  Aligned_cols=200  Identities=29%  Similarity=0.401  Sum_probs=172.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++...||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++|||++++++++.+....++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            479999999999999999999998999999999875432 2223345778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|..++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........   
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---  156 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---  156 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc---
Confidence            99999888888776678999999999999999999999999999999999999999999999999999865422100   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlGvi  344 (358)
                                                                    .....+++.|+|||++.+ ..++.++|+|||||+
T Consensus       157 ----------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i  190 (286)
T cd07847         157 ----------------------------------------------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCV  190 (286)
T ss_pred             ----------------------------------------------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHH
Confidence                                                          002357889999999876 558899999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|||+++..+|
T Consensus       191 ~~~l~~g~~p~  201 (286)
T cd07847         191 FAELLTGQPLW  201 (286)
T ss_pred             HHHHHhCCCCC
Confidence            99999987655

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.9e-36  Score=272.18  Aligned_cols=190  Identities=23%  Similarity=0.312  Sum_probs=161.7

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g  191 (358)
                      +.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.++||||++++++|.+....++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            36899999999999999999999999886442  3344566889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          192 DVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       192 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...........      
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~------  152 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST------  152 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccccc------
Confidence            999998654 4688999999999999999999999999999999999999999999999999875431100000      


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                               .....++..|+|||.+.+..++.++|+|||||++||++.
T Consensus       153 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~  191 (252)
T cd05084         153 -----------------------------------------GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS  191 (252)
T ss_pred             -----------------------------------------CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence                                                     000123467999999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6e-36  Score=282.78  Aligned_cols=203  Identities=19%  Similarity=0.310  Sum_probs=167.6

Q ss_pred             eeeeEeee--eeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEee
Q 018275          110 LLTIIGRG--AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       110 ~~~~IG~G--~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      ++++||+|  +||+||++.+..+|+.||+|.+..... .......+.+|+.+++.++||||++++++|.+++..|+||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            46789999  789999999999999999999976532 233455678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          188 LPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       188 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++++|||.+............
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999999653  46889999999999999999999999999999999999999999999999876543211100000


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCccchhhhhhH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWLAYWN  343 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~~DiwSlGv  343 (358)
                                      .                          .......+++..|+|||++.+  .+|+.++|+|||||
T Consensus       161 ----------------~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~  198 (327)
T cd08227         161 ----------------V--------------------------HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI  198 (327)
T ss_pred             ----------------c--------------------------ccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence                            0                          000112357888999999986  46999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|||+++..+|
T Consensus       199 il~el~~g~~pf  210 (327)
T cd08227         199 TACELANGHVPF  210 (327)
T ss_pred             HHHHHHHCCCCC
Confidence            999999987765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.9e-36  Score=273.10  Aligned_cols=201  Identities=23%  Similarity=0.346  Sum_probs=170.0

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .+..++|++.++||+|+||.||+|... ++..||+|.+....    ...+.+.+|+.+++.++|+||+++++.+.+.+..
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            356689999999999999999999864 56689999887543    2345688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ++||||+++++|.+++...  ..++......++.|++.||.|||+.+++||||||+||+++.++.++|+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999999998653  46788888899999999999999999999999999999999999999999999865421


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ....                                                .....++..|+|||++.+..++.++|+|
T Consensus       157 ~~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~  188 (261)
T cd05072         157 EYTA------------------------------------------------REGAKFPIKWTAPEAINFGSFTIKSDVW  188 (261)
T ss_pred             ceec------------------------------------------------cCCCccceecCCHHHhccCCCChhhhhh
Confidence            1000                                                0022467789999999999999999999


Q ss_pred             hhhHHHHhhcc-ccccc
Q 018275          340 AYWNETLSCNY-LSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~-~~~~~  355 (358)
                      ||||++|+|+. +..+|
T Consensus       189 slG~~l~~l~t~g~~p~  205 (261)
T cd05072         189 SFGILLYEIVTYGKIPY  205 (261)
T ss_pred             hhHHHHHHHHccCCCCC
Confidence            99999999996 55443

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-36  Score=280.00  Aligned_cols=202  Identities=21%  Similarity=0.327  Sum_probs=167.1

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecC--------------CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKS--------------GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV  169 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~--------------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv  169 (358)
                      ..++|++.+.||+|+||.||+|.+..+              ...||+|.++...  .......+.+|+.+++.++|||++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            457899999999999999999986542              2358999987542  334455688999999999999999


Q ss_pred             EEEEEeecCCEEEEEEeecCCCCHHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 018275          170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL  237 (358)
Q Consensus       170 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NI  237 (358)
                      ++++++......++||||+++++|.+++....            .++...+..++.|++.||.|||+.+++|+||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999985432            357778888999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC
Q 018275          238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG  317 (358)
Q Consensus       238 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g  317 (358)
                      +++.++.+||+|||++..+.......                                               ......+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~  193 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYR-----------------------------------------------IQGRAVL  193 (295)
T ss_pred             EEcCCCcEEecccccccccccCccee-----------------------------------------------ccCcCcC
Confidence            99999999999999987553111000                                               0012246


Q ss_pred             CCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccc
Q 018275          318 TPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDI  354 (358)
Q Consensus       318 t~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~  354 (358)
                      ++.|+|||++.+..++.++|+|||||++|+++++...
T Consensus       194 ~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~  230 (295)
T cd05097         194 PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE  230 (295)
T ss_pred             ceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence            7889999999999999999999999999999875433

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.3e-36  Score=276.38  Aligned_cols=199  Identities=25%  Similarity=0.329  Sum_probs=168.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||+|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999875532  22233467899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||++ ++|.+.+.. ...+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||+++........ 
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  159 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-  159 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence            99996 677776654 356788888999999999999999999999999999999999999999999998754321100 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                      ....++++.|+|||++.+ ..++.++|+||||
T Consensus       160 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  191 (291)
T cd07870         160 ------------------------------------------------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAG  191 (291)
T ss_pred             ------------------------------------------------CCCccccccccCCceeecCCCCCcHHHHHHHH
Confidence                                                            012357899999999976 4588999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++||++++...|
T Consensus       192 ~~l~~l~~g~~~f  204 (291)
T cd07870         192 CIFIEMLQGQPAF  204 (291)
T ss_pred             HHHHHHHhCCCCC
Confidence            9999999987765

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-36  Score=275.58  Aligned_cols=198  Identities=34%  Similarity=0.554  Sum_probs=175.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||.|+||.||+|.+..++..||+|.+....  .......+.+|+.+++.++||||+++++.+.++..+|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            46888999999999999999999999999999987653  2344566888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|.+++... ++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++.+......   
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~---  154 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK---  154 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc---
Confidence            999999999998655 8899999999999999999999999999999999999999999999999999876422100   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                    ....+|++.|+|||++.+..++.++|+|||||++
T Consensus       155 ----------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il  188 (274)
T cd06609         155 ----------------------------------------------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA  188 (274)
T ss_pred             ----------------------------------------------cccccCCccccChhhhccCCCCchhhHHHHHHHH
Confidence                                                          1133689999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |+|+++..+|
T Consensus       189 ~~l~tg~~p~  198 (274)
T cd06609         189 IELAKGEPPL  198 (274)
T ss_pred             HHHHhCCCCc
Confidence            9999987665

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-36  Score=276.67  Aligned_cols=199  Identities=25%  Similarity=0.372  Sum_probs=169.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++.+.||.|+||.||+|.+..+++.||||.+.....  ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            4789999999999999999999988999999999875431  12223466799999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++ +|.+++... ..+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++........ 
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-  159 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-  159 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence            999974 999988654 46889999999999999999999999999999999999999999999999998754211100 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                      .....+++.|+|||++.+ ..++.++||||+|
T Consensus       160 ------------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG  191 (291)
T cd07844         160 ------------------------------------------------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVG  191 (291)
T ss_pred             ------------------------------------------------ccccccccccCCcHHhhcCcccCcHHHHHHHH
Confidence                                                            002257889999999976 5689999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|+|+++..+|
T Consensus       192 ~il~~l~~g~~~~  204 (291)
T cd07844         192 CIFYEMATGRPLF  204 (291)
T ss_pred             HHHHHHHhCCCCC
Confidence            9999999987665

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-36  Score=278.55  Aligned_cols=200  Identities=22%  Similarity=0.350  Sum_probs=175.8

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|++++.||+|+||+||++.+..++..||+|++....  .......+.+|+.+++.++||||+++++.+.+....++
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            3468899999999999999999999999999999886542  23345668899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||||+++++|.+++...+++++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++.......  
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            99999999999999877889999999999999999999997 689999999999999999999999999986442110  


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ....+||..|+|||++.+..++.++|+||||
T Consensus       159 -------------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG  189 (284)
T cd06620         159 -------------------------------------------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLG  189 (284)
T ss_pred             -------------------------------------------------cCccccCcccCCHHHHccCCCCccchHHHHH
Confidence                                                             0123689999999999998999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|+++++..+|.
T Consensus       190 ~~l~~l~tg~~p~~  203 (284)
T cd06620         190 ISIIELALGKFPFA  203 (284)
T ss_pred             HHHHHHHhCCCCCc
Confidence            99999998877653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.5e-36  Score=281.11  Aligned_cols=193  Identities=23%  Similarity=0.330  Sum_probs=156.8

Q ss_pred             eeeEeeeeeEEEEEEEEec--CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee--cCCEEEEEEe
Q 018275          111 LTIIGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEYLYLIME  186 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lV~E  186 (358)
                      ..+||+|+||.||+|.+..  ++..||+|.+.....     ...+.+|+.+++.++||||+++++++.  .+..+++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            3689999999999998654  568899998875421     234678999999999999999999885  4567899999


Q ss_pred             ecCCCCHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE----cCCCcEEEEecCCC
Q 018275          187 YLPGGDVMTLLMR---------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLC  253 (358)
Q Consensus       187 ~~~~g~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl----~~~~~vkl~DFGla  253 (358)
                      |++ ++|.+++..         ...+++..+..++.|++.||.|||+.+|+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            996 577777642         1257888999999999999999999999999999999999    56789999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGY  332 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y  332 (358)
                      +.........                                              ......+||+.|+|||++.+ ..+
T Consensus       160 ~~~~~~~~~~----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~  193 (317)
T cd07867         160 RLFNSPLKPL----------------------------------------------ADLDPVVVTFWYRAPELLLGARHY  193 (317)
T ss_pred             eccCCCcccc----------------------------------------------cccCcceecccccCcHHhcCCCcc
Confidence            8664221100                                              00113479999999999987 458


Q ss_pred             CccchhhhhhHHHHhhccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +.++|||||||++|||+++..+|
T Consensus       194 ~~~~DiwSlG~il~el~tg~~~f  216 (317)
T cd07867         194 TKAIDIWAIGCIFAELLTSEPIF  216 (317)
T ss_pred             CcHHHHHhHHHHHHHHHhCCCCc
Confidence            99999999999999999988766

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=271.39  Aligned_cols=204  Identities=31%  Similarity=0.495  Sum_probs=174.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhh--hhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC--CEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE--MLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYL  181 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~  181 (358)
                      .+|.+.+.||+|+||.||+|.+..++..||+|.+....  .........+.+|+.+++.++|+||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999999999999999875431  11234556788999999999999999999998764  468


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            99999999999999998777889999999999999999999999999999999999999999999999999986532110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      ...                                              ......|++.|+|||++.+..++.++|+|||
T Consensus       162 ~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  195 (264)
T cd06653         162 SGT----------------------------------------------GIKSVTGTPYWMSPEVISGEGYGRKADVWSV  195 (264)
T ss_pred             cCc----------------------------------------------cccccCCcccccCHhhhcCCCCCccccHHHH
Confidence            000                                              0012368999999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|+++++..+|
T Consensus       196 G~il~~l~~g~~p~  209 (264)
T cd06653         196 ACTVVEMLTEKPPW  209 (264)
T ss_pred             HHHHHHHHhCCCCC
Confidence            99999999887665

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.4e-35  Score=269.73  Aligned_cols=199  Identities=29%  Similarity=0.469  Sum_probs=174.6

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++++.||.|+||.||.+.+..++..+++|.+..... .......+.+|+.+++.++|+||+++++++.+...+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            58999999999999999999999999999999875542 23445668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       187 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---  156 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---  156 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence            99999999999764  4688999999999999999999999999999999999999999999999999876532110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                    ......|++.|+|||++.+..++.++|+|||||+
T Consensus       157 ----------------------------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i  190 (256)
T cd08221         157 ----------------------------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCV  190 (256)
T ss_pred             ----------------------------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHH
Confidence                                                          0113468999999999999889999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|||+.+..+|
T Consensus       191 ~~~l~~g~~~~  201 (256)
T cd08221         191 LYELLTLKRTF  201 (256)
T ss_pred             HHHHHHCCCCC
Confidence            99999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-36  Score=274.07  Aligned_cols=203  Identities=18%  Similarity=0.249  Sum_probs=169.6

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecC-----CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      ++..++|.+.+.||+|+||.||+|.+...     +..||+|.+....  .......+.+|+.++..++||||+++++++.
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            34568899999999999999999987643     3789999987543  2334456788999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEE
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMREE----------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK  246 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vk  246 (358)
                      +....++||||+++++|.+++....          .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+|
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            9999999999999999999986432          356778888999999999999999999999999999999999999


Q ss_pred             EEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhh
Q 018275          247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV  326 (358)
Q Consensus       247 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv  326 (358)
                      |+|||+++.+.......                                               ......+|..|+|||+
T Consensus       160 l~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~  192 (277)
T cd05032         160 IGDFGMTRDIYETDYYR-----------------------------------------------KGGKGLLPVRWMAPES  192 (277)
T ss_pred             ECCcccchhhccCcccc-----------------------------------------------cCCCCCccccccCHHH
Confidence            99999987653221000                                               0012257889999999


Q ss_pred             hcCCCCCccchhhhhhHHHHhhcc-ccc
Q 018275          327 LLKKGYGMECDWLAYWNETLSCNY-LSD  353 (358)
Q Consensus       327 ~~~~~y~~~~DiwSlGvil~e~l~-~~~  353 (358)
                      +.+..++.++|+|||||++||++. +..
T Consensus       193 ~~~~~~~~~~Di~slG~il~el~t~g~~  220 (277)
T cd05032         193 LKDGVFTTKSDVWSFGVVLWEMATLAEQ  220 (277)
T ss_pred             HhcCCCCcccchHHHHHHHHHhhccCCC
Confidence            999999999999999999999986 443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.7e-36  Score=274.95  Aligned_cols=198  Identities=31%  Similarity=0.418  Sum_probs=168.3

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|.+.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            58899999999999999999999999999999875432 22334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          187 YLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       187 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |++ ++|.+++...   ..+++..+..++.|++.||.|||+.+|+|+||||+|||++.++.++|+|||++........  
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--  156 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence            997 5888887542   5689999999999999999999999999999999999999999999999999875431110  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                     ......+++.|+|||++.+ ..++.++|+||||
T Consensus       157 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  189 (285)
T cd07861         157 -----------------------------------------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIG  189 (285)
T ss_pred             -----------------------------------------------cccCCcccccccChHHhcCCCCcCcHHHHHHHH
Confidence                                                           0012367899999999875 4578999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|+++++...|
T Consensus       190 ~il~~l~tg~~~~  202 (285)
T cd07861         190 TIFAEMATKKPLF  202 (285)
T ss_pred             HHHHHHHHCCCCC
Confidence            9999999987655

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.8e-36  Score=274.11  Aligned_cols=198  Identities=28%  Similarity=0.483  Sum_probs=168.5

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecC-----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDA-----  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~-----  178 (358)
                      .+.|.+.+.||+|+||.||+|.+..++..||+|.+....    .....+..|+.++..+ +||||+++++.|...     
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            467889999999999999999999999999999986542    2334577899999988 699999999998753     


Q ss_pred             -CEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          179 -EYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       179 -~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                       ...|+||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++..
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence             4689999999999999998763  4688999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----CC
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KK  330 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----~~  330 (358)
                      .......                                                 .....|++.|+|||++.     +.
T Consensus       161 ~~~~~~~-------------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~  191 (272)
T cd06637         161 LDRTVGR-------------------------------------------------RNTFIGTPYWMAPEVIACDENPDA  191 (272)
T ss_pred             ccccccc-------------------------------------------------CCcccccccccCHhHhccccCcCC
Confidence            5321100                                                 01346999999999996     34


Q ss_pred             CCCccchhhhhhHHHHhhccccccc
Q 018275          331 GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .|+.++|+|||||++||++++...|
T Consensus       192 ~~~~~~Dv~slGv~l~el~~g~~p~  216 (272)
T cd06637         192 TYDFKSDLWSLGITAIEMAEGAPPL  216 (272)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCc
Confidence            6889999999999999999988765

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.6e-35  Score=274.77  Aligned_cols=199  Identities=28%  Similarity=0.445  Sum_probs=174.3

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ...+|++.+.||.|+||.||+|.+..+++.||+|.+....   ......+.+|+.+++.++|||++++++.+.+.+..|+
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence            3467999999999999999999999999999999987542   2334567889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |+||+++++|..++.. ..+++..+..++.+++.||.|||+.|++|+||||+||+++.++.++|+|||++......... 
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence            9999999999998854 46889999999999999999999999999999999999999999999999998765321100 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      .....|++.|+|||.+.+..++.++|+|||||
T Consensus       172 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv  203 (296)
T cd06655         172 ------------------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI  203 (296)
T ss_pred             ------------------------------------------------CCCcCCCccccCcchhcCCCCCchhhHHHHHH
Confidence                                                            01236899999999999999999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|+++++...|
T Consensus       204 il~~lltg~~pf  215 (296)
T cd06655         204 MAIEMVEGEPPY  215 (296)
T ss_pred             HHHHHHhCCCCC
Confidence            999999987765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.9e-36  Score=272.92  Aligned_cols=204  Identities=26%  Similarity=0.409  Sum_probs=174.4

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh---chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML---SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      +|+..+.||+|+||.||++.+..++..||+|++......   .......+..|+.+++.++|+||+++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999999999999999998754311   12245678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-cEEEEecCCCccCCCCCCc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~vkl~DFGla~~~~~~~~~  262 (358)
                      ||||+++++|.+++....++++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..+......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998876 5999999998766422100


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                      ..                                             ......+||+.|+|||++.+..++.++|+||||
T Consensus       161 ~~---------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG  195 (268)
T cd06630         161 AG---------------------------------------------EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVG  195 (268)
T ss_pred             CC---------------------------------------------ccccccccccceeCHhHhccCCCCcccchHHHH
Confidence            00                                             000123689999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|+++++...|
T Consensus       196 ~~l~~l~~g~~p~  208 (268)
T cd06630         196 CVIIEMATAKPPW  208 (268)
T ss_pred             HHHHHHHhCCCCC
Confidence            9999999887654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1e-35  Score=276.30  Aligned_cols=204  Identities=23%  Similarity=0.330  Sum_probs=170.0

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecC-----CCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~  174 (358)
                      ..+..++|++.+.||+|+||.||++.+...     ...+|+|.+....  .......+.+|+.++..+ +|+||++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            345668899999999999999999987643     3689999987542  233455688899999999 89999999999


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMR----------------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLL  238 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~----------------~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NIL  238 (358)
                      +.....+++||||+++|+|..++..                ...+++..+..++.|++.||.|||+.+|+||||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            9999999999999999999999854                245788888999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCC
Q 018275          239 LDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT  318 (358)
Q Consensus       239 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt  318 (358)
                      ++.++.+||+|||+++.+........                                               .....++
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~-----------------------------------------------~~~~~~~  197 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRK-----------------------------------------------TTNGRLP  197 (293)
T ss_pred             EcCCCeEEeCccccccccccccceec-----------------------------------------------cCCCCCC
Confidence            99999999999999986642211000                                               0011356


Q ss_pred             CCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccc
Q 018275          319 PDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSD  353 (358)
Q Consensus       319 ~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~  353 (358)
                      +.|+|||++.+..++.++|||||||++||++. +..
T Consensus       198 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~  233 (293)
T cd05053         198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS  233 (293)
T ss_pred             ccccCHHHhccCCcCcccceeehhhHHHHHhcCCCC
Confidence            78999999999999999999999999999885 443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=273.94  Aligned_cols=199  Identities=24%  Similarity=0.392  Sum_probs=170.5

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||+|+|+.|--|....+|..+|||++.+..   .....++.+|++++..+ .|+||++|+.+|.++..+|||||-|.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G  160 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG  160 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence            57999999999999999999999999998763   44556688999999988 599999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC---cEEEEecCCCccCCCCCCcccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPLDCTNLSAINEN  267 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~vkl~DFGla~~~~~~~~~~~~~~  267 (358)
                      |+|...+....-|++..+..++..|+.||.|||.+||.||||||+|||.....   -+|||||.++..+...++-+..  
T Consensus       161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa--  238 (463)
T KOG0607|consen  161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA--  238 (463)
T ss_pred             chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC--
Confidence            99999999999999999999999999999999999999999999999997654   4899999998765433322210  


Q ss_pred             cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----CCCCCccchhhhhh
Q 018275          268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWLAYW  342 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----~~~y~~~~DiwSlG  342 (358)
                                      +.|                        -.-+.||+-.||||||..     ..-|+..||.||||
T Consensus       239 ----------------stP------------------------~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG  278 (463)
T KOG0607|consen  239 ----------------STP------------------------ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG  278 (463)
T ss_pred             ----------------CCc------------------------cccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence                            000                        012569999999999974     34599999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      ||||=||.|...|
T Consensus       279 vIlYImLsGYpPF  291 (463)
T KOG0607|consen  279 VILYIMLSGYPPF  291 (463)
T ss_pred             HHHHHHHhCCCCc
Confidence            9999999887665

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=271.80  Aligned_cols=198  Identities=21%  Similarity=0.266  Sum_probs=168.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..++|++.+.||+|+||.||+|.+..+   ...||||.++...  .......+..|+.+++.++||||+++++.+.+.+.
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            357899999999999999999988644   4589999987543  33445568889999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .++||||+++++|.+++... +.+++..+..++.|++.||.|||+.+|+|+||||+|||++.++.++|+|||+++.+...
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999998664 47899999999999999999999999999999999999999999999999999876411


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .....                                               .....+++.|+|||.+.+..++.++|+|
T Consensus       160 ~~~~~-----------------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~  192 (266)
T cd05033         160 EATYT-----------------------------------------------TKGGKIPIRWTAPEAIAYRKFTSASDVW  192 (266)
T ss_pred             cccee-----------------------------------------------ccCCCCCccccChhhhccCCCccccchH
Confidence            11000                                               0012457789999999999999999999


Q ss_pred             hhhHHHHhhcc
Q 018275          340 AYWNETLSCNY  350 (358)
Q Consensus       340 SlGvil~e~l~  350 (358)
                      |||+++|+|+.
T Consensus       193 slG~~l~~l~~  203 (266)
T cd05033         193 SFGIVMWEVMS  203 (266)
T ss_pred             HHHHHHHHHHc
Confidence            99999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1e-35  Score=270.94  Aligned_cols=197  Identities=19%  Similarity=0.312  Sum_probs=166.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++.+.||+|+||.||++.++ ++..+|+|.+.....    ....+.+|+.+++.++||||+++++++.+....++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            467999999999999999999865 456899998875432    234578899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999999998653 468889999999999999999999999999999999999999999999999987653211000


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      .....++..|+|||++.+..++.++|+||||+
T Consensus       158 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~  189 (256)
T cd05114         158 ------------------------------------------------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV  189 (256)
T ss_pred             ------------------------------------------------cCCCCCchhhCChhhcccCccchhhhhHHHHH
Confidence                                                            00123567899999999999999999999999


Q ss_pred             HHHhhcc-cccc
Q 018275          344 ETLSCNY-LSDI  354 (358)
Q Consensus       344 il~e~l~-~~~~  354 (358)
                      ++||+++ +...
T Consensus       190 ~l~el~~~g~~p  201 (256)
T cd05114         190 LMWEVFTEGKMP  201 (256)
T ss_pred             HHHHHHcCCCCC
Confidence            9999988 4443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.4e-36  Score=278.03  Aligned_cols=197  Identities=26%  Similarity=0.404  Sum_probs=167.7

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||+|+||.||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            48899999999999999999999999999999876432 22233457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          187 YLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       187 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      |++ ++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++........   
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~---  155 (284)
T cd07839          80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---  155 (284)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC---
Confidence            996 578887754 467899999999999999999999999999999999999999999999999998755321100   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGvi  344 (358)
                                                                    .....+++.|+|||++.+. .++.++|+|||||+
T Consensus       156 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  189 (284)
T cd07839         156 ----------------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI  189 (284)
T ss_pred             ----------------------------------------------cCCCccccCCcChHHHhCCcccCcHHHHHHHHHH
Confidence                                                          0123578999999998774 47999999999999


Q ss_pred             HHhhcccccc
Q 018275          345 TLSCNYLSDI  354 (358)
Q Consensus       345 l~e~l~~~~~  354 (358)
                      +|+|+++...
T Consensus       190 l~~l~tg~~p  199 (284)
T cd07839         190 FAELANAGRP  199 (284)
T ss_pred             HHHHHhcCCC
Confidence            9999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-35  Score=276.79  Aligned_cols=198  Identities=27%  Similarity=0.436  Sum_probs=173.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ..+|.+.+.||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++.|......|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            478999999999999999999998999999999987543   22345578899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.........  
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--  171 (297)
T cd06656          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--  171 (297)
T ss_pred             ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence            999999999999854 56788899999999999999999999999999999999999999999999998754321100  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                     .....|++.|+|||.+.+..++.++|+|||||+
T Consensus       172 -----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvi  204 (297)
T cd06656         172 -----------------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM  204 (297)
T ss_pred             -----------------------------------------------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHH
Confidence                                                           012368999999999999999999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|+++++...|
T Consensus       205 l~~l~tg~~pf  215 (297)
T cd06656         205 AIEMVEGEPPY  215 (297)
T ss_pred             HHHHHhCCCCC
Confidence            99999887655

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-35  Score=270.83  Aligned_cols=207  Identities=30%  Similarity=0.444  Sum_probs=175.6

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh------chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML------SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~------~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      +|.+...||.|+||.||+|.+..++..||+|.+......      .......+..|+.+++.++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367788999999999999999889999999988654321      12334668889999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      .++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999998664211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .....                                           ........|++.|+|||++.+..++.++|+||
T Consensus       161 ~~~~~-------------------------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s  197 (267)
T cd06628         161 LSTKT-------------------------------------------NGARPSLQGSVFWMAPEVVKQTSYTRKADIWS  197 (267)
T ss_pred             ccCCc-------------------------------------------cccccccCCCcCccChhHhccCCCCchhhhHH
Confidence            10000                                           00001346899999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|+++.+..+|.
T Consensus       198 lG~il~~l~~g~~p~~  213 (267)
T cd06628         198 LGCLVVEMLTGKHPFP  213 (267)
T ss_pred             HHHHHHHHhhCCCCCC
Confidence            9999999998876653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-35  Score=273.70  Aligned_cols=192  Identities=34%  Similarity=0.574  Sum_probs=161.0

Q ss_pred             eEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHH---HHHHhcCcceEEEEEEeecCCEEEEEEeecC
Q 018275          113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN---LLAEVASHCIVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~---il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      .||+|+||.||+|.+..+++.||+|.+.+...........+..|..   +++...||+|+.+++.+.+.+..|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999999999999999987654322222222333433   3444579999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccc
Q 018275          190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV  269 (358)
Q Consensus       190 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  269 (358)
                      |++|..++.....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+....         
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---------  151 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---------  151 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999987543110         


Q ss_pred             cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhhHHHHhh
Q 018275          270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYWNETLSC  348 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlGvil~e~  348 (358)
                                                                ....+|++.|+|||++.+ ..++.++|+||+||++||+
T Consensus       152 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l  189 (278)
T cd05606         152 ------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL  189 (278)
T ss_pred             ------------------------------------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHH
Confidence                                                      012369999999999975 4689999999999999999


Q ss_pred             ccccccc
Q 018275          349 NYLSDIM  355 (358)
Q Consensus       349 l~~~~~~  355 (358)
                      +.+...|
T Consensus       190 ~~g~~p~  196 (278)
T cd05606         190 LRGHSPF  196 (278)
T ss_pred             HhCCCCC
Confidence            9987665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-35  Score=274.16  Aligned_cols=200  Identities=26%  Similarity=0.408  Sum_probs=166.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEE----ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--C
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQE----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--A  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~  178 (358)
                      ..+|++.+.||+|+||.||+|..    ..++..||+|.+....   ......+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            36899999999999999999873    4578899999987542   3445668899999999999999999998743  4


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.+.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            5689999999999999999654 468899999999999999999999999999999999999999999999999998664


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      .......                                              ......++..|+|||++.+..++.++|
T Consensus       160 ~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D  193 (284)
T cd05081         160 QDKEYYK----------------------------------------------VREPGESPIFWYAPESLTESKFSVASD  193 (284)
T ss_pred             CCCccee----------------------------------------------ecCCCCCceEeeCHHHhccCCcChHHH
Confidence            2211000                                              000112445699999999999999999


Q ss_pred             hhhhhHHHHhhccccc
Q 018275          338 WLAYWNETLSCNYLSD  353 (358)
Q Consensus       338 iwSlGvil~e~l~~~~  353 (358)
                      +|||||++||++.+..
T Consensus       194 i~slG~~l~el~~~~~  209 (284)
T cd05081         194 VWSFGVVLYELFTYSD  209 (284)
T ss_pred             HHHHHHHHHHHhhcCC
Confidence            9999999999988643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-35  Score=274.72  Aligned_cols=202  Identities=17%  Similarity=0.256  Sum_probs=165.7

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCC----EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ..++|++++.||+|+||.||+|.+..++.    .|++|.+....  .......+..|+.+++.+.||||+++++++.. .
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            34789999999999999999999877766    47777775331  23344567778888999999999999998864 4


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..++++||+++|+|.+++... ..+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            578999999999999999764 5789999999999999999999999999999999999999999999999999976532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .....                                               ......|+..|+|||++.+..|+.++|+
T Consensus       162 ~~~~~-----------------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv  194 (279)
T cd05111         162 DDKKY-----------------------------------------------FYSEHKTPIKWMALESILFGRYTHQSDV  194 (279)
T ss_pred             CCccc-----------------------------------------------ccCCCCCcccccCHHHhccCCcCchhhH
Confidence            11100                                               0002247778999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      |||||++||++. +..+|
T Consensus       195 ~slG~il~el~t~g~~p~  212 (279)
T cd05111         195 WSYGVTVWEMMSYGAEPY  212 (279)
T ss_pred             HHHHHHHHHHHcCCCCCC
Confidence            999999999986 55444

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-35  Score=278.34  Aligned_cols=202  Identities=21%  Similarity=0.312  Sum_probs=167.7

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEec-------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEE
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKL  171 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l  171 (358)
                      +..+..++|.+.+.||+|+||.||+|.+..       +...+|+|.+....  .......+..|+.++..+ +||||+++
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            445566899999999999999999997643       23579999987542  233445678899999999 79999999


Q ss_pred             EEEeecCCEEEEEEeecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 018275          172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD  235 (358)
Q Consensus       172 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~  235 (358)
                      ++++.+....|+||||+++|+|.+++....                .++...+..++.|++.||.|||+.|++||||||+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  169 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR  169 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence            999999999999999999999999996532                4777888899999999999999999999999999


Q ss_pred             CEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccc
Q 018275          236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST  315 (358)
Q Consensus       236 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  315 (358)
                      |||++.++.+||+|||+++.........                                               .....
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~-----------------------------------------------~~~~~  202 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYK-----------------------------------------------KTTNG  202 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhh-----------------------------------------------ccccC
Confidence            9999999999999999987653211000                                               00011


Q ss_pred             cCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          316 VGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       316 ~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                      .+++.|+|||++.+..++.++|+|||||++|||++
T Consensus       203 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~  237 (307)
T cd05098         203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT  237 (307)
T ss_pred             CCccceeChHHhccCCCCcHHHHHHHHHHHHHHHc
Confidence            35578999999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.9e-36  Score=277.70  Aligned_cols=198  Identities=19%  Similarity=0.275  Sum_probs=165.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecC-----CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ...+|.+.+.||+|+||.||+|.+..+     +..||||++....  .......+..|..++..++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            345688889999999999999987543     5789999997543  233445688899999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN  242 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~  242 (358)
                      ...++++||+++++|.+++...                ..+++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998532                247778888999999999999999999999999999999999


Q ss_pred             CcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCc
Q 018275          243 GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI  322 (358)
Q Consensus       243 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~  322 (358)
                      +.+||+|||+++.+......                                               .......+++.|+
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~  193 (283)
T cd05091         161 LNVKISDLGLFREVYAADYY-----------------------------------------------KLMGNSLLPIRWM  193 (283)
T ss_pred             CceEecccccccccccchhe-----------------------------------------------eeccCccCCcccc
Confidence            99999999998865321110                                               0011235678999


Q ss_pred             hhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          323 APEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       323 APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                      |||++.+..++.++|||||||++|||++
T Consensus       194 aPE~~~~~~~~~~~Dv~slG~~l~el~~  221 (283)
T cd05091         194 SPEAIMYGKFSIDSDIWSYGVVLWEVFS  221 (283)
T ss_pred             CHHHHhcCCCCcchhHHHHHHHHHHHHc
Confidence            9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.4e-36  Score=277.98  Aligned_cols=203  Identities=22%  Similarity=0.354  Sum_probs=166.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEec----------------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKK----------------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC  167 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~  167 (358)
                      +.++|++.+.||+|+||.||++.+..                ++..||+|++....  .......+.+|+.+++.++|+|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence            34789999999999999999986432                34479999987542  2334556889999999999999


Q ss_pred             eEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 018275          168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-----------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN  236 (358)
Q Consensus       168 iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~N  236 (358)
                      |+++++++.+....++||||+++++|.+++....           .++...+..++.|++.||.|||+.||+|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999986542           35567889999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccccc
Q 018275          237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV  316 (358)
Q Consensus       237 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  316 (358)
                      ||++.++.++|+|||+++.+.......                                               ......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~  193 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYR-----------------------------------------------IQGRAV  193 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCccee-----------------------------------------------ccCcCc
Confidence            999999999999999987653211000                                               000124


Q ss_pred             CCCCCchhhhhcCCCCCccchhhhhhHHHHhhccccccc
Q 018275          317 GTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       317 gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +++.|+|||+..+..++.++|+|||||++|||+.+....
T Consensus       194 ~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~  232 (296)
T cd05095         194 LPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ  232 (296)
T ss_pred             CccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence            567899999999889999999999999999998744333

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-37  Score=295.59  Aligned_cols=192  Identities=28%  Similarity=0.491  Sum_probs=169.9

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g  191 (358)
                      -+||+|.||+||-|++..+....|||.+....   ....+-+..|+.+.+.++|.|||+++|++..++++-+.||-+|||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            37999999999999999999999999998664   233445788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc-CCCcEEEEecCCCccCCCCCCcccccc
Q 018275          192 DVMTLLMRE-ETL--TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSAINEN  267 (358)
Q Consensus       192 ~L~~~l~~~-~~~--~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~  267 (358)
                      +|.++|... +|+  ++..+.+|..||+.||.|||.+.|||||||-+|||++ -.|.+||+|||.++.+..-+       
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-------  730 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-------  730 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC-------
Confidence            999999764 777  8899999999999999999999999999999999996 56999999999998774211       


Q ss_pred             cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCccchhhhhhHHH
Q 018275          268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWLAYWNET  345 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~~DiwSlGvil  345 (358)
                                                                .+..++.||..|||||++..  .+|+.++|||||||++
T Consensus       731 ------------------------------------------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~  768 (1226)
T KOG4279|consen  731 ------------------------------------------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTM  768 (1226)
T ss_pred             ------------------------------------------ccccccccchhhhChHhhccCCcCCCchhhhhhcccee
Confidence                                                      12336689999999999974  5799999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      .||-+|...|
T Consensus       769 vEMATGrPPF  778 (1226)
T KOG4279|consen  769 VEMATGRPPF  778 (1226)
T ss_pred             EeeccCCCCe
Confidence            9999998776

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.8e-36  Score=276.90  Aligned_cols=197  Identities=28%  Similarity=0.454  Sum_probs=169.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            46889999999999999999999899999999887532  2334466888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          186 EYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       186 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ||+++++|..++...   ..+++..+..++.+++.||.|||. .+|+|+||||+||+++.++.++|+|||++..+.... 
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999999999888653   378999999999999999999996 599999999999999999999999999987553111 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC------CCCcc
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK------GYGME  335 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~------~y~~~  335 (358)
                                                                        ....+|++.|+|||++.+.      .++.+
T Consensus       158 --------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~  187 (286)
T cd06622         158 --------------------------------------------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQ  187 (286)
T ss_pred             --------------------------------------------------cccCCCccCccCcchhcCCCCCccCCCCcc
Confidence                                                              0123688999999998544      35889


Q ss_pred             chhhhhhHHHHhhccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~  355 (358)
                      +|+|||||++|+|+++..+|
T Consensus       188 ~DiwslG~il~~l~~g~~pf  207 (286)
T cd06622         188 SDVWSLGLSILEMALGRYPY  207 (286)
T ss_pred             cchHhHHHHHHHHHhCCCCC
Confidence            99999999999999887665

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.3e-35  Score=273.69  Aligned_cols=192  Identities=35%  Similarity=0.592  Sum_probs=167.9

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCH
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV  193 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L  193 (358)
                      ||+|+||+||+|.+..+|+.||+|.+.............+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999999865443344455567899999999999999999999999999999999999999


Q ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccc
Q 018275          194 MTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD  271 (358)
Q Consensus       194 ~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~  271 (358)
                      .+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........          
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----------  150 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----------  150 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----------
Confidence            99997655  789999999999999999999999999999999999999999999999999875431100          


Q ss_pred             cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccc
Q 018275          272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                                                              .....|++.|+|||++.+..++.++|+|||||++|+|+++
T Consensus       151 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g  190 (277)
T cd05577         151 ----------------------------------------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG  190 (277)
T ss_pred             ----------------------------------------cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC
Confidence                                                    0123588899999999998899999999999999999988


Q ss_pred             cccc
Q 018275          352 SDIM  355 (358)
Q Consensus       352 ~~~~  355 (358)
                      ..+|
T Consensus       191 ~~p~  194 (277)
T cd05577         191 RSPF  194 (277)
T ss_pred             CCCC
Confidence            7665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-35  Score=270.19  Aligned_cols=205  Identities=27%  Similarity=0.441  Sum_probs=173.3

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh---hchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM---LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      +|.+.+.||.|+||.||+|.+ .++..+|+|.+.....   ........+.+|+.+++.++|+||++++++|.+....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            477889999999999999975 5788999998875421   123345668899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||||+++++|.+++....++++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++..........
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999999887889999999999999999999999999999999999999999999999999987653211110


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                      ..                                           ........|++.|+|||++.+..++.++|+|||||
T Consensus       160 ~~-------------------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~  196 (265)
T cd06631         160 TH-------------------------------------------SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGC  196 (265)
T ss_pred             cc-------------------------------------------cccccccCCCccccChhhhcCCCCcchhhHHHHHH
Confidence            00                                           00111346999999999999999999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|+++++...|
T Consensus       197 ~~~~l~~g~~p~  208 (265)
T cd06631         197 TVFEMATGKPPL  208 (265)
T ss_pred             HHHHHHhCCCcc
Confidence            999999987655

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-35  Score=273.59  Aligned_cols=202  Identities=22%  Similarity=0.277  Sum_probs=168.1

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      +..++|.+.+.||+|+||.||+|.+..     ++..||+|.+....  .......+..|+.+++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            345789999999999999999999877     77899999886542  23334568889999999999999999999998


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC---cEEE
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREE-------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKL  247 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~vkl  247 (358)
                      ....++||||+++++|.+++....       .+++..+..++.||+.||.|||+.+++||||||+|||++.++   .+||
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence            889999999999999999986543       478888999999999999999999999999999999998765   6999


Q ss_pred             EecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh
Q 018275          248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL  327 (358)
Q Consensus       248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~  327 (358)
                      +|||+++.+........                                               .....+++.|+|||++
T Consensus       161 ~dfg~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~y~aPE~~  193 (277)
T cd05036         161 ADFGMARDIYRASYYRK-----------------------------------------------GGRAMLPIKWMPPEAF  193 (277)
T ss_pred             ccCccccccCCccceec-----------------------------------------------CCCCCccHhhCCHHHH
Confidence            99999986632111000                                               0012345679999999


Q ss_pred             cCCCCCccchhhhhhHHHHhhcc-ccc
Q 018275          328 LKKGYGMECDWLAYWNETLSCNY-LSD  353 (358)
Q Consensus       328 ~~~~y~~~~DiwSlGvil~e~l~-~~~  353 (358)
                      .+..++.++|+|||||++||++. +..
T Consensus       194 ~~~~~~~~~DiwslG~il~el~~~g~~  220 (277)
T cd05036         194 LDGIFTSKTDVWSFGVLLWEIFSLGYM  220 (277)
T ss_pred             hcCCcCchhHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999886 443

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-35  Score=273.93  Aligned_cols=201  Identities=19%  Similarity=0.266  Sum_probs=165.9

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      ++..++|++.+.||+|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            3556889999999999999999997652     35589999987543  2233345778999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEE
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMRE----------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK  246 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vk  246 (358)
                      +....|+||||+++|+|.+++...          ..++...+..++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            999999999999999999999642          2345667888999999999999999999999999999999999999


Q ss_pred             EEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhh
Q 018275          247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV  326 (358)
Q Consensus       247 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv  326 (358)
                      |+|||+++..........                                               .....+++.|+|||.
T Consensus       160 L~Dfg~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~y~~pE~  192 (288)
T cd05061         160 IGDFGMTRDIYETDYYRK-----------------------------------------------GGKGLLPVRWMAPES  192 (288)
T ss_pred             ECcCCccccccccccccc-----------------------------------------------cCCCcccccccCHHH
Confidence            999999876532110000                                               001246778999999


Q ss_pred             hcCCCCCccchhhhhhHHHHhhccc
Q 018275          327 LLKKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       327 ~~~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                      +.+..++.++|+|||||++||++.+
T Consensus       193 ~~~~~~~~~~DvwslG~~l~el~~~  217 (288)
T cd05061         193 LKDGVFTTSSDMWSFGVVLWEITSL  217 (288)
T ss_pred             hccCCCChHhHHHHHHHHHHHHHhC
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=298.40  Aligned_cols=213  Identities=24%  Similarity=0.347  Sum_probs=173.1

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEee---
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQ---  176 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~---  176 (358)
                      ..+...++++.+.|.+|||+.||+|++...|..||+|.+-..   .....+.+++|+++|+.|. |+|||.+++...   
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            344556778899999999999999999888899999988765   4667788999999999997 999999999431   


Q ss_pred             -c---CCEEEEEEeecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEcCCCcEEEE
Q 018275          177 -D---AEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGHMKLS  248 (358)
Q Consensus       177 -~---~~~~~lV~E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~vkl~  248 (358)
                       .   .-.++|+||||.||.|.+++..  ...|++..+..|+.+++.||.+||..+  |||||||-+||||+.+|+.|||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence             1   1347899999999999999974  356999999999999999999999876  9999999999999999999999


Q ss_pred             ecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc
Q 018275          249 DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL  328 (358)
Q Consensus       249 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~  328 (358)
                      |||.|......-.+...                                 ..+-+...       ...-||.|+|||++.
T Consensus       189 DFGSatt~~~~~~~~~e---------------------------------~~~ve~eI-------~k~TTp~YRsPEMID  228 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQE---------------------------------VNYVEEEI-------EKYTTPQYRSPEMID  228 (738)
T ss_pred             cccccccccCCCccHHH---------------------------------HHHHHHHH-------HhhCCccccChHHHh
Confidence            99998643211110000                                 00001111       124799999999984


Q ss_pred             ---CCCCCccchhhhhhHHHHhhcccccccc
Q 018275          329 ---KKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       329 ---~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                         +.+.++++|||+|||+||-++|.+-.|.
T Consensus       229 lysg~pI~eKsDIWALGclLYkLCy~t~PFe  259 (738)
T KOG1989|consen  229 LYSGLPIGEKSDIWALGCLLYKLCYFTTPFE  259 (738)
T ss_pred             hhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence               8899999999999999999999888774

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-35  Score=271.49  Aligned_cols=202  Identities=21%  Similarity=0.269  Sum_probs=168.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCC---EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ..+|++.+.||+|+||.||+|.+..++.   .+|+|.+....  .......+..|+.+++.++||||+++++++.+.+..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4689999999999999999998865443   79999987542  233456788899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      |+||||+++++|.+++... ..++...+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++..+....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999999765 467888999999999999999999999999999999999999999999999998664211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ....                                              ......+++.|+|||++.+..++.++|+||
T Consensus       161 ~~~~----------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s  194 (267)
T cd05066         161 EAAY----------------------------------------------TTRGGKIPIRWTAPEAIAYRKFTSASDVWS  194 (267)
T ss_pred             ceee----------------------------------------------ecCCCccceeecCHhHhccCccCchhhhHH
Confidence            1000                                              000123467899999999999999999999


Q ss_pred             hhHHHHhhcc-cccc
Q 018275          341 YWNETLSCNY-LSDI  354 (358)
Q Consensus       341 lGvil~e~l~-~~~~  354 (358)
                      |||++||++. +...
T Consensus       195 lG~~l~ell~~g~~p  209 (267)
T cd05066         195 YGIVMWEVMSYGERP  209 (267)
T ss_pred             HHHHHHHHhcCCCCC
Confidence            9999999775 5543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-35  Score=277.88  Aligned_cols=202  Identities=23%  Similarity=0.342  Sum_probs=168.3

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe-------cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-------KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLY  172 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~  172 (358)
                      ..+..++|.+.+.||+|+||.||+|.+.       ..+..||+|.+....  .......+.+|+.+++.+ +||||++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            4456688999999999999999999753       234579999987542  234456688999999999 899999999


Q ss_pred             EEeecCCEEEEEEeecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 018275          173 YSFQDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN  236 (358)
Q Consensus       173 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~N  236 (358)
                      +.+.+....|+||||+++|+|.+++...                ..++...+..++.|++.||.|||+.||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            9999999999999999999999999653                236667788899999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccccc
Q 018275          237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV  316 (358)
Q Consensus       237 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  316 (358)
                      ||++.++.+||+|||+++.+.......                                               ......
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~-----------------------------------------------~~~~~~  200 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYK-----------------------------------------------KTTNGR  200 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccc-----------------------------------------------cccCCC
Confidence            999999999999999998664221100                                               001224


Q ss_pred             CCCCCchhhhhcCCCCCccchhhhhhHHHHhhccc
Q 018275          317 GTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       317 gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                      +++.|+|||++.+..|+.++|||||||++|+++++
T Consensus       201 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~  235 (304)
T cd05101         201 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL  235 (304)
T ss_pred             CCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence            67889999999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.7e-35  Score=270.20  Aligned_cols=192  Identities=40%  Similarity=0.686  Sum_probs=171.7

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCH
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV  193 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L  193 (358)
                      ||.|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+....|+||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            68999999999999989999999999876554455567789999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccc
Q 018275          194 MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE  273 (358)
Q Consensus       194 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......             
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------------  147 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------------  147 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------------
Confidence            9999887889999999999999999999999999999999999999999999999999987654211             


Q ss_pred             cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccccc
Q 018275          274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                                                           .....+|++.|+|||++.+..++.++|+||||+++|+++++..
T Consensus       148 -------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~  190 (262)
T cd05572         148 -------------------------------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP  190 (262)
T ss_pred             -------------------------------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCC
Confidence                                                 0113368999999999999999999999999999999998776


Q ss_pred             cc
Q 018275          354 IM  355 (358)
Q Consensus       354 ~~  355 (358)
                      +|
T Consensus       191 p~  192 (262)
T cd05572         191 PF  192 (262)
T ss_pred             Cc
Confidence            55

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.7e-35  Score=276.81  Aligned_cols=204  Identities=23%  Similarity=0.273  Sum_probs=170.9

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEe
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF  175 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~  175 (358)
                      .+..++|.+.+.||+|+||.||+|.+.     .++..||+|.++...  .....+.+.+|+.+++.+ +||||+++++.+
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            455678999999999999999999752     345689999987543  233456688999999999 799999999999


Q ss_pred             ecCCEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          176 QDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      ...+..++||||+++|+|.+++....  .+++..+..++.+++.||.|||+.+|+|+||||+|||++.++.++|+|||++
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999999996543  3889999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +.+........                                               .....+++.|+|||++.+..++
T Consensus       189 ~~~~~~~~~~~-----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~  221 (302)
T cd05055         189 RDIMNDSNYVV-----------------------------------------------KGNARLPVKWMAPESIFNCVYT  221 (302)
T ss_pred             ccccCCCceee-----------------------------------------------cCCCCcccccCCHhhhccCCCC
Confidence            76532210000                                               0022467889999999999999


Q ss_pred             ccchhhhhhHHHHhhcc-cccc
Q 018275          334 MECDWLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~-~~~~  354 (358)
                      .++|+|||||++||++. +...
T Consensus       222 ~~~DiwslGvil~el~t~g~~p  243 (302)
T cd05055         222 FESDVWSYGILLWEIFSLGSNP  243 (302)
T ss_pred             cHhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999986 5544

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-35  Score=270.56  Aligned_cols=205  Identities=21%  Similarity=0.268  Sum_probs=171.0

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCC---EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      +..++|+..+.||+|+||.||+|.+..++.   .+|+|.+....  .......+..|+.+++.++|||++++++++.+.+
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            456789999999999999999999876654   79999987542  2334566888999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..++||||+++++|.+++... ..+++..+..++.+++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999999999654 5788999999999999999999999999999999999999999999999999876542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .......                                              ......++.|+|||++.+..++.++||
T Consensus       160 ~~~~~~~----------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv  193 (268)
T cd05063         160 DPEGTYT----------------------------------------------TSGGKIPIRWTAPEAIAYRKFTSASDV  193 (268)
T ss_pred             cccccee----------------------------------------------ccCCCcCceecCHHHhhcCCcChHhHH
Confidence            2110000                                              001124567999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      |||||++||+++ +..+|
T Consensus       194 ~slG~il~ell~~g~~p~  211 (268)
T cd05063         194 WSFGIVMWEVMSFGERPY  211 (268)
T ss_pred             HHHHHHHHHHHhCCCCCC
Confidence            999999999886 55444

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-36  Score=298.63  Aligned_cols=199  Identities=24%  Similarity=0.337  Sum_probs=157.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCC-CEEEEE--------------ecchhhhhchhhHHHHHHHHHHHHHhcCcceE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSG-NIYAMK--------------KLKKSEMLSRGQVEHVRAERNLLAEVASHCIV  169 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~-~~vaiK--------------~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv  169 (358)
                      .++|.+++.||+|+||+||+|..+... ..+++|              .+.+...........+.+|+.+++.++|||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            478999999999999999998765332 222222              11111111223345678899999999999999


Q ss_pred             EEEEEeecCCEEEEEEeecCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc
Q 018275          170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE-----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH  244 (358)
Q Consensus       170 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~  244 (358)
                      ++++++.+.+..|+|++++. ++|..++...     .......++.++.|++.||.|||++|||||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            99999999999999999994 5777776432     22345677889999999999999999999999999999999999


Q ss_pred             EEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchh
Q 018275          245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP  324 (358)
Q Consensus       245 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~AP  324 (358)
                      +||+|||+++.+.....                                                ....+.+||+.|+||
T Consensus       306 vkL~DFGla~~~~~~~~------------------------------------------------~~~~~~~gt~~y~aP  337 (501)
T PHA03210        306 IVLGDFGTAMPFEKERE------------------------------------------------AFDYGWVGTVATNSP  337 (501)
T ss_pred             EEEEeCCCceecCcccc------------------------------------------------cccccccCCcCCCCc
Confidence            99999999986542110                                                011235799999999


Q ss_pred             hhhcCCCCCccchhhhhhHHHHhhcccc
Q 018275          325 EVLLKKGYGMECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       325 Ev~~~~~y~~~~DiwSlGvil~e~l~~~  352 (358)
                      |++.+.+|+.++|||||||+||||+.+.
T Consensus       338 E~~~~~~~~~~~DiwSlGvil~ell~~~  365 (501)
T PHA03210        338 EILAGDGYCEITDIWSCGLILLDMLSHD  365 (501)
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999999999764

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.4e-36  Score=275.49  Aligned_cols=200  Identities=31%  Similarity=0.444  Sum_probs=172.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||++++++|.+....|+||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            4789999999999999999999889999999998765322 233456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|..+......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+......   
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~---  156 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV---  156 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc---
Confidence            99999999888766667899999999999999999999999999999999999999999999999998765321100   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlGvi  344 (358)
                                                                    ....+|++.|+|||++.+ ..++.++|+|||||+
T Consensus       157 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~  190 (286)
T cd07846         157 ----------------------------------------------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCL  190 (286)
T ss_pred             ----------------------------------------------cCcccceeeccCcHHhccccccCchHhHHHHHHH
Confidence                                                          012368899999999976 457889999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +||++++..+|
T Consensus       191 l~el~~g~~~~  201 (286)
T cd07846         191 VTEMLTGEPLF  201 (286)
T ss_pred             HHHHHcCCCCC
Confidence            99999987655

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=272.73  Aligned_cols=201  Identities=33%  Similarity=0.475  Sum_probs=174.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            479999999999999999999999999999999876532 3334566889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||++++.+..+......+++..+..++.|++.||.|||..+++|+||+|+||+++.++.+||+|||++..........  
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~--  157 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--  157 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc--
Confidence            999987777776666779999999999999999999999999999999999999999999999999988764322100  


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGvi  344 (358)
                                                                    ....+|++.|+|||++.+. .++.++|+||||++
T Consensus       158 ----------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~  191 (288)
T cd07833         158 ----------------------------------------------LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI  191 (288)
T ss_pred             ----------------------------------------------ccCcccccCCcCCchhcCCCCcCchhhHHHHHHH
Confidence                                                          0123688999999999988 89999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|+|+.+..+|
T Consensus       192 l~~l~~g~~~~  202 (288)
T cd07833         192 MAELLDGEPLF  202 (288)
T ss_pred             HHHHHhCCCCC
Confidence            99999887654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=293.28  Aligned_cols=198  Identities=25%  Similarity=0.400  Sum_probs=175.7

Q ss_pred             CCc-eeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh-hchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE--E
Q 018275          106 DDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY--L  181 (358)
Q Consensus       106 ~~~-~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~--~  181 (358)
                      ++| .....||+|+|-+||+|.+..+|..||--.++..+. ..+...+.+..|+.+|+.|+|||||++|.+|.+...  +
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            444 345789999999999999999999999776665543 356667899999999999999999999999987655  8


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCCEEEcCC-CcEEEEecCCCccCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH--NYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDC  258 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~iiHrDikp~NILl~~~-~~vkl~DFGla~~~~~  258 (358)
                      -+|+|++..|+|..++.+.+..+...++.|+.||+.||.|||++  .|||||||-+||+|+-+ |.|||+|+|||+.+..
T Consensus       119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            89999999999999999999999999999999999999999987  69999999999999865 8999999999987653


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .                                                   .+.+++|||.|||||+.. ..|+..+||
T Consensus       199 s---------------------------------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDV  226 (632)
T KOG0584|consen  199 S---------------------------------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDV  226 (632)
T ss_pred             c---------------------------------------------------ccceeccCccccChHHHh-hhcchhhhh
Confidence            2                                                   244679999999999998 789999999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      ||||.||+||.+..|++
T Consensus       227 YaFGMCmLEMvT~eYPY  243 (632)
T KOG0584|consen  227 YAFGMCMLEMVTSEYPY  243 (632)
T ss_pred             hhhhHHHHHHHhccCCh
Confidence            99999999999998864

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.8e-37  Score=273.66  Aligned_cols=202  Identities=24%  Similarity=0.345  Sum_probs=168.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCC----CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec-CCE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSG----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-AEY  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~  180 (358)
                      ..|+.+..||+|.||.||+|..+.+.    +.+|||.++..... ........+|+.+++.++|||++.|..+|.. +..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            56889999999999999999655442    37899999765321 2222346789999999999999999999876 889


Q ss_pred             EEEEEeecCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC----CcEEEEecC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE-----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN----GHMKLSDFG  251 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~----~~vkl~DFG  251 (358)
                      +++++||.+. ||...+.-.     ..++...++.++.||+.|++|||++-|+||||||.|||+..+    |.|||+|||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999999965 999988542     468899999999999999999999999999999999999877    999999999


Q ss_pred             CCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-C
Q 018275          252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-K  330 (358)
Q Consensus       252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~  330 (358)
                      +++.+...-.+-+.                                              ...+|.|.+|+|||.++| .
T Consensus       182 laR~~~~plkpl~s----------------------------------------------~d~VVVTiWYRAPELLLGa~  215 (438)
T KOG0666|consen  182 LARLFNNPLKPLAS----------------------------------------------LDPVVVTIWYRAPELLLGAR  215 (438)
T ss_pred             HHHHhhcccccccc----------------------------------------------CCceEEEEEecChHHhcccc
Confidence            99988643221111                                              114588999999999997 4


Q ss_pred             CCCccchhhhhhHHHHhhccccccc
Q 018275          331 GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .|+.+.|+|++|||+.|+|..+.+|
T Consensus       216 hYT~AiDvWAiGCIfaElLtl~PlF  240 (438)
T KOG0666|consen  216 HYTKAIDVWAIGCIFAELLTLEPLF  240 (438)
T ss_pred             cccchhhhHHHHHHHHHHHccCccc
Confidence            5999999999999999999998887

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-35  Score=270.25  Aligned_cols=204  Identities=21%  Similarity=0.276  Sum_probs=169.2

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCC---EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .++|++.+.||+|+||.||+|.+..++.   .||||.+....  .......+..|+.+++.++||||+++++++.+....
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4678999999999999999999877665   69999987542  344556788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      ++||||+++++|.+++... +.++...+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999998753 568899999999999999999999999999999999999999999999999987653221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ......                                            ...+..++..|+|||++.+..++.++|+||
T Consensus       161 ~~~~~~--------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dvws  196 (269)
T cd05065         161 SDPTYT--------------------------------------------SSLGGKIPIRWTAPEAIAYRKFTSASDVWS  196 (269)
T ss_pred             cccccc--------------------------------------------cccCCCcceeecCHhHhccCcccchhhhhh
Confidence            100000                                            000112346799999999999999999999


Q ss_pred             hhHHHHhhcc-cccc
Q 018275          341 YWNETLSCNY-LSDI  354 (358)
Q Consensus       341 lGvil~e~l~-~~~~  354 (358)
                      |||++||++. +...
T Consensus       197 lG~~l~e~l~~g~~p  211 (269)
T cd05065         197 YGIVMWEVMSYGERP  211 (269)
T ss_pred             hHHHHHHHhcCCCCC
Confidence            9999999775 5443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=268.52  Aligned_cols=191  Identities=44%  Similarity=0.734  Sum_probs=164.8

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHH-HHhcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL-AEVASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il-~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +.||.|+||.||+|.+..+++.||+|++++...........+..|..++ ...+|||++++++.+...+.+|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999999999999999999765443333334445555444 455899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      ++|.+++....++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++.....           
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----------  150 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----------  150 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc-----------
Confidence            999999988888999999999999999999999999999999999999999999999999988653210           


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                                ....|++.|+|||.+.+..++.++||||||+++|++++
T Consensus       151 ------------------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~  188 (260)
T cd05611         151 ------------------------------------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF  188 (260)
T ss_pred             ------------------------------------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH
Confidence                                                      02368899999999999889999999999999999998


Q ss_pred             ccccc
Q 018275          351 LSDIM  355 (358)
Q Consensus       351 ~~~~~  355 (358)
                      +..+|
T Consensus       189 g~~p~  193 (260)
T cd05611         189 GYPPF  193 (260)
T ss_pred             CCCCC
Confidence            87665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.8e-35  Score=276.58  Aligned_cols=202  Identities=22%  Similarity=0.304  Sum_probs=167.4

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEec-------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLY  172 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~  172 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..       ....||+|.+....  .......+..|+.+++.+ +||||++++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLL   84 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence            34556889999999999999999997632       34579999987542  234456688899999999 699999999


Q ss_pred             EEeecCCEEEEEEeecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 018275          173 YSFQDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN  236 (358)
Q Consensus       173 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~N  236 (358)
                      ++|.+....|+||||+++|+|.+++...                ..++...+..++.|++.||.|||+.||+||||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  164 (314)
T cd05099          85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN  164 (314)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence            9999999999999999999999999653                247778888899999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccccc
Q 018275          237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV  316 (358)
Q Consensus       237 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  316 (358)
                      ||++.++.+||+|||+++.........                                               ......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~  197 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYK-----------------------------------------------KTSNGR  197 (314)
T ss_pred             EEEcCCCcEEEcccccccccccccccc-----------------------------------------------ccccCC
Confidence            999999999999999998654211100                                               000113


Q ss_pred             CCCCCchhhhhcCCCCCccchhhhhhHHHHhhccc
Q 018275          317 GTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       317 gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                      +++.|+|||++.+..++.++|||||||++||++++
T Consensus       198 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~  232 (314)
T cd05099         198 LPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL  232 (314)
T ss_pred             CCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence            55689999999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=269.11  Aligned_cols=193  Identities=20%  Similarity=0.313  Sum_probs=163.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|.+.....    ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            456889999999999999999875 466899999865432    223477899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999998654 468899999999999999999999999999999999999999999999999987553111000


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      .....++..|+|||++.+..++.++|+|||||
T Consensus       158 ------------------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~  189 (256)
T cd05059         158 ------------------------------------------------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGV  189 (256)
T ss_pred             ------------------------------------------------cCCCCCCccccCHHHhccCCCCchhhHHHHHH
Confidence                                                            00112456799999999999999999999999


Q ss_pred             HHHhhcc
Q 018275          344 ETLSCNY  350 (358)
Q Consensus       344 il~e~l~  350 (358)
                      ++||+++
T Consensus       190 il~~l~~  196 (256)
T cd05059         190 LMWEVFS  196 (256)
T ss_pred             HHHHHhc
Confidence            9999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.3e-35  Score=270.97  Aligned_cols=201  Identities=29%  Similarity=0.509  Sum_probs=168.2

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEee----
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ----  176 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~----  176 (358)
                      ....++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+ +||||+++++++.    
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            345689999999999999999999999999999999876532    1224477899999998 6999999999873    


Q ss_pred             -cCCEEEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecC
Q 018275          177 -DAEYLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG  251 (358)
Q Consensus       177 -~~~~~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFG  251 (358)
                       +.+..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence             45679999999999999988752    3568888899999999999999999999999999999999999999999999


Q ss_pred             CCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---
Q 018275          252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---  328 (358)
Q Consensus       252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---  328 (358)
                      ++..+.....                                                 .....+|++.|+|||++.   
T Consensus       170 ~~~~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~  200 (286)
T cd06638         170 VSAQLTSTRL-------------------------------------------------RRNTSVGTPFWMAPEVIACEQ  200 (286)
T ss_pred             ceeecccCCC-------------------------------------------------ccccccCCCcccChhhhchhh
Confidence            9876532110                                                 011336999999999985   


Q ss_pred             --CCCCCccchhhhhhHHHHhhccccccc
Q 018275          329 --KKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       329 --~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                        +..|+.++|||||||++||++.+..+|
T Consensus       201 ~~~~~~~~~~Dv~slGvi~~el~~g~~p~  229 (286)
T cd06638         201 QLDSTYDARCDVWSLGITAIELGDGDPPL  229 (286)
T ss_pred             hccccccchhhhhhHHHHHHHHhcCCCCC
Confidence              355889999999999999999876654

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.6e-35  Score=266.60  Aligned_cols=197  Identities=30%  Similarity=0.474  Sum_probs=174.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++.+.||+|+||.||+|.+..++..+++|.+.....     ...+.+|+.+++.++||||+++++.+.+....|++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            3789999999999999999999988899999999876532     56688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      +||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........  
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            999999999999865 45789999999999999999999999999999999999999999999999999876542210  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                     ......|++.|+|||++.+..++.++|+|||||
T Consensus       155 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~  187 (256)
T cd06612         155 -----------------------------------------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI  187 (256)
T ss_pred             -----------------------------------------------ccccccCCccccCHHHHhcCCCCchhhHHHHHH
Confidence                                                           011235889999999999999999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|+|+++..+|
T Consensus       188 il~~l~~g~~p~  199 (256)
T cd06612         188 TAIEMAEGKPPY  199 (256)
T ss_pred             HHHHHHhCCCCC
Confidence            999999987665

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=256.34  Aligned_cols=203  Identities=24%  Similarity=0.395  Sum_probs=170.0

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHH-hcCcceEEEEEEeecCC
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE-VASHCIVKLYYSFQDAE  179 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~-l~h~~iv~l~~~~~~~~  179 (358)
                      .++..++...+..||+|+||.|-+.++..+|...|+|.++..-  ..........|+++..+ ..+|.+|.+||...+..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            4455567777889999999999999999999999999998663  34445557778877654 57999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          180 YLYLIMEYLPGGDVMTLL----MREETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                      .+++.||.|+ .+|..+.    ..++.+++..+-.++..++.||.|||++ .+||||+||+||||+.+|.+|+||||++.
T Consensus       119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999995 5777664    4467899999999999999999999975 89999999999999999999999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC----C
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK----K  330 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~----~  330 (358)
                      .+..+-..+                                                  -..|...|||||.+..    .
T Consensus       198 ~L~dSiAkt--------------------------------------------------~daGCkpYmaPEri~~e~n~~  227 (282)
T KOG0984|consen  198 YLVDSIAKT--------------------------------------------------MDAGCKPYMAPERINPELNQK  227 (282)
T ss_pred             eehhhhHHH--------------------------------------------------HhcCCCccCChhhcCcccCcc
Confidence            775322111                                                  1268899999999863    5


Q ss_pred             CCCccchhhhhhHHHHhhcccccccc
Q 018275          331 GYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +|+.++|+||||++++||-.+.+.++
T Consensus       228 gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  228 GYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             cceeehhhhhhhhhhhhhhhcccccc
Confidence            89999999999999999998887654

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.4e-35  Score=273.85  Aligned_cols=201  Identities=22%  Similarity=0.316  Sum_probs=168.4

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ...+|.+.+.||+|+||.||+|.+..     ++..+++|.+....   ......+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            34679999999999999999997543     45678999886543   23345588899999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN  242 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~  242 (358)
                      ...++||||+++++|.+++....                .+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999996543                37888899999999999999999999999999999999999


Q ss_pred             CcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCc
Q 018275          243 GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI  322 (358)
Q Consensus       243 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~  322 (358)
                      +.++|+|||++..........                                               ......|++.|+
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~  192 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYR-----------------------------------------------VGGHTMLPIRWM  192 (291)
T ss_pred             CcEEECCCCcccccCCCceee-----------------------------------------------cCCCCCcceeec
Confidence            999999999987553211000                                               011235788999


Q ss_pred             hhhhhcCCCCCccchhhhhhHHHHhhcc-cccc
Q 018275          323 APEVLLKKGYGMECDWLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       323 APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~  354 (358)
                      |||++.+..++.++|+|||||++|||+. +...
T Consensus       193 aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  225 (291)
T cd05094         193 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP  225 (291)
T ss_pred             ChHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999999987 5544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=269.86  Aligned_cols=199  Identities=22%  Similarity=0.284  Sum_probs=163.7

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE----
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY----  180 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~----  180 (358)
                      |.+.+.||+|+||.||.|....+   +..||+|.++.... .......+..|+.+++.++||||+++++.+.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            56788999999999999987653   47899999876432 34455678899999999999999999998865443    


Q ss_pred             --EEEEEeecCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          181 --LYLIMEYLPGGDVMTLLMRE------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       181 --~~lV~E~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                        .++||||+++|+|..++...      ..+++..+..++.|++.||.|||+.+|+||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999988442      3588889999999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY  332 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y  332 (358)
                      ++.........                                               ......+++.|+|||++.+..+
T Consensus       160 ~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~  192 (273)
T cd05035         160 SKKIYSGDYYR-----------------------------------------------QGRIAKMPVKWIAIESLADRVY  192 (273)
T ss_pred             eeecccccccc-----------------------------------------------ccccccCCccccCHhhcccCCC
Confidence            98654221100                                               0001235678999999999999


Q ss_pred             CccchhhhhhHHHHhhcc-cccc
Q 018275          333 GMECDWLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~-~~~~  354 (358)
                      +.++|||||||++||++. +..+
T Consensus       193 ~~~~Dv~SlG~il~el~~~g~~p  215 (273)
T cd05035         193 TSKSDVWAFGVTMWEIATRGQTP  215 (273)
T ss_pred             CcccchHHHHHHHHHHHhCCCCC
Confidence            999999999999999987 4433

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-35  Score=287.09  Aligned_cols=205  Identities=22%  Similarity=0.273  Sum_probs=168.9

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~  174 (358)
                      +.+..++|.+.+.||+|+||.||+|.+.     .++..||+|++....  .......+..|+.++..+. |||||+++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            4566688999999999999999999864     345689999997643  2333456888999999997 9999999999


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhhcC-----------------------------------------------------
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMREE-----------------------------------------------------  201 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~~~-----------------------------------------------------  201 (358)
                      |......++||||+++|+|.+++....                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999986431                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 018275          202 ---------------------------------------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN  236 (358)
Q Consensus       202 ---------------------------------------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~N  236 (358)
                                                                   .++...+..++.|++.||.|||+.+|+||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         24556677788999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccccc
Q 018275          237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV  316 (358)
Q Consensus       237 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  316 (358)
                      ||++.++.+||+|||+++.........                                               ...+.+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~-----------------------------------------------~~~~~~  302 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYI-----------------------------------------------SKGSTF  302 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccc-----------------------------------------------cCCCcC
Confidence            999999999999999997643211000                                               001336


Q ss_pred             CCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-cccc
Q 018275          317 GTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       317 gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~  354 (358)
                      +++.|+|||++.+..++.++|||||||++|||+. +...
T Consensus       303 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P  341 (401)
T cd05107         303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP  341 (401)
T ss_pred             CCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence            7899999999999999999999999999999987 4433

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.3e-35  Score=274.54  Aligned_cols=199  Identities=27%  Similarity=0.409  Sum_probs=170.3

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh--chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      +|++.+.||+|+||.||+|.+..+++.||||.++.....  .......+..|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            488899999999999999999989999999999866432  122334567899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+ +++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-  158 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence            9999 899999997765 7999999999999999999999999999999999999999999999999998765422100 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                      .....+++.|+|||++.+ ..++.++|+||||
T Consensus       159 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  190 (298)
T cd07841         159 ------------------------------------------------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVG  190 (298)
T ss_pred             ------------------------------------------------ccccccceeeeCHHHHhCCCCCCcHHHHHHHH
Confidence                                                            012257889999999865 5688999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|||+.+..+|
T Consensus       191 ~il~e~~~g~~~~  203 (298)
T cd07841         191 CIFAELLLRVPFL  203 (298)
T ss_pred             HHHHHHHcCCccc
Confidence            9999999885544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.4e-35  Score=268.76  Aligned_cols=195  Identities=23%  Similarity=0.274  Sum_probs=163.1

Q ss_pred             eEeeeeeEEEEEEEE--ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          113 IIGRGAFGEVRLCQE--KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      .||+|+||.||+|.+  ..++..+|+|++.... ......+.+..|+.+++.++||||+++++++.. ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            589999999999965  4567899999987543 234455678899999999999999999998864 567899999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      ++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+........      
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~------  153 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK------  153 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee------
Confidence            99999998878899999999999999999999999999999999999999999999999999986642211000      


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                              ......+++.|+|||++.+..++.++|+|||||++||++.
T Consensus       154 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t  193 (257)
T cd05116         154 ----------------------------------------AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS  193 (257)
T ss_pred             ----------------------------------------ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence                                                    0001245688999999998899999999999999999996


Q ss_pred             -ccccc
Q 018275          351 -LSDIM  355 (358)
Q Consensus       351 -~~~~~  355 (358)
                       +..+|
T Consensus       194 ~g~~p~  199 (257)
T cd05116         194 YGQKPY  199 (257)
T ss_pred             CCCCCC
Confidence             55554

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-36  Score=301.13  Aligned_cols=206  Identities=25%  Similarity=0.388  Sum_probs=174.0

Q ss_pred             hhccCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEE
Q 018275           98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY  172 (358)
Q Consensus        98 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~  172 (358)
                      .....+...+....+.||+|+||+||+|...     .....||||.++...  ..+....|++|+++++.++|||||+|+
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLl  555 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLL  555 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence            3445677788899999999999999999753     244689999998774  445677899999999999999999999


Q ss_pred             EEeecCCEEEEEEeecCCCCHHHHHhhc----------C----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 018275          173 YSFQDAEYLYLIMEYLPGGDVMTLLMRE----------E----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLL  238 (358)
Q Consensus       173 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~----------~----~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NIL  238 (358)
                      |+|..++.+|+|+|||..|||..+|...          .    +++..+...++.||+.|+.||-++.+|||||...|+|
T Consensus       556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL  635 (774)
T KOG1026|consen  556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL  635 (774)
T ss_pred             EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence            9999999999999999999999999642          1    2778889999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCC
Q 018275          239 LDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT  318 (358)
Q Consensus       239 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt  318 (358)
                      +.++..|||+|||+++..-..++-....                                               ...=.
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~-----------------------------------------------~t~lP  668 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRG-----------------------------------------------NTLLP  668 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccC-----------------------------------------------Cceee
Confidence            9999999999999998664332211100                                               11234


Q ss_pred             CCCchhhhhcCCCCCccchhhhhhHHHHhhcccc
Q 018275          319 PDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       319 ~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~  352 (358)
                      -.|||||.++.+.|+++|||||+||+|||++...
T Consensus       669 IRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG  702 (774)
T KOG1026|consen  669 IRWMPPESILYGKFTTESDVWSFGVVLWEIFSYG  702 (774)
T ss_pred             eecCCHHHhhcCcccchhhhhhhhhhhhhhhccc
Confidence            5799999999999999999999999999977644

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-35  Score=272.64  Aligned_cols=198  Identities=23%  Similarity=0.377  Sum_probs=166.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEE----ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC--C
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQE----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--E  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~  179 (358)
                      ..|++++.||+|+||.||+|..    ..++..||+|.+....  .......+.+|+.+++.+.|||++++++++.+.  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            4578899999999999999974    4578899999987542  234456688999999999999999999998775  5


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..++||||++|++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            789999999999999998654 4688899999999999999999999999999999999999999999999999986542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .....                                              .......|+..|+|||++.+..++.++|+
T Consensus       162 ~~~~~----------------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di  195 (284)
T cd05079         162 DKEYY----------------------------------------------TVKDDLDSPVFWYAPECLIQSKFYIASDV  195 (284)
T ss_pred             Cccce----------------------------------------------eecCCCCCCccccCHHHhccCCCCccccc
Confidence            21100                                              00012357778999999999999999999


Q ss_pred             hhhhHHHHhhccc
Q 018275          339 LAYWNETLSCNYL  351 (358)
Q Consensus       339 wSlGvil~e~l~~  351 (358)
                      |||||++||++++
T Consensus       196 ~slG~il~ellt~  208 (284)
T cd05079         196 WSFGVTLYELLTY  208 (284)
T ss_pred             hhhhhhhhhhhcC
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-35  Score=268.67  Aligned_cols=196  Identities=23%  Similarity=0.314  Sum_probs=167.0

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ++..++|++.+.||+|+||.||+|.+. +++.||+|.++....    ....+.+|+.+++.++||||+++++++...+..
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            355678999999999999999999864 456899999876532    234578899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      |+||||+++++|.+++....  .++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99999999999999996643  6889999999999999999999999999999999999999999999999999876411


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ....                                                .....++..|+|||++.+..++.++|+|
T Consensus       157 ~~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~  188 (261)
T cd05068         157 IYEA------------------------------------------------REGAKFPIKWTAPEAALYNRFSIKSDVW  188 (261)
T ss_pred             cccc------------------------------------------------cCCCcCceeccCccccccCCCCchhhHH
Confidence            1000                                                0011234679999999999999999999


Q ss_pred             hhhHHHHhhcc
Q 018275          340 AYWNETLSCNY  350 (358)
Q Consensus       340 SlGvil~e~l~  350 (358)
                      ||||++||++.
T Consensus       189 slG~~l~el~t  199 (261)
T cd05068         189 SFGILLTEIVT  199 (261)
T ss_pred             HHHHHHHHHHh
Confidence            99999999987

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.1e-35  Score=270.49  Aligned_cols=197  Identities=25%  Similarity=0.404  Sum_probs=163.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHH-HHHhcCcceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ++|++.+.||+|+||.||+|.+..+|..||||.++.... .... ..+..|..+ ++..+||||+++++++..++..|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            479999999999999999999999999999999876532 2222 234445554 6677899999999999999999999


Q ss_pred             EeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          185 MEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      |||++ |+|.+++..    ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99996 688777753    34689999999999999999999997 9999999999999999999999999998754311


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC----CCCCcc
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK----KGYGME  335 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~----~~y~~~  335 (358)
                      ..                                                  .....|++.|+|||++.+    .+++.+
T Consensus       158 ~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~  187 (283)
T cd06617         158 VA--------------------------------------------------KTIDAGCKPYMAPERINPELNQKGYDVK  187 (283)
T ss_pred             cc--------------------------------------------------cccccCCccccChhhcCCcccccccCcc
Confidence            00                                                  002368899999999865    567899


Q ss_pred             chhhhhhHHHHhhccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~  355 (358)
                      +|+|||||++|+|+.+...|
T Consensus       188 ~Di~slG~~l~~l~~g~~p~  207 (283)
T cd06617         188 SDVWSLGITMIELATGRFPY  207 (283)
T ss_pred             ccchhhHHHHHHHHhCCCCC
Confidence            99999999999999987765

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.2e-35  Score=272.64  Aligned_cols=201  Identities=23%  Similarity=0.322  Sum_probs=168.2

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ...+|...+.||+|+||.||++...     .++..+|+|.+...   .......+.+|+.+++.++|+||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            3467888999999999999999643     35668999988754   234456788999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE---------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG  243 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  243 (358)
                      ...++||||+++++|.+++....               .+++..+..++.|++.||.|||+.|++||||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999986543               378888999999999999999999999999999999999999


Q ss_pred             cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCch
Q 018275          244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA  323 (358)
Q Consensus       244 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~A  323 (358)
                      .+||+|||+++........                                               .......+++.|+|
T Consensus       160 ~~kL~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~a  192 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYY-----------------------------------------------RVGGRTMLPIRWMP  192 (280)
T ss_pred             CEEECCCCceeEcCCCcee-----------------------------------------------ecCCCccccccccC
Confidence            9999999998755321100                                               00012346788999


Q ss_pred             hhhhcCCCCCccchhhhhhHHHHhhcc-cccc
Q 018275          324 PEVLLKKGYGMECDWLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       324 PEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~  354 (358)
                      ||++.+..++.++|+|||||++||+++ +...
T Consensus       193 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p  224 (280)
T cd05092         193 PESILYRKFTTESDIWSFGVVLWEIFTYGKQP  224 (280)
T ss_pred             HHHhccCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999986 5443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.1e-35  Score=267.01  Aligned_cols=203  Identities=28%  Similarity=0.485  Sum_probs=175.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||.|+||+||+|.+..++..+|+|++.....  ......+.+|+.+++.++|+|++++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            479999999999999999999888999999999876542  225667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          186 EYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       186 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      |++++++|.+++...   ..+++..+..++.|++.||.|||+.||+|+||+|+||++++++.++|+|||++..+......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   45899999999999999999999999999999999999999999999999998766432111


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAY  341 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSl  341 (358)
                      .                                             .......+|++.|+|||++... .++.++|+|||
T Consensus       159 ~---------------------------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~sl  193 (267)
T cd06610         159 T---------------------------------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF  193 (267)
T ss_pred             c---------------------------------------------ccccccccCChhhcChHHHccccCcCcccchHhH
Confidence            0                                             0011234799999999999877 88999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|+|+.+...|
T Consensus       194 G~i~~~l~~g~~p~  207 (267)
T cd06610         194 GITAIELATGAAPY  207 (267)
T ss_pred             hHHHHHHHhCCCCc
Confidence            99999999987654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.4e-35  Score=268.32  Aligned_cols=202  Identities=27%  Similarity=0.426  Sum_probs=171.8

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh-------chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-------SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      +|.+.+.||.|+||.||+|.+..++..||+|.++.....       .....+.+..|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477889999999999999999889999999988643211       1123456788999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ..++||||+++++|.+++.....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988788999999999999999999999999999999999999999999999999998754311


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC--CCccch
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--YGMECD  337 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~--y~~~~D  337 (358)
                      ...                                               .......|+..|+|||++.+..  ++.++|
T Consensus       162 ~~~-----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~D  194 (272)
T cd06629         162 YDN-----------------------------------------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVD  194 (272)
T ss_pred             ccc-----------------------------------------------cccccccCCccccCHHHhccccCCCCccch
Confidence            100                                               0011235889999999998755  899999


Q ss_pred             hhhhhHHHHhhccccccc
Q 018275          338 WLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~  355 (358)
                      +||||+++|+++.+...|
T Consensus       195 v~slG~~l~~l~~g~~p~  212 (272)
T cd06629         195 IWSLGCVVLEMFAGRRPW  212 (272)
T ss_pred             hHHHHHHHHHHHhCCCCC
Confidence            999999999999987655

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.8e-35  Score=269.36  Aligned_cols=195  Identities=24%  Similarity=0.372  Sum_probs=164.3

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|.+.++||+|+||.||+|.+..+ ..||+|.+.....    ....+.+|+.+++.++||||+++++.+.. ...+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   76 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence            4557899999999999999999987655 4699999976432    22457889999999999999999998754 5689


Q ss_pred             EEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||+++.+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999999999753  457888999999999999999999999999999999999999999999999997654221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ...                                                .....++..|+|||+..+..++.++|+||
T Consensus       157 ~~~------------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dvws  188 (262)
T cd05071         157 YTA------------------------------------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWS  188 (262)
T ss_pred             ccc------------------------------------------------ccCCcccceecCHhHhccCCCCchhhHHH
Confidence            000                                                01234678899999999999999999999


Q ss_pred             hhHHHHhhccc
Q 018275          341 YWNETLSCNYL  351 (358)
Q Consensus       341 lGvil~e~l~~  351 (358)
                      |||++||++++
T Consensus       189 lG~~l~ellt~  199 (262)
T cd05071         189 FGILLTELTTK  199 (262)
T ss_pred             HHHHHHHHHcC
Confidence            99999999983

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-35  Score=274.06  Aligned_cols=198  Identities=24%  Similarity=0.332  Sum_probs=164.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCC--EEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~  182 (358)
                      ++|++.+.||+|+||.||+|....++.  .+++|.++...  .......+.+|+.++.++ +||||+++++++.+...+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999998877664  46888876421  233445688899999999 7999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEE
Q 018275          183 LIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK  246 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vk  246 (358)
                      +||||+++++|.+++....                .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999996532                477888999999999999999999999999999999999999999


Q ss_pred             EEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhh
Q 018275          247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV  326 (358)
Q Consensus       247 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv  326 (358)
                      |+|||++........                                                  ......+..|+|||+
T Consensus       160 l~dfg~~~~~~~~~~--------------------------------------------------~~~~~~~~~y~aPE~  189 (297)
T cd05089         160 IADFGLSRGEEVYVK--------------------------------------------------KTMGRLPVRWMAIES  189 (297)
T ss_pred             ECCcCCCccccceec--------------------------------------------------cCCCCcCccccCchh
Confidence            999999863221000                                                  001123557999999


Q ss_pred             hcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          327 LLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       327 ~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      +.+..++.++|||||||++|||+. +...|
T Consensus       190 ~~~~~~~~~~DvwSlG~il~el~t~g~~pf  219 (297)
T cd05089         190 LNYSVYTTKSDVWSFGVLLWEIVSLGGTPY  219 (297)
T ss_pred             hccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999985 54443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=268.56  Aligned_cols=194  Identities=28%  Similarity=0.422  Sum_probs=167.2

Q ss_pred             CCCceee-eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEee----cC
Q 018275          105 VDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ----DA  178 (358)
Q Consensus       105 ~~~~~~~-~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~----~~  178 (358)
                      +++|.+. .+||-|-.|.|-.|.++.+|+.+|+|++....        ..++|+++.-.. .|||||.++++|.    ..
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            4677764 68999999999999999999999999987542        267788876544 6999999998875    45


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---CCcEEEEecCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLC  253 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~vkl~DFGla  253 (358)
                      .++.+|||.|+||.|.+.+..++  .+++..+..++.||+.|+.|||+.+|.||||||+|+|...   |..+||+|||+|
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence            68899999999999999998765  5999999999999999999999999999999999999964   567999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +.-....                                                  ...+.|-||.|.||||+....|+
T Consensus       212 K~t~~~~--------------------------------------------------~L~TPc~TPyYvaPevlg~eKyd  241 (400)
T KOG0604|consen  212 KETQEPG--------------------------------------------------DLMTPCFTPYYVAPEVLGPEKYD  241 (400)
T ss_pred             cccCCCc--------------------------------------------------cccCCcccccccCHHHhCchhcC
Confidence            8654211                                                  11256899999999999999999


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .+||+||+||+||-+|.|...|-
T Consensus       242 kscdmwSlgVimYIlLCGyPPFY  264 (400)
T KOG0604|consen  242 KSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_pred             CCCCccchhHHHHHhhcCCCccc
Confidence            99999999999999999987773

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.3e-35  Score=265.53  Aligned_cols=199  Identities=29%  Similarity=0.482  Sum_probs=177.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||.|++|.||+|.+..+++.|++|++.....  ......+..|+.++..++|+|++++++.+...+..++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            478999999999999999999999999999999876542  144566889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||+++++|.+++....++++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........  
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--  156 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--  156 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence            999999999999888889999999999999999999999 99999999999999999999999999998765422110  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                     .....|+..|+|||++.+..++.++|+||||++
T Consensus       157 -----------------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~i  189 (264)
T cd06623         157 -----------------------------------------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLT  189 (264)
T ss_pred             -----------------------------------------------ccceeecccccCHhhhCCCCCCchhhHHHHHHH
Confidence                                                           012368899999999999999999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|+|+++..+|
T Consensus       190 l~~l~tg~~p~  200 (264)
T cd06623         190 LLECALGKFPF  200 (264)
T ss_pred             HHHHHhCCCCC
Confidence            99999987665

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-36  Score=283.48  Aligned_cols=202  Identities=28%  Similarity=0.443  Sum_probs=168.5

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~  181 (358)
                      +....|++++.||+||.+.||++.... .+.+|+|.+.... .....+..+++|+.+|.+++ |.+||+|+++-..+.++
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            344679999999999999999987543 4567777765543 25667788999999999995 78999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      |+||||= ..||..+|..... .+.+.++++..|++.|++++|.+||||.||||.|+|+ -.|.+||+|||+|..+....
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence            9999976 5699999987754 4457899999999999999999999999999999999 57899999999999876443


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC---------
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG---------  331 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~---------  331 (358)
                      .+.+                                               ..+.|||+.|||||.+....         
T Consensus       514 TsI~-----------------------------------------------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k  546 (677)
T KOG0596|consen  514 TSIV-----------------------------------------------KDSQVGTVNYMSPEALTDMSSSRENGKSK  546 (677)
T ss_pred             ccee-----------------------------------------------eccccCcccccCHHHHhhccccccCCCcc
Confidence            3322                                               12569999999999998544         


Q ss_pred             --CCccchhhhhhHHHHhhccccccc
Q 018275          332 --YGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       332 --y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                        .+.++||||||||||+|+|+.-.|
T Consensus       547 ~Ki~r~SDvWSLGCILYqMvYgktPf  572 (677)
T KOG0596|consen  547 IKISRKSDVWSLGCILYQMVYGKTPF  572 (677)
T ss_pred             eeecCccchhhhhhHHHHHHhcCCch
Confidence              347899999999999999987665

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.8e-35  Score=265.85  Aligned_cols=199  Identities=30%  Similarity=0.515  Sum_probs=173.8

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh--hchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      +|+..+.||+|+||.||+|.+..++..|++|.+.....  ........+.+|+.+++.++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            46777899999999999999988999999999875431  1234556788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++........   
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~---  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc---
Confidence            99999999999998877889999999999999999999999999999999999999999999999999876532110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC-CCccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~-y~~~~DiwSlGv  343 (358)
                                                                     .....|++.|+|||.+.... ++.++|+|||||
T Consensus       158 -----------------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~  190 (258)
T cd06632         158 -----------------------------------------------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC  190 (258)
T ss_pred             -----------------------------------------------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHH
Confidence                                                           01236899999999998777 999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|+++.+..+|
T Consensus       191 ~l~~l~~g~~pf  202 (258)
T cd06632         191 TVLEMATGKPPW  202 (258)
T ss_pred             HHHHHHhCCCCc
Confidence            999999987765

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.4e-35  Score=270.12  Aligned_cols=198  Identities=29%  Similarity=0.482  Sum_probs=172.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ..|+.++.||.|+||.||+|.+..++..||+|++....  .......+.+|+.+++.+.||||+++++.+.+....|+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45778899999999999999999899999999987543  2344567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|.+++. .+++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........   
T Consensus        82 e~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---  157 (277)
T cd06640          82 EYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---  157 (277)
T ss_pred             ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc---
Confidence            9999999999885 457889999999999999999999999999999999999999999999999998765321100   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                    .....++..|+|||++.+..++.++|+|||||++
T Consensus       158 ----------------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il  191 (277)
T cd06640         158 ----------------------------------------------RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITA  191 (277)
T ss_pred             ----------------------------------------------cccccCcccccCHhHhccCCCccHHHHHHHHHHH
Confidence                                                          0123688899999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |||+++...|
T Consensus       192 ~el~tg~~p~  201 (277)
T cd06640         192 IELAKGEPPN  201 (277)
T ss_pred             HHHHHCCCCC
Confidence            9999877554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-35  Score=274.79  Aligned_cols=202  Identities=26%  Similarity=0.374  Sum_probs=168.2

Q ss_pred             CceeeeeEeeeeeEEEEEEEEec--CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC--CEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYLY  182 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~  182 (358)
                      .|.+.+.||+|+||.||+|.+..  ++..||+|.+.............+.+|+.+++.++||||+++++++.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48899999999999999999988  8999999999874322233445577899999999999999999999988  8899


Q ss_pred             EEEeecCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC----CCcEEEEecCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE-----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ----NGHMKLSDFGLC  253 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~----~~~vkl~DFGla  253 (358)
                      +||||+++ +|.+++...     ..+++..+..++.|++.||.|||+.+|+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999964 677766422     36889999999999999999999999999999999999999    999999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGY  332 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y  332 (358)
                      ..+........                                              .....++|+.|+|||++.+ ..+
T Consensus       160 ~~~~~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~  193 (316)
T cd07842         160 RLFNAPLKPLA----------------------------------------------DLDPVVVTIWYRAPELLLGARHY  193 (316)
T ss_pred             cccCCCccccc----------------------------------------------ccCCccccccccCHHHHhCCCCC
Confidence            86643211100                                              0113468999999999876 468


Q ss_pred             CccchhhhhhHHHHhhccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +.++|+|||||++|+++++..+|
T Consensus       194 ~~~~Dv~slG~~l~~l~~~~~~~  216 (316)
T cd07842         194 TKAIDIWAIGCIFAELLTLEPIF  216 (316)
T ss_pred             CcHHHHHHHHHHHHHHHhcCCCC
Confidence            99999999999999999887665

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-34  Score=266.06  Aligned_cols=201  Identities=27%  Similarity=0.420  Sum_probs=169.6

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..+++.....||+|+||.||+|.+..++..||+|.+....   ......+.+|+.+++.++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            44566777789999999999999999899999999887542   234556889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-CCcEEEEecCCCccCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE-ETL--TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~-~~~--~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~vkl~DFGla~~~~~  258 (358)
                      +|+||+++++|.+++... .++  ++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            999999999999999764 455  78888889999999999999999999999999999986 67999999999875532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC--CCCccc
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK--GYGMEC  336 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~--~y~~~~  336 (358)
                      ....                                                 .....|++.|+|||++.+.  .++.++
T Consensus       162 ~~~~-------------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~  192 (268)
T cd06624         162 INPC-------------------------------------------------TETFTGTLQYMAPEVIDKGPRGYGAPA  192 (268)
T ss_pred             CCCc-------------------------------------------------cccCCCCccccChhhhccccccCCchh
Confidence            1100                                                 0122589999999999764  388999


Q ss_pred             hhhhhhHHHHhhccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~  355 (358)
                      |+|||||++|+++.+...|
T Consensus       193 Dv~slGvvl~~l~~g~~p~  211 (268)
T cd06624         193 DIWSLGCTIVEMATGKPPF  211 (268)
T ss_pred             hhHHHHHHHHHHHhCCCCC
Confidence            9999999999999876554

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.2e-35  Score=268.85  Aligned_cols=200  Identities=20%  Similarity=0.272  Sum_probs=162.9

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCC--EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC------C
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------E  179 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------~  179 (358)
                      |.+.+.||+|+||.||+|.+..++.  .||+|.++... ........+..|..+++.++||||+++++.+...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3567899999999999999877765  68999887643 2345567788899999999999999999977422      2


Q ss_pred             EEEEEEeecCCCCHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMR------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      ..++||||+++|+|.+++..      ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            47899999999999988742      234788999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +.+.......                                               ......+++.|+|||++.+..++
T Consensus       160 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~  192 (272)
T cd05075         160 KKIYNGDYYR-----------------------------------------------QGRIAKMPVKWIAIESLADRVYT  192 (272)
T ss_pred             cccCccccee-----------------------------------------------cCCcccCCcccCCHHHccCCCcC
Confidence            8654211000                                               00022467789999999999999


Q ss_pred             ccchhhhhhHHHHhhcc-ccccc
Q 018275          334 MECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      .++|||||||++|||++ +...|
T Consensus       193 ~~~Di~slG~il~el~~~g~~p~  215 (272)
T cd05075         193 TKSDVWSFGVTMWEIATRGQTPY  215 (272)
T ss_pred             hHHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999988 44443

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-35  Score=270.26  Aligned_cols=200  Identities=25%  Similarity=0.361  Sum_probs=164.5

Q ss_pred             CCc-eeeeeEeeeeeEEEEEEE----EecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--C
Q 018275          106 DDF-DLLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--A  178 (358)
Q Consensus       106 ~~~-~~~~~IG~G~fG~Vy~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~  178 (358)
                      ++| ++++.||+|+||+||++.    ...++..||+|.++...  .......+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            344 889999999999998765    34578899999987642  22344567889999999999999999998865  3


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||+++....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            468999999999999999865 4689999999999999999999999999999999999999999999999999876542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .....                                              .......+++.|+|||++.+..++.++||
T Consensus       160 ~~~~~----------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di  193 (283)
T cd05080         160 GHEYY----------------------------------------------RVREDGDSPVFWYAVECLKENKFSYASDV  193 (283)
T ss_pred             cchhh----------------------------------------------ccCCCCCCCceeeCHhHhcccCCCccccc
Confidence            11000                                              00001235677999999999999999999


Q ss_pred             hhhhHHHHhhcccccc
Q 018275          339 LAYWNETLSCNYLSDI  354 (358)
Q Consensus       339 wSlGvil~e~l~~~~~  354 (358)
                      |||||++|||+++...
T Consensus       194 ~slG~~l~el~tg~~p  209 (283)
T cd05080         194 WSFGVTLYELLTHCDS  209 (283)
T ss_pred             HHHHHHHHHHHhCCCC
Confidence            9999999999987644

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.5e-35  Score=267.08  Aligned_cols=193  Identities=21%  Similarity=0.347  Sum_probs=164.2

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||+|+||.||+|.+.. +..||+|.+.....    ....+.+|+.++..++||||+++++++.+....++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            4679999999999999999997654 45699999875432    234578899999999999999999999988899999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999998764 468999999999999999999999999999999999999999999999999987553211000


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      .....++..|+|||++.+..++.++|+|||||
T Consensus       158 ------------------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~  189 (256)
T cd05113         158 ------------------------------------------------SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGV  189 (256)
T ss_pred             ------------------------------------------------cCCCccChhhCCHHHHhcCcccchhHHHHHHH
Confidence                                                            00123667899999999989999999999999


Q ss_pred             HHHhhcc
Q 018275          344 ETLSCNY  350 (358)
Q Consensus       344 il~e~l~  350 (358)
                      ++|++++
T Consensus       190 ~l~~l~~  196 (256)
T cd05113         190 LMWEVYS  196 (256)
T ss_pred             HHHHHhc
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-35  Score=265.46  Aligned_cols=191  Identities=24%  Similarity=0.342  Sum_probs=167.3

Q ss_pred             eeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeec
Q 018275          112 TIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL  188 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~  188 (358)
                      +.||+|+||.||+|.+...   +..||+|.+.....  ......+..|+.++..++|+|++++++++.+....++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4699999999999998866   88999999987643  224677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          189 PGGDVMTLLMRE---------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       189 ~~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ++++|.+++...         ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         78999999999999999999999999999999999999999999999999999876532


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ...                                               .......+++.|+|||++.+..++.++|+|
T Consensus       159 ~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  191 (262)
T cd00192         159 DYY-----------------------------------------------RKKTGGKLPIRWMAPESLKDGIFTSKSDVW  191 (262)
T ss_pred             ccc-----------------------------------------------ccccCCCcCccccCHHHhccCCcchhhccH
Confidence            210                                               001133688999999999998999999999


Q ss_pred             hhhHHHHhhccc
Q 018275          340 AYWNETLSCNYL  351 (358)
Q Consensus       340 SlGvil~e~l~~  351 (358)
                      ||||++|||+.+
T Consensus       192 slG~il~~l~~~  203 (262)
T cd00192         192 SFGVLLWEIFTL  203 (262)
T ss_pred             HHHHHHHHHHhc
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.5e-35  Score=280.57  Aligned_cols=204  Identities=22%  Similarity=0.287  Sum_probs=164.9

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEE-----ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEe
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQE-----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF  175 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~  175 (358)
                      .++.++|.+.+.||+|+||.||+|.+     ..+++.||||+++...  .......+.+|+.++..+ +||||+++++++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            34567899999999999999999974     3467899999997543  233455688899999999 689999999988


Q ss_pred             ec-CCEEEEEEeecCCCCHHHHHhhc------------------------------------------------------
Q 018275          176 QD-AEYLYLIMEYLPGGDVMTLLMRE------------------------------------------------------  200 (358)
Q Consensus       176 ~~-~~~~~lV~E~~~~g~L~~~l~~~------------------------------------------------------  200 (358)
                      .. ...+++||||+++|+|.+++...                                                      
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            64 45689999999999999998542                                                      


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccc
Q 018275          201 -------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN  267 (358)
Q Consensus       201 -------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  267 (358)
                                   ..++...+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..........    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~----  236 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----  236 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh----
Confidence                         125666778889999999999999999999999999999999999999999987653111000    


Q ss_pred             cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHh
Q 018275          268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLS  347 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e  347 (358)
                                                                 ......+++.|+|||++.+..|+.++|+|||||++|+
T Consensus       237 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e  273 (343)
T cd05103         237 -------------------------------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE  273 (343)
T ss_pred             -------------------------------------------hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHH
Confidence                                                       0001246678999999999999999999999999999


Q ss_pred             hcc-cccc
Q 018275          348 CNY-LSDI  354 (358)
Q Consensus       348 ~l~-~~~~  354 (358)
                      |+. +...
T Consensus       274 l~~~g~~p  281 (343)
T cd05103         274 IFSLGASP  281 (343)
T ss_pred             HHHCCCCC
Confidence            985 4443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5e-35  Score=279.48  Aligned_cols=198  Identities=25%  Similarity=0.351  Sum_probs=168.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC------
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------  178 (358)
                      .++|++.+.||+|+||.||+|.+..++..||||.+..... .......+.+|+.+++.++||||++++++|...      
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4789999999999999999999999999999999865421 233445577899999999999999999988644      


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ...|+||||++ ++|.+.+...  ++...+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            35799999995 5888877544  88889999999999999999999999999999999999999999999999976532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ...                                                  .....||+.|+|||++.+..++.++|+
T Consensus       171 ~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv  200 (353)
T cd07850         171 SFM--------------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDI  200 (353)
T ss_pred             CCC--------------------------------------------------CCCCcccccccCHHHHhCCCCCCchhh
Confidence            110                                                  012368999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||++|+|+++..+|.
T Consensus       201 wslG~~l~~l~~g~~pf~  218 (353)
T cd07850         201 WSVGCIMGEMIRGTVLFP  218 (353)
T ss_pred             HhHHHHHHHHHHCCCCCC
Confidence            999999999999887664

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-35  Score=268.81  Aligned_cols=202  Identities=21%  Similarity=0.284  Sum_probs=169.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCC----EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ...+|++.+.||+|+||.||+|.++.+|.    .||+|.+....  .......+.+|+.+++.++||||+++++++.. .
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            45789999999999999999999876665    58999887653  24455668889999999999999999999987 7


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            889999999999999999764 5689999999999999999999999999999999999999999999999999986642


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ......                                               .....+++.|+|||.+.+..++.++|+
T Consensus       162 ~~~~~~-----------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di  194 (279)
T cd05057         162 DEKEYH-----------------------------------------------AEGGKVPIKWMALESILHRIYTHKSDV  194 (279)
T ss_pred             ccccee-----------------------------------------------cCCCcccccccCHHHhhcCCcCchhhH
Confidence            211000                                               001124678999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      |||||++||++. +..+|
T Consensus       195 ~slG~~l~el~~~g~~p~  212 (279)
T cd05057         195 WSYGVTVWELMTFGAKPY  212 (279)
T ss_pred             HHHHHHHHHHhcCCCCCC
Confidence            999999999886 55544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.2e-35  Score=272.84  Aligned_cols=199  Identities=27%  Similarity=0.387  Sum_probs=170.5

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      .....|.+.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||++++++|.+.+..|
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            34467999999999999999999998899999999987554334445567889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      +||||++ |++.+++.. ..++++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++....... 
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-  169 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-  169 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence            9999996 577776653 4678999999999999999999999999999999999999999999999999886542110 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCccchh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDW  338 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~~~Di  338 (358)
                                                                          ...|++.|+|||++.   ...++.++|+
T Consensus       170 ----------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~sDv  197 (307)
T cd06607         170 ----------------------------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDV  197 (307)
T ss_pred             ----------------------------------------------------CccCCccccCceeeeccCCCCCCcccch
Confidence                                                                235888999999985   4568899999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      ||||+++||++++...|
T Consensus       198 ~s~G~il~el~tg~~p~  214 (307)
T cd06607         198 WSLGITCIELAERKPPL  214 (307)
T ss_pred             HHHHHHHHHHHcCCCCC
Confidence            99999999999887554

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.3e-35  Score=270.23  Aligned_cols=201  Identities=38%  Similarity=0.634  Sum_probs=171.4

Q ss_pred             CceeeeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhh-chhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEML-SRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~  181 (358)
                      +|++.+.||.|+||.||+|.+.   .+|..||+|+++..... .....+.+..|+.++..+ +|++|+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999874   47899999999765432 223345678899999999 589999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||+++++|.+++....++++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++........
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999876532110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCccchhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWL  339 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~~Diw  339 (358)
                      .                                                ......|++.|+|||++.+  ..++.++|+|
T Consensus       161 ~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~  192 (290)
T cd05613         161 E------------------------------------------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWW  192 (290)
T ss_pred             c------------------------------------------------ccccccCCcccCChhhccCCCCCCCccccHH
Confidence            0                                                0113468999999999975  3578899999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      |||+++|+++++...|
T Consensus       193 slG~~l~~ll~g~~p~  208 (290)
T cd05613         193 SMGVLMYELLTGASPF  208 (290)
T ss_pred             HHHHHHHHHhcCCCCC
Confidence            9999999999987655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.9e-35  Score=265.16  Aligned_cols=203  Identities=30%  Similarity=0.437  Sum_probs=176.9

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||+|+||.||+|.+..++..||+|.++.... .......+.+|+.+++.++|+||+++++.+.+.+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            58889999999999999999988999999999886643 24567789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      |+++++|.+++.....+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.+||+|||++............ 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~-  158 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE-  158 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc-
Confidence            9999999999988777889999999999999999999999999999999999999999999999998876432211100 


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC---CCccchhhhhhH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG---YGMECDWLAYWN  343 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~---y~~~~DiwSlGv  343 (358)
                                                                  ......+++.|+|||++.+..   ++.++|+||||+
T Consensus       159 --------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~  194 (264)
T cd06626         159 --------------------------------------------EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC  194 (264)
T ss_pred             --------------------------------------------cccCCcCCcCccChhhccCCCCCCCCcccchHHHHH
Confidence                                                        011236889999999998776   899999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|+++.+...|
T Consensus       195 il~~l~~g~~pf  206 (264)
T cd06626         195 VVLEMATGKRPW  206 (264)
T ss_pred             HHHHHHhCCCCc
Confidence            999999987665

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-35  Score=269.41  Aligned_cols=198  Identities=20%  Similarity=0.241  Sum_probs=169.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ..+|++.+.||.|+||.||+|.+.. +..+|+|++....   ......+..|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            4678999999999999999999877 8899999987653   22344588899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          185 MEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      |||+++++|.+++...  ..++...+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999999753  46888899999999999999999999999999999999999999999999998765311100


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ..+..+++.|+|||++.+..++.++|+||||
T Consensus       161 -------------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG  191 (261)
T cd05148         161 -------------------------------------------------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFG  191 (261)
T ss_pred             -------------------------------------------------ccCCCCceEecCHHHHccCCCCchhhHHHHH
Confidence                                                             0022467789999999999999999999999


Q ss_pred             HHHHhhcc-ccccc
Q 018275          343 NETLSCNY-LSDIM  355 (358)
Q Consensus       343 vil~e~l~-~~~~~  355 (358)
                      |++|+|+. +..+|
T Consensus       192 ~~l~~l~~~g~~p~  205 (261)
T cd05148         192 ILLYEMFTYGQVPY  205 (261)
T ss_pred             HHHHHHHcCCCCCC
Confidence            99999987 44333

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.3e-35  Score=268.13  Aligned_cols=190  Identities=18%  Similarity=0.204  Sum_probs=153.7

Q ss_pred             eEeeeeeEEEEEEEEec--CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          113 IIGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      .||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.++||||+++++.+.+....|+||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            58999999999996533  34578888876442  233345678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          191 GDVMTLLMREE-----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       191 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      |+|.+++....     ..++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..........  
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~--  157 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI--  157 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee--
Confidence            99999996643     24567788899999999999999999999999999999999999999999986532111000  


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-------CCCCccchh
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-------KGYGMECDW  338 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-------~~y~~~~Di  338 (358)
                                                                   ......+++.|+|||++..       ..++.++||
T Consensus       158 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Di  192 (269)
T cd05042         158 ---------------------------------------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNI  192 (269)
T ss_pred             ---------------------------------------------ccCCCCCcccccCHHHHhhccccccccccchhhHH
Confidence                                                         0012356788999999753       457889999


Q ss_pred             hhhhHHHHhhccc
Q 018275          339 LAYWNETLSCNYL  351 (358)
Q Consensus       339 wSlGvil~e~l~~  351 (358)
                      |||||++|||+.+
T Consensus       193 wslG~~l~el~~~  205 (269)
T cd05042         193 WSLGVTMWELFTA  205 (269)
T ss_pred             HHHHHHHHHHHhC
Confidence            9999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-35  Score=273.09  Aligned_cols=198  Identities=30%  Similarity=0.499  Sum_probs=171.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.+++.++||||+++++.|.+....|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            34677788999999999999998899999999987543  2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|.+++. .+.+++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+......   
T Consensus        82 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---  157 (277)
T cd06642          82 EYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---  157 (277)
T ss_pred             EccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh---
Confidence            9999999999885 457889999999999999999999999999999999999999999999999998765321100   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                    .....|+..|+|||++.+..++.++|+|||||++
T Consensus       158 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il  191 (277)
T cd06642         158 ----------------------------------------------RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITA  191 (277)
T ss_pred             ----------------------------------------------hhcccCcccccCHHHhCcCCCchhhhHHHHHHHH
Confidence                                                          0123588999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |||+++..++
T Consensus       192 ~el~tg~~p~  201 (277)
T cd06642         192 IELAKGEPPN  201 (277)
T ss_pred             HHHHhCCCCC
Confidence            9999876553

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-34  Score=263.46  Aligned_cols=199  Identities=30%  Similarity=0.515  Sum_probs=173.4

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            58899999999999999999999999999999876533 23344568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       187 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |+++++|.+.+...  ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........   
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~---  156 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---  156 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence            99999999998654  3578889999999999999999999999999999999999999999999999876532110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                    ......|++.|+|||++.+..++.++|+|||||+
T Consensus       157 ----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i  190 (256)
T cd08218         157 ----------------------------------------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCV  190 (256)
T ss_pred             ----------------------------------------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHH
Confidence                                                          0012368999999999999999999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|+++.+..+|
T Consensus       191 ~~~l~~g~~~~  201 (256)
T cd08218         191 LYEMCTLKHAF  201 (256)
T ss_pred             HHHHHcCCCCc
Confidence            99999987765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.3e-35  Score=269.47  Aligned_cols=199  Identities=28%  Similarity=0.402  Sum_probs=171.8

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            58899999999999999999998999999999876542 23345668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          187 YLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       187 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      |+ +++|.+++.. ..++++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.........   
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~---  155 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR---  155 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC---
Confidence            99 9999999865 467899999999999999999999999999999999999999999999999998766422110   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGvi  344 (358)
                                                                   ......|++.|+|||++.+. .++.++||||+||+
T Consensus       156 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~  190 (286)
T cd07832         156 ---------------------------------------------LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCI  190 (286)
T ss_pred             ---------------------------------------------ccccccCcccccCceeeeccccCCchhHHHHHHHH
Confidence                                                         01123689999999998754 47899999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +||++++..+|
T Consensus       191 l~~l~tg~~~~  201 (286)
T cd07832         191 FAELLNGSPLF  201 (286)
T ss_pred             HHHHHcCCcCc
Confidence            99999986554

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-36  Score=258.16  Aligned_cols=212  Identities=23%  Similarity=0.326  Sum_probs=178.6

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC---
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE---  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~---  179 (358)
                      +..++|.+.+.+|+|||+.||++.+..++..+|+|++...   ...+.+..++|++..++++|||+++++++.....   
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            4568899999999999999999999999999999999866   3567788999999999999999999987775433   


Q ss_pred             --EEEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEcCCCcEEEEecC
Q 018275          180 --YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGHMKLSDFG  251 (358)
Q Consensus       180 --~~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~vkl~DFG  251 (358)
                        ..||+++|...|+|.+.+..    +..+++.....++.+++.||.+||...  +.||||||.|||+...+.++|.|||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence              48999999999999999854    347999999999999999999999987  9999999999999999999999999


Q ss_pred             CCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---
Q 018275          252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---  328 (358)
Q Consensus       252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---  328 (358)
                      .++.....-..                                ....-.+..|...        --|-.|+|||.|.   
T Consensus       175 S~~~a~i~i~~--------------------------------~~~a~~lQe~a~e--------~Ct~pyRAPELf~vk~  214 (302)
T KOG2345|consen  175 SATQAPIQIEG--------------------------------SRQALRLQEWAEE--------RCTIPYRAPELFNVKS  214 (302)
T ss_pred             CccccceEeec--------------------------------hHHHHHHHHHHHH--------hCCCcccCchheeccc
Confidence            98765422111                                1123344455433        2577899999997   


Q ss_pred             CCCCCccchhhhhhHHHHhhccccccccc
Q 018275          329 KKGYGMECDWLAYWNETLSCNYLSDIMLY  357 (358)
Q Consensus       329 ~~~y~~~~DiwSlGvil~e~l~~~~~~~~  357 (358)
                      +...+.++|||||||+||.|+|+..+|.+
T Consensus       215 ~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  215 HCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             CcccccccchhhhhHHHHHHHHcCCcchH
Confidence            44567999999999999999999999875

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.3e-35  Score=267.64  Aligned_cols=189  Identities=30%  Similarity=0.479  Sum_probs=161.8

Q ss_pred             CCceeeeeE--eeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHH-hcCcceEEEEEEeecCCEEE
Q 018275          106 DDFDLLTII--GRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE-VASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       106 ~~~~~~~~I--G~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~-l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ++|.+.+.+  |.|+||.||++.++.++..+|+|.+.......        .|..+... .+||||+++++.|...+..|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            456666665  99999999999999999999999987653211        12222222 27999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-cEEEEecCCCccCCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~vkl~DFGla~~~~~~~~  261 (358)
                      +||||+++++|.+++....++++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....... 
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-  164 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-  164 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence            9999999999999998877999999999999999999999999999999999999999998 99999999987543110 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                          ...|++.|+|||++.+..++.++|+|||
T Consensus       165 ----------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  192 (267)
T PHA03390        165 ----------------------------------------------------CYDGTLDYFSPEKIKGHNYDVSFDWWAV  192 (267)
T ss_pred             ----------------------------------------------------cCCCCCcccChhhhcCCCCCchhhHHHH
Confidence                                                                1258899999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|+|+++..+|
T Consensus       193 G~il~~l~~g~~p~  206 (267)
T PHA03390        193 GVLTYELLTGKHPF  206 (267)
T ss_pred             HHHHHHHHHCCCCC
Confidence            99999999988665

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-35  Score=268.04  Aligned_cols=197  Identities=31%  Similarity=0.481  Sum_probs=170.4

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc---CcceEEEEEEeecCCEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~~~~~l  183 (358)
                      .|++.+.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.+++.+.   |||+++++++|.+....|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            5788899999999999999999999999999987542  2344556788999999987   9999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||||+++++|.+++.. .++++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+...... 
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-  157 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-  157 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence            9999999999998854 57899999999999999999999999999999999999999999999999998766422100 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                      .....|++.|+|||.+.+ ..++.++|+||||
T Consensus       158 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  189 (277)
T cd06917         158 ------------------------------------------------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLG  189 (277)
T ss_pred             ------------------------------------------------cccccCCcceeCHHHhccCCccccchhHHHHH
Confidence                                                            012368999999999875 4578999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|+++++..+|
T Consensus       190 ~~l~~ll~g~~p~  202 (277)
T cd06917         190 ITIYEMATGNPPY  202 (277)
T ss_pred             HHHHHHHhCCCCC
Confidence            9999999987655

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-35  Score=267.99  Aligned_cols=195  Identities=34%  Similarity=0.453  Sum_probs=162.9

Q ss_pred             eeeeeEeeeeeEEEEEEEEe----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          109 DLLTIIGRGAFGEVRLCQEK----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       109 ~~~~~IG~G~fG~Vy~~~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .+.+.||.|+||.||+|.+.    ..+..|+||.+....  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence            46789999999999999987    456789999996532  344567799999999999999999999999988889999


Q ss_pred             EeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          185 MEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      |||+++|+|.+++...  ..+++.....++.|++.||.|||+.+++|+||+|+|||++.++.+||+|||++.........
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999886  68899999999999999999999999999999999999999999999999999766211110


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                      .                                               ......+...|+|||++.+..++.++||||||
T Consensus       160 ~-----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG  192 (259)
T PF07714_consen  160 K-----------------------------------------------NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFG  192 (259)
T ss_dssp             E-----------------------------------------------ESTTSESGGGGS-HHHHHHSEESHHHHHHHHH
T ss_pred             c-----------------------------------------------cccccccccccccccccccccccccccccccc
Confidence            0                                               01123467789999999999999999999999


Q ss_pred             HHHHhhcccc
Q 018275          343 NETLSCNYLS  352 (358)
Q Consensus       343 vil~e~l~~~  352 (358)
                      +++||++++.
T Consensus       193 ~~l~ei~~~~  202 (259)
T PF07714_consen  193 MLLYEILTLG  202 (259)
T ss_dssp             HHHHHHHTTS
T ss_pred             cccccccccc
Confidence            9999999954

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.7e-35  Score=267.59  Aligned_cols=195  Identities=21%  Similarity=0.209  Sum_probs=157.2

Q ss_pred             eeEeeeeeEEEEEEEEe--cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecC
Q 018275          112 TIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      +.||+|+||.||+|...  .++..+|+|.++...  .......+.+|+.+++.++||||+++++.+.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            36899999999999754  345679999887653  22333467889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          190 GGDVMTLLMREE-----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       190 ~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      +|+|.+++....     ..+...+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||+++......... 
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~-  157 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV-  157 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee-
Confidence            999999986432     35566777889999999999999999999999999999999999999999986432111000 


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-------CCCccch
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-------GYGMECD  337 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-------~y~~~~D  337 (358)
                                                                    ......|++.|+|||++.+.       .++.++|
T Consensus       158 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D  191 (269)
T cd05087         158 ----------------------------------------------TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN  191 (269)
T ss_pred             ----------------------------------------------cCCCcCCcccccCHhHhccccccccccCCCccch
Confidence                                                          00123578899999998643       3678999


Q ss_pred             hhhhhHHHHhhcc-ccccc
Q 018275          338 WLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~~  355 (358)
                      +|||||++|||+. +...|
T Consensus       192 iwslG~~l~el~~~g~~p~  210 (269)
T cd05087         192 VWSLGVTIWELFELGSQPY  210 (269)
T ss_pred             hHHHHHHHHHHHhCCCCCC
Confidence            9999999999985 66554

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-34  Score=264.92  Aligned_cols=193  Identities=23%  Similarity=0.298  Sum_probs=158.9

Q ss_pred             eEeeeeeEEEEEEEEe--cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          113 IIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      .||+|+||.||+|.+.  ..+..||+|++....  .....+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            3899999999999765  445679999987653  33445668899999999999999999998864 568999999999


Q ss_pred             CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccc
Q 018275          191 GDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV  269 (358)
Q Consensus       191 g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  269 (358)
                      ++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++..+........     
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-----  153 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-----  153 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee-----
Confidence            999999875 45789999999999999999999999999999999999999999999999999975532211000     


Q ss_pred             cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhc
Q 018275          270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCN  349 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l  349 (358)
                                                               ......+++.|+|||++.+..++.++|+|||||++||++
T Consensus       154 -----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  192 (257)
T cd05115         154 -----------------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAF  192 (257)
T ss_pred             -----------------------------------------ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHh
Confidence                                                     000113467899999999999999999999999999988


Q ss_pred             c-cccc
Q 018275          350 Y-LSDI  354 (358)
Q Consensus       350 ~-~~~~  354 (358)
                      . +..+
T Consensus       193 ~~g~~p  198 (257)
T cd05115         193 SYGQKP  198 (257)
T ss_pred             cCCCCC
Confidence            5 5443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.8e-35  Score=276.87  Aligned_cols=202  Identities=21%  Similarity=0.306  Sum_probs=166.4

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecC-------CCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEE
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKS-------GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKL  171 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l  171 (358)
                      .+++...+|.+.+.||+|+||.||+|.+...       +..||+|.+....  .......+.+|+.+++.+ +||||+++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            3455557899999999999999999986432       2368999887542  234456788999999999 79999999


Q ss_pred             EEEeecCCEEEEEEeecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 018275          172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD  235 (358)
Q Consensus       172 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~  235 (358)
                      +++|.+.+.+++||||+++|+|.+++....                .++...+..++.|++.||.|||+.||+||||||+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            999999999999999999999999986532                3666777889999999999999999999999999


Q ss_pred             CEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccc
Q 018275          236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST  315 (358)
Q Consensus       236 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  315 (358)
                      |||++.++.+||+|||+++.........                                               .....
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~  196 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYK-----------------------------------------------KTTNG  196 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccc-----------------------------------------------cccCC
Confidence            9999999999999999987653211000                                               00012


Q ss_pred             cCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          316 VGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       316 ~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                      .+++.|+|||++.+..++.++|+|||||++||++.
T Consensus       197 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  231 (334)
T cd05100         197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT  231 (334)
T ss_pred             CcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh
Confidence            35677999999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.4e-35  Score=270.86  Aligned_cols=199  Identities=24%  Similarity=0.324  Sum_probs=166.5

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      +..++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            345789999999999999999998743     67899999987543  23344568889999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREE----------------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD  235 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~  235 (358)
                      ....++||||+++++|.+++....                      .+++..+..++.|++.||.|||+.+++||||||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            999999999999999999996432                      3667778899999999999999999999999999


Q ss_pred             CEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccc
Q 018275          236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST  315 (358)
Q Consensus       236 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  315 (358)
                      ||+++.++.++|+|||++..+........                                               ....
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~-----------------------------------------------~~~~  192 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKA-----------------------------------------------SEND  192 (288)
T ss_pred             heEecCCCceEECccccceecccCccccc-----------------------------------------------cCCC
Confidence            99999999999999999875532110000                                               0011


Q ss_pred             cCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          316 VGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       316 ~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                      .+++.|+|||++.+..++.++|+|||||++||++.
T Consensus       193 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~  227 (288)
T cd05050         193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  227 (288)
T ss_pred             ccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence            35667999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.1e-35  Score=275.48  Aligned_cols=197  Identities=29%  Similarity=0.439  Sum_probs=169.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ..|.....||+|+||.||+|.+..++..||+|.+....   ......+.+|+.++..++|||++++++.|...+..|+||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            44555668999999999999998899999999986543   223455788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|..++. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++..+......   
T Consensus        98 e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~---  173 (297)
T cd06659          98 EFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---  173 (297)
T ss_pred             ecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc---
Confidence            9999999998774 456889999999999999999999999999999999999999999999999998654311100   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                    ....+|++.|+|||++.+..++.++|+|||||++
T Consensus       174 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il  207 (297)
T cd06659         174 ----------------------------------------------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMV  207 (297)
T ss_pred             ----------------------------------------------ccceecCccccCHHHHccCCCCchhhHHHHHHHH
Confidence                                                          0134689999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |||+++...|
T Consensus       208 ~el~~g~~p~  217 (297)
T cd06659         208 IEMVDGEPPY  217 (297)
T ss_pred             HHHHhCCCCC
Confidence            9999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.3e-34  Score=267.07  Aligned_cols=201  Identities=30%  Similarity=0.522  Sum_probs=168.3

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecC--
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDA--  178 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~--  178 (358)
                      ....++|.+...||+|+||.||+|.+..+++.+|+|++....    .....+..|+.++..+ +|||+++++++|...  
T Consensus        18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            345689999999999999999999999999999999986542    1234467788899988 899999999998643  


Q ss_pred             ---CEEEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecC
Q 018275          179 ---EYLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG  251 (358)
Q Consensus       179 ---~~~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFG  251 (358)
                         ...|+||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+++|+||||+||+++.++.+||+|||
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence               368999999999999998753    4578999999999999999999999999999999999999999999999999


Q ss_pred             CCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-
Q 018275          252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-  330 (358)
Q Consensus       252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-  330 (358)
                      ++.........                                                 ....+|++.|+|||++... 
T Consensus       174 ~~~~~~~~~~~-------------------------------------------------~~~~~~~~~y~aPE~~~~~~  204 (291)
T cd06639         174 VSAQLTSTRLR-------------------------------------------------RNTSVGTPFWMAPEVIACEQ  204 (291)
T ss_pred             cchhccccccc-------------------------------------------------ccCccCCccccChhhhcCCC
Confidence            98765321100                                                 0123689999999998643 


Q ss_pred             ----CCCccchhhhhhHHHHhhccccccc
Q 018275          331 ----GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       331 ----~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                          .++.++|+|||||++||++.+...|
T Consensus       205 ~~~~~~~~~~Di~slGvi~~el~~g~~p~  233 (291)
T cd06639         205 QYDYSYDARCDVWSLGITAIELGDGDPPL  233 (291)
T ss_pred             CcccccCCccchHHHHHHHHHHhhCCCCC
Confidence                3789999999999999999887654

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.2e-34  Score=263.23  Aligned_cols=198  Identities=30%  Similarity=0.543  Sum_probs=172.2

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+++.++|||++++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            58899999999999999999999999999999876543 34456678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-CcEEEEecCCCccCCCCCCcc
Q 018275          187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       187 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |+++++|.+++...  ..+++..+..++.+++.||.|||++|++|+||+|+||+++.+ +.+||+|||++........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--  157 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--  157 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence            99999999999763  458899999999999999999999999999999999999865 4689999999976532110  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      ....+|++.|+|||++.+..++.++|+||||+
T Consensus       158 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~  189 (256)
T cd08220         158 ------------------------------------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGC  189 (256)
T ss_pred             ------------------------------------------------ccccccCCcccCchhccCCCCCcccchHHHHH
Confidence                                                            01236899999999999999999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|+|+.+...|
T Consensus       190 ~l~~l~~~~~~~  201 (256)
T cd08220         190 VLYELASLKRAF  201 (256)
T ss_pred             HHHHHHhCCCCc
Confidence            999999876554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.3e-34  Score=297.57  Aligned_cols=153  Identities=46%  Similarity=0.771  Sum_probs=142.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+++.||+|+||.||+|.+..++..||||+++............+..|+.++..++||||+++++.+.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            47899999999999999999999999999999999876555555667788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      |||+++++|.+++.....+++..++.++.||+.||.|||..+|+||||||+|||++.++.+||+|||+++...
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~  155 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL  155 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence            9999999999999887889999999999999999999999999999999999999999999999999998553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-35  Score=264.81  Aligned_cols=199  Identities=23%  Similarity=0.326  Sum_probs=169.1

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ++..++|.+.+.||+|+||.||+|.+. .+..||||.+.....    ....+.+|+.+++.++||||+++++.+.+....
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            356689999999999999999999865 457899999876432    234588899999999999999999999988999


Q ss_pred             EEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ++||||+++++|.+++...  ..++...+..++.+++.||.|||+.+++|+||||+||+++.++.++|+|||++..+...
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            9999999999999999664  36889999999999999999999999999999999999999999999999998765421


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ....                                                .....++..|+|||.+.+..++.++|+|
T Consensus       157 ~~~~------------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~  188 (261)
T cd05034         157 EYTA------------------------------------------------REGAKFPIKWTAPEAANYGRFTIKSDVW  188 (261)
T ss_pred             hhhh------------------------------------------------hhccCCCccccCHHHhccCCcCchhHHH
Confidence            1000                                                0012356789999999999999999999


Q ss_pred             hhhHHHHhhcc-ccc
Q 018275          340 AYWNETLSCNY-LSD  353 (358)
Q Consensus       340 SlGvil~e~l~-~~~  353 (358)
                      ||||++|++++ +.-
T Consensus       189 slG~il~~l~t~g~~  203 (261)
T cd05034         189 SFGILLTEIVTYGRV  203 (261)
T ss_pred             HHHHHHHHHHhCCCC
Confidence            99999999997 443

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.6e-35  Score=267.78  Aligned_cols=198  Identities=21%  Similarity=0.341  Sum_probs=168.2

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ..++|.++..||.|+||.||+|..+.     +...|++|.+....  .......+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            34689999999999999999998653     35689999886542  223456688999999999999999999999998


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEe
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE---------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSD  249 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~D  249 (358)
                      ...|+||||+++|+|.+++....         .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999999997655         689999999999999999999999999999999999999999999999


Q ss_pred             cCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC
Q 018275          250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK  329 (358)
Q Consensus       250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~  329 (358)
                      ||+++........                                                ......+++.|+|||.+.+
T Consensus       161 ~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~y~~PE~~~~  192 (275)
T cd05046         161 LSLSKDVYNSEYY------------------------------------------------KLRNALIPLRWLAPEAVQE  192 (275)
T ss_pred             cccccccCccccc------------------------------------------------ccCCceeEEeecChhhhcc
Confidence            9998644211100                                                0012357788999999999


Q ss_pred             CCCCccchhhhhhHHHHhhccc
Q 018275          330 KGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       330 ~~y~~~~DiwSlGvil~e~l~~  351 (358)
                      ..++.++|||||||++|+++.+
T Consensus       193 ~~~~~~~Di~slG~~l~~l~~~  214 (275)
T cd05046         193 DDFSTKSDVWSFGVLMWEVFTQ  214 (275)
T ss_pred             CCCCchhhHHHHHHHHHHHHhC
Confidence            8999999999999999998873

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=263.69  Aligned_cols=195  Identities=21%  Similarity=0.288  Sum_probs=162.6

Q ss_pred             eeEeeeeeEEEEEEEEecCC---CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeec
Q 018275          112 TIIGRGAFGEVRLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL  188 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~  188 (358)
                      +.||+|+||.||+|.....+   ..+|+|.+......  .....+..|+.+++.++|||||++++++. .+..++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            46999999999999875544   78999999866432  34566888999999999999999999876 44679999999


Q ss_pred             CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccc
Q 018275          189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE  268 (358)
Q Consensus       189 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~  268 (358)
                      ++++|.+++.....+++..+..++.|++.||.|||..+++|+||||+|||++.++.+||+|||+++.+........    
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~----  153 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR----  153 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc----
Confidence            9999999998878899999999999999999999999999999999999999999999999999886542211000    


Q ss_pred             ccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhh
Q 018275          269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSC  348 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~  348 (358)
                                                                ......++..|+|||.+.+..++.++|+|||||++||+
T Consensus       154 ------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~  191 (257)
T cd05060         154 ------------------------------------------ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEA  191 (257)
T ss_pred             ------------------------------------------cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHH
Confidence                                                      00011245689999999999999999999999999999


Q ss_pred             cc-ccccc
Q 018275          349 NY-LSDIM  355 (358)
Q Consensus       349 l~-~~~~~  355 (358)
                      +. +..+|
T Consensus       192 ~~~g~~p~  199 (257)
T cd05060         192 FSYGAKPY  199 (257)
T ss_pred             HcCCCCCc
Confidence            96 55443

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.8e-35  Score=275.21  Aligned_cols=197  Identities=28%  Similarity=0.449  Sum_probs=169.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +.|.....||+|+||.||++.+..++..||||.+....   ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            44555678999999999999998899999999986542   234456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|.+++. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++........    
T Consensus        99 e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~----  173 (292)
T cd06658          99 EFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP----  173 (292)
T ss_pred             eCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc----
Confidence            9999999999874 45688999999999999999999999999999999999999999999999999865431110    


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                   .....+|++.|+|||++.+..++.++|+|||||++
T Consensus       174 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil  208 (292)
T cd06658         174 ---------------------------------------------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV  208 (292)
T ss_pred             ---------------------------------------------cCceeecCccccCHHHHccCCCCchhhHHHHHHHH
Confidence                                                         00134689999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |||+++..+|
T Consensus       209 ~el~~g~~p~  218 (292)
T cd06658         209 IEMIDGEPPY  218 (292)
T ss_pred             HHHHhCCCCC
Confidence            9999987665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-34  Score=267.90  Aligned_cols=197  Identities=25%  Similarity=0.392  Sum_probs=168.5

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||.|++|.||+|.+..+|..||||++.....  ......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            58899999999999999999999999999999876532  2233456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          187 YLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       187 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......... 
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~-  156 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-  156 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence            9975 888887653   36899999999999999999999999999999999999999999999999998755321100 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                      ..+.++|+.|+|||++.+ ..++.++|+||||
T Consensus       157 ------------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG  188 (284)
T cd07836         157 ------------------------------------------------FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG  188 (284)
T ss_pred             ------------------------------------------------cccccccccccChHHhcCCCCCCcHHHHHHHH
Confidence                                                            012368899999999876 4578999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|+++++...|
T Consensus       189 ~~l~~l~~g~~~~  201 (284)
T cd07836         189 CIMAEMITGRPLF  201 (284)
T ss_pred             HHHHHHHhCCCCC
Confidence            9999999987665

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-34  Score=267.78  Aligned_cols=200  Identities=28%  Similarity=0.461  Sum_probs=168.7

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeec----
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD----  177 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~----  177 (358)
                      ...+.|++.+.||.|+||.||+|.+..+++.||+|++....    .....+..|+.++..+ +|+||++++++|..    
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            34578999999999999999999999999999999986542    2334577888888888 69999999999853    


Q ss_pred             --CCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          178 --AEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       178 --~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                        ....|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence              46789999999999999998653  45888888899999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----  328 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----  328 (358)
                      ........                                                 .....+|++.|+|||++.     
T Consensus       169 ~~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~l~~~~~~  199 (282)
T cd06636         169 AQLDRTVG-------------------------------------------------RRNTFIGTPYWMAPEVIACDENP  199 (282)
T ss_pred             hhhhcccc-------------------------------------------------CCCcccccccccCHhhcCcccCc
Confidence            75531110                                                 011347999999999986     


Q ss_pred             CCCCCccchhhhhhHHHHhhccccccc
Q 018275          329 KKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       329 ~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +..|+.++|+|||||++||++++..+|
T Consensus       200 ~~~~~~~~DvwslG~~l~el~~g~~p~  226 (282)
T cd06636         200 DATYDYRSDIWSLGITAIEMAEGAPPL  226 (282)
T ss_pred             CcCCCcccchhHHHHHHHHHHhCCCCc
Confidence            456889999999999999999987655

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9e-35  Score=269.76  Aligned_cols=199  Identities=23%  Similarity=0.281  Sum_probs=164.6

Q ss_pred             CceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....  .......+.+|+.+++.++||||+++++.|...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            47888999999999999998753     23578999887543  233456688899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 018275          182 YLIMEYLPGGDVMTLLMRE------------------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL  237 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NI  237 (358)
                      ++||||+++++|.+++...                        .+++...+..++.|++.||.|||+.+|+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999987542                        2467888899999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC
Q 018275          238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG  317 (358)
Q Consensus       238 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g  317 (358)
                      |++.++.+||+|||+++.........                                               ......+
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~  191 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYV-----------------------------------------------KRSKGRI  191 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchh-----------------------------------------------cccCCCC
Confidence            99999999999999987653211000                                               0001245


Q ss_pred             CCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-cccc
Q 018275          318 TPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       318 t~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~  354 (358)
                      +..|+|||++.+..++.++|+|||||++||+++ +..+
T Consensus       192 ~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p  229 (290)
T cd05045         192 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  229 (290)
T ss_pred             CccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCC
Confidence            678999999999999999999999999999996 5543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-34  Score=266.32  Aligned_cols=198  Identities=30%  Similarity=0.488  Sum_probs=171.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +-|++.+.||.|+||.||+|.+..++..||+|.+....  .......+.+|+.+++.++||||+++++.+.+....|+||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            34778889999999999999998899999999986543  2334566889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|..++. ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++..+.....    
T Consensus        82 e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~----  156 (277)
T cd06641          82 EYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----  156 (277)
T ss_pred             EeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh----
Confidence            9999999999885 45688999999999999999999999999999999999999999999999999875532110    


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                   ......|++.|+|||++.+..++.++|+|||||++
T Consensus       157 ---------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l  191 (277)
T cd06641         157 ---------------------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA  191 (277)
T ss_pred             ---------------------------------------------hhccccCCccccChhhhccCCCCchhhHHHHHHHH
Confidence                                                         00123688999999999998999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |+++++.-+|
T Consensus       192 ~~l~~g~~p~  201 (277)
T cd06641         192 IELAKGEPPH  201 (277)
T ss_pred             HHHHcCCCCC
Confidence            9999876544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=270.09  Aligned_cols=210  Identities=18%  Similarity=0.156  Sum_probs=157.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhH--------HHHHHHHHHHHHhcCcceEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQV--------EHVRAERNLLAEVASHCIVKL  171 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~--------~~~~~E~~il~~l~h~~iv~l  171 (358)
                      +..++|.+.+.||+|+||.||+|.+..+   +..+|+|+............        .....+...+..+.|++++.+
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4457899999999999999999998777   66778876433211000000        111123334556789999999


Q ss_pred             EEEeecCC----EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEE
Q 018275          172 YYSFQDAE----YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL  247 (358)
Q Consensus       172 ~~~~~~~~----~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl  247 (358)
                      ++.+....    ..+++++++. .++.+.+......++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            98765443    4578888874 477777766566788889999999999999999999999999999999999999999


Q ss_pred             EecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh
Q 018275          248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL  327 (358)
Q Consensus       248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~  327 (358)
                      +|||+|+.+.........                                          .........||+.|+|||++
T Consensus       168 ~DFGla~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~ape~~  205 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEY------------------------------------------SKEQKDLHRGTLYYAGLDAH  205 (294)
T ss_pred             EEcCCceeeccCCccccc------------------------------------------ccccccccCCCccccCHHHh
Confidence            999999876422111000                                          00011134699999999999


Q ss_pred             cCCCCCccchhhhhhHHHHhhccccccc
Q 018275          328 LKKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       328 ~~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .+..|+.++|||||||++|||+++..+|
T Consensus       206 ~~~~~~~~~DiwSlG~~l~el~~g~~P~  233 (294)
T PHA02882        206 NGACVTRRGDLESLGYCMLKWAGIKLPW  233 (294)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999887665

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.1e-35  Score=265.25  Aligned_cols=199  Identities=24%  Similarity=0.354  Sum_probs=165.5

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++.+.||+|+||.||+|.+. ++..||+|.+.....    ..+.+.+|+.+++.++|||++++++.+.. ...+
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY   76 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence            44578999999999999999999765 566799999876532    12458889999999999999999998854 5689


Q ss_pred             EEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +||||+++++|.+++...  ..+++..+..++.+++.||.|||+.+|+||||||+||+++.++.++|+|||++..+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999998653  458889999999999999999999999999999999999999999999999997653211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ...                                                ..+..++..|+|||++.+..++.++|+||
T Consensus       157 ~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  188 (260)
T cd05070         157 YTA------------------------------------------------RQGAKFPIKWTAPEAALYGRFTIKSDVWS  188 (260)
T ss_pred             ccc------------------------------------------------ccCCCCCccccChHHHhcCCCcchhhhHH
Confidence            000                                                01224567899999999999999999999


Q ss_pred             hhHHHHhhcc-ccccc
Q 018275          341 YWNETLSCNY-LSDIM  355 (358)
Q Consensus       341 lGvil~e~l~-~~~~~  355 (358)
                      |||++|++++ +..+|
T Consensus       189 lG~~l~~l~~~g~~p~  204 (260)
T cd05070         189 FGILLTELVTKGRVPY  204 (260)
T ss_pred             HHHHHHHHHhcCCCCC
Confidence            9999999998 44333

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.6e-35  Score=269.05  Aligned_cols=197  Identities=26%  Similarity=0.425  Sum_probs=173.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.++||||+++++.+.+....++|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            46888899999999999999999999999999987653  2344556888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       186 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||+++++|.+++... .++++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+.......   
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence            999999999999776 788999999999999999999999 999999999999999999999999999886542110   


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      .....|++.|+|||++.+..++.++|+|||||
T Consensus       156 ------------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~  187 (265)
T cd06605         156 ------------------------------------------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGL  187 (265)
T ss_pred             ------------------------------------------------hhcccCChhccCHHHHcCCCCCchhhHHHHHH
Confidence                                                            00136889999999999999999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|+++++...|
T Consensus       188 ~l~~l~~g~~p~  199 (265)
T cd06605         188 SLIELATGRFPY  199 (265)
T ss_pred             HHHHHHhCCCCC
Confidence            999999977655

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-34  Score=266.56  Aligned_cols=198  Identities=28%  Similarity=0.400  Sum_probs=170.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--CCEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEYLYL  183 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~l  183 (358)
                      ++|...+.||.|++|.||+|.+..+++.+|+|.+....  .......+.+|+.+++.++||||+++++.|.+  ...+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            47899999999999999999999999999999987653  22345668889999999999999999999865  347899


Q ss_pred             EEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          184 IMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999988643    356888999999999999999999999999999999999999999999999998654311


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ..                                                   ....++..|+|||.+.+..++.++|+|
T Consensus       159 ~~---------------------------------------------------~~~~~~~~y~~pE~~~~~~~~~~~Dv~  187 (287)
T cd06621         159 LA---------------------------------------------------GTFTGTSFYMAPERIQGKPYSITSDVW  187 (287)
T ss_pred             cc---------------------------------------------------ccccCCccccCHHHhcCCCCCchhhHH
Confidence            10                                                   012578889999999999999999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||++|+++++..+|.
T Consensus       188 slG~il~~l~~g~~p~~  204 (287)
T cd06621         188 SLGLTLLEVAQNRFPFP  204 (287)
T ss_pred             HHHHHHHHHHhCCCCCC
Confidence            99999999999876653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=262.80  Aligned_cols=193  Identities=24%  Similarity=0.340  Sum_probs=168.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++.+.||.|+||.||+|...  |+.||+|.+.....    ....+.+|+.+++.++|+||+++++.+.+....+
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            44578999999999999999999764  78999999976532    4566889999999999999999999999889999


Q ss_pred             EEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999999997665  78999999999999999999999999999999999999999999999999997653111


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .                                                    ...++..|+|||++.+..++.++|+||
T Consensus       157 ~----------------------------------------------------~~~~~~~~~ape~~~~~~~~~~~Di~s  184 (256)
T cd05039         157 D----------------------------------------------------SGKLPVKWTAPEALREKKFSTKSDVWS  184 (256)
T ss_pred             c----------------------------------------------------cCCCcccccCchhhcCCcCCcHHHHHH
Confidence            0                                                    113456799999999889999999999


Q ss_pred             hhHHHHhhcc-ccc
Q 018275          341 YWNETLSCNY-LSD  353 (358)
Q Consensus       341 lGvil~e~l~-~~~  353 (358)
                      ||+++||++. +..
T Consensus       185 lG~il~~l~~~g~~  198 (256)
T cd05039         185 FGILLWEIYSFGRV  198 (256)
T ss_pred             HHHHHHHHHhcCCC
Confidence            9999999986 443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.5e-34  Score=263.25  Aligned_cols=199  Identities=33%  Similarity=0.541  Sum_probs=171.7

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee--cCCEEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEYLYLI  184 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lV  184 (358)
                      +|++.+.||.|+||.||+|.+..++..||+|.+..... .......+..|+.+++.++||||+++++.+.  .....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            58899999999999999999999999999999876533 3444566888999999999999999999875  34578999


Q ss_pred             EeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          185 MEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIH-----KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-----~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      |||+++++|.+++..    ..++++..+..++.|++.||.|||     +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999865    367899999999999999999999     88999999999999999999999999999886


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      ......                                                 ......|++.|+|||++.+..++.+
T Consensus       160 ~~~~~~-------------------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~  190 (265)
T cd08217         160 LGHDSS-------------------------------------------------FAKTYVGTPYYMSPEQLNHMSYDEK  190 (265)
T ss_pred             ccCCcc-------------------------------------------------cccccccCCCccChhhhcCCCCCch
Confidence            642210                                                 0012368999999999999999999


Q ss_pred             chhhhhhHHHHhhccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~  355 (358)
                      +|+||||+++|+|+.+...|
T Consensus       191 ~Dv~slG~il~~l~~g~~p~  210 (265)
T cd08217         191 SDIWSLGCLIYELCALSPPF  210 (265)
T ss_pred             hHHHHHHHHHHHHHHCCCcc
Confidence            99999999999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-36  Score=263.34  Aligned_cols=201  Identities=23%  Similarity=0.378  Sum_probs=167.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~  181 (358)
                      ...++.+.+..||.|+-|+||+++.+.+|...|||.++...  ......++...++++...+ +|+||+++|+|..+..+
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV  166 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV  166 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence            34577778889999999999999999999999999998764  4555666777777766554 89999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ++.||.|. ..+..++.. .+++++..+-.+...++.||.||.. ++|||||+||+|||+|..|++||||||++..+..+
T Consensus       167 ~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  167 FICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            99999994 455555544 4789999999999999999999974 68999999999999999999999999999877532


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC---CCCCccc
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMEC  336 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~---~~y~~~~  336 (358)
                      ..++                                                  -..|.+.|||||.+..   ..|+-.+
T Consensus       246 kAht--------------------------------------------------rsAGC~~YMaPERidp~~~~kYDiRa  275 (391)
T KOG0983|consen  246 KAHT--------------------------------------------------RSAGCAAYMAPERIDPPDKPKYDIRA  275 (391)
T ss_pred             cccc--------------------------------------------------cccCCccccCccccCCCCCCccchhh
Confidence            2111                                                  1269999999999974   4699999


Q ss_pred             hhhhhhHHHHhhcccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~~  356 (358)
                      |+||||++|+|+.++.+.|.
T Consensus       276 DVWSlGITlveLaTg~yPy~  295 (391)
T KOG0983|consen  276 DVWSLGITLVELATGQYPYK  295 (391)
T ss_pred             hhhhhccchhhhhcccCCCC
Confidence            99999999999887776653

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-35  Score=276.08  Aligned_cols=201  Identities=26%  Similarity=0.394  Sum_probs=167.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC-----C
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----E  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~  179 (358)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||.+....  .......+..|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            378999999999999999999999999999999986432  223445577899999999999999999877543     3


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ..|+|+||++ ++|...+ ....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~lv~e~~~-~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELME-TDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhcc-cCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            5899999996 5888777 4467899999999999999999999999999999999999999999999999998765321


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Di  338 (358)
                      ....                                              ......+||+.|+|||++.+ ..++.++|+
T Consensus       160 ~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv  193 (336)
T cd07849         160 HDHT----------------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKAIDI  193 (336)
T ss_pred             cccc----------------------------------------------CCcCCcCcCCCccChHHhhCCCCCCcHHHH
Confidence            1100                                              00112468999999999765 568999999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      |||||++|+|+++..+|
T Consensus       194 wslGvil~el~~G~~~f  210 (336)
T cd07849         194 WSVGCILAEMLSNRPLF  210 (336)
T ss_pred             HHHHHHHHHHHhCCCCC
Confidence            99999999999987665

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.4e-34  Score=264.02  Aligned_cols=199  Identities=25%  Similarity=0.351  Sum_probs=166.6

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++.++||+|+||.||+|... ++..||+|.+.....    ....+.+|+.+++.++||||+++++.+. ....+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            45688999999999999999999854 567899999876532    2345788999999999999999998875 45689


Q ss_pred             EEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +||||+++++|.+++...  ..++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999999998653  468888899999999999999999999999999999999999999999999987654211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ...                                                .....++..|+|||++.+..++.++|+||
T Consensus       157 ~~~------------------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~s  188 (260)
T cd05067         157 YTA------------------------------------------------REGAKFPIKWTAPEAINYGTFTIKSDVWS  188 (260)
T ss_pred             ccc------------------------------------------------ccCCcccccccCHHHhccCCcCcccchHH
Confidence            000                                                01224678899999999999999999999


Q ss_pred             hhHHHHhhcc-ccccc
Q 018275          341 YWNETLSCNY-LSDIM  355 (358)
Q Consensus       341 lGvil~e~l~-~~~~~  355 (358)
                      |||++||+++ +...|
T Consensus       189 lG~~l~el~~~g~~p~  204 (260)
T cd05067         189 FGILLTEIVTYGRIPY  204 (260)
T ss_pred             HHHHHHHHHhCCCCCC
Confidence            9999999997 55443

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.6e-34  Score=267.09  Aligned_cols=199  Identities=27%  Similarity=0.403  Sum_probs=167.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            679999999999999999999999999999999876532 2233456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-CCcEEEEecCCCccCCCCCCc
Q 018275          186 EYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||++ ++|.+.+....  .+++..+..++.||+.||.|||+.+++|+||+|+||+++. ++.+||+|||++........ 
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-  158 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-  158 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence            9996 57888775543  3578888889999999999999999999999999999985 56799999999975532110 


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAY  341 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSl  341 (358)
                                                                      .....+|++.|+|||++.+ ..++.++|||||
T Consensus       159 ------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  190 (294)
T PLN00009        159 ------------------------------------------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSV  190 (294)
T ss_pred             ------------------------------------------------ccccCceeecccCHHHHhCCCCCCcHHHHHHH
Confidence                                                            0012367899999999876 468899999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|+++++...|
T Consensus       191 G~i~~~l~tg~~pf  204 (294)
T PLN00009        191 GCIFAEMVNQKPLF  204 (294)
T ss_pred             HHHHHHHHhCCCCC
Confidence            99999999987665

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-34  Score=262.90  Aligned_cols=192  Identities=24%  Similarity=0.389  Sum_probs=162.5

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe-ecCCEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF-QDAEYL  181 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-~~~~~~  181 (358)
                      +...+|.+.+.||+|+||.||++...  |..||+|.+....     ....+.+|+.+++.++|+|++++++++ .+....
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            44578999999999999999998654  7789999986442     234578899999999999999999875 455678


Q ss_pred             EEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ++||||+++++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999999987643  4788888999999999999999999999999999999999999999999998754311


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ..                                                    ...++..|+|||++.+..++.++|+|
T Consensus       156 ~~----------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~Dv~  183 (256)
T cd05082         156 QD----------------------------------------------------TGKLPVKWTAPEALREKKFSTKSDVW  183 (256)
T ss_pred             CC----------------------------------------------------CCccceeecCHHHHccCCCCchhhhH
Confidence            10                                                    12356679999999999999999999


Q ss_pred             hhhHHHHhhcc-ccc
Q 018275          340 AYWNETLSCNY-LSD  353 (358)
Q Consensus       340 SlGvil~e~l~-~~~  353 (358)
                      ||||++||++. +..
T Consensus       184 slG~i~~~l~~~g~~  198 (256)
T cd05082         184 SFGILLWEIYSFGRV  198 (256)
T ss_pred             HHHHHHHHHHhCCCC
Confidence            99999999986 443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-37  Score=312.71  Aligned_cols=203  Identities=30%  Similarity=0.436  Sum_probs=177.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      -++.-...||.|.||.||-|.+..+|...|+|-++..... ......+.+|..++..++|||+|++||+-.+.+..+|.|
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3456677899999999999999999999999998766543 455566889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      |||.+|+|.+.+......++...+.+..|++.|+.|||++|||||||||+||+|+.+|.+|++|||.|..+.... .+++
T Consensus      1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~-~~~~ 1392 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA-QTMP 1392 (1509)
T ss_pred             HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch-hcCC
Confidence            999999999999888889999999999999999999999999999999999999999999999999998875431 1110


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC---CCCCccchhhhhh
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMECDWLAYW  342 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~---~~y~~~~DiwSlG  342 (358)
                      .                                            -..+.+|||-|||||++.+   ++..-+.||||||
T Consensus      1393 ~--------------------------------------------el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslG 1428 (1509)
T KOG4645|consen 1393 G--------------------------------------------ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLG 1428 (1509)
T ss_pred             H--------------------------------------------HHHhhcCCchhcCchhhcccccCCCCcchhhhccc
Confidence            0                                            0115689999999999975   5678899999999


Q ss_pred             HHHHhhcccccc
Q 018275          343 NETLSCNYLSDI  354 (358)
Q Consensus       343 vil~e~l~~~~~  354 (358)
                      |++.||.+|..+
T Consensus      1429 CVVlEM~tGkrP 1440 (1509)
T KOG4645|consen 1429 CVVLEMATGKRP 1440 (1509)
T ss_pred             ceEEEeecCCCc
Confidence            999999997654

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-34  Score=265.02  Aligned_cols=184  Identities=20%  Similarity=0.226  Sum_probs=154.5

Q ss_pred             eeEeeeeeEEEEEEEEec------------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          112 TIIGRGAFGEVRLCQEKK------------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      +.||+|+||.||+|....            ....|++|++....   ......+..|+.+++.++||||+++++++.+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            368999999999997532            23368999877643   333455778889999999999999999999988


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc-------EEEEecC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH-------MKLSDFG  251 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~-------vkl~DFG  251 (358)
                      ..++||||+++++|..++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999999888653 57899999999999999999999999999999999999987664       8999999


Q ss_pred             CCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-CC
Q 018275          252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KK  330 (358)
Q Consensus       252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-~~  330 (358)
                      ++.......                                                     ..+|++.|+|||++. +.
T Consensus       158 ~~~~~~~~~-----------------------------------------------------~~~~~~~y~aPE~~~~~~  184 (262)
T cd05077         158 IPITVLSRQ-----------------------------------------------------ECVERIPWIAPECVEDSK  184 (262)
T ss_pred             CCccccCcc-----------------------------------------------------cccccccccChhhhcCCC
Confidence            886542110                                                     235888999999987 57


Q ss_pred             CCCccchhhhhhHHHHhhccc
Q 018275          331 GYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~  351 (358)
                      .++.++|||||||++|||++.
T Consensus       185 ~~~~~~DiwslG~~l~el~~~  205 (262)
T cd05077         185 NLSIAADKWSFGTTLWEICYN  205 (262)
T ss_pred             CCCchhHHHHHHHHHHHHHhC
Confidence            799999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=265.35  Aligned_cols=191  Identities=25%  Similarity=0.360  Sum_probs=158.6

Q ss_pred             eEeeeeeEEEEEEEEecCCC--EEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEEeecC
Q 018275          113 IIGRGAFGEVRLCQEKKSGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      .||+|+||.||+|.+..++.  .+++|.+....  .......+..|+.++..+ +||||++++++|......|+||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            68999999999999887775  46888876432  234455688899999999 89999999999999999999999999


Q ss_pred             CCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          190 GGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       190 ~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      +|+|.+++....                .++...+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            999999986532                3678888999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      ........                                                  ......++.|+|||++.+..++
T Consensus       160 ~~~~~~~~--------------------------------------------------~~~~~~~~~y~apE~~~~~~~~  189 (270)
T cd05047         160 RGQEVYVK--------------------------------------------------KTMGRLPVRWMAIESLNYSVYT  189 (270)
T ss_pred             cccchhhh--------------------------------------------------ccCCCCccccCChHHHccCCCC
Confidence            53210000                                                  0011245679999999999999


Q ss_pred             ccchhhhhhHHHHhhcc-ccccc
Q 018275          334 MECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      .++|+|||||++|||+. +.-+|
T Consensus       190 ~~~Di~slG~il~el~~~g~~pf  212 (270)
T cd05047         190 TNSDVWSYGVLLWEIVSLGGTPY  212 (270)
T ss_pred             chhhHHHHHHHHHHHHcCCCCCc
Confidence            99999999999999985 55444

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1e-34  Score=271.38  Aligned_cols=197  Identities=18%  Similarity=0.263  Sum_probs=164.6

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCC----EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ..++|+..+.||+|+||.||+|.+..++.    .||+|.+....  .......+.+|+.+++.++||||+++++.+... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            45788999999999999999999877776    47888886543  233344578899999999999999999998754 


Q ss_pred             EEEEEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            4679999999999999987643 688889999999999999999999999999999999999999999999999986542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .....                                               ......+++.|+|||++.+..++.++|+
T Consensus       162 ~~~~~-----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di  194 (303)
T cd05110         162 DEKEY-----------------------------------------------NADGGKMPIKWMALECIHYRKFTHQSDV  194 (303)
T ss_pred             ccccc-----------------------------------------------ccCCCccccccCCHHHhccCCCChHHHH
Confidence            11100                                               0012246788999999999999999999


Q ss_pred             hhhhHHHHhhcc
Q 018275          339 LAYWNETLSCNY  350 (358)
Q Consensus       339 wSlGvil~e~l~  350 (358)
                      |||||++||++.
T Consensus       195 wslG~~l~el~t  206 (303)
T cd05110         195 WSYGVTIWELMT  206 (303)
T ss_pred             HHHHHHHHHHHh
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.5e-34  Score=266.67  Aligned_cols=203  Identities=20%  Similarity=0.232  Sum_probs=169.6

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEec----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec-
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKK----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-  177 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-  177 (358)
                      +..++|.+.+.||+|+||.||+|.+..    ++..|++|.+....  .......+.+|+.+++.++||||+++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            456889999999999999999999876    35789999887442  44556778899999999999999999998765 


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEe
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMRE--------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSD  249 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~D  249 (358)
                      ....+++++|+++++|.+++...        ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            56789999999999999998653        4588999999999999999999999999999999999999999999999


Q ss_pred             cCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC
Q 018275          250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK  329 (358)
Q Consensus       250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~  329 (358)
                      ||+++.+.........                                               ....++..|+|||++.+
T Consensus       161 ~g~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~y~apE~~~~  193 (280)
T cd05043         161 NALSRDLFPMDYHCLG-----------------------------------------------DNENRPVKWMALESLVN  193 (280)
T ss_pred             CCCcccccCCceEEeC-----------------------------------------------CCCCcchhccCHHHHhc
Confidence            9999865422211100                                               01235677999999999


Q ss_pred             CCCCccchhhhhhHHHHhhcc-cccc
Q 018275          330 KGYGMECDWLAYWNETLSCNY-LSDI  354 (358)
Q Consensus       330 ~~y~~~~DiwSlGvil~e~l~-~~~~  354 (358)
                      ..++.++|+|||||++||++. +..+
T Consensus       194 ~~~~~~~Di~slG~~l~el~~~g~~p  219 (280)
T cd05043         194 KEYSSASDVWSFGVLLWELMTLGQTP  219 (280)
T ss_pred             CCCCchhhHHHhHHHHHHHhcCCCCC
Confidence            999999999999999999987 4443

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=271.71  Aligned_cols=200  Identities=22%  Similarity=0.331  Sum_probs=170.5

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC--c----ceEEEE
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--H----CIVKLY  172 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--~----~iv~l~  172 (358)
                      ....+..++|.++..+|+|.||.|-.|.+..++..||||+++.-..    ..+..+-|+++|.++.+  |    .+|++.
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            3344557899999999999999999999999999999999986532    23336678999999843  2    388999


Q ss_pred             EEeecCCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---------
Q 018275          173 YSFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---------  241 (358)
Q Consensus       173 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---------  241 (358)
                      ++|.-.++.|||+|.+ |.++.+++..+  .+++...++.+..|++.++++||+.+++|.||||+|||+.+         
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence            9999999999999999 77999999775  47999999999999999999999999999999999999942         


Q ss_pred             -----------CCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcc
Q 018275          242 -----------NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRK  310 (358)
Q Consensus       242 -----------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (358)
                                 +..|+|+|||.|+.....+                                                  
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--------------------------------------------------  266 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH--------------------------------------------------  266 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccCc--------------------------------------------------
Confidence                       3469999999998665433                                                  


Q ss_pred             ccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccccccc
Q 018275          311 LAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       311 ~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                        .++|.|..|+||||+++-+++++||+||+||||+|..+|.-+|
T Consensus       267 --s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  267 --STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             --ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence              1568999999999999999999999999999999976666554

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.6e-35  Score=269.85  Aligned_cols=199  Identities=27%  Similarity=0.384  Sum_probs=169.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC--CEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYLYL  183 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~l  183 (358)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.++..... ......+.+|+.+++.++||||+++++++.+.  ...|+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            6799999999999999999999989999999999765422 22334467899999999999999999999877  89999


Q ss_pred             EEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          184 IMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||||++ ++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.........
T Consensus        84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            999997 5999988664 45899999999999999999999999999999999999999999999999998765422100


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAY  341 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSl  341 (358)
                                                                       .....+++.|+|||++.+. .++.++|+|||
T Consensus       163 -------------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  193 (293)
T cd07843         163 -------------------------------------------------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSV  193 (293)
T ss_pred             -------------------------------------------------cccccccccccCchhhcCCccccchhhHHHH
Confidence                                                             0123578999999999764 46899999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|+|+.+..+|
T Consensus       194 G~~l~~l~~g~~~f  207 (293)
T cd07843         194 GCIFAELLTKKPLF  207 (293)
T ss_pred             HHHHHHHHhCCCCC
Confidence            99999999987655

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.5e-34  Score=269.18  Aligned_cols=199  Identities=28%  Similarity=0.441  Sum_probs=173.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||+|+||.||++.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++.|.+.+..|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            478999999999999999999988889999999986542   23345678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      +||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........  
T Consensus        95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--  171 (293)
T cd06647          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--  171 (293)
T ss_pred             EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--
Confidence            999999999999854 45788888999999999999999999999999999999999999999999988755321100  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                     .....|++.|+|||++.+..++.++|+|||||+
T Consensus       172 -----------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~l  204 (293)
T cd06647         172 -----------------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM  204 (293)
T ss_pred             -----------------------------------------------cccccCChhhcCchhhccCCCCchhhHHHHHHH
Confidence                                                           012368999999999999999999999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +|+++++..+|.
T Consensus       205 l~~ll~g~~pf~  216 (293)
T cd06647         205 AIEMVEGEPPYL  216 (293)
T ss_pred             HHHHHhCCCCCC
Confidence            999999877664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-34  Score=264.12  Aligned_cols=182  Identities=19%  Similarity=0.230  Sum_probs=157.2

Q ss_pred             eeEeeeeeEEEEEEEEecCC----------CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          112 TIIGRGAFGEVRLCQEKKSG----------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~----------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      +.||+|+||.||+|.+..++          ..|++|.+.....   . ...+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---D-SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---h-HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            36899999999999988776          3588887765431   1 4568889999999999999999999987 778


Q ss_pred             EEEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-------cEEEEecCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-------HMKLSDFGLC  253 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-------~vkl~DFGla  253 (358)
                      ++||||+++|+|.+++.... .++...+..++.|++.||.|||+.||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999997765 788999999999999999999999999999999999999888       8999999998


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC--C
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK--G  331 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~--~  331 (358)
                      .......                                                     ..++++.|+|||++.+.  .
T Consensus       156 ~~~~~~~-----------------------------------------------------~~~~~~~y~aPE~~~~~~~~  182 (259)
T cd05037         156 ITVLSRE-----------------------------------------------------ERVERIPWIAPECIRNGQAS  182 (259)
T ss_pred             ccccccc-----------------------------------------------------ccccCCCccChhhhcCCCCC
Confidence            7653200                                                     22577889999999877  7


Q ss_pred             CCccchhhhhhHHHHhhccc
Q 018275          332 YGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~  351 (358)
                      ++.++|+|||||++||++++
T Consensus       183 ~~~~~Di~slG~~~~~l~~~  202 (259)
T cd05037         183 LTIAADKWSFGTTLLEICSN  202 (259)
T ss_pred             cchhhHHHHHHHHHHHHHhC
Confidence            99999999999999999885

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.4e-34  Score=267.16  Aligned_cols=199  Identities=29%  Similarity=0.422  Sum_probs=165.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCE----
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEY----  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~----  180 (358)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            479999999999999999999999999999999876432 2233455778999999995 5999999999986665    


Q ss_pred             -EEEEEeecCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-CCcEEEEecCCC
Q 018275          181 -LYLIMEYLPGGDVMTLLMRE-----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLC  253 (358)
Q Consensus       181 -~~lV~E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~vkl~DFGla  253 (358)
                       .|+||||+++ +|.+++...     ..+++..+..++.||+.||.|||+.+|+||||+|+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999975 888887542     35799999999999999999999999999999999999998 899999999998


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGY  332 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y  332 (358)
                      ..+.....                                                 ......+++.|+|||++.+ ..+
T Consensus       159 ~~~~~~~~-------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~  189 (295)
T cd07837         159 RAFSIPVK-------------------------------------------------SYTHEIVTLWYRAPEVLLGSTHY  189 (295)
T ss_pred             eecCCCcc-------------------------------------------------ccCCcccccCCCChHHhhCCCCC
Confidence            75531110                                                 0012357899999999875 568


Q ss_pred             CccchhhhhhHHHHhhccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +.++|+|||||++|+|+++...|
T Consensus       190 ~~~~Di~slG~~l~~l~~g~~~~  212 (295)
T cd07837         190 STPVDIWSVGCIFAEMSRKQPLF  212 (295)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999987665

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.7e-36  Score=304.11  Aligned_cols=213  Identities=29%  Similarity=0.426  Sum_probs=165.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee---------
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ---------  176 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~---------  176 (358)
                      ++|+.+..||+||||.||+++++-+|+.||||+|+...  +......+.+|+.+|++++|||||++|.+|.         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            67889999999999999999999999999999998775  4555667889999999999999999985540         


Q ss_pred             ---------------------------------------------------------------------cC---------
Q 018275          177 ---------------------------------------------------------------------DA---------  178 (358)
Q Consensus       177 ---------------------------------------------------------------------~~---------  178 (358)
                                                                                           +.         
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                 00         


Q ss_pred             --------------------------------CEEEEEEeecCCCCHHHHHhhcCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 018275          179 --------------------------------EYLYLIMEYLPGGDVMTLLMREETL-TETVARFYIAQSVLAIESIHKH  225 (358)
Q Consensus       179 --------------------------------~~~~lV~E~~~~g~L~~~l~~~~~~-~~~~~~~~~~qi~~aL~~LH~~  225 (358)
                                                      -.+||-||||+..++.+++..+... ....+..++++|+.||.|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                            2468999999887777777555443 4667888999999999999999


Q ss_pred             CceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHh
Q 018275          226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQ  305 (358)
Q Consensus       226 ~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (358)
                      |||||||||.||+|++++.|||+|||+|+.........-.                +..+.+...+.             
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~----------------~~~~~~~~~g~-------------  767 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQ----------------DLSFSTNRAGS-------------  767 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhh----------------ccCccccccCC-------------
Confidence            9999999999999999999999999999874311000000                00000000000             


Q ss_pred             hhhccccccccCCCCCchhhhhcCCC---CCccchhhhhhHHHHhhccc
Q 018275          306 INRRKLAYSTVGTPDYIAPEVLLKKG---YGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       306 ~~~~~~~~s~~gt~~Y~APEv~~~~~---y~~~~DiwSlGvil~e~l~~  351 (358)
                        .-.-..+.+||--|+|||++.+..   |+.++|+||||+++|||++-
T Consensus       768 --~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP  814 (1351)
T KOG1035|consen  768 --NDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP  814 (1351)
T ss_pred             --CCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc
Confidence              000112569999999999998765   99999999999999999973

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.9e-35  Score=268.25  Aligned_cols=198  Identities=28%  Similarity=0.418  Sum_probs=168.7

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|+.++.||.|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            58899999999999999999999999999999875432 23334568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          187 YLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       187 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |++ ++|..++..  ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++..+......  
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--  156 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--  156 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--
Confidence            995 688888854  356889999999999999999999999999999999999999999999999998755321100  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC-CCccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~-y~~~~DiwSlGv  343 (358)
                                                                     .....+++.|+|||++.+.. ++.++|+|||||
T Consensus       157 -----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  189 (284)
T cd07860         157 -----------------------------------------------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC  189 (284)
T ss_pred             -----------------------------------------------cccccccccccCCeEEecCCCCCcHHHHHHHHH
Confidence                                                           01225788999999987644 688999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++||++++..+|
T Consensus       190 il~~l~tg~~p~  201 (284)
T cd07860         190 IFAEMVTRRALF  201 (284)
T ss_pred             HHHHHHHCCCCC
Confidence            999999988765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=263.96  Aligned_cols=199  Identities=29%  Similarity=0.479  Sum_probs=169.3

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCC---
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE---  179 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~---  179 (358)
                      ..++|++.+.||.|+||.||+|.+..+++.+++|++....    .....+..|+.+++.+ .|+||+++++.|.+..   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            4589999999999999999999998889999999987653    2335688999999998 7999999999997544   


Q ss_pred             ---EEEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          180 ---YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       180 ---~~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                         .+|+||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence               58999999999999998864    35789999999999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC---
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---  329 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~---  329 (358)
                      +.........                                                 .....|++.|+|||++..   
T Consensus       160 ~~~~~~~~~~-------------------------------------------------~~~~~~~~~y~aPE~~~~~~~  190 (275)
T cd06608         160 SAQLDSTLGR-------------------------------------------------RNTFIGTPYWMAPEVIACDEQ  190 (275)
T ss_pred             ceecccchhh-------------------------------------------------hcCccccccccCHhHhccccc
Confidence            8754321100                                                 013368999999999864   


Q ss_pred             --CCCCccchhhhhhHHHHhhccccccc
Q 018275          330 --KGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       330 --~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                        ..++.++|+|||||+||+|+.+...|
T Consensus       191 ~~~~~~~~~Dv~slG~il~~l~~g~~p~  218 (275)
T cd06608         191 PDASYDARSDVWSLGITAIELADGKPPL  218 (275)
T ss_pred             ccCCccccccHHHhHHHHHHHHhCCCCc
Confidence              35788999999999999999877655

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-34  Score=266.61  Aligned_cols=221  Identities=36%  Similarity=0.591  Sum_probs=181.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ++|.+.+.||+|+||.||+|.+..++..||+|++.+...........+..|..+++.++ ||||+++++.+.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998765544555567888999999998 99999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999986643321110


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                      ......              .+....               ...........|++.|+|||++.+..++.++|+||||++
T Consensus       161 ~~~~~~--------------~~~~~~---------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~  211 (280)
T cd05581         161 NKGDAT--------------NIDSQI---------------EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCI  211 (280)
T ss_pred             CCCCCc--------------cccccc---------------cccccccccccCCccccCHHHhCCCCCChhhhHHHHHHH
Confidence            000000              000000               000011224578999999999999999999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|+++.+...|
T Consensus       212 l~~l~~g~~p~  222 (280)
T cd05581         212 IYQMLTGKPPF  222 (280)
T ss_pred             HHHHHhCCCCC
Confidence            99998876554

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.4e-34  Score=269.67  Aligned_cols=196  Identities=28%  Similarity=0.409  Sum_probs=168.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ..|...+.||+|+||.||++.+..++..||+|.+.............+..|+.+++.++|||++++++++.+....++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            45888899999999999999998899999999987654334445567888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||++| +|.+.+.. ..++++..+..++.+++.||.|||+.+|+||||+|+||+++.++.++|+|||++.......    
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~----  179 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN----  179 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcc----
Confidence            99975 77777654 5678999999999999999999999999999999999999999999999999886432110    


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCccchhhhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWLAY  341 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~~~DiwSl  341 (358)
                                                                       ...|++.|+|||++.   ++.++.++|+|||
T Consensus       180 -------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~sl  210 (317)
T cd06635         180 -------------------------------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  210 (317)
T ss_pred             -------------------------------------------------cccCCccccChhhhhcCCCCCCCccccHHHH
Confidence                                                             235889999999984   4568899999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|||+++...|
T Consensus       211 Gvil~el~~g~~p~  224 (317)
T cd06635         211 GITCIELAERKPPL  224 (317)
T ss_pred             HHHHHHHHhCCCCC
Confidence            99999999887653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-34  Score=262.06  Aligned_cols=195  Identities=20%  Similarity=0.300  Sum_probs=164.3

Q ss_pred             eeEeeeeeEEEEEEEEec-CCC--EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeec
Q 018275          112 TIIGRGAFGEVRLCQEKK-SGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL  188 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~  188 (358)
                      +.||+|++|.||+|.+.. .+.  .||||.+......  .....+..|+.+++.++||||+++++.+.+ ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            368999999999998765 333  6999999876532  556778899999999999999999999988 8899999999


Q ss_pred             CCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          189 PGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       189 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      ++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||+++.+........  
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--  155 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV--  155 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee--
Confidence            9999999997654  688899999999999999999999999999999999999999999999999987642211000  


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETL  346 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~  346 (358)
                                                                  ......++..|+|||++.+..++.++|+|||||++|
T Consensus       156 --------------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~  191 (257)
T cd05040         156 --------------------------------------------MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLW  191 (257)
T ss_pred             --------------------------------------------cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHH
Confidence                                                        000235788899999999999999999999999999


Q ss_pred             hhcc-ccccc
Q 018275          347 SCNY-LSDIM  355 (358)
Q Consensus       347 e~l~-~~~~~  355 (358)
                      ||+. +...|
T Consensus       192 el~t~g~~p~  201 (257)
T cd05040         192 EMFTYGEEPW  201 (257)
T ss_pred             HHHhCCCCCC
Confidence            9986 55443

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-36  Score=247.28  Aligned_cols=193  Identities=27%  Similarity=0.408  Sum_probs=167.2

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|.-.++||+|.||+||+|++..++..||+|.++.++. ....-....+|+.+++.++|.|||++++....++.+.+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            56677899999999999999999999999999987653 23333457889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          187 YLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       187 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||. .+|..+... ++.+....++.++.|++.||.++|++++.|||+||.|.||+.||.+||+|||+++.++....    
T Consensus        82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr----  156 (292)
T KOG0662|consen   82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR----  156 (292)
T ss_pred             Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE----
Confidence            995 588887754 57899999999999999999999999999999999999999999999999999998763221    


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlGvi  344 (358)
                                                                   ....-+.|.+|++|.|+.| +-|+++.|+||-|||
T Consensus       157 ---------------------------------------------cysaevvtlwyrppdvlfgakly~tsidmwsagci  191 (292)
T KOG0662|consen  157 ---------------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI  191 (292)
T ss_pred             ---------------------------------------------eeeceeeeeeccCcceeeeeehhccchHhhhcchH
Confidence                                                         1112378999999999987 459999999999999


Q ss_pred             HHhhcc
Q 018275          345 TLSCNY  350 (358)
Q Consensus       345 l~e~l~  350 (358)
                      +.|+-.
T Consensus       192 faelan  197 (292)
T KOG0662|consen  192 FAELAN  197 (292)
T ss_pred             HHHHhh
Confidence            999654

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.1e-34  Score=265.84  Aligned_cols=196  Identities=29%  Similarity=0.438  Sum_probs=169.6

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      .|...+.||.|++|.||++.+..++..+++|.+....   ......+.+|+.+++.++||||+++++++...+..++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            4555679999999999999998899999999886432   2334557889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      |+++++|.+++.. .++++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........     
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-----  170 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-----  170 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-----
Confidence            9999999999866 6788999999999999999999999999999999999999999999999998765421100     


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETL  346 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~  346 (358)
                                                                  ......|++.|+|||++.+..++.++|+|||||++|
T Consensus       171 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~  206 (285)
T cd06648         171 --------------------------------------------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI  206 (285)
T ss_pred             --------------------------------------------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHH
Confidence                                                        001236899999999999999999999999999999


Q ss_pred             hhccccccc
Q 018275          347 SCNYLSDIM  355 (358)
Q Consensus       347 e~l~~~~~~  355 (358)
                      ||+.+...|
T Consensus       207 ell~g~~p~  215 (285)
T cd06648         207 EMVDGEPPY  215 (285)
T ss_pred             HHHhCCCCC
Confidence            999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.8e-35  Score=267.06  Aligned_cols=185  Identities=17%  Similarity=0.219  Sum_probs=156.2

Q ss_pred             eEeeeeeEEEEEEEEecCCC-------EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          113 IIGRGAFGEVRLCQEKKSGN-------IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~~~~~~-------~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      .||+|+||.||+|.+...+.       .||+|.+....   ....+.+.+|..+++.++||||+++++++..+...++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            68999999999998765443       48888876542   334456788999999999999999999999988999999


Q ss_pred             eecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc--------EEEEecCCCccC
Q 018275          186 EYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH--------MKLSDFGLCKPL  256 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~--------vkl~DFGla~~~  256 (358)
                      ||+++|+|..++.... .+++.....++.|++.||.|||+.||+||||||+|||++.++.        ++++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999999997654 5788888999999999999999999999999999999987765        689999987643


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCcc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGME  335 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~  335 (358)
                      ...                                                     ....|++.|+|||++.+ ..++.+
T Consensus       159 ~~~-----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~  185 (258)
T cd05078         159 LPK-----------------------------------------------------EILLERIPWVPPECIENPQNLSLA  185 (258)
T ss_pred             CCc-----------------------------------------------------hhccccCCccCchhccCCCCCCch
Confidence            211                                                     02358889999999987 458999


Q ss_pred             chhhhhhHHHHhhccccc
Q 018275          336 CDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~  353 (358)
                      +|+|||||++||++.+..
T Consensus       186 ~DiwslG~~l~~l~~g~~  203 (258)
T cd05078         186 ADKWSFGTTLWEIFSGGD  203 (258)
T ss_pred             hhHHHHHHHHHHHHcCCC
Confidence            999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=299.83  Aligned_cols=202  Identities=22%  Similarity=0.333  Sum_probs=171.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCC-----CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSG-----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      ++....++.+.||+|+||.||.|......     ..||||.+++..  +...+..|..|..+|+.++|||||+++|++.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            45678889999999999999999876432     249999988764  56778889999999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEec
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMRE-------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF  250 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DF  250 (358)
                      ....+|++|||.||||..+|...       ..++......++.+|+.|+.||+++++|||||...|+||+....+||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999764       35788888999999999999999999999999999999999999999999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK  330 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~  330 (358)
                      |+|+.+...+.-...                                          .     -..-...|||||.|..+
T Consensus       847 GlArDiy~~~yyr~~------------------------------------------~-----~a~lPvkWm~PEsl~d~  879 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKH------------------------------------------G-----EAMLPVKWMPPESLKDG  879 (1025)
T ss_pred             chhHhhhhchheecc------------------------------------------C-----ccccceecCCHHHHhhc
Confidence            999944322111000                                          0     00123569999999999


Q ss_pred             CCCccchhhhhhHHHHhhccccc
Q 018275          331 GYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                      .++.++|||||||+|||++.+..
T Consensus       880 iFtskSDvWsFGVllWEifslG~  902 (1025)
T KOG1095|consen  880 IFTSKSDVWSFGVLLWEIFSLGA  902 (1025)
T ss_pred             ccccccchhhhHHHHHHHHhCCC
Confidence            99999999999999999988654

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.2e-34  Score=269.65  Aligned_cols=201  Identities=29%  Similarity=0.399  Sum_probs=168.4

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC--CEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYL  181 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~  181 (358)
                      ..++|++.+.||.|+||.||+|.+..+|..||+|.++.... .......+.+|+.+++.++|+||+++++++.+.  +.+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            46899999999999999999999999999999999875432 122223356799999999999999999998754  568


Q ss_pred             EEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      ++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            99999996 588888865 3678999999999999999999999999999999999999999999999999987654211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Diw  339 (358)
                      ..                                                 .....+++.|+|||++.+ ..++.++|+|
T Consensus       163 ~~-------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw  193 (309)
T cd07845         163 KP-------------------------------------------------MTPKVVTLWYRAPELLLGCTTYTTAIDMW  193 (309)
T ss_pred             CC-------------------------------------------------CCcccccccccChhhhcCCCCcCchHHHH
Confidence            00                                                 001246889999999875 5689999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      ||||++||++++..+|
T Consensus       194 slG~il~el~~g~~~f  209 (309)
T cd07845         194 AVGCILAELLAHKPLL  209 (309)
T ss_pred             HHHHHHHHHHhCCCCC
Confidence            9999999999987665

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3e-34  Score=263.24  Aligned_cols=201  Identities=22%  Similarity=0.275  Sum_probs=166.4

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..++|.+.+.||+|+||.||+|.+...   ...||||.+....  .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            446799999999999999999987544   4579999887543  23455678899999999999999999999876 45


Q ss_pred             EEEEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .|+||||+++++|.+++.... .+++..+..++.+++.||.|||+.+++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            789999999999999997643 5889999999999999999999999999999999999999999999999998765322


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ....                                                .....+++.|+|||++.+..++.++|+|
T Consensus       161 ~~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~  192 (270)
T cd05056         161 SYYK------------------------------------------------ASKGKLPIKWMAPESINFRRFTSASDVW  192 (270)
T ss_pred             ccee------------------------------------------------cCCCCccccccChhhhccCCCCchhhhH
Confidence            1000                                                0012356789999999999999999999


Q ss_pred             hhhHHHHhhcc-ccccc
Q 018275          340 AYWNETLSCNY-LSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~-~~~~~  355 (358)
                      ||||++||+++ +...|
T Consensus       193 slG~il~el~~~g~~pf  209 (270)
T cd05056         193 MFGVCMWEILMLGVKPF  209 (270)
T ss_pred             HHHHHHHHHHHcCCCCC
Confidence            99999999885 55443

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.6e-34  Score=261.46  Aligned_cols=194  Identities=24%  Similarity=0.344  Sum_probs=162.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|.+...||+|+||.||+|.+..+ ..+|+|.+.....    ....+.+|+.+++.++|||++++++.+. .+..+
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY   76 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence            3457799999999999999999987655 4699998875432    2345778999999999999999998885 45689


Q ss_pred             EEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +||||+++++|.+++...  ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999999999654  347888889999999999999999999999999999999999999999999997653211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ..                                                ......++..|+|||++.+..++.++|+||
T Consensus       157 ~~------------------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s  188 (260)
T cd05069         157 YT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWS  188 (260)
T ss_pred             cc------------------------------------------------ccCCCccchhhCCHHHhccCCcChHHHHHH
Confidence            00                                                001224677899999999999999999999


Q ss_pred             hhHHHHhhcc
Q 018275          341 YWNETLSCNY  350 (358)
Q Consensus       341 lGvil~e~l~  350 (358)
                      |||++||+++
T Consensus       189 lG~~l~el~t  198 (260)
T cd05069         189 FGILLTELVT  198 (260)
T ss_pred             HHHHHHHHHh
Confidence            9999999988

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.1e-34  Score=259.11  Aligned_cols=188  Identities=26%  Similarity=0.346  Sum_probs=158.6

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g  191 (358)
                      +.||+|+||.||+|.. .++..||+|.+....  .......+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            3689999999999985 468899999987543  2333446888999999999999999999999999999999999999


Q ss_pred             CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          192 DVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       192 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      +|.+++... ..+++..+..++.+++.||.|||+.|++|+||||+||+++.++.+||+|||++..........       
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-------  150 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-------  150 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc-------
Confidence            999998654 467888999999999999999999999999999999999999999999999986543111000       


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                               .....+++.|+|||++.+..++.++|+|||||++|+++.
T Consensus       151 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~  189 (250)
T cd05085         151 -----------------------------------------SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS  189 (250)
T ss_pred             -----------------------------------------CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence                                                     001134677999999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.5e-34  Score=259.97  Aligned_cols=194  Identities=27%  Similarity=0.352  Sum_probs=167.2

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCC----CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSG----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      |++.+.||.|+||.||+|.+...+    ..||+|++....  .......+..|+.++..++|+||+++++.+.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            456789999999999999988766    899999997653  22256678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          184 IMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      +|||+++++|.+++.....  +++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999976544  89999999999999999999999999999999999999999999999999876542210


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      ...                                                ....+++.|+|||.+.+..++.++|+|||
T Consensus       159 ~~~------------------------------------------------~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl  190 (258)
T smart00219      159 YKK------------------------------------------------KGGKLPIRWMAPESLKDGKFTSKSDVWSF  190 (258)
T ss_pred             ccc------------------------------------------------ccCCCcccccChHHhccCCCCcchhHHHH
Confidence            000                                                01137889999999988899999999999


Q ss_pred             hHHHHhhccc
Q 018275          342 WNETLSCNYL  351 (358)
Q Consensus       342 Gvil~e~l~~  351 (358)
                      ||++|++++.
T Consensus       191 G~i~~~l~~~  200 (258)
T smart00219      191 GVLLWEIFTL  200 (258)
T ss_pred             HHHHHHHHhC
Confidence            9999999873

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-34  Score=265.33  Aligned_cols=182  Identities=17%  Similarity=0.184  Sum_probs=151.8

Q ss_pred             eEeeeeeEEEEEEEEecC------------------------CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcce
Q 018275          113 IIGRGAFGEVRLCQEKKS------------------------GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI  168 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~~~~------------------------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i  168 (358)
                      .||+|+||.||+|....+                        ...||+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            699999999999975322                        2468999987543   2334557788999999999999


Q ss_pred             EEEEEEeecCCEEEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC----
Q 018275          169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----  243 (358)
Q Consensus       169 v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----  243 (358)
                      +++++++.+....++||||+++|+|..++.. .+.+++..+..++.|++.||.|||+.+|+||||||+|||++.++    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999999865 45788999999999999999999999999999999999997654    


Q ss_pred             ---cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCC
Q 018275          244 ---HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD  320 (358)
Q Consensus       244 ---~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~  320 (358)
                         .+|++|||++.......                                                     ...+++.
T Consensus       159 ~~~~~kl~d~g~~~~~~~~~-----------------------------------------------------~~~~~~~  185 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSRE-----------------------------------------------------ERVERIP  185 (274)
T ss_pred             ccceeeecCCcccccccccc-----------------------------------------------------ccccCCc
Confidence               48999999875432100                                                     1257888


Q ss_pred             CchhhhhcC-CCCCccchhhhhhHHHHhhcc
Q 018275          321 YIAPEVLLK-KGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       321 Y~APEv~~~-~~y~~~~DiwSlGvil~e~l~  350 (358)
                      |+|||++.+ ..++.++|+|||||++||+++
T Consensus       186 ~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~  216 (274)
T cd05076         186 WIAPECVPGGNSLSTAADKWSFGTTLLEICF  216 (274)
T ss_pred             ccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence            999999875 568999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.2e-34  Score=259.91  Aligned_cols=195  Identities=24%  Similarity=0.350  Sum_probs=164.3

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ++..++|.+.+.||+|+||.||++.+. .+..+|+|.+....    .....+.+|+.+++.++|+||+++++.+.+ ...
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   75 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI   75 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence            355689999999999999999999754 45679999887542    234568889999999999999999999987 778


Q ss_pred             EEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      +++|||+++++|.+++...  ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++..+...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999999999653  35677788889999999999999999999999999999999999999999998765321


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ....                                                .....++..|+|||++.+..++.++|+|
T Consensus       156 ~~~~------------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~  187 (260)
T cd05073         156 EYTA------------------------------------------------REGAKFPIKWTAPEAINFGSFTIKSDVW  187 (260)
T ss_pred             Cccc------------------------------------------------ccCCcccccccCHhHhccCCcCccccch
Confidence            1000                                                0012466789999999999999999999


Q ss_pred             hhhHHHHhhcc
Q 018275          340 AYWNETLSCNY  350 (358)
Q Consensus       340 SlGvil~e~l~  350 (358)
                      ||||++|++++
T Consensus       188 slG~~l~~l~t  198 (260)
T cd05073         188 SFGILLMEIVT  198 (260)
T ss_pred             HHHHHHHHHHh
Confidence            99999999997

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5e-34  Score=259.44  Aligned_cols=193  Identities=20%  Similarity=0.275  Sum_probs=164.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++.+.||.|+||.||+|.+. .+..+|+|.+.....    ....+.+|+.+++.++|||++++++++.+....++|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            468999999999999999999875 466899999875432    223477899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++++|.+++... .++++..+..++.+++.||.|||+.+++|+||||+||+++.++.++|+|||++..........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999998754 568899999999999999999999999999999999999999999999999987543111000


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      .....++..|+|||++.+..++.++|+|||||
T Consensus       158 ------------------------------------------------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~  189 (256)
T cd05112         158 ------------------------------------------------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGV  189 (256)
T ss_pred             ------------------------------------------------cCCCccchhhcCHhHhccCCcChHHHHHHHHH
Confidence                                                            00224567899999999999999999999999


Q ss_pred             HHHhhcc
Q 018275          344 ETLSCNY  350 (358)
Q Consensus       344 il~e~l~  350 (358)
                      ++||++.
T Consensus       190 ~l~el~~  196 (256)
T cd05112         190 LMWEVFS  196 (256)
T ss_pred             HHHHHHc
Confidence            9999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-34  Score=274.60  Aligned_cols=203  Identities=24%  Similarity=0.384  Sum_probs=171.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee----cCCEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ----DAEYL  181 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~----~~~~~  181 (358)
                      ++|++.+.||.|+||.||+|.+..++..||+|++..... .......+..|+.+++.++||||++++++|.    +...+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            789999999999999999999999999999999876432 2334556778999999999999999998875    34578


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||+. ++|.+++.....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++........
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999995 68999998778899999999999999999999999999999999999999999999999999876542211


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLA  340 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwS  340 (358)
                      ...                                             ......+|++.|+|||++.+ ..++.++|+||
T Consensus       163 ~~~---------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s  197 (334)
T cd07855         163 EHK---------------------------------------------YFMTEYVATRWYRAPELLLSLPEYTTAIDMWS  197 (334)
T ss_pred             CCC---------------------------------------------cccccccccccccChHHhcCCcccccccchHH
Confidence            100                                             00113478999999999876 56899999999


Q ss_pred             hhHHHHhhccccccc
Q 018275          341 YWNETLSCNYLSDIM  355 (358)
Q Consensus       341 lGvil~e~l~~~~~~  355 (358)
                      |||++|||+.+..+|
T Consensus       198 lG~~l~el~~g~~pf  212 (334)
T cd07855         198 VGCIFAEMLGRRQLF  212 (334)
T ss_pred             HHHHHHHHHcCCCcc
Confidence            999999999877665

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-34  Score=262.22  Aligned_cols=201  Identities=46%  Similarity=0.756  Sum_probs=171.6

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCH
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV  193 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L  193 (358)
                      ||.|+||.||+|.+..+++.|++|.+.............+.+|+.+++.++||||+++++.+.+....|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999989999999999876554456677788999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccc
Q 018275          194 MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE  273 (358)
Q Consensus       194 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.............       
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~-------  153 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND-------  153 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc-------
Confidence            9999887789999999999999999999999999999999999999999999999999987543221100000       


Q ss_pred             cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccccc
Q 018275          274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                                                        .........+++.|+|||++.+..++.++|+||||+++|+++.+..
T Consensus       154 ----------------------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~  199 (265)
T cd05579         154 ----------------------------------DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP  199 (265)
T ss_pred             ----------------------------------ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence                                              0000113468899999999999889999999999999999998766


Q ss_pred             cc
Q 018275          354 IM  355 (358)
Q Consensus       354 ~~  355 (358)
                      .|
T Consensus       200 p~  201 (265)
T cd05579         200 PF  201 (265)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.3e-34  Score=261.53  Aligned_cols=194  Identities=18%  Similarity=0.231  Sum_probs=156.9

Q ss_pred             eeEeeeeeEEEEEEEEec---CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee-cCCEEEEEEee
Q 018275          112 TIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DAEYLYLIMEY  187 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-~~~~~~lV~E~  187 (358)
                      +.||+|+||.||+|.+..   ....||+|.+....  .......+..|+.+++.++||||+++++.+. .+...++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            368999999999998653   34579999885432  2344566888999999999999999999775 45568999999


Q ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          188 LPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       188 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      +++++|.+++... ...+......++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++.+......... 
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~-  157 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH-  157 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec-
Confidence            9999999999764 34567777888899999999999999999999999999999999999999998755321110000 


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETL  346 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~  346 (358)
                                                                  ......+++.|+|||++.+..++.++|||||||++|
T Consensus       158 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~  193 (262)
T cd05058         158 --------------------------------------------NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW  193 (262)
T ss_pred             --------------------------------------------ccccCcCCccccChhHhccCccchHHHHHHHHHHHH
Confidence                                                        001224678899999999999999999999999999


Q ss_pred             hhcccc
Q 018275          347 SCNYLS  352 (358)
Q Consensus       347 e~l~~~  352 (358)
                      ||+++.
T Consensus       194 el~~~~  199 (262)
T cd05058         194 ELMTRG  199 (262)
T ss_pred             HHHcCC
Confidence            998853

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.3e-34  Score=266.52  Aligned_cols=198  Identities=26%  Similarity=0.374  Sum_probs=165.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ++|...+.||+|+||.||++.+..++..||+|.+.....  ......+..|+.++.++. ||||+++++++.++...+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            567778899999999999999999999999999876532  244556788999999996 99999999999999999999


Q ss_pred             EeecCCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          185 MEYLPGGDVMTLLM-----REETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       185 ~E~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      |||++ +++.++..     ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++.+..
T Consensus        82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            99985 45555432     236789999999999999999999974 999999999999999999999999999875432


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC---CCCcc
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK---GYGME  335 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~---~y~~~  335 (358)
                      ....                                                  ....|++.|+|||++.+.   .++.+
T Consensus       161 ~~~~--------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~  190 (288)
T cd06616         161 SIAK--------------------------------------------------TRDAGCRPYMAPERIDPSARDGYDVR  190 (288)
T ss_pred             CCcc--------------------------------------------------ccccCccCccCHHHhccccccCCcch
Confidence            1100                                                  122588999999999876   68999


Q ss_pred             chhhhhhHHHHhhcccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +|+|||||++|||+++..+|.
T Consensus       191 ~Di~slG~il~el~~g~~p~~  211 (288)
T cd06616         191 SDVWSLGITLYEVATGKFPYP  211 (288)
T ss_pred             hhhhHHHHHHHHHHhCCCCch
Confidence            999999999999998877653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.2e-34  Score=263.06  Aligned_cols=200  Identities=29%  Similarity=0.463  Sum_probs=175.0

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      -..+.|++...||+|+||.||+|.+..++..|++|++.....    ....+..|+.+++.++|+|++++++.+......|
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            345789999999999999999999988899999999876532    4456788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      +|+||+++++|.+++.... .++...+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            9999999999999998776 899999999999999999999999999999999999999999999999998865432110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      .                                                 .....|++.|+|||++.+..++.++|+|||
T Consensus       172 ~-------------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  202 (286)
T cd06614         172 K-------------------------------------------------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSL  202 (286)
T ss_pred             h-------------------------------------------------hccccCCcccCCHhHhcCCCCCCccccHHH
Confidence            0                                                 012358899999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|+|+.+..+|
T Consensus       203 Gvil~~l~~g~~p~  216 (286)
T cd06614         203 GIMCIEMAEGEPPY  216 (286)
T ss_pred             HHHHHHHHhCCCCC
Confidence            99999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.2e-34  Score=266.36  Aligned_cols=204  Identities=27%  Similarity=0.364  Sum_probs=166.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----  179 (358)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++.+..     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            4789999999999999999999999999999999865432 2222334567999999999999999999986553     


Q ss_pred             ---EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          180 ---YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       180 ---~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                         ..++||||+. ++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++..
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence               4599999996 5888877654 3789999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGM  334 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~  334 (358)
                      +........                                             ......++++.|+|||++.+. .++.
T Consensus       169 ~~~~~~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~  203 (310)
T cd07865         169 FSLSKNSKP---------------------------------------------NRYTNRVVTLWYRPPELLLGERDYGP  203 (310)
T ss_pred             ccCCcccCC---------------------------------------------CCccCcccCccccCcHHhcCCcccCc
Confidence            642211100                                             001123688999999998764 4789


Q ss_pred             cchhhhhhHHHHhhccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ++|+||||+++||++++..+|
T Consensus       204 ~~Di~slG~~l~el~t~~~~~  224 (310)
T cd07865         204 PIDMWGAGCIMAEMWTRSPIM  224 (310)
T ss_pred             hhhhHHHHHHHHHHHhCCCCC
Confidence            999999999999998876544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.3e-34  Score=262.84  Aligned_cols=202  Identities=25%  Similarity=0.363  Sum_probs=168.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEe----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--CC
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEK----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AE  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~  179 (358)
                      .+|.+.+.||+|+||.||+|...    .++..||+|.+......  .....+.+|+.+++.+.||||+++++++.+  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            56888899999999999999864    34789999999865321  345678999999999999999999999877  56


Q ss_pred             EEEEEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            7999999999999999997654 688899999999999999999999999999999999999999999999999987642


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ......                                              ......++..|+|||.+.+..++.++|+
T Consensus       162 ~~~~~~----------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Di  195 (284)
T cd05038         162 DKDYYY----------------------------------------------VKEPGESPIFWYAPECLRTSKFSSASDV  195 (284)
T ss_pred             CCccee----------------------------------------------ccCCCCCcccccCcHHHccCCCCcccch
Confidence            211000                                              0001135567999999999999999999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      |||||++|||+++...+
T Consensus       196 ~slG~~l~el~tg~~p~  212 (284)
T cd05038         196 WSFGVTLYELFTYGDPS  212 (284)
T ss_pred             HHHhhhhheeeccCCCc
Confidence            99999999999876543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.9e-34  Score=262.01  Aligned_cols=190  Identities=18%  Similarity=0.199  Sum_probs=152.3

Q ss_pred             eEeeeeeEEEEEEEEecC--CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          113 IIGRGAFGEVRLCQEKKS--GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      .||+|+||.||+|.....  ...+++|.+....  .......+.+|+.+++.++||||+++++.|.+....|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            589999999999975433  3356677665442  233456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          191 GDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       191 g~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      |+|.+++...    ..++...+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++.........    
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~----  155 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI----  155 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh----
Confidence            9999999653    24566677888999999999999999999999999999999999999999987643211000    


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-------CCCCccchhh
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-------KGYGMECDWL  339 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-------~~y~~~~Diw  339 (358)
                                                                 ......+|++.|+|||++..       ..++.++|||
T Consensus       156 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw  192 (268)
T cd05086         156 -------------------------------------------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVW  192 (268)
T ss_pred             -------------------------------------------hcccCCcCcccccCchhcccccCccccCCCCCcchhH
Confidence                                                       00013468899999999853       3467899999


Q ss_pred             hhhHHHHhhccc
Q 018275          340 AYWNETLSCNYL  351 (358)
Q Consensus       340 SlGvil~e~l~~  351 (358)
                      ||||++|||+.+
T Consensus       193 slG~~l~el~~~  204 (268)
T cd05086         193 ALGVTLWELFEN  204 (268)
T ss_pred             HHHHHHHHHHhC
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-34  Score=257.38  Aligned_cols=190  Identities=25%  Similarity=0.312  Sum_probs=161.5

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g  191 (358)
                      ++||.|+||.||+|.+.. ++.||+|.+.....  ......+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            468999999999999877 99999999876542  234566889999999999999999999999999999999999999


Q ss_pred             CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccc
Q 018275          192 DVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL  270 (358)
Q Consensus       192 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  270 (358)
                      +|.+++.. ...++...+..++.+++.||.|||+.+++||||+|+|||++.++.++|+|||++...........      
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~------  151 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS------  151 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec------
Confidence            99999865 35678888899999999999999999999999999999999999999999999875531110000      


Q ss_pred             ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc
Q 018275          271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~  350 (358)
                                                               .....++..|+|||++.+..++.++|+|||||++|||+.
T Consensus       152 -----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t  190 (251)
T cd05041         152 -----------------------------------------DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS  190 (251)
T ss_pred             -----------------------------------------cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence                                                     001134667999999999999999999999999999997


Q ss_pred             c
Q 018275          351 L  351 (358)
Q Consensus       351 ~  351 (358)
                      +
T Consensus       191 ~  191 (251)
T cd05041         191 L  191 (251)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-34  Score=264.38  Aligned_cols=197  Identities=29%  Similarity=0.430  Sum_probs=168.3

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEee
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      |++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.++|||++++++++.+....|+||||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            6778999999999999999999999999999876532 223345577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          188 LPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       188 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ++ ++|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+......   
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---  155 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT---  155 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc---
Confidence            95 68999987655  7899999999999999999999999999999999999999999999999998755321100   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGvi  344 (358)
                                                                    ....++++.|+|||++.+. .++.++|+|||||+
T Consensus       156 ----------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~  189 (283)
T cd07835         156 ----------------------------------------------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI  189 (283)
T ss_pred             ----------------------------------------------cCccccccCCCCCceeecCcccCcHHHHHHHHHH
Confidence                                                          0123578999999998764 57899999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|+|+++..+|
T Consensus       190 l~~l~~g~~pf  200 (283)
T cd07835         190 FAEMVNRRPLF  200 (283)
T ss_pred             HHHHHhCCCCC
Confidence            99999987655

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7e-34  Score=261.96  Aligned_cols=195  Identities=30%  Similarity=0.422  Sum_probs=161.9

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecC--CEEEEE
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDA--EYLYLI  184 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~--~~~~lV  184 (358)
                      |++.+.||+|+||.||+|.+..++..||+|.++.... ..... ....|+.++.++. |+|++++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6788999999999999999999999999999876431 22222 2446888888885 99999999999987  889999


Q ss_pred             EeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||++ ++|.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++. +.+||+|||+++.+...... 
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~-  155 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY-  155 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence            99996 588887765 357899999999999999999999999999999999999999 99999999999765321100 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlG  342 (358)
                                                                       ....+++.|+|||++.+ ..++.++|+||||
T Consensus       156 -------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  186 (282)
T cd07831         156 -------------------------------------------------TEYISTRWYRAPECLLTDGYYGPKMDIWAVG  186 (282)
T ss_pred             -------------------------------------------------CCCCCCcccCChhHhhcCCCCCcchhHHHHH
Confidence                                                             02258899999998754 5578999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|||+++...|.
T Consensus       187 v~l~el~~~~~p~~  200 (282)
T cd07831         187 CVFFEILSLFPLFP  200 (282)
T ss_pred             HHHHHHHcCCcCCC
Confidence            99999998876553

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=254.86  Aligned_cols=199  Identities=28%  Similarity=0.458  Sum_probs=176.5

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|+.+++.++|||++++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            58889999999999999999998999999999987643 23456778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........    
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~----  155 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD----  155 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence            9999999999988888999999999999999999999999999999999999999999999999999866422110    


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETL  346 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~  346 (358)
                                                                   .....|++.|+|||.+.+..++.++|+||||+++|
T Consensus       156 ---------------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~  190 (254)
T cd06627         156 ---------------------------------------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVI  190 (254)
T ss_pred             ---------------------------------------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHH
Confidence                                                         01236889999999999888999999999999999


Q ss_pred             hhccccccc
Q 018275          347 SCNYLSDIM  355 (358)
Q Consensus       347 e~l~~~~~~  355 (358)
                      +++.+...|
T Consensus       191 ~l~~g~~p~  199 (254)
T cd06627         191 ELLTGNPPY  199 (254)
T ss_pred             HHHhCCCCC
Confidence            999877554

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.8e-34  Score=270.97  Aligned_cols=201  Identities=24%  Similarity=0.349  Sum_probs=170.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC-----C
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----E  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~  179 (358)
                      .++|.+.+.||+|+||.||+|.+..++..||||.+..... .......+..|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            3679999999999999999999999999999999875422 233344567899999999999999999887644     3


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ..|+||||+. ++|.+++.....+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            5899999995 689999988888999999999999999999999999999999999999999999999999998765321


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Di  338 (358)
                      ..                                                 .....+||+.|+|||++.+ ..++.++|+
T Consensus       162 ~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  192 (337)
T cd07858         162 GD-------------------------------------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDV  192 (337)
T ss_pred             cc-------------------------------------------------cccccccccCccChHHHhcCCCCCCcccH
Confidence            10                                                 0012368899999999875 568999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||++|+|+.+..+|.
T Consensus       193 wslG~il~~l~~g~~pf~  210 (337)
T cd07858         193 WSVGCIFAELLGRKPLFP  210 (337)
T ss_pred             HHHHHHHHHHHcCCCCCC
Confidence            999999999998887663

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.7e-34  Score=258.36  Aligned_cols=199  Identities=31%  Similarity=0.539  Sum_probs=171.6

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|.+.+.||+|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++|+||+++++.+.+....++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            58899999999999999999999999999999877543 22344567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-cEEEEecCCCccCCCCCCcc
Q 018275          187 YLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~vkl~DFGla~~~~~~~~~~  263 (358)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .+||+|||.+........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--  157 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--  157 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence            999999999986543  578999999999999999999999999999999999999886 469999999876532110  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                     ......|++.|+|||++.+..++.++|+|||||
T Consensus       158 -----------------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~  190 (257)
T cd08225         158 -----------------------------------------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGC  190 (257)
T ss_pred             -----------------------------------------------cccccCCCccccCHHHHcCCCCCchhhHHHHHH
Confidence                                                           011235899999999999999999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++||++.+...|
T Consensus       191 il~~l~~g~~p~  202 (257)
T cd08225         191 VLYELCTLKHPF  202 (257)
T ss_pred             HHHHHHhCCCCC
Confidence            999999876654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-33  Score=269.29  Aligned_cols=197  Identities=27%  Similarity=0.386  Sum_probs=166.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC------
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------  178 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..++||||+++++++...      
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            4889999999999999999999989999999999875421 223345577899999999999999999988643      


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            3478899887 7899887754 4688999999999999999999999999999999999999999999999999875421


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~D  337 (358)
                      ..                                                    ....||+.|+|||++.+ ..++.++|
T Consensus       173 ~~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~D  200 (345)
T cd07877         173 EM----------------------------------------------------TGYVATRWYRAPEIMLNWMHYNQTVD  200 (345)
T ss_pred             cc----------------------------------------------------cccccCCCccCHHHHhCccCCCchhh
Confidence            10                                                    02368899999999876 57899999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      +|||||++|||+.+...|.
T Consensus       201 vwslG~il~el~~g~~pf~  219 (345)
T cd07877         201 IWSVGCIMAELLTGRTLFP  219 (345)
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999877663

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-34  Score=262.33  Aligned_cols=198  Identities=29%  Similarity=0.443  Sum_probs=169.0

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC--CEEEEEE
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYLYLIM  185 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lV~  185 (358)
                      |++.+.||.|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++.+.  ...++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            678899999999999999999899999999998764 2233445577899999999999999999999988  8999999


Q ss_pred             eecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......... 
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~-  157 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD-  157 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc-
Confidence            99974 898888665 578999999999999999999999999999999999999999999999999988664322100 


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlGv  343 (358)
                                                                     .....+++.|+|||.+.+ ..++.++|+||||+
T Consensus       158 -----------------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~  190 (287)
T cd07840         158 -----------------------------------------------YTNRVITLWYRPPELLLGATRYGPEVDMWSVGC  190 (287)
T ss_pred             -----------------------------------------------ccccccccccCCceeeEccccCChHHHHHHHHH
Confidence                                                           012257889999998765 46889999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++||++++...|
T Consensus       191 ~l~el~t~~~p~  202 (287)
T cd07840         191 ILAELFLGKPIF  202 (287)
T ss_pred             HHHHHHhCCCCC
Confidence            999999987655

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-33  Score=264.81  Aligned_cols=194  Identities=27%  Similarity=0.401  Sum_probs=166.5

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEee
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      |...+.||+|+||.||+|.+..++..|++|.+.............+..|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999999899999999998765443445556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          188 LPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       188 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      ++ |++.+++.. ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......       
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-------  174 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-------  174 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-------
Confidence            96 577777754 457889999999999999999999999999999999999999999999999987532100       


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCccchhhhhhH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWLAYWN  343 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~~~DiwSlGv  343 (358)
                                                                    ....|++.|+|||++.   +..++.++|+|||||
T Consensus       175 ----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGv  208 (313)
T cd06633         175 ----------------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  208 (313)
T ss_pred             ----------------------------------------------CCccccccccChhhccccCCCCCCchhhHHHHHH
Confidence                                                          0236889999999984   456889999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|+|+.+...|
T Consensus       209 il~el~~g~~p~  220 (313)
T cd06633         209 TCIELAERKPPL  220 (313)
T ss_pred             HHHHHHhCCCCC
Confidence            999999877654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-33  Score=262.15  Aligned_cols=201  Identities=39%  Similarity=0.635  Sum_probs=170.5

Q ss_pred             CceeeeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhhc-hhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~~-~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~  181 (358)
                      +|++.+.||+|+||.||++.+.   .++..||||++++..... ......+..|+.++..+ +||||+++++.+.+....
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999998764   467899999997654322 23445678899999999 599999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||+++++|.+++.....+++..++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||+++.+.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            99999999999999998778899999999999999999999999999999999999999999999999999876532110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC--CCccchhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--YGMECDWL  339 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~--y~~~~Diw  339 (358)
                      .                                                ......|++.|+|||++.+..  ++.++|+|
T Consensus       161 ~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~  192 (288)
T cd05583         161 E------------------------------------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWW  192 (288)
T ss_pred             c------------------------------------------------ccccccCCccccCHHHhcCCCCCCcchhhhH
Confidence            0                                                011346899999999997765  78899999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      |||+++|||+++...|
T Consensus       193 slG~il~el~tg~~p~  208 (288)
T cd05583         193 SLGVLTFELLTGASPF  208 (288)
T ss_pred             HHHHHHHHHHhCCCCc
Confidence            9999999999877655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.9e-33  Score=252.20  Aligned_cols=196  Identities=33%  Similarity=0.504  Sum_probs=173.8

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|...+.||+|++|.||++.+..++..+++|++.....   .....+.+|+.+++.++|++++++++.+.+....++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            47888999999999999999988999999999976542   345668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          187 YLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       187 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      |+++++|.+++... ..+++..+..++.|++.||.+||..|++|+||+|+||+++.++.++|+|||.+........    
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----  153 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----  153 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence            99999999999776 5889999999999999999999999999999999999999999999999999876542210    


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                    .....|+..|+|||++.+..++.++|+||||+++
T Consensus       154 ----------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il  187 (253)
T cd05122         154 ----------------------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA  187 (253)
T ss_pred             ----------------------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHH
Confidence                                                          0123688999999999988899999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |+|+++...|
T Consensus       188 ~~l~~g~~p~  197 (253)
T cd05122         188 IELAEGKPPY  197 (253)
T ss_pred             HHHHhCCCCC
Confidence            9999987654

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.8e-33  Score=253.34  Aligned_cols=201  Identities=31%  Similarity=0.472  Sum_probs=176.7

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC--CEEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYLYLI  184 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lV  184 (358)
                      +|...+.||+|++|.||+|.+..++..|++|++..... .......+.+|+.+++.++||||+++++.+.+.  ...++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            47888999999999999999998999999999876643 245567788999999999999999999999988  899999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      +||+++++|.+++.....+++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~-  158 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE-  158 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc-
Confidence            9999999999999887789999999999999999999999999999999999999999999999999988665322100 


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                    ......+++.|+|||.+.+..++.++|+||||++
T Consensus       159 ----------------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~i  192 (260)
T cd06606         159 ----------------------------------------------GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCT  192 (260)
T ss_pred             ----------------------------------------------cccCCCCCccccCHhhhcCCCCCchhhHHHHHHH
Confidence                                                          0012368899999999999889999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|+++.+...|
T Consensus       193 l~~l~~g~~p~  203 (260)
T cd06606         193 VIEMATGKPPW  203 (260)
T ss_pred             HHHHHhCCCCC
Confidence            99999977655

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-33  Score=268.47  Aligned_cols=196  Identities=28%  Similarity=0.397  Sum_probs=167.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----  179 (358)
                      .++|++++.||+|+||.||+|.+..++..||||.+.... ........+.+|+.+++.++||||+++++++....     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            478999999999999999999999999999999986532 12333456778999999999999999999987654     


Q ss_pred             -EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 -~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                       ..++||||+ +++|..++. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence             458999999 779988875 45789999999999999999999999999999999999999999999999999875431


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~D  337 (358)
                      ..                                                    ....+++.|+|||++.+ ..++.++|
T Consensus       171 ~~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~D  198 (343)
T cd07880         171 EM----------------------------------------------------TGYVVTRWYRAPEVILNWMHYTQTVD  198 (343)
T ss_pred             Cc----------------------------------------------------cccccCCcccCHHHHhCCCCCCcHHH
Confidence            10                                                    02357899999999976 45889999


Q ss_pred             hhhhhHHHHhhccccccc
Q 018275          338 WLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~  355 (358)
                      +|||||++|+++.+..+|
T Consensus       199 i~slG~ll~~l~~g~~pf  216 (343)
T cd07880         199 IWSVGCIMAEMLTGKPLF  216 (343)
T ss_pred             HHHHHHHHHHHHhCCCCC
Confidence            999999999999887655

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=263.63  Aligned_cols=201  Identities=26%  Similarity=0.425  Sum_probs=165.2

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHH-HHHhcCcceEEEEEEeecCC
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~h~~iv~l~~~~~~~~  179 (358)
                      ..+..++.+-+..||.|+||+|++..++.+|+..|||.++....  .....+++.|.+. ++.-+.||||++||++..++
T Consensus        59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG  136 (361)
T KOG1006|consen   59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG  136 (361)
T ss_pred             cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence            34555777788899999999999999999999999999987653  3344556667764 56668999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLM-----REETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      ..|+.||+|+ .+|..+..     ....+++..+-.+....+.||.||.. ..|||||+||+|||++..|.+||||||++
T Consensus       137 dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc  215 (361)
T KOG1006|consen  137 DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC  215 (361)
T ss_pred             ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence            9999999995 57666553     34678999999999999999999975 58999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc--CCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL--KKG  331 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~--~~~  331 (358)
                      ..+..+-..+                                                  --+|...|||||.+.  +.+
T Consensus       216 GqLv~SiAkT--------------------------------------------------~daGCrpYmAPERi~p~~~g  245 (361)
T KOG1006|consen  216 GQLVDSIAKT--------------------------------------------------VDAGCRPYMAPERIDPSDKG  245 (361)
T ss_pred             HhHHHHHHhh--------------------------------------------------hccCCccccChhccCCccCC
Confidence            8764221111                                                  126889999999996  467


Q ss_pred             CCccchhhhhhHHHHhhcccccc
Q 018275          332 YGMECDWLAYWNETLSCNYLSDI  354 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~~~~  354 (358)
                      |+.++|+||||++|||.-+|.++
T Consensus       246 yDiRSDvWSLGITL~EvAtG~fP  268 (361)
T KOG1006|consen  246 YDIRSDVWSLGITLYEVATGNFP  268 (361)
T ss_pred             cchhhhhhhhcceEeeeecCCCC
Confidence            99999999999999997665543

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2e-33  Score=254.51  Aligned_cols=200  Identities=33%  Similarity=0.560  Sum_probs=175.4

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|.+.+.||.|+||.||++.+..++..||+|++..... .......+..|+.+++.++|||++++++.+.+....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            58899999999999999999988999999999876542 23455668889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          187 YLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       187 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      |+++++|.+++...    ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  157 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--  157 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence            99999999999763    678999999999999999999999999999999999999999999999999987653221  


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                     .......|++.|+|||.+.+..++.++|+||+|
T Consensus       158 -----------------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG  190 (258)
T cd08215         158 -----------------------------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLG  190 (258)
T ss_pred             -----------------------------------------------ceecceeeeecccChhHhccCCCCccccHHHHH
Confidence                                                           001134689999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      +++|+++.+...|.
T Consensus       191 ~~~~~l~~g~~p~~  204 (258)
T cd08215         191 CVLYELCTLKHPFE  204 (258)
T ss_pred             HHHHHHHcCCCCCC
Confidence            99999998876653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7e-34  Score=260.35  Aligned_cols=195  Identities=24%  Similarity=0.286  Sum_probs=160.4

Q ss_pred             eeEeeeeeEEEEEEEEecCC------CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          112 TIIGRGAFGEVRLCQEKKSG------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +.||+|+||.||+|.+....      ..+|||.+....  .......+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999876433      689999886542  2234556888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-----cEEEEecCCC
Q 018275          186 EYLPGGDVMTLLMRE-------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-----HMKLSDFGLC  253 (358)
Q Consensus       186 E~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-----~vkl~DFGla  253 (358)
                      ||+++++|.+++...       ..++...+..++.|++.||.|||+.+++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998642       3467788889999999999999999999999999999999888     8999999998


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +..........                                               .....+++.|+|||++.+..++
T Consensus       159 ~~~~~~~~~~~-----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~  191 (269)
T cd05044         159 RDIYKSDYYRK-----------------------------------------------EGEGLLPVRWMAPESLLDGKFT  191 (269)
T ss_pred             ccccccccccc-----------------------------------------------CcccCCCccccCHHHHccCCcc
Confidence            76532111000                                               0012467889999999999999


Q ss_pred             ccchhhhhhHHHHhhcc-ccccc
Q 018275          334 MECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      .++|+|||||++||++. +...|
T Consensus       192 ~~~Dv~slG~il~ellt~g~~p~  214 (269)
T cd05044         192 TQSDVWSFGVLMWEILTLGQQPY  214 (269)
T ss_pred             cchhHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999986 54433

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-33  Score=267.08  Aligned_cols=202  Identities=24%  Similarity=0.329  Sum_probs=166.3

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecC--CCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeec----CC
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKS--GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD----AE  179 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~----~~  179 (358)
                      +|.+.+.||+|+||.||++.+..+  +..||+|.+.... ........+..|+.++..+ .||||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            488999999999999999999887  8999999987532 1223345577899999998 59999999987532    24


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ..|++++|+. ++|.+.+.....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.+...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            6789999985 699999988888999999999999999999999999999999999999999999999999999865422


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Di  338 (358)
                      .....                                             ......+||+.|+|||++.+ ..++.++|+
T Consensus       159 ~~~~~---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di  193 (332)
T cd07857         159 PGENA---------------------------------------------GFMTEYVATRWYRAPEIMLSFQSYTKAIDV  193 (332)
T ss_pred             ccccc---------------------------------------------ccccCcccCccccCcHHHhCCCCCCcHHHH
Confidence            11000                                             00113479999999998865 578999999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      |||||++|+|+.+..+|
T Consensus       194 ~slGv~l~~l~~g~~pf  210 (332)
T cd07857         194 WSVGCILAELLGRKPVF  210 (332)
T ss_pred             HHHHHHHHHHHhCCcCC
Confidence            99999999999887655

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=276.02  Aligned_cols=199  Identities=31%  Similarity=0.427  Sum_probs=174.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc-----hhhHHHHHHHHHHHHHhc---CcceEEEEEEeec
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-----RGQVEHVRAERNLLAEVA---SHCIVKLYYSFQD  177 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~  177 (358)
                      .+|..++.+|.|+||.|++|.++.....|+||.|.+..+.-     ......+-.|+.||+.++   |+||++++++|.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            56899999999999999999999999999999998875321     112233557999999997   9999999999999


Q ss_pred             CCEEEEEEeec-CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          178 AEYLYLIMEYL-PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       178 ~~~~~lV~E~~-~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ++++||+||-. +|-||.+++.....+++..++.++.|++.|+++||++||||||||-+||.++.+|.+||+|||.|...
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence            99999999975 45699999999999999999999999999999999999999999999999999999999999988654


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC-cc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG-ME  335 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~-~~  335 (358)
                      ...                                                   ....++||-+|.|||++.|.+|- ..
T Consensus       721 ksg---------------------------------------------------pfd~f~gtv~~aapevl~g~~y~gk~  749 (772)
T KOG1152|consen  721 KSG---------------------------------------------------PFDVFVGTVDYAAPEVLGGEKYLGKP  749 (772)
T ss_pred             cCC---------------------------------------------------CcceeeeeccccchhhhCCCccCCCc
Confidence            311                                                   12256899999999999999885 67


Q ss_pred             chhhhhhHHHHhhccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~  355 (358)
                      -|||+||++||-+.|.++.+
T Consensus       750 qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  750 QDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             chhhhhhheeeEEEeccCCC
Confidence            89999999999999988765

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-33  Score=258.52  Aligned_cols=196  Identities=27%  Similarity=0.379  Sum_probs=164.3

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh---cCcceEEEEEEeecCCE----
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQDAEY----  180 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~~iv~l~~~~~~~~~----  180 (358)
                      |++.+.||.|+||.||+|.+..++..||+|.++.... .......+.+|+.++..+   .|||++++++++.+...    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            6788999999999999999988899999999975432 222234466677777666   59999999999988776    


Q ss_pred             -EEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          181 -LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       181 -~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                       ++++|||++ ++|.+++...  ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             999999996 4898888664  358999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ....                                                  .....+++.|+|||++.+..++.++|
T Consensus       159 ~~~~--------------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~D  188 (287)
T cd07838         159 FEMA--------------------------------------------------LTSVVVTLWYRAPEVLLQSSYATPVD  188 (287)
T ss_pred             CCcc--------------------------------------------------cccccccccccChHHhccCCCCCcch
Confidence            2210                                                  01235789999999999999999999


Q ss_pred             hhhhhHHHHhhccccccc
Q 018275          338 WLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~  355 (358)
                      +|||||++|||+.+...|
T Consensus       189 i~s~G~~l~~l~~~~~~~  206 (287)
T cd07838         189 MWSVGCIFAELFRRRPLF  206 (287)
T ss_pred             hhhHHHHHHHHHhCCCcc
Confidence            999999999999876544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=255.54  Aligned_cols=194  Identities=45%  Similarity=0.774  Sum_probs=173.0

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCH
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV  193 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L  193 (358)
                      ||.|+||.||++.+..+++.+|+|.+.............+..|+.+++.++||||+++++.+.+....|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            68999999999999888999999999887655556677889999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccc
Q 018275          194 MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE  273 (358)
Q Consensus       194 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........           
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~-----------  149 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-----------  149 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc-----------
Confidence            999988878999999999999999999999999999999999999999999999999998765422100           


Q ss_pred             cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccccc
Q 018275          274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                                                            .....|+..|+|||.+.+..++.++|+||||+++|+++++..
T Consensus       150 --------------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~  191 (250)
T cd05123         150 --------------------------------------TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP  191 (250)
T ss_pred             --------------------------------------ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence                                                  012368899999999999989999999999999999999877


Q ss_pred             ccc
Q 018275          354 IML  356 (358)
Q Consensus       354 ~~~  356 (358)
                      +|.
T Consensus       192 p~~  194 (250)
T cd05123         192 PFY  194 (250)
T ss_pred             CCC
Confidence            663

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1e-33  Score=263.56  Aligned_cols=193  Identities=28%  Similarity=0.443  Sum_probs=166.4

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecC
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      ....||+|+||.||++....++..||||.+....   ......+.+|+.+++.++|+|++++++.|...+..++||||++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            3468999999999999999999999999875432   2344568889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccc
Q 018275          190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV  269 (358)
Q Consensus       190 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  269 (358)
                      +++|.+++. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........       
T Consensus       101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-------  172 (292)
T cd06657         101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-------  172 (292)
T ss_pred             CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-------
Confidence            999998774 456889999999999999999999999999999999999999999999999988654311100       


Q ss_pred             cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhc
Q 018275          270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCN  349 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l  349 (358)
                                                                .....|++.|+|||++.+..++.++|+||+||++|+++
T Consensus       173 ------------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~  210 (292)
T cd06657         173 ------------------------------------------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV  210 (292)
T ss_pred             ------------------------------------------ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence                                                      01236899999999999888999999999999999999


Q ss_pred             cccccc
Q 018275          350 YLSDIM  355 (358)
Q Consensus       350 ~~~~~~  355 (358)
                      .+..+|
T Consensus       211 tg~~p~  216 (292)
T cd06657         211 DGEPPY  216 (292)
T ss_pred             hCCCCC
Confidence            877654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-33  Score=256.68  Aligned_cols=191  Identities=21%  Similarity=0.316  Sum_probs=161.5

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|.+.+.||+|+||.||++.  .++..||+|.++...     ....+.+|+.+++.++|||++++++++... ..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            34679999999999999999885  568899999986542     234578899999999999999999998765 4799


Q ss_pred             EEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          184 IMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ||||+++++|.+++....  .++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....... 
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            999999999999997543  57888889999999999999999999999999999999999999999999986432110 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                         .....++.|+|||++.+..++.++|+|||
T Consensus       155 ---------------------------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  183 (254)
T cd05083         155 ---------------------------------------------------DNSKLPVKWTAPEALKHKKFSSKSDVWSY  183 (254)
T ss_pred             ---------------------------------------------------CCCCCCceecCHHHhccCCcCchhhHHHH
Confidence                                                               01134567999999999999999999999


Q ss_pred             hHHHHhhcc-cccc
Q 018275          342 WNETLSCNY-LSDI  354 (358)
Q Consensus       342 Gvil~e~l~-~~~~  354 (358)
                      ||++|||+. +...
T Consensus       184 G~~l~el~~~g~~p  197 (254)
T cd05083         184 GVLLWEVFSYGRAP  197 (254)
T ss_pred             HHHHHHHHhCCCCC
Confidence            999999986 4443

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-33  Score=263.37  Aligned_cols=203  Identities=30%  Similarity=0.445  Sum_probs=168.1

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC---
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE---  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~---  179 (358)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.++.... .......+.+|+.+++.++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345789999999999999999999999999999999875432 2223345678999999999999999999987654   


Q ss_pred             -------EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecC
Q 018275          180 -------YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG  251 (358)
Q Consensus       180 -------~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFG  251 (358)
                             .+|+|+||+++ ++...+... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence                   79999999976 777777553 478999999999999999999999999999999999999999999999999


Q ss_pred             CCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-C
Q 018275          252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-K  330 (358)
Q Consensus       252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~  330 (358)
                      ++..+.......                                                .....+++.|+|||++.+ .
T Consensus       162 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~~y~~PE~~~~~~  193 (302)
T cd07864         162 LARLYNSEESRP------------------------------------------------YTNKVITLWYRPPELLLGEE  193 (302)
T ss_pred             ccccccCCcccc------------------------------------------------cccceeccCccChHHhcCCC
Confidence            998664221100                                                012256888999999875 4


Q ss_pred             CCCccchhhhhhHHHHhhccccccc
Q 018275          331 GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .++.++|+|||||++||++.+...|
T Consensus       194 ~~~~~~Di~slG~~~~el~~g~~~~  218 (302)
T cd07864         194 RYGPAIDVWSCGCILGELFTKKPIF  218 (302)
T ss_pred             CCCchhHHHHHHHHHHHHHhCCCCC
Confidence            5789999999999999999876554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-33  Score=264.10  Aligned_cols=196  Identities=27%  Similarity=0.405  Sum_probs=167.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ..|...+.||+|+||.||+|.+..++..||+|.+.............+..|+.+++.++|+|++++++++.+....++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45777889999999999999999999999999987543333344556778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||+. |++.+.+.. ..++++..+..++.|++.||.|||+.+++||||+|+|||++.++.++|+|||++.......    
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~----  169 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----  169 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcc----
Confidence            9996 577777644 4568999999999999999999999999999999999999999999999999986543110    


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCccchhhhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWLAY  341 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~~~DiwSl  341 (358)
                                                                       ...|++.|+|||++.   ...++.++|||||
T Consensus       170 -------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl  200 (308)
T cd06634         170 -------------------------------------------------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  200 (308)
T ss_pred             -------------------------------------------------cccCCccccCHHHHhhcccCCCCcccchHHH
Confidence                                                             235889999999985   3568899999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|+++++..+|
T Consensus       201 G~il~el~~g~~p~  214 (308)
T cd06634         201 GITCIELAERKPPL  214 (308)
T ss_pred             HHHHHHHHcCCCCC
Confidence            99999999887654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2e-33  Score=254.90  Aligned_cols=197  Identities=27%  Similarity=0.455  Sum_probs=172.6

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +|++.+.||.|+||.||++.+..++..+|+|.+..... .......+..|+.+++.++|+||+++++.+.+....|+|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            58899999999999999999999999999999876543 23445567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          187 YLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       187 ~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      |+++++|.+++..    ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~--  157 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--  157 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence            9999999999866    3568888999999999999999999999999999999999999999999999987654210  


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       .....|++.|+|||.+.+..++.++|+||||
T Consensus       158 -------------------------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG  188 (256)
T cd08530         158 -------------------------------------------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLG  188 (256)
T ss_pred             -------------------------------------------------cccccCCccccCHHHHCCCCCCchhhHHHHH
Confidence                                                             0123588999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      +++|+++.+...|
T Consensus       189 ~~~~~l~~g~~p~  201 (256)
T cd08530         189 CLLYEMATFAPPF  201 (256)
T ss_pred             HHHHHHHhCCCCC
Confidence            9999998876544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=275.36  Aligned_cols=200  Identities=23%  Similarity=0.335  Sum_probs=169.0

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      +++.+...+.++||+|-||.|.+|... .+..||+|+++...  .......|..|+.+|.+++|||||.|+|+|..++.+
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            345566778999999999999999754 36899999999875  344567799999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      |+|+|||++|+|..++..+..  ..-.....++.||++|++||.+.++|||||.|.|+|++.++++||+|||+++.+-..
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            999999999999999987732  233344558899999999999999999999999999999999999999999966433


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      +...+.                 |                              -.|-...|||||.+.-+.+++++|+|
T Consensus       691 ~yy~vq-----------------g------------------------------r~vlpiRwmawEsillgkFttaSDvW  723 (807)
T KOG1094|consen  691 DYYRVQ-----------------G------------------------------RAVLPIRWMAWESILLGKFTTASDVW  723 (807)
T ss_pred             Cceeee-----------------c------------------------------ceeeeeeehhHHHHHhccccchhhhh
Confidence            322111                 0                              12456789999999999999999999


Q ss_pred             hhhHHHHhhccc
Q 018275          340 AYWNETLSCNYL  351 (358)
Q Consensus       340 SlGvil~e~l~~  351 (358)
                      +|||+|||+++.
T Consensus       724 afgvTlwE~~~~  735 (807)
T KOG1094|consen  724 AFGVTLWEVFML  735 (807)
T ss_pred             hhHHHHHHHHHH
Confidence            999999999874

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.4e-33  Score=265.32  Aligned_cols=198  Identities=27%  Similarity=0.394  Sum_probs=168.1

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec-CCEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-AEYLY  182 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~  182 (358)
                      ..++|++.+.||.|+||.||+|.+..++..||+|.+.+... .......+..|+.+++.++||||++++++|.. ....|
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45889999999999999999999999999999998865422 23344567789999999999999999999875 56789


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||+ +++|..++. ..++++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++.......  
T Consensus        87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~--  162 (328)
T cd07856          87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--  162 (328)
T ss_pred             EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence            999999 568888774 4567888888999999999999999999999999999999999999999999987442110  


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAY  341 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSl  341 (358)
                                                                        .+.++++.|+|||++.+ ..++.++|+|||
T Consensus       163 --------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  192 (328)
T cd07856         163 --------------------------------------------------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSA  192 (328)
T ss_pred             --------------------------------------------------CCCcccccccCceeeeccCCcCcHHHHHHH
Confidence                                                              02367889999999866 678999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|+++++...|.
T Consensus       193 G~il~el~tg~~~f~  207 (328)
T cd07856         193 GCIFAEMLEGKPLFP  207 (328)
T ss_pred             HHHHHHHHhCCCCCC
Confidence            999999998876553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.3e-33  Score=261.24  Aligned_cols=201  Identities=25%  Similarity=0.390  Sum_probs=166.3

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~  180 (358)
                      .+..++|.+.+.||+|+||.||+|.+..+++.||||.++....  ......+..|+.++... .||||++++++|.+...
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            4556899999999999999999999998899999999876432  22334455566666666 49999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      .|+||||++ ++|.+++.. ..++++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++..+..
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            999999985 577777755 4578899999999999999999997 5999999999999999999999999999875532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC----CCc
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG----YGM  334 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~----y~~  334 (358)
                      ....                                                  ....|++.|+|||++.+..    ++.
T Consensus       168 ~~~~--------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~  197 (296)
T cd06618         168 SKAK--------------------------------------------------TRSAGCAAYMAPERIDPPDPNPKYDI  197 (296)
T ss_pred             CCcc--------------------------------------------------cCCCCCccccCHhhcCCCCCcccccc
Confidence            1100                                                  0125888999999997654    889


Q ss_pred             cchhhhhhHHHHhhccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ++|+||||+++|+++++..+|
T Consensus       198 ~~Di~slG~il~el~~g~~p~  218 (296)
T cd06618         198 RADVWSLGISLVELATGQFPY  218 (296)
T ss_pred             chhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999987765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-33  Score=264.29  Aligned_cols=211  Identities=27%  Similarity=0.393  Sum_probs=168.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC------
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------  178 (358)
                      .++|.+.+.||.|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++.+.+.      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            5899999999999999999999999999999999875432 122223467899999999999999999887433      


Q ss_pred             --CEEEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          179 --EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       179 --~~~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                        ..+++||||+.+ +|...+.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++.
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence              357999999964 77777654 35799999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGM  334 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~  334 (358)
                      ............                                      ........+.+|++.|+|||++.+ ..++.
T Consensus       165 ~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (311)
T cd07866         165 YDGPPPNPKGGG--------------------------------------GGGTRKYTNLVVTRWYRPPELLLGERRYTT  206 (311)
T ss_pred             ccCCCcccccCC--------------------------------------cccccccccceeccCcCChHHhhCCCccCc
Confidence            542211100000                                      000011224578999999999875 45899


Q ss_pred             cchhhhhhHHHHhhccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ++|+|||||++|||+.+..+|
T Consensus       207 ~~Dv~slG~il~el~~g~~~~  227 (311)
T cd07866         207 AVDIWGIGCVFAEMFTRRPIL  227 (311)
T ss_pred             hhHhHHHHHHHHHHHhCCCCC
Confidence            999999999999999987655

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=279.24  Aligned_cols=191  Identities=26%  Similarity=0.458  Sum_probs=165.5

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHH-HhcCcceEEEEEEeecCCEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA-EVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      .+.|.+...+|.|+||.|..|.+..+++..++|++.+....       ..+|..++. .-+||||+++++.+.+..+.|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence            57788899999999999999999999999999999876321       334664444 4579999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE-cCCCcEEEEecCCCccCCCCCCc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL-DQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl-~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      |||++.|+-+.+.+.....+. ..+..|+++|+.|+.|||.+|||||||||+|||+ +..++++|+|||.++.....   
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence            999999998888886665555 7888899999999999999999999999999999 68999999999999876422   


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ..+.+-|..|.|||++...+|+.+|||||||
T Consensus       470 -------------------------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLG  500 (612)
T KOG0603|consen  470 -------------------------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLG  500 (612)
T ss_pred             -------------------------------------------------hcccchhhcccChhhhccCCCCcchhhHHHH
Confidence                                                             1133678899999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      ++||+||.|.-+|
T Consensus       501 vlLy~ML~G~tp~  513 (612)
T KOG0603|consen  501 VLLYEMLTGRTLF  513 (612)
T ss_pred             HHHHHHHhCCCcc
Confidence            9999999987665

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.4e-33  Score=254.56  Aligned_cols=179  Identities=21%  Similarity=0.350  Sum_probs=155.6

Q ss_pred             eeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCHHHH
Q 018275          117 GAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL  196 (358)
Q Consensus       117 G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~  196 (358)
                      |.||.||++.+..+++.||+|.++....        ...|...+....||||+++++.+.+....++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            8999999999999999999999976531        23344455566799999999999999999999999999999999


Q ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccccccccccccc
Q 018275          197 LMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN  276 (358)
Q Consensus       197 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      +....++++..+..++.|++.||.|||+.||+||||||+||+++.++.++++|||.+..+....                
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----------------  139 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----------------  139 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----------------
Confidence            9887789999999999999999999999999999999999999999999999999876543110                


Q ss_pred             ccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccccccc
Q 018275          277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                                                          .+..+++.|+|||.+.+.+++.++|+||+||++|||+.+..++
T Consensus       140 ------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~  182 (237)
T cd05576         140 ------------------------------------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLV  182 (237)
T ss_pred             ------------------------------------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchh
Confidence                                                0224677899999999899999999999999999999887543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-34  Score=268.07  Aligned_cols=201  Identities=25%  Similarity=0.385  Sum_probs=173.0

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----EE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----YL  181 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~~  181 (358)
                      +|.+.+.||.|+||.||+|.+..++..||||.+.... ........+..|+.+++.++||||+++++++.+..     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            5889999999999999999998889999999987642 12344566888999999999999999999998775     78


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||++ ++|.+++....++++..+..++.+++.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999997 58999998777999999999999999999999999999999999999999999999999999986542211


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLA  340 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwS  340 (358)
                      .                                              ........+|+.|+|||++.+. .++.++|+||
T Consensus       159 ~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s  192 (330)
T cd07834         159 E----------------------------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWS  192 (330)
T ss_pred             c----------------------------------------------cccccccccccCcCCceeeecccCCCcchhHHH
Confidence            0                                              0001134689999999999988 8999999999


Q ss_pred             hhHHHHhhccccccc
Q 018275          341 YWNETLSCNYLSDIM  355 (358)
Q Consensus       341 lGvil~e~l~~~~~~  355 (358)
                      |||++|+|+++..+|
T Consensus       193 lG~il~~l~~g~~pf  207 (330)
T cd07834         193 VGCIFAELLTRKPLF  207 (330)
T ss_pred             HHHHHHHHHcCCCCc
Confidence            999999999987766

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.3e-33  Score=267.77  Aligned_cols=204  Identities=26%  Similarity=0.406  Sum_probs=167.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeec--CCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD--AEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~--~~~~  181 (358)
                      .++|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+..|+.+++.+ +||||++++++|..  ....
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4789999999999999999999988999999998865321 223344567899999999 99999999999864  3468


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||++ ++|..++... .+++.....++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            99999997 5999888655 788888889999999999999999999999999999999999999999999986642221


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLA  340 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwS  340 (358)
                      ...                                            .......+||+.|+|||++.+ ..++.++|+||
T Consensus       163 ~~~--------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s  198 (337)
T cd07852         163 NPE--------------------------------------------NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWS  198 (337)
T ss_pred             ccc--------------------------------------------CcchhcccccccccCceeeeccccccccchHHH
Confidence            100                                            000112368999999999865 56889999999


Q ss_pred             hhHHHHhhccccccc
Q 018275          341 YWNETLSCNYLSDIM  355 (358)
Q Consensus       341 lGvil~e~l~~~~~~  355 (358)
                      |||++|+++++...|
T Consensus       199 lG~~l~el~tg~~pf  213 (337)
T cd07852         199 VGCILGEMLLGKPLF  213 (337)
T ss_pred             HHHHHHHHHhCCCCC
Confidence            999999999987655

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.8e-33  Score=267.60  Aligned_cols=199  Identities=24%  Similarity=0.343  Sum_probs=164.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC-------
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-------  178 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-------  178 (358)
                      ++|.+.+.||.|+||.||+|.+..++..||+|.+....   ......+.+|+.+++.++||||+++++.+...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            78999999999999999999999999999999986653   23456688899999999999999998766543       


Q ss_pred             -------CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-CCcEEEEec
Q 018275          179 -------EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDF  250 (358)
Q Consensus       179 -------~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~vkl~DF  250 (358)
                             ...|+||||++ ++|.+++. ...+++..++.++.|++.||.|||+.||+||||||+||+++. ++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                   46899999996 58888874 457889999999999999999999999999999999999974 567899999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-  329 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-  329 (358)
                      |+++.+........                                              .....+|++.|+|||++.+ 
T Consensus       160 g~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~  193 (342)
T cd07854         160 GLARIVDPHYSHKG----------------------------------------------YLSEGLVTKWYRSPRLLLSP  193 (342)
T ss_pred             ccceecCCcccccc----------------------------------------------ccccccccccccCHHHHhCc
Confidence            99876532111000                                              0001258899999998764 


Q ss_pred             CCCCccchhhhhhHHHHhhccccccc
Q 018275          330 KGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       330 ~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ..++.++|+|||||++|+++++...|
T Consensus       194 ~~~~~~~DiwSlGvil~el~~g~~pf  219 (342)
T cd07854         194 NNYTKAIDMWAAGCIFAEMLTGKPLF  219 (342)
T ss_pred             cccCchhhHHHHHHHHHHHHhCCCCC
Confidence            66889999999999999999988776

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.5e-33  Score=265.01  Aligned_cols=201  Identities=19%  Similarity=0.290  Sum_probs=162.5

Q ss_pred             eeEeee--eeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecC
Q 018275          112 TIIGRG--AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       112 ~~IG~G--~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      ..||+|  +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|.+....++||||++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            356666  999999999999999999999876532 23345678889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccc
Q 018275          190 GGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN  267 (358)
Q Consensus       190 ~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  267 (358)
                      +++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++++|||.+............  
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~--  160 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV--  160 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc--
Confidence            99999998764  35889999999999999999999999999999999999999999999999865433211100000  


Q ss_pred             cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCccchhhhhhHHH
Q 018275          268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWLAYWNET  345 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~~DiwSlGvil  345 (358)
                       .             .                          .......++..|+|||++.+  ..|+.++|+|||||++
T Consensus       161 -~-------------~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l  200 (328)
T cd08226         161 -V-------------Y--------------------------DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITA  200 (328)
T ss_pred             -c-------------c--------------------------cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHH
Confidence             0             0                          00001245677999999986  4578999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      ||++.+...|
T Consensus       201 ~el~~g~~p~  210 (328)
T cd08226         201 CELATGRVPF  210 (328)
T ss_pred             HHHHhCCCCC
Confidence            9999877665

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.9e-33  Score=256.84  Aligned_cols=195  Identities=25%  Similarity=0.322  Sum_probs=159.7

Q ss_pred             ceeeeeEeeeeeEEEEEEEEec---CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----  179 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----  179 (358)
                      |.+.+.||+|+||.||+|.+..   ++..||||++.... ......+.+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            5677899999999999998643   57899999987543 23344566888999999999999999999886432     


Q ss_pred             -EEEEEEeecCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          180 -YLYLIMEYLPGGDVMTLLMRE------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       180 -~~~lV~E~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                       ..+++++|+++|+|..++...      ..++...+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             347899999999998887432      2478888999999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY  332 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y  332 (358)
                      ++.........                                               ......+++.|++||.+.+..+
T Consensus       160 ~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~  192 (273)
T cd05074         160 SKKIYSGDYYR-----------------------------------------------QGCASKLPVKWLALESLADNVY  192 (273)
T ss_pred             cccccCCccee-----------------------------------------------cCCCccCchhhcCHhHHhcCcc
Confidence            88653211000                                               0012246678999999999999


Q ss_pred             CccchhhhhhHHHHhhcc
Q 018275          333 GMECDWLAYWNETLSCNY  350 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~  350 (358)
                      +.++|+|||||++||++.
T Consensus       193 ~~~sDi~slG~il~el~~  210 (273)
T cd05074         193 TTHSDVWAFGVTMWEIMT  210 (273)
T ss_pred             chhhhhHHHHHHHHHHhh
Confidence            999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.2e-33  Score=255.36  Aligned_cols=199  Identities=26%  Similarity=0.449  Sum_probs=167.3

Q ss_pred             CceeeeeEeeeeeEEEEEEEEec-CCCEEEEEecchhhh-------hchhhHHHHHHHHHHHHH-hcCcceEEEEEEeec
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEM-------LSRGQVEHVRAERNLLAE-VASHCIVKLYYSFQD  177 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~-~~~~vaiK~i~~~~~-------~~~~~~~~~~~E~~il~~-l~h~~iv~l~~~~~~  177 (358)
                      +|++.+.||+|+||.||+|.+.. ++..+|+|.+.....       ........+..|+.++.. ++||||+++++.+.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999887 688999998864321       123344556778887764 799999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                      .+..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999988743    3568899999999999999999996 6899999999999999999999999999


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY  332 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y  332 (358)
                      +.......                                                  ......|+..|+|||++.+..+
T Consensus       161 ~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~  190 (269)
T cd08528         161 AKQKQPES--------------------------------------------------KLTSVVGTILYSCPEIVKNEPY  190 (269)
T ss_pred             eeeccccc--------------------------------------------------ccccccCcccCcChhhhcCCCC
Confidence            87643211                                                  0113368999999999999999


Q ss_pred             CccchhhhhhHHHHhhccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +.++|+||||+++|+++.+..+|
T Consensus       191 ~~~~Dv~slG~ll~~l~~g~~p~  213 (269)
T cd08528         191 GEKADVWAFGCILYQMCTLQPPF  213 (269)
T ss_pred             chHHHHHHHHHHHHHHHhCCCcc
Confidence            99999999999999999876554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-33  Score=266.00  Aligned_cols=194  Identities=27%  Similarity=0.421  Sum_probs=163.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC------C
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------E  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------~  179 (358)
                      ++|.+.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||++++++|...      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            689999999999999999999999999999999875421 223344577899999999999999999998654      3


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ..|+|+||+. .+|..++  ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             eEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            4699999996 4777665  346889999999999999999999999999999999999999999999999998754211


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Di  338 (358)
                      .                                                    ...+||+.|+|||++.+ ..++.++|+
T Consensus       171 ~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv  198 (342)
T cd07879         171 M----------------------------------------------------TGYVVTRWYRAPEVILNWMHYNQTVDI  198 (342)
T ss_pred             C----------------------------------------------------CCceeeecccChhhhcCccccCchHHH
Confidence            0                                                    02368899999999976 468999999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      |||||++|||+++..+|
T Consensus       199 ~slGvil~el~~g~~pf  215 (342)
T cd07879         199 WSVGCIMAEMLTGKTLF  215 (342)
T ss_pred             HHHHHHHHHHHhCCCCC
Confidence            99999999999987665

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.2e-33  Score=264.89  Aligned_cols=214  Identities=23%  Similarity=0.358  Sum_probs=170.3

Q ss_pred             CCcee-eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchh-----------hHHHHHHHHHHHHHhcCcceEEEEE
Q 018275          106 DDFDL-LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG-----------QVEHVRAERNLLAEVASHCIVKLYY  173 (358)
Q Consensus       106 ~~~~~-~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~-----------~~~~~~~E~~il~~l~h~~iv~l~~  173 (358)
                      ++|.. .+.||.|+||+||+|.+..+++.||||++.........           ....+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            56654 57799999999999999999999999998754321100           0124678999999999999999999


Q ss_pred             EeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       174 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      ++...+..|+||||++ |+|.+++.....+++.....++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999999996 699999988788999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GY  332 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y  332 (358)
                      ................              ..                     ..+.......+++.|+|||++.+. .+
T Consensus       167 ~~~~~~~~~~~~~~~~--------------~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~  211 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDE--------------TM---------------------QRREEMTSKVVTLWYRAPELLMGAEKY  211 (335)
T ss_pred             eecccccccccccccc--------------cc---------------------cccccccccccccCCCCChhcccCCCC
Confidence            8664322111000000              00                     000011234678999999999764 47


Q ss_pred             CccchhhhhhHHHHhhccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +.++|+|||||++|||+++..+|
T Consensus       212 ~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        212 HFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCC
Confidence            89999999999999999977655

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-33  Score=256.73  Aligned_cols=196  Identities=31%  Similarity=0.484  Sum_probs=165.9

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEEEEEEe
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      |.+.+.||+|+||.||+|....++..|+||.+..... . .......+|+..++.++ |||++++++.+.+....++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            6788999999999999999988899999999876432 1 12223446888999999 9999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          187 YLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |+ +|+|.+.+....  .+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++........   
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence            99 789999887654  789999999999999999999999999999999999999999999999999875532110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-CCCCCccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-~~~y~~~~DiwSlGv  343 (358)
                                                                     ....+|+..|+|||++. +..++.++|+||||+
T Consensus       155 -----------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~  187 (283)
T cd07830         155 -----------------------------------------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGC  187 (283)
T ss_pred             -----------------------------------------------cCCCCCcccccCceeeecCcCcCCccchhhHHH
Confidence                                                           00236889999999885 456899999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++||++.+...|.
T Consensus       188 ~l~el~~g~~~~~  200 (283)
T cd07830         188 IMAELYTLRPLFP  200 (283)
T ss_pred             HHHHHHhCCCccC
Confidence            9999999876653

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.9e-33  Score=260.32  Aligned_cols=195  Identities=21%  Similarity=0.278  Sum_probs=159.6

Q ss_pred             eeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCHHHHH
Q 018275          118 AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL  197 (358)
Q Consensus       118 ~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l  197 (358)
                      ++|.||.+.+..+++.||||++..... .......+..|+.+++.++||||++++++|.+.+..+++|||+++++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            445566666677999999999976532 3445677999999999999999999999999999999999999999999999


Q ss_pred             hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccc
Q 018275          198 MRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL  275 (358)
Q Consensus       198 ~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ...  ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||.+..+..........         
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~---------  161 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV---------  161 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc---------
Confidence            753  468899999999999999999999999999999999999999999999999887654221110000         


Q ss_pred             cccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCccchhhhhhHHHHhhccccc
Q 018275          276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                                                       ........+++.|+|||++.+  ..|+.++|+|||||++|||+.+..
T Consensus       162 ---------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~  208 (314)
T cd08216         162 ---------------------------------HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHV  208 (314)
T ss_pred             ---------------------------------ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCC
Confidence                                             000113468889999999976  468999999999999999998765


Q ss_pred             cc
Q 018275          354 IM  355 (358)
Q Consensus       354 ~~  355 (358)
                      .|
T Consensus       209 pf  210 (314)
T cd08216         209 PF  210 (314)
T ss_pred             CC
Confidence            54

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-33  Score=255.63  Aligned_cols=197  Identities=28%  Similarity=0.421  Sum_probs=169.7

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEee
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      |++.+.||+|+||.||+|.+..+++.||+|++.... ........+..|+.+++.++|+|++++++++.+....++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            567789999999999999999999999999998754 2233345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          188 LPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       188 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      ++ ++|.+++... ..+++..+..++.+++.||.|||+.||+||||+|+||+++.++.++|+|||+++........    
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----  154 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT----  154 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc----
Confidence            97 5899999776 58999999999999999999999999999999999999999999999999998765422110    


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWNET  345 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGvil  345 (358)
                                                                   .....+++.|+|||++.+. .++.++|+|||||++
T Consensus       155 ---------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l  189 (282)
T cd07829         155 ---------------------------------------------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIF  189 (282)
T ss_pred             ---------------------------------------------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHH
Confidence                                                         0022467889999999876 889999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      ||++.+..+|
T Consensus       190 ~~l~~~~~~~  199 (282)
T cd07829         190 AEMITGKPLF  199 (282)
T ss_pred             HHHHhCCCCC
Confidence            9999986655

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7e-33  Score=263.68  Aligned_cols=197  Identities=26%  Similarity=0.395  Sum_probs=168.2

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY----  180 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~----  180 (358)
                      .++|.+.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.+.|||++++++++...+.    
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            5789999999999999999999999999999999875422 22334557789999999999999999988876554    


Q ss_pred             --EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 --LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 --~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                        .++|+||+ +++|.+++.. .++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence              89999999 6799998854 5789999999999999999999999999999999999999999999999999875431


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~D  337 (358)
                      .                                                    .....+|+.|+|||++.+ ..++.++|
T Consensus       171 ~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~D  198 (343)
T cd07851         171 E----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVD  198 (343)
T ss_pred             c----------------------------------------------------ccCCcccccccCHHHHhCCCCCCchHh
Confidence            1                                                    012368899999999875 46889999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      +|||||++||++++..+|.
T Consensus       199 vwslGv~l~elltg~~pf~  217 (343)
T cd07851         199 IWSVGCIMAELLTGKTLFP  217 (343)
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999877653

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=254.14  Aligned_cols=197  Identities=31%  Similarity=0.455  Sum_probs=169.4

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEee
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+..... .......+..|+.+++.++|+||+++++.+.+....++||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            5677899999999999999988999999999876542 223445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          188 LPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       188 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      +++ +|..++... ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||.+........     
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-----  153 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-----  153 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-----
Confidence            975 888887663 5889999999999999999999999999999999999999999999999999876642210     


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWNET  345 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGvil  345 (358)
                                                                  ......+++.|+|||.+.+. .++.++|+||||+++
T Consensus       154 --------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l  189 (283)
T cd05118         154 --------------------------------------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF  189 (283)
T ss_pred             --------------------------------------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHH
Confidence                                                        00023588899999999877 789999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |+++++..+|
T Consensus       190 ~~l~tg~~~~  199 (283)
T cd05118         190 AELLSRRPLF  199 (283)
T ss_pred             HHHHhCCCCC
Confidence            9999987766

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=272.75  Aligned_cols=200  Identities=28%  Similarity=0.475  Sum_probs=170.8

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEee---
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ---  176 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~---  176 (358)
                      .....+-|++...||.|.+|.||++.++.+++.+|+|++.....    .-+.+..|.++|+.. +|||++.++|+|.   
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            44567889999999999999999999999999999999876542    223466788888766 6999999999985   


Q ss_pred             --cCCEEEEEEeecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          177 --DAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       177 --~~~~~~lV~E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                        .++.+|||||||.||+..++++.  ...+.+..+..++..++.||.+||+..+||||||-.|||++.++.|||+|||+
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence              35689999999999999999865  46788999999999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC---
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---  329 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~---  329 (358)
                      +..++..                                                 +...++.+|||.||||||+..   
T Consensus       170 SaQldsT-------------------------------------------------~grRnT~iGtP~WMAPEViac~e~  200 (953)
T KOG0587|consen  170 SAQLDST-------------------------------------------------VGRRNTFIGTPYWMAPEVIACDES  200 (953)
T ss_pred             eeeeecc-------------------------------------------------cccccCcCCCcccccceeeecccC
Confidence            9876522                                                 223346799999999999974   


Q ss_pred             --CCCCccchhhhhhHHHHhhccccc
Q 018275          330 --KGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       330 --~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                        ..|+..||+||||++..||.-+-.
T Consensus       201 ~d~tyd~R~D~WsLGITaIEladG~P  226 (953)
T KOG0587|consen  201 PDATYDYRSDLWSLGITAIEMAEGAP  226 (953)
T ss_pred             CCCCcccccchhhccceeehhcCCCC
Confidence              358899999999999999876543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-35  Score=256.57  Aligned_cols=196  Identities=27%  Similarity=0.381  Sum_probs=164.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----E
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----Y  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~  180 (358)
                      .+.+..+-||-|+||.||.+++..+|+.||+|++..-. .+-.....+.+|+.+|...+|.|+...++..+...     .
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            34455678999999999999999999999999987542 23344566888999999999999999888877553     3


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+|+|+|. .||..++-..+.++.+.++-++.||+.||.|||+.+|.||||||.|.|+++|..+||||||+|+..+...
T Consensus       132 iYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  132 LYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            688999994 6999999888999999999999999999999999999999999999999999999999999998764222


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~Diw  339 (358)
                      ...                                               +. .-|.|..|+|||+++|. .|+...|||
T Consensus       211 ~~h-----------------------------------------------MT-qEVVTQYYRAPEiLMGaRhYs~AvDiW  242 (449)
T KOG0664|consen  211 RLN-----------------------------------------------MT-HEVVTQYYRAPELLMGARRYTGAVDIW  242 (449)
T ss_pred             hhh-----------------------------------------------hH-HHHHHHHhccHHHhhcchhhcCcccee
Confidence            111                                               11 22678999999999984 599999999


Q ss_pred             hhhHHHHhhccc
Q 018275          340 AYWNETLSCNYL  351 (358)
Q Consensus       340 SlGvil~e~l~~  351 (358)
                      |+|||+.|+|-.
T Consensus       243 SVGCIFaELLgR  254 (449)
T KOG0664|consen  243 SVGCIFAELLQR  254 (449)
T ss_pred             hhhHHHHHHHhh
Confidence            999999996643

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.5e-32  Score=250.35  Aligned_cols=199  Identities=28%  Similarity=0.433  Sum_probs=165.9

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh--hchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      +|.+.+.||+|+||.||++.+...+..+++|+++....  ........+..|..+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            48889999999999999999888777777777654322  1223334566788999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          185 MEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988853    357899999999999999999999999999999999999975 569999999987653211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ..                                                 .....|++.|+|||.+.+..++.++|+||
T Consensus       160 ~~-------------------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s  190 (260)
T cd08222         160 DL-------------------------------------------------ATTFTGTPYYMSPEALKHQGYDSKSDIWS  190 (260)
T ss_pred             cc-------------------------------------------------ccCCCCCcCccCHHHHccCCCCchhhHHH
Confidence            00                                                 01235889999999999999999999999


Q ss_pred             hhHHHHhhccccccc
Q 018275          341 YWNETLSCNYLSDIM  355 (358)
Q Consensus       341 lGvil~e~l~~~~~~  355 (358)
                      ||+++|+++++...|
T Consensus       191 lG~~~~~l~~~~~~~  205 (260)
T cd08222         191 LGCILYEMCCLAHAF  205 (260)
T ss_pred             HHHHHHHHHhCCCCC
Confidence            999999999877665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-34  Score=251.58  Aligned_cols=206  Identities=26%  Similarity=0.351  Sum_probs=169.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee-------
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-------  176 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-------  176 (358)
                      ..+.|.-+.+||+|.||.||+|+.+.+|+.||+|++--... ....-....+|+.+|..++|+|++.++..|.       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            34778888999999999999999999999999987644221 1222233667999999999999999987774       


Q ss_pred             -cCCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          177 -DAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       177 -~~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                       +...+|+||++|+ .||..+|... ..++...+..++..++.||.|+|...|+|||+||.|+||+.+|.+||+|||+++
T Consensus        94 r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   94 RDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             cccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence             2345899999996 4999998665 689999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCC
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYG  333 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~  333 (358)
                      .+........                  .                           .....|.|..|++||.+.| ..|+
T Consensus       173 ~fs~~~n~~k------------------p---------------------------rytnrvvTLwYrppEllLG~r~yg  207 (376)
T KOG0669|consen  173 AFSTSKNVVK------------------P---------------------------RYTNRVVTLWYRPPELLLGDREYG  207 (376)
T ss_pred             ceecccccCC------------------C---------------------------CcccceeeeecCCHHHhhcccccC
Confidence            7753321110                  0                           0113478999999999987 5699


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .+.|+|.-||||.||+.++.+|-
T Consensus       208 ~~iDiWgAgCimaeMwtrspimq  230 (376)
T KOG0669|consen  208 PPIDIWGAGCIMAEMWTRSPIMQ  230 (376)
T ss_pred             CcchhHhHHHHHHHHHccCcccc
Confidence            99999999999999999998873

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=263.39  Aligned_cols=194  Identities=21%  Similarity=0.309  Sum_probs=164.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEec----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKK----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ....+.++||.|-||.||.|....    ..--||||+++.+.  ..+..+.|.+|..+|+.++|||||+|+|+|.+ ...
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            344556799999999999997532    23469999998865  45557889999999999999999999999985 468


Q ss_pred             EEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      |||||+++-|.|..+|..+ ..++-.....++.||+.||.|||+..+|||||...|||+.+...|||+|||+++.+....
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            9999999999999999876 467788888899999999999999999999999999999999999999999999886332


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .   +...                                             ...-.-.|||||.+.-..++.++|+|.
T Consensus       546 y---YkaS---------------------------------------------~~kLPIKWmaPESINfRrFTtASDVWM  577 (974)
T KOG4257|consen  546 Y---YKAS---------------------------------------------RGKLPIKWMAPESINFRRFTTASDVWM  577 (974)
T ss_pred             h---hhcc---------------------------------------------ccccceeecCccccchhcccchhhHHH
Confidence            1   1100                                             001234699999999999999999999


Q ss_pred             hhHHHHhhcc
Q 018275          341 YWNETLSCNY  350 (358)
Q Consensus       341 lGvil~e~l~  350 (358)
                      |||||||+|-
T Consensus       578 FgVCmWEIl~  587 (974)
T KOG4257|consen  578 FGVCMWEILS  587 (974)
T ss_pred             HHHHHHHHHH
Confidence            9999999885

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=269.76  Aligned_cols=200  Identities=25%  Similarity=0.349  Sum_probs=174.7

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCC---CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      ..++..+...+.++||.|.||.|++|+.+..|   ..||||.++...  ...+...|..|..||-+.+||||++|-|+..
T Consensus       623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT  700 (996)
T KOG0196|consen  623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT  700 (996)
T ss_pred             hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence            35677888999999999999999999987665   479999998764  5677788999999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      ..+.++||+|||++|+|..+|..+ +.|+.-+..-++..|+.|+.||-++++|||||...|||++.+..+|++|||+++.
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence            999999999999999999999765 5688888888999999999999999999999999999999999999999999997


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC---CCCCchhhhhcCCCC
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG---TPDYIAPEVLLKKGY  332 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g---t~~Y~APEv~~~~~y  332 (358)
                      +..... .                                                ++++.|   ...|.|||.+....+
T Consensus       781 ledd~~-~------------------------------------------------~ytt~GGKIPiRWTAPEAIa~RKF  811 (996)
T KOG0196|consen  781 LEDDPE-A------------------------------------------------AYTTLGGKIPIRWTAPEAIAYRKF  811 (996)
T ss_pred             cccCCC-c------------------------------------------------cccccCCccceeecChhHhhhccc
Confidence            753221 1                                                111222   346999999999999


Q ss_pred             CccchhhhhhHHHHhhcc
Q 018275          333 GMECDWLAYWNETLSCNY  350 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~  350 (358)
                      +.++|+||+|++|||.+-
T Consensus       812 TsASDVWSyGIVmWEVmS  829 (996)
T KOG0196|consen  812 TSASDVWSYGIVMWEVMS  829 (996)
T ss_pred             CchhhccccceEEEEecc
Confidence            999999999999999654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.5e-31  Score=269.23  Aligned_cols=196  Identities=21%  Similarity=0.322  Sum_probs=140.8

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecC----CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEE--
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKS----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYS--  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~--  174 (358)
                      .....++|.+.+.||+|+||.||+|.+..+    +..||+|++.....     .+....+  .+....+.+++.+...  
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~  199 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFL  199 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhh
Confidence            445678999999999999999999999888    89999998764321     1111111  1111222222221111  


Q ss_pred             ----eecCCEEEEEEeecCCCCHHHHHhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 018275          175 ----FQDAEYLYLIMEYLPGGDVMTLLMREET--------------------LTETVARFYIAQSVLAIESIHKHNYIHR  230 (358)
Q Consensus       175 ----~~~~~~~~lV~E~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~qi~~aL~~LH~~~iiHr  230 (358)
                          ..+....++||||+++++|.+++.....                    .....+..++.|++.||.|||+++|+||
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR  279 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR  279 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence                2456679999999999999999864321                    1123456788999999999999999999


Q ss_pred             CCCCCCEEEcC-CCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhc
Q 018275          231 DIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRR  309 (358)
Q Consensus       231 Dikp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (358)
                      ||||+|||++. ++.+||+|||+|+.+......                                               
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-----------------------------------------------  312 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-----------------------------------------------  312 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCcccccccccc-----------------------------------------------
Confidence            99999999986 589999999999765321100                                               


Q ss_pred             cccccccCCCCCchhhhhcCC----------------------CCCccchhhhhhHHHHhhccc
Q 018275          310 KLAYSTVGTPDYIAPEVLLKK----------------------GYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       310 ~~~~s~~gt~~Y~APEv~~~~----------------------~y~~~~DiwSlGvil~e~l~~  351 (358)
                       .....+|||.|||||++...                      .++.++|||||||+||||++.
T Consensus       313 -~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~  375 (566)
T PLN03225        313 -IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFP  375 (566)
T ss_pred             -CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhC
Confidence             01134799999999976432                      244567999999999999874

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=7.2e-33  Score=261.06  Aligned_cols=206  Identities=22%  Similarity=0.344  Sum_probs=171.7

Q ss_pred             HhHhhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC------cce
Q 018275           95 YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS------HCI  168 (358)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h------~~i  168 (358)
                      |.++...++-.++|.+....|+|-||+|..|.+...|+.||||+|+.....    ...-..|+.||++|..      .++
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHH
Confidence            344445556668899999999999999999999999999999999987543    2334579999999853      378


Q ss_pred             EEEEEEeecCCEEEEEEeecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-Cc
Q 018275          169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GH  244 (358)
Q Consensus       169 v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~  244 (358)
                      +.|+..|...+++|||+|-+ ..+|.++|+..+   .+....++.|+.|+..||..|-..||+|.||||+|||++.. ..
T Consensus       497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence            89999999999999999988 569999998754   57888999999999999999999999999999999999876 56


Q ss_pred             EEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchh
Q 018275          245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP  324 (358)
Q Consensus       245 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~AP  324 (358)
                      +||||||.|........+.                                                   ...+..|.||
T Consensus       576 LKLCDfGSA~~~~eneitP---------------------------------------------------YLVSRFYRaP  604 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEITP---------------------------------------------------YLVSRFYRAP  604 (752)
T ss_pred             eeeccCccccccccccccH---------------------------------------------------HHHHHhccCc
Confidence            8999999997665332211                                                   1345679999


Q ss_pred             hhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          325 EVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       325 Ev~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      |+++|.+|++..|+||+||+|||+-+|.-+|+
T Consensus       605 EIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  605 EIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             ceeecCcccCCccceeeceeeEEeeccceecC
Confidence            99999999999999999999999666665554

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=264.18  Aligned_cols=200  Identities=21%  Similarity=0.311  Sum_probs=168.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecC-C--CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKS-G--NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~-~--~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .....+.+.||+|+||.|++|.|... |  ..||||.++.....  .....|++|+.+|.+++|+|+++|||...+ ..+
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence            34566778999999999999988653 3  46899999877532  266789999999999999999999999987 678


Q ss_pred             EEEEeecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+|||+++.|+|.+.|..  ...|.......|+.||+.||.||..+++|||||...|+|+...-.||||||||.+.+...
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            899999999999999976  357888899999999999999999999999999999999999999999999999988644


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .+...                                              ++-..--...|+|||.+....++.++|+|
T Consensus       266 ed~Yv----------------------------------------------m~p~rkvPfAWCaPEsLrh~kFShaSDvW  299 (1039)
T KOG0199|consen  266 EDMYV----------------------------------------------MAPQRKVPFAWCAPESLRHRKFSHASDVW  299 (1039)
T ss_pred             CcceE----------------------------------------------ecCCCcCcccccCHhHhccccccccchhh
Confidence            32211                                              00011234569999999999999999999


Q ss_pred             hhhHHHHhhccccc
Q 018275          340 AYWNETLSCNYLSD  353 (358)
Q Consensus       340 SlGvil~e~l~~~~  353 (358)
                      +|||+||||+.+..
T Consensus       300 myGVTiWEMFtyGE  313 (1039)
T KOG0199|consen  300 MYGVTIWEMFTYGE  313 (1039)
T ss_pred             hhhhhHHhhhccCC
Confidence            99999999998654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=2.3e-31  Score=285.30  Aligned_cols=185  Identities=18%  Similarity=0.212  Sum_probs=158.1

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      .|.....||+|+||.||+|.+..++..||||.+......       ...|+.+++.++|||||+++++|.+....|+|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            466678999999999999999889999999998654211       1245788999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH---KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |+++|+|.+++.   .+++.....++.+++.||.|||   +.+|+||||||+||+++.++.+++. ||.+......    
T Consensus       764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----  835 (968)
T PLN00113        764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----  835 (968)
T ss_pred             CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence            999999999995   3778888999999999999999   6699999999999999999988876 6654332100    


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                       ...+||+.|||||++.+..|+.++|||||||
T Consensus       836 -------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gv  866 (968)
T PLN00113        836 -------------------------------------------------TKCFISSAYVAPETRETKDITEKSDIYGFGL  866 (968)
T ss_pred             -------------------------------------------------CCccccccccCcccccCCCCCcccchhhHHH
Confidence                                                             0226899999999999999999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|||+++...|
T Consensus       867 vl~el~tg~~p~  878 (968)
T PLN00113        867 ILIELLTGKSPA  878 (968)
T ss_pred             HHHHHHhCCCCC
Confidence            999999987765

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.9e-32  Score=251.99  Aligned_cols=192  Identities=23%  Similarity=0.314  Sum_probs=157.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHH--hcCcceEEEEEEeecCC---
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE--VASHCIVKLYYSFQDAE---  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~--l~h~~iv~l~~~~~~~~---  179 (358)
                      ....+++..||+|.||.||+|...  ++.||||+++..      ..+.+.+|.+|.+.  +.|+||++++++-....   
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            466778899999999999999654  689999998754      34558889998875  58999999998765444   


Q ss_pred             -EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeCCCCCCCEEEcCCCcEEEEe
Q 018275          180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK---------HNYIHRDIKPDNLLLDQNGHMKLSD  249 (358)
Q Consensus       180 -~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---------~~iiHrDikp~NILl~~~~~vkl~D  249 (358)
                       .++||++|.+.|+|.++|. ...+++.....++..++.||+|||.         .+|+|||||..|||+..|++..|+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~-~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLK-ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cceeEEeeeccCCcHHHHHH-hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence             7899999999999999994 5678889999999999999999994         3599999999999999999999999


Q ss_pred             cCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC
Q 018275          250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK  329 (358)
Q Consensus       250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~  329 (358)
                      ||+|..+.......                                               .+-+-|||..|||||++.+
T Consensus       360 FGLAl~~~p~~~~~-----------------------------------------------d~~~qVGT~RYMAPEvLEg  392 (534)
T KOG3653|consen  360 FGLALRLEPGKPQG-----------------------------------------------DTHGQVGTRRYMAPEVLEG  392 (534)
T ss_pred             cceeEEecCCCCCc-----------------------------------------------chhhhhhhhhhcCHHHHhh
Confidence            99999876221100                                               0113489999999999986


Q ss_pred             CC-CC-----ccchhhhhhHHHHhhcccc
Q 018275          330 KG-YG-----MECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       330 ~~-y~-----~~~DiwSlGvil~e~l~~~  352 (358)
                      .. +.     .+.|+||+|.+|||++-.-
T Consensus       393 ainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  393 AINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             hcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            42 11     3589999999999987643

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-31  Score=246.89  Aligned_cols=132  Identities=24%  Similarity=0.439  Sum_probs=115.0

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-----Cc---ceEEEEEEe
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-----SH---CIVKLYYSF  175 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----h~---~iv~l~~~~  175 (358)
                      ..++|.+.++||+|.|++||+|.+....+.||+|+.+...    ...+....|+.+|+.++     |+   +||+|++.|
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            3489999999999999999999999999999999998653    34455778999998874     33   699999999


Q ss_pred             ec----CCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEc
Q 018275          176 QD----AEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLD  240 (358)
Q Consensus       176 ~~----~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~  240 (358)
                      ..    ..++|+|+|++ |.+|..++...  ..++...++.|+.|++.||.|||.. ||||.||||+|||+.
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            74    45899999999 77999998764  5799999999999999999999965 999999999999994

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-32  Score=258.65  Aligned_cols=199  Identities=24%  Similarity=0.338  Sum_probs=170.6

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      +++...+.....+||-|-||.||.|.|+.-.-.||||.++.+.    ..++.|..|..+|+.++|||+|+|+|+|.....
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            3444566677889999999999999999988899999998765    356779999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      +|||+|||..|+|.++|...  ..++.-....++.||.+|+.||..+++|||||...|+|+.++..||++||||++.+..
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            99999999999999999654  3566667777888999999999999999999999999999999999999999998853


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .....                  .     +                         ..--...|.|||.+.-..++-++|+
T Consensus       418 DTYTA------------------H-----A-------------------------GAKFPIKWTAPEsLAyNtFSiKSDV  449 (1157)
T KOG4278|consen  418 DTYTA------------------H-----A-------------------------GAKFPIKWTAPESLAYNTFSIKSDV  449 (1157)
T ss_pred             Cceec------------------c-----c-------------------------CccCcccccCcccccccccccchhh
Confidence            32111                  0     0                         1123456999999999999999999


Q ss_pred             hhhhHHHHhhccc
Q 018275          339 LAYWNETLSCNYL  351 (358)
Q Consensus       339 wSlGvil~e~l~~  351 (358)
                      |+|||+|||+-++
T Consensus       450 WAFGVLLWEIATY  462 (1157)
T KOG4278|consen  450 WAFGVLLWEIATY  462 (1157)
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999998653

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=246.14  Aligned_cols=192  Identities=24%  Similarity=0.339  Sum_probs=154.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHH--HhcCcceEEEEEEeecC----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA--EVASHCIVKLYYSFQDA----  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~--~l~h~~iv~l~~~~~~~----  178 (358)
                      .....+.+.||+|.||.||+|.++  |..||||++...+     + ....+|.+|..  .++|+||..++++-..+    
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-----E-~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-----E-RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEecccc-----h-hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            467889999999999999999877  7799999987543     1 22556777776  46999999998775433    


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCCEEEcCCCcEEEEec
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDQNGHMKLSDF  250 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~iiHrDikp~NILl~~~~~vkl~DF  250 (358)
                      ..+|||++|.+.|+|.|+|.. ..++......++..++.||++||..        .|.|||||..|||+.+|+..-|+|+
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            358999999999999999976 7788888899999999999999942        4999999999999999999999999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK  330 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~  330 (358)
                      |||....... ..+.-                 .                           .+..|||..||||||+...
T Consensus       361 GLAv~h~~~t-~~idi-----------------~---------------------------~N~rVGTKRYMAPEvLdet  395 (513)
T KOG2052|consen  361 GLAVRHDSDT-DTIDI-----------------P---------------------------PNPRVGTKRYMAPEVLDET  395 (513)
T ss_pred             eeeEEecccC-CcccC-----------------C---------------------------CCCccceeeccChHHhhhh
Confidence            9998765332 11100                 0                           1134999999999999753


Q ss_pred             C----C-C-ccchhhhhhHHHHhhcc
Q 018275          331 G----Y-G-MECDWLAYWNETLSCNY  350 (358)
Q Consensus       331 ~----y-~-~~~DiwSlGvil~e~l~  350 (358)
                      -    + + ..+||||||.++||+.-
T Consensus       396 in~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  396 INMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             cChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            2    1 1 34899999999999764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=262.92  Aligned_cols=195  Identities=18%  Similarity=0.221  Sum_probs=166.1

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCC----EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ....++||+|+||+||+|.+...|+    +||||++....  .......+.+|+-+|.+++|||+++|+++|.... +.|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            3445789999999999999865554    78999987654  4555667999999999999999999999998765 889


Q ss_pred             EEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          184 IMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      |++|||+|+|.+++..+ .++-......|..||+.||.|||.++++||||-..|||+..-.++||+|||+|+.+......
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999999764 67888889999999999999999999999999999999999999999999999988643322


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                      -..                                               .+..-.+.|||-|.+....|+.++||||||
T Consensus       855 y~~-----------------------------------------------~~gK~pikwmale~i~~~~~thqSDVWsfG  887 (1177)
T KOG1025|consen  855 YSA-----------------------------------------------PGGKVPIKWMALESIRIRKYTHQSDVWSFG  887 (1177)
T ss_pred             ccc-----------------------------------------------cccccCcHHHHHHHhhccCCCchhhhhhhh
Confidence            110                                               012346779999999999999999999999


Q ss_pred             HHHHhhcccc
Q 018275          343 NETLSCNYLS  352 (358)
Q Consensus       343 vil~e~l~~~  352 (358)
                      |++|||++..
T Consensus       888 VtiWElmTFG  897 (1177)
T KOG1025|consen  888 VTIWELMTFG  897 (1177)
T ss_pred             hhHHHHHhcC
Confidence            9999998743

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.3e-30  Score=255.34  Aligned_cols=203  Identities=21%  Similarity=0.260  Sum_probs=148.7

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEe----------------cCCCEEEEEecchhhhhc-----------hhhHHHHH
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEK----------------KSGNIYAMKKLKKSEMLS-----------RGQVEHVR  154 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~----------------~~~~~vaiK~i~~~~~~~-----------~~~~~~~~  154 (358)
                      .+..++|.+.++||+|+||+||+|...                ..++.||||.+.......           ....+...
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            456789999999999999999999642                345689999986432110           01112233


Q ss_pred             HHHHHHHHhcCcce-----EEEEEEeec--------CCEEEEEEeecCCCCHHHHHhhcC--------------------
Q 018275          155 AERNLLAEVASHCI-----VKLYYSFQD--------AEYLYLIMEYLPGGDVMTLLMREE--------------------  201 (358)
Q Consensus       155 ~E~~il~~l~h~~i-----v~l~~~~~~--------~~~~~lV~E~~~~g~L~~~l~~~~--------------------  201 (358)
                      .|+.++..++|.++     +.++++|..        ....+|||||+++++|.+++....                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46667777776654     566666542        356899999999999999886421                    


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccc
Q 018275          202 ----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE  277 (358)
Q Consensus       202 ----~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                          .++...++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+.......              
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--------------  366 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--------------  366 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--------------
Confidence                13455677889999999999999999999999999999999999999999986543111000              


Q ss_pred             cCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC--------------------CC--cc
Q 018275          278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--------------------YG--ME  335 (358)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~--------------------y~--~~  335 (358)
                                                        .....+||.|+|||++....                    |+  ..
T Consensus       367 ----------------------------------~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~  412 (507)
T PLN03224        367 ----------------------------------PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDL  412 (507)
T ss_pred             ----------------------------------ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCc
Confidence                                              00124689999999986432                    22  24


Q ss_pred             chhhhhhHHHHhhcccc
Q 018275          336 CDWLAYWNETLSCNYLS  352 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~  352 (358)
                      +|+||+||++|+|+++.
T Consensus       413 ~DvwSlGvil~em~~~~  429 (507)
T PLN03224        413 FDSYTAGVLLMQMCVPE  429 (507)
T ss_pred             cchhhHHHHHHHHHhCC
Confidence            79999999999999864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=265.83  Aligned_cols=195  Identities=30%  Similarity=0.511  Sum_probs=174.6

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      -..++|.++..+|.|+||.||+++++.++...|+|+++..   ..+....+++|+-+++.++|||||.+++.+.....++
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            3458999999999999999999999999999999999876   3455566888999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ++||||.||+|.+..+..+++++.++.....+.+.||+|||+.|-+|||||-.|||++..|.+|++|||.+..+...-  
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--  166 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--  166 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh--
Confidence            999999999999999989999999999999999999999999999999999999999999999999999886553211  


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCccchhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWL  339 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~~~Diw  339 (358)
                                                                     ....++.|||.||||||-.   ..+|+..||+|
T Consensus       167 -----------------------------------------------~KrksfiGtpywmapEvaaverkggynqlcdiw  199 (829)
T KOG0576|consen  167 -----------------------------------------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIW  199 (829)
T ss_pred             -----------------------------------------------hhhhcccCCccccchhHHHHHhccccccccccc
Confidence                                                           1123679999999999974   67899999999


Q ss_pred             hhhHHHHhhc
Q 018275          340 AYWNETLSCN  349 (358)
Q Consensus       340 SlGvil~e~l  349 (358)
                      ++|++..|.-
T Consensus       200 a~gitAiel~  209 (829)
T KOG0576|consen  200 ALGITAIELG  209 (829)
T ss_pred             ccccchhhhh
Confidence            9999988854

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=8.4e-30  Score=226.01  Aligned_cols=198  Identities=39%  Similarity=0.599  Sum_probs=172.1

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEee
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      |.+.+.||.|++|.||++.+..++..+|+|.+......  .....+..|+..+..++|+|++++++.+......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            56788999999999999999888999999999876422  2456788899999999999999999999988999999999


Q ss_pred             cCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          188 LPGGDVMTLLMREET-LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       188 ~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      +++++|.+++..... +++.....++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.........    
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~----  154 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA----  154 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc----
Confidence            999999999977666 889999999999999999999999999999999999999999999999998765422100    


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh-cCCCCCccchhhhhhHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-LKKGYGMECDWLAYWNET  345 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~-~~~~y~~~~DiwSlGvil  345 (358)
                                                                  ......++..|++||++ ...+++.++|+||||+++
T Consensus       155 --------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~  190 (225)
T smart00221      155 --------------------------------------------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVIL  190 (225)
T ss_pred             --------------------------------------------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHH
Confidence                                                        00123688899999999 777888999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      ++++.+...|
T Consensus       191 ~~l~~g~~pf  200 (225)
T smart00221      191 YELLWGPEPF  200 (225)
T ss_pred             HHHHHCCCCc
Confidence            9999987776

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.5e-31  Score=229.57  Aligned_cols=194  Identities=25%  Similarity=0.400  Sum_probs=165.3

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCC--E
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE--Y  180 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~--~  180 (358)
                      ..++|++.+++|+|.|+.||.|.+..+...++||++++..      ...+.+|+.||..++ ||||++|++...|+.  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            3589999999999999999999999999999999998653      345889999999997 999999999998754  5


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-CcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~vkl~DFGla~~~~~~  259 (358)
                      ..||+||+.+.+...+.   +.++...++.++.+++.||.|+|++||+|||+||.|++||.. -.++|+|+|+|......
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            78999999887766654   567888999999999999999999999999999999999865 57999999999876522


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Di  338 (358)
                      ..                                                  .+-.|.+..|--||.+.. +-|+++-|+
T Consensus       187 ~e--------------------------------------------------YnVRVASRyfKGPELLVdy~~YDYSLD~  216 (338)
T KOG0668|consen  187 KE--------------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDM  216 (338)
T ss_pred             ce--------------------------------------------------eeeeeehhhcCCchheeechhccccHHH
Confidence            11                                                  112366777889999976 569999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||+|.+|.+....|-
T Consensus       217 WS~GcmlA~miFrkepFF  234 (338)
T KOG0668|consen  217 WSLGCMLASMIFRKEPFF  234 (338)
T ss_pred             HHHHHHHHHHHhccCccc
Confidence            999999999999777663

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=237.70  Aligned_cols=198  Identities=25%  Similarity=0.352  Sum_probs=166.7

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC----
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----  179 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~----  179 (358)
                      ...+|.-+..+|.|+- .|-.+.+.-.+++||+|++... ........+..+|..++..+.|+||+.++.+|....    
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            3478888999999998 7778888889999999998766 334445566788999999999999999999997554    


Q ss_pred             --EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          180 --YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       180 --~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                        ..|+|||+|. .+|...+.  -.++-..++.++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+.-+
T Consensus        93 ~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   93 FQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence              4799999995 58888775  445667788999999999999999999999999999999999999999999998543


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ..-.                                                  -...+.|..|+|||++.+.+|...+|
T Consensus       170 ~~~~--------------------------------------------------mtpyVvtRyyrapevil~~~~ke~vd  199 (369)
T KOG0665|consen  170 TDFM--------------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVD  199 (369)
T ss_pred             cccc--------------------------------------------------cCchhheeeccCchheeccCCcccch
Confidence            2100                                                  01248999999999999999999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      |||+|||+.||+.++=+|+
T Consensus       200 iwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  200 IWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             hhhhhhHHHHHhhceEEec
Confidence            9999999999999876664

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=2.9e-29  Score=224.38  Aligned_cols=186  Identities=42%  Similarity=0.690  Sum_probs=163.5

Q ss_pred             eeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCHHHHH
Q 018275          118 AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL  197 (358)
Q Consensus       118 ~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l  197 (358)
                      +||.||+|.+..++..+|+|++........  ...+.+|+..++.++|+|++++++.+......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999988899999999986643221  567889999999999999999999999989999999999999999999


Q ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccc
Q 018275          198 MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE  277 (358)
Q Consensus       198 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .....++...+..++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+........                
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~----------------  142 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL----------------  142 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc----------------
Confidence            7776688999999999999999999999999999999999999999999999999886642210                


Q ss_pred             cCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccccccc
Q 018275          278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                                                        .....|++.|+|||.+.+..++.++|+||||+++|+++.+...|
T Consensus       143 ----------------------------------~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~  186 (244)
T smart00220      143 ----------------------------------LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPF  186 (244)
T ss_pred             ----------------------------------cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                                              01236889999999999999999999999999999999876655

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-29  Score=254.98  Aligned_cols=203  Identities=25%  Similarity=0.347  Sum_probs=169.0

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEec-------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEE
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKL  171 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l  171 (358)
                      ..++..++..+.+.||+|.||.|++|....       ....||||.++....  ..+...+..|+.+|..+ .|+|||.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence            355566777788899999999999997431       145799999987653  36677899999999988 59999999


Q ss_pred             EEEeecCCEEEEEEeecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 018275          172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD  235 (358)
Q Consensus       172 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~  235 (358)
                      +|+|.....+++|+||+..|+|..+|....                .++......++.||+.|+.||++.++|||||...
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999999999999999999999999997654                3778888999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccc
Q 018275          236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST  315 (358)
Q Consensus       236 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  315 (358)
                      |||+..+..+||+|||+|+.......-..                                                .+.
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~------------------------------------------------~~~  479 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRT------------------------------------------------KSS  479 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEe------------------------------------------------cCC
Confidence            99999999999999999986542221100                                                011


Q ss_pred             cCC--CCCchhhhhcCCCCCccchhhhhhHHHHhhcccc
Q 018275          316 VGT--PDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       316 ~gt--~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~  352 (358)
                      .|+  -.|||||.+....|+.++|+|||||+|||+..+.
T Consensus       480 ~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG  518 (609)
T KOG0200|consen  480 AGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG  518 (609)
T ss_pred             CCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence            222  2399999999999999999999999999987754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.7e-27  Score=207.52  Aligned_cols=184  Identities=40%  Similarity=0.611  Sum_probs=160.4

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCH
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV  193 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L  193 (358)
                      ||+|++|.||++....++..+++|++.......  ....+.+|+.+++.+.|++++++++++......+++||++++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999988889999999998664211  346688999999999999999999999998999999999999999


Q ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-CCcEEEEecCCCccCCCCCCcccccccccc
Q 018275          194 MTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSAINENEVLD  271 (358)
Q Consensus       194 ~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~~~  271 (358)
                      .+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........          
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----------  148 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----------  148 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence            9999765 57889999999999999999999999999999999999999 89999999999876542211          


Q ss_pred             cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhHHHHhh
Q 018275          272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWNETLSC  348 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGvil~e~  348 (358)
                                                             ......+.+.|++||.+... .++.++|+||+|++++++
T Consensus       149 ---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         149 ---------------------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             ---------------------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence                                                   01123588899999999887 889999999999999987

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=2e-29  Score=233.29  Aligned_cols=239  Identities=21%  Similarity=0.298  Sum_probs=169.9

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEec---CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEY  180 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~  180 (358)
                      .+.|..+++||.|+|++||++.+..   .+..||+|.+.....     ...+.+|+.+|..+. +.||+++.+++...+.
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3778999999999999999998877   788999999876532     233888999999885 6799999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-CcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~vkl~DFGla~~~~~~  259 (358)
                      .++|+||++..+..+++..   ++-..++.++..++.||.++|..|||||||||+|+|.+.. +.-.|+|||+|...+..
T Consensus       110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            9999999999888888743   4577899999999999999999999999999999999854 78899999999843211


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~Di  338 (358)
                      ..+.-.....  ......  ......+...+.. ...+.-........++....+..|||+|+||||+..- .-+.++|+
T Consensus       187 ~~~~~s~~~~--~~~~~~--~~g~~~~~~~~~~-~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  187 QQTEHSRSYS--GRHATP--AMGKDVHCQSVAT-ASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             hhhhhhhhhh--cccCCc--cccCccccccccc-ccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            1000000000  000000  0000000000000 0000000000012345555677999999999999864 46788999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      ||.|||++..+...+.|-
T Consensus       262 ws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             eeccceeehhhccccccc
Confidence            999999999888777653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=6.9e-28  Score=228.63  Aligned_cols=145  Identities=17%  Similarity=0.162  Sum_probs=116.4

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEec-CCCEEEEEecchhhh--hchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~-~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ...++|.+.+.||+|+||+||+|.+.. +++.||||++.....  ........+.+|+.+|+.++|+|+++.+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            345889999999999999999998876 678889998753311  1223355689999999999999998543332   3


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCCEEEcCCCcEEEEecCCCccCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI-KPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDi-kp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ..|+||||++|++|... ..   ..   ...++.+++.||.|||+.||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            57999999999999632 11   11   1456789999999999999999999 9999999999999999999998764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-28  Score=242.78  Aligned_cols=189  Identities=25%  Similarity=0.310  Sum_probs=153.1

Q ss_pred             ceeeeeEeeeeeEE-EEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEE
Q 018275          108 FDLLTIIGRGAFGE-VRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       108 ~~~~~~IG~G~fG~-Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      |...+++|.|+.|+ ||+|.  ..|+.||||.+-...      ....++|+..|... .|||||++|+.-+++...||..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe--eCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            44456889999886 68886  458899999886543      34478899999887 5999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---C--CcEEEEecCCCccC
Q 018275          186 EYLPGGDVMTLLMREET----LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---N--GHMKLSDFGLCKPL  256 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~--~~vkl~DFGla~~~  256 (358)
                      |.| ..+|.+++.....    ...-..+..+.|++.||++||+.+||||||||.||||+.   +  ..++|+|||+|+.+
T Consensus       583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            999 5699999976311    111334667889999999999999999999999999976   3  47899999999988


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      .....+-                                              +...+..||-+|+|||++....-..++
T Consensus       662 ~~~~sS~----------------------------------------------~r~s~~sGt~GW~APE~L~~~~~~~av  695 (903)
T KOG1027|consen  662 AGGKSSF----------------------------------------------SRLSGGSGTSGWQAPEQLREDRKTQAV  695 (903)
T ss_pred             CCCcchh----------------------------------------------hcccCCCCcccccCHHHHhccccCccc
Confidence            6322111                                              112355799999999999998888899


Q ss_pred             hhhhhhHHHHhhccc
Q 018275          337 DWLAYWNETLSCNYL  351 (358)
Q Consensus       337 DiwSlGvil~e~l~~  351 (358)
                      |++|+||++|.++.+
T Consensus       696 DiFslGCvfyYvltg  710 (903)
T KOG1027|consen  696 DIFSLGCVFYYVLTG  710 (903)
T ss_pred             chhhcCceEEEEecC
Confidence            999999999999986

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=216.60  Aligned_cols=191  Identities=23%  Similarity=0.317  Sum_probs=154.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEE-EEeecCCEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLY-YSFQDAEYLYL  183 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~-~~~~~~~~~~l  183 (358)
                      +.|.+.+.+|+|.||.+-+|.++.+.+.+++|.++...    .....|.+|..---.+ .|.||+.-| .+|+..+.+.+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            77999999999999999999999999999999998763    2344577776544344 577888777 56888889999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc--CCCcEEEEecCCCccCCCCCC
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--QNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~--~~~~vkl~DFGla~~~~~~~~  261 (358)
                      ++||+|.|||.+-+.. ..+-+...+.++.|+++||.|+|+.++||||||.+||||.  +...+||||||+.+..+....
T Consensus       100 ~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             eeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            9999999999998854 5577888899999999999999999999999999999994  335899999999876542110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC-----CCccc
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-----YGMEC  336 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~-----y~~~~  336 (358)
                                                                          ..--+..|.|||+.....     -+.++
T Consensus       179 ----------------------------------------------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~  206 (378)
T KOG1345|consen  179 ----------------------------------------------------YLEYVNNYHAPELCDTVVNEKLVVNPST  206 (378)
T ss_pred             ----------------------------------------------------hhhhhcccCCcHHHhhccccceEecccc
Confidence                                                                012456688999986432     46789


Q ss_pred             hhhhhhHHHHhhccccc
Q 018275          337 DWLAYWNETLSCNYLSD  353 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~  353 (358)
                      |+|.||+++|.||+|--
T Consensus       207 D~WqfGIi~f~cltG~~  223 (378)
T KOG1345|consen  207 DIWQFGIIFFYCLTGKF  223 (378)
T ss_pred             cchheeeeeeeeecCCC
Confidence            99999999999998753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=2.5e-24  Score=198.72  Aligned_cols=202  Identities=38%  Similarity=0.539  Sum_probs=169.7

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCc-ceEEEEEEeecCCEEEEEEe
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~-~iv~l~~~~~~~~~~~lV~E  186 (358)
                      |.+...||.|+||.||.+.+.   ..+++|.+.............+.+|..+++.+.|+ +++.+++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            778899999999999999876   78999999887654433567788999999999998 79999999988888899999


Q ss_pred             ecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-cEEEEecCCCccCCCCCCc
Q 018275          187 YLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~vkl~DFGla~~~~~~~~~  262 (358)
                      ++.++++.+++....   .++......++.|++.++.|+|..+++||||||+||+++..+ .++++|||+++.+......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997776654   799999999999999999999999999999999999999998 7999999999855422211


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC---CCCCccchhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMECDWL  339 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~---~~y~~~~Diw  339 (358)
                      ....                                           ......+||+.|+|||++.+   ..++...|+|
T Consensus       159 ~~~~-------------------------------------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~  195 (384)
T COG0515         159 SSIP-------------------------------------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIW  195 (384)
T ss_pred             cccc-------------------------------------------ccccccccccccCCHHHhcCCCCCCCCchHhHH
Confidence            1000                                           01225689999999999998   5788999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      |+|+++++++.+...|
T Consensus       196 s~g~~~~~~~~~~~p~  211 (384)
T COG0515         196 SLGITLYELLTGLPPF  211 (384)
T ss_pred             HHHHHHHHHHhCCCCC
Confidence            9999999988776543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=4.2e-25  Score=196.02  Aligned_cols=142  Identities=16%  Similarity=0.203  Sum_probs=115.6

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHH------HHHHHHHHHHhcCcceEEEEEEeec
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH------VRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~------~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      ..++|..++.+|.|+||.||++..  ++..+|||+++......+.....      +.+|+..+.++.||+|..+..++.+
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            358999999999999999999644  46689999998665434433333      5788899999999999988877654


Q ss_pred             C--------CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEe
Q 018275          178 A--------EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSD  249 (358)
Q Consensus       178 ~--------~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~D  249 (358)
                      .        ...+|||||++|.+|.++.    .+++.    ...+++.+|..+|..|++||||||+||+++++| ++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            3        3578999999999998874    23332    355899999999999999999999999999999 99999


Q ss_pred             cCCCccC
Q 018275          250 FGLCKPL  256 (358)
Q Consensus       250 FGla~~~  256 (358)
                      ||.++..
T Consensus       178 fg~~~~~  184 (232)
T PRK10359        178 LSGKRCT  184 (232)
T ss_pred             CCCcccc
Confidence            9987644

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=3e-25  Score=193.65  Aligned_cols=143  Identities=19%  Similarity=0.214  Sum_probs=111.4

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhh-----------------------HHHHHHHHHHHHHhcCcc
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-----------------------VEHVRAERNLLAEVASHC  167 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~-----------------------~~~~~~E~~il~~l~h~~  167 (358)
                      ...||+|+||.||+|.+. +|+.||||+++.........                       ......|..++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999986 89999999998653211110                       122345889999998776


Q ss_pred             eEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCCCEEEcCCCcEE
Q 018275          168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI-HKHNYIHRDIKPDNLLLDQNGHMK  246 (358)
Q Consensus       168 iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~L-H~~~iiHrDikp~NILl~~~~~vk  246 (358)
                      +..........  .+|||||++|+++........+++...+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            53322222222  379999999887766544567889999999999999999999 799999999999999998 57899


Q ss_pred             EEecCCCccCC
Q 018275          247 LSDFGLCKPLD  257 (358)
Q Consensus       247 l~DFGla~~~~  257 (358)
                      |+|||+|...+
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-24  Score=202.41  Aligned_cols=203  Identities=27%  Similarity=0.321  Sum_probs=160.7

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCC-CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC----cceEEEEEEe-ecCCE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS----HCIVKLYYSF-QDAEY  180 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h----~~iv~l~~~~-~~~~~  180 (358)
                      +|.+.+.||+|+||.||+|.+..++ ..+|+|...........   .+..|..++..+..    +++..+++.. ....+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999987764 57888887654321111   36778888888863    5888888888 57888


Q ss_pred             EEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-----CcEEEEecCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-----GHMKLSDFGLC  253 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-----~~vkl~DFGla  253 (358)
                      .|+||+.+ |.+|.++....  +.++...+..++.|++.+|.+||+.|++||||||+|+++...     ..+.|.|||+|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999988 88999988543  579999999999999999999999999999999999999765     46999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +...........                                   +    ...+.......||..|+++.+..+...+
T Consensus       175 r~~~~~~~~~~~-----------------------------------~----~~~r~~~~~~rGT~ry~S~~~H~~~e~~  215 (322)
T KOG1164|consen  175 RRFKYVGDSGGN-----------------------------------L----RPPRPQKGLFRGTLRYASINVHLGIEQG  215 (322)
T ss_pred             ccccccCCCCcc-----------------------------------c----ccCCCCccCCCCccccccHHHhCCCccC
Confidence            843211110000                                   0    0001111244699999999999999999


Q ss_pred             ccchhhhhhHHHHhhcccc
Q 018275          334 MECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~  352 (358)
                      ..-|+||++.++.|++.+.
T Consensus       216 r~DDles~~Y~l~el~~g~  234 (322)
T KOG1164|consen  216 RRDDLESLFYMLLELLKGS  234 (322)
T ss_pred             CchhhhhHHHHHHHHhcCC
Confidence            9999999999999998765

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=1.6e-25  Score=235.18  Aligned_cols=176  Identities=10%  Similarity=0.096  Sum_probs=117.8

Q ss_pred             hcC-cceEEEEEEe-------ecCCEEEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 018275          163 VAS-HCIVKLYYSF-------QDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIK  233 (358)
Q Consensus       163 l~h-~~iv~l~~~~-------~~~~~~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDik  233 (358)
                      +.| .||+.++++|       .....+++++|++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            344 4666777766       2345678899988 5699999965 3569999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhh-cccc
Q 018275          234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR-RKLA  312 (358)
Q Consensus       234 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  312 (358)
                      |+||||+..+.+|++|||++............   + .+..+......   ..        ......+....... ....
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~k---i-~DfG~a~~~~~---~~--------~~~~~~~~~~~~~~~~~~~  172 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTK---S-REIGSSRREEI---LS--------ERRIEKLEEVKKQPFPMKQ  172 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCccc---c-ccccccccccc---cc--------ccchhhhhccccCCCcccc
Confidence            99999999899999999988754321110000   0 00000000000   00        00000000000000 0001


Q ss_pred             ccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccc
Q 018275          313 YSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDI  354 (358)
Q Consensus       313 ~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~  354 (358)
                      ...+||+.|||||++.+..|+.++|||||||+||||+.+...
T Consensus       173 ~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~  214 (793)
T PLN00181        173 ILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSS  214 (793)
T ss_pred             cccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCc
Confidence            124799999999999999999999999999999999875443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.6e-26  Score=222.50  Aligned_cols=186  Identities=37%  Similarity=0.589  Sum_probs=163.7

Q ss_pred             EeeeeeEEEEEEEE---ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEEEEEEeecC
Q 018275          114 IGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       114 IG~G~fG~Vy~~~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      +|.|+||.|+++..   ...|..+|+|++.+......... +...|..++..++ ||.+|.+..+|+.+..+++++++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            68999999998743   45678899999987654433333 6778999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccc
Q 018275          190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV  269 (358)
Q Consensus       190 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  269 (358)
                      ||+|...+.....+.+...+.+.++++.+++++|+.+|+|||+|++||+++.+|++++.|||+++......         
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---------  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---------  151 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh---------
Confidence            99999999888899999999999999999999999999999999999999999999999999998653111         


Q ss_pred             cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhc
Q 018275          270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCN  349 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l  349 (358)
                                                                  -.|||..|||||++.  ++..++||||||+++||++
T Consensus       152 --------------------------------------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~fell  185 (612)
T KOG0603|consen  152 --------------------------------------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELL  185 (612)
T ss_pred             --------------------------------------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHh
Confidence                                                        118999999999998  7889999999999999999


Q ss_pred             cccccc
Q 018275          350 YLSDIM  355 (358)
Q Consensus       350 ~~~~~~  355 (358)
                      ++...|
T Consensus       186 tg~~pf  191 (612)
T KOG0603|consen  186 TGTLPF  191 (612)
T ss_pred             hCCCCC
Confidence            987665

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=5.6e-24  Score=185.81  Aligned_cols=144  Identities=18%  Similarity=0.158  Sum_probs=113.2

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhch-----------------------hhHHHHHHHHHHHHHhcCcc
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR-----------------------GQVEHVRAERNLLAEVASHC  167 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~-----------------------~~~~~~~~E~~il~~l~h~~  167 (358)
                      ...||+|+||.||+|.+. +|+.||||+++.......                       ........|...+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999977 899999999986531100                       00123457889999999998


Q ss_pred             eEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEE
Q 018275          168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMK  246 (358)
Q Consensus       168 iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vk  246 (358)
                      +..........  .+|||||++|+++.........++......++.|++.+|.++|. .||+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            64333332222  47999999988655443345677888889999999999999999 9999999999999999 89999


Q ss_pred             EEecCCCccCCC
Q 018275          247 LSDFGLCKPLDC  258 (358)
Q Consensus       247 l~DFGla~~~~~  258 (358)
                      |+|||+|+.+..
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999987753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.91  E-value=6.1e-25  Score=201.67  Aligned_cols=206  Identities=20%  Similarity=0.241  Sum_probs=168.6

Q ss_pred             hhccCccCCCceeeeeEeeeeeEEEEEEEEecC-----CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEE
Q 018275           98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY  172 (358)
Q Consensus        98 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~  172 (358)
                      .....+...++.....+-+|.||.||.|.++..     .+.|-+|.++...  ++-+...+..|.-.+..+.|||+.++.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            344455567888899999999999999976543     3356677776553  567778899999999999999999999


Q ss_pred             EEee-cCCEEEEEEeecCCCCHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC
Q 018275          173 YSFQ-DAEYLYLIMEYLPGGDVMTLLMR--------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG  243 (358)
Q Consensus       173 ~~~~-~~~~~~lV~E~~~~g~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  243 (358)
                      +++. +....+.++.++.-|+|..+|..        .+.++..+...++.|++.|++|||++||||.||...|.+||+.-
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe
Confidence            8875 45567888999988999999962        12456667778889999999999999999999999999999999


Q ss_pred             cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCch
Q 018275          244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA  323 (358)
Q Consensus       244 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~A  323 (358)
                      .+||+|=.+++.+...+.+....+.                                               -....|||
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnE-----------------------------------------------nRPvkWMs  466 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNE-----------------------------------------------NRPVKWMS  466 (563)
T ss_pred             eEEeccchhccccCcccccccCCCC-----------------------------------------------CCcccccC
Confidence            9999999999988766655443211                                               14567999


Q ss_pred             hhhhcCCCCCccchhhhhhHHHHhhcccc
Q 018275          324 PEVLLKKGYGMECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       324 PEv~~~~~y~~~~DiwSlGvil~e~l~~~  352 (358)
                      ||.+.+..|+..+|+|||||+|||+..+.
T Consensus       467 lEal~n~~yssasDvWsfGVllWELmtlg  495 (563)
T KOG1024|consen  467 LEALQNSHYSSASDVWSFGVLLWELMTLG  495 (563)
T ss_pred             HHHHhhhhhcchhhhHHHHHHHHHHHhcC
Confidence            99999999999999999999999987754

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.1e-24  Score=186.00  Aligned_cols=200  Identities=25%  Similarity=0.285  Sum_probs=162.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC-cceEEEEEEeecCCEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYL  181 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~  181 (358)
                      +..+.|.++++||+|+||.+|+|....+|..||||+-....-     ...+.-|..+...+++ +.|..+..++....+-
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            446899999999999999999999999999999998655431     1236678888888865 5788888888888899


Q ss_pred             EEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC---CcEEEEecCCCccCC
Q 018275          182 YLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPLD  257 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~vkl~DFGla~~~~  257 (358)
                      .+||+++ |-+|.+++.- ...++...+...+-|++.-++|+|.+++|||||||+|+|+.-+   ..+.|+|||+|+.+-
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999999 8899999853 5678888988889999999999999999999999999999644   579999999999774


Q ss_pred             CCCC-cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          258 CTNL-SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       258 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      .... ..++                                           .+.-...+||-.|.+-....+..-+..-
T Consensus       166 d~~t~~HIp-------------------------------------------yre~r~ltGTaRYASinAh~g~eqSRRD  202 (341)
T KOG1163|consen  166 DIRTRQHIP-------------------------------------------YREDRNLTGTARYASINAHLGIEQSRRD  202 (341)
T ss_pred             cccccccCc-------------------------------------------cccCCccceeeeehhhhhhhhhhhhhhh
Confidence            2211 1110                                           0111245799999999888888888899


Q ss_pred             hhhhhhHHHHhhccc
Q 018275          337 DWLAYWNETLSCNYL  351 (358)
Q Consensus       337 DiwSlGvil~e~l~~  351 (358)
                      |+-|+|.+|..++-+
T Consensus       203 DmeSvgYvLmYfnrG  217 (341)
T KOG1163|consen  203 DMESVGYVLMYFNRG  217 (341)
T ss_pred             hhhhhcceeeeeecC
Confidence            999999999886554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.1e-23  Score=216.83  Aligned_cols=198  Identities=20%  Similarity=0.262  Sum_probs=157.8

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc---CcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~~  179 (358)
                      +....|.+.+.||+|+||.||+|.+.. |+.||+|+-++...+.--      --..++.+|+   -+.|..+..++.-.+
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY------I~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY------ICLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee------ehHHHHHhhchhhhcchHHHHHHHccCC
Confidence            344779999999999999999999877 999999998876544211      1122333333   223444444444455


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc-------CCCcEEEEecCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-------QNGHMKLSDFGL  252 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~-------~~~~vkl~DFGl  252 (358)
                      .-+||+||.+.|+|.+++.....+++..+.+++.|++..|+.||..+|||+||||+|+||.       .+..++|+|||.
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            6789999999999999999888999999999999999999999999999999999999994       234699999998


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY  332 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y  332 (358)
                      |..+.....                                               .......++|-.+-.+|+..|.+|
T Consensus       848 siDm~lfp~-----------------------------------------------~~~F~~~~~td~f~C~EM~~grpW  880 (974)
T KOG1166|consen  848 SIDMKLFPD-----------------------------------------------GTKFKAVWHTDLFDCIEMREGRPW  880 (974)
T ss_pred             ceeeeEcCC-----------------------------------------------CcEEeeeeccccchhHHHhcCCCC
Confidence            875532111                                               112335688999999999999999


Q ss_pred             CccchhhhhhHHHHhhcccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDI  354 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~  354 (358)
                      ++++|.|.|+.+++-||+|.||
T Consensus       881 tYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  881 TYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             chhhhhHHHHHHHHHHHHHHHH
Confidence            9999999999999999999886

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=3.9e-23  Score=186.47  Aligned_cols=201  Identities=22%  Similarity=0.302  Sum_probs=165.5

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~  182 (358)
                      ..-+|.+.++||+|+||+++.|.+..++++||||.-+..     .....++.|....+.|. .++|...|.+.+...+..
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            346899999999999999999999999999999975533     22334777888877774 678999998888899999


Q ss_pred             EEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-----CcEEEEecCCCccC
Q 018275          183 LIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-----GHMKLSDFGLCKPL  256 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-----~~vkl~DFGla~~~  256 (358)
                      ||+|++ |-+|.+++.- ...|+...+..++.|++.-+.|+|.+.+|.|||||+|+||...     ..+.|+|||+|+..
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999999 8899998854 5689999999999999999999999999999999999999644     46899999999977


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      .......              ++      |+                      +--.|..||-.||+-.-.+|..-+..-
T Consensus       180 rDp~Tkq--------------HI------PY----------------------rE~KSLsGTARYMSINTHlGrEQSRRD  217 (449)
T KOG1165|consen  180 RDPKTKQ--------------HI------PY----------------------REHKSLSGTARYMSINTHLGREQSRRD  217 (449)
T ss_pred             cCccccc--------------cC------cc----------------------ccccccccceeeeEeeccccchhhhhh
Confidence            5322110              00      00                      112266899999999999999999999


Q ss_pred             hhhhhhHHHHhhcccc
Q 018275          337 DWLAYWNETLSCNYLS  352 (358)
Q Consensus       337 DiwSlGvil~e~l~~~  352 (358)
                      |.-|||=+++.+|-++
T Consensus       218 DLEaLGHvFmYFLRGs  233 (449)
T KOG1165|consen  218 DLEALGHVFMYFLRGS  233 (449)
T ss_pred             hHHHhhhhhhhhccCC
Confidence            9999999999977654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.9e-22  Score=173.76  Aligned_cols=197  Identities=17%  Similarity=0.166  Sum_probs=139.3

Q ss_pred             eeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhh-HHHHHHHHHHHHHhcC-cceEEEEEEeecCCEEEEEEe
Q 018275          109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       109 ~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~-~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      .+...|++|+||+|+++..  .+.+++.+.+.......... ...+.+|+.+|+.+.| ++++.++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4567899999999997653  67788878776554322211 2247889999999965 678888875    34689999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI-KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDi-kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      |+.|.+|...+..      . ...++.|++.+|.++|..||+|||| ||+|||++.++.++|+|||+|..........  
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~--  149 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM--  149 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH--
Confidence            9999988654321      1 1346779999999999999999999 7999999999999999999997543211000  


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCC-ccchhhhhhH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYG-MECDWLAYWN  343 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~-~~~DiwSlGv  343 (358)
                        .+.                       -.....++-++..         -.+|.|++|+...-. ..+ ...+|++.|+
T Consensus       150 --r~L-----------------------~~rDl~~llk~~~---------~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~  195 (218)
T PRK12274        150 --RLL-----------------------AREDLRHLLKHKR---------MYCPAALTPVERRVLKRTSWIRELWFATGK  195 (218)
T ss_pred             --HHH-----------------------HHHHHHHHHHHHH---------hcCCCCCCHHHHhhhccchhHHHHHHHhcc
Confidence              000                       0001122222211         378999999886532 334 6789999999


Q ss_pred             HHHhhcccccc
Q 018275          344 ETLSCNYLSDI  354 (358)
Q Consensus       344 il~e~l~~~~~  354 (358)
                      .+|.+.++.=+
T Consensus       196 ~~~~~~~~~~~  206 (218)
T PRK12274        196 PVYRFVTRRVL  206 (218)
T ss_pred             hHHHHHhccCC
Confidence            99999886543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=1.6e-23  Score=212.34  Aligned_cols=179  Identities=35%  Similarity=0.558  Sum_probs=131.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...++|..++.|..|+||.||+++|+.+.+.+|+| +.+.....       ++   ++....+|.+|             
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil-------Rn---ilt~a~npfvv-------------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL-------RN---ILTFAGNPFVV-------------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh-------hc---cccccCCccee-------------
Confidence            34589999999999999999999999999999994 44433211       11   34444455544             


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                              ||-...++.-++++...        +.+++|||+.||+|||+||+|.||..-|++|++|||+++..-.....
T Consensus       136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                    55566665555555433        78999999999999999999999999999999999999865432222


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                      ..+...+                                ..+  .+.-....+||||.|+||||+..++|+..+|||++|
T Consensus       200 nl~eg~I--------------------------------~k~--t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamG  245 (1205)
T KOG0606|consen  200 NLKEGHI--------------------------------EKD--THEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG  245 (1205)
T ss_pred             hhhhcch--------------------------------HHH--HHHhhhccccCCccccChhhhhhhccCCCccHHHHH
Confidence            2111111                                000  011112356999999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      +|+||+|.+-..|
T Consensus       246 iIlyeFLVgcvpf  258 (1205)
T KOG0606|consen  246 IILYEFLVGCVPF  258 (1205)
T ss_pred             HHHHHHheeeeec
Confidence            9999998876655

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3e-23  Score=209.02  Aligned_cols=202  Identities=24%  Similarity=0.322  Sum_probs=161.1

Q ss_pred             eeeeeEeeeeeEEEEEEEEecCCCEEEEEecch---hhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       109 ~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      .....+|.|++|.|+.+.........+.|..+.   ...........+..|..+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            456889999999888887766666666665542   11112222333666777778899999988877776666566669


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++ ||..++.....+....+..++.|++.||.|+|..||.||||||+|+++..+|.+||+|||.+..+........ 
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~-  478 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI-  478 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh-
Confidence            99999 9999998888899999999999999999999999999999999999999999999999999887643221110 


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCc-cchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM-ECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~-~~DiwSlGvi  344 (358)
                                                                  ......+|+..|+|||++.+..|+. ..|+||.|++
T Consensus       479 --------------------------------------------~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii  514 (601)
T KOG0590|consen  479 --------------------------------------------HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGII  514 (601)
T ss_pred             --------------------------------------------hhhcCcccCCcCcCcccccccccCcchhhhhhccce
Confidence                                                        1223568999999999999999996 5999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +..|.++.+...
T Consensus       515 ~~~m~~~~~~Wk  526 (601)
T KOG0590|consen  515 YICMILGRFPWK  526 (601)
T ss_pred             EEEEecCCCccc
Confidence            999999866543

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.2e-21  Score=172.84  Aligned_cols=137  Identities=15%  Similarity=0.181  Sum_probs=107.8

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-----cCcceEEEEEEeecCC---EE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-----ASHCIVKLYYSFQDAE---YL  181 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~l~~~~~~~~---~~  181 (358)
                      -...||+|+||.||.  +..++.. +||++....   ....+.+.+|+.+++.+     +||||+++++++.++.   .+
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            346899999999995  6666665 699887643   22345689999999999     5799999999998873   43


Q ss_pred             E-EEEee--cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeCCCCCCCEEEcCC----CcEEEEecCCC
Q 018275          182 Y-LIMEY--LPGGDVMTLLMREETLTETVARFYIAQSVLAI-ESIHKHNYIHRDIKPDNLLLDQN----GHMKLSDFGLC  253 (358)
Q Consensus       182 ~-lV~E~--~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL-~~LH~~~iiHrDikp~NILl~~~----~~vkl~DFGla  253 (358)
                      + +||||  +++++|.+++... .+++.  ..++.+++.++ .|||+++|+||||||+|||++..    +.++|+||+-+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            4 78999  5579999999653 46655  35577888777 99999999999999999999743    37999995544


Q ss_pred             cc
Q 018275          254 KP  255 (358)
Q Consensus       254 ~~  255 (358)
                      ..
T Consensus       157 ~~  158 (210)
T PRK10345        157 ST  158 (210)
T ss_pred             cc
Confidence            43

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.86  E-value=9.5e-22  Score=168.85  Aligned_cols=103  Identities=20%  Similarity=0.198  Sum_probs=91.2

Q ss_pred             CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccc
Q 018275          191 GDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV  269 (358)
Q Consensus       191 g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  269 (358)
                      |+|.+++.. ..++++..+..++.|++.||.|||+.+      ||+|||++.++.+|+  ||+++.....          
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence            689999976 456999999999999999999999998      999999999999999  9998754311          


Q ss_pred             cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhc
Q 018275          270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCN  349 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l  349 (358)
                                                                  ...||+.|||||++.+..|+.++|||||||++|||+
T Consensus        63 --------------------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell   98 (176)
T smart00750       63 --------------------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL   98 (176)
T ss_pred             --------------------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHH
Confidence                                                        125899999999999999999999999999999999


Q ss_pred             cccccc
Q 018275          350 YLSDIM  355 (358)
Q Consensus       350 ~~~~~~  355 (358)
                      ++...|
T Consensus        99 tg~~p~  104 (176)
T smart00750       99 DYELPY  104 (176)
T ss_pred             hCCCCc
Confidence            987654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>smart00090 RIO RIO-like kinase

Probab=99.86  E-value=2.1e-21  Score=175.14  Aligned_cols=147  Identities=16%  Similarity=0.121  Sum_probs=115.8

Q ss_pred             CceeeeeEeeeeeEEEEEEE-EecCCCEEEEEecchhhhhc---------------------hhhHHHHHHHHHHHHHhc
Q 018275          107 DFDLLTIIGRGAFGEVRLCQ-EKKSGNIYAMKKLKKSEMLS---------------------RGQVEHVRAERNLLAEVA  164 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~-~~~~~~~vaiK~i~~~~~~~---------------------~~~~~~~~~E~~il~~l~  164 (358)
                      .|.+.+.||+|+||.||+|. +..+|+.||||+++......                     ......+..|..++..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 66789999999997542110                     001123567999999997


Q ss_pred             Ccc--eEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCCEEEcC
Q 018275          165 SHC--IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN-YIHRDIKPDNLLLDQ  241 (358)
Q Consensus       165 h~~--iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-iiHrDikp~NILl~~  241 (358)
                      +.+  +..++..   . ..++||||++|.+|.........+....+..++.|++.+|.+||..| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            643  3444442   1 24799999999888776544556666677889999999999999999 99999999999999 


Q ss_pred             CCcEEEEecCCCccCCC
Q 018275          242 NGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       242 ~~~vkl~DFGla~~~~~  258 (358)
                      ++.++|+|||.|.....
T Consensus       184 ~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      184 DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             CCCEEEEEChhhhccCC
Confidence            88999999999986653

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=2.6e-20  Score=164.94  Aligned_cols=138  Identities=23%  Similarity=0.291  Sum_probs=113.2

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh-----chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      +.||+|++|.||+|.+  .|..|++|+.......     .......+.+|..++..+.|++++....++.+....++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999976  6778999986543211     11223457789999999999988766666666778899999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      |++|++|.+++.....    ....++.+++.+|.++|+.+++|+|++|.|||++ ++.++|+|||++...
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            9999999999865432    6677888999999999999999999999999999 889999999998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.83  E-value=3.7e-20  Score=162.45  Aligned_cols=134  Identities=21%  Similarity=0.272  Sum_probs=106.3

Q ss_pred             eEeeeeeEEEEEEEEecCCCEEEEEecchhhhh-----chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEee
Q 018275          113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      .||+|+||.||+|.  .++..|++|........     .......+.+|..++..+.|+++.....++.+....++||||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            38999999999997  45778999986543211     112235677899999999988654444444456667899999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       188 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ++|++|.+++.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999998754321       6788999999999999999999999999999 899999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.83  E-value=5.7e-20  Score=161.45  Aligned_cols=141  Identities=20%  Similarity=0.172  Sum_probs=109.2

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc-------------------hhhHHHHHHHHHHHHHhcCcc-
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-------------------RGQVEHVRAERNLLAEVASHC-  167 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~-------------------~~~~~~~~~E~~il~~l~h~~-  167 (358)
                      |.+.+.||+|+||.||+|.+. +|+.||||+++......                   .........|..++..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            777899999999999999864 79999999876532100                   001123567888888888874 


Q ss_pred             -eEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEE
Q 018275          168 -IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK  246 (358)
Q Consensus       168 -iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vk  246 (358)
                       ++..++.    ...++||||++|++|......      .....++.+++.++.++|..||+||||||+||+++.++.++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             4444432    345899999999998766421      23456778999999999999999999999999999999999


Q ss_pred             EEecCCCccCCCC
Q 018275          247 LSDFGLCKPLDCT  259 (358)
Q Consensus       247 l~DFGla~~~~~~  259 (358)
                      |+|||++..+...
T Consensus       166 liDfg~~~~~~~~  178 (198)
T cd05144         166 IIDWPQMVSTDHP  178 (198)
T ss_pred             EEECCccccCCCc
Confidence            9999999877643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=3.6e-19  Score=179.17  Aligned_cols=139  Identities=24%  Similarity=0.279  Sum_probs=111.0

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhh-----hhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE-----MLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      |...+.||+|+||.||+|.+...  .+++|+.....     .........+.+|+.++..++|++++....++.+....+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            45678999999999999876433  34444322111     111223456889999999999999888777777777789


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      +||||++|++|.+++.        ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+|+...
T Consensus       413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            9999999999999884        346678899999999999999999999999999 67899999999998754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=1.8e-19  Score=164.76  Aligned_cols=197  Identities=20%  Similarity=0.211  Sum_probs=129.1

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC----------cceEEEEEEe-
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS----------HCIVKLYYSF-  175 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h----------~~iv~l~~~~-  175 (358)
                      .+.....||.|+++.||.+++..+++.+|+|++...........+.+++|.-....+.+          -.++-.++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            35567899999999999999999999999999876654455666777766644433221          1111111111 


Q ss_pred             -----------ecCC-----EEEEEEeecCCCCHHHHHh---hcCCC---CHHHHHH-HHHHHHHHHHHHHhCCceeCCC
Q 018275          176 -----------QDAE-----YLYLIMEYLPGGDVMTLLM---REETL---TETVARF-YIAQSVLAIESIHKHNYIHRDI  232 (358)
Q Consensus       176 -----------~~~~-----~~~lV~E~~~~g~L~~~l~---~~~~~---~~~~~~~-~~~qi~~aL~~LH~~~iiHrDi  232 (358)
                                 .+..     +.+++|+-+ -+||.+++.   .....   ....++. +..|++..+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                       1111     246788877 468887753   22222   2223433 3479999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccc
Q 018275          233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLA  312 (358)
Q Consensus       233 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (358)
                      +|+|++++.+|.++|+||+.....+...                                                    
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~----------------------------------------------------  199 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRY----------------------------------------------------  199 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEE----------------------------------------------------
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCcee----------------------------------------------------
Confidence            9999999999999999998766543110                                                    


Q ss_pred             ccccCCCCCchhhhhcC--------CCCCccchhhhhhHHHHhhcccccccc
Q 018275          313 YSTVGTPDYIAPEVLLK--------KGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       313 ~s~~gt~~Y~APEv~~~--------~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .....++.|.+||+...        -.++++.|.|+||+++|.++++..+|.
T Consensus       200 ~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~  251 (288)
T PF14531_consen  200 RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG  251 (288)
T ss_dssp             EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred             eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence            00235577999998854        247899999999999999999877664

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.80  E-value=4.2e-19  Score=154.15  Aligned_cols=141  Identities=18%  Similarity=0.216  Sum_probs=100.0

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHH---------------------HHHHHHHHHHHhcCcc--
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE---------------------HVRAERNLLAEVASHC--  167 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~---------------------~~~~E~~il~~l~h~~--  167 (358)
                      .+.||+|+||.||+|.+. +++.||||+++...........                     ....|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999876 7899999998764321111111                     1134566666665543  


Q ss_pred             eEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEE
Q 018275          168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMK  246 (358)
Q Consensus       168 iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vk  246 (358)
                      +.++++.    ...++||||++++++........... ..+..++.+++.++.++|. .+|+|+||||+||+++ ++.++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~  154 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY  154 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence            3444443    23589999999854332111111111 5567788999999999999 9999999999999999 99999


Q ss_pred             EEecCCCccCCC
Q 018275          247 LSDFGLCKPLDC  258 (358)
Q Consensus       247 l~DFGla~~~~~  258 (358)
                      |+|||.+.....
T Consensus       155 liDfg~a~~~~~  166 (187)
T cd05119         155 IIDVPQAVEIDH  166 (187)
T ss_pred             EEECcccccccC
Confidence            999999976653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=2.3e-20  Score=189.91  Aligned_cols=204  Identities=18%  Similarity=0.208  Sum_probs=154.3

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhh-hhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE-MLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++...+.+|++.|=.|.+|.+.. | .|+||++-+.. ..+-....+...|+. ....++||++++.-+-..++..|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            78888999999999999987653 3 58999987654 222223333333444 66679999999888777788889999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      +|.. .+|.|.+..+..+..-..++++.|++.||..+|..||+|+|||.+||||+.-+-+.|+||..-+..-...++...
T Consensus       101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            9994 599999988888888889999999999999999999999999999999999999999999876644332222211


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC-----------CCc
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-----------YGM  334 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~-----------y~~  334 (358)
                      ....++                                          +.-.-..|+|||.|....           ...
T Consensus       180 f~fFFD------------------------------------------TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~p  217 (1431)
T KOG1240|consen  180 FTFFFD------------------------------------------TSRRRTCYIAPERFVSALGKTSVGQDAPLLTP  217 (1431)
T ss_pred             ceEEEe------------------------------------------cCCceeeecChHhhhccccccccCCcccccCh
Confidence            111100                                          111234599999997532           567


Q ss_pred             cchhhhhhHHHHhhccc-ccccc
Q 018275          335 ECDWLAYWNETLSCNYL-SDIML  356 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~-~~~~~  356 (358)
                      +-||||+||+++|+++- +.+|.
T Consensus       218 aMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  218 AMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             hhhhhhhhHHHHHHHhcCCCccc
Confidence            88999999999998873 55554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.3e-18  Score=160.72  Aligned_cols=147  Identities=27%  Similarity=0.355  Sum_probs=110.6

Q ss_pred             cCcceEEEEEEeec---------------------------CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHH
Q 018275          164 ASHCIVKLYYSFQD---------------------------AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV  216 (358)
Q Consensus       164 ~h~~iv~l~~~~~~---------------------------~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~  216 (358)
                      +|||||.++++|.+                           +..+|+||..++ .+|..++..+ ..+....+.+++|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            69999999988843                           246799999885 5999998554 456778888999999


Q ss_pred             HHHHHHHhCCceeCCCCCCCEEE--cCCC--cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCC
Q 018275          217 LAIESIHKHNYIHRDIKPDNLLL--DQNG--HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR  292 (358)
Q Consensus       217 ~aL~~LH~~~iiHrDikp~NILl--~~~~--~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (358)
                      .|+.|||.+||.|||+|.+|||+  |+|+  .+.|+|||+|-..+.....-.+..           .++           
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S-----------~~V-----------  409 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYES-----------DEV-----------  409 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecccccccccccc-----------ccc-----------
Confidence            99999999999999999999999  3443  578999998865443322221110           001           


Q ss_pred             CCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC-----CC-ccchhhhhhHHHHhhccccccc
Q 018275          293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-----YG-MECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~-----y~-~~~DiwSlGvil~e~l~~~~~~  355 (358)
                                           +.-|.-.-||||+....+     .+ .++|.|+.|.+.||++-.++.|
T Consensus       410 ---------------------d~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPF  457 (598)
T KOG4158|consen  410 ---------------------DLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPF  457 (598)
T ss_pred             ---------------------cCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcc
Confidence                                 113566679999997543     23 4799999999999999888876

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=3.4e-17  Score=147.94  Aligned_cols=138  Identities=20%  Similarity=0.287  Sum_probs=104.2

Q ss_pred             eeEe-eeeeEEEEEEEEecCCCEEEEEecchhhh----------hchhhHHHHHHHHHHHHHhcCcce--EEEEEEeecC
Q 018275          112 TIIG-RGAFGEVRLCQEKKSGNIYAMKKLKKSEM----------LSRGQVEHVRAERNLLAEVASHCI--VKLYYSFQDA  178 (358)
Q Consensus       112 ~~IG-~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~----------~~~~~~~~~~~E~~il~~l~h~~i--v~l~~~~~~~  178 (358)
                      ..|| .|+.|+||.+..  .+..++||.+.....          ........+.+|+.++..+.|+++  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 788888887754  367899998854221          112334567889999999998874  5666654322


Q ss_pred             -C---EEEEEEeecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          179 -E---YLYLIMEYLPG-GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       179 -~---~~~lV~E~~~~-g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                       .   ..++|||+++| .+|.+++.. .++++..    +.+++.+|.+||+.||+||||||.|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             2   23599999997 689888754 4555543    568999999999999999999999999999999999999998


Q ss_pred             ccC
Q 018275          254 KPL  256 (358)
Q Consensus       254 ~~~  256 (358)
                      ...
T Consensus       190 ~~~  192 (239)
T PRK01723        190 ELR  192 (239)
T ss_pred             ccC
Confidence            764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=5.3e-17  Score=134.50  Aligned_cols=134  Identities=20%  Similarity=0.256  Sum_probs=111.6

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCc--ceEEEEEEeecCCEEEEEEee
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH--CIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~--~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      +++.||.|.++.||++....  ..+++|.......     ...+..|..++..+.++  ++++++.++...+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            45789999999999998643  6899999866532     34588899999999874  889999888877889999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH---NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       188 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ++++++..+       +......++.+++.+|.++|..   +++|+|++|+||+++.++.++++|||.+....
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence            998877654       4455566788999999999985   69999999999999999999999999987543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.70  E-value=3.5e-18  Score=150.89  Aligned_cols=195  Identities=18%  Similarity=0.234  Sum_probs=152.1

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .+......++.+|.+...|..|+|++.  |..+++|++....... .....|..|...|+-..||||.+++++|..+.++
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnl  262 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNL  262 (448)
T ss_pred             CcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence            344566677889999999999999876  5567788887765432 2334578888899999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-cee-CCCCCCCEEEcCCCcEEEE--ecCCCcc
Q 018275          182 YLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHN-YIH-RDIKPDNLLLDQNGHMKLS--DFGLCKP  255 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~-iiH-rDikp~NILl~~~~~vkl~--DFGla~~  255 (358)
                      .++..|||.|+|...|....  ..+..++..++..++.|+.|||+.. +|- --|....+++|++...+|+  |--++  
T Consensus       263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--  340 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--  340 (448)
T ss_pred             eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--
Confidence            99999999999999997764  3566778888999999999999974 444 4588899999999877765  21111  


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC--
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG--  333 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~--  333 (358)
                                                   |.+.                         ...-.|.||+||.+..++-+  
T Consensus       341 -----------------------------fqe~-------------------------gr~y~pawmspealqrkped~n  366 (448)
T KOG0195|consen  341 -----------------------------FQEV-------------------------GRAYSPAWMSPEALQRKPEDLN  366 (448)
T ss_pred             -----------------------------eecc-------------------------ccccCcccCCHHHHhcCchhcc
Confidence                                         0010                         11457899999999987755  


Q ss_pred             -ccchhhhhhHHHHhhccccccc
Q 018275          334 -MECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       334 -~~~DiwSlGvil~e~l~~~~~~  355 (358)
                       .++|+|||++++||+.+.+-.|
T Consensus       367 ~raadmwsfaillwel~trevpf  389 (448)
T KOG0195|consen  367 IRAADMWSFAILLWELNTREVPF  389 (448)
T ss_pred             hhhhhHHHHHHHHHHhhcccccc
Confidence             5799999999999987765443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=8e-18  Score=169.86  Aligned_cols=201  Identities=24%  Similarity=0.366  Sum_probs=162.9

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEe-cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEK-KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~  182 (358)
                      ...|.+.+.||+|+|+.|-++... .....+|+|.+.... .......+...|..+-..+. |+|++.+++...+....+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            467888899999999999987663 344567777765543 23445555666777777777 999999999999999999


Q ss_pred             EEEeecCCCCHHHHH-hhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCCEEEcCCC-cEEEEecCCCccCCC
Q 018275          183 LIMEYLPGGDVMTLL-MREE-TLTETVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDC  258 (358)
Q Consensus       183 lV~E~~~~g~L~~~l-~~~~-~~~~~~~~~~~~qi~~aL~~LH-~~~iiHrDikp~NILl~~~~-~vkl~DFGla~~~~~  258 (358)
                      ++++|..|+++.+.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++.++ .++++|||+|..+..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999988 5554 6778888999999999999999 99999999999999999999 999999999987753


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC-CCCCchhhhhcCCCC-Cccc
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG-TPDYIAPEVLLKKGY-GMEC  336 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g-t~~Y~APEv~~~~~y-~~~~  336 (358)
                      ....                                              .......+| ++.|+|||++.+..| ....
T Consensus       178 ~~g~----------------------------------------------~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~  211 (601)
T KOG0590|consen  178 KNGA----------------------------------------------ERSLKDRCGSSPPYGAPEHLSGKAYRGPSV  211 (601)
T ss_pred             cCCc----------------------------------------------ceeeecccCCCCCCCCcccccchhhcCCCc
Confidence            2110                                              111223478 999999999998644 5789


Q ss_pred             hhhhhhHHHHhhcccc
Q 018275          337 DWLAYWNETLSCNYLS  352 (358)
Q Consensus       337 DiwSlGvil~e~l~~~  352 (358)
                      |+||.|+++.-++.+.
T Consensus       212 d~~S~g~~l~~~~~g~  227 (601)
T KOG0590|consen  212 DVWSLGIVLSAMLTGE  227 (601)
T ss_pred             ccccccccccccccCC
Confidence            9999999999988754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.63  E-value=5.1e-17  Score=155.40  Aligned_cols=126  Identities=25%  Similarity=0.325  Sum_probs=103.7

Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      .++|+.|++|.-.+|.+++.+..   ..+......++.|+..|+.|   ++.+|+|+||.||.+..+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            46899999999999999997543   45666788899999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      .........                                           +...-...+||+.||+||.+.+..|+.+
T Consensus       406 ~~~~~~~~~-------------------------------------------~~a~~t~~~gt~~YmsPEQi~g~~y~~k  442 (516)
T KOG1033|consen  406 QDKDETVAP-------------------------------------------AAASHTQQVGTLLYMSPEQIRGQQYSEK  442 (516)
T ss_pred             cccCCcccc-------------------------------------------hhhhhhhcccccccCCHHHHhhhhhhhh
Confidence            643220000                                           0000113489999999999999999999


Q ss_pred             chhhhhhHHHHhhcc
Q 018275          336 CDWLAYWNETLSCNY  350 (358)
Q Consensus       336 ~DiwSlGvil~e~l~  350 (358)
                      +||||||+||+|.+.
T Consensus       443 vdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  443 VDIYALGLILAELLI  457 (516)
T ss_pred             cchhhHHHHHHHHHH
Confidence            999999999999776

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.59  E-value=1.1e-15  Score=151.72  Aligned_cols=144  Identities=18%  Similarity=0.376  Sum_probs=94.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh--------------------------c-----hhhHHHHH
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--------------------------S-----RGQVEHVR  154 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~--------------------------~-----~~~~~~~~  154 (358)
                      ..|+. +.||+|++|.||+|+.+.+|+.||||++++....                          .     ......+.
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 7899999999999999888999999999864200                          0     01122333


Q ss_pred             HHHHHHH------Hhc----CcceE---EEEEEeecCCEEEEEEeecCCCCHHHHH--hhcC----CCCHHHHHHHHHHH
Q 018275          155 AERNLLA------EVA----SHCIV---KLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREE----TLTETVARFYIAQS  215 (358)
Q Consensus       155 ~E~~il~------~l~----h~~iv---~l~~~~~~~~~~~lV~E~~~~g~L~~~l--~~~~----~~~~~~~~~~~~qi  215 (358)
                      +|++...      ++.    +...+   .++.-+  ....+|||||++|+.+.++-  ...+    .+.+..+..++   
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~--st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~---  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY--CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF---  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc--CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH---
Confidence            4444433      222    22222   223222  23467999999999997742  2222    12222333333   


Q ss_pred             HHHHHHHHhCCceeCCCCCCCEEEcCCC----cEEEEecCCCccCCCC
Q 018275          216 VLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLDCT  259 (358)
Q Consensus       216 ~~aL~~LH~~~iiHrDikp~NILl~~~~----~vkl~DFGla~~~~~~  259 (358)
                          ..++..|++|+|+||.||+++.++    .++++|||++..++..
T Consensus       274 ----~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        274 ----TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             ----HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                344569999999999999999988    9999999999877543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=1.7e-16  Score=161.87  Aligned_cols=234  Identities=27%  Similarity=0.325  Sum_probs=176.1

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...+.|.+.+-+-+|++|.++.+.-..+|...++|+......+.....+..+.+..++-..++|.++.....|......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            46688999999999999999998877788777888877766666666666777777777677888888777776678899


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||++|+.+++|...|...++.++.-++.++..+..+++|||...++|+|++|.|+|+..+++.+++|||.......-...
T Consensus       881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999965544321100


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCC-CchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWK-SPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      .-.                .|........+... ....++..-   .-+.....+||++|.|||.+.+......+|||++
T Consensus       961 ~~~----------------sg~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen  961 TDL----------------SGPSSSGTPRRLSRSERRPQLSAD---EARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred             CCc----------------ccccccCccccccccccccccccc---hhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence            000                00000000000000 001111111   1122346799999999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      |++++|.|++...|
T Consensus      1022 g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPF 1035 (1205)
T ss_pred             hhhhhhhhcCCCCC
Confidence            99999998876554

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.7e-14  Score=141.22  Aligned_cols=141  Identities=16%  Similarity=0.275  Sum_probs=95.3

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc--h-----------------------------hhHH------HHH
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--R-----------------------------GQVE------HVR  154 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~--~-----------------------------~~~~------~~~  154 (358)
                      +.||.|++|.||+|+. .+|+.||||+.++.....  .                             ....      .+.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5699999999999986 478999999987542000  0                             0000      133


Q ss_pred             HHHHHHHHhc-----Ccce--EEEEEEeecCCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 018275          155 AERNLLAEVA-----SHCI--VKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVL-AIESIHKH  225 (358)
Q Consensus       155 ~E~~il~~l~-----h~~i--v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~-aL~~LH~~  225 (358)
                      +|...+..+.     ++++  .+++..+  ....+|||||++|++|.++.... ....   ...++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence            3444444442     2332  2333222  33468999999999998876432 1222   2234444544 57889999


Q ss_pred             CceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       226 ~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      |++|+|++|.||+++.++.++++|||++..++.
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999999987753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.54  E-value=8.4e-15  Score=142.34  Aligned_cols=150  Identities=21%  Similarity=0.212  Sum_probs=120.6

Q ss_pred             HHHhcCcceEEEEEEeecCCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc-eeCCCCCCCE
Q 018275          160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNY-IHRDIKPDNL  237 (358)
Q Consensus       160 l~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i-iHrDikp~NI  237 (358)
                      |+.+.|.|+.+++|.+.+....+.|.+|+..|+|.+.+... ..++......++..++.||.|||.-.| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            35678999999999999999999999999999999999773 467777777888999999999998766 9999999999


Q ss_pred             EEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC
Q 018275          238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG  317 (358)
Q Consensus       238 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g  317 (358)
                      ++|....+||+|||+.............                                               ....-
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~-----------------------------------------------~~~~~  113 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAH-----------------------------------------------HPIRK  113 (484)
T ss_pred             eeeeeEEEEechhhhccccccccccccc-----------------------------------------------chhHH
Confidence            9999999999999998766420000000                                               00012


Q ss_pred             CCCCchhhhhcCCC-------CCccchhhhhhHHHHhhcccccccc
Q 018275          318 TPDYIAPEVLLKKG-------YGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       318 t~~Y~APEv~~~~~-------y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ..-|.|||.+.+..       .+.+.|+||+|++++|+++....|.
T Consensus       114 ~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen  114 ALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             HHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence            23488999998742       3556999999999999999887764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.51  E-value=3e-13  Score=117.65  Aligned_cols=142  Identities=14%  Similarity=0.144  Sum_probs=101.2

Q ss_pred             eeeEeeeeeEEEEEEEEec------CCCEEEEEecchhhh--------h-----------chhhHHHH----HHHHHHHH
Q 018275          111 LTIIGRGAFGEVRLCQEKK------SGNIYAMKKLKKSEM--------L-----------SRGQVEHV----RAERNLLA  161 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~------~~~~vaiK~i~~~~~--------~-----------~~~~~~~~----~~E~~il~  161 (358)
                      ...||.|--+.||.|....      .+..+|||+.+....        .           ..+....+    ..|...|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997543      357999999864310        0           01112233    37888898


Q ss_pred             HhcCc--ceEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCCCEE
Q 018275          162 EVASH--CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI-HKHNYIHRDIKPDNLL  238 (358)
Q Consensus       162 ~l~h~--~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~L-H~~~iiHrDikp~NIL  238 (358)
                      ++...  ++..++..    ..-+|||||+.+..+..-......+++.....+..+++.+|..+ |..||||+||+|.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            88643  45555543    34579999997654432222333455556667778999999998 8999999999999999


Q ss_pred             EcCCCcEEEEecCCCccCC
Q 018275          239 LDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       239 l~~~~~vkl~DFGla~~~~  257 (358)
                      ++ ++.+.|+|||.|...+
T Consensus       158 ~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE-CCcEEEEECCCceeCC
Confidence            96 5789999999998765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.51  E-value=1.1e-13  Score=117.87  Aligned_cols=129  Identities=20%  Similarity=0.251  Sum_probs=95.3

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceE-EEEEEeecCCEEEEEEeecC
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV-KLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~l~~~~~~~~~~~lV~E~~~  189 (358)
                      ++.|+.|.++.||++...  +..|++|.......    ....+..|..++..+.+.+++ +++...  ....++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence            356889999999998754  77899998765421    112356788888888766554 444443  223579999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY-----IHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       190 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i-----iHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      |.++...    .    ......+.+++.+|..||..++     +|+|++|.||+++ ++.++++|||.+...
T Consensus        75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            9877543    0    1112345789999999999885     9999999999999 678999999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=4.1e-12  Score=107.58  Aligned_cols=136  Identities=21%  Similarity=0.245  Sum_probs=98.6

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchh-----hhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS-----EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~-----~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      ..|++|+-+.+|.+.+.  |.++++|.=.+.     .....--...-.+|..+++.+.--.|....-++.++....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            35789999999988553  445666643222     22222223456678889988876655544445566777889999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      |++|-.|.+.+...   .    ..++..+-.-+.-||..||+|+||.++||++..++ +.++|||++..-+
T Consensus        80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            99998888888655   1    23455666677889999999999999999997665 9999999998544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.37  E-value=1.4e-11  Score=104.03  Aligned_cols=149  Identities=22%  Similarity=0.266  Sum_probs=109.8

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEec-----chhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKL-----KKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i-----~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .+..|-+|+-+.|+++.+  .|+.+.||.-     +.+.....-...+..+|..+|.++.--.|.-..-+|.|...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            677899999999998854  5777777743     333333344456677899999988766655445566777778899


Q ss_pred             EeecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC---cEEEEecCCCccCCC
Q 018275          185 MEYLPG-GDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPLDC  258 (358)
Q Consensus       185 ~E~~~~-g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~vkl~DFGla~~~~~  258 (358)
                      |||++| .++.+++...  ....+......+..|-..+.-||..+|||+||..+||++.+++   .+.++|||++..-..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~~  168 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSRL  168 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcccC
Confidence            999987 3777777543  2333333367778888999999999999999999999998776   358999999876543


Q ss_pred             CC
Q 018275          259 TN  260 (358)
Q Consensus       259 ~~  260 (358)
                      ..
T Consensus       169 ~E  170 (229)
T KOG3087|consen  169 PE  170 (229)
T ss_pred             cc
Confidence            33

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=3.7e-13  Score=131.13  Aligned_cols=201  Identities=20%  Similarity=0.216  Sum_probs=155.5

Q ss_pred             CCCceeeeeEee--eeeEEEEEEEE--ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCC
Q 018275          105 VDDFDLLTIIGR--GAFGEVRLCQE--KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE  179 (358)
Q Consensus       105 ~~~~~~~~~IG~--G~fG~Vy~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~  179 (358)
                      ...|.+...+|.  |.+|.||.+..  ..++..+|+|.-+.... .+.....-.+|+.-...+ .|+|.|+.+..+...+
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCC
Confidence            355778889999  99999999988  88899999997433211 112222233455555555 4889999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCceeCCCCCCCEEEcCC-CcEEEEecCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVL----AIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLC  253 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~----aL~~LH~~~iiHrDikp~NILl~~~-~~vkl~DFGla  253 (358)
                      .+++-+|++ +.+|..+...... +++..+...+.+...    ||.++|..+++|-|+||+||++..+ ...+++|||+.
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            999999988 5788888766544 778888888888888    9999999999999999999999999 89999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      ..+...+........                                            ...-|..-|++||+..+. ++
T Consensus       271 ~~i~~~~~~~~~~~~--------------------------------------------~r~~~~~~Y~~ke~~~~l-~~  305 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVS--------------------------------------------KRPEGDCIYAAKELLNGL-AT  305 (524)
T ss_pred             EEccCCccccceeee--------------------------------------------ecCCCCceEeChhhhccc-cc
Confidence            888755433322111                                            122477889999999765 78


Q ss_pred             ccchhhhhhHHHHhhcccc
Q 018275          334 MECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~  352 (358)
                      ...|++|+|-+..+..++.
T Consensus       306 ~~~di~sl~ev~l~~~l~~  324 (524)
T KOG0601|consen  306 FASDIFSLGEVILEAILGS  324 (524)
T ss_pred             hHhhhcchhhhhHhhHhhc
Confidence            9999999999999876654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=1e-12  Score=128.15  Aligned_cols=197  Identities=22%  Similarity=0.202  Sum_probs=150.7

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEe-cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCC
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEK-KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE  179 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~  179 (358)
                      .....+|..+..||.|.|+.|+.+... .++..+++|.+.+......+.+. -..|+.+...+ .|.+++..+..|....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccc
Confidence            345578999999999999999988755 67889999988766433333322 23455555555 5888888888887777


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-CcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~vkl~DFGla~~~~~  258 (358)
                      ..|+--||+.++++...+.....+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+++.+..
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence            888999999999888877666678888888899999999999999999999999999999886 8889999999875432


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCc--hhhhhcCCCCCccc
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI--APEVLLKKGYGMEC  336 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~--APEv~~~~~y~~~~  336 (358)
                      ...                                                    ...++-.+.  +|.......+..+.
T Consensus       420 ~~~----------------------------------------------------~~~~~~r~~p~~~~~~e~~~~~~~~  447 (524)
T KOG0601|consen  420 SSG----------------------------------------------------VFHHIDRLYPIAEILLEDYPHLSKA  447 (524)
T ss_pred             ecc----------------------------------------------------cccccccccccchhhcccccccccc
Confidence            111                                                    011223333  55555567788999


Q ss_pred             hhhhhhHHHHhhccc
Q 018275          337 DWLAYWNETLSCNYL  351 (358)
Q Consensus       337 DiwSlGvil~e~l~~  351 (358)
                      |++|||..+.+-..+
T Consensus       448 ~~~sl~~~~~e~~~~  462 (524)
T KOG0601|consen  448 DIFSLGLSVDEAITG  462 (524)
T ss_pred             ccccccccccccccC
Confidence            999999988875553

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.28  E-value=2.3e-11  Score=120.13  Aligned_cols=125  Identities=18%  Similarity=0.227  Sum_probs=103.9

Q ss_pred             EEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCC
Q 018275          124 LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETL  203 (358)
Q Consensus       124 ~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~  203 (358)
                      .|..+.++.+|.|.......   ........+-+.-|+.++||||++++..+...+.+|||+|-+.  .|...+...+  
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence            45667888999999887653   2334456677888999999999999999999999999999883  5666665443  


Q ss_pred             CHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          204 TETVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       204 ~~~~~~~~~~qi~~aL~~LH-~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                       .......+.||+.||.||| +.+++|++|.-+.|+++..|..||++|-++...
T Consensus       103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence             6677788899999999998 568999999999999999999999999987654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=3.8e-11  Score=106.45  Aligned_cols=141  Identities=17%  Similarity=0.228  Sum_probs=100.1

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc--eEEEEEEeecC---CEEEEEEe
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYSFQDA---EYLYLIME  186 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~~~~~---~~~~lV~E  186 (358)
                      +.||.|..+.||++... +|..+++|........  .....+..|..++..+.+.+  +.+++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            56899999999998764 3578999997654321  12345788999999987643  56666666543   25689999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK------------------------------------------  224 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~------------------------------------------  224 (358)
                      |++|.++...+.. ..+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999877665421 334444544555555555555552                                          


Q ss_pred             --------------CCceeCCCCCCCEEEcC--CCcEEEEecCCCccC
Q 018275          225 --------------HNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKPL  256 (358)
Q Consensus       225 --------------~~iiHrDikp~NILl~~--~~~vkl~DFGla~~~  256 (358)
                                    ..++|+|++|.|||++.  ++.+.|+||+.+...
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                          34799999999999998  677899999988653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.08  E-value=2.2e-09  Score=98.37  Aligned_cols=126  Identities=14%  Similarity=0.112  Sum_probs=88.5

Q ss_pred             CCCEEEEEecchhhhh---c-----hhhHHHHHHHHHHHHHhcCcc--eEEEEEEeec-----CCEEEEEEeecCCC-CH
Q 018275          130 SGNIYAMKKLKKSEML---S-----RGQVEHVRAERNLLAEVASHC--IVKLYYSFQD-----AEYLYLIMEYLPGG-DV  193 (358)
Q Consensus       130 ~~~~vaiK~i~~~~~~---~-----~~~~~~~~~E~~il~~l~h~~--iv~l~~~~~~-----~~~~~lV~E~~~~g-~L  193 (358)
                      .|+.|.||........   .     ......+.+|...+..+...+  ++.++.++..     ....+||||++++. +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            4667888865332100   0     011123678888887774333  2333333322     23478999999876 89


Q ss_pred             HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-------CCcEEEEecCCCcc
Q 018275          194 MTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-------NGHMKLSDFGLCKP  255 (358)
Q Consensus       194 ~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-------~~~vkl~DFGla~~  255 (358)
                      .+++..  ..+.+......++.+++..+.-||..||+|+|++|.|||++.       ++.+.|+||+.+..
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            888853  345566677788899999999999999999999999999985       46899999998854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=8.2e-10  Score=95.75  Aligned_cols=129  Identities=20%  Similarity=0.235  Sum_probs=80.4

Q ss_pred             EEEEEEEecCCCEEEEEecchhh-----------------------hhchhhHHHHHHHHHHHHHhcCcc--eEEEEEEe
Q 018275          121 EVRLCQEKKSGNIYAMKKLKKSE-----------------------MLSRGQVEHVRAERNLLAEVASHC--IVKLYYSF  175 (358)
Q Consensus       121 ~Vy~~~~~~~~~~vaiK~i~~~~-----------------------~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~~  175 (358)
                      .||.|.. .+|..+|||+.+...                       ...........+|...|..+...+  +..++.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3888875 457799999886431                       011122345778999999997764  55555442


Q ss_pred             ecCCEEEEEEeecC--CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          176 QDAEYLYLIMEYLP--GGDVMTLLMREETLTETVARFYIAQSVLAIES-IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       176 ~~~~~~~lV~E~~~--~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~-LH~~~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                        .  .+|||||++  |..+..+....  ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.
T Consensus        80 --~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             --C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence              2  359999998  54444433211  1133345566677775444 589999999999999999887 999999999


Q ss_pred             CccCC
Q 018275          253 CKPLD  257 (358)
Q Consensus       253 a~~~~  257 (358)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            87654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.01  E-value=7.7e-10  Score=100.93  Aligned_cols=154  Identities=22%  Similarity=0.336  Sum_probs=113.8

Q ss_pred             HHHHHHHHHHhcCcceEEEEEEeecCCE-----EEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH
Q 018275          153 VRAERNLLAEVASHCIVKLYYSFQDAEY-----LYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIH  223 (358)
Q Consensus       153 ~~~E~~il~~l~h~~iv~l~~~~~~~~~-----~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH  223 (358)
                      .+.-.+-|-.+.|.|+|+++.+|.+.++     ..++.|||..|++..+|.+    ...+.......|+-||+.||.|||
T Consensus       114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh  193 (458)
T KOG1266|consen  114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH  193 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence            3344555667789999999998876543     7899999999999999965    245778888899999999999999


Q ss_pred             hC--CceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHH
Q 018275          224 KH--NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQL  301 (358)
Q Consensus       224 ~~--~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (358)
                      +.  .|+|+++.-+-|++..+|-+|+.-   ... +..+.+.                                   ...
T Consensus       194 s~~PpiihgnlTc~tifiq~ngLIkig~---~ap-~s~h~s~-----------------------------------~~~  234 (458)
T KOG1266|consen  194 SCDPPIIHGNLTCDTIFIQHNGLIKIGS---VAP-DSTHPSV-----------------------------------NST  234 (458)
T ss_pred             ccCCccccCCcchhheeecCCceEEecc---cCc-cccchhh-----------------------------------hhh
Confidence            75  699999999999999999888752   110 0000000                                   000


Q ss_pred             HHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccc
Q 018275          302 QHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       302 ~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                      ....+.      --.|-|+|.|||.=.....+.++|||+||.+..||-.+
T Consensus       235 ~~~Ek~------~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  235 REAEKS------VNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             hHhhhh------ccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            011111      11477899999988777778899999999999998654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.96  E-value=1e-08  Score=98.94  Aligned_cols=136  Identities=19%  Similarity=0.256  Sum_probs=110.2

Q ss_pred             EEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee----cCCEEEEEEeecCC-CCHH
Q 018275          120 GEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ----DAEYLYLIMEYLPG-GDVM  194 (358)
Q Consensus       120 G~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~----~~~~~~lV~E~~~~-g~L~  194 (358)
                      .+.|+|....+|..|++|.++.........   ...-++..+++.|+|+|++..+|.    .+..++||++|.|+ ++|.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            568999999999999999995443322222   234567899999999999998887    35579999999986 4777


Q ss_pred             HHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          195 TLLMRE---------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       195 ~~l~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ++....               ...++..++.++.|+..||.++|+.|+..+-|.|.+||++.+.+++|+..|+...+..
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            776432               2366788999999999999999999999999999999999999999998887766543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=1.9e-08  Score=88.88  Aligned_cols=107  Identities=23%  Similarity=0.271  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHHHHhcCcc--eEEEEEEeecC----CEEEEEEeecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 018275          150 VEHVRAERNLLAEVASHC--IVKLYYSFQDA----EYLYLIMEYLPGG-DVMTLLMREETLTETVARFYIAQSVLAIESI  222 (358)
Q Consensus       150 ~~~~~~E~~il~~l~h~~--iv~l~~~~~~~----~~~~lV~E~~~~g-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~L  222 (358)
                      .....+|...+..+....  +...+++....    ...+||+|++++. +|.+++......+......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            345777888777765433  33344443321    2458999999884 8999987755567777888899999999999


Q ss_pred             HhCCceeCCCCCCCEEEcCCC---cEEEEecCCCccC
Q 018275          223 HKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPL  256 (358)
Q Consensus       223 H~~~iiHrDikp~NILl~~~~---~vkl~DFGla~~~  256 (358)
                      |..||+|+|++|.|||++.++   .+.++||+-++..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999887   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.83  E-value=2.4e-08  Score=89.65  Aligned_cols=140  Identities=16%  Similarity=0.196  Sum_probs=97.2

Q ss_pred             eeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh-------------------hchhhHHHHHHHHHHHHHhcCc--c
Q 018275          109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-------------------LSRGQVEHVRAERNLLAEVASH--C  167 (358)
Q Consensus       109 ~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~-------------------~~~~~~~~~~~E~~il~~l~h~--~  167 (358)
                      .+...||-|--|.||.|.+. .|.++|||.-+....                   +-........+|..+|..+...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            35689999999999999864 688999997653210                   0011233466788888888755  5


Q ss_pred             eEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEE
Q 018275          168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL  247 (358)
Q Consensus       168 iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl  247 (358)
                      |...++    .+.-.+|||+++|-.|...-.     +...+..++-.|+.-+.-+-..||||+|+.+=|||++.||.+.+
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             CCCccc----cccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence            555554    344579999998865544321     22333334444454444444889999999999999999999999


Q ss_pred             EecCCCccCCC
Q 018275          248 SDFGLCKPLDC  258 (358)
Q Consensus       248 ~DFGla~~~~~  258 (358)
                      +||-.+.....
T Consensus       244 IDwPQ~v~~~h  254 (304)
T COG0478         244 IDWPQAVPISH  254 (304)
T ss_pred             EeCcccccCCC
Confidence            99998876543

>PRK09902 hypothetical protein; Provisional

Probab=98.73  E-value=2.2e-07  Score=81.39  Aligned_cols=139  Identities=13%  Similarity=0.174  Sum_probs=98.8

Q ss_pred             eeeeeEEEEEEEEecCCCEEEEEecchhh---hhchhhHHHHHHHHHHHHHhcCcc--eEEEEEEee--c--CCEEEEEE
Q 018275          115 GRGAFGEVRLCQEKKSGNIYAMKKLKKSE---MLSRGQVEHVRAERNLLAEVASHC--IVKLYYSFQ--D--AEYLYLIM  185 (358)
Q Consensus       115 G~G~fG~Vy~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~~~--~--~~~~~lV~  185 (358)
                      |+||-+-|+...  ..|..+=+|.-...-   ...+.....+.+|...|..+...+  +.+......  .  .-..+||+
T Consensus        27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            567888888654  334467778664211   111445567899999998886443  333331111  1  12367999


Q ss_pred             eecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc--EEEEecCCCcc
Q 018275          186 EYLPG-GDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH--MKLSDFGLCKP  255 (358)
Q Consensus       186 E~~~~-g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~--vkl~DFGla~~  255 (358)
                      |-++| -||.+++...  .+.++.....++.+++.++.-||..|+.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98864 4888888553  35567777788999999999999999999999999999987777  99999997764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.71  E-value=1.2e-07  Score=94.16  Aligned_cols=143  Identities=18%  Similarity=0.303  Sum_probs=90.9

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh--------------------c-----------hhhHHHHHHH----
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--------------------S-----------RGQVEHVRAE----  156 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~--------------------~-----------~~~~~~~~~E----  156 (358)
                      .-|+.++-|.||.|..+. |+.||||+.++.-..                    .           ....+.+..|    
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            568899999999998654 999999999864200                    0           0001122223    


Q ss_pred             --HHHHHHhc-----Ccce--EEEEEEeecCCEEEEEEeecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 018275          157 --RNLLAEVA-----SHCI--VKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHN  226 (358)
Q Consensus       157 --~~il~~l~-----h~~i--v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~  226 (358)
                        ...+..+.     .+++  .+++.-+  ...-.|+|||++|-.+.+... ....++...+.....++  .+..+-..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~--t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEY--TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhc--cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence              32233321     2332  2333222  344579999999988887742 22455533332222221  244455689


Q ss_pred             ceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       227 iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ++|.|.+|.||+++.+|.+.+.|||+...++..
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            999999999999999999999999998877643

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.68  E-value=4.8e-07  Score=79.66  Aligned_cols=141  Identities=21%  Similarity=0.342  Sum_probs=89.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHH------HHHHHHHHHHhcC---cceEEEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH------VRAERNLLAEVAS---HCIVKLYY  173 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~------~~~E~~il~~l~h---~~iv~l~~  173 (358)
                      +..++|...+.+-.....-|.+-  .-+|..+++|..+............      ..+.+..+..+..   ..++.++.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            34578888888888777767654  4557899999887653222111111      1223333333322   22222222


Q ss_pred             E-----eecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEE
Q 018275          174 S-----FQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLS  248 (358)
Q Consensus       174 ~-----~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~  248 (358)
                      +     +.-....+|||||++|-.|.+...    +++.    +.-.+..++.-||..|+.|+|.+|.|++++.++ ++++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI  176 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII  176 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence            2     222344579999999987766542    2232    334566789999999999999999999998555 9999


Q ss_pred             ecCCCc
Q 018275          249 DFGLCK  254 (358)
Q Consensus       249 DFGla~  254 (358)
                      ||+..+
T Consensus       177 D~~~k~  182 (229)
T PF06176_consen  177 DTQGKR  182 (229)
T ss_pred             ECcccc
Confidence            998655

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.58  E-value=1e-06  Score=78.51  Aligned_cols=139  Identities=19%  Similarity=0.160  Sum_probs=93.0

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhch---------------------hhHHHHHHHHHHHHHhcCc--ce
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR---------------------GQVEHVRAERNLLAEVASH--CI  168 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~---------------------~~~~~~~~E~~il~~l~h~--~i  168 (358)
                      ..|+.|--+.||+|.. .++..+|+|+++.......                     ........|..-|.++...  .+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            4777888889999874 5688999999975432111                     1123345566677766433  33


Q ss_pred             EEEEEEeecCCEEEEEEeecCCCC-HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEE
Q 018275          169 VKLYYSFQDAEYLYLIMEYLPGGD-VMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMK  246 (358)
Q Consensus       169 v~l~~~~~~~~~~~lV~E~~~~g~-L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vk  246 (358)
                      .+.+.+.    ...|||||+.... -.-.|. .-++....+..+..+++..+.-|-. .++||+||..=|||+. ++.+.
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            4444443    2459999995431 111111 1122333566667788888777765 8999999999999999 89999


Q ss_pred             EEecCCCccCC
Q 018275          247 LSDFGLCKPLD  257 (358)
Q Consensus       247 l~DFGla~~~~  257 (358)
                      |+|||.|....
T Consensus       207 iID~~QaV~~~  217 (268)
T COG1718         207 IIDVSQAVTID  217 (268)
T ss_pred             EEECccccccC
Confidence            99999998765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.55  E-value=5.8e-07  Score=85.13  Aligned_cols=182  Identities=12%  Similarity=0.075  Sum_probs=119.0

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEE--------EEEEeecCCE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVK--------LYYSFQDAEY  180 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~--------l~~~~~~~~~  180 (358)
                      ..+.||+|+-+.+|-.-  .-+ -.+.|++.........      +.+..|... .||-+-.        |+|.- ....
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~-d~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~   84 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVR-DQVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGGR-RGKV   84 (637)
T ss_pred             CCccccCCccceeeecc--hhh-chhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCCC-ccce
Confidence            45789999999999532  222 2345888765321111      122223332 4443221        12211 1233


Q ss_pred             EEEEEeecCCC-CHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          181 LYLIMEYLPGG-DVMTLLMR------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       181 ~~lV~E~~~~g-~L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      +-++|..++|. .+..++..      ..-..+..+......++.+.+.||..|.+-+|++++|+|+++++.+.|+|=..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            77888888764 23333321      123566777788889999999999999999999999999999999999974321


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----  328 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----  328 (358)
                      .... .                                                 .......||.+.|.+||...     
T Consensus       165 qi~~-n-------------------------------------------------g~~~~cpVg~~eftPPElQ~~~sf~  194 (637)
T COG4248         165 QINA-N-------------------------------------------------GTLHLCPVGVSEFTPPELQTLPSFV  194 (637)
T ss_pred             eecc-C-------------------------------------------------CceEecccCccccCCHHHhcccccc
Confidence            1110 0                                                 01122458999999999876     


Q ss_pred             CCCCCccchhhhhhHHHHhhccc
Q 018275          329 KKGYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       329 ~~~y~~~~DiwSlGvil~e~l~~  351 (358)
                      +.+-+..+|-|.|||++|++|++
T Consensus       195 g~~r~~~hD~FGLavLiF~lL~g  217 (637)
T COG4248         195 GFERTANHDNFGLAVLIFHLLFG  217 (637)
T ss_pred             ccCCCccccchhHHHHHHHHHhc
Confidence            45567889999999999999997

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.52  E-value=2.5e-06  Score=76.50  Aligned_cols=134  Identities=19%  Similarity=0.155  Sum_probs=84.4

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc--eEEEEEEeecCCEEEEEEeecC
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      ..||.|..+.||+.    .+..+++|..+...     ....+.+|..+++.+....  +.+.+.+..+.+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            57899999999973    24467889876532     2234688999998886544  4566777777777889999998


Q ss_pred             CCC-HHHHH---------------------hhc--C--CCCHHHHHHHHH----------HHHH-HHHHHH----hCCce
Q 018275          190 GGD-VMTLL---------------------MRE--E--TLTETVARFYIA----------QSVL-AIESIH----KHNYI  228 (358)
Q Consensus       190 ~g~-L~~~l---------------------~~~--~--~~~~~~~~~~~~----------qi~~-aL~~LH----~~~ii  228 (358)
                      |.+ +...+                     +.-  .  .++... ..+..          .+.. ...+|.    ...++
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            863 11111                     000  0  111100 00100          1111 122222    12478


Q ss_pred             eCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          229 HRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       229 HrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      |+|+.|.||+++.++ +.|+||+.+..-
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~~G  183 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFGYG  183 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence            999999999999888 999999988644

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=2.9e-06  Score=84.20  Aligned_cols=143  Identities=19%  Similarity=0.272  Sum_probs=89.4

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc----------------------------hhhHHHHHHHHHHH---
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS----------------------------RGQVEHVRAERNLL---  160 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~----------------------------~~~~~~~~~E~~il---  160 (358)
                      +-||..+.|.|++|+.+. |+.||||+-++.-...                            .+....+..|++.+   
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            468999999999999766 9999999987642000                            00011122222222   


Q ss_pred             -------HHhcCcc------eEEEEEEeecCCEEEEEEeecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 018275          161 -------AEVASHC------IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHN  226 (358)
Q Consensus       161 -------~~l~h~~------iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~  226 (358)
                             ..+.|-+      |.++|..+  ...-.|+||||+|..+.+... ....++...+...+.+.  .+..+-..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~--~~~qIf~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA--YLEQIFKTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence                   2223333      44444444  234679999999986655532 23345554333322222  133344678


Q ss_pred             ceeCCCCCCCEEEcC----CCcEEEEecCCCccCCCC
Q 018275          227 YIHRDIKPDNLLLDQ----NGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       227 iiHrDikp~NILl~~----~~~vkl~DFGla~~~~~~  259 (358)
                      ++|+|-+|.||++.+    ++.+.+-|||+...+...
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            999999999999984    678999999998876543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.48  E-value=3.2e-08  Score=97.68  Aligned_cols=175  Identities=19%  Similarity=0.234  Sum_probs=124.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc-eEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~-iv~l~~~~~~~~~~~lV  184 (358)
                      ..+....-.++|+++.+++.+...+...+ .+.+...        ...+-++++|.+++||| .+..++.++.+.+.+++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence            44555667789999999987655444333 4444322        23566889999999999 78888888888899999


Q ss_pred             EeecCCC-CHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          185 MEYLPGG-DVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       185 ~E~~~~g-~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ++++.++ +-..... ..-.+.+.........-..+++++|+.-=+|+|    |||..+ +..+..||+....+....  
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence            9999776 2111111 111222333333444556789999988778998    777755 778999999876654221  


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                      ...+..+|+.++|||+.....++..-|.||+|
T Consensus       386 ------------------------------------------------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~  417 (829)
T KOG0576|consen  386 ------------------------------------------------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLA  417 (829)
T ss_pred             ------------------------------------------------ccccCCCCCCCCCchhhcccccccCCCccCCC
Confidence                                                            12256899999999999999999999999999


Q ss_pred             HH
Q 018275          343 NE  344 (358)
Q Consensus       343 vi  344 (358)
                      +-
T Consensus       418 ~~  419 (829)
T KOG0576|consen  418 VS  419 (829)
T ss_pred             cc
Confidence            73

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.44  E-value=4.6e-06  Score=74.11  Aligned_cols=138  Identities=21%  Similarity=0.345  Sum_probs=81.3

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc--eEEEEEEe---ecCCEEEEEE
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYSF---QDAEYLYLIM  185 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~~---~~~~~~~lV~  185 (358)
                      ++.|+.|..+.||++....  ..+++|.....     .....+..|..+++.+....  +..++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4678999999999987554  48999987654     23445778888888775443  44555533   2334579999


Q ss_pred             eecCCCCHHH----------------HHh---hc----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 018275          186 EYLPGGDVMT----------------LLM---RE----ETLTETV------ARFY---------------IAQSVL-AIE  220 (358)
Q Consensus       186 E~~~~g~L~~----------------~l~---~~----~~~~~~~------~~~~---------------~~qi~~-aL~  220 (358)
                      ++++|..+..                .+.   ..    .++....      ....               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987777                111   11    1111100      0000               011111 233


Q ss_pred             HHH-------hCCceeCCCCCCCEEEc-CCCcEEEEecCCCcc
Q 018275          221 SIH-------KHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKP  255 (358)
Q Consensus       221 ~LH-------~~~iiHrDikp~NILl~-~~~~vkl~DFGla~~  255 (358)
                      .++       ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            333       23599999999999999 667778999998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.34  E-value=9e-06  Score=70.83  Aligned_cols=128  Identities=23%  Similarity=0.335  Sum_probs=88.9

Q ss_pred             CCceeeeeEeeeee-EEEEEEEEecCCCEEEEEecchhhhhch------------------hhHHHHHHHHHHHHHhc--
Q 018275          106 DDFDLLTIIGRGAF-GEVRLCQEKKSGNIYAMKKLKKSEMLSR------------------GQVEHVRAERNLLAEVA--  164 (358)
Q Consensus       106 ~~~~~~~~IG~G~f-G~Vy~~~~~~~~~~vaiK~i~~~~~~~~------------------~~~~~~~~E~~il~~l~--  164 (358)
                      .+++.++.||.|.- |.||++..  .|+.+|+|+++.-.....                  ....-|..|.....+++  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 99999864  477999999332110000                  12234556666666554  


Q ss_pred             -Ccce--EEEEEEeecC------------------CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 018275          165 -SHCI--VKLYYSFQDA------------------EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH  223 (358)
Q Consensus       165 -h~~i--v~l~~~~~~~------------------~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH  223 (358)
                       +.++  |+++|+..-.                  ....||.||++...         .+    ...-+.+|..-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence             3344  9999887211                  12467888886543         12    2234567888889999


Q ss_pred             hCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       224 ~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      ..||+-+|+++.|..     .-||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999985     3589999964

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.26  E-value=1.5e-05  Score=72.13  Aligned_cols=135  Identities=13%  Similarity=0.073  Sum_probs=81.3

Q ss_pred             Eeeeee-EEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC-cceEEEEEEeecCCEEEEEEeecCCC
Q 018275          114 IGRGAF-GEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       114 IG~G~f-G~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lV~E~~~~g  191 (358)
                      |-.|.. ..||+....  +..+.+|......      ...+..|+.++..+.. --+.+++++..+.+..++|||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            344544 678987543  4578888876442      2236678888877743 33556677776666788999999987


Q ss_pred             CHHHHH-------------------hhcC----CCCHHH---HHH---HHH----------------HHHHHHHHHH---
Q 018275          192 DVMTLL-------------------MREE----TLTETV---ARF---YIA----------------QSVLAIESIH---  223 (358)
Q Consensus       192 ~L~~~l-------------------~~~~----~~~~~~---~~~---~~~----------------qi~~aL~~LH---  223 (358)
                      ++....                   +.-.    ++....   ...   .+.                .+...+..|-   
T Consensus        78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  157 (244)
T cd05150          78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR  157 (244)
T ss_pred             cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence            765431                   0000    111000   000   000                0111122221   


Q ss_pred             ----hCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          224 ----KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       224 ----~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                          ...++|+|+.|.|||++.++.+.|+||+.|...
T Consensus       158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g  194 (244)
T cd05150         158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA  194 (244)
T ss_pred             CCcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence                234999999999999999888899999988644

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.25  E-value=1.6e-05  Score=84.32  Aligned_cols=81  Identities=25%  Similarity=0.369  Sum_probs=56.2

Q ss_pred             eeeeEeeeeeEEEEEEEEecCC--CEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-Ccc--eEEEEEEeecC---CEE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSG--NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHC--IVKLYYSFQDA---EYL  181 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~--iv~l~~~~~~~---~~~  181 (358)
                      .+..++.|.+..+|+......+  ..+++|+.+.....  .....+.+|..+++.+. |++  +.+++.+|.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            3577899999999987654322  36778876543211  12235778999999986 565  47777777664   457


Q ss_pred             EEEEeecCCCC
Q 018275          182 YLIMEYLPGGD  192 (358)
Q Consensus       182 ~lV~E~~~~g~  192 (358)
                      |+||||++|..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            89999998754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.21  E-value=6.7e-07  Score=89.31  Aligned_cols=101  Identities=20%  Similarity=0.281  Sum_probs=72.8

Q ss_pred             HHHHHHHHHHhC-CceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCC
Q 018275          214 QSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR  292 (358)
Q Consensus       214 qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (358)
                      +++.|+.|+|.. ++||++|.|++|.++.++..||+.|+.+........  +....            .+..        
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~~~------------yd~~--------  164 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPFSE------------YDPP--------  164 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--ccccc------------CCCC--------
Confidence            444899999965 899999999999999999999999998765432111  11000            0000        


Q ss_pred             CCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhc-ccccc
Q 018275          293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCN-YLSDI  354 (358)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l-~~~~~  354 (358)
                                        +.-...-...|.|||++.+..-+..+|++|+||.+|-+. .+..+
T Consensus       165 ------------------lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i  209 (700)
T KOG2137|consen  165 ------------------LPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSI  209 (700)
T ss_pred             ------------------CChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcch
Confidence                              111224567799999999988889999999999998765 34433

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=5.2e-05  Score=66.35  Aligned_cols=135  Identities=17%  Similarity=0.221  Sum_probs=94.1

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhh-------------hhchhhHHHHHHHHHHHHHhc------CcceEEE
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE-------------MLSRGQVEHVRAERNLLAEVA------SHCIVKL  171 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~-------------~~~~~~~~~~~~E~~il~~l~------h~~iv~l  171 (358)
                      ...||+|+.-.||.  |. .....+||+.....             ..........++|+.-...+.      +..|.++
T Consensus         6 ~~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35799999999994  43 34456789987764             001122345666776666655      6789999


Q ss_pred             EEEeecCCEEEEEEeecCC------CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC--
Q 018275          172 YYSFQDAEYLYLIMEYLPG------GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG--  243 (358)
Q Consensus       172 ~~~~~~~~~~~lV~E~~~~------g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~--  243 (358)
                      +|+.+++..+-+|+|.+.+      -+|.+++. .+.+++ ..   ...+-.-..||-..+|+.+|++|.||++..+.  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999998742      26788873 344555 22   22333456788899999999999999996442  


Q ss_pred             --cEEEEe-cCCC
Q 018275          244 --HMKLSD-FGLC  253 (358)
Q Consensus       244 --~vkl~D-FGla  253 (358)
                        .+.|+| ||..
T Consensus       158 ~~~lvlIDG~G~~  170 (199)
T PF10707_consen  158 EFRLVLIDGLGEK  170 (199)
T ss_pred             ceEEEEEeCCCCc
Confidence              577887 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.18  E-value=1e-05  Score=68.52  Aligned_cols=131  Identities=16%  Similarity=0.227  Sum_probs=90.5

Q ss_pred             eeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeec
Q 018275          109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL  188 (358)
Q Consensus       109 ~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~  188 (358)
                      ...+.||+|.+|.||+|.+.  |..+|+|+-+.+.     ....+..|..+|..+...++-+=+..+..   ..+.|||+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i   94 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYI   94 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhh
Confidence            34578999999999999765  5699999876553     34458889999999887776543333321   23569999


Q ss_pred             CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC-CCCEEEcCCCcEEEEecCCCccC
Q 018275          189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK-PDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       189 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDik-p~NILl~~~~~vkl~DFGla~~~  256 (358)
                      .|-.|.+.-...   .    +.-+..++.+---|-..||-|..|. |..++|..++.+.|+||..|+..
T Consensus        95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            988887765322   1    2223344554334566799999885 55566666669999999998743

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.04  E-value=3.9e-05  Score=69.03  Aligned_cols=32  Identities=31%  Similarity=0.485  Sum_probs=27.3

Q ss_pred             CceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       226 ~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      +++|+|+.|.|||++.++..-|+||+.|..-+
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gD  196 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGD  196 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCcCC
Confidence            48999999999999877667899999886543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.91  E-value=0.00017  Score=64.63  Aligned_cols=75  Identities=19%  Similarity=0.255  Sum_probs=46.6

Q ss_pred             eeeEeeeeeEEEEEEEEec-CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcce-EEEEEEeecCCEEEEEEeec
Q 018275          111 LTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDAEYLYLIMEYL  188 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lV~E~~  188 (358)
                      ++.|..|-...+|++.... .+..|++|+......   .. -...+|..++..+...++ +++++.+. .   .+||||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LI-IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ce-ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEee
Confidence            3566778788999876432 356888997754321   11 123468888888865444 34444332 2   3899999


Q ss_pred             CCCCH
Q 018275          189 PGGDV  193 (358)
Q Consensus       189 ~~g~L  193 (358)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            88664

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.81  E-value=0.0011  Score=64.19  Aligned_cols=81  Identities=22%  Similarity=0.197  Sum_probs=53.4

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh---hc-hhhHHHHHHHHHHHHHhc---CcceEEEEEEeecCCEEE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM---LS-RGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~---~~-~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~~~~~  182 (358)
                      -.+.||.|.+..||++.....++.|+||.-.+...   .. +...++...|...|..+.   ...+++++.+  +....+
T Consensus        30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~  107 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV  107 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence            34679999999999998754335899998542211   00 224456777888877653   2346666655  345578


Q ss_pred             EEEeecCCCC
Q 018275          183 LIMEYLPGGD  192 (358)
Q Consensus       183 lV~E~~~~g~  192 (358)
                      +||||+++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998643

>PRK10593 hypothetical protein; Provisional

Probab=97.78  E-value=0.0005  Score=64.23  Aligned_cols=77  Identities=14%  Similarity=0.078  Sum_probs=52.9

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC---cceEEEEEEeec---CCEEEE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS---HCIVKLYYSFQD---AEYLYL  183 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h---~~iv~l~~~~~~---~~~~~l  183 (358)
                      -...||.|..+.||.... .++ .+.+|..+..     .....+..|...|+.+..   ..+.++++.+.+   .+..+|
T Consensus        18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         18 RVECISEQPYAALWALYD-SQG-NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeeecCCccceeEEEEEc-CCC-CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            346799999999997642 223 5666774321     012347889999988854   357778877754   356899


Q ss_pred             EEeecCCCCH
Q 018275          184 IMEYLPGGDV  193 (358)
Q Consensus       184 V~E~~~~g~L  193 (358)
                      |||+++|.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.76  E-value=0.0001  Score=64.07  Aligned_cols=99  Identities=21%  Similarity=0.234  Sum_probs=77.6

Q ss_pred             HHHHHHHHhcC-cceEEEEEEeecCCEEEEEEeecCCCCHHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q 018275          155 AERNLLAEVAS-HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL---LMREETLTETVARFYIAQSVLAIESIHK---HNY  227 (358)
Q Consensus       155 ~E~~il~~l~h-~~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~---l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i  227 (358)
                      .|.-++..+.+ +++++++|+|-+    ++|.||.+.+++...   +...-..++.....++.+++..+++++.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47778888876 589999999932    478999987765422   1122345677888899999999999986   347


Q ss_pred             eeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       228 iHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      .-.|++|+|+-++++|++|++|...+...+
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            779999999999999999999999776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.75  E-value=0.00022  Score=64.92  Aligned_cols=133  Identities=17%  Similarity=0.191  Sum_probs=75.3

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceE-EEEEEeecCCEEEEEEeecCCCC
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV-KLYYSFQDAEYLYLIMEYLPGGD  192 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~l~~~~~~~~~~~lV~E~~~~g~  192 (358)
                      +..|-...+|+..  .++..+++|.......  .... ...+|..+++.+....++ +++..+  .  -++||||++|..
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~--~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK--ALGV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccc--cccC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence            3457777889775  4566888887654321  1001 246788888888654433 333333  2  268999998865


Q ss_pred             HHHH--------------Hh---hc----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceeCCCC
Q 018275          193 VMTL--------------LM---RE----ETLTET-VARFYIAQS---------VLAIESIHK--------HNYIHRDIK  233 (358)
Q Consensus       193 L~~~--------------l~---~~----~~~~~~-~~~~~~~qi---------~~aL~~LH~--------~~iiHrDik  233 (358)
                      +...              +.   .-    .+++.. .+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            4311              11   11    111111 111211111         111222211        248999999


Q ss_pred             CCCEEEcCCCcEEEEecCCCccC
Q 018275          234 PDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       234 p~NILl~~~~~vkl~DFGla~~~  256 (358)
                      |.||+++.++ +.|+||..|..-
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCcC
Confidence            9999999877 789999988654

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.51  E-value=0.00096  Score=62.00  Aligned_cols=139  Identities=17%  Similarity=0.112  Sum_probs=81.9

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc--eEEEEEE------eecCCEE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYS------FQDAEYL  181 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~------~~~~~~~  181 (358)
                      -++.|..|....+|+...  .+..+++|+....      ....+..|..++..+.+.+  +.+++..      ....+..
T Consensus        18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             heecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            356777787788998753  3447889987641      1233566777777775433  3444332      1224456


Q ss_pred             EEEEeecCCCCHHH----H-------H---hh--cC---C-----CCHHHHH-----------HHHHHHHHHHHHHHh--
Q 018275          182 YLIMEYLPGGDVMT----L-------L---MR--EE---T-----LTETVAR-----------FYIAQSVLAIESIHK--  224 (358)
Q Consensus       182 ~lV~E~~~~g~L~~----~-------l---~~--~~---~-----~~~~~~~-----------~~~~qi~~aL~~LH~--  224 (358)
                      ++|++|++|..+..    .       +   +.  ..   .     ...+...           .....+..++.++..  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            89999998865421    0       0   00  00   0     0011000           001112233444442  


Q ss_pred             -----CCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          225 -----HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       225 -----~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                           .+++|+|+.|.|||++.++.+.|+||+.+..-
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g  206 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACTD  206 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence                 46999999999999999888899999987643

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.45  E-value=0.00096  Score=62.24  Aligned_cols=75  Identities=17%  Similarity=0.177  Sum_probs=45.9

Q ss_pred             eeEeeeeeEEEEEEEEec------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcce-EEEEEEeecCCEEEEE
Q 018275          112 TIIGRGAFGEVRLCQEKK------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDAEYLYLI  184 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lV  184 (358)
                      +.+..|--..||++....      .+..+++|+.....    .......+|..++..+....+ .++++.+..    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            345556666888876432      25789999866532    112235678888887764443 345555532    368


Q ss_pred             EeecCCCCHH
Q 018275          185 MEYLPGGDVM  194 (358)
Q Consensus       185 ~E~~~~g~L~  194 (358)
                      +||++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.42  E-value=0.00015  Score=67.17  Aligned_cols=140  Identities=14%  Similarity=0.127  Sum_probs=91.9

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc-------------------hhhHHHHHHHHHHHHHhcCc-
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-------------------RGQVEHVRAERNLLAEVASH-  166 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~-------------------~~~~~~~~~E~~il~~l~h~-  166 (358)
                      -+.+.+.||-|--+.||.+.+ ..|++.++|.-+.....-                   .-..-....|...|+.+..+ 
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            456788999999999999875 457889999765432110                   01111233566666666432 


Q ss_pred             -ceEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcE
Q 018275          167 -CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM  245 (358)
Q Consensus       167 -~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~v  245 (358)
                       -|.+.++    .+.-|+|||++.|..|...-.-.   ++..   +...++.-+--|-.+|+||+|..-=||+++.++.+
T Consensus       172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~---d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHVE---DPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCCccc----ccceeeHHHhhcccceeeeeecC---ChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence             2333333    34568999999887765543222   2222   22233344555778999999999999999999999


Q ss_pred             EEEecCCCccCC
Q 018275          246 KLSDFGLCKPLD  257 (358)
Q Consensus       246 kl~DFGla~~~~  257 (358)
                      +++||-.+....
T Consensus       242 ~vIDFPQmvS~s  253 (465)
T KOG2268|consen  242 VVIDFPQMVSTS  253 (465)
T ss_pred             EEeechHhhccC
Confidence            999998765543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.40  E-value=3.1e-05  Score=83.64  Aligned_cols=190  Identities=14%  Similarity=0.058  Sum_probs=125.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCC-EEEEEecchhhhh--chhhHHHHHHHHHHHHHhcCcceEEEEEEeec--CCE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGN-IYAMKKLKKSEML--SRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEY  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~-~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~  180 (358)
                      .++++.--||.|.++.   +.+..... -+.+|+.+.-...  .+-..+....|++.++...|++++..+.-..+  ...
T Consensus      1229 e~~EV~l~i~~~~~~R---~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHFR---NKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred             hhhheeeecccceeec---cchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence            4555555566655543   22221111 2344554433221  23334456667777888899998766544433  234


Q ss_pred             EEEEEeecCCCCHHHHHhhcC----CCCHHHHHHHHHHH-HHHHHHHHhC-----CceeCCCCCCCEEEcCCCcEEEEec
Q 018275          181 LYLIMEYLPGGDVMTLLMREE----TLTETVARFYIAQS-VLAIESIHKH-----NYIHRDIKPDNLLLDQNGHMKLSDF  250 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi-~~aL~~LH~~-----~iiHrDikp~NILl~~~~~vkl~DF  250 (358)
                      .|.+++|+.+|++.+.+.++.    ++.+.-+ ....++ +.+..-+|+.     -.+|+++|+-|.+|..+..+|+.++
T Consensus      1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v-~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPV-HLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred             HHHHHHHHHHhHHHHHHHhccccCCcchhchH-HHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence            689999999999999997652    2322222 233344 6666776654     2899999999999999999999999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK  330 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~  330 (358)
                      |+.+.....                                                 ...+...+++|.|++|++...-
T Consensus      1385 gLdKIknp~-------------------------------------------------~sf~Gl~l~sp~~v~qli~N~i 1415 (2724)
T KOG1826|consen 1385 GLDKIKNPV-------------------------------------------------LSFFGLELCSPIYVLQLIKNEI 1415 (2724)
T ss_pred             ccccccCch-------------------------------------------------HhhhhhhhCCHHHHHHHHHHHH
Confidence            999833211                                                 0112245789999999999999


Q ss_pred             CCCccchhhhhhHHHHhh
Q 018275          331 GYGMECDWLAYWNETLSC  348 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~  348 (358)
                      .++.++|+|+.|+-+|+-
T Consensus      1416 k~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1416 KFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             hhhhHHHHHHHHHHHHHH
Confidence            999999999999988873

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.39  E-value=0.0017  Score=61.35  Aligned_cols=146  Identities=21%  Similarity=0.239  Sum_probs=94.2

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh----------------------ch-hhHHHHHHHHHHHHHhcCc
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML----------------------SR-GQVEHVRAERNLLAEVASH  166 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~----------------------~~-~~~~~~~~E~~il~~l~h~  166 (358)
                      +-.+|..|--+.||.|.. .+|..+|||+++.+-+.                      ++ -..-....|+.-|.+++..
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            446888899999999874 56778999998743110                      00 1112344566667777655


Q ss_pred             ceEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCCCEEEcCCCcE
Q 018275          167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI-HKHNYIHRDIKPDNLLLDQNGHM  245 (358)
Q Consensus       167 ~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~L-H~~~iiHrDikp~NILl~~~~~v  245 (358)
                      .|.-.--..  =..-.|||+|+.......-....-.++...+..+-.+++.-+.-| |..++||.||.-=|+|+ .+|.+
T Consensus       227 GIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  227 GIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence            432110000  012359999995322222122334567777777777777777766 46689999999999998 57899


Q ss_pred             EEEecCCCccCCCC
Q 018275          246 KLSDFGLCKPLDCT  259 (358)
Q Consensus       246 kl~DFGla~~~~~~  259 (358)
                      .|+|.+.+...+.+
T Consensus       304 yiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  304 YIIDVSQSVEHDHP  317 (520)
T ss_pred             EEEEccccccCCCh
Confidence            99999988765543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.29  E-value=0.0039  Score=58.41  Aligned_cols=143  Identities=20%  Similarity=0.162  Sum_probs=81.6

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc--eEEEEEEe------ecC
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYSF------QDA  178 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~~------~~~  178 (358)
                      ....+..++.|....+|++.. .+| .+++|+.....  .   ...+..|..++..+....  +.+++...      ...
T Consensus        23 ~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        23 ELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             CceeccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            344566778787788998753 333 67788765421  1   223455667776664332  33433321      124


Q ss_pred             CEEEEEEeecCCCCHH-----H------H---Hhh-cCC----------CCHHHH--H-----------HHHHHHHHHHH
Q 018275          179 EYLYLIMEYLPGGDVM-----T------L---LMR-EET----------LTETVA--R-----------FYIAQSVLAIE  220 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~-----~------~---l~~-~~~----------~~~~~~--~-----------~~~~qi~~aL~  220 (358)
                      +..++|++|++|..+.     .      .   ++. ...          .+.+..  .           .....+...+.
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            5678999999885431     0      0   110 000          111100  0           00111223455


Q ss_pred             HHH-------hCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          221 SIH-------KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       221 ~LH-------~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ++.       ..+++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~  218 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACTD  218 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccCc
Confidence            553       257999999999999999887899999988643

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.24  E-value=0.0011  Score=70.57  Aligned_cols=155  Identities=17%  Similarity=0.128  Sum_probs=110.3

Q ss_pred             HHHHHHHHHHHHhcCcceEEEEEEeecCCEE----EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 018275          151 EHVRAERNLLAEVASHCIVKLYYSFQDAEYL----YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN  226 (358)
Q Consensus       151 ~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~----~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~  226 (358)
                      ....-|...+..+.|+|++.++.+-......    .+..+++..-++...+..-+..+....+.+..++..||.|+|+..
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            3344566678889999999998776544332    244567888888888888889999999999999999999999985


Q ss_pred             ceeCCCCCC---CEEEcCCCcEEEE--ecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHH
Q 018275          227 YIHRDIKPD---NLLLDQNGHMKLS--DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQL  301 (358)
Q Consensus       227 iiHrDikp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (358)
                      ..|.-+..+   +...+..+.+.++  ||+.++.+......                                       
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---------------------------------------  347 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---------------------------------------  347 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcccc---------------------------------------
Confidence            555444433   3333445566666  77776655422111                                       


Q ss_pred             HHHhhhhccccccccCCCCCchhhhhcCCCCCcc--chhhhhhHHHHhhccccccc
Q 018275          302 QHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME--CDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       302 ~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~--~DiwSlGvil~e~l~~~~~~  355 (358)
                                 .+..-++.+.|||......++.+  .|+|.+|..+..+..++++-
T Consensus       348 -----------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~  392 (1351)
T KOG1035|consen  348 -----------FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDIS  392 (1351)
T ss_pred             -----------hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccc
Confidence                       12345667889999988777765  79999999999887776653

>PRK05231 homoserine kinase; Provisional

Probab=97.21  E-value=0.0079  Score=56.52  Aligned_cols=32  Identities=25%  Similarity=0.315  Sum_probs=27.4

Q ss_pred             CCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       225 ~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      .++||+|+.|+|||++.+...-|+||+.+..-
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~  218 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACND  218 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence            37999999999999997666689999988643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.19  E-value=0.0055  Score=58.37  Aligned_cols=78  Identities=18%  Similarity=0.167  Sum_probs=48.7

Q ss_pred             eEeeeeeEEEEEEEEecCCCEEEEEecchhhh----hchhhHHHHHHHHHHHHHhc--CcceEEEEEEeecCCEEEEEEe
Q 018275          113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM----LSRGQVEHVRAERNLLAEVA--SHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       113 ~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~----~~~~~~~~~~~E~~il~~l~--h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      .||-|....||++.....++.|+||.-.+-..    .-+-...+..-|...|....  -|..|+-+..| |+....+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehHh
Confidence            47889999999998754336899996543211    11344556667777776653  34334333333 3555679999


Q ss_pred             ecCCC
Q 018275          187 YLPGG  191 (358)
Q Consensus       187 ~~~~g  191 (358)
                      +++..
T Consensus        81 dL~~~   85 (370)
T TIGR01767        81 DLSHH   85 (370)
T ss_pred             hCccc
Confidence            99653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.01  E-value=0.0099  Score=54.89  Aligned_cols=32  Identities=28%  Similarity=0.514  Sum_probs=27.0

Q ss_pred             CceeCCCCCCCEEEcCCCc-EEEEecCCCccCC
Q 018275          226 NYIHRDIKPDNLLLDQNGH-MKLSDFGLCKPLD  257 (358)
Q Consensus       226 ~iiHrDikp~NILl~~~~~-vkl~DFGla~~~~  257 (358)
                      .++|+|++|.|||++.++. .-|+||+.+...+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence            4899999999999997554 5799999987654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.93  E-value=0.0085  Score=57.17  Aligned_cols=141  Identities=11%  Similarity=0.139  Sum_probs=80.5

Q ss_pred             CceeeeeEeeeeeEEEEEEEEec----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceE-EEEEEeecCCEE
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKK----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV-KLYYSFQDAEYL  181 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~l~~~~~~~~~~  181 (358)
                      ...+. .|-.|-.-.+|++....    .+..|++|+.....   ...+. ..+|..++..+...++. ++++.+...   
T Consensus        38 ~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g---  109 (344)
T PLN02236         38 ALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG---  109 (344)
T ss_pred             cEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc---
Confidence            34443 44447777899876432    24689999876542   22222 35688888888765543 445555332   


Q ss_pred             EEEEeecCCCCHHHH-----------------HhhcC-C----CC-HHHHHHHHHH-----------------HHHHHHH
Q 018275          182 YLIMEYLPGGDVMTL-----------------LMREE-T----LT-ETVARFYIAQ-----------------SVLAIES  221 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~-----------------l~~~~-~----~~-~~~~~~~~~q-----------------i~~aL~~  221 (358)
                       .|.+|+++.++...                 ++.-. +    .. ...+..+..+                 +...+..
T Consensus       110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence             68999977655311                 01100 0    11 1112222211                 1111112


Q ss_pred             H----H----hCCceeCCCCCCCEEEcC-CCcEEEEecCCCccC
Q 018275          222 I----H----KHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPL  256 (358)
Q Consensus       222 L----H----~~~iiHrDikp~NILl~~-~~~vkl~DFGla~~~  256 (358)
                      |    .    ...++|+|+++.|||++. ++.+.++||..|..-
T Consensus       189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            2    1    235999999999999986 478999999988754

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.77  E-value=0.028  Score=54.55  Aligned_cols=77  Identities=17%  Similarity=0.175  Sum_probs=49.9

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh-hch---hhHHHHHHHHHHHHHhc---CcceEEEEEEeecCCEEE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-LSR---GQVEHVRAERNLLAEVA---SHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~-~~~---~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~~~~~  182 (358)
                      ..+.||-|..-.||+..+  .+..++||.-..... .+.   ....+...|...|..+.   ...+.+++.++.+  ..+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence            367789999999999775  345688997652211 011   13344455666666554   2467778877763  456


Q ss_pred             EEEeecCC
Q 018275          183 LIMEYLPG  190 (358)
Q Consensus       183 lV~E~~~~  190 (358)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            89999976

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.66  E-value=0.031  Score=52.50  Aligned_cols=148  Identities=14%  Similarity=0.166  Sum_probs=82.8

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCc--ceEEEEEEeecCC--EEEE
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH--CIVKLYYSFQDAE--YLYL  183 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~--~iv~l~~~~~~~~--~~~l  183 (358)
                      ..+++.+..|-.-.+|...  .+++.+++. .+. ............+|..+++.+..-  -+...++.|.+..  ..+.
T Consensus        27 ~~~v~~~~~G~sn~t~~~~--~~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLG--DTGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CceeeeccCCcccceEEEe--cCCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            3344444333223344332  337788888 332 122334455567788888877542  3344566676555  5689


Q ss_pred             EEeecCCCCHH------------------HHHhh-------c-CC------CCHHHHHHHHHH--------------HHH
Q 018275          184 IMEYLPGGDVM------------------TLLMR-------E-ET------LTETVARFYIAQ--------------SVL  217 (358)
Q Consensus       184 V~E~~~~g~L~------------------~~l~~-------~-~~------~~~~~~~~~~~q--------------i~~  217 (358)
                      ||+|+.|..+.                  ++|..       . ..      ........+..+              ...
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            99999873211                  11110       0 00      011111111111              112


Q ss_pred             HHHHHHh--------CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          218 AIESIHK--------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       218 aL~~LH~--------~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      -..+|+.        ..++|+|+.+.||+++.++-+-+.||+++..-+..
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence            2445543        24999999999999999999999999999876543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.43  E-value=0.027  Score=53.44  Aligned_cols=142  Identities=15%  Similarity=0.201  Sum_probs=78.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceE-EEEEEeecCCEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV-KLYYSFQDAEYL  181 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~l~~~~~~~~~~  181 (358)
                      +...+....| |=--.+|++.....   +..|++|+.....   .. .-...+|..+++.+...++. ++++.+. ..  
T Consensus        15 ~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--   86 (330)
T PLN02421         15 SDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT---DY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG--   86 (330)
T ss_pred             CceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc---Ce-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc--
Confidence            4455444444 66667888754322   3378899876532   11 12245688888888766553 4455553 22  


Q ss_pred             EEEEeecCCCCHHH-------HH----------hhcC-C----CC-HHHHHHHHHHH-----------------------
Q 018275          182 YLIMEYLPGGDVMT-------LL----------MREE-T----LT-ETVARFYIAQS-----------------------  215 (358)
Q Consensus       182 ~lV~E~~~~g~L~~-------~l----------~~~~-~----~~-~~~~~~~~~qi-----------------------  215 (358)
                       +|.+|++|..+..       .+          +... +    ++ ...+..+..++                       
T Consensus        87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~  165 (330)
T PLN02421         87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR  165 (330)
T ss_pred             -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence             5899997765421       01          1111 0    11 11122222111                       


Q ss_pred             --HHHHHHHH-hC----CceeCCCCCCCEEEcC-CCcEEEEecCCCccC
Q 018275          216 --VLAIESIH-KH----NYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPL  256 (358)
Q Consensus       216 --~~aL~~LH-~~----~iiHrDikp~NILl~~-~~~vkl~DFGla~~~  256 (358)
                        +..+..+. ..    -++|.|+.|.|||+++ ++.++++||..|..-
T Consensus       166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence              11111121 11    3899999999999975 578999999988643

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.31  E-value=0.039  Score=53.33  Aligned_cols=78  Identities=19%  Similarity=0.238  Sum_probs=50.9

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh---chhhHHHHHHHHHHHHHhc--Ccc-eEEEEEEeecCCEEEEE
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML---SRGQVEHVRAERNLLAEVA--SHC-IVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~E~~il~~l~--h~~-iv~l~~~~~~~~~~~lV  184 (358)
                      .+.||-|.-..||++.+...+..|+||.-..-...   -+-..++.+-|...|+...  .|. ++++|. | |+....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-CcHHhhHH
Confidence            67889999999999987434567899864322111   1345566777888887653  344 444443 3 35556799


Q ss_pred             EeecCC
Q 018275          185 MEYLPG  190 (358)
Q Consensus       185 ~E~~~~  190 (358)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.27  E-value=0.066  Score=50.15  Aligned_cols=31  Identities=13%  Similarity=0.171  Sum_probs=28.4

Q ss_pred             CceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       226 ~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      +++|+|+.++|||++.++.+.++||..+..-
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            6999999999999999999999999988653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.19  E-value=0.018  Score=55.30  Aligned_cols=61  Identities=25%  Similarity=0.402  Sum_probs=42.3

Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeCCCCCCCEEEcCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES-IHKHNYIHRDIKPDNLLLDQN  242 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~-LH~~~iiHrDikp~NILl~~~  242 (358)
                      ..||=+|++|-++..++.. ...++...+.++.-.+.|+.- |--.+++|.|+.|.||++..+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            4566778888888888854 334455555555555555443 345689999999999999543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.99  E-value=0.018  Score=54.63  Aligned_cols=73  Identities=23%  Similarity=0.412  Sum_probs=52.1

Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ..+.|++|++- |+++...-    .....++..++.+.+..++-+.. ..+=|||+..+||||+ +|.|-|+||-+|+.-
T Consensus       298 ~~y~yl~~kdh-gt~is~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDH-GTPISIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecC-Cceeeeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            45678888876 55543322    12344555566666665555554 4799999999999999 999999999999943

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.47  E-value=0.076  Score=47.14  Aligned_cols=102  Identities=20%  Similarity=0.207  Sum_probs=66.2

Q ss_pred             EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHH
Q 018275          133 IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI  212 (358)
Q Consensus       133 ~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~  212 (358)
                      +..+|+++.....  -....+..+..+++++  +.|+++..-  +.-.+-++.|+|-.-.             .....++
T Consensus        87 ~L~lKKi~slp~~--~~~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~-------------i~~~N~i  147 (308)
T PF07387_consen   87 PLFLKKIRSLPCC--INDALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIK-------------INFSNFI  147 (308)
T ss_pred             hhhhhhccCCCcc--cchhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCcc-------------cchhHHH
Confidence            4556766654321  1123357778888876  467777733  3334668889883211             0111222


Q ss_pred             HHHHHHHHHHHh--CCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          213 AQSVLAIESIHK--HNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       213 ~qi~~aL~~LH~--~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      ..-+.+|.-.|+  .+.+|+|-.|+||+-|+.|-+||.|-+..
T Consensus       148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            333567777884  47999999999999999999999998753

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=95.14  E-value=0.18  Score=48.84  Aligned_cols=80  Identities=14%  Similarity=0.147  Sum_probs=45.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecC-CC-----EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceE-EEEEEeecC
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKS-GN-----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV-KLYYSFQDA  178 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~-~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~l~~~~~~~  178 (358)
                      +.+.+ +.|..|-...+|++..... +.     .|.++.....    ....-...+|..+++.+...++. ++++.|.  
T Consensus        51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~--  123 (383)
T PTZ00384         51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG--  123 (383)
T ss_pred             ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecC--
Confidence            33444 4454488888998864322 12     2444443211    11111235688899988776654 4555553  


Q ss_pred             CEEEEEEeecCCCCHH
Q 018275          179 EYLYLIMEYLPGGDVM  194 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~  194 (358)
                        .++|.||++|.+|.
T Consensus       124 --~g~l~efIeGr~l~  137 (383)
T PTZ00384        124 --DFTIQEWVEGNTMG  137 (383)
T ss_pred             --CEEEEEEeccccCC
Confidence              25999999886543

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.12  E-value=0.28  Score=45.43  Aligned_cols=31  Identities=29%  Similarity=0.453  Sum_probs=26.6

Q ss_pred             ceeCCCCCCCEEEcCC--C---cEEEEecCCCccCC
Q 018275          227 YIHRDIKPDNLLLDQN--G---HMKLSDFGLCKPLD  257 (358)
Q Consensus       227 iiHrDikp~NILl~~~--~---~vkl~DFGla~~~~  257 (358)
                      ++|+|++++|||+..+  |   .+++.||.+++...
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g~  252 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYGS  252 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccccCCC
Confidence            9999999999999765  3   69999999987653

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.99  E-value=0.31  Score=45.29  Aligned_cols=75  Identities=19%  Similarity=0.211  Sum_probs=45.3

Q ss_pred             eeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc---CcceEEEEEEeecCCEEEEEE
Q 018275          109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       109 ~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +-...++-|....+|...  .+++.+.||+-...      ....+..|..-|+.+.   .-.+.+.+++....+..+|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            345678889999999764  77889999986632      1223777888888773   335677777776666679999


Q ss_pred             eecCCC
Q 018275          186 EYLPGG  191 (358)
Q Consensus       186 E~~~~g  191 (358)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.84  E-value=0.064  Score=50.00  Aligned_cols=30  Identities=27%  Similarity=0.562  Sum_probs=26.2

Q ss_pred             CCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       225 ~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            47999999999999987 6789999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.18  E-value=0.05  Score=47.06  Aligned_cols=31  Identities=26%  Similarity=0.455  Sum_probs=26.7

Q ss_pred             CceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       226 ~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ..+|+|+.|.||+++.++ ++|+||+.|...+
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD  108 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGD  108 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence            479999999999998877 8999999886543

>PTZ00296 choline kinase; Provisional

Probab=94.10  E-value=0.77  Score=45.35  Aligned_cols=79  Identities=18%  Similarity=0.111  Sum_probs=47.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEec--------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceE-EEEEEee
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKK--------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV-KLYYSFQ  176 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~l~~~~~  176 (358)
                      ++. -++.|..|-.-.+|++....        .++.|.+++.-...   ...+ ....|..++..+...+|- ++++.+.
T Consensus       106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~  180 (442)
T PTZ00296        106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS  180 (442)
T ss_pred             ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC
Confidence            444 45566556666788876432        14678889875542   1112 245688888777665543 4455553


Q ss_pred             cCCEEEEEEeecCCCCH
Q 018275          177 DAEYLYLIMEYLPGGDV  193 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L  193 (358)
                          -+.|.||++|.+|
T Consensus       181 ----gg~I~efi~g~~l  193 (442)
T PTZ00296        181 ----GGRIEEWLYGDPL  193 (442)
T ss_pred             ----CCEEEEeeCCccC
Confidence                2468999987633

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.06  E-value=0.26  Score=46.35  Aligned_cols=40  Identities=30%  Similarity=0.443  Sum_probs=28.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHH----hCCceeCCCCCCCEEEcCCC
Q 018275          204 TETVARFYIAQSVLAIESIH----KHNYIHRDIKPDNLLLDQNG  243 (358)
Q Consensus       204 ~~~~~~~~~~qi~~aL~~LH----~~~iiHrDikp~NILl~~~~  243 (358)
                      ...-+++++.||+.-.-.+-    ...++|-||||+|||+-+..
T Consensus       277 ~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        277 LVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence            35567788888875443332    24699999999999995543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=93.71  E-value=0.011  Score=57.80  Aligned_cols=71  Identities=28%  Similarity=0.412  Sum_probs=59.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      .++|.....+|.|+||+|+.+....++..+|||.|....  .........++..-++.+.|++++.++..|..
T Consensus        48 a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn--~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   48 ANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN--REESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hccccccccccccCccccCCccccccchhhHHHHhcccc--hhhhhhhhhccccchhhhcccchhhheeceec
Confidence            488999999999999999999998888899999987654  23334456778888999999999999887753

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=93.61  E-value=0.25  Score=45.00  Aligned_cols=75  Identities=20%  Similarity=0.142  Sum_probs=52.7

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHH---HHHHHhcCcceEEEEEEeecCCEEEEEEeec
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER---NLLAEVASHCIVKLYYSFQDAEYLYLIMEYL  188 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~---~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~  188 (358)
                      ..+..|..+.|+.++ ..+|.++++|+......        ...|.   ..|+..+....|+++..-  ...-.+++|.+
T Consensus         8 ~~~~~g~~s~V~pv~-~~dG~~avLKl~~p~~~--------~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl   76 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVR-RADGTPAVLKLAPPHAE--------AEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERL   76 (253)
T ss_pred             CCCCCCcceEEEEEE-cCCCCeEEEEecCCccc--------chhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhc
Confidence            345668889999987 46789999999875431        12233   458888888899999865  33456899998


Q ss_pred             -CCCCHHHHH
Q 018275          189 -PGGDVMTLL  197 (358)
Q Consensus       189 -~~g~L~~~l  197 (358)
                       ++.+|.+..
T Consensus        77 ~~g~~L~~~~   86 (253)
T PF04655_consen   77 DPGRSLASLP   86 (253)
T ss_pred             cCCCchhhcc
Confidence             555666554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	358
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-42
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-41
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-40
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-40
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-40
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-40
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-40
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-40
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-35
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-35
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-34
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-34
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-34
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-34
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-34
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-34
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-34
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-34
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-34
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-34
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-34
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-34
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-34
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-34
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-34
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-34
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-34
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-34
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-34
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-34
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-34
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-34
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-34
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-34
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-34
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-34
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-34
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-34
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-34
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-34
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-34
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-34
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-34
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-34
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-33
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-33
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-33
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-33
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-33
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-33
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-33
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-33
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-33
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-33
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-33
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-33
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-33
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-33
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-33
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-32
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-32
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-32
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-31
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-31
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-31
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-31
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-31
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-31
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-31
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-30
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-30
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-30
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-30
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-30
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-30
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-30
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-30
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-29
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-29
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-28
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-28
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-28
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-28
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-28
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-28
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-28
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-28
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-27
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-27
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-26
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-25
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-25
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-23
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-23
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-23
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-23
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-23
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-23
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-23
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-23
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-23
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-23
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-23
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-23
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-23
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-23
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-23
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-23
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-22
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-22
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-22
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-22
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-21
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-21
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-21
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-21
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-21
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-21
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-21
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-21
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-21
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-21
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-21
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-21
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-21
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-21
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-20
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-20
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-20
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-20
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-20
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-20
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-20
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-19
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-19
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-19
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-17
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-17
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-17
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-16
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-15
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-15
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-15
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-15
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-15
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-15
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-15
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-15
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-14
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-13
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-12
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-12
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-11
3soa_A	444	Full-Length Human Camkii Length = 444		1e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-11
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-06
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-06
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-05
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-05
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-05
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-04
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		1e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-04
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		2e-04
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-04
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-04
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		3e-04
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-04
4ax8_A	569	Medium Resolution Structure Of The Bifunctional Kin		7e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-04
4azs_A	569	High Resolution (2.2 A) Crystal Structure Of Wbdd.		7e-04
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-04

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 95/262 (36%), Positives = 138/262 (52%), Gaps = 53/262 (20%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           NI   L R E    +++  ++  +D+D++ +IGRGAFGEV+L + K S  +YAMK L K 
Sbjct: 52  NIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKF 111
Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXX 202
           EM+ R        ER+++A   S  +V+L+ +FQD +YLY++MEY+PGGD+         
Sbjct: 112 EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV 171
Query: 203 XXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
                A+FY A+ VLA+++IH    IHRD+KPDN+LLD++GH+KL+DFG C  +D T + 
Sbjct: 172 PEKW-AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 230
Query: 263 AIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
                                                              + VGTPDYI
Sbjct: 231 HCD------------------------------------------------TAVGTPDYI 242
Query: 323 APEVLLKKG----YGMECDWLA 340
           +PEVL  +G    YG ECDW +
Sbjct: 243 SPEVLKSQGGDGYYGRECDWWS 264

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 98/273 (35%), Positives = 143/273 (52%), Gaps = 58/273 (21%)
Query: 74  SDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI 133
           ++ P   + NIL+ LE  +    ++K+ ++  +DF++L +IGRGAFGEV + + K +  +
Sbjct: 42  NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV 101
Query: 134 YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV 193
           +AMK L K EML R +    R ER++L    S  I  L+Y+FQD   LYL+M+Y  GGD+
Sbjct: 102 FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL 161
Query: 194 XXXXXXXX-XXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                         +ARFY+A+ V+AI+S+H+ +Y+HRDIKPDN+L+D NGH++L+DFG 
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221
Query: 253 CKPL--DCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRK 310
           C  L  D T  S++                                              
Sbjct: 222 CLKLMEDGTVQSSV---------------------------------------------- 235
Query: 311 LAYSTVGTPDYIAPEVLL-----KKGYGMECDW 338
                VGTPDYI+PE+L      K  YG ECDW
Sbjct: 236 ----AVGTPDYISPEILQAMEGGKGRYGPECDW 264

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 90/262 (34%), Positives = 136/262 (51%), Gaps = 53/262 (20%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           NI   L R +    +++  ++  +D++++ +IGRGAFGEV+L + K +  +YAMK L K 
Sbjct: 46  NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 105
Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXX 202
           EM+ R        ER+++A   S  +V+L+Y+FQD  YLY++MEY+PGGD+         
Sbjct: 106 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV 165
Query: 203 XXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
                ARFY A+ VLA+++IH   +IHRD+KPDN+LLD++GH+KL+DFG C  ++   + 
Sbjct: 166 PEKW-ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 263 AIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
                                      C     +P                      DYI
Sbjct: 225 R--------------------------CDTAVGTP----------------------DYI 236
Query: 323 APEVLLKKG----YGMECDWLA 340
           +PEVL  +G    YG ECDW +
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWS 258

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 90/262 (34%), Positives = 136/262 (51%), Gaps = 53/262 (20%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           NI   L R +    +++  ++  +D++++ +IGRGAFGEV+L + K +  +YAMK L K 
Sbjct: 51  NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 110
Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXX 202
           EM+ R        ER+++A   S  +V+L+Y+FQD  YLY++MEY+PGGD+         
Sbjct: 111 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV 170
Query: 203 XXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
                ARFY A+ VLA+++IH   +IHRD+KPDN+LLD++GH+KL+DFG C  ++   + 
Sbjct: 171 PEKW-ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 263 AIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
                                      C     +P                      DYI
Sbjct: 230 R--------------------------CDTAVGTP----------------------DYI 241
Query: 323 APEVLLKKG----YGMECDWLA 340
           +PEVL  +G    YG ECDW +
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWS 263

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 90/262 (34%), Positives = 136/262 (51%), Gaps = 53/262 (20%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           NI   L R +    +++  ++  +D++++ +IGRGAFGEV+L + K +  +YAMK L K 
Sbjct: 51  NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 110
Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXX 202
           EM+ R        ER+++A   S  +V+L+Y+FQD  YLY++MEY+PGGD+         
Sbjct: 111 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV 170
Query: 203 XXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
                ARFY A+ VLA+++IH   +IHRD+KPDN+LLD++GH+KL+DFG C  ++   + 
Sbjct: 171 PEKW-ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 263 AIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
                                      C     +P                      DYI
Sbjct: 230 R--------------------------CDTAVGTP----------------------DYI 241
Query: 323 APEVLLKKG----YGMECDWLA 340
           +PEVL  +G    YG ECDW +
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWS 263

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 99/282 (35%), Positives = 149/282 (52%), Gaps = 58/282 (20%)
Query: 67  LERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQ 126
           + ++L +S++ +++ +     L+  E   +RLK  ++  DDF++L +IGRGAF EV + +
Sbjct: 24  VHQELGASELAQDKYVADF--LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVK 81
Query: 127 EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186
            K++G +YAMK + K +ML RG+V   R ER++L       I +L+++FQD  YLYL+ME
Sbjct: 82  MKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141
Query: 187 YLPGGDVXXXXXXX-XXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM 245
           Y  GGD+              +ARFY+A+ V+AI+S+H+  Y+HRDIKPDN+LLD+ GH+
Sbjct: 142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI 201
Query: 246 KLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQ 305
           +L+DFG C                         +  DG                      
Sbjct: 202 RLADFGSC-----------------------LKLRADG---------------------- 216
Query: 306 INRRKLAYSTVGTPDYIAPEVL-------LKKGYGMECDWLA 340
              R L    VGTPDY++PE+L           YG ECDW A
Sbjct: 217 -TVRSLV--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 95/249 (38%), Positives = 131/249 (52%), Gaps = 54/249 (21%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           +K  ++  +DF+++ +IGRGAFGEV + + K +  IYAMK L K EML R +    R ER
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 125
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXX-XXXXXVARFYIAQSV 216
           ++L       I  L+Y+FQD  +LYL+M+Y  GGD+              +ARFYI + V
Sbjct: 126 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 185
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXX 276
           LAI+SIH+ +Y+HRDIKPDN+LLD NGH++L+DFG C                       
Sbjct: 186 LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC----------------------- 222
Query: 277 XSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL--LKKG--- 331
             M+ DG    S                           VGTPDYI+PE+L  ++ G   
Sbjct: 223 LKMNDDGTVQSS-------------------------VAVGTPDYISPEILQAMEDGMGK 257
Query: 332 YGMECDWLA 340
           YG ECDW +
Sbjct: 258 YGPECDWWS 266

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  160 bits (406), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 95/249 (38%), Positives = 131/249 (52%), Gaps = 54/249 (21%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           +K  ++  +DF+++ +IGRGAFGEV + + K +  IYAMK L K EML R +    R ER
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 141
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXX-XXXXXVARFYIAQSV 216
           ++L       I  L+Y+FQD  +LYL+M+Y  GGD+              +ARFYI + V
Sbjct: 142 DVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 201
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXX 276
           LAI+SIH+ +Y+HRDIKPDN+LLD NGH++L+DFG C                       
Sbjct: 202 LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC----------------------- 238
Query: 277 XSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL--LKKG--- 331
             M+ DG    S                           VGTPDYI+PE+L  ++ G   
Sbjct: 239 LKMNDDGTVQSS-------------------------VAVGTPDYISPEILQAMEDGMGK 273
Query: 332 YGMECDWLA 340
           YG ECDW +
Sbjct: 274 YGPECDWWS 282

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 81/236 (34%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  IG G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGGD+              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G++K++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 81/236 (34%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  IG G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGGD+              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G++K++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLAGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN +AMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL YSF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN +AMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL YSF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN +AMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL YSF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 185
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 186 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 216

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NL++DQ G++K++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 213
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 214 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 244

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  IG G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G++K++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLXGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 118/236 (50%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 185
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 186 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 216

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 80/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 81/236 (34%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 154
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 155 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 187
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 188 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 218

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 81/236 (34%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 81/236 (34%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 81/236 (34%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 213
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 214 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 244

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 81/236 (34%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                   +  GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------TLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 146 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 178
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                   +  GTP+Y+APE++L KGY    DW A
Sbjct: 179 ------GRTW-------------------TLCGTPEYLAPEIILSKGYNKAVDWWA 209

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NL++DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE+++ KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIIISKGYNKAVDWWA 223

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 86
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 146
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+D+ G+++++DFG  K +                            
Sbjct: 147 LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--------------------------- 179
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 180 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 210

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 213
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 G  W                   +  GTP+Y+APE++L KGY    DW A
Sbjct: 214 ------GATW-------------------TLCGTPEYLAPEIILSKGYNKAVDWWA 244

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 115/236 (48%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+AP ++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPAIILSKGYNKAVDWWA 223

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 117/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 115/236 (48%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NL++DQ G++K++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   ++EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NL++DQ G++K++DFGL K +                            
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NL++DQ G++K++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 115/236 (48%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L + K++GN YAMK L K +++   Q+EH   E+ +   V 
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY+++EY PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G++K++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 79/236 (33%), Positives = 115/236 (48%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D FD +  +G G+FG V L + K+SGN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+ +APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEALAPEIILSKGYNKAVDWWA 223

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 114/236 (48%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              + KL +SF+D   LY++MEY PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NL++DQ G++K++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 115/236 (48%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NL++DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 114/236 (48%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              + KL +SF+D   LY++MEY PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NL++DQ G++K++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   ++EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY PGG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NL++DQ G+++++DFGL K +                            
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 78/236 (33%), Positives = 115/236 (48%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              + KL +SF+D   LY++MEY PGG++              ARFY AQ VL  E +H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NL++DQ G++K++DFG  K +                            
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--------------------------- 193
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 194 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 115/236 (48%), Gaps = 52/236 (22%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +D F+ +  +G G+FG V L +  ++GN YAMK L K +++   Q+EH   E+ +L  V 
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VKL +SF+D   LY++MEY+ GG++              ARFY AQ VL  E +H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            + I+RD+KP+NLL+DQ G+++++DFG  K +                            
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------------- 192
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                 GR W                      GTP+Y+APE++L KGY    DW A
Sbjct: 193 ------GRTW-------------------XLCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 100/153 (65%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K S+ DF +L  +G G+FG V L + + +G  YAMK LKK  ++   QVEH   ER +L+
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
            V    I++++ +FQDA+ +++IM+Y+ GG++             VA+FY A+  LA+E 
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           +H  + I+RD+KP+N+LLD+NGH+K++DFG  K
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAK 154

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 128/252 (50%), Gaps = 53/252 (21%)
Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQ 149
           T +++    K     F+LL ++G+G+FG+V L ++     SG++YAMK LKK+ +  R +
Sbjct: 15  THHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDR 74
Query: 150 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVAR 209
           V   + ER++LA+V    +VKL+Y+FQ    LYLI+++L GGD+               +
Sbjct: 75  VR-TKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 133
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXX 269
           FY+A+  L ++ +H    I+RD+KP+N+LLD+ GH+KL+DFGL K               
Sbjct: 134 FYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-------------- 179
Query: 270 XXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
                                               I+  K AYS  GT +Y+APEV+ +
Sbjct: 180 -----------------------------------AIDHEKKAYSFCGTVEYMAPEVVNR 204
Query: 330 KGYGMECDWLAY 341
           +G+    DW +Y
Sbjct: 205 QGHSHSADWWSY 216

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 119/239 (49%), Gaps = 49/239 (20%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
           R K++++DFD L ++G+G FG+V L +EK +G  YAMK L+K  ++++ +V H   E  +
Sbjct: 2   RAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 61
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L       +  L Y+FQ  + L  +MEY  GG++              ARFY A+ V A+
Sbjct: 62  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 121
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           E +H  + ++RDIK +NL+LD++GH+K++DFGLCK      +S                 
Sbjct: 122 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGIS----------------- 160
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
             DG   ++ C                          GTP+Y+APEVL    YG   DW
Sbjct: 161 --DGATMKTFC--------------------------GTPEYLAPEVLEDNDYGRAVDW 191

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 84/253 (33%), Positives = 130/253 (51%), Gaps = 55/253 (21%)
Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRG 148
           T +++    K     F+LL ++G+G+FG+V L + K SG+    +YAMK LKK+ +  R 
Sbjct: 11  THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRD 69
Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           +V   + ER++L EV    IVKL+Y+FQ    LYLI+++L GGD+               
Sbjct: 70  RVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV 128
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXX 268
           +FY+A+  LA++ +H    I+RD+KP+N+LLD+ GH+KL+DFGL K              
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-------------- 174
Query: 269 XXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
                             ES                 I+  K AYS  GT +Y+APEV+ 
Sbjct: 175 ------------------ES-----------------IDHEKKAYSFCGTVEYMAPEVVN 199
Query: 329 KKGYGMECDWLAY 341
           ++G+    DW ++
Sbjct: 200 RRGHTQSADWWSF 212

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 128/253 (50%), Gaps = 55/253 (21%)
Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRG 148
           T +++    K     F+LL ++G+G+FG+V L + K SG+    +YAMK LKK+ +  R 
Sbjct: 12  THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRD 70
Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           +V   + ER++L EV    IVKL+Y+FQ    LYLI+++L GGD+               
Sbjct: 71  RVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV 129
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXX 268
           +FY+A+  LA++ +H    I+RD+KP+N+LLD+ GH+KL+DFGL K              
Sbjct: 130 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE------------- 176
Query: 269 XXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
                                                I+  K AYS  GT +Y+APEV+ 
Sbjct: 177 ------------------------------------SIDHEKKAYSFCGTVEYMAPEVVN 200
Query: 329 KKGYGMECDWLAY 341
           ++G+    DW ++
Sbjct: 201 RRGHTQSADWWSF 213

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 128/253 (50%), Gaps = 55/253 (21%)
Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRG 148
           T +++    K     F+LL ++G+G+FG+V L + K SG+    +YAMK LKK+ +  R 
Sbjct: 11  THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRD 69
Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           +V   + ER++L EV    IVKL+Y+FQ    LYLI+++L GGD+               
Sbjct: 70  RVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV 128
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXX 268
           +FY+A+  LA++ +H    I+RD+KP+N+LLD+ GH+KL+DFGL K              
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE------------- 175
Query: 269 XXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
                                                I+  K AYS  GT +Y+APEV+ 
Sbjct: 176 ------------------------------------SIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 329 KKGYGMECDWLAY 341
           ++G+    DW ++
Sbjct: 200 RRGHTQSADWWSF 212

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 118/237 (49%), Gaps = 49/237 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K++++DFD L ++G+G FG+V L +EK +G  YAMK L+K  ++++ +V H   E  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 +  L Y+FQ  + L  +MEY  GG++              ARFY A+ V A+E 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDV 281
           +H  + ++RDIK +NL+LD++GH+K++DFGLCK      +S                   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGIS------------------- 157
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
           DG   ++ C                          GTP+Y+APEVL    YG   DW
Sbjct: 158 DGATMKTFC--------------------------GTPEYLAPEVLEDNDYGRAVDW 188

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 118/237 (49%), Gaps = 49/237 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K++++DFD L ++G+G FG+V L +EK +G  YAMK L+K  ++++ +V H   E  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 +  L Y+FQ  + L  +MEY  GG++              ARFY A+ V A+E 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDV 281
           +H  + ++RDIK +NL+LD++GH+K++DFGLCK      +S                   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGIS------------------- 157
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
           DG   ++ C                          GTP+Y+APEVL    YG   DW
Sbjct: 158 DGATMKTFC--------------------------GTPEYLAPEVLEDNDYGRAVDW 188

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 117/237 (49%), Gaps = 49/237 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K++++DFD L ++G+G FG+V L +EK +G  YAMK L+K  ++++ +V H   E  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 +  L Y+FQ  + L  +MEY  GG++              ARFY A+ V A+E 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDV 281
           +H  + ++RDIK +NL+LD++GH+K++DFGLCK      +S                   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGIS------------------- 157
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
           DG   +  C                          GTP+Y+APEVL    YG   DW
Sbjct: 158 DGATMKXFC--------------------------GTPEYLAPEVLEDNDYGRAVDW 188

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 117/237 (49%), Gaps = 49/237 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K++++DFD L ++G+G FG+V L +EK +G  YAMK L+K  ++++ +V H   E  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 +  L Y+FQ  + L  +MEY  GG++              ARFY A+ V A+E 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDV 281
           +H  + ++RDIK +NL+LD++GH+K++DFGLCK      +S                   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGIS------------------- 157
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
           DG   +  C                          GTP+Y+APEVL    YG   DW
Sbjct: 158 DGATMKXFC--------------------------GTPEYLAPEVLEDNDYGRAVDW 188

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 117/237 (49%), Gaps = 49/237 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K++++DFD L ++G+G FG+V L +EK +G  YAMK L+K  ++++ +V H   E  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 +  L Y+FQ  + L  +MEY  GG++              ARFY A+ V A+E 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDV 281
           +H  + ++RDIK +NL+LD++GH+K++DFGLCK      +S                   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGIS------------------- 157
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
           DG   +  C                          GTP+Y+APEVL    YG   DW
Sbjct: 158 DGATMKXFC--------------------------GTPEYLAPEVLEDNDYGRAVDW 188

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 117/237 (49%), Gaps = 49/237 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K++++DFD L ++G+G FG+V L +EK +G  YAMK L+K  ++++ +V H   E  +L 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 +  L Y+FQ  + L  +MEY  GG++              ARFY A+ V A+E 
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 125
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDV 281
           +H  + ++RDIK +NL+LD++GH+K++DFGLCK      +S                   
Sbjct: 126 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGIS------------------- 162
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
           DG   +  C                          GTP+Y+APEVL    YG   DW
Sbjct: 163 DGATMKXFC--------------------------GTPEYLAPEVLEDNDYGRAVDW 193

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 118/241 (48%), Gaps = 50/241 (20%)
Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
           +++ +D+F+ + ++G+G+FG+V L + K++G++YA+K LKK  +L    VE    E+ +L
Sbjct: 18  NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRIL 77
Query: 161 AEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           +   +H  + +L+  FQ  + L+ +ME++ GGD+              ARFY A+ + A+
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISAL 137
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
             +H    I+RD+K DN+LLD  GH KL+DFG+CK   C  ++                 
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA--------------- 182
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL 339
                                             +  GTPDYIAPE+L +  YG   DW 
Sbjct: 183 ----------------------------------TFCGTPDYIAPEILQEMLYGPAVDWW 208
Query: 340 A 340
           A
Sbjct: 209 A 209

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 50/233 (21%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           DF  L +IG+G+FG+V L + K     YA+K L+K  +L + + +H+ +ERN+L +   H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 167 -CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             +V L++SFQ A+ LY +++Y+ GG++              ARFY A+   A+  +H  
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRF 285
           N ++RD+KP+N+LLD  GH+ L+DFGLCK                               
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK------------------------------- 187
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                        E ++H          +  GTP+Y+APEVL K+ Y    DW
Sbjct: 188 -------------ENIEH-----NSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 120/241 (49%), Gaps = 53/241 (21%)
Query: 102 KISVDDFDLLTIIGRGAFG---EVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAER 157
           KI  + F+LL ++G+G +G   +VR      +G I+AMK LKK+ ++   +   H +AER
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL 217
           N+L EV    IV L Y+FQ    LYLI+EYL GG++              A FY+A+  +
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXX 277
           A+  +H+   I+RD+KP+N++L+  GH+KL+DFGLCK                       
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK----------------------- 169
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                    ES                 I+   + ++  GT +Y+APE+L++ G+    D
Sbjct: 170 ---------ES-----------------IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVD 203
Query: 338 W 338
           W
Sbjct: 204 W 204

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 120/240 (50%), Gaps = 50/240 (20%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
           +H++++++F+ L ++G+G FG+V L +EK +G  YAMK LKK  ++++ +V H   E  +
Sbjct: 145 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 204
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L       +  L YSFQ  + L  +MEY  GG++              ARFY A+ V A+
Sbjct: 205 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 264
Query: 220 ESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXS 278
           + +H + N ++RD+K +NL+LD++GH+K++DFGLCK         I              
Sbjct: 265 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIK------------- 304
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
              DG   ++ C                          GTP+Y+APEVL    YG   DW
Sbjct: 305 ---DGATMKTFC--------------------------GTPEYLAPEVLEDNDYGRAVDW 335

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 120/240 (50%), Gaps = 50/240 (20%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
           +H++++++F+ L ++G+G FG+V L +EK +G  YAMK LKK  ++++ +V H   E  +
Sbjct: 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 201
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L       +  L YSFQ  + L  +MEY  GG++              ARFY A+ V A+
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 261
Query: 220 ESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXS 278
           + +H + N ++RD+K +NL+LD++GH+K++DFGLCK         I              
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIK------------- 301
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
              DG   ++ C                          GTP+Y+APEVL    YG   DW
Sbjct: 302 ---DGATMKTFC--------------------------GTPEYLAPEVLEDNDYGRAVDW 332

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 119/241 (49%), Gaps = 53/241 (21%)
Query: 102 KISVDDFDLLTIIGRGAFG---EVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAER 157
           KI  + F+LL ++G+G +G   +VR      +G I+AMK LKK+ ++   +   H +AER
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL 217
           N+L EV    IV L Y+FQ    LYLI+EYL GG++              A FY+A+  +
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXX 277
           A+  +H+   I+RD+KP+N++L+  GH+KL+DFGLCK                       
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK----------------------- 169
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                    ES                 I+   + +   GT +Y+APE+L++ G+    D
Sbjct: 170 ---------ES-----------------IHDGTVTHXFCGTIEYMAPEILMRSGHNRAVD 203
Query: 338 W 338
           W
Sbjct: 204 W 204

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 119/241 (49%), Gaps = 50/241 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K+ ++DF+L  ++G+G+FG+V L + KK+   +A+K LKK  +L    VE    E+ +L+
Sbjct: 14  KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 73
Query: 162 EVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
               H  +  ++ +FQ  E L+ +MEYL GGD+              A FY A+ +L ++
Sbjct: 74  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMD 280
            +H    ++RD+K DN+LLD++GH+K++DFG+CK                       +M 
Sbjct: 134 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------------------ENML 171
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
            D +  E  CG                          TPDYIAPE+LL + Y    DW +
Sbjct: 172 GDAKTNEF-CG--------------------------TPDYIAPEILLGQKYNHSVDWWS 204
Query: 341 Y 341
           +
Sbjct: 205 F 205

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 117/243 (48%), Gaps = 58/243 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           + + DFDLL +IGRG++ +V L + KK+  IYAM+ +KK  +     ++ V+ E+++  +
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 163 VASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
            ++H  +V L+  FQ    L+ ++EY+ GGD+              ARFY A+  LA+  
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK----PLDCTNLSAIXXXXXXXXXXXXX 277
           +H+   I+RD+K DN+LLD  GH+KL+D+G+CK    P D T+                 
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS----------------- 211
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                                               +  GTP+YIAPE+L  + YG   D
Sbjct: 212 ------------------------------------TFCGTPNYIAPEILRGEDYGFSVD 235
Query: 338 WLA 340
           W A
Sbjct: 236 WWA 238

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 117/241 (48%), Gaps = 50/241 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K+ ++DF L  ++G+G+FG+V L + KK+   +A+K LKK  +L    VE    E+ +L+
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 162 EVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
               H  +  ++ +FQ  E L+ +MEYL GGD+              A FY A+ +L ++
Sbjct: 73  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMD 280
            +H    ++RD+K DN+LLD++GH+K++DFG+CK                       +M 
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------------------ENML 170
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
            D +     CG                          TPDYIAPE+LL + Y    DW +
Sbjct: 171 GDAK-TNXFCG--------------------------TPDYIAPEILLGQKYNHSVDWWS 203
Query: 341 Y 341
           +
Sbjct: 204 F 204

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 117/243 (48%), Gaps = 58/243 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           + + DFDLL +IGRG++ +V L + KK+  IYAMK +KK  +     ++ V+ E+++  +
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 163 VASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
            ++H  +V L+  FQ    L+ ++EY+ GGD+              ARFY A+  LA+  
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK----PLDCTNLSAIXXXXXXXXXXXXX 277
           +H+   I+RD+K DN+LLD  GH+KL+D+G+CK    P D T+                 
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF--------------- 181
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                       CG                          TP+YIAPE+L  + YG   D
Sbjct: 182 ------------CG--------------------------TPNYIAPEILRGEDYGFSVD 203
Query: 338 WLA 340
           W A
Sbjct: 204 WWA 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 117/243 (48%), Gaps = 58/243 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           + + DFDLL +IGRG++ +V L + KK+  IYAMK +KK  +     ++ V+ E+++  +
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 163 VASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
            ++H  +V L+  FQ    L+ ++EY+ GGD+              ARFY A+  LA+  
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK----PLDCTNLSAIXXXXXXXXXXXXX 277
           +H+   I+RD+K DN+LLD  GH+KL+D+G+CK    P D T+                 
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF--------------- 166
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                       CG                          TP+YIAPE+L  + YG   D
Sbjct: 167 ------------CG--------------------------TPNYIAPEILRGEDYGFSVD 188
Query: 338 WLA 340
           W A
Sbjct: 189 WWA 191

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 117/243 (48%), Gaps = 58/243 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           + + DFDLL +IGRG++ +V L + KK+  IYAMK +KK  +     ++ V+ E+++  +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 163 VASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
            ++H  +V L+  FQ    L+ ++EY+ GGD+              ARFY A+  LA+  
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK----PLDCTNLSAIXXXXXXXXXXXXX 277
           +H+   I+RD+K DN+LLD  GH+KL+D+G+CK    P D T+                 
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF--------------- 170
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                       CG                          TP+YIAPE+L  + YG   D
Sbjct: 171 ------------CG--------------------------TPNYIAPEILRGEDYGFSVD 192
Query: 338 WLA 340
           W A
Sbjct: 193 WWA 195

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 117/238 (49%), Gaps = 50/238 (21%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++++++F+ L ++G+G FG+V L +EK +G  YAMK LKK  ++++ +V H   E  +L 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 +  L YSFQ  + L  +MEY  GG++              ARFY A+ V A++ 
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 124
Query: 222 IH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMD 280
           +H + N ++RD+K +NL+LD++GH+K++DFGLCK         I                
Sbjct: 125 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIK--------------- 162
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
            DG   +  CG                          TP+Y+APEVL    YG   DW
Sbjct: 163 -DGATMKXFCG--------------------------TPEYLAPEVLEDNDYGRAVDW 193

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 117/238 (49%), Gaps = 50/238 (21%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++++++F+ L ++G+G FG+V L +EK +G  YAMK LKK  ++++ +V H   E  +L 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 +  L YSFQ  + L  +MEY  GG++              ARFY A+ V A++ 
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 125
Query: 222 IH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMD 280
           +H + N ++RD+K +NL+LD++GH+K++DFGLCK         I                
Sbjct: 126 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIK--------------- 163
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
            DG   +  CG                          TP+Y+APEVL    YG   DW
Sbjct: 164 -DGATMKXFCG--------------------------TPEYLAPEVLEDNDYGRAVDW 194

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 117/238 (49%), Gaps = 50/238 (21%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++++++F+ L ++G+G FG+V L +EK +G  YAMK LKK  ++++ +V H   E  +L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 +  L YSFQ  + L  +MEY  GG++              ARFY A+ V A++ 
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 123
Query: 222 IH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMD 280
           +H + N ++RD+K +NL+LD++GH+K++DFGLCK         I                
Sbjct: 124 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIK--------------- 161
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
            DG   +  CG                          TP+Y+APEVL    YG   DW
Sbjct: 162 -DGATMKXFCG--------------------------TPEYLAPEVLEDNDYGRAVDW 192

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 112/241 (46%), Gaps = 50/241 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++ + DF+ L ++G+G+FG+V L   K +  +YA+K LKK  ++    VE    E+ +LA
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLA 74
Query: 162 EV-ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            +     + +L+  FQ  + LY +MEY+ GGD+              A FY A+  + + 
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLF 134
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMD 280
            +HK   I+RD+K DN++LD  GH+K++DFG+CK                          
Sbjct: 135 FLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----------------------EHM 171
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
           +DG      CG                          TPDYIAPE++  + YG   DW A
Sbjct: 172 MDGVTTREFCG--------------------------TPDYIAPEIIAYQPYGKSVDWWA 205
Query: 341 Y 341
           Y
Sbjct: 206 Y 206

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 61/158 (38%), Positives = 100/158 (63%), Gaps = 5/158 (3%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQV-EHVRAER 157
           K+ +++F+LL ++G GA+G+V L ++     +G +YAMK LKK+ ++ + +  EH R ER
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 158 NLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSV 216
            +L  +  S  +V L+Y+FQ    L+LI++Y+ GG++               + Y+ + V
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           LA+E +HK   I+RDIK +N+LLD NGH+ L+DFGL K
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 121/270 (44%), Gaps = 56/270 (20%)
Query: 73  SSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN 132
            +  PEE+  N +   +          R ++ + DF+ L ++G+G+FG+V L + K +  
Sbjct: 314 GTKAPEEKTANTISKFDNNGN------RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 133 IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLIMEYLPGG 191
           +YA+K LKK  ++    VE    E+ +LA       + +L+  FQ  + LY +MEY+ GG
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 192 DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           D+              A FY A+  + +  +     I+RD+K DN++LD  GH+K++DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 252 LCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL 311
           +CK     N+                    DG   +  CG                    
Sbjct: 488 MCK----ENI-------------------WDGVTTKXFCG-------------------- 504
Query: 312 AYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                 TPDYIAPE++  + YG   DW A+
Sbjct: 505 ------TPDYIAPEIIAYQPYGKSVDWWAF 528

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 113/243 (46%), Gaps = 50/243 (20%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
           R ++ + DF+ L ++G+G+FG+V L + K +  +YA+K LKK  ++    VE    E+ +
Sbjct: 14  RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 73
Query: 160 LAEVA-SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA 218
           LA       + +L+  FQ  + LY +MEY+ GGD+              A FY A+  + 
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 133
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXS 278
           +  +     I+RD+K DN++LD  GH+K++DFG+CK     N+                 
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIW---------------- 173
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
              DG   +  CG                          TPDYIAPE++  + YG   DW
Sbjct: 174 ---DGVTTKXFCG--------------------------TPDYIAPEIIAYQPYGKSVDW 204
Query: 339 LAY 341
            A+
Sbjct: 205 WAF 207

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 92/151 (60%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           ++ D F++L  IG+G+FG+V + Q+  +  +YAMK + K + + R +V +V  E  ++  
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
           +    +V L+YSFQD E ++++++ L GGD+               + +I + V+A++ +
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
                IHRD+KPDN+LLD++GH+ ++DF + 
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 159

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 157

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 160

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 158

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 183

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 47/235 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRF 285
             IHRD+KP+N+LL+++ H++++DFG  K L                             
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLS---------------------------- 180
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
           PES   R                   A S VGT  Y++PE+L +K      D  A
Sbjct: 181 PESKQAR-------------------ANSFVGTAQYVSPELLTEKSACKSSDLWA 216

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 183

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 179

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 164

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 87/151 (57%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 185

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 86/151 (56%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY+ FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 187

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 47/235 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G +               RFY A+ V A+E +H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRF 285
             IHRD+KP+N+LL+++ H++++DFG  K L                             
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLS---------------------------- 183
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
           PES   R                   A S VGT  Y++PE+L +K      D  A
Sbjct: 184 PESKQAR-------------------ANSFVGTAQYVSPELLTEKSASKSSDLWA 219

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 86/151 (56%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +DF    I+G G+F    L +E  +   YA+K L+K  ++   +V +V  ER++++ +  
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
              VKLY++FQD E LY  + Y   G++               RFY A+ V A+E +H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             IHRD+KP+N+LL+++ H++++DFG  K L
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 110/242 (45%), Gaps = 55/242 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           ++++DF +  IIGRG FGEV  C++  +G +YAMK L K  +  +        ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 163 VAS-HC--IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           V++  C  IV + Y+F   + L  I++ + GGD+               RFY A+ +L +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           E +H    ++RD+KP N+LLD++GH+++SD GL                           
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGL--------------------------- 338
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDW 338
                     C    K P               +++VGT  Y+APEVL K   Y    DW
Sbjct: 339 ---------ACDFSKKKP---------------HASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 339 LA 340
            +
Sbjct: 375 FS 376

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 110/242 (45%), Gaps = 55/242 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           ++++DF +  IIGRG FGEV  C++  +G +YAMK L K  +  +        ER +L+ 
Sbjct: 185 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 244
Query: 163 VAS-HC--IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           V++  C  IV + Y+F   + L  I++ + GGD+               RFY A+ +L +
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           E +H    ++RD+KP N+LLD++GH+++SD GL                           
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGL--------------------------- 337
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDW 338
                     C    K P               +++VGT  Y+APEVL K   Y    DW
Sbjct: 338 ---------ACDFSKKKP---------------HASVGTHGYMAPEVLQKGVAYDSSADW 373
Query: 339 LA 340
            +
Sbjct: 374 FS 375

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 110/242 (45%), Gaps = 55/242 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           ++++DF +  IIGRG FGEV  C++  +G +YAMK L K  +  +        ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 163 VAS-HC--IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           V++  C  IV + Y+F   + L  I++ + GGD+               RFY A+ +L +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           E +H    ++RD+KP N+LLD++GH+++SD GL                           
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGL--------------------------- 338
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDW 338
                     C    K P               +++VGT  Y+APEVL K   Y    DW
Sbjct: 339 ---------ACDFSKKKP---------------HASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 339 LA 340
            +
Sbjct: 375 FS 376

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 110/242 (45%), Gaps = 55/242 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           ++++DF +  IIGRG FGEV  C++  +G +YAMK L K  +  +        ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 163 VAS-HC--IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           V++  C  IV + Y+F   + L  I++ + GGD+               RFY A+ +L +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           E +H    ++RD+KP N+LLD++GH+++SD GL                           
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGL--------------------------- 338
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDW 338
                     C    K P               +++VGT  Y+APEVL K   Y    DW
Sbjct: 339 ---------ACDFSKKKP---------------HASVGTHGYMAPEVLQKGVAYDSSADW 374
Query: 339 LA 340
            +
Sbjct: 375 FS 376

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 94/180 (52%), Gaps = 8/180 (4%)
Query: 72  ASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSG 131
           A  + PEEE  +  K+ E K+ ++        +++DF++   +G+G FG V L +EK+S 
Sbjct: 8   APENNPEEELASKQKNEESKKRQW--------ALEDFEIGRPLGKGKFGNVYLAREKQSK 59
Query: 132 NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG 191
            I A+K L K+++   G    +R E  + + +    I++LY  F DA  +YLI+EY P G
Sbjct: 60  FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 119
Query: 192 DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
            V                 YI +   A+   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 120 TVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 94/180 (52%), Gaps = 8/180 (4%)
Query: 72  ASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSG 131
           A  + PEEE  +  K+ E K+ ++        +++DF++   +G+G FG V L +EK+S 
Sbjct: 8   APENNPEEELASKQKNEESKKRQW--------ALEDFEIGRPLGKGKFGNVYLAREKQSK 59
Query: 132 NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG 191
            I A+K L K+++   G    +R E  + + +    I++LY  F DA  +YLI+EY P G
Sbjct: 60  FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 119
Query: 192 DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
            V                 YI +   A+   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 120 TVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 85/156 (54%)
Query: 96  MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           M  K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQS 215
           E  + + +    I++LY  F DA  +YLI+EY P G+V                 YI + 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
             A+   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 85/156 (54%)
Query: 96  MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           M  K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQS 215
           E  + + +    I++LY  F DA  +YLI+EY P G+V                 YI + 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
             A+   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 54/148 (36%), Positives = 81/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DFD+   +G+G FG V L +E++S  I A+K L K+++   G    +R E  + + +
Sbjct: 10  TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHL 69
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL  NG +K++DFG
Sbjct: 130 SKRVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 54/148 (36%), Positives = 81/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DFD+   +G+G FG V L +E++S  I A+K L K+++   G    +R E  + + +
Sbjct: 10  TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHL 69
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL  NG +K++DFG
Sbjct: 130 SKRVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 92/175 (52%), Gaps = 8/175 (4%)
Query: 77  PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
           PEEE  +  K+ E K+ ++        +++DF++   +G+G FG V L +EK+S  I A+
Sbjct: 4   PEEELASKQKNEESKKRQW--------ALEDFEIGRPLGKGKFGNVYLAREKQSKFILAL 55
Query: 137 KKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXX 196
           K L K+++   G    +R E  + + +    I++LY  F DA  +YLI+EY P G V   
Sbjct: 56  KVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRE 115
Query: 197 XXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
                         YI +   A+   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 116 LQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 170

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 84/156 (53%)
Query: 96  MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           M  K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQS 215
           E  + + +    I++LY  F DA  +YLI+EY P G V                 YI + 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
             A+   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 110/247 (44%), Gaps = 53/247 (21%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           L+   +  D F    ++GRG FGEV  CQ K +G +YA KKL K  +  R   +    E+
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXV----ARFYIA 213
            +LA+V S  IV L Y+F+    L L+M  + GGD+                  A FY A
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXX 273
           Q V  +E +H+ N I+RD+KP+N+LLD +G++++SD GL                     
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV------------------- 337
Query: 274 XXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333
                                     +L+  Q   +  A    GTP ++APE+LL + Y 
Sbjct: 338 --------------------------ELKAGQTKTKGYA----GTPGFMAPELLLGEEYD 367
Query: 334 MECDWLA 340
              D+ A
Sbjct: 368 FSVDYFA 374

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 110/247 (44%), Gaps = 53/247 (21%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           L+   +  D F    ++GRG FGEV  CQ K +G +YA KKL K  +  R   +    E+
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXV----ARFYIA 213
            +LA+V S  IV L Y+F+    L L+M  + GGD+                  A FY A
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXX 273
           Q V  +E +H+ N I+RD+KP+N+LLD +G++++SD GL                     
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV------------------- 337
Query: 274 XXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333
                                     +L+  Q   +  A    GTP ++APE+LL + Y 
Sbjct: 338 --------------------------ELKAGQTKTKGYA----GTPGFMAPELLLGEEYD 367
Query: 334 MECDWLA 340
              D+ A
Sbjct: 368 FSVDYFA 374

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 110/247 (44%), Gaps = 53/247 (21%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           L+   +  D F    ++GRG FGEV  CQ K +G +YA KKL K  +  R   +    E+
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXV----ARFYIA 213
            +LA+V S  IV L Y+F+    L L+M  + GGD+                  A FY A
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXX 273
           Q V  +E +H+ N I+RD+KP+N+LLD +G++++SD GL                     
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV------------------- 337
Query: 274 XXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333
                                     +L+  Q   +  A    GTP ++APE+LL + Y 
Sbjct: 338 --------------------------ELKAGQTKTKGYA----GTPGFMAPELLLGEEYD 367
Query: 334 MECDWLA 340
              D+ A
Sbjct: 368 FSVDYFA 374

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 84/156 (53%)
Query: 96  MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           M  K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQS 215
           E  + + +    I++LY  F DA  +YLI+EY P G V                 YI + 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
             A+   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 110/247 (44%), Gaps = 53/247 (21%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           L+   +  D F    ++GRG FGEV  CQ K +G +YA KKL K  +  R   +    E+
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXV----ARFYIA 213
            +LA+V S  IV L Y+F+    L L+M  + GGD+                  A FY A
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXX 273
           Q V  +E +H+ N I+RD+KP+N+LLD +G++++SD GL                     
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV------------------- 337
Query: 274 XXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333
                                     +L+  Q   +  A    GTP ++APE+LL + Y 
Sbjct: 338 --------------------------ELKAGQTKTKGYA----GTPGFMAPELLLGEEYD 367
Query: 334 MECDWLA 340
              D+ A
Sbjct: 368 FSVDYFA 374

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 84/156 (53%)
Query: 96  MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           M  K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQS 215
           E  + + +    I++LY  F DA  +YLI+EY P G V                 YI + 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
             A+   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 84/156 (53%)
Query: 96  MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           M  K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQS 215
           E  + + +    I++LY  F DA  +YLI+EY P G V                 YI + 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
             A+   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 83/153 (54%)
Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA 218
           + + +    I++LY  F DA  +YLI+EY P G V                 YI +   A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           +   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 83/153 (54%)
Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA 218
           + + +    I++LY  F DA  +YLI+EY P G V                 YI +   A
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           +   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 155

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 83/153 (54%)
Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA 218
           + + +    I++LY  F DA  +YLI+EY P G V                 YI +   A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           +   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 83/153 (54%)
Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA 218
           + + +    I++LY  F DA  +YLI+EY P G V                 YI +   A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           +   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 83/153 (54%)
Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA 218
           + + +    I++LY  F DA  +YLI+EY P G V                 YI +   A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           +   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 83/153 (54%)
Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA 218
           + + +    I++LY  F DA  +YLI+EY P G V                 YI +   A
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           +   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 83/153 (54%)
Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA 218
           + + +    I++LY  F DA  +YLI+EY P G V                 YI +   A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           +   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 84/156 (53%)
Query: 96  MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           M  K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQS 215
           E  + + +    I++LY  F DA  +YLI+EY P G V                 YI + 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
             A+   H    IHRDIKP+NLLL   G +K+++FG
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG 156

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 88/159 (55%)
Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH 152
           T    + + K ++DDFD++  +G+G FG V L +EK++  I A+K L KS++   G    
Sbjct: 1   TALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYI 212
           +R E  + + +    I+++Y  F D + +YL++E+ P G++              +  ++
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
            +   A+   H+   IHRDIKP+NLL+   G +K++DFG
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 83/153 (54%)
Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA 218
           + + +    I++LY  F DA  +YLI+EY P G V                 YI +   A
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           +   H    IHRDIKP+NLLL   G +K+++FG
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIANFG 155

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 124
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELKIADFG 152

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 129
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 130 SKRVIHRDIKPENLLLGSAGELKIADFG 157

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 80/148 (54%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 87/159 (54%)
Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH 152
           T    + + K ++DDFD+   +G+G FG V L +EK++  I A+K L KS++   G    
Sbjct: 2   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 61
Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYI 212
           +R E  + + +    I+++Y  F D + +YL++E+ P G++              +  ++
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 121
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
            +   A+   H+   IHRDIKP+NLL+   G +K++DFG
Sbjct: 122 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 89/157 (56%), Gaps = 2/157 (1%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           L+R  ++ + F    ++G+G FGEV  CQ + +G +YA KKL+K  +  R        E+
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVAR--FYIAQS 215
            +L +V S  +V L Y+++  + L L++  + GGD+              AR  FY A+ 
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI 295
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
              +E +H+   ++RD+KP+N+LLD +GH+++SD GL
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 89/157 (56%), Gaps = 2/157 (1%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           L+R  ++ + F    ++G+G FGEV  CQ + +G +YA KKL+K  +  R        E+
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVAR--FYIAQS 215
            +L +V S  +V L Y+++  + L L++  + GGD+              AR  FY A+ 
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEI 295
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
              +E +H+   ++RD+KP+N+LLD +GH+++SD GL
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 79/148 (53%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK S  I A+K L K+++   G    +R E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F D+  +YLI+EY P G V                 YI +   A+   H
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 79/148 (53%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +++DF++   +G+G FG V L +EK+   I A+K L K+++   G    +R E  + + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++LY  F DA  +YLI+EY P G V                 YI +   A+   H
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 122
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
               IHRDIKP+NLLL   G +K++DFG
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELKIADFG 150

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 104/236 (44%), Gaps = 51/236 (21%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           ++DF +  ++G+G+F  V   +   +G   A+K + K  M   G V+ V+ E  +  ++ 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXX-XXXXXXXXXXXVARFYIAQSVLAIESIH 223
              I++LY  F+D+ Y+YL++E    G++               AR ++ Q +  +  +H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDG 283
            H  +HRD+   NLLL +N ++K++DFGL   L                           
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL--------------------------- 162
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                      K P E+            Y+  GTP+YI+PE+  +  +G+E D W
Sbjct: 163 -----------KMPHEK-----------HYTLCGTPNYISPEIATRSAHGLESDVW 196

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 83/150 (55%), Gaps = 3/150 (2%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G+FGEV LC++K +G   A+K + K ++  +   E +  E  LL ++    I+KLY
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D  Y YL+ E   GG++              A   I Q +  I  +HK+  +HRD+
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDL 175
Query: 233 KPDNLLLD---QNGHMKLSDFGLCKPLDCT 259
           KP+NLLL+   ++ ++++ DFGL    + +
Sbjct: 176 KPENLLLESKSKDANIRIIDFGLSTHFEAS 205

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 83/150 (55%), Gaps = 3/150 (2%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G+FGEV LC++K +G   A+K + K ++  +   E +  E  LL ++    I+KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D  Y YL+ E   GG++              A   I Q +  I  +HK+  +HRD+
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDL 152
Query: 233 KPDNLLLD---QNGHMKLSDFGLCKPLDCT 259
           KP+NLLL+   ++ ++++ DFGL    + +
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEAS 182

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 83/150 (55%), Gaps = 3/150 (2%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G+FGEV LC++K +G   A+K + K ++  +   E +  E  LL ++    I+KLY
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D  Y YL+ E   GG++              A   I Q +  I  +HK+  +HRD+
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDL 176
Query: 233 KPDNLLLD---QNGHMKLSDFGLCKPLDCT 259
           KP+NLLL+   ++ ++++ DFGL    + +
Sbjct: 177 KPENLLLESKSKDANIRIIDFGLSTHFEAS 206

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 106/246 (43%), Gaps = 61/246 (24%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G GA+GEV LC++K +G   A+K +KKS + +      +  E  +L ++    I+KLY 
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
            F+D    YL+ME   GG++              A   + Q +     +HKHN +HRD+K
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLK 131
Query: 234 PDNLLLD---QNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGC 290
           P+NLLL+   ++  +K+ DFGL                           +V G+  E   
Sbjct: 132 PENLLLESKSRDALIKIVDFGLS-----------------------AHFEVGGKMKER-- 166
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY 350
                                    +GT  YIAPEVL KK Y  +CD    W    SC  
Sbjct: 167 -------------------------LGTAYYIAPEVLRKK-YDEKCD---VW----SCGV 193
Query: 351 LSDIML 356
           +  I+L
Sbjct: 194 ILYILL 199

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 90/172 (52%), Gaps = 16/172 (9%)
Query: 95  YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQV---- 150
           Y+R K  KI    F +  + G GA+GEV LC+EK   +  A+K +KKS+   +G+     
Sbjct: 26  YVRKKEGKIGESYFKVRKL-GSGAYGEVLLCKEKNGHSEKAIKVIKKSQ-FDKGRYSDDN 83
Query: 151 -------EHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXX 203
                  E +  E +LL  +    I+KL+  F+D +Y YL+ E+  GG++          
Sbjct: 84  KNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF 143
Query: 204 XXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGL 252
               A   + Q +  I  +HKHN +HRDIKP+N+LL+      ++K+ DFGL
Sbjct: 144 DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 83/150 (55%), Gaps = 3/150 (2%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G+FGEV LC++K +G   A+K + K ++  +   E +  E  LL ++    I+KLY
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D  Y YL+ E   GG++              A   I Q +  I  +HK+  +HRD+
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDL 158
Query: 233 KPDNLLLD---QNGHMKLSDFGLCKPLDCT 259
           KP+NLLL+   ++ ++++ DFGL    + +
Sbjct: 159 KPENLLLESKSKDANIRIIDFGLSTHFEAS 188

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 81/150 (54%), Gaps = 3/150 (2%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D +  +  +G GA+GEV LC++K +G   A+K +KKS + +      +  E  +L ++  
Sbjct: 21  DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 80
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             I+KLY  F+D    YL+ME   GG++              A   + Q +     +HKH
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 226 NYIHRDIKPDNLLLD---QNGHMKLSDFGL 252
           N +HRD+KP+NLLL+   ++  +K+ DFGL
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGL 170

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 81/150 (54%), Gaps = 3/150 (2%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G+G+FGEV LC++K +G   A+K + K ++  +   E +  E  LL ++    I KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D  Y YL+ E   GG++              A   I Q +  I   HK+  +HRD+
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDL 152
Query: 233 KPDNLLLD---QNGHMKLSDFGLCKPLDCT 259
           KP+NLLL+   ++ ++++ DFGL    + +
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEAS 182

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 62/245 (25%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRA----ERNLLAE 162
           +D   +IGRG    VR C  + +G+ +A+K ++  +E LS  Q+E VR     E ++L +
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 163 VASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
           VA H  I+ L  S++ + +++L+ + +  G++               R  +   + A+  
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDV 281
           +H +N +HRD+KP+N+LLD N  ++LSDFG    L+                        
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE------------------------ 251
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL------LKKGYGME 335
                          P E+L       R+L     GTP Y+APE+L         GYG E
Sbjct: 252 ---------------PGEKL-------RELC----GTPGYLAPEILKCSMDETHPGYGKE 285
Query: 336 CDWLA 340
            D  A
Sbjct: 286 VDLWA 290

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 105/251 (41%), Gaps = 63/251 (25%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F+    +G GAF EV L +EK +G ++A+K + K  +  +G+   +  E  +L ++    
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL--KGKESSIENEIAVLRKIKHEN 81
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           IV L   ++   +LYL+M+ + GG++              A   I Q + A+  +H+   
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 228 IHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
           +HRD+KP+NLL    D+   + +SDFGL K                        M+  G 
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSK------------------------MEGKGD 177
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W----L 339
              + C                          GTP Y+APEVL +K Y    D W    +
Sbjct: 178 VMSTAC--------------------------GTPGYVAPEVLAQKPYSKAVDCWSIGVI 211
Query: 340 AYWNETLSCNY 350
           AY    L C Y
Sbjct: 212 AY---ILLCGY 219

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 59/248 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  + ++G GAF EV L +++ +G ++A+K +KKS       +E+   E  +L ++    
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHEN 67
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           IV L   ++   + YL+M+ + GG++              A   I Q + A++ +H++  
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 228 IHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
           +HRD+KP+NLL    ++N  + ++DFGL K                        M+ +G 
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK------------------------MEQNG- 162
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY--GMECDWLAYW 342
                                     +  +  GTP Y+APEVL +K Y   ++C  +   
Sbjct: 163 --------------------------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
Query: 343 NETLSCNY 350
              L C Y
Sbjct: 197 TYILLCGY 204

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/154 (36%), Positives = 82/154 (53%), Gaps = 1/154 (0%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           L RH  ++DDF++   +G+G FG V L +EKKS  I A+K L KS++   G    +R E 
Sbjct: 16  LTRH-FTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREI 74
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL 217
            + A +    I++LY  F D   +YLI+EY P G++                  + +   
Sbjct: 75  EIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELAD 134
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           A+   H    IHRDIKP+NLLL   G +K++DFG
Sbjct: 135 ALMYCHGKKVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 113/266 (42%), Gaps = 76/266 (28%)
Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK-----KLKKSEMLSRGQVEHV 153
           KRH   +  + +   +G G+FG+V+L    K+    A+K      LKKS+M       H+
Sbjct: 5   KRH---IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM-------HM 54
Query: 154 RAERNL--LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY 211
           R ER +  L  +    I+KLY        + +++EY  GG++               R +
Sbjct: 55  RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRF 113
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXX 271
             Q + AIE  H+H  +HRD+KP+NLLLD N ++K++DFGL                   
Sbjct: 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS------------------ 155
Query: 272 XXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
                 ++  DG F ++ C                          G+P+Y APEV+  K 
Sbjct: 156 ------NIMTDGNFLKTSC--------------------------GSPNYAAPEVINGKL 183
Query: 332 Y-GMECDWLAYWNETLSCNYLSDIML 356
           Y G E D    W    SC  +  +ML
Sbjct: 184 YAGPEVD---VW----SCGIVLYVML 202

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 90/164 (54%), Gaps = 9/164 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-----HVRAERNLL 160
           D++ +   +G GA GEV+L  E+K+    A+K + K +       E     +V  E  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            ++   CI+K+  +F DAE  Y+++E + GG++               + Y  Q +LA++
Sbjct: 70  KKLNHPCIIKIK-NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 221 SIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNL 261
            +H++  IHRD+KP+N+LL   +++  +K++DFG  K L  T+L
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 90/164 (54%), Gaps = 9/164 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-----HVRAERNLL 160
           D++ +   +G GA GEV+L  E+K+    A+K + K +       E     +V  E  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            ++   CI+K+  +F DAE  Y+++E + GG++               + Y  Q +LA++
Sbjct: 70  KKLNHPCIIKIK-NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 221 SIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNL 261
            +H++  IHRD+KP+N+LL   +++  +K++DFG  K L  T+L
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 90/164 (54%), Gaps = 9/164 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-----HVRAERNLL 160
           D++ +   +G GA GEV+L  E+K+    A+K + K +       E     +V  E  +L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            ++   CI+K+  +F DAE  Y+++E + GG++               + Y  Q +LA++
Sbjct: 76  KKLNHPCIIKIK-NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 221 SIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNL 261
            +H++  IHRD+KP+N+LL   +++  +K++DFG  K L  T+L
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 178

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 57/241 (23%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEV 163
            DD+ L   +G+GAF  VR C +K     YA K +   ++ +R   +H + ER   +  +
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSAR---DHQKLEREARICRL 86
Query: 164 ASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
             H  IV+L+ S  +  + YL+ + + GG++              A   I Q + ++  I
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHI 146
Query: 223 HKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           H+H+ +HRD+KP+NLLL    +   +KL+DFGL                         ++
Sbjct: 147 HQHDIVHRDLKPENLLLASKCKGAAVKLADFGL-------------------------AI 181
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL 339
           +V G               EQ Q W        +   GTP Y++PEVL K  YG   D  
Sbjct: 182 EVQG---------------EQ-QAW--------FGFAGTPGYLSPEVLRKDPYGKPVDIW 217
Query: 340 A 340
           A
Sbjct: 218 A 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 90/164 (54%), Gaps = 9/164 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-----HVRAERNLL 160
           D++ +   +G GA GEV+L  E+K+    A+K + K +       E     +V  E  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            ++   CI+K+  +F DAE  Y+++E + GG++               + Y  Q +LA++
Sbjct: 70  KKLNHPCIIKIK-NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 221 SIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNL 261
            +H++  IHRD+KP+N+LL   +++  +K++DFG  K L  T+L
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 90/164 (54%), Gaps = 9/164 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-----HVRAERNLL 160
           D++ +   +G GA GEV+L  E+K+    A+K + K +       E     +V  E  +L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            ++   CI+K+  +F DAE  Y+++E + GG++               + Y  Q +LA++
Sbjct: 69  KKLNHPCIIKIK-NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 221 SIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNL 261
            +H++  IHRD+KP+N+LL   +++  +K++DFG  K L  T+L
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 171

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 3/157 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ LL  IG+G F +V+L +   +G   A+K + K+++ S    +  R  R  + +V 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR--IMKVL 70
Query: 165 SHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
           +H  IVKL+   +  + LYL+MEY  GG+V              AR    Q V A++  H
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           +   +HRD+K +NLLLD + ++K++DFG        N
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 3/157 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ LL  IG+G F +V+L +   +G   A+K + K+++ S    +  R  R  + +V 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR--IMKVL 70
Query: 165 SHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
           +H  IVKL+   +  + LYL+MEY  GG+V              AR    Q V A++  H
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           +   +HRD+K +NLLLD + ++K++DFG        N
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 3/157 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ LL  IG+G F +V+L +   +G   A+K + K+++ S    +  R  R  + +V 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR--IMKVL 70
Query: 165 SHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
           +H  IVKL+   +  + LYL+MEY  GG+V              AR    Q V A++  H
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           +   +HRD+K +NLLLD + ++K++DFG        N
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 84/159 (52%), Gaps = 3/159 (1%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           + + ++ LL  IG+G F +V+L +   +G   A+K + K+++ S    +  R  R  + +
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR--IMK 61
Query: 163 VASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
           V +H  IVKL+   +  + LYL+MEY  GG+V              AR    Q V A++ 
Sbjct: 62  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQY 121
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
            H+   +HRD+K +NLLLD + ++K++DFG        N
Sbjct: 122 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 160

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 26/175 (14%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML----------------- 145
           + ++ + L   IG+G++G V+L   +     YAMK L K +++                 
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 146 ------SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYLYLIMEYLPGGDVXXXX 197
                  RG +E V  E  +L ++    +VKL     D   ++LY++ E +  G V    
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 198 XXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                     ARFY    +  IE +H    IHRDIKP NLL+ ++GH+K++DFG+
Sbjct: 130 TLKPLSEDQ-ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 1/149 (0%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ LL  IG+G F +V+L +   +G   A+K + K++ L+   ++ +  E  ++  + 
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILN 69
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              IVKL+   +  + LYLIMEY  GG+V              AR    Q V A++  H+
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
              +HRD+K +NLLLD + ++K++DFG  
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFS 158

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 81/148 (54%), Gaps = 1/148 (0%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ LL  IG+G F +V+L +   +G   A+K + K++ L+   ++ +  E  ++  + 
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILN 72
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              IVKL+   +  + LYLIMEY  GG+V              AR    Q V A++  H+
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
              +HRD+K +NLLLD + ++K++DFG 
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGF 160

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 109/253 (43%), Gaps = 59/253 (23%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ ++  +G G+FG+V+L     +G   A+K + K  +        +  E + L  + 
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              I+KLY   +  + + +++EY  G ++              AR +  Q + A+E  H+
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
           H  +HRD+KP+NLLLD++ ++K++DFGL                         ++  DG 
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLS------------------------NIMTDGN 167
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAYWN 343
           F ++ C                          G+P+Y APEV+  K Y G E D    W 
Sbjct: 168 FLKTSC--------------------------GSPNYAAPEVISGKLYAGPEVD---VW- 197
Query: 344 ETLSCNYLSDIML 356
              SC  +  +ML
Sbjct: 198 ---SCGVILYVML 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 109/253 (43%), Gaps = 59/253 (23%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ ++  +G G+FG+V+L     +G   A+K + K  +        +  E + L  + 
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              I+KLY   +  + + +++EY  G ++              AR +  Q + A+E  H+
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
           H  +HRD+KP+NLLLD++ ++K++DFGL                         ++  DG 
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLS------------------------NIMTDGN 157
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAYWN 343
           F ++ C                          G+P+Y APEV+  K Y G E D    W 
Sbjct: 158 FLKTSC--------------------------GSPNYAAPEVISGKLYAGPEVD---VW- 187
Query: 344 ETLSCNYLSDIML 356
              SC  +  +ML
Sbjct: 188 ---SCGVILYVML 197

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 109/253 (43%), Gaps = 59/253 (23%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ ++  +G G+FG+V+L     +G   A+K + K  +        +  E + L  + 
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              I+KLY   +  + + +++EY  G ++              AR +  Q + A+E  H+
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
           H  +HRD+KP+NLLLD++ ++K++DFGL                         ++  DG 
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLS------------------------NIMTDGN 166
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAYWN 343
           F ++ C                          G+P+Y APEV+  K Y G E D    W 
Sbjct: 167 FLKTSC--------------------------GSPNYAAPEVISGKLYAGPEVD---VW- 196
Query: 344 ETLSCNYLSDIML 356
              SC  +  +ML
Sbjct: 197 ---SCGVILYVML 206

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 83/157 (52%), Gaps = 3/157 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ LL  IG+G F +V+L +   +G   A++ + K+++ S    +  R  R  + +V 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVR--IMKVL 70
Query: 165 SHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
           +H  IVKL+   +  + LYL+MEY  GG+V              AR    Q V A++  H
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           +   +HRD+K +NLLLD + ++K++DFG        N
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 83/157 (52%), Gaps = 3/157 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ LL  IG+G F +V+L +   +G   A++ + K+++ S    +  R  R  + +V 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVR--IMKVL 70
Query: 165 SHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
           +H  IVKL+   +  + LYL+MEY  GG+V              AR    Q V A++  H
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           +   +HRD+K +NLLLD + ++K++DFG        N
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 109/253 (43%), Gaps = 59/253 (23%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ ++  +G G+FG+V+L     +G   A+K + K  +        +  E + L  + 
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              I+KLY   +  + + +++EY  G ++              AR +  Q + A+E  H+
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
           H  +HRD+KP+NLLLD++ ++K++DFGL                         ++  DG 
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLS------------------------NIMTDGN 161
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAYWN 343
           F ++ C                          G+P+Y APEV+  K Y G E D    W 
Sbjct: 162 FLKTSC--------------------------GSPNYAAPEVISGKLYAGPEVD---VW- 191
Query: 344 ETLSCNYLSDIML 356
              SC  +  +ML
Sbjct: 192 ---SCGVILYVML 201

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 51/237 (21%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++ +  + L   +G G FG+V++ + + +G+  A+K L + ++ S   V  ++ E   L 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 I+KLY         +++MEY+ GG++              AR    Q + A++ 
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDV 281
            H+H  +HRD+KP+N+LLD + + K++DFGL                         +M  
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL------------------------SNMMS 162
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD 337
           DG F  + C                          G+P+Y APEV+  + Y G E D
Sbjct: 163 DGEFLRTSC--------------------------GSPNYAAPEVISGRLYAGPEVD 193

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 90/164 (54%), Gaps = 9/164 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-----HVRAERNLL 160
           D++ +   +G GA GEV+L  E+K+    A++ + K +       E     +V  E  +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            ++   CI+K+  +F DAE  Y+++E + GG++               + Y  Q +LA++
Sbjct: 195 KKLNHPCIIKIK-NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 221 SIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNL 261
            +H++  IHRD+KP+N+LL   +++  +K++DFG  K L  T+L
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 3/158 (1%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S++ +  L  IG G+FG+  L +  + G  Y +K++  S M S+ + E  R E  +LA +
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANM 80
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF--YIAQSVLAIES 221
               IV+   SF++   LY++M+Y  GGD+               +   +  Q  LA++ 
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
           +H    +HRDIK  N+ L ++G ++L DFG+ + L+ T
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 90/164 (54%), Gaps = 9/164 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-----HVRAERNLL 160
           D++ +   +G GA GEV+L  E+K+    A++ + K +       E     +V  E  +L
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            ++   CI+K+  +F DAE  Y+++E + GG++               + Y  Q +LA++
Sbjct: 209 KKLNHPCIIKIK-NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 221 SIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNL 261
            +H++  IHRD+KP+N+LL   +++  +K++DFG  K L  T+L
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 311

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 3/157 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ LL  IG+G F +V+L +   +G   A+K + K+++ S    +  R  R  + +V 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR--IXKVL 70
Query: 165 SHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
           +H  IVKL+   +  + LYL+ EY  GG+V              AR    Q V A++  H
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           +   +HRD+K +NLLLD + ++K++DFG        N
Sbjct: 131 QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN 167

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 57/250 (22%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D +D   ++G GAF EV L ++K++  + A+K + K  +   G+   +  E  +L ++  
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKH 75
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV L   ++   +LYLIM+ + GG++              A   I Q + A++ +H  
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 226 NYIHRDIKPDNLL---LDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVD 282
             +HRD+KP+NLL   LD++  + +SDFGL K                        M+  
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK------------------------MEDP 171
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY--GMECDWLA 340
           G    + C                          GTP Y+APEVL +K Y   ++C  + 
Sbjct: 172 GSVLSTAC--------------------------GTPGYVAPEVLAQKPYSKAVDCWSIG 205
Query: 341 YWNETLSCNY 350
                L C Y
Sbjct: 206 VIAYILLCGY 215

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 57/250 (22%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D +D   ++G GAF EV L ++K++  + A+K + K  +   G+   +  E  +L ++  
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 75
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV L   ++   +LYLIM+ + GG++              A   I Q + A++ +H  
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 226 NYIHRDIKPDNLL---LDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVD 282
             +HRD+KP+NLL   LD++  + +SDFGL K                        M+  
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK------------------------MEDP 171
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY--GMECDWLA 340
           G    + C                          GTP Y+APEVL +K Y   ++C  + 
Sbjct: 172 GSVLSTAC--------------------------GTPGYVAPEVLAQKPYSKAVDCWSIG 205
Query: 341 YWNETLSCNY 350
                L C Y
Sbjct: 206 VIAYILLCGY 215

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 51/237 (21%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++ +  + L   +G G FG+V++ + + +G+  A+K L + ++ S   V  ++ E   L 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 I+KLY         +++MEY+ GG++              AR    Q + A++ 
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDV 281
            H+H  +HRD+KP+N+LLD + + K++DFGL                         +M  
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL------------------------SNMMS 162
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD 337
           DG F    C                          G+P+Y APEV+  + Y G E D
Sbjct: 163 DGEFLRDSC--------------------------GSPNYAAPEVISGRLYAGPEVD 193

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 57/250 (22%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D +D   ++G GAF EV L ++K++  + A+K + K  +   G+   +  E  +L ++  
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIAVLHKIKH 75
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV L   ++   +LYLIM+ + GG++              A   I Q + A++ +H  
Sbjct: 76  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 135
Query: 226 NYIHRDIKPDNLL---LDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVD 282
             +HRD+KP+NLL   LD++  + +SDFGL K                        M+  
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK------------------------MEDP 171
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY--GMECDWLA 340
           G    + C                          GTP Y+APEVL +K Y   ++C  + 
Sbjct: 172 GSVLSTAC--------------------------GTPGYVAPEVLAQKPYSKAVDCWSIG 205
Query: 341 YWNETLSCNY 350
                L C Y
Sbjct: 206 VIAYILLCGY 215

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 110/259 (42%), Gaps = 57/259 (22%)
Query: 97  RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
           R K+ +   D +D   ++G GAF EV L ++K++  + A+K + K  +   G+   +  E
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENE 66
Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSV 216
             +L ++    IV L   ++   +LYLIM+ + GG++              A   I Q +
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 217 LAIESIHKHNYIHRDIKPDNLL---LDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXX 273
            A++ +H    +HRD+KP+NLL   LD++  + +SDFGL K                   
Sbjct: 127 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK------------------- 167
Query: 274 XXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY- 332
                M+  G    + C                          GTP Y+APEVL +K Y 
Sbjct: 168 -----MEDPGSVLSTAC--------------------------GTPGYVAPEVLAQKPYS 196
Query: 333 -GMECDWLAYWNETLSCNY 350
             ++C  +      L C Y
Sbjct: 197 KAVDCWSIGVIAYILLCGY 215

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 51/237 (21%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++ +  + L   +G G FG+V++ + + +G+  A+K L + ++ S   V  +R E   L 
Sbjct: 12  RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
                 I+KLY        ++++MEY+ GG++              +R    Q +  ++ 
Sbjct: 72  LFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDV 281
            H+H  +HRD+KP+N+LLD + + K++DFGL                         +M  
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL------------------------SNMMS 167
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD 337
           DG F    C                          G+P+Y APEV+  + Y G E D
Sbjct: 168 DGEFLRXSC--------------------------GSPNYAAPEVISGRLYAGPEVD 198

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 82/148 (55%), Gaps = 4/148 (2%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           ++++ ++G+G+FGEV  C+++ +   YA+K + K+   ++     +R E  LL ++    
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPN 82
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           I+KL+   +D+   Y++ E   GG++              A   I Q    I  +HKHN 
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 228 IHRDIKPDNLLL---DQNGHMKLSDFGL 252
           +HRD+KP+N+LL   +++  +K+ DFGL
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGL 170

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 77/142 (54%), Gaps = 4/142 (2%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G GA+GEV LC++K +    A+K ++K+  +S      +  E  +L  +    I+KLY 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
            F+D    YL+ME   GG++              A   I Q +  +  +HKHN +HRD+K
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLK 163
Query: 234 PDNLLL---DQNGHMKLSDFGL 252
           P+NLLL   +++  +K+ DFGL
Sbjct: 164 PENLLLESKEKDALIKIVDFGL 185

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 1/156 (0%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           + ++ L   IG+G F +V+L +   +G   A+K + K++ L+   ++ +  E  ++  + 
Sbjct: 14  IGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQ-LNPTSLQKLFREVRIMKILN 72
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              IVKL+   +  + LYL+MEY  GG+V              AR    Q V A++  H+
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
              +HRD+K +NLLLD + ++K++DFG        N
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN 168

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 82/148 (55%), Gaps = 4/148 (2%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           ++++ ++G+G+FGEV  C+++ +   YA+K + K+   ++     +R E  LL ++    
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPN 82
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           I+KL+   +D+   Y++ E   GG++              A   I Q    I  +HKHN 
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 228 IHRDIKPDNLLL---DQNGHMKLSDFGL 252
           +HRD+KP+N+LL   +++  +K+ DFGL
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGL 170

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 82/148 (55%), Gaps = 4/148 (2%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           ++++ ++G+G+FGEV  C+++ +   YA+K + K+   ++     +R E  LL ++    
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPN 82
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           I+KL+   +D+   Y++ E   GG++              A   I Q    I  +HKHN 
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 228 IHRDIKPDNLLL---DQNGHMKLSDFGL 252
           +HRD+KP+N+LL   +++  +K+ DFGL
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGL 170

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 50/227 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            +G+G F +     +  +  ++A K + KS +L   Q E +  E ++   +A   +V  +
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D +++++++E      +              AR+Y+ Q VL  + +H++  IHRD+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K  NL L+++  +K+ DFGL                          ++ DG   ++ C  
Sbjct: 144 KLGNLFLNEDLEVKIGDFGLA-----------------------TKVEYDGERKKTLC-- 178
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                   GTP+YIAPEVL KKG+  E D W
Sbjct: 179 ------------------------GTPNYIAPEVLSKKGHSFEVDVW 201

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 50/227 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            +G+G F +     +  +  ++A K + KS +L   Q E +  E ++   +A   +V  +
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D +++++++E      +              AR+Y+ Q VL  + +H++  IHRD+
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K  NL L+++  +K+ DFGL                          ++ DG   ++ C  
Sbjct: 148 KLGNLFLNEDLEVKIGDFGLA-----------------------TKVEYDGERKKTLC-- 182
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                   GTP+YIAPEVL KKG+  E D W
Sbjct: 183 ------------------------GTPNYIAPEVLSKKGHSFEVDVW 205

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 50/227 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            +G+G F +     +  +  ++A K + KS +L   Q E +  E ++   +A   +V  +
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D +++++++E      +              AR+Y+ Q VL  + +H++  IHRD+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K  NL L+++  +K+ DFGL                          ++ DG   ++ C  
Sbjct: 144 KLGNLFLNEDLEVKIGDFGLA-----------------------TKVEYDGERKKTLC-- 178
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                   GTP+YIAPEVL KKG+  E D W
Sbjct: 179 ------------------------GTPNYIAPEVLSKKGHSFEVDVW 201

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 77/148 (52%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  + A + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINAMLN 63
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGL 151

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
            +D+++L  IG G++G  +  + K  G I   K+L    M +  + + + +E NLL E+ 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK 63
Query: 165 SHCIVKLYYSFQD--AEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYI----AQSVLA 218
              IV+ Y    D     LY++MEY  GGD+             +   ++     Q  LA
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 219 IESIHK-----HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           ++  H+     H  +HRD+KP N+ LD   ++KL DFGL + L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
            +D+++L  IG G++G  +  + K  G I   K+L    M +  + + + +E NLL E+ 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK 63
Query: 165 SHCIVKLYYSFQD--AEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYI----AQSVLA 218
              IV+ Y    D     LY++MEY  GGD+             +   ++     Q  LA
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 219 IESIHK-----HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           ++  H+     H  +HRD+KP N+ LD   ++KL DFGL + L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 82/156 (52%), Gaps = 7/156 (4%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE---MLSRGQVEHVRAERNLL 160
           S++ ++ L ++G G++G V  C+ K +G I A+KK  +S+   M+ +  +  ++    LL
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK----LL 78
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            ++    +V L    +  +  YL+ E++    +             V + Y+ Q +  I 
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             H HN IHRDIKP+N+L+ Q+G +KL DFG  + L
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
            +D+++L  IG G++G  +  + K  G I   K+L    M +  + + + +E NLL E+ 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK 63
Query: 165 SHCIVKLYYSFQD--AEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYI----AQSVLA 218
              IV+ Y    D     LY++MEY  GGD+             +   ++     Q  LA
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 219 IESIHK-----HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           ++  H+     H  +HRD+KP N+ LD   ++KL DFGL + L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 58/241 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG--QVEHVRAERNLLAEV 163
           D ++L  +IG+GAF  VR C  +++G  +A+K +  ++  S      E ++ E ++   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGD----VXXXXXXXXXXXXXVARFYIAQSVLAI 219
               IV+L  ++     LY++ E++ G D    +             VA  Y+ Q + A+
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 220 ESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXX 276
              H +N IHRD+KP+N+LL   + +  +KL DFG+   L  + L A             
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVA------------- 190
Query: 277 XSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
                 GR                               VGTP ++APEV+ ++ YG   
Sbjct: 191 -----GGR-------------------------------VGTPHFMAPEVVKREPYGKPV 214
Query: 337 D 337
           D
Sbjct: 215 D 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 50/227 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            +G+G F +     +  +  ++A K + KS +L   Q E +  E ++   +A   +V  +
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D +++++++E      +              AR+Y+ Q VL  + +H++  IHRD+
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K  NL L+++  +K+ DFGL                          ++ DG         
Sbjct: 166 KLGNLFLNEDLEVKIGDFGLA-----------------------TKVEYDG--------- 193
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                          R+K+     GTP+YIAPEVL KKG+  E D W
Sbjct: 194 --------------ERKKV---LCGTPNYIAPEVLSKKGHSFEVDVW 223

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 50/227 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            +G+G F +     +  +  ++A K + KS +L   Q E +  E ++   +A   +V  +
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D +++++++E      +              AR+Y+ Q VL  + +H++  IHRD+
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K  NL L+++  +K+ DFGL                          ++ DG         
Sbjct: 168 KLGNLFLNEDLEVKIGDFGLA-----------------------TKVEYDG--------- 195
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                          R+K+     GTP+YIAPEVL KKG+  E D W
Sbjct: 196 --------------ERKKV---LCGTPNYIAPEVLSKKGHSFEVDVW 225

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 50/227 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            +G+G F +     +  +  ++A K + KS +L   Q E +  E ++   +A   +V  +
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D +++++++E      +              AR+Y+ Q VL  + +H++  IHRD+
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K  NL L+++  +K+ DFGL                          ++ DG         
Sbjct: 142 KLGNLFLNEDLEVKIGDFGLA-----------------------TKVEYDG--------- 169
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                          R+K+     GTP+YIAPEVL KKG+  E D W
Sbjct: 170 --------------ERKKV---LCGTPNYIAPEVLSKKGHSFEVDVW 199

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 57/238 (23%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEV 163
            D++ L   IG+GAF  VR C +  +G+ YA K +   ++ +R   +H + ER   +  +
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSAR---DHQKLEREARICRL 59
Query: 164 ASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
             H  IV+L+ S  +  + YL+ + + GG++              A   I Q + A+   
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 223 HKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           H+   +HRD+KP+NLLL    +   +KL+DFGL                         ++
Sbjct: 120 HQMGVVHRDLKPENLLLASKCKGAAVKLADFGL-------------------------AI 154
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
           +V G                  Q W        +   GTP Y++PEVL K+ YG   D
Sbjct: 155 EVQG----------------DQQAW--------FGFAGTPGYLSPEVLRKEAYGKPVD 188

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 2/149 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLN 63
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
               HRDIKP+NLLLD+  ++K+SDFGL 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 2/149 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
               HRDIKP+NLLLD+  ++K+SDFGL 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 101/241 (41%), Gaps = 57/241 (23%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEV 163
            D++ L   +G+GAF  VR C +  +G  YA K +   ++ +R   +H + ER   +  +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR---DHQKLEREARICRL 59
Query: 164 ASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
             H  IV+L+ S  +  + YL+ + + GG++              A   I Q + ++   
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 223 HKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           H +  +HRD+KP+NLLL    +   +KL+DFGL                         ++
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGL-------------------------AI 154
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL 339
           +V G                  Q W        +   GTP Y++PEVL K  YG   D  
Sbjct: 155 EVQG----------------DQQAW--------FGFAGTPGYLSPEVLRKDPYGKPVDMW 190
Query: 340 A 340
           A
Sbjct: 191 A 191

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 2/149 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIXINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
               HRDIKP+NLLLD+  ++K+SDFGL 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 2/149 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
               HRDIKP+NLLLD+  ++K+SDFGL 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGL 151

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGL 151

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGL 151

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 2/149 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
               HRDIKP+NLLLD+  ++K+SDFGL 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGL 151

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 2/149 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
               HRDIKP+NLLLD+  ++K+SDFGL 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 61
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGL 149

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGL 150

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 2/149 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
               HRDIKP+NLLLD+  ++K+SDFGL 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGL 150

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGL 150

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGL 151

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGL 150

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 104 SVDD-FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           ++DD F     +G GAFG+V L +E+ SG    +K + K    S+  +E + AE  +L  
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKS 76
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA----QSVLA 218
           +    I+K++  F+D   +Y++ME   GG++             ++  Y+A    Q + A
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 219 IESIHKHNYIHRDIKPDNLLL-DQNGH--MKLSDFGLCK 254
           +   H  + +H+D+KP+N+L  D + H  +K+ DFGL +
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 101/241 (41%), Gaps = 57/241 (23%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEV 163
            D++ L   +G+GAF  VR C +  +G  YA K +   ++ +R   +H + ER   +  +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR---DHQKLEREARICRL 59
Query: 164 ASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
             H  IV+L+ S  +  + YL+ + + GG++              A   I Q + ++   
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 223 HKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           H +  +HRD+KP+NLLL    +   +KL+DFGL                         ++
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGL-------------------------AI 154
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL 339
           +V G                  Q W        +   GTP Y++PEVL K  YG   D  
Sbjct: 155 EVQG----------------DQQAW--------FGFAGTPGYLSPEVLRKDPYGKPVDMW 190
Query: 340 A 340
           A
Sbjct: 191 A 191

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGL 150

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 2/149 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
               HRDIKP+NLLLD+  ++K+SDFGL 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 11/140 (7%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASHCIVKLY 172
           +GRG+FGEV   ++K++G   A+KK++         +E  RAE  +  A + S  IV LY
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
            + ++  ++ + ME L GG +              A +Y+ Q++  +E +H    +H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 233 KPDNLLLDQNG-HMKLSDFG 251
           K DN+LL  +G H  L DFG
Sbjct: 193 KADNVLLSSDGSHAALCDFG 212

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 11/140 (7%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASHCIVKLY 172
           +GRG+FGEV   ++K++G   A+KK++         +E  RAE  +  A + S  IV LY
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
            + ++  ++ + ME L GG +              A +Y+ Q++  +E +H    +H D+
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 233 KPDNLLLDQNG-HMKLSDFG 251
           K DN+LL  +G H  L DFG
Sbjct: 212 KADNVLLSSDGSHAALCDFG 231

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 50/227 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            +G+G F +     +  +  ++A K + KS +L   Q E +  E  +   + +  +V  +
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D +++Y+++E      +              AR+++ Q++  ++ +H +  IHRD+
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 168
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K  NL L+ +  +K+ DFGL                          ++ DG   ++ C  
Sbjct: 169 KLGNLFLNDDMDVKIGDFGLA-----------------------TKIEFDGERKKTLC-- 203
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                   GTP+YIAPEVL KKG+  E D W
Sbjct: 204 ------------------------GTPNYIAPEVLCKKGHSFEVDIW 226

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 5/164 (3%)
Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH 152
           +E+M     K S D++D+   +G+GAF  VR C  K +G  +A K +   ++ +R   + 
Sbjct: 17  SEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQK 74
Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYI 212
           +  E  +  ++    IV+L+ S Q+  + YL+ + + GG++              A   I
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLC 253
            Q + +I   H +  +HR++KP+NLLL    +   +KL+DFGL 
Sbjct: 135 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           FD+L  +G G++G V     K++G I A+K++          ++ +  E +++ +  S  
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIMQQCDSPH 85
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHN 226
           +VK Y S+     L+++MEY   G V                  I QS L  +E +H   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLC 253
            IHRDIK  N+LL+  GH KL+DFG+ 
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVA 172

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 50/227 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            +G+G F +     +  +  ++A K + KS +L   Q E +  E  +   + +  +V  +
Sbjct: 33  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D +++Y+++E      +              AR+++ Q++  ++ +H +  IHRD+
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 152
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K  NL L+ +  +K+ DFGL                          ++ DG   +  C  
Sbjct: 153 KLGNLFLNDDMDVKIGDFGLA-----------------------TKIEFDGERKKDLC-- 187
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                   GTP+YIAPEVL KKG+  E D W
Sbjct: 188 ------------------------GTPNYIAPEVLCKKGHSFEVDIW 210

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 2/148 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++              A+ +  Q +  +  +H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               HRDIKP+NLLLD+  ++K+SDFGL
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGL 150

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 86/167 (51%), Gaps = 8/167 (4%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK--SEMLSRG-QVEHVR 154
            K+ K+  D +D+   +G G F  V+ C+EK +G  YA K +KK  S    RG   E + 
Sbjct: 5   FKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E ++L +V  H ++ L+  +++   + LI+E + GG++              A  +I Q
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 215 SVLAIESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLD 257
            +  +  +H     H D+KP+N +LLD+N    H+KL DFGL   ++
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 50/227 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            +G+G F +     +  +  ++A K + KS +L   Q E +  E  +   + +  +V  +
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D +++Y+++E      +              AR+++ Q++  ++ +H +  IHRD+
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 168
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K  NL L+ +  +K+ DFGL                          ++ DG   +  C  
Sbjct: 169 KLGNLFLNDDMDVKIGDFGLA-----------------------TKIEFDGERKKDLC-- 203
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                   GTP+YIAPEVL KKG+  E D W
Sbjct: 204 ------------------------GTPNYIAPEVLCKKGHSFEVDIW 226

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 8/161 (4%)
Query: 105 VDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK--SEMLSRG-QVEHVRAERNLL 160
           V+DF D+   +G G F  V+ C+EK +G  YA K +KK  S    RG   E +  E ++L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            +V  H ++ L+  +++   + LI+E + GG++              A  +I Q +  + 
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 221 SIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLD 257
            +H     H D+KP+N +LLD+N    H+KL DFGL   ++
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 84/163 (51%), Gaps = 8/163 (4%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK--SEMLSRG-QVEHVR 154
            K+ K+  D +D+   +G G F  V+ C+EK +G  YA K +KK  S    RG   E + 
Sbjct: 5   FKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E ++L +V  H ++ L+  +++   + LI+E + GG++              A  +I Q
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 215 SVLAIESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLC 253
            +  +  +H     H D+KP+N +LLD+N    H+KL DFGL 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 50/227 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            +G+G F +     +  +  ++A K + KS +L   Q E +  E  +   + +  +V  +
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D +++Y+++E      +              AR+++ Q++  ++ +H +  IHRD+
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 168
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K  NL L+ +  +K+ DFGL                          ++ DG   +  C  
Sbjct: 169 KLGNLFLNDDMDVKIGDFGLA-----------------------TKIEFDGERKKXLC-- 203
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                   GTP+YIAPEVL KKG+  E D W
Sbjct: 204 ------------------------GTPNYIAPEVLCKKGHSFEVDIW 226

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 8/161 (4%)
Query: 105 VDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK--SEMLSRG-QVEHVRAERNLL 160
           V+DF D+   +G G F  V+ C+EK +G  YA K +KK  S    RG   E +  E ++L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            +V  H ++ L+  +++   + LI+E + GG++              A  +I Q +  + 
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 221 SIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLD 257
            +H     H D+KP+N +LLD+N    H+KL DFGL   ++
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 56/229 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++L+  IG G FG  RL ++K+S  + A+K +++ E ++      +   R+L      
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSL----RH 74
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV+         +L ++MEY  GG++              ARF+  Q +  +   H  
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 226 NYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDG 283
              HRD+K +N LLD +    +K+ DFG  K                             
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK----------------------------- 165
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
                            + H Q        STVGTP YIAPEVLLKK Y
Sbjct: 166 ---------------SSVLHSQ------PKSTVGTPAYIAPEVLLKKEY 193

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 8/161 (4%)
Query: 105 VDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK--SEMLSRG-QVEHVRAERNLL 160
           V+DF D+   +G G F  V+ C+EK +G  YA K +KK  S    RG   E +  E ++L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            +V  H ++ L+  +++   + LI+E + GG++              A  +I Q +  + 
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 221 SIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLD 257
            +H     H D+KP+N +LLD+N    H+KL DFGL   ++
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 75/141 (53%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+ G V L +EK SG   A+K +   +   R   E +  E  ++ +     +V++Y 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHFNVVEMYK 109
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHNYIHRDI 232
           S+   E L+++ME+L GG +             +A   + ++VL A+  +H    IHRDI
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT--VCEAVLQALAYLHAQGVIHRDI 167
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K D++LL  +G +KLSDFG C
Sbjct: 168 KSDSILLTLDGRVKLSDFGFC 188

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 4/156 (2%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVA 164
           ++ L  +G G F  V   ++K +  I A+KK+K   +SE    G       E  LL E++
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELS 70
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
              I+ L  +F     + L+ +++                    + Y+  ++  +E +H+
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           H  +HRD+KP+NLLLD+NG +KL+DFGL K     N
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 55/225 (24%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+ G V +  EK +G   A+KK+   +   R   E +  E  ++ +     +V +Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYHHDNVVDMYS 109
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHNYIHRDI 232
           S+   + L+++ME+L GG +             +A   +  SVL A+  +H    IHRDI
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--VCLSVLRALSYLHNQGVIHRDI 167
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGR 292
           K D++LL  +G +KLSDFG C  +                                    
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSK---------------------------------- 193
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                       ++ +RK     VGTP ++APEV+ +  YG E D
Sbjct: 194 ------------EVPKRK---XLVGTPYWMAPEVISRLPYGTEVD 223

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 59/227 (25%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG+GA G V    +  +G   A++++   +   +   E +  E  ++ E  +  IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 174 SFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHR 230
           S+   + L+++MEYL GG   DV             V R    + + A+E +H +  IHR
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFLHSNQVIHR 140
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGC 290
           DIK DN+LL  +G +KL+DFG C                                     
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCA------------------------------------ 164
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                    Q+   Q  R ++    VGTP ++APEV+ +K YG + D
Sbjct: 165 ---------QITPEQSKRSEM----VGTPYWMAPEVVTRKAYGPKVD 198

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 83/155 (53%), Gaps = 6/155 (3%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D +D+L  +G GAFG V  C EK +G ++  K +     L +  V++   E +++ ++  
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHH 107
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLAIESIHK 224
             ++ L+ +F+D   + LI+E+L GG++                  Y+ Q+   ++ +H+
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 225 HNYIHRDIKPDNLLLD--QNGHMKLSDFGLCKPLD 257
           H+ +H DIKP+N++ +  +   +K+ DFGL   L+
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 76/146 (52%), Gaps = 4/146 (2%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
            D    IG G+ G V +   + SG + A+KK+   ++  + + E +  E  ++ +     
Sbjct: 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHEN 209
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           +V++Y S+   + L+++ME+L GG +             +A   +A  + A+  +H    
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGV 268
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLC 253
           IHRDIK D++LL  +G +KLSDFG C
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFC 294

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 53/224 (23%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+ G V +   + SG + A+KK+   +   R   E +  E  ++ +     +V++Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 93
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
           S+   + L+++ME+L GG +             +A   +A  + A+  +H    IHRDIK
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 152
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRR 293
            D++LL  +G +KLSDFG C  +                                     
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSK----------------------------------- 177
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                      ++ RRK     VGTP ++APE++ +  YG E D
Sbjct: 178 -----------EVPRRK---XLVGTPYWMAPELISRLPYGPEVD 207

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 53/224 (23%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+ G V +   + SG + A+KK+   +   R   E +  E  ++ +     +V++Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 95
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
           S+   + L+++ME+L GG +             +A   +A  + A+  +H    IHRDIK
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 154
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRR 293
            D++LL  +G +KLSDFG C  +                                     
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSK----------------------------------- 179
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                      ++ RRK     VGTP ++APE++ +  YG E D
Sbjct: 180 -----------EVPRRK---XLVGTPYWMAPELISRLPYGPEVD 209

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 53/224 (23%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+ G V +   + SG + A+KK+   +   R   E +  E  ++ +     +V++Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 84
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
           S+   + L+++ME+L GG +             +A   +A  + A+  +H    IHRDIK
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 143
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRR 293
            D++LL  +G +KLSDFG C  +                                     
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSK----------------------------------- 168
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                      ++ RRK     VGTP ++APE++ +  YG E D
Sbjct: 169 -----------EVPRRK---XLVGTPYWMAPELISRLPYGPEVD 198

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 90/229 (39%), Gaps = 56/229 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++L+  IG G FG  RL ++K+S  + A+K +++ E +       +   R+L      
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RH 73
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV+         +L ++MEY  GG++              ARF+  Q +  +   H  
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 133
Query: 226 NYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDG 283
              HRD+K +N LLD +    +K+ DFG  K                             
Sbjct: 134 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK----------------------------- 164
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
                            + H Q        STVGTP YIAPEVLLKK Y
Sbjct: 165 ---------------SSVLHSQ------PKSTVGTPAYIAPEVLLKKEY 192

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 53/230 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
            D    IG G+ G V +   + SG + A+KK+   +   R   E +  E  ++ +     
Sbjct: 76  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHEN 132
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           +V++Y S+   + L+++ME+L GG +             +A   +A  + A+  +H    
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGV 191
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPE 287
           IHRDIK D++LL  +G +KLSDFG C  +                               
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----------------------------- 222
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                            ++ RRK     VGTP ++APE++ +  YG E D
Sbjct: 223 -----------------EVPRRK---XLVGTPYWMAPELISRLPYGPEVD 252

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 53/224 (23%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+ G V +   + SG + A+KK+   +   R   E +  E  ++ +     +V++Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 88
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
           S+   + L+++ME+L GG +             +A   +A  + A+  +H    IHRDIK
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 147
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRR 293
            D++LL  +G +KLSDFG C  +                                     
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSK----------------------------------- 172
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                      ++ RRK     VGTP ++APE++ +  YG E D
Sbjct: 173 -----------EVPRRK---XLVGTPYWMAPELISRLPYGPEVD 202

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 59/227 (25%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG+GA G V    +  +G   A++++   +   +   E +  E  ++ E  +  IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 174 SFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHR 230
           S+   + L+++MEYL GG   DV             V R    + + A+E +H +  IHR
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFLHSNQVIHR 140
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGC 290
           DIK DN+LL  +G +KL+DFG C                                     
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCA------------------------------------ 164
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                    Q+   Q  R  +    VGTP ++APEV+ +K YG + D
Sbjct: 165 ---------QITPEQSKRSTM----VGTPYWMAPEVVTRKAYGPKVD 198

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 59/227 (25%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG+GA G V    +  +G   A++++   +   +   E +  E  ++ E  +  IV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 85
Query: 174 SFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHR 230
           S+   + L+++MEYL GG   DV             V R    + + A+E +H +  IHR
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFLHSNQVIHR 141
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGC 290
           DIK DN+LL  +G +KL+DFG C                                     
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCA------------------------------------ 165
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                    Q+   Q  R  +    VGTP ++APEV+ +K YG + D
Sbjct: 166 ---------QITPEQSKRSXM----VGTPYWMAPEVVTRKAYGPKVD 199

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 58/237 (24%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           + L   IGRG++GEV++  +K +    A KK+ K  +     V+  + E  ++  +    
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPN 84
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           I++LY +F+D   +YL+ME   GG++              A   +   + A+   HK N 
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 228 IHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            HRD+KP+N L      +  +KL DFGL                               R
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLA-----------------------------AR 175
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-WLA 340
           F                        K+  + VGTP Y++P+V L+  YG ECD W A
Sbjct: 176 FKPG---------------------KMMRTKVGTPYYVSPQV-LEGLYGPECDEWSA 210

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 58/237 (24%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           + L   IGRG++GEV++  +K +    A KK+ K  +     V+  + E  ++  +    
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPN 67
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           I++LY +F+D   +YL+ME   GG++              A   +   + A+   HK N 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 228 IHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGR 284
            HRD+KP+N L      +  +KL DFGL                               R
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLA-----------------------------AR 158
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-WLA 340
           F                        K+  + VGTP Y++P+V L+  YG ECD W A
Sbjct: 159 FKPG---------------------KMMRTKVGTPYYVSPQV-LEGLYGPECDEWSA 193

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 59/227 (25%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG+GA G V    +  +G   A++++   +   +   E +  E  ++ E  +  IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 174 SFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHR 230
           S+   + L+++MEYL GG   DV             V R    + + A+E +H +  IHR
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFLHSNQVIHR 140
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGC 290
           DIK DN+LL  +G +KL+DFG C                                     
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCA------------------------------------ 164
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                    Q+   Q  R  +    VGTP ++APEV+ +K YG + D
Sbjct: 165 ---------QITPEQSKRSXM----VGTPYWMAPEVVTRKAYGPKVD 198

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 7/162 (4%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNLLAE 162
           D +++   +G G F  VR C++K +G  YA K +KK  + S  RG   E +  E N+L E
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
           +    I+ L+  F++   + LI+E + GG++              A  ++ Q +  +  +
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 145
Query: 223 HKHNYIHRDIKPDN-LLLDQ---NGHMKLSDFGLCKPLDCTN 260
           H     H D+KP+N +LLD+   N  +KL DFG+   ++  N
Sbjct: 146 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 187

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 57/238 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASH 166
           + L   +G+GAF  VR C +  +G  YA K +   ++ +R   +H + ER   +  +  H
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSAR---DHQKLEREARICRLLKH 80
Query: 167 C-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV+L+ S  +  + YLI + + GG++              A   I Q + A+   H+ 
Sbjct: 81  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 140
Query: 226 NYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVD 282
             +HRD+KP+NLLL    +   +KL+DFGL                         +++V+
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGL-------------------------AIEVE 175
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
           G                + Q W        +   GTP Y++PEVL K  YG   D  A
Sbjct: 176 G----------------EQQAW--------FGFAGTPGYLSPEVLRKDPYGKPVDLWA 209

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 6/161 (3%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
           +H   +D +D+   +G GAFG V    E+ +GN +A K +       +   E VR E   
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQT 207
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV-XXXXXXXXXXXXXVARFYIAQSVLA 218
           ++ +    +V L+ +F+D   + +I E++ GG++               A  Y+ Q    
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267
Query: 219 IESIHKHNYIHRDIKPDNLLLD--QNGHMKLSDFGLCKPLD 257
           +  +H++NY+H D+KP+N++    ++  +KL DFGL   LD
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 7/162 (4%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNLLAE 162
           D +++   +G G F  VR C++K +G  YA K +KK  + S  RG   E +  E N+L E
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
           +    I+ L+  F++   + LI+E + GG++              A  ++ Q +  +  +
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 223 HKHNYIHRDIKPDN-LLLDQ---NGHMKLSDFGLCKPLDCTN 260
           H     H D+KP+N +LLD+   N  +KL DFG+   ++  N
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 6/161 (3%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
           +H   +D +D+   +G GAFG V    E+ +GN +A K +       +   E VR E   
Sbjct: 45  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQT 101
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV-XXXXXXXXXXXXXVARFYIAQSVLA 218
           ++ +    +V L+ +F+D   + +I E++ GG++               A  Y+ Q    
Sbjct: 102 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 161
Query: 219 IESIHKHNYIHRDIKPDNLLLD--QNGHMKLSDFGLCKPLD 257
           +  +H++NY+H D+KP+N++    ++  +KL DFGL   LD
Sbjct: 162 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 202

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 7/162 (4%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNLLAE 162
           D +++   +G G F  VR C++K +G  YA K +KK  + S  RG   E +  E N+L E
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
           +    I+ L+  F++   + LI+E + GG++              A  ++ Q +  +  +
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 131
Query: 223 HKHNYIHRDIKPDN-LLLDQ---NGHMKLSDFGLCKPLDCTN 260
           H     H D+KP+N +LLD+   N  +KL DFG+   ++  N
Sbjct: 132 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 173

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 4/150 (2%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D++D+   +G+GAF  VR C  K +G  +A K +   ++ +R   + +  E  +  ++  
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 63
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV+L+ S Q+  + YL+ + + GG++              A   I Q + +I   H +
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGL 252
             +HR++KP+NLLL    +   +KL+DFGL
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGL 153

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 4/150 (2%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D++D+   +G+GAF  VR C  K +G  +A K +   ++ +R   + +  E  +  ++  
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 64
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV+L+ S Q+  + YL+ + + GG++              A   I Q + +I   H +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGL 252
             +HR++KP+NLLL    +   +KL+DFGL
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGL 154

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 4/150 (2%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D++D+   +G+GAF  VR C  K +G  +A K +   ++ +R   + +  E  +  ++  
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 64
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV+L+ S Q+  + YL+ + + GG++              A   I Q + +I   H +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGL 252
             +HR++KP+NLLL    +   +KL+DFGL
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGL 154

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 84/163 (51%), Gaps = 17/163 (10%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F+L+ ++G G +G+V   +  K+G + A+K +     ++  + E ++ E N+L + + H 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 81
Query: 168 IVKLYY-SFQDA------EYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVL 217
            +  YY +F         + L+L+ME+   G   D+             +A  YI + +L
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREIL 139
Query: 218 -AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
             +  +H+H  IHRDIK  N+LL +N  +KL DFG+   LD T
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 75/146 (51%), Gaps = 7/146 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSE---MLSRGQVEHVRAERNLLAEVASHCIVK 170
           IG G++G V  C+ + +G I A+KK  +SE   ++ +  +  +R    +L ++    +V 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR----MLKQLKHPNLVN 66
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHR 230
           L   F+    L+L+ EY     +             + +    Q++ A+   HKHN IHR
Sbjct: 67  LLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHR 126
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPL 256
           D+KP+N+L+ ++  +KL DFG  + L
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLL 152

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP+NLL++  G +KL+DFGL +
Sbjct: 122 CHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 60
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP+NLL++  G +KL+DFGL +
Sbjct: 120 CHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 59/227 (25%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG+GA G V    +  +G   A++++   +   +   E +  E  ++ E  +  IV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 85
Query: 174 SFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHR 230
           S+   + L+++MEYL GG   DV             V R    + + A+E +H +  IHR
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFLHSNQVIHR 141
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGC 290
           +IK DN+LL  +G +KL+DFG C                                     
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFCA------------------------------------ 165
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                    Q+   Q  R  +    VGTP ++APEV+ +K YG + D
Sbjct: 166 ---------QITPEQSKRSTM----VGTPYWMAPEVVTRKAYGPKVD 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 61
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP+NLL++  G +KL+DFGL +
Sbjct: 121 CHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 83/161 (51%), Gaps = 8/161 (4%)
Query: 105 VDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK--SEMLSRGQV-EHVRAERNLL 160
           V+DF D+   +G G F  V+ C+EK +G  YA K +KK  S    RG   E +  E ++L
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            +V    I+ L+  +++   + LI+E + GG++              A  +I Q +  + 
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 221 SIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLD 257
            +H     H D+KP+N +LLD+N    H+KL DFGL   ++
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 60
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP+NLL++  G +KL+DFGL +
Sbjct: 120 CHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 11/143 (7%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +GRG+FGEV   ++K++G   A+KK++    L   +VE + A     A ++S  IV LY 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVA----CAGLSSPRIVPLYG 133
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
           + ++  ++ + ME L GG +              A +Y+ Q++  +E +H    +H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 234 PDNLLLDQNG-HMKLSDFG--LC 253
            DN+LL  +G    L DFG  LC
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALC 216

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 11/143 (7%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +GRG+FGEV   ++K++G   A+KK++    L   +VE + A     A ++S  IV LY 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVA----CAGLSSPRIVPLYG 117
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
           + ++  ++ + ME L GG +              A +Y+ Q++  +E +H    +H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 234 PDNLLLDQNG-HMKLSDFG--LC 253
            DN+LL  +G    L DFG  LC
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALC 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 2/152 (1%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGG-DVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
               IVKL         LYL+ E+L                   + + Y+ Q +  +   
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 59
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP+NLL++  G +KL+DFGL +
Sbjct: 119 CHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 61
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE--MLSRGQVEHVRAERNLLAEVA 164
           DF L +++G GA+G V     K +G I A+KK++  +  + +   +  ++    +L    
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKHFK 67
Query: 165 SHCIVKLYY-----SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
              I+ ++      SF++   +Y+I E +   D+             + +++I Q++ A+
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHI-QYFIYQTLRAV 125
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           + +H  N IHRD+KP NLL++ N  +K+ DFGL + +D
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 61
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 59
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE--MLSRGQVEHVRAERNLLAEVA 164
           DF L +++G GA+G V     K +G I A+KK++  +  + +   +  ++    +L    
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKHFK 67
Query: 165 SHCIVKLYY-----SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
              I+ ++      SF++   +Y+I E +   D+             + +++I Q++ A+
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHI-QYFIYQTLRAV 125
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           + +H  N IHRD+KP NLL++ N  +K+ DFGL + +D
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 61
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 11/143 (7%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +GRG+FGEV   ++K++G   A+KK++    L   +VE + A     A ++S  IV LY 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVA----CAGLSSPRIVPLYG 131
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
           + ++  ++ + ME L GG +              A +Y+ Q++  +E +H    +H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 234 PDNLLLDQNG-HMKLSDFG--LC 253
            DN+LL  +G    L DFG  LC
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALC 214

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 60
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 60
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 63
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 59
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 59
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE--MLSRGQVEHVRAERNLLAEVA 164
           DF L +++G GA+G V     K +G I A+KK++  +  + +   +  ++    +L    
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKHFK 67
Query: 165 SHCIVKLYY-----SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
              I+ ++      SF++   +Y+I E +   D+             + +++I Q++ A+
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHI-QYFIYQTLRAV 125
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           + +H  N IHRD+KP NLL++ N  +K+ DFGL + +D
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 59
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E+L   D+             +   + Y+ Q +  +  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 89/229 (38%), Gaps = 56/229 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++L+  IG G FG  RL ++K+S  + A+K +++ E +       +   R+L      
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RH 74
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV+         +L ++MEY  GG++              ARF+  Q +  +   H  
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 226 NYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDG 283
              HRD+K +N LLD +    +K+  FG  K                             
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSK----------------------------- 165
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
                            + H Q        STVGTP YIAPEVLLKK Y
Sbjct: 166 ---------------SSVLHSQ------PKSTVGTPAYIAPEVLLKKEY 193

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 4/154 (2%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           + +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKE 62
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIE 220
           +    IVKL         LYL+ E+L   D+             +   + Y+ Q +  + 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 57/241 (23%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEV 163
            +++ L   +G+GAF  VR C +  +G  YA   +   ++ +R   +H + ER   +  +
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR---DHQKLEREARICRL 66
Query: 164 ASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
             H  IV+L+ S  +  + YLI + + GG++              A   I Q + A+   
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 223 HKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           H+   +HR++KP+NLLL    +   +KL+DFGL                         ++
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGL-------------------------AI 161
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL 339
           +V+G                + Q W        +   GTP Y++PEVL K  YG   D  
Sbjct: 162 EVEG----------------EQQAW--------FGFAGTPGYLSPEVLRKDPYGKPVDLW 197
Query: 340 A 340
           A
Sbjct: 198 A 198

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 58/235 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D F++ + +GRGA   V  C++K +   YA+K LKK+        + VR E  +L  ++ 
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSH 107
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             I+KL   F+    + L++E + GG++              A   + Q + A+  +H++
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 226 NYIHRDIKPDNLLLDQ---NGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVD 282
             +HRD+KP+NLL      +  +K++DFGL K                            
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSK---------------------------- 199
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                                  +  + L  +  GTP Y APE+L    YG E D
Sbjct: 200 ----------------------IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVD 232

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 63/238 (26%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVR----AERNLLAEVASH 166
           I+GRG    VR C  K +   YA+K   +      S  +V+ +R     E ++L +V+ H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 167 C-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             I++L  +++   + +L+ + +  G++               R  +   +  I ++HK 
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRF 285
           N +HRD+KP+N+LLD + ++KL+DFG    LD                            
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---------------------------- 175
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL------LKKGYGMECD 337
                      P E+L+           S  GTP Y+APE++         GYG E D
Sbjct: 176 -----------PGEKLR-----------SVCGTPSYLAPEIIECSMNDNHPGYGKEVD 211

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVR----AERNLLAEVASH 166
           I+GRG    VR C  K +   YA+K   +      S  +V+ +R     E ++L +V+ H
Sbjct: 11  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 70
Query: 167 C-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             I++L  +++   + +L+ + +  G++               R  +   +  I ++HK 
Sbjct: 71  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 130
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           N +HRD+KP+N+LLD + ++KL+DFG    LD
Sbjct: 131 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 162

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 12/150 (8%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLY 172
           +G G+F   R C  KKS   +A+K      ++S+    + + E   L     H  IVKL+
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVK------IISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F D  + +L+ME L GG++              A + + + V A+  +H    +HRD+
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 233 KPDNLLL-DQNGHM--KLSDFGLC--KPLD 257
           KP+NLL  D+N ++  K+ DFG    KP D
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPD 162

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVR----AERNLLAEVASH 166
           I+GRG    VR C  K +   YA+K   +      S  +V+ +R     E ++L +V+ H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 167 C-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             I++L  +++   + +L+ + +  G++               R  +   +  I ++HK 
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           N +HRD+KP+N+LLD + ++KL+DFG    LD
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 60
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 67
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 52/230 (22%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG+G+FGEV    + ++  + A+K +   E     ++E ++ E  +L++  S  
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSSY 82
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           + K Y S+     L++IMEYL GG               +A   + + +  ++ +H    
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATM-LKEILKGLDYLHSEKK 141
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPE 287
           IHRDIK  N+LL + G +KL+DFG+                                   
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAG--------------------------------- 168
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                       QL   QI R       VGTP ++APEV+ +  Y  + D
Sbjct: 169 ------------QLTDTQIKRNTF----VGTPFWMAPEVIQQSAYDSKAD 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 67
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 60
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 58/241 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG--QVEHVRAERNLLAEV 163
           D ++L  +IG+G F  VR C  +++G  +A+K +  ++  S      E ++ E ++   +
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGD----VXXXXXXXXXXXXXVARFYIAQSVLAI 219
               IV+L  ++     LY++ E++ G D    +             VA  Y+ Q + A+
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 220 ESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXX 276
              H +N IHRD+KP  +LL   + +  +KL  FG+   L  + L A             
Sbjct: 146 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA------------- 192
Query: 277 XSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
                 GR                               VGTP ++APEV+ ++ YG   
Sbjct: 193 -----GGR-------------------------------VGTPHFMAPEVVKREPYGKPV 216
Query: 337 D 337
           D
Sbjct: 217 D 217

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 60
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 60
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 59
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 59
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 4/153 (2%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIES 221
               IVKL         LYL+ E++   D+             +   + Y+ Q +  +  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 58/241 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG--QVEHVRAERNLLAEV 163
           D ++L  +IG+G F  VR C  +++G  +A+K +  ++  S      E ++ E ++   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGD----VXXXXXXXXXXXXXVARFYIAQSVLAI 219
               IV+L  ++     LY++ E++ G D    +             VA  Y+ Q + A+
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 220 ESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXX 276
              H +N IHRD+KP  +LL   + +  +KL  FG+   L  + L A             
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA------------- 190
Query: 277 XSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
                 GR                               VGTP ++APEV+ ++ YG   
Sbjct: 191 -----GGR-------------------------------VGTPHFMAPEVVKREPYGKPV 214
Query: 337 D 337
           D
Sbjct: 215 D 215

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 59
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 4/151 (2%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           ++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNH 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESIH 223
             IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
            F  L+ +G G++GEV   + K+ G +YA+K+   S    RG  +  R     LAEV SH
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR---SMSPFRGPKDRARK----LAEVGSH 110
Query: 167 -------CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
                  C V+L  ++++   LYL  E L G  +                + Y+  ++LA
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLA 169
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +  +H    +H D+KP N+ L   G  KL DFGL
Sbjct: 170 LAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 61
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 19/166 (11%)
Query: 104 SVDDFDLLTI--IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE---RN 158
           + ++F +LT   +GRG F  VR C  K +G  YA K LKK     RGQ    RAE     
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR---RGQ--DCRAEILHEI 79
Query: 159 LLAEVASHC--IVKLYYSFQDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIA 213
            + E+A  C  ++ L+  +++   + LI+EY  GG++                V R  I 
Sbjct: 80  AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-IK 138
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPL 256
           Q +  +  +H++N +H D+KP N+LL      G +K+ DFG+ + +
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 88/229 (38%), Gaps = 56/229 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++L+  IG G FG  RL ++K+S  + A+K +++ E +       +   R+L      
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RH 74
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV+         +L ++MEY  GG++              ARF+  Q +  +   H  
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 134
Query: 226 NYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDG 283
              HRD+K +N LLD +    +K+  FG  K                             
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSK----------------------------- 165
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
                            + H Q         TVGTP YIAPEVLLKK Y
Sbjct: 166 ---------------SSVLHSQ------PKDTVGTPAYIAPEVLLKKEY 193

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 4/164 (2%)
Query: 90  RKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ 149
           RK  EY  ++R     + ++++  +G GAFG+V   + K++G + A K +   E  S  +
Sbjct: 3   RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEE 59
Query: 150 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVAR 209
           +E    E  +LA      IVKL  ++     L++++E+ PGG V                
Sbjct: 60  LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 210 FYIAQSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             + + +L A+  +H    IHRD+K  N+L+   G ++L+DFG+
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGV 163

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 54/231 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG+G+FGEV    + ++  + A+K +   E     ++E ++ E  +L++  S  
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPY 86
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHN 226
           + K Y S+     L++IMEYL GG               +A   I + +L  ++ +H   
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--ILREILKGLDYLHSEK 144
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFP 286
            IHRDIK  N+LL ++G +KL+DFG+                                  
Sbjct: 145 KIHRDIKAANVLLSEHGEVKLADFGVAG-------------------------------- 172
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                        QL   QI R       VGTP ++APEV+ +  Y  + D
Sbjct: 173 -------------QLTDTQIKRNTF----VGTPFWMAPEVIKQSAYDSKAD 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI+E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 54/231 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG+G+FGEV    + ++  + A+K +   E     ++E ++ E  +L++  S  
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPY 66
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHN 226
           + K Y S+     L++IMEYL GG               +A   I + +L  ++ +H   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--ILREILKGLDYLHSEK 124
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFP 286
            IHRDIK  N+LL ++G +KL+DFG+                                  
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAG-------------------------------- 152
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                        QL   QI R       VGTP ++APEV+ +  Y  + D
Sbjct: 153 -------------QLTDTQIKRNTF----VGTPFWMAPEVIKQSAYDSKAD 186

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 52/230 (22%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG+G+FGEV    + ++  + A+K +   E     ++E ++ E  +L++  S  
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPY 81
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           + K Y S+     L++IMEYL GG               +A   + + +  ++ +H    
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI-LREILKGLDYLHSEKK 140
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPE 287
           IHRDIK  N+LL ++G +KL+DFG+                                   
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAG--------------------------------- 167
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                       QL   QI R       VGTP ++APEV+ +  Y  + D
Sbjct: 168 ------------QLTDTQIKRNXF----VGTPFWMAPEVIKQSAYDSKAD 201

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 54/231 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG+G+FGEV    + ++  + A+K +   E     ++E ++ E  +L++  S  
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPY 66
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHN 226
           + K Y S+     L++IMEYL GG               +A   I + +L  ++ +H   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--ILREILKGLDYLHSEK 124
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFP 286
            IHRDIK  N+LL ++G +KL+DFG+                                  
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAG-------------------------------- 152
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                        QL   QI R       VGTP ++APEV+ +  Y  + D
Sbjct: 153 -------------QLTDTQIKRNXF----VGTPFWMAPEVIKQSAYDSKAD 186

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 89/229 (38%), Gaps = 56/229 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++L+  IG G FG  RL ++K++  + A+K +++ E +       +   R+L      
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSL----RH 74
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV+         +L ++MEY  GG++              ARF+  Q +  +   H  
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAM 134
Query: 226 NYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDG 283
              HRD+K +N LLD +    +K++DFG  K                          V  
Sbjct: 135 QVAHRDLKLENTLLDGSPAPRLKIADFGYSK------------------------ASVLH 170
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
             P+S  G                          TP YIAPEVLLKK Y
Sbjct: 171 SQPKSAVG--------------------------TPAYIAPEVLLKKEY 193

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 87/229 (37%), Gaps = 56/229 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D +D +  IG G FG  RL ++K +  + A+K +++   +       +   R+L      
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL----RH 75
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
             IV+         +L +IMEY  GG++              ARF+  Q +  +   H  
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 226 NYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDG 283
              HRD+K +N LLD +    +K+ DFG  K                             
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSK----------------------------- 166
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
                            + H Q        STVGTP YIAPEVLL++ Y
Sbjct: 167 ---------------SSVLHSQ------PKSTVGTPAYIAPEVLLRQEY 194

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 2/151 (1%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELN 59
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGG-DVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
              IVKL         LYL+ E++                   + + Y+ Q +  +   H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           DF+ + ++G+GAFG+V   +       YA+KK++ +E     ++  + +E  LLA +   
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQ 62
Query: 167 CIVKLYYSF-------------QDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA 213
            +V+ Y ++             +    L++ MEY   G +                + + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 214 QSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           + +L A+  IH    IHRD+KP N+ +D++ ++K+ DFGL K
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 98/261 (37%), Gaps = 58/261 (22%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           ++ +F +   IGRG F EV        G   A+KK++  +++          E +LL ++
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF----YIAQSVLAI 219
               ++K Y SF +   L +++E    GD+             +       Y  Q   A+
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSM 279
           E +H    +HRDIKP N+ +   G +KL D GL                           
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGL--------------------------- 182
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
              GRF  S                   +   A+S VGTP Y++PE + + GY  + D W
Sbjct: 183 ---GRFFSS-------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
Query: 339 ----LAYWNETLSCNYLSDIM 355
               L Y    L   +  D M
Sbjct: 221 SLGCLLYEMAALQSPFYGDKM 241

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+ K++  +  + G       E +LL E+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELN 60
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 4/152 (2%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           +++F  +  IG G +G V   + K +G + A+ K++  +  + G       E +LL E+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELN 59
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA--RFYIAQSVLAIESI 222
              IVKL         LYL+ E+L   D+             +   + Y+ Q +  +   
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP NLL++  G +KL+DFGL +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 54/231 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG+G+FGEV    +  +  + A+K +   E     ++E ++ E  +L++  S  
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPY 78
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHN 226
           I + + S+  +  L++IMEYL GG               +A   I + +L  ++ +H   
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIAT--ILREILKGLDYLHSER 136
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFP 286
            IHRDIK  N+LL + G +KL+DFG+                                  
Sbjct: 137 KIHRDIKAANVLLSEQGDVKLADFGVAG-------------------------------- 164
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                        QL   QI R       VGTP ++APEV+ +  Y  + D
Sbjct: 165 -------------QLTDTQIKRNXF----VGTPFWMAPEVIKQSAYDFKAD 198

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 8/165 (4%)
Query: 104 SVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RG-QVEHVRAERNL 159
           +VDD+ D    +G G F  V+ C+EK +G  YA K +KK    S  RG   E +  E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           L E+    ++ L+  +++   + LI E + GG++              A  ++ Q +  +
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 220 ESIHKHNYIHRDIKPDN-LLLDQN---GHMKLSDFGLCKPLDCTN 260
             +H     H D+KP+N +LLD+N     +K+ DFGL   +D  N
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 89/171 (52%), Gaps = 16/171 (9%)
Query: 91  KETEYMRL--KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
           K+T Y+ +  +R++  ++D + L  +G G  G+V   + +K+G++ A+K++++S      
Sbjct: 8   KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG----N 63
Query: 149 QVEHVRAERNLLAEVASH-C--IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXX 205
           + E+ R   +L   + SH C  IV+ + +F     +++ ME +                 
Sbjct: 64  KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM---GTCAEKLKKRMQGP 120
Query: 206 XVARFYIAQSVLAIESIH----KHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
              R     +V  +++++    KH  IHRD+KP N+LLD+ G +KL DFG+
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 4/160 (2%)
Query: 94  EYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHV 153
           +Y  + R     D ++++  +G GAFG+V   Q K++  + A K +      S  ++E  
Sbjct: 25  QYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDY 81
Query: 154 RAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXV-ARFYI 212
             E ++LA      IVKL  +F     L++++E+  GG V                +   
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 141
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            Q++ A+  +H +  IHRD+K  N+L   +G +KL+DFG+
Sbjct: 142 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV 181

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 4/160 (2%)
Query: 94  EYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHV 153
           +Y  + R     D ++++  +G GAFG+V   Q K++  + A K +      S  ++E  
Sbjct: 25  QYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDY 81
Query: 154 RAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXV-ARFYI 212
             E ++LA      IVKL  +F     L++++E+  GG V                +   
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 141
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            Q++ A+  +H +  IHRD+K  N+L   +G +KL+DFG+
Sbjct: 142 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV 181

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 4/160 (2%)
Query: 94  EYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHV 153
           +Y  + R     D ++++  +G GAFG+V   Q K++  + A K +      S  ++E  
Sbjct: 25  QYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDY 81
Query: 154 RAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXV-ARFYI 212
             E ++LA      IVKL  +F     L++++E+  GG V                +   
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 141
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            Q++ A+  +H +  IHRD+K  N+L   +G +KL+DFG+
Sbjct: 142 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV 181

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKSQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGLC+  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD 176

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 7/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L+  +G G FGEV +     S  + A+K LK   M     V+    E NL+ 
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMK 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF--YIAQSVLAI 219
            +    +V+LY      E +Y+I EY+  G +             + +   + AQ    +
Sbjct: 64  TLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 123
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+ ++   K++DFGL + ++    +A
Sbjct: 124 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 167

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D + +   IG G++ E + C  K +   YA+K + KS+     ++E       +L     
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE-------ILLRYGQ 79
Query: 166 HC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           H  I+ L   + D +++YL+ E + GG++              A F +      +E +H 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 225 HNYIHRDIKPDNLL-LDQNGH---MKLSDFGLCKPLDCTN 260
              +HRD+KP N+L +D++G+   +++ DFG  K L   N
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D + +   IG G++ E + C  K +   YA+K + KS+     ++E       +L     
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE-------ILLRYGQ 79
Query: 166 HC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           H  I+ L   + D +++YL+ E + GG++              A F +      +E +H 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 225 HNYIHRDIKPDNLL-LDQNGH---MKLSDFGLCKPLDCTN 260
              +HRD+KP N+L +D++G+   +++ DFG  K L   N
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G +G V   + +++  I A+K+++  +    G       E  LL E+    IV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
                + L L+ E+                   + + ++ Q +  +   H  N +HRD+K
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128
Query: 234 PDNLLLDQNGHMKLSDFGLCK----PLDC 258
           P NLL+++NG +KL+DFGL +    P+ C
Sbjct: 129 PQNLLINRNGELKLADFGLARAFGIPVRC 157

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK--------LDHCNIVRL 78
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           DF+ + ++G+GAFG+V   +       YA+KK++ +E     ++  + +E  LLA +   
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQ 62
Query: 167 CIVKLYYSF-------------QDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA 213
            +V+ Y ++             +    L++ MEY     +                + + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 214 QSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           + +L A+  IH    IHRD+KP N+ +D++ ++K+ DFGL K
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 7/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L+  +G G FGEV +     S  + A+K LK   M     V+    E NL+ 
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMK 62
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF--YIAQSVLAI 219
            +    +V+LY      E +Y+I E++  G +             + +   + AQ    +
Sbjct: 63  TLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 122
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+ ++   K++DFGL + ++    +A
Sbjct: 123 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 166

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 4/140 (2%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G GAFG+V   + K++G + A K +   E  S  ++E    E  +LA      IVKL  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDHPYIVKLLG 75
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHNYIHRDI 232
           ++     L++++E+ PGG V                  + + +L A+  +H    IHRD+
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 233 KPDNLLLDQNGHMKLSDFGL 252
           K  N+L+   G ++L+DFG+
Sbjct: 136 KAGNVLMTLEGDIRLADFGV 155

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 77/145 (53%), Gaps = 6/145 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           I+G G FG+V  C+E  +G   A K +K   M  +   E V+ E +++ ++    +++LY
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLIQLY 152
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVAR-FYIAQSVLAIESIHKHNYIHRD 231
            +F+    + L+MEY+ GG++             +    ++ Q    I  +H+   +H D
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 232 IKPDNLL-LDQNG-HMKLSDFGLCK 254
           +KP+N+L ++++   +K+ DFGL +
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 6/179 (3%)
Query: 87  DLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS 146
           DL  +   +  + + ++   D  +   +G G +GEV +   KK     A+K LK+  M  
Sbjct: 13  DLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM-- 70
Query: 147 RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXX 205
             +VE    E  ++ E+    +V+L          Y++ EY+P G++             
Sbjct: 71  --EVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVT 128
Query: 206 XVARFYIAQSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
            V   Y+A  +  A+E + K N+IHRD+   N L+ +N  +K++DFGL + +     +A
Sbjct: 129 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTA 187

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 78
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 2/141 (1%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G +G V   Q    G  +A+KK++  E    G       E ++L E+    IVKLY 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
                + L L+ E+L                   A+ ++ Q +  I   H    +HRD+K
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 234 PDNLLLDQNGHMKLSDFGLCK 254
           P NLL+++ G +K++DFGL +
Sbjct: 128 PQNLLINREGELKIADFGLAR 148

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 2/141 (1%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G +G V   Q    G  +A+KK++  E    G       E ++L E+    IVKLY 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
                + L L+ E+L                   A+ ++ Q +  I   H    +HRD+K
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 234 PDNLLLDQNGHMKLSDFGLCK 254
           P NLL+++ G +K++DFGL +
Sbjct: 128 PQNLLINREGELKIADFGLAR 148

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 2/141 (1%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G +G V   Q    G  +A+KK++  E    G       E ++L E+    IVKLY 
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
                + L L+ E+L                   A+ ++ Q +  I   H    +HRD+K
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 234 PDNLLLDQNGHMKLSDFGLCK 254
           P NLL+++ G +K++DFGL +
Sbjct: 128 PQNLLINREGELKIADFGLAR 148

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK--------LDHCNIVRL 78
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 82/161 (50%), Gaps = 9/161 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE--- 162
           D+++++  IG GA+G V   + + +G   A+KK+  +  +       +R E  +L     
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 113
Query: 163 ---VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
              +A   I++    + + + +Y++++ +   D+               R+++ Q +  +
Sbjct: 114 DNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           + +H    IHRD+KP NLL+++N  +K+ DFG+ + L CT+
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL-CTS 212

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK--------LDHCNIVRL 78
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 59/250 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRL--CQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
           I+ DD++L  +IG GA   V+   C  KK         L+K +      ++ +  E   +
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT----SMDELLKEIQAM 67
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVL 217
           ++     IV  Y SF   + L+L+M+ L GG   D+             V       ++L
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 218 -----AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXX 272
                 +E +HK+  IHRD+K  N+LL ++G ++++DFG+                    
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV-------------------- 167
Query: 273 XXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KG 331
                       F  +G                I R K+  + VGTP ++APEV+ + +G
Sbjct: 168 ----------SAFLATGG--------------DITRNKVRKTFVGTPCWMAPEVMEQVRG 203
Query: 332 YGMECDWLAY 341
           Y  + D  ++
Sbjct: 204 YDFKADIWSF 213

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 78
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 46  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 97
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 158 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 40  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 91
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 152 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 78
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 82/161 (50%), Gaps = 9/161 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE--- 162
           D+++++  IG GA+G V   + + +G   A+KK+  +  +       +R E  +L     
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 112
Query: 163 ---VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
              +A   I++    + + + +Y++++ +   D+               R+++ Q +  +
Sbjct: 113 DNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           + +H    IHRD+KP NLL+++N  +K+ DFG+ + L CT+
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL-CTS 211

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 112
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 90
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 151 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 28  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 79
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 140 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 35  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 86
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 147 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 78
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 55  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 106
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 167 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 32  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 83
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 144 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 31  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 82
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 143 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 112
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 90
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 151 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 59/250 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRL--CQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
           I+ DD++L  +IG GA   V+   C  KK         L+K +      ++ +  E   +
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT----SMDELLKEIQAM 62
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVL 217
           ++     IV  Y SF   + L+L+M+ L GG   D+             V       ++L
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 218 -----AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXX 272
                 +E +HK+  IHRD+K  N+LL ++G ++++DFG+                    
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA------------------ 164
Query: 273 XXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KG 331
                       F  +G                I R K+  + VGTP ++APEV+ + +G
Sbjct: 165 ------------FLATGG--------------DITRNKVRKTFVGTPCWMAPEVMEQVRG 198
Query: 332 YGMECDWLAY 341
           Y  + D  ++
Sbjct: 199 YDFKADIWSF 208

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 5/149 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G +G V   + +++  I A+K+++  +    G       E  LL E+    IV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
                + L L+ E+                   + + ++ Q +  +   H  N +HRD+K
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128
Query: 234 PDNLLLDQNGHMKLSDFGLCK----PLDC 258
           P NLL+++NG +KL++FGL +    P+ C
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRC 157

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 63  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 114
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 175 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 65  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 116
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 177 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKL 171
           +IG G+FG V   +   SG + A+KK+ + +     +++ +R           HC IV+L
Sbjct: 106 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK--------LDHCNIVRL 157
Query: 172 YYSF------QDAEYLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESI 222
            Y F      +D  YL L+++Y+P                      + Y+ Q   ++  I
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 223 HKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPL 256
           H     HRDIKP NLLLD +   +KL DFG  K L
Sbjct: 218 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 70
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 71  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 70
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 71  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE------EHLRDFEREIEILKS 65
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 66  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 162

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE------EHLRDFEREIEILKS 66
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 67  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 126 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 163

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 72
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 73  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 132 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 169

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 73
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 74  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 170

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 74
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 75  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 134 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 171

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 98
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 99  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE------EHLRDFEREIEILKS 67
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 68  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 71
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 72  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 131 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 168

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 67
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 68  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 67
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 68  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 85
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 86  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 6/170 (3%)
Query: 96  MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           M L + ++   D  +   +G G FGEV     KK     A+K LK+  M    +VE    
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLK 56
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQ 214
           E  ++ E+    +V+L          Y+I E++  G++              V   Y+A 
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 215 SVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
            +  A+E + K N+IHRD+   N L+ +N  +K++DFGL + +     +A
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 166

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 21/157 (13%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ ++ +G G  G V   Q + SG I A +KL   E+    + + +R E  +L E  S
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 73
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI--- 222
             IV  Y +F     + + ME++ GG +                  I + +L   SI   
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---------IPEEILGKVSIAVL 124
Query: 223 -------HKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                   KH  +HRD+KP N+L++  G +KL DFG+
Sbjct: 125 RGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV 161

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 85
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 86  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G FGEV +    K   + A+K +K   M     VE   AE N++  +    +VKL+ 
Sbjct: 190 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 243
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF--YIAQSVLAIESIHKHNYIHRD 231
           +    E +Y+I E++  G +             + +   + AQ    +  I + NYIHRD
Sbjct: 244 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 303
Query: 232 IKPDNLLLDQNGHMKLSDFGLCK-----PLDCTNLSAI 264
           ++  N+L+  +   K++DFGL +     P+  T   AI
Sbjct: 304 LRAANILVSASLVCKIADFGLARVGAKFPIKWTAPEAI 341

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           DF+ + ++G+GAFG+V   +       YA+KK++ +E     ++  + +E  LLA +   
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVXLLASLNHQ 62
Query: 167 CIVKLYYSF-------------QDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA 213
            +V+ Y ++             +    L++  EY     +                + + 
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 214 QSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           + +L A+  IH    IHR++KP N+ +D++ ++K+ DFGL K
Sbjct: 123 RQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G FGEV +    K   + A+K +K   M     VE   AE N++  +    +VKL+ 
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 249
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF--YIAQSVLAIESIHKHNYIHRD 231
           +    E +Y+I E++  G +             + +   + AQ    +  I + NYIHRD
Sbjct: 250 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           ++  N+L+  +   K++DFGL + ++    +A
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTA 341

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 85  LKDLERKETEYMRLKRHKISV---DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK 141
           L + +RK  E    ++ K+     DDF+ ++ +G G  G V     K SG + A +KL  
Sbjct: 9   LDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIH 67
Query: 142 SEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXX 201
            E+    + + +R E  +L E  S  IV  Y +F     + + ME++ GG +        
Sbjct: 68  LEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 126
Query: 202 XXXXXVARFYIAQSVLAIESI----HKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                +       S+  I+ +     KH  +HRD+KP N+L++  G +KL DFG+
Sbjct: 127 RIPEQILG---KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 47  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 163
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 196

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 46  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 104
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 105 LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 162
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 195

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G FGEV +    K   + A+K +K   M     VE   AE N++  +    +VKL+ 
Sbjct: 23  LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 76
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF--YIAQSVLAIESIHKHNYIHRD 231
           +    E +Y+I E++  G +             + +   + AQ    +  I + NYIHRD
Sbjct: 77  AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 136
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           ++  N+L+  +   K++DFGL + ++    +A
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIEDNEYTA 168

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 47  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 163
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 196

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 12/171 (7%)
Query: 89  ERKETEYMRLKRHKISV---DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
           +RK  E    ++ K+     DDF+ ++ +G G  G V     K SG + A +KL   E+ 
Sbjct: 48  QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIK 106
Query: 146 SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXX 205
              + + +R E  +L E  S  IV  Y +F     + + ME++ GG +            
Sbjct: 107 PAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 165
Query: 206 XVARFYIAQSVLAIESI----HKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            +       S+  I+ +     KH  +HRD+KP N+L++  G +KL DFG+
Sbjct: 166 QILG---KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 213

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 7/156 (4%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S   F  L  +G G +  V     K +G   A+K++K       G       E +L+ E+
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKEL 60
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGG-----DVXXXXXXXXXXXXXVARFYIAQSVLA 218
               IV+LY        L L+ E++        D              + +++  Q +  
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           +   H++  +HRD+KP NLL+++ G +KL DFGL +
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 33  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 149
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 182

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS--------------EMLSRGQV 150
           ++D+ ++  + +G F ++ LC+  K    YA+KK +KS              ++  + + 
Sbjct: 30  INDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 151 EHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF 210
           +  + E  ++ ++ +   +       + + +Y+I EY+    +                F
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 211 Y-------IAQSVL-AIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFG 251
                   I +SVL +   IH   N  HRD+KP N+L+D+NG +KLSDFG
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG 197

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 23  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 82  LLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 139
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 23  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 82  LLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCAKLTDDHV-QFLIYQILRGLKYIHS 139
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 6/170 (3%)
Query: 96  MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           M L + ++   D  +   +G G +GEV     KK     A+K LK+  M    +VE    
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLK 56
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQ 214
           E  ++ E+    +V+L          Y+I E++  G++              V   Y+A 
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 215 SVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
            +  A+E + K N+IHRD+   N L+ +N  +K++DFGL + +     +A
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTA 166

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 23  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 82  LLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 139
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 71
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 72  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 130
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 131 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 174

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL K    S    +    E  LL  +    ++ 
Sbjct: 39  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKP-FQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 98  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 155
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 188

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 69
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 70  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 128
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 129 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 172

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 2/141 (1%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +G V   ++ + G I A+K+++  +    G       E +LL E+    IV L  
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
                  L L+ E++                    + Y+ Q +  +   H+H  +HRD+K
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 234 PDNLLLDQNGHMKLSDFGLCK 254
           P NLL++ +G +KL+DFGL +
Sbjct: 147 PQNLLINSDGALKLADFGLAR 167

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 64  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 166

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L  +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 37  LAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 95
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 96  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 153
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 154 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 186

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 73
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 74  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 132
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 133 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 176

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 33  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 149
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 150 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTD 182

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 70
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIME+LP G +             +    Y +Q    
Sbjct: 71  LQHDNIVKYKGVCYS-AGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKG 129
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHRD+   N+L++    +K+ DFGL K L
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 2/141 (1%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +G V   ++ + G I A+K+++  +    G       E +LL E+    IV L  
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
                  L L+ E++                    + Y+ Q +  +   H+H  +HRD+K
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 234 PDNLLLDQNGHMKLSDFGLCK 254
           P NLL++ +G +KL+DFGL +
Sbjct: 147 PQNLLINSDGALKLADFGLAR 167

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 29  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 145
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 146 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTD 178

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ IG GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 32  LSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 148
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD 181

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 68
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 69  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 127
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 128 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 171

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 72
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 73  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 131
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 132 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 175

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 69
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 70  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 128
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 129 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 172

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 4/146 (2%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG G+FG V   ++ ++  + A+KK+  S   S  + + +  E   L ++    
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGG--DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
            ++    +      +L+MEY  G   D+              A  + A   LA   +H H
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY--LHSH 173
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFG 251
           N IHRD+K  N+LL + G +KL DFG
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFG 199

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 4/146 (2%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           F  L  IG G+FG V   ++ ++  + A+KK+  S   S  + + +  E   L ++    
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGG--DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKH 225
            ++    +      +L+MEY  G   D+              A  + A   LA   +H H
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY--LHSH 134
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFG 251
           N IHRD+K  N+LL + G +KL DFG
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFG 160

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKXQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD 176

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 12/175 (6%)
Query: 89  ERKETEYMRLKRHKISV---DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
           +RK  E    ++ K+     DDF+ ++ +G G  G V     K SG + A +KL   E+ 
Sbjct: 5   QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIK 63
Query: 146 SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXX 205
              + + +R E  +L E  S  IV  Y +F     + + ME++ GG +            
Sbjct: 64  PAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 122
Query: 206 XVARFYIAQSVLAIESI----HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
            +       S+  I+ +     KH  +HRD+KP N+L++  G +KL DFG+   L
Sbjct: 123 QILG---KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 174

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 64
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 65  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 123
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 124 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 167

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 64  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 166

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 65
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 66  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 124
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 125 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 168

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 97  RLKRHKIS-VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           +L R+ I   D +++   IG G++   + C  K +   +A+K + KS+     ++E    
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---- 67
Query: 156 ERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
              +L     H  I+ L   + D +Y+Y++ E + GG++              A   +  
Sbjct: 68  ---ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124
Query: 215 SVLAIESIHKHNYIHRDIKPDNLL-LDQNGH---MKLSDFGLCKPLDCTN 260
               +E +H    +HRD+KP N+L +D++G+   +++ DFG  K L   N
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 64  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           +  L+ +G GA+G V    + KSG   A+KKL +    S    +    E  LL  +    
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHEN 111
Query: 168 IVKLYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
           ++ L   F  A  L      YL+  +L G D+             V +F I Q +  ++ 
Sbjct: 112 VIGLLDVFTPATSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKY 169
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           IH  + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 205

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKXQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 32  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 148
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD 181

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 38  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 96
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 97  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 154
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 155 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD 187

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 58
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 59  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 117
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 118 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 161

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 110 LLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVR---AERNLLAE 162
            L  +G+G FG V +C+    +  +G + A+KKL+ S        EH+R    E  +L  
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------TEEHLRDFEREIEILKS 68
Query: 163 VASHCIVK---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLA 218
           +    IVK   + YS      L LIMEYLP G +             +    Y +Q    
Sbjct: 69  LQHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 127
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +E +    YIHR++   N+L++    +K+ DFGL K L
Sbjct: 128 MEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVL 165

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 33  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 149
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 182

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 111 LTIIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           ++ +G+G FG V LC+    G N  A+  +K+ +     Q    + E  +L  + S  IV
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 71
Query: 170 K---LYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF--YIAQSVLAIESIHK 224
           K   + Y     E L L+MEYLP G                +R   Y +Q    +E +  
Sbjct: 72  KYRGVSYGPGRPE-LRLVMEYLPSG-CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK--PLD 257
              +HRD+   N+L++   H+K++DFGL K  PLD
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 164

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 97  RLKRHKIS-VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           +L R+ I   D +++   IG G++   + C  K +   +A+K + KS+     ++E    
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---- 67
Query: 156 ERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
              +L     H  I+ L   + D +Y+Y++ E   GG++              A   +  
Sbjct: 68  ---ILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFT 124
Query: 215 SVLAIESIHKHNYIHRDIKPDNLL-LDQNGH---MKLSDFGLCKPLDCTN 260
               +E +H    +HRD+KP N+L +D++G+   +++ DFG  K L   N
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 39  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 98  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 155
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 188

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 39  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 98  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 155
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 188

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 38  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 96
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 97  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 154
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 155 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 187

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 29  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 145
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 178

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 150
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 183

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 29  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 145
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 178

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 29  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 145
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 178

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 46  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 104
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 105 LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 162
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 195

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 47  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 163
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 196

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 32  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 148
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 181

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 26  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 84
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 85  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 142
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 143 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 175

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 83/162 (51%), Gaps = 10/162 (6%)
Query: 97  RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
           R+ RH +    ++L+  +G+GA+G V    ++++G + A+KK+  +   S       R E
Sbjct: 2   RVDRHVLR--KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-E 58
Query: 157 RNLLAEVASH-CIVKLYYSFQ--DAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA 213
             +L E++ H  IV L    +  +   +YL+ +Y+   +              V + Y+ 
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQYVV 115
Query: 214 -QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            Q +  I+ +H    +HRD+KP N+LL+   H+K++DFGL +
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 50  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 108
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 109 LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 166
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 199

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 17/171 (9%)
Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           +R +  +D F +  + G+G FG V+L +EK +G   A+KK+ +       +++ ++    
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD--- 72
Query: 159 LLAEVASHCIVKL---YYSFQDAE----YLYLIMEYLPGG---DVXXXXXXXXXXXXXVA 208
            LA +    IV+L   +Y+  + +    YL ++MEY+P                    + 
Sbjct: 73  -LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 209 RFYIAQSVLAIESIH--KHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPL 256
           + ++ Q + +I  +H    N  HRDIKP N+L+++ +G +KL DFG  K L
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 15/157 (9%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNLLAEVASHC 167
           L  +G GA+G V    + ++G   A+KKL +   SE+ ++     +R    LL  +    
Sbjct: 30  LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKHMRHEN 85
Query: 168 IVKLYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
           ++ L   F   E L      YL+M ++ G D+             + +F + Q +  +  
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRI-QFLVYQMLKGLRY 143
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258
           IH    IHRD+KP NL ++++  +K+ DFGL +  D 
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 24  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 82
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 83  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 140
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 173

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 50  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 108
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 109 LLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 166
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 199

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 24  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 82
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 83  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 140
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 173

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 16/158 (10%)
Query: 111 LTIIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           ++ +G+G FG V LC+    G N  A+  +K+ +     Q    + E  +L  + S  IV
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 74
Query: 170 KLYYSFQDAEY------LYLIMEYLPGGDVXXXXXXXXXXXXXVARF--YIAQSVLAIES 221
           K    ++   Y      L L+MEYLP G                +R   Y +Q    +E 
Sbjct: 75  K----YRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLLLYSSQICKGMEY 129
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK--PLD 257
           +     +HRD+   N+L++   H+K++DFGL K  PLD
Sbjct: 130 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 167

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 32  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 91  LLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 148
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 181

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 23  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 82  LLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 139
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 25  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 83
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 84  LLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 141
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 142 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 174

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 33  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 149
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 182

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 16/158 (10%)
Query: 111 LTIIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           ++ +G+G FG V LC+    G N  A+  +K+ +     Q    + E  +L  + S  IV
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 75
Query: 170 KLYYSFQDAEY------LYLIMEYLPGGDVXXXXXXXXXXXXXVARF--YIAQSVLAIES 221
           K    ++   Y      L L+MEYLP G                +R   Y +Q    +E 
Sbjct: 76  K----YRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLLLYSSQICKGMEY 130
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK--PLD 257
           +     +HRD+   N+L++   H+K++DFGL K  PLD
Sbjct: 131 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 168

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 77/166 (46%), Gaps = 10/166 (6%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL-----KKSEMLSRGQVEHVRAE 156
           KI  + + ++  +G G    V L ++       A+K +     +K E L R + E   + 
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS- 65
Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSV 216
               ++++   IV +    ++ +  YL+MEY+ G  +              A  +  Q +
Sbjct: 66  ----SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQIL 121
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
             I+  H    +HRDIKP N+L+D N  +K+ DFG+ K L  T+L+
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 16/158 (10%)
Query: 111 LTIIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           ++ +G+G FG V LC+    G N  A+  +K+ +     Q    + E  +L  + S  IV
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 170 KLYYSFQDAEY------LYLIMEYLPGGDVXXXXXXXXXXXXXVARF--YIAQSVLAIES 221
           K    ++   Y      L L+MEYLP G                +R   Y +Q    +E 
Sbjct: 88  K----YRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK--PLD 257
           +     +HRD+   N+L++   H+K++DFGL K  PLD
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 150
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            + IHRD+KP NL ++++  +K+ DFGL +
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 150
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            + IHRD+KP NL ++++  +K+ DFGL +
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ ++ +G G  G V     K SG + A +KL   E+    + + +R E  +L E  S
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 63
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI--- 222
             IV  Y +F     + + ME++ GG +             +       S+  I+ +   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYL 120
Query: 223 -HKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             KH  +HRD+KP N+L++  G +KL DFG+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 150
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            + IHRD+KP NL ++++  +K+ DFGL +
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ ++ +G G  G V     K SG + A +KL   E+    + + +R E  +L E  S
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 63
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI--- 222
             IV  Y +F     + + ME++ GG +             +       S+  I+ +   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYL 120
Query: 223 -HKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             KH  +HRD+KP N+L++  G +KL DFG+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ ++ +G G  G V     K SG + A +KL   E+    + + +R E  +L E  S
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 63
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI--- 222
             IV  Y +F     + + ME++ GG +             +       S+  I+ +   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYL 120
Query: 223 -HKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             KH  +HRD+KP N+L++  G +KL DFG+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ ++ +G G  G V     K SG + A +KL   E+    + + +R E  +L E  S
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 63
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI--- 222
             IV  Y +F     + + ME++ GG +             +       S+  I+ +   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYL 120
Query: 223 -HKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             KH  +HRD+KP N+L++  G +KL DFG+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ ++ +G G  G V     K SG + A +KL   E+    + + +R E  +L E  S
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 66
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI--- 222
             IV  Y +F     + + ME++ GG +             +       S+  I+ +   
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYL 123
Query: 223 -HKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             KH  +HRD+KP N+L++  G +KL DFG+
Sbjct: 124 REKHKIMHRDVKPSNILVNSRGEIKLCDFGV 154

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           DDF+ ++ +G G  G V     K SG + A +KL   E+    + + +R E  +L E  S
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 63
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI--- 222
             IV  Y +F     + + ME++ GG +             +       S+  I+ +   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYL 120
Query: 223 -HKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             KH  +HRD+KP N+L++  G +KL DFG+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 20/162 (12%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
            + +D   L  IGRGA+G V     K SG I A+K++       R  V+  + ++ LL +
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-------RSTVDE-KEQKQLLMD 70
Query: 163 V-----ASHC--IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQS 215
           +     +S C  IV+ Y +       ++ ME +                  +    + + 
Sbjct: 71  LDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 216 VLAIESIHKH-----NYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            LA      H       IHRDIKP N+LLD++G++KL DFG+
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 105 VDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
            DD+ L   ++G G  G+V  C  +++G   A+K L  S   +R +V+H     +  A  
Sbjct: 8   TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQEVDH-----HWQASG 61
Query: 164 ASH--CIVKLYYSFQDAEY-LYLIMEYLPGGDVXXXXXXX--XXXXXXVARFYIAQSVLA 218
             H  CI+ +Y +    +  L +IME + GG++                A   +     A
Sbjct: 62  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 121
Query: 219 IESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCK 254
           I+ +H HN  HRD+KP+NLL    +++  +KL+DFG  K
Sbjct: 122 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
           D ++L  I+G G   EV L ++ +     A+K L+    L+R    ++R  R      A 
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAAL 69
Query: 165 SHCIVKLYYSFQDAE-----YLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           +H  +   Y   +AE       Y++MEY+ G  +              A   IA +  A+
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
              H++  IHRD+KP N+L+     +K+ DFG+ +
Sbjct: 130 NFSHQNGIIHRDVKPANILISATNAVKVVDFGIAR 164

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 6/168 (3%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           L + ++   D  +   +G G +GEV     KK     A+K LK+  M    +VE    E 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEA 58
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSV 216
            ++ E+    +V+L          Y+I+E++  G++              V   Y+A  +
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 217 L-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             A+E + K N+IHRD+   N L+ +N  +K++DFGL + +     +A
Sbjct: 119 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 166

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 2/141 (1%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +  V   + K + N+ A+K+++       G       E +LL ++    IV L+ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIK 233
                + L L+ EYL                    + ++ Q +  +   H+   +HRD+K
Sbjct: 68  IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127
Query: 234 PDNLLLDQNGHMKLSDFGLCK 254
           P NLL+++ G +KL+DFGL +
Sbjct: 128 PQNLLINERGELKLADFGLAR 148

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 105 VDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
            DD+ L   ++G G  G+V  C  +++G   A+K L  S   +R +V+H     +  A  
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQEVDH-----HWQASG 80
Query: 164 ASH--CIVKLYYSFQDAEY-LYLIMEYLPGGDVXXXXXXX--XXXXXXVARFYIAQSVLA 218
             H  CI+ +Y +    +  L +IME + GG++                A   +     A
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 219 IESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCK 254
           I+ +H HN  HRD+KP+NLL    +++  +KL+DFG  K
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
           H I   + ++  ++GRGAFG V  C+ K      A+K+++     S  + +    E   L
Sbjct: 3   HMIDYKEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIE-----SESERKAFIVELRQL 55
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA------Q 214
           + V    IVKLY +  +   + L+MEY  GG +              A   ++      Q
Sbjct: 56  SRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGH-MKLSDFG 251
            V  + S+     IHRD+KP NLLL   G  +K+ DFG
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
           H I   + ++  ++GRGAFG V  C+ K      A+K+++     S  + +    E   L
Sbjct: 4   HMIDYKEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIE-----SESERKAFIVELRQL 56
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA------Q 214
           + V    IVKLY +  +   + L+MEY  GG +              A   ++      Q
Sbjct: 57  SRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 114
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGH-MKLSDFG 251
            V  + S+     IHRD+KP NLLL   G  +K+ DFG
Sbjct: 115 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 152

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 59
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 60  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 118
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHR+++  N+L+      K++DFGL + ++    +A
Sbjct: 119 AFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTA 162

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I+E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I+E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ D+GL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDYGLARHTD 176

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I+E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 137
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTXTA 169

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
           D ++L  I+G G   EV L ++ +     A+K L+    L+R    ++R  R      A 
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAAL 69
Query: 165 SHCIVKLYYSFQDAEYL-----YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           +H  +   Y   +AE       Y++MEY+ G  +              A   IA +  A+
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
              H++  IHRD+KP N+++     +K+ DFG+ +
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I+E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 173

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
           D ++L  I+G G   EV L ++ +     A+K L+    L+R    ++R  R      A 
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAAL 69
Query: 165 SHCIVKLYYSFQDAEYL-----YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           +H  +   Y   +AE       Y++MEY+ G  +              A   IA +  A+
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
              H++  IHRD+KP N+++     +K+ DFG+ +
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 173

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 77/157 (49%), Gaps = 7/157 (4%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D++++  +IGRG++G V L  +K +    A+KK+ +         + +  E  +L  + S
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRM-FEDLIDCKRILREITILNRLKS 86
Query: 166 HCIVKLY-----YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
             I++L+           + LY+++E +   D+               +  +   +L  +
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEK 145
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            IH+   IHRD+KP N LL+Q+  +K+ DFGL + ++
Sbjct: 146 FIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTIN 182

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNLL--AEVASH 166
           T +G GA+G V    +K+SG   A+KKL +   SE+ ++      RA R LL    +   
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK------RAYRELLLLKHMQHE 101
Query: 167 CIVKLYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            ++ L   F  A  L      YL+M ++                    ++ + Q +  ++
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFM---QTDLQKIMGMEFSEEKIQYLVYQMLKGLK 158
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258
            IH    +HRD+KP NL ++++  +K+ DFGL +  D 
Sbjct: 159 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G+  A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ DF L +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFYLARHTD 176

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 173

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
           D ++L  I+G G   EV L ++ +     A+K L+    L+R    ++R  R      A 
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAAL 69
Query: 165 SHCIVKLYYSFQDAE-----YLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           +H  +   Y+  +AE       Y++MEY+ G  +              A   IA +  A+
Sbjct: 70  NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
              H++  IHRD+KP N+++     +K+ DFG+ +
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 137
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 169

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 41/231 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKK-SEMLSRGQVEHVRAERNLLAEVASHCIVKL 171
           ++G+G FG+      +++G +  MK+L +  E   R  ++ V+  R L        I  L
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 172 YYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA-IESIHKHNYIHR 230
           Y      + L  I EY+ GG +               R   A+ + + +  +H  N IHR
Sbjct: 77  YKD----KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGC 290
           D+   N L+ +N ++ ++DFGL +                        + VD        
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLAR------------------------LMVDE------- 161
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
               K+  E L+  +   RK  Y+ VG P ++APE++  + Y  + D  ++
Sbjct: 162 ----KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 170

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKL 171
           +GRG FG V  C E  S   Y  K  K+K ++ +       V+ E ++L       I+ L
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISILNIARHRNILHL 66
Query: 172 YYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLAIESIHKHNYIHR 230
           + SF+  E L +I E++ G D+                  Y+ Q   A++ +H HN  H 
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 231 DIKPDNLLLD--QNGHMKLSDFGLCKPL 256
           DI+P+N++    ++  +K+ +FG  + L
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQL 154

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 149
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 181

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 170

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-----HVRAERNLLAE 162
           +  ++ +G GAFG V    +K+      +K +KK ++L    +E      V  E  +L+ 
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 163 VASHCIVKLYYSFQDAEYLYLIME-YLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
           V    I+K+   F++  +  L+ME +  G D+             +A +   Q V A+  
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           +   + IHRDIK +N+++ ++  +KL DFG
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNLL--AEVASH 166
           T +G GA+G V    +K+SG   A+KKL +   SE+ ++      RA R LL    +   
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK------RAYRELLLLKHMQHE 83
Query: 167 CIVKLYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
            ++ L   F  A  L      YL+M ++                    ++ + Q +  ++
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFM---QTDLQKIMGLKFSEEKIQYLVYQMLKGLK 140
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258
            IH    +HRD+KP NL ++++  +K+ DFGL +  D 
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 14/163 (8%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
           ++G GA+ +V+     ++G  YA+K ++K    SR +V   R    L     +  I++L 
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV--FREVETLYQCQGNKNILELI 77
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDI 232
             F+D    YL+ E L GG +              A   +     A++ +H     HRD+
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 233 KPDNLLLDQN---GHMKLSDFGL---------CKPLDCTNLSA 263
           KP+N+L +       +K+ DF L         C P+    L+ 
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTT 180

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 173

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTXTA 173

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 140
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 170

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  +   L+  +G G  GEV +        + A+K LK+  M      +   AE NL+ 
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMK 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+I EY+  G +             + +     AQ    +
Sbjct: 64  QLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTA 166

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+    +V+L  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHKHNYIHRD 231
                   Y+I E++  G++              V   Y+A  +  A+E + K N+IHRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
           +   N L+ +N  +K++DFGL + +     +A
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+  FGL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILGFGLARHTD 176

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
           D ++L  I+G G   EV L ++ +     A+K L+    L+R    ++R  R      A 
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAAL 69
Query: 165 SHCIVKLYYSFQDAE-----YLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           +H  +   Y   +AE       Y++MEY+ G  +              A   IA +  A+
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
              H++  IHRD+KP N+++     +K+ DFG+ +
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
           D ++L  I+G G   EV L ++ +     A+K L+    L+R    ++R  R      A 
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAAL 86
Query: 165 SHCIVKLYYSFQDAE-----YLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
           +H  +   Y   +AE       Y++MEY+ G  +              A   IA +  A+
Sbjct: 87  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 146
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
              H++  IHRD+KP N+++     +K+ DFG+ +
Sbjct: 147 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 181

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E + P  D+             +AR +  Q + A+   H   
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 134
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFG 160

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M     ++  +  + L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRH 72
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           E     +V+LY +    E +Y++MEY+  G +             + +     AQ    +
Sbjct: 73  EK----LVQLY-AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ D GL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDAGLARHTD 176

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 19/159 (11%)
Query: 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH----- 166
            ++G+G +G V   ++  +    A+K++ + +          R  + L  E+A H     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---------RYSQPLHEEIALHKHLKH 78
Query: 167 -CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXX---XXXXXXVARFYIAQSVLAIESI 222
             IV+   SF +  ++ + ME +PGG +                   FY  Q +  ++ +
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138
Query: 223 HKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTN 260
           H +  +HRDIK DN+L++  +G +K+SDFG  K L   N
Sbjct: 139 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMK 68
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y++ EY+  G +             + +     AQ    +
Sbjct: 69  KIRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 7/156 (4%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+D +  +T +G G +GEV    +  +    A+K+++  E    G       E +LL E+
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-EHEEEGVPGTAIREVSLLKEL 90
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
               I++L         L+LI EY    D+             V + ++ Q +  +   H
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 224 KHNYIHRDIKPDNLLL-----DQNGHMKLSDFGLCK 254
               +HRD+KP NLLL      +   +K+ DFGL +
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ D GL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDRGLARHTD 176

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMK 68
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY    + E +Y+++EY+  G +             + +     AQ    +
Sbjct: 69  KLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +    ++ 
Sbjct: 27  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 171 LYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L   F  A  L      YL+  +L G D+             V +F I Q +  ++ IH 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHS 143
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            + IHRD+KP NL ++++  +K+ D GL +  D
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDGGLARHTD 176

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 75/157 (47%), Gaps = 7/157 (4%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D++ +  +IGRG++G V L  +K +    A+KK+ +         + +  E  +L  + S
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKS 84
Query: 166 HCIVKLYY-----SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIE 220
             I++LY           + LY+++E +   D+               +  +   +L   
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            IH+   IHRD+KP N LL+Q+  +K+ DFGL + ++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMK 68
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y+++EY+  G +             + +     AQ    +
Sbjct: 69  KLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 19/159 (11%)
Query: 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH----- 166
            ++G+G +G V   ++  +    A+K++ + +          R  + L  E+A H     
Sbjct: 14  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---------RYSQPLHEEIALHKHLKH 64
Query: 167 -CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXX---XXXXXXVARFYIAQSVLAIESI 222
             IV+   SF +  ++ + ME +PGG +                   FY  Q +  ++ +
Sbjct: 65  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 124
Query: 223 HKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTN 260
           H +  +HRDIK DN+L++  +G +K+SDFG  K L   N
Sbjct: 125 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 163

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ 
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMK 61
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY    + E +Y++ EY+  G +             + +     AQ    +
Sbjct: 62  KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 120
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 121 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 155

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 22/194 (11%)
Query: 75  DVPEEEQINI-LKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKS 130
           DVP EE   + L  L+R       L+  +++ D+F    I+GRG FG+V   RL      
Sbjct: 3   DVPAEEDPEVHLGQLKR-----FSLRELQVASDNFXNKNILGRGGFGKVYKGRLA----D 53
Query: 131 GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190
           G + A+K+LK+    ++G     + E  +++      +++L           L+  Y+  
Sbjct: 54  GXLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 191 GDVXXXXXXXXXXXXXV---ARFYIA-QSVLAIESIHKH---NYIHRDIKPDNLLLDQNG 243
           G V             +    R  IA  S   +  +H H     IHRD+K  N+LLD+  
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 244 HMKLSDFGLCKPLD 257
              + DFGL K +D
Sbjct: 172 EAVVGDFGLAKLMD 185

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ 
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMK 57
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y++ EY+  G +             + +     AQ    +
Sbjct: 58  KLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 116
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 117 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 151

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 22/194 (11%)
Query: 75  DVPEEEQINI-LKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKS 130
           DVP EE   + L  L+R       L+  +++ D+F    I+GRG FG+V   RL      
Sbjct: 11  DVPAEEDPEVHLGQLKR-----FSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----D 61
Query: 131 GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190
           G + A+K+LK+ E    G+++  + E  +++      +++L           L+  Y+  
Sbjct: 62  GTLVAVKRLKE-ERXQGGELQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 119
Query: 191 GDVXXXXXXXXXXXXXV---ARFYIA-QSVLAIESIHKH---NYIHRDIKPDNLLLDQNG 243
           G V             +    R  IA  S   +  +H H     IHRD+K  N+LLD+  
Sbjct: 120 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 179
Query: 244 HMKLSDFGLCKPLD 257
              + DFGL K +D
Sbjct: 180 EAVVGDFGLAKLMD 193

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           D  +   +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+   
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 276
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHK 224
            +V+L          Y+I E++  G++              V   Y+A  +  A+E + K
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            N+IHR++   N L+ +N  +K++DFGL +
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSR 366

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 68/143 (47%), Gaps = 8/143 (5%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G+G FGEV +     +  + A+K LK   M     ++  +  + L  E     +V+LY 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEK----LVQLY- 245
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAIESIHKHNYIHRD 231
           +    E +Y++ EY+  G +             + +     AQ    +  + + NY+HRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 232 IKPDNLLLDQNGHMKLSDFGLCK 254
           ++  N+L+ +N   K++DFGL +
Sbjct: 306 LRAANILVGENLVCKVADFGLAR 328

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M     ++  +  + L  
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRH 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           E     +V+LY +    E +Y++ EY+  G +             + +     AQ    +
Sbjct: 64  EK----LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 118
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 119 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 153

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/176 (22%), Positives = 80/176 (45%), Gaps = 8/176 (4%)
Query: 81  QINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK 140
           ++  +    + +T+ +     +I  +   L   +G+G FGEV +     +  + A+K LK
Sbjct: 242 RLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLK 300
Query: 141 KSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXX 200
              M      E    E  ++ ++    +V+LY    + E +Y++ EY+  G +       
Sbjct: 301 PGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE 355
Query: 201 XXXXXXVARFY--IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                 + +     AQ    +  + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 411

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 68/143 (47%), Gaps = 8/143 (5%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G+G FGEV +     +  + A+K LK   M     ++  +  + L  E     +V+LY 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEK----LVQLY- 245
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAIESIHKHNYIHRD 231
           +    E +Y++ EY+  G +             + +     AQ    +  + + NY+HRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 232 IKPDNLLLDQNGHMKLSDFGLCK 254
           ++  N+L+ +N   K++DFGL +
Sbjct: 306 LRAANILVGENLVCKVADFGLAR 328

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNXG 130
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M     ++  +  + L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRH 72
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           E     +V+LY +    E +Y++ EY+  G +             + +     AQ    +
Sbjct: 73  EK----LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 134
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFG 160

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M     ++  +  + L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRH 72
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           E     +V+LY +    E +Y++ EY+  G +             + +     AQ    +
Sbjct: 73  EK----LVQLY-AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 135
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMK 65
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY    + E +Y++ EY+  G +             + +     AQ    +
Sbjct: 66  KLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGM 124
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 125 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 159

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 150
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 149
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFG 175

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 6/159 (3%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           D  +   +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E+   
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 315
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXX-XXXXXXXVARFYIAQSVL-AIESIHK 224
            +V+L          Y+I E++  G++              V   Y+A  +  A+E + K
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
            N+IHR++   N L+ +N  +K++DFGL + +     +A
Sbjct: 376 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 414

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 133
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFG 159

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 149
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFG 175

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 150
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 150
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFG 176

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 135
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 135
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFG 161

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 157
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFG 183

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 9/154 (5%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEV 163
           ++ L  ++G+G FG V            A+K + ++ +L    +        E  LL +V
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 164 AS----HCIVKLYYSFQDAEYLYLIME-YLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA 218
            +      +++L   F+  E   L++E  LP  D+              +R +  Q V A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 219 IESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFG 251
           I+  H    +HRDIK +N+L+D + G  KL DFG
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMK 65
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY +    E +Y++ EY+  G +             + +     AQ    +
Sbjct: 66  KLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGM 124
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 125 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 159

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFG 156

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 169
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFG 195

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 177
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFG 203

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L+  +G G FGEV +     +  + A+K LK   M     +E    E  ++ 
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKV-AIKTLKPGTMSPESFLE----EAQIMK 59
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY    + E +Y++ EY+  G +             +       AQ    +
Sbjct: 60  KLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 118
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
             I + NYIHRD++  N+L+      K++DFGL + ++    +A
Sbjct: 119 AYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTA 162

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 163
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFG 189

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 162
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFG 188

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 177
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFG 203

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HC 167
           ++G G FG V            A+K ++K  +   G++ +   V  E  LL +V+S    
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 168 IVKLYYSFQDAEYLYLIMEYL-PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHN 226
           +++L   F+  +   LI+E   P  D+             +AR +  Q + A+   H   
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 182
Query: 227 YIHRDIKPDNLLLDQN-GHMKLSDFG 251
            +HRDIK +N+L+D N G +KL DFG
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFG 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 68/143 (47%), Gaps = 8/143 (5%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G+G FGEV +     +  + A+K LK   M     ++  +  + L  E     +V+LY 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEK----LVQLY- 245
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAIESIHKHNYIHRD 231
           +    E +Y++ EY+  G +             + +     AQ    +  + + NY+HRD
Sbjct: 246 AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 232 IKPDNLLLDQNGHMKLSDFGLCK 254
           ++  N+L+ +N   K++DFGL +
Sbjct: 306 LRAANILVGENLVCKVADFGLAR 328

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 76/165 (46%), Gaps = 8/165 (4%)
Query: 90  RKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ 149
           + +T+ +     +I  +   L   +G+G FGEV +     +  + A+K LK   M     
Sbjct: 169 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGNM----S 223
Query: 150 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVAR 209
            E    E  ++ ++    +V+LY +    E +Y++ EY+  G +             + +
Sbjct: 224 PEAFLQEAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 282
Query: 210 FY--IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                AQ    +  + + NY+HRD++  N+L+ +N   K++DFGL
Sbjct: 283 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 327

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 10/176 (5%)
Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEV-RLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           TE +  +   +    + +L  IG G   +V ++  EKK   IYA+K +   E  ++  ++
Sbjct: 15  TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQ--IYAIKYVNLEEADNQ-TLD 71
Query: 152 HVRAERNLLAEVASHC--IVKLY-YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
             R E   L ++  H   I++LY Y   D +Y+Y++ME     D+               
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKKSIDPWER 129
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
           + Y    + A+ +IH+H  +H D+KP N L+  +G +KL DFG+   +     S +
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 184

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMK 68
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY    + E +Y++ EY+  G +             + +     AQ    +
Sbjct: 69  KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD+   N+L+ +N   K++DFGL +
Sbjct: 128 AYVERMNYVHRDLAAANILVGENLVCKVADFGLAR 162

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 108 FDLLTIIGRGAFGEV-RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           + +L  IG G   +V ++  EKK   IYA+K +   E  ++  ++  R E   L ++  H
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 114
Query: 167 C--IVKLY-YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
              I++LY Y   D +Y+Y++ME     D+               + Y    + A+ +IH
Sbjct: 115 SDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
           +H  +H D+KP N L+  +G +KL DFG+   +     S +
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 212

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 108 FDLLTIIGRGAFGEV-RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           + +L  IG G   +V ++  EKK   IYA+K +   E  ++  ++  R E   L ++  H
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 114
Query: 167 C--IVKLY-YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
              I++LY Y   D +Y+Y++ME     D+               + Y    + A+ +IH
Sbjct: 115 SDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
           +H  +H D+KP N L+  +G +KL DFG+   +     S +
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 212

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 108 FDLLTIIGRGAFGEV-RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           + +L  IG G   +V ++  EKK   IYA+K +   E  ++  ++  R E   L ++  H
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK--QIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 114
Query: 167 C--IVKLY-YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
              I++LY Y   D +Y+Y++ME     D+               + Y    + A+ +IH
Sbjct: 115 SDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
           +H  +H D+KP N L+  +G +KL DFG+   +     S +
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSG--NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +D     +IG G FG+V   + KK G     A+K++K  E  S+        E  +L ++
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKL 72
Query: 164 ASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES- 221
             H  I+ L  + +   YLYL +EY P G++              A F IA S  +  S 
Sbjct: 73  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA-FAIANSTASTLSS 131
Query: 222 ----------------IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                           + +  +IHRD+   N+L+ +N   K++DFGL +
Sbjct: 132 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 108 FDLLTIIGRGAFGEV-RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           + +L  IG G   +V ++  EKK   IYA+K +   E  ++  ++  R E   L ++  H
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQ--IYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 67
Query: 167 C--IVKLY-YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
              I++LY Y   D +Y+Y++ME     D+               + Y    + A+ +IH
Sbjct: 68  SDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
           +H  +H D+KP N L+  +G +KL DFG+   +     S +
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 165

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M     ++  +  + L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRH 72
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           E     +V+LY +    E +Y++ EY+  G +             + +     AQ    +
Sbjct: 73  EK----LVQLY-AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 128 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSG--NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +D     +IG G FG+V   + KK G     A+K++K  E  S+        E  +L ++
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKL 82
Query: 164 ASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES- 221
             H  I+ L  + +   YLYL +EY P G++              A F IA S  +  S 
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA-FAIANSTASTLSS 141
Query: 222 ----------------IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                           + +  +IHRD+   N+L+ +N   K++DFGL +
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 12/163 (7%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           LKR  + + D +L    G G FG VR  + + +K     A+K LK+     +   E +  
Sbjct: 6   LKRDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMR 59
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXX--XXXXVARFYIA 213
           E  ++ ++ +  IV+L    Q AE L L+ME   GG +               VA   + 
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LH 117
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           Q  + ++ + + N++HRD+   N+LL    + K+SDFGL K L
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +++ +  LL  IG+G FG+V L   +  GN  A+K +K          +   AE +++ +
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQ 70
Query: 163 VASHCIVKLY-YSFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVLA 218
           +    +V+L     ++   LY++ EY+  G   D              + +F +     A
Sbjct: 71  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEA 129
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
           +E +  +N++HRD+   N+L+ ++   K+SDFGL K    T
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 108 FDLLTIIGRGAFGEV-RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           + +L  IG G   +V ++  EKK   IYA+K +   E  ++  ++  R E   L ++  H
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQ--IYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 70
Query: 167 C--IVKLY-YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
              I++LY Y   D +Y+Y++ME     D+               + Y    + A+ +IH
Sbjct: 71  SDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 128
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
           +H  +H D+KP N L+  +G +KL DFG+   +     S +
Sbjct: 129 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 168

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +++ +  LL  IG+G FG+V L   +  GN  A+K +K          +   AE +++ +
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQ 242
Query: 163 VASHCIVKLY-YSFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVLA 218
           +    +V+L     ++   LY++ EY+  G   D              + +F +     A
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEA 301
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
           +E +  +N++HRD+   N+L+ ++   K+SDFGL K    T
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 108 FDLLTIIGRGAFGEV-RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           + +L  IG G   +V ++  EKK   IYA+K +   E  ++  ++  R E   L ++  H
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQ--IYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 66
Query: 167 C--IVKLY-YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIH 223
              I++LY Y   D +Y+Y++ME     D+               + Y    + A+ +IH
Sbjct: 67  SDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 124
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
           +H  +H D+KP N L+  +G +KL DFG+   +     S +
Sbjct: 125 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 164

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +++ +  LL  IG+G FG+V L   +  GN  A+K +K          +   AE +++ +
Sbjct: 9   LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQ 61
Query: 163 VASHCIVKLY-YSFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVLA 218
           +    +V+L     ++   LY++ EY+  G   D              + +F +     A
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEA 120
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
           +E +  +N++HRD+   N+L+ ++   K+SDFGL K    T
Sbjct: 121 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 161

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +++ +  LL  IG+G FG+V L   +  GN  A+K +K          +   AE +++ +
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQ 55
Query: 163 VASHCIVKLY-YSFQDAEYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVLA 218
           +    +V+L     ++   LY++ EY+  G   D              + +F +     A
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEA 114
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
           +E +  +N++HRD+   N+L+ ++   K+SDFGL K    T
Sbjct: 115 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 10/165 (6%)
Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEV-RLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           TE +  +   +    + +L  IG G   +V ++  EKK   IYA+K +   E  ++  ++
Sbjct: 15  TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQ--IYAIKYVNLEEADNQ-TLD 71
Query: 152 HVRAERNLLAEVASHC--IVKLY-YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
             R E   L ++  H   I++LY Y   D +Y+Y++ME     D+               
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKKSIDPWER 129
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
           + Y    + A+ +IH+H  +H D+KP N L+  +G +KL DFG+ 
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 114 IGRGAFGEVRL-CQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +G G FG+V L C +     +G + A+K LK             + E ++L  +    I+
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHII 96
Query: 170 KLYYSFQDA--EYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHN 226
           K     +DA    L L+MEY+P G +             +  F  AQ +   +  +H  +
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQICEGMAYLHAQH 154
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           YIHRD+   N+LLD +  +K+ DFGL K
Sbjct: 155 YIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           +++L +IG+G+FG+V    + K     A+K ++  +   R   E +R   +L  +   + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 168 --IVKLYYSFQDAEYLYLIMEYLPGG--DVXXXXXXXXXXXXXVARFYIAQSVL-AIESI 222
             ++ +  +F    ++ +  E L     ++             V +F  A S+L  ++++
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDAL 216
Query: 223 HKHNYIHRDIKPDNLLLDQNGH--MKLSDFG 251
           HK+  IH D+KP+N+LL Q G   +K+ DFG
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 47/192 (24%)
Query: 86  KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
           +DL+ K    +  +  ++  DD + +  +GRGA+G V   +   SG I A+K++      
Sbjct: 31  RDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI------ 84
Query: 146 SRGQVEHVRAERNLL------AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXX 199
            R  V     +R L+        V     V  Y +      +++ ME +           
Sbjct: 85  -RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM----------- 132
Query: 200 XXXXXXXVARFY-----------------IAQSVL-AIESIH-KHNYIHRDIKPDNLLLD 240
                  + +FY                 IA S++ A+E +H K + IHRD+KP N+L++
Sbjct: 133 ----DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 188
Query: 241 QNGHMKLSDFGL 252
             G +K+ DFG+
Sbjct: 189 ALGQVKMCDFGI 200

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 18/197 (9%)
Query: 70  KLASSDVPEEEQINI------LKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVR 123
           ++ S D P    ++         D E  + + + LKR  + + D +L    G G FG VR
Sbjct: 298 RITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIEL----GCGNFGSVR 353
Query: 124 --LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181
             + + +K     A+K LK+     +   E +  E  ++ ++ +  IV+L    Q AE L
Sbjct: 354 QGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEAL 410
Query: 182 YLIMEYLPGGDVXXXXXXXXX--XXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 239
            L+ME   GG +               VA   + Q  + ++ + + N++HR++   N+LL
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKNFVHRNLAARNVLL 469
Query: 240 DQNGHMKLSDFGLCKPL 256
               + K+SDFGL K L
Sbjct: 470 VNRHYAKISDFGLSKAL 486

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           +++L +IG+G+FG+V    + K     A+K ++  +   R   E +R   +L  +   + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 168 --IVKLYYSFQDAEYLYLIMEYLPGG--DVXXXXXXXXXXXXXVARFYIAQSVL-AIESI 222
             ++ +  +F    ++ +  E L     ++             V +F  A S+L  ++++
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDAL 216
Query: 223 HKHNYIHRDIKPDNLLLDQNGH--MKLSDFG 251
           HK+  IH D+KP+N+LL Q G   +K+ DFG
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ 
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMK 58
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY--IAQSVLAI 219
           ++    +V+LY    + E + ++ EY+  G +             + +     AQ    +
Sbjct: 59  KLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 117
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             + + NY+HRD++  N+L+ +N   K++DFGL +
Sbjct: 118 AYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 152

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 19/169 (11%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAERNLLAEV 163
           + DF+ +  +GRG FG V   + K     YA+K+++  +  L+R   E V  E   LA++
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR---EKVMREVKALAKL 60
Query: 164 ASHCIVKLYYSFQDAE------------YLYLIMEYLPG---GDVXXXXXXXXXXXXXVA 208
               IV+ + ++ +              YLY+ M+        D              V 
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
                Q   A+E +H    +HRD+KP N+    +  +K+ DFGL   +D
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSG--NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +D     +IG G FG+V   + KK G     A+K++K  E  S+        E  +L ++
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKL 79
Query: 164 ASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES- 221
             H  I+ L  + +   YLYL +EY P G++              A F IA S  +  S 
Sbjct: 80  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA-FAIANSTASTLSS 138
Query: 222 ----------------IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                           + +  +IHR++   N+L+ +N   K++DFGL +
Sbjct: 139 QQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 22/187 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +   G   A+KKL + 
Sbjct: 8   NQFYSVEVADSTFTVLKRYQ-------QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 255 PLDCTNL 261
              CTN 
Sbjct: 175 -TACTNF 180

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 114 IGRGAFGEVRLCQE-KKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASHC-I 168
           IG GA+G+V   ++ K  G   A+K+++     E +    +  V   R+L  E   H  +
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL--ETFEHPNV 76
Query: 169 VKLY----YSFQDAEY-LYLIMEYLPGG-DVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
           V+L+     S  D E  L L+ E++                     +  + Q +  ++ +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP N+L+  +G +KL+DFGL +
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 74/151 (49%), Gaps = 9/151 (5%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
           +++L +IG+G FG+V    + K     A+K ++  +   R   E +R   +L  +   + 
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 168 --IVKLYYSFQDAEYLYLIMEYLPGG--DVXXXXXXXXXXXXXVARFYIAQSVL-AIESI 222
             ++ +  +F    ++ +  E L     ++             V +F  A S+L  ++++
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDAL 216
Query: 223 HKHNYIHRDIKPDNLLLDQNGH--MKLSDFG 251
           HK+  IH D+KP+N+LL Q G   +K+ DFG
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 14/150 (9%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG-QVEHVRAERNLLAEVASHCIVKL 171
           +IG G+FG V   +  +S  +   K L+     +R  Q+  +    N++   A       
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKA------F 100
Query: 172 YYSFQDAE---YLYLIMEYLPGGDVXXX---XXXXXXXXXXVARFYIAQSVLAIESIHKH 225
           +YS  D +   +L L++EY+P                    + + Y+ Q + ++  IH  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 226 NYIHRDIKPDNLLLD-QNGHMKLSDFGLCK 254
              HRDIKP NLLLD  +G +KL DFG  K
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 114 IGRGAFGEVRLCQE-KKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASHC-I 168
           IG GA+G+V   ++ K  G   A+K+++     E +    +  V   R+L  E   H  +
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL--ETFEHPNV 76
Query: 169 VKLY----YSFQDAEY-LYLIMEYLPGG-DVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
           V+L+     S  D E  L L+ E++                     +  + Q +  ++ +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP N+L+  +G +KL+DFGL +
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 114 IGRGAFGEVRLCQE-KKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASHC-I 168
           IG GA+G+V   ++ K  G   A+K+++     E +    +  V   R+L  E   H  +
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL--ETFEHPNV 76
Query: 169 VKLY----YSFQDAEY-LYLIMEYLPGG-DVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
           V+L+     S  D E  L L+ E++                     +  + Q +  ++ +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H H  +HRD+KP N+L+  +G +KL+DFGL +
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 44/191 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVAS 165
           + L   IG+G++G VR+  E ++  I A+K + K+++  ++   VE ++ E  L+ ++  
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-------- 217
             I +LY  ++D +Y+ L+ME   GG +                  + ++ +        
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 218 -AIE-SIHKH------------------------NYIH------RDIKPDNLLLDQNG-- 243
            AI  SIH                          +Y+H      RDIKP+N L   N   
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 244 HMKLSDFGLCK 254
            +KL DFGL K
Sbjct: 208 EIKLVDFGLSK 218

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 9/151 (5%)
Query: 114 IGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +G G FG+V LC    +   +G   A+K LK         +  ++ E  +L  +    IV
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 86
Query: 170 KL--YYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLAIESIHKHN 226
           K     +      + LIME+LP G +               +  Y  Q    ++ +    
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           Y+HRD+   N+L++    +K+ DFGL K ++
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 9/151 (5%)
Query: 114 IGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +G G FG+V LC    +   +G   A+K LK         +  ++ E  +L  +    IV
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 74
Query: 170 KL--YYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLAIESIHKHN 226
           K     +      + LIME+LP G +               +  Y  Q    ++ +    
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           Y+HRD+   N+L++    +K+ DFGL K ++
Sbjct: 135 YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 165

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L  +G GA+G V    + +     A+KKL +    S         E  LL  +    ++ 
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 171 LY------YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L        S +D   +YL+   + G D+             V +F + Q +  ++ IH 
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHV-QFLVYQLLRGLKYIHS 149
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              IHRD+KP N+ ++++  +++ DFGL +  D
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQAD 182

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 86  KDLERKETEYMRLKRHKIS--VDDFDLLTI------IGRGAFGEVRLCQEKKSGNIYAMK 137
           K LE  +T +     +++    ++FD   I      +G G FG V   +   +    A+K
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVK 60
Query: 138 KLKKSEMLSRGQV-EHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXX 196
           KL     ++  ++ +    E  ++A+     +V+L     D + L L+  Y+P G +   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 197 XXXXXXXXXXV--ARFYIAQSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
                         R  IAQ     I  +H++++IHRDIK  N+LLD+    K+SDFGL 
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 254 K 254
           +
Sbjct: 181 R 181

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 86  KDLERKETEYMRLKRHKIS--VDDFDLLTI------IGRGAFGEVRLCQEKKSGNIYAMK 137
           K LE  +T +     +++    ++FD   I      +G G FG V   +   +    A+K
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVK 60
Query: 138 KLKKSEMLSRGQV-EHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXX 196
           KL     ++  ++ +    E  ++A+     +V+L     D + L L+  Y+P G +   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 197 XXXXXXXXXXV--ARFYIAQSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
                         R  IAQ     I  +H++++IHRDIK  N+LLD+    K+SDFGL 
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 254 K 254
           +
Sbjct: 181 R 181

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 3/150 (2%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +D  L   IGRG FGEV   + +    + A+K  +  E L          E  +L + + 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR--ETLPPDLKAKFLQEARILKQYSH 171
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLAIESIHK 224
             IV+L       + +Y++ME + GGD                    +  +   +E +  
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
              IHRD+   N L+ +   +K+SDFG+ +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I   D   L  +G G FG V+  + +   ++ A+K +K+  M     +E  +   NL  
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMNLSH 78
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIE 220
           E     +V+LY        +++I EY+  G +                  + + V  A+E
Sbjct: 79  EK----LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +    ++HRD+   N L++  G +K+SDFGL +
Sbjct: 135 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 3/150 (2%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +D  L   IGRG FGEV   + +    + A+K  +  E L          E  +L + + 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR--ETLPPDLKAKFLQEARILKQYSH 171
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARF-YIAQSVLAIESIHK 224
             IV+L       + +Y++ME + GGD                    +  +   +E +  
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
              IHRD+   N L+ +   +K+SDFG+ +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I   D   L  +G G FG V+  + +   ++ A+K +K+  M     +E  +   NL  
Sbjct: 4   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMNLSH 62
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIE 220
           E     +V+LY        +++I EY+  G +                  + + V  A+E
Sbjct: 63  EK----LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 118
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +    ++HRD+   N L++  G +K+SDFGL +
Sbjct: 119 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 152

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I   D   L  +G G FG V+  + +   ++ A+K +K+  M     +E  +   NL  
Sbjct: 11  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMNLSH 69
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIE 220
           E     +V+LY        +++I EY+  G +                  + + V  A+E
Sbjct: 70  EK----LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 125
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +    ++HRD+   N L++  G +K+SDFGL +
Sbjct: 126 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 159

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I   D   L  +G G FG V+  + +   ++ A+K +K+  M     +E  +   NL  
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMNLSH 78
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIE 220
           E     +V+LY        +++I EY+  G +                  + + V  A+E
Sbjct: 79  EK----LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +    ++HRD+   N L++  G +K+SDFGL +
Sbjct: 135 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I   D   L  +G G FG V+  + +   ++ A+K +K+  M     +E  +   NL  
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMNLSH 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIE 220
           E     +V+LY        +++I EY+  G +                  + + V  A+E
Sbjct: 64  EK----LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +    ++HRD+   N L++  G +K+SDFGL +
Sbjct: 120 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I   D   L  +G G FG V+  + +   ++ A+K +K+  M     +E  +   NL  
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMNLSH 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIE 220
           E     +V+LY        +++I EY+  G +                  + + V  A+E
Sbjct: 64  EK----LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +    ++HRD+   N L++  G +K+SDFGL +
Sbjct: 120 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 52  LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 110
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 111 A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 67/150 (44%), Gaps = 7/150 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168
           +IG G FGEV     K S        A+K LK     +  Q      E  ++ + + H I
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 169 VKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA-IESIHKHNY 227
           ++L       + + +I EY+  G +             +    + + + A ++ +   NY
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLE 198

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 8   LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 66
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 67  A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 58  LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 116
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 117 A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 167
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 168 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 218

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 111 LTIIGRGAFG----------EVRLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAER 157
           L+ IG GA+G          +VR+  +K S      Y  + L++ ++L R + E++    
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL 217
           +++             + +  + +YL+  +L G D+             +  +++ Q + 
Sbjct: 108 DIIRAP----------TIEQMKDVYLV-THLMGADLYKLLKTQHLSNDHIC-YFLYQILR 155
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVAD 195

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEV------RLCQEKKSGNIYAMKKLKKSEML 145
           +T    +KRH I      L   +G GAFG+V       LC E+    + A+K LK +   
Sbjct: 4   DTFVQHIKRHNIV-----LKRELGEGAFGKVFLAECYNLCPEQDK-ILVAVKTLKDASDN 57
Query: 146 SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXX 205
           +R   +    E  LL  +    IVK Y    + + L ++ EY+  GD+            
Sbjct: 58  AR---KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAV 114
Query: 206 XVAR------------FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            +A              +IAQ + A +  +   +++HRD+   N L+ +N  +K+ DFG+
Sbjct: 115 LMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGM 174
Query: 253 CKPLDCTN 260
            + +  T+
Sbjct: 175 SRDVYSTD 182

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 6   LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 64
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 65  A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 115
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 116 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 18/147 (12%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           +F  L  IG G FG V  C ++  G IYA+K+ KK      G V+    E+N L EV +H
Sbjct: 10  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---GSVD----EQNALREVYAH 62
Query: 167 C-------IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-- 217
                   +V+ + ++ + +++ +  EY  GG +                  +   +L  
Sbjct: 63  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 218 --AIESIHKHNYIHRDIKPDNLLLDQN 242
              +  IH  + +H DIKP N+ + + 
Sbjct: 123 GRGLRYIHSMSLVHMDIKPSNIFISRT 149

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 18/147 (12%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           +F  L  IG G FG V  C ++  G IYA+K+ KK      G V+    E+N L EV +H
Sbjct: 10  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---GSVD----EQNALREVYAH 62
Query: 167 C-------IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-- 217
                   +V+ + ++ + +++ +  EY  GG +                  +   +L  
Sbjct: 63  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 218 --AIESIHKHNYIHRDIKPDNLLLDQN 242
              +  IH  + +H DIKP N+ + + 
Sbjct: 123 GRGLRYIHSMSLVHMDIKPSNIFISRT 149

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 6   LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 64
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 65  A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 115
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 116 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L  +G GA+G V    + +     A+KKL +    S         E  LL  +    ++ 
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 171 LY------YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L        S +D   +YL+   + G D+             V +F + Q +  ++ IH 
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHV-QFLVYQLLRGLKYIHS 149
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              IHRD+KP N+ ++++  +++ DFGL +  D
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQAD 182

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 14  LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 72
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 73  A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 123
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 124 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 174

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 6/153 (3%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I   D   L  +G G FG V+  + +   ++ A+K +K+  M     +E  +   NL  E
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMNLSHE 59
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIES 221
                +V+LY        +++I EY+  G +                  + + V  A+E 
Sbjct: 60  K----LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           +    ++HRD+   N L++  G +K+SDFGL +
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 12  LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 70
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 71  A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 121
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 122 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 172

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 18/147 (12%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           +F  L  IG G FG V  C ++  G IYA+K+ KK      G V+    E+N L EV +H
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---GSVD----EQNALREVYAH 64
Query: 167 C-------IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-- 217
                   +V+ + ++ + +++ +  EY  GG +                  +   +L  
Sbjct: 65  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 218 --AIESIHKHNYIHRDIKPDNLLLDQN 242
              +  IH  + +H DIKP N+ + + 
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRT 151

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 22  LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 80
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 81  A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 131
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 132 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 182

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 13  LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 71
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 72  A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 122
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 123 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 173

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 18/147 (12%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           +F  L  IG G FG V  C ++  G IYA+K+ KK      G V+    E+N L EV +H
Sbjct: 8   EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---GSVD----EQNALREVYAH 60
Query: 167 C-------IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-- 217
                   +V+ + ++ + +++ +  EY  GG +                  +   +L  
Sbjct: 61  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 120
Query: 218 --AIESIHKHNYIHRDIKPDNLLLDQN 242
              +  IH  + +H DIKP N+ + + 
Sbjct: 121 GRGLRYIHSMSLVHMDIKPSNIFISRT 147

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 8   LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 66
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 67  A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 7   LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 65
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 66  A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 116
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 117 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 167

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 8   LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 66
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ME L GG++               
Sbjct: 67  A---------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 6/145 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQV-EHVRAERNLLAEVASHCIVKLY 172
           +G G FG V   +   +    A+KKL     ++  ++ +    E  ++A+     +V+L 
Sbjct: 33  MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 173 YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXV--ARFYIAQSVL-AIESIHKHNYIH 229
               D + L L+  Y+P G +                 R  IAQ     I  +H++++IH
Sbjct: 91  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 150
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCK 254
           RDIK  N+LLD+    K+SDFGL +
Sbjct: 151 RDIKSANILLDEAFTAKISDFGLAR 175

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 72/163 (44%), Gaps = 19/163 (11%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC----- 167
           ++G GA   V+ C    +   YA+K ++K       Q  H+R+      E+   C     
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK-------QPGHIRSRVFREVEMLYQCQGHRN 72
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           +++L   F++ +  YL+ E + GG +              A   +     A++ +H    
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 228 IHRDIKPDNLLL---DQNGHMKLSDFGLCKPL----DCTNLSA 263
            HRD+KP+N+L    +Q   +K+ DFGL   +    DC+ +S 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +I   +  L T IG G+FG V   + K  G++ A+K LK  +       E  +A RN +A
Sbjct: 32  EIEASEVMLSTRIGSGSFGTV--YKGKWHGDV-AVKILKVVDPTP----EQFQAFRNEVA 84
Query: 162 EV--ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLA 218
            +    H  + L+  +   + L ++ ++  G  +                  IA Q+   
Sbjct: 85  VLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQG 144
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
           ++ +H  N IHRD+K +N+ L +   +K+ DFGL 
Sbjct: 145 MDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 13/162 (8%)
Query: 95  YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +M LKR +I+     LL  +G G FG V+L + K   ++ A+K +K+  M    + E  +
Sbjct: 2   HMELKREEIT-----LLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM---SEDEFFQ 52
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEY-LYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA 213
             + ++    SH  +  +Y     EY +Y++ EY+  G +                  + 
Sbjct: 53  EAQTMMK--LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110
Query: 214 QSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             V   +  +  H +IHRD+   N L+D++  +K+SDFG+ +
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 78/189 (41%), Gaps = 27/189 (14%)
Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK------KSEML 145
           ET+Y   KR  +   DF  + +IG G FG+V   + +  G  Y ++++K      + E+ 
Sbjct: 1   ETKYTVDKRFGM---DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVK 57
Query: 146 SRGQVEHVRAER--------NLLAEVASHCIVKLYYSFQDAEY--------LYLIMEYLP 189
           +  +++HV            +   E +   +    Y  ++++         L++ ME+  
Sbjct: 58  ALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCD 117
Query: 190 GGDVXX--XXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247
            G +               +A     Q    ++ IH    IHRD+KP N+ L     +K+
Sbjct: 118 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKI 177
Query: 248 SDFGLCKPL 256
            DFGL   L
Sbjct: 178 GDFGLVTSL 186

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 9/153 (5%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           L  +G GA+G V    + +     A+KKL +    S         E  LL  +    ++ 
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 171 LY------YSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHK 224
           L        S +D   +YL+   + G D+             V +F + Q +  ++ IH 
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHV-QFLVYQLLRGLKYIHS 141
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              IHRD+KP N+ ++++  +++ DFGL +  D
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 174

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASH-CI 168
           L  IG GA G V    +       A+KKL +     + Q    RA R L L +V +H  I
Sbjct: 29  LKPIGSGAQGIVVAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 169 VKLYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
           + L   F   + L      Y++ME +   D                 + + Q ++ I+ +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM---DANLSQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 114 IGRGAFGEVRL-CQEKK---SGNIYAMKKLKKS--EMLSRGQVEHVRAERNLLAEVASHC 167
           +G G FG+V L C +     +G + A+K LK+     L  G    +   R L  E     
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEH---- 71
Query: 168 IVKLYYSFQDA--EYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHK 224
           IVK     +D   + + L+MEY+P G +             +  F  AQ +   +  +H 
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLF--AQQICEGMAYLHA 129
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +YIHR +   N+LLD +  +K+ DFGL K
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 114 IGRGAFGEVRL-CQEKK---SGNIYAMKKLKKS--EMLSRGQVEHVRAERNLLAEVASHC 167
           +G G FG+V L C +     +G + A+K LK+     L  G    +   R L  E     
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEH---- 72
Query: 168 IVKLYYSFQDA--EYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHK 224
           IVK     +D   + + L+MEY+P G +             +  F  AQ +   +  +H 
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLF--AQQICEGMAYLHA 130
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +YIHR +   N+LLD +  +K+ DFGL K
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVAD 177

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 35/170 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  DD + +  +GRGA+G V   +   SG I A+K+++ + + S+ Q   +      + 
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY---------- 211
            V     V  Y +      +++ ME +                  + +FY          
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM---------------DTSLDKFYKQVIDKGQTI 106
Query: 212 -------IAQSVL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                  IA S++ A+E +H K + IHRD+KP N+L++  G +K+ DFG+
Sbjct: 107 PEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 114 IGRGAFGEVRL-CQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +G G FG+V L C +     +G + A+K LK             + E ++L  +    I+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHEHII 79
Query: 170 KLYYSFQDA--EYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHN 226
           K     +D   + L L+MEY+P G +             +  F  AQ +   +  +H  +
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQICEGMAYLHSQH 137
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           YIHR++   N+LLD +  +K+ DFGL K
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 25/160 (15%)
Query: 111 LTIIGRGAFGEV----------RLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAER 157
           L  IG GA+G V          R+  +K S      Y  + L++ ++L R + E+V   R
Sbjct: 48  LQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIR 107
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL 217
           ++L       +  +Y           I++ L   D+             +  +++ Q + 
Sbjct: 108 DILRASTLEAMRDVY-----------IVQDLMETDLYKLLKSQQLSNDHIC-YFLYQILR 155
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            ++ IH  N +HRD+KP NLL++    +K+ DFGL +  D
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIAD 195

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 22/171 (12%)
Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R    H R
Sbjct: 52  LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWR 110
Query: 155 AERNLLAEVASHC-----IVKLYYS-FQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA 208
           A         S C     IV +Y + +   + L ++ E L GG++               
Sbjct: 111 A---------SQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTER 161
Query: 209 RFY-IAQSV-LAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCK 254
               I +S+  AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K
Sbjct: 162 EASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 114 IGRGAFGEVRL-CQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +G G FG+V L C +     +G + A+K LK             + E ++L  +    I+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHEHII 79
Query: 170 KLYYSFQDA--EYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHN 226
           K     +D   + L L+MEY+P G +             +  F  AQ +   +  +H  +
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQICEGMAYLHAQH 137
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           YIHR++   N+LLD +  +K+ DFGL K
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +V +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q ++ I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 62/124 (50%), Gaps = 7/124 (5%)
Query: 135 AMKKLKKSEMLSRGQVEH---VRAERNLLAEVAS--HCIVKLYYSFQDAEYLYLIMEYL- 188
           A+K ++K  +   G++ +   V  E  LL +V+S    +++L   F+  +   LI+E   
Sbjct: 80  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 139
Query: 189 PGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKL 247
           P  D+             +AR +  Q + A+   H    +HRDIK +N+L+D N G +KL
Sbjct: 140 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 199
Query: 248 SDFG 251
            DFG
Sbjct: 200 IDFG 203

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVAD 175

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +V +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q ++ I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVAD 179

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 65/168 (38%), Gaps = 25/168 (14%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           DF  + +IG G FG+V   + +  G  Y +K++K +        E    E   LA++   
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64
Query: 167 CIVKLYYSFQDAEY----------------LYLIMEYLPGGDVXX--XXXXXXXXXXXVA 208
            IV     +   +Y                L++ ME+   G +               +A
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
                Q    ++ IH    I+RD+KP N+ L     +K+ DFGL   L
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVAD 179

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVAD 175

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVAD 175

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 177

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 136 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 183

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 175

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 177

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 126 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 173

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 126 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 173

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 175

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 133 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 180

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 134 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 181

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 125 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 172

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 195

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/48 (39%), Positives = 31/48 (64%)
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +++ Q +  ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 133 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 180

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/168 (23%), Positives = 70/168 (41%), Gaps = 24/168 (14%)
Query: 114 IGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168
           +G GAFG+V L +       K   + A+K LK   + +R   +    E  LL  +    I
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQHEHI 79
Query: 169 VKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVA---------------RFYIA 213
           VK Y    D + L ++ EY+  GD+             +                  +IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 214 QSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
             + + +  +   +++HRD+   N L+  N  +K+ DFG+ + +  T+
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/166 (22%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK--------------LKKSEMLSRGQVE 151
           D +++  +IG G++G V    +K    + A+KK              L++  +L+R   +
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY 211
           HV        +V    I K    F +   LY+++E +   D                +  
Sbjct: 113 HV-------VKVLDIVIPKDVEKFDE---LYVVLE-IADSDFKKLFRTPVYLTELHIKTL 161
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +   ++ ++ +H    +HRD+KP N L++Q+  +K+ DFGL + +D
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +V +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 32  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRKT-RHVNILLFM 86
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +  A  L ++ ++  G  +                  IA Q+   ++ +H  + IHRD+
Sbjct: 87  GYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLA 167

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 68/141 (48%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 16  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK-TRHVNILLFM 70
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +  A  L ++ ++  G  +             +    IA Q+   ++ +H  + IHRD+
Sbjct: 71  GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLA 151

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 7/157 (4%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL----- 159
           V  ++ L  IG+G FGEV   + +K+G   A+KK+          +  +R  + L     
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 160 --LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL 217
             +  +   C  K     +    +YL+ ++                     +  +   + 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +  IH++  +HRD+K  N+L+ ++G +KL+DFGL +
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 6/144 (4%)
Query: 115 GRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQV-EHVRAERNLLAEVASHCIVKLYY 173
           G G FG V   +   +    A+KKL     ++  ++ +    E  + A+     +V+L  
Sbjct: 31  GEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXV--ARFYIAQSVL-AIESIHKHNYIHR 230
              D + L L+  Y P G +                 R  IAQ     I  +H++++IHR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCK 254
           DIK  N+LLD+    K+SDFGL +
Sbjct: 149 DIKSANILLDEAFTAKISDFGLAR 172

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 30/160 (18%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKS---EMLSRGQVEHVRAERNLLAEVASHCI-- 168
           IG GA+G V   ++  SG+  A+K ++     E L    V  V   R L A    + +  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 169 --------------VKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
                         V L +   D +    + +  P G                 +  + Q
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-----------LPAETIKDLMRQ 120
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +  ++ +H +  +HRD+KP+N+L+   G +KL+DFGL +
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 160

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 14/152 (9%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASH-CI 168
           L  IG GA G V    +   G   A+KKL +     + Q    RA R L L +  +H  I
Sbjct: 27  LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 169 VKLYYSFQDAEYL------YLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI 222
           + L   F   + L      YL+ME +   D                 + + Q +  I+ +
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELM---DANLCQVIHMELDHERMSYLLYQMLCGIKHL 140
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 141 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 172

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKS---EMLSRGQVEHVRAERNLLAEVASHC-IV 169
           IG GA+G V   ++  SG+  A+K ++     E L    V  V   R L  E   H  +V
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL--EAFEHPNVV 69
Query: 170 KLY----YSFQDAEY-LYLIMEYLPGGDVXX--XXXXXXXXXXXVARFYIAQSVLAIESI 222
           +L      S  D E  + L+ E++   D+                 +  + Q +  ++ +
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H +  +HRD+KP+N+L+   G +KL+DFGL +
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLAR 160

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKS---EMLSRGQVEHVRAERNLLAEVASHC-IV 169
           IG GA+G V   ++  SG+  A+K ++     E L    V  V   R L  E   H  +V
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL--EAFEHPNVV 69
Query: 170 KLY----YSFQDAEY-LYLIMEYLPGGDVXXXXXXXXXX--XXXVARFYIAQSVLAIESI 222
           +L      S  D E  + L+ E++   D+                 +  + Q +  ++ +
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           H +  +HRD+KP+N+L+   G +KL+DFGL +
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLAR 160

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 77/169 (45%), Gaps = 6/169 (3%)
Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQ 149
            E +R    +I V    +  +IG G FGEV   RL    K  +  A+K LK     +  Q
Sbjct: 3   NEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG--YTERQ 60
Query: 150 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVAR 209
                +E +++ +     I++L     ++  + ++ E++  G +             +  
Sbjct: 61  RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL 120
Query: 210 FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
             + + + + +  + + +Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 121 VGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 169

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL--LAEVASHCIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L  +  V    I+ L   F   + L      YL+ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 13  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 65
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ EY+  G +              A+F + Q
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQ 119
Query: 215 SVLAIESIHK-------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 120 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 169

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC----- 167
           ++G GA   V+ C    +   YA+K ++K       Q  H+R+      E+   C     
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK-------QPGHIRSRVFREVEMLYQCQGHRN 72
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNY 227
           +++L   F++ +  YL+ E + GG +              A   +     A++ +H    
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 228 IHRDIKPDNLLL---DQNGHMKLSDFGLCKPL----DCTNLSA 263
            HRD+KP+N+L    +Q   +K+ DF L   +    DC+ +S 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 7/157 (4%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL----- 159
           V  ++ L  IG+G FGEV   + +K+G   A+KK+          +  +R  + L     
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 160 --LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL 217
             +  +   C  K     +    +YL+ ++                     +  +   + 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +  IH++  +HRD+K  N+L+ ++G +KL+DFGL +
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 53
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 54  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 107
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 108 LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 167

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 46  NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 99  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 152
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 153 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 30  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 82
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ EY+  G +              A+F + Q
Sbjct: 83  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQ 136
Query: 215 SVLAIESIHK-------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 137 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 186

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 65/147 (44%), Gaps = 10/147 (6%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G FGE+RL +   +    A   +K   + SR    H+          A   + ++YY
Sbjct: 8   IGCGNFGELRLGKNLYTNEYVA---IKLEPIKSRAPQLHLEYRFYKQLGSAGEGLPQVYY 64
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA-IESIHKHNYIHRDI 232
                +Y  +++E L G  +                  IA  +L+ +E +H  N I+RD+
Sbjct: 65  FGPXGKYNAMVLELL-GPSLEDLFDLCDRTFTLKTVLMIAIQLLSRMEYVHSKNLIYRDV 123
Query: 233 KPDNLLLDQNGHMK-----LSDFGLCK 254
           KP+N L+ + G+ K     + DFGL K
Sbjct: 124 KPENFLIGRQGNKKEHVIHIIDFGLAK 150

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           L  I+G+GA   V   + KK+G+++A+K       L    V+    E  +L ++    IV
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLNHKNIV 70
Query: 170 KLYYSFQD--AEYLYLIMEYLPGGDVXXXXXXXXXXXXXV-ARFYIA--QSVLAIESIHK 224
           KL+   ++    +  LIME+ P G +               + F I     V  +  + +
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 225 HNYIHRDIKPDNLL--LDQNGH--MKLSDFGLCKPLD 257
           +  +HR+IKP N++  + ++G    KL+DFG  + L+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 7/157 (4%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL----- 159
           V  ++ L  IG+G FGEV   + +K+G   A+KK+          +  +R  + L     
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 160 --LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL 217
             +  +   C  K     +    +YL+ ++                     +  +   + 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +  IH++  +HRD+K  N+L+ ++G +KL+DFGL +
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 42  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 94
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ EY+  G +              A+F + Q
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQ 148
Query: 215 SVLAIESIHKH-------NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE 198

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 7/157 (4%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL----- 159
           V  ++ L  IG+G FGEV   + +K+G   A+KK+          +  +R  + L     
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 160 --LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL 217
             +  +   C  K     +    +YL+ ++                     +  +   + 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
            +  IH++  +HRD+K  N+L+ ++G +KL+DFGL +
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/149 (22%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +IG G FGEV   RL    K  +  A+K LK     +  Q     +E +++ +     I+
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG--YTERQRREFLSEASIMGQFEHPNII 78
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA-IESIHKHNYI 228
           +L     ++  + ++ E++  G +             +    + + + + +  + + +Y+
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 229 HRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 139 HRDLAARNILVNSNLVCKVSDFGLSRFLE 167

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL--LAEVASHCIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L  +  V    I+ L   F   + L      YL+ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 9   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 61
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 62  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 115
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 116 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 42  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 94
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ EY+  G +              A+F + Q
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQ 148
Query: 215 SVLAIESIHKH-------NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           L  I+G+GA   V   + KK+G+++A+K       L    V+    E  +L ++    IV
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKLNHKNIV 70
Query: 170 KLYYSFQD--AEYLYLIMEYLPGGDVXXXXXXXXXXXXXV-ARFYIA--QSVLAIESIHK 224
           KL+   ++    +  LIME+ P G +               + F I     V  +  + +
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 225 HNYIHRDIKPDNLL--LDQNGH--MKLSDFGLCKPLD 257
           +  +HR+IKP N++  + ++G    KL+DFG  + L+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 7   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 59
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 60  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 113
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 114 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 173

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 2   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 54
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 55  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 108
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 109 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 53
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 54  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 107
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 108 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 73/148 (49%), Gaps = 4/148 (2%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-HVRAERNLLAEVASHCIVKL 171
           ++G G++G+V+   + ++    A+K LKK ++      E +V+ E  LL  +    +++L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 172 YYSF--QDAEYLYLIMEY-LPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYI 228
                 ++ + +Y++MEY + G                 A  Y  Q +  +E +H    +
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 229 HRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           H+DIKP NLLL   G +K+S  G+ + L
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEAL 159

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 7/165 (4%)
Query: 94  EYMRLKRHKISVDDFDLLTI--IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           E +  + H + +D+   L I  +G G F  V L +    G+ YA+K++   E   R + +
Sbjct: 15  ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEY-LYLIMEYLPGGDVXXXXXXXXXXXXXVARF 210
                  L        +V      + A++  +L++ +   G +             +   
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 211 YIAQSVLAI----ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
            I   +L I    E+IH   Y HRD+KP N+LL   G   L D G
Sbjct: 135 QILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 46  NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 99  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 152
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 153 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 2   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 54
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 55  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 108
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 109 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 42  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 94
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ EY+  G +              A+F + Q
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQ 148
Query: 215 SVLAIESIHKH-------NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 42  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 94
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ EY+  G +              A+F + Q
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQ 148
Query: 215 SVLAIESIHKH-------NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 9   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 61
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      YL+ME +   D  
Sbjct: 62  ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 115
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 116 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 40  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 92
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ EY+  G +              A+F + Q
Sbjct: 93  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQ 146
Query: 215 SVLAIESIHK-------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 147 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 196

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 42  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 94
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ EY+  G +              A+F + Q
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQ 148
Query: 215 SVLAIESIHKH-------NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 16/41 (39%), Positives = 29/41 (70%)
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           Q +  ++ +H +  +HRD+KP+N+L+   G +KL+DFGL +
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 113 IIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +IG G FGEV     K  G      A+K LK     +  Q     +E +++ +     ++
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA-IESIHKHNYI 228
            L      +  + +I E++  G +             +    + + + A ++ +   NY+
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 229 HRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 158 HRDLAARNILVNSNLVCKVSDFGLSRFLE 186

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL--LAEVASHCIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L  +  V    I+ L   F   + L      YL+ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 64/148 (43%), Gaps = 15/148 (10%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMK----KLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           IG G+FG++ L     SG   A+K    K K  ++       H+ ++   + +     I 
Sbjct: 17  IGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQL-------HIESKFYKMMQ-GGVGIP 68
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIH 229
            + +   + +Y  ++ME L                         Q +  IE IH  N+IH
Sbjct: 69  SIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128
Query: 230 RDIKPDNLL--LDQNGHM-KLSDFGLCK 254
           RD+KPDN L  L + G++  + DFGL K
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 18/155 (11%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKL------KKSEMLSRGQVEHVRAERNLLAEVASHC 167
           IG+G FG V   +  K  ++ A+K L       ++EM+ + Q    + E  +++ +    
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ--EFQREVFIMSNLNHPN 84
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSV-LAIESIHKHN 226
           IVKLY    +     ++ME++P GD+               +  +   + L IE +   N
Sbjct: 85  IVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 227 --YIHRDIKPDNLL---LDQNGHM--KLSDFGLCK 254
              +HRD++  N+    LD+N  +  K++DFGL +
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 42  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 94
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ EY+  G +              A+F + Q
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQ 148
Query: 215 SVLAIESIHKH-------NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +IG G FGEV   RL    K     A+K LK     +  Q     +E +++ +     I+
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG--YTDKQRRDFLSEASIMGQFDHPNII 78
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI------- 222
            L       + + +I EY+  G +               RF + Q V  +  I       
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKND------GRFTVIQLVGMLRGIGSGMKYL 132
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              +Y+HRD+   N+L++ N   K+SDFG+ + L+
Sbjct: 133 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE 167

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 74/170 (43%), Gaps = 35/170 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           ++  DD + +  +GRGA+G V   +   SG I A+K++       R  V     +R L  
Sbjct: 30  EVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI-------RATVNSQEQKRLLXD 82
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY---------- 211
              S   V     F    Y  L  E    GDV             + +FY          
Sbjct: 83  LDISXRTVDC--PFTVTFYGALFRE----GDVWICXELXDTS---LDKFYKQVIDKGQTI 133
Query: 212 -------IAQSVL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                  IA S++ A+E +H K + IHRD+KP N+L++  G +K  DFG+
Sbjct: 134 PEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGI 183

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 104 SVDDFDL----LTI---IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
           S DD+++    +T+   IG G+FG V   + K  G++ A+K L  +    + Q++  + E
Sbjct: 15  SSDDWEIPDGQITVGQRIGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNE 70
Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QS 215
             +L +   H  + L+  +     L ++ ++  G  +                  IA Q+
Sbjct: 71  VGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
              ++ +H  + IHRD+K +N+ L ++  +K+ DFGL 
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 18/155 (11%)
Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +IG G FGEV   RL    K     A+K LK     +  Q     +E +++ +     I+
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG--YTDKQRRDFLSEASIMGQFDHPNII 72
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESI------- 222
            L       + + +I EY+  G +               RF + Q V  +  I       
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKND------GRFTVIQLVGMLRGIGSGMKYL 126
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              +Y+HRD+   N+L++ N   K+SDFG+ + L+
Sbjct: 127 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE 161

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/44 (50%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLL--LDQNGHM-KLSDFGLCK 254
           Q +  IE IH  N+IHRD+KPDN L  L + G++  + DFGL K
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/51 (37%), Positives = 34/51 (66%), Gaps = 1/51 (1%)
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLD 257
           AR ++ Q +  ++ IH  N +HRD+KP NL ++ ++  +K+ DFGL + +D
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/44 (50%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLL--LDQNGHM-KLSDFGLCK 254
           Q +  IE IH  N+IHRD+KPDN L  L + G++  + DFGL K
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 104 SVDDFDL----LTI---IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
           S DD+++    +T+   IG G+FG V   + K  G++ A+K L  +    + Q++  + E
Sbjct: 3   SSDDWEIPDGQITVGQRIGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNE 58
Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QS 215
             +L +   H  + L+  +     L ++ ++  G  +                  IA Q+
Sbjct: 59  VGVLRKT-RHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 117
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
              ++ +H  + IHRD+K +N+ L ++  +K+ DFGL 
Sbjct: 118 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 155

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 16  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK-TRHVNILLFM 70
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +     L ++ ++  G  +             +    IA Q+   ++ +H  + IHRD+
Sbjct: 71  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLA 151

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 21  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK-TRHVNILLFM 75
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +     L ++ ++  G  +             +    IA Q+   ++ +H  + IHRD+
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLA 156

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 44  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK-TRHVNILLFM 98
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +     L ++ ++  G  +             +    IA Q+   ++ +H  + IHRD+
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLA 179

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 44  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK-TRHVNILLFM 98
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +     L ++ ++  G  +             +    IA Q+   ++ +H  + IHRD+
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLA 179

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 16  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK-TRHVNILLFM 70
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +     L ++ ++  G  +             +    IA Q+   ++ +H  + IHRD+
Sbjct: 71  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLA 151

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 43  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK-TRHVNILLFM 97
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +     L ++ ++  G  +             +    IA Q+   ++ +H  + IHRD+
Sbjct: 98  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 157
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 158 KSNNIFLHEDLTVKIGDFGLA 178

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +IG G FGEV   RL    K     A+K LK     +  Q      E +++ +     I+
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNII 86
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLA-IESIHKHNYI 228
            L      ++ + ++ EY+  G +             +    + + + A ++ +    Y+
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 229 HRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLSRVLE 175

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 36  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK-TRHVNILLFM 90
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +     L ++ ++  G  +             +    IA Q+   ++ +H  + IHRD+
Sbjct: 91  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 150
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 151 KSNNIFLHEDLTVKIGDFGLA 171

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 42  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 94
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ EY+  G +              A+F + Q
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQ 148
Query: 215 SVLAIESIHKH-------NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           ++HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 149 LVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE 198

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 18  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK-TRHVNILLFM 72
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +     L ++ ++  G  +             +    IA Q+   ++ +H  + IHRD+
Sbjct: 73  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 132
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 133 KSNNIFLHEDLTVKIGDFGLA 153

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           IG G+FG V   + K  G++ A+K L  +    + Q++  + E  +L +   H  + L+ 
Sbjct: 21  IGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRK-TRHVNILLFM 75
Query: 174 SFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHKHNYIHRDI 232
            +     L ++ ++  G  +             +    IA Q+   ++ +H  + IHRD+
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 233 KPDNLLLDQNGHMKLSDFGLC 253
           K +N+ L ++  +K+ DFGL 
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLA 156

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 5/50 (10%)
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMK----LSDFGLCKPL 256
           + Q+   +  +H  N +HRD+KP N+L+   N H K    +SDFGLCK L
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 13/155 (8%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS- 165
           +F +   IG G FGE+RL +   +    A   +K   M SR    H+  E     ++ S 
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRAPQLHL--EYRFYKQLGSG 64
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIA-QSVLAIESIHK 224
             I ++YY     +Y  +++E L G  +                  IA Q +  +E +H 
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 225 HNYIHRDIKPDNLLLDQNGH-----MKLSDFGLCK 254
            N I+RD+KP+N L+ + G+     + + DFGL K
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAK 158

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 40/82 (48%), Gaps = 4/82 (4%)
Query: 179 EYLYLIMEYLPGG---DVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPD 235
           +YL +IMEY+P      +             +   YI Q   A+  IH     HRDIKP 
Sbjct: 111 KYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 236 NLLLD-QNGHMKLSDFGLCKPL 256
           NLL++ ++  +KL DFG  K L
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKL 192

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKL-KKSEMLSRGQVEHV------RAERNLLAEVAS 165
           ++  G F  V   Q+  SG  YA+K+L    E  +R  ++ V          N++   ++
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXX----XXVARFYIAQSVLAIES 221
             I K       AE+L L+ E   G  V                 +  FY  Q+  A++ 
Sbjct: 95  ASIGKEESDTGQAEFL-LLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY--QTCRAVQH 151
Query: 222 IHKHN--YIHRDIKPDNLLLDQNGHMKLSDFG 251
           +H+     IHRD+K +NLLL   G +KL DFG
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 19/156 (12%)
Query: 106 DDFDLLTIIGRGAFGEV----RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           DD+ L+  +GRG + EV     +   ++          KK        +E++R   N   
Sbjct: 38  DDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTN--- 94
Query: 162 EVASHCIVKLYYSFQD--AEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
                 I+KL  + +D  ++   L+ EY+   D                RFY+ + + A+
Sbjct: 95  ------IIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFD---IRFYMYELLKAL 145
Query: 220 ESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCK 254
           +  H    +HRD+KP N+++D Q   ++L D+GL +
Sbjct: 146 DYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAE 181

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 10  NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 62
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 63  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 116
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 117 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 176

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 19/156 (12%)
Query: 106 DDFDLLTIIGRGAFGEV----RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           DD+ L+  +GRG + EV     +   ++          KK        +E++R   N   
Sbjct: 43  DDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTN--- 99
Query: 162 EVASHCIVKLYYSFQD--AEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAI 219
                 I+KL  + +D  ++   L+ EY+   D                RFY+ + + A+
Sbjct: 100 ------IIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFD---IRFYMYELLKAL 150
Query: 220 ESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCK 254
           +  H    +HRD+KP N+++D Q   ++L D+GL +
Sbjct: 151 DYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAE 186

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|4AX8|A Chain A, Medium Resolution Structure Of The Bifunctional Kinase- Methyltransferase Wbdd Length = 569

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 176 QDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHNYIHRDIKP 234
           ++A+  +L+ME LPG                + R  I  S+L ++ ++ K  + H D++P
Sbjct: 312 ENAQSGWLVMEKLPG----RLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRP 367
Query: 235 DNLLLDQNGHMKLSDFG--LCKPLDC---TNL 261
            N+++D   H +L DFG  +  P DC   TNL
Sbjct: 368 WNVMVDARQHARLIDFGSIVTTPQDCSWPTNL 399

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 9   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 61
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 62  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 115
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 116 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 13  NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 65
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 66  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 119
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 120 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 179

>pdb|4AZS|A Chain A, High Resolution (2.2 A) Crystal Structure Of Wbdd. Length = 569

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 176 QDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVL-AIESIHKHNYIHRDIKP 234
           ++A+  +L+ME LPG                + R  I  S+L ++ ++ K  + H D++P
Sbjct: 312 ENAQSGWLVMEKLPG----RLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRP 367
Query: 235 DNLLLDQNGHMKLSDFG--LCKPLDC---TNL 261
            N+++D   H +L DFG  +  P DC   TNL
Sbjct: 368 WNVMVDARQHARLIDFGSIVTTPQDCSWPTNL 399

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 18/152 (11%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKL------KKSEMLSRGQVEHVRAERNLLAEVASHC 167
           IG+G FG V   +  K  ++ A+K L       ++EM+ + Q    + E  +++ +    
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ--EFQREVFIMSNLNHPN 84
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSV-LAIESIHKHN 226
           IVKLY    +     ++ME++P GD+               +  +   + L IE +   N
Sbjct: 85  IVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 227 --YIHRDIKPDNLL---LDQNGHM--KLSDFG 251
              +HRD++  N+    LD+N  +  K++DFG
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 2   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 54
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 55  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 108
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 109 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 21/180 (11%)
Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           N    +E  ++ +  LKR++        L  IG GA G V    +       A+KKL + 
Sbjct: 8   NNFYSVEIGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSFQDAEYL------YLIMEYLPGGDVX 194
               + Q    RA R L L +  +H  I+ L   F   + L      Y++ME +   D  
Sbjct: 61  ---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DAN 114
Query: 195 XXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                          + + Q +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +
Sbjct: 115 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 23/170 (13%)
Query: 98  LKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           L    IS+D      ++G G FGEV   RL    K     A+K LK     +  Q     
Sbjct: 13  LDATNISIDK-----VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFL 65
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQ 214
            E +++ +     I++L      ++ + ++ E +  G +              A+F + Q
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD------AQFTVIQ 119
Query: 215 SVLAIESIHK-------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            V  +  I           Y+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 120 LVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 169

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 6/155 (3%)
Query: 107 DFDLLTI----IGRGAFGEVRLCQ-EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           D  LLT+    +G G FG V+    + K        K+ K+E       + + AE N++ 
Sbjct: 14  DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 73
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIES 221
           ++ +  IV++     +AE   L+ME    G +                  + Q  + ++ 
Sbjct: 74  QLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           + + N++HRD+   N+LL    + K+SDFGL K L
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	358
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-99
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-95
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-84
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-82
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-80
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-80
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-79
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-79
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-78
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-78
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-78
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-78
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-77
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-77
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-77
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-76
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-73
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-73
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-73
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-71
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-70
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-65
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-64
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-58
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-55
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-52
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-52
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-51
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-51
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-49
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-47
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-47
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-46
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-46
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-46
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-46
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-46
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-46
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-46
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-45
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-45
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-45
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-45
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-44
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-44
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-44
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-44
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-44
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-44
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-44
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-44
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-43
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-43
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-43
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-43
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-43
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-43
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-43
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-43
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-43
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-43
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-42
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-42
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-42
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-42
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-42
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-42
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-42
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-41
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-41
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-40
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-39
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-39
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-39
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-39
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-39
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-39
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-38
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-38
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-37
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-37
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-36
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-36
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-36
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-36
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-36
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-36
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-35
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-35
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-35
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-33
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-32
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-32
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-32
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-31
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-28
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-28
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-27
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-25
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-24
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-23
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-21
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-21
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-21
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-20
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-20
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-20
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-20
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-19
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-19
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-18
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-17
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-17
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-17
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-16
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-16
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-15
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-15
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-15
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-15
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-15
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-15
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-15
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-15
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-14
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-14
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-14
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-14
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-14
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-14
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-13
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-13
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-12
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-12
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-12
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-12
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-12
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-11
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-11
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-10
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-10
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-10
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-04

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  300 bits (769), Expect = e-99
 Identities = 99/281 (35%), Positives = 153/281 (54%), Gaps = 58/281 (20%)

Query: 66  VLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLC 125
            + ++L +S++ +++   +   L+  E   +RLK  ++  DDF++L +IGRGAF EV + 
Sbjct: 23  GVHQELGASELAQDK--YVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVV 80

Query: 126 QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185
           + K++G +YAMK + K +ML RG+V   R ER++L       I +L+++FQD  YLYL+M
Sbjct: 81  KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140

Query: 186 EYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH 244
           EY  GGD++TLL +    +   +ARFY+A+ V+AI+S+H+  Y+HRDIKPDN+LLD+ GH
Sbjct: 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH 200

Query: 245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHW 304
           ++L+DFG C  L                                                
Sbjct: 201 IRLADFGSCLKLR----------------------------------------------- 213

Query: 305 QINRRKLAYSTVGTPDYIAPEVLLKKG-------YGMECDW 338
             +    +   VGTPDY++PE+L   G       YG ECDW
Sbjct: 214 -ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDW 253

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  293 bits (751), Expect = 1e-96
 Identities = 101/272 (37%), Positives = 153/272 (56%), Gaps = 54/272 (19%)

Query: 73  SSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN 132
            ++ P   + NIL+ LE  +    ++K+ ++  +DF++L +IGRGAFGEV + + K +  
Sbjct: 41  CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK 100

Query: 133 IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD 192
           ++AMK L K EML R +    R ER++L    S  I  L+Y+FQD   LYL+M+Y  GGD
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160

Query: 193 VMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           ++TLL + E+ L E +ARFY+A+ V+AI+S+H+ +Y+HRDIKPDN+L+D NGH++L+DFG
Sbjct: 161 LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 220

Query: 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL 311
            C              ++++D  +                                    
Sbjct: 221 SCL-------------KLMEDGTVQ----------------------------------- 232

Query: 312 AYSTVGTPDYIAPEVLL-----KKGYGMECDW 338
           +   VGTPDYI+PE+L      K  YG ECDW
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  289 bits (741), Expect = 2e-95
 Identities = 94/266 (35%), Positives = 143/266 (53%), Gaps = 53/266 (19%)

Query: 77  PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
              +  NI   L R +    +++  ++  +D++++ +IGRGAFGEV+L + K +  +YAM
Sbjct: 40  ALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99

Query: 137 KKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL 196
           K L K EM+ R        ER+++A   S  +V+L+Y+FQD  YLY++MEY+PGGD++ L
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 159

Query: 197 LMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
           +   + + E  ARFY A+ VLA+++IH   +IHRD+KPDN+LLD++GH+KL+DFG C  +
Sbjct: 160 MSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218

Query: 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV 316
           +                                                        + V
Sbjct: 219 N------------------------------------------------KEGMVRCDTAV 230

Query: 317 GTPDYIAPEVLLKKG----YGMECDW 338
           GTPDYI+PEVL  +G    YG ECDW
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDW 256

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  257 bits (659), Expect = 2e-84
 Identities = 66/247 (26%), Positives = 113/247 (45%), Gaps = 47/247 (19%)

Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
           +      +  K   +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V 
Sbjct: 16  QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75

Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
           +V  ER++++ +     VKLY++FQD E LY  + Y   G+++  + +  +  ET  RFY
Sbjct: 76  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
            A+ V A+E +H    IHRD+KP+N+LL+++ H++++DFG  K              +  
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK-------------VLSP 182

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
           +                                    +  A S VGT  Y++PE+L +K 
Sbjct: 183 ESK----------------------------------QARANSFVGTAQYVSPELLTEKS 208

Query: 332 YGMECDW 338
                D 
Sbjct: 209 ACKSSDL 215

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  251 bits (644), Expect = 4e-82
 Identities = 82/238 (34%), Positives = 125/238 (52%), Gaps = 54/238 (22%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K S+ DF +L  +G G+FG V L + + +G  YAMK LKK  ++   QVEH   ER +L+
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
            V    I++++ +FQDA+ +++IM+Y+ GG++ +LL + +     VA+FY A+  LA+E 
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL-DCTNLSAINENEVLDDENLNESMD 280
           +H  + I+RD+KP+N+LLD+NGH+K++DFG  K + D T                     
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-------------------- 161

Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                  + CG                          TPDYIAPEV+  K Y    DW
Sbjct: 162 -------TLCG--------------------------TPDYIAPEVVSTKPYNKSIDW 186

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  249 bits (639), Expect = 2e-80
 Identities = 64/251 (25%), Positives = 114/251 (45%), Gaps = 58/251 (23%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           +   ++ D F++L  IG+G+FG+V + Q+  +  +YAMK + K + + R +V +V  E  
Sbjct: 8   ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67

Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
           ++  +    +V L+YSFQD E ++++++ L GGD+   L +     E   + +I + V+A
Sbjct: 68  IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
           ++ +     IHRD+KPDN+LLD++GH+ ++DF +                          
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA------------------------ 163

Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK---GYGME 335
                                      + R     +  GT  Y+APE+   +   GY   
Sbjct: 164 --------------------------MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA 197

Query: 336 CDW-----LAY 341
            DW      AY
Sbjct: 198 VDWWSLGVTAY 208

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  247 bits (634), Expect = 7e-80
 Identities = 80/270 (29%), Positives = 127/270 (47%), Gaps = 51/270 (18%)

Query: 71  LASSDVPEEEQINILKD-LERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKK 129
           ++    PE    N        ++              DF  L +IG+G+FG+V L + K 
Sbjct: 2   ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61

Query: 130 SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYL 188
               YA+K L+K  +L + + +H+ +ERN+L +   H  +V L++SFQ A+ LY +++Y+
Sbjct: 62  EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121

Query: 189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLS 248
            GG++   L RE    E  ARFY A+   A+  +H  N ++RD+KP+N+LLD  GH+ L+
Sbjct: 122 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT 181

Query: 249 DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR 308
           DFGLCK                      E+++ +                          
Sbjct: 182 DFGLCK----------------------ENIEHNST------------------------ 195

Query: 309 RKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                +  GTP+Y+APEVL K+ Y    DW
Sbjct: 196 ---TSTFCGTPEYLAPEVLHKQPYDRTVDW 222

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  245 bits (628), Expect = 2e-79
 Identities = 74/241 (30%), Positives = 120/241 (49%), Gaps = 50/241 (20%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
            + K+ ++DF L  ++G+G+FG+V L + KK+   +A+K LKK  +L    VE    E+ 
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69

Query: 159 LLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
           +L+    H  +  ++ +FQ  E L+ +MEYL GGD+M  +        + A FY A+ +L
Sbjct: 70  VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
            ++ +H    ++RD+K DN+LLD++GH+K++DFG+CK                      E
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------------------E 167

Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
           +M  D +                             +  GTPDYIAPE+LL + Y    D
Sbjct: 168 NMLGDAK---------------------------TNTFCGTPDYIAPEILLGQKYNHSVD 200

Query: 338 W 338
           W
Sbjct: 201 W 201

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  245 bits (628), Expect = 2e-79
 Identities = 83/270 (30%), Positives = 132/270 (48%), Gaps = 56/270 (20%)

Query: 72  ASSDVPEEEQINILKDLERKE--TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKK 129
           A+    E+E +       +++   ++    ++   +D FD +  +G G+FG V L + K+
Sbjct: 5   AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64

Query: 130 SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP 189
           SGN YAMK L K +++   Q+EH   E+ +L  V    +VKL +SF+D   LY++MEY+ 
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124

Query: 190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSD 249
           GG++ + L R    +E  ARFY AQ VL  E +H  + I+RD+KP+NLL+DQ G+++++D
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184

Query: 250 FGLCKPL-DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR 308
           FG  K +   T                            + CG                 
Sbjct: 185 FGFAKRVKGRTW---------------------------TLCG----------------- 200

Query: 309 RKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                    TP+ +APE++L KGY    DW
Sbjct: 201 ---------TPEALAPEIILSKGYNKAVDW 221

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  242 bits (621), Expect = 1e-78
 Identities = 79/252 (31%), Positives = 123/252 (48%), Gaps = 53/252 (21%)

Query: 91  KETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSR 147
                +     KI  + F+LL ++G+G +G+V   ++     +G I+AMK LKK+ ++  
Sbjct: 2   SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61

Query: 148 G-QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTET 206
                H +AERN+L EV    IV L Y+FQ    LYLI+EYL GG++   L RE    E 
Sbjct: 62  AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121

Query: 207 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266
            A FY+A+  +A+  +H+   I+RD+KP+N++L+  GH+KL+DFGLCK            
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK------------ 169

Query: 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326
                     ES+                                 ++  GT +Y+APE+
Sbjct: 170 ----------ESIHDGTV---------------------------THTFCGTIEYMAPEI 192

Query: 327 LLKKGYGMECDW 338
           L++ G+    DW
Sbjct: 193 LMRSGHNRAVDW 204

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  243 bits (623), Expect = 2e-78
 Identities = 74/254 (29%), Positives = 124/254 (48%), Gaps = 50/254 (19%)

Query: 86  KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
           K+  ++         +++ +D+F+ + ++G+G+FG+V L + K++G++YA+K LKK  +L
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62

Query: 146 SRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLT 204
               VE    E+ +L+   +H  + +L+  FQ  + L+ +ME++ GGD+M  + +     
Sbjct: 63  QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122

Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
           E  ARFY A+ + A+  +H    I+RD+K DN+LLD  GH KL+DFG+CK          
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---------- 172

Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
                       E +                                  +  GTPDYIAP
Sbjct: 173 ------------EGICNGVT---------------------------TATFCGTPDYIAP 193

Query: 325 EVLLKKGYGMECDW 338
           E+L +  YG   DW
Sbjct: 194 EILQEMLYGPAVDW 207

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  242 bits (620), Expect = 4e-78
 Identities = 69/241 (28%), Positives = 113/241 (46%), Gaps = 50/241 (20%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
            R ++ + DF+ L ++G+G+FG+V L + K +  +YA+K LKK  ++    VE    E+ 
Sbjct: 13  NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72

Query: 159 LLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
           +LA       + +L+  FQ  + LY +MEY+ GGD+M  + +     E  A FY A+  +
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
            +  +     I+RD+K DN++LD  GH+K++DFG+CK                      E
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------------------E 170

Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
           ++                                  +  GTPDYIAPE++  + YG   D
Sbjct: 171 NIWDGVT---------------------------TKTFCGTPDYIAPEIIAYQPYGKSVD 203

Query: 338 W 338
           W
Sbjct: 204 W 204

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  241 bits (618), Expect = 9e-78
 Identities = 83/291 (28%), Positives = 137/291 (47%), Gaps = 56/291 (19%)

Query: 55  KHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTII 114
            H    ++  S       S+D  +  +  +    E +          K+ +++F+LL ++
Sbjct: 4   HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTG-HAEKVGIENFELLKVL 62

Query: 115 GRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRG-QVEHVRAERNLLAEVASHC-IV 169
           G GA+G+V L ++     +G +YAMK LKK+ ++ +    EH R ER +L  +     +V
Sbjct: 63  GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
            L+Y+FQ    L+LI++Y+ GG++ T L + E  TE   + Y+ + VLA+E +HK   I+
Sbjct: 123 TLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIY 182

Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
           RDIK +N+LLD NGH+ L+DFGL K             E + DE                
Sbjct: 183 RDIKLENILLDSNGHVVLTDFGLSK-------------EFVADET--------------- 214

Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL--KKGYGMECDW 338
                               + AY   GT +Y+AP+++     G+    DW
Sbjct: 215 --------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 245

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  240 bits (616), Expect = 1e-77
 Identities = 79/237 (33%), Positives = 119/237 (50%), Gaps = 49/237 (20%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K++++DFD L ++G+G FG+V L +EK +G  YAMK L+K  ++++ +V H   E  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
                 +  L Y+FQ  + L  +MEY  GG++   L RE   TE  ARFY A+ V A+E 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +H  + ++RDIK +NL+LD++GH+K++DFGLCK                      E +  
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----------------------EGISD 158

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                           +  GTP+Y+APEVL    YG   DW
Sbjct: 159 GAT---------------------------MKTFCGTPEYLAPEVLEDNDYGRAVDW 188

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  239 bits (612), Expect = 4e-77
 Identities = 85/249 (34%), Positives = 133/249 (53%), Gaps = 53/249 (21%)

Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQ 149
           T +++    K     F+LL ++G+G+FG+V L ++     +  +YAMK LKK+ +  R +
Sbjct: 11  THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70

Query: 150 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVAR 209
           V   + ER++L EV    IVKL+Y+FQ    LYLI+++L GGD+ T L +E   TE   +
Sbjct: 71  V-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129

Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269
           FY+A+  LA++ +H    I+RD+KP+N+LLD+ GH+KL+DFGL K               
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------------- 174

Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
                  ES+D + +                           AYS  GT +Y+APEV+ +
Sbjct: 175 -------ESIDHEKK---------------------------AYSFCGTVEYMAPEVVNR 200

Query: 330 KGYGMECDW 338
           +G+    DW
Sbjct: 201 RGHTQSADW 209

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  239 bits (613), Expect = 5e-77
 Identities = 76/238 (31%), Positives = 120/238 (50%), Gaps = 50/238 (21%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
            + + DFDLL +IGRG++ +V L + KK+  IYAMK +KK  +     ++ V+ E+++  
Sbjct: 5   PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64

Query: 162 EVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIE 220
           + ++H  +V L+  FQ    L+ ++EY+ GGD+M  + R+  L E  ARFY A+  LA+ 
Sbjct: 65  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
            +H+   I+RD+K DN+LLD  GH+KL+D+G+CK                      E + 
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------------------EGLR 162

Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                            +  GTP+YIAPE+L  + YG   DW
Sbjct: 163 PGDT---------------------------TSTFCGTPNYIAPEILRGEDYGFSVDW 193

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  238 bits (609), Expect = 7e-76
 Identities = 80/275 (29%), Positives = 128/275 (46%), Gaps = 58/275 (21%)

Query: 73  SSDVPEEEQINILKDL--------ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRL 124
             D+P  E +     +        E   T         + + DFDLL +IGRG++ +V L
Sbjct: 11  DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLL 70

Query: 125 CQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYL 183
            + KK+  IYAM+ +KK  +     ++ V+ E+++  + ++H  +V L+  FQ    L+ 
Sbjct: 71  VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130

Query: 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243
           ++EY+ GGD+M  + R+  L E  ARFY A+  LA+  +H+   I+RD+K DN+LLD  G
Sbjct: 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG 190

Query: 244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQH 303
           H+KL+D+G+CK                      E +                        
Sbjct: 191 HIKLTDYGMCK----------------------EGLRPGDT------------------- 209

Query: 304 WQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                     +  GTP+YIAPE+L  + YG   DW
Sbjct: 210 --------TSTFCGTPNYIAPEILRGEDYGFSVDW 236

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  233 bits (597), Expect = 1e-73
 Identities = 77/241 (31%), Positives = 122/241 (50%), Gaps = 50/241 (20%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
            +H++++++F+ L ++G+G FG+V L +EK +G  YAMK LKK  ++++ +V H   E  
Sbjct: 141 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200

Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
           +L       +  L YSFQ  + L  +MEY  GG++   L RE   +E  ARFY A+ V A
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260

Query: 219 IESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
           ++ +H + N ++RD+K +NL+LD++GH+K++DFGLCK                      E
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----------------------E 298

Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
            +                                  +  GTP+Y+APEVL    YG   D
Sbjct: 299 GIKDGAT---------------------------MKTFCGTPEYLAPEVLEDNDYGRAVD 331

Query: 338 W 338
           W
Sbjct: 332 W 332

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  235 bits (602), Expect = 3e-73
 Identities = 78/338 (23%), Positives = 130/338 (38%), Gaps = 76/338 (22%)

Query: 22  EVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQ 81
           +  ++           R   A+    ++ + Q +         +V   +  + D   +  
Sbjct: 96  DTADDA---------LRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPL 146

Query: 82  INILKDLERKE--------------TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE 127
           +  +     +                ++  L+   +  D F    ++GRG FGEV  CQ 
Sbjct: 147 LRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQM 206

Query: 128 KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187
           K +G +YA KKL K  +  R   +    E+ +LA+V S  IV L Y+F+    L L+M  
Sbjct: 207 KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266

Query: 188 LPGGDVM----TLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243
           + GGD+      +        E  A FY AQ V  +E +H+ N I+RD+KP+N+LLD +G
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG 326

Query: 244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQH 303
           ++++SD GL                        E      +                   
Sbjct: 327 NVRISDLGLAV----------------------ELKAGQTK------------------- 345

Query: 304 WQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                        GTP ++APE+LL + Y    D+ A 
Sbjct: 346 --------TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  238 bits (608), Expect = 4e-73
 Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 50/270 (18%)

Query: 73  SSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN 132
            + + +  +    K             R ++ + DF+ L ++G+G+FG+V L + K +  
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367

Query: 133 IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGG 191
           +YA+K LKK  ++    VE    E+ +LA       + +L+  FQ  + LY +MEY+ GG
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427

Query: 192 DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           D+M  + +     E  A FY A+  + +  +     I+RD+K DN++LD  GH+K++DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487

Query: 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL 311
           +CK                      E++                                
Sbjct: 488 MCK----------------------ENIWDGVT--------------------------- 498

Query: 312 AYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
             +  GTPDYIAPE++  + YG   DW A+
Sbjct: 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 528

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  232 bits (594), Expect = 1e-71
 Identities = 75/328 (22%), Positives = 131/328 (39%), Gaps = 76/328 (23%)

Query: 37  ERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYM 96
           +R A  +   ++        +     R+ V          P ++   + ++L R   EY+
Sbjct: 97  KRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKD---LFQELTRLTHEYL 153

Query: 97  R---------------------LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYA 135
                                 L+R  ++ + F    ++G+G FGEV  CQ + +G +YA
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213

Query: 136 MKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMT 195
            KKL+K  +  R        E+ +L +V S  +V L Y+++  + L L++  + GGD+  
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273

Query: 196 LL--MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
            +  M +    E  A FY A+    +E +H+   ++RD+KP+N+LLD +GH+++SD GL 
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333

Query: 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAY 313
                          V + +                                        
Sbjct: 334 V-------------HVPEGQ-------------------------------------TIK 343

Query: 314 STVGTPDYIAPEVLLKKGYGMECDWLAY 341
             VGT  Y+APEV+  + Y    DW A 
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWAL 371

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  230 bits (589), Expect = 5e-70
 Identities = 71/269 (26%), Positives = 119/269 (44%), Gaps = 56/269 (20%)

Query: 74  SDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI 133
                ++ I   K     + + + L    ++++DF +  IIGRG FGEV  C++  +G +
Sbjct: 158 RGDVFQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKM 216

Query: 134 YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC---IVKLYYSFQDAEYLYLIMEYLPG 190
           YAMK L K  +  +        ER +L+ V++     IV + Y+F   + L  I++ + G
Sbjct: 217 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 276

Query: 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF 250
           GD+   L +    +E   RFY A+ +L +E +H    ++RD+KP N+LLD++GH+++SD 
Sbjct: 277 GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 336

Query: 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRK 310
           GL               +    +                                     
Sbjct: 337 GLAC-------------DFSKKK------------------------------------- 346

Query: 311 LAYSTVGTPDYIAPEVLLKK-GYGMECDW 338
             +++VGT  Y+APEVL K   Y    DW
Sbjct: 347 -PHASVGTHGYMAPEVLQKGVAYDSSADW 374

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  207 bits (528), Expect = 4e-65
 Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 62/266 (23%)

Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH 152
           T    + + K ++DDFD+   +G+G FG V L +EK++  I A+K L KS++   G    
Sbjct: 1   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60

Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI 212
           +R E  + + +    I+++Y  F D + +YL++E+ P G++   L +     E  +  ++
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120

Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
            +   A+   H+   IHRDIKP+NLL+   G +K++DFG                     
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162

Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
                                         H    RR+   +  GT DY+ PE++  K +
Sbjct: 163 ------------------------------HAPSLRRR---TMCGTLDYLPPEMIEGKTH 189

Query: 333 GMECDWLAYWNETLSCNYLSDIMLYV 358
             + D    W           ++ Y 
Sbjct: 190 DEKVDL---W----CAG----VLCYE 204

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  204 bits (522), Expect = 3e-64
 Identities = 68/260 (26%), Positives = 107/260 (41%), Gaps = 62/260 (23%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
           K+ + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
           + + +    I++LY  F DA  +YLI+EY P G V   L +     E     YI +   A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
           +   H    IHRDIKP+NLLL   G +K++DFG                           
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------------------- 161

Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                       +RR       GT DY+ PE++  + +  + D 
Sbjct: 162 ----------------------------SRRT---DLCGTLDYLPPEMIEGRMHDEKVDL 190

Query: 339 LAYWNETLSCNYLSDIMLYV 358
              W    S      ++ Y 
Sbjct: 191 ---W----SLG----VLCYE 199

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  189 bits (482), Expect = 5e-58
 Identities = 54/250 (21%), Positives = 87/250 (34%), Gaps = 55/250 (22%)

Query: 91  KETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQV 150
           +   Y   +        F  L+ +G G++GEV   + K+ G +YA+K+        +   
Sbjct: 42  QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DR 100

Query: 151 EHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVA 208
               AE     +V  H C V+L  ++++   LYL  E   G  +         +L E   
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV 159

Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268
             Y+  ++LA+  +H    +H D+KP N+ L   G  KL DFGL                
Sbjct: 160 WGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV-------------- 205

Query: 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
                                               ++          G P Y+APE+ L
Sbjct: 206 ------------------------------------ELGTAGAGEVQEGDPRYMAPEL-L 228

Query: 329 KKGYGMECDW 338
           +  YG   D 
Sbjct: 229 QGSYGTAADV 238

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  182 bits (465), Expect = 1e-55
 Identities = 56/248 (22%), Positives = 100/248 (40%), Gaps = 54/248 (21%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
            DF+ + ++G+GAFG+V   +       YA+KK++ +E     ++  + +E  LLA +  
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNH 61

Query: 166 HCIVKLYYSFQDAE-------------YLYLIMEYLPGGDVMTLLMREETLT-ETVARFY 211
             +V+ Y ++ +                L++ MEY   G +  L+  E            
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
             Q + A+  IH    IHRD+KP N+ +D++ ++K+ DFGL K +  +      +++ L 
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
             +                                       S +GT  Y+A EVL   G
Sbjct: 182 GSS-----------------------------------DNLTSAIGTAMYVATEVLDGTG 206

Query: 332 -YGMECDW 338
            Y  + D 
Sbjct: 207 HYNEKIDM 214

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  173 bits (440), Expect = 8e-52
 Identities = 63/256 (24%), Positives = 110/256 (42%), Gaps = 62/256 (24%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S   +     +G+G F +     +  +  ++A K + KS +L   Q E +  E ++   +
Sbjct: 13  SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
           A   +V  +  F+D +++++++E      ++ L  R + LTE  AR+Y+ Q VL  + +H
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
           ++  IHRD+K  NL L+++  +K+ DFG         L+                ++ DG
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFG---------LATK--------------VEYDG 169

Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-WLAYW 342
              +  C                          GTP+YIAPEVL KKG+  E D W    
Sbjct: 170 ERKKVLC--------------------------GTPNYIAPEVLSKKGHSFEVDVW---- 199

Query: 343 NETLSCNYLSDIMLYV 358
               S       ++Y 
Sbjct: 200 ----SI----GCIMYT 207

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  174 bits (442), Expect = 8e-52
 Identities = 63/256 (24%), Positives = 110/256 (42%), Gaps = 62/256 (24%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S   +     +G+G F +     +  +  ++A K + KS +L   Q E +  E ++   +
Sbjct: 39  SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 98

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
           A   +V  +  F+D +++++++E      ++ L  R + LTE  AR+Y+ Q VL  + +H
Sbjct: 99  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
           ++  IHRD+K  NL L+++  +K+ DFG         L+                ++ DG
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFG---------LATK--------------VEYDG 195

Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-WLAYW 342
              +  C                          GTP+YIAPEVL KKG+  E D W    
Sbjct: 196 ERKKVLC--------------------------GTPNYIAPEVLSKKGHSFEVDVW---- 225

Query: 343 NETLSCNYLSDIMLYV 358
               S       ++Y 
Sbjct: 226 ----SI----GCIMYT 233

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  171 bits (436), Expect = 2e-51
 Identities = 61/260 (23%), Positives = 110/260 (42%), Gaps = 65/260 (25%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
              ++DF +  ++G+G+F  V   +   +G   A+K + K  M   G V+ V+ E  +  
Sbjct: 7   GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIE 220
           ++    I++LY  F+D+ Y+YL++E    G++   L  R +  +E  AR ++ Q +  + 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
            +H H  +HRD+   NLLL +N ++K++DFG         L+   +              
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFG---------LATQLKMPH----------- 166

Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV-GTPDYIAPEVLLKKGYGMECD-W 338
                                      +      T+ GTP+YI+PE+  +  +G+E D W
Sbjct: 167 --------------------------EKHY----TLCGTPNYISPEIATRSAHGLESDVW 196

Query: 339 LAYWNETLSCNYLSDIMLYV 358
                   S       M Y 
Sbjct: 197 --------SLG----CMFYT 204

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  172 bits (438), Expect = 5e-51
 Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 53/241 (21%)

Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
           +  S++ +  L  IG G+FG+  L +  + G  Y +K++  S M S  + E  R E  +L
Sbjct: 19  YFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVL 77

Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLA 218
           A +    IV+   SF++   LY++M+Y  GGD+   +  +      E     +  Q  LA
Sbjct: 78  ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
           ++ +H    +HRDIK  N+ L ++G ++L DFG+ + L+ T                   
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV------------------ 179

Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD- 337
                                          +LA + +GTP Y++PE+   K Y  + D 
Sbjct: 180 -------------------------------ELARACIGTPYYLSPEICENKPYNNKSDI 208

Query: 338 W 338
           W
Sbjct: 209 W 209

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  167 bits (426), Expect = 3e-49
 Identities = 56/307 (18%), Positives = 106/307 (34%), Gaps = 89/307 (28%)

Query: 77  PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
           P     +IL +          +K     ++D+ ++  + +G F ++ LC  +K    YA+
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYAL 59

Query: 137 KKLKKSEML--------------SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182
           KK +KS +                + + +  + E  ++ ++ +   +       + + +Y
Sbjct: 60  KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY 119

Query: 183 LIMEYLPGGDVMTLLMREETL--------TETVARFYIAQSVLAIESIHKHNYI-HRDIK 233
           +I EY+    ++        L           V +  I   + +   IH    I HRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179

Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
           P N+L+D+NG +KLSDFG          S    ++ +                       
Sbjct: 180 PSNILMDKNGRVKLSDFG---------ESEYMVDKKI----------------------- 207

Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--YGMECDWLAYWNETLSCNYL 351
                                + GT +++ PE    +    G + D    W    S    
Sbjct: 208 -------------------KGSRGTYEFMPPEFFSNESSYNGAKVDI---W----SLG-- 239

Query: 352 SDIMLYV 358
             I LYV
Sbjct: 240 --ICLYV 244

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  161 bits (410), Expect = 2e-47
 Identities = 55/240 (22%), Positives = 93/240 (38%), Gaps = 54/240 (22%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           ++ +F +   IGRG F EV        G   A+KK++  +++          E +LL ++
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL----MREETLTETVARFYIAQSVLAI 219
               ++K Y SF +   L +++E    GD+  ++     ++  + E     Y  Q   A+
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
           E +H    +HRDIKP N+ +   G +KL D GL +                         
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT------------------- 190

Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                           A+S VGTP Y++PE + + GY  + D W
Sbjct: 191 ------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIW 220

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  159 bits (405), Expect = 6e-47
 Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 62/245 (25%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +D+++L  IG G++G  +  + K  G I   K+L    M +  + + + +E NLL E+  
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 64

Query: 166 HCIVKLYYSFQDAE--YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAI 219
             IV+ Y    D     LY++MEY  GGD+ +++ +     + L E      + Q  LA+
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 220 ESIHKHNY-----IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
           +  H+ +      +HRD+KP N+ LD   ++KL DFGL + L+                 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------------- 170

Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
                                                A + VGTP Y++PE + +  Y  
Sbjct: 171 -----------------------------------SFAKTFVGTPYYMSPEQMNRMSYNE 195

Query: 335 ECD-W 338
           + D W
Sbjct: 196 KSDIW 200

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  159 bits (404), Expect = 1e-46
 Identities = 51/252 (20%), Positives = 84/252 (33%), Gaps = 76/252 (30%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
            DF  + +IG G FG+V   + +  G  Y +K++K +        E    E   LA++  
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63

Query: 166 HCIVKLYYSFQDAE----------------YLYLIMEYLPGGDVMTLL--MREETLTETV 207
             IV     +   +                 L++ ME+   G +   +   R E L + +
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
           A     Q    ++ IH    I+RD+KP N+ L     +K+ DFGL   L           
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG------- 176

Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
                                                          + GT  Y++PE +
Sbjct: 177 -------------------------------------------KRTRSKGTLRYMSPEQI 193

Query: 328 LKKGYGMECD-W 338
             + YG E D +
Sbjct: 194 SSQDYGKEVDLY 205

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  158 bits (403), Expect = 1e-46
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 55/237 (23%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D++D+   +G+GAF  VR C  K +G  +A K +   ++ +R   + +  E  +  ++  
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 64

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IV+L+ S Q+  + YL+ + + GG++   ++  E  +E  A   I Q + +I   H +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
             +HR++KP+NLLL    +   +KL+DFGL           +N++E              
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI--------EVNDSEAW------------ 164

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                         +   GTP Y++PEVL K  Y    D W
Sbjct: 165 ------------------------------HGFAGTPGYLSPEVLKKDPYSKPVDIW 191

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  161 bits (408), Expect = 2e-46
 Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 64/291 (21%)

Query: 61  KQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFG 120
           +    + E K  +   P+  +    + +  ++         +     +D   +IGRG   
Sbjct: 50  QSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY-QKYDPKDVIGRGVSS 108

Query: 121 EVRLCQEKKSGNIYAMK-----KLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYS 174
            VR C  + +G+ +A+K       + S        E  R E ++L +VA H  I+ L  S
Sbjct: 109 VVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168

Query: 175 FQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKP 234
           ++ + +++L+ + +  G++   L  +  L+E   R  +   + A+  +H +N +HRD+KP
Sbjct: 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKP 228

Query: 235 DNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRW 294
           +N+LLD N  ++LSDFG            +   E L +                      
Sbjct: 229 ENILLDDNMQIRLSDFGFSC--------HLEPGEKLRE---------------------- 258

Query: 295 KSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL------LKKGYGMECD-W 338
                                 GTP Y+APE+L         GYG E D W
Sbjct: 259 --------------------LCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  160 bits (407), Expect = 3e-46
 Identities = 64/252 (25%), Positives = 109/252 (43%), Gaps = 56/252 (22%)

Query: 91  KETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQV 150
           + +E+M     K S D++D+   +G+GAF  VR C  K +G  +A K +   + LS    
Sbjct: 15  RGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDF 72

Query: 151 EHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF 210
           + +  E  +  ++    IV+L+ S Q+  + YL+ + + GG++   ++  E  +E  A  
Sbjct: 73  QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132

Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINEN 267
            I Q + +I   H +  +HR++KP+NLLL    +   +KL+DFGL           +N++
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--------EVNDS 184

Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
           E                                            +   GTP Y++PEVL
Sbjct: 185 EAW------------------------------------------HGFAGTPGYLSPEVL 202

Query: 328 LKKGYGMECD-W 338
            K  Y    D W
Sbjct: 203 KKDPYSKPVDIW 214

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  158 bits (403), Expect = 3e-46
 Identities = 60/249 (24%), Positives = 109/249 (43%), Gaps = 59/249 (23%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVR 154
            K+ K+  D +D+   +G G F  V+ C+EK +G  YA K +KK +  +  +    E + 
Sbjct: 5   FKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63

Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
            E ++L +V  H ++ L+  +++   + LI+E + GG++   L ++E+L+E  A  +I Q
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
            +  +  +H     H D+KP+N++L        H+KL DFGL           I +    
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--------EIEDGVEF 175

Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
            +                                            GTP+++APE++  +
Sbjct: 176 KN------------------------------------------IFGTPEFVAPEIVNYE 193

Query: 331 GYGMECD-W 338
             G+E D W
Sbjct: 194 PLGLEADMW 202

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  156 bits (398), Expect = 8e-46
 Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 58/241 (24%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVRAERNLLAE 162
           D +++   +G G F  VR C++K +G  YA K +KK  + S  +    E +  E N+L E
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
           +    I+ L+  F++   + LI+E + GG++   L  +E+LTE  A  ++ Q +  +  +
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 223 HKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
           H     H D+KP+N++L      N  +KL DFG+           I       +      
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--------KIEAGNEFKN------ 170

Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD- 337
                                                 GTP+++APE++  +  G+E D 
Sbjct: 171 ------------------------------------IFGTPEFVAPEIVNYEPLGLEADM 194

Query: 338 W 338
           W
Sbjct: 195 W 195

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  157 bits (398), Expect = 9e-46
 Identities = 59/237 (24%), Positives = 108/237 (45%), Gaps = 56/237 (23%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + ++++ ++G+G+FGEV  C+++ +   YA+K + K+   ++     +  E  LL ++  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             I+KL+   +D+   Y++ E   GG++   +++ +  +E  A   I Q    I  +HKH
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
           N +HRD+KP+N+LL   +++  +K+ DFGL             +N  + D          
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST--------CFQQNTKMKD---------- 182

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                            +GT  YIAPEV L+  Y  +CD W
Sbjct: 183 --------------------------------RIGTAYYIAPEV-LRGTYDEKCDVW 206

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  157 bits (398), Expect = 1e-45
 Identities = 59/247 (23%), Positives = 100/247 (40%), Gaps = 64/247 (25%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
           ++++   I+GRG    VR C  K +   YA+K +  +   S    E        L EV  
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 165 -----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
                 H  I++L  +++   + +L+ + +  G++   L  + TL+E   R  +   +  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
           I ++HK N +HRD+KP+N+LLD + ++KL+DFG            ++  E L +      
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC--------QLDPGEKLRE------ 182

Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL------LKKGY 332
                                                 GTP Y+APE++         GY
Sbjct: 183 ------------------------------------VCGTPSYLAPEIIECSMNDNHPGY 206

Query: 333 GMECD-W 338
           G E D W
Sbjct: 207 GKEVDMW 213

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  156 bits (398), Expect = 1e-45
 Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 58/237 (24%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
             F  + ++G GAF EV L +++ +G ++A+K +KKS      +   +  E  +L ++  
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSSLENEIAVLKKIKH 65

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IV L   ++   + YL+M+ + GG++   ++     TE  A   I Q + A++ +H++
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
             +HRD+KP+NLL    ++N  + ++DFG         LS + +N ++            
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFG---------LSKMEQNGIM------------ 164

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                          +  GTP Y+APEVL +K Y    D W
Sbjct: 165 ------------------------------STACGTPGYVAPEVLAQKPYSKAVDCW 191

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  158 bits (401), Expect = 1e-45
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 59/243 (24%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ--VEHVRAERNLLAEV 163
           D ++L  +IG+G F  VR C  +++G  +A+K +  ++  S      E ++ E ++   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGD----VMTLLMREETLTETVARFYIAQSVLAI 219
               IV+L  ++     LY++ E++ G D    ++         +E VA  Y+ Q + A+
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 220 ESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
              H +N IHRD+KP  +LL   + +  +KL  FG+                        
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---------------------- 181

Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
                  +  ESG                     +A   VGTP ++APEV+ ++ YG   
Sbjct: 182 -------QLGESG--------------------LVAGGRVGTPHFMAPEVVKREPYGKPV 214

Query: 337 D-W 338
           D W
Sbjct: 215 DVW 217

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  157 bits (398), Expect = 3e-45
 Identities = 56/249 (22%), Positives = 103/249 (41%), Gaps = 59/249 (23%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVR 154
            ++  +  D +D    +G G F  V+ C+EK +G  YA K +KK    S  +    E + 
Sbjct: 4   FRQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62

Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
            E ++L E+    ++ L+  +++   + LI+E + GG++   L  +E+LTE  A  ++ Q
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
            +  +  +H     H D+KP+N++L         +K+ DFGL           I+     
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--------KIDFGNEF 174

Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
            +                                            GTP+++APE++  +
Sbjct: 175 KN------------------------------------------IFGTPEFVAPEIVNYE 192

Query: 331 GYGMECD-W 338
             G+E D W
Sbjct: 193 PLGLEADMW 201

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  159 bits (403), Expect = 1e-44
 Identities = 66/260 (25%), Positives = 114/260 (43%), Gaps = 56/260 (21%)

Query: 83  NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
           +++  L      +++      S D +    ++G+G+FGEV LC++K +G   A+K + K 
Sbjct: 4   SMMDHLHATPGMFVQHSTAIFS-DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62

Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET 202
           ++  +   E +  E  LL ++    I+KLY  F+D  Y YL+ E   GG++   ++  + 
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 122

Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCT 259
            +E  A   I Q +  I  +HK+  +HRD+KP+NLLL    ++ ++++ DFGL       
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST----- 177

Query: 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTP 319
                  ++ + D                                           +GT 
Sbjct: 178 ---HFEASKKMKD------------------------------------------KIGTA 192

Query: 320 DYIAPEVLLKKGYGMECD-W 338
            YIAPEV L   Y  +CD W
Sbjct: 193 YYIAPEV-LHGTYDEKCDVW 211

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  156 bits (396), Expect = 1e-44
 Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 59/249 (23%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVR 154
            K+ K+  D +D+   +G G F  V+ C+EK +G  YA K +KK +  +  +    E + 
Sbjct: 5   FKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63

Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
            E ++L +V    I+ L+  +++   + LI+E + GG++   L ++E+L+E  A  +I Q
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
            +  +  +H     H D+KP+N++L        H+KL DFGL           I +    
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--------EIEDGVEF 175

Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
            +                                            GTP+++APE++  +
Sbjct: 176 KN------------------------------------------IFGTPEFVAPEIVNYE 193

Query: 331 GYGMECD-W 338
             G+E D W
Sbjct: 194 PLGLEADMW 202

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  154 bits (391), Expect = 3e-44
 Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 58/232 (25%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLY 172
           +GRG F  VR C  K +G  YA K LKK     +     +  E  +L    S   ++ L+
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHR 230
             +++   + LI+EY  GG++ +L + E  E ++E      I Q +  +  +H++N +H 
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155

Query: 231 DIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           D+KP N+LL      G +K+ DFG+ +         I     L +               
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSR--------KIGHACELRE--------------- 192

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                       +GTP+Y+APE+L         D W
Sbjct: 193 ---------------------------IMGTPEYLAPEILNYDPITTATDMW 217

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  152 bits (387), Expect = 4e-44
 Identities = 57/242 (23%), Positives = 99/242 (40%), Gaps = 63/242 (26%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D F     +G GAFG+V L +E+ SG    +K + K     +  +E + AE  +L  +  
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSL-D 78

Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGD----VMTLLMREETLTETVARFYIAQSVLAIE 220
           H  I+K++  F+D   +Y++ME   GG+    +++   R + L+E      + Q + A+ 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138

Query: 221 SIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
             H  + +H+D+KP+N+L      +  +K+ DFGL +            +E   +     
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE--------LFKSDEHSTN----- 185

Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                                                  GT  Y+APEV  K+    +CD
Sbjct: 186 -------------------------------------AAGTALYMAPEV-FKRDVTFKCD 207

Query: 338 -W 338
            W
Sbjct: 208 IW 209

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  153 bits (388), Expect = 4e-44
 Identities = 49/247 (19%), Positives = 85/247 (34%), Gaps = 54/247 (21%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
            DF+ +  +GRG FG V   + K     YA+K+++          E V  E   LA++  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62

Query: 166 HCIVKLYYSFQD------------AEYLYLIMEYLPGGDVMTLLMREETLT---ETVARF 210
             IV+ + ++ +              YLY+ M+     ++   +    T+     +V   
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
              Q   A+E +H    +HRD+KP N+    +  +K+ DFGL   +D           + 
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
                                                        VGT  Y++PE +   
Sbjct: 183 AYARH-------------------------------------TGQVGTKLYMSPEQIHGN 205

Query: 331 GYGMECD 337
            Y  + D
Sbjct: 206 SYSHKVD 212

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  156 bits (397), Expect = 4e-44
 Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 54/237 (22%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +++ L   +G+GAF  VR C +  +G  YA   +     LS    + +  E  +   +  
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKH 69

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IV+L+ S  +  + YLI + + GG++   ++  E  +E  A   I Q + A+   H+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
             +HR++KP+NLLL    +   +KL+DFGL   ++        E +              
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-------GEQQAW------------ 170

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                         +   GTP Y++PEVL K  YG   D W
Sbjct: 171 ------------------------------FGFAGTPGYLSPEVLRKDPYGKPVDLW 197

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  155 bits (393), Expect = 5e-44
 Identities = 56/289 (19%), Positives = 121/289 (41%), Gaps = 59/289 (20%)

Query: 54  MKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTI 113
           M+         S +  K     + + ++       ++   + + +K+  +  D +D+L  
Sbjct: 1   MRGSHHHHHHGSKVRGKYDGPKINDYDK-FYEDIWKKYVPQPVEVKQGSVY-DYYDILEE 58

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
           +G GAFG V  C EK +G ++  K +     L +     V+ E +++ ++    ++ L+ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHD 115

Query: 174 SFQDAEYLYLIMEYLPGGDVM-TLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
           +F+D   + LI+E+L GG++   +   +  ++E     Y+ Q+   ++ +H+H+ +H DI
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175

Query: 233 KPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
           KP+N++    +   +K+ DFGL           +N +E++                    
Sbjct: 176 KPENIMCETKKASSVKIIDFGLAT--------KLNPDEIVKV------------------ 209

Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                   T  T ++ APE++ ++  G   D W
Sbjct: 210 ------------------------TTATAEFAAPEIVDREPVGFYTDMW 234

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  152 bits (387), Expect = 7e-44
 Identities = 53/263 (20%), Positives = 97/263 (36%), Gaps = 65/263 (24%)

Query: 90  RKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ 149
              TE +  +   +    + +L  IG G   +V     +    IYA+K +   E      
Sbjct: 12  DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQT 69

Query: 150 VEHVRAERNLLAEVASHC--IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
           ++  R E   L ++  H   I++LY      +Y+Y++ME     D+ + L +++++    
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE 128

Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
            + Y    + A+ +IH+H  +H D+KP N L+  +G +KL DFG+               
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN------------- 174

Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
             +  +  +   D                                 S VGT +Y+ PE +
Sbjct: 175 -QMQPDTTSVVKD---------------------------------SQVGTVNYMPPEAI 200

Query: 328 L-----------KKGYGMECD-W 338
                       K     + D W
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVW 223

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  152 bits (385), Expect = 2e-43
 Identities = 61/249 (24%), Positives = 97/249 (38%), Gaps = 64/249 (25%)

Query: 98  LKRHKISVDDFDLLT---IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +K        +DL      +G G+F   R C  KKS   +A+K + K          + +
Sbjct: 1   MKDSPFY-QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQ 53

Query: 155 AERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIA 213
            E   L     H  IVKL+  F D  + +L+ME L GG++   + +++  +ET A + + 
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR 113

Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
           + V A+  +H    +HRD+KP+NLL    + N  +K+ DFG  +           +N+ L
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-------PDNQPL 166

Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
                                                          T  Y APE+L + 
Sbjct: 167 KT------------------------------------------PCFTLHYAAPELLNQN 184

Query: 331 GYGMECD-W 338
           GY   CD W
Sbjct: 185 GYDESCDLW 193

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  155 bits (394), Expect = 2e-43
 Identities = 68/266 (25%), Positives = 114/266 (42%), Gaps = 57/266 (21%)

Query: 77  PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
              E +    DL+     ++  K+  +S + +  +  +G GA+GEV LC++K +    A+
Sbjct: 9   SGRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67

Query: 137 KKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL 196
           K ++K+  +S      +  E  +L  +    I+KLY  F+D    YL+ME   GG++   
Sbjct: 68  KIIRKTS-VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE 126

Query: 197 LMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLC 253
           ++      E  A   I Q +  +  +HKHN +HRD+KP+NLLL   +++  +K+ DFGL 
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186

Query: 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAY 313
                         + + +                                         
Sbjct: 187 A--------VFENQKKMKE----------------------------------------- 197

Query: 314 STVGTPDYIAPEVLLKKGYGMECD-W 338
             +GT  YIAPEV L+K Y  +CD W
Sbjct: 198 -RLGTAYYIAPEV-LRKKYDEKCDVW 221

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  150 bits (381), Expect = 2e-43
 Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 58/237 (24%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
             + L   IGRG++GEV++  +K +    A KK+ K  +     V+  + E  ++  +  
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             I++LY +F+D   +YL+ME   GG++   ++ +    E+ A   +   + A+   HK 
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
           N  HRD+KP+N L      +  +KL DFGL               +++            
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA--------RFKPGKMMRT---------- 167

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                            VGTP Y++P+V L+  YG ECD W
Sbjct: 168 --------------------------------KVGTPYYVSPQV-LEGLYGPECDEW 191

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  156 bits (396), Expect = 3e-43
 Identities = 60/314 (19%), Positives = 120/314 (38%), Gaps = 67/314 (21%)

Query: 38  RVAAAKQFIESHY-----KAQMKHIQERKQRRSVLERKLASSDVPEEEQIN----ILKDL 88
           R+ A  +  +S          +   + +++R   ++ +            N    +    
Sbjct: 81  RIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIW 140

Query: 89  ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
           ++   + + +K   +  D +D+   +G GAFG V    E+ +GN +A K +         
Sbjct: 141 KQYYPQPVEIKHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---S 196

Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVM-TLLMREETLTETV 207
             E VR E   ++ +    +V L+ +F+D   + +I E++ GG++   +      ++E  
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE 256

Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAIN 265
           A  Y+ Q    +  +H++NY+H D+KP+N++    ++  +KL DFGL           ++
Sbjct: 257 AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA--------HLD 308

Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
             + +                                            T GT ++ APE
Sbjct: 309 PKQSVKV------------------------------------------TTGTAEFAAPE 326

Query: 326 VLLKKGYGMECD-W 338
           V   K  G   D W
Sbjct: 327 VAEGKPVGYYTDMW 340

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  151 bits (383), Expect = 5e-43
 Identities = 60/255 (23%), Positives = 109/255 (42%), Gaps = 60/255 (23%)

Query: 89  ERKETEYMRLKRHKISVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
                +Y     ++ ++ DF ++ + +GRGA   V  C++K +   YA+K LKK+     
Sbjct: 35  ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---- 90

Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
              + VR E  +L  ++   I+KL   F+    + L++E + GG++   ++ +   +E  
Sbjct: 91  -DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149

Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAI 264
           A   + Q + A+  +H++  +HRD+KP+NLL      +  +K++DFGL K ++       
Sbjct: 150 AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE------- 202

Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
               ++                                           +  GTP Y AP
Sbjct: 203 -HQVLM------------------------------------------KTVCGTPGYCAP 219

Query: 325 EVLLKKGYGMECD-W 338
           E+L    YG E D W
Sbjct: 220 EILRGCAYGPEVDMW 234

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  152 bits (387), Expect = 7e-43
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 65/246 (26%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
           D++ +   +G GA GEV+L  E+K+    A++ + K +       E   A   +  E+  
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALN-VETEIEI 193

Query: 165 ----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
               +H CI+K+   F   +Y Y+++E + GG++   ++  + L E   + Y  Q +LA+
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252

Query: 220 ESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
           + +H++  IHRD+KP+N+LL   +++  +K++DFG  K         + E  ++      
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--------ILGETSLMRT---- 300

Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGYG 333
                                                   GTP Y+APEVL      GY 
Sbjct: 301 --------------------------------------LCGTPTYLAPEVLVSVGTAGYN 322

Query: 334 MECD-W 338
              D W
Sbjct: 323 RAVDCW 328

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  150 bits (381), Expect = 8e-43
 Identities = 49/237 (20%), Positives = 82/237 (34%), Gaps = 58/237 (24%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + + +   +GRG FG V  C E  S   Y  K +K            V+ E ++L     
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVM-TLLMREETLTETVARFYIAQSVLAIESIHK 224
             I+ L+ SF+  E L +I E++ G D+   +      L E     Y+ Q   A++ +H 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 225 HNYIHRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
           HN  H DI+P+N++    ++  +K+ +FG  +         +   +              
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--------QLKPGDNFRL---------- 162

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                               P+Y APEV          D W
Sbjct: 163 --------------------------------LFTAPEYYAPEVHQHDVVSTATDMW 187

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  150 bits (380), Expect = 8e-43
 Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 65/246 (26%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
           D++ +   +G GA GEV+L  E+K+    A+K + K +       E   A   +  E+  
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN-VETEIEI 68

Query: 165 ----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
               +H CI+K+   F   +Y Y+++E + GG++   ++  + L E   + Y  Q +LA+
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127

Query: 220 ESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
           + +H++  IHRD+KP+N+LL   +++  +K++DFG  K L         E  ++      
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--------ETSLMRT---- 175

Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGYG 333
                                                   GTP Y+APEVL      GY 
Sbjct: 176 --------------------------------------LCGTPTYLAPEVLVSVGTAGYN 197

Query: 334 MECD-W 338
              D W
Sbjct: 198 RAVDCW 203

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  154 bits (390), Expect = 8e-43
 Identities = 60/238 (25%), Positives = 109/238 (45%), Gaps = 58/238 (24%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + ++++ ++G+G+FGEV  C+++ +   YA+K + K+   ++     +  E  LL ++  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-D 79

Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
           H  I+KL+   +D+   Y++ E   GG++   +++ +  +E  A   I Q    I  +HK
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139

Query: 225 HNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           HN +HRD+KP+N+LL   +++  +K+ DFGL             +N  + D         
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLST--------CFQQNTKMKD--------- 182

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                             +GT  YIAPEV L+  Y  +CD W
Sbjct: 183 ---------------------------------RIGTAYYIAPEV-LRGTYDEKCDVW 206

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  150 bits (380), Expect = 9e-43
 Identities = 57/255 (22%), Positives = 95/255 (37%), Gaps = 70/255 (27%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
             S   + L  I+G+GA   V   + KK+G+++A+K       L    V+    E  +L 
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLK 62

Query: 162 EVASHCIVKLYYSFQD--AEYLYLIMEYLPGGDVMTLLM---REETLTETVARFYIAQSV 216
           ++    IVKL+   ++    +  LIME+ P G + T+L        L E+     +   V
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 217 LAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
             +  + ++  +HR+IKP N++     D     KL+DFG  + L+             DD
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------------DD 169

Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL----- 327
           E                                        S  GT +Y+ P++      
Sbjct: 170 EQFV-------------------------------------SLYGTEEYLHPDMYERAVL 192

Query: 328 ---LKKGYGMECD-W 338
               +K YG   D W
Sbjct: 193 RKDHQKKYGATVDLW 207

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  151 bits (384), Expect = 1e-42
 Identities = 57/255 (22%), Positives = 95/255 (37%), Gaps = 70/255 (27%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
             S   + L  I+G+GA   V   + KK+G+++A+K       L    V+    E  +L 
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLK 62

Query: 162 EVASHCIVKLYYSFQD--AEYLYLIMEYLPGGDVMTLLM---REETLTETVARFYIAQSV 216
           ++    IVKL+   ++    +  LIME+ P G + T+L        L E+     +   V
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 217 LAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
             +  + ++  +HR+IKP N++     D     KL+DFG  + L+             DD
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------------DD 169

Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL----- 327
           E                                        S  GT +Y+ P++      
Sbjct: 170 EQFV-------------------------------------SLYGTEEYLHPDMYERAVL 192

Query: 328 ---LKKGYGMECD-W 338
               +K YG   D W
Sbjct: 193 RKDHQKKYGATVDLW 207

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  150 bits (380), Expect = 2e-42
 Identities = 37/258 (14%), Positives = 76/258 (29%), Gaps = 71/258 (27%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
           ++      +  ++G GAF +V    +      K+   + +K  K +      +       
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQL 117

Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-----EETLTETVARFY 211
              L     H  +K Y +        L+ E    G ++  +       E+ + + +   +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLL-----------DQNGHMKLSDFGLCKPLDCTN 260
             + +  IE +H    IH DIKPDN +L           D +  + L D G        +
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-----D 232

Query: 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD 320
           +    +  +                                            +   T  
Sbjct: 233 MKLFPKGTIF------------------------------------------TAKCETSG 250

Query: 321 YIAPEVLLKKGYGMECDW 338
           +   E+L  K +  + D+
Sbjct: 251 FQCVEMLSNKPWNYQIDY 268

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  152 bits (387), Expect = 2e-42
 Identities = 72/274 (26%), Positives = 116/274 (42%), Gaps = 66/274 (24%)

Query: 79  EEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK 138
             +    + +      Y+R K  KI  + +  +  +G GA+GEV LC+EK   +  A+K 
Sbjct: 10  GRENLYFQGIAINPGMYVRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68

Query: 139 LKKSEMLSRGQVEHVRA----ERNLLAEVA-----SH-CIVKLYYSFQDAEYLYLIMEYL 188
           +KKS+       +  +        +  E++      H  I+KL+  F+D +Y YL+ E+ 
Sbjct: 69  IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128

Query: 189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHM 245
            GG++   ++      E  A   + Q +  I  +HKHN +HRDIKP+N+LL   +   ++
Sbjct: 129 EGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188

Query: 246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQ 305
           K+ DFGL            +++  L D                                 
Sbjct: 189 KIVDFGLSS--------FFSKDYKLRD--------------------------------- 207

Query: 306 INRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                     +GT  YIAPEV LKK Y  +CD W
Sbjct: 208 ---------RLGTAYYIAPEV-LKKKYNEKCDVW 231

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  150 bits (380), Expect = 3e-42
 Identities = 59/293 (20%), Positives = 109/293 (37%), Gaps = 58/293 (19%)

Query: 51  KAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVD-DFD 109
           ++     +E      + ER    S       ++I       +   +  K+  ++      
Sbjct: 33  RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92

Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
              I+G G FG+V  C+E  +G   A K +K   M  +   E V+ E +++ ++    ++
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLI 149

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVM-TLLMREETLTETVARFYIAQSVLAIESIHKHNYI 228
           +LY +F+    + L+MEY+ GG++   ++     LTE     ++ Q    I  +H+   +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209

Query: 229 HRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFP 286
           H D+KP+N+L        +K+ DFGL +             E L                
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLAR--------RYKPREKLKV-------------- 247

Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                         GTP+++APEV+         D W
Sbjct: 248 ----------------------------NFGTPEFLAPEVVNYDFVSFPTDMW 272

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  148 bits (376), Expect = 6e-42
 Identities = 55/248 (22%), Positives = 98/248 (39%), Gaps = 63/248 (25%)

Query: 98  LKRHKISV-DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
           L R+ I   D +++   IG G++   + C  K +   +A+K + KS+            E
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEE 65

Query: 157 RNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
             +L     H  I+ L   + D +Y+Y++ E + GG+++  ++R++  +E  A   +   
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125

Query: 216 VLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
              +E +H    +HRD+KP N+L          +++ DFG  K L         EN +L 
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-------AENGLLM 178

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
                                                         T +++APEVL ++G
Sbjct: 179 T------------------------------------------PCYTANFVAPEVLERQG 196

Query: 332 YGMECD-W 338
           Y   CD W
Sbjct: 197 YDAACDIW 204

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  147 bits (374), Expect = 6e-42
 Identities = 48/236 (20%), Positives = 87/236 (36%), Gaps = 55/236 (23%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
           ++G GA   V+ C    +   YA+K ++K     R     V  E  +L +   H  +++L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
              F++ +  YL+ E + GG +++ + +     E  A   +     A++ +H     HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136

Query: 232 IKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPES 288
           +KP+N+L    +Q   +K+ DF L   +      +      L                  
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL------------------ 178

Query: 289 GCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KGYGMECD-W 338
                                    +  G+ +Y+APEV+         Y   CD W
Sbjct: 179 ------------------------LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLW 210

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  148 bits (375), Expect = 8e-42
 Identities = 48/236 (20%), Positives = 89/236 (37%), Gaps = 53/236 (22%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
            +    + +L  IG G   +V      +   IYA+K +   E      ++  R E   L 
Sbjct: 5   SVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLN 62

Query: 162 EVASHC--IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
           ++  H   I++LY      +Y+Y++ME     D+ + L +++++     + Y    + A+
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
            +IH+H  +H D+KP N L+  +G +KL DFG+           +  +            
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN--------QMQPDTT---------- 162

Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
                                          +  S VGT +Y+ PE +       E
Sbjct: 163 -----------------------------SVVKDSQVGTVNYMPPEAIKDMSSSRE 189

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  146 bits (371), Expect = 3e-41
 Identities = 59/296 (19%), Positives = 105/296 (35%), Gaps = 93/296 (31%)

Query: 90  RKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSR 147
           R+   +      ++    + L   IG+G++G VR+  E ++  I A+K + K+++  ++ 
Sbjct: 11  RENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69

Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD--------------- 192
             VE ++ E  L+ ++    I +LY  ++D +Y+ L+ME   GG                
Sbjct: 70  KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129

Query: 193 -------------------------VMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
                                           +    E +    + Q   A+  +H    
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189

Query: 228 IHRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
            HRDIKP+N L   +++  +KL DFGL K           +    +   +          
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSK--------EFYKLNNGEYYGMTT-------- 233

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL--LKKGYGMECD-W 338
                                          GTP ++APEVL    + YG +CD W
Sbjct: 234 -----------------------------KAGTPYFVAPEVLNTTNESYGPKCDAW 260

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  147 bits (372), Expect = 5e-41
 Identities = 57/284 (20%), Positives = 102/284 (35%), Gaps = 66/284 (23%)

Query: 54  MKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTI 113
           MK     K  R  ++     +D  ++   +  + +  K   Y  LK              
Sbjct: 17  MKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILK-------------Q 63

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKL 171
           IG G   +V      +   IYA+K +   E      ++  R E   L ++  H   I++L
Sbjct: 64  IGSGGSSKVFQVL-NEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
           Y      +Y+Y++ME     D+ + L +++++     + Y    + A+ +IH+H  +H D
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180

Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
           +KP N L+  +G +KL DFG+        +     + V D                    
Sbjct: 181 LKPANFLIV-DGMLKLIDFGIAN-----QMQPDTTSVVKD-------------------- 214

Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
                                 S VG  +Y+ PE +       E
Sbjct: 215 ----------------------SQVGAVNYMPPEAIKDMSSSRE 236

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  143 bits (363), Expect = 2e-40
 Identities = 45/234 (19%), Positives = 75/234 (32%), Gaps = 51/234 (21%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
            +  +  +G G F  V L +    G+ YA+K++   E   R   E  + E ++       
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHP 86

Query: 167 CIVKLYYSFQDAE----YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLA 218
            I++L              +L++ +   G +   + R       LTE    + +      
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
           +E+IH   Y HRD+KP N+LL   G   L D G           +               
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS--------------- 191

Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
                                 LQ W         +   T  Y APE+   + +
Sbjct: 192 -----------------RQALTLQDW--------AAQRCTISYRAPELFSVQSH 220

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  140 bits (355), Expect = 1e-39
 Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 64/262 (24%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
              ++ +  + L   +G G FG+V++ + + +G+  A+K L + ++ S   V  ++ E  
Sbjct: 4   HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63

Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
            L       I+KLY         +++MEY+ GG++   + +   + E  AR    Q + A
Sbjct: 64  NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
           ++  H+H  +HRD+KP+N+LLD + + K++DFGL              N + D E L  S
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-------------NMMSDGEFLRTS 170

Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD 337
                      C                          G+P+Y APEV+  + Y G E D
Sbjct: 171 -----------C--------------------------GSPNYAAPEVISGRLYAGPEVD 193

Query: 338 -WLAYWNETLSCNYLSDIMLYV 358
            W        SC     ++LY 
Sbjct: 194 IW--------SCG----VILYA 203

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  140 bits (356), Expect = 3e-39
 Identities = 59/264 (22%), Positives = 99/264 (37%), Gaps = 78/264 (29%)

Query: 90  RKETEYMRLKRHKISVDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
               +    K++ ++ DD+ L   ++G G  G+V  C  +++G   A+K L  S    + 
Sbjct: 13  EVLFQGPEPKKYAVT-DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ- 70

Query: 149 QVEHVRAERNLLAEVASH-CIVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMR---- 199
                  E +   + +    IV +   +++       L +IME + GG+   L  R    
Sbjct: 71  -------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE---LFSRIQER 120

Query: 200 -EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKP 255
            ++  TE  A   +     AI+ +H HN  HRD+KP+NLL    +++  +KL+DFG    
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG---- 176

Query: 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST 315
                 +       L                                           + 
Sbjct: 177 -----FAKETTQNAL------------------------------------------QTP 189

Query: 316 VGTPDYIAPEVLLKKGYGMECD-W 338
             TP Y+APEVL  + Y   CD W
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMW 213

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  140 bits (355), Expect = 4e-39
 Identities = 61/268 (22%), Positives = 107/268 (39%), Gaps = 60/268 (22%)

Query: 73  SSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN 132
             +  + E + + + L+  + EY      +  V        +GRG+FGEV   ++K++G 
Sbjct: 31  GPETEDNEGVLLTEKLKPVDYEY------REEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84

Query: 133 IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD 192
             A+KK++               E    A ++S  IV LY + ++  ++ + ME L GG 
Sbjct: 85  QCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136

Query: 193 VMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFG 251
           +  L+ +   L E  A +Y+ Q++  +E +H    +H D+K DN+LL  +G    L DFG
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196

Query: 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL 311
                             L  + L +S+                                
Sbjct: 197 HAL--------------CLQPDGLGKSLLTGDYI-------------------------- 216

Query: 312 AYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                GT  ++APEV++ K    + D W
Sbjct: 217 ----PGTETHMAPEVVMGKPCDAKVDIW 240

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  139 bits (352), Expect = 5e-39
 Identities = 49/239 (20%), Positives = 86/239 (35%), Gaps = 43/239 (17%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
            +F  L  IG G FG V  C ++  G IYA+K+ KK    S  +   +R E    A +  
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQ 69

Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL----MREETLTETVARFYIAQSVLAIE 220
           H  +V+ + ++ + +++ +  EY  GG +   +           E   +  + Q    + 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
            IH  + +H DIKP N+ + +      +                   E  +D+  +  + 
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASE-----------------EGDEDDWASNKVM 172

Query: 281 VD-GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECD 337
              G     G   R  SP                   G   ++A EVL     +  + D
Sbjct: 173 FKIGDL---GHVTRISSP---------------QVEEGDSRFLANEVLQENYTHLPKAD 213

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  140 bits (355), Expect = 5e-39
 Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 58/247 (23%)

Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-----HVR 154
                   +  ++ +G GAFG V    +K+      +K +KK ++L    +E      V 
Sbjct: 18  CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77

Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIME-YLPGGDVMTLLMREETLTETVARFYIA 213
            E  +L+ V    I+K+   F++  +  L+ME +  G D+   + R   L E +A +   
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137

Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273
           Q V A+  +   + IHRDIK +N+++ ++  +KL DFG                 +   +
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-------------AYLERGK 184

Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY- 332
                                                   +  GT +Y APEVL+   Y 
Sbjct: 185 LFY-------------------------------------TFCGTIEYCAPEVLMGNPYR 207

Query: 333 GMECD-W 338
           G E + W
Sbjct: 208 GPELEMW 214

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  141 bits (358), Expect = 6e-39
 Identities = 60/258 (23%), Positives = 99/258 (38%), Gaps = 77/258 (29%)

Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R       
Sbjct: 52  LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------- 103

Query: 155 AERNLLAEVASH-CIVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMR-----EETLT 204
            E  L    +    IV++   +++     + L ++ME L GG+   L  R     ++  T
Sbjct: 104 -EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFT 159

Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNL 261
           E  A   +     AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K       
Sbjct: 160 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------- 212

Query: 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321
                +  L                                               TP Y
Sbjct: 213 -ETTSHNSLTT------------------------------------------PCYTPYY 229

Query: 322 IAPEVLLKKGYGMECD-W 338
           +APEVL  + Y   CD W
Sbjct: 230 VAPEVLGPEKYDKSCDMW 247

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  138 bits (351), Expect = 1e-38
 Identities = 52/251 (20%), Positives = 87/251 (34%), Gaps = 62/251 (24%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH-VRAER 157
           K  +    ++ L  ++G+G FG V            A+K + ++ +L    +   V    
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83

Query: 158 -----NLLAEVASH-CIVKLYYSFQDAEYLYLIMEY-LPGGDVMTLLMREETLTETVARF 210
                  +     H  +++L   F+  E   L++E  LP  D+   +  +  L E  +R 
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143

Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSAINENEV 269
           +  Q V AI+  H    +HRDIK +N+L+D + G  KL DFG           A+  +E 
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG---------SGALLHDEP 194

Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
             D                                            GT  Y  PE + +
Sbjct: 195 YTD------------------------------------------FDGTRVYSPPEWISR 212

Query: 330 KGY-GMECD-W 338
             Y  +    W
Sbjct: 213 HQYHALPATVW 223

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  144 bits (364), Expect = 2e-38
 Identities = 56/251 (22%), Positives = 90/251 (35%), Gaps = 67/251 (26%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           +   +++   +G G FG V     + +G   A+K+ ++   LS    E    E  ++ ++
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL 69

Query: 164 ASHCIVKLYYSFQDAEYL------YLIMEYLPGGDVMTLLMREET---LTETVARFYIAQ 214
               +V         + L       L MEY  GGD+   L + E    L E   R  ++ 
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLDCTNLSAINENEVLD 271
              A+  +H++  IHRD+KP+N++L         K+ D G  K LD              
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-------------Q 176

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
            E                                          VGT  Y+APE+L +K 
Sbjct: 177 GELCT-------------------------------------EFVGTLQYLAPELLEQKK 199

Query: 332 YGMECDWLAYW 342
           Y +  D   YW
Sbjct: 200 YTVTVD---YW 207

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  134 bits (340), Expect = 3e-37
 Identities = 61/256 (23%), Positives = 105/256 (41%), Gaps = 63/256 (24%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++   +  +  + E  A+ +  Q +  +  +H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
               HRDIKP+NLLLD+  ++K+SDFG         L+ +                    
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFG---------LATVFR------------------ 156

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD-WLAYW 342
                                 NR +L     GT  Y+APE+L ++ +     D W    
Sbjct: 157 --------------------YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW---- 192

Query: 343 NETLSCNYLSDIMLYV 358
               SC     I+L  
Sbjct: 193 ----SCG----IVLTA 200

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  136 bits (344), Expect = 2e-36
 Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 64/262 (24%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
              ++ +  + L   +G G FG+V++ + + +G+  A+K L + ++ S   V  +R E  
Sbjct: 9   HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68

Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
            L       I+KLY        ++++MEY+ GG++   + +   L E  +R    Q +  
Sbjct: 69  NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
           ++  H+H  +HRD+KP+N+LLD + + K++DFGL              N + D E L  S
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-------------NMMSDGEFLRTS 175

Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD 337
                      C                          G+P+Y APEV+  + Y G E D
Sbjct: 176 -----------C--------------------------GSPNYAAPEVISGRLYAGPEVD 198

Query: 338 -WLAYWNETLSCNYLSDIMLYV 358
            W        S      ++LY 
Sbjct: 199 IW--------SSG----VILYA 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  132 bits (334), Expect = 2e-36
 Identities = 69/269 (25%), Positives = 105/269 (39%), Gaps = 79/269 (29%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
               + ++ + L   IG+G++G V+L   +     YAMK L K +++ +         R 
Sbjct: 6   SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRG 65

Query: 159 LLA-----------------EVA-----SH-CIVKLYYSFQDAE--YLYLIMEYLPGGDV 193
                               E+A      H  +VKL     D    +LY++ E +  G V
Sbjct: 66  TRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV 125

Query: 194 MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
           M +    + L+E  ARFY    +  IE +H    IHRDIKP NLL+ ++GH+K++DFG+ 
Sbjct: 126 MEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAY 313
                                 NE    D                            L  
Sbjct: 185 ----------------------NEFKGSDA---------------------------LLS 195

Query: 314 STVGTPDYIAPEVL--LKKGY-GMECD-W 338
           +TVGTP ++APE L   +K + G   D W
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVW 224

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  133 bits (337), Expect = 3e-36
 Identities = 66/264 (25%), Positives = 98/264 (37%), Gaps = 70/264 (26%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
                  D +D +  IG G FG  RL ++K +  + A+K +++   +     E+V+ E  
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREII 68

Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
               +    IV+         +L +IMEY  GG++   +      +E  ARF+  Q +  
Sbjct: 69  NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG 128

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHM--KLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
           +   H     HRD+K +N LLD +     K+ DFG  K                      
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------- 166

Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GME 335
               V    P+S                            GTP YIAPEVLL++ Y G  
Sbjct: 167 --SSVLHSQPKSTV--------------------------GTPAYIAPEVLLRQEYDGKI 198

Query: 336 CD-WLAYWNETLSCNYLSDIMLYV 358
            D W        SC     + LYV
Sbjct: 199 ADVW--------SCG----VTLYV 210

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  132 bits (334), Expect = 4e-36
 Identities = 57/259 (22%), Positives = 94/259 (36%), Gaps = 60/259 (23%)

Query: 89  ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
           +   T+    K  +     + +  ++G G FG V            A+K ++K  +   G
Sbjct: 26  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 85

Query: 149 QVEH---VRAERNLLAEVASHC--IVKLYYSFQDAEYLYLIMEY-LPGGDVMTLLMREET 202
           ++ +   V  E  LL +V+S    +++L   F+  +   LI+E   P  D+   +     
Sbjct: 86  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 145

Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCTNL 261
           L E +AR +  Q + A+   H    +HRDIK +N+L+D N G +KL DFG          
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG---------S 196

Query: 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321
            A+ ++ V  D                                            GT  Y
Sbjct: 197 GALLKDTVYTD------------------------------------------FDGTRVY 214

Query: 322 IAPEVLLKKGY-GMECD-W 338
             PE +    Y G     W
Sbjct: 215 SPPEWIRYHRYHGRSAAVW 233

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  132 bits (333), Expect = 6e-36
 Identities = 61/256 (23%), Positives = 105/256 (41%), Gaps = 63/256 (24%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++   +  +  + E  A+ +  Q +  +  +H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
               HRDIKP+NLLLD+  ++K+SDFG         L+ +                    
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFG---------LATVFR------------------ 156

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD-WLAYW 342
                                 NR +L     GT  Y+APE+L ++ +     D W    
Sbjct: 157 --------------------YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW---- 192

Query: 343 NETLSCNYLSDIMLYV 358
               SC     I+L  
Sbjct: 193 ----SCG----IVLTA 200

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  131 bits (332), Expect = 9e-36
 Identities = 65/239 (27%), Positives = 104/239 (43%), Gaps = 53/239 (22%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           +  + ++ LL  IG+G F +V+L +   +G   A+K + K++ L+   ++ +  E  ++ 
Sbjct: 11  QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMK 69

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
            +    IVKL+   +  + LYLIMEY  GG+V   L+    + E  AR    Q V A++ 
Sbjct: 70  ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
            H+   +HRD+K +NLLLD + ++K++DFG               NE      L+     
Sbjct: 130 CHQKRIVHRDLKAENLLLDADMNIKIADFGFS-------------NEFTVGGKLDAF--- 173

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD-W 338
                   C                          G P Y APE+   K Y G E D W
Sbjct: 174 --------C--------------------------GAPPYAAPELFQGKKYDGPEVDVW 198

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  129 bits (327), Expect = 3e-35
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 53/234 (22%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + F  L  IG+G+FGEV    + ++  + A+K +   E  +  ++E ++ E  +L++  S
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDS 79

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             + K Y S+     L++IMEYL GG  + L +    L ET     + + +  ++ +H  
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSE 138

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
             IHRDIK  N+LL ++G +KL+DFG+   L  T                          
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-------------------------- 172

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                 +R    + VGTP ++APEV+ +  Y  + D W
Sbjct: 173 --------------------QIKRN---TFVGTPFWMAPEVIKQSAYDSKADIW 203

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  129 bits (327), Expect = 6e-35
 Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 53/243 (21%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           +   K  +  + +   +G G+FG+V+L    K+    A+K + +  +        V  E 
Sbjct: 1   MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
           + L  +    I+KLY        + +++EY  GG++   ++ ++ +TE   R +  Q + 
Sbjct: 61  SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC 119

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
           AIE  H+H  +HRD+KP+NLLLD N ++K++DFGL              N + D   L  
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS-------------NIMTDGNFLKT 166

Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMEC 336
           S           C                          G+P+Y APEV+  K Y G E 
Sbjct: 167 S-----------C--------------------------GSPNYAAPEVINGKLYAGPEV 189

Query: 337 D-W 338
           D W
Sbjct: 190 DVW 192

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  129 bits (325), Expect = 8e-35
 Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 58/252 (23%)

Query: 92  ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
             ++    R  +   D     D    IG G+ G V L +EK SG   A+K +   ++  +
Sbjct: 27  HEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQ 83

Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
            + E +  E  ++ +     +V++Y S+   E L+++ME+L GG + T ++ +  L E  
Sbjct: 84  QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQ 142

Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
                   + A+  +H    IHRDIK D++LL  +G +KLSDFG C  +           
Sbjct: 143 IATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-------- 194

Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
                                                 + +RK   S VGTP ++APEV+
Sbjct: 195 --------------------------------------VPKRK---SLVGTPYWMAPEVI 213

Query: 328 LKKGYGMECD-W 338
            +  Y  E D W
Sbjct: 214 SRSLYATEVDIW 225

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  125 bits (316), Expect = 9e-34
 Identities = 65/256 (25%), Positives = 110/256 (42%), Gaps = 66/256 (25%)

Query: 92  ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
           + E +   R  +SV D    +     IG+GA G V    +  +G   A++++    +  +
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQ 58

Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
            + E +  E  ++ E  +  IV    S+   + L+++MEYL GG + T ++ E  + E  
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEG- 116

Query: 208 ARFYIA----QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
               IA    + + A+E +H +  IHRDIK DN+LL  +G +KL+DFG C  +       
Sbjct: 117 ---QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169

Query: 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA 323
                                                      ++R    + VGTP ++A
Sbjct: 170 ------------------------------------------QSKRS---TMVGTPYWMA 184

Query: 324 PEVLLKKGYGMECD-W 338
           PEV+ +K YG + D W
Sbjct: 185 PEVVTRKAYGPKVDIW 200

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  125 bits (316), Expect = 1e-33
 Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 56/235 (23%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + FD+L  +G G++G V     K++G I A+K++          ++ +  E +++ +  S
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHK 224
             +VK Y S+     L+++MEY   G V  ++ +R +TLTE      +  ++  +E +H 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
              IHRDIK  N+LL+  GH KL+DFG+   L  T                         
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT------------------------- 178

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                + +R    + +GTP ++APEV+ + GY    D W
Sbjct: 179 ---------------------MAKRN---TVIGTPFWMAPEVIQEIGYNCVADIW 209

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  127 bits (322), Expect = 1e-33
 Identities = 49/259 (18%), Positives = 80/259 (30%), Gaps = 79/259 (30%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +      I+G G+ G V        G   A+K++           +    E  LL E   
Sbjct: 15  NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDD 67

Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGG--DVM----TLLMREETLTETVARFYIAQSVLA 218
           H  +++ Y S     +LY+ +E       D++          +   E      + Q    
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 219 IESIHKHNYIHRDIKPDNLLLD-------------QNGHMKLSDFGLCKPLDCTNLSAIN 265
           +  +H    IHRD+KP N+L+              +N  + +SDFGLCK           
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK----------- 176

Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
                                             +L   Q + R    +  GT  + APE
Sbjct: 177 ----------------------------------KLDSGQSSFRTNLNNPSGTSGWRAPE 202

Query: 326 VLL-------KKGYGMECD 337
           +L        K+      D
Sbjct: 203 LLEESNNLQTKRRLTRSID 221

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  127 bits (320), Expect = 2e-33
 Identities = 42/245 (17%), Positives = 77/245 (31%), Gaps = 62/245 (25%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
            +    F    ++G GA G + + +        A+K++                E  LL 
Sbjct: 20  IVGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPE------CFSFADREVQLLR 72

Query: 162 EVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIE 220
           E   H  +++ + + +D ++ Y+ +E         +  ++           + Q+   + 
Sbjct: 73  ESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGH-----MKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
            +H  N +HRD+KP N+L+            +SDFGLCK L                 + 
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA-------------VGRHS 179

Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGY 332
                                                    GT  +IAPE+L    K+  
Sbjct: 180 FSRR---------------------------------SGVPGTEGWIAPEMLSEDCKENP 206

Query: 333 GMECD 337
               D
Sbjct: 207 TYTVD 211

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  122 bits (309), Expect = 9e-33
 Identities = 55/235 (23%), Positives = 92/235 (39%), Gaps = 63/235 (26%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
           ++G+G +G V   ++  +    A+K    + S        + +  E  L   +    IV+
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY-----SQPLHEEIALHKHLKHKNIVQ 83

Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNY 227
              SF +  ++ + ME +PGG +  LL  +       E    FY  Q +  ++ +H +  
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143

Query: 228 IHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFP 286
           +HRDIK DN+L++  +G +K+SDFG  K L   N                E+        
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-------------PCTETF------- 183

Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECD-W 338
                                         GT  Y+APE++ K  +GYG   D W
Sbjct: 184 -----------------------------TGTLQYMAPEIIDKGPRGYGKAADIW 209

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  124 bits (312), Expect = 1e-32
 Identities = 63/299 (21%), Positives = 108/299 (36%), Gaps = 71/299 (23%)

Query: 48  SHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDD 107
           S+Y     H  +     ++  +      +P   +   LKD +  E             DD
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDP-MPAGGRAGSLKDPDVAEL---------FFKDD 51

Query: 108 ----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
               F  L  IG G+FG V   ++ ++  + A+KK+  S   S  + + +  E   L ++
Sbjct: 52  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
                ++    +      +L+MEY  G     L + ++ L E         ++  +  +H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
            HN IHRD+K  N+LL + G +KL DFG          ++                    
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGS---------AS-------------------- 202

Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECD-W 338
                                 +       S VGTP ++APEV+L   +  Y  + D W
Sbjct: 203 ---------------------IMAPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVW 237

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  124 bits (313), Expect = 1e-32
 Identities = 30/332 (9%), Positives = 86/332 (25%), Gaps = 110/332 (33%)

Query: 51  KAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDL 110
             Q       +  +S  +  +++S     +   +  +L  +    +R             
Sbjct: 31  IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGT----------- 79

Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER------------- 157
             ++G+          ++++G  + +     +E      ++ ++ E              
Sbjct: 80  --VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137

Query: 158 ------------NLLAEVASHCIVKLYYSFQD--AEYLYLIME------YLPGGDVMTLL 197
                       +L+ +     ++++    +D      + +           G  +++  
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197

Query: 198 MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              ++L          Q +  + S+H +  +H  ++P +++LDQ G + L+ F       
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 255

Query: 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317
                                   DG    S                             
Sbjct: 256 ------------------------DGARVVS-SV-------------------------- 264

Query: 318 TPDYIAPEVLL-----------KKGYGMECDW 338
           +  +  PE+             +       D 
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDA 296

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  123 bits (310), Expect = 2e-32
 Identities = 62/265 (23%), Positives = 104/265 (39%), Gaps = 65/265 (24%)

Query: 85  LKDLERKETEYMRL--------KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
           L++LE  E +  RL        K  ++  DDF+ ++ +G G  G V     K SG + A 
Sbjct: 4   LEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMAR 63

Query: 137 KKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL 196
           K +             +  E  +L E  S  IV  Y +F     + + ME++ GG +  +
Sbjct: 64  KLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121

Query: 197 LMREETLTETVARFYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           L +   + E +    ++ +V+  +  +  KH  +HRD+KP N+L++  G +KL DFG+  
Sbjct: 122 LKKAGRIPEQILG-KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180

Query: 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYS 314
            L  +                                                   +A S
Sbjct: 181 QLIDS---------------------------------------------------MANS 189

Query: 315 TVGTPDYIAPEVLLKKGYGMECD-W 338
            VGT  Y++PE L    Y ++ D W
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIW 214

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  121 bits (306), Expect = 2e-32
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 26/171 (15%)

Query: 96  MRLKRHKISVDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ +   ++G G  G+V     K++   +A+K L+      R       
Sbjct: 8   LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------- 59

Query: 155 AERNLLAEVASH-CIVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMR-----EETLT 204
            E  L    +    IV++   +++     + L ++ME L GG+   L  R     ++  T
Sbjct: 60  -EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFT 115

Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGL 252
           E  A   +     AI+ +H  N  HRD+KP+NLL      N  +KL+DFG 
Sbjct: 116 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  121 bits (307), Expect = 3e-32
 Identities = 49/232 (21%), Positives = 89/232 (38%), Gaps = 54/232 (23%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-HVRAERNLLAEVASHCIVKLY 172
           +G G++G+V+   + ++    A+K LKK ++      E +V+ E  LL  +    +++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 173 --YSFQDAEYLYLIMEYLPGGDV-MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
                ++ + +Y++MEY   G   M   + E+      A  Y  Q +  +E +H    +H
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH 132

Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
           +DIKP NLLL   G +K+S  G         ++        DD               + 
Sbjct: 133 KDIKPGNLLLTTGGTLKISALG---------VAEALHPFAADD------------TCRTS 171

Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGY-GMECD-W 338
                                      G+P +  PE+      + G + D W
Sbjct: 172 Q--------------------------GSPAFQPPEIANGLDTFSGFKVDIW 197

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  121 bits (306), Expect = 3e-32
 Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 60/248 (24%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLL 160
           I+ DD++L  +IG GA   V+           A+K   L+K +      ++ +  E   +
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAM 67

Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREE-----TLTETVARFYI 212
           ++     IV  Y SF   + L+L+M+ L GG   D++  ++ +       L E+     +
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127

Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
            + +  +E +HK+  IHRD+K  N+LL ++G ++++DFG+                    
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA------------------ 169

Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KG 331
             L    D                         I R K+  + VGTP ++APEV+ + +G
Sbjct: 170 -FLATGGD-------------------------ITRNKVRKTFVGTPCWMAPEVMEQVRG 203

Query: 332 YGMECD-W 338
           Y  + D W
Sbjct: 204 YDFKADIW 211

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (306), Expect = 1e-31
 Identities = 41/261 (15%), Positives = 87/261 (33%), Gaps = 50/261 (19%)

Query: 85  LKDLERKETEYMRLKRHKISVDDFDLLTIIGRGA--FGEVRLCQEKKSGNIYAMKKLKKS 142
                 +   +  +         ++LLT+IG+G      V L + K +G    ++++   
Sbjct: 4   HHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-L 62

Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MRE 200
           E  S   V  ++ E ++        IV    +F     L+++  ++  G    L+     
Sbjct: 63  EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM 122

Query: 201 ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           + + E    + +   + A++ IH   Y+HR +K  ++L+  +G + LS       +    
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH- 181

Query: 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD 320
                                                       Q         +V    
Sbjct: 182 -----------------------------------------GQRQRVVHDFPKYSVKVLP 200

Query: 321 YIAPEVL--LKKGYGMECD-W 338
           +++PEVL    +GY  + D +
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIY 221

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  119 bits (301), Expect = 2e-31
 Identities = 63/259 (24%), Positives = 108/259 (41%), Gaps = 63/259 (24%)

Query: 89  ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
            RK  EY  ++R     + ++++  +G GAFG+V   + K++G + A K +   E  S  
Sbjct: 2   MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEE 58

Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLTE 205
           ++E    E  +LA      IVKL  ++     L++++E+ PGG    +M  L  +  LTE
Sbjct: 59  ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--DRGLTE 116

Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265
              +    Q + A+  +H    IHRD+K  N+L+   G ++L+DFG+      T      
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT------ 170

Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
                                                   + +R    S +GTP ++APE
Sbjct: 171 ----------------------------------------LQKRD---SFIGTPYWMAPE 187

Query: 326 VLL-----KKGYGMECD-W 338
           V++        Y  + D W
Sbjct: 188 VVMCETMKDTPYDYKADIW 206

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  119 bits (301), Expect = 3e-31
 Identities = 48/242 (19%), Positives = 84/242 (34%), Gaps = 57/242 (23%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLY 172
           +  G F  V   Q+  SG  YA+K+L  +E         +  E   + +++ H  IV+  
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHPNIVQFC 92

Query: 173 YSF-------QDAEYLYLIMEYLPGGDVMTLLMREET---LTETVARFYIAQSVLAIESI 222
            +           +  +L++  L  G ++  L + E+   L+         Q+  A++ +
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 223 HKHN--YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
           H+     IHRD+K +NLLL   G +KL DFG    +                        
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS----------------------- 189

Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGYGMECD 337
                           P       +    +   +   TP Y  PE++        G + D
Sbjct: 190 --------------HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235

Query: 338 -W 338
            W
Sbjct: 236 IW 237

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  120 bits (301), Expect = 4e-31
 Identities = 26/232 (11%), Positives = 62/232 (26%), Gaps = 45/232 (19%)

Query: 58  QERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRG 117
           +E  +  + +   + ++  P+  +  +   L + E +   ++              +  G
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE-------------PLRVG 73

Query: 118 AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY----- 172
               V L ++ +    +A+K        SR ++E +       A +      +       
Sbjct: 74  DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133

Query: 173 ---------------------YSFQDAEYLYLIMEYLPG--GDVMTLLMR----EETLTE 205
                                          L+M         + + L            
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGI 193

Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
                  AQ +    ++     +H    PDNL +  +G + L D      + 
Sbjct: 194 LALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (294), Expect = 2e-30
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 68/248 (27%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
             F+L+ ++G G +G+V   +  K+G + A+K +     ++  + E ++ E N+L + + 
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79

Query: 166 HC-IVKLYYSF------QDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSV 216
           H  I   Y +F         + L+L+ME+   G V  L+   +  TL E    +   + +
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
             +  +H+H  IHRDIK  N+LL +N  +KL DFG+   LD T                 
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT----------------- 182

Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-----G 331
                                        + RR    + +GTP ++APEV+         
Sbjct: 183 -----------------------------VGRRN---TFIGTPYWMAPEVIACDENPDAT 210

Query: 332 YGMECD-W 338
           Y  + D W
Sbjct: 211 YDFKSDLW 218

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  116 bits (292), Expect = 2e-30
 Identities = 53/240 (22%), Positives = 98/240 (40%), Gaps = 53/240 (22%)

Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN-- 158
            ++  DD + +  +GRGA+G V   +   SG I A+K++         +      E+   
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI---------RATVNSQEQKRL 52

Query: 159 ------LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLTETVAR 209
                  +  V     V  Y +      +++ ME +          ++ + +T+ E +  
Sbjct: 53  LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG 112

Query: 210 FYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
             IA S++ A+E +H K + IHRD+KP N+L++  G +K+ DFG+   L   +  A + +
Sbjct: 113 -KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDID 169

Query: 268 ---------EVLDDENLNESMDV---------------DGRFPESGCGRRWKSPLEQLQH 303
                    E ++ E   +   V                 RFP       W +P +QL+ 
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS----WGTPFQQLKQ 225

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (295), Expect = 6e-30
 Identities = 25/264 (9%), Positives = 65/264 (24%), Gaps = 86/264 (32%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH------ 166
           ++G+          ++++G  + +     +E      ++ ++ E   L  +         
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 167 ----------------CIVKLYYSFQDAEYLYLIMEYLP-----------GGDVMTLLMR 199
                              K+     D   ++++  +             G  +++    
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 200 EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
            ++L          Q +  + S+H +  +H  ++P +++LDQ G + L+ F         
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-- 262

Query: 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTP 319
                                        G                             P
Sbjct: 263 ----------------------ASAVSPIG------------------------RGFAPP 276

Query: 320 DYIAPEVLL-----KKGYGMECDW 338
           +  A  +L              D 
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDT 300

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  114 bits (287), Expect = 1e-29
 Identities = 47/232 (20%), Positives = 90/232 (38%), Gaps = 60/232 (25%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
            IGRG+F  V    + ++    A  +L+  + L++ + +  + E  +L  +    IV+ Y
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 173 YSFQDA----EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY- 227
            S++      + + L+ E +  G + T L R + +   V R +  Q +  ++ +H     
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151

Query: 228 -IHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
            IHRD+K DN+ +    G +K+ D GL                                 
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLAT------------------------------- 180

Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                               + R   A + +GTP+++APE+  ++ Y    D
Sbjct: 181 --------------------LKRASFAKAVIGTPEFMAPEM-YEEKYDESVD 211

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  112 bits (283), Expect = 8e-29
 Identities = 39/158 (24%), Positives = 79/158 (50%), Gaps = 10/158 (6%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRA 155
           +R++  ++D + L  +G G  G+V   + +K+G++ A+K+++     E   R  ++    
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL--- 74

Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
              +L       IV+ + +F     +++ ME +           +  + E +    +  +
Sbjct: 75  -DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-KMTVA 132

Query: 216 VL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           ++ A+  +  KH  IHRD+KP N+LLD+ G +KL DFG
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG 170

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  111 bits (280), Expect = 2e-28
 Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 14/162 (8%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRA 155
           +    + +D   L  IGRGA+G V     K SG I A+K+++     +   +  ++    
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL--- 71

Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG--DVMTLLM--REETLTETVARFY 211
              ++       IV+ Y +       ++ ME +          +    ++ + E +    
Sbjct: 72  -DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-K 129

Query: 212 IAQSVL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
           I  + + A+  +      IHRDIKP N+LLD++G++KL DFG
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (278), Expect = 5e-28
 Identities = 34/216 (15%), Positives = 66/216 (30%), Gaps = 40/216 (18%)

Query: 125 CQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184
             +++   I+   +     + S   ++    +   +   ++   V          YLY+ 
Sbjct: 80  KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQ 139

Query: 185 MEYLPGGDVMTLLMREETLT---ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ 241
           M+     ++   + R  +L      V      Q   A+E +H    +HRD+KP N+    
Sbjct: 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM 199

Query: 242 NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQL 301
           +  +K+ DFGL   +D           +                                
Sbjct: 200 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT------------------------- 234

Query: 302 QHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
                         VGT  Y++PE +    Y  + D
Sbjct: 235 ------------GQVGTKLYMSPEQIHGNNYSHKVD 258

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  110 bits (277), Expect = 5e-28
 Identities = 44/153 (28%), Positives = 80/153 (52%), Gaps = 11/153 (7%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA----ERNLL 160
           ++ ++ +  IG G++G V  C+ + +G I A+KK  +SE         ++     E  +L
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRML 56

Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAI 219
            ++    +V L   F+    L+L+ EY     V+  L   +  + E + +    Q++ A+
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAV 115

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
              HKHN IHRD+KP+N+L+ ++  +KL DFG 
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  110 bits (276), Expect = 1e-27
 Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 11/154 (7%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA----ERNL 159
           S++ ++ L ++G G++G V  C+ K +G I A+KK  +S+       + V+     E  L
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----DDKMVKKIAMREIKL 77

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLA 218
           L ++    +V L    +  +  YL+ E++    ++  L +    L   V + Y+ Q +  
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           I   H HN IHRDIKP+N+L+ Q+G +KL DFG 
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  103 bits (258), Expect = 2e-25
 Identities = 51/243 (20%), Positives = 94/243 (38%), Gaps = 53/243 (21%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK-SEMLSRGQVEHVRAERNLLA 161
               D     ++G+G FG+      +++G +  MK+L +  E            +R  L 
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE----------TQRTFLK 56

Query: 162 EVA-----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
           EV       H  ++K        + L  I EY+ GG +  ++   ++      R   A+ 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116

Query: 216 V-LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
           +   +  +H  N IHRD+   N L+ +N ++ ++DFGL +              ++ DE 
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR--------------LMVDEK 162

Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
                    + P+                     RK  Y+ VG P ++APE++  + Y  
Sbjct: 163 TQPEGLRSLKKPD---------------------RKKRYTVVGNPYWMAPEMINGRSYDE 201

Query: 335 ECD 337
           + D
Sbjct: 202 KVD 204

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (259), Expect = 3e-25
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 12/156 (7%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH------VRAER 157
               ++ L  +G G F  V   ++K +  I A+KK+K   +  R + +       +R E 
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALR-EI 63

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSV 216
            LL E++   I+ L  +F     + L+ +++   D+  ++      LT +  + Y+  ++
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             +E +H+H  +HRD+KP+NLLLD+NG +KL+DFGL
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  102 bits (256), Expect = 3e-25
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 22/159 (13%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------VRA 155
           +++F  +  IG G +G V   + K +G + A+KK++         ++          +R 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---------LDTETEGVPSTAIR- 51

Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIA 213
           E +LL E+    IVKL         LYL+ E+L   D+   +       +   + + Y+ 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110

Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           Q +  +   H H  +HRD+KP NLL++  G +KL+DFGL
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  101 bits (254), Expect = 8e-25
 Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 17/163 (10%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH----VRAERNL 159
           +   ++ +  IG GA+G V   ++  SG+  A+K ++       G        VR E  L
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR-EVAL 64

Query: 160 LAE--VASH-CIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVAR 209
           L       H  +V+L              + L+ E++   D+ T L       L     +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             + Q +  ++ +H +  +HRD+KP+N+L+   G +KL+DFGL
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  101 bits (253), Expect = 1e-24
 Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 24/227 (10%)

Query: 68  ERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE 127
              ++  D+P  E +     ++  + +        I   D ++   IG G+FG V   + 
Sbjct: 7   HHPMSDYDIPTTENLYFQGAMDGDDMD--------IPWCDLNIKEKIGAGSFGTVHRAEW 58

Query: 128 KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187
              G+  A+K L + +  +  +V     E  ++  +    IV    +      L ++ EY
Sbjct: 59  H--GSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115

Query: 188 LPGGDVMTLLMREETLTE--TVARFYIAQSV-LAIESIHKHNY--IHRDIKPDNLLLDQN 242
           L  G +  LL +     +     R  +A  V   +  +H  N   +HR++K  NLL+D+ 
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK 175

Query: 243 GHMKLSDFGLCKPLDCTNLSAINEN--------EVLDDENLNESMDV 281
             +K+ DFGL +    T LS+ +          EVL DE  NE  DV
Sbjct: 176 YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  101 bits (253), Expect = 1e-24
 Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 25/163 (15%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH--------VRA 155
           S   F  L  +G G +  V     K +G   A+K++K         ++         +R 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---------LDSEEGTPSTAIR- 52

Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL------MREETLTETVAR 209
           E +L+ E+    IV+LY        L L+ E++   D+   +           L   + +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           ++  Q +  +   H++  +HRD+KP NLL+++ G +KL DFGL
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL 154

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  102 bits (256), Expect = 2e-24
 Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 29/166 (17%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK-LKKSEMLSRGQVEHVRAERNLLAEVASH 166
           +    +IG G+FG V   +   SG + A+KK L+     +R        E  ++ ++  H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL-DH 106

Query: 167 C-IVKLYYSF------QDAEYLYLIMEYLPGGDVMTL--LMRE-----ETLTETVARFYI 212
           C IV+L Y F      +D  YL L+++Y+P     T+  + R      +TL     + Y+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYM 162

Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLD 257
            Q   ++  IH     HRDIKP NLLLD +   +KL DFG  K L 
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  100 bits (252), Expect = 2e-24
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 20/157 (12%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH--------VRAE 156
           ++ +  L  +G G +  V   + K + N+ A+K+++         +EH        +R E
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIR-E 50

Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQS 215
            +LL ++    IV L+      + L L+ EYL   D+   L      +     + ++ Q 
Sbjct: 51  VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +  +   H+   +HRD+KP NLL+++ G +KL+DFGL
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL 146

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =   99 bits (250), Expect = 2e-24
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 21/158 (13%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------VRA 155
           +  ++ L  IG G +G V   + +++  I A+K+++         ++          +R 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---------LDDDDEGVPSSALR- 50

Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQ 214
           E  LL E+    IV+L+      + L L+ E+    D+          L   + + ++ Q
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            +  +   H  N +HRD+KP NLL+++NG +KL++FGL
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 99.2 bits (248), Expect = 9e-24
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 25/163 (15%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------VR 154
           S+D +  +T +G G +GEV    +  +    A+K+++         +EH         +R
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---------LEHEEEGVPGTAIR 82

Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
            E +LL E+    I++L         L+LI EY    D+   + +   ++  V + ++ Q
Sbjct: 83  -EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQN-----GHMKLSDFGL 252
            +  +   H    +HRD+KP NLLL  +       +K+ DFGL
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 55/242 (22%), Positives = 85/242 (35%), Gaps = 68/242 (28%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I   + ++  ++GRGAFG V  C+ K      A+K+++          +    E   L+ 
Sbjct: 5   IDYKEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESESER-----KAFIVELRQLSR 57

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVA--RFYIAQSV-LAI 219
           V    IVKLY +  +   + L+MEY  GG +  +L   E L    A             +
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 220 ESIHKHNY---IHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
             +H       IHRD+KP NLLL   G  +K+ DFG                      ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------------------DI 156

Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
              M                                  +  G+  ++APEV     Y  +
Sbjct: 157 QTHM---------------------------------TNNKGSAAWMAPEVFEGSNYSEK 183

Query: 336 CD 337
           CD
Sbjct: 184 CD 185

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 20/173 (11%)

Query: 89  ERKETEYMRLKRHKIS---VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
             +  EY   + H +     DD+ L+  +GRG + EV       +     +K LK     
Sbjct: 16  THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---- 71

Query: 146 SRGQVEHVRAER--NLLAEVASH-CIVKLYYSFQDAE--YLYLIMEYLPGGDVMTLLMRE 200
               V+  + +R   +L  +     I+ L    +D       L+ E++   D   L    
Sbjct: 72  ----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--- 124

Query: 201 ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGL 252
           +TLT+   RFY+ + + A++  H    +HRD+KP N+++D ++  ++L D+GL
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 96.4 bits (241), Expect = 5e-23
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 22/158 (13%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------VRA 155
           ++ +  L  IG G +G V   Q    G  +A+KK++         +E          +R 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR---------LEKEDEGIPSTTIR- 49

Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQ 214
           E ++L E+    IVKLY      + L L+ E+L   D+  LL + E  L    A+ ++ Q
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            +  I   H    +HRD+KP NLL+++ G +K++DFGL
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.9 bits (242), Expect = 7e-23
 Identities = 43/187 (22%), Positives = 81/187 (43%), Gaps = 35/187 (18%)

Query: 84  ILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE 143
           + K  +  E  +         V  ++ L  IG+G FGEV   + +K+G   A+KK+    
Sbjct: 1   MAKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--- 51

Query: 144 MLSRGQVEH---------VRAERNLLAEVASHCIVKLY--------YSFQDAEYLYLIME 186
                 +E+         +R E  +L  +    +V L            +    +YL+ +
Sbjct: 52  ------MENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD 104

Query: 187 YLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM 245
           +    D+  LL       T +  +  +   +  +  IH++  +HRD+K  N+L+ ++G +
Sbjct: 105 FCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVL 163

Query: 246 KLSDFGL 252
           KL+DFGL
Sbjct: 164 KLADFGL 170

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.1 bits (240), Expect = 7e-23
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 22/159 (13%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------VR 154
            ++ +  L  +G G +G V   ++   G I A+K+++         ++          +R
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR---------LDAEDEGIPSTAIR 68

Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIA 213
            E +LL E+    IV L         L L+ E++   D+  +L   +  L ++  + Y+ 
Sbjct: 69  -EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY 126

Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           Q +  +   H+H  +HRD+KP NLL++ +G +KL+DFGL
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL 165

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 97.4 bits (243), Expect = 9e-23
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 43/188 (22%)

Query: 86  KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK-SEM 144
           K  E++E  Y   K             +IG G+FG V   +  +S  + A+KK+ +    
Sbjct: 33  KTGEQREIAYTNCK-------------VIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRF 78

Query: 145 LSRGQVEHVRAERNLLAEVASHC-IVKLYYSF------QDAEYLYLIMEYLPGGDVMTL- 196
            +R        E  ++  V  H  +V L   F      +D  +L L++EY+P     T+ 
Sbjct: 79  KNR--------ELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVY 125

Query: 197 -LMR-----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSD 249
              R     ++T+   + + Y+ Q + ++  IH     HRDIKP NLLLD   G +KL D
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185

Query: 250 FGLCKPLD 257
           FG  K L 
Sbjct: 186 FGSAKILI 193

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 41/169 (24%), Positives = 77/169 (45%), Gaps = 31/169 (18%)

Query: 104 SVDDFDLLTIIGRGAFGEV-RLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------V 153
           +   ++ +  IG GA+G+V +    K  G   A+K+++         V+          +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---------VQTGEEGMPLSTI 59

Query: 154 RAERNLLAE--VASH-CIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLL--MREETL 203
           R E  +L       H  +V+L+             L L+ E++   D+ T L  + E  +
Sbjct: 60  R-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117

Query: 204 TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                +  + Q +  ++ +H H  +HRD+KP N+L+  +G +KL+DFGL
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 38/152 (25%), Positives = 71/152 (46%)

Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           ++  +G G    V L ++       A+K +          ++    E +  ++++   IV
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
            +    ++ +  YL+MEY+ G  +   +     L+   A  +  Q +  I+  H    +H
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVH 134

Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261
           RDIKP N+L+D N  +K+ DFG+ K L  T+L
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 21/197 (10%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLA 161
           I   +  L  IIG G FG+V        G+  A+K  +        Q +E+VR E  L A
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
            +    I+ L         L L+ME+  GG +  +L   + +   +   +  Q    +  
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNY 120

Query: 222 IHKHNY---IHRDIKPDNLLLDQ--------NGHMKLSDFGLCKPLDCTNLSAINEN--- 267
           +H       IHRD+K  N+L+ Q        N  +K++DFGL +    T   +       
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW 180

Query: 268 ---EVLDDENLNESMDV 281
              EV+     ++  DV
Sbjct: 181 MAPEVIRASMFSKGSDV 197

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 91.2 bits (227), Expect = 3e-21
 Identities = 37/164 (22%), Positives = 74/164 (45%), Gaps = 14/164 (8%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK----SEMLSRGQVEHVRAERN 158
           ++ ++ +    IG+G FG V   +  K  ++ A+K L       E     + +  + E  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75

Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV-L 217
           +++ +    IVKLY    +     ++ME++P GD+   L+ +    +   +  +   + L
Sbjct: 76  IMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133

Query: 218 AIESIHKHNY--IHRDIKPDNLLLDQNG-----HMKLSDFGLCK 254
            IE +   N   +HRD++  N+ L           K++DFGL +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 37/158 (23%), Positives = 70/158 (44%), Gaps = 4/158 (2%)

Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ--VEHVRAERNLLAEVASHC 167
           L  ++GRG  G+V   ++     I A+K + ++  LS        ++ E      +    
Sbjct: 38  LRRLVGRGGMGDVYEAEDTVRERIVALKLMSET--LSSDPVFRTRMQREARTAGRLQEPH 95

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           +V ++   +    LY+ M  + G D+  +L R+  L    A   + Q   A+++ H    
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265
            HRD+KP+N+L+  +    L DFG+        L+ + 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG 193

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 31/156 (19%), Positives = 66/156 (42%), Gaps = 12/156 (7%)

Query: 103 ISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
           I  +  ++  +IG+G FG+V   R   E       A++ +      +  Q++  + E   
Sbjct: 30  IPFEQLEIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERD-NEDQLKAFKREVMA 82

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV-LA 218
             +     +V    +     +L +I     G  + +++   + + +      IAQ +   
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           +  +H    +H+D+K  N+  D NG + ++DFGL  
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 4/165 (2%)

Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           L  I+G G   EV L ++ +     A+K L+             R E    A +    IV
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 170 KLY----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
            +Y             Y++MEY+ G  +  ++  E  +T   A   IA +  A+   H++
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
             IHRD+KP N+++     +K+ DFG+ + +  +  S      V+
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 42/196 (21%), Positives = 76/196 (38%), Gaps = 25/196 (12%)

Query: 103 ISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
           I      +   IG G+FG V   +   +       A+K L  +   +  Q++  + E  +
Sbjct: 21  IPDGQITVGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAP-TPQQLQAFKNEVGV 73

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV-LA 218
           L +     I+           L ++ ++  G  +   L   ET  E      IA+     
Sbjct: 74  LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN----------E 268
           ++ +H  + IHRD+K +N+ L ++  +K+ DFGL       + S   E           E
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192

Query: 269 VLDDENLN---ESMDV 281
           V+  ++ N      DV
Sbjct: 193 VIRMQDSNPYSFQSDV 208

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 18/175 (10%)

Query: 89  ERKETEYMRLKRHKISVDD-FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEM 144
             K T  M        + D +++  +IG G++G V    +K    + A+KK+ +     +
Sbjct: 35  SSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI 94

Query: 145 LSRGQVEHVRAER--NLLAEVASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLL 197
             +      R  R   +L  +    +VK+         +  + LY+++E     D   L 
Sbjct: 95  DCK------RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLF 147

Query: 198 MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                LTE   +  +   ++ ++ +H    +HRD+KP N L++Q+  +K+ DFGL
Sbjct: 148 RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 88.1 bits (219), Expect = 3e-20
 Identities = 24/170 (14%), Positives = 58/170 (34%), Gaps = 10/170 (5%)

Query: 98  LKRHK-ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
           + +H  I     + LT +     GE+   + +  GN   +K LK  +  +R +      E
Sbjct: 1   MNKHSGIDFKQLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEE 57

Query: 157 RNLLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMTLLMREETLT-ETVARFYIA 213
              L   +   ++ +        A +  LI  ++P G +  +L        +       A
Sbjct: 58  CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117

Query: 214 QSV-LAIESIHKHNY--IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
             +   +  +H          +   ++++D++   ++S   +        
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG 167

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.5 bits (217), Expect = 7e-20
 Identities = 15/148 (10%), Positives = 47/148 (31%), Gaps = 2/148 (1%)

Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           LL   G     +     +       A+  +    +L    ++   +    L+ +    + 
Sbjct: 35  LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
           ++           ++ E++ GG +  +   + + +   A   +     A ++ H+     
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
               P  + +  +G + L+        +
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMPDAN 180

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 31/163 (19%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE----- 162
           + +   IG G+FG +       +    A+K             E  R++   L +     
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRSDAPQLRDEYRTY 59

Query: 163 ---VASHCIVKLYYSFQDAEYLYLIMEYLPG---GDVMTLLMREETLTETVARFYIAQSV 216
                   I  +YY  Q+  +  L+++ L G    D++ L  R+ ++ +TVA     Q +
Sbjct: 60  KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV-KTVAMAAK-QML 116

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMK-----LSDFGLCK 254
             ++SIH+ + ++RDIKPDN L+ +          + DFG+ K
Sbjct: 117 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 37/176 (21%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR-AERNL---- 159
           +D F +  + G+G FG V+L +EK +G   A+KK+          ++  R   R L    
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----------IQDPRFRNRELQIMQ 71

Query: 160 LAEVASHC-IVKLYYSF-------QDAEYLYLIMEYLPGGDVMTL--LMR-----EETLT 204
              V  H  IV+L   F       +   YL ++MEY+P     TL    R     +    
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPP 127

Query: 205 ETVARFYIAQSVLAIESIHK--HNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLD 257
             + + ++ Q + +I  +H    N  HRDIKP N+L++  +G +KL DFG  K L 
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 45/161 (27%), Positives = 69/161 (42%), Gaps = 29/161 (18%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER-NLLAEVA-- 164
           + L   IG G+FG++ L  +  +G   A+K             E V+ +   L  E    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIY 58

Query: 165 -----SHCIVKLYYSFQDAEYLYLIMEYLPG---GDVMTLLMREETLTETVARFYIAQSV 216
                   I  + +   + +Y  ++ME L G    D+     R+ +L +TV      Q +
Sbjct: 59  KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL-KTVLLLAD-QMI 115

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMK---LSDFGLCK 254
             IE IH  N+IHRD+KPDN L+          + DFGL K
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 33/164 (20%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE----- 162
           F +   IG G FGE+RL +   +    A+K            +E +++    L       
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFY 58

Query: 163 ---VASHCIVKLYYSFQDAEYLYLIMEYLPGG----DVMTLLMREETLTETVARFYIAQS 215
               +   I ++YY     +Y  +++E L  G    D+  L  R  +L +TV    I Q 
Sbjct: 59  KQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL-KTVLMIAI-QL 114

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMK-----LSDFGLCK 254
           +  +E +H  N I+RD+KP+N L+ + G+       + DF L K
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 36/157 (22%), Positives = 68/157 (43%), Gaps = 11/157 (7%)

Query: 110 LLTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168
           +   I  G  G + L  ++  +G    +K L  S            AER  LAEV    I
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSI 141

Query: 169 VKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
           V+++              Y++MEY+ G  +     ++  + E +A  Y+ + + A+  +H
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLH 199

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
               ++ D+KP+N++L +   +KL D G    ++   
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG 235

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 9/160 (5%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY----AMKKLKKSEMLSRGQVEHVRAERN 158
                   +  +G G FG+V L     + +      A+K LK             + E +
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK--ADAGPQHRSGWKQEID 85

Query: 159 LLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
           +L  +    I+K         A  L L+MEY+P G +   L    ++       +  Q  
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQIC 144

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
             +  +H  +YIHRD+   N+LLD +  +K+ DFGL K +
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 17/188 (9%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
           D++ +  +IGRG++G V L  +K +    A+KK+ +     +  +      R  R   +L
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK------RILREITIL 79

Query: 161 AEVASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
             + S  I++LY           + LY+++E     D+  L      LTE   +  +   
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNL 138

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
           +L    IH+   IHRD+KP N LL+Q+  +K+ DFGL + ++    + I  +   ++E  
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 276 NESMDVDG 283
             + ++  
Sbjct: 199 PHNKNLKK 206

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 29/162 (17%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE-RNLLAEVA-- 164
           F L   IG G+FGE+ L    ++    A+K             E+V+ +   LL E    
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIY 56

Query: 165 -----SHCIVKLYYSFQDAEYLYLIMEYLPG---GDVMTLLMREETLTETVARFYIAQSV 216
                   I  + +   + +Y  L+M+ L G    D+     R+ +L +TV      Q +
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL-KTVLMLAD-QMI 113

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMK---LSDFGLCKP 255
             +E +H  +++HRDIKPDN L+          + DFGL K 
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 10/162 (6%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
                   L  +G+G FG V +C     +  +G + A+KKL+ S       +     E  
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIE 94

Query: 159 LLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQS 215
           +L  +    IVK            L LIMEYLP G +   L   +E +       Y +Q 
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              +E +    YIHRD+   N+L++    +K+ DFGL K L 
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 10/162 (6%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
                   L  +G+G FG V +C     +  +G + A+KKL+ S       +     E  
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIE 63

Query: 159 LLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQS 215
           +L  +    IVK            L LIMEYLP G +   L + +E +       Y +Q 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              +E +    YIHRD+   N+L++    +K+ DFGL K L 
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 42/186 (22%), Positives = 68/186 (36%), Gaps = 37/186 (19%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL---------------------------- 139
           + L   +G G+FG V    + +SG  +A+KK+                            
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68

Query: 140 ---KKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV--- 193
                 E     Q      +        ++    +  +    +YL +IMEY+P   +   
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127

Query: 194 -MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFG 251
             + +    ++   +   YI Q   A+  IH     HRDIKP NLL++     +KL DFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187

Query: 252 LCKPLD 257
             K L 
Sbjct: 188 SAKKLI 193

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 82.0 bits (203), Expect = 8e-18
 Identities = 39/162 (24%), Positives = 68/162 (41%), Gaps = 9/162 (5%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY----AMKKLKKSEMLSRGQVEHVRAERN 158
                   +  +G G FG+V LC+    G+      A+K LK         +  ++ E  
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIE 75

Query: 159 LLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQS 215
           +L  +    IVK     +      + LIME+LP G +   L   +  +       Y  Q 
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              ++ +    Y+HRD+   N+L++    +K+ DFGL K ++
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 45/188 (23%), Positives = 90/188 (47%), Gaps = 22/188 (11%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
             ++L+  +G+GA+G V    ++++G + A+KK+     +   ++      R  R   +L
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ------RTFREIMIL 62

Query: 161 AEVASH-CIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
            E++ H  IV L       + +D   +YL+ +Y+   D +  ++R   L     ++ + Q
Sbjct: 63  TELSGHENIVNLLNVLRADNDRD---VYLVFDYM-ETD-LHAVIRANILEPVHKQYVVYQ 117

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
            +  I+ +H    +HRD+KP N+LL+   H+K++DFGL +          N    +++  
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 275 LNESMDVD 282
            N   D  
Sbjct: 178 ENFDDDQP 185

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 10/162 (6%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
                   ++ +G+G FG V LC        +G + A+K+L+ S    +      + E  
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQ 76

Query: 159 LLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQS 215
           +L  + S  IVK          + L L+MEYLP G +   L      L  +    Y +Q 
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              +E +     +HRD+   N+L++   H+K++DFGL K L 
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 80.3 bits (198), Expect = 4e-17
 Identities = 53/245 (21%), Positives = 80/245 (32%), Gaps = 74/245 (30%)

Query: 103 ISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN- 158
           + +D+  LL +IGRG +G V    L +        A+K    +   +         E+N 
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSLDERP-----VAVKVFSFANRQN------FINEKNI 58

Query: 159 -LLAEVASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI 212
             +  +    I +        +        L+MEY P G +   L    +   +  R  +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR--L 116

Query: 213 AQSV----------LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
           A SV          L     +K    HRD+   N+L+  +G   +SDFGL   L    L 
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
              E +                                           A S VGT  Y+
Sbjct: 177 RPGEEDN-----------------------------------------AAISEVGTIRYM 195

Query: 323 APEVL 327
           APEVL
Sbjct: 196 APEVL 200

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 22/160 (13%)

Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLK---------KSEM--LSRGQVEHVRAERNLLAE 162
           IG G FG + L          A   +K          SE+    R   +    +     +
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 163 VASHCIVKLYYS----FQDAEYLYLIMEYLPGGDVMTLLMREETLTE-TVARFYIA-QSV 216
           +    I   Y S    F+   Y +++ME L G D+  +  +  T  + TV +  +  + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQ--LGIRML 161

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMK--LSDFGLCK 254
             +E IH++ Y+H DIK  NLLL      +  L+D+GL  
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 15/162 (9%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           ++ +D  L   IGRG FGEV   + +    + A+K  +++             +   L E
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP--------DLKAKFLQE 162

Query: 163 VA-----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQS 215
                  SH  IV+L       + +Y++ME + GGD +T L      L        +  +
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
              +E +     IHRD+   N L+ +   +K+SDFG+ +   
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 6/152 (3%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +   D  +   +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 272

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIE 220
           +    +V+L          Y+I E++  G+++  L        +         Q   A+E
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            + K N+IHR++   N L+ +N  +K++DFGL
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 19/163 (11%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
           + +  L+ +G GA+G V    + K+G   A+KKL +   S + ++      R  R   LL
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK------RTYRELRLL 82

Query: 161 AEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
             +    ++ L        S ++   +YL+   + G D +  +++ + LT+   +F I Q
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GAD-LNNIVKCQKLTDDHVQFLIYQ 140

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            +  ++ IH  + IHRD+KP NL ++++  +K+ DFGL +   
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 79.0 bits (195), Expect = 8e-17
 Identities = 38/192 (19%), Positives = 65/192 (33%), Gaps = 33/192 (17%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS---------EMLSRG 148
            +          LL +  RG FG V   Q        A+K              E+ S  
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLP 73

Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVA 208
            ++H     N+L  + +               L+LI  +   G +   L +   ++    
Sbjct: 74  GMKH----ENILQFIGA-EKRGTSVDVD----LWLITAFHEKGSLSDFL-KANVVSWN-E 122

Query: 209 RFYIAQSV-----------LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
             +IA+++             ++  HK    HRDIK  N+LL  N    ++DFGL    +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 258 CTNLSAINENEV 269
               +     +V
Sbjct: 183 AGKSAGDTHGQV 194

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 19/163 (11%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
             +  L  +G GA+G V    + ++G   A+KKL +   SE+ ++      RA R   LL
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK------RAYRELRLL 78

Query: 161 AEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
             +    ++ L        +  D    YL+M ++ G D +  LM+ E L E   +F + Q
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTD-LGKLMKHEKLGEDRIQFLVYQ 136

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            +  +  IH    IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 45/154 (29%), Positives = 82/154 (53%), Gaps = 13/154 (8%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER--NLLAEV 163
            DF L +++G GA+G V     K +G I A+KK++  +          R  R   +L   
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL----RTLREIKILKHF 66

Query: 164 ASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
               I+ ++      SF++   +Y+I E +   D +  ++  + L++   +++I Q++ A
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELM-QTD-LHRVISTQMLSDDHIQYFIYQTLRA 124

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           ++ +H  N IHRD+KP NLL++ N  +K+ DFGL
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 8/152 (5%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ +
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKK 318

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIE 220
           +    +V+LY    + E +Y++ EY+  G ++  L  E      + +     AQ    + 
Sbjct: 319 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            + + NY+HRD++  N+L+ +N   K++DFGL
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGL 409

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 34/171 (19%), Positives = 70/171 (40%), Gaps = 22/171 (12%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVR 154
               +   +F  + ++G GAFG V       E +   I  A+K+L+++           +
Sbjct: 8   LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PK 59

Query: 155 AERNLLAEVA-----SH-CIVKLY-YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTET 206
           A + +L E        +  + +L          + LI + +P G ++  +   ++ +   
Sbjct: 60  ANKEILDEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 207 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
               +  Q    +  +     +HRD+   N+L+    H+K++DFGL K L 
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 45/208 (21%), Positives = 72/208 (34%), Gaps = 35/208 (16%)

Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
            +       ++  IG+G +GEV + + +  G   A+K    +E  S  +   +     + 
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLM- 88

Query: 161 AEVASH-CIVKLY----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
                H  I+               LYLI +Y   G +   L +  TL        +A S
Sbjct: 89  ----RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKS-MLKLAYS 142

Query: 216 V---------LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL-CKPLDCTNLSAIN 265
                         +  K    HRD+K  N+L+ +NG   ++D GL  K +  TN   I 
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202

Query: 266 EN-----------EVLDDENLNESMDVD 282
            N           EVLD+          
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSY 230

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 13/159 (8%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER--NLLAEV 163
             +  L+ IG GA+G V    +  +    A+KK+   E  +  Q    R  R   +L   
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ----RTLREIKILLRF 82

Query: 164 ASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
               I+ +       + +  + +Y++ + +   D +  L++ + L+     +++ Q +  
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETD-LYKLLKTQHLSNDHICYFLYQILRG 140

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           ++ IH  N +HRD+KP NLLL+    +K+ DFGL +  D
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 38/184 (20%), Positives = 76/184 (41%), Gaps = 27/184 (14%)

Query: 87  DLERKETEYMRLKRHKISVDDFDLLTI-IGRGAFGEVRLCQEK--KSGNIYAMKKLKKSE 143
           D + K       +R     D F+     +GRG +G V   + K  K    YA+K+++ + 
Sbjct: 4   DYDFKVKLSSERER---VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG 60

Query: 144 MLSRGQVEHVRAERNLLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMTLL---- 197
           +      E       LL E+    ++ L   +       ++L+ +Y    D+  ++    
Sbjct: 61  ISMSACREI-----ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHR 114

Query: 198 -----MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLS 248
                 +   L   + +  + Q +  I  +H +  +HRD+KP N+L+     + G +K++
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174

Query: 249 DFGL 252
           D G 
Sbjct: 175 DMGF 178

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 76.1 bits (188), Expect = 7e-16
 Identities = 38/163 (23%), Positives = 63/163 (38%), Gaps = 13/163 (7%)

Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNL 159
           I   D  LL  +G G+FG VR           +  A+K LK   +     ++    E N 
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74

Query: 160 LAEVASHCIVKLYYSFQDA----EYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQ 214
           +  +    +++LY            + ++ E  P G ++  L   +          Y  Q
Sbjct: 75  MHSLDHRNLIRLY-----GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
               +  +    +IHRD+   NLLL     +K+ DFGL + L 
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 43/163 (26%), Positives = 80/163 (49%), Gaps = 20/163 (12%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
             +   T +G GA+G V    +K+SG   A+KKL +   SE+ ++      RA R   LL
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK------RAYRELLLL 77

Query: 161 AEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
             +    ++ L        S ++    YL+M ++   D+  ++      +E   ++ + Q
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQ 134

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            +  ++ IH    +HRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 32/151 (21%), Positives = 62/151 (41%), Gaps = 6/151 (3%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I   +   +  IG G FG V L        + A+K +++  M      E    E  ++ +
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMK 59

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIES 221
           ++   +V+LY    +   + L+ E++  G +   L  +                   +  
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           + +   IHRD+   N L+ +N  +K+SDFG+
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGM 150

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 8/152 (5%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I  +   L   +G+G FGEV +     +  + A+K LK   M      E    E  ++ +
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKK 235

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIE 220
           +    +V+LY    + E +Y++ EY+  G ++  L  E      + +     AQ    + 
Sbjct: 236 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            + + NY+HRD++  N+L+ +N   K++DFGL
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGL 326

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 27/163 (16%), Positives = 58/163 (35%), Gaps = 25/163 (15%)

Query: 114 IGRGAFGEVRLCQEKKSGNI--------YAMKKLKKSEMLSRGQVEHVRAERNL------ 159
             R   G +       +           +++K   K   L   Q    RA + L      
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 160 -LAEVASHCIVKLYYS-FQDAEYLYLIMEYLPGGDVMTLLM---REETLTETVARFYIA- 213
            L       I           +Y +L++  L G  + + L    +      +V +  +A 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQ--VAC 166

Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK--LSDFGLCK 254
           + + A+E +H++ Y+H ++  +N+ +D     +  L+ +G   
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 6/152 (3%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +   D  +   +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 65

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIE 220
           +    +V+L          Y+I E++  G+++  L     + ++  V  +   Q   A+E
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            + K N+IHRD+   N L+ +N  +K++DFGL
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 20/163 (12%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
             +  L  IG GA G V    +       A+KKL +   ++  ++      RA R   L+
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK------RAYRELVLM 115

Query: 161 AEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
             V    I+ L        + ++ + +YL+ME +   ++  ++  E  L      + + Q
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQ 172

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +   
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 20/163 (12%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
             +  L  IG GA G V    +       A+KKL +   ++  ++      RA R   L+
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK------RAYRELVLM 78

Query: 161 AEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
             V    I+ L        S ++ + +Y++ME +   ++  ++  E  L      + + Q
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQ 135

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            +  I+ +H    IHRD+KP N+++  +  +K+ DFGL +   
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 38/160 (23%), Positives = 59/160 (36%), Gaps = 23/160 (14%)

Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
           D  LL  +G+G +GEV     +  G   A+K     +  S  +   +     L      H
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVML-----RH 61

Query: 167 -CIVKLY----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV----- 216
             I+        S   +  L+LI  Y   G +   L +  TL        I  S+     
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVS-CLRIVLSIASGLA 119

Query: 217 ----LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                   +  K    HRD+K  N+L+ +NG   ++D GL
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 46/198 (23%), Positives = 70/198 (35%), Gaps = 33/198 (16%)

Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
            +       L   IG+G FGEV   + +  G   A+K     E  S        AE    
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS----WFREAEIYQT 90

Query: 161 AEVASHCIVKLYYS----FQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
             +    I+    +          L+L+ +Y   G +   L R     E + +  +A S 
Sbjct: 91  VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK--LALST 148

Query: 217 ---------LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD-CTNLSAINE 266
                      + +  K    HRD+K  N+L+ +NG   ++D GL    D  T+   I  
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208

Query: 267 N-----------EVLDDE 273
           N           EVLDD 
Sbjct: 209 NHRVGTKRYMAPEVLDDS 226

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 34/165 (20%), Positives = 71/165 (43%), Gaps = 10/165 (6%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVR 154
               +   +F  + ++G GAFG V       E +   I  A+K+L+++        + + 
Sbjct: 8   LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEIL 65

Query: 155 AERNLLAEVASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYI 212
            E  ++A V +  + +L          + LI + +P G ++  +   ++ +       + 
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            Q    +  +     +HRD+   N+L+    H+K++DFGL K L 
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 35/164 (21%), Positives = 65/164 (39%), Gaps = 27/164 (16%)

Query: 114 IGRGAFGEVRLCQEKKSGNI-----YAMKKLKK--------SEMLSRGQVEHVRAERNLL 160
           IG+G FG + L     S ++       +K             +   R        +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 161 AEVASHCIVKLYYS----FQDAEYLYLIMEYLPGGDVMTLLM---REETLTETVARFYIA 213
            ++    + K + S         Y ++IM+   G D+  +     +  +  +TV +  ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR-KTVLQ--LS 158

Query: 214 -QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK--LSDFGLCK 254
            + +  +E IH+H Y+H DIK  NLLL+     +  L D+GL  
Sbjct: 159 LRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 11/175 (6%)

Query: 85  LKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIYAMKKLKKS 142
           L+++  KE     L R  ++++D      +G G FG V+    Q KK     A+K LK  
Sbjct: 3   LEEIRPKEVY---LDRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE 55

Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET 202
                   + + AE N++ ++ +  IV++     +AE   L+ME    G +   L +   
Sbjct: 56  AN-DPALKDELLAEANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRH 113

Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           + +      + Q  + ++ + + N++HRD+   N+LL    + K+SDFGL K L 
Sbjct: 114 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 17/225 (7%)

Query: 32  SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
            S  +      ++ + S  K      Q  +     +      +++ +EE    +      
Sbjct: 326 QSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDY 385

Query: 92  ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRG 148
           E          I  +  +L   IG G FG+V   +    ++  +  A+K  K     S  
Sbjct: 386 E----------IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-- 433

Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETV 207
             E    E   + +     IVKL     +   +++IME    G++ + L +R+ +L    
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLAS 492

Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
              Y  Q   A+  +    ++HRDI   N+L+  N  +KL DFGL
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 8/152 (5%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I  +   L   +G G FGEV +    K   + A+K +K   M     VE   AE N++  
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKT 239

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIE 220
           +    +VKL+      E +Y+I E++  G ++  L  +E   + + +   + AQ    + 
Sbjct: 240 LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            I + NYIHRD++  N+L+  +   K++DFGL
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGL 330

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 30/186 (16%)

Query: 76  VPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYA 135
              E  +    +  R            +++ +  LL  IG+G FG+V L   +  GN  A
Sbjct: 171 KVMEGTVAAQDEFYRSGWA--------LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVA 220

Query: 136 MKKLKKSEMLSRGQVEHVRAERNLLAEVA-----SH-CIVKLY-YSFQDAEYLYLIMEYL 188
           +K +K                +  LAE +      H  +V+L     ++   LY++ EY+
Sbjct: 221 VKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269

Query: 189 PGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK 246
             G ++  L       L       +      A+E +  +N++HRD+   N+L+ ++   K
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 329

Query: 247 LSDFGL 252
           +SDFGL
Sbjct: 330 VSDFGL 335

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 73.9 bits (182), Expect = 5e-15
 Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 18/160 (11%)

Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNL 159
           I      +  IIG G  GEV     +     ++  A+K LK             R  R+ 
Sbjct: 46  IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--------RQRRDF 97

Query: 160 LAEVA-----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYI 212
           L+E +      H  I++L           ++ EY+  G + T L   +   T       +
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157

Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                 +  +    Y+HRD+   N+L+D N   K+SDFGL
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 73.0 bits (180), Expect = 8e-15
 Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 12/154 (7%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I   D   L  +G G FG V+  + +   ++ A+K +K+  M      +    E  ++  
Sbjct: 21  IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMN 75

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA---- 218
           ++   +V+LY        +++I EY+  G ++  L       +T     + + V      
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +ES     ++HRD+   N L++  G +K+SDFGL
Sbjct: 136 LES---KQFLHRDLAARNCLVNDQGVVKVSDFGL 166

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 72.6 bits (179), Expect = 8e-15
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 22/159 (13%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +++ +  LL  IG+G FG+V L   +  GN  A+K +K                +  LAE
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----------AQAFLAE 64

Query: 163 VA-----SHC-IVKLY-YSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIA 213
            +      H  +V+L     ++   LY++ EY+  G ++  L       L       +  
Sbjct: 65  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124

Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               A+E +  +N++HRD+   N+L+ ++   K+SDFGL
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 33/162 (20%), Positives = 64/162 (39%), Gaps = 18/162 (11%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEK-KSGNIYAMKKLKKSEMLSRGQV--EHV----RAER- 157
             + +   I  G++G V  C      G   A+K++  +    R            R  R 
Sbjct: 22  SPYTVQRFISSGSYGAV--CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 158 -NLLAEVASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARF 210
             LL       I+ L      +       LYL+ E +   D+  ++  +   ++    ++
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY 138

Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           ++   +L +  +H+   +HRD+ P N+LL  N  + + DF L
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 33/164 (20%), Positives = 64/164 (39%), Gaps = 16/164 (9%)

Query: 103 ISVDDFDLLTIIGRGAFGEVR---LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERN 158
               +   L ++G G FG V       E +S  I   +K ++  +   R   + V     
Sbjct: 10  FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVTDHML 67

Query: 159 LLAEVASHCIVKLYYSFQDA----EYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIA 213
            +  +    IV+L             L L+ +YLP G ++  +      L   +   +  
Sbjct: 68  AIGSLDHAHIVRLL-----GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122

Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           Q    +  + +H  +HR++   N+LL     ++++DFG+   L 
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 46/238 (19%), Positives = 92/238 (38%), Gaps = 12/238 (5%)

Query: 24  LEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQIN 83
           ++  G         R + A   +       +  I   ++  + L +K  S ++  +    
Sbjct: 4   IDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANT 63

Query: 84  ILKDLERKETEYMRLKRH---KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY---AMK 137
           +  DL     E ++  +H     S        +IGRG FG V       +       A+K
Sbjct: 64  VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123

Query: 138 KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMTL 196
            L    +   G+V     E  ++ + +   ++ L     +      +++ Y+  GD+   
Sbjct: 124 SLN--RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181

Query: 197 LMREETLTETVARF--YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           + R ET   TV     +  Q    ++ +    ++HRD+   N +LD+   +K++DFGL
Sbjct: 182 I-RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 238

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 6/151 (3%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +  ++  LL  +G G FG V+L + K   ++ A+K +K+  M      +    E   + +
Sbjct: 5   LKREEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMK 59

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV-LAIES 221
           ++   +VK Y        +Y++ EY+  G ++  L       E      +   V   +  
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +  H +IHRD+   N L+D++  +K+SDFG+
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGM 150

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 33/154 (21%), Positives = 65/154 (42%), Gaps = 6/154 (3%)

Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNL 159
           +   +  +  ++G G FGEV     +      I  A+K LK        Q      E ++
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASI 99

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLA 218
           + +     I++L      ++ + ++ EY+  G + + L   +   T       +      
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           ++ +    Y+HRD+   N+L++ N   K+SDFGL
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 12/176 (6%)

Query: 86  KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVR---LCQEKKSGNIYAMKKLKKS 142
            D E  + + + LKR  + + D      +G G FG VR       KK  ++ A+K LK  
Sbjct: 320 SDPEELKDKKLFLKRDNLLIAD----IELGCGNFGSVRQGVYRMRKKQIDV-AIKVLK-- 372

Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMT-LLMREE 201
           +   +   E +  E  ++ ++ +  IV+L      AE L L+ME   GG +   L+ + E
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKRE 431

Query: 202 TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            +  +     + Q  + ++ + + N++HR++   N+LL    + K+SDFGL K L 
Sbjct: 432 EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 48/154 (31%), Positives = 71/154 (46%), Gaps = 7/154 (4%)

Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNL 159
           I+ +D  L  I+G G FGEV   +    K   I  A+K  KK   L     E   +E  +
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVI 66

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLA 218
           +  +    IVKL    ++ E  ++IME  P G++   L R + +L       Y  Q   A
Sbjct: 67  MKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +  +   N +HRDI   N+L+     +KL DFGL
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 7/159 (4%)

Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNL 159
           I  +  +L   IG G FG+V   +    ++  +  A+K  K     S    E    E   
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALT 69

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQSVLA 218
           + +     IVKL     +   +++IME    G++ + L +R+ +L       Y  Q   A
Sbjct: 70  MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +  +    ++HRDI   N+L+  N  +KL DFGL + ++
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 39/168 (23%), Positives = 74/168 (44%), Gaps = 26/168 (15%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAER--NLLAEVA 164
           +  L  +G G  G V    +       A+KK+        +       A R   ++  + 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK------HALREIKIIRRLD 66

Query: 165 SHCIVKLY--------------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF 210
              IVK++               S  +   +Y++ EY+   D +  ++ +  L E  AR 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETD-LANVLEQGPLLEEHARL 124

Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLD 257
           ++ Q +  ++ IH  N +HRD+KP NL ++ ++  +K+ DFGL + +D
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 21/174 (12%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY--AMKKLKKSEMLSRGQVEHVRAERNLL 160
           +  +D     +IG G FG+V   + KK G     A+K++K  E  S+        E  +L
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVL 79

Query: 161 AEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVL 217
            ++  H  I+ L  + +   YLYL +EY P G+++  L   R        A      S L
Sbjct: 80  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139

Query: 218 AIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           + + +                  +IHRD+   N+L+ +N   K++DFGL +  +
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 193

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 37/155 (23%), Positives = 64/155 (41%), Gaps = 7/155 (4%)

Query: 103 ISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERN 158
           I         +IG G FGEV    L        +  A+K LK        Q      E  
Sbjct: 41  IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAG 98

Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVL 217
           ++ + + H I++L       + + +I EY+  G +   L  ++   +       +     
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            ++ +   NY+HRD+   N+L++ N   K+SDFGL
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 70.4 bits (173), Expect = 8e-14
 Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 27/173 (15%)

Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEHVR 154
           R+ +          +G GAFG+V         K+   +  A+K LK +      + E + 
Sbjct: 45  RNNLQ-----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALM 97

Query: 155 AERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIA 213
           +E  +++ +  H  IV L  +      + +I EY   GD++  L R+  + ET   F IA
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157

Query: 214 QSVLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            S  +   +                 N IHRD+   N+LL      K+ DFGL
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 70.3 bits (173), Expect = 8e-14
 Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 40/169 (23%)

Query: 106 DDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKS------------EMLSRGQV 150
           ++FD   +IG G FG+V    L    + G   A+K+                E LS    
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGVL----RDGAKVALKRRTPESSQGIEEFETEIETLSF--C 92

Query: 151 EHVRAERNLLAEVASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTET--- 206
            H     +L         V L  +  +  E + LI +Y+  G++   L   +  T +   
Sbjct: 93  RH----PHL---------VSLIGFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSW 138

Query: 207 VARFYIA-QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             R  I   +   +  +H    IHRD+K  N+LLD+N   K++DFG+ K
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 69.5 bits (171), Expect = 1e-13
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 16/156 (10%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +  +   L+  +G G FGEV +        + A+K LK+  M      +   AE NL+ +
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 64

Query: 163 VASHCIVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSV 216
           +    +V+LY     A    E +Y+I EY+  G ++  L     +  T+ +     AQ  
Sbjct: 65  LQHQRLVRLY-----AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             +  I + NYIHRD++  N+L+      K++DFGL
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 32/171 (18%), Positives = 69/171 (40%), Gaps = 25/171 (14%)

Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY-------AMKKLKKSEMLSRGQVEHV 153
           HKI  +D      +G+G F ++     ++ G+          +K L K+        E  
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESF 59

Query: 154 RAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIA 213
               +++++++   +V  Y      +   L+ E++  G + T L + +     + +  +A
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 214 QSVLA----IESIHKHNYIHRDIKPDNLLLD--------QNGHMKLSDFGL 252
           + + A    +E    +  IH ++   N+LL             +KLSD G+
Sbjct: 120 KQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 18/172 (10%)

Query: 97  RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY---AMKKLKKSEMLSRGQVEHV 153
           +L+   I    F L  ++G+G FG VR  Q K+    +   A+K LK   + +   +E  
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEF 72

Query: 154 RAERNLLAEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
             E   + E     + KL        +        +I+ ++  GD+   L     + E  
Sbjct: 73  LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENP 131

Query: 208 ARFYIAQSVLAIESIHK-------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               +   V  +  I          N+IHRD+   N +L ++  + ++DFGL
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 48/239 (20%), Positives = 99/239 (41%), Gaps = 62/239 (25%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAERNLLAEVA-- 164
           +++L +IG+G+FG+V    + K     A+K ++ +     +   E +R   +L  +    
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDN 157

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESI 222
           +  ++ +  +F    ++ +  E L   ++  L+   + +  +  + R +    +  ++++
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 223 HKHNYIHRDIKPDNLLLDQNGH--MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
           HK+  IH D+KP+N+LL Q G   +K+ DFG          S+  E++ +          
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG----------SSCYEHQRV---------- 256

Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD-W 338
                                           Y+ + +  Y APEV+L   YGM  D W
Sbjct: 257 --------------------------------YTYIQSRFYRAPEVILGARYGMPIDMW 283

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 36/206 (17%)

Query: 71  LASSDVPEEEQINIL-KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQ--- 126
           +   ++P +E    L  D  + E       R ++      L   +GRGAFG+V       
Sbjct: 1   MDPDELPLDEHCERLPYDASKWE-----FPRDRLK-----LGKPLGRGAFGQVIEADAFG 50

Query: 127 --EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLY-YSFQDAEYLY 182
             +  +    A+K LK+    S  +   + +E  +L  +  H  +V L     +    L 
Sbjct: 51  IDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 108

Query: 183 LIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVLAIESIHK--------------HN 226
           +I+E+   G++ T L   R E +   VA   + +  L +E +                  
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168

Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGL 252
            IHRD+   N+LL +   +K+ DFGL
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGL 194

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 45/245 (18%), Positives = 93/245 (37%), Gaps = 43/245 (17%)

Query: 49  HYK-AQMKHIQERKQRRSVLERKL---ASSDVPEEEQINILKDLERKET-----EYMRLK 99
           H+  +Q      +  +R  L R++   A S         +++   R  +         + 
Sbjct: 7   HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66

Query: 100 RHKISVDD--------FDLLTIIGRGAFGEV------RLCQEKKSGNIY-AMKKLKKSEM 144
            +++  D           L   +G G FG+V       + ++K    +  A+K LK  + 
Sbjct: 67  EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DD 124

Query: 145 LSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REE 201
            +   +  + +E  ++  +  H  I+ L  +      LY+I+EY   G++   L   R  
Sbjct: 125 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 184

Query: 202 TLTETVARFYIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKL 247
            +  +     + +  +  + +                   IHRD+   N+L+ +N  MK+
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244

Query: 248 SDFGL 252
           +DFGL
Sbjct: 245 ADFGL 249

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 15/152 (9%)

Query: 110 LLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
              +IGRG FG V    L          A+K L    +   G+V     E  ++ + +  
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHP 86

Query: 167 CIVKLY-YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY-----IAQSVLAIE 220
            ++ L     +      +++ Y+  GD+   + R ET   TV         +A+ +  + 
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           S     ++HRD+   N +LD+   +K++DFGL
Sbjct: 146 S---KKFVHRDLAARNCMLDEKFTVKVADFGL 174

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 32/148 (21%), Positives = 63/148 (42%), Gaps = 7/148 (4%)

Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIY---AMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
              +IG+G FG V   +           A+K L    +    QVE    E  L+  +   
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS--RITEMQQVEAFLREGLLMRGLNHP 82

Query: 167 CIVKLY-YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQSVLAIESIHK 224
            ++ L           ++++ Y+  GD++  +   +   T      +  Q    +E + +
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             ++HRD+   N +LD++  +K++DFGL
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGL 170

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 67.6 bits (166), Expect = 6e-13
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 30/158 (18%)

Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA----- 164
            +G G FG V    +     +    A+KKL     ++  +      ++    E+      
Sbjct: 38  KMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEE-----LKQQFDQEIKVMAKC 87

Query: 165 SH-CIVKLY-YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLT---ETVARFYIAQSVLA 218
            H  +V+L  +S    +   L+  Y+P G ++  L   + T         R  IAQ   A
Sbjct: 88  QHENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHM--RCKIAQGA-A 143

Query: 219 --IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
             I  +H++++IHRDIK  N+LLD+    K+SDFGL +
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR 181

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 66.9 bits (164), Expect = 9e-13
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 7/163 (4%)

Query: 99  KRHKISVDDFDLLTI-IGRGAFGEVRLCQEKKSGNIY--AMKKLKKSEMLSRGQVEHVRA 155
           K+  +  D+  +  I +G G FG VR    +        A+K LK  +   +   E +  
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK--QGTEKADTEEMMR 59

Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQ 214
           E  ++ ++ +  IV+L      AE L L+ME   GG +   L+ + E +  +     + Q
Sbjct: 60  EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
             + ++ + + N++HRD+   N+LL    + K+SDFGL K L 
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 50/208 (24%)

Query: 75  DVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSG 131
           DVP EE   +     ++ +    L+  +++ D+F    I+GRG FG+V   RL      G
Sbjct: 3   DVPAEEDPEVHLGQLKRFS----LRELQVASDNFSNKNILGRGGFGKVYKGRL----ADG 54

Query: 132 NIYAMKKLKKS-------------EMLSRGQVEHVRAERNLLAEVASHCIVKLY-YSFQD 177
            + A+K+LK+              EM+S     H    RNL         ++L  +    
Sbjct: 55  TLVAVKRLKEERTQGGELQFQTEVEMISM--AVH----RNL---------LRLRGFCMTP 99

Query: 178 AEYLYLIMEYLPGGDVMTLLMREETLTETV---ARFYIAQSV---LAI--ESIHKHNYIH 229
            E L L+  Y+  G V + L         +    R  IA      LA   +       IH
Sbjct: 100 TERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK-IIH 157

Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           RD+K  N+LLD+     + DFGL K +D
Sbjct: 158 RDVKAANILLDEEFEAVVGDFGLAKLMD 185

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 31/177 (17%)

Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEHVR 154
           R+++S         +G GAFG+V         K    +  A+K LK S  L+  + E + 
Sbjct: 22  RNRLS-----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALM 74

Query: 155 AERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFY 211
           +E  +L+ + +H  IV L  +        +I EY   GD++  L   R+  +    +   
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 212 IAQSVLAIES----------------IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +    LA++                 +   N IHRD+   N+LL      K+ DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 38/191 (19%), Positives = 74/191 (38%), Gaps = 34/191 (17%)

Query: 94  EYMRLKRHKISVDD--------FDLLTIIGRGAFGEV------RLCQEKKSGNIY-AMKK 138
               +  +++  D           L   +G GAFG+V       + ++K    +  A+K 
Sbjct: 15  MLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74

Query: 139 LKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLL 197
           LK         +  + +E  ++  +  H  I+ L  +      LY+I+EY   G++   L
Sbjct: 75  LKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132

Query: 198 --MREETLTETVARFYIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDQ 241
              R   +  +     + +  +  + +                   IHRD+   N+L+ +
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192

Query: 242 NGHMKLSDFGL 252
           N  MK++DFGL
Sbjct: 193 NNVMKIADFGL 203

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 39/211 (18%)

Query: 79  EEQINILKDLERKETEYMRLKRHKISVDD---FD-----LLTIIGRGAFGEVRLCQ---- 126
           E Q+ +++     + EY  +   +   D    F         ++G GAFG+V        
Sbjct: 10  ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 69

Query: 127 EKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLI 184
            K   +I  A+K LK+    S  + E + +E  ++ ++ SH  IV L  +   +  +YLI
Sbjct: 70  SKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127

Query: 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-------------------- 224
            EY   GD++  L  +          Y  Q  L  E                        
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187

Query: 225 ---HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
               + +HRD+   N+L+     +K+ DFGL
Sbjct: 188 LEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 35/164 (21%), Positives = 71/164 (43%), Gaps = 15/164 (9%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY---AMKKLKKSEMLSRGQVEHVRAERNL 159
           I  +   L  I+G G FG V     K+        A+K +K  +  S+ ++E   +E   
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL-DNSSQREIEEFLSEAAC 89

Query: 160 LAEVASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMR------EETLTETVA 208
           + + +   +++L       S Q      +I+ ++  GD+ T L+        + +     
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149

Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
             ++    L +E +   N++HRD+   N +L  +  + ++DFGL
Sbjct: 150 LKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 41/296 (13%)

Query: 68  ERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDD-----FDLLTIIGRGAFGEV 122
           E ++  SD  E+E  N          +Y +   H + + D     + ++  +G G F  V
Sbjct: 4   EEEILGSDDDEQEDPN----------DYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTV 53

Query: 123 RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--------HCIVKLYYS 174
            L  + +     AMK +K +E       E    E  LL  V +          +V+L   
Sbjct: 54  WLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109

Query: 175 FQ----DAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKH-NY 227
           F+    +  ++ ++ E L G  ++  +++   + L     +  I Q +  ++ +H     
Sbjct: 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI 168

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           IH DIKP+N+LL  N                +     + + V        +  V+   P+
Sbjct: 169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPK 228

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN 343
           +    + K        W           + T  Y + EVL+  GY    D    W+
Sbjct: 229 NAEKLKVKIADLGNACWVHKHFT---EDIQTRQYRSLEVLIGSGYNTPAD---IWS 278

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 40/179 (22%), Positives = 71/179 (39%), Gaps = 31/179 (17%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLC-------QEKKSGNIYAMKKLKKSEMLSRGQV 150
           L R ++      L   +G GAFG+V L         +       A+K LK         +
Sbjct: 66  LPRDRLV-----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DL 118

Query: 151 EHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETV 207
             + +E  ++  +  H  I+ L  +      LY+I+EY   G++   L   R   L  + 
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178

Query: 208 ARFYIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
              +  +  L+ + +                   IHRD+   N+L+ ++  MK++DFGL
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 64.6 bits (158), Expect = 6e-12
 Identities = 41/182 (22%), Positives = 69/182 (37%), Gaps = 41/182 (22%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEH 152
           +KR  I      L   +G GAFG+V L +          +  A+K LK   +        
Sbjct: 12  IKRRDIV-----LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-------- 58

Query: 153 VRAERNLLAEVA-----SHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLT 204
             A ++   E        H  IVK Y    D + L ++ EY+  GD+   L     + + 
Sbjct: 59  -AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 117

Query: 205 ETVARFYIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDF 250
               +   A+  L +  +                 +++HRD+   N L+  N  +K+ DF
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 177

Query: 251 GL 252
           G+
Sbjct: 178 GM 179

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 64.6 bits (158), Expect = 6e-12
 Identities = 39/175 (22%), Positives = 70/175 (40%), Gaps = 28/175 (16%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEH 152
           +KR  I      L   +G GAFG+V L +      +   +  A+K LK++   +R   + 
Sbjct: 38  IKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QD 89

Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFY 211
            + E  LL  +    IV+ +    +   L ++ EY+  GD+   L               
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149

Query: 212 IAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
           +A   L +  +                 +++HRD+   N L+ Q   +K+ DFG+
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM 204

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 33/170 (19%), Positives = 70/170 (41%), Gaps = 22/170 (12%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEH 152
           + R KI+     +   +G+G+FG V         + +     A+K +   E  S  +   
Sbjct: 22  VAREKIT-----MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIE 74

Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARF 210
              E +++ E   H +V+L       +   +IME +  GD+ + L   R       V   
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 211 YIAQSVLAI--------ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
                ++ +          ++ + ++HRD+   N ++ ++  +K+ DFG+
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 53/254 (20%), Positives = 97/254 (38%), Gaps = 64/254 (25%)

Query: 95  YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHV 153
              +K  +  +D +++ ++IG+G+FG+V    ++      A+K +K K   L++ Q+E V
Sbjct: 43  DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-V 101

Query: 154 RAERNLLAE--VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVAR 209
           R    +        + IV L   F    +L L+ E L   ++  LL       ++  + R
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTR 160

Query: 210 FYIAQSVLAIESIH--KHNYIHRDIKPDNLLLDQNGH--MKLSDFGLCKPLDCTNLSAIN 265
            +  Q   A+  +   + + IH D+KP+N+LL       +K+ DFG          S+  
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----------SSCQ 210

Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
             + +                                          Y  + +  Y +PE
Sbjct: 211 LGQRI------------------------------------------YQYIQSRFYRSPE 228

Query: 326 VLLKKGYGMECD-W 338
           VLL   Y +  D W
Sbjct: 229 VLLGMPYDLAIDMW 242

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 45/249 (18%), Positives = 90/249 (36%), Gaps = 74/249 (29%)

Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVE-----HVR-AERNLLAEV 163
           +  +G G F  V L ++  +    AMK ++         + E      V  A+      +
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 164 ASHCIVKLYYSFQ----DAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVL 217
            ++ I+KL   F     +  ++ ++ E L G +++ L+ +     +     +    Q +L
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 218 AIESIHKH-NYIHRDIKPDNLLLD------QNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
            ++ +H+    IH DIKP+N+L++          +K++D G          +A   +E  
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG----------NACWYDEHY 192

Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
                                                      +++ T +Y +PEVLL  
Sbjct: 193 ------------------------------------------TNSIQTREYRSPEVLLGA 210

Query: 331 GYGMECD-W 338
            +G   D W
Sbjct: 211 PWGCGADIW 219

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 42/184 (22%), Positives = 70/184 (38%), Gaps = 36/184 (19%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEH 152
             R  +      L   +G G FG+V        + ++G    A+K LK++   S  ++  
Sbjct: 20  FPRKNLV-----LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRD 72

Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARF 210
           + +E N+L +V    ++KLY +      L LI+EY   G +   L   R+       +  
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132

Query: 211 YIAQSVLAIESIHK----------------------HNYIHRDIKPDNLLLDQNGHMKLS 248
               S L                                +HRD+   N+L+ +   MK+S
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192

Query: 249 DFGL 252
           DFGL
Sbjct: 193 DFGL 196

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 35/171 (20%), Positives = 57/171 (33%), Gaps = 23/171 (13%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEHVRAER 157
           IS+     +  +G   FG+V                 A+K LK          E  R E 
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREEFRHEA 63

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQS 215
            L A +    +V L       + L +I  Y   GD+   L      +   +       +S
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123

Query: 216 VLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
            L                     H+ +H+D+   N+L+    ++K+SD GL
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 42/184 (22%), Positives = 64/184 (34%), Gaps = 36/184 (19%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEH 152
             R+ I       +  IG GAFG V   +             A+K LK  E  S      
Sbjct: 44  YPRNNIE-----YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQAD 96

Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI 212
            + E  L+AE  +  IVKL       + + L+ EY+  GD+   L      T        
Sbjct: 97  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156

Query: 213 AQSVLAIESIHK------------------------HNYIHRDIKPDNLLLDQNGHMKLS 248
             +   + S                             ++HRD+   N L+ +N  +K++
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216

Query: 249 DFGL 252
           DFGL
Sbjct: 217 DFGL 220

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 38/166 (22%), Positives = 69/166 (41%), Gaps = 19/166 (11%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEHVRAER 157
           +   +  L+  +G GAFGEV   Q          +  A+K L   E+ S         E 
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEA 125

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
            ++++     IV+       +   ++++E + GGD+ + L RE     +         +L
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 184

Query: 218 AI--------ESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGL 252
            +        + + ++++IHRDI   N LL   G     K+ DFG+
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 19/166 (11%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEHVRAER 157
           +   +  L+  +G GAFGEV   Q          +  A+K L   E+ S         E 
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEA 84

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
            ++++     IV+       +   +++ME + GGD+ + L RE     +         +L
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 143

Query: 218 AI--------ESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGL 252
            +        + + ++++IHRDI   N LL   G     K+ DFG+
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 45/247 (18%), Positives = 87/247 (35%), Gaps = 60/247 (24%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGN-IYAMKKLK-KSEMLSRGQVEHVRAERNLLAEVA- 164
           ++++  +G GAFG+V  C + K+G    A+K +K         + E       +L  +  
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNT 70

Query: 165 -----SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVL 217
                +   V++   F+   ++ ++ E L G      +             R    Q   
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD-----D 272
           ++  +H +   H D+KP+N+L  Q+ + +  +  + +         I   +V+D      
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI---KVVDFGSATY 186

Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
           ++ + S  V  R                                    Y APEV+L  G+
Sbjct: 187 DDEHHSTLVSTRH-----------------------------------YRAPEVILALGW 211

Query: 333 GMECD-W 338
              CD W
Sbjct: 212 SQPCDVW 218

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 47/250 (18%), Positives = 87/250 (34%), Gaps = 62/250 (24%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAERNLLAEVAS- 165
           F ++  +G G FG V LCQ   +   YA+K ++   +     ++E      ++L ++ + 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADILKKIQND 91

Query: 166 ----HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAI 219
               + IVK +  F   +++ LI E L G  +  ++ R           + Y  + + A+
Sbjct: 92  DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL--------- 270
             + K +  H D+KP+N+LLD     K                   ++  +         
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210

Query: 271 -DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
              +                                        S + T  Y APEV+L 
Sbjct: 211 FKSDYH-------------------------------------GSIINTRQYRAPEVILN 233

Query: 330 KGYGMECD-W 338
            G+ +  D W
Sbjct: 234 LGWDVSSDMW 243

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.0 bits (134), Expect = 5e-09
 Identities = 33/200 (16%), Positives = 60/200 (30%), Gaps = 48/200 (24%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL-----KKSEMLSRGQVEHVRAER 157
           +  +       IG G FGEV            A+K +            +   E +  E 
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 158 NLLAEVA-----------------SHCIVKLYY----------------------SFQDA 178
            +  E++                 S   V+  Y                       F   
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNL 237
           + L++++E+  GG  +   MR +  +   A+  + Q   ++        + HRD+   N+
Sbjct: 135 DQLFIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193

Query: 238 LLDQNGHMKLSDFGLCKPLD 257
           LL +    KL      K   
Sbjct: 194 LLKKTSLKKLHYTLNGKSST 213

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 30/167 (17%), Positives = 63/167 (37%), Gaps = 16/167 (9%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIY-AMKKLK-KSEMLSRGQVEHVRAERNLLAEVA- 164
           ++++  +G G FG+V  C +   G    A+K ++   +     ++E      N+L ++  
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-----INVLKKIKE 75

Query: 165 -----SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVL 217
                    V +   F    ++ +  E L G +    L     +       R    Q   
Sbjct: 76  KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
           A+  +H++   H D+KP+N+L   +    L +            ++I
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 38/192 (19%), Positives = 67/192 (34%), Gaps = 22/192 (11%)

Query: 76  VPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQ-----EKKS 130
           +P +E    L   +  + E+ R        D   L   +GRGAFG+V         +  +
Sbjct: 1   LPLDEHCERL-PYDASKWEFPR--------DRLKLGKPLGRGAFGQVIEADAFGIDKTAT 51

Query: 131 GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLY-YSFQDAEYLYLIMEYL 188
               A+K LK+    S  +   + +E  +L  +  H  +V L     +    L +I+E+ 
Sbjct: 52  CRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 109

Query: 189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLS 248
             G++ T L  +          Y  +     +       I  D+K     +  +     S
Sbjct: 110 KFGNLSTYLRSKRNEFVP----YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS 165

Query: 249 DFGLCKPLDCTN 260
            F   K L    
Sbjct: 166 GFVEEKSLSDVE 177

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 30/147 (20%), Positives = 56/147 (38%), Gaps = 17/147 (11%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKK-LKKS----EMLSRGQVEHVRAERNLLAEVASHC 167
           +IG+GA  E  + ++        +K+ +KK      +    +      E   LA V    
Sbjct: 343 LIGKGA--EADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFG 400

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           I   Y    D +   ++M Y+ G     ++     +   +           +  +HK++ 
Sbjct: 401 IPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGE--------IVGKLHKNDV 452

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCK 254
           IH D+   N + D    + + DFGL K
Sbjct: 453 IHNDLTTSNFIFD--KDLYIIDFGLGK 477

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	358
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.95
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.23
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.89
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.67
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.5
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.32
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.18
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.0
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.86
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.7
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.56
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.49
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.4
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.34
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.32
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.31
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.27
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.9
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.79
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.0
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.74
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.52
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.67
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.21

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.2e-57  Score=418.79  Aligned_cols=206  Identities=33%  Similarity=0.529  Sum_probs=189.3

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|++++.||+|+||+||+|.++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++++.+||
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34789999999999999999999999999999999998766666777889999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.....  
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~--  187 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--  187 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT--
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC--
Confidence            999999999999999889999999999999999999999999999999999999999999999999999987642211  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                   .....+.||||.|||||++.+.+|+.++|||||||
T Consensus       188 ---------------------------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGv  222 (311)
T 4aw0_A          188 ---------------------------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGC  222 (311)
T ss_dssp             ---------------------------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHH
T ss_pred             ---------------------------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHH
Confidence                                                         11233669999999999999999999999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      +|||||++..+|.
T Consensus       223 ilyeml~G~~PF~  235 (311)
T 4aw0_A          223 IIYQLVAGLPPFR  235 (311)
T ss_dssp             HHHHHHHSSCSSC
T ss_pred             HHHHHHhCCCCCC
Confidence            9999999988774

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.2e-55  Score=413.65  Aligned_cols=203  Identities=31%  Similarity=0.514  Sum_probs=176.8

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|++++.||+|+||+||+|.++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+++.+||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            35799999999999999999999999999999999987653 34456789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          184 IMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |||||+||+|.+++...  ..+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...  
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--  178 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--  178 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence            99999999999999654  46789999999999999999999999999999999999999999999999999876411  


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                     .....+.+|||.|||||++.+.+|+.++|||||
T Consensus       179 -----------------------------------------------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSl  211 (350)
T 4b9d_A          179 -----------------------------------------------VELARACIGTPYYLSPEICENKPYNNKSDIWAL  211 (350)
T ss_dssp             -----------------------------------------------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             -----------------------------------------------cccccccCCCccccCHHHHCCCCCCcHHHHHHH
Confidence                                                           011225689999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||+||||+++..+|.
T Consensus       212 GvilyemltG~~PF~  226 (350)
T 4b9d_A          212 GCVLYELCTLKHAFE  226 (350)
T ss_dssp             HHHHHHHHHSSCSCC
T ss_pred             HHHHHHHHHCCCCCC
Confidence            999999999988774

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5e-54  Score=405.70  Aligned_cols=199  Identities=27%  Similarity=0.429  Sum_probs=179.5

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ...|++++.||+|+||+||+|.++.+|+.||||++......   ..+.+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46799999999999999999999999999999999766432   334578999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||||+||+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.....   
T Consensus       150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---  225 (346)
T 4fih_A          150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---  225 (346)
T ss_dssp             ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC---
T ss_pred             EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC---
Confidence            999999999998864 6799999999999999999999999999999999999999999999999999987642211   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                    ...+.+|||.|||||++.+.+|+.++|||||||+
T Consensus       226 ----------------------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvi  259 (346)
T 4fih_A          226 ----------------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIM  259 (346)
T ss_dssp             ----------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred             ----------------------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHH
Confidence                                                          1225689999999999999999999999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      ||||+++..+|.
T Consensus       260 lyeml~G~~PF~  271 (346)
T 4fih_A          260 VIEMVDGEPPYF  271 (346)
T ss_dssp             HHHHHHSSCTTT
T ss_pred             HHHHHHCCCCCC
Confidence            999999988763

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.6e-54  Score=395.32  Aligned_cols=201  Identities=27%  Similarity=0.496  Sum_probs=167.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++++.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++|||||+++++|.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            47899999999999999999999999999999999876655555667799999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+ +|+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......    
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----  166 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----
Confidence            9999 68999999999999999999999999999999999999999999999999999999999999997653211    


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-CccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-~~~~DiwSlGv  343 (358)
                                                                    ...+.+|||.|||||++.+.+| +.++|||||||
T Consensus       167 ----------------------------------------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGv  200 (275)
T 3hyh_A          167 ----------------------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV  200 (275)
T ss_dssp             ------------------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHH
T ss_pred             ----------------------------------------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHH
Confidence                                                          1124589999999999999887 57999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|||+++..+|.
T Consensus       201 ily~lltg~~PF~  213 (275)
T 3hyh_A          201 ILYVMLCRRLPFD  213 (275)
T ss_dssp             HHHHHHHSSCSSC
T ss_pred             HHHHHHHCCCCCC
Confidence            9999999988774

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.1e-54  Score=405.00  Aligned_cols=201  Identities=28%  Similarity=0.369  Sum_probs=176.2

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..+.|.+.++||+|+||.||+|.++.+|+.||||+++....        ..+|+.+++.++|||||+++++|.+.+.+||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34679999999999999999999999999999999986542        2469999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-cEEEEecCCCccCCCCCCc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~vkl~DFGla~~~~~~~~~  262 (358)
                      |||||+||+|.+++...+++++..++.++.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+.+......
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999889999999999999999999999999999999999999999998 6999999999876432110


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                      .                                            ......+.+|||.|||||++.+.+|+.++||||||
T Consensus       208 ~--------------------------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlG  243 (336)
T 4g3f_A          208 K--------------------------------------------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC  243 (336)
T ss_dssp             --------------------------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHH
T ss_pred             c--------------------------------------------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHH
Confidence            0                                            00012246899999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |+|||||++..+|.
T Consensus       244 vilyemltG~~Pf~  257 (336)
T 4g3f_A          244 CMMLHMLNGCHPWT  257 (336)
T ss_dssp             HHHHHHHHSSCSST
T ss_pred             HHHHHHHHCcCCCC
Confidence            99999999987763

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-54  Score=403.79  Aligned_cols=205  Identities=39%  Similarity=0.645  Sum_probs=175.4

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ....++|++++.||+|+||+||+|++.   .+++.||||++++..... .....+.+|+.+|+.++|||||+++++|.++
T Consensus        20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   98 (304)
T 3ubd_A           20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTE   98 (304)
T ss_dssp             CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEET
T ss_pred             cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence            345578999999999999999999874   468899999998754322 2233577899999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      +.+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999999999999989999999999999999999999999999999999999999999999999999986532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ..                                                 ....+.+|||.|||||++.+.+|+.++||
T Consensus       179 ~~-------------------------------------------------~~~~~~~GT~~YmAPE~~~~~~y~~~~Di  209 (304)
T 3ubd_A          179 HE-------------------------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADW  209 (304)
T ss_dssp             ---------------------------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHH
T ss_pred             CC-------------------------------------------------ccccccccCcccCCHHHhccCCCCCCCcc
Confidence            11                                                 11235689999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||+|||||++..+|.
T Consensus       210 wSlGvilyemltG~~PF~  227 (304)
T 3ubd_A          210 WSFGVLMFEMLTGTLPFQ  227 (304)
T ss_dssp             HHHHHHHHHHHHSSCSSC
T ss_pred             cchHHHHHHHHhCCCCCC
Confidence            999999999999988774

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.1e-53  Score=407.71  Aligned_cols=200  Identities=27%  Similarity=0.429  Sum_probs=179.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..+.|++++.||+|+||.||+|.++.+|+.||||++.....   ...+.+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            44779999999999999999999999999999999976543   233458899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||||+||+|.+++. ...+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.....  
T Consensus       226 VmEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          226 VMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             EEECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             EEeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            999999999999885 45799999999999999999999999999999999999999999999999999987642211  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                     ...+.||||.|||||++.+.+|+.++|||||||
T Consensus       303 -----------------------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGv  335 (423)
T 4fie_A          303 -----------------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI  335 (423)
T ss_dssp             -----------------------------------------------CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHH
T ss_pred             -----------------------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHH
Confidence                                                           122568999999999999999999999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|||+++...|.
T Consensus       336 ilyeml~G~~PF~  348 (423)
T 4fie_A          336 MVIEMVDGEPPYF  348 (423)
T ss_dssp             HHHHHHHSSCTTT
T ss_pred             HHHHHHHCCCCCC
Confidence            9999999988763

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-52  Score=387.88  Aligned_cols=198  Identities=24%  Similarity=0.401  Sum_probs=175.2

Q ss_pred             CCc-eeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec----CCE
Q 018275          106 DDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----AEY  180 (358)
Q Consensus       106 ~~~-~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~~~  180 (358)
                      ++| ++.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+++.++|||||+++++|.+    ...
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            455 777889999999999999999999999999986643 44556779999999999999999999999865    456


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEc-CCCcEEEEecCCCccCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--iiHrDikp~NILl~-~~~~vkl~DFGla~~~~  257 (358)
                      +|||||||+||+|.+++....++++..++.++.||+.||.|||+++  ||||||||+||||+ .+|.+||+|||+|+...
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            8999999999999999998899999999999999999999999998  99999999999998 48999999999997532


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ..                                                   ...+.+|||.|||||++.+ +|+.++|
T Consensus       184 ~~---------------------------------------------------~~~~~~GTp~YmAPE~~~~-~y~~~~D  211 (290)
T 3fpq_A          184 AS---------------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVD  211 (290)
T ss_dssp             TT---------------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHH
T ss_pred             CC---------------------------------------------------ccCCcccCccccCHHHcCC-CCCcHHH
Confidence            11                                                   1225689999999999875 6999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||+||||+++..+|.
T Consensus       212 iwSlGvilyelltg~~Pf~  230 (290)
T 3fpq_A          212 VYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             HHHHHHHHHHHHHSSCTTT
T ss_pred             HHHHHHHHHHHHHCCCCCC
Confidence            9999999999999988763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.6e-52  Score=387.44  Aligned_cols=206  Identities=24%  Similarity=0.381  Sum_probs=162.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC------
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE------  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~------  179 (358)
                      ++|++++.||+|+||+||+|.++.+|+.||||+++...  .....+.+.+|+.+|+.++|||||+++++|.+.+      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            46999999999999999999999999999999997653  3344567889999999999999999999997543      


Q ss_pred             ------EEEEEEeecCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEec
Q 018275          180 ------YLYLIMEYLPGGDVMTLLMREET---LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF  250 (358)
Q Consensus       180 ------~~~lV~E~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DF  250 (358)
                            ++|+|||||+||+|.+++.....   .....++.++.||+.||.|||++|||||||||+||||+.++.+||+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence                  47999999999999999977654   445668889999999999999999999999999999999999999999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK  330 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~  330 (358)
                      |+|+.+...........                                     .........+.+|||.|||||++.+.
T Consensus       163 Gla~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~GT~~YmAPE~~~~~  205 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLT-------------------------------------PMPAYARHTGQVGTKLYMSPEQIHGN  205 (299)
T ss_dssp             CCC---------------------------------------------------------------CCCTTSCHHHHTTC
T ss_pred             ccceecCCCcccccccc-------------------------------------ccccccccCCcccCccccCHHHHcCC
Confidence            99987753321110000                                     00001112356899999999999999


Q ss_pred             CCCccchhhhhhHHHHhhcc
Q 018275          331 GYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~  350 (358)
                      +|+.++|||||||+|||||+
T Consensus       206 ~y~~~~DiwSlGvilyell~  225 (299)
T 4g31_A          206 SYSHKVDIFSLGLILFELLY  225 (299)
T ss_dssp             CCCTHHHHHHHHHHHHHHHS
T ss_pred             CCCCHHHHHHHHHHHHHHcc
Confidence            99999999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.2e-52  Score=419.06  Aligned_cols=205  Identities=32%  Similarity=0.550  Sum_probs=183.0

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHH---HHHHhcCcceEEEEEEeec
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN---LLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~---il~~l~h~~iv~l~~~~~~  177 (358)
                      ..+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|..   +++.++|||||+++++|++
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            3677899999999999999999999999999999999998876555555555666644   4556689999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      .+.+||||||++||+|.+++...+.+++..++++++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998653


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-CCCCCccc
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMEC  336 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-~~~y~~~~  336 (358)
                      ..                                                   ...+.||||.|||||++. +.+|+.++
T Consensus       344 ~~---------------------------------------------------~~~t~~GTp~YmAPEvl~~~~~y~~~v  372 (689)
T 3v5w_A          344 KK---------------------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSA  372 (689)
T ss_dssp             SC---------------------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHH
T ss_pred             CC---------------------------------------------------CCCCccCCcCccCHHHHhCCCCCCcHH
Confidence            21                                                   123569999999999997 46899999


Q ss_pred             hhhhhhHHHHhhcccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~~  356 (358)
                      |||||||+|||||+|..+|.
T Consensus       373 DiWSLGvilYEmLtG~~PF~  392 (689)
T 3v5w_A          373 DWFSLGCMLFKLLRGHSPFR  392 (689)
T ss_dssp             HHHHHHHHHHHHHHSSCTTC
T ss_pred             HHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999988873

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.8e-52  Score=386.36  Aligned_cols=204  Identities=23%  Similarity=0.332  Sum_probs=175.2

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      .+..++|.+.+.||+|+||+||+|.+.     .++..||||+++..   .....+.+.+|+.+|++++|||||+++++|.
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            466689999999999999999999875     35789999999764   3445677999999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMRE-------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG  243 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  243 (358)
                      +.+.+|||||||++|+|.++|...             ..+++..+..++.||+.||.|||+++||||||||+||||+.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999653             3689999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCch
Q 018275          244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA  323 (358)
Q Consensus       244 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~A  323 (358)
                      .+||+|||+|+........                                               ......+||+.|||
T Consensus       166 ~~Ki~DFGla~~~~~~~~~-----------------------------------------------~~~~~~~gt~~ymA  198 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYY-----------------------------------------------RVGGHTMLPIRWMP  198 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCE-----------------------------------------------EETTTEEECGGGCC
T ss_pred             cEEECCcccceecCCCCce-----------------------------------------------eecCceecChhhcC
Confidence            9999999999865322110                                               11224579999999


Q ss_pred             hhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          324 PEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       324 PEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ||++.+..|+.++|||||||+||||++ +..+|
T Consensus       199 PE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf  231 (299)
T 4asz_A          199 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW  231 (299)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             HHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999999997 56554

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3e-51  Score=381.67  Aligned_cols=205  Identities=21%  Similarity=0.244  Sum_probs=172.9

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      .+++..+++.+.+.||+|+||+||+|.+.   ..||||+++.... .....+.+.+|+.+++.++|||||++++++.+ +
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~  104 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D  104 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence            35778899999999999999999999754   3699999975432 45566789999999999999999999998865 5


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      .+|||||||+||+|.++|... .++++..+..++.||+.||.|||+++||||||||+||||+.++.+||+|||+|+....
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            689999999999999999754 6799999999999999999999999999999999999999999999999999986542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC---CCCCcc
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGME  335 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~---~~y~~~  335 (358)
                      ....                                               ....+.+|||.|||||++.+   .+|+.+
T Consensus       185 ~~~~-----------------------------------------------~~~~~~~GT~~ymAPE~l~~~~~~~y~~k  217 (307)
T 3omv_A          185 WSGS-----------------------------------------------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQ  217 (307)
T ss_dssp             --------------------------------------------------------CCCCTTSCCHHHHHCCSSCCCCHH
T ss_pred             CCcc-----------------------------------------------eeecccccCCCccCHHHhhccCCCCCCcH
Confidence            2110                                               11224589999999999974   469999


Q ss_pred             chhhhhhHHHHhhcccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +|||||||+||||+++..+|.
T Consensus       218 sDVwS~Gvvl~Elltg~~Pf~  238 (307)
T 3omv_A          218 SDVYSYGIVLYELMTGELPYS  238 (307)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTT
T ss_pred             HHhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999887763

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.5e-51  Score=383.61  Aligned_cols=205  Identities=22%  Similarity=0.319  Sum_probs=170.7

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      ..+..++|.+.++||+|+||+||+|.+.     .++..||||+++..   .....+.+.+|+.+|+.++|||||+++++|
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~  112 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVC  112 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3456688999999999999999999865     36889999999764   345567799999999999999999999999


Q ss_pred             ecCCEEEEEEeecCCCCHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 018275          176 QDAEYLYLIMEYLPGGDVMTLLMRE---------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD  240 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~g~L~~~l~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~  240 (358)
                      .+.+.+|||||||++|+|.+++...               .++++..+..++.||+.||.|||+++||||||||+||||+
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence            9999999999999999999999653               3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCC
Q 018275          241 QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD  320 (358)
Q Consensus       241 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~  320 (358)
                      .++.+||+|||+|+.+......                                               ......+||+.
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~-----------------------------------------------~~~~~~~gt~~  225 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYY-----------------------------------------------RVGGRTMLPIR  225 (329)
T ss_dssp             TTTEEEECCCC---------------------------------------------------------------CCCCGG
T ss_pred             CCCcEEEcccccceeccCCCcc-----------------------------------------------eecCccccccc
Confidence            9999999999999866422111                                               01124579999


Q ss_pred             CchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          321 YIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       321 Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      |||||++.+..|+.++|||||||+||||++ +..+|
T Consensus       226 ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf  261 (329)
T 4aoj_A          226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW  261 (329)
T ss_dssp             GCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccChhhhcCCCCCccccccchHHHHHHHHcCCCCCC
Confidence            999999999999999999999999999997 55554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.4e-51  Score=381.40  Aligned_cols=206  Identities=21%  Similarity=0.284  Sum_probs=175.4

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      .++..+++++++.||+|+||+||+|...     .+++.||||+++...  .....+.+.+|+.++++++|||||+++++|
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            4566788999999999999999999863     467899999997553  334456799999999999999999999999


Q ss_pred             ecCCEEEEEEeecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE
Q 018275          176 QDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL  239 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl  239 (358)
                      .+++.+|||||||++|+|.++|...                ..+++..+..++.||+.||.|||+++||||||||+||||
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence            9999999999999999999999643                358899999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCC
Q 018275          240 DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTP  319 (358)
Q Consensus       240 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~  319 (358)
                      +.++.+||+|||+|+.+......                                               ....+.+||+
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~-----------------------------------------------~~~~~~~gt~  211 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYY-----------------------------------------------KLLGNSLLPI  211 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCB-----------------------------------------------CSSSSSCBCG
T ss_pred             CCCCCEEECCcccceeccCCCce-----------------------------------------------eEecccccCC
Confidence            99999999999999865322110                                               1112457999


Q ss_pred             CCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          320 DYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       320 ~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      .|||||++.+..|+.++|||||||+||||+. +..+|
T Consensus       212 ~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf  248 (308)
T 4gt4_A          212 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY  248 (308)
T ss_dssp             GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             cccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999999999997 55444

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-50  Score=387.19  Aligned_cols=204  Identities=22%  Similarity=0.378  Sum_probs=176.7

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec------CC
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------AE  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~------~~  179 (358)
                      ++|++++.||+|+||+||+|.++.+|+.||||++++... .......+.+|+.+|+.++|||||++++++.+      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            689999999999999999999999999999999976542 34445678899999999999999999998753      46


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+|||||||+ |+|.+++...+++++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7999999995 689999988899999999999999999999999999999999999999999999999999999876422


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~Di  338 (358)
                      ...                                             ......+.+|||.|||||++.+. .|+.++||
T Consensus       212 ~~~---------------------------------------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~Di  246 (398)
T 4b99_A          212 PAE---------------------------------------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDL  246 (398)
T ss_dssp             -------------------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred             ccc---------------------------------------------cccccccceeChHhcCHHHhcCCCCCCChhhe
Confidence            110                                             01122356999999999999875 56999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      ||+|||+|||+++..+|.
T Consensus       247 WSlG~il~ell~G~~pF~  264 (398)
T 4b99_A          247 WSVGCIFGEMLARRQLFP  264 (398)
T ss_dssp             HHHHHHHHHHHHTSCSSC
T ss_pred             ehhHHHHHHHHHCCCCCC
Confidence            999999999999988874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.5e-49  Score=377.53  Aligned_cols=208  Identities=22%  Similarity=0.276  Sum_probs=177.3

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCC-----CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC-cceEEEE
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLY  172 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~  172 (358)
                      ..+++..++|++.+.||+|+||+||+|.+..++     +.||||++....  .......+.+|+.+|..+.| ||||+++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            345788899999999999999999999987543     579999997653  34455678999999999976 8999999


Q ss_pred             EEeec-CCEEEEEEeecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 018275          173 YSFQD-AEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD  235 (358)
Q Consensus       173 ~~~~~-~~~~~lV~E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~  235 (358)
                      ++|.+ .+.+|||||||++|+|.++|...                ..+++..+..++.||+.||.|||+++||||||||+
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~  214 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  214 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence            99965 45789999999999999999652                34889999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccc
Q 018275          236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST  315 (358)
Q Consensus       236 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  315 (358)
                      |||++.++.+||+|||+|+.+.......                                               ...+.
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~-----------------------------------------------~~~~~  247 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYV-----------------------------------------------RKGDA  247 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSE-----------------------------------------------EETTE
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCce-----------------------------------------------eeccc
Confidence            9999999999999999998764322110                                               11245


Q ss_pred             cCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          316 VGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       316 ~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      +||+.|||||++.+..|+.++|||||||+||||+. +..+|
T Consensus       248 ~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             cccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            79999999999999999999999999999999996 66555

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.1e-48  Score=371.28  Aligned_cols=222  Identities=24%  Similarity=0.331  Sum_probs=170.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~  180 (358)
                      .++|++.+.||+|+||+||+|.++   .+++.||||++.+..     ....+.+|+.+|..+ +|||||+++++|.+.++
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            378999999999999999999875   357899999986542     234577899999988 69999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-CcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~vkl~DFGla~~~~~~  259 (358)
                      +|+||||++||+|.+++   +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus        95 ~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            99999999999999998   358999999999999999999999999999999999999887 89999999999876533


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~Di  338 (358)
                      ..........   ...      ....            ..........++....+.+|||.|||||++.+. .|+.++||
T Consensus       172 ~~~~~~~~~~---~~~------~~~~------------~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di  230 (361)
T 4f9c_A          172 KIELLKFVQS---EAQ------QERC------------SQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM  230 (361)
T ss_dssp             SCGGGGGC-----------------------------------------------CCCCGGGCCHHHHTTCSCCCTHHHH
T ss_pred             cccccccccc---ccc------cccc------------ccccccccccccccccccccCccccCHHHHcCCCCCCCccch
Confidence            2211110000   000      0000            000000011123334567999999999999876 59999999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      ||+||++||||+|..+|
T Consensus       231 WSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          231 WSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             HHHHHHHHHHHHTCSSS
T ss_pred             hhhHHHHHHHHHCCCCC
Confidence            99999999999998765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.9e-48  Score=388.93  Aligned_cols=199  Identities=28%  Similarity=0.430  Sum_probs=179.5

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++++.||+|+||.||+|.++.+|+.||||++....   ....+.+.+|+.+|+.++|||||+++++|.+...+|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999997653   33456688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC--CcEEEEecCCCccCCCCCC
Q 018275          185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~--~~vkl~DFGla~~~~~~~~  261 (358)
                      ||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+|+.+.... 
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            999999999999864 4689999999999999999999999999999999999999854  899999999998764221 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                       ...+.+|||.|||||++.+.+|+.++|||||
T Consensus       312 -------------------------------------------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSl  342 (573)
T 3uto_A          312 -------------------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV  342 (573)
T ss_dssp             -------------------------------------------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred             -------------------------------------------------ceeeeEECccccCHHHhCCCCCCcHHHHHHH
Confidence                                                             1225689999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||+|||||++..+|.
T Consensus       343 Gvilyeml~G~~Pf~  357 (573)
T 3uto_A          343 GVLSYILLSGLSPFG  357 (573)
T ss_dssp             HHHHHHHHHSCCSSC
T ss_pred             HHHHHHHHHCCCCCC
Confidence            999999999987763

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.7e-48  Score=362.28  Aligned_cols=198  Identities=24%  Similarity=0.246  Sum_probs=159.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC----EE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----YL  181 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~----~~  181 (358)
                      .+|.+.+.||+|+||+||+|.+  +|+.||||++.....    .......|+..+..++|||||+++++|.+++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4588899999999999999976  588999999976531    1112334555667889999999999997653    68


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      |||||||++|+|.+++.. .++++..+..++.|++.||.|||+.        +||||||||+||||+.++.+||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999999965 5688889999999999999999977        9999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC---
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK---  330 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~---  330 (358)
                      +..........                                             ....+.+||+.|||||++.+.   
T Consensus       156 ~~~~~~~~~~~---------------------------------------------~~~~~~~GT~~ymAPE~l~~~~~~  190 (303)
T 3hmm_A          156 VRHDSATDTID---------------------------------------------IAPNHRVGTKRYMAPEVLDDSINM  190 (303)
T ss_dssp             EEEETTTTEES---------------------------------------------CC-----CCGGGCCHHHHTTCSCT
T ss_pred             ccccCCCCcee---------------------------------------------eecccccccccccCHHHhcccccc
Confidence            87643221110                                             011245899999999999865   


Q ss_pred             ---CCCccchhhhhhHHHHhhccccccc
Q 018275          331 ---GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       331 ---~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                         .|+.++|||||||+||||+++..++
T Consensus       191 ~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          191 KHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             TCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             cCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence               3778999999999999999876543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7e-46  Score=351.04  Aligned_cols=204  Identities=38%  Similarity=0.651  Sum_probs=185.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++++.||+|+||.||+|.++.+|+.||||++++...........+.+|+.+++.++||||++++++|.+.+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            45689999999999999999999999999999999998876555666778899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....... 
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-  160 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999975431110 


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                      ...+.+||+.|+|||++.+.+|+.++||||||
T Consensus       161 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  192 (337)
T 1o6l_A          161 ------------------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG  192 (337)
T ss_dssp             ------------------------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHH
T ss_pred             ------------------------------------------------cccccccChhhCChhhhcCCCCCchhhcccch
Confidence                                                            11245899999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|||+++..+|
T Consensus       193 ~il~ell~g~~Pf  205 (337)
T 1o6l_A          193 VVMYEMMCGRLPF  205 (337)
T ss_dssp             HHHHHHHHSSCSS
T ss_pred             hHHHHHhcCCCCC
Confidence            9999999988766

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=354.42  Aligned_cols=206  Identities=35%  Similarity=0.650  Sum_probs=181.2

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~  180 (358)
                      .+..++|++++.||+|+||.||+|.++.+++.||||++++...........+..|..++..+ +||||++++++|.+.+.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            45678999999999999999999999999999999999987655666777888999999988 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+......
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999997543111


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                                                                       ....+.+||+.|+|||++.+..|+.++||||
T Consensus       179 -------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  209 (353)
T 3txo_A          179 -------------------------------------------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWA  209 (353)
T ss_dssp             --------------------------------------------------------CCGGGCCHHHHHHHHCTTHHHHHH
T ss_pred             -------------------------------------------------ccccccCCCcCeEChhhcCCCCcCCccCCCc
Confidence                                                             0112458999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       210 lG~il~ell~G~~Pf~  225 (353)
T 3txo_A          210 MGVLLYEMLCGHAPFE  225 (353)
T ss_dssp             HHHHHHHHHHSSCSSC
T ss_pred             chHHHHHHHhCCCCCC
Confidence            9999999999887764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1e-45  Score=356.98  Aligned_cols=206  Identities=36%  Similarity=0.623  Sum_probs=182.8

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~  180 (358)
                      .+..++|++++.||+|+||.||+|.++.+++.||||++++...........+..|..++..+ +|||||+++++|++...
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            45668999999999999999999999999999999999887655555566788899999887 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++||+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+......
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999997532111


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                                                                       ....+.+||+.|+|||++.+.+|+.++||||
T Consensus       208 -------------------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diws  238 (396)
T 4dc2_A          208 -------------------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWA  238 (396)
T ss_dssp             -------------------------------------------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred             -------------------------------------------------CccccccCCcccCCchhhcCCCCChHHHHHH
Confidence                                                             0122458999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       239 lGvllyell~G~~Pf~  254 (396)
T 4dc2_A          239 LGVLMFEMMAGRSPFD  254 (396)
T ss_dssp             HHHHHHHHHHSSCSST
T ss_pred             HHHHHHHHHhCCCCCc
Confidence            9999999999988773

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.2e-46  Score=358.96  Aligned_cols=211  Identities=43%  Similarity=0.814  Sum_probs=185.7

Q ss_pred             HhhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275           97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus        97 ~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      .+....+..++|.+++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++|||||+++++|.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            34445677899999999999999999999999999999999998765544555556889999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      +...+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            99999999999999999999864 57899999999999999999999999999999999999999999999999999866


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC----C
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG----Y  332 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~----y  332 (358)
                      .....                                                ....+.+||+.|+|||++.+.+    |
T Consensus       219 ~~~~~------------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~  250 (410)
T 3v8s_A          219 NKEGM------------------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYY  250 (410)
T ss_dssp             CTTSE------------------------------------------------EECCSCCSCGGGCCHHHHHTTTTTCEE
T ss_pred             ccCCc------------------------------------------------ccccCCcCCccccCHHHhhccCCCcCC
Confidence            42211                                                0122458999999999998776    8


Q ss_pred             CccchhhhhhHHHHhhcccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +.++|||||||+||||+++..+|.
T Consensus       251 ~~~~DiwSlGvilyell~G~~Pf~  274 (410)
T 3v8s_A          251 GRECDWWSVGVFLYEMLVGDTPFY  274 (410)
T ss_dssp             ETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCcceEecchHHHHHHHhCCCCCC
Confidence            899999999999999999887763

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=357.99  Aligned_cols=213  Identities=46%  Similarity=0.828  Sum_probs=187.8

Q ss_pred             hHhhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275           96 MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus        96 ~~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      .++....+..++|++++.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.++..++||||++++++|
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            44555677789999999999999999999999999999999999876554555566688999999999999999999999


Q ss_pred             ecCCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          176 QDAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                      ++.+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence            9999999999999999999999775 489999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc------
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------  328 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~------  328 (358)
                      .+......                                                ...+.+||+.|+|||++.      
T Consensus       211 ~~~~~~~~------------------------------------------------~~~~~~Gt~~Y~APE~l~~~~~~~  242 (412)
T 2vd5_A          211 KLRADGTV------------------------------------------------RSLVAVGTPDYLSPEILQAVGGGP  242 (412)
T ss_dssp             ECCTTSCE------------------------------------------------ECSSCCSCGGGCCHHHHHHHHTCT
T ss_pred             eccCCCcc------------------------------------------------ccceeccccCcCCHHHHhhcccCc
Confidence            66422110                                                112458999999999998      


Q ss_pred             -CCCCCccchhhhhhHHHHhhcccccccc
Q 018275          329 -KKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       329 -~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                       +..|+.++|||||||++|||+++..+|.
T Consensus       243 ~~~~~~~~~DiwSlGvilyelltG~~Pf~  271 (412)
T 2vd5_A          243 GTGSYGPECDWWALGVFAYEMFYGQTPFY  271 (412)
T ss_dssp             TCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence             4679999999999999999999887763

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.4e-45  Score=360.37  Aligned_cols=212  Identities=45%  Similarity=0.804  Sum_probs=186.5

Q ss_pred             HhhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275           97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus        97 ~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      .+....+..++|++++.||+|+||+||+|.++.+++.||||++.+...........+.+|+.++..++|||||+++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34455677799999999999999999999999999999999998765544555556889999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      +.+.+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+.
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            99999999999999999999977 57899999999999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----CC
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KK  330 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----~~  330 (358)
                      +......                                                .....+||+.|||||++.     +.
T Consensus       225 ~~~~~~~------------------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~  256 (437)
T 4aw2_A          225 LMEDGTV------------------------------------------------QSSVAVGTPDYISPEILQAMEGGKG  256 (437)
T ss_dssp             CCTTSCE------------------------------------------------ECCSCCSCGGGCCHHHHHHHHTSCC
T ss_pred             cccCCCc------------------------------------------------ccccccCCcCeeChHHHhhcccCCC
Confidence            5422110                                                111358999999999997     56


Q ss_pred             CCCccchhhhhhHHHHhhcccccccc
Q 018275          331 GYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .|+.++|||||||++|||+++..+|.
T Consensus       257 ~~~~~~DvwSlGvil~elltG~~Pf~  282 (437)
T 4aw2_A          257 RYGPECDWWSLGVCMYEMLYGETPFY  282 (437)
T ss_dssp             EECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence            79999999999999999999887763

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.1e-45  Score=347.73  Aligned_cols=206  Identities=34%  Similarity=0.613  Sum_probs=183.6

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~  180 (358)
                      .+..++|.+.+.||+|+||.||+|.++.+++.||||++++...........+..|..++..+ +||||++++++|++.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            45678999999999999999999999999999999999887655556667788899999887 99999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999997543111


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .                                                 ...+.+||+.|+|||++.+.+|+.++||||
T Consensus       173 ~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  203 (345)
T 1xjd_A          173 A-------------------------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWS  203 (345)
T ss_dssp             C-------------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred             C-------------------------------------------------cccCCCCCcccCChhhhcCCCCCChhhhHH
Confidence            0                                                 112458999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       204 lG~il~ell~g~~Pf~  219 (345)
T 1xjd_A          204 FGVLLYEMLIGQSPFH  219 (345)
T ss_dssp             HHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHhcCCCCCC
Confidence            9999999999887663

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-45  Score=344.06  Aligned_cols=201  Identities=39%  Similarity=0.713  Sum_probs=184.3

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++++.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.+++.++||||++++++|.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            45688999999999999999999999999999999998876555566777889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....   
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999764311   


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ..+.+||+.|+|||++.+.+|+.++||||||
T Consensus       160 -------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  190 (318)
T 1fot_A          160 -------------------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFG  190 (318)
T ss_dssp             -------------------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHH
T ss_pred             -------------------------------------------------cccccCCccccCHhHhcCCCCCcccchhhhH
Confidence                                                             1145799999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|||+++..+|
T Consensus       191 ~il~ell~g~~pf  203 (318)
T 1fot_A          191 ILIYEMLAGYTPF  203 (318)
T ss_dssp             HHHHHHHHSSCTT
T ss_pred             HHHHHHHhCCCCC
Confidence            9999999987766

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.6e-45  Score=346.52  Aligned_cols=206  Identities=36%  Similarity=0.615  Sum_probs=185.9

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~  180 (358)
                      .+..++|.+++.||+|+||.||+|.++.+++.||||++.+...........+..|..++..+ +|||||+++++|.+...
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            45568999999999999999999999999999999999887655666677888999999987 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+......
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999997542111


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .                                                 ...+.+||+.|+|||++.+..|+.++||||
T Consensus       165 ~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  195 (345)
T 3a8x_A          165 D-------------------------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWA  195 (345)
T ss_dssp             C-------------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred             C-------------------------------------------------cccccCCCccccCccccCCCCCChHHhHHH
Confidence            0                                                 112458999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       196 lG~il~ell~g~~pf~  211 (345)
T 3a8x_A          196 LGVLMFEMMAGRSPFD  211 (345)
T ss_dssp             HHHHHHHHHHSSCTTT
T ss_pred             HHHHHHHHHhCCCCcC
Confidence            9999999999887763

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.7e-45  Score=348.17  Aligned_cols=206  Identities=33%  Similarity=0.586  Sum_probs=183.8

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~  180 (358)
                      .+..++|.+++.||+|+||.||+|.++.+++.||||++.+...........+..|..++..+ +||+|++++++|++.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            45678999999999999999999999999999999999887655556677788999999887 89999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+......
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999997543111


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .                                                 ...+.+||+.|+|||++.+.+|+.++||||
T Consensus       176 ~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  206 (353)
T 2i0e_A          176 V-------------------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWA  206 (353)
T ss_dssp             C-------------------------------------------------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHH
T ss_pred             c-------------------------------------------------ccccccCCccccChhhhcCCCcCCcccccc
Confidence            0                                                 112458999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       207 lG~il~ell~G~~Pf~  222 (353)
T 2i0e_A          207 FGVLLYEMLAGQAPFE  222 (353)
T ss_dssp             HHHHHHHHHHSSCSSC
T ss_pred             hHHHHHHHHcCCCCCC
Confidence            9999999999887663

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5e-45  Score=350.89  Aligned_cols=206  Identities=30%  Similarity=0.595  Sum_probs=186.7

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|.+++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++|||||+++++|.+...
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            45667899999999999999999999999999999999988766666677889999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++||+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.+....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999998654211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCccch
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECD  337 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~~~D  337 (358)
                                                                        ...+.+||+.|+|||++.   +.+|+.++|
T Consensus       170 --------------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~D  199 (384)
T 4fr4_A          170 --------------------------------------------------QITTMAGTKPYMAPEMFSSRKGAGYSFAVD  199 (384)
T ss_dssp             --------------------------------------------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHH
T ss_pred             --------------------------------------------------ceeccCCCccccCCeeeccCCCCCCCccce
Confidence                                                              112458999999999997   456999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|||+++..+|.
T Consensus       200 iwSlG~il~elltG~~Pf~  218 (384)
T 4fr4_A          200 WWSLGVTAYELLRGRRPYH  218 (384)
T ss_dssp             HHHHHHHHHHHHHSSCSSC
T ss_pred             eechHHHHHHHHhCCCCCC
Confidence            9999999999999887764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-44  Score=344.87  Aligned_cols=204  Identities=39%  Similarity=0.672  Sum_probs=186.4

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      .....++|.+++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||++++++|.+...
T Consensus        36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            34566899999999999999999999999999999999988765555667788999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999999865311 


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                                                                         ..+.+||+.|+|||++.+.+|+.++||||
T Consensus       195 ---------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diws  223 (350)
T 1rdq_E          195 ---------------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWA  223 (350)
T ss_dssp             ---------------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHH
T ss_pred             ---------------------------------------------------cccccCCccccCHHHhcCCCCCCcCCEec
Confidence                                                               11447999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       224 lG~il~ell~g~~Pf~  239 (350)
T 1rdq_E          224 LGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             HHHHHHHHHHSSCSSC
T ss_pred             ccHhHhHHhhCCCCCC
Confidence            9999999999877663

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-44  Score=338.40  Aligned_cols=204  Identities=29%  Similarity=0.451  Sum_probs=182.9

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ....++|.+++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            4456899999999999999999999999999999999987643 345566788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||+++|+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++...... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            9999999999999999888999999999999999999999999999999999999999999999999999997553211 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC-ccchhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG-MECDWLA  340 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~-~~~DiwS  340 (358)
                                                                       .....+||+.|+|||++.+..|+ .++||||
T Consensus       169 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws  199 (328)
T 3fe3_A          169 -------------------------------------------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWS  199 (328)
T ss_dssp             -------------------------------------------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHH
T ss_pred             -------------------------------------------------ccccccCCcceeCcccccCCCcCCchhhhhh
Confidence                                                             01134799999999999998876 7899999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|+|+++..+|.
T Consensus       200 lG~il~ell~g~~pf~  215 (328)
T 3fe3_A          200 LGVILYTLVSGSLPFD  215 (328)
T ss_dssp             HHHHHHHHHHSSCSSC
T ss_pred             hHHHHHHHHhCCCCCC
Confidence            9999999999887764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.6e-45  Score=348.94  Aligned_cols=205  Identities=38%  Similarity=0.657  Sum_probs=173.9

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHH-HHHhcCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~h~~iv~l~~~~~~~~~  180 (358)
                      .+..++|++++.||+|+||.||+|.++.+++.||||++.+...........+..|..+ ++.++|||||+++++|++.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            4556899999999999999999999999999999999988765555555667777776 577899999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999997532111


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                                                                       ....+.+||+.|+|||++.+.+|+.++||||
T Consensus       194 -------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  224 (373)
T 2r5t_A          194 -------------------------------------------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWC  224 (373)
T ss_dssp             -------------------------------------------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHH
T ss_pred             -------------------------------------------------CccccccCCccccCHHHhCCCCCCchhhhHH
Confidence                                                             0122458999999999999999999999999


Q ss_pred             hhHHHHhhccccccc
Q 018275          341 YWNETLSCNYLSDIM  355 (358)
Q Consensus       341 lGvil~e~l~~~~~~  355 (358)
                      |||++|||+++...|
T Consensus       225 lG~il~ell~G~~Pf  239 (373)
T 2r5t_A          225 LGAVLYEMLYGLPPF  239 (373)
T ss_dssp             HHHHHHHHHHSSCTT
T ss_pred             HHHHHHHHHcCCCCC
Confidence            999999999988766

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.8e-44  Score=329.85  Aligned_cols=207  Identities=22%  Similarity=0.308  Sum_probs=180.7

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .+..++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++.+.+..
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            34458899999999999999999999999999999998765444556667789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||++|++|.+++....++++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999986542210


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      .                                                .....+||+.|+|||++.+..++.++|||||
T Consensus       167 ~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  198 (294)
T 4eqm_A          167 T------------------------------------------------QTNHVLGTVQYFSPEQAKGEATDECTDIYSI  198 (294)
T ss_dssp             --------------------------------------------------------CCSSCCHHHHHTCCCCTTHHHHHH
T ss_pred             c------------------------------------------------ccCccccCccccCHhHhcCCCCCchHhHHHH
Confidence            0                                                0113479999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|+|+++..+|.
T Consensus       199 G~~l~~ll~g~~pf~  213 (294)
T 4eqm_A          199 GIVLYEMLVGEPPFN  213 (294)
T ss_dssp             HHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHhCCCCCC
Confidence            999999999887763

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.7e-44  Score=357.36  Aligned_cols=208  Identities=30%  Similarity=0.542  Sum_probs=186.8

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ....+..++|.+.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++|||||+++++|.+.
T Consensus       177 ~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             HTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            44567789999999999999999999999999999999999887655556667788999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      +.+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999999999997654  4999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      ....                                                  ...+.+||+.|+|||++.+.+|+.++
T Consensus       337 ~~~~--------------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~~~  366 (576)
T 2acx_A          337 PEGQ--------------------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSP  366 (576)
T ss_dssp             CTTC--------------------------------------------------CEECCCSCGGGCCHHHHTTCEESSHH
T ss_pred             ccCc--------------------------------------------------cccccCCCccccCHHHHcCCCCCccc
Confidence            3211                                                  01134899999999999999999999


Q ss_pred             hhhhhhHHHHhhcccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~~  356 (358)
                      |||||||++|||+++..+|.
T Consensus       367 DiwSLGvilyeLltG~~PF~  386 (576)
T 2acx_A          367 DWWALGCLLYEMIAGQSPFQ  386 (576)
T ss_dssp             HHHHHHHHHHHHHHSSCSSS
T ss_pred             hHHHHHHHHHHHHhCCCCCc
Confidence            99999999999999887764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-43  Score=354.44  Aligned_cols=207  Identities=35%  Similarity=0.558  Sum_probs=186.0

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|.+.+.||+|+||.||+|.++.+|+.||||++.+...........+..|+.+++.++|||||+++++|.+...
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            55677999999999999999999999999999999999988765555667788999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      +|+||||++||+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999999998653    46999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      .....                                                 ...+.+||+.|+|||++.+.+|+.++
T Consensus       340 ~~~~~-------------------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~  370 (543)
T 3c4z_A          340 KAGQT-------------------------------------------------KTKGYAGTPGFMAPELLLGEEYDFSV  370 (543)
T ss_dssp             CTTCC-------------------------------------------------CBCCCCSCTTTSCHHHHTTCCBCTHH
T ss_pred             cCCCc-------------------------------------------------ccccccCCccccChhhhcCCCCChHH
Confidence            42210                                                 01134899999999999999999999


Q ss_pred             hhhhhhHHHHhhcccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~~  356 (358)
                      |||||||++|||+++..+|.
T Consensus       371 DiwSlGvilyelltG~~PF~  390 (543)
T 3c4z_A          371 DYFALGVTLYEMIAARGPFR  390 (543)
T ss_dssp             HHHHHHHHHHHHHHSSCSSC
T ss_pred             hcCcchHHHHHHHhCCCCCC
Confidence            99999999999999887763

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-43  Score=336.94  Aligned_cols=202  Identities=29%  Similarity=0.445  Sum_probs=180.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc---hhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS---RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .+.|.+.+.||+|+||.||+|.++.+|..||+|++.+.....   ....+.+.+|+.+++.++||||++++++|.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            478999999999999999999999999999999998754321   12346688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC----cEEEEecCCCccCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLD  257 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~vkl~DFGla~~~~  257 (358)
                      |+||||++||+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++    .+||+|||+++.+.
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999998888999999999999999999999999999999999999998877    79999999998654


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ...                                                  ...+.+|||.|+|||++.+.+|+.++|
T Consensus       171 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D  200 (361)
T 2yab_A          171 DGV--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEAD  200 (361)
T ss_dssp             TTC--------------------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred             CCC--------------------------------------------------ccccCCCCccEECchHHcCCCCCcccc
Confidence            211                                                  011347999999999999999999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|+|+++..+|.
T Consensus       201 iwslGvil~~ll~g~~Pf~  219 (361)
T 2yab_A          201 MWSIGVITYILLSGASPFL  219 (361)
T ss_dssp             HHHHHHHHHHHHHSCCSSC
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999887763

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.3e-43  Score=325.17  Aligned_cols=200  Identities=27%  Similarity=0.428  Sum_probs=178.1

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.+++.++||||++++++|.+.+..|
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence            34578999999999999999999999999999999997654   233456889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||+++|+|.+++... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus        94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            999999999999999654 6899999999999999999999999999999999999999999999999999765422110


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ....+||+.|+|||++.+..|+.++||||||
T Consensus       173 -------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  203 (297)
T 3fxz_A          173 -------------------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG  203 (297)
T ss_dssp             -------------------------------------------------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHH
T ss_pred             -------------------------------------------------cCCccCCcCccChhhhcCCCCCcHHHHHHHH
Confidence                                                             1134799999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|||+++..+|
T Consensus       204 ~il~ell~g~~pf  216 (297)
T 3fxz_A          204 IMAIEMIEGEPPY  216 (297)
T ss_dssp             HHHHHHHHSSCTT
T ss_pred             HHHHHHHhCCCCC
Confidence            9999999988766

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.5e-43  Score=332.39  Aligned_cols=203  Identities=29%  Similarity=0.449  Sum_probs=180.8

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+...++
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34589999999999999999999999999999999998765444444566889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||+ +|+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......  
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--  162 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--  162 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence            999999 78999999888899999999999999999999999999999999999999999999999999997653211  


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-Cccchhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAY  341 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-~~~~DiwSl  341 (358)
                                                                      ...+.+||+.|+|||++.+..| +.++|||||
T Consensus       163 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  194 (336)
T 3h4j_B          163 ------------------------------------------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC  194 (336)
T ss_dssp             ------------------------------------------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred             ------------------------------------------------ccccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence                                                            1114479999999999998887 689999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|+|+++..+|.
T Consensus       195 G~il~~ll~g~~Pf~  209 (336)
T 3h4j_B          195 GIVLYVMLVGRLPFD  209 (336)
T ss_dssp             HHHHHHHHHSSCSSB
T ss_pred             HHHHHHHHhCCCCCC
Confidence            999999999887764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-43  Score=347.86  Aligned_cols=206  Identities=37%  Similarity=0.645  Sum_probs=174.2

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||++++++|.+.+.
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            44567899999999999999999999999999999999987755555666778889999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      +|+||||+++|+|.+++.....+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+|+.....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999999999888899999999999999999999998 99999999999999999999999999999754311


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ..                                                 ...+.+||+.|+|||++.+..|+.++|||
T Consensus       303 ~~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  333 (446)
T 4ejn_A          303 GA-------------------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWW  333 (446)
T ss_dssp             -----------------------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHH
T ss_pred             Cc-------------------------------------------------ccccccCCccccCHhhcCCCCCCCccchh
Confidence            10                                                 01145899999999999999999999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      ||||++|||+++..+|
T Consensus       334 slG~il~ell~g~~Pf  349 (446)
T 4ejn_A          334 GLGVVMYEMMCGRLPF  349 (446)
T ss_dssp             HHHHHHHHHHHSSCSS
T ss_pred             hhHHHHHHHhhCCCCC
Confidence            9999999999987766

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.1e-43  Score=361.24  Aligned_cols=206  Identities=33%  Similarity=0.586  Sum_probs=184.0

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~  180 (358)
                      .+..++|.+++.||+|+||.||+|.++.+++.||||++++...........+..|..++..+ +||+|+.++++|++.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            45678999999999999999999999999999999999987655566677788899999887 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +||||||++||+|..++...+.+++..++.++.||+.||.|||+.||+||||||+||||+.++++||+|||+|+......
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999998543211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .                                                 ...+.+||+.|||||++.+.+|+.++||||
T Consensus       497 ~-------------------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwS  527 (674)
T 3pfq_A          497 V-------------------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWA  527 (674)
T ss_dssp             C-------------------------------------------------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHH
T ss_pred             c-------------------------------------------------ccccccCCCcccCHhhhcCCCCCccceEec
Confidence            1                                                 112458999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||+||||+++..+|.
T Consensus       528 lGvilyelltG~~Pf~  543 (674)
T 3pfq_A          528 FGVLLYEMLAGQAPFE  543 (674)
T ss_dssp             HHHHHHHHHHSSCSSC
T ss_pred             hHHHHHHHHcCCCCCC
Confidence            9999999999887764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.4e-43  Score=332.67  Aligned_cols=199  Identities=29%  Similarity=0.457  Sum_probs=178.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++|||||+++++|.+.+..|+||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            679999999999999999999999999999999986543 3445667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC---cEEEEecCCCccCCCCCCc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~vkl~DFGla~~~~~~~~~  262 (358)
                      ||+++|+|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++   .+||+|||++........ 
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~-  186 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-  186 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS-
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc-
Confidence            9999999999998888999999999999999999999999999999999999998654   599999999976542110 


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ....+||+.|+|||++.+..|+.++||||||
T Consensus       187 -------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  217 (362)
T 2bdw_A          187 -------------------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACG  217 (362)
T ss_dssp             -------------------------------------------------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHH
T ss_pred             -------------------------------------------------cccCCCCccccCHHHHccCCCCchhhHHHHH
Confidence                                                             1134799999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|+|+++..+|
T Consensus       218 ~il~~ll~g~~Pf  230 (362)
T 2bdw_A          218 VILYILLVGYPPF  230 (362)
T ss_dssp             HHHHHHHHSSCSS
T ss_pred             HHHHHHHHCCCCC
Confidence            9999999987765

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.8e-43  Score=328.48  Aligned_cols=207  Identities=37%  Similarity=0.664  Sum_probs=171.9

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhh-chhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEML-SRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      ..+..++|++.+.||+|+||.||+|.+.   .+++.||+|++.+.... .......+.+|+.+++.++||||++++++|.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            3456689999999999999999999885   68999999999865422 2234456788999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      +.+.+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      ....                                                 ......+||+.|+|||++.+..|+.++
T Consensus       172 ~~~~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~  202 (327)
T 3a62_A          172 IHDG-------------------------------------------------TVTHTFCGTIEYMAPEILMRSGHNRAV  202 (327)
T ss_dssp             --------------------------------------------------------CTTSSCCTTSCHHHHTTSCCCTHH
T ss_pred             ccCC-------------------------------------------------ccccccCCCcCccCHhhCcCCCCCCcc
Confidence            2111                                                 011245799999999999999999999


Q ss_pred             hhhhhhHHHHhhcccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~~  356 (358)
                      |||||||++|||+++..+|.
T Consensus       203 DiwslG~il~el~~g~~pf~  222 (327)
T 3a62_A          203 DWWSLGALMYDMLTGAPPFT  222 (327)
T ss_dssp             HHHHHHHHHHHHHHSSCSCC
T ss_pred             cchhHHHHHHHHHHCCCCCC
Confidence            99999999999999887663

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=323.35  Aligned_cols=215  Identities=19%  Similarity=0.316  Sum_probs=179.7

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|.+.+.||+|+||.||+|.+..++..||+|++...   .......+.+|+.+++.++||||+++++++.+....+
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            4568999999999999999999999999999999988653   3455667899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      +||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999987 56799999999999999999999999999999999999999999999999999987653321


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      .....                                   ............+.+||+.|+|||++.+..|+.++|||||
T Consensus       164 ~~~~~-----------------------------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  208 (310)
T 3s95_A          164 QPEGL-----------------------------------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF  208 (310)
T ss_dssp             ---------------------------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             ccccc-----------------------------------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence            11000                                   0000111222345689999999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|||+.+...+
T Consensus       209 G~~l~el~~g~~~~  222 (310)
T 3s95_A          209 GIVLCEIIGRVNAD  222 (310)
T ss_dssp             HHHHHHHHHTCCSS
T ss_pred             HHHHHHHhcCCCCC
Confidence            99999999876554

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=340.54  Aligned_cols=200  Identities=28%  Similarity=0.441  Sum_probs=177.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++|||||+++++|.+.+..|+||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            679999999999999999999999999999999976543 3344566889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc---CCCcEEEEecCCCccCCCCCCc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~---~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||++||+|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||+|+....... 
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-  168 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-  168 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-
Confidence            9999999999999889999999999999999999999999999999999999998   468899999999976542211 


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                      ...+.+||+.|+|||++.+..|+.++||||||
T Consensus       169 ------------------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlG  200 (444)
T 3soa_A          169 ------------------------------------------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG  200 (444)
T ss_dssp             ------------------------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred             ------------------------------------------------eeecccCCcccCCHHHhcCCCCCCccccHHHH
Confidence                                                            01134799999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|+|+++..+|
T Consensus       201 vilyell~G~~Pf  213 (444)
T 3soa_A          201 VILYILLVGYPPF  213 (444)
T ss_dssp             HHHHHHHHSSCSC
T ss_pred             HHHHHHHhCCCCC
Confidence            9999999988766

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=325.75  Aligned_cols=202  Identities=29%  Similarity=0.444  Sum_probs=179.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc---hhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS---RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .++|.+.+.||+|+||.||+|.+..++..||+|++.......   ....+.+.+|+.+++.++||||++++++|.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            367999999999999999999999999999999997653221   12356688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC----cEEEEecCCCccCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLD  257 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~vkl~DFGla~~~~  257 (358)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++    .+||+|||+++...
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999998888999999999999999999999999999999999999999887    89999999998664


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ....                                                  ....+||+.|+|||++.+..|+.++|
T Consensus       170 ~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~D  199 (326)
T 2y0a_A          170 FGNE--------------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEAD  199 (326)
T ss_dssp             TTSC--------------------------------------------------CCCCCSCTTTCCHHHHTTCCCCTHHH
T ss_pred             CCCc--------------------------------------------------cccccCCcCcCCceeecCCCCCcHHH
Confidence            2110                                                  11347999999999999999999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|+|+++..+|.
T Consensus       200 iwslG~il~~ll~g~~pf~  218 (326)
T 2y0a_A          200 MWSIGVITYILLSGASPFL  218 (326)
T ss_dssp             HHHHHHHHHHHHHSCCSSC
T ss_pred             HHHHHHHHHHHHHCcCCCC
Confidence            9999999999999887663

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=331.44  Aligned_cols=202  Identities=18%  Similarity=0.283  Sum_probs=171.2

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEE-----EEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc---CcceEEEEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLC-----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVKLYY  173 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~-----~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---h~~iv~l~~  173 (358)
                      .+..++|.+.+.||+|+||.||+|     .+..+++.||||++....      ...+..|..++..++   |+||+.+++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            345578999999999999999999     467789999999987542      234667777777776   899999999


Q ss_pred             EeecCCEEEEEEeecCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-------
Q 018275          174 SFQDAEYLYLIMEYLPGGDVMTLLMR-----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-------  241 (358)
Q Consensus       174 ~~~~~~~~~lV~E~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-------  241 (358)
                      ++...+..|+||||+++|+|.+++..     ...+++..+..++.|++.||.|||+.||+||||||+|||++.       
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999999974     467999999999999999999999999999999999999998       


Q ss_pred             ----CCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC
Q 018275          242 ----NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG  317 (358)
Q Consensus       242 ----~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g  317 (358)
                          ++.+||+|||+|+.+......                                               ....+.+|
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~-----------------------------------------------~~~~~~~g  247 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKG-----------------------------------------------TIFTAKCE  247 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTT-----------------------------------------------EEECCSSC
T ss_pred             cccccCCEEEeeCchhhhhhccCCC-----------------------------------------------ceeeeecC
Confidence                899999999999754311110                                               01124579


Q ss_pred             CCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          318 TPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       318 t~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      |+.|||||++.+..|+.++|||||||++|||+++..+|.
T Consensus       248 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             TTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             CCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence            999999999999999999999999999999999987763

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.3e-42  Score=319.35  Aligned_cols=199  Identities=24%  Similarity=0.373  Sum_probs=172.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            689999999999999999999999999999999976542 3444566889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||+++ ++.+.+. ....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......   
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---  156 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---  156 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS---
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc---
Confidence            99976 5555554 467899999999999999999999999999999999999999999999999999986542211   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC-CCccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~-y~~~~DiwSlGv  343 (358)
                                                                    .....+||+.|+|||++.+.. |+.++|||||||
T Consensus       157 ----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  190 (292)
T 3o0g_A          157 ----------------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC  190 (292)
T ss_dssp             ----------------------------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred             ----------------------------------------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHH
Confidence                                                          011347999999999998766 899999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|||+++...+
T Consensus       191 il~~l~~~~~p~  202 (292)
T 3o0g_A          191 IFAELANAGRPL  202 (292)
T ss_dssp             HHHHHTTTSCCS
T ss_pred             HHHHHHHcCCCC
Confidence            999999776553

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.9e-42  Score=329.04  Aligned_cols=201  Identities=28%  Similarity=0.477  Sum_probs=175.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc--hhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      +.|++.+.||+|+||.||+|.+..+++.||||++.......  ....+.+.+|+.+++.++|||||+++++|.+.+.+|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            67999999999999999999999999999999997654322  1245678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc---EEEEecCCCccC
Q 018275          184 IMEYLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPL  256 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~---vkl~DFGla~~~  256 (358)
                      ||||++|++|.+.+...    ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.   +||+|||+++..
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999998887543    35899999999999999999999999999999999999987655   999999999866


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      .....                                                 ...+.+||+.|+|||++.+..|+.++
T Consensus       184 ~~~~~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~  214 (351)
T 3c0i_A          184 GESGL-------------------------------------------------VAGGRVGTPHFMAPEVVKREPYGKPV  214 (351)
T ss_dssp             CTTSC-------------------------------------------------BCCCCCSCGGGCCHHHHTTCCBCTHH
T ss_pred             cCCCe-------------------------------------------------eecCCcCCcCccCHHHHcCCCCCchH
Confidence            42211                                                 01134799999999999999999999


Q ss_pred             hhhhhhHHHHhhccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~  355 (358)
                      |||||||++|+|+++..+|
T Consensus       215 DiwslG~il~~ll~g~~pf  233 (351)
T 3c0i_A          215 DVWGCGVILFILLSGCLPF  233 (351)
T ss_dssp             HHHHHHHHHHHHHHSSCSS
T ss_pred             hhHHHHHHHHHHHHCCCCC
Confidence            9999999999999987665

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.9e-43  Score=327.74  Aligned_cols=208  Identities=23%  Similarity=0.313  Sum_probs=175.3

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC---
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE---  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~---  179 (358)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++....   
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence            34588999999999999999999999999999999998765545566677899999999999999999999987543   


Q ss_pred             -EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 -~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                       ..|+||||++|++|.+++....++++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+..
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence             3599999999999999998888999999999999999999999999999999999999999999999999999986642


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .....                                              ......+||+.|+|||++.+..++.++||
T Consensus       169 ~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  202 (311)
T 3ork_A          169 SGNSV----------------------------------------------TQTAAVIGTAQYLSPEQARGDSVDARSDV  202 (311)
T ss_dssp             -----------------------------------------------------------CCTTCCHHHHHTCCCCHHHHH
T ss_pred             ccccc----------------------------------------------ccccccCcCcccCCHHHhcCCCCCchHhH
Confidence            21110                                              01123479999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||++|||+++..+|.
T Consensus       203 ~slG~~l~~ll~g~~pf~  220 (311)
T 3ork_A          203 YSLGCVLYEVLTGEPPFT  220 (311)
T ss_dssp             HHHHHHHHHHHHSSCSCC
T ss_pred             HHHHHHHHHHHhCCCCCC
Confidence            999999999999877663

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.9e-43  Score=327.64  Aligned_cols=203  Identities=27%  Similarity=0.420  Sum_probs=176.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4899999999999999999999999999999999875432  22335578899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....   
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  160 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---  160 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc---
Confidence            99999999999998888899999999999999999999999999999999999999999999999999976532111   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-CccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-~~~~DiwSlGv  343 (358)
                                                                  .......+||+.|+|||++.+..+ +.++|||||||
T Consensus       161 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  196 (323)
T 3tki_A          161 --------------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI  196 (323)
T ss_dssp             --------------------------------------------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHH
T ss_pred             --------------------------------------------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHH
Confidence                                                        011124579999999999998876 77899999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|+|+++..+|.
T Consensus       197 il~~ll~g~~pf~  209 (323)
T 3tki_A          197 VLTAMLAGELPWD  209 (323)
T ss_dssp             HHHHHHHSSCSCS
T ss_pred             HHHHHHhCCCCCC
Confidence            9999999887764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-42  Score=324.23  Aligned_cols=198  Identities=25%  Similarity=0.346  Sum_probs=177.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||+|+||.||+|.+..++..||+|++....    .....+.+|+.+++.++||||++++++|.+.+.+++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            478999999999999999999999999999999987542    3345588999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC--CCcEEEEecCCCccCCCCCC
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~--~~~vkl~DFGla~~~~~~~~  261 (358)
                      |||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.  ++.+||+|||+++.+.....
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            9999999999999765 47999999999999999999999999999999999999987  78999999999986642110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                        ....+|||.|+|||++.+..++.++|+|||
T Consensus       160 --------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  189 (321)
T 1tki_A          160 --------------------------------------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSL  189 (321)
T ss_dssp             --------------------------------------------------EEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred             --------------------------------------------------cccccCChhhcCcHHhcCCCCCchhhHHHH
Confidence                                                              113479999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|+|+++..+|.
T Consensus       190 G~il~~ll~g~~pf~  204 (321)
T 1tki_A          190 GTLVYVLLSGINPFL  204 (321)
T ss_dssp             HHHHHHHHHSSCTTC
T ss_pred             HHHHHHHHhCCCCCc
Confidence            999999999887663

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-42  Score=341.42  Aligned_cols=206  Identities=27%  Similarity=0.455  Sum_probs=185.0

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++.+...
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            45567999999999999999999999999999999999987755445556778999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||+++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999998654211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-Cccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-~~~~Diw  339 (358)
                                                                        ...+.+||+.|+|||++.+..| +.++|||
T Consensus       171 --------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  200 (476)
T 2y94_A          171 --------------------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIW  200 (476)
T ss_dssp             --------------------------------------------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHH
T ss_pred             --------------------------------------------------cccccCCCcCeEChhhccCCCCCCCcceeh
Confidence                                                              0113479999999999998876 6899999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||++|+|+++...|.
T Consensus       201 SlGvil~elltG~~Pf~  217 (476)
T 2y94_A          201 SSGVILYALLCGTLPFD  217 (476)
T ss_dssp             HHHHHHHHHHHSSCSSC
T ss_pred             hhHHHHHHHhhCCCCCC
Confidence            99999999999887663

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-42  Score=337.82  Aligned_cols=220  Identities=22%  Similarity=0.294  Sum_probs=161.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec-----CC
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-----AE  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~  179 (358)
                      .++|.+++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++|||||+++++|..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            488999999999999999999999999999999987542 234456678899999999999999999999943     35


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+|+||||+ +++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.....
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            799999998 5799999988888999999999999999999999999999999999999999999999999999877533


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHH--hhhhccccccccCCCCCchhhhh-cCCCCCccc
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHW--QINRRKLAYSTVGTPDYIAPEVL-LKKGYGMEC  336 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~gt~~Y~APEv~-~~~~y~~~~  336 (358)
                      .............                        ....+..+  .........+.+||+.|+|||++ .+..|+.++
T Consensus       210 ~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~  265 (458)
T 3rp9_A          210 ENGNSQLPISPRE------------------------DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI  265 (458)
T ss_dssp             TTCCCCCC---------------------------------------------------CCCTTCCHHHHTTCCCCCTHH
T ss_pred             cccccccccCccc------------------------cccccccccccccccccccCCcccccccChHHhhCCCCCCcHh
Confidence            2111100000000                        00000000  00111223466899999999987 466799999


Q ss_pred             hhhhhhHHHHhhcc
Q 018275          337 DWLAYWNETLSCNY  350 (358)
Q Consensus       337 DiwSlGvil~e~l~  350 (358)
                      ||||||||||||++
T Consensus       266 DiwSlG~il~ellt  279 (458)
T 3rp9_A          266 DVWSIGCIFAELLN  279 (458)
T ss_dssp             HHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHH
Confidence            99999999999997

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.3e-42  Score=314.24  Aligned_cols=205  Identities=30%  Similarity=0.451  Sum_probs=182.0

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||++++++|.+...
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            35667899999999999999999999999999999999987655445556678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      .++||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999885432111


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                                                                         ....+||+.|+|||++.+..++.++|+||
T Consensus       164 ---------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  192 (279)
T 3fdn_A          164 ---------------------------------------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWS  192 (279)
T ss_dssp             -------------------------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHH
T ss_pred             ---------------------------------------------------ccccCCCCCccCHhHhccCCCCccchhHh
Confidence                                                               11347999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      ||+++|+|+++...|.
T Consensus       193 lG~il~~l~~g~~p~~  208 (279)
T 3fdn_A          193 LGVLCYEFLVGKPPFE  208 (279)
T ss_dssp             HHHHHHHHHHSSCTTC
T ss_pred             HHHHHHHHHHCCCCCC
Confidence            9999999999877653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.5e-42  Score=328.21  Aligned_cols=211  Identities=18%  Similarity=0.296  Sum_probs=181.8

Q ss_pred             ccCCCceeeeeEeee--eeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          103 ISVDDFDLLTIIGRG--AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G--~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ...++|++++.||+|  +||.||+|.+..+++.||||++..... .......+.+|+.+++.++|||||+++++|.+.+.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            345889999999999  999999999999999999999987643 34566778899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      +|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999999775  6799999999999999999999999999999999999999999999999999875532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCccc
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMEC  336 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~~  336 (358)
                      .......                                          ........+||+.|+|||++.+  ..|+.++
T Consensus       181 ~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  218 (389)
T 3gni_B          181 HGQRQRV------------------------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS  218 (389)
T ss_dssp             TTEECSC------------------------------------------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHH
T ss_pred             ccccccc------------------------------------------cccccccccccccccCHHHHhccCCCCCcHh
Confidence            1110000                                          0001113479999999999988  6899999


Q ss_pred             hhhhhhHHHHhhcccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~~  356 (358)
                      |||||||++|||+++..+|.
T Consensus       219 DiwslG~il~el~~g~~pf~  238 (389)
T 3gni_B          219 DIYSVGITACELANGHVPFK  238 (389)
T ss_dssp             HHHHHHHHHHHHHHSSCTTT
T ss_pred             HHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999887763

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.5e-42  Score=319.37  Aligned_cols=205  Identities=25%  Similarity=0.349  Sum_probs=170.9

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ...+..++|.+.+.||+|+||.||+|.+  ++..||||++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            3456678999999999999999999975  578999999876542 3445567889999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          180 YLYLIMEYLPGGDVMTLLMREET---LTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                      ..++||||+++|+|.+++.....   +++..+..++.|++.||.|||+.|  |+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            99999999999999999976543   899999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCc
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM  334 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~  334 (358)
                      .......                                                 ...+.+||+.|+|||++.+..++.
T Consensus       188 ~~~~~~~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  218 (309)
T 3p86_A          188 LKASTFL-------------------------------------------------SSKSAAGTPEWMAPEVLRDEPSNE  218 (309)
T ss_dssp             ---------------------------------------------------------------CCTTSCHHHHTTCCCCT
T ss_pred             ccccccc-------------------------------------------------ccccCCCCccccChhhhcCCCCCc
Confidence            5431110                                                 011347999999999999999999


Q ss_pred             cchhhhhhHHHHhhcccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ++|||||||++|||+++..+|.
T Consensus       219 ~~DiwslG~il~elltg~~Pf~  240 (309)
T 3p86_A          219 KSDVYSFGVILWELATLQQPWG  240 (309)
T ss_dssp             THHHHHHHHHHHHHHHCCCTTT
T ss_pred             hhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999877653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.2e-42  Score=327.05  Aligned_cols=205  Identities=21%  Similarity=0.307  Sum_probs=175.7

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEec-------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYY  173 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~  173 (358)
                      .+..++|.+.+.||+|+||.||+|.+..       ++..||||+++...  .......+.+|+.+++.+ +|||||++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            4566899999999999999999998753       45579999997653  345567789999999999 8999999999


Q ss_pred             EeecCCEEEEEEeecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 018275          174 SFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL  237 (358)
Q Consensus       174 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NI  237 (358)
                      +|.+.+.+|+||||+++|+|.+++....                .++...+..++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999997643                478889999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC
Q 018275          238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG  317 (358)
Q Consensus       238 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g  317 (358)
                      |++.++.+||+|||+++.+.......                                               ......|
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~-----------------------------------------------~~~~~~~  267 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYK-----------------------------------------------KTTNGRL  267 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTC-----------------------------------------------TTTTTTS
T ss_pred             EECCCCCEEEccccCCcccCccccee-----------------------------------------------cccCCCc
Confidence            99999999999999998654221100                                               0112368


Q ss_pred             CCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          318 TPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       318 t~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      |+.|+|||++.+..|+.++|||||||++|||++ +...|
T Consensus       268 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             CGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            899999999999999999999999999999998 65554

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.8e-42  Score=327.02  Aligned_cols=199  Identities=30%  Similarity=0.418  Sum_probs=169.8

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|.+++.||+|+||.||+|.+..+++.||||++......    ...+.+|+.+++.++|||||++++++.+...+|+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            458999999999999999999999999999999999765322    2447789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc--EEEEecCCCccCCCCCC
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH--MKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~--vkl~DFGla~~~~~~~~  261 (358)
                      ||||+++|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+|+...... 
T Consensus        94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            9999999999999988889999999999999999999999999999999999999987765  9999999987432111 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc-chhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME-CDWLA  340 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~-~DiwS  340 (358)
                                                                       ...+.+||+.|+|||++.+..|+.+ +||||
T Consensus       173 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws  203 (361)
T 3uc3_A          173 -------------------------------------------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWS  203 (361)
T ss_dssp             ---------------------------------------------------------CTTSCHHHHHCSSCCHHHHHHHH
T ss_pred             -------------------------------------------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeeh
Confidence                                                             0113479999999999999888766 89999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|+|+++..+|.
T Consensus       204 lG~il~ell~g~~Pf~  219 (361)
T 3uc3_A          204 CGVTLYVMLVGAYPFE  219 (361)
T ss_dssp             HHHHHHHHHHSSCSCC
T ss_pred             hHHHHHHHHhCCCCCC
Confidence            9999999999887763

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=318.81  Aligned_cols=202  Identities=26%  Similarity=0.366  Sum_probs=175.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC--E
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE--Y  180 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~  180 (358)
                      +..++|.+.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.+++.++||||+++++++.+..  .
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            345789999999999999999999999999999999986543  233566789999999999999999999998655  7


Q ss_pred             EEEEEeecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE----cCCCcEEEEecCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLC  253 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl----~~~~~vkl~DFGla  253 (358)
                      .|+||||+++++|.+++....   .+++..+..++.|++.||.|||+.||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            899999999999999997643   38999999999999999999999999999999999999    88889999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----  328 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----  328 (358)
                      +.......                                                  ..+.+||+.|+|||++.     
T Consensus       164 ~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~  193 (319)
T 4euu_A          164 RELEDDEQ--------------------------------------------------FVSLYGTEEYLHPDMYERAVLR  193 (319)
T ss_dssp             EECCTTCC--------------------------------------------------BCCCCSCGGGCCHHHHHHHTSC
T ss_pred             eecCCCCc--------------------------------------------------eeecccCCCccCHHHhhhcccc
Confidence            86642211                                                  11347999999999997     


Q ss_pred             ---CCCCCccchhhhhhHHHHhhcccccccc
Q 018275          329 ---KKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       329 ---~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                         +..|+.++|||||||++|||+++..+|.
T Consensus       194 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~  224 (319)
T 4euu_A          194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFR  224 (319)
T ss_dssp             CCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred             ccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence               5789999999999999999999887763

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=327.60  Aligned_cols=199  Identities=26%  Similarity=0.434  Sum_probs=176.2

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+++.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++|||||+++++|.+...+++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999987653   22345688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC--CCcEEEEecCCCccCCCCCC
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~--~~~vkl~DFGla~~~~~~~~  261 (358)
                      |||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.  ++.+||+|||+++.+.....
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            9999999999999765 47999999999999999999999999999999999999974  47899999999986642211


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                        ....+||+.|+|||++.+..|+.++|||||
T Consensus       207 --------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  236 (387)
T 1kob_A          207 --------------------------------------------------VKVTTATAEFAAPEIVDREPVGFYTDMWAI  236 (387)
T ss_dssp             --------------------------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred             --------------------------------------------------eeeeccCCCccCchhccCCCCCCcccEeeH
Confidence                                                              113479999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|||+++..+|.
T Consensus       237 G~il~elltg~~Pf~  251 (387)
T 1kob_A          237 GVLGYVLLSGLSPFA  251 (387)
T ss_dssp             HHHHHHHHHSCCSSC
T ss_pred             hHHHHHHHhCCCCCC
Confidence            999999999877663

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-41  Score=317.11  Aligned_cols=203  Identities=26%  Similarity=0.408  Sum_probs=171.8

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      +...++|++++.||+|+||+||+|.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++.+...+
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            344589999999999999999999984 589999999976532 334456688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      ++||||+++ +|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus        95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999999975 788877654 469999999999999999999999999999999999999999999999999998654221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Diw  339 (358)
                      ..                                                 ....+||+.|+|||++.+ ..|+.++|||
T Consensus       174 ~~-------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  204 (311)
T 3niz_A          174 RS-------------------------------------------------YTHEVVTLWYRAPDVLMGSKKYSTSVDIW  204 (311)
T ss_dssp             C----------------------------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHHH
T ss_pred             cc-------------------------------------------------ccCCcccCCcCCHHHhcCCCCCCchHHhH
Confidence            10                                                 113479999999999987 5689999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||++|+|+++..+|.
T Consensus       205 slG~il~~ll~g~~pf~  221 (311)
T 3niz_A          205 SIGCIFAEMITGKPLFP  221 (311)
T ss_dssp             HHHHHHHHHHHSSCSCC
T ss_pred             HHHHHHHHHHhCCCCCC
Confidence            99999999999887764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.7e-41  Score=321.26  Aligned_cols=207  Identities=25%  Similarity=0.386  Sum_probs=180.3

Q ss_pred             HHHhHhhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-----Ccc
Q 018275           93 TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-----SHC  167 (358)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----h~~  167 (358)
                      ...+.+....+..++|.+++.||+|+||.||+|.+..+++.||||++...    ......+..|+.+++.+.     |||
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            33345556667779999999999999999999999999999999998753    233445677999999986     999


Q ss_pred             eEEEEEEeecCCEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC----
Q 018275          168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ----  241 (358)
Q Consensus       168 iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~----  241 (358)
                      ||++++++...+..|+||||+ +++|.+++....  .+++..++.++.||+.||.|||+.||+||||||+|||++.    
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A           98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred             eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999999 899999997654  5999999999999999999999999999999999999975    


Q ss_pred             ---------------------CCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHH
Q 018275          242 ---------------------NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQ  300 (358)
Q Consensus       242 ---------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (358)
                                           ++.+||+|||+|+......                                        
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----------------------------------------  216 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----------------------------------------  216 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----------------------------------------
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCC----------------------------------------
Confidence                                 7899999999997543111                                        


Q ss_pred             HHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          301 LQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       301 ~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                                  .+.+||+.|+|||++.+.+|+.++|||||||++|||+++..+|.
T Consensus       217 ------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          217 ------------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             ------------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ------------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                        13479999999999999999999999999999999999987763

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-41  Score=319.17  Aligned_cols=200  Identities=25%  Similarity=0.383  Sum_probs=160.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            478999999999999999999999999999999997653  223335578899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          185 MEYLPGGDVMTLLMRE------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      |||++ |+|.+++...      ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            99997 5999988653      3589999999999999999999999999999999999999999999999999986542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~D  337 (358)
                      ...                                                 ...+.+||+.|+|||++.+ ..|+.++|
T Consensus       161 ~~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~D  191 (317)
T 2pmi_A          161 PVN-------------------------------------------------TFSSEVVTLWYRAPDVLMGSRTYSTSID  191 (317)
T ss_dssp             CCC-------------------------------------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHH
T ss_pred             Ccc-------------------------------------------------cCCCCcccccccCchHhhCCCCCCcHHH
Confidence            110                                                 0113479999999999987 46899999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|||+++..+|.
T Consensus       192 iwslG~il~el~~g~~pf~  210 (317)
T 2pmi_A          192 IWSCGCILAEMITGKPLFP  210 (317)
T ss_dssp             HHHHHHHHHHHHHSSCSCC
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999887764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5e-42  Score=325.22  Aligned_cols=195  Identities=25%  Similarity=0.449  Sum_probs=171.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ++|.+.+.||+|+||.||+|.++.+++.||||++.+....       ..+|+.++..+ +||||++++++|.+...+|+|
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            6799999999999999999999999999999999765321       34678888877 799999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC----CcEEEEecCCCccCCCCC
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN----GHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~----~~vkl~DFGla~~~~~~~  260 (358)
                      |||++||+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||+..+    +.+||+|||+++......
T Consensus        95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            9999999999999888899999999999999999999999999999999999998543    359999999998653221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .                                                 ...+.+||+.|+|||++.+.+|+.++||||
T Consensus       175 ~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  205 (342)
T 2qr7_A          175 G-------------------------------------------------LLMTPCYTANFVAPEVLERQGYDAACDIWS  205 (342)
T ss_dssp             C-------------------------------------------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHH
T ss_pred             C-------------------------------------------------ceeccCCCccccCHHHhcCCCCCCccCeee
Confidence            1                                                 112457999999999999988999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       206 lG~il~ell~g~~Pf~  221 (342)
T 2qr7_A          206 LGVLLYTMLTGYTPFA  221 (342)
T ss_dssp             HHHHHHHHHHSSCSSC
T ss_pred             HhHHHHHHhcCCCCCC
Confidence            9999999999887663

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.2e-41  Score=311.38  Aligned_cols=206  Identities=28%  Similarity=0.461  Sum_probs=183.1

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ...+..++|.+.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++.+.+
T Consensus         8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A            8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK   87 (284)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence            34566789999999999999999999999999999999998765444445567889999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ..|+||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998654311


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .                                                   ....+||+.|+|||++.+..++.++|+|
T Consensus       168 ~---------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~  196 (284)
T 2vgo_A          168 R---------------------------------------------------RRTMCGTLDYLPPEMIEGKTHDEKVDLW  196 (284)
T ss_dssp             C---------------------------------------------------BCCCCSCGGGCCHHHHTTCCBCTTHHHH
T ss_pred             c---------------------------------------------------cccccCCCCcCCHHHhccCCCCcccchh
Confidence            1                                                   0134799999999999999999999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      |||+++|+|+++...|.
T Consensus       197 slG~il~~l~~g~~pf~  213 (284)
T 2vgo_A          197 CAGVLCYEFLVGMPPFD  213 (284)
T ss_dssp             HHHHHHHHHHHSSCTTC
T ss_pred             hHHHHHHHHHHCCCCCC
Confidence            99999999999877664

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.4e-41  Score=308.41  Aligned_cols=200  Identities=29%  Similarity=0.455  Sum_probs=179.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4899999999999999999999999999999999986643 344556788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc---EEEEecCCCccCCCCCC
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~---vkl~DFGla~~~~~~~~  261 (358)
                      |||+++++|.+.+.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.   +||+|||++........
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            999999999999988889999999999999999999999999999999999999987665   99999999976542110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                        .....||+.|+|||++.+..++.++|||||
T Consensus       164 --------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (284)
T 3kk8_A          164 --------------------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWAC  193 (284)
T ss_dssp             --------------------------------------------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             --------------------------------------------------ccCCCCCcCCcCchhhcCCCCCcccchHHH
Confidence                                                              113479999999999999999999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      |+++|+|+++..+|
T Consensus       194 G~~l~~l~~g~~pf  207 (284)
T 3kk8_A          194 GVILYILLVGYPPF  207 (284)
T ss_dssp             HHHHHHHHHSSCSS
T ss_pred             HHHHHHHHHCCCCC
Confidence            99999999987765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-41  Score=325.36  Aligned_cols=221  Identities=23%  Similarity=0.377  Sum_probs=166.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCC--EE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE--YL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~--~~  181 (358)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.++..+. |||||+++++|...+  .+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            478999999999999999999999999999999986542 23445566788999999997 999999999997544  79


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |+||||++ ++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus        87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            99999997 689988865 5789999999999999999999999999999999999999999999999999987643221


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLA  340 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwS  340 (358)
                      ........           ..                .....+ ........+.+||+.|+|||++.+ ..|+.++||||
T Consensus       165 ~~~~~~~~-----------~~----------------~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  216 (388)
T 3oz6_A          165 VTNNIPLS-----------IN----------------ENTENF-DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS  216 (388)
T ss_dssp             CCCCGGGC-----------CC--------------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred             cccccccc-----------cc----------------cccccc-ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHH
Confidence            11000000           00                000000 000112235689999999999987 67999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       217 lG~il~ell~g~~pf~  232 (388)
T 3oz6_A          217 LGCILGEILCGKPIFP  232 (388)
T ss_dssp             HHHHHHHHHHSSCSCC
T ss_pred             HHHHHHHHHhCCCCCC
Confidence            9999999999987774

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.9e-41  Score=333.97  Aligned_cols=198  Identities=24%  Similarity=0.335  Sum_probs=168.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC------
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------  178 (358)
                      .++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++|||||+++++|.+.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            488999999999999999999999999999999997653 2445566788999999999999999999999654      


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..+|+||||+++ +|...+.  ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            467999999975 5666663  3589999999999999999999999999999999999999999999999999986532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ..                                                  .....+||+.|+|||++.+.+|+.++||
T Consensus       217 ~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di  246 (464)
T 3ttj_A          217 SF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDI  246 (464)
T ss_dssp             CC--------------------------------------------------CC----CCCTTCCHHHHTTCCCCTTHHH
T ss_pred             Cc--------------------------------------------------ccCCCcccccccCHHHHcCCCCCHHHHH
Confidence            11                                                  0113589999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||++|||+++..+|.
T Consensus       247 wSlG~il~ell~g~~pF~  264 (464)
T 3ttj_A          247 WSVGCIMGEMVRHKILFP  264 (464)
T ss_dssp             HHHHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHHHHhCCCCCC
Confidence            999999999999887764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.4e-41  Score=318.40  Aligned_cols=209  Identities=24%  Similarity=0.371  Sum_probs=169.7

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC------
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE------  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~------  179 (358)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.++|||||+++++|.+..      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            57999999999999999999999999999999997543  3445567899999999999999999999986543      


Q ss_pred             ---------------------------------------------------EEEEEEeecCCCCHHHHHhhcC---CCCH
Q 018275          180 ---------------------------------------------------YLYLIMEYLPGGDVMTLLMREE---TLTE  205 (358)
Q Consensus       180 ---------------------------------------------------~~~lV~E~~~~g~L~~~l~~~~---~~~~  205 (358)
                                                                         +.++||||+++++|.+++....   ..++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               4899999999999999997654   3455


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCC
Q 018275          206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF  285 (358)
Q Consensus       206 ~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (358)
                      ..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.............                  
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~------------------  225 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT------------------  225 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc------------------
Confidence            66888999999999999999999999999999999999999999999987653321110000                  


Q ss_pred             CCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccccc
Q 018275          286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                                         ...........+||+.|+|||++.+..|+.++|||||||++|||+++..
T Consensus       226 -------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~  274 (332)
T 3qd2_B          226 -------------------PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS  274 (332)
T ss_dssp             -------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCC
T ss_pred             -------------------cccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCC
Confidence                               0000011224579999999999999999999999999999999998654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=320.51  Aligned_cols=207  Identities=21%  Similarity=0.253  Sum_probs=176.1

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCC---EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..++.   .||||++....  .......+.+|+.+++.++||||++++++|.+
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            45667899999999999999999999986555   49999997643  34455678899999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      .+..|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999999999654 58999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      ........                                              ......||+.|+|||++.+..|+.++
T Consensus       202 ~~~~~~~~----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~  235 (325)
T 3kul_A          202 EDDPDAAY----------------------------------------------TTTGGKIPIRWTAPEAIAFRTFSSAS  235 (325)
T ss_dssp             C----CCE----------------------------------------------ECC---CCGGGSCHHHHHHCEECHHH
T ss_pred             ccCcccee----------------------------------------------eccCCCCcccccCHhHhcCCCCCcHH
Confidence            43221110                                              01123578899999999999999999


Q ss_pred             hhhhhhHHHHhhcc-ccccc
Q 018275          337 DWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~-~~~~~  355 (358)
                      |||||||++|||+. +..+|
T Consensus       236 Di~slG~il~ell~~g~~p~  255 (325)
T 3kul_A          236 DVWSFGVVMWEVLAYGERPY  255 (325)
T ss_dssp             HHHHHHHHHHHHHTTSCCTT
T ss_pred             HHHHHHHHHHHHHcCCCCCc
Confidence            99999999999998 66554

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=321.86  Aligned_cols=198  Identities=30%  Similarity=0.443  Sum_probs=163.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++....     ..+.+.+|+.+++.++||||++++++|.+....+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            34578999999999999999999999999999999997643     2345778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---CCcEEEEecCCCccCCCC
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~vkl~DFGla~~~~~~  259 (358)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.   ++.+||+|||+++.....
T Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            99999999999999988888999999999999999999999999999999999999976   899999999999765321


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .                                                  ...+.+||+.|+|||++.+..|+.++|||
T Consensus       205 ~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  234 (349)
T 2w4o_A          205 V--------------------------------------------------LMKTVCGTPGYCAPEILRGCAYGPEVDMW  234 (349)
T ss_dssp             ----------------------------------------------------------CGGGSCHHHHTTCCCCTHHHHH
T ss_pred             c--------------------------------------------------ccccccCCCCccCHHHhcCCCCCcccchH
Confidence            1                                                  01134799999999999999999999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      ||||++|||+++..+|
T Consensus       235 slG~il~ell~g~~pf  250 (349)
T 2w4o_A          235 SVGIITYILLCGFEPF  250 (349)
T ss_dssp             HHHHHHHHHHHSSCTT
T ss_pred             HHHHHHHHHHhCCCCC
Confidence            9999999999987665

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.4e-41  Score=315.70  Aligned_cols=196  Identities=30%  Similarity=0.431  Sum_probs=174.3

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      .|...+.||+|+||.||+|.+..+|+.||||++....   ....+.+.+|+.+++.++||||++++++|...+..++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4778889999999999999999899999999997653   3345568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                      |+++++|.+++. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.........    
T Consensus       123 ~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----  197 (321)
T 2c30_A          123 FLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK----  197 (321)
T ss_dssp             CCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC----
T ss_pred             cCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc----
Confidence            999999999885 457899999999999999999999999999999999999999999999999999765422110    


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETL  346 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~  346 (358)
                                                                   ..+.+||+.|+|||++.+..|+.++|||||||++|
T Consensus       198 ---------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~  232 (321)
T 2c30_A          198 ---------------------------------------------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI  232 (321)
T ss_dssp             ---------------------------------------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred             ---------------------------------------------cccccCCccccCHhhhcCCCCCchhhHHHHHHHHH
Confidence                                                         11347999999999999999999999999999999


Q ss_pred             hhccccccc
Q 018275          347 SCNYLSDIM  355 (358)
Q Consensus       347 e~l~~~~~~  355 (358)
                      ||+++..+|
T Consensus       233 el~~g~~pf  241 (321)
T 2c30_A          233 EMVDGEPPY  241 (321)
T ss_dssp             HHHHSSCTT
T ss_pred             HHHhCCCCC
Confidence            999987765

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=315.14  Aligned_cols=203  Identities=33%  Similarity=0.566  Sum_probs=170.1

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc-----------------------hhhHHHHHHHHHH
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-----------------------RGQVEHVRAERNL  159 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~E~~i  159 (358)
                      +..++|.+.+.||+|+||.||+|.+..+++.||||++.......                       ....+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            45689999999999999999999999999999999997653211                       1223568899999


Q ss_pred             HHHhcCcceEEEEEEeec--CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 018275          160 LAEVASHCIVKLYYSFQD--AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL  237 (358)
Q Consensus       160 l~~l~h~~iv~l~~~~~~--~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NI  237 (358)
                      ++.++||||+++++++.+  ...+|+||||+++++|.+++ ...++++..+..++.|++.||.|||+.||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999999999999999986  56899999999999998865 456799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC
Q 018275          238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG  317 (358)
Q Consensus       238 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g  317 (358)
                      |++.++.+||+|||+++.......                                                 .....+|
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------------~~~~~~g  199 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDA-------------------------------------------------LLSNTVG  199 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSC-------------------------------------------------EECCCCS
T ss_pred             EECCCCCEEEecCCCccccccccc-------------------------------------------------cccCCcC
Confidence            999999999999999986542211                                                 0113479


Q ss_pred             CCCCchhhhhcCCC---CCccchhhhhhHHHHhhccccccc
Q 018275          318 TPDYIAPEVLLKKG---YGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       318 t~~Y~APEv~~~~~---y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      |+.|+|||++.+..   ++.++|||||||++|+|+++..+|
T Consensus       200 t~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  240 (298)
T 2zv2_A          200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF  240 (298)
T ss_dssp             CGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            99999999998766   478899999999999999987665

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.1e-41  Score=318.54  Aligned_cols=195  Identities=29%  Similarity=0.433  Sum_probs=155.6

Q ss_pred             Cceee---eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEEE
Q 018275          107 DFDLL---TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       107 ~~~~~---~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~  182 (358)
                      +|++.   +.||+|+||.||+|.+..+++.||||++...      ....+.+|+.++..+. ||||++++++|.+....|
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~   82 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF   82 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence            45554   7899999999999999999999999998754      2344778999999997 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC---cEEEEecCCCccCCCC
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPLDCT  259 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~vkl~DFGla~~~~~~  259 (358)
                      +||||+++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++   .+||+|||+++.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999999999999999889999999999999999999999999999999999999998766   8999999999765321


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ..                                                 ...+.+||+.|+|||++.+..|+.++|||
T Consensus       163 ~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Diw  193 (325)
T 3kn6_A          163 NQ-------------------------------------------------PLKTPCFTLHYAAPELLNQNGYDESCDLW  193 (325)
T ss_dssp             ----------------------------------------------------------------------CCCCHHHHHH
T ss_pred             CC-------------------------------------------------cccccCCCcCccCHHHhcCCCCCCccchH
Confidence            10                                                 01134799999999999999999999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||++|+|+++..+|.
T Consensus       194 slG~il~~ll~g~~pf~  210 (325)
T 3kn6_A          194 SLGVILYTMLSGQVPFQ  210 (325)
T ss_dssp             HHHHHHHHHHHSSCTTC
T ss_pred             HHHHHHHHHHhCCCCCC
Confidence            99999999999877663

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=313.04  Aligned_cols=202  Identities=24%  Similarity=0.339  Sum_probs=168.7

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh--chhhHHHHHHHHHHHHHhc---CcceEEEEEEeec
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--SRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQD  177 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~---h~~iv~l~~~~~~  177 (358)
                      +..++|++.+.||+|+||+||+|.+..+++.||||++......  .......+.+|+.+++.+.   ||||++++++|.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4468999999999999999999999999999999999754311  1111234566777776665   9999999999987


Q ss_pred             CC-----EEEEEEeecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEec
Q 018275          178 AE-----YLYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF  250 (358)
Q Consensus       178 ~~-----~~~lV~E~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DF  250 (358)
                      ..     .+++||||++ ++|.+++.....  +++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            55     5899999996 599999977643  999999999999999999999999999999999999999999999999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK  330 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~  330 (358)
                      |+|+.......                                                  ....+||+.|+|||++.+.
T Consensus       165 g~a~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~  194 (308)
T 3g33_A          165 GLARIYSYQMA--------------------------------------------------LTPVVVTLWYRAPEVLLQS  194 (308)
T ss_dssp             SCTTTSTTCCC--------------------------------------------------SGGGGCCCSSCCHHHHHTS
T ss_pred             ccccccCCCcc--------------------------------------------------cCCccccccccCchHHcCC
Confidence            99976542111                                                  1134799999999999999


Q ss_pred             CCCccchhhhhhHHHHhhccccccc
Q 018275          331 GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .|+.++|||||||++|||+++..+|
T Consensus       195 ~~~~~~DiwslG~il~~l~~g~~pf  219 (308)
T 3g33_A          195 TYATPVDMWSVGCIFAEMFRRKPLF  219 (308)
T ss_dssp             CCCSTHHHHHHHHHHHHTTTSSCSC
T ss_pred             CCCchHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999988776

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-41  Score=317.81  Aligned_cols=205  Identities=22%  Similarity=0.259  Sum_probs=175.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~  182 (358)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++.....     ...+..|+.+++.+ +||||+++++++.+....+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            34789999999999999999999999999999999875532     12377899999999 9999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc-----EEEEecCCCccC
Q 018275          183 LIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH-----MKLSDFGLCKPL  256 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~-----vkl~DFGla~~~  256 (358)
                      +||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.     +||+|||+|+.+
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999999 9999999976 468999999999999999999999999999999999999999887     999999999875


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      .........                                          ......+.+||+.|+|||++.+..|+.++
T Consensus       161 ~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  198 (330)
T 2izr_A          161 IDPETKKHI------------------------------------------PYREHKSLTGTARYMSINTHLGKEQSRRD  198 (330)
T ss_dssp             BCTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHH
T ss_pred             ecCCCCccc------------------------------------------cccccCCcCCCccccChHHHcCCCCCchh
Confidence            422211000                                          00011245899999999999999999999


Q ss_pred             hhhhhhHHHHhhcccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~~  356 (358)
                      |||||||++|||+++..+|.
T Consensus       199 Di~slG~il~ell~g~~Pf~  218 (330)
T 2izr_A          199 DLEALGHMFMYFLRGSLPWQ  218 (330)
T ss_dssp             HHHHHHHHHHHHHHSSCTTT
T ss_pred             HHHHHHHHHHHHhcCCCCcc
Confidence            99999999999999877764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.6e-41  Score=316.16  Aligned_cols=204  Identities=28%  Similarity=0.421  Sum_probs=183.8

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            45789999999999999999999999999999999987655555667778999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++........ 
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-  197 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-  197 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc-
Confidence            9999999999999988889999999999999999999999999999999999999999999999999999865422110 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      ....+||+.|+|||++.+..++.++|||||||
T Consensus       198 ------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  229 (335)
T 2owb_A          198 ------------------------------------------------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGC  229 (335)
T ss_dssp             ------------------------------------------------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHH
T ss_pred             ------------------------------------------------ccccCCCccccCHHHhccCCCCchhhHHHHHH
Confidence                                                            11347999999999999999999999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|+|+++...|.
T Consensus       230 il~~l~~g~~pf~  242 (335)
T 2owb_A          230 IMYTLLVGKPPFE  242 (335)
T ss_dssp             HHHHHHHSSCTTC
T ss_pred             HHHHHHHCcCCCC
Confidence            9999999877664

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.4e-41  Score=308.69  Aligned_cols=205  Identities=28%  Similarity=0.415  Sum_probs=183.7

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            34578999999999999999999999999999999998765555566777899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999999765421110


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ....+||+.|+|||++.+..++.++|+||||
T Consensus       172 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  202 (294)
T 2rku_A          172 -------------------------------------------------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG  202 (294)
T ss_dssp             -------------------------------------------------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHH
T ss_pred             -------------------------------------------------cccccCCCCcCCcchhccCCCCchhhHHHHH
Confidence                                                             1134799999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      +++|+|+++...|.
T Consensus       203 ~~l~~l~~g~~p~~  216 (294)
T 2rku_A          203 CIMYTLLVGKPPFE  216 (294)
T ss_dssp             HHHHHHHHSSCTTC
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999999877653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=314.84  Aligned_cols=197  Identities=27%  Similarity=0.431  Sum_probs=165.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ++|++.++||+|+||+||+|.+..+++.||||++...... .........|+..+..+ .|||||+++++|.+.+.+|+|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            6799999999999999999999999999999998654322 22233344555555554 899999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+ +++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~--  212 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--  212 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC--
Confidence            9999 67898888664 5699999999999999999999999999999999999999999999999999876542211  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      ....+||+.|+|||++.+ .|+.++|||||||
T Consensus       213 ------------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~  243 (311)
T 3p1a_A          213 ------------------------------------------------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGL  243 (311)
T ss_dssp             --------------------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHH
T ss_pred             ------------------------------------------------CcccCCCccccCHhHhcC-CCCchhhHHHHHH
Confidence                                                            113369999999999986 7999999999999


Q ss_pred             HHHhhccccccc
Q 018275          344 ETLSCNYLSDIM  355 (358)
Q Consensus       344 il~e~l~~~~~~  355 (358)
                      ++|||+++..++
T Consensus       244 il~el~~g~~~~  255 (311)
T 3p1a_A          244 TILEVACNMELP  255 (311)
T ss_dssp             HHHHHHHTCCCC
T ss_pred             HHHHHHhCCCCC
Confidence            999999885543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=309.02  Aligned_cols=203  Identities=28%  Similarity=0.505  Sum_probs=160.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            47899999999999999999999999999999999876544445567789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++++|.+++... .++++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence            9999999999999765 6799999999999999999999999999999999999999999999999999976542111  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                     .....+||+.|+|||++.+..++.++|+|||||
T Consensus       168 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  200 (278)
T 3cok_A          168 -----------------------------------------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGC  200 (278)
T ss_dssp             -----------------------------------------------------------------------CTHHHHHHH
T ss_pred             -----------------------------------------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHH
Confidence                                                           011347999999999999999999999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|+|+++..+|.
T Consensus       201 il~~l~~g~~p~~  213 (278)
T 3cok_A          201 MFYTLLIGRPPFD  213 (278)
T ss_dssp             HHHHHHHSSCSSC
T ss_pred             HHHHHHhCCCCCC
Confidence            9999999877654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.5e-41  Score=328.31  Aligned_cols=218  Identities=27%  Similarity=0.352  Sum_probs=171.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC-----C
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----E  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~  179 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            489999999999999999999999999999999997542 2344556788999999999999999999999766     5


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            7999999995 699999988888999999999999999999999999999999999999999999999999999877533


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh-cCCCCCccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-LKKGYGMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~-~~~~y~~~~Di  338 (358)
                      ..........             .. ..             ........+....+.+||+.|+|||++ .+..|+.++||
T Consensus       183 ~~~~~~~~~~-------------~~-~~-------------~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~Di  235 (432)
T 3n9x_A          183 KDTNIVNDLE-------------EN-EE-------------PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI  235 (432)
T ss_dssp             -------------------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred             cccccccccc-------------cc-cc-------------ccccccchhccccCCCCCccccCHHHHhcCCCCCccccc
Confidence            2211100000             00 00             000000111223466999999999997 56679999999


Q ss_pred             hhhhHHHHhhccc
Q 018275          339 LAYWNETLSCNYL  351 (358)
Q Consensus       339 wSlGvil~e~l~~  351 (358)
                      |||||++|||+.+
T Consensus       236 wSlG~il~ell~g  248 (432)
T 3n9x_A          236 WSTGCIFAELLNM  248 (432)
T ss_dssp             HHHHHHHHHHHTT
T ss_pred             chHHHHHHHHHhc
Confidence            9999999999974

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.2e-41  Score=325.47  Aligned_cols=194  Identities=28%  Similarity=0.412  Sum_probs=162.7

Q ss_pred             cCCCceee-eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHH-HhcCcceEEEEEEeec----
Q 018275          104 SVDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA-EVASHCIVKLYYSFQD----  177 (358)
Q Consensus       104 ~~~~~~~~-~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~l~~~~~~----  177 (358)
                      ..++|.+. +.||+|+||.||+|.+..+++.||||++...        ..+.+|+.++. ..+||||++++++|..    
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            34678776 7899999999999999999999999998643        12567887764 4589999999998875    


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---CCcEEEEecCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGL  252 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~vkl~DFGl  252 (358)
                      ..++|+||||++||+|.+++....  .+++..++.++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            667999999999999999997653  5999999999999999999999999999999999999998   78999999999


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY  332 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y  332 (358)
                      ++......                                                  ...+.+||+.|+|||++.+..|
T Consensus       211 a~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~  240 (400)
T 1nxk_A          211 AKETTSHN--------------------------------------------------SLTTPCYTPYYVAPEVLGPEKY  240 (400)
T ss_dssp             CEECC-------------------------------------------------------------CTTCCGGGSCCCCS
T ss_pred             ccccCCCC--------------------------------------------------ccccCCCCCCccCHhhcCCCCC
Confidence            98553211                                                  0114479999999999999999


Q ss_pred             CccchhhhhhHHHHhhccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +.++|||||||++|||+++...|
T Consensus       241 ~~~~DiwslG~il~ell~g~~pf  263 (400)
T 1nxk_A          241 DKSCDMWSLGVIMYILLCGYPPF  263 (400)
T ss_dssp             SSHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999987766

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=312.91  Aligned_cols=202  Identities=27%  Similarity=0.366  Sum_probs=173.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            3789999999999999999999999999999999876532 334456688899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++++|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........   
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---  157 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD---  157 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---
Confidence            99999999999988888899999999999999999999999999999999999999999999999999976542110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlGv  343 (358)
                                                                    .....+||+.|+|||++.+ ..|+.++|+|||||
T Consensus       158 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~  191 (311)
T 4agu_A          158 ----------------------------------------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGC  191 (311)
T ss_dssp             ------------------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHH
T ss_pred             ----------------------------------------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHH
Confidence                                                          0113479999999999986 67899999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|+|+++..+|.
T Consensus       192 il~~l~~g~~p~~  204 (311)
T 4agu_A          192 VFAELLSGVPLWP  204 (311)
T ss_dssp             HHHHHHHSSCSCC
T ss_pred             HHHHHHhCCCCCC
Confidence            9999999877663

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.4e-41  Score=315.26  Aligned_cols=201  Identities=28%  Similarity=0.455  Sum_probs=178.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc---hhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS---RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .++|.+.+.||+|+||.||+|.+..+|..||+|++.......   ......+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            367999999999999999999999999999999997654221   12356688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC----cEEEEecCCCccCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLD  257 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~vkl~DFGla~~~~  257 (358)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++    .+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999998888899999999999999999999999999999999999999888    89999999997654


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ....                                                  ....+||+.|+|||++.+..++.++|
T Consensus       171 ~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~D  200 (321)
T 2a2a_A          171 DGVE--------------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEAD  200 (321)
T ss_dssp             TTCC--------------------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred             cccc--------------------------------------------------ccccCCCCCccCcccccCCCCCCccc
Confidence            2110                                                  11347999999999999999999999


Q ss_pred             hhhhhHHHHhhccccccc
Q 018275          338 WLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~  355 (358)
                      +|||||++|+|+++..+|
T Consensus       201 i~slG~il~~l~~g~~pf  218 (321)
T 2a2a_A          201 MWSIGVITYILLSGASPF  218 (321)
T ss_dssp             HHHHHHHHHHHHHSCCSS
T ss_pred             cHHHHHHHHHHHHCCCCC
Confidence            999999999999988766

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2e-41  Score=312.61  Aligned_cols=199  Identities=27%  Similarity=0.387  Sum_probs=169.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+++.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            6899999999999999999988 6789999999876532 2233355788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||+++ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......   
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---  155 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---  155 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc---
Confidence            99975 899888764 6799999999999999999999999999999999999999999999999999875431110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGv  343 (358)
                                                                    .....+||+.|+|||++.+. .|+.++|||||||
T Consensus       156 ----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  189 (288)
T 1ob3_A          156 ----------------------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC  189 (288)
T ss_dssp             ----------------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred             ----------------------------------------------ccccccccccccCchheeCCCCCCcHHHHHHHHH
Confidence                                                          01134799999999999864 5899999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|||+++..+|.
T Consensus       190 il~~l~~g~~pf~  202 (288)
T 1ob3_A          190 IFAEMVNGTPLFP  202 (288)
T ss_dssp             HHHHHHHSSCSCC
T ss_pred             HHHHHHhCCCCCC
Confidence            9999999887764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.4e-41  Score=322.68  Aligned_cols=208  Identities=22%  Similarity=0.279  Sum_probs=175.8

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEE-----ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEE
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQE-----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYY  173 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~  173 (358)
                      ...+..++|.+.+.||+|+||.||+|.+     ..+++.||||++....  .......+.+|+.++..+ +|||||++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            3456779999999999999999999984     4566899999997653  344556789999999999 7899999999


Q ss_pred             EeecCC-EEEEEEeecCCCCHHHHHhhcCC--------------------------------------------------
Q 018275          174 SFQDAE-YLYLIMEYLPGGDVMTLLMREET--------------------------------------------------  202 (358)
Q Consensus       174 ~~~~~~-~~~lV~E~~~~g~L~~~l~~~~~--------------------------------------------------  202 (358)
                      +|.+.+ .+++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            998754 48999999999999999976432                                                  


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccccc
Q 018275          203 ----------------LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE  266 (358)
Q Consensus       203 ----------------~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  266 (358)
                                      +++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.......   
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~---  250 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---  250 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE---
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch---
Confidence                            8899999999999999999999999999999999999999999999999998654221100   


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHH
Q 018275          267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETL  346 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~  346 (358)
                                                                  ......||+.|+|||++.+..|+.++|||||||++|
T Consensus       251 --------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~  286 (359)
T 3vhe_A          251 --------------------------------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW  286 (359)
T ss_dssp             --------------------------------------------EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             --------------------------------------------hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHH
Confidence                                                        011346899999999999999999999999999999


Q ss_pred             hhcc-cccccc
Q 018275          347 SCNY-LSDIML  356 (358)
Q Consensus       347 e~l~-~~~~~~  356 (358)
                      ||++ +..+|.
T Consensus       287 ellt~g~~p~~  297 (359)
T 3vhe_A          287 EIFSLGASPYP  297 (359)
T ss_dssp             HHTTTSCCSST
T ss_pred             HHHhcCCCCCC
Confidence            9997 766553

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.4e-41  Score=312.62  Aligned_cols=206  Identities=23%  Similarity=0.281  Sum_probs=172.7

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++.+.+..|
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            34589999999999999999999999999999999998765545555677899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||+++++|.+++....++++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999998765421100


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                      .....+||+.|+|||++.+..++.++||||||
T Consensus       191 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  222 (309)
T 2h34_A          191 ------------------------------------------------QLGNTVGTLYYMAPERFSESHATYRADIYALT  222 (309)
T ss_dssp             ------------------------------------------------------CCGGGCCGGGTCC----CCCHHHHHH
T ss_pred             ------------------------------------------------cccccCCCcCccCHHHHcCCCCCchHhHHHHH
Confidence                                                            01134799999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      +++|||+++..+|.
T Consensus       223 ~il~~l~~g~~pf~  236 (309)
T 2h34_A          223 CVLYECLTGSPPYQ  236 (309)
T ss_dssp             HHHHHHHHSSCSSC
T ss_pred             HHHHHHHHCCCCCC
Confidence            99999999877663

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.1e-41  Score=320.22  Aligned_cols=205  Identities=25%  Similarity=0.358  Sum_probs=181.8

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ....+..++|.+.+.||+|+||.||+|.+..++..||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  103 (360)
T 3eqc_A           26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD  103 (360)
T ss_dssp             TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred             cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence            345667789999999999999999999999999999999997652  344556788999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      +..|+||||+++++|.+++.....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus       104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            99999999999999999998888999999999999999999999996 99999999999999999999999999986432


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ..                                                   ...+.+||+.|+|||++.+..|+.++|
T Consensus       184 ~~---------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D  212 (360)
T 3eqc_A          184 DS---------------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSD  212 (360)
T ss_dssp             HH---------------------------------------------------C----CCCCTTCCHHHHTTCCCSHHHH
T ss_pred             cc---------------------------------------------------cccCCCCCCCeECHHHHcCCCCCchhh
Confidence            10                                                   111347999999999999999999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|+|+++..+|.
T Consensus       213 i~slG~il~~l~~g~~pf~  231 (360)
T 3eqc_A          213 IWSMGLSLVEMAVGRYPIP  231 (360)
T ss_dssp             HHHHHHHHHHHHHTSCCSS
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999887764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6e-41  Score=318.54  Aligned_cols=196  Identities=27%  Similarity=0.403  Sum_probs=173.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +.|.+++.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++|||||+++++|.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            56999999999999999999999999999999997654334455567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||++ |+|.+++. ...++++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....     
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-----  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence            9997 57888775 4568999999999999999999999999999999999999999999999999999765311     


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCccchhhhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWLAY  341 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~~~DiwSl  341 (358)
                                                                      .+.+||+.|+|||++.   +..|+.++|||||
T Consensus       208 ------------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl  239 (348)
T 1u5q_A          208 ------------------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  239 (348)
T ss_dssp             ------------------------------------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHH
T ss_pred             ------------------------------------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHH
Confidence                                                            1347999999999995   5679999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|||+++...|
T Consensus       240 G~il~ell~g~~p~  253 (348)
T 1u5q_A          240 GITCIELAERKPPL  253 (348)
T ss_dssp             HHHHHHHHHSSCTT
T ss_pred             HHHHHHHHhCCCCC
Confidence            99999999987765

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-40  Score=305.29  Aligned_cols=197  Identities=29%  Similarity=0.475  Sum_probs=176.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||+|.+..++..||+|++.....   ...+.+.+|+.+++.++||||++++++|.+....++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            679999999999999999999999999999999986532   33566889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---cCCCcEEEEecCCCccCCCCCCc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++........ 
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~-  164 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-  164 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC-
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc-
Confidence            999999999999888899999999999999999999999999999999999999   7889999999999976542210 


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ....+||+.|+|||++.+. ++.++|+||||
T Consensus       165 -------------------------------------------------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG  194 (277)
T 3f3z_A          165 -------------------------------------------------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAG  194 (277)
T ss_dssp             -------------------------------------------------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHH
T ss_pred             -------------------------------------------------hhccCCCCCccChHHhccc-CCchhhehhHH
Confidence                                                             1134799999999999765 99999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|+|+++..+|.
T Consensus       195 ~~l~~l~~g~~p~~  208 (277)
T 3f3z_A          195 VMMYVLLCGYPPFS  208 (277)
T ss_dssp             HHHHHHHHSSCSSC
T ss_pred             HHHHHHHHCCCCCC
Confidence            99999999876653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-41  Score=335.51  Aligned_cols=203  Identities=31%  Similarity=0.512  Sum_probs=181.1

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|.+.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++|||||+++++|.+....|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34478999999999999999999999999999999998765444556677999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---cCCCcEEEEecCCCccCCCC
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~vkl~DFGla~~~~~~  259 (358)
                      +||||+++|+|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+|+.+...
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999999888899999999999999999999999999999999999999   56789999999998765421


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ..                                                  ..+.+||+.|+|||++.+ .|+.++|||
T Consensus       183 ~~--------------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~Diw  211 (484)
T 3nyv_A          183 KK--------------------------------------------------MKDKIGTAYYIAPEVLHG-TYDEKCDVW  211 (484)
T ss_dssp             CS--------------------------------------------------HHHHTTGGGTCCHHHHHT-CCCTHHHHH
T ss_pred             cc--------------------------------------------------cccCCCCccccCceeecC-CCCCcceeH
Confidence            10                                                  113479999999999987 699999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||++|+|+++..+|.
T Consensus       212 slG~il~~ll~g~~pf~  228 (484)
T 3nyv_A          212 STGVILYILLSGCPPFN  228 (484)
T ss_dssp             HHHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHHHHCCCCCC
Confidence            99999999999887763

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=322.89  Aligned_cols=200  Identities=28%  Similarity=0.449  Sum_probs=176.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhch-----hhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR-----GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ++|.+.+.||+|+||.||+|.+..++..||||++........     .....+.+|+.+++.++||||++++++|.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            689999999999999999999999999999999987542211     123346779999999999999999999999999


Q ss_pred             EEEEEeecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGG-DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .++||||+.+| +|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  183 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG  183 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence            99999999776 99999988889999999999999999999999999999999999999999999999999999865422


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-Cccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-~~~~Di  338 (358)
                      .                                                  ...+.+||+.|+|||++.+..+ +.++||
T Consensus       184 ~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  213 (335)
T 3dls_A          184 K--------------------------------------------------LFYTFCGTIEYCAPEVLMGNPYRGPELEM  213 (335)
T ss_dssp             C--------------------------------------------------CBCEECSCGGGCCHHHHTTCCBCSHHHHH
T ss_pred             C--------------------------------------------------ceeccCCCccccChhhhcCCCCCCCcccc
Confidence            1                                                  1124579999999999998887 789999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      |||||++|+|+++...|
T Consensus       214 wslG~il~el~~g~~pf  230 (335)
T 3dls_A          214 WSLGVTLYTLVFEENPF  230 (335)
T ss_dssp             HHHHHHHHHHHHSSCSC
T ss_pred             hhHHHHHHHHHhCCCch
Confidence            99999999999987765

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5e-41  Score=332.66  Aligned_cols=199  Identities=28%  Similarity=0.504  Sum_probs=176.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+++.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+++.++|||||++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3679999999999999999999999999999999986543 233456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc---CCCcEEEEecCCCccCCCCCC
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~---~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |||+++|+|.+.+.....+++..+..++.|++.||.|||+.||+||||||+|||++   .++.+||+|||+++.......
T Consensus       100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence            99999999999998888999999999999999999999999999999999999995   456799999999976532110


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                        ....+||+.|+|||++.+ .|+.++|||||
T Consensus       180 --------------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl  208 (486)
T 3mwu_A          180 --------------------------------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSA  208 (486)
T ss_dssp             ----------------------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHH
T ss_pred             --------------------------------------------------cCCCcCCCCCCCHHHhCC-CCCchhhHHHH
Confidence                                                              113479999999999986 59999999999


Q ss_pred             hHHHHhhccccccc
Q 018275          342 WNETLSCNYLSDIM  355 (358)
Q Consensus       342 Gvil~e~l~~~~~~  355 (358)
                      ||++|+|+++..+|
T Consensus       209 G~il~~ll~g~~pf  222 (486)
T 3mwu_A          209 GVILYILLSGTPPF  222 (486)
T ss_dssp             HHHHHHHHHSSCSS
T ss_pred             HHHHHHHHhCCCCC
Confidence            99999999988776

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=319.05  Aligned_cols=208  Identities=22%  Similarity=0.306  Sum_probs=178.5

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCC-------CEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEE
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVK  170 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~  170 (358)
                      ....+..++|.+.+.||+|+||.||+|.+..++       ..||||++....  .......+.+|+.+++.+ +|||||+
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            345667789999999999999999999976433       579999997653  345567788999999999 9999999


Q ss_pred             EEEEeecCCEEEEEEeecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 018275          171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKP  234 (358)
Q Consensus       171 l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp  234 (358)
                      ++++|.+.+..++||||+++|+|.+++....                .+++..+..++.|++.||.|||+.||+||||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999997653                489999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccc
Q 018275          235 DNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYS  314 (358)
Q Consensus       235 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  314 (358)
                      +|||++.++.+||+|||+|+.........                                               ....
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~-----------------------------------------------~~~~  252 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYK-----------------------------------------------KTTN  252 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTC-----------------------------------------------CCTT
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccc-----------------------------------------------cccC
Confidence            99999999999999999998664221100                                               0112


Q ss_pred             ccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          315 TVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       315 ~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ..||+.|+|||++.+..++.++|||||||++|||++ +..+|
T Consensus       253 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~  294 (382)
T 3tt0_A          253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  294 (382)
T ss_dssp             CCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            368899999999999999999999999999999998 65554

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-40  Score=331.06  Aligned_cols=202  Identities=32%  Similarity=0.488  Sum_probs=174.5

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc----------hhhHHHHHHHHHHHHHhcCcceEEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS----------RGQVEHVRAERNLLAEVASHCIVKLYY  173 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~----------~~~~~~~~~E~~il~~l~h~~iv~l~~  173 (358)
                      ..++|.+++.||+|+||+||+|.+..++..||||++.+.....          ....+.+.+|+.+++.++|||||++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999999999999999998654321          134567889999999999999999999


Q ss_pred             EeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC---cEEEEec
Q 018275          174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDF  250 (358)
Q Consensus       174 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~vkl~DF  250 (358)
                      +|.+...+|+||||+++|+|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++   .+||+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            9999999999999999999999998888999999999999999999999999999999999999999876   6999999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK  330 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~  330 (358)
                      |+|+.......                                                  ....+||+.|+|||++.+ 
T Consensus       194 g~a~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~-  222 (504)
T 3q5i_A          194 GLSSFFSKDYK--------------------------------------------------LRDRLGTAYYIAPEVLKK-  222 (504)
T ss_dssp             TTCEECCTTSC--------------------------------------------------BCCCCSCTTTCCHHHHTT-
T ss_pred             CCCEEcCCCCc--------------------------------------------------cccccCCcCCCCHHHhcc-
Confidence            99986542210                                                  113479999999999874 


Q ss_pred             CCCccchhhhhhHHHHhhcccccccc
Q 018275          331 GYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .|+.++|||||||++|+|+++..+|.
T Consensus       223 ~~~~~~DiwslG~il~~ll~g~~pf~  248 (504)
T 3q5i_A          223 KYNEKCDVWSCGVIMYILLCGYPPFG  248 (504)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCchHHHHHHHHHHHHHHhCCCCCC
Confidence            69999999999999999999877663

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.8e-41  Score=309.49  Aligned_cols=196  Identities=18%  Similarity=0.219  Sum_probs=172.7

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCC-------CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSG-------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYS  174 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~  174 (358)
                      .+..++|.+.+.||+|+||.||+|.+..++       ..||+|++....   ....+.+.+|+.+++.++||||++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            355689999999999999999999998877       479999987653   3455678899999999999999999999


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc--------E
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH--------M  245 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~--------v  245 (358)
                      +.+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            999999999999999999999997765 4999999999999999999999999999999999999999887        9


Q ss_pred             EEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhh
Q 018275          246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE  325 (358)
Q Consensus       246 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APE  325 (358)
                      ||+|||++......                                                     ....||+.|+|||
T Consensus       161 kl~Dfg~~~~~~~~-----------------------------------------------------~~~~~~~~y~aPE  187 (289)
T 4fvq_A          161 KLSDPGISITVLPK-----------------------------------------------------DILQERIPWVPPE  187 (289)
T ss_dssp             EECCCCSCTTTSCH-----------------------------------------------------HHHHHTTTTSCHH
T ss_pred             eeccCcccccccCc-----------------------------------------------------cccCCcCcccCHH
Confidence            99999998654211                                                     0235899999999


Q ss_pred             hhcC-CCCCccchhhhhhHHHHhhccccc
Q 018275          326 VLLK-KGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       326 v~~~-~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                      ++.+ ..++.++|||||||++|||+++..
T Consensus       188 ~~~~~~~~~~~~DiwslG~il~el~~g~~  216 (289)
T 4fvq_A          188 CIENPKNLNLATDKWSFGTTLWEICSGGD  216 (289)
T ss_dssp             HHHCGGGCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             HhCCCCCCCchhHHHHHHHHHHHHHcCCC
Confidence            9988 779999999999999999999643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-41  Score=321.74  Aligned_cols=207  Identities=37%  Similarity=0.640  Sum_probs=175.2

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhh-chhhHHHHHHHHHHHHHh-cCcceEEEEEEee
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEML-SRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ  176 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~  176 (358)
                      .+..++|.+.+.||+|+||.||+|.+.   .+++.||||+++..... .......+.+|+.++..+ +||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            344589999999999999999999884   58999999999764321 122234466799999999 6999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      +...+++||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGM  334 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~  334 (358)
                      .....                                                ......+||+.|+|||++.+  ..++.
T Consensus       210 ~~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~  241 (355)
T 1vzo_A          210 VADET------------------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDK  241 (355)
T ss_dssp             CGGGG------------------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CT
T ss_pred             ccCCC------------------------------------------------CcccCcccCcCccChhhhcCCCCCCCc
Confidence            32110                                                01124579999999999986  45889


Q ss_pred             cchhhhhhHHHHhhcccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ++|||||||++|||+++..+|.
T Consensus       242 ~~DvwslG~il~ell~g~~pf~  263 (355)
T 1vzo_A          242 AVDWWSLGVLMYELLTGASPFT  263 (355)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTS
T ss_pred             hhhHHHHHHHHHHHHHCCCCCc
Confidence            9999999999999999887764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.1e-41  Score=312.11  Aligned_cols=204  Identities=25%  Similarity=0.399  Sum_probs=171.1

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEE----EecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      .+..++|++++.||+|+||.||+|.    +..+++.||||++...   .......+.+|+.+++.++||||++++++|.+
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4566899999999999999999998    5668899999998754   34455678899999999999999999999854


Q ss_pred             --CCEEEEEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          178 --AEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       178 --~~~~~lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                        ...+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              356899999999999999997654 59999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCc
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM  334 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~  334 (358)
                      .........                                              .......||+.|+|||++.+..|+.
T Consensus       163 ~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~  196 (295)
T 3ugc_A          163 VLPQDKEFF----------------------------------------------KVKEPGESPIFWYAPESLTESKFSV  196 (295)
T ss_dssp             -----------------------------------------------------------CTTCGGGGCCHHHHHHCCCCH
T ss_pred             cccCCccee----------------------------------------------eeccCCCCccceeCcHHhcCCCCCh
Confidence            764221100                                              0011235788899999999999999


Q ss_pred             cchhhhhhHHHHhhcccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDI  354 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~  354 (358)
                      ++|||||||++|||+++...
T Consensus       197 ~~Di~slG~~l~~l~~g~~~  216 (295)
T 3ugc_A          197 ASDVWSFGVVLYELFTYIEK  216 (295)
T ss_dssp             HHHHHHHHHHHHHHHHTTCT
T ss_pred             HHHHHHHHHHHHHHHhcccc
Confidence            99999999999999986544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.1e-41  Score=313.34  Aligned_cols=208  Identities=22%  Similarity=0.261  Sum_probs=178.6

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEE
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY  173 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~  173 (358)
                      ....+..++|.+.+.||+|+||.||+|.+.     .++..||||++....  .......+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence            345667789999999999999999999874     455899999997653  3455677889999999999999999999


Q ss_pred             EeecCCEEEEEEeecCCCCHHHHHhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcee
Q 018275          174 SFQDAEYLYLIMEYLPGGDVMTLLMREET------------------------LTETVARFYIAQSVLAIESIHKHNYIH  229 (358)
Q Consensus       174 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~------------------------~~~~~~~~~~~qi~~aL~~LH~~~iiH  229 (358)
                      ++.+.+..++||||+++++|.+++.....                        +++..+..++.|++.||.|||+.||+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  173 (314)
T 2ivs_A           94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH  173 (314)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            99999999999999999999999976433                        889999999999999999999999999


Q ss_pred             CCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhc
Q 018275          230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRR  309 (358)
Q Consensus       230 rDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (358)
                      |||||+|||++.++.+||+|||+++.........                                              
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~----------------------------------------------  207 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV----------------------------------------------  207 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE----------------------------------------------
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccce----------------------------------------------
Confidence            9999999999999999999999998664221110                                              


Q ss_pred             cccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          310 KLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       310 ~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                       ......||+.|+|||++.+..|+.++|||||||++|||++ +..+|
T Consensus       208 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          208 -KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             -CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             -eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence             0112358899999999999999999999999999999998 66554

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-40  Score=304.20  Aligned_cols=205  Identities=27%  Similarity=0.464  Sum_probs=175.3

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+...
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            34566899999999999999999999999999999999987654445556778899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      .|+||||+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999987653211


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-Cccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-~~~~Diw  339 (358)
                      .                                                  ....+||+.|+|||++.+..+ +.++|+|
T Consensus       166 ~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  195 (276)
T 2h6d_A          166 F--------------------------------------------------LRTSCGSPNYAAPEVISGRLYAGPEVDIW  195 (276)
T ss_dssp             -------------------------------------------------------------CCTGGGTTSCCCHHHHHHH
T ss_pred             c--------------------------------------------------eecccCCccccCHHHHcCCCCCCccchHH
Confidence            0                                                  113369999999999998876 6899999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      |||+++|+|+++...|
T Consensus       196 slG~~l~~l~~g~~p~  211 (276)
T 2h6d_A          196 SCGVILYALLCGTLPF  211 (276)
T ss_dssp             HHHHHHHHHHHSSCSS
T ss_pred             HHHHHHHHHHhCCCCC
Confidence            9999999999987665

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=315.81  Aligned_cols=203  Identities=24%  Similarity=0.388  Sum_probs=170.7

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC--cceEEEEEEeecCCE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDAEY  180 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--~~iv~l~~~~~~~~~  180 (358)
                      +..++|.+++.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.++..++|  |||+++++++.+...
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            4457899999999999999999987 5688999999976542 34556778999999999987  899999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+|||+ .+++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++ ++.+||+|||+++.+....
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            9999995 5889999999989999999999999999999999999999999999999997 6889999999998664221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-----------
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----------  329 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-----------  329 (358)
                      ...                                               ...+.+||+.|+|||++.+           
T Consensus       162 ~~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  194 (343)
T 3dbq_A          162 TSV-----------------------------------------------VKDSQVGTVNYMPPEAIKDMSSSRENGKSK  194 (343)
T ss_dssp             -------------------------------------------------------CCCCSSCCHHHHHHCC---------
T ss_pred             ccc-----------------------------------------------cCCCCcCCcCcCCHHHHhhccccccccccc
Confidence            100                                               1114479999999999975           


Q ss_pred             CCCCccchhhhhhHHHHhhcccccccc
Q 018275          330 KGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       330 ~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ..|+.++|||||||++|||+++..+|.
T Consensus       195 ~~~~~~~DiwslG~il~ell~g~~pf~  221 (343)
T 3dbq_A          195 SKISPKSDVWSLGCILYYMTYGKTPFQ  221 (343)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cCCCchhhHHHHHHHHHHHHhCCCcch
Confidence            678999999999999999999887663

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.3e-41  Score=317.40  Aligned_cols=204  Identities=24%  Similarity=0.352  Sum_probs=168.6

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ....++|.+++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            4456899999999999999999999999999999999976532 233345577899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc-----CCCcEEEEecCCCccC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-----QNGHMKLSDFGLCKPL  256 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~-----~~~~vkl~DFGla~~~  256 (358)
                      |+||||++ |+|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++     .++.+||+|||+++..
T Consensus       109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99999997 59999998888999999999999999999999999999999999999994     5556999999999765


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCcc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGME  335 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~  335 (358)
                      .....                                                 .....+||+.|+|||++.+. .|+.+
T Consensus       188 ~~~~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~  218 (329)
T 3gbz_A          188 GIPIR-------------------------------------------------QFTHEIITLWYRPPEILLGSRHYSTS  218 (329)
T ss_dssp             C------------------------------------------------------------CCTTCCHHHHTTCCCCCTH
T ss_pred             CCccc-------------------------------------------------ccCCCcCCccccCHHHhcCCCCCCcH
Confidence            32110                                                 01134789999999999874 48999


Q ss_pred             chhhhhhHHHHhhcccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +|||||||++|||+++..+|.
T Consensus       219 ~DiwslG~il~ell~g~~pf~  239 (329)
T 3gbz_A          219 VDIWSIACIWAEMLMKTPLFP  239 (329)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHHHHHHHHCCCCcC
Confidence            999999999999999887764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=319.32  Aligned_cols=193  Identities=26%  Similarity=0.436  Sum_probs=165.7

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecCC
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      .+.||+|+||.||+|.+..+|..||+|++....   ....+.+.+|+.+++.++|||||+++++|.+.+.+++||||+++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            678999999999999999999999999998653   23456688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE--cCCCcEEEEecCCCccCCCCCCcccccc
Q 018275          191 GDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINEN  267 (358)
Q Consensus       191 g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl--~~~~~vkl~DFGla~~~~~~~~~~~~~~  267 (358)
                      ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+  +.++.+||+|||+++.+.....      
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~------  244 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK------  244 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB------
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc------
Confidence            9999988654 478999999999999999999999999999999999999  5678999999999986642211      


Q ss_pred             cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHh
Q 018275          268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLS  347 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e  347 (358)
                                                                  ....+||+.|+|||++.+..++.++|||||||++||
T Consensus       245 --------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  280 (373)
T 2x4f_A          245 --------------------------------------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYM  280 (373)
T ss_dssp             --------------------------------------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHH
T ss_pred             --------------------------------------------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHH
Confidence                                                        113479999999999999999999999999999999


Q ss_pred             hcccccccc
Q 018275          348 CNYLSDIML  356 (358)
Q Consensus       348 ~l~~~~~~~  356 (358)
                      |+++..+|.
T Consensus       281 lltg~~pf~  289 (373)
T 2x4f_A          281 LLSGLSPFL  289 (373)
T ss_dssp             HHHSSCTTC
T ss_pred             HHhCCCCCC
Confidence            999877663

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.5e-41  Score=325.98  Aligned_cols=201  Identities=30%  Similarity=0.537  Sum_probs=166.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh-----chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.+....     .......+.+|+.+++.++|||||++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            37899999999999999999999999999999999865422     11222347889999999999999999999864 5


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC---cEEEEecCCCccC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPL  256 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~vkl~DFGla~~~  256 (358)
                      ..|+||||+++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++   .+||+|||+|+..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            5899999999999999998888999999999999999999999999999999999999997654   5999999999865


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC---CCCC
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYG  333 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~---~~y~  333 (358)
                      ....                                                  ...+.+||+.|+|||++.+   ..|+
T Consensus       293 ~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~  322 (419)
T 3i6u_A          293 GETS--------------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYN  322 (419)
T ss_dssp             C-------------------------------------------------------------CTTCCTTTTC----CTTH
T ss_pred             CCCc--------------------------------------------------cccccCCCCCccCceeeecCCCCCCC
Confidence            4211                                                  0113479999999999864   6788


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|||||||++|+|+++..+|.
T Consensus       323 ~~~DiwslG~il~~lltg~~pf~  345 (419)
T 3i6u_A          323 RAVDCWSLGVILFICLSGYPPFS  345 (419)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             chhhhHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999877663

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-41  Score=316.31  Aligned_cols=207  Identities=23%  Similarity=0.291  Sum_probs=177.5

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEE
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYS  174 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~  174 (358)
                      ...+..++|.+.+.||+|+||.||+|.+.     .++..||||+++...  .......+.+|+.+++.++||||++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            34567799999999999999999999987     345899999998653  34456678999999999999999999999


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMRE------------------------ETLTETVARFYIAQSVLAIESIHKHNYIHR  230 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHr  230 (358)
                      |.+.+..|+||||+++|+|.+++...                        ..+++..+..++.|++.||.|||+.||+||
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999999999999999999763                        568999999999999999999999999999


Q ss_pred             CCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcc
Q 018275          231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRK  310 (358)
Q Consensus       231 Dikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (358)
                      ||||+|||++.++.+||+|||+++........                                               .
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~  231 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-----------------------------------------------K  231 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-----------------------------------------------C
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccc-----------------------------------------------c
Confidence            99999999999999999999998765321100                                               0


Q ss_pred             ccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          311 LAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       311 ~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ......||+.|+|||++.+..|+.++|+|||||++|||+. +..+|
T Consensus       232 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            0113468999999999999999999999999999999997 65444

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.2e-41  Score=324.77  Aligned_cols=206  Identities=23%  Similarity=0.290  Sum_probs=176.1

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..+++.||||+++...  .......+.+|+.+++.++|||||++++++.+.+.
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            3456688999999999999999999999899999999987542  33444568889999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      +|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999999999765 46899999999999999999999999999999999999999999999999999754321


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ....                                               ......+|+.|+|||++.+..|+.++|||
T Consensus       267 ~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  299 (377)
T 3cbl_A          267 VYAA-----------------------------------------------SGGLRQVPVKWTAPEALNYGRYSSESDVW  299 (377)
T ss_dssp             EEEC-----------------------------------------------CSSCCEEEGGGSCHHHHHHCEEEHHHHHH
T ss_pred             ceee-----------------------------------------------cCCCCCCCcCcCCHhHhccCCCCchhhHH
Confidence            1000                                               00012367889999999999999999999


Q ss_pred             hhhHHHHhhcc-ccccc
Q 018275          340 AYWNETLSCNY-LSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~-~~~~~  355 (358)
                      ||||++|||+. +..+|
T Consensus       300 slG~il~el~t~g~~p~  316 (377)
T 3cbl_A          300 SFGILLWETFSLGASPY  316 (377)
T ss_dssp             HHHHHHHHHHTTSCCSS
T ss_pred             HHHHHHHHHHhCCCCCC
Confidence            99999999997 65544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.4e-40  Score=303.95  Aligned_cols=201  Identities=29%  Similarity=0.482  Sum_probs=176.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc---hhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS---RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++.......   ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57999999999999999999999999999999987654221   123567889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC----cEEEEecCCCccCCC
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLDC  258 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~vkl~DFGla~~~~~  258 (358)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++    .+||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888999999999999999999999999999999999999998887    899999999976532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ...                                                  .....||+.|+|||++.+..++.++|+
T Consensus       165 ~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di  194 (283)
T 3bhy_A          165 GNE--------------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADM  194 (283)
T ss_dssp             ---------------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHH
T ss_pred             CCc--------------------------------------------------ccccCCCcCccCcceecCCCCCcchhh
Confidence            110                                                  113469999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      ||||+++|+|+++..+|.
T Consensus       195 ~slG~il~~l~~g~~p~~  212 (283)
T 3bhy_A          195 WSIGVITYILLSGASPFL  212 (283)
T ss_dssp             HHHHHHHHHHHHSSCTTC
T ss_pred             hhHHHHHHHHHHCCCCCC
Confidence            999999999999877653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7e-41  Score=316.26  Aligned_cols=206  Identities=29%  Similarity=0.446  Sum_probs=171.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh--chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ++|.+.+.||+|+||.||+|.+..++..||+|++......  .......+.+|+.+++.++|||||+++++|.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            6799999999999999999999999999999999876432  34556778999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 018275          184 IMEYLPGGDVMTLLMR----------------------------------------EETLTETVARFYIAQSVLAIESIH  223 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~----------------------------------------~~~~~~~~~~~~~~qi~~aL~~LH  223 (358)
                      ||||+++|+|.+++..                                        ...+++..+..++.|++.||.|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999842                                        112356778889999999999999


Q ss_pred             hCCceeCCCCCCCEEEcCCC--cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHH
Q 018275          224 KHNYIHRDIKPDNLLLDQNG--HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQL  301 (358)
Q Consensus       224 ~~~iiHrDikp~NILl~~~~--~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (358)
                      +.||+||||||+|||++.++  .+||+|||+++.+........                                     
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~-------------------------------------  228 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY-------------------------------------  228 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc-------------------------------------
Confidence            99999999999999998776  899999999986532111000                                     


Q ss_pred             HHHhhhhccccccccCCCCCchhhhhcC--CCCCccchhhhhhHHHHhhcccccccc
Q 018275          302 QHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       302 ~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                              ....+.+||+.|+|||++.+  ..|+.++|||||||++|||+++..+|.
T Consensus       229 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  277 (345)
T 3hko_A          229 --------YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFP  277 (345)
T ss_dssp             --------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             --------ccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence                    00114479999999999975  679999999999999999999887663

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=323.80  Aligned_cols=206  Identities=19%  Similarity=0.236  Sum_probs=172.2

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEE-----EecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      ..+..++|.+.+.||+|+||.||+|.     +..++..||||+++...  .......+.+|+.+++.++|||||++++++
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            34566899999999999999999998     44577899999997542  344455688899999999999999999999


Q ss_pred             ecCCEEEEEEeecCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC---cE
Q 018275          176 QDAEYLYLIMEYLPGGDVMTLLMRE-------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HM  245 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~---~v  245 (358)
                      .+....++||||+++|+|.+++...       ..++...+..++.|++.||.|||+.||+||||||+|||++.++   .+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            9999999999999999999999764       3588999999999999999999999999999999999999655   59


Q ss_pred             EEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhh
Q 018275          246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE  325 (358)
Q Consensus       246 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APE  325 (358)
                      ||+|||+|+.+.....                                               ........||+.|+|||
T Consensus       224 kL~DFG~a~~~~~~~~-----------------------------------------------~~~~~~~~~t~~y~aPE  256 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGY-----------------------------------------------YRKGGCAMLPVKWMPPE  256 (367)
T ss_dssp             EECCCHHHHHHHHHSS-----------------------------------------------CTTCCGGGSCGGGCCHH
T ss_pred             EECCCccccccccccc-----------------------------------------------cccCCCcCCcccEECHH
Confidence            9999999875421110                                               00112347899999999


Q ss_pred             hhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          326 VLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       326 v~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ++.+..|+.++|||||||++|||+. +..+|
T Consensus       257 ~~~~~~~~~~~DvwslG~il~ellt~g~~pf  287 (367)
T 3l9p_A          257 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY  287 (367)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             HhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999997 65544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=318.89  Aligned_cols=197  Identities=28%  Similarity=0.378  Sum_probs=167.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----  179 (358)
                      .++|.+++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            478999999999999999999999999999999996543 23445567889999999999999999999997653     


Q ss_pred             -EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 -~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                       .+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence             469999999 8899999865 6789999999999999999999999999999999999999999999999999986531


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~D  337 (358)
                      ..                                                    ...+||+.|+|||++.+ ..|+.++|
T Consensus       181 ~~----------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~D  208 (367)
T 1cm8_A          181 EM----------------------------------------------------TGYVVTRWYRAPEVILNWMRYTQTVD  208 (367)
T ss_dssp             SC----------------------------------------------------CSSCSCGGGCCTHHHHTTTCCCTTHH
T ss_pred             cc----------------------------------------------------CcCcCCCCcCCHHHHhCCCCCChhhh
Confidence            10                                                    13479999999999987 78999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|||+++..+|.
T Consensus       209 iwslG~il~ell~g~~pf~  227 (367)
T 1cm8_A          209 IWSVGCIMAEMITGKTLFK  227 (367)
T ss_dssp             HHHHHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999887764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-40  Score=329.59  Aligned_cols=199  Identities=31%  Similarity=0.475  Sum_probs=170.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      +.|.+++.||+|+||+||+|.+..++..||||++.+.... ......+.+|+.+++.++|||||+++++|.+...+|+||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5699999999999999999999999999999999875432 233456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC---CcEEEEecCCCccCCCCCCc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||+++|+|.+.+....++++..+..++.||+.||.|||+.||+||||||+|||++.+   +.+||+|||+|+......  
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--  193 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--  193 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence            999999999999888899999999999999999999999999999999999999764   559999999997654211  


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                      ...+.+||+.|+|||++. ..|+.++||||||
T Consensus       194 ------------------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG  224 (494)
T 3lij_A          194 ------------------------------------------------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIG  224 (494)
T ss_dssp             ------------------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHH
T ss_pred             ------------------------------------------------cccccCCCcCeeCHHHHc-ccCCCchhHHHHH
Confidence                                                            011347999999999986 4699999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|+|+++..+|.
T Consensus       225 ~il~~ll~g~~pf~  238 (494)
T 3lij_A          225 VILFILLAGYPPFG  238 (494)
T ss_dssp             HHHHHHHHSSCSSC
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999999877663

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=315.14  Aligned_cols=206  Identities=21%  Similarity=0.290  Sum_probs=173.4

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~  174 (358)
                      ..+..++|.+.+.||+|+||.||+|.+.     .++..||||++....  .......+.+|+.++..+ +||||++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            4567789999999999999999999973     356689999997543  233456688999999999 89999999999


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMREE-----------------------TLTETVARFYIAQSVLAIESIHKHNYIHRD  231 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrD  231 (358)
                      +.+.+..++||||+++|+|.+++....                       .+++..+..++.|++.||.|||+.||+|||
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  197 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  197 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            999999999999999999999997643                       378889999999999999999999999999


Q ss_pred             CCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccc
Q 018275          232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL  311 (358)
Q Consensus       232 ikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (358)
                      |||+|||++.++.+||+|||++..........                                               .
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-----------------------------------------------~  230 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYV-----------------------------------------------V  230 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSE-----------------------------------------------E
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccce-----------------------------------------------e
Confidence            99999999999999999999998653221100                                               0


Q ss_pred             cccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          312 AYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       312 ~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      .....||+.|+|||++.+..|+.++|||||||++|||++ +..+|
T Consensus       231 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          231 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            113468899999999999999999999999999999997 66554

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.5e-40  Score=315.09  Aligned_cols=200  Identities=30%  Similarity=0.496  Sum_probs=175.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh-----hchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCC
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-----LSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~  179 (358)
                      ++|.+.+.||+|+||.||+|.+..+|+.||||++.....     ........+.+|+.++..+ +||||++++++|....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999998999999999876431     1122345678899999999 7999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ..|+||||++|++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..+...
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999766422


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC------CCCC
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK------KGYG  333 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~------~~y~  333 (358)
                      ..                                                  ....+||+.|+|||++.+      ..|+
T Consensus       254 ~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~  283 (365)
T 2y7j_A          254 EK--------------------------------------------------LRELCGTPGYLAPEILKCSMDETHPGYG  283 (365)
T ss_dssp             CC--------------------------------------------------BCCCCSCGGGCCHHHHHHTTCTTSCCBC
T ss_pred             cc--------------------------------------------------cccCCCCCCccChhhccccccccCcCCC
Confidence            10                                                  113479999999999963      4689


Q ss_pred             ccchhhhhhHHHHhhccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .++|||||||++|||+++..+|
T Consensus       284 ~~~Di~slG~il~ell~g~~pf  305 (365)
T 2y7j_A          284 KEVDLWACGVILFTLLAGSPPF  305 (365)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSS
T ss_pred             chhhHHhHHHHHHHHHHCCCCC
Confidence            9999999999999999988765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.8e-41  Score=305.00  Aligned_cols=202  Identities=19%  Similarity=0.232  Sum_probs=174.4

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.++||||+++++++.+...
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   79 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence            3456789999999999999999999876 467899999986532    23458899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999999999999654 56899999999999999999999999999999999999999999999999999765321


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ..                                                .......||+.|+|||++.+..++.++|+|
T Consensus       160 ~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  191 (269)
T 4hcu_A          160 QY------------------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVW  191 (269)
T ss_dssp             HH------------------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred             cc------------------------------------------------ccccCcccccccCCHHHhcCCCCCchhhhH
Confidence            10                                                011134678899999999999999999999


Q ss_pred             hhhHHHHhhcc-ccccc
Q 018275          340 AYWNETLSCNY-LSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~-~~~~~  355 (358)
                      ||||++|+|++ +..+|
T Consensus       192 slG~~l~~ll~~g~~p~  208 (269)
T 4hcu_A          192 SFGVLMWEVFSEGKIPY  208 (269)
T ss_dssp             HHHHHHHHHHTTSCCTT
T ss_pred             HHHHHHHHHhcCCCCCC
Confidence            99999999998 65554

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.4e-40  Score=302.59  Aligned_cols=196  Identities=22%  Similarity=0.343  Sum_probs=170.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            679999999999999999999999999999999986532 233445677889899988 999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC------------------
Q 018275          185 MEYLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN------------------  242 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~------------------  242 (358)
                      |||+++++|.+++...    ..+++..+..++.|++.||.|||+.||+||||||+|||++.+                  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            9999999999999764    679999999999999999999999999999999999999854                  


Q ss_pred             -CcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCC
Q 018275          243 -GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY  321 (358)
Q Consensus       243 -~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y  321 (358)
                       ..+||+|||++.......                                                     ...||+.|
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~-----------------------------------------------------~~~gt~~y  196 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSPQ-----------------------------------------------------VEEGDSRF  196 (289)
T ss_dssp             CCCEEECCCTTCEETTCSC-----------------------------------------------------CCCCCGGG
T ss_pred             ceEEEEcccccccccCCcc-----------------------------------------------------ccCCCccc
Confidence             479999999987654211                                                     23599999


Q ss_pred             chhhhhcCC-CCCccchhhhhhHHHHhhccccccc
Q 018275          322 IAPEVLLKK-GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       322 ~APEv~~~~-~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +|||++.+. .++.++|||||||++|+++.+..++
T Consensus       197 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          197 LANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             CCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence            999999876 6678999999999999999876543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-40  Score=305.22  Aligned_cols=198  Identities=27%  Similarity=0.449  Sum_probs=171.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+.+.||+|+||.||+|.+..++..||+|++....  .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            378999999999999999999999999999999998764  334456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---cCCCcEEEEecCCCccCC
Q 018275          185 MEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~vkl~DFGla~~~~  257 (358)
                      |||+++|+|.+.+..    ...+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++....
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999998854    3689999999999999999999999999999999999999   556889999999997653


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ....                                                  ....+||+.|+|||++. ..++.++|
T Consensus       179 ~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~D  207 (285)
T 3is5_A          179 SDEH--------------------------------------------------STNAAGTALYMAPEVFK-RDVTFKCD  207 (285)
T ss_dssp             ----------------------------------------------------------CTTGGGCCHHHHT-TCCCHHHH
T ss_pred             Cccc--------------------------------------------------CcCcccccCcCChHHhc-cCCCcccC
Confidence            2110                                                  11347999999999986 56899999


Q ss_pred             hhhhhHHHHhhccccccc
Q 018275          338 WLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~  355 (358)
                      +|||||++|||+++..+|
T Consensus       208 i~slG~il~~ll~g~~pf  225 (285)
T 3is5_A          208 IWSAGVVMYFLLTGCLPF  225 (285)
T ss_dssp             HHHHHHHHHHHHHSSCSS
T ss_pred             eehHHHHHHHHHhCCCCC
Confidence            999999999999987665

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.4e-41  Score=312.77  Aligned_cols=209  Identities=21%  Similarity=0.289  Sum_probs=160.6

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCC---EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      ....+..++|.+.+.||+|+||.||+|.+..++.   .||||++..... .....+.+.+|+.+++.++||||+++++++
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            3445667899999999999999999999877665   899999976543 344567789999999999999999999999


Q ss_pred             ecCCEE------EEEEeecCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC
Q 018275          176 QDAEYL------YLIMEYLPGGDVMTLLMREE------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG  243 (358)
Q Consensus       176 ~~~~~~------~lV~E~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  243 (358)
                      .+....      ++||||+++|+|.+++....      .+++..+..++.|++.||.|||+.||+||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            877655      99999999999999996432      689999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCch
Q 018275          244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA  323 (358)
Q Consensus       244 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~A  323 (358)
                      .+||+|||+++.........                                               ......||+.|+|
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~a  207 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYR-----------------------------------------------QGCASKLPVKWLA  207 (323)
T ss_dssp             CEEECCCCC----------------------------------------------------------------CCGGGCC
T ss_pred             CEEEeecccccccccccccc-----------------------------------------------ccccccCcccccC
Confidence            99999999998654221100                                               0113357889999


Q ss_pred             hhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          324 PEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       324 PEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ||++.+..|+.++|||||||++|||++ +..+|
T Consensus       208 PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~  240 (323)
T 3qup_A          208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY  240 (323)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             chhhcCCCCCCccchhhHHHHHHHHHhCCCCCc
Confidence            999999999999999999999999998 65554

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1e-40  Score=313.82  Aligned_cols=203  Identities=21%  Similarity=0.293  Sum_probs=166.0

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCE----EEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI----YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      +..++|++.+.||+|+||.||+|.+..++..    ||+|.+....  .......+.+|+.+++.++||||++++++|.+.
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            3457899999999999999999998877765    4788776542  334456788999999999999999999999876


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      . .++|+||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+.+.
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            5 78999999999999999774 679999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ......                                               ......||+.|+|||++.+..|+.++|
T Consensus       169 ~~~~~~-----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~D  201 (327)
T 3poz_A          169 AEEKEY-----------------------------------------------HAEGGKVPIKWMALESILHRIYTHQSD  201 (327)
T ss_dssp             TTCC------------------------------------------------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred             CCcccc-----------------------------------------------cccCCCccccccChHHhccCCCCchhh
Confidence            221110                                               011335788999999999999999999


Q ss_pred             hhhhhHHHHhhcc-ccccc
Q 018275          338 WLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~~  355 (358)
                      ||||||++|||++ +..+|
T Consensus       202 i~slG~il~ellt~g~~p~  220 (327)
T 3poz_A          202 VWSYGVTVWELMTFGSKPY  220 (327)
T ss_dssp             HHHHHHHHHHHHTTSCCTT
T ss_pred             hhhhHHHHHHHHhcCCCCc
Confidence            9999999999998 66555

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.9e-41  Score=311.47  Aligned_cols=207  Identities=22%  Similarity=0.373  Sum_probs=171.2

Q ss_pred             CCCceee-eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEE
Q 018275          105 VDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       105 ~~~~~~~-~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~  182 (358)
                      .+.|.+. +.||+|+||.||+|.+..+++.||||++....   ......+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            3678885 78999999999999999999999999997652   33455688899999885 7999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc---EEEEecCCCccCCCC
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLDCT  259 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~---vkl~DFGla~~~~~~  259 (358)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.   +||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999988889999999999999999999999999999999999999998876   999999999865422


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-----CCCCc
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KGYGM  334 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-----~~y~~  334 (358)
                      ......                                          ........+||+.|+|||++.+     ..|+.
T Consensus       168 ~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  205 (316)
T 2ac3_A          168 GDCSPI------------------------------------------STPELLTPCGSAEYMAPEVVEAFSEEASIYDK  205 (316)
T ss_dssp             --------------------------------------------------------CCSGGGCCHHHHHHTSHHHHHHTT
T ss_pred             Cccccc------------------------------------------cccccccccCCcCccChHHhhcccccccCCCc
Confidence            110000                                          0001123479999999999975     56899


Q ss_pred             cchhhhhhHHHHhhcccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ++|||||||++|||+++..+|.
T Consensus       206 ~~DiwslG~il~~l~~g~~pf~  227 (316)
T 2ac3_A          206 RCDLWSLGVILYILLSGYPPFV  227 (316)
T ss_dssp             THHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccHhHHHHHHHHHHCCCCCc
Confidence            9999999999999999887763

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.1e-40  Score=303.81  Aligned_cols=199  Identities=24%  Similarity=0.369  Sum_probs=174.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec----CCE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----AEY  180 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~~~  180 (358)
                      ...|.+.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||++++++|.+    ...
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            3568999999999999999999999999999999986543 44556778899999999999999999998865    467


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEc-CCCcEEEEecCCCccCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--iiHrDikp~NILl~-~~~~vkl~DFGla~~~~  257 (358)
                      +++||||+++++|.+++.....+++..+..++.|++.||.|||+.+  |+||||||+|||++ .++.+||+|||++....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            9999999999999999988889999999999999999999999999  99999999999998 78999999999986543


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ...                                                   ....+||+.|+|||++.+ .++.++|
T Consensus       184 ~~~---------------------------------------------------~~~~~~t~~y~aPE~~~~-~~~~~~D  211 (290)
T 1t4h_A          184 ASF---------------------------------------------------AKAVIGTPEFMAPEMYEE-KYDESVD  211 (290)
T ss_dssp             TTS---------------------------------------------------BEESCSSCCCCCGGGGGT-CCCTHHH
T ss_pred             ccc---------------------------------------------------cccccCCcCcCCHHHHhc-cCCCcch
Confidence            111                                                   113479999999999875 5999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      +|||||++|+|+++..+|.
T Consensus       212 i~slG~~l~~l~~g~~pf~  230 (290)
T 1t4h_A          212 VYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             HHHHHHHHHHHHHSSCTTT
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999877653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-40  Score=313.06  Aligned_cols=203  Identities=29%  Similarity=0.427  Sum_probs=175.3

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            45889999999999999999999999999999999865532 33445567889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||||+++++|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....  
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  179 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--  179 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence            999999999999887778899999999999999999999999999999999999999999999999999976542110  


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYW  342 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlG  342 (358)
                                                                     .....+||+.|+|||++.+. .++.++||||||
T Consensus       180 -----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG  212 (331)
T 4aaa_A          180 -----------------------------------------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIG  212 (331)
T ss_dssp             ---------------------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHH
T ss_pred             -----------------------------------------------ccCCCcCCccccCcccccCCCCcchHHHHHHHH
Confidence                                                           01134799999999999876 789999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|+|+++..+|.
T Consensus       213 ~il~~l~~g~~pf~  226 (331)
T 4aaa_A          213 CLVTEMFMGEPLFP  226 (331)
T ss_dssp             HHHHHHHHSSCSCC
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999999987764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.2e-40  Score=319.29  Aligned_cols=201  Identities=25%  Similarity=0.390  Sum_probs=170.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc--CcceEEEEEEeecCCEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA--SHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~l~~~~~~~~~~~  182 (358)
                      ..+|.+++.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.++..+.  |||||++++++.+...+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            4569999999999999999998754 89999999976542 3455677899999999997  499999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||| +.+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.+......
T Consensus       133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9999 56889999999888999999999999999999999999999999999999995 689999999999876422110


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-----------CC
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----------KG  331 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-----------~~  331 (358)
                      .                                               ...+.+||+.|+|||++.+           ..
T Consensus       211 ~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  243 (390)
T 2zmd_A          211 V-----------------------------------------------VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSK  243 (390)
T ss_dssp             --------------------------------------------------CCSCCCGGGCCHHHHHCC------------
T ss_pred             c-----------------------------------------------cCCCCCcCCCccChHHhhhccccccccccccC
Confidence            0                                               1124579999999999976           46


Q ss_pred             CCccchhhhhhHHHHhhcccccccc
Q 018275          332 YGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      |+.++|||||||++|||+++..+|.
T Consensus       244 ~~~~~DiwSlGvil~ell~G~~Pf~  268 (390)
T 2zmd_A          244 ISPKSDVWSLGCILYYMTYGKTPFQ  268 (390)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCChhhHHHHHHHHHHHHHCCCcch
Confidence            8999999999999999999887663

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.3e-40  Score=307.76  Aligned_cols=196  Identities=30%  Similarity=0.484  Sum_probs=173.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.....   .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            679999999999999999999999999999999986532   22345788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---cCCCcEEEEecCCCccCCCCCCc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--  163 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--  163 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT--
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc--
Confidence            999999999999888899999999999999999999999999999999999999   788999999999987543110  


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ....+||+.|+|||++.+..|+.++|+||||
T Consensus       164 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  194 (304)
T 2jam_A          164 -------------------------------------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIG  194 (304)
T ss_dssp             -------------------------------------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHH
T ss_pred             -------------------------------------------------cccccCCCCccChHHhccCCCCchhhHHHHH
Confidence                                                             1134699999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|+|+++..+|
T Consensus       195 ~il~~l~~g~~pf  207 (304)
T 2jam_A          195 VITYILLCGYPPF  207 (304)
T ss_dssp             HHHHHHHHSSCTT
T ss_pred             HHHHHHHHCCCCC
Confidence            9999999987765

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-40  Score=318.17  Aligned_cols=211  Identities=17%  Similarity=0.150  Sum_probs=169.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecC-----CCEEEEEecchhhhhchhh--------HHHHHHHHHHHHHhcCcceE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQ--------VEHVRAERNLLAEVASHCIV  169 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~--------~~~~~~E~~il~~l~h~~iv  169 (358)
                      +..++|.+.+.||+|+||.||+|.+..+     ++.||||++..........        ...+..|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3456999999999999999999988764     5889999987553111111        11233455566677899999


Q ss_pred             EEEEEeecC----CEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc--CC
Q 018275          170 KLYYSFQDA----EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--QN  242 (358)
Q Consensus       170 ~l~~~~~~~----~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~--~~  242 (358)
                      ++++++.+.    .+.|+||||+ |++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    5689999999 99999999776 6899999999999999999999999999999999999999  88


Q ss_pred             CcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCc
Q 018275          243 GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI  322 (358)
Q Consensus       243 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~  322 (358)
                      +.+||+|||+|+.+..........                                          .......+||+.|+
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~------------------------------------------~~~~~~~~gt~~y~  228 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYA------------------------------------------ADPKRCHDGTIEFT  228 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSS------------------------------------------CCSSCCCCCCTTTC
T ss_pred             CeEEEEECCcceecccCCcccccc------------------------------------------cCcccccCCCCCcc
Confidence            999999999998765322111000                                          00112457999999


Q ss_pred             hhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          323 APEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       323 APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      |||++.+..|+.++|||||||++|||+++..+|.
T Consensus       229 aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          229 SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             CHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999999999999999999999999999887764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.4e-40  Score=302.25  Aligned_cols=207  Identities=20%  Similarity=0.194  Sum_probs=176.4

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~  180 (358)
                      .+..++|.+.+.||+|+||.||+|.+..+++.||||++.....     ...+.+|+.++..+ +|++++.+++++.+...
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            3456889999999999999999999999999999999865432     12377899999999 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc-----EEEEecCCCc
Q 018275          181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH-----MKLSDFGLCK  254 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~-----vkl~DFGla~  254 (358)
                      .++||||+ +++|.+++... .++++..+..++.|++.||.|||+.||+||||||+|||++.++.     +||+|||+++
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999999 99999999765 46999999999999999999999999999999999999988776     9999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCc
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM  334 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~  334 (358)
                      ............                                          .......+||+.|+|||++.+..++.
T Consensus       160 ~~~~~~~~~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~  197 (298)
T 1csn_A          160 FYRDPVTKQHIP------------------------------------------YREKKNLSGTARYMSINTHLGREQSR  197 (298)
T ss_dssp             ESBCTTTCCBCC------------------------------------------CCCCCCCCSCTTTCCHHHHTTCCCCH
T ss_pred             cccccccccccc------------------------------------------ccCccCCCCCcccCCchhhcCCCCCh
Confidence            764322111000                                          00122457999999999999999999


Q ss_pred             cchhhhhhHHHHhhcccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ++|||||||++|||+++..+|.
T Consensus       198 ~~Di~slG~il~el~~g~~pf~  219 (298)
T 1csn_A          198 RDDLEALGHVFMYFLRGSLPWQ  219 (298)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTS
T ss_pred             HHHHHHHHHHHHHHHcCCCCcc
Confidence            9999999999999999887764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.3e-41  Score=323.61  Aligned_cols=202  Identities=26%  Similarity=0.368  Sum_probs=175.1

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC--E
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE--Y  180 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~  180 (358)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.+++.++||||+++++++.+..  .
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            345789999999999999999999999999999999986543  233566788999999999999999999998655  7


Q ss_pred             EEEEEeecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE----cCCCcEEEEecCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLC  253 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl----~~~~~vkl~DFGla  253 (358)
                      .|+||||+++|+|.+++....   .+++..+..++.|++.||.|||+.||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            899999999999999997543   39999999999999999999999999999999999999    78888999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC----
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK----  329 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~----  329 (358)
                      +......                                                  ...+.+||+.|+|||++.+    
T Consensus       164 ~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~  193 (396)
T 4eut_A          164 RELEDDE--------------------------------------------------QFVSLYGTEEYLHPDMYERAVLR  193 (396)
T ss_dssp             EECCCGG--------------------------------------------------GSSCSSSCCTTCCHHHHHHHCC-
T ss_pred             eEccCCC--------------------------------------------------ccccccCCccccCHHHhhccccc
Confidence            8654211                                                  0113479999999999975    


Q ss_pred             ----CCCCccchhhhhhHHHHhhcccccccc
Q 018275          330 ----KGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       330 ----~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                          ..|+.++|||||||++|||+++..+|.
T Consensus       194 ~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~  224 (396)
T 4eut_A          194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFR  224 (396)
T ss_dssp             -CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred             cccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence                568899999999999999999887763

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.9e-41  Score=312.69  Aligned_cols=203  Identities=23%  Similarity=0.313  Sum_probs=176.1

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ....++|.+.+.||+|+||.||+|.+ .++..||||++...   .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            34568999999999999999999985 46889999998765   234566788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          182 YLIMEYLPGGDVMTLLMREE----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  190 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT  190 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99999999999999986543    58899999999999999999999999999999999999999999999999997643


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ......                                               ......||+.|+|||++.+..|+.++|
T Consensus       191 ~~~~~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D  223 (321)
T 2qkw_B          191 ELDQTH-----------------------------------------------LSTVVKGTLGYIDPEYFIKGRLTEKSD  223 (321)
T ss_dssp             SSSCCC-----------------------------------------------CBCCCEEETTTCCHHHHHHCBCCTHHH
T ss_pred             cccccc-----------------------------------------------cccccCCCccccCHHHhcCCCCCcccc
Confidence            221110                                               011346999999999999999999999


Q ss_pred             hhhhhHHHHhhccccccc
Q 018275          338 WLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~  355 (358)
                      ||||||++|||+++...|
T Consensus       224 i~slG~il~ell~g~~p~  241 (321)
T 2qkw_B          224 VYSFGVVLFEVLCARSAI  241 (321)
T ss_dssp             HHHHHHHHHHHHHCCTTC
T ss_pred             hHhHHHHHHHHHhCCCcc
Confidence            999999999999987665

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.8e-40  Score=314.66  Aligned_cols=198  Identities=24%  Similarity=0.325  Sum_probs=165.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----  179 (358)
                      .++|.+++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++.+..     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            489999999999999999999999999999999997643 23445567889999999999999999999997665     


Q ss_pred             -EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 -~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                       ..|+||||++ ++|.+.+.  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          103 QDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             CEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             cceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence             7899999996 47888874  4588999999999999999999999999999999999999999999999999975531


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ..                                                  .....+||+.|+|||++.+..|+.++||
T Consensus       180 ~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di  209 (371)
T 2xrw_A          180 SF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDI  209 (371)
T ss_dssp             ------------------------------------------------------------CTTCCHHHHTTCCCCTTHHH
T ss_pred             cc--------------------------------------------------ccCCceecCCccCHHHhcCCCCCchHhH
Confidence            11                                                  0113479999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||++|||+++..+|.
T Consensus       210 wslG~il~el~~g~~pf~  227 (371)
T 2xrw_A          210 WSVGCIMGEMIKGGVLFP  227 (371)
T ss_dssp             HHHHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHHHHhCCCCCC
Confidence            999999999999887764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.4e-41  Score=320.08  Aligned_cols=207  Identities=19%  Similarity=0.265  Sum_probs=166.2

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      ..+..++|.+.+.||+|+||.||+|.+.   .++..||||+++...  .......+.+|+.+++.++||||+++++++.+
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            3456689999999999999999999876   467789999997653  34456678999999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999999999999765 47999999999999999999999999999999999999999999999999999866


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      ........                                              ......+|+.|+|||++.+..|+.++
T Consensus       198 ~~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~  231 (373)
T 2qol_A          198 EDDPEAAY----------------------------------------------TTRGGKIPIRWTSPEAIAYRKFTSAS  231 (373)
T ss_dssp             --------------------------------------------------------------CTTSCHHHHHHCCCCHHH
T ss_pred             ccCCccce----------------------------------------------eccCCCcCCCccChhhhccCCcCchh
Confidence            42211000                                              00122468899999999999999999


Q ss_pred             hhhhhhHHHHhhcc-ccccc
Q 018275          337 DWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~-~~~~~  355 (358)
                      |||||||++||++. +..+|
T Consensus       232 Dv~SlG~il~ellt~g~~P~  251 (373)
T 2qol_A          232 DVWSYGIVLWEVMSYGERPY  251 (373)
T ss_dssp             HHHHHHHHHHHHHTTC-CTT
T ss_pred             cHHHHHHHHHHHHhCCCCCC
Confidence            99999999999886 65544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-40  Score=301.95  Aligned_cols=201  Identities=22%  Similarity=0.286  Sum_probs=173.7

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .+..++|.+.+.||+|+||.||+|.+. ++..||+|++.....    ....+.+|+.++..++||||+++++++.+....
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            456689999999999999999999765 566899999976532    234588999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999999999999765 459999999999999999999999999999999999999999999999999997654221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ..                                                ......||+.|+|||++.+..++.++|+||
T Consensus       159 ~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  190 (268)
T 3sxs_A          159 YV------------------------------------------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWA  190 (268)
T ss_dssp             EE------------------------------------------------ECCSCCCCGGGCCHHHHHHSEEETTHHHHH
T ss_pred             hh------------------------------------------------cccCCCcCcccCCHHHHhccCCchhhhhHH
Confidence            10                                                011335788899999999999999999999


Q ss_pred             hhHHHHhhcc-ccccc
Q 018275          341 YWNETLSCNY-LSDIM  355 (358)
Q Consensus       341 lGvil~e~l~-~~~~~  355 (358)
                      ||+++|+|+. +..+|
T Consensus       191 lG~il~~l~~~g~~p~  206 (268)
T 3sxs_A          191 FGILMWEVFSLGKMPY  206 (268)
T ss_dssp             HHHHHHHHHTTTCCTT
T ss_pred             HHHHHHHHHcCCCCCc
Confidence            9999999997 66554

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-40  Score=305.34  Aligned_cols=204  Identities=22%  Similarity=0.264  Sum_probs=164.5

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      ..+..++|++.+.||+|+||.||+|.+..+   +..||+|++....  .....+.+.+|+.+++.++||||+++++++. 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence            456678999999999999999999998653   4579999987643  3445567889999999999999999999985 


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      .+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            456899999999999999997654 7899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      ......                                                ......+|+.|+|||++.+..|+.++
T Consensus       167 ~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~  198 (281)
T 1mp8_A          167 EDSTYY------------------------------------------------KASKGKLPIKWMAPESINFRRFTSAS  198 (281)
T ss_dssp             ------------------------------------------------------------CCGGGCCHHHHHHCCCSHHH
T ss_pred             Cccccc------------------------------------------------ccccCCCcccccChhhcccCCCCCcc
Confidence            422100                                                01123578899999999999999999


Q ss_pred             hhhhhhHHHHhhcc-ccccc
Q 018275          337 DWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~-~~~~~  355 (358)
                      |||||||++|||++ +..+|
T Consensus       199 Di~slG~~l~ell~~g~~pf  218 (281)
T 1mp8_A          199 DVWMFGVCMWEILMHGVKPF  218 (281)
T ss_dssp             HHHHHHHHHHHHHTTSCCTT
T ss_pred             CchHHHHHHHHHHhcCCCCC
Confidence            99999999999996 55444

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.1e-40  Score=308.48  Aligned_cols=206  Identities=23%  Similarity=0.255  Sum_probs=177.3

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEE-----ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQE-----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~  174 (358)
                      ..+..++|.+.+.||+|+||.||+|.+     ..++..||||++....  .....+.+.+|+.+++.+ +||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            456678999999999999999999985     3467899999998653  234456788999999999 99999999999


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMREE------------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN  236 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~N  236 (358)
                      +.+.+..++||||+++|+|.+++....                  ++++..+..++.|++.||.|||+.||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            999999999999999999999997653                  48999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccccc
Q 018275          237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV  316 (358)
Q Consensus       237 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  316 (358)
                      ||++.++.+||+|||+++.........                                               ......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~  208 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYV-----------------------------------------------VKGNAR  208 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSE-----------------------------------------------ECSSSE
T ss_pred             EEEcCCCCEEEccccccccccccccce-----------------------------------------------eccCCC
Confidence            999999999999999998664322110                                               011335


Q ss_pred             CCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          317 GTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       317 gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ||+.|+|||++.+..++.++|+|||||++|||++ +..+|
T Consensus       209 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  248 (313)
T 1t46_A          209 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (313)
T ss_dssp             ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence            8899999999999999999999999999999997 66554

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.6e-41  Score=314.45  Aligned_cols=200  Identities=22%  Similarity=0.227  Sum_probs=168.4

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC---
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA---  178 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~---  178 (358)
                      .+..++|++.+.||+|+||.||+|.+.  ++.||||++....    ........|+.+++.++|||||++++++.+.   
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            355688999999999999999999765  7899999997653    2233455688889999999999999999864   


Q ss_pred             -CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeCCCCCCCEEEcCCCcEEE
Q 018275          179 -EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH----------NYIHRDIKPDNLLLDQNGHMKL  247 (358)
Q Consensus       179 -~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~----------~iiHrDikp~NILl~~~~~vkl  247 (358)
                       ..+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.          ||+||||||+|||++.++.+||
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence             347999999999999999965 5689999999999999999999999          9999999999999999999999


Q ss_pred             EecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh
Q 018275          248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL  327 (358)
Q Consensus       248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~  327 (358)
                      +|||+|+.+.......                                               .....+||+.|+|||++
T Consensus       173 ~DFg~a~~~~~~~~~~-----------------------------------------------~~~~~~gt~~y~aPE~~  205 (322)
T 3soc_A          173 ADFGLALKFEAGKSAG-----------------------------------------------DTHGQVGTRRYMAPEVL  205 (322)
T ss_dssp             CCCTTCEEECTTSCCC-----------------------------------------------CCTTCCCCGGGCCHHHH
T ss_pred             ccCCcccccccccCcc-----------------------------------------------ccccCccCccccCHhhc
Confidence            9999997664221110                                               01134799999999999


Q ss_pred             cC-----CCCCccchhhhhhHHHHhhccccccc
Q 018275          328 LK-----KGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       328 ~~-----~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .+     ..++.++|||||||++|||+++..+|
T Consensus       206 ~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf  238 (322)
T 3soc_A          206 EGAINFQRDAFLRIDMYAMGLVLWELASRCTAA  238 (322)
T ss_dssp             TTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred             ccccccCcCCCccchhHHHHHHHHHHHhCCCCC
Confidence            87     35677899999999999999987665

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-40  Score=303.20  Aligned_cols=202  Identities=27%  Similarity=0.419  Sum_probs=177.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG--CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc--chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            67999999999999999999999999999999997654  2344567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........   
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~---  161 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE---  161 (276)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE---
T ss_pred             EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch---
Confidence            99999999999987788999999999999999999999999999999999999999999999999999765321100   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-CccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-~~~~DiwSlGvi  344 (358)
                                                                  ......+||+.|+|||++.+..+ +.++|+|||||+
T Consensus       162 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i  197 (276)
T 2yex_A          162 --------------------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV  197 (276)
T ss_dssp             --------------------------------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHH
T ss_pred             --------------------------------------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHH
Confidence                                                        01123479999999999998776 778999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +|+|+++...|.
T Consensus       198 l~~l~~g~~p~~  209 (276)
T 2yex_A          198 LTAMLAGELPWD  209 (276)
T ss_dssp             HHHHHHSSCCCS
T ss_pred             HHHHHhCCCCCC
Confidence            999999877653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-41  Score=325.98  Aligned_cols=199  Identities=14%  Similarity=0.125  Sum_probs=166.3

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHH---HHHHHhcCcceEEEE-------E
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER---NLLAEVASHCIVKLY-------Y  173 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~---~il~~l~h~~iv~l~-------~  173 (358)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+   .+++.++|||||+++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357899999999999999999999899999999999865444556667788999   455666899999998       5


Q ss_pred             EeecCC-----------------EEEEEEeecCCCCHHHHHhhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCcee
Q 018275          174 SFQDAE-----------------YLYLIMEYLPGGDVMTLLMREETLTE-------TVARFYIAQSVLAIESIHKHNYIH  229 (358)
Q Consensus       174 ~~~~~~-----------------~~~lV~E~~~~g~L~~~l~~~~~~~~-------~~~~~~~~qi~~aL~~LH~~~iiH  229 (358)
                      ++.+.+                 ..|+||||+ +|+|.+++.....+++       ..+..++.||+.||.|||+.||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  229 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  229 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            555443                 288999999 6899999987555555       677779999999999999999999


Q ss_pred             CCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhc
Q 018275          230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRR  309 (358)
Q Consensus       230 rDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (358)
                      |||||+|||++.++.+||+|||+|+.....                                                  
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~~~--------------------------------------------------  259 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAR--------------------------------------------------  259 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTCE--------------------------------------------------
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecCCc--------------------------------------------------
Confidence            999999999999999999999999753210                                                  


Q ss_pred             cccccccCCCCCchhhhhcCC-----------CCCccchhhhhhHHHHhhcccccccc
Q 018275          310 KLAYSTVGTPDYIAPEVLLKK-----------GYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       310 ~~~~s~~gt~~Y~APEv~~~~-----------~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                        ..+.+| +.|+|||++.+.           .|+.++|||||||++|||+++..+|.
T Consensus       260 --~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~  314 (377)
T 3byv_A          260 --VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT  314 (377)
T ss_dssp             --EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             --ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCc
Confidence              113468 999999999988           89999999999999999999877653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.2e-40  Score=306.93  Aligned_cols=205  Identities=22%  Similarity=0.369  Sum_probs=173.1

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEE----EecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      .+....|++.+.||+|+||.||+|.    +..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            3445679999999999999999998    46689999999998654  34455678899999999999999999999987


Q ss_pred             C--CEEEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          178 A--EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       178 ~--~~~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                      .  ..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence            6  678999999999999999954 4679999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCc
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM  334 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~  334 (358)
                      .........                                              .......||+.|+|||++.+..++.
T Consensus       175 ~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~  208 (302)
T 4e5w_A          175 AIETDKEYY----------------------------------------------TVKDDRDSPVFWYAPECLMQSKFYI  208 (302)
T ss_dssp             ECCTTCCEE----------------------------------------------ECCCCTTCCGGGCCHHHHHHCEEEH
T ss_pred             cccCCCcce----------------------------------------------eccCCCCCCccccCCeeecCCCCCc
Confidence            765322110                                              0111346889999999999999999


Q ss_pred             cchhhhhhHHHHhhcccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDI  354 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~  354 (358)
                      ++|+|||||++|+|+++...
T Consensus       209 ~~Di~slG~il~~l~~g~~p  228 (302)
T 4e5w_A          209 ASDVWSFGVTLHELLTYCDS  228 (302)
T ss_dssp             HHHHHHHHHHHHHHHTTTCG
T ss_pred             chhHHHHHHHHHHHHHccCC
Confidence            99999999999999997654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-40  Score=314.09  Aligned_cols=206  Identities=26%  Similarity=0.355  Sum_probs=172.6

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec------
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------  177 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~------  177 (358)
                      ..++|.+++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.+      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            35889999999999999999999999999999999876542 22333457789999999999999999999986      


Q ss_pred             --CCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          178 --AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       178 --~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                        .+.+|+||||+++ +|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence              4468999999975 777776543 679999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCC
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYG  333 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~  333 (358)
                      .+........                                             ......+||+.|+|||++.+ ..|+
T Consensus       173 ~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~  207 (351)
T 3mi9_A          173 AFSLAKNSQP---------------------------------------------NRYTNRVVTLWYRPPELLLGERDYG  207 (351)
T ss_dssp             ECCCCSSSSC---------------------------------------------CCCCSSCSCGGGCCHHHHTTCCSCC
T ss_pred             cccccccccc---------------------------------------------cccCCcccccCccCchhhcCCCCCC
Confidence            7642221110                                             01124479999999999986 5689


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|||||||++|||+++..+|.
T Consensus       208 ~~~DiwslG~il~ell~g~~pf~  230 (351)
T 3mi9_A          208 PPIDLWGAGCIMAEMWTRSPIMQ  230 (351)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cHhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999877663

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.3e-41  Score=313.70  Aligned_cols=205  Identities=18%  Similarity=0.251  Sum_probs=170.5

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCE----EEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI----YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      .+..++|.+.+.||+|+||.||+|.+..++..    ||+|.+....  .......+.+|+.+++.++||||+++++++.+
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            35568999999999999999999999888876    7777765432  22223346789999999999999999999874


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                       ...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+
T Consensus        87 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           87 -SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             -SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             -CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence             5688999999999999999764 57899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      .......                                               ......||+.|+|||++.+..|+.++
T Consensus       166 ~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~  198 (325)
T 3kex_A          166 PPDDKQL-----------------------------------------------LYSEAKTPIKWMALESIHFGKYTHQS  198 (325)
T ss_dssp             CCCTTCC-----------------------------------------------C-----CCTTTSCHHHHHHCCCCHHH
T ss_pred             Ccccccc-----------------------------------------------cccCCCCcccccChHHhccCCCChhh
Confidence            4322111                                               01134688899999999999999999


Q ss_pred             hhhhhhHHHHhhcc-cccccc
Q 018275          337 DWLAYWNETLSCNY-LSDIML  356 (358)
Q Consensus       337 DiwSlGvil~e~l~-~~~~~~  356 (358)
                      |||||||++|||++ +..+|.
T Consensus       199 Di~slG~~l~el~~~g~~p~~  219 (325)
T 3kex_A          199 DVWSYGVTVWELMTFGAEPYA  219 (325)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTT
T ss_pred             HhHHhHHHHHHHHhCCCCCcc
Confidence            99999999999998 766553

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.7e-40  Score=315.97  Aligned_cols=196  Identities=28%  Similarity=0.385  Sum_probs=164.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee------
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ------  176 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~------  176 (358)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||||++......       ..+|+.+++.++|||||+++++|.      
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            4458999999999999999999999999999999998754321       236999999999999999999984      


Q ss_pred             --------------------------------cCCEEEEEEeecCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHH
Q 018275          177 --------------------------------DAEYLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIE  220 (358)
Q Consensus       177 --------------------------------~~~~~~lV~E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~  220 (358)
                                                      +..++++||||++ |+|.+.+.    ....+++..++.++.|++.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                            3445899999997 47776664    3578999999999999999999


Q ss_pred             HHHhCCceeCCCCCCCEEEc-CCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchH
Q 018275          221 SIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLE  299 (358)
Q Consensus       221 ~LH~~~iiHrDikp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (358)
                      |||+.||+||||||+|||++ .++.+||+|||+|+.+.....                                      
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--------------------------------------  197 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--------------------------------------  197 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--------------------------------------
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--------------------------------------
Confidence            99999999999999999998 689999999999986642211                                      


Q ss_pred             HHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhHHHHhhcccccccc
Q 018275          300 QLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       300 ~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                                  ..+.+||+.|+|||++.+. .|+.++|||||||++|||+++..+|.
T Consensus       198 ------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  243 (383)
T 3eb0_A          198 ------------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS  243 (383)
T ss_dssp             ------------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ------------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence                        1134789999999999875 49999999999999999999887764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.2e-40  Score=310.42  Aligned_cols=206  Identities=21%  Similarity=0.281  Sum_probs=176.5

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCC-----EEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN-----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~  174 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..++.     .||+|++....  .......+.+|+.+++.+ +||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            45677999999999999999999999876654     79999997653  344556788999999999 89999999999


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMRE--------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD  240 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~~--------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~  240 (358)
                      +.+.+..++||||+++|+|.+++...              ..+++..+..++.|++.||.|||+.||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999998642              3578999999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCC
Q 018275          241 QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD  320 (358)
Q Consensus       241 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~  320 (358)
                      .++.+||+|||+++.........                                               ......||+.
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~  231 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYI-----------------------------------------------VKGNARLPVK  231 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSE-----------------------------------------------ECSSCEECGG
T ss_pred             CCCeEEECcccccccccccccee-----------------------------------------------ecCCCCCCcc
Confidence            99999999999997653221100                                               0113367899


Q ss_pred             CchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          321 YIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       321 Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      |+|||++.+..++.++|||||||++|||++ +..+|
T Consensus       232 y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  267 (333)
T 2i1m_A          232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY  267 (333)
T ss_dssp             GSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999999999997 65544

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.5e-40  Score=310.77  Aligned_cols=208  Identities=22%  Similarity=0.315  Sum_probs=176.3

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEe-------cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEE
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEK-------KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVK  170 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~  170 (358)
                      +...+..++|.+.+.||+|+||.||+|.+.       .++..||||++....  .......+.+|+.+++.+ +||||++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~  105 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN  105 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence            445667799999999999999999999875       457789999997653  344566788999999999 8999999


Q ss_pred             EEEEeecCCEEEEEEeecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 018275          171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKP  234 (358)
Q Consensus       171 l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp  234 (358)
                      +++++.+.+.+|+||||+++|+|.+++....                .+++..+..++.|++.||.|||+.||+||||||
T Consensus       106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  185 (334)
T 2pvf_A          106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  185 (334)
T ss_dssp             EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence            9999999999999999999999999997643                388899999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccc
Q 018275          235 DNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYS  314 (358)
Q Consensus       235 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  314 (358)
                      +|||++.++.+||+|||+++.........                                               ....
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~  218 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYK-----------------------------------------------KTTN  218 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEE-----------------------------------------------CCSC
T ss_pred             ceEEEcCCCCEEEcccccccccccccccc-----------------------------------------------ccCC
Confidence            99999999999999999998654221100                                               0112


Q ss_pred             ccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          315 TVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       315 ~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ..||+.|+|||++.+..++.++|||||||++|||++ +...|
T Consensus       219 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  260 (334)
T 2pvf_A          219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  260 (334)
T ss_dssp             CCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence            357899999999999999999999999999999998 65554

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-40  Score=307.06  Aligned_cols=205  Identities=23%  Similarity=0.322  Sum_probs=179.9

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ....+..++|.+.+.||+|+||.||+|.+..++..||+|++...    ....+.+.+|+.+++.++||||+++++++.+.
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            34567779999999999999999999999999999999998754    23456688999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ...++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999999999999764  45899999999999999999999999999999999999999999999999999866


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      .......                                                .....||+.|+|||++.+..++.++
T Consensus       162 ~~~~~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~  193 (288)
T 3kfa_A          162 TGDTYTA------------------------------------------------HAGAKFPIKWTAPESLAYNKFSIKS  193 (288)
T ss_dssp             CSSSSEE------------------------------------------------ETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred             cCCcccc------------------------------------------------ccCCccccCcCChhhhccCCCCchh
Confidence            4221110                                                1134678999999999999999999


Q ss_pred             hhhhhhHHHHhhcc-ccccc
Q 018275          337 DWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~-~~~~~  355 (358)
                      |+|||||++|+|+. +..+|
T Consensus       194 Di~slG~il~~ll~~g~~p~  213 (288)
T 3kfa_A          194 DVWAFGVLLWEIATYGMSPY  213 (288)
T ss_dssp             HHHHHHHHHHHHHTTSCCSS
T ss_pred             hHHHHHHHHHHHHhCCCCCC
Confidence            99999999999998 65554

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.7e-41  Score=314.67  Aligned_cols=199  Identities=24%  Similarity=0.352  Sum_probs=165.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+++.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            689999999999999999999999999999999875431  111112456899999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||++ |+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......   
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---  155 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---  155 (324)
T ss_dssp             ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc---
Confidence            9997 5888888765 4689999999999999999999999999999999999999999999999999875432110   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlGv  343 (358)
                                                                    .....+||+.|+|||++.+ ..|+.++|||||||
T Consensus       156 ----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  189 (324)
T 3mtl_A          156 ----------------------------------------------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGC  189 (324)
T ss_dssp             -----------------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred             ----------------------------------------------ccccccCcccccChhhhcCCCCCCcHHHHHHHHH
Confidence                                                          0113478999999999987 67899999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|+|+++..+|.
T Consensus       190 il~~l~~g~~pf~  202 (324)
T 3mtl_A          190 IFYEMATGRPLFP  202 (324)
T ss_dssp             HHHHHHHSSCSCC
T ss_pred             HHHHHHhCCCCCC
Confidence            9999999887764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.9e-40  Score=304.82  Aligned_cols=204  Identities=20%  Similarity=0.306  Sum_probs=173.4

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ....+..++|.+++.||+|+||.||+|.+. ++..||+|++.....    ....+.+|+.++..++||||+++++++.+.
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            445677789999999999999999999765 567899999986532    234588999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      +..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            999999999999999999976 4679999999999999999999999999999999999999999999999999997653


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ....                                                .......||+.|+|||++.+..++.++|
T Consensus       172 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D  203 (283)
T 3gen_A          172 DDEY------------------------------------------------TSSVGSKFPVRWSPPEVLMYSKFSSKSD  203 (283)
T ss_dssp             CHHH------------------------------------------------HSTTSTTSCGGGCCHHHHHHCCCSHHHH
T ss_pred             cccc------------------------------------------------ccccCCccCcccCCHHHhccCCCCchhh
Confidence            2110                                                0111335788999999999999999999


Q ss_pred             hhhhhHHHHhhcc-ccccc
Q 018275          338 WLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~~  355 (358)
                      +|||||++|+|+. +..+|
T Consensus       204 v~slG~~l~~l~t~g~~p~  222 (283)
T 3gen_A          204 IWAFGVLMWEIYSLGKMPY  222 (283)
T ss_dssp             HHHHHHHHHHHHTTTCCTT
T ss_pred             HHHHHHHHHHHHhCCCCCc
Confidence            9999999999997 66554

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-39  Score=303.93  Aligned_cols=204  Identities=27%  Similarity=0.428  Sum_probs=170.0

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+.+..+
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            34578999999999999999999999999999999998654445556677889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          183 LIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      +||||+++++|.+++..    ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999999864    46789999999999999999999999999999999999999999999999999876532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ...                                                 ......||+.|+|||++.+..++.++|+
T Consensus       189 ~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  219 (310)
T 2wqm_A          189 KTT-------------------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDI  219 (310)
T ss_dssp             -----------------------------------------------------------CCSSCCHHHHTTCCCCHHHHH
T ss_pred             CCc-------------------------------------------------cccccCCCeeEeChHHhCCCCCCchhhH
Confidence            110                                                 0113479999999999999999999999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      |||||++|+|+++...|
T Consensus       220 ~slG~il~~l~~g~~p~  236 (310)
T 2wqm_A          220 WSLGCLLYEMAALQSPF  236 (310)
T ss_dssp             HHHHHHHHHHHHSSCTT
T ss_pred             HHHHHHHHHHHhCCCCC
Confidence            99999999999987665

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.6e-41  Score=315.26  Aligned_cols=207  Identities=25%  Similarity=0.334  Sum_probs=176.2

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      .......++|.+.+.||+|+||.||+|.+ .+++.||||++......  .....+.+|+.+++.++||||++++++|.+.
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   99 (326)
T 3uim_A           23 RELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTP   99 (326)
T ss_dssp             HHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred             HHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence            33455679999999999999999999974 46889999999865422  1222478899999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCCEEEcCCCcEEEEecC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE----TLTETVARFYIAQSVLAIESIHKH---NYIHRDIKPDNLLLDQNGHMKLSDFG  251 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~iiHrDikp~NILl~~~~~vkl~DFG  251 (358)
                      ...++||||+++|+|.+++....    ++++..+..++.|++.||.|||+.   ||+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  179 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG  179 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred             CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence            99999999999999999997543    489999999999999999999999   99999999999999999999999999


Q ss_pred             CCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC
Q 018275          252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG  331 (358)
Q Consensus       252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~  331 (358)
                      +++.........                                                ....+||+.|+|||++.+..
T Consensus       180 ~~~~~~~~~~~~------------------------------------------------~~~~~gt~~y~aPE~~~~~~  211 (326)
T 3uim_A          180 LAKLMDYKDTHV------------------------------------------------TTAVRGTIGHIAPEYLSTGK  211 (326)
T ss_dssp             SCEECCSSSSCE------------------------------------------------ECCCCSCGGGCCHHHHHHSE
T ss_pred             cccccCcccccc------------------------------------------------cccccCCcCccCHHHhccCC
Confidence            998764322111                                                11346999999999999999


Q ss_pred             CCccchhhhhhHHHHhhcccccccc
Q 018275          332 YGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ++.++|||||||++|||+++..+|.
T Consensus       212 ~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          212 SSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             ECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CCccccchhHHHHHHHHHhCCCccc
Confidence            9999999999999999999888774

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-39  Score=300.42  Aligned_cols=201  Identities=28%  Similarity=0.462  Sum_probs=176.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh------hchhhHHHHHHHHHHHHHhc-CcceEEEEEEeec
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM------LSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD  177 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~------~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~  177 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.....      ......+.+.+|+.+++.+. ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            4899999999999999999999999999999999875421      11233456788999999996 9999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ....++||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  175 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  175 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc------CCC
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------KKG  331 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~------~~~  331 (358)
                      ....                                                  ....+||+.|+|||++.      ...
T Consensus       176 ~~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~  205 (298)
T 1phk_A          176 PGEK--------------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPG  205 (298)
T ss_dssp             TTCC--------------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCC
T ss_pred             CCcc--------------------------------------------------cccccCCccccCHHHhcccccccccc
Confidence            2110                                                  11347999999999995      567


Q ss_pred             CCccchhhhhhHHHHhhccccccc
Q 018275          332 YGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ++.++|+|||||++|+|+++...|
T Consensus       206 ~~~~~Di~slG~~l~~l~~g~~p~  229 (298)
T 1phk_A          206 YGKEVDMWSTGVIMYTLLAGSPPF  229 (298)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCcccccHhHHHHHHHHHHCCCCC
Confidence            899999999999999999987665

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-39  Score=302.53  Aligned_cols=199  Identities=30%  Similarity=0.487  Sum_probs=177.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .+.|.+++.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT--CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            367999999999999999999999999999999997654  234567789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++++|.+++. ..++++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.........  
T Consensus        99 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  175 (303)
T 3a7i_A           99 MEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--  175 (303)
T ss_dssp             EECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--
T ss_pred             EEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc--
Confidence            99999999999985 467899999999999999999999999999999999999999999999999999765321100  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                     ....+||+.|+|||++.+..++.++|+|||||+
T Consensus       176 -----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  208 (303)
T 3a7i_A          176 -----------------------------------------------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT  208 (303)
T ss_dssp             -----------------------------------------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred             -----------------------------------------------cCccCCCcCccCHHHHhcCCCCchhhhHHHHHH
Confidence                                                           113479999999999999999999999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|+|+++...|
T Consensus       209 l~~l~~g~~p~  219 (303)
T 3a7i_A          209 AIELARGEPPH  219 (303)
T ss_dssp             HHHHHHSSCTT
T ss_pred             HHHHccCCCCC
Confidence            99999987665

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.9e-40  Score=299.44  Aligned_cols=201  Identities=26%  Similarity=0.342  Sum_probs=163.9

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc-hhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ++..++|.+.+.||+|+||.||+|.+.  +..||||+++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            456789999999999999999999864  7899999997653222 3345678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCCCCEEEcC--------CCcEEEEe
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN---YIHRDIKPDNLLLDQ--------NGHMKLSD  249 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---iiHrDikp~NILl~~--------~~~vkl~D  249 (358)
                      .++||||+++++|.+++. ...+++..+..++.|++.||.|||+.|   |+||||||+|||++.        ++.+||+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999999999884 568999999999999999999999999   999999999999986        78899999


Q ss_pred             cCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC
Q 018275          250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK  329 (358)
Q Consensus       250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~  329 (358)
                      ||+++......                                                   ..+..||+.|+|||++.+
T Consensus       160 fg~~~~~~~~~---------------------------------------------------~~~~~~~~~y~aPE~~~~  188 (271)
T 3dtc_A          160 FGLAREWHRTT---------------------------------------------------KMSAAGAYAWMAPEVIRA  188 (271)
T ss_dssp             CCC----------------------------------------------------------------CCGGGSCHHHHHH
T ss_pred             CCccccccccc---------------------------------------------------ccCCCCccceeCHHHhcc
Confidence            99997553211                                                   013369999999999999


Q ss_pred             CCCCccchhhhhhHHHHhhcccccccc
Q 018275          330 KGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       330 ~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ..++.++|+||||+++|+|+++..+|.
T Consensus       189 ~~~~~~~Di~slG~~l~~l~~g~~p~~  215 (271)
T 3dtc_A          189 SMFSKGSDVWSYGVLLWELLTGEVPFR  215 (271)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999876653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-40  Score=312.39  Aligned_cols=202  Identities=29%  Similarity=0.446  Sum_probs=166.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc--hhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++.......  ......+.+|+.+++.++||||++++++|.+....+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            478999999999999999999999999999999997643211  111235778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      +||||+++ +|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999975 888888665 4688999999999999999999999999999999999999999999999999986642211


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLA  340 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwS  340 (358)
                      .                                                 ....+||+.|+|||++.+ ..|+.++|+||
T Consensus       168 ~-------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  198 (346)
T 1ua2_A          168 A-------------------------------------------------YTHQVVTRWYRAPELLFGARMYGVGVDMWA  198 (346)
T ss_dssp             C-------------------------------------------------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred             c-------------------------------------------------CCcccccccccCchHhhCCCCCCchhhhHh
Confidence            0                                                 113479999999999976 45899999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       199 lG~il~ell~g~~~~~  214 (346)
T 1ua2_A          199 VGCILAELLLRVPFLP  214 (346)
T ss_dssp             HHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHHHCCCCCC
Confidence            9999999999876653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.5e-40  Score=315.92  Aligned_cols=202  Identities=23%  Similarity=0.346  Sum_probs=173.1

Q ss_pred             hhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc--------CcceE
Q 018275           98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA--------SHCIV  169 (358)
Q Consensus        98 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--------h~~iv  169 (358)
                      +....+..++|.+.+.||+|+||.||+|.+..+++.||||++...    ......+.+|+.+++.++        |+||+
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv  104 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVV  104 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence            333445568999999999999999999999999999999999754    234456888999999986        78899


Q ss_pred             EEEEEee----cCCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcCC
Q 018275          170 KLYYSFQ----DAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQN  242 (358)
Q Consensus       170 ~l~~~~~----~~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~  242 (358)
                      +++++|.    +...+|+||||+ +++|.+.+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus       105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~  183 (397)
T 1wak_A          105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN  183 (397)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred             eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence            9999997    567899999999 56777666554  5799999999999999999999998 99999999999999977


Q ss_pred             C-------------------------------------------------cEEEEecCCCccCCCCCCcccccccccccc
Q 018275          243 G-------------------------------------------------HMKLSDFGLCKPLDCTNLSAINENEVLDDE  273 (358)
Q Consensus       243 ~-------------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +                                                 .+||+|||+++......             
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-------------  250 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-------------  250 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-------------
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-------------
Confidence            6                                                 79999999997653210             


Q ss_pred             cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccccc
Q 018275          274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                                                             ...+||+.|+|||++.+..|+.++|||||||+||||+++..
T Consensus       251 ---------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  291 (397)
T 1wak_A          251 ---------------------------------------TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY  291 (397)
T ss_dssp             ---------------------------------------CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ---------------------------------------ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCC
Confidence                                                   13479999999999999999999999999999999999987


Q ss_pred             ccc
Q 018275          354 IML  356 (358)
Q Consensus       354 ~~~  356 (358)
                      +|.
T Consensus       292 pf~  294 (397)
T 1wak_A          292 LFE  294 (397)
T ss_dssp             SCC
T ss_pred             CCC
Confidence            764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.4e-39  Score=303.94  Aligned_cols=192  Identities=24%  Similarity=0.367  Sum_probs=169.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeec--CCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD--AEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~--~~~~  181 (358)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....      ...+.+|+.+++.+. ||||+++++++.+  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            488999999999999999999999999999999987432      345889999999997 9999999999987  6779


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-cEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~vkl~DFGla~~~~~~~  260 (358)
                      ++||||+++++|..++.   .+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||+|+......
T Consensus       109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999999999999884   488999999999999999999999999999999999999777 89999999997654221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Diw  339 (358)
                      .                                                  ....+||+.|+|||++.+ ..|+.++|||
T Consensus       186 ~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  215 (330)
T 3nsz_A          186 E--------------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMW  215 (330)
T ss_dssp             C--------------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHH
T ss_pred             c--------------------------------------------------cccccccccccChhhhcCCCcCCchhhHH
Confidence            1                                                  113479999999999987 7799999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      ||||++|||+++...|
T Consensus       216 slG~il~~ll~g~~p~  231 (330)
T 3nsz_A          216 SLGCMLASMIFRKEPF  231 (330)
T ss_dssp             HHHHHHHHHHHTCSSS
T ss_pred             HHHHHHHHHHhCCCCc
Confidence            9999999999988766

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.7e-40  Score=308.91  Aligned_cols=199  Identities=31%  Similarity=0.557  Sum_probs=168.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh-----chhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++......     .......+.+|+.+++.++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            6799999999999999999999999999999999765321     1223345788999999999999999999997665 


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc---EEEEecCCCccCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLD  257 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~---vkl~DFGla~~~~  257 (358)
                      .|+||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.   +||+|||+++...
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            8999999999999999988889999999999999999999999999999999999999987665   9999999997653


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCCCc
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGM  334 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y~~  334 (358)
                      ...                                                  .....+||+.|+|||++.   +..|+.
T Consensus       169 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~  198 (322)
T 2ycf_A          169 ETS--------------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNR  198 (322)
T ss_dssp             CCH--------------------------------------------------HHHHHHSCCTTCCHHHHHHTTTTTCTT
T ss_pred             ccc--------------------------------------------------ccccccCCcCccCchhhccCCCCCCCc
Confidence            110                                                  011346999999999984   567899


Q ss_pred             cchhhhhhHHHHhhccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ++|||||||++|+|+++...|
T Consensus       199 ~~Di~slG~il~~l~~g~~pf  219 (322)
T 2ycf_A          199 AVDCWSLGVILFICLSGYPPF  219 (322)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSS
T ss_pred             hhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999987765

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.5e-40  Score=300.72  Aligned_cols=203  Identities=21%  Similarity=0.344  Sum_probs=173.1

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhh----HHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ----VEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~----~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      ...+..++|.+.+.||+|+||.||+|.+..+++.||+|++..........    ...+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            34566799999999999999999999999999999999997654322221    15688999999999999999999999


Q ss_pred             ecCCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEcCCCc-----EEE
Q 018275          176 QDAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGH-----MKL  247 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~-----vkl  247 (358)
                      .+..  ++||||+++++|.+.+... .++++..+..++.|++.||.|||+.|  |+||||||+|||++.++.     +||
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            7766  6999999999998888654 57999999999999999999999999  999999999999988876     999


Q ss_pred             EecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh
Q 018275          248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL  327 (358)
Q Consensus       248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~  327 (358)
                      +|||+++.....                                                    ....+||+.|+|||++
T Consensus       171 ~Dfg~~~~~~~~----------------------------------------------------~~~~~g~~~y~aPE~~  198 (287)
T 4f0f_A          171 ADFGLSQQSVHS----------------------------------------------------VSGLLGNFQWMAPETI  198 (287)
T ss_dssp             CCCTTCBCCSSC----------------------------------------------------EECCCCCCTTSCGGGS
T ss_pred             CCCCcccccccc----------------------------------------------------ccccCCCccccCchhh
Confidence            999998743211                                                    0134799999999999


Q ss_pred             --cCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          328 --LKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       328 --~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                        .+..|+.++|||||||++|||+++..+|.
T Consensus       199 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  229 (287)
T 4f0f_A          199 GAEEESYTEKADTYSFAMILYTILTGEGPFD  229 (287)
T ss_dssp             SCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence              45568899999999999999999877663

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.6e-39  Score=317.07  Aligned_cols=196  Identities=22%  Similarity=0.380  Sum_probs=171.7

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh------cCcceEEEEEEeec
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV------ASHCIVKLYYSFQD  177 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l------~h~~iv~l~~~~~~  177 (358)
                      ..++|++++.||+|+||.||+|.+..+++.||||++....    .....+.+|+.++..+      .|+||+.++++|..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3478999999999999999999999999999999997643    2334577788888887      46699999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc--EEEEecCCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH--MKLSDFGLC  253 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~--vkl~DFGla  253 (358)
                      ...+|+||||++ ++|.+++....  .+++..++.++.||+.||.|||+.||+||||||+|||++.++.  +||+|||+|
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999999995 69999987653  5899999999999999999999999999999999999999987  999999998


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +.....                                                    ..+.+||+.|+|||++.+..|+
T Consensus       250 ~~~~~~----------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~  277 (429)
T 3kvw_A          250 CYEHQR----------------------------------------------------VYTYIQSRFYRAPEVILGARYG  277 (429)
T ss_dssp             EETTCC----------------------------------------------------CCSSCSCGGGCCHHHHHTBCCC
T ss_pred             eecCCc----------------------------------------------------ccccCCCCCccChHHHhCCCCC
Confidence            654311                                                    1134799999999999999999


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|||||||+||||+++..+|.
T Consensus       278 ~~~DiwSlG~il~elltG~~pf~  300 (429)
T 3kvw_A          278 MPIDMWSLGCILAELLTGYPLLP  300 (429)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSC
T ss_pred             chHHHHhHHHHHHHHHhCCCCCC
Confidence            99999999999999999987764

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.6e-40  Score=317.77  Aligned_cols=199  Identities=15%  Similarity=0.087  Sum_probs=155.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh--cCcceEEEE-------EEe
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV--ASHCIVKLY-------YSF  175 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l--~h~~iv~l~-------~~~  175 (358)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++.............+++|+.++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34599999999999999999999999999999999886544556667788886666655  599988866       333


Q ss_pred             ecC-----------------CEEEEEEeecCCCCHHHHHhhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceeCC
Q 018275          176 QDA-----------------EYLYLIMEYLPGGDVMTLLMRE-ETLTETVA------RFYIAQSVLAIESIHKHNYIHRD  231 (358)
Q Consensus       176 ~~~-----------------~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~------~~~~~qi~~aL~~LH~~~iiHrD  231 (358)
                      ...                 ..+|+||||++ |+|.+++... ..+.....      ..++.||+.||.|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            322                 44899999998 8999999764 23333333      45669999999999999999999


Q ss_pred             CCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccc
Q 018275          232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL  311 (358)
Q Consensus       232 ikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (358)
                      |||+|||++.++.+||+|||+|+......                                                   
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~---------------------------------------------------  248 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG---------------------------------------------------  248 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEE---------------------------------------------------
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCc---------------------------------------------------
Confidence            99999999999999999999998653110                                                   


Q ss_pred             cccccCCCCCchhhhhcC--CCCCccchhhhhhHHHHhhcccccccc
Q 018275          312 AYSTVGTPDYIAPEVLLK--KGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       312 ~~s~~gt~~Y~APEv~~~--~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                       ....||+.|+|||++.+  ..|+.++|||||||+||||+++..+|.
T Consensus       249 -~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          249 -PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             -EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             -cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence             02357799999999988  789999999999999999999876653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.7e-40  Score=308.27  Aligned_cols=204  Identities=25%  Similarity=0.391  Sum_probs=176.3

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEE----EecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee--
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--  176 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--  176 (358)
                      +..++|++.+.||+|+||.||+|.    +..++..||||++...   .....+.+.+|+.+++.++||||+++++++.  
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            455899999999999999999998    4668899999999765   3445566889999999999999999999886  


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      +....|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            56779999999999999999976 45699999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      .........                                              ......||+.|+|||++.+..++.+
T Consensus       177 ~~~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~  210 (327)
T 3lxl_A          177 LPLDKDYYV----------------------------------------------VREPGQSPIFWYAPESLSDNIFSRQ  210 (327)
T ss_dssp             CCTTCSEEE----------------------------------------------CSSCCCSCGGGSCHHHHHHCEEEHH
T ss_pred             cccCCccce----------------------------------------------eeccCCccccccCHHHhccCCCChH
Confidence            643221110                                              0113368999999999999999999


Q ss_pred             chhhhhhHHHHhhccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~  355 (358)
                      +|||||||++|+|+++...|
T Consensus       211 ~Di~slG~il~~ll~g~~p~  230 (327)
T 3lxl_A          211 SDVWSFGVVLYELFTYCDKS  230 (327)
T ss_dssp             HHHHHHHHHHHHHHTTTCGG
T ss_pred             HhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999987655

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.5e-40  Score=315.44  Aligned_cols=197  Identities=26%  Similarity=0.379  Sum_probs=157.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC------
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------  178 (358)
                      .++|.+++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            388999999999999999999999999999999997542 2344556788999999999999999999998654      


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ...|+|||++ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            5689999999 7899988854 6799999999999999999999999999999999999999999999999999975431


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~D  337 (358)
                      .                                                    ....+||+.|+|||++.+ ..|+.++|
T Consensus       185 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D  212 (367)
T 2fst_X          185 E----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVD  212 (367)
T ss_dssp             ----------------------------------------------------------CCCTTCCHHHHTTCCSCCTTHH
T ss_pred             c----------------------------------------------------CCCcCcCcCccChHHHcCCcCCCchhh
Confidence            1                                                    013479999999999987 78999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|||+++..+|.
T Consensus       213 iwslG~il~ell~g~~pf~  231 (367)
T 2fst_X          213 IWSVGCIMAELLTGRTLFP  231 (367)
T ss_dssp             HHHHHHHHHHHHHSSCSCC
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999987764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.6e-40  Score=301.81  Aligned_cols=203  Identities=25%  Similarity=0.370  Sum_probs=161.7

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ++..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+..+...++.++||||+++++++.+.+..
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            4566899999999999999999999999999999999976532 223334455555667888999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          182 YLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ++||||++ |+|.+++..    ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999997 588777643    56899999999999999999999998 9999999999999999999999999999765


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh----cCCCC
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL----LKKGY  332 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~----~~~~y  332 (358)
                      .....                                                  .....||+.|+|||++    .+..+
T Consensus       161 ~~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~  190 (290)
T 3fme_A          161 VDDVA--------------------------------------------------KDIDAGCKPYMAPERINPELNQKGY  190 (290)
T ss_dssp             -----------------------------------------------------------CCCCCCSCHHHHSCCTTC--C
T ss_pred             ccccc--------------------------------------------------ccccCCCccccChhhcChhhcCcCC
Confidence            42110                                                  0123699999999996    56779


Q ss_pred             CccchhhhhhHHHHhhcccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +.++|+|||||++|+|+++..+|.
T Consensus       191 ~~~~Di~slG~il~~l~~g~~p~~  214 (290)
T 3fme_A          191 SVKSDIWSLGITMIELAILRFPYD  214 (290)
T ss_dssp             CHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCcc
Confidence            999999999999999999887664

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.1e-39  Score=303.13  Aligned_cols=199  Identities=24%  Similarity=0.377  Sum_probs=173.8

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEE-ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc------eEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQE-KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC------IVKLYY  173 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~------iv~l~~  173 (358)
                      ..+..++|++.+.||+|+||.||+|.+ ..+++.||||++....    .....+.+|+.+++.++|++      ++++++
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            445568999999999999999999998 5678999999987542    33456788999999988765      999999


Q ss_pred             EeecCCEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC----------
Q 018275          174 SFQDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ----------  241 (358)
Q Consensus       174 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~----------  241 (358)
                      ++.+.+..|+||||+ +++|.+++....  ++++..+..++.|++.||.|||+.||+||||||+|||++.          
T Consensus        85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence            999999999999999 889999997765  6889999999999999999999999999999999999987          


Q ss_pred             ---------CCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccc
Q 018275          242 ---------NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLA  312 (358)
Q Consensus       242 ---------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (358)
                               ++.+||+|||+++......                                                    
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----------------------------------------------------  191 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEHH----------------------------------------------------  191 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSCC----------------------------------------------------
T ss_pred             cccccccccCCCceEeeCcccccCcccc----------------------------------------------------
Confidence                     6789999999987543111                                                    


Q ss_pred             ccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          313 YSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       313 ~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .+.+||+.|+|||++.+..|+.++|||||||++|||+++..+|.
T Consensus       192 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  235 (339)
T 1z57_A          192 STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP  235 (339)
T ss_dssp             CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            13479999999999999999999999999999999999887775

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.5e-39  Score=319.25  Aligned_cols=198  Identities=24%  Similarity=0.369  Sum_probs=171.0

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ....+..++|.+.+.||+|+||.||+|.+.  ++.||||+++...     ..+.+.+|+.+++.++|||||++++++.+.
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            345677899999999999999999999764  7799999997653     335588999999999999999999998765


Q ss_pred             C-EEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          179 E-YLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       179 ~-~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      . .+|+||||+++|+|.+++...+  .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            4 7999999999999999997654  378999999999999999999999999999999999999999999999999974


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      .....                                                    ....+|+.|+|||++.+..|+.+
T Consensus       339 ~~~~~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~  366 (450)
T 1k9a_A          339 ASSTQ----------------------------------------------------DTGKLPVKWTAPEALREKKFSTK  366 (450)
T ss_dssp             CC----------------------------------------------------------CCCTTTSCHHHHHSSCCCHH
T ss_pred             ccccc----------------------------------------------------cCCCCCcceeCHHHhcCCCCCcH
Confidence            42110                                                    01257889999999999999999


Q ss_pred             chhhhhhHHHHhhcc-ccccc
Q 018275          336 CDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       336 ~DiwSlGvil~e~l~-~~~~~  355 (358)
                      +|||||||+||||+. +..+|
T Consensus       367 sDvwslG~~l~el~t~g~~P~  387 (450)
T 1k9a_A          367 SDVWSFGILLWEIYSFGRVPY  387 (450)
T ss_dssp             HHHHHHHHHHHHHHTTTCCSS
T ss_pred             HHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999997 66554

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=311.52  Aligned_cols=210  Identities=19%  Similarity=0.145  Sum_probs=169.4

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEec---CCCEEEEEecchhhhhc--------hhhHHHHHHHHHHHHHhcCcceEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLS--------RGQVEHVRAERNLLAEVASHCIVKL  171 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~---~~~~vaiK~i~~~~~~~--------~~~~~~~~~E~~il~~l~h~~iv~l  171 (358)
                      +..++|.+.+.||+|+||.||+|.+..   ++..||||++.......        ......+.+|+.++..++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            345789999999999999999999987   78899999987643111        1112235577888899999999999


Q ss_pred             EEEeec----CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC--cE
Q 018275          172 YYSFQD----AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG--HM  245 (358)
Q Consensus       172 ~~~~~~----~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~--~v  245 (358)
                      ++++.+    ....|+||||+ +++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999987    78899999999 999999998877999999999999999999999999999999999999999887  99


Q ss_pred             EEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhh
Q 018275          246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE  325 (358)
Q Consensus       246 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APE  325 (358)
                      ||+|||+|+.+.........                                          ........+||+.|+|||
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE  230 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQY------------------------------------------QENPRKGHNGTIEFTSLD  230 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCC------------------------------------------CCCGGGCSCSCTTTCCHH
T ss_pred             EEEeCCCceecccccccccc------------------------------------------hhccccccCCCccccCHH
Confidence            99999999876432111000                                          001112457999999999


Q ss_pred             hhcCCCCCccchhhhhhHHHHhhccccccc
Q 018275          326 VLLKKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       326 v~~~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ++.+..|+.++|||||||++|||+++..+|
T Consensus       231 ~~~~~~~~~~~Di~slG~il~ell~g~~pf  260 (345)
T 2v62_A          231 AHKGVALSRRSDVEILGYCMLRWLCGKLPW  260 (345)
T ss_dssp             HHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            999999999999999999999999988776

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.7e-40  Score=302.93  Aligned_cols=196  Identities=24%  Similarity=0.281  Sum_probs=162.8

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHH--hcCcceEEEEEEeec--
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE--VASHCIVKLYYSFQD--  177 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~--l~h~~iv~l~~~~~~--  177 (358)
                      .+..++|.+.+.||+|+||.||+|.+  +++.||||++....      ...+..|..++..  ++||||+++++++.+  
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            34568999999999999999999976  68899999987542      2335567777776  799999999998653  


Q ss_pred             --CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCCEEEcCCCcEEE
Q 018275          178 --AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH--------KHNYIHRDIKPDNLLLDQNGHMKL  247 (358)
Q Consensus       178 --~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------~~~iiHrDikp~NILl~~~~~vkl  247 (358)
                        ...+++||||+++|+|.+++. ...+++..+..++.|++.||.|||        +.+|+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              356899999999999999994 457899999999999999999999        999999999999999999999999


Q ss_pred             EecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh
Q 018275          248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL  327 (358)
Q Consensus       248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~  327 (358)
                      +|||+|+..........                                             ......+||+.|+|||++
T Consensus       155 ~Dfg~a~~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~  189 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLD---------------------------------------------VGNNPRVGTKRYMAPEVL  189 (301)
T ss_dssp             CCCTTCEEEETTTTEEE---------------------------------------------CCCCCCCCCGGGCCHHHH
T ss_pred             eeCCCeeeccccccccc---------------------------------------------ccccccccccceeChhhh
Confidence            99999976532211100                                             001134799999999999


Q ss_pred             cCC------CCCccchhhhhhHHHHhhccc
Q 018275          328 LKK------GYGMECDWLAYWNETLSCNYL  351 (358)
Q Consensus       328 ~~~------~y~~~~DiwSlGvil~e~l~~  351 (358)
                      .+.      .++.++|||||||++|||+++
T Consensus       190 ~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          190 DETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             TTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            887      456799999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.1e-40  Score=328.97  Aligned_cols=203  Identities=23%  Similarity=0.310  Sum_probs=176.8

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..++..||||++....    ...+.+.+|+.+++.++|||||+++++|.+...
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            4556678999999999999999999999999999999997653    235568899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      +|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999999999763  4688999999999999999999999999999999999999999999999999986642


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ....                                                ......+|+.|+|||++.+..|+.++||
T Consensus       371 ~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDv  402 (495)
T 1opk_A          371 DTYT------------------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDV  402 (495)
T ss_dssp             CCEE------------------------------------------------CCTTCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred             Ccee------------------------------------------------ecCCCcCCcceeCHhHHhcCCCCcHHhH
Confidence            1100                                                0112357889999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      |||||+||||++ +..+|
T Consensus       403 wSlG~~l~el~t~g~~p~  420 (495)
T 1opk_A          403 WAFGVLLWEIATYGMSPY  420 (495)
T ss_dssp             HHHHHHHHHHHTTSCCSS
T ss_pred             HhHHHHHHHHHhCCCCCC
Confidence            999999999997 55444

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.7e-40  Score=307.14  Aligned_cols=200  Identities=27%  Similarity=0.421  Sum_probs=172.8

Q ss_pred             CCceee-eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEEEE
Q 018275          106 DDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       106 ~~~~~~-~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~l  183 (358)
                      +.|.+. +.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+. ||||++++++|.+....++
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            567777 899999999999999999999999999986543 2334566888999999985 6999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---CCcEEEEecCCCccCCC
Q 018275          184 IMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~vkl~DFGla~~~~~  258 (358)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+|||++.   ++.+||+|||+++....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999998553  67999999999999999999999999999999999999998   78999999999986542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ...                                                  ....+||+.|+|||++.+..|+.++||
T Consensus       187 ~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di  216 (327)
T 3lm5_A          187 ACE--------------------------------------------------LREIMGTPEYLAPEILNYDPITTATDM  216 (327)
T ss_dssp             ---------------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHH
T ss_pred             ccc--------------------------------------------------cccccCCcCccCCeeecCCCCCchhhH
Confidence            110                                                  113479999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||++|+|+++..+|.
T Consensus       217 wslG~il~~ll~g~~pf~  234 (327)
T 3lm5_A          217 WNIGIIAYMLLTHTSPFV  234 (327)
T ss_dssp             HHHHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHHHHhCCCCCC
Confidence            999999999999887663

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.5e-39  Score=310.19  Aligned_cols=201  Identities=25%  Similarity=0.359  Sum_probs=172.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC-----CE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----EY  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~  180 (358)
                      ++|.+++.||+|+||.||+|.+..++..||||++....  .......+.+|+.++..++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            78999999999999999999999999999999997543  344456788999999999999999999999754     46


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      .|+||||++ |+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            899999996 599998854 568999999999999999999999999999999999999999999999999998664221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~Diw  339 (358)
                      ...                                              ......+||+.|+|||++.+ ..|+.++|||
T Consensus       183 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  216 (364)
T 3qyz_A          183 DHT----------------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIW  216 (364)
T ss_dssp             CBC----------------------------------------------CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHH
T ss_pred             Ccc----------------------------------------------ccccccccccCCCCCHHhcCCCCCCcchhHH
Confidence            110                                              01124489999999998764 5599999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||++|+|+++..+|.
T Consensus       217 slG~il~ell~g~~pf~  233 (364)
T 3qyz_A          217 SVGCILAEMLSNRPIFP  233 (364)
T ss_dssp             HHHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHHHHCCCCCC
Confidence            99999999999887663

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.4e-40  Score=306.66  Aligned_cols=206  Identities=22%  Similarity=0.276  Sum_probs=174.8

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~  174 (358)
                      ..+..++|.+.+.||+|+||.||+|.+.     .+++.||||++....  .......+.+|+.++..+ +||||++++++
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            4566789999999999999999999853     467899999997653  344556788999999999 78999999999


Q ss_pred             eecCC-EEEEEEeecCCCCHHHHHhhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 018275          175 FQDAE-YLYLIMEYLPGGDVMTLLMREET----------------LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL  237 (358)
Q Consensus       175 ~~~~~-~~~lV~E~~~~g~L~~~l~~~~~----------------~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NI  237 (358)
                      +.+.+ .+++||||+++++|.+++.....                +++..+..++.|++.||.|||+.||+||||||+||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            87654 58999999999999999976543                78999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC
Q 018275          238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG  317 (358)
Q Consensus       238 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g  317 (358)
                      |++.++.+||+|||+++.........                                               ......|
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~  212 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYV-----------------------------------------------RKGDARL  212 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSE-----------------------------------------------EETTEEE
T ss_pred             EECCCCCEEECCCccccccccCccce-----------------------------------------------eccCCCc
Confidence            99999999999999998654221100                                               0113468


Q ss_pred             CCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          318 TPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       318 t~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      |+.|+|||++.+..++.++|||||||++|||++ +..+|
T Consensus       213 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999999999997 66554

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-39  Score=299.15  Aligned_cols=193  Identities=27%  Similarity=0.439  Sum_probs=169.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--------
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--------  177 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--------  177 (358)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....       ..+.+|+.+++.++||||+++++++.+        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            67999999999999999999999899999999987542       126689999999999999999998864        


Q ss_pred             --------CCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEE
Q 018275          178 --------AEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL  247 (358)
Q Consensus       178 --------~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl  247 (358)
                              ...+++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence                    45689999999999999999654  67999999999999999999999999999999999999999999999


Q ss_pred             EecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh
Q 018275          248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL  327 (358)
Q Consensus       248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~  327 (358)
                      +|||++........                                                  .....||+.|+|||++
T Consensus       164 ~Dfg~~~~~~~~~~--------------------------------------------------~~~~~~~~~y~aPE~~  193 (284)
T 2a19_B          164 GDFGLVTSLKNDGK--------------------------------------------------RTRSKGTLRYMSPEQI  193 (284)
T ss_dssp             CCCTTCEESSCCSC--------------------------------------------------CCCCCSCCTTSCHHHH
T ss_pred             Ccchhheecccccc--------------------------------------------------ccccCCcccccChhhh
Confidence            99999876542210                                                  0123699999999999


Q ss_pred             cCCCCCccchhhhhhHHHHhhccccccc
Q 018275          328 LKKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       328 ~~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .+..++.++|+|||||++|+|+++...+
T Consensus       194 ~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          194 SSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             HCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             ccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            9999999999999999999999876543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.2e-40  Score=306.88  Aligned_cols=206  Identities=16%  Similarity=0.235  Sum_probs=175.4

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      ..+..++|.+.+.||+|+||.||+|.+.     .++..||||++....  .......+.+|+.+++.++||||+++++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            4556689999999999999999999876     467899999997543  334455688999999999999999999999


Q ss_pred             ecCCEEEEEEeecCCCCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcE
Q 018275          176 QDAEYLYLIMEYLPGGDVMTLLMRE----------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM  245 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~v  245 (358)
                      .+....++||||+++|+|.+++...          .++++..+..++.|++.||.|||+.||+||||||+|||++.++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence            9999999999999999999998652          456889999999999999999999999999999999999999999


Q ss_pred             EEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhh
Q 018275          246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE  325 (358)
Q Consensus       246 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APE  325 (358)
                      ||+|||+++........                                               .......||+.|+|||
T Consensus       178 kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE  210 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYY-----------------------------------------------RKGGKGLLPVRWMSPE  210 (322)
T ss_dssp             EECCTTCCCGGGGGGCE-----------------------------------------------EGGGSSEECGGGCCHH
T ss_pred             EECcCcccccccccccc-----------------------------------------------ccccCCCCCCCccChh
Confidence            99999998755321100                                               0111336899999999


Q ss_pred             hhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          326 VLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       326 v~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ++.+..++.++|||||||++|+|++ +..+|
T Consensus       211 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~  241 (322)
T 1p4o_A          211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPY  241 (322)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHhcCCCcc
Confidence            9999999999999999999999998 55444

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-40  Score=307.54  Aligned_cols=203  Identities=21%  Similarity=0.293  Sum_probs=166.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEE----EEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY----AMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      +..++|++++.||+|+||.||+|.+..++..|    |+|.+....  .......+.+|+.+++.++||||++++++|.+.
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            44589999999999999999999998888765    666654332  344556788999999999999999999999876


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      . .++|++|+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            5 78999999999999999764 679999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ......                                               ......||+.|+|||++.+..|+.++|
T Consensus       169 ~~~~~~-----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~D  201 (327)
T 3lzb_A          169 AEEKEY-----------------------------------------------HAEGGKVPIKWMALESILHRIYTHQSD  201 (327)
T ss_dssp             ----------------------------------------------------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred             Cccccc-----------------------------------------------cccCCCccccccCHHHHcCCCCChHHH
Confidence            221110                                               011335788999999999999999999


Q ss_pred             hhhhhHHHHhhcc-ccccc
Q 018275          338 WLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~~  355 (358)
                      ||||||++|||++ +..+|
T Consensus       202 i~slG~il~ell~~g~~p~  220 (327)
T 3lzb_A          202 VWSYGVTVWELMTFGSKPY  220 (327)
T ss_dssp             HHHHHHHHHHHHTTSCCTT
T ss_pred             HHHHHHHHHHHHHCCCCCC
Confidence            9999999999998 66555

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-39  Score=316.03  Aligned_cols=193  Identities=28%  Similarity=0.410  Sum_probs=162.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec------CC
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------AE  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~------~~  179 (358)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++......       ..+|+.+++.++|||||+++++|..      ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            5799999999999999999999999999999998754311       3369999999999999999998843      23


Q ss_pred             EEEEEEeecCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-CcEEEEecCCCc
Q 018275          180 YLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCK  254 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~vkl~DFGla~  254 (358)
                      ++++||||+++ +|...+.    ....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            57899999975 6666553    35689999999999999999999999999999999999999965 678999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCC
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYG  333 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~  333 (358)
                      .+.....                                                  ..+.+||+.|+|||++.+. .|+
T Consensus       206 ~~~~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~  235 (420)
T 1j1b_A          206 QLVRGEP--------------------------------------------------NVSYICSRYYRAPELIFGATDYT  235 (420)
T ss_dssp             ECCTTCC--------------------------------------------------CCSCCSCTTSCCHHHHTTCSSCC
T ss_pred             hcccCCC--------------------------------------------------ceeeeeCCCcCCHHHHcCCCCCC
Confidence            6532110                                                  1134799999999999765 799


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|||||||+||||+++..+|.
T Consensus       236 ~~~DiwSlG~il~ell~G~~pf~  258 (420)
T 1j1b_A          236 SSIDVWSAGCVLAELLLGQPIFP  258 (420)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSC
T ss_pred             chhhhHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999887764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-39  Score=305.92  Aligned_cols=207  Identities=21%  Similarity=0.248  Sum_probs=170.3

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCC----CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSG----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      .++..++|.+.+.||+|+||.||+|.+..++    ..||||++....  .......+.+|+.+++.++||||+++++++.
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  116 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS  116 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            4567789999999999999999999887553    359999997643  3344556889999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      +.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999999999999765 6799999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      .........                                              ......||+.|+|||++.+..++.+
T Consensus       197 ~~~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~  230 (333)
T 1mqb_A          197 LEDDPEATY----------------------------------------------TTSGGKIPIRWTAPEAISYRKFTSA  230 (333)
T ss_dssp             ------------------------------------------------------------CCCGGGSCHHHHHSCCCCHH
T ss_pred             hcccccccc----------------------------------------------ccCCCCccccccCchhcccCCCCch
Confidence            642211000                                              0012357889999999999999999


Q ss_pred             chhhhhhHHHHhhcc-ccccc
Q 018275          336 CDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       336 ~DiwSlGvil~e~l~-~~~~~  355 (358)
                      +|+|||||++|||++ +...|
T Consensus       231 ~Di~slG~il~ellt~g~~pf  251 (333)
T 1mqb_A          231 SDVWSFGIVMWEVMTYGERPY  251 (333)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTT
T ss_pred             hhhHHHHHHHHHHHcCCCCCc
Confidence            999999999999987 66554

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=302.57  Aligned_cols=203  Identities=28%  Similarity=0.462  Sum_probs=169.5

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeec-
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD-  177 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~-  177 (358)
                      ......++|.+.+.||+|+||.||+|.+..+++.||||++....    .....+.+|+.+++.+ +||||+++++++.. 
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            34456689999999999999999999999999999999987542    2335588899999999 79999999999976 


Q ss_pred             -----CCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEec
Q 018275          178 -----AEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF  250 (358)
Q Consensus       178 -----~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DF  250 (358)
                           ...+++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence                 56899999999999999999764  57899999999999999999999999999999999999999999999999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc--
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL--  328 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~--  328 (358)
                      |++........                                                 .....+||+.|+|||++.  
T Consensus       174 g~~~~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~  204 (326)
T 2x7f_A          174 GVSAQLDRTVG-------------------------------------------------RRNTFIGTPYWMAPEVIACD  204 (326)
T ss_dssp             TTTC--------------------------------------------------------------CCGGGCCHHHHC--
T ss_pred             cCceecCcCcc-------------------------------------------------ccccccCCccccChhhhccc
Confidence            99876532110                                                 011347999999999997  


Q ss_pred             ---CCCCCccchhhhhhHHHHhhccccccc
Q 018275          329 ---KKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       329 ---~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                         +..++.++|+|||||++|+|+++...|
T Consensus       205 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~  234 (326)
T 2x7f_A          205 ENPDATYDFKSDLWSLGITAIEMAEGAPPL  234 (326)
T ss_dssp             ------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence               567999999999999999999987665

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=301.47  Aligned_cols=198  Identities=30%  Similarity=0.477  Sum_probs=170.4

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++....     ....+.+|+.++..++||||+++++++.+.+..|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            3578999999999999999999999999999999987642     23457889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          184 IMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       184 V~E~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||||+++++|.+++. ....+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++........ 
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence            999999999999996 456899999999999999999999999999999999999999999999999999976532110 


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                      ......||+.|+|||++.+..++.++|+||||
T Consensus       181 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  212 (314)
T 3com_A          181 ------------------------------------------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG  212 (314)
T ss_dssp             ------------------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHH
T ss_pred             ------------------------------------------------ccCccCCCCCccChhhcCCCCCCccccHHHHH
Confidence                                                            01134799999999999999999999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|+|+++...|
T Consensus       213 ~il~~l~~g~~p~  225 (314)
T 3com_A          213 ITAIEMAEGKPPY  225 (314)
T ss_dssp             HHHHHHHHSSCTT
T ss_pred             HHHHHHHhCCCCC
Confidence            9999999987765

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-39  Score=296.57  Aligned_cols=199  Identities=16%  Similarity=0.179  Sum_probs=173.3

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC--
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--  178 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--  178 (358)
                      ..+..++|.+.+.||+|+||.||+|.+.  +..||||++..... .......+.+|+.+++.++||||+++++++.+.  
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            4566789999999999999999999874  78999999986532 344556788999999999999999999999877  


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                      ...++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            78899999999999999997764  5899999999999999999999999  9999999999999999999999999875


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCc
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM  334 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~  334 (358)
                      ....                                                      ...+||+.|+|||++.+..++.
T Consensus       162 ~~~~------------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~  187 (271)
T 3kmu_A          162 SFQS------------------------------------------------------PGRMYAPAWVAPEALQKKPEDT  187 (271)
T ss_dssp             TTSC------------------------------------------------------TTCBSCGGGSCHHHHHSCGGGS
T ss_pred             eecc------------------------------------------------------cCccCCccccChhhhccCCCCC
Confidence            4221                                                      0236899999999999876655


Q ss_pred             ---cchhhhhhHHHHhhcccccccc
Q 018275          335 ---ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       335 ---~~DiwSlGvil~e~l~~~~~~~  356 (358)
                         ++|+|||||++|||+++..+|.
T Consensus       188 ~~~~~Di~slG~il~el~~g~~p~~  212 (271)
T 3kmu_A          188 NRRSADMWSFAVLLWELVTREVPFA  212 (271)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcc
Confidence               7999999999999999877653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.6e-40  Score=303.75  Aligned_cols=205  Identities=26%  Similarity=0.425  Sum_probs=172.5

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ......++|++.+.||+|+||.||+|.+..++..||+|++....   ......+.+|+.+++.++||||+++++++.+.+
T Consensus        13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred             cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence            33445588999999999999999999999999999999987653   344566889999999999999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999999998865 46799999999999999999999999999999999999999999999999998753210


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh-----cCCCCC
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-----LKKGYG  333 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~-----~~~~y~  333 (358)
                      .                                                 .......+||+.|+|||++     .+..++
T Consensus       170 ~-------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~  200 (302)
T 2j7t_A          170 T-------------------------------------------------LQKRDSFIGTPYWMAPEVVMCETMKDTPYD  200 (302)
T ss_dssp             H-------------------------------------------------HHC-----CCGGGCCHHHHHHHHTTSTTTT
T ss_pred             c-------------------------------------------------ccccccccCChhhcCCeeeccccCCCCCCc
Confidence            0                                                 0011134799999999999     467899


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|+|||||++|+|+++..+|.
T Consensus       201 ~~~Di~slG~il~~l~~g~~p~~  223 (302)
T 2j7t_A          201 YKADIWSLGITLIEMAQIEPPHH  223 (302)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTT
T ss_pred             hhhhHHHHHHHHHHHhcCCCCCc
Confidence            99999999999999999877653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.2e-39  Score=300.79  Aligned_cols=209  Identities=20%  Similarity=0.217  Sum_probs=163.8

Q ss_pred             HhHhhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEE
Q 018275           95 YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYS  174 (358)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~  174 (358)
                      .......++..++|.+.+.||+|+||.||+|.+.   ..||+|+++.... .......+.+|+.+++.++||||++++++
T Consensus        13 ~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             -----CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            3444567788899999999999999999999753   3599999876532 44556778999999999999999999996


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      + .....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus        89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             E-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             c-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence            5 45568999999999999999954 457899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KK  330 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~  330 (358)
                      +.........                                               ......||+.|+|||++.   +.
T Consensus       168 ~~~~~~~~~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~  200 (289)
T 3og7_A          168 TEKSRWSGSH-----------------------------------------------QFEQLSGSILWMAPEVIRMQDSN  200 (289)
T ss_dssp             ---------------------------------------------------------------CCCTTCCHHHHC----C
T ss_pred             cccccccccc-----------------------------------------------cccccCCCccccCchhhcccCCC
Confidence            7553211100                                               011347999999999997   67


Q ss_pred             CCCccchhhhhhHHHHhhccccccc
Q 018275          331 GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .++.++|+|||||++|+|+++..+|
T Consensus       201 ~~~~~~Di~slG~il~el~~g~~p~  225 (289)
T 3og7_A          201 PYSFQSDVYAFGIVLYELMTGQLPY  225 (289)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCcccchHHHHHHHHHHHHCCCCc
Confidence            7899999999999999999987665

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.7e-40  Score=306.72  Aligned_cols=201  Identities=24%  Similarity=0.363  Sum_probs=170.4

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEE--EEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY--AMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~v--aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~  179 (358)
                      +..++|.+.+.||+|+||.||+|.+..++..+  |+|.+....  .......+.+|+.++..+ +||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            45589999999999999999999999888865  999887532  334455688999999999 8999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG  243 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  243 (358)
                      ..|+||||+++++|.+++....                .+++..+..++.|++.||.|||+.||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999997653                789999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCch
Q 018275          244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA  323 (358)
Q Consensus       244 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~A  323 (358)
                      .+||+|||+++.......                                                  .....+|+.|+|
T Consensus       180 ~~kL~Dfg~~~~~~~~~~--------------------------------------------------~~~~~~~~~y~a  209 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVK--------------------------------------------------KTMGRLPVRWMA  209 (327)
T ss_dssp             CEEECCTTCEESSCEECC--------------------------------------------------C----CCTTTCC
T ss_pred             eEEEcccCcCcccccccc--------------------------------------------------ccCCCCCccccC
Confidence            999999999874321100                                                  012357899999


Q ss_pred             hhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          324 PEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       324 PEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ||++.+..++.++|||||||++|||+. +..+|
T Consensus       210 PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf  242 (327)
T 1fvr_A          210 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY  242 (327)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             hhhhccccCCchhcchHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999999996 66554

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.3e-39  Score=300.76  Aligned_cols=207  Identities=21%  Similarity=0.238  Sum_probs=173.2

Q ss_pred             cCccCCCceeee-eEeeeeeEEEEEEEE--ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          101 HKISVDDFDLLT-IIGRGAFGEVRLCQE--KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       101 ~~~~~~~~~~~~-~IG~G~fG~Vy~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      ..+..++|.+.. .||+|+||.||+|.+  ..++..||||++..... .......+.+|+.+++.++||||+++++++ .
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            345567899998 999999999999954  45678999999986532 344466789999999999999999999999 5


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      .+..++||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            56789999999999999999888889999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      .......                                              ......||+.|+|||++.+..++.++|
T Consensus       169 ~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D  202 (291)
T 1xbb_A          169 ADENYYK----------------------------------------------AQTHGKWPVKWYAPECINYYKFSSKSD  202 (291)
T ss_dssp             TTCSEEE----------------------------------------------C----CCCGGGCCHHHHHHCEEEHHHH
T ss_pred             cCCCccc----------------------------------------------ccccCCCCceeeChHHhccCCCChhhh
Confidence            3221100                                              011235789999999999999999999


Q ss_pred             hhhhhHHHHhhcc-ccccc
Q 018275          338 WLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~~  355 (358)
                      +||||+++|+|++ +..+|
T Consensus       203 i~slG~il~~l~~~g~~p~  221 (291)
T 1xbb_A          203 VWSFGVLMWEAFSYGQKPY  221 (291)
T ss_dssp             HHHHHHHHHHHHTTTCCSS
T ss_pred             HHHHHHHHHHHHhcCCCCC
Confidence            9999999999998 66655

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.5e-40  Score=300.38  Aligned_cols=202  Identities=30%  Similarity=0.506  Sum_probs=173.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee--cCCEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEYLY  182 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~  182 (358)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.  .....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            4789999999999999999999999999999999976542 3445667889999999999999999999884  467899


Q ss_pred             EEEeecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHN-----YIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~-----iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      +||||+++++|.+++...    ..+++..+..++.|++.||.|||+.+     |+||||||+|||++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999999999653    35899999999999999999999999     999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +.......                                                 ......||+.|+|||++.+..++
T Consensus       164 ~~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~  194 (279)
T 2w5a_A          164 RILNHDTS-------------------------------------------------FAKTFVGTPYYMSPEQMNRMSYN  194 (279)
T ss_dssp             HHC---CH-------------------------------------------------HHHHHHSCCTTCCHHHHHCC-CC
T ss_pred             eeeccccc-------------------------------------------------cccccCCCccccChHHhccCCCC
Confidence            76532110                                                 01134699999999999999999


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|+|||||++|+|+++...|.
T Consensus       195 ~~~Di~slG~il~~l~~g~~p~~  217 (279)
T 2w5a_A          195 EKSDIWSLGCLLYELCALMPPFT  217 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             chhhHHHHHHHHHHHHHCCCCCc
Confidence            99999999999999999876653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.6e-40  Score=306.14  Aligned_cols=209  Identities=26%  Similarity=0.450  Sum_probs=157.3

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..+++.||||++.....  ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            45667999999999999999999999988999999999976532  3345567889999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          181 LYLIMEYLPGGDVMTLLMR--------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                      .++||||+++++|.+++..        ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999999864        45689999999999999999999999999999999999999999999999999


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CC
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KG  331 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~  331 (358)
                      +..........                                            +.......+||+.|+|||++.+ ..
T Consensus       168 ~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~  203 (303)
T 2vwi_A          168 SAFLATGGDIT--------------------------------------------RNKVRKTFVGTPCWMAPEVMEQVRG  203 (303)
T ss_dssp             HHHCC-----------------------------------------------------------CCCTTCCHHHHHHHHC
T ss_pred             hheeccCCCcc--------------------------------------------chhhhcccCCCccccCHHHhccccC
Confidence            87654221100                                            0001123479999999999976 67


Q ss_pred             CCccchhhhhhHHHHhhccccccc
Q 018275          332 YGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ++.++|+|||||++|||+++..+|
T Consensus       204 ~~~~~Di~slG~il~~l~~g~~pf  227 (303)
T 2vwi_A          204 YDFKADIWSFGITAIELATGAAPY  227 (303)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCC
Confidence            899999999999999999987765

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-39  Score=296.20  Aligned_cols=201  Identities=19%  Similarity=0.231  Sum_probs=174.1

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .+..++|.+.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            456689999999999999999999875 577899999986542    234588999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999999999765 568999999999999999999999999999999999999999999999999987653110


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .                                                .......||+.|+|||++.+..++.++|+||
T Consensus       159 ~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  190 (267)
T 3t9t_A          159 Y------------------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWS  190 (267)
T ss_dssp             H------------------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             c------------------------------------------------cccccccccccccChhhhcCCCccchhchhh
Confidence            0                                                0011336888999999999999999999999


Q ss_pred             hhHHHHhhcc-ccccc
Q 018275          341 YWNETLSCNY-LSDIM  355 (358)
Q Consensus       341 lGvil~e~l~-~~~~~  355 (358)
                      ||+++|+|++ +..+|
T Consensus       191 lG~il~~l~~~g~~p~  206 (267)
T 3t9t_A          191 FGVLMWEVFSEGKIPY  206 (267)
T ss_dssp             HHHHHHHHHTTSCCTT
T ss_pred             hHHHHHHHhccCCCCC
Confidence            9999999998 56554

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.9e-39  Score=295.94  Aligned_cols=204  Identities=24%  Similarity=0.267  Sum_probs=171.9

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      ..+..++|.+.+.||+|+||.||+|.+...   +..||+|++....  .....+.+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            456678999999999999999999987543   3469999998653  34455678899999999999999999999875


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      . ..|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            4 468999999999999999765 46999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      ......                                                ......||+.|+|||++.+..++.++
T Consensus       164 ~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~  195 (281)
T 3cc6_A          164 EDEDYY------------------------------------------------KASVTRLPIKWMSPESINFRRFTTAS  195 (281)
T ss_dssp             ---------------------------------------------------------CCCCCGGGCCHHHHHHCCCCHHH
T ss_pred             cccccc------------------------------------------------ccccCCCCcceeCchhhccCCCCchh
Confidence            422110                                                01123578899999999999999999


Q ss_pred             hhhhhhHHHHhhcc-ccccc
Q 018275          337 DWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~-~~~~~  355 (358)
                      |+|||||++|||+. +..+|
T Consensus       196 Di~slG~il~~llt~g~~p~  215 (281)
T 3cc6_A          196 DVWMFAVCMWEILSFGKQPF  215 (281)
T ss_dssp             HHHHHHHHHHHHHTTTCCTT
T ss_pred             ccHHHHHHHHHHHhCCCCCc
Confidence            99999999999996 77665

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-39  Score=297.30  Aligned_cols=202  Identities=19%  Similarity=0.206  Sum_probs=170.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCC---EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE-
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL-  181 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~-  181 (358)
                      ..|.+.+.||+|+||.||+|.+..++.   .||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+.. 
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            356677999999999999999766555   79999987542  345567788999999999999999999999876655 


Q ss_pred             EEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      ++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999999976 4578899999999999999999999999999999999999999999999999998654221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ....                                             .......||+.|+|||++.+..++.++|+||
T Consensus       179 ~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  213 (298)
T 3pls_A          179 YYSV---------------------------------------------QQHRHARLPVKWTALESLQTYRFTTKSDVWS  213 (298)
T ss_dssp             GGCS---------------------------------------------CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHH
T ss_pred             cccc---------------------------------------------ccCcCCCCCccccChhhhccCCCChhhchhh
Confidence            1000                                             0111346899999999999999999999999


Q ss_pred             hhHHHHhhcccccc
Q 018275          341 YWNETLSCNYLSDI  354 (358)
Q Consensus       341 lGvil~e~l~~~~~  354 (358)
                      |||++|+|+++...
T Consensus       214 lG~il~~l~~g~~~  227 (298)
T 3pls_A          214 FGVLLWELLTRGAP  227 (298)
T ss_dssp             HHHHHHHHHHTSCC
T ss_pred             HHHHHHHHhhCCCC
Confidence            99999999995443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.9e-39  Score=301.35  Aligned_cols=209  Identities=20%  Similarity=0.258  Sum_probs=166.4

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEec---CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      ....+..++|.+.+.||+|+||.||+|.+..   ++..||+|++..... .......+.+|+.+++.++||||+++++++
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3445667899999999999999999998765   455899999976532 344566788999999999999999999999


Q ss_pred             ecCC-----EEEEEEeecCCCCHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc
Q 018275          176 QDAE-----YLYLIMEYLPGGDVMTLLM------REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH  244 (358)
Q Consensus       176 ~~~~-----~~~lV~E~~~~g~L~~~l~------~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~  244 (358)
                      .+..     ..++||||+++++|.+++.      ....+++..+..++.|++.||.|||+.||+||||||+|||++.++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence            8654     3599999999999999984      3357999999999999999999999999999999999999999999


Q ss_pred             EEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchh
Q 018275          245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP  324 (358)
Q Consensus       245 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~AP  324 (358)
                      +||+|||+++.........                                               ......||+.|+||
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aP  218 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYR-----------------------------------------------QGRIAKMPVKWIAI  218 (313)
T ss_dssp             EEECSCSCC---------------------------------------------------------------CCGGGSCH
T ss_pred             EEEeecCcceecccccccC-----------------------------------------------cccccCCCccccCc
Confidence            9999999997654221000                                               01123578899999


Q ss_pred             hhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          325 EVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       325 Ev~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      |++.+..|+.++|+|||||++|+|++ +..+|
T Consensus       219 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~  250 (313)
T 3brb_A          219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPY  250 (313)
T ss_dssp             HHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             hhhcCCCccchhhhHHHHHHHHHHHhcCCCCC
Confidence            99999999999999999999999998 55544

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.9e-39  Score=304.53  Aligned_cols=210  Identities=26%  Similarity=0.394  Sum_probs=172.3

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC-----
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----  178 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----  178 (358)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++.++||||+++++++...     
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            3589999999999999999999999999999999996532  334455678899999999999999999988654     


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ...|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            67999999996 689998865 5789999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~D  337 (358)
                      .........                                       .........+||+.|+|||++.+ ..++.++|
T Consensus       165 ~~~~~~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  205 (353)
T 2b9h_A          165 SAADNSEPT---------------------------------------GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD  205 (353)
T ss_dssp             ------------------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHH
T ss_pred             ccccccCcc---------------------------------------ccccchhhccccccccCCeeeccCCCccchhh
Confidence            221110000                                       00011124589999999999865 77999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|+|+++..+|.
T Consensus       206 i~slG~il~~l~~g~~pf~  224 (353)
T 2b9h_A          206 VWSCGCILAELFLRRPIFP  224 (353)
T ss_dssp             HHHHHHHHHHHHHSSCSCC
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999887663

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=302.60  Aligned_cols=211  Identities=21%  Similarity=0.276  Sum_probs=173.3

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee----cC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ----DA  178 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~----~~  178 (358)
                      +..++|.+.+.||+|+||.||+|.+..+++.||||++...   .......+.+|+.+++.++||||+++++++.    ..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            4457899999999999999999999999999999998654   3345567889999999999999999999986    34


Q ss_pred             CEEEEEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          179 EYLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                      ...++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            578999999999999999875    4679999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC---
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG---  331 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~---  331 (358)
                      ..........                                .......        .....||+.|+|||++.+..   
T Consensus       183 ~~~~~~~~~~--------------------------------~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~  222 (317)
T 2buj_A          183 QACIHVEGSR--------------------------------QALTLQD--------WAAQRCTISYRAPELFSVQSHCV  222 (317)
T ss_dssp             ESCEEEESHH--------------------------------HHHHHHH--------HHHHHSCGGGCCGGGSSCCSEEE
T ss_pred             hccccccccc--------------------------------ccccccc--------cccccCCcccCCHhHhccCCCcC
Confidence            6531110000                                0000000        11346899999999998665   


Q ss_pred             CCccchhhhhhHHHHhhcccccccc
Q 018275          332 YGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ++.++|||||||++|||+++..+|.
T Consensus       223 ~~~~~Di~slG~il~el~~g~~p~~  247 (317)
T 2buj_A          223 IDERTDVWSLGCVLYAMMFGEGPYD  247 (317)
T ss_dssp             ECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCChh
Confidence            7899999999999999999887663

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=306.02  Aligned_cols=201  Identities=15%  Similarity=0.167  Sum_probs=169.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEec--------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEE------
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKK--------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK------  170 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~------  170 (358)
                      .++|.+.+.||+|+||.||+|.+..        .++.||||++....        .+.+|+.+++.++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~--------~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG--------RLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS--------THHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc--------hHHHHHHHHHHhcccchhhhhhhhc
Confidence            4789999999999999999999887        48899999987542        3778999999999999887      


Q ss_pred             ---------EEEEeec-CCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 018275          171 ---------LYYSFQD-AEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLL  238 (358)
Q Consensus       171 ---------l~~~~~~-~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NIL  238 (358)
                               +++++.. ....|+||||+ +++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5666665 78899999999 99999999876  78999999999999999999999999999999999999


Q ss_pred             EcCCC--cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccccc
Q 018275          239 LDQNG--HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV  316 (358)
Q Consensus       239 l~~~~--~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  316 (358)
                      ++.++  .+||+|||+++.+..........                                          .......+
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~------------------------------------------~~~~~~~~  229 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYV------------------------------------------EGSRSPHE  229 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCC------------------------------------------TTSSCTTC
T ss_pred             EcCCCCceEEEecCcceeeccCCCcccccc------------------------------------------cccccccc
Confidence            99998  99999999998765322111000                                          00112347


Q ss_pred             CCCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          317 GTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       317 gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ||+.|+|||++.+..|+.++|+|||||++|||+++...|.
T Consensus       230 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          230 GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             CCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999999999999999999999999999999999877664

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-39  Score=320.27  Aligned_cols=202  Identities=22%  Similarity=0.308  Sum_probs=172.4

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      ...+..++|.+.+.||+|+||.||+|.+. .+..||||+++...    ...+.+.+|+.+++.++|||||++++++. .+
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            34567789999999999999999999875 46789999998653    23566899999999999999999999987 56


Q ss_pred             EEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      .+|+||||+++|+|.+++...  ..++...+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            789999999999999999754  368888999999999999999999999999999999999999999999999998653


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ....                                                .......+|+.|+|||++.+..|+.++|
T Consensus       336 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D  367 (454)
T 1qcf_A          336 DNEY------------------------------------------------TAREGAKFPIKWTAPEAINFGSFTIKSD  367 (454)
T ss_dssp             CHHH------------------------------------------------HTTCSSSSCGGGSCHHHHHHCCCCHHHH
T ss_pred             CCce------------------------------------------------eccCCCcccccccCHHHhccCCCCcHHH
Confidence            2110                                                0011235788999999999999999999


Q ss_pred             hhhhhHHHHhhcc-ccccc
Q 018275          338 WLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~~  355 (358)
                      ||||||+||||++ +..+|
T Consensus       368 vwslG~~l~el~t~g~~P~  386 (454)
T 1qcf_A          368 VWSFGILLMEIVTYGRIPY  386 (454)
T ss_dssp             HHHHHHHHHHHHTTSCCSS
T ss_pred             HHhHHHHHHHHHhCCCCCC
Confidence            9999999999998 66554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.7e-39  Score=307.80  Aligned_cols=196  Identities=27%  Similarity=0.373  Sum_probs=169.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE---
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL---  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~---  181 (358)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||++++++|.+....   
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            378999999999999999999999999999999997653 2344556788999999999999999999999877654   


Q ss_pred             ---EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          182 ---YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       182 ---~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                         |+||||++ ++|.+.+  ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             eeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence               99999996 6888877  34589999999999999999999999999999999999999999999999999975431


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~D  337 (358)
                      .                                                    ....+||+.|+|||++.+ ..|+.++|
T Consensus       197 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D  224 (371)
T 4exu_A          197 E----------------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVD  224 (371)
T ss_dssp             -------------------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHH
T ss_pred             C----------------------------------------------------cCCcccCccccCHHHhcCCCCCCcHHh
Confidence            1                                                    013479999999999987 78999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|+|+++..+|.
T Consensus       225 iwslG~il~el~~g~~pf~  243 (371)
T 4exu_A          225 IWSVGCIMAEMLTGKTLFK  243 (371)
T ss_dssp             HHHHHHHHHHHHHSSCSCC
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999887663

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-38  Score=293.33  Aligned_cols=204  Identities=22%  Similarity=0.252  Sum_probs=170.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe-ecCCEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF-QDAEYLYL  183 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-~~~~~~~l  183 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.....     ...+.+|+.+++.++|++++..+..+ .+....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            4789999999999999999999999999999999875432     12378899999999998766555444 67788999


Q ss_pred             EEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---cCCCcEEEEecCCCccCCCC
Q 018275          184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~vkl~DFGla~~~~~~  259 (358)
                      ||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 8999999974 4679999999999999999999999999999999999999   58899999999999876432


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .......                                          ........||+.|+|||++.+..++.++|||
T Consensus       162 ~~~~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~  199 (296)
T 3uzp_A          162 RTHQHIP------------------------------------------YRENKNLTGTARYASINTHLGIEQSRRDDLE  199 (296)
T ss_dssp             TTCCBCC------------------------------------------CCCSCCCCSCTTTCCHHHHTTCCCCHHHHHH
T ss_pred             ccccccc------------------------------------------cccccccccccccCChhhhcCCCCCcchhhH
Confidence            2111000                                          0011245799999999999999999999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||++|||+++..+|.
T Consensus       200 slG~il~~l~~g~~pf~  216 (296)
T 3uzp_A          200 SLGYVLMYFNLGSLPWQ  216 (296)
T ss_dssp             HHHHHHHHHHHSSCTTS
T ss_pred             HHHHHHHHHHhCCCCCC
Confidence            99999999999887764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-38  Score=294.36  Aligned_cols=204  Identities=22%  Similarity=0.252  Sum_probs=167.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe-ecCCEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF-QDAEYLYL  183 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-~~~~~~~l  183 (358)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++......     ..+..|+.++..+.|++++..+..+ .+....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            37899999999999999999999999999999987654322     2377899999999988766665554 67788999


Q ss_pred             EEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---cCCCcEEEEecCCCccCCCC
Q 018275          184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~vkl~DFGla~~~~~~  259 (358)
                      ||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 8999999974 4679999999999999999999999999999999999999   78999999999999876432


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .......                                          ........||+.|+|||++.+..++.++|||
T Consensus       162 ~~~~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~  199 (296)
T 4hgt_A          162 RTHQHIP------------------------------------------YRENKNLTGTARYASINTHLGIEQSRRDDLE  199 (296)
T ss_dssp             TTCCBCC------------------------------------------CCCSCCCCSCGGGCCHHHHTTCCCCHHHHHH
T ss_pred             ccCccCC------------------------------------------CCcccccCCCccccchHHhcCCCCCchhHHH
Confidence            2111000                                          0011245799999999999999999999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||++|+|+++..+|.
T Consensus       200 slG~il~~l~~g~~pf~  216 (296)
T 4hgt_A          200 SLGYVLMYFNLGSLPWQ  216 (296)
T ss_dssp             HHHHHHHHHHHSSCTTS
T ss_pred             HHHHHHHHHhcCCCCCc
Confidence            99999999999887764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.8e-39  Score=297.57  Aligned_cols=202  Identities=18%  Similarity=0.224  Sum_probs=167.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe-ecCC
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF-QDAE  179 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-~~~~  179 (358)
                      ...+|.+.+.||+|+||.||+|.+..+   ...||+|.+....  .......+.+|+.+++.++||||+++++++ .+.+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            346799999999999999999986543   3368999987542  345566788999999999999999999985 4566


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      ..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            789999999999999999753 5688999999999999999999999999999999999999999999999999986642


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ......                                             .......||+.|+|||++.+..++.++|+
T Consensus       181 ~~~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  215 (298)
T 3f66_A          181 KEYYSV---------------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDV  215 (298)
T ss_dssp             GGGCBC--------------------------------------------------CCBCGGGSCHHHHHHCCCCHHHHH
T ss_pred             cchhcc---------------------------------------------ccccCCCCCccccChHHhcCCCCChHHHH
Confidence            211100                                             00113468899999999999999999999


Q ss_pred             hhhhHHHHhhcccc
Q 018275          339 LAYWNETLSCNYLS  352 (358)
Q Consensus       339 wSlGvil~e~l~~~  352 (358)
                      |||||++|+|+++.
T Consensus       216 ~slG~il~~l~~~~  229 (298)
T 3f66_A          216 WSFGVLLWELMTRG  229 (298)
T ss_dssp             HHHHHHHHHHHTTS
T ss_pred             HHHHHHHHHHHhCC
Confidence            99999999999843

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-39  Score=296.42  Aligned_cols=205  Identities=24%  Similarity=0.320  Sum_probs=173.1

Q ss_pred             CccCCCceeee-eEeeeeeEEEEEEEEe--cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          102 KISVDDFDLLT-IIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       102 ~~~~~~~~~~~-~IG~G~fG~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      .+..++|.+.. .||+|+||.||+|.+.  .++..||||++....  .......+.+|+.+++.++||||+++++++. .
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   81 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A   81 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C
Confidence            34557888887 9999999999999854  467889999998652  3455677889999999999999999999995 5


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      +..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            5689999999999999999654 569999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ......                                              .......||+.|+|||++.+..++.++|
T Consensus       162 ~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D  195 (287)
T 1u59_A          162 ADDSYY----------------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSD  195 (287)
T ss_dssp             TCSCEE----------------------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHH
T ss_pred             cCccee----------------------------------------------eccccccccccccCHHHhccCCCCchhh
Confidence            322110                                              0011235789999999999999999999


Q ss_pred             hhhhhHHHHhhcc-ccccc
Q 018275          338 WLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~~  355 (358)
                      +|||||++|||+. +..+|
T Consensus       196 i~slG~il~ellt~g~~p~  214 (287)
T 1u59_A          196 VWSYGVTMWEALSYGQKPY  214 (287)
T ss_dssp             HHHHHHHHHHHHTTSCCTT
T ss_pred             HHHHHHHHHHHHcCCCCCc
Confidence            9999999999997 76655

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.4e-39  Score=294.46  Aligned_cols=201  Identities=23%  Similarity=0.334  Sum_probs=171.3

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|.+.+.||+|+||.||+|.+. ++..||+|++....    ...+.+.+|+.+++.++||||+++++++.+ +.
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence            4566689999999999999999999864 56789999987653    224568899999999999999999999874 45


Q ss_pred             EEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            899999999999999996543  789999999999999999999999999999999999999999999999999986642


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ....                                                ......||+.|+|||++.+..++.++|+
T Consensus       162 ~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di  193 (279)
T 1qpc_A          162 NEYT------------------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDV  193 (279)
T ss_dssp             SCEE------------------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHH
T ss_pred             cccc------------------------------------------------cccCCCCccCccChhhhccCCCCchhhh
Confidence            2110                                                0112357889999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      |||||++|||++ +...|
T Consensus       194 ~slG~il~el~~~g~~p~  211 (279)
T 1qpc_A          194 WSFGILLTEIVTHGRIPY  211 (279)
T ss_dssp             HHHHHHHHHHHTTTCCSS
T ss_pred             HHHHHHHHHHHhCCCCCC
Confidence            999999999998 55544

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.5e-39  Score=310.56  Aligned_cols=194  Identities=26%  Similarity=0.338  Sum_probs=160.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec------C
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------A  178 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~------~  178 (358)
                      ..+|.+.+.||+|+||.||+|.+..++. ||+|++......       ..+|+.+++.++|||||+++++|..      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            4679999999999999999999877665 888877654321       2368999999999999999999953      3


Q ss_pred             CEEEEEEeecCCCCHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc-CCCcEEEEecCCCc
Q 018275          179 EYLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCK  254 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~vkl~DFGla~  254 (358)
                      .++++||||++++.+....   .....+++..++.++.|++.||.|||+.||+||||||+|||++ .++.+||+|||+|+
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            3589999999765333322   2356899999999999999999999999999999999999999 79999999999998


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCC
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYG  333 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~  333 (358)
                      .+.....                                                  ..+.+||+.|+|||++.+. .|+
T Consensus       191 ~~~~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~  220 (394)
T 4e7w_A          191 ILIAGEP--------------------------------------------------NVSYICSRYYRAPELIFGATNYT  220 (394)
T ss_dssp             ECCTTCC--------------------------------------------------CCSSCSCGGGCCHHHHTTCSSCC
T ss_pred             cccCCCC--------------------------------------------------CcccccCcCccCHHHHcCCCCCC
Confidence            6532211                                                  1134799999999999765 599


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|||||||++|||+++..+|.
T Consensus       221 ~~~DiwSlG~il~ell~g~~pf~  243 (394)
T 4e7w_A          221 TNIDIWSTGCVMAELMQGQPLFP  243 (394)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999987764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.8e-39  Score=294.63  Aligned_cols=198  Identities=28%  Similarity=0.504  Sum_probs=174.3

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            679999999999999999999999999999999976543 2344567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC---CcEEEEecCCCccCCCCCCc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~---~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||+++++|.+.+.....+++..+..++.|++.||.|||+.||+||||||+||+++.+   +.+||+|||++........ 
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~-  179 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-  179 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-
Confidence            999999999999888899999999999999999999999999999999999999764   4799999999876532110 


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       .....||+.|+|||++.+. ++.++|+||||
T Consensus       180 -------------------------------------------------~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG  209 (287)
T 2wei_A          180 -------------------------------------------------MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAG  209 (287)
T ss_dssp             -------------------------------------------------CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHH
T ss_pred             -------------------------------------------------cccccCcccccChHHhcCC-CCCchhhHhHH
Confidence                                                             0123689999999999765 89999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      +++|+|+++...|
T Consensus       210 ~~l~~l~~g~~p~  222 (287)
T 2wei_A          210 VILYILLSGTPPF  222 (287)
T ss_dssp             HHHHHHHHSSCSS
T ss_pred             HHHHHHHhCCCCC
Confidence            9999999987665

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.1e-39  Score=300.95  Aligned_cols=202  Identities=24%  Similarity=0.338  Sum_probs=170.7

Q ss_pred             CCCc-eeeeeEeeeeeEEEEEEEE----ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--
Q 018275          105 VDDF-DLLTIIGRGAFGEVRLCQE----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--  177 (358)
Q Consensus       105 ~~~~-~~~~~IG~G~fG~Vy~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--  177 (358)
                      .++| ++++.||+|+||.||+|..    ..+++.||||++....  .......+.+|+.+++.++||||+++++++.+  
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            3445 9999999999999988754    4578899999998653  34556678999999999999999999999987  


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ...+++||||+++++|.+++... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            46899999999999999999654 58999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ......                                              .......||+.|+|||++.+..++.++|
T Consensus       186 ~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D  219 (318)
T 3lxp_A          186 EGHEYY----------------------------------------------RVREDGDSPVFWYAPECLKEYKFYYASD  219 (318)
T ss_dssp             TTCSEE----------------------------------------------EC---CCCCGGGCCHHHHHHCEEEHHHH
T ss_pred             cccccc----------------------------------------------ccccCCCCCceeeChHHhcCCCCCcHHH
Confidence            322110                                              0011336889999999999999999999


Q ss_pred             hhhhhHHHHhhccccccc
Q 018275          338 WLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~  355 (358)
                      ||||||++|+|+++...|
T Consensus       220 i~slG~il~~ll~g~~p~  237 (318)
T 3lxp_A          220 VWSFGVTLYELLTHCDSS  237 (318)
T ss_dssp             HHHHHHHHHHHHTTTCGG
T ss_pred             HHHHHHHHHHHHhCCCcc
Confidence            999999999999986655

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.8e-39  Score=304.36  Aligned_cols=197  Identities=27%  Similarity=0.399  Sum_probs=154.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----  179 (358)
                      .++|.+.+.||+|+||.||+|.+..++..||||++......    .....+++..++.++||||++++++|.+..     
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            47999999999999999999999999999999998654322    223556778889999999999999986433     


Q ss_pred             --EEEEEEeecCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCCEEEcC-CCcEEEEec
Q 018275          180 --YLYLIMEYLPGGDVMTLL----MREETLTETVARFYIAQSVLAIESIH--KHNYIHRDIKPDNLLLDQ-NGHMKLSDF  250 (358)
Q Consensus       180 --~~~lV~E~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~iiHrDikp~NILl~~-~~~vkl~DF  250 (358)
                        ++++||||+++ +|...+    .....+++..+..++.|++.||.|||  +.||+||||||+|||++. ++.+||+||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df  176 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF  176 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence              38999999976 544433    34568899999999999999999999  999999999999999997 899999999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK  330 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~  330 (358)
                      |+++.+.....                                                  ....+||+.|+|||++.+.
T Consensus       177 g~a~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~  206 (360)
T 3e3p_A          177 GSAKKLSPSEP--------------------------------------------------NVAYICSRYYRAPELIFGN  206 (360)
T ss_dssp             TTCBCCCTTSC--------------------------------------------------CCSTTSCGGGCCHHHHTTC
T ss_pred             CCceecCCCCC--------------------------------------------------cccccCCcceeCHHHHcCC
Confidence            99986642211                                                  1134799999999999765


Q ss_pred             C-CCccchhhhhhHHHHhhcccccccc
Q 018275          331 G-YGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       331 ~-y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      . |+.++|||||||++|||+++..+|.
T Consensus       207 ~~~~~~~Di~slG~il~ell~g~~pf~  233 (360)
T 3e3p_A          207 QHYTTAVDIWSVGCIFAEMMLGEPIFR  233 (360)
T ss_dssp             SSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence            4 8999999999999999999887663

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=303.39  Aligned_cols=203  Identities=25%  Similarity=0.313  Sum_probs=160.1

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHH--HHHhcCcceEEEEEEee--
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL--LAEVASHCIVKLYYSFQ--  176 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~i--l~~l~h~~iv~l~~~~~--  176 (358)
                      ..+..++|++.+.||+|+||.||+|.+  +++.||||++....      ...+..|..+  +..++||||+++++.+.  
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence            356779999999999999999999965  68899999987543      1223344444  44589999999997543  


Q ss_pred             ---cCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeCCCCCCCEEEcCCCc
Q 018275          177 ---DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH---------NYIHRDIKPDNLLLDQNGH  244 (358)
Q Consensus       177 ---~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---------~iiHrDikp~NILl~~~~~  244 (358)
                         ....+|+||||+++|+|.+++... ..++..+..++.|++.||.|||+.         ||+||||||+|||++.++.
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence               334689999999999999999654 448888889999999999999999         9999999999999999999


Q ss_pred             EEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchh
Q 018275          245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP  324 (358)
Q Consensus       245 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~AP  324 (358)
                      +||+|||+++.+..........                                         ......+.+||+.|+||
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aP  197 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGE-----------------------------------------EDNAAISEVGTIRYMAP  197 (336)
T ss_dssp             EEECCCTTCEECSSSSCC--------------------------------------------------CCTTSCGGGCCH
T ss_pred             EEEeeccceeecccccccCccc-----------------------------------------cccccccCCCccceeCc
Confidence            9999999998765322111000                                         00112245799999999


Q ss_pred             hhhcC-------CCCCccchhhhhhHHHHhhccccc
Q 018275          325 EVLLK-------KGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       325 Ev~~~-------~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                      |++.+       ..++.++|||||||++|||+++..
T Consensus       198 E~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~  233 (336)
T 3g2f_A          198 EVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT  233 (336)
T ss_dssp             HHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred             hhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence            99987       457789999999999999998744

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-38  Score=304.70  Aligned_cols=199  Identities=24%  Similarity=0.351  Sum_probs=171.2

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-Cc-----ceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SH-----CIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~-----~iv~l~~~  174 (358)
                      .....++|.+.+.||+|+||.||+|.+..+++.||||++....    .....+..|+.++..+. |+     +|+.++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            3445689999999999999999999999999999999997542    23455777888888875 44     49999999


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCCEEEc--CCCcEEEE
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIH--KHNYIHRDIKPDNLLLD--QNGHMKLS  248 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~iiHrDikp~NILl~--~~~~vkl~  248 (358)
                      |...+..|+||||++ ++|.+++...  ..+++..++.++.|++.||.|||  ..||+||||||+|||++  .++.+||+
T Consensus       125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999999996 5999999765  46899999999999999999999  57999999999999995  47889999


Q ss_pred             ecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc
Q 018275          249 DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL  328 (358)
Q Consensus       249 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~  328 (358)
                      |||+|+.....                                                    ....+||+.|+|||++.
T Consensus       204 DFG~a~~~~~~----------------------------------------------------~~~~~~t~~y~aPE~~~  231 (382)
T 2vx3_A          204 DFGSSCQLGQR----------------------------------------------------IYQYIQSRFYRSPEVLL  231 (382)
T ss_dssp             CCTTCEETTCC----------------------------------------------------CCSSCSCGGGCCHHHHT
T ss_pred             eccCceecccc----------------------------------------------------cccccCCccccChHHHc
Confidence            99999765311                                                    11347999999999999


Q ss_pred             CCCCCccchhhhhhHHHHhhcccccccc
Q 018275          329 KKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       329 ~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +..|+.++|||||||++|||+++..+|.
T Consensus       232 ~~~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          232 GMPYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999887764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=296.94  Aligned_cols=201  Identities=24%  Similarity=0.334  Sum_probs=164.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee--------
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--------  176 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--------  176 (358)
                      .++|.+++.||+|+||.||+|.+..+++.||||++...   .......+.+|+.+++.++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            48899999999999999999999999999999998754   3445667889999999999999999998873        


Q ss_pred             ------cCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc-CCCcEEEEe
Q 018275          177 ------DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSD  249 (358)
Q Consensus       177 ------~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~vkl~D  249 (358)
                            +....|+||||++ |+|.+++. ..++++..+..++.|++.||.|||+.||+||||||+|||++ .++.+||+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  4478999999997 69999885 46789999999999999999999999999999999999997 567999999


Q ss_pred             cCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC
Q 018275          250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK  329 (358)
Q Consensus       250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~  329 (358)
                      ||+++.........                                              .......||+.|+|||++.+
T Consensus       165 fg~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~  198 (320)
T 2i6l_A          165 FGLARIMDPHYSHK----------------------------------------------GHLSEGLVTKWYRSPRLLLS  198 (320)
T ss_dssp             CTTCBCC------------------------------------------------------CCCGGGSCCTTCCHHHHHC
T ss_pred             CccccccCCCcccc----------------------------------------------cccccccccccccCcHHhcC
Confidence            99998664211100                                              01113468999999999876


Q ss_pred             -CCCCccchhhhhhHHHHhhcccccccc
Q 018275          330 -KGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       330 -~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                       ..++.++|+|||||++|||+++..+|.
T Consensus       199 ~~~~~~~~Di~slG~il~el~~g~~pf~  226 (320)
T 2i6l_A          199 PNNYTKAIDMWAAGCIFAEMLTGKTLFA  226 (320)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence             779999999999999999999877663

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=295.81  Aligned_cols=204  Identities=23%  Similarity=0.359  Sum_probs=170.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh-chhhHHHHHHHHHHHHHhcCcceEEEEEEee--cCCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-SRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~  181 (358)
                      .++|.+.+.||+|+||.||+|.+..++..||+|++...... .......+.+|+.+++.++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            37899999999999999999999999999999999876432 2345677899999999999999999999984  45678


Q ss_pred             EEEEeecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      |+||||++++ |.+++..  ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999999876 7777755  457899999999999999999999999999999999999999999999999999865422


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC--CCccch
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--YGMECD  337 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~--y~~~~D  337 (358)
                      ....                                               ......||+.|+|||++.+..  ++.++|
T Consensus       163 ~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~D  195 (305)
T 2wtk_C          163 AADD-----------------------------------------------TCRTSQGSPAFQPPEIANGLDTFSGFKVD  195 (305)
T ss_dssp             CSSC-----------------------------------------------EECCCCSCGGGCCHHHHTCCSCEESHHHH
T ss_pred             cccc-----------------------------------------------ccccCCCCCCCcChhhccCcccCCcchhh
Confidence            1100                                               011346999999999998754  378999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      +|||||++|||+++..+|.
T Consensus       196 i~slG~il~~l~~g~~p~~  214 (305)
T 2wtk_C          196 IWSAGVTLYNITTGLYPFE  214 (305)
T ss_dssp             HHHHHHHHHHHHHSSCSCC
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999877654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-38  Score=294.87  Aligned_cols=206  Identities=27%  Similarity=0.439  Sum_probs=163.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--------
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--------  177 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--------  177 (358)
                      ++|++++.||+|+||.||+|.+..+++.||||++...    ......+.+|+.+++.++||||++++++|.+        
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            5799999999999999999999999999999999653    3345668899999999999999999998864        


Q ss_pred             -----CCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecC
Q 018275          178 -----AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG  251 (358)
Q Consensus       178 -----~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFG  251 (358)
                           ....|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence                 45789999999999999999754 367888899999999999999999999999999999999999999999999


Q ss_pred             CCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-
Q 018275          252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-  330 (358)
Q Consensus       252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-  330 (358)
                      ++..............               ...+                    .........+||+.|+|||++.+. 
T Consensus       162 ~~~~~~~~~~~~~~~~---------------~~~~--------------------~~~~~~~~~~~~~~y~aPE~~~~~~  206 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDS---------------QNLP--------------------GSSDNLTSAIGTAMYVATEVLDGTG  206 (303)
T ss_dssp             CCSCTTC------------------------------------------------------------CTTSCHHHHTSCS
T ss_pred             chhhcccccchhcccc---------------cccc--------------------ccccccccCCCcccccCcccccCCC
Confidence            9987642211000000               0000                    000112245799999999999875 


Q ss_pred             CCCccchhhhhhHHHHhhcc
Q 018275          331 GYGMECDWLAYWNETLSCNY  350 (358)
Q Consensus       331 ~y~~~~DiwSlGvil~e~l~  350 (358)
                      .++.++|+|||||++|||++
T Consensus       207 ~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          207 HYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCTHHHHHHHHHHHHHHHS
T ss_pred             CCcchhhHHHHHHHHHHHHh
Confidence            69999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.5e-39  Score=299.81  Aligned_cols=214  Identities=21%  Similarity=0.276  Sum_probs=160.0

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEe-----
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSF-----  175 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~-----  175 (358)
                      .+...+|.+.+.||+|+||.||+|.+..+++.||||++...   .......+.+|+.++..+. ||||+++++++     
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            34456899999999999999999999999999999998654   2344556889999999996 99999999998     


Q ss_pred             ---ecCCEEEEEEeecCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEcCCCcEEE
Q 018275          176 ---QDAEYLYLIMEYLPGGDVMTLLMR---EETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGHMKL  247 (358)
Q Consensus       176 ---~~~~~~~lV~E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--iiHrDikp~NILl~~~~~vkl  247 (358)
                         .....+++||||++ |+|.+++..   ..++++..+..++.|++.||.|||+.|  |+||||||+|||++.++.+||
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence               34556899999995 799888864   467999999999999999999999999  999999999999999999999


Q ss_pred             EecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh
Q 018275          248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL  327 (358)
Q Consensus       248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~  327 (358)
                      +|||+++..............                                     ..........+||+.|+|||++
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~t~~y~aPE~~  222 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQR-------------------------------------RALVEEEITRNTTPMYRTPEII  222 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------------------------------------------
T ss_pred             ecCccceeccccCcccccccc-------------------------------------cccchhhccccCCCCcCChhhh
Confidence            999999876533211100000                                     0000011244799999999999


Q ss_pred             ---cCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          328 ---LKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       328 ---~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                         .+..++.++|||||||++|+|+++..+|.
T Consensus       223 ~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          223 DLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             -CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             hccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence               57779999999999999999999877653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.6e-39  Score=295.42  Aligned_cols=201  Identities=26%  Similarity=0.402  Sum_probs=171.0

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...++|.....||+|+||.||+|.+..++..||||.+....   ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            44566777779999999999999999999999999987652   334566889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-CCcEEEEecCCCccCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-~~~vkl~DFGla~~~~~  258 (358)
                      +||||+++++|.+++...   ..+++..+..++.|++.||.|||+.||+|+||||+|||++. ++.+||+|||++.....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            999999999999999764   25678888999999999999999999999999999999988 89999999999976542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC--CCccc
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--YGMEC  336 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~--y~~~~  336 (358)
                      ...                                                 ......||+.|+|||++.+..  ++.++
T Consensus       176 ~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~  206 (295)
T 2clq_A          176 INP-------------------------------------------------CTETFTGTLQYMAPEIIDKGPRGYGKAA  206 (295)
T ss_dssp             ------------------------------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHH
T ss_pred             CCC-------------------------------------------------cccccCCCccccChhhhcCCCCCCCcHH
Confidence            110                                                 011346999999999998654  89999


Q ss_pred             hhhhhhHHHHhhccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~  355 (358)
                      |+|||||++|+|+++..+|
T Consensus       207 Di~slG~il~~l~~g~~pf  225 (295)
T 2clq_A          207 DIWSLGCTIIEMATGKPPF  225 (295)
T ss_dssp             HHHHHHHHHHHHHHTSCTT
T ss_pred             HHHHHHHHHHHHHHCCCCc
Confidence            9999999999999987665

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=311.96  Aligned_cols=198  Identities=24%  Similarity=0.335  Sum_probs=153.9

Q ss_pred             CCcee-eeeEeeeeeEEEEEEEEe--cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee--cCCE
Q 018275          106 DDFDL-LTIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEY  180 (358)
Q Consensus       106 ~~~~~-~~~IG~G~fG~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~  180 (358)
                      +.|.+ .++||+|+||.||+|.++  .++..||||++.....     ...+.+|+.+++.++|||||+++++|.  ....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            45666 458999999999999976  4688999999975432     234778999999999999999999994  4778


Q ss_pred             EEEEEeecCCCCHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE----cCCCcEEE
Q 018275          181 LYLIMEYLPGGDVMTLLMRE---------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKL  247 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl----~~~~~vkl  247 (358)
                      +|+||||++ ++|.+++...         ..+++..++.++.||+.||.|||+.||+||||||+|||+    +.++.+||
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999999996 5888877532         248999999999999999999999999999999999999    77899999


Q ss_pred             EecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh
Q 018275          248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL  327 (358)
Q Consensus       248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~  327 (358)
                      +|||+|+.+.......                                              ......+||+.|+|||++
T Consensus       174 ~Dfg~a~~~~~~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~  207 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPL----------------------------------------------ADLDPVVVTFWYRAPELL  207 (405)
T ss_dssp             CCTTCCC--------------------------------------------------------------CCCTTCCHHHH
T ss_pred             EECCCceecCCCCccc----------------------------------------------ccCCCceecCcccCchhh
Confidence            9999998764221100                                              011245899999999999


Q ss_pred             cCC-CCCccchhhhhhHHHHhhccccccc
Q 018275          328 LKK-GYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       328 ~~~-~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .+. .|+.++|||||||++|||+++..+|
T Consensus       208 ~~~~~~~~~~DiwSlG~il~ell~g~~pf  236 (405)
T 3rgf_A          208 LGARHYTKAIDIWAIGCIFAELLTSEPIF  236 (405)
T ss_dssp             TTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence            884 5999999999999999999998777

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3e-38  Score=298.48  Aligned_cols=199  Identities=22%  Similarity=0.345  Sum_probs=171.5

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCC-CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc------eEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC------IVKLYY  173 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~------iv~l~~  173 (358)
                      .....++|.+.+.||+|+||.||+|.+..++ ..||+|+++...    .....+..|+.+++.+.|++      ++.+++
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            4455689999999999999999999998776 689999997542    33456788999999998776      899999


Q ss_pred             EeecCCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE------------
Q 018275          174 SFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL------------  239 (358)
Q Consensus       174 ~~~~~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl------------  239 (358)
                      ++......|+||||+ +++|.+.+...  .++++..+..++.||+.||.|||+.||+||||||+|||+            
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence            999999999999999 66777777654  479999999999999999999999999999999999999            


Q ss_pred             -------cCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccc
Q 018275          240 -------DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLA  312 (358)
Q Consensus       240 -------~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (358)
                             +.++.+||+|||+++......                                                    
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----------------------------------------------------  196 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEHH----------------------------------------------------  196 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSCC----------------------------------------------------
T ss_pred             ccccccccCCCcEEEeecCccccccccc----------------------------------------------------
Confidence                   678899999999997543110                                                    


Q ss_pred             ccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          313 YSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       313 ~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ...+||+.|+|||++.+..|+.++|||||||++|||+++..+|.
T Consensus       197 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          197 TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence            13479999999999999999999999999999999999877664

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=297.29  Aligned_cols=193  Identities=27%  Similarity=0.424  Sum_probs=162.9

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++.+.||+|+||.||+|.+.  ++.||||++...     .....+.+|+.+++.++||||+++++++.+.  .+
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~   75 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VC   75 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cE
Confidence            45688999999999999999999764  778999998643     3345688999999999999999999998754  78


Q ss_pred             EEEeecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCCCCEEEcCCCc-EEEEecCCCcc
Q 018275          183 LIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHK---HNYIHRDIKPDNLLLDQNGH-MKLSDFGLCKP  255 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~iiHrDikp~NILl~~~~~-vkl~DFGla~~  255 (358)
                      +||||+++++|.+++....   .++...+..++.|++.||.|||+   .||+||||||+|||++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999997654   47888899999999999999999   89999999999999998886 79999999875


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      .....                                                    ....||+.|+|||++.+..++.+
T Consensus       156 ~~~~~----------------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~  183 (307)
T 2eva_A          156 IQTHM----------------------------------------------------TNNKGSAAWMAPEVFEGSNYSEK  183 (307)
T ss_dssp             -------------------------------------------------------------CCTTSSCHHHHTCCCCCTH
T ss_pred             ccccc----------------------------------------------------ccCCCCCceEChhhhCCCCCCcH
Confidence            43110                                                    02369999999999999999999


Q ss_pred             chhhhhhHHHHhhcccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +|||||||++|||+++...|.
T Consensus       184 ~Di~slG~il~el~~g~~p~~  204 (307)
T 2eva_A          184 CDVFSWGIILWEVITRRKPFD  204 (307)
T ss_dssp             HHHHHHHHHHHHHHHTCCTTT
T ss_pred             HHHHHHHHHHHHHHHCCCCch
Confidence            999999999999999887663

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-38  Score=294.98  Aligned_cols=199  Identities=25%  Similarity=0.272  Sum_probs=168.6

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh-hchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEe
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME  186 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E  186 (358)
                      |...+.||+|+||.||+|.+  ++..||||++..... ........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            34458999999999999974  688999999875432 234456678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          187 YLPGGDVMTLLMR---EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       187 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |+++++|.+++..   ..++++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999999863   3568999999999999999999999999999999999999999999999999997654221110


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                     .....+||+.|+|||++.+ .++.++|+|||||
T Consensus       191 -----------------------------------------------~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~  222 (307)
T 2nru_A          191 -----------------------------------------------MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGV  222 (307)
T ss_dssp             -----------------------------------------------ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHH
T ss_pred             -----------------------------------------------cccccCCCcCcCChHHhcC-CCCccchhHHHHH
Confidence                                                           0113479999999999876 4899999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|+|+++..+|.
T Consensus       223 il~~l~~g~~p~~  235 (307)
T 2nru_A          223 VLLEIITGLPAVD  235 (307)
T ss_dssp             HHHHHHHCCCSBC
T ss_pred             HHHHHHHCCCCcc
Confidence            9999999876653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.5e-38  Score=297.86  Aligned_cols=200  Identities=25%  Similarity=0.351  Sum_probs=168.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEe-cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh---cCcceEEEEEEee----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEK-KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQ----  176 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~~iv~l~~~~~----  176 (358)
                      .++|.+.+.||+|+||.||+|.+. .+++.||+|++...... ......+.+|+.+++.+   .||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            478999999999999999999985 67889999999754321 11122355677777766   8999999999987    


Q ss_pred             -cCCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          177 -DAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       177 -~~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                       .....++||||++ |+|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5678999999997 6999999764  34899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +......                                                  ...+.+||+.|+|||++.+..++
T Consensus       168 ~~~~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~  197 (326)
T 1blx_A          168 RIYSFQM--------------------------------------------------ALTSVVVTLWYRAPEVLLQSSYA  197 (326)
T ss_dssp             CCCCGGG--------------------------------------------------GGCCCCCCCTTCCHHHHTTCCCC
T ss_pred             ccccCCC--------------------------------------------------CccccccccceeCHHHHhcCCCC
Confidence            7653111                                                  01134799999999999999999


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|+|||||++|+|+++..+|.
T Consensus       198 ~~~Di~slG~il~~l~~g~~pf~  220 (326)
T 1blx_A          198 TPVDLWSVGCIFAEMFRRKPLFR  220 (326)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cchhHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999998877663

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-38  Score=303.14  Aligned_cols=201  Identities=20%  Similarity=0.303  Sum_probs=163.6

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh--------hchhhHHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--------LSRGQVEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~--------~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      ..++|.+.+.||+|+||.||+|.+.. +..||||++.....        ........+.+|+.+++.++||||++++++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            35899999999999999999998754 89999999865421        1223346789999999999999999999998


Q ss_pred             e-----cCCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEe
Q 018275          176 Q-----DAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSD  249 (358)
Q Consensus       176 ~-----~~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~D  249 (358)
                      .     ....+|+||||++ |+|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence            4     3457899999997 5888887654 4799999999999999999999999999999999999999999999999


Q ss_pred             cCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC
Q 018275          250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK  329 (358)
Q Consensus       250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~  329 (358)
                      ||+++.......                                                  ....+||+.|+|||++.+
T Consensus       178 fg~~~~~~~~~~--------------------------------------------------~~~~~~t~~y~aPE~~~~  207 (362)
T 3pg1_A          178 FNLAREDTADAN--------------------------------------------------KTHYVTHRWYRAPELVMQ  207 (362)
T ss_dssp             TTC-----------------------------------------------------------------CGGGCCHHHHTT
T ss_pred             cCcccccccccc--------------------------------------------------cceecccceecCcHHhcC
Confidence            999974431110                                                  113479999999999987


Q ss_pred             -CCCCccchhhhhhHHHHhhcccccccc
Q 018275          330 -KGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       330 -~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                       ..++.++|+|||||++|+|+++..+|.
T Consensus       208 ~~~~~~~~DiwslG~il~~l~~g~~pf~  235 (362)
T 3pg1_A          208 FKGFTKLVDMWSAGCVMAEMFNRKALFR  235 (362)
T ss_dssp             CTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence             779999999999999999999887663

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.6e-39  Score=303.80  Aligned_cols=205  Identities=19%  Similarity=0.229  Sum_probs=168.3

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEE-----EecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      .+..++|.+.+.||+|+||.||+|.     +..++..||||++....  .......+.+|+.+++.++||||+++++++.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            4566899999999999999999998     55678899999997542  3444556889999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---CCcEE
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMRE-------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMK  246 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~vk  246 (358)
                      +....|+||||+++++|.+++...       ..+++..+..++.|++.||.|||+.||+||||||+|||++.   +..+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            999999999999999999999765       34889999999999999999999999999999999999994   44699


Q ss_pred             EEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhh
Q 018275          247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV  326 (358)
Q Consensus       247 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv  326 (358)
                      |+|||++.........                                               .......||+.|+|||+
T Consensus       184 l~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~  216 (327)
T 2yfx_A          184 IGDFGMARDIYRASYY-----------------------------------------------RKGGCAMLPVKWMPPEA  216 (327)
T ss_dssp             ECCCHHHHHHHC-----------------------------------------------------CCGGGSCGGGCCHHH
T ss_pred             ECcccccccccccccc-----------------------------------------------ccCCCcCCCcceeCHhH
Confidence            9999998754211100                                               00113468999999999


Q ss_pred             hcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          327 LLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       327 ~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      +.+..|+.++|||||||++|+|++ +..+|
T Consensus       217 ~~~~~~~~~~Di~slG~il~ellt~g~~p~  246 (327)
T 2yfx_A          217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPY  246 (327)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999997 55544

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.2e-39  Score=306.29  Aligned_cols=203  Identities=22%  Similarity=0.415  Sum_probs=176.7

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhh--------------HHHHHHHHHHHHHhcCc
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ--------------VEHVRAERNLLAEVASH  166 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~--------------~~~~~~E~~il~~l~h~  166 (358)
                      .....++|.+.+.||+|+||.||+|.+  +++.||||++..........              ...+.+|+.+++.++||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            344568999999999999999999988  89999999998765432211              26688999999999999


Q ss_pred             ceEEEEEEeecCCEEEEEEeecCCCCHHHH------Hhh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCE
Q 018275          167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTL------LMR--EETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNL  237 (358)
Q Consensus       167 ~iv~l~~~~~~~~~~~lV~E~~~~g~L~~~------l~~--~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NI  237 (358)
                      ||+++++++.+.+..|+||||+++++|.++      +..  ...+++..+..++.|++.||.|||+ .||+||||||+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            999999999999999999999999999998      655  5689999999999999999999999 9999999999999


Q ss_pred             EEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC
Q 018275          238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG  317 (358)
Q Consensus       238 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g  317 (358)
                      |++.++.+||+|||++.......                                                   .....|
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~~---------------------------------------------------~~~~~~  212 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDKK---------------------------------------------------IKGSRG  212 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTTE---------------------------------------------------ECSSCS
T ss_pred             EEcCCCcEEEecccccccccccc---------------------------------------------------ccCCCC
Confidence            99999999999999997653210                                                   113479


Q ss_pred             CCCCchhhhhcCC-CCCc-cchhhhhhHHHHhhcccccccc
Q 018275          318 TPDYIAPEVLLKK-GYGM-ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       318 t~~Y~APEv~~~~-~y~~-~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      |+.|+|||++.+. .|+. ++|||||||++|||+++..+|.
T Consensus       213 ~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  253 (348)
T 2pml_X          213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS  253 (348)
T ss_dssp             CGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999987 6776 9999999999999999877663

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.6e-39  Score=315.29  Aligned_cols=201  Identities=23%  Similarity=0.338  Sum_probs=167.8

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..+..++|.+.+.||+|+||.||+|.+.. +..||||+++....    ..+.+.+|+.+++.++||||+++++++.+ +.
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            45667889999999999999999998764 45799999986532    23568899999999999999999999876 67


Q ss_pred             EEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      .|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            89999999999999999643  5689999999999999999999999999999999999999999999999999986542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ....                                                ......+|+.|+|||++.+..|+.++||
T Consensus       333 ~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDv  364 (452)
T 1fmk_A          333 NEYT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDV  364 (452)
T ss_dssp             ----------------------------------------------------------CCGGGSCHHHHHHCCCCHHHHH
T ss_pred             Ccee------------------------------------------------cccCCcccccccCHhHHhcCCCCccccH
Confidence            1100                                                0012357889999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      |||||++|||++ +..+|
T Consensus       365 wslG~~l~el~t~g~~P~  382 (452)
T 1fmk_A          365 WSFGILLTELTTKGRVPY  382 (452)
T ss_dssp             HHHHHHHHHHHTTTCCSS
T ss_pred             HhHHHHHHHHHhCCCCCC
Confidence            999999999998 55444

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=302.60  Aligned_cols=196  Identities=26%  Similarity=0.364  Sum_probs=168.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY----  180 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~----  180 (358)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.+...    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            378999999999999999999999999999999997643 234455678899999999999999999999987654    


Q ss_pred             --EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 --LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 --~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                        .|+||||++ ++|.+++.  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              499999996 68888774  3589999999999999999999999999999999999999999999999999875431


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~D  337 (358)
                      .                                                    ....+||+.|+|||++.+ ..++.++|
T Consensus       179 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D  206 (353)
T 3coi_A          179 E----------------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVD  206 (353)
T ss_dssp             ---------------------------------------------------------CCSBCCSCHHHHSCCSCCCTTHH
T ss_pred             C----------------------------------------------------ccccccCcCcCCHHHHhCcCCCCchhh
Confidence            1                                                    013479999999999987 77999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      +|||||++|+|+++..+|.
T Consensus       207 i~slG~il~el~~g~~pf~  225 (353)
T 3coi_A          207 IWSVGCIMAEMLTGKTLFK  225 (353)
T ss_dssp             HHHHHHHHHHHHHSSCSSB
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999999887663

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.4e-39  Score=296.41  Aligned_cols=206  Identities=22%  Similarity=0.299  Sum_probs=164.4

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEec-CCC--EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-SGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      +..++|++.+.||+|+||.||+|.+.. ++.  .||||+++..........+.+.+|+.+++.++||||+++++++.+..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            445789999999999999999998654 333  68999998765445566778899999999999999999999998765


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                       .++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence             88999999999999999764 5789999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ......                                              ......||+.|+|||++.+..++.++|+
T Consensus       174 ~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di  207 (291)
T 1u46_A          174 NDDHYV----------------------------------------------MQEHRKVPFAWCAPESLKTRTFSHASDT  207 (291)
T ss_dssp             -CCEEE----------------------------------------------C-----CCGGGCCHHHHHHCEEEHHHHH
T ss_pred             cccchh----------------------------------------------hhccCCCCceeeCchhhcCCCCCchhhH
Confidence            221100                                              0113368889999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      ||||+++|+|++ +..+|
T Consensus       208 ~slG~il~~l~~~g~~p~  225 (291)
T 1u46_A          208 WMFGVTLWEMFTYGQEPW  225 (291)
T ss_dssp             HHHHHHHHHHHTTSCCTT
T ss_pred             HHHHHHHHHHHhCCCCCc
Confidence            999999999998 66554

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.8e-40  Score=309.52  Aligned_cols=193  Identities=16%  Similarity=0.180  Sum_probs=158.6

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh-----chhhHHHHHHHHHHHHHhc---------CcceE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----SRGQVEHVRAERNLLAEVA---------SHCIV  169 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~---------h~~iv  169 (358)
                      ..++|.+.+.||+|+||.||+|.+  +|+.||||++......     .......+.+|+.+++.++         |||||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            347799999999999999999987  6899999999865321     2334466889999999886         66666


Q ss_pred             EEEEEe-----------------ec-------------CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHH
Q 018275          170 KLYYSF-----------------QD-------------AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI  219 (358)
Q Consensus       170 ~l~~~~-----------------~~-------------~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL  219 (358)
                      ++.+.+                 .+             ...+|+||||+++|++.+.+.. ..+++..++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            666553                 32             6789999999999977776643 6789999999999999999


Q ss_pred             HHHH-hCCceeCCCCCCCEEEcCCC--------------------cEEEEecCCCccCCCCCCccccccccccccccccc
Q 018275          220 ESIH-KHNYIHRDIKPDNLLLDQNG--------------------HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES  278 (358)
Q Consensus       220 ~~LH-~~~iiHrDikp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .||| +.||+||||||+|||++.++                    .+||+|||+|+.....                   
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------------------  235 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------------------  235 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------------------
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------------------
Confidence            9999 99999999999999999987                    9999999999865310                   


Q ss_pred             CCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH-HHhhcccccc
Q 018275          279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE-TLSCNYLSDI  354 (358)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi-l~e~l~~~~~  354 (358)
                                                         ..+||+.|||||++.+.. +.++||||||++ .++++.+...
T Consensus       236 -----------------------------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p  276 (336)
T 2vuw_A          236 -----------------------------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHP  276 (336)
T ss_dssp             -----------------------------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCT
T ss_pred             -----------------------------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCC
Confidence                                               247999999999999877 999999998877 6665544433

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-38  Score=298.64  Aligned_cols=204  Identities=24%  Similarity=0.387  Sum_probs=154.6

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHH-HHHHhcCcceEEEEEEeecC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~h~~iv~l~~~~~~~  178 (358)
                      ...+..++|.+.+.||+|+||.||+|.+..+++.||||++....  .......+..|.. +++.++||||+++++++.+.
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            34567799999999999999999999999999999999997643  2223334445555 67778999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMR-----EETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                      +..++||||+++ +|.+++..     ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            999999999975 88887753     56899999999999999999999998 999999999999999999999999999


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhh----c
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL----L  328 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~----~  328 (358)
                      ++.......                                                  .....||+.|+|||++    .
T Consensus       173 ~~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~  202 (327)
T 3aln_A          173 SGQLVDSIA--------------------------------------------------KTRDAGCRPYMAPERIDPSAS  202 (327)
T ss_dssp             SCC-----------------------------------------------------------------------------
T ss_pred             ceecccccc--------------------------------------------------cccCCCCccccCceeeccccC
Confidence            976532110                                                  0123699999999999    5


Q ss_pred             CCCCCccchhhhhhHHHHhhcccccccc
Q 018275          329 KKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       329 ~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +..|+.++|||||||++|+|+++..+|.
T Consensus       203 ~~~~~~~~Di~slG~il~~l~~g~~pf~  230 (327)
T 3aln_A          203 RQGYDVRSDVWSLGITLYELATGRFPYP  230 (327)
T ss_dssp             ---CCSHHHHHHHHHHHHHHHHSCCCSS
T ss_pred             cCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            6779999999999999999999876653

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.8e-39  Score=300.21  Aligned_cols=206  Identities=26%  Similarity=0.394  Sum_probs=173.7

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEE----ecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQE----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      ..+..++|++++.||+|+||.||+|..    ..+++.||||++...   .......+.+|+.+++.++||||+++++++.
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            345567899999999999999999984    568899999998764   3445567889999999999999999999987


Q ss_pred             cCC--EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          177 DAE--YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       177 ~~~--~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      +.+  .+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            544  689999999999999999775 46899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      ..........                                              .......||+.|+|||++.+..++
T Consensus       193 ~~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~  226 (326)
T 2w1i_A          193 KVLPQDKEYY----------------------------------------------KVKEPGESPIFWYAPESLTESKFS  226 (326)
T ss_dssp             EECCSSCSEE----------------------------------------------ECSSCCSCCGGGCCHHHHHHCEEE
T ss_pred             hhcccccccc----------------------------------------------ccccCCCCceeEECchhhcCCCCC
Confidence            8764322100                                              001123578889999999999999


Q ss_pred             ccchhhhhhHHHHhhccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .++|||||||++|||+++...+
T Consensus       227 ~~~Di~slG~il~el~tg~~~~  248 (326)
T 2w1i_A          227 VASDVWSFGVVLYELFTYIEKS  248 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCGG
T ss_pred             chhhHHHHHHHHHHHHhcCCCC
Confidence            9999999999999999875543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=323.30  Aligned_cols=204  Identities=23%  Similarity=0.311  Sum_probs=167.8

Q ss_pred             ccCCCceeee-eEeeeeeEEEEEEEEec--CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLT-IIGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~-~IG~G~fG~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      +..+++.+.. .||+|+||.||+|.+..  ++..||||+++...  .....+.+.+|+.+++.++|||||+++++|.+ +
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  408 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E  408 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence            3445666666 89999999999998763  45679999998653  34456778999999999999999999999986 5


Q ss_pred             EEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      .+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            689999999999999999654 5699999999999999999999999999999999999999999999999999987642


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .....                                              .......+|+.|+|||++.+..|+.++||
T Consensus       489 ~~~~~----------------------------------------------~~~~~~~~~~~y~APE~~~~~~~~~~sDv  522 (613)
T 2ozo_A          489 DDSYY----------------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDV  522 (613)
T ss_dssp             -----------------------------------------------------------CCTTSCHHHHHHCCCCHHHHH
T ss_pred             CCcee----------------------------------------------eeccCCCCccceeCHhhhcCCCCCcHHHH
Confidence            21100                                              00012246789999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      |||||+||||+. +...|
T Consensus       523 wSlGv~l~ellt~G~~Pf  540 (613)
T 2ozo_A          523 WSYGVTMWEALSYGQKPY  540 (613)
T ss_dssp             HHHHHHHHHHHTTSCCTT
T ss_pred             HHHHHHHHHHHHCCCCCC
Confidence            999999999996 66554

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.7e-38  Score=302.88  Aligned_cols=199  Identities=23%  Similarity=0.329  Sum_probs=170.8

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-----------CcceE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-----------SHCIV  169 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------h~~iv  169 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..+++.||||++....    .....+.+|+.++..+.           ||||+
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~   89 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL   89 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence            3445689999999999999999999999999999999997543    23455778899888876           88999


Q ss_pred             EEEEEeecCC----EEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEc--
Q 018275          170 KLYYSFQDAE----YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLD--  240 (358)
Q Consensus       170 ~l~~~~~~~~----~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~--  240 (358)
                      ++++++....    .+++||||+ +++|.+++...  ..+++..+..++.||+.||.|||++ ||+||||||+|||++  
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence            9999997654    789999999 88999999763  4699999999999999999999998 999999999999994  


Q ss_pred             ----CCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccccc
Q 018275          241 ----QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV  316 (358)
Q Consensus       241 ----~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  316 (358)
                          .++.+||+|||+++......                                                    ...+
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~----------------------------------------------------~~~~  196 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHY----------------------------------------------------TNSI  196 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCC----------------------------------------------------CSCC
T ss_pred             CCCcCcceEEEcccccccccCCCC----------------------------------------------------CCCC
Confidence                44589999999997653211                                                    1237


Q ss_pred             CCCCCchhhhhcCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          317 GTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       317 gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ||+.|+|||++.+..|+.++|||||||++|||+++..+|.
T Consensus       197 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  236 (373)
T 1q8y_A          197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  236 (373)
T ss_dssp             SCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999999999999999887664

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5e-39  Score=301.38  Aligned_cols=205  Identities=24%  Similarity=0.287  Sum_probs=175.3

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhch---hhHHHHHHHHHHHHHhc--CcceEEEEEEe
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR---GQVEHVRAERNLLAEVA--SHCIVKLYYSF  175 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~--h~~iv~l~~~~  175 (358)
                      .....++|.+.+.||+|+||.||+|.+..+++.||||++........   .....+..|+.+++.+.  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            44556899999999999999999999999999999999987643221   11233667999999996  59999999999


Q ss_pred             ecCCEEEEEEeecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc-CCCcEEEEecCCC
Q 018275          176 QDAEYLYLIMEYLPG-GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLC  253 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~-g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~vkl~DFGla  253 (358)
                      .+.+..++|||++.+ ++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            999999999999976 89999998888999999999999999999999999999999999999999 7899999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-  332 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-  332 (358)
                      +......                                                   .....||+.|+|||++.+..+ 
T Consensus       198 ~~~~~~~---------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~  226 (320)
T 3a99_A          198 ALLKDTV---------------------------------------------------YTDFDGTRVYSPPEWIRYHRYH  226 (320)
T ss_dssp             EECCSSC---------------------------------------------------BCCCCSCGGGSCHHHHHHSCBC
T ss_pred             ccccccc---------------------------------------------------ccCCCCCccCCChHHhccCCCC
Confidence            7654211                                                   013469999999999987776 


Q ss_pred             CccchhhhhhHHHHhhcccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +.++|||||||++|||+++...|.
T Consensus       227 ~~~~Di~slG~il~el~~g~~pf~  250 (320)
T 3a99_A          227 GRSAAVWSLGILLYDMVCGDIPFE  250 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CccchHHhHHHHHHHHHHCCCCCC
Confidence            688999999999999999877653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-38  Score=325.23  Aligned_cols=196  Identities=21%  Similarity=0.250  Sum_probs=164.9

Q ss_pred             eeEeeeeeEEEEEEEEe--cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecC
Q 018275          112 TIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      +.||+|+||.||+|.+.  .+++.||||+++.... .....+.+.+|+.++..++|||||++++++.+. ..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccC
Confidence            48999999999999653  5668999999986532 344567799999999999999999999999754 5889999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccc
Q 018275          190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV  269 (358)
Q Consensus       190 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  269 (358)
                      +|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.......      
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~------  526 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------  526 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc------
Confidence            99999999888899999999999999999999999999999999999999999999999999998764221100      


Q ss_pred             cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhc
Q 018275          270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCN  349 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l  349 (358)
                                                              .......||+.|+|||++.+..|+.++|||||||+||||+
T Consensus       527 ----------------------------------------~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ell  566 (635)
T 4fl3_A          527 ----------------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF  566 (635)
T ss_dssp             ------------------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ----------------------------------------ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence                                                    0011235788999999999999999999999999999999


Q ss_pred             c-ccccc
Q 018275          350 Y-LSDIM  355 (358)
Q Consensus       350 ~-~~~~~  355 (358)
                      . +..+|
T Consensus       567 t~G~~Pf  573 (635)
T 4fl3_A          567 SYGQKPY  573 (635)
T ss_dssp             TTTCCSS
T ss_pred             hCCCCCC
Confidence            6 66555

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-39  Score=307.64  Aligned_cols=199  Identities=18%  Similarity=0.228  Sum_probs=158.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCC---CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee-cCCEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DAEYL  181 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-~~~~~  181 (358)
                      ..|.+.+.||+|+||.||+|.+..++   ..||+|.+....  .......+.+|+.+++.++||||+++++++. ..+..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            45788999999999999999876443   468999987532  3455677899999999999999999999865 45678


Q ss_pred             EEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      ++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999999764 468888999999999999999999999999999999999999999999999998654221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ....                                             .......||+.|+|||++.+..|+.++||||
T Consensus       247 ~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS  281 (373)
T 3c1x_A          247 FDSV---------------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWS  281 (373)
T ss_dssp             --------------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHH
T ss_pred             cccc---------------------------------------------cccCCCCCcccccChHHhcCCCCCcHHHHHH
Confidence            1000                                             0011336889999999999999999999999


Q ss_pred             hhHHHHhhccc
Q 018275          341 YWNETLSCNYL  351 (358)
Q Consensus       341 lGvil~e~l~~  351 (358)
                      |||++|||+++
T Consensus       282 lG~il~ellt~  292 (373)
T 3c1x_A          282 FGVLLWELMTR  292 (373)
T ss_dssp             HHHHHHHHHTT
T ss_pred             HHHHHHHHHhC
Confidence            99999999984

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-38  Score=296.10  Aligned_cols=194  Identities=23%  Similarity=0.297  Sum_probs=160.2

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHH--hcCcceEEEEEEeecC---
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE--VASHCIVKLYYSFQDA---  178 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~--l~h~~iv~l~~~~~~~---  178 (358)
                      ..++|++.+.||+|+||.||+|.+.  +..||||++....      ......|..++..  ++||||+++++++.+.   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            3478999999999999999999764  8899999986542      1224445555554  4899999999999877   


Q ss_pred             -CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCCEEEcCCCcEEEEe
Q 018275          179 -EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDQNGHMKLSD  249 (358)
Q Consensus       179 -~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~iiHrDikp~NILl~~~~~vkl~D  249 (358)
                       ...|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.        ||+||||||+|||++.++.+||+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence             789999999999999999954 4789999999999999999999998        999999999999999999999999


Q ss_pred             cCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC
Q 018275          250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK  329 (358)
Q Consensus       250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~  329 (358)
                      ||+++.+........                                             ....+.+||+.|+|||++.+
T Consensus       186 fg~a~~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~  220 (337)
T 3mdy_A          186 LGLAVKFISDTNEVD---------------------------------------------IPPNTRVGTKRYMPPEVLDE  220 (337)
T ss_dssp             CTTCEECC------------------------------------------------------CCSSCSCGGGCCHHHHTT
T ss_pred             CCCceeecccccccc---------------------------------------------CCCCCCccCcceeChhhccc
Confidence            999976642211100                                             00113479999999999998


Q ss_pred             CCCCcc------chhhhhhHHHHhhccc
Q 018275          330 KGYGME------CDWLAYWNETLSCNYL  351 (358)
Q Consensus       330 ~~y~~~------~DiwSlGvil~e~l~~  351 (358)
                      ..++..      +|||||||++|||+++
T Consensus       221 ~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          221 SLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccCCccccCccccchHHHHHHHHHHHhc
Confidence            877765      9999999999999988

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.9e-39  Score=293.42  Aligned_cols=196  Identities=24%  Similarity=0.366  Sum_probs=163.8

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC-C
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-E  179 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-~  179 (358)
                      ..+..++|++.+.||+|+||.||+|.+  +|..||||++....     ..+.+.+|+.+++.++||||+++++++.+. +
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            456678999999999999999999976  47899999987542     345688999999999999999999997544 4


Q ss_pred             EEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            7899999999999999997654  38899999999999999999999999999999999999999999999999987543


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ...                                                    ....+|+.|+|||++.+..++.++|
T Consensus       169 ~~~----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~D  196 (278)
T 1byg_A          169 STQ----------------------------------------------------DTGKLPVKWTAPEALREKKFSTKSD  196 (278)
T ss_dssp             -----------------------------------------------------------CCTTTSCHHHHHHCCCCHHHH
T ss_pred             ccc----------------------------------------------------cCCCccccccCHHHhCCCCCCchhc
Confidence            110                                                    0225789999999999999999999


Q ss_pred             hhhhhHHHHhhcc-ccccc
Q 018275          338 WLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~~  355 (358)
                      +||||+++|+|+. +..+|
T Consensus       197 i~slG~il~~l~t~g~~p~  215 (278)
T 1byg_A          197 VWSFGILLWEIYSFGRVPY  215 (278)
T ss_dssp             HHHHHHHHHHHHTTSCCSC
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999997 66554

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.5e-38  Score=294.19  Aligned_cols=206  Identities=24%  Similarity=0.386  Sum_probs=170.6

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc--CcceEEEEEEee
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA--SHCIVKLYYSFQ  176 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~l~~~~~  176 (358)
                      ....+..++|.+.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.++..++  ||||+++++++.
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            334455678999999999999999999874 588999999976532 3445677899999999997  499999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      +....|+||| +.+++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++ ++.+||+|||+++..
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~  176 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  176 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence            9999999999 55889999999888999999999999999999999999999999999999996 589999999999866


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-------
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-------  329 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-------  329 (358)
                      .......                                               .....+||+.|+|||++.+       
T Consensus       177 ~~~~~~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~  209 (313)
T 3cek_A          177 QPDTTSV-----------------------------------------------VKDSQVGTVNYMPPEAIKDMSSSREN  209 (313)
T ss_dssp             ------------------------------------------------------------CCGGGCCHHHHTTCC-----
T ss_pred             cCccccc-----------------------------------------------cccCCCCCCCcCCHHHHhhccccccc
Confidence            4221100                                               0113479999999999976       


Q ss_pred             ----CCCCccchhhhhhHHHHhhccccccc
Q 018275          330 ----KGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       330 ----~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                          ..++.++|||||||++|||+++...|
T Consensus       210 ~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (313)
T 3cek_A          210 GKSKSKISPKSDVWSLGCILYYMTYGKTPF  239 (313)
T ss_dssp             -----CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence                57899999999999999999987765

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-37  Score=307.83  Aligned_cols=205  Identities=21%  Similarity=0.239  Sum_probs=171.6

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCc-ceEEEEEEeecCCEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLY  182 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~-~iv~l~~~~~~~~~~~  182 (358)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++......     ..+..|+.++..+.|+ +++.+..++.+....+
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            358999999999999999999999999999999987755321     1277899999999875 5556666667888999


Q ss_pred             EEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE---cCCCcEEEEecCCCccCCC
Q 018275          183 LIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl---~~~~~vkl~DFGla~~~~~  258 (358)
                      |||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||||   +.++.+||+|||+++.+..
T Consensus        80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999999 8999999975 5689999999999999999999999999999999999999   6889999999999987643


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      .......                                          ........+||+.|+|||++.+..|+.++||
T Consensus       159 ~~~~~~~------------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDv  196 (483)
T 3sv0_A          159 TSTHQHI------------------------------------------PYRENKNLTGTARYASVNTHLGIEQSRRDDL  196 (483)
T ss_dssp             TTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred             Ccccccc------------------------------------------ccccccccCCCccccCHHHhcCCCCChHHHH
Confidence            2211000                                          0001124589999999999999999999999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||+||||+++...|.
T Consensus       197 wSlGvil~elltG~~Pf~  214 (483)
T 3sv0_A          197 ESLGYVLMYFLRGSLPWQ  214 (483)
T ss_dssp             HHHHHHHHHHHHSSCTTS
T ss_pred             HHHHHHHHHHHhCCCCCc
Confidence            999999999999877663

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=296.06  Aligned_cols=202  Identities=25%  Similarity=0.328  Sum_probs=165.7

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhch---hhHHHHHHHHHHHHHh----cCcceEEEEEEe
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR---GQVEHVRAERNLLAEV----ASHCIVKLYYSF  175 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l----~h~~iv~l~~~~  175 (358)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++........   .....+..|+.++..+    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            345889999999999999999999999999999999976543211   1223355789999998    899999999999


Q ss_pred             ecCCEEEEEEee-cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc-CCCcEEEEecCCC
Q 018275          176 QDAEYLYLIMEY-LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLC  253 (358)
Q Consensus       176 ~~~~~~~lV~E~-~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~-~~~~vkl~DFGla  253 (358)
                      .+.+..++|||+ +.+++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            999999999999 78999999998888899999999999999999999999999999999999999 8899999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      .......                                                   .....||+.|+|||++.+..+.
T Consensus       188 ~~~~~~~---------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~  216 (312)
T 2iwi_A          188 ALLHDEP---------------------------------------------------YTDFDGTRVYSPPEWISRHQYH  216 (312)
T ss_dssp             EECCSSC---------------------------------------------------BCCCCSCTTTSCHHHHHHSCBC
T ss_pred             hhcccCc---------------------------------------------------ccccCCcccccCceeeecCCCC
Confidence            8654211                                                   0133699999999999877764


Q ss_pred             -ccchhhhhhHHHHhhccccccc
Q 018275          334 -MECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       334 -~~~DiwSlGvil~e~l~~~~~~  355 (358)
                       .++|+|||||++|||+++...|
T Consensus       217 ~~~~Di~slG~il~~l~~g~~pf  239 (312)
T 2iwi_A          217 ALPATVWSLGILLYDMVCGDIPF  239 (312)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CccchHHHHHHHHHHHHHCCCCC
Confidence             5899999999999999987665

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.7e-38  Score=297.65  Aligned_cols=194  Identities=28%  Similarity=0.409  Sum_probs=148.3

Q ss_pred             cCCCceeee-eEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec----C
Q 018275          104 SVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----A  178 (358)
Q Consensus       104 ~~~~~~~~~-~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~  178 (358)
                      ..++|.+.+ .||+|+||.||+|.+..+++.||||++.....    .   .......+..+.||||+++++++..    .
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----A---RQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----H---HHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----H---HHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            448899965 69999999999999999999999999865421    1   2223334677799999999999876    5


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---CCcEEEEecCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLC  253 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~vkl~DFGla  253 (358)
                      ..+++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.||+||||||+|||++.   ++.+||+|||++
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            56899999999999999997653  6999999999999999999999999999999999999986   455999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +......                                                   ....+||+.|+|||++.+..|+
T Consensus       179 ~~~~~~~---------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~  207 (336)
T 3fhr_A          179 KETTQNA---------------------------------------------------LQTPCYTPYYVAPEVLGPEKYD  207 (336)
T ss_dssp             EEC-------------------------------------------------------------------------CHHH
T ss_pred             eeccccc---------------------------------------------------cccCCCCcCccChhhhCCCCCC
Confidence            7543111                                                   1134789999999999999999


Q ss_pred             ccchhhhhhHHHHhhccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      .++|||||||++|+|+++..+|
T Consensus       208 ~~~Di~slG~il~~l~~g~~pf  229 (336)
T 3fhr_A          208 KSCDMWSLGVIMYILLCGFPPF  229 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCCC
T ss_pred             chhhHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999987766

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=317.85  Aligned_cols=202  Identities=23%  Similarity=0.333  Sum_probs=171.7

Q ss_pred             ccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       100 ~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      .+.+..++|.+.+.||+|+||.||+|.+.. +..||||+++....    ..+.+.+|+.+|+.++|||||++++++.+ +
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            345667889999999999999999998764 45799999986532    23568899999999999999999999876 6


Q ss_pred             EEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      .+||||||+++|+|.+++...  ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            789999999999999999643  568999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ....                                                .......+|+.|+|||++.+..|+.++|
T Consensus       415 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sD  446 (535)
T 2h8h_A          415 DNEY------------------------------------------------TARQGAKFPIKWTAPEAALYGRFTIKSD  446 (535)
T ss_dssp             CHHH------------------------------------------------HTTCSTTSCGGGSCHHHHHHCCCCHHHH
T ss_pred             CCce------------------------------------------------ecccCCcCcccccCHHHhccCCCCchhh
Confidence            2100                                                0011235788999999999999999999


Q ss_pred             hhhhhHHHHhhcc-ccccc
Q 018275          338 WLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~~  355 (358)
                      ||||||+||||++ +...|
T Consensus       447 vwSlGv~l~el~t~g~~P~  465 (535)
T 2h8h_A          447 VWSFGILLTELTTKGRVPY  465 (535)
T ss_dssp             HHHHHHHHHHHTTTTCCSS
T ss_pred             HHHHHHHHHHHHhCCCCCC
Confidence            9999999999998 55443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-38  Score=325.00  Aligned_cols=195  Identities=23%  Similarity=0.348  Sum_probs=165.6

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEec-CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      .+..++|.+.+.||+|+||.||+|.+.. +++.||||++....  .......+.+|+.+++.++|||||+++++|.+.+.
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            3445899999999999999999999976 78999999987542  33455668899999999999999999999986554


Q ss_pred             -----EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          181 -----LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       181 -----~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                           .||||||++|++|.+++..  .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                 7999999999999988744  78999999999999999999999999999999999999885 899999999976


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      ....                                                     ...+||+.|+|||++.+. ++.+
T Consensus       231 ~~~~-----------------------------------------------------~~~~gt~~y~aPE~~~~~-~~~~  256 (681)
T 2pzi_A          231 INSF-----------------------------------------------------GYLYGTPGFQAPEIVRTG-PTVA  256 (681)
T ss_dssp             TTCC-----------------------------------------------------SCCCCCTTTSCTTHHHHC-SCHH
T ss_pred             cccC-----------------------------------------------------CccCCCccccCHHHHcCC-CCCc
Confidence            5321                                                     134799999999999765 4899


Q ss_pred             chhhhhhHHHHhhccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~  355 (358)
                      +|||||||++|+|+++...+
T Consensus       257 sDi~slG~~l~~l~~g~~~~  276 (681)
T 2pzi_A          257 TDIYTVGRTLAALTLDLPTR  276 (681)
T ss_dssp             HHHHHHHHHHHHHHSCCCEE
T ss_pred             eehhhhHHHHHHHHhCCCCC
Confidence            99999999999999875443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=290.62  Aligned_cols=202  Identities=24%  Similarity=0.357  Sum_probs=155.6

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ....++|.+++.||+|+||.||+|.+..+|+.||||++..... .......+..+..+++.++||||+++++++.+.+..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~   99 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV   99 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence            3456889999999999999999999999999999999976532 222333445555678888999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~-~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ++||||+ ++.+..+... ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999999 5566666543 56899999999999999999999995 9999999999999999999999999998765321


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----CCCCCc
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGM  334 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----~~~y~~  334 (358)
                      ..                                                  .....||+.|+|||++.     +..++.
T Consensus       179 ~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~  208 (318)
T 2dyl_A          179 KA--------------------------------------------------KDRSAGCAAYMAPERIDPPDPTKPDYDI  208 (318)
T ss_dssp             ----------------------------------------------------------CCTTCCHHHHC--------CCT
T ss_pred             cc--------------------------------------------------ccccCCCccccChhhcccccccccCCcc
Confidence            10                                                  01236999999999994     567899


Q ss_pred             cchhhhhhHHHHhhccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~  355 (358)
                      ++|||||||++|||+++...|
T Consensus       209 ~~Di~slG~il~~l~~g~~pf  229 (318)
T 2dyl_A          209 RADVWSLGISLVELATGQFPY  229 (318)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccchhhHHHHHHHHHhCCCCC
Confidence            999999999999999987665

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.1e-38  Score=319.69  Aligned_cols=204  Identities=22%  Similarity=0.264  Sum_probs=170.6

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      ..+..++|.+.+.||+|+||.||+|.+..+   +..||||++....  .....+.+.+|+.+++.++|||||++++++.+
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  462 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE  462 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            345568899999999999999999988653   4579999987542  34455678899999999999999999999854


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                       +..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence             5689999999999999999765 47899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      .......                                                .....||+.|+|||++.+..|+.++
T Consensus       542 ~~~~~~~------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~  573 (656)
T 2j0j_A          542 EDSTYYK------------------------------------------------ASKGKLPIKWMAPESINFRRFTSAS  573 (656)
T ss_dssp             CC----------------------------------------------------------CCGGGCCHHHHHHCCCCHHH
T ss_pred             CCCccee------------------------------------------------ccCCCCCcceeCHHHhcCCCCCchh
Confidence            4221100                                                0123578899999999999999999


Q ss_pred             hhhhhhHHHHhhcc-ccccc
Q 018275          337 DWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~-~~~~~  355 (358)
                      |||||||++|||++ +..+|
T Consensus       574 DiwSlG~il~ellt~g~~Pf  593 (656)
T 2j0j_A          574 DVWMFGVCMWEILMHGVKPF  593 (656)
T ss_dssp             HHHHHHHHHHHHHTTSCCTT
T ss_pred             hHHHHHHHHHHHHHcCCCCC
Confidence            99999999999997 55444

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-37  Score=292.20  Aligned_cols=194  Identities=24%  Similarity=0.269  Sum_probs=163.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHH--hcCcceEEEEEEeecCC---
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE--VASHCIVKLYYSFQDAE---  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~--l~h~~iv~l~~~~~~~~---  179 (358)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++....      ...+..|..++..  ++||||+++++++.+..   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            36899999999999999999976  58899999986542      2446778888887  79999999999998776   


Q ss_pred             -EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCCEEEcCCCcEEEEec
Q 018275          180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH--------KHNYIHRDIKPDNLLLDQNGHMKLSDF  250 (358)
Q Consensus       180 -~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH--------~~~iiHrDikp~NILl~~~~~vkl~DF  250 (358)
                       ..|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||        +.+|+||||||+|||++.++.+||+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             79999999999999999965 56899999999999999999999        899999999999999999999999999


Q ss_pred             CCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC
Q 018275          251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK  330 (358)
Q Consensus       251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~  330 (358)
                      |++..........                                             .......+||+.|+|||++.+.
T Consensus       192 g~~~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~  226 (342)
T 1b6c_B          192 GLAVRHDSATDTI---------------------------------------------DIAPNHRVGTKRYMAPEVLDDS  226 (342)
T ss_dssp             TTCEEEETTTTEE---------------------------------------------EECCCSCCCCGGGCCHHHHTSC
T ss_pred             CCceecccccccc---------------------------------------------ccccccCCcCcccCCHhhhccc
Confidence            9997654221100                                             0011234799999999999876


Q ss_pred             C------CCccchhhhhhHHHHhhcccc
Q 018275          331 G------YGMECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       331 ~------y~~~~DiwSlGvil~e~l~~~  352 (358)
                      .      ++.++|||||||++|||+++.
T Consensus       227 ~~~~~~~~~~~~Di~slG~il~el~tg~  254 (342)
T 1b6c_B          227 INMKHFESFKRADIYAMGLVFWEIARRC  254 (342)
T ss_dssp             CCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             ccccccccCCcccHHHHHHHHHHHHhcc
Confidence            3      347899999999999999873

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=296.21  Aligned_cols=210  Identities=18%  Similarity=0.237  Sum_probs=169.9

Q ss_pred             hhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275           98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus        98 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      .....+..++|.+.+.||+|+||.||+|.+..   .||+|++..... .......+.+|+.+++.++||||+++++++.+
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            45567788999999999999999999998753   499999876432 22233446789999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ....++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++ ++.+||+|||+++..
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            999999999999999999997654 789999999999999999999999999999999999998 789999999998765


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-------
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-------  329 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-------  329 (358)
                      .......                                            .........||+.|+|||++.+       
T Consensus       180 ~~~~~~~--------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~  215 (319)
T 2y4i_B          180 GVLQAGR--------------------------------------------REDKLRIQNGWLCHLAPEIIRQLSPDTEE  215 (319)
T ss_dssp             ----------------------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--C
T ss_pred             ccccccc--------------------------------------------cccccccCCCcccccChHHhhhccccccc
Confidence            3211100                                            0011123469999999999975       


Q ss_pred             --CCCCccchhhhhhHHHHhhcccccccc
Q 018275          330 --KGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       330 --~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                        ..|+.++|||||||++|||+++...|.
T Consensus       216 ~~~~~~~~~Di~slG~il~el~~g~~p~~  244 (319)
T 2y4i_B          216 DKLPFSKHSDVFALGTIWYELHAREWPFK  244 (319)
T ss_dssp             CCSCCCHHHHHHHHHHHHHHHHHSSCSSS
T ss_pred             cccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence              458899999999999999999876653

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.5e-37  Score=299.09  Aligned_cols=197  Identities=24%  Similarity=0.296  Sum_probs=153.5

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      +.|.+.+.||+|+||+||.+ ...+|+.||||++....      .+.+.+|+.++..+ +|||||++++++.+...+|+|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            55566789999999999875 45689999999987542      23467899999876 899999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-------------Cc
Q 018275          185 MEYLPGGDVMTLLMREETLT-------ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-------------GH  244 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~-------~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-------------~~  244 (358)
                      |||++ |+|.+++.......       +..+..++.||+.||.|||+.||+||||||+|||++.+             +.
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            99995 69999997654332       22346789999999999999999999999999999754             48


Q ss_pred             EEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchh
Q 018275          245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP  324 (358)
Q Consensus       245 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~AP  324 (358)
                      +||+|||+|+.+.......                                             .......+||+.|+||
T Consensus       167 ~kL~DFG~a~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aP  201 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSF---------------------------------------------RTNLNNPSGTSGWRAP  201 (434)
T ss_dssp             EEECCCTTCEECCC-----------------------------------------------------------CCTTSCH
T ss_pred             EEEcccccceecCCCCccc---------------------------------------------eeeecCCCCCCCccCH
Confidence            9999999998764321100                                             0011244799999999


Q ss_pred             hhhcC-------CCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          325 EVLLK-------KGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       325 Ev~~~-------~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      |++.+       ..++.++|||||||++|||++ +..+|
T Consensus       202 E~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          202 ELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             HHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             HHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence            99976       679999999999999999998 66554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8e-38  Score=317.34  Aligned_cols=200  Identities=27%  Similarity=0.401  Sum_probs=172.1

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec------
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------  177 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~------  177 (358)
                      ..++|.+.+.||+|+||.||+|.+..+|..||||++....  .......+.+|+.+++.++||||+++++++.+      
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            3488999999999999999999999999999999987642  34556678899999999999999999998765      


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCc---EEEEecC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFG  251 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~---vkl~DFG  251 (358)
                      .+..|+||||++||+|.+++....   .+++..+..++.|++.||.|||+.||+||||||+|||++.++.   +||+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            677899999999999999997643   6889999999999999999999999999999999999997765   9999999


Q ss_pred             CCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC
Q 018275          252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG  331 (358)
Q Consensus       252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~  331 (358)
                      ++........                                                  ....+||+.|+|||++.+..
T Consensus       170 ~a~~~~~~~~--------------------------------------------------~~~~~gt~~Y~APE~l~~~~  199 (676)
T 3qa8_A          170 YAKELDQGEL--------------------------------------------------CTEFVGTLQYLAPELLEQKK  199 (676)
T ss_dssp             CCCBTTSCCC--------------------------------------------------CCCCCSCCTTCSSCSSCCSC
T ss_pred             cccccccccc--------------------------------------------------cccccCCcccCChHHhccCC
Confidence            9986542211                                                  11347999999999999999


Q ss_pred             CCccchhhhhhHHHHhhccccccc
Q 018275          332 YGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       332 y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      |+.++|+|||||++|+|+++..+|
T Consensus       200 ~s~ksDIwSLGviLyeLltG~~Pf  223 (676)
T 3qa8_A          200 YTVTVDYWSFGTLAFECITGFRPF  223 (676)
T ss_dssp             CSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCchhHHHHHHHHHHHHHHCCCCC
Confidence            999999999999999999987766

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-37  Score=300.43  Aligned_cols=199  Identities=22%  Similarity=0.294  Sum_probs=157.3

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~  181 (358)
                      +...+|.+.+.||+|+||+|+. ....+++.||||++......      .+.+|+.+++.+ +|||||++++++.+....
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            4446799999999999999764 44678999999998764321      145799999999 799999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-----CcEEEEecCCCcc
Q 018275          182 YLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-----GHMKLSDFGLCKP  255 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-----~~vkl~DFGla~~  255 (358)
                      |+||||++ |+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+     ..+||+|||+|+.
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            99999996 69999997653 45555667889999999999999999999999999999532     3688999999987


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc---CCCC
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGY  332 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~---~~~y  332 (358)
                      +.......                                              ......+||+.|+|||++.   +..+
T Consensus       173 ~~~~~~~~----------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~  206 (432)
T 3p23_A          173 LAVGRHSF----------------------------------------------SRRSGVPGTEGWIAPEMLSEDCKENP  206 (432)
T ss_dssp             C----------------------------------------------------------CCSCTTSCCGGGTSCC---CC
T ss_pred             ccCCCcce----------------------------------------------eeccccCCCcCccChhhhhcccccCC
Confidence            64221100                                              0112457999999999998   4667


Q ss_pred             CccchhhhhhHHHHhhcc-ccccc
Q 018275          333 GMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      +.++|||||||++|||++ +..+|
T Consensus       207 t~~~DiwSlG~il~ellt~g~~pf  230 (432)
T 3p23_A          207 TYTVDIFSAGCVFYYVISEGSHPF  230 (432)
T ss_dssp             CTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred             CcHHHHHHHHHHHHHHHcCCCCCc
Confidence            889999999999999998 65554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.6e-36  Score=277.26  Aligned_cols=176  Identities=10%  Similarity=0.037  Sum_probs=155.3

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++++.+.+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44578999999999999999999999999999999998765444556677899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||++|++|.+++.. + ..+..+..++.|++.||.|||++||+||||||+|||++.++.+||+++|           
T Consensus       108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            99999999999999954 3 3566778899999999999999999999999999999999999987443           


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                                |++|       ++.++||||||
T Consensus       175 ----------------------------------------------------------~~~~-------~~~~~Di~slG  189 (286)
T 3uqc_A          175 ----------------------------------------------------------TMPD-------ANPQDDIRGIG  189 (286)
T ss_dssp             ----------------------------------------------------------CCTT-------CCHHHHHHHHH
T ss_pred             ----------------------------------------------------------ccCC-------CCchhHHHHHH
Confidence                                                                      2332       78899999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|||+++...|.
T Consensus       190 ~il~elltg~~Pf~  203 (286)
T 3uqc_A          190 ASLYALLVNRWPLP  203 (286)
T ss_dssp             HHHHHHHHSEECSC
T ss_pred             HHHHHHHHCCCCCC
Confidence            99999999887764

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-36  Score=292.72  Aligned_cols=199  Identities=14%  Similarity=0.118  Sum_probs=153.1

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCc-c---------------
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-C---------------  167 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~-~---------------  167 (358)
                      ....|...+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++..+.|. +               
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            345688999999999999999999999999999998854433344456788999999888762 1               


Q ss_pred             eEE------EEEEeec-----CCEEEEEEeecCCCCHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 018275          168 IVK------LYYSFQD-----AEYLYLIMEYLPGGDVMTLLMR-------EETLTETVARFYIAQSVLAIESIHKHNYIH  229 (358)
Q Consensus       168 iv~------l~~~~~~-----~~~~~lV~E~~~~g~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~iiH  229 (358)
                      ++.      +...+..     ....+++|+++ +++|.+++..       ...+++..+..++.|++.||.|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            111      1111111     22467888876 6899988841       234667778888899999999999999999


Q ss_pred             CCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhc
Q 018275          230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRR  309 (358)
Q Consensus       230 rDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (358)
                      |||||+|||++.++.+||+|||+++.....                                                  
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------------------------------------------------  264 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------------------------------------------------  264 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE--------------------------------------------------
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc--------------------------------------------------
Confidence            999999999999999999999998764311                                                  


Q ss_pred             cccccccCCCCCchhhhh----------cCCCCCccchhhhhhHHHHhhcccccccc
Q 018275          310 KLAYSTVGTPDYIAPEVL----------LKKGYGMECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       310 ~~~~s~~gt~~Y~APEv~----------~~~~y~~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                        ..+.+| +.|+|||++          .+..|+.++|||||||++|||+++..+|.
T Consensus       265 --~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~  318 (413)
T 3dzo_A          265 --AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT  318 (413)
T ss_dssp             --ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             --cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence              113478 999999999          66678999999999999999999876653

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.7e-36  Score=305.31  Aligned_cols=186  Identities=17%  Similarity=0.153  Sum_probs=135.7

Q ss_pred             EeeeeeEEEEEEEEecCCCEEEEEecchhhhh-------chhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCCEEEEEE
Q 018275          114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-------SRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       114 IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      .+.|++|.+..++....|..||+|++.+....       .....+.+.+|+.+|+++ .|+||+++++++.++..+||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45677777777777788999999999764211       233446689999999999 6999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||++|++|.+++...+++++.   .++.||+.||.|+|++|||||||||+||||+.+|.+||+|||+|+......     
T Consensus       322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-----  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-----  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--------
T ss_pred             ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-----
Confidence            999999999999988888865   478999999999999999999999999999999999999999998664221     


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                  ....+.+|||.|||||++.+. +..++|+||+|+++
T Consensus       394 --------------------------------------------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~  428 (569)
T 4azs_A          394 --------------------------------------------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHP  428 (569)
T ss_dssp             --------------------------------------------CCSHHHHHHHHHHHHHHC------------------
T ss_pred             --------------------------------------------ccccCceechhhccHHHhCCC-CCCcccccccccch
Confidence                                                        112256899999999999875 67889999999999


Q ss_pred             Hhhcccc
Q 018275          346 LSCNYLS  352 (358)
Q Consensus       346 ~e~l~~~  352 (358)
                      ++|+.+.
T Consensus       429 ~~l~~~~  435 (569)
T 4azs_A          429 FNLPQPW  435 (569)
T ss_dssp             CCCCTTH
T ss_pred             hhhcccc
Confidence            9987643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9e-35  Score=269.61  Aligned_cols=173  Identities=27%  Similarity=0.407  Sum_probs=151.2

Q ss_pred             cCCCceee-eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHH-HHhcCcceEEEEEEeec----
Q 018275          104 SVDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL-AEVASHCIVKLYYSFQD----  177 (358)
Q Consensus       104 ~~~~~~~~-~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il-~~l~h~~iv~l~~~~~~----  177 (358)
                      ..++|.+. +.||+|+||.||+|.+..+++.||||++....        .+.+|+.++ +..+||||+++++++.+    
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH--------HHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence            34778887 78999999999999999999999999986432        256788877 66699999999999976    


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---CCcEEEEecCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGL  252 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~vkl~DFGl  252 (358)
                      ...+++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.||+||||||+|||++.   ++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            778999999999999999997754  6999999999999999999999999999999999999998   78999999998


Q ss_pred             CccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC
Q 018275          253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY  332 (358)
Q Consensus       253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y  332 (358)
                      +....                                                                       +..|
T Consensus       167 a~~~~-----------------------------------------------------------------------~~~~  175 (299)
T 3m2w_A          167 AKETT-----------------------------------------------------------------------GEKY  175 (299)
T ss_dssp             CEECT-----------------------------------------------------------------------TCGG
T ss_pred             ccccc-----------------------------------------------------------------------cccC
Confidence            86432                                                                       1346


Q ss_pred             CccchhhhhhHHHHhhccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +.++|||||||++|||+++..+|
T Consensus       176 ~~~~DiwslG~il~el~tg~~pf  198 (299)
T 3m2w_A          176 DKSCDMWSLGVIMYILLCGYPPF  198 (299)
T ss_dssp             GGHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CchhhHHHHHHHHHHHHHCCCCC
Confidence            78899999999999999987766

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=6.4e-31  Score=263.18  Aligned_cols=186  Identities=19%  Similarity=0.175  Sum_probs=139.9

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh-----hchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-----LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ..+.||+|+||.||+|  ...+..+++|.......     ......+.+.+|+.+++.++||||+.+..++.+.+..|||
T Consensus       340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3568999999999999  45678899998654321     1222345688999999999999999555555556677999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||++.  .+||+|||+|+......... 
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~-  486 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA-  486 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH-
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc-
Confidence            999999999999965        5678999999999999999999999999999998  99999999998764211000 


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC--CCCCccchhhhhh
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWLAYW  342 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~--~~y~~~~DiwSlG  342 (358)
                                                               .+......+.+||+.|||||++.+  .+|+..+|+||..
T Consensus       487 -----------------------------------------~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~v  525 (540)
T 3en9_A          487 -----------------------------------------VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEII  525 (540)
T ss_dssp             -----------------------------------------HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHH
T ss_pred             -----------------------------------------cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHH
Confidence                                                     000011235689999999999987  7799999999988


Q ss_pred             HHHHhhc
Q 018275          343 NETLSCN  349 (358)
Q Consensus       343 vil~e~l  349 (358)
                      .-..+-.
T Consensus       526 l~~l~~v  532 (540)
T 3en9_A          526 LELMKDV  532 (540)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            7776643

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.95  E-value=3.1e-28  Score=224.40  Aligned_cols=134  Identities=13%  Similarity=0.126  Sum_probs=107.4

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhch---------------hhHHHHHHHHHHHHHhcCcceEEEE
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR---------------GQVEHVRAERNLLAEVASHCIVKLY  172 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~---------------~~~~~~~~E~~il~~l~h~~iv~l~  172 (358)
                      |.+.+.||+|+||.||+|.+ .+|+.||||+++.......               .....+.+|+.+++.++|   +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence            34449999999999999998 8899999999975432111               235568899999999984   5555


Q ss_pred             EEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       173 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                      +.+.. +..|+||||++|++|.+ +..      .....++.|++.||.|||+.||+||||||+|||++ ++.+||+|||+
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            54433 45699999999999988 421      22446889999999999999999999999999999 99999999999


Q ss_pred             Cc
Q 018275          253 CK  254 (358)
Q Consensus       253 a~  254 (358)
                      |+
T Consensus       239 a~  240 (282)
T 1zar_A          239 SV  240 (282)
T ss_dssp             CE
T ss_pred             Ce
Confidence            85

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=8.1e-23  Score=185.65  Aligned_cols=142  Identities=15%  Similarity=0.122  Sum_probs=109.2

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCE--EEEEecchhhhhc---------------------hhhHHHHHHHHHHHHHh
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNI--YAMKKLKKSEMLS---------------------RGQVEHVRAERNLLAEV  163 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~--vaiK~i~~~~~~~---------------------~~~~~~~~~E~~il~~l  163 (358)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||+++......                     ......+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            377899999999999999998778989  9999876532110                     01123578899999999


Q ss_pred             cCcce--EEEEEEeecCCEEEEEEeecCC-C----CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCC
Q 018275          164 ASHCI--VKLYYSFQDAEYLYLIMEYLPG-G----DVMTLLMREETLTETVARFYIAQSVLAIESIH-KHNYIHRDIKPD  235 (358)
Q Consensus       164 ~h~~i--v~l~~~~~~~~~~~lV~E~~~~-g----~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~iiHrDikp~  235 (358)
                      .|+++  +.++..    ...+|||||+.+ |    +|.+....   .++..+..++.|++.||.||| +.||+||||||+
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            88854  333332    245799999942 3    67666532   224456788899999999999 999999999999


Q ss_pred             CEEEcCCCcEEEEecCCCccCC
Q 018275          236 NLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       236 NILl~~~~~vkl~DFGla~~~~  257 (358)
                      |||++.  .++|+|||+|....
T Consensus       201 NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             SEEESS--SEEECCCTTCEETT
T ss_pred             HEEEcC--cEEEEECcccccCC
Confidence            999998  99999999998664

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=2.4e-20  Score=177.59  Aligned_cols=140  Identities=13%  Similarity=0.127  Sum_probs=101.8

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh-----------chh--------hHHHHHHHHHHHHHhcCcc
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----------SRG--------QVEHVRAERNLLAEVASHC  167 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~-----------~~~--------~~~~~~~E~~il~~l~h~~  167 (358)
                      -|.+...||.|+||.||+|.+ .+|+.||||+++.....           ...        ..-....|...|.++.+++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            389999999999999999986 46999999998643210           000        0111234666777776554


Q ss_pred             eE--EEEEEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC--
Q 018275          168 IV--KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG--  243 (358)
Q Consensus       168 iv--~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~--  243 (358)
                      +.  ..+...  .  .+|||||++|++|..+...      ..+..++.|++.+|.+||+.|||||||||.|||++.++  
T Consensus       175 v~vp~p~~~~--~--~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          175 FPVPEPIAQS--R--HTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CSCCCEEEEE--T--TEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred             CCCCeeeecc--C--ceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence            32  222221  2  2699999999888665421      23456778999999999999999999999999998877  


Q ss_pred             --------cEEEEecCCCccCC
Q 018275          244 --------HMKLSDFGLCKPLD  257 (358)
Q Consensus       244 --------~vkl~DFGla~~~~  257 (358)
                              .+.|+||+.+....
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEETT
T ss_pred             ccccccccceEEEEeCCcccCC
Confidence                    48999999887654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=3.7e-13  Score=121.51  Aligned_cols=141  Identities=12%  Similarity=0.058  Sum_probs=110.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lV  184 (358)
                      +.|.+...+|.|+.+.||++..  .+..+++|+........   ...+.+|..+++.+. +..+.++++++.+.+..|+|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            5688888999999999998853  36799999987532111   123788999999885 56777889988888899999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK----------------------------------------  224 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~----------------------------------------  224 (358)
                      |||++|.+|.+.+.     +......++.++..+|..||+                                        
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999877631     112233567788889999998                                        


Q ss_pred             -------------------CCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          225 -------------------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       225 -------------------~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                                         ..++|+|++|.|||++.++.+.|+||+.+...
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                               44899999999999987666789999987643

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.33  E-value=5.6e-12  Score=112.96  Aligned_cols=136  Identities=14%  Similarity=0.120  Sum_probs=98.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc--eEEEEEEeecCCEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYSFQDAEYLYL  183 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~~~~~~~~~l  183 (358)
                      ..+.+....+.|..+.||++. ..+|..+++|+.....      ...+..|..+++.+.+.+  +.++++++.+.+..++
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            456655444556679999985 3557789999876431      123678999999887655  4558888887778999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN-------------------------------------  226 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-------------------------------------  226 (358)
                      ||||++|.+|.  ..   ....   ..++.+++..|..||+..                                     
T Consensus        93 v~e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           93 LLGEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99999998873  21   1121   234556667777777543                                     


Q ss_pred             ---------------------ceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          227 ---------------------YIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       227 ---------------------iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                                           ++|+|++|.|||++.++.+.|+|||.+...
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                 999999999999987766789999998643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.23  E-value=2.9e-11  Score=114.26  Aligned_cols=142  Identities=18%  Similarity=0.246  Sum_probs=104.9

Q ss_pred             eeeeeEeeeeeEEEEEEEEecCCCEEEEEecc--hhhhhchhhHHHHHHHHHHHHHhcC--cceEEEEEEeecC---CEE
Q 018275          109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK--KSEMLSRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDA---EYL  181 (358)
Q Consensus       109 ~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~--~~~~~~~~~~~~~~~E~~il~~l~h--~~iv~l~~~~~~~---~~~  181 (358)
                      ..++.|+.|.++.||++..  .+..+++|+..  .....  .....+.+|..+++.+..  ..+++++..+.+.   +..
T Consensus        41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            3467889999999998764  34688999876  43211  122347789999999874  4578888888766   447


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-------------------------------------  224 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-------------------------------------  224 (358)
                      |+||||++|..+.+..  ...+++.....++.+++.+|..||+                                     
T Consensus       117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            8999999988774421  2346777778888999999999997                                     


Q ss_pred             ---------------------CCceeCCCCCCCEEEcCCCc--EEEEecCCCccC
Q 018275          225 ---------------------HNYIHRDIKPDNLLLDQNGH--MKLSDFGLCKPL  256 (358)
Q Consensus       225 ---------------------~~iiHrDikp~NILl~~~~~--vkl~DFGla~~~  256 (358)
                                           ..++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                 35999999999999998753  699999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=6.2e-10  Score=102.66  Aligned_cols=134  Identities=19%  Similarity=0.217  Sum_probs=94.7

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-Ccc--eEEEEEEeecCC---EEEEE
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHC--IVKLYYSFQDAE---YLYLI  184 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~--iv~l~~~~~~~~---~~~lV  184 (358)
                      ++.++.|....||++.     ..+++|+....     .....+.+|..+++.+. +..  +..++....+..   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4568999999999752     46888985533     23455888999998884 322  344444443333   34799


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK----------------------------------------  224 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~----------------------------------------  224 (358)
                      |++++|.+|.....  ..++......++.+++..|..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988765332  235566666677777777777774                                        


Q ss_pred             ------------------CCceeCCCCCCCEEEcC--CCcEEEEecCCCccC
Q 018275          225 ------------------HNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKPL  256 (358)
Q Consensus       225 ------------------~~iiHrDikp~NILl~~--~~~vkl~DFGla~~~  256 (358)
                                        ..++|+|++|.||+++.  +..+.|+||+.+...
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                              23799999999999998  566899999988654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=2.6e-07  Score=85.24  Aligned_cols=135  Identities=17%  Similarity=0.180  Sum_probs=88.2

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCc---ceEEEEEEee-cCCEEEEEEe
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH---CIVKLYYSFQ-DAEYLYLIME  186 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~---~iv~l~~~~~-~~~~~~lV~E  186 (358)
                      +..++.|....||+.     +..+++|+-..     ......+..|..+|..+.+.   .+...+.++. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456788888899976     56788887432     22345688999999999753   2455555553 4456789999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 018275          187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK------------------------------------------  224 (358)
Q Consensus       187 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~------------------------------------------  224 (358)
                      +++|.++.....  ..++......++.++...|..||+                                          
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999987765321  112222333333333333333332                                          


Q ss_pred             ------------------CCceeCCCCCCCEEEcC---CCc-EEEEecCCCccCC
Q 018275          225 ------------------HNYIHRDIKPDNLLLDQ---NGH-MKLSDFGLCKPLD  257 (358)
Q Consensus       225 ------------------~~iiHrDikp~NILl~~---~~~-vkl~DFGla~~~~  257 (358)
                                        ..++|+|++|.|||++.   ++. +.|+||+.+...+
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                              24699999999999987   455 5899999887543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.67  E-value=3.1e-07  Score=82.67  Aligned_cols=134  Identities=16%  Similarity=0.151  Sum_probs=90.4

Q ss_pred             eEeeeeeE-EEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC-cceEEEEEEeecCCEEEEEEeecCC
Q 018275          113 IIGRGAFG-EVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       113 ~IG~G~fG-~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      .+..|..| .||+......+..+++|+-+..      ....+.+|..+|+.+.. --+.+++.++.+.+..++|||+++|
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            34445544 6898776667778999986543      23457789999888753 2366778888888999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 018275          191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHK----------------------------------------------  224 (358)
Q Consensus       191 g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~----------------------------------------------  224 (358)
                      .++.+......    .....+..++...|..||.                                              
T Consensus       105 ~~~~~~~~~~~----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          105 KTAFQVLEEYP----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EEHHHHHHHCG----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccccccCCH----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            87766542210    0111122233333333331                                              


Q ss_pred             -----C-------CceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          225 -----H-------NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       225 -----~-------~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                           .       .++|+|+.|.|||++.++.+-|+||+.+...
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                 1       2799999999999998877889999988754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.50  E-value=2.2e-07  Score=88.71  Aligned_cols=80  Identities=18%  Similarity=0.190  Sum_probs=49.9

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhh-hc---hhhHHHHHHHHHHHHHhcC--cc-eEEEEEEeecCCEEE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-LS---RGQVEHVRAERNLLAEVAS--HC-IVKLYYSFQDAEYLY  182 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~-~~---~~~~~~~~~E~~il~~l~h--~~-iv~l~~~~~~~~~~~  182 (358)
                      ..+.||.|.++.||++....++..++||....... ..   ......+..|..+++.+..  |. +..++.+.  ....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccE
Confidence            45789999999999997655678899998653211 00   1123446778888887753  33 44555432  34457


Q ss_pred             EEEeecCCC
Q 018275          183 LIMEYLPGG  191 (358)
Q Consensus       183 lV~E~~~~g  191 (358)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.32  E-value=2.2e-06  Score=80.36  Aligned_cols=83  Identities=8%  Similarity=0.124  Sum_probs=54.5

Q ss_pred             eeeeeE-eeeeeEEEEEEEEe--c----CCCEEEEEecchhh---hhchhhHHHHHHHHHHHHHhcC---cceEEEEEEe
Q 018275          109 DLLTII-GRGAFGEVRLCQEK--K----SGNIYAMKKLKKSE---MLSRGQVEHVRAERNLLAEVAS---HCIVKLYYSF  175 (358)
Q Consensus       109 ~~~~~I-G~G~fG~Vy~~~~~--~----~~~~vaiK~i~~~~---~~~~~~~~~~~~E~~il~~l~h---~~iv~l~~~~  175 (358)
                      ...+.| +.|....+|+....  .    ++..+++|+.....   ....   ..+..|..+++.+..   ..+.+++.++
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~---~~~~~E~~~l~~L~~~~~vpvP~v~~~~   99 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT---YRLDHQFEVIRLVGELTDVPVPRVRWIE   99 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC---CCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch---hHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence            345677 78888999987643  1    15678899876543   1011   236778888887753   2466777777


Q ss_pred             ecC---CEEEEEEeecCCCCHH
Q 018275          176 QDA---EYLYLIMEYLPGGDVM  194 (358)
Q Consensus       176 ~~~---~~~~lV~E~~~~g~L~  194 (358)
                      .+.   ...++||||++|..+.
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCCC
T ss_pred             cCCCccCCceEEEEecCCCChh
Confidence            654   3468999999886543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.18  E-value=1.7e-05  Score=73.40  Aligned_cols=32  Identities=25%  Similarity=0.267  Sum_probs=28.6

Q ss_pred             CCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       225 ~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ..++|+|++|.|||++.++.+.|+||+.+...
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence            57999999999999988889999999988643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.00  E-value=3.3e-05  Score=74.23  Aligned_cols=32  Identities=16%  Similarity=0.238  Sum_probs=28.2

Q ss_pred             hCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       224 ~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ...++|+|++|.|||++.++ +.|+||+.+...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            46799999999999998877 999999988754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.86  E-value=0.00012  Score=67.48  Aligned_cols=77  Identities=19%  Similarity=0.144  Sum_probs=58.6

Q ss_pred             eeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC---cceEEEEEEeecCCEEEEEE
Q 018275          109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS---HCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       109 ~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h---~~iv~l~~~~~~~~~~~lV~  185 (358)
                      .-...|+.|....+|+...  ++..+++|+....      ....+..|...|+.+..   ..+++++.++.+.+..++||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm  110 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL  110 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence            3457789999999998753  4678889986543      23457889888887742   45778888887778899999


Q ss_pred             eecCCCCH
Q 018275          186 EYLPGGDV  193 (358)
Q Consensus       186 E~~~~g~L  193 (358)
                      ||++|..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.70  E-value=0.00013  Score=66.55  Aligned_cols=133  Identities=12%  Similarity=0.002  Sum_probs=73.9

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcce-EEEEEEeecCCEEEEEEeec-
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDAEYLYLIMEYL-  188 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lV~E~~-  188 (358)
                      ++.|+.|....+|++      ..+++|+........    .....|..+++.+...++ .++++.+  ...-++|+||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            678988999999987      468889876532110    113457777776654333 3455544  33346899999 


Q ss_pred             CCCCHHHH---------------H---hhcC-CC----CH-HHHHHHHH--------------HHHHHHHH----HHh--
Q 018275          189 PGGDVMTL---------------L---MREE-TL----TE-TVARFYIA--------------QSVLAIES----IHK--  224 (358)
Q Consensus       189 ~~g~L~~~---------------l---~~~~-~~----~~-~~~~~~~~--------------qi~~aL~~----LH~--  224 (358)
                      +|.++...               +   +... .+    .. .....+..              .+...+..    +..  
T Consensus        91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~  170 (301)
T 3dxq_A           91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP  170 (301)
T ss_dssp             TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence            65443210               0   1111 01    11 11111111              11111111    111  


Q ss_pred             --CCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          225 --HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       225 --~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                        ..++|+|+.|.||+ ..++.+.|+||..+..-
T Consensus       171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence              23899999999999 66778899999987643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.56  E-value=0.00013  Score=67.10  Aligned_cols=142  Identities=13%  Similarity=0.046  Sum_probs=78.3

Q ss_pred             CceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc--eEEEEEE------eecC
Q 018275          107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYS------FQDA  178 (358)
Q Consensus       107 ~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~------~~~~  178 (358)
                      ...-++.|+.|....+|++... +| .+++|+.....  ...   .+..|..++..+...+  +.+++..      ....
T Consensus        23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~~---~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~   95 (322)
T 2ppq_A           23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKN---DLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   95 (322)
T ss_dssp             CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CC---HHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CHH---HHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence            3345567788888899987643 33 68899887531  122   2556777777665332  2233311      1123


Q ss_pred             CEEEEEEeecCCCCHHH--------------HHhh---c-C-C----CC--HHHHH--H-----------HHHHHHHHHH
Q 018275          179 EYLYLIMEYLPGGDVMT--------------LLMR---E-E-T----LT--ETVAR--F-----------YIAQSVLAIE  220 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~--------------~l~~---~-~-~----~~--~~~~~--~-----------~~~qi~~aL~  220 (358)
                      +..++||+|++|..+..              .++.   . . +    ..  .+...  .           +...+...+.
T Consensus        96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~  175 (322)
T 2ppq_A           96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  175 (322)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence            56789999998854311              0111   0 0 1    01  11110  0           0011333455


Q ss_pred             HHHh-------CCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          221 SIHK-------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       221 ~LH~-------~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      .+..       .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            5542       3699999999999999876668999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.49  E-value=0.00026  Score=65.44  Aligned_cols=33  Identities=27%  Similarity=0.369  Sum_probs=28.3

Q ss_pred             CCceeCCCCCCCEEEcCC----CcEEEEecCCCccCC
Q 018275          225 HNYIHRDIKPDNLLLDQN----GHMKLSDFGLCKPLD  257 (358)
Q Consensus       225 ~~iiHrDikp~NILl~~~----~~vkl~DFGla~~~~  257 (358)
                      ..++|+|+.|.|||++.+    +.+.|+||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            469999999999999875    789999999887543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.40  E-value=0.0017  Score=58.69  Aligned_cols=79  Identities=14%  Similarity=-0.003  Sum_probs=54.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCc---ceEEEEEEeecCCEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH---CIVKLYYSFQDAEYLY  182 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~---~iv~l~~~~~~~~~~~  182 (358)
                      ....-+..+|.|..+.||+.. ..+|+.|.+|+-+....   .....+..|...|+.+...   -+.+++...  .  -+
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~   86 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RT   86 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TE
T ss_pred             CCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ce
Confidence            345667889999999999976 45788999998765432   1223377899999888532   234444432  2  26


Q ss_pred             EEEeecCCCC
Q 018275          183 LIMEYLPGGD  192 (358)
Q Consensus       183 lV~E~~~~g~  192 (358)
                      +||||++++.
T Consensus        87 lv~e~l~~~~   96 (288)
T 3f7w_A           87 LAMEWVDERP   96 (288)
T ss_dssp             EEEECCCCCC
T ss_pred             EEEEeecccC
Confidence            8999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.34  E-value=0.00056  Score=62.88  Aligned_cols=137  Identities=10%  Similarity=0.153  Sum_probs=76.6

Q ss_pred             eeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc--eEEEEEE-----eecCCEEEEE
Q 018275          112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYS-----FQDAEYLYLI  184 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~-----~~~~~~~~lV  184 (358)
                      ..++ |....||++.. .+|..+++|..+....    ....+..|..++..+....  +++++..     ....+..++|
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4456 77788997643 3466799999864321    1234566788777775332  3334332     1224566899


Q ss_pred             EeecCCCCHH-----HH---------Hhh---cC------CCCHHHH----HHHH--------------HHHH-HHHHHH
Q 018275          185 MEYLPGGDVM-----TL---------LMR---EE------TLTETVA----RFYI--------------AQSV-LAIESI  222 (358)
Q Consensus       185 ~E~~~~g~L~-----~~---------l~~---~~------~~~~~~~----~~~~--------------~qi~-~aL~~L  222 (358)
                      |++++|..+.     ..         ++.   ..      .++....    ..++              ..++ ..+..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999874321     11         110   00      1111100    0010              0111 122222


Q ss_pred             H-------hCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          223 H-------KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       223 H-------~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      .       ...++|+|++|.|||++ + .+.|+||+.+...
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            2       23589999999999998 5 8999999987643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.32  E-value=0.00098  Score=62.54  Aligned_cols=74  Identities=16%  Similarity=0.086  Sum_probs=43.4

Q ss_pred             eeeEeeeeeEEEEEEEEec--------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcce-EEEEEEeecCCEE
Q 018275          111 LTIIGRGAFGEVRLCQEKK--------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDAEYL  181 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~  181 (358)
                      +..|+.|..-.+|++....        .+..+++|+......    .......|..++..+...++ .++++.+  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            4567778788899887543        136889998765321    11113567888877754443 3555544  22  


Q ss_pred             EEEEeecCCCC
Q 018275          182 YLIMEYLPGGD  192 (358)
Q Consensus       182 ~lV~E~~~~g~  192 (358)
                      ++||||++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.31  E-value=0.00043  Score=66.66  Aligned_cols=73  Identities=22%  Similarity=0.312  Sum_probs=47.9

Q ss_pred             eeeeEeeeeeEEEEEEEEec-------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcce-EEEEEEeecCCEE
Q 018275          110 LLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDAEYL  181 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~  181 (358)
                      -++.|+.|....||++....       .+..+++|+.....  .   ...+..|..++..+...++ .++++.+.+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            35677878888999987542       25789999874311  1   1234568888887754444 456666542    


Q ss_pred             EEEEeecCCC
Q 018275          182 YLIMEYLPGG  191 (358)
Q Consensus       182 ~lV~E~~~~g  191 (358)
                      .+|+||++|.
T Consensus       148 g~v~e~l~G~  157 (429)
T 1nw1_A          148 GRLEEYIPSR  157 (429)
T ss_dssp             EEEECCCCEE
T ss_pred             CEEEEEeCCc
Confidence            2899999863

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.27  E-value=0.0007  Score=64.08  Aligned_cols=136  Identities=17%  Similarity=0.200  Sum_probs=78.5

Q ss_pred             eeEeeeeeEEEEEEEEec-------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcce-EEEEEEeecCCEEEE
Q 018275          112 TIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDAEYLYL  183 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~l  183 (358)
                      +.|.-|-...+|++....       .+..+++|+.....    .....+.+|..+++.+...++ .++++.+.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            456557777889886532       35789999864321    123445688888887754333 455666543    29


Q ss_pred             EEeecCCCCHHH--------------HH---hhc-----CCCC--HHHHHHHHHHHH-------------------HHHH
Q 018275          184 IMEYLPGGDVMT--------------LL---MRE-----ETLT--ETVARFYIAQSV-------------------LAIE  220 (358)
Q Consensus       184 V~E~~~~g~L~~--------------~l---~~~-----~~~~--~~~~~~~~~qi~-------------------~aL~  220 (358)
                      ||||++|.+|..              .|   +.-     .+..  ...+..+..++.                   ..+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            999998754321              11   111     1111  233444443332                   1233


Q ss_pred             HHH----h----CCceeCCCCCCCEEEcCC----CcEEEEecCCCcc
Q 018275          221 SIH----K----HNYIHRDIKPDNLLLDQN----GHMKLSDFGLCKP  255 (358)
Q Consensus       221 ~LH----~----~~iiHrDikp~NILl~~~----~~vkl~DFGla~~  255 (358)
                      .|.    .    ..++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            332    2    249999999999999877    7899999998864

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.90  E-value=0.0019  Score=60.08  Aligned_cols=32  Identities=19%  Similarity=0.222  Sum_probs=28.2

Q ss_pred             CCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       225 ~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                      ..++|+|+.|.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            35999999999999998889999999887644

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.79  E-value=0.0055  Score=59.43  Aligned_cols=75  Identities=16%  Similarity=0.205  Sum_probs=47.3

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcce-EEEEEEeecCCEEEEEEeec
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDAEYLYLIMEYL  188 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~~lV~E~~  188 (358)
                      -++.|+.|-...+|++.....+..+++|+.....   ...+ ....|..++..+...++ .++++.+.  +.  +||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence            4567887888999998764434788899875431   1111 12578888988876554 46666663  22  599999


Q ss_pred             CCCC
Q 018275          189 PGGD  192 (358)
Q Consensus       189 ~~g~  192 (358)
                      +|.+
T Consensus       184 ~G~~  187 (458)
T 2qg7_A          184 DGYA  187 (458)
T ss_dssp             CSEE
T ss_pred             CCcc
Confidence            8743

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.74  E-value=0.032  Score=53.42  Aligned_cols=75  Identities=13%  Similarity=0.085  Sum_probs=45.9

Q ss_pred             eeeeEeeeeeEEEEEEEEecC-------CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcce-EEEEEEeecCCEE
Q 018275          110 LLTIIGRGAFGEVRLCQEKKS-------GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDAEYL  181 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-v~l~~~~~~~~~~  181 (358)
                      -++.+..|-...+|++.....       +..+++++.....   ... -...+|..+++.+...++ .++++.+  .+  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKF-YDSKVELDVFRYLSNINIAPNIIADF--PE--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence            345666677788998875421       5789999865432   111 113568888877754333 4445444  22  


Q ss_pred             EEEEeecCCCC
Q 018275          182 YLIMEYLPGGD  192 (358)
Q Consensus       182 ~lV~E~~~~g~  192 (358)
                      ++||||++|..
T Consensus       146 ~~I~efI~G~~  156 (424)
T 3mes_A          146 GRIEEFIDGEP  156 (424)
T ss_dssp             EEEEECCCSEE
T ss_pred             CEEEEEeCCcc
Confidence            68999999854

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.52  E-value=0.031  Score=48.31  Aligned_cols=58  Identities=14%  Similarity=0.145  Sum_probs=44.4

Q ss_pred             CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEe
Q 018275          192 DVMTLLMR-EETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSD  249 (358)
Q Consensus       192 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~D  249 (358)
                      +|.++|.. +.++++.++..++.|.+.+|.-+-. ..-..+=+.|..|+|..+|.|-+.+
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~   93 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP   93 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence            78999865 5799999999999999999877622 2212334557899999999988763

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.67  E-value=0.05  Score=52.73  Aligned_cols=63  Identities=8%  Similarity=-0.023  Sum_probs=16.8

Q ss_pred             eeeeeEeeeeeEEEEEEEEecCCCEEEE------EecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275          109 DLLTIIGRGAFGEVRLCQEKKSGNIYAM------KKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus       109 ~~~~~IG~G~fG~Vy~~~~~~~~~~vai------K~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      .+.+.||   ||.||++.......+||+      |.++.... .......+.++..++...+|||+++.+++-
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceE
Confidence            3445666   999999988765568888      76654332 334445577788888889999998887554

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=84.21  E-value=0.45  Score=44.88  Aligned_cols=29  Identities=28%  Similarity=0.504  Sum_probs=25.2

Q ss_pred             ceeCCCCCCCEEE------cCCCcEEEEecCCCcc
Q 018275          227 YIHRDIKPDNLLL------DQNGHMKLSDFGLCKP  255 (358)
Q Consensus       227 iiHrDikp~NILl------~~~~~vkl~DFGla~~  255 (358)
                      ++|+|+.+.|||+      +.+..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4567899999998864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	358
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-49
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-48
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-45
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-43
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-43
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-42
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-37
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-36
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-36
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-35
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-35
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-32
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-32
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-31
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-31
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-30
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-29
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-27
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-27
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-14

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-53
 Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 51/237 (21%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           + +++DF++   +G+G FG V L +EK+S  I A+K L K+++   G    +R E  + +
Sbjct: 2   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
            +    I++LY  F DA  +YLI+EY P G V   L +     E     YI +   A+  
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
            H    IHRDIKP+NLLL   G +K++DFG       +                      
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------------------- 161

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
                                           +  GT DY+ PE++  + +  + D 
Sbjct: 162 -------------------------------TTLCGTLDYLPPEMIEGRMHDEKVDL 187

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-52
 Identities = 67/241 (27%), Positives = 112/241 (46%), Gaps = 47/241 (19%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K   +DF    I+G G+F  V L +E  +   YA+K L+K  ++   +V +V  ER++++
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
            +     VKLY++FQD E LY  + Y   G+++  + +  +  ET  RFY A+ V A+E 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +H    IHRD+KP+N+LL+++ H++++DFG  K                           
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAK--------------------------- 156

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                    +++  A S VGT  Y++PE+L +K      D  A 
Sbjct: 157 --------------------VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196

Query: 342 W 342
            
Sbjct: 197 G 197

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 8e-49
 Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 50/239 (20%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           V+D+DL+  +G GA+GEV+L   + +    A+K +     +     E+++ E  +   + 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61

Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
              +VK Y   ++    YL +EY  GG++   +  +  + E  A+ +  Q +  +  +H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
               HRDIKP+NLLLD+  ++K+SDFGL                                
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN------------------------- 156

Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAYW 342
                                 NR +L     GT  Y+APE+L ++ +     D  +  
Sbjct: 157 ----------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-48
 Identities = 53/240 (22%), Positives = 90/240 (37%), Gaps = 54/240 (22%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +  DDF+ ++ +G G  G V     K SG + A K +     +       +  E  +L E
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
             S  IV  Y +F     + + ME++ GG +  +L +   + E +        +  +  +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 223 H-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
             KH  +HRD+KP N+L++  G +KL DFG+   L  +                      
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---------------------- 158

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                        +A S VGT  Y++PE L    Y ++ D  + 
Sbjct: 159 -----------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-46
 Identities = 78/240 (32%), Positives = 117/240 (48%), Gaps = 49/240 (20%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
           K++++DFD L ++G+G FG+V L +EK +G  YAMK L+K  ++++ +V H   E  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
                 +  L Y+FQ  + L  +MEY  GG++   L RE   TE  ARFY A+ V A+E 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +H  + ++RDIK +NL+LD++GH+K++DFGLCK                           
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------------------- 159

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                           +  GTP+Y+APEVL    YG   DW   
Sbjct: 160 ----------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 1e-45
 Identities = 46/153 (30%), Positives = 82/153 (53%), Gaps = 4/153 (2%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++++  +G GAFG+V   Q K++  + A K +      S  ++E    E ++LA    
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
             IVKL  +F     L++++E+  GG V  +++  E  LTE+  +    Q++ A+  +H 
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +  IHRD+K  N+L   +G +KL+DFG+     
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  155 bits (393), Expect = 2e-45
 Identities = 69/183 (37%), Positives = 115/183 (62%), Gaps = 5/183 (2%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
           S+ DF +L  +G G+FG V L + + +G  YAMK LKK  ++   QVEH   ER +L+ V
Sbjct: 2   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
               I++++ +FQDA+ +++IM+Y+ GG++ +LL + +     VA+FY A+  LA+E +H
Sbjct: 62  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE-----NEVLDDENLNES 278
             + I+RD+KP+N+LLD+NGH+K++DFG  K +     +          EV+  +  N+S
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181

Query: 279 MDV 281
           +D 
Sbjct: 182 IDW 184

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 5e-45
 Identities = 70/238 (29%), Positives = 115/238 (48%), Gaps = 50/238 (21%)

Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
           ++DF L  ++G+G+FG+V L + KK+   +A+K LKK  +L    VE    E+ +L+   
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 165 SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
            H  +  ++ +FQ  E L+ +MEYL GGD+M  +        + A FY A+ +L ++ +H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
               ++RD+K DN+LLD++GH+K++DFG+CK     +                       
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----------------------- 157

Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                         +  GTPDYIAPE+LL + Y    DW ++
Sbjct: 158 --------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 189

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 7e-45
 Identities = 41/155 (26%), Positives = 71/155 (45%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
             F  L  IG G+FG V   ++ ++  + A+KK+  S   S  + + +  E   L ++  
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
              ++    +      +L+MEY  G     L + ++ L E         ++  +  +H H
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           N IHRD+K  N+LL + G +KL DFG    +   N
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  153 bits (387), Expect = 7e-45
 Identities = 46/159 (28%), Positives = 86/159 (54%), Gaps = 7/159 (4%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS------RGQVEHVRAERNL 159
           ++++   I+GRG    VR C  K +   YA+K +  +   S      +   E    E ++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 160 LAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
           L +V+ H  I++L  +++   + +L+ + +  G++   L  + TL+E   R  +   +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           I ++HK N +HRD+KP+N+LLD + ++KL+DFG    LD
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-44
 Identities = 61/247 (24%), Positives = 104/247 (42%), Gaps = 61/247 (24%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           +D+++L  IG G++G  +  + K  G I   K+L    M +  + + + +E NLL E+  
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 62

Query: 166 HCIVKLYYSFQDAE--YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAI 219
             IV+ Y    D     LY++MEY  GGD+ +++ +     + L E      + Q  LA+
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 220 ESIHK-----HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
           +  H+     H  +HRD+KP N+ LD   ++KL DFGL + L+                 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----------------- 165

Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
                                           +    A + VGTP Y++PE + +  Y  
Sbjct: 166 --------------------------------HDTSFAKAFVGTPYYMSPEQMNRMSYNE 193

Query: 335 ECDWLAY 341
           + D  + 
Sbjct: 194 KSDIWSL 200

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  152 bits (385), Expect = 1e-43
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 56/242 (23%)

Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
           +H   +D +D+   +G GAFG V    E+ +GN +A K +       +   E VR E   
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQT 76

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLA 218
           ++ +    +V L+ +F+D   + +I E++ GG++   +  E   ++E  A  Y+ Q    
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 219 IESIHKHNYIHRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
           +  +H++NY+H D+KP+N++    ++  +KL DFGL                        
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---------------------- 174

Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
                                        ++ ++    T GT ++ APEV   K  G   
Sbjct: 175 ----------------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206

Query: 337 DW 338
           D 
Sbjct: 207 DM 208

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 55/158 (34%), Positives = 92/158 (58%), Gaps = 3/158 (1%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           ++++DF +  IIGRG FGEV  C++  +G +YAMK L K  +  +        ER +L+ 
Sbjct: 1   LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60

Query: 163 VASHC---IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
           V++     IV + Y+F   + L  I++ + GGD+   L +    +E   RFY A+ +L +
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           E +H    ++RD+KP N+LLD++GH+++SD GL     
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 6e-43
 Identities = 59/254 (23%), Positives = 101/254 (39%), Gaps = 57/254 (22%)

Query: 92  ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
           + E +   R  +SV D    +     IG+GA G V    +  +G   A++++   +    
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--- 58

Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
            + E +  E  ++ E  +  IV    S+   + L+++MEYL GG +  ++       E  
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQ 117

Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
                 + + A+E +H +  IHRDIK DN+LL  +G +KL+DFG C  +           
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------- 170

Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
                                                         + VGTP ++APEV+
Sbjct: 171 ------------------------------------------SKRSTMVGTPYWMAPEVV 188

Query: 328 LKKGYGMECDWLAY 341
            +K YG + D  + 
Sbjct: 189 TRKAYGPKVDIWSL 202

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  148 bits (374), Expect = 3e-42
 Identities = 77/270 (28%), Positives = 140/270 (51%), Gaps = 22/270 (8%)

Query: 72  ASSDVPEEEQINILKDLERKETEYMR----LKRHKISVDDFDLLTIIGRGAFGEVRLCQE 127
           A++     EQ ++ + L + + ++++      ++   +D FD +  +G G+FG V L + 
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62

Query: 128 KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187
           K+SGN YAMK L K +++   Q+EH   E+ +L  V    +VKL +SF+D   LY++MEY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122

Query: 188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247
           + GG++ + L R    +E  ARFY AQ VL  E +H  + I+RD+KP+NLL+DQ G++++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182

Query: 248 SDFGLCKPLDCTNLSAIN-----ENEVLDDENLNESMDVDGRFP---ESGCGRRW---KS 296
           +DFG  K +     +          E++  +  N+++D         E   G        
Sbjct: 183 TDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

Query: 297 PLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326
           P++  +     + +        P + + ++
Sbjct: 243 PIQIYEKIVSGKVRF-------PSHFSSDL 265

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  148 bits (374), Expect = 4e-42
 Identities = 54/260 (20%), Positives = 115/260 (44%), Gaps = 58/260 (22%)

Query: 83  NILKDLERKET-EYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK 141
              +D+ +K   + + +K+  +  D +D+L  +G GAFG V  C EK +G ++  K +  
Sbjct: 6   KFYEDIWKKYVPQPVEVKQGSV-YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 64

Query: 142 SEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE 201
              L +     V+ E +++ ++    ++ L+ +F+D   + LI+E+L GG++   +  E+
Sbjct: 65  PYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121

Query: 202 -TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--QNGHMKLSDFGLCKPLDC 258
             ++E     Y+ Q+   ++ +H+H+ +H DIKP+N++ +  +   +K+ DFGL      
Sbjct: 122 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---- 177

Query: 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT 318
                                                         ++N  ++   T  T
Sbjct: 178 ----------------------------------------------KLNPDEIVKVTTAT 191

Query: 319 PDYIAPEVLLKKGYGMECDW 338
            ++ APE++ ++  G   D 
Sbjct: 192 AEFAAPEIVDREPVGFYTDM 211

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (370), Expect = 5e-42
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 55/239 (23%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D +D   ++G GAF EV L ++K++  + A+K + K  +   G+   +  E  +L ++  
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IV L   ++   +LYLIM+ + GG++   ++ +   TE  A   I Q + A++ +H  
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
             +HRD+KP+NLL    D++  + +SDFGL K                            
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---------------------------- 158

Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                   +   +  +  GTP Y+APEVL +K Y    D  + 
Sbjct: 159 ----------------------MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 195

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 6e-41
 Identities = 47/242 (19%), Positives = 92/242 (38%), Gaps = 60/242 (24%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
                 IGRG+F  V    + ++    A  +L+  ++ ++ + +  + E  +L  +    
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPN 69

Query: 168 IVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
           IV+ Y S++      + + L+ E +  G + T L R + +   V R +  Q +  ++ +H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 224 KHNY--IHRDIKPDNLLL-DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
                 IHRD+K DN+ +    G +K+ D GL                            
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------------------------- 163

Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                    + R   A + +GTP+++APE+  ++ Y    D  A
Sbjct: 164 -------------------------LKRASFAKAVIGTPEFMAPEM-YEEKYDESVDVYA 197

Query: 341 YW 342
           + 
Sbjct: 198 FG 199

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  136 bits (344), Expect = 1e-38
 Identities = 47/239 (19%), Positives = 84/239 (35%), Gaps = 50/239 (20%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           D ++L  I+G G   EV L ++ +     A+K L+             R E    A +  
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 166 HCIVKLYYSFQD----AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
             IV +Y + +         Y++MEY+ G  +  ++  E  +T   A   IA +  A+  
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
            H++  IHRD+KP N+++     +K+ DFG+ + +                         
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI------------------------- 161

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                    N      + +GT  Y++PE           D  +
Sbjct: 162 ---------------------ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 199

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (342), Expect = 3e-38
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 6/163 (3%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +   D  +   +G G +GEV     KK     A+K LK+  M    +VE    E  ++ E
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVLAIE 220
           +    +V+L          Y+I E++  G+++  L     + ++  V  +   Q   A+E
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
            + K N+IHRD+   N L+ +N  +K++DFGL + +     +A
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 9e-38
 Identities = 65/164 (39%), Positives = 105/164 (64%), Gaps = 5/164 (3%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQ-VEHVRAER 157
           K+ +++F+LL ++G GA+G+V L ++     +G +YAMK LKK+ ++ + +  EH R ER
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79

Query: 158 NLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
            +L  +     +V L+Y+FQ    L+LI++Y+ GG++ T L + E  TE   + Y+ + V
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           LA+E +HK   I+RDIK +N+LLD NGH+ L+DFGL K      
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-37
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 7/158 (4%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + + +   +GRG FG V  C E  S   Y  K +K            V+ E ++L     
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHK 224
             I+ L+ SF+  E L +I E++ G D+   +      L E     Y+ Q   A++ +H 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 225 HNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKPLDCTN 260
           HN  H DI+P+N++     +  +K+ +FG  + L   +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-37
 Identities = 58/252 (23%), Positives = 104/252 (41%), Gaps = 30/252 (11%)

Query: 96  MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
           +++K++ I +DD+ + + ++G G  G+V     K++   +A+K L+      R       
Sbjct: 2   LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------- 53

Query: 155 AERNLLAEVASH-CIVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMR--EETLTETV 207
            E  L    +    IV++   +++     + L ++ME L GG++ + +    ++  TE  
Sbjct: 54  -EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112

Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNLSAI 264
           A   +     AI+ +H  N  HRD+KP+NLL      N  +KL+DFG  K     N    
Sbjct: 113 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172

Query: 265 NEN-------EVLDDENLNESMDVDGRFP---ESGCGRRWKSPLEQLQHWQINRRKLAYS 314
                     EVL  E  ++S D+           CG         L      + ++   
Sbjct: 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232

Query: 315 TVGTPDYIAPEV 326
               P+    EV
Sbjct: 233 QYEFPNPEWSEV 244

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 2e-37
 Identities = 56/247 (22%), Positives = 103/247 (41%), Gaps = 58/247 (23%)

Query: 99  KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVRA 155
           ++  +  D +D    +G G F  V+ C+EK +G  YA K +KK    S  +    E +  
Sbjct: 4   RQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
           E ++L E+    ++ L+  +++   + LI+E + GG++   L  +E+LTE  A  ++ Q 
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLDCTNLSAINENEVLD 271
           +  +  +H     H D+KP+N++L         +K+ DFGL   +D  N           
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--------- 173

Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
                                                     +  GTP+++APE++  + 
Sbjct: 174 -----------------------------------------KNIFGTPEFVAPEIVNYEP 192

Query: 332 YGMECDW 338
            G+E D 
Sbjct: 193 LGLEADM 199

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 7e-37
 Identities = 34/156 (21%), Positives = 65/156 (41%), Gaps = 6/156 (3%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I      +   IG G+FG V   +        A+K L  +   +  Q++  + E  +L +
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRK 60

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIES 221
                I+  +  +  A  L ++ ++  G  +   L   ET            Q+   ++ 
Sbjct: 61  TRHVNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +H  + IHRD+K +N+ L ++  +K+ DFGL     
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-36
 Identities = 50/250 (20%), Positives = 92/250 (36%), Gaps = 56/250 (22%)

Query: 96  MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHV 153
           + LKR  + + D +    +G G FG VR    +  K     A+K LK+     +   E +
Sbjct: 3   LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEM 56

Query: 154 RAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYI 212
             E  ++ ++ +  IV+L    Q    L L+ME   GG +   L+ + E +  +     +
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115

Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
            Q  + ++ + + N++HRD+   N+LL    + K+SDFGL K L   +            
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD------------ 163

Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
                                             +      +      + APE +  + +
Sbjct: 164 ----------------------------------SYYTARSAGKWPLKWYAPECINFRKF 189

Query: 333 GMECDWLAYW 342
               D  +Y 
Sbjct: 190 SSRSDVWSYG 199

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-36
 Identities = 49/247 (19%), Positives = 89/247 (36%), Gaps = 54/247 (21%)

Query: 98  LKRHKISVDDFDLLTIIGRGAFGEVRLC--QEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
           L R  ++++D      +G G FG V+    Q KK     A+K LK  E       + + A
Sbjct: 3   LDRKLLTLEDK----ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLA 57

Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
           E N++ ++ +  IV++    +  E   L+ME    G +   L +   + +      + Q 
Sbjct: 58  EANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
            + ++ + + N++HRD+   N+LL    + K+SDFGL K L                   
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------------- 161

Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
                                          N  K          + APE +    +  +
Sbjct: 162 -------------------------------NYYKAQTHGKWPVKWYAPECINYYKFSSK 190

Query: 336 CDWLAYW 342
            D  ++ 
Sbjct: 191 SDVWSFG 197

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 3e-36
 Identities = 45/187 (24%), Positives = 85/187 (45%), Gaps = 15/187 (8%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +++ +  LL  IG+G FG+V L   +  GN  A+K +K          +   AE +++ +
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQ 56

Query: 163 VASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAI 219
           +    +V+L     ++   LY++ EY+  G ++  L       L       +      A+
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN-----EVLDDEN 274
           E +  +N++HRD+   N+L+ ++   K+SDFGL K    T  +          E L ++ 
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKK 176

Query: 275 LNESMDV 281
            +   DV
Sbjct: 177 FSTKSDV 183

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 6e-36
 Identities = 50/301 (16%), Positives = 99/301 (32%), Gaps = 86/301 (28%)

Query: 79  EEQINILKDLERKETEYMRLKRHK--------ISVDDFDLLTIIGRGAFGEVRLCQEKKS 130
           E Q+ +++     + EY  +   +           ++ +   ++G GAFG+V        
Sbjct: 2   ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61

Query: 131 GNI-----YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLI 184
                    A+K LK+       + E + +E  ++ ++ SH  IV L  +   +  +YLI
Sbjct: 62  SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119

Query: 185 MEYLPGGDVMTLLMREE-----------------------TLTETVARFYIAQSVLAIES 221
            EY   GD++  L  +                         LT      +  Q    +E 
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +   + +HRD+   N+L+     +K+ DFGL + +                         
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM------------------------ 215

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                    +   +  +      ++APE L +  Y ++ D  +Y
Sbjct: 216 -----------------------SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252

Query: 342 W 342
            
Sbjct: 253 G 253

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 7e-36
 Identities = 41/241 (17%), Positives = 80/241 (33%), Gaps = 54/241 (22%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I   D   L  +G G FG V+  +  +     A+K +K+  M      +    E  ++  
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMN 55

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIES 221
           ++   +V+LY        +++I EY+  G ++  L                     A+E 
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 115

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           +    ++HRD+   N L++  G +K+SDFGL +                           
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--------------------------- 148

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                +   +    +  +     +  PEVL+   +  + D  A+
Sbjct: 149 ---------------------YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187

Query: 342 W 342
            
Sbjct: 188 G 188

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 9/170 (5%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
            V  ++ L  IG+G FGEV   + +K+G   A+KK+        G       E  +L  +
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL 66

Query: 164 ASHCIVKLYYSFQDAE--------YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
               +V L    +            +YL+ ++        L       T +  +  +   
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126

Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265
           +  +  IH++  +HRD+K  N+L+ ++G +KL+DFGL +       S  N
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-35
 Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 5/159 (3%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNL 159
           I   D  LL  +G G+FG VR  +           A+K LK   +     ++    E N 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLA 218
           +  +    +++LY        + ++ E  P G ++  L + +          Y  Q    
Sbjct: 65  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +  +    +IHRD+   NLLL     +K+ DFGL + L 
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (321), Expect = 4e-35
 Identities = 34/158 (21%), Positives = 68/158 (43%), Gaps = 2/158 (1%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK-SEMLSRGQVEHVRAERNLL 160
           +I +    +  +IG G FGEV     K  G       +K      +  Q     +E +++
Sbjct: 22  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81

Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAI 219
            +     ++ L      +  + +I E++  G + + L + +   T       +      +
Sbjct: 82  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           + +   NY+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 5e-35
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 7/166 (4%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAE 162
             + +  ++G G FG V            A+K ++K  +   G++ +   V  E  LL +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 163 VASHC--IVKLYYSFQDAEYLYLIMEYL-PGGDVMTLLMREETLTETVARFYIAQSVLAI 219
           V+S    +++L   F+  +   LI+E   P  D+   +     L E +AR +  Q + A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 220 ESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCTNLSAI 264
              H    +HRDIK +N+L+D N G +KL DFG    L  T  +  
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 169

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 8e-35
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 8/160 (5%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           +  +   L+  +G G FGEV +          A+K LK+  M      +   AE NL+ +
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQ 64

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIE 220
           +    +V+LY      E +Y+I EY+  G ++  L       LT        AQ    + 
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
            I + NYIHRD++  N+L+      K++DFGL + ++   
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 8e-35
 Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 17/170 (10%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
            +  +D     +IG G FG+V   + KK G        +  E  S+        E  +L 
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 162 EVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLT 204
           ++  H  I+ L  + +   YLYL +EY P G+++  L +                  TL+
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
                 + A     ++ + +  +IHRD+   N+L+ +N   K++DFGL +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 175

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  126 bits (318), Expect = 9e-35
 Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 2/155 (1%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + +  L  IG G +G V   Q    G  +A+KK++  E    G       E ++L E+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IVKLY      + L L+ E+L       L + E  L    A+ ++ Q +  I   H  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
             +HRD+KP NLL+++ G +K++DFGL +      
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-34
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 2/150 (1%)

Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHC 167
            L  +G G F  V   ++K +  I A+KK+K         G       E  LL E++   
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
           I+ L  +F     + L+ +++     + +      LT +  + Y+  ++  +E +H+H  
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           +HRD+KP+NLLLD+NG +KL+DFGL K   
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFG 151

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (318), Expect = 2e-34
 Identities = 42/176 (23%), Positives = 81/176 (46%), Gaps = 16/176 (9%)

Query: 89  ERKETEYMRLKRHKI---SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
             +  EY   + H +   + DD+ L+  +GRG + EV       +     +K LK     
Sbjct: 15  THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--- 71

Query: 146 SRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDA--EYLYLIMEYLPGGDVMTLLMREET 202
              + + ++ E  +L  +     I+ L    +D       L+ E++   D   L    +T
Sbjct: 72  ---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QT 125

Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLD 257
           LT+   RFY+ + + A++  H    +HRD+KP N+++D ++  ++L D+GL +   
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-34
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 17/162 (10%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
             +    +IG G+FG V   +   SG + A+KK+ + +            E  ++ ++  
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDH 72

Query: 166 HCIVKLYYSF------QDAEYLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSV 216
             IV+L Y F      +D  YL L+++Y+P             ++TL     + Y+ Q  
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLD 257
            ++  IH     HRDIKP NLLLD +   +KL DFG  K L 
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 6e-34
 Identities = 43/189 (22%), Positives = 71/189 (37%), Gaps = 26/189 (13%)

Query: 93  TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSR 147
           T+     + +   +       +G GAFG+V         +  +    A+K LK S  L  
Sbjct: 10  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-- 67

Query: 148 GQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR------- 199
            + E + +E  +L+ + +H  IV L  +        +I EY   GD++  L R       
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 200 -----------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLS 248
                      E  L       +  Q    +  +   N IHRD+   N+LL      K+ 
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187

Query: 249 DFGLCKPLD 257
           DFGL + + 
Sbjct: 188 DFGLARDIK 196

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 7e-34
 Identities = 40/241 (16%), Positives = 82/241 (34%), Gaps = 54/241 (22%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I   +   +  IG G FG V L     + +  A+K +++  M      E    E  ++ +
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMK 56

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIES 221
           ++   +V+LY    +   + L+ E++  G +   L  +  L        +   V   +  
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 116

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
           + +   IHRD+   N L+ +N  +K+SDFG+ + +                         
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----------------------- 153

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                    ++   +  T     + +PEV     Y  + D  ++
Sbjct: 154 -------------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188

Query: 342 W 342
            
Sbjct: 189 G 189

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-33
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 2/156 (1%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           ++F  +  IG G +G V   + K +G + A+KK++  +  + G       E +LL E+  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIESIHK 224
             IVKL         LYL+ E+L       +     T +   + + Y+ Q +  +   H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           H  +HRD+KP NLL++  G +KL+DFGL +      
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-33
 Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 7/159 (4%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
             +  L+ IG GA+G V    +  +    A+KK+   E   +   +    E  +L     
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65

Query: 166 HCIVKLYYSFQDAEY----LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
             I+ +    +           ++ +L G D+  LL + + L+     +++ Q +  ++ 
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124

Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           IH  N +HRD+KP NLLL+    +K+ DFGL +  D  +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  121 bits (303), Expect = 2e-32
 Identities = 40/193 (20%), Positives = 74/193 (38%), Gaps = 31/193 (16%)

Query: 97  RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVE 151
           +L   +   ++ + +  IG GAFG V   +       +   + A+K LK+    S     
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQA 61

Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE----------- 200
             + E  L+AE  +  IVKL       + + L+ EY+  GD+   L              
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 201 -------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247
                          L+         Q    +  + +  ++HRD+   N L+ +N  +K+
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181

Query: 248 SDFGLCKPLDCTN 260
           +DFGL + +   +
Sbjct: 182 ADFGLSRNIYSAD 194

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-32
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 8/163 (4%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
           I  +   L   +G+G FGEV +          A+K LK   M      E    E  ++ +
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM----SPEAFLQEAQVMKK 68

Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIE 220
           +    +V+LY +    E +Y++ EY+  G ++  L  E    L         AQ    + 
Sbjct: 69  LRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
            + + NY+HRD++  N+L+ +N   K++DFGL + ++    +A
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 2e-32
 Identities = 39/155 (25%), Positives = 72/155 (46%), Gaps = 1/155 (0%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
             ++ L  IG G +G V   + +++  I A+K+++  +    G       E  LL E+  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60

Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
             IV+L+      + L L+ E+               L   + + ++ Q +  +   H  
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           N +HRD+KP NLL+++NG +KL++FGL +      
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  119 bits (300), Expect = 5e-32
 Identities = 41/240 (17%), Positives = 74/240 (30%), Gaps = 53/240 (22%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH- 166
           + +   IG G+FG +       +    A+K   +     R     +R E      +A   
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61

Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN 226
            I  +YY  Q+  +  L+++ L       L +     +         Q +  ++SIH+ +
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 227 YIHRDIKPDNLLLD-----QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
            ++RDIKPDN L+          + + DFG+ K                           
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK------------------- 162

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                                  Q    +   +  GT  Y++    L +      D  A 
Sbjct: 163 -----------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 199

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 9e-32
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 9/158 (5%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
             +  L  +G GA+G V    + ++G   A+KKL +    S    +    E  LL  +  
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76

Query: 166 HCIVKLYYSFQDAE------YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
             ++ L   F   E        YL+M ++  G  +  LM+ E L E   +F + Q +  +
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
             IH    IHRD+KP NL ++++  +K+ DFGL +  D
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-31
 Identities = 39/160 (24%), Positives = 65/160 (40%), Gaps = 3/160 (1%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK-SEMLSRGQVEHVRAERNLLA 161
           I  +  +L   IG G FG+V         N      +K      S    E    E   + 
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63

Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIE 220
           +     IVKL     +   +++IME    G++ + L   + +L       Y  Q   A+ 
Sbjct: 64  QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
            +    ++HRDI   N+L+  N  +KL DFGL + ++ + 
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 4e-31
 Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 7/161 (4%)

Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAER 157
           +I         +IG G FGEV     K S        A+K LK     +  Q      E 
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSV 216
            ++ + + H I++L       + + +I EY+  G +   L  ++   +       +    
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
             ++ +   NY+HRD+   N+L++ N   K+SDFGL + L+
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 5e-31
 Identities = 44/160 (27%), Positives = 79/160 (49%), Gaps = 7/160 (4%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + +  L+ +G GA+G V    + K+G   A+KKL +    S    +    E  LL  +  
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76

Query: 166 HCIVKLYYSFQDAEYL-----YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIE 220
             ++ L   F  A  L       ++ +L G D+  + ++ + LT+   +F I Q +  ++
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
            IH  + IHRD+KP NL ++++  +K+ DFGL +  D   
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-30
 Identities = 37/242 (15%), Positives = 74/242 (30%), Gaps = 49/242 (20%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK--SEMLSRGQVEHVRAERNLL 160
           +   +F  + ++G GAFG V        G    +    K   E  S    + +  E  ++
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIE 220
           A V +  + +L      +    +      G  +  +   ++ +       +  Q    + 
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
            +     +HRD+   N+L+    H+K++DFGL K L                        
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--------------------- 164

Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA 340
                                      +   A        ++A E +L + Y  + D  +
Sbjct: 165 --------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 198

Query: 341 YW 342
           Y 
Sbjct: 199 YG 200

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (287), Expect = 3e-30
 Identities = 43/240 (17%), Positives = 70/240 (29%), Gaps = 51/240 (21%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
           + + L   IG G+FG++ L  +  +G   A+K               +  E  +   +  
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQG 61

Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
              I  + +   + +Y  ++ME L               +         Q +  IE IH 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 225 HNYIHRDIKPDNLLLDQNGHMKL---SDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
            N+IHRD+KPDN L+       L    DFGL K                           
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA---------------------- 159

Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY 341
                               +  Q    +   +  GT  Y +    L        D  + 
Sbjct: 160 --------------------RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 199

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 4e-30
 Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 10/161 (6%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
             +  L  IG GA G V    +       A+KKL +    ++   +    E  L+  V  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75

Query: 166 HCIVKLYYSF------QDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
             I+ L   F      ++ + +YL+ME +       + M           + + Q +  I
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGI 132

Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
           + +H    IHRD+KP N+++  +  +K+ DFGL +    + 
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 7e-30
 Identities = 49/248 (19%), Positives = 90/248 (36%), Gaps = 59/248 (23%)

Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGN-IYAMKKLKKSEMLSRGQVEHVR--AERNLL 160
           +   ++ +  IG GA+G+V   ++ K+G    A+K+++         +  +R  A    L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 161 AEVASHCIVKLYYSFQDAE-----YLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQ 214
                  +V+L+     +       L L+ E++       L    E  +     +  + Q
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
            +  ++ +H H  +HRD+KP N+L+  +G +KL+DFGL +                    
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-------------------- 164

Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
                                           + +    S V T  Y APEVLL+  Y  
Sbjct: 165 ------------------------------IYSFQMALTSVVVTLWYRAPEVLLQSSYAT 194

Query: 335 ECDWLAYW 342
             D  +  
Sbjct: 195 PVDLWSVG 202

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 4e-29
 Identities = 39/251 (15%), Positives = 93/251 (37%), Gaps = 28/251 (11%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
           ++ +   +   +G+G+FG V     K     +     A+K + ++   S  +      E 
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEA 74

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM----------REETLTETV 207
           +++ E   H +V+L       +   +IME +  GD+ + L                + + 
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
                 +    +  ++ + ++HRD+   N ++ ++  +K+ DFG+ + +  T+       
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 268 EVLDDENLNESMDVDGRFPESGCGRRW-----------KSPLEQLQHWQINRRKLAYSTV 316
            +L    ++     DG F        +           + P + L + Q+ R  +    +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254

Query: 317 GTPDYIAPEVL 327
             PD     + 
Sbjct: 255 DKPDNCPDMLF 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-28
 Identities = 41/182 (22%), Positives = 72/182 (39%), Gaps = 26/182 (14%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRA 155
           +  D   L   +G GAFG+V L +               A+K LK     +   +  + +
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLIS 67

Query: 156 ERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR--------------- 199
           E  ++  +  H  I+ L  +      LY+I+EY   G++   L                 
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 200 -EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258
            EE L+         Q    +E +     IHRD+   N+L+ ++  MK++DFGL + +  
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 259 TN 260
            +
Sbjct: 188 ID 189

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 1e-27
 Identities = 40/178 (22%), Positives = 69/178 (38%), Gaps = 25/178 (14%)

Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
              D   L   +GRGAFG+V         +  +    A+K LK+       +   + +E 
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSEL 67

Query: 158 NLLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMTLL----------------MR 199
            +L  +  H  V        +    L +I+E+   G++ T L                + 
Sbjct: 68  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127

Query: 200 EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
           ++ LT      Y  Q    +E +     IHRD+   N+LL +   +K+ DFGL + + 
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 7e-27
 Identities = 35/235 (14%), Positives = 76/235 (32%), Gaps = 52/235 (22%)

Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
           +IGRG FG V    L          A+K L +      G+V     E  ++ + +   ++
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 170 KLY-YSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNY 227
            L     +      +++ Y+  GD+   +       T      +  Q    ++ +    +
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151

Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
           +HRD+   N +LD+   +K++DFGL + +      +++                      
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT------------------- 192

Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW 342
                                            ++A E L  + +  + D  ++ 
Sbjct: 193 --------------------------GAKLPVKWMALESLQTQKFTTKSDVWSFG 221

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 6e-26
 Identities = 36/166 (21%), Positives = 59/166 (35%), Gaps = 17/166 (10%)

Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
               L   IG+G FGEV     K  G   A+K     E     +     AE      +  
Sbjct: 3   RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLRH 56

Query: 166 HCIVKLYYSFQDAE----YLYLIMEYLPGGDVMTLLMREETLTETVARFYIA-------Q 214
             I+    +          L+L+ +Y   G +   L R     E + +  ++        
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116

Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
            +  + +  K    HRD+K  N+L+ +NG   ++D GL    D   
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 83.9 bits (206), Expect = 9e-19
 Identities = 27/160 (16%), Positives = 69/160 (43%), Gaps = 14/160 (8%)

Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-------L 160
           + L+  +G G F  V L ++  +    AMK ++  ++ +    + ++  + +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 161 AEVASHCIVKLYYSFQD--AEYLYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQS 215
             + ++ I+KL   F       ++++M +   G+ +  L+++     +     +    Q 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 216 VLAIESI-HKHNYIHRDIKPDNLLLDQNGHM-KLSDFGLC 253
           +L ++ +  +   IH DIKP+N+L++       L    + 
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 174

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 68.3 bits (166), Expect = 3e-14
 Identities = 21/160 (13%), Positives = 48/160 (30%), Gaps = 28/160 (17%)

Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKS---------------EMLSRGQVEHVRAER 157
           ++G G    V  C   +      +K  K                    S   +   R E 
Sbjct: 7   LMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
             L ++    + K+Y    +     ++ME +   ++  +               +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILE 114

Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
            +   +    +H D+   N+L+ + G   + DF     + 
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	358
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.57
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.11
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.23
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.36
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.33

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=387.66  Aligned_cols=203  Identities=31%  Similarity=0.454  Sum_probs=185.8

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++++.||+|+||+||+|.++.+++.||||++.+...........+.+|+.+++.++|||||++++++.+++.+|
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            34678999999999999999999999999999999998776555566777899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||+++|+|.+++....++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......  
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--  160 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--  160 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence            999999999999999988999999999999999999999999999999999999999999999999999997654211  


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ..+.+||+.|||||++.+.+|+.++||||||
T Consensus       161 -------------------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlG  191 (263)
T d2j4za1         161 -------------------------------------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG  191 (263)
T ss_dssp             -------------------------------------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred             -------------------------------------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHh
Confidence                                                             1144799999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |+||||+++..+|.
T Consensus       192 vilyell~G~~Pf~  205 (263)
T d2j4za1         192 VLCYEFLVGKPPFE  205 (263)
T ss_dssp             HHHHHHHHSSCTTC
T ss_pred             HHHHHHhcCCCCCC
Confidence            99999999987764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=398.68  Aligned_cols=205  Identities=38%  Similarity=0.648  Sum_probs=188.6

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++++.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++.+.+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            56789999999999999999999999999999999999876666667788999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||++||+|.+++.....+++..++.+++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....... 
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999986542211 


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                      ...+.+|||.|||||++.+.+|+.++||||||
T Consensus       161 ------------------------------------------------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlG  192 (337)
T d1o6la_         161 ------------------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG  192 (337)
T ss_dssp             ------------------------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHH
T ss_pred             ------------------------------------------------ccccceeCHHHhhhhhccCCCCChhhcccchh
Confidence                                                            12256899999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|||++|..+|.
T Consensus       193 vilyeml~G~~pf~  206 (337)
T d1o6la_         193 VVMYEMMCGRLPFY  206 (337)
T ss_dssp             HHHHHHHHSSCSSC
T ss_pred             hHHHHHHHCCCCCC
Confidence            99999999987764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=389.88  Aligned_cols=206  Identities=33%  Similarity=0.527  Sum_probs=184.9

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+++.++|||||+++++|.+++.+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            34789999999999999999999999999999999988765566667789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||||++||+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+.+...... 
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~-  164 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-  164 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc-
Confidence            9999999999999998899999999999999999999999999999999999999999999999999999876422111 


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                    ....+.+||+.|||||++.+..|+.++|||||||
T Consensus       165 ----------------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGv  198 (288)
T d1uu3a_         165 ----------------------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGC  198 (288)
T ss_dssp             ---------------------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHH
T ss_pred             ----------------------------------------------cccccccCCccccCceeeccCCCCcccceehhhH
Confidence                                                          1122458999999999999999999999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      +||||+++..+|.
T Consensus       199 ilyell~g~~Pf~  211 (288)
T d1uu3a_         199 IIYQLVAGLPPFR  211 (288)
T ss_dssp             HHHHHHHSSCSSC
T ss_pred             HHHHHhhCCCCCC
Confidence            9999999987764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=387.70  Aligned_cols=203  Identities=27%  Similarity=0.420  Sum_probs=178.2

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++++.||+|+||+||+|.++.+|+.||||++.....  ....+.+.+|+.+++.++|||||++++++.+++.+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            4789999999999999999999999999999999976532  23345688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.....   
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~---  158 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---  158 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---
Confidence            99999999999998888999999999999999999999999999999999999999999999999999987642211   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-CccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-~~~~DiwSlGv  343 (358)
                                                                  .....+.+|||.|||||++.+.+| +.++|||||||
T Consensus       159 --------------------------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGv  194 (271)
T d1nvra_         159 --------------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI  194 (271)
T ss_dssp             --------------------------------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHH
T ss_pred             --------------------------------------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHH
Confidence                                                        111225689999999999998886 57899999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|||+++..+|.
T Consensus       195 ilyeml~G~~pf~  207 (271)
T d1nvra_         195 VLTAMLAGELPWD  207 (271)
T ss_dssp             HHHHHHHSSCSCS
T ss_pred             HHHHHHhCCCCCC
Confidence            9999999988774

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.9e-52  Score=386.88  Aligned_cols=201  Identities=39%  Similarity=0.714  Sum_probs=185.7

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+++.++|||||++++++.+++.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            35789999999999999999999999999999999988765556667889999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      ||||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....    
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----  157 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----  157 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999865421    


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhH
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWN  343 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGv  343 (358)
                                                                      ..+.+|||.|||||++.+.+|+.++|||||||
T Consensus       158 ------------------------------------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGv  189 (316)
T d1fota_         158 ------------------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGI  189 (316)
T ss_dssp             ------------------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHH
T ss_pred             ------------------------------------------------cccccCcccccCHHHHcCCCCCchhhccccch
Confidence                                                            11458999999999999999999999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|||+++..+|.
T Consensus       190 ilyemltG~~Pf~  202 (316)
T d1fota_         190 LIYEMLAGYTPFY  202 (316)
T ss_dssp             HHHHHHHSSCTTC
T ss_pred             hHHHHHhCCCCCC
Confidence            9999999987763

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-53  Score=393.63  Aligned_cols=202  Identities=26%  Similarity=0.370  Sum_probs=181.2

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      ++..++|++++.||+|+||+||+|.++.+|+.||+|+++...  .......+.+|+.+|+.++|||||+++++|.+++.+
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   79 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   79 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            355689999999999999999999999999999999997652  344456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      |+||||++||+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.+..  
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--  157 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--  157 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence            9999999999999999988899999999999999999999997 5999999999999999999999999999975421  


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                                                                       ....+.+||+.|||||++.+..|+.++||||
T Consensus       158 -------------------------------------------------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWS  188 (322)
T d1s9ja_         158 -------------------------------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWS  188 (322)
T ss_dssp             -------------------------------------------------HTC---CCSSCCCCHHHHHCSCCCTTHHHHH
T ss_pred             -------------------------------------------------CccccccCCccccCchHHcCCCCCcHHHHHH
Confidence                                                             1122568999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      +||++|||+++..+|.
T Consensus       189 lGvil~ell~G~~Pf~  204 (322)
T d1s9ja_         189 MGLSLVEMAVGRYPIP  204 (322)
T ss_dssp             HHHHHHHHHHSSCCSS
T ss_pred             HHHHHHHHHHCCCCCC
Confidence            9999999999987763

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=380.77  Aligned_cols=199  Identities=28%  Similarity=0.434  Sum_probs=178.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++++.||+|+||+||+|.+..+|+.||||++.....   ...+.+.+|+.+++.++|||||+++++|.+++.+|+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            4689999999999999999999999999999999986642   2345688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||++||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.....   
T Consensus        96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~---  171 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---  171 (293)
T ss_dssp             EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---
T ss_pred             EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc---
Confidence            999999999998754 5799999999999999999999999999999999999999999999999999987642211   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                    ...+.+|||.|||||++.+.+|+.++|||||||+
T Consensus       172 ----------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  205 (293)
T d1yhwa1         172 ----------------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM  205 (293)
T ss_dssp             ----------------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHH
T ss_pred             ----------------------------------------------cccccccCCCccChhhhcCCCCCchhceehHhHH
Confidence                                                          1124489999999999999999999999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +|||++|..+|.
T Consensus       206 lyemltG~~Pf~  217 (293)
T d1yhwa1         206 AIEMIEGEPPYL  217 (293)
T ss_dssp             HHHHHHSSCTTT
T ss_pred             HHHHhhCCCCCC
Confidence            999999987763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-51  Score=385.06  Aligned_cols=202  Identities=39%  Similarity=0.677  Sum_probs=186.2

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      ...++|++++.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...++
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            34589999999999999999999999999999999998776555666778999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      +||||+.+|+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+...   
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence            99999999999999998899999999999999999999999999999999999999999999999999999876421   


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                                                                       ..+.+|||.|||||++.+.+|+.++||||||
T Consensus       195 -------------------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlG  225 (350)
T d1rdqe_         195 -------------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALG  225 (350)
T ss_dssp             -------------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred             -------------------------------------------------cccccCccccCCHHHHcCCCCCccccccchh
Confidence                                                             1134799999999999999999999999999


Q ss_pred             HHHHhhcccccccc
Q 018275          343 NETLSCNYLSDIML  356 (358)
Q Consensus       343 vil~e~l~~~~~~~  356 (358)
                      |++|||++|..+|.
T Consensus       226 vilyemltG~~Pf~  239 (350)
T d1rdqe_         226 VLIYEMAAGYPPFF  239 (350)
T ss_dssp             HHHHHHHHSSCSSC
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999999988764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=377.07  Aligned_cols=199  Identities=28%  Similarity=0.457  Sum_probs=176.2

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .+.|++++.||+|+||+||+|.++.++..||||++....   ....+.+.+|+.+++.++|||||+++++|.+++.+|+|
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence            367999999999999999999999999999999997652   34455688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcc
Q 018275          185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA  263 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~  263 (358)
                      |||+++|+|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......   
T Consensus        88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---  164 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---  164 (288)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH---
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc---
Confidence            999999999999765 4679999999999999999999999999999999999999999999999999997542110   


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-----CCCCCccchh
Q 018275          264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDW  338 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-----~~~y~~~~Di  338 (358)
                                                                    ....+.+|||.|||||++.     +.+|+.++||
T Consensus       165 ----------------------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~Di  198 (288)
T d2jfla1         165 ----------------------------------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV  198 (288)
T ss_dssp             ----------------------------------------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHH
T ss_pred             ----------------------------------------------ccccccccccccCCHHHHhhcccCCCCCChhhhH
Confidence                                                          0112458999999999994     5678999999


Q ss_pred             hhhhHHHHhhccccccc
Q 018275          339 LAYWNETLSCNYLSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~  355 (358)
                      |||||++|||+++..+|
T Consensus       199 wSlGvilyemltg~~Pf  215 (288)
T d2jfla1         199 WSLGITLIEMAEIEPPH  215 (288)
T ss_dssp             HHHHHHHHHHHHSSCTT
T ss_pred             HHHHHHHHHHhhCCCCC
Confidence            99999999999998766

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-51  Score=380.29  Aligned_cols=197  Identities=26%  Similarity=0.385  Sum_probs=178.6

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ..|+.++.||+|+||+||+|.+..+++.||||++...........+.+.+|+.+++.++|||||+++++|.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35999999999999999999999999999999998765545566677899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      ||+++|+|..++....++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....      
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC------
Confidence            99999999888888889999999999999999999999999999999999999999999999999999764311      


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC---CCCCccchhhhhh
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMECDWLAYW  342 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~---~~y~~~~DiwSlG  342 (358)
                                                                     .+.+|||.|||||++.+   ..|+.++||||||
T Consensus       169 -----------------------------------------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlG  201 (309)
T d1u5ra_         169 -----------------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  201 (309)
T ss_dssp             -----------------------------------------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHH
T ss_pred             -----------------------------------------------CccccCccccCHHHHhccCCCCcCchhhhhhHH
Confidence                                                           13479999999999974   4699999999999


Q ss_pred             HHHHhhccccccc
Q 018275          343 NETLSCNYLSDIM  355 (358)
Q Consensus       343 vil~e~l~~~~~~  355 (358)
                      |++|||+++..+|
T Consensus       202 vilyel~~g~~Pf  214 (309)
T d1u5ra_         202 ITCIELAERKPPL  214 (309)
T ss_dssp             HHHHHHHHSSCTT
T ss_pred             HHHHHHHHCCCCC
Confidence            9999999988765

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-51  Score=381.37  Aligned_cols=200  Identities=30%  Similarity=0.452  Sum_probs=165.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .+.|++.+.||+|+||+||+|.++.+++.||||++.+....  .....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46799999999999999999999999999999999876432  2335578899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc---CCCcEEEEecCCCccCCCCCC
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~---~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+.   .++.+||+|||+|+...... 
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-  164 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-  164 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence            99999999999998888999999999999999999999999999999999999995   57899999999998653211 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                       ...+.+||+.|||||++.+.+|+.++|||||
T Consensus       165 -------------------------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSl  195 (307)
T d1a06a_         165 -------------------------------------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSI  195 (307)
T ss_dssp             ---------------------------------------------------------CTTSCHHHHTTCCCCTHHHHHHH
T ss_pred             -------------------------------------------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhh
Confidence                                                             1124589999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|||+++..+|.
T Consensus       196 Gvilyell~g~~Pf~  210 (307)
T d1a06a_         196 GVIAYILLCGYPPFY  210 (307)
T ss_dssp             HHHHHHHHHSSCSCC
T ss_pred             hHHHHHHHhCCCCCC
Confidence            999999999987763

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=372.85  Aligned_cols=202  Identities=30%  Similarity=0.519  Sum_probs=168.7

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec--CCEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEYLY  182 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~  182 (358)
                      .++|++++.||+|+||+||+|.++.+|+.||||++..... .....+.+.+|+.+++.++|||||++++++.+  .+.+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            3689999999999999999999999999999999987643 44556778999999999999999999999965  45689


Q ss_pred             EEEeecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          183 LIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHN-----YIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-----iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      +||||+++|+|.+++..    ...+++..++.++.|++.||.|||+.+     |+||||||+|||++.++.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999999854    467999999999999999999999876     999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +.+....                                                 ....+.+|||.|||||++.+.+|+
T Consensus       162 ~~~~~~~-------------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~  192 (269)
T d2java1         162 RILNHDT-------------------------------------------------SFAKAFVGTPYYMSPEQMNRMSYN  192 (269)
T ss_dssp             HHC------------------------------------------------------------CCCSCCCHHHHTTCCCC
T ss_pred             eecccCC-------------------------------------------------CccccCCCCcccCCHHHHcCCCCC
Confidence            8764211                                                 011245899999999999999999


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|||||||++|||+++..+|.
T Consensus       193 ~~~DIwSlGvilyel~tg~~Pf~  215 (269)
T d2java1         193 EKSDIWSLGCLLYELCALMPPFT  215 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             hHHHHHhhCHHHHHHhhCCCCCC
Confidence            99999999999999999887663

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.3e-50  Score=383.11  Aligned_cols=202  Identities=32%  Similarity=0.556  Sum_probs=177.6

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHH---HHHHHHhcCcceEEEEEEeecCCE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE---RNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E---~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|   +.+++.++|||||+++++|.+.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            56899999999999999999999999999999999987654433333444445   555666789999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+....
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  161 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999998654221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-CCCCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-~~~y~~~~Diw  339 (358)
                                                                         ....+|||.|||||++. +..|+.++|||
T Consensus       162 ---------------------------------------------------~~~~~GT~~y~APE~~~~~~~~~~~~Diw  190 (364)
T d1omwa3         162 ---------------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWF  190 (364)
T ss_dssp             ---------------------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHH
T ss_pred             ---------------------------------------------------ccccccccccchhHHhhcCCCCCcccchh
Confidence                                                               11347999999999997 46799999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      ||||+||||++|..+|.
T Consensus       191 SlGvilyemltG~~Pf~  207 (364)
T d1omwa3         191 SLGCMLFKLLRGHSPFR  207 (364)
T ss_dssp             HHHHHHHHHHHSSCSSC
T ss_pred             HHHHHHHHHHhCCCCCC
Confidence            99999999999988774

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.3e-50  Score=379.11  Aligned_cols=199  Identities=28%  Similarity=0.430  Sum_probs=178.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++++.||+|+||.||+|.++.+|+.||||++....   ....+.+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999997653   33456688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC--CCcEEEEecCCCccCCCCCC
Q 018275          185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~--~~~vkl~DFGla~~~~~~~~  261 (358)
                      |||++||+|.+++.. .+++++..++.++.||+.||.|||++|||||||||+|||++.  ++.+||+|||+|+.+.....
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            999999999999854 467999999999999999999999999999999999999964  68899999999987642211


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                        ..+.+||+.|||||++.+.+|+.++|||||
T Consensus       182 --------------------------------------------------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSl  211 (350)
T d1koaa2         182 --------------------------------------------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSV  211 (350)
T ss_dssp             --------------------------------------------------EEEECSCTTTCCHHHHHTCCBCHHHHHHHH
T ss_pred             --------------------------------------------------cceecCcccccCHHHHcCCCCChhHhhhhh
Confidence                                                              124589999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|||++|..+|.
T Consensus       212 Gvilyell~G~~Pf~  226 (350)
T d1koaa2         212 GVLSYILLSGLSPFG  226 (350)
T ss_dssp             HHHHHHHHHSSCSSC
T ss_pred             hHHHHHHHhCCCCCC
Confidence            999999999887763

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-50  Score=364.56  Aligned_cols=197  Identities=24%  Similarity=0.406  Sum_probs=173.8

Q ss_pred             CCc-eeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec----CCE
Q 018275          106 DDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----AEY  180 (358)
Q Consensus       106 ~~~-~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~~~  180 (358)
                      ++| ++.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+|+.++|||||+++++|.+    ...
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            344 677899999999999999999999999999987643 34556778999999999999999999999865    467


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEc-CCCcEEEEecCCCccCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--iiHrDikp~NILl~-~~~~vkl~DFGla~~~~  257 (358)
                      +|+||||+++|+|.+++.....+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+|+...
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            8999999999999999988899999999999999999999999998  99999999999996 57999999999997543


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ..                                                   ...+.+|||.|||||++.+ +|+.++|
T Consensus       167 ~~---------------------------------------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~D  194 (270)
T d1t4ha_         167 AS---------------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVD  194 (270)
T ss_dssp             TT---------------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHH
T ss_pred             CC---------------------------------------------------ccCCcccCccccCHHHhCC-CCCCcCc
Confidence            11                                                   1124589999999999876 5999999


Q ss_pred             hhhhhHHHHhhccccccc
Q 018275          338 WLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~  355 (358)
                      ||||||++|||+++..+|
T Consensus       195 IwSlGvilyel~~g~~Pf  212 (270)
T d1t4ha_         195 VYAFGMCMLEMATSEYPY  212 (270)
T ss_dssp             HHHHHHHHHHHHHSSCTT
T ss_pred             hhhHHHHHHHHHHCCCCC
Confidence            999999999999998776

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-50  Score=372.72  Aligned_cols=202  Identities=34%  Similarity=0.613  Sum_probs=181.3

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHH-HhcCcceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA-EVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      ++|.+++.||+|+||+||+|.++.+++.||||++++.........+.+..|..++. .++|||||+++++|.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999999999999999998776555556666777777665 68999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      |||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........  
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~--  159 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--  159 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC--
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc--
Confidence            999999999999998899999999999999999999999999999999999999999999999999999865422110  


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNE  344 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvi  344 (358)
                                                                     ....+||+.|+|||++.+.+|+.++|||||||+
T Consensus       160 -----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  192 (320)
T d1xjda_         160 -----------------------------------------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVL  192 (320)
T ss_dssp             -----------------------------------------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred             -----------------------------------------------ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHH
Confidence                                                           113479999999999999999999999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +|||++|..+|.
T Consensus       193 lyemltG~~PF~  204 (320)
T d1xjda_         193 LYEMLIGQSPFH  204 (320)
T ss_dssp             HHHHHHSSCSSC
T ss_pred             HHHHHhCCCCCC
Confidence            999999987763

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=367.71  Aligned_cols=202  Identities=29%  Similarity=0.444  Sum_probs=180.8

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc---hhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS---RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~  181 (358)
                      .++|++++.||+|+||+||+|.++.+|+.||||++.+.....   ....+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999999999999999997654322   23456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC----cEEEEecCCCccCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLD  257 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~----~vkl~DFGla~~~~  257 (358)
                      |+||||++||+|.+++...+.+++..++.++.|++.||.|||+.+|+||||||+|||++.++    .+||+|||+|+...
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            99999999999999998888999999999999999999999999999999999999998876    59999999998764


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ....                                                  ..+.+||+.|||||++.+..|+.++|
T Consensus       169 ~~~~--------------------------------------------------~~~~~~t~~y~APE~~~~~~~~~~~D  198 (293)
T d1jksa_         169 FGNE--------------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEAD  198 (293)
T ss_dssp             TSCB--------------------------------------------------CSCCCCCGGGCCHHHHTTCCBCTHHH
T ss_pred             CCcc--------------------------------------------------ccccCCCCcccCHHHHcCCCCCCccc
Confidence            2211                                                  11347999999999999999999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|||+++..+|.
T Consensus       199 iwSlGvilyell~g~~Pf~  217 (293)
T d1jksa_         199 MWSIGVITYILLSGASPFL  217 (293)
T ss_dssp             HHHHHHHHHHHHHSSCSSC
T ss_pred             chhhhHHHHHHHcCCCCCC
Confidence            9999999999999987764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-49  Score=376.20  Aligned_cols=199  Identities=26%  Similarity=0.436  Sum_probs=178.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|++++.||+|+||.||+|.+..+|+.||||++....   ......+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367999999999999999999999999999999997653   23345688899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEc--CCCcEEEEecCCCccCCCCCC
Q 018275          185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--QNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~--~~~~vkl~DFGla~~~~~~~~  261 (358)
                      |||++||+|.+.+... .++++..++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            9999999999887654 4799999999999999999999999999999999999998  57899999999998765321 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                       ...+.+||+.|||||++.+.+|+.++|||||
T Consensus       184 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  214 (352)
T d1koba_         184 -------------------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAI  214 (352)
T ss_dssp             -------------------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred             -------------------------------------------------ceeeccCcccccCHHHHcCCCCCCccchHHH
Confidence                                                             1124579999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|||+++..+|.
T Consensus       215 GvilyelltG~~Pf~  229 (352)
T d1koba_         215 GVLGYVLLSGLSPFA  229 (352)
T ss_dssp             HHHHHHHHHSCCSSC
T ss_pred             HHHHHHHHhCCCCCC
Confidence            999999999987763

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-50  Score=371.00  Aligned_cols=205  Identities=23%  Similarity=0.328  Sum_probs=181.0

Q ss_pred             hhccCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275           98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus        98 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      +..+++..++|++.+.||+|+||+||+|.++.+++.||||+++...    ...+.+.+|+.+++.++|||||+++++|.+
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   84 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence            3446777889999999999999999999999999999999997653    234568899999999999999999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      .+.+|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence            99999999999999999999654  5789999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      ........                                                ..+..||+.|||||++.+..|+.+
T Consensus       165 ~~~~~~~~------------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~k  196 (287)
T d1opja_         165 MTGDTYTA------------------------------------------------HAGAKFPIKWTAPESLAYNKFSIK  196 (287)
T ss_dssp             CCSSSSEE------------------------------------------------ETTEEECGGGCCHHHHHHCCCSHH
T ss_pred             cCCCCcee------------------------------------------------eccccccccccChHHHcCCCCCch
Confidence            64322110                                                113468999999999999999999


Q ss_pred             chhhhhhHHHHhhcccccc
Q 018275          336 CDWLAYWNETLSCNYLSDI  354 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~  354 (358)
                      +|||||||++|||+++...
T Consensus       197 ~DiwS~Gv~l~ell~~~~p  215 (287)
T d1opja_         197 SDVWAFGVLLWEIATYGMS  215 (287)
T ss_dssp             HHHHHHHHHHHHHHTTSCC
T ss_pred             hhhhhHHHHHHHHHhCCCC
Confidence            9999999999999986554

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.6e-49  Score=361.40  Aligned_cols=206  Identities=23%  Similarity=0.315  Sum_probs=176.3

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC----E
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----Y  180 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~----~  180 (358)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++++...........+.+|+.+++.++|||||++++++.+.+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            377999999999999999999999999999999998776555666778999999999999999999999997543    4


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|+||||++|++|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.++......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            89999999999999999888999999999999999999999999999999999999999999999999999987654221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      ..                                              .....+.+||+.|||||++.+..|+.++||||
T Consensus       166 ~~----------------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwS  199 (277)
T d1o6ya_         166 NS----------------------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYS  199 (277)
T ss_dssp             -----------------------------------------------------------TTCCHHHHTTCCCCHHHHHHH
T ss_pred             cc----------------------------------------------ccccccccCcccccCHHHHcCCCCCcceeccc
Confidence            10                                              11123568999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       200 lGvilyelltG~~Pf~  215 (277)
T d1o6ya_         200 LGCVLYEVLTGEPPFT  215 (277)
T ss_dssp             HHHHHHHHHHSSCSCC
T ss_pred             chHHHHHHHhCCCCCC
Confidence            9999999999987764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=361.46  Aligned_cols=203  Identities=20%  Similarity=0.206  Sum_probs=170.7

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      +++..++|.+.+.||+|+||+||+|...   ..||||+++.... .....+.+.+|+.+++.++|||||++++++.+ +.
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~   77 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ   77 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence            4677899999999999999999999643   3699999976543 44567789999999999999999999998764 56


Q ss_pred             EEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      +++||||+++|+|.+++... .++++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+.....
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            89999999999999999654 57999999999999999999999999999999999999999999999999999866422


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC---CCCCccc
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMEC  336 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~---~~y~~~~  336 (358)
                      ...                                               ....+.+||+.|||||++.+   .+|+.++
T Consensus       158 ~~~-----------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~s  190 (276)
T d1uwha_         158 SGS-----------------------------------------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQS  190 (276)
T ss_dssp             -------------------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHH
T ss_pred             CCc-----------------------------------------------ccccccccCcccCCHHHHhcccCCCCCchh
Confidence            110                                               01124579999999999974   3589999


Q ss_pred             hhhhhhHHHHhhccccccc
Q 018275          337 DWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       337 DiwSlGvil~e~l~~~~~~  355 (358)
                      |||||||+||||+++..+|
T Consensus       191 DiwS~Gv~l~el~tg~~Pf  209 (276)
T d1uwha_         191 DVYAFGIVLYELMTGQLPY  209 (276)
T ss_dssp             HHHHHHHHHHHHHHSSCTT
T ss_pred             hhhhhHHHHHHHHHCCCCC
Confidence            9999999999999987765

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=355.77  Aligned_cols=198  Identities=19%  Similarity=0.245  Sum_probs=164.6

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEE
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY  182 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~  182 (358)
                      +..++|++++.||+|+||+||+|.+. ++..||||+++...    ...+.+.+|+.+++.++|||||+++++|.+++.++
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            34679999999999999999999875 56789999997643    22356889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCC
Q 018275          183 LIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       183 lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~  261 (358)
                      +||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus        77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999999999998655 5688999999999999999999999999999999999999999999999999986642211


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                      .                                                ......||+.|||||++.+..|+.++|||||
T Consensus       157 ~------------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~  188 (263)
T d1sm2a_         157 T------------------------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSF  188 (263)
T ss_dssp             --------------------------------------------------------CTTSCCHHHHTTCCCCHHHHHHHH
T ss_pred             e------------------------------------------------eecceecCcccCChHHhcCCCCCchhhhcch
Confidence            1                                                0113479999999999999999999999999


Q ss_pred             hHHHHhhccccc
Q 018275          342 WNETLSCNYLSD  353 (358)
Q Consensus       342 Gvil~e~l~~~~  353 (358)
                      ||++|||+++..
T Consensus       189 Gvil~el~t~~~  200 (263)
T d1sm2a_         189 GVLMWEVFSEGK  200 (263)
T ss_dssp             HHHHHHHHTTSC
T ss_pred             HHHHHHHHHCCC
Confidence            999999998543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.2e-49  Score=362.92  Aligned_cols=208  Identities=21%  Similarity=0.277  Sum_probs=166.3

Q ss_pred             CccCCCceeeeeEeeeeeEEEEEEEEecCCC---EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC
Q 018275          102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA  178 (358)
Q Consensus       102 ~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~  178 (358)
                      ++..++|++.+.||+|+||+||+|.++.+++   .||||.+....  .....+.+.+|+.+|+.++|||||+++++|.+.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            4666889999999999999999999877664   58999887543  344566789999999999999999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      +.+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+.
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999999999988764 578999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ........                                            .......||+.|||||++.+..|+.++|
T Consensus       180 ~~~~~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~sD  215 (299)
T d1jpaa_         180 DDTSDPTY--------------------------------------------TSALGGKIPIRWTAPEAIQYRKFTSASD  215 (299)
T ss_dssp             ------------------------------------------------------------CGGGSCHHHHHSCCCCHHHH
T ss_pred             CCCCccee--------------------------------------------eecccccCCccccCHHHHhcCCCCcccc
Confidence            32211100                                            0011236899999999999999999999


Q ss_pred             hhhhhHHHHhhcc-ccccc
Q 018275          338 WLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       338 iwSlGvil~e~l~-~~~~~  355 (358)
                      ||||||+||||++ +..+|
T Consensus       216 vwS~Gvvl~el~t~g~~Pf  234 (299)
T d1jpaa_         216 VWSYGIVMWEVMSYGERPY  234 (299)
T ss_dssp             HHHHHHHHHHHHTTSCCTT
T ss_pred             cccchHHHHHHHhCCCCCC
Confidence            9999999999996 55544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=365.68  Aligned_cols=206  Identities=21%  Similarity=0.292  Sum_probs=173.6

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCC-----EEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN-----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~  174 (358)
                      +++..++|++.+.||+|+||+||+|.+..+++     .||+|.+....  .......+.+|+.++..+ +|||||+++++
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~  109 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA  109 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence            45677899999999999999999999876554     69999987553  233445688999999998 89999999999


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMRE-----------------------ETLTETVARFYIAQSVLAIESIHKHNYIHRD  231 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrD  231 (358)
                      |.+.+.+|+||||+++|+|.+++...                       ..+++..+..++.|++.||.|||+++|||||
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD  189 (325)
T d1rjba_         110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  189 (325)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            99999999999999999999999653                       2478899999999999999999999999999


Q ss_pred             CCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccc
Q 018275          232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL  311 (358)
Q Consensus       232 ikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (358)
                      |||+|||++.++.+||+|||+|+........                                               ..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-----------------------------------------------~~  222 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-----------------------------------------------VV  222 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-----------------------------------------------EE
T ss_pred             CchhccccccCCeEEEeeccccccccCCCce-----------------------------------------------ee
Confidence            9999999999999999999999865422111                                               11


Q ss_pred             cccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          312 AYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       312 ~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ..+.+||+.|||||++.+..|+.++|||||||+||||+. +..+|
T Consensus       223 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         223 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             eccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            124578999999999999999999999999999999996 66655

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.2e-48  Score=353.60  Aligned_cols=200  Identities=29%  Similarity=0.463  Sum_probs=177.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhc------hhhHHHHHHHHHHHHHhc-CcceEEEEEEeecC
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS------RGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDA  178 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~  178 (358)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.+.....      ....+.+.+|+.+++.++ |||||+++++|.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            78999999999999999999999999999999997654221      223456888999999997 99999999999999


Q ss_pred             CEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      +.+||||||++||+|.+++..++++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  162 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  162 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999987642


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC------CCC
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK------KGY  332 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~------~~y  332 (358)
                      ...                                                  ....+||+.|+|||++.+      ..|
T Consensus       163 ~~~--------------------------------------------------~~~~~gt~~y~~PE~~~~~~~~~~~~~  192 (277)
T d1phka_         163 GEK--------------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGY  192 (277)
T ss_dssp             TCC--------------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCB
T ss_pred             CCc--------------------------------------------------eeeeeccCCCCCHHHhhccccccCCCC
Confidence            211                                                  113479999999999963      457


Q ss_pred             CccchhhhhhHHHHhhccccccc
Q 018275          333 GMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       333 ~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      +.++||||+||++|||+++..+|
T Consensus       193 ~~~~DiwslGvilyeml~g~~Pf  215 (277)
T d1phka_         193 GKEVDMWSTGVIMYTLLAGSPPF  215 (277)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CchheEcccchhhhhhccCCCCC
Confidence            88999999999999999988766

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=361.81  Aligned_cols=198  Identities=25%  Similarity=0.352  Sum_probs=177.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV  184 (358)
                      .++|.+++.||+|+||+||+|.++.+++.||||+++...    .....+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999998653    2234578999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC--CcEEEEecCCCccCCCCCC
Q 018275          185 MEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPLDCTNL  261 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~--~~vkl~DFGla~~~~~~~~  261 (358)
                      |||++||+|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+++...... 
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            99999999999997664 79999999999999999999999999999999999999854  589999999998654221 


Q ss_pred             cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhh
Q 018275          262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAY  341 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSl  341 (358)
                                                                       ...+.+|||.|+|||++.+..|+.++|||||
T Consensus       159 -------------------------------------------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSl  189 (321)
T d1tkia_         159 -------------------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSL  189 (321)
T ss_dssp             -------------------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred             -------------------------------------------------cccccccccccccchhccCCCCCchhhcccH
Confidence                                                             1124579999999999999999999999999


Q ss_pred             hHHHHhhcccccccc
Q 018275          342 WNETLSCNYLSDIML  356 (358)
Q Consensus       342 Gvil~e~l~~~~~~~  356 (358)
                      ||++|+|+++..+|.
T Consensus       190 Gvily~ll~G~~Pf~  204 (321)
T d1tkia_         190 GTLVYVLLSGINPFL  204 (321)
T ss_dssp             HHHHHHHHHSSCTTC
T ss_pred             HHHHHHHHhCCCCCC
Confidence            999999999987764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=355.91  Aligned_cols=200  Identities=24%  Similarity=0.353  Sum_probs=172.1

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      +++..++|++.+.||+|+||.||+|.++ ++..||||+++...    ...+.+.+|+.+++.++|||||++++++.+ +.
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~   81 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence            4567789999999999999999999864 57789999997643    233568999999999999999999998865 55


Q ss_pred             EEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      +|+||||+++|+|.+++...  .++++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence            79999999999999987543  3689999999999999999999999999999999999999999999999999987642


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ....                                                ...+..||+.|||||++.+..|+.++||
T Consensus       162 ~~~~------------------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~sDv  193 (272)
T d1qpca_         162 NEYT------------------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDV  193 (272)
T ss_dssp             SCEE------------------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHH
T ss_pred             Cccc------------------------------------------------cccccCCcccccChHHHhCCCCCchhhh
Confidence            2110                                                0113479999999999999999999999


Q ss_pred             hhhhHHHHhhcccccc
Q 018275          339 LAYWNETLSCNYLSDI  354 (358)
Q Consensus       339 wSlGvil~e~l~~~~~  354 (358)
                      |||||++|||+++..+
T Consensus       194 wS~Gvvl~ellt~~~~  209 (272)
T d1qpca_         194 WSFGILLTEIVTHGRI  209 (272)
T ss_dssp             HHHHHHHHHHHTTTCC
T ss_pred             hhhHHHHHHHHhCCCC
Confidence            9999999999986543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=360.14  Aligned_cols=198  Identities=29%  Similarity=0.414  Sum_probs=168.6

Q ss_pred             eeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhch--hhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEee
Q 018275          110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR--GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY  187 (358)
Q Consensus       110 ~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~  187 (358)
                      .++.||+|+||+||+|.++.+|+.||||+++.......  .....+.+|+.+++.++|||||+++++|.+.+++|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            46899999999999999999999999999976543211  1234588999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccc
Q 018275          188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN  267 (358)
Q Consensus       188 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  267 (358)
                      ++++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........     
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-----  156 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-----  156 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-----
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc-----
Confidence            998888877777788999999999999999999999999999999999999999999999999999866432211     


Q ss_pred             cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCccchhhhhhHHHH
Q 018275          268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWLAYWNETL  346 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~~~DiwSlGvil~  346 (358)
                                                                  ..+.+||+.|||||++.+ ..|+.++|||||||++|
T Consensus       157 --------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  192 (299)
T d1ua2a_         157 --------------------------------------------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA  192 (299)
T ss_dssp             --------------------------------------------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHH
T ss_pred             --------------------------------------------ccceecChhhccHHHHccCCCCChhhhhhhcchHHH
Confidence                                                        124589999999999975 56899999999999999


Q ss_pred             hhcccccccc
Q 018275          347 SCNYLSDIML  356 (358)
Q Consensus       347 e~l~~~~~~~  356 (358)
                      ||+++..+|.
T Consensus       193 el~~g~~pf~  202 (299)
T d1ua2a_         193 ELLLRVPFLP  202 (299)
T ss_dssp             HHHHSSCSSC
T ss_pred             HHHhCcCCCC
Confidence            9999987764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-48  Score=363.28  Aligned_cols=194  Identities=28%  Similarity=0.424  Sum_probs=169.2

Q ss_pred             CCCceeee-eEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeec----C
Q 018275          105 VDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD----A  178 (358)
Q Consensus       105 ~~~~~~~~-~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~----~  178 (358)
                      .++|.++. .||+|+||+||+|.+..+++.||||+++...        .+.+|+.++.++ +|||||+++++|.+    .
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            57899875 5999999999999999999999999986532        366788887654 89999999999975    4


Q ss_pred             CEEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---CCcEEEEecCCC
Q 018275          179 EYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLC  253 (358)
Q Consensus       179 ~~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~vkl~DFGla  253 (358)
                      ..+|+|||||+||+|.+++...  .++++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence            6799999999999999999764  47999999999999999999999999999999999999986   567999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCC
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG  333 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~  333 (358)
                      +.......                                                  ..+.+|||.|||||++.+..|+
T Consensus       162 ~~~~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~y~  191 (335)
T d2ozaa1         162 KETTSHNS--------------------------------------------------LTTPCYTPYYVAPEVLGPEKYD  191 (335)
T ss_dssp             EECCCCCC--------------------------------------------------CCCCSCCCSSCCCCCCCGGGGS
T ss_pred             eeccCCCc--------------------------------------------------cccccCCcccCCcHHHcCCCCC
Confidence            86642211                                                  1145799999999999999999


Q ss_pred             ccchhhhhhHHHHhhcccccccc
Q 018275          334 MECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       334 ~~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      .++|||||||+||+|+++..+|.
T Consensus       192 ~~~DiwSlGvily~lltg~~Pf~  214 (335)
T d2ozaa1         192 KSCDMWSLGVIMYILLCGYPPFY  214 (335)
T ss_dssp             HHHHHHHHHHHHHHHTTSSCSCE
T ss_pred             HHHHHHhhchhHHHHhhCCCCCC
Confidence            99999999999999999987763

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-48  Score=353.14  Aligned_cols=206  Identities=21%  Similarity=0.262  Sum_probs=170.3

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCC----CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSG----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ  176 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~  176 (358)
                      .++..++|++.+.||+|+||.||+|.++.++    ..||||++....  .......+.+|+.+++.++|||||+++++|.
T Consensus         2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            3567789999999999999999999887654    479999987543  3444566889999999999999999999999


Q ss_pred             cCCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          177 DAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       177 ~~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                      +.+.+++||||+.++++.+.+... ..+++..+..++.|++.||.|||+.+|+||||||+||||+.++.+||+|||+|+.
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999999999988655 6799999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCcc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME  335 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~  335 (358)
                      +........                                              ......||+.|||||++.+..|+.+
T Consensus       160 ~~~~~~~~~----------------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~  193 (283)
T d1mqba_         160 LEDDPEATY----------------------------------------------TTSGGKIPIRWTAPEAISYRKFTSA  193 (283)
T ss_dssp             ------------------------------------------------------------CCCGGGSCHHHHHSCCCCHH
T ss_pred             ccCCCccce----------------------------------------------EeccCCCCccccCHHHHccCCCCCc
Confidence            642211100                                              0113468999999999999999999


Q ss_pred             chhhhhhHHHHhhcccccc
Q 018275          336 CDWLAYWNETLSCNYLSDI  354 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~  354 (358)
                      +|||||||++|||+++...
T Consensus       194 sDI~S~Gvil~el~t~~~~  212 (283)
T d1mqba_         194 SDVWSFGIVMWEVMTYGER  212 (283)
T ss_dssp             HHHHHHHHHHHHHHTTSCC
T ss_pred             ccccccHHHHHHHHhCCCC
Confidence            9999999999999986544

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-48  Score=353.53  Aligned_cols=204  Identities=23%  Similarity=0.318  Sum_probs=172.5

Q ss_pred             ccCCCceeeee-EeeeeeEEEEEEEEec--CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLTI-IGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~~-IG~G~fG~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~  179 (358)
                      +..++|.+... ||+|+||+||+|.++.  ++..||||+++...  .....+.+.+|+.+|+.++|||||++++++.++ 
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-   81 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-   81 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence            34567888885 9999999999998754  45579999997653  345567799999999999999999999999754 


Q ss_pred             EEEEEEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      .+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            58999999999999999765 46799999999999999999999999999999999999999999999999999987753


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ......                                              .....+||+.|||||++.+..|+.++||
T Consensus       162 ~~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV  195 (285)
T d1u59a_         162 DDSYYT----------------------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDV  195 (285)
T ss_dssp             CSCEEC----------------------------------------------CCCSSCCCGGGCCHHHHHHCEECHHHHH
T ss_pred             cccccc----------------------------------------------cccccccCccccChHHHhCCCCCccchh
Confidence            221110                                              0113469999999999999999999999


Q ss_pred             hhhhHHHHhhcc-ccccc
Q 018275          339 LAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       339 wSlGvil~e~l~-~~~~~  355 (358)
                      |||||++|||++ +..+|
T Consensus       196 wS~Gv~l~E~lt~G~~Pf  213 (285)
T d1u59a_         196 WSYGVTMWEALSYGQKPY  213 (285)
T ss_dssp             HHHHHHHHHHHTTSCCTT
T ss_pred             hcchHHHHHHHhCCCCCC
Confidence            999999999997 56554

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=351.25  Aligned_cols=196  Identities=20%  Similarity=0.242  Sum_probs=165.5

Q ss_pred             eeEeeeeeEEEEEEEEec--CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEEeecC
Q 018275          112 TIIGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP  189 (358)
Q Consensus       112 ~~IG~G~fG~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~E~~~  189 (358)
                      +.||+|+||+||+|.+..  +++.||||+++.... .....+.+.+|+.++++++|||||+++++|.++ ..||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            479999999999998654  457899999976542 445567799999999999999999999999754 5789999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccc
Q 018275          190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV  269 (358)
Q Consensus       190 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  269 (358)
                      +|+|.+++....++++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+.+.......      
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~------  164 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------  164 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE------
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc------
Confidence            99999999988999999999999999999999999999999999999999999999999999998764322111      


Q ss_pred             cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhc
Q 018275          270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCN  349 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l  349 (358)
                                                              .......||+.|||||++.+..|+.++|||||||++|||+
T Consensus       165 ----------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell  204 (277)
T d1xbba_         165 ----------------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF  204 (277)
T ss_dssp             ----------------------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             ----------------------------------------ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence                                                    0111347999999999999999999999999999999998


Q ss_pred             c-ccccc
Q 018275          350 Y-LSDIM  355 (358)
Q Consensus       350 ~-~~~~~  355 (358)
                      . +..+|
T Consensus       205 t~g~~Pf  211 (277)
T d1xbba_         205 SYGQKPY  211 (277)
T ss_dssp             TTTCCSS
T ss_pred             hCCCCCC
Confidence            6 56554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=350.86  Aligned_cols=200  Identities=26%  Similarity=0.318  Sum_probs=173.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchh---hHHHHHHHHHHHHHhc--CcceEEEEEEeecCCE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG---QVEHVRAERNLLAEVA--SHCIVKLYYSFQDAEY  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~~E~~il~~l~--h~~iv~l~~~~~~~~~  180 (358)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.+.......   ....+.+|+.+++.++  |||||+++++|.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            6899999999999999999999999999999999875432211   1123567999999997  8999999999999999


Q ss_pred             EEEEEeecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCC-CcEEEEecCCCccCCC
Q 018275          181 LYLIMEYLPG-GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 ~~lV~E~~~~-g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~-~~vkl~DFGla~~~~~  258 (358)
                      .|+||||+.+ +++.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999976 6888888888899999999999999999999999999999999999999855 7999999999976532


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-Cccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-~~~~D  337 (358)
                      ..                                                   ..+.+||+.|||||++.+..| +.++|
T Consensus       164 ~~---------------------------------------------------~~~~~GT~~y~aPE~~~~~~~~~~~~D  192 (273)
T d1xwsa_         164 TV---------------------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAA  192 (273)
T ss_dssp             SC---------------------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHH
T ss_pred             cc---------------------------------------------------ccccccCCCcCCHHHHcCCCCCCcccc
Confidence            11                                                   114579999999999987765 57799


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|||+++..+|.
T Consensus       193 iwSlGvilyell~g~~Pf~  211 (273)
T d1xwsa_         193 VWSLGILLYDMVCGDIPFE  211 (273)
T ss_dssp             HHHHHHHHHHHHHSSCSCC
T ss_pred             cccceeeehhHhhCCCCCC
Confidence            9999999999999987764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=343.15  Aligned_cols=199  Identities=20%  Similarity=0.316  Sum_probs=173.8

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l  183 (358)
                      ..++|++++.||+|+||+||+|.+ .+++.||||++++...    ..+.+.+|+.+++.++|||||+++++|.+++.+++
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            458999999999999999999997 4778999999986532    23458899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCc
Q 018275          184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS  262 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~  262 (358)
                      ||||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+.+......
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999999999999755 467899999999999999999999999999999999999999999999999999866432211


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhh
Q 018275          263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYW  342 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlG  342 (358)
                      .                                                .....||+.|+|||++.+..|+.++||||||
T Consensus       157 ~------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G  188 (258)
T d1k2pa_         157 S------------------------------------------------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG  188 (258)
T ss_dssp             C------------------------------------------------CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             e------------------------------------------------ecccCCCCCcCCcHHhcCCCCCcceeecccc
Confidence            1                                                1123699999999999999999999999999


Q ss_pred             HHHHhhcc-ccccc
Q 018275          343 NETLSCNY-LSDIM  355 (358)
Q Consensus       343 vil~e~l~-~~~~~  355 (358)
                      |++|||++ +..+|
T Consensus       189 ~~l~el~t~g~~Pf  202 (258)
T d1k2pa_         189 VLMWEIYSLGKMPY  202 (258)
T ss_dssp             HHHHHHHTTSCCTT
T ss_pred             hhhHhHHhcCCCCC
Confidence            99999997 45544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-47  Score=349.86  Aligned_cols=201  Identities=27%  Similarity=0.378  Sum_probs=170.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||+||+|.+..+|+.||||+++.... .......+.+|+.+++.++|||||+++++|.+...+|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            689999999999999999999999999999999976532 3334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCccc
Q 018275          186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI  264 (358)
Q Consensus       186 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  264 (358)
                      ||+.++.+...... ...+++..++.++.|++.||.|||++|||||||||+|||++.++.+||+|||+|+.......   
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~---  157 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---  157 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB---
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc---
Confidence            99976444433333 45799999999999999999999999999999999999999999999999999976532211   


Q ss_pred             ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCC-CccchhhhhhH
Q 018275          265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWLAYWN  343 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y-~~~~DiwSlGv  343 (358)
                                                                    .....+||+.|+|||++....+ +.++|+|||||
T Consensus       158 ----------------------------------------------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGv  191 (298)
T d1gz8a_         158 ----------------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC  191 (298)
T ss_dssp             ----------------------------------------------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             ----------------------------------------------cceeecccceeeehhhhccccCCCccccccccch
Confidence                                                          1123479999999999988775 78999999999


Q ss_pred             HHHhhcccccccc
Q 018275          344 ETLSCNYLSDIML  356 (358)
Q Consensus       344 il~e~l~~~~~~~  356 (358)
                      ++|+|++|..+|.
T Consensus       192 ily~m~~G~~Pf~  204 (298)
T d1gz8a_         192 IFAEMVTRRALFP  204 (298)
T ss_dssp             HHHHHHHSSCSCC
T ss_pred             hhhHHhhCCCCCC
Confidence            9999999987764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-47  Score=344.75  Aligned_cols=205  Identities=22%  Similarity=0.258  Sum_probs=165.5

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecC---CCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD  177 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~  177 (358)
                      +++..++|++.+.||+|+||.||+|.+..+   +..||||.++...  .....+.+.+|+.+++.++|||||+++++|.+
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~   79 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE   79 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            356678999999999999999999988654   3568999886543  34556779999999999999999999999964


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL  256 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~  256 (358)
                       +.+|+||||+++|+|.+++... .++++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus        80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence             5789999999999999987654 57899999999999999999999999999999999999999999999999999866


Q ss_pred             CCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccc
Q 018275          257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC  336 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~  336 (358)
                      ......                                                .....+||+.|+|||++.+..|+.++
T Consensus       159 ~~~~~~------------------------------------------------~~~~~~gt~~y~apE~l~~~~~~~~~  190 (273)
T d1mp8a_         159 EDSTYY------------------------------------------------KASKGKLPIKWMAPESINFRRFTSAS  190 (273)
T ss_dssp             ------------------------------------------------------------CCGGGCCHHHHHHCCCSHHH
T ss_pred             cCCcce------------------------------------------------eccceecCcccchhhHhccCCCCCcc
Confidence            422110                                                11134689999999999999999999


Q ss_pred             hhhhhhHHHHhhcc-cccccc
Q 018275          337 DWLAYWNETLSCNY-LSDIML  356 (358)
Q Consensus       337 DiwSlGvil~e~l~-~~~~~~  356 (358)
                      |||||||++|||++ +..+|.
T Consensus       191 DiwSlGvil~e~lt~g~~P~~  211 (273)
T d1mp8a_         191 DVWMFGVCMWEILMHGVKPFQ  211 (273)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccchHHHHHHHhcCCCCCC
Confidence            99999999999987 555543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=348.86  Aligned_cols=201  Identities=21%  Similarity=0.287  Sum_probs=166.1

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCC----EEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      .++|++++.||+|+||+||+|.+..+|+    .||+|.++...  .....+.+.+|+.+++.++|||||+++++|.++ .
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            3679999999999999999999887776    58888876543  344566789999999999999999999999875 4


Q ss_pred             EEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+++|||+.+|+|.+.+... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            67889999999999888664 67999999999999999999999999999999999999999999999999999876532


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      ....                                               .....+||+.|||||++.++.|+.++|||
T Consensus       165 ~~~~-----------------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~sDvw  197 (317)
T d1xkka_         165 EKEY-----------------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVW  197 (317)
T ss_dssp             CC-------------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHH
T ss_pred             cccc-----------------------------------------------cccccccCccccChHHHhcCCCChhhhhh
Confidence            2110                                               11234699999999999999999999999


Q ss_pred             hhhHHHHhhcc-ccccc
Q 018275          340 AYWNETLSCNY-LSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~-~~~~~  355 (358)
                      ||||++|||++ +..+|
T Consensus       198 S~Gvil~el~t~g~~p~  214 (317)
T d1xkka_         198 SYGVTVWELMTFGSKPY  214 (317)
T ss_dssp             HHHHHHHHHHTTSCCTT
T ss_pred             hHHHHHHHHHHCCCCCC
Confidence            99999999997 45444

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=346.07  Aligned_cols=203  Identities=23%  Similarity=0.295  Sum_probs=162.4

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~  174 (358)
                      +++..++|++.+.||+|+||.||+|.+..     +++.||||+++...  .......+..|..++.++ +|+|||.++++
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            45667899999999999999999999764     34689999997653  334455677788887777 67899999998


Q ss_pred             eec-CCEEEEEEeecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 018275          175 FQD-AEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL  237 (358)
Q Consensus       175 ~~~-~~~~~lV~E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NI  237 (358)
                      +.. ...+++||||+++|+|.+++...                ..+++..+..++.||+.||.|||+++||||||||+||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI  165 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  165 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence            765 45689999999999999999643                2488999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccC
Q 018275          238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG  317 (358)
Q Consensus       238 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~g  317 (358)
                      ||+.++.+||+|||+|+.........                                               ...+.+|
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~-----------------------------------------------~~~~~~g  198 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYV-----------------------------------------------RKGDARL  198 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSC-----------------------------------------------CTTSCCC
T ss_pred             eECCCCcEEEccCcchhhcccccccc-----------------------------------------------ccCceee
Confidence            99999999999999998654322111                                               1124579


Q ss_pred             CCCCchhhhhcCCCCCccchhhhhhHHHHhhcccc
Q 018275          318 TPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       318 t~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~  352 (358)
                      |+.|||||++.+..|+.++|||||||++|||+.+.
T Consensus       199 t~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~  233 (299)
T d1ywna1         199 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG  233 (299)
T ss_dssp             GGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CccccchhHhhcCCCCcccceeehHHHHHHHHhCC
Confidence            99999999999999999999999999999999754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-46  Score=347.53  Aligned_cols=206  Identities=23%  Similarity=0.307  Sum_probs=176.7

Q ss_pred             hhccCccCCCceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEE
Q 018275           98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY  172 (358)
Q Consensus        98 ~~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~  172 (358)
                      +...+++.++|++++.||+|+||+||+|.++.     ++..||||++....  .......+.+|+.+++.++||||++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~   82 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLL   82 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccce
Confidence            34456677899999999999999999998763     56789999997653  344566789999999999999999999


Q ss_pred             EEeecCCEEEEEEeecCCCCHHHHHhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 018275          173 YSFQDAEYLYLIMEYLPGGDVMTLLMREE------------------------TLTETVARFYIAQSVLAIESIHKHNYI  228 (358)
Q Consensus       173 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~------------------------~~~~~~~~~~~~qi~~aL~~LH~~~ii  228 (358)
                      ++|.+.+..++||||+++|+|.+++....                        .++...+..++.|++.||+|||+++||
T Consensus        83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv  162 (301)
T d1lufa_          83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV  162 (301)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence            99999999999999999999999986432                        378889999999999999999999999


Q ss_pred             eCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhh
Q 018275          229 HRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR  308 (358)
Q Consensus       229 HrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (358)
                      ||||||+|||++.++.+||+|||+|+.+......                                              
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~----------------------------------------------  196 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----------------------------------------------  196 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB----------------------------------------------
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccc----------------------------------------------
Confidence            9999999999999999999999999765322110                                              


Q ss_pred             ccccccccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhcccc
Q 018275          309 RKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       309 ~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~~  352 (358)
                       ....+.+||+.|+|||++.+..|+.++|||||||++|||+++.
T Consensus       197 -~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         197 -KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             -C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             -cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence             1112457999999999999999999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=343.68  Aligned_cols=200  Identities=23%  Similarity=0.355  Sum_probs=168.0

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      +++..++|++.+.||+|+||+||+|.+..+ +.||||+++....    ..+.+.+|+.+++.++|||||+++++|.+ +.
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~   85 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP   85 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence            456778999999999999999999988654 5799999976532    23568899999999999999999999965 45


Q ss_pred             EEEEEeecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                      .++||||+++|+|..++..  ...+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||+|+....
T Consensus        86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            7899999999999998865  35799999999999999999999999999999999999999999999999999986542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchh
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW  338 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Di  338 (358)
                      ....                                                ...+..||+.|+|||++.+..|+.++||
T Consensus       166 ~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDI  197 (285)
T d1fmka3         166 NEYT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDV  197 (285)
T ss_dssp             ----------------------------------------------------------CCGGGSCHHHHHHCCCCHHHHH
T ss_pred             CCce------------------------------------------------eeccccccccccChHHHhCCCCCcHHhh
Confidence            2111                                                0113479999999999999999999999


Q ss_pred             hhhhHHHHhhcccccc
Q 018275          339 LAYWNETLSCNYLSDI  354 (358)
Q Consensus       339 wSlGvil~e~l~~~~~  354 (358)
                      |||||++|||+++..+
T Consensus       198 ~S~Giil~el~t~~~p  213 (285)
T d1fmka3         198 WSFGILLTELTTKGRV  213 (285)
T ss_dssp             HHHHHHHHHHHTTTCC
T ss_pred             hcchHHHHHHHhCCCC
Confidence            9999999999986544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-46  Score=344.49  Aligned_cols=201  Identities=24%  Similarity=0.325  Sum_probs=166.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecC-CCEEEEEecchhhhhchhhHHHHHHHHHHHHHh---cCcceEEEEEEeec---
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKS-GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQD---  177 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~~iv~l~~~~~~---  177 (358)
                      .++|++++.||+|+||+||+|.+..+ ++.||||+++..... ......+.+|+.+++.+   +|||||+++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            37899999999999999999999765 667999999765322 12222355677777665   79999999999853   


Q ss_pred             --CCEEEEEEeecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          178 --AEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       178 --~~~~~lV~E~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                        ...++++|||++++++..... ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              357899999998877654443 34678999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCc
Q 018275          255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM  334 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~  334 (358)
                      ......                                                  ...+.+||+.|||||++.+.+|+.
T Consensus       165 ~~~~~~--------------------------------------------------~~~~~~gT~~Y~APE~~~~~~y~~  194 (305)
T d1blxa_         165 IYSFQM--------------------------------------------------ALTSVVVTLWYRAPEVLLQSSYAT  194 (305)
T ss_dssp             CCCGGG--------------------------------------------------GGCCCCCCCTTCCHHHHTTCCCCT
T ss_pred             hhcccc--------------------------------------------------cCCCcccChhhcCcchhcCCCCCh
Confidence            543111                                                  112458999999999999999999


Q ss_pred             cchhhhhhHHHHhhcccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ++|||||||++|||+++..+|.
T Consensus       195 ~~DiwSlG~il~ell~g~~pf~  216 (305)
T d1blxa_         195 PVDLWSVGCIFAEMFRRKPLFR  216 (305)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCC
T ss_pred             hehhhchHHHHHHHHHCCCCCC
Confidence            9999999999999999987763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.4e-46  Score=340.70  Aligned_cols=200  Identities=27%  Similarity=0.371  Sum_probs=172.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||+||+|.++ +|+.||||++..... .......+.+|+.+|+.++|||||+++++|.+++..|++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            78999999999999999999875 789999999976543 3344567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      |++.++++..+....+.+++..++.++.||+.||.|||+.+||||||||+|||++.++.+||+|||+|.........   
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~---  156 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---  156 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc---
Confidence            99988777777777889999999999999999999999999999999999999999999999999998765422110   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~DiwSlGvi  344 (358)
                                                                    ....+||+.|+|||++.+. .++.++|+|||||+
T Consensus       157 ----------------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~  190 (286)
T d1ob3a_         157 ----------------------------------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI  190 (286)
T ss_dssp             ---------------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred             ----------------------------------------------cceecccchhhhHHHHhCCCCCCcceeehhcCcH
Confidence                                                          1134799999999999764 57899999999999


Q ss_pred             HHhhcccccccc
Q 018275          345 TLSCNYLSDIML  356 (358)
Q Consensus       345 l~e~l~~~~~~~  356 (358)
                      +|||++|..+|.
T Consensus       191 l~el~~G~~pf~  202 (286)
T d1ob3a_         191 FAEMVNGTPLFP  202 (286)
T ss_dssp             HHHHHHSSCSCC
T ss_pred             HHHHHHCCCCCC
Confidence            999999987763

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=342.78  Aligned_cols=207  Identities=25%  Similarity=0.313  Sum_probs=172.4

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec------
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------  177 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~------  177 (358)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++..      
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            35899999999999999999999999999999999976643 33445567899999999999999999999865      


Q ss_pred             --CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          178 --AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       178 --~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                        ...+|+||||+.++++.........+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence              345899999998877777766678899999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGM  334 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~  334 (358)
                      +........                                             ....+.+||+.|+|||++.+. +|+.
T Consensus       167 ~~~~~~~~~---------------------------------------------~~~~~~~gT~~Y~aPE~~~~~~~~~~  201 (318)
T d3blha1         167 FSLAKNSQP---------------------------------------------NRYTNRVVTLWYRPPELLLGERDYGP  201 (318)
T ss_dssp             CCC-----C---------------------------------------------CCCCSCCSCGGGCCHHHHTTCSSCCT
T ss_pred             ccccccccc---------------------------------------------ccccceecCHHHhhHHHHcCCCCCCc
Confidence            653221111                                             112245899999999999865 7999


Q ss_pred             cchhhhhhHHHHhhcccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ++|||||||++|||+++..+|.
T Consensus       202 k~DiwSlGvil~el~~g~~pf~  223 (318)
T d3blha1         202 PIDLWGAGCIMAEMWTRSPIMQ  223 (318)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCC
T ss_pred             HHHcccCCceeeeHhhCCCCCC
Confidence            9999999999999999877663

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-46  Score=339.22  Aligned_cols=205  Identities=21%  Similarity=0.282  Sum_probs=163.5

Q ss_pred             cCCCceeeeeEeeeeeEEEEEEEEecC-C--CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCE
Q 018275          104 SVDDFDLLTIIGRGAFGEVRLCQEKKS-G--NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY  180 (358)
Q Consensus       104 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~-~--~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~  180 (358)
                      ..++|++++.||+|+||.||+|....+ +  ..||||++.+.........+.+.+|+.+++.++|||||+++++|.++ .
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~   84 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P   84 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence            457899999999999999999986543 3  36899999877655566677899999999999999999999999764 6


Q ss_pred             EEEEEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .++||||+++|++.+.+... .++++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+...
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            78999999999999887654 57999999999999999999999999999999999999999999999999999876533


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .....                                              ......||+.|+|||++.+..|+.++|||
T Consensus       165 ~~~~~----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~  198 (273)
T d1u46a_         165 DDHYV----------------------------------------------MQEHRKVPFAWCAPESLKTRTFSHASDTW  198 (273)
T ss_dssp             CCEEE----------------------------------------------C-----CCGGGCCHHHHHHCEEEHHHHHH
T ss_pred             CCcce----------------------------------------------ecCccccCcccCCHHHHhCCCCCcchhhh
Confidence            22111                                              11134688899999999999999999999


Q ss_pred             hhhHHHHhhcc-ccccc
Q 018275          340 AYWNETLSCNY-LSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~-~~~~~  355 (358)
                      ||||++|||++ +..+|
T Consensus       199 S~Gvil~emlt~G~~Pf  215 (273)
T d1u46a_         199 MFGVTLWEMFTYGQEPW  215 (273)
T ss_dssp             HHHHHHHHHHTTSCCTT
T ss_pred             hhHHHHHHHHhCCCCCC
Confidence            99999999996 56554

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-45  Score=338.56  Aligned_cols=208  Identities=23%  Similarity=0.331  Sum_probs=172.7

Q ss_pred             hccCccCCCceeeeeEeeeeeEEEEEEEEecCC-------CEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEE
Q 018275           99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVK  170 (358)
Q Consensus        99 ~~~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~  170 (358)
                      +++.+..++|.+.+.||+|+||.||+|++..++       ..||||++++..  .......+.+|...+..+ +|||||+
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~   83 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN   83 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence            346677899999999999999999999876554       479999997653  344556788899988888 7999999


Q ss_pred             EEEEeecCCEEEEEEeecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 018275          171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKP  234 (358)
Q Consensus       171 l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp  234 (358)
                      ++++|.++..+++||||+++|+|.+++...                ..+++..+..++.||+.||+|||+.+||||||||
T Consensus        84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp  163 (299)
T d1fgka_          84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  163 (299)
T ss_dssp             EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence            999999999999999999999999999644                3589999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccc
Q 018275          235 DNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYS  314 (358)
Q Consensus       235 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  314 (358)
                      +|||++.++.+||+|||+++........                                               .....
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~-----------------------------------------------~~~~~  196 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYY-----------------------------------------------KKTTN  196 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTT-----------------------------------------------CCCTT
T ss_pred             cceeecCCCCeEeccchhhccccccccc-----------------------------------------------ccccc
Confidence            9999999999999999999876422111                                               11124


Q ss_pred             ccCCCCCchhhhhcCCCCCccchhhhhhHHHHhhccc-cccc
Q 018275          315 TVGTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNYL-SDIM  355 (358)
Q Consensus       315 ~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~~-~~~~  355 (358)
                      .+||+.|+|||++.++.|+.++|||||||++|||+.+ ..+|
T Consensus       197 ~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             SCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence            5799999999999999999999999999999999974 4444

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=342.57  Aligned_cols=199  Identities=25%  Similarity=0.382  Sum_probs=169.3

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEecCCCE--EEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEEeecCC
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI--YAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE  179 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~  179 (358)
                      +..++|++.+.||+|+||+||+|.++.++..  ||||.+....  .....+.+.+|+.+|+.+ +|||||+++++|.+.+
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            4568999999999999999999999888764  6777765432  334456689999999998 7999999999999999


Q ss_pred             EEEEEEeecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG  243 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~  243 (358)
                      .+++||||+++|+|.+++...                ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999999643                5689999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCch
Q 018275          244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA  323 (358)
Q Consensus       244 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~A  323 (358)
                      .+||+|||+|+.......                                                  .....||+.|+|
T Consensus       165 ~~kl~DfG~a~~~~~~~~--------------------------------------------------~~~~~gt~~y~a  194 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVK--------------------------------------------------KTMGRLPVRWMA  194 (309)
T ss_dssp             CEEECCTTCEESSCEECC--------------------------------------------------C----CCTTTCC
T ss_pred             ceEEcccccccccccccc--------------------------------------------------ccceecCCcccc
Confidence            999999999976532111                                                  113369999999


Q ss_pred             hhhhcCCCCCccchhhhhhHHHHhhccccc
Q 018275          324 PEVLLKKGYGMECDWLAYWNETLSCNYLSD  353 (358)
Q Consensus       324 PEv~~~~~y~~~~DiwSlGvil~e~l~~~~  353 (358)
                      ||++.+..|+.++|||||||++|||+++..
T Consensus       195 PE~l~~~~~~~~sDvwSfGvil~ell~~~~  224 (309)
T d1fvra_         195 IESLNYSVYTTNSDVWSYGVLLWEIVSLGG  224 (309)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             hHHhccCCCCccceeehhHHHHHHHHhcCC
Confidence            999999999999999999999999998754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-45  Score=338.22  Aligned_cols=206  Identities=23%  Similarity=0.252  Sum_probs=177.6

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEe-----cCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHh-cCcceEEEEEE
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS  174 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~  174 (358)
                      +++..++|++.+.||+|+||.||+|.+.     .+++.||||+++...  .......+.+|+.+++.+ +|||||+++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            4577799999999999999999999864     456789999998653  344556788999999999 69999999999


Q ss_pred             eecCCEEEEEEeecCCCCHHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 018275          175 FQDAEYLYLIMEYLPGGDVMTLLMREE------------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN  236 (358)
Q Consensus       175 ~~~~~~~~lV~E~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~N  236 (358)
                      |.+...+|+||||+++|+|.+++....                  .+++..+..++.||+.||.|||+++|+||||||+|
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence            999999999999999999999986542                  58899999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhcccccccc
Q 018275          237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV  316 (358)
Q Consensus       237 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  316 (358)
                      ||++.++.+||+|||+++.........                                               .....+
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~-----------------------------------------------~~~~~~  208 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYV-----------------------------------------------VKGNAR  208 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSE-----------------------------------------------ECSSSE
T ss_pred             ccccccCcccccccchheeccCCCcce-----------------------------------------------Eeeecc
Confidence            999999999999999998764322111                                               111347


Q ss_pred             CCCCCchhhhhcCCCCCccchhhhhhHHHHhhcc-ccccc
Q 018275          317 GTPDYIAPEVLLKKGYGMECDWLAYWNETLSCNY-LSDIM  355 (358)
Q Consensus       317 gt~~Y~APEv~~~~~y~~~~DiwSlGvil~e~l~-~~~~~  355 (358)
                      ||+.|+|||++.+..|+.++|||||||++|||++ +..++
T Consensus       209 gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~  248 (311)
T d1t46a_         209 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (311)
T ss_dssp             ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence            9999999999999999999999999999999998 44444

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-45  Score=343.22  Aligned_cols=194  Identities=28%  Similarity=0.383  Sum_probs=164.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec------CC
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------AE  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~------~~  179 (358)
                      -+|+.+++||+|+||+||+|.+..+|+.||||++......       ..+|+.+|+.++|||||+++++|..      ..
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            3699999999999999999999999999999999765321       3469999999999999999999843      44


Q ss_pred             EEEEEEeecCCCCHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-cEEEEecCCCcc
Q 018275          180 YLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKP  255 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~vkl~DFGla~~  255 (358)
                      ++||||||++++.+..+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            689999999866433332   3456899999999999999999999999999999999999999875 899999999986


Q ss_pred             CCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcC-CCCCc
Q 018275          256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGM  334 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~-~~y~~  334 (358)
                      +....                                                  ...+.+||+.|+|||++.+ ..|+.
T Consensus       173 ~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~  202 (350)
T d1q5ka_         173 LVRGE--------------------------------------------------PNVSYICSRYYRAPELIFGATDYTS  202 (350)
T ss_dssp             CCTTS--------------------------------------------------CCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred             ccCCc--------------------------------------------------ccccccccccccChHHhhcccCCCc
Confidence            54221                                                  1124589999999999875 57999


Q ss_pred             cchhhhhhHHHHhhcccccccc
Q 018275          335 ECDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       335 ~~DiwSlGvil~e~l~~~~~~~  356 (358)
                      ++|||||||++|||+++..+|.
T Consensus       203 ~~DIwSlG~il~el~~g~~pf~  224 (350)
T d1q5ka_         203 SIDVWSAGCVLAELLLGQPIFP  224 (350)
T ss_dssp             HHHHHHHHHHHHHHHHTSCSSC
T ss_pred             ceeecccceEEEehhhCCCCCC
Confidence            9999999999999999987774

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=333.23  Aligned_cols=192  Identities=24%  Similarity=0.401  Sum_probs=162.5

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec-CC
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-AE  179 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~  179 (358)
                      +++..++|++++.||+|+||.||+|.++  |..||||+++...     ..+.+.+|+.+++.++|||||+++++|.+ .+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            4677789999999999999999999874  7799999997543     34568899999999999999999999864 45


Q ss_pred             EEEEEEeecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      .+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence            689999999999999999654  358999999999999999999999999999999999999999999999999997543


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ...                                                    ....+|+.|+|||++.+..|+.++|
T Consensus       155 ~~~----------------------------------------------------~~~~~~~~y~aPE~l~~~~~t~~sD  182 (262)
T d1byga_         155 STQ----------------------------------------------------DTGKLPVKWTAPEALREKKFSTKSD  182 (262)
T ss_dssp             -----------------------------------------------------------CCTTTSCHHHHHHCCCCHHHH
T ss_pred             CCC----------------------------------------------------ccccccccCCChHHHhCCCCChHHH
Confidence            111                                                    1236899999999999999999999


Q ss_pred             hhhhhHHHHhhccc
Q 018275          338 WLAYWNETLSCNYL  351 (358)
Q Consensus       338 iwSlGvil~e~l~~  351 (358)
                      ||||||++|||+.+
T Consensus       183 IwSfG~il~el~t~  196 (262)
T d1byga_         183 VWSFGILLWEIYSF  196 (262)
T ss_dssp             HHHHHHHHHHHHTT
T ss_pred             HHhHHHHHHHHHHC
Confidence            99999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-45  Score=341.90  Aligned_cols=206  Identities=36%  Similarity=0.631  Sum_probs=177.0

Q ss_pred             ccCCCceeeeeEeeeeeEEEEEEEEe---cCCCEEEEEecchhhhh-chhhHHHHHHHHHHHHHhcC-cceEEEEEEeec
Q 018275          103 ISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEML-SRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQD  177 (358)
Q Consensus       103 ~~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~  177 (358)
                      +..++|++++.||+|+||+||+|.+.   .+|+.||||++++.... .....+.+.+|+.++++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            45688999999999999999999873   47899999999765322 22234457889999999987 799999999999


Q ss_pred             CCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCC
Q 018275          178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD  257 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~  257 (358)
                      ...+++||||+.+|+|.+++.....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC--CCCcc
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK--GYGME  335 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~--~y~~~  335 (358)
                      .....                                                ...+..||+.|+|||++.+.  .|+.+
T Consensus       181 ~~~~~------------------------------------------------~~~~~~g~~~~~~pe~~~~~~~~~~~k  212 (322)
T d1vzoa_         181 ADETE------------------------------------------------RAYDFCGTIEYMAPDIVRGGDSGHDKA  212 (322)
T ss_dssp             GGGGG------------------------------------------------GGCGGGSCCTTCCHHHHTTCC---CTH
T ss_pred             ccccc------------------------------------------------cccccccccccchhHHhhcCCcCCCch
Confidence            22111                                                11245799999999999865  46789


Q ss_pred             chhhhhhHHHHhhcccccccc
Q 018275          336 CDWLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       336 ~DiwSlGvil~e~l~~~~~~~  356 (358)
                      +|||||||+||||++|..+|.
T Consensus       213 sDIWSlG~iLyelltG~~PF~  233 (322)
T d1vzoa_         213 VDWWSLGVLMYELLTGASPFT  233 (322)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTS
T ss_pred             hhhHHHHHHHHHHHhCCCCCC
Confidence            999999999999999988773

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.5e-44  Score=330.77  Aligned_cols=204  Identities=21%  Similarity=0.194  Sum_probs=173.4

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC-cceEEEEEEeecCCEEEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~l  183 (358)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....     ...+++|+.+++.+.| +|++.+++++.+....++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            4789999999999999999999999999999999865432     1236778899999876 799999999999999999


Q ss_pred             EEeecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC-----CCcEEEEecCCCccCC
Q 018275          184 IMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-----NGHMKLSDFGLCKPLD  257 (358)
Q Consensus       184 V~E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~-----~~~vkl~DFGla~~~~  257 (358)
                      ||||+ +++|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+.+.
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999 78999988665 57999999999999999999999999999999999999974     5789999999998764


Q ss_pred             CCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccch
Q 018275          258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD  337 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~D  337 (358)
                      ........                                          ......+.+|||.|||||++.+.+|+.++|
T Consensus       158 ~~~~~~~~------------------------------------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~D  195 (293)
T d1csna_         158 DPVTKQHI------------------------------------------PYREKKNLSGTARYMSINTHLGREQSRRDD  195 (293)
T ss_dssp             CTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHH
T ss_pred             cCccccce------------------------------------------eecccCceEEchhhcCHHHhcCCCCChHHH
Confidence            32211100                                          001122568999999999999999999999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|||+++..+|.
T Consensus       196 iwSlG~~l~elltg~~Pf~  214 (293)
T d1csna_         196 LEALGHVFMYFLRGSLPWQ  214 (293)
T ss_dssp             HHHHHHHHHHHHHSSCTTS
T ss_pred             HHHhhHHHHHHHhCCCcCC
Confidence            9999999999999887774

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=341.37  Aligned_cols=201  Identities=26%  Similarity=0.365  Sum_probs=167.8

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----E
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----Y  180 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~  180 (358)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+..  .....+.+.+|+.+|+.++|||||++++++....     .
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            67999999999999999999999999999999997643  3445667889999999999999999999997543     3


Q ss_pred             EEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCC
Q 018275          181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       181 ~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~  260 (358)
                      +|++ +++.+|+|.+++.. ..+++..++.++.|++.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus        86 ~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          86 VYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            4555 55668999999954 579999999999999999999999999999999999999999999999999998764322


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhc-CCCCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~-~~~y~~~~Diw  339 (358)
                      ...                                              ......+||+.|+|||++. +..|+.++|+|
T Consensus       164 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diw  197 (345)
T d1pmea_         164 DHT----------------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIW  197 (345)
T ss_dssp             CBC----------------------------------------------CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHH
T ss_pred             ccc----------------------------------------------eeeccccccceechHHHhhcCCCCCchhhhh
Confidence            111                                              0112458999999999985 56689999999


Q ss_pred             hhhHHHHhhcccccccc
Q 018275          340 AYWNETLSCNYLSDIML  356 (358)
Q Consensus       340 SlGvil~e~l~~~~~~~  356 (358)
                      |+||++|||+++..+|.
T Consensus       198 SlG~il~eml~g~~pf~  214 (345)
T d1pmea_         198 SVGCILAEMLSNRPIFP  214 (345)
T ss_dssp             HHHHHHHHHHHSSCSCC
T ss_pred             ccCceehHHhhCCCCCC
Confidence            99999999999987763

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-45  Score=342.05  Aligned_cols=197  Identities=28%  Similarity=0.381  Sum_probs=167.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC-----
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----  179 (358)
                      .++|++++.||+|+||+||+|.++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|.+.+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            589999999999999999999999999999999998653 24455677889999999999999999999997654     


Q ss_pred             -EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCC
Q 018275          180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC  258 (358)
Q Consensus       180 -~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~  258 (358)
                       .+|+||||+ +++|..++ ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             579999999 56777766 456899999999999999999999999999999999999999999999999999986542


Q ss_pred             CCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccch
Q 018275          259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECD  337 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~D  337 (358)
                      ..                                                    .+.+||+.|+|||++.+. .++.++|
T Consensus       174 ~~----------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~D  201 (346)
T d1cm8a_         174 EM----------------------------------------------------TGYVVTRWYRAPEVILNWMRYTQTVD  201 (346)
T ss_dssp             SC----------------------------------------------------CSSCSCGGGCCTHHHHTTTCCCTTHH
T ss_pred             cc----------------------------------------------------ccccccccccCHHHHcCCCCCCccch
Confidence            11                                                    134799999999999874 5789999


Q ss_pred             hhhhhHHHHhhcccccccc
Q 018275          338 WLAYWNETLSCNYLSDIML  356 (358)
Q Consensus       338 iwSlGvil~e~l~~~~~~~  356 (358)
                      ||||||++|||+++..+|.
T Consensus       202 iwSlGvil~ell~g~~pf~  220 (346)
T d1cm8a_         202 IWSVGCIMAEMITGKTLFK  220 (346)
T ss_dssp             HHHHHHHHHHHHHSSCSSC
T ss_pred             hhcchHHHHHHHHCcCCCC
Confidence            9999999999999987763

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-44  Score=329.49  Aligned_cols=200  Identities=24%  Similarity=0.346  Sum_probs=178.4

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCCEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM  185 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lV~  185 (358)
                      ++|++++.||+|+||+||+|.+..+++.||||+++.... .......+.+|+.+++.++|||||+++++|.+....++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            689999999999999999999999999999999976542 4456677899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       186 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      +++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+........   
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~---  157 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---  157 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC---
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc---
Confidence            99999999998888889999999999999999999999999999999999999999999999999999876432211   


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC-CCccchhhhhhHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWLAYWNE  344 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~-y~~~~DiwSlGvi  344 (358)
                                                                    .....+++.|+|||++.+.. ++.++|+|||||+
T Consensus       158 ----------------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~i  191 (292)
T d1unla_         158 ----------------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI  191 (292)
T ss_dssp             ----------------------------------------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred             ----------------------------------------------ceeeccccchhhhhHhccCCCCCchhhccccchH
Confidence                                                          11236889999999998765 6899999999999


Q ss_pred             HHhhccccccc
Q 018275          345 TLSCNYLSDIM  355 (358)
Q Consensus       345 l~e~l~~~~~~  355 (358)
                      +|||+++..+|
T Consensus       192 l~ell~g~~p~  202 (292)
T d1unla_         192 FAELANAGRPL  202 (292)
T ss_dssp             HHHHTTTSCCS
T ss_pred             HHHHhhCCCCC
Confidence            99999977654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=335.57  Aligned_cols=203  Identities=17%  Similarity=0.248  Sum_probs=175.6

Q ss_pred             cCccCCCceeeeeEeeeeeEEEEEEEEec-----CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEe
Q 018275          101 HKISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF  175 (358)
Q Consensus       101 ~~~~~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~  175 (358)
                      +++..++|++.+.||+|+||+||+|.+..     ++..||||+++...  .......+.+|+.+++.++|||||+++++|
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            46777999999999999999999998753     35789999997653  344556789999999999999999999999


Q ss_pred             ecCCEEEEEEeecCCCCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcE
Q 018275          176 QDAEYLYLIMEYLPGGDVMTLLMRE----------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM  245 (358)
Q Consensus       176 ~~~~~~~lV~E~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~v  245 (358)
                      ...+..++||||+++|+|.+++...          ..++...+..++.|++.||.|||+.+|+||||||+|||++.++.+
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence            9999999999999999999998542          246888899999999999999999999999999999999999999


Q ss_pred             EEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhh
Q 018275          246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE  325 (358)
Q Consensus       246 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APE  325 (358)
                      ||+|||+|+.+......                                               ......+||+.|+|||
T Consensus       173 Kl~DFGla~~~~~~~~~-----------------------------------------------~~~~~~~~t~~y~aPe  205 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYY-----------------------------------------------RKGGKGLLPVRWMSPE  205 (308)
T ss_dssp             EECCTTCCCGGGGGGCE-----------------------------------------------EGGGSSEECGGGCCHH
T ss_pred             EEeecccceeccCCcce-----------------------------------------------eeccceecccccCCHH
Confidence            99999999866422111                                               1112347999999999


Q ss_pred             hhcCCCCCccchhhhhhHHHHhhcccc
Q 018275          326 VLLKKGYGMECDWLAYWNETLSCNYLS  352 (358)
Q Consensus       326 v~~~~~y~~~~DiwSlGvil~e~l~~~  352 (358)
                      ++.+..|+.++|+|||||++|||+++.
T Consensus       206 ~l~~~~~~~~~Dv~S~G~il~El~t~~  232 (308)
T d1p4oa_         206 SLKDGVFTTYSDVWSFGVVLWEIATLA  232 (308)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred             HHccCCCCcccccccHHHHHHHHHhCC
Confidence            999999999999999999999999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.8e-44  Score=333.80  Aligned_cols=192  Identities=24%  Similarity=0.365  Sum_probs=167.0

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-CcceEEEEEEeec--CCEE
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD--AEYL  181 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~--~~~~  181 (358)
                      .++|++++.||+|+||+||+|++..+|+.||||+++...      ...+.+|+.+|+.+. ||||++++++|..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            478999999999999999999999999999999987542      345788999999995 9999999999974  4579


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCC-cEEEEecCCCccCCCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~-~vkl~DFGla~~~~~~~  260 (358)
                      ++||||+++++|..+.   ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999999987764   5699999999999999999999999999999999999998655 69999999998664221


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCC-CCCccchhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWL  339 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~-~y~~~~Diw  339 (358)
                      .                                                  ....+||+.|+|||++.+. .|+.++|+|
T Consensus       185 ~--------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  214 (328)
T d3bqca1         185 E--------------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMW  214 (328)
T ss_dssp             C--------------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHH
T ss_pred             c--------------------------------------------------ccccccCccccCcccccCCCCCCcccchh
Confidence            1                                                  1134799999999998875 589999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      |+||++|||+++..+|
T Consensus       215 slG~~l~e~~~g~~pf  230 (328)
T d3bqca1         215 SLGCMLASMIFRKEPF  230 (328)
T ss_dssp             HHHHHHHHHHHTCSSS
T ss_pred             hhhhhhHHhccCCCCC
Confidence            9999999999987765

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-43  Score=326.79  Aligned_cols=203  Identities=22%  Similarity=0.261  Sum_probs=166.7

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc-eEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~-iv~l~~~~~~~~~~~lV  184 (358)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++......     ..+..|+.+++.++|++ |+.+..++.+.+..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            6799999999999999999999999999999998765321     23678999999998776 55556666788899999


Q ss_pred             EeecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcC---CCcEEEEecCCCccCCCCC
Q 018275          185 MEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCKPLDCTN  260 (358)
Q Consensus       185 ~E~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~---~~~vkl~DFGla~~~~~~~  260 (358)
                      |||+. ++|...+. ....+++..+..++.|++.||+|||++|||||||||+|||++.   +..+||+|||+|+.+....
T Consensus        82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            99994 56665554 4568999999999999999999999999999999999999864   4579999999998775332


Q ss_pred             CcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhh
Q 018275          261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLA  340 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwS  340 (358)
                      .....                                          ......+.+||+.|||||++.+.+|+.++||||
T Consensus       161 ~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  198 (299)
T d1ckia_         161 THQHI------------------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLES  198 (299)
T ss_dssp             TCCBC------------------------------------------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHH
T ss_pred             cccce------------------------------------------eccccCCcCCCccccCHHHHhCCCCCChhhEEe
Confidence            11110                                          001122568999999999999999999999999


Q ss_pred             hhHHHHhhcccccccc
Q 018275          341 YWNETLSCNYLSDIML  356 (358)
Q Consensus       341 lGvil~e~l~~~~~~~  356 (358)
                      |||++|||+++..+|.
T Consensus       199 lG~~l~el~tg~~P~~  214 (299)
T d1ckia_         199 LGYVLMYFNLGSLPWQ  214 (299)
T ss_dssp             HHHHHHHHHHSSCTTC
T ss_pred             cCHHHHHHHhCCCccc
Confidence            9999999999877764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=329.16  Aligned_cols=198  Identities=18%  Similarity=0.229  Sum_probs=167.1

Q ss_pred             eeeEeeeeeEEEEEEEEecCC---CEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeec-CCEEEEEEe
Q 018275          111 LTIIGRGAFGEVRLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-AEYLYLIME  186 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lV~E  186 (358)
                      .++||+|+||+||+|.+..++   ..||||+++...  .......+.+|+.++++++|||||++++++.+ +...++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            578999999999999986543   368999987532  45566789999999999999999999999865 568999999


Q ss_pred             ecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCCCCcccc
Q 018275          187 YLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN  265 (358)
Q Consensus       187 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  265 (358)
                      |+++|+|.+++... ..++...+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.+.........
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence            99999999998754 46777888899999999999999999999999999999999999999999999877533221110


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhhhhhHHH
Q 018275          266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWLAYWNET  345 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~DiwSlGvil  345 (358)
                                                                   ......||+.|+|||++.+..|+.++||||||+++
T Consensus       190 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl  224 (311)
T d1r0pa_         190 ---------------------------------------------NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL  224 (311)
T ss_dssp             ---------------------------------------------CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             ---------------------------------------------ecccccccccccChHHHhcCCCCChhHhhhhHHHH
Confidence                                                         01134699999999999999999999999999999


Q ss_pred             Hhhccccccc
Q 018275          346 LSCNYLSDIM  355 (358)
Q Consensus       346 ~e~l~~~~~~  355 (358)
                      |||+++...|
T Consensus       225 ~El~t~~~p~  234 (311)
T d1r0pa_         225 WELMTRGAPP  234 (311)
T ss_dssp             HHHHTTSCCS
T ss_pred             HHHHHCCCCC
Confidence            9999876654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=335.66  Aligned_cols=196  Identities=24%  Similarity=0.344  Sum_probs=162.9

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEee------cCC
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ------DAE  179 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~------~~~  179 (358)
                      ++|++++.||+|+||+||+|.++.+|+.||||+++.... .......+.+|+.+++.++|||||+++++|.      +..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            789999999999999999999999999999999986542 4555667889999999999999999999996      347


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      .+|+||||+.++ +...+  ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus        96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            899999999665 44444  356899999999999999999999999999999999999999999999999998765321


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCCCCccchhh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWL  339 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~y~~~~Diw  339 (358)
                      .                                                  .....+||+.|+|||++.+..|+.++|+|
T Consensus       173 ~--------------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~Diw  202 (355)
T d2b1pa1         173 F--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIW  202 (355)
T ss_dssp             ----------------------------------------------------------CCTTCCHHHHTTCCCCTTHHHH
T ss_pred             c--------------------------------------------------ccccccccccccChhhhcCCCCCCCcccc
Confidence            1                                                  11244799999999999999999999999


Q ss_pred             hhhHHHHhhccccccc
Q 018275          340 AYWNETLSCNYLSDIM  355 (358)
Q Consensus       340 SlGvil~e~l~~~~~~  355 (358)
                      |+||++|||+++..+|
T Consensus       203 SlG~~l~ell~g~~pF  218 (355)
T d2b1pa1         203 SVGCIMGEMVRHKILF  218 (355)
T ss_dssp             HHHHHHHHHHHSSCSS
T ss_pred             cccchHHHHhhCCCCC
Confidence            9999999999998776

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=327.97  Aligned_cols=198  Identities=24%  Similarity=0.237  Sum_probs=159.0

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecCC----EE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----YL  181 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~----~~  181 (358)
                      .+|.+.+.||+|+||.||+|.+  +|+.||||+++....    .......|+..+..++|||||++++++.+..    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            4688899999999999999975  588999999875431    1111223444556789999999999997643    68


Q ss_pred             EEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeCCCCCCCEEEcCCCcEEEEecCCC
Q 018275          182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK--------HNYIHRDIKPDNLLLDQNGHMKLSDFGLC  253 (358)
Q Consensus       182 ~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~--------~~iiHrDikp~NILl~~~~~vkl~DFGla  253 (358)
                      |+||||+++|+|.+++.. .++++.....++.+++.||.|||+        +||+||||||+|||++.++.+||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999999965 468888889999999999999996        59999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC--
Q 018275          254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--  331 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~--  331 (358)
                      +..........                                             ......+||+.|||||++.+..  
T Consensus       156 ~~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~  190 (303)
T d1vjya_         156 VRHDSATDTID---------------------------------------------IAPNHRVGTKRYMAPEVLDDSINM  190 (303)
T ss_dssp             EEEETTTTEEC---------------------------------------------C----CCSCGGGCCHHHHTTCSCT
T ss_pred             ccccCCCccee---------------------------------------------ccccceecccCcCChhhccccccc
Confidence            87643221110                                             0111358999999999998653  


Q ss_pred             ----CCccchhhhhhHHHHhhccccccc
Q 018275          332 ----YGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       332 ----y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                          |+.++|||||||+||||+++..++
T Consensus       191 ~~~~~~~k~Di~S~Gvvl~el~tg~~~~  218 (303)
T d1vjya_         191 KHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             TCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             cCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence                677899999999999999876544

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=331.49  Aligned_cols=198  Identities=26%  Similarity=0.338  Sum_probs=167.6

Q ss_pred             CCCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceEEEEEEeecC-----C
Q 018275          105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----E  179 (358)
Q Consensus       105 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~  179 (358)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            4789999999999999999999999999999999986532 344556788999999999999999999998633     3


Q ss_pred             EEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCCCccCCCC
Q 018275          180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT  259 (358)
Q Consensus       180 ~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGla~~~~~~  259 (358)
                      ..+++|+|+.+|+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|......
T Consensus        96 ~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             ceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence            3456677788999999884 457999999999999999999999999999999999999999999999999998754311


Q ss_pred             CCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCchhhhhcCCC-CCccchh
Q 018275          260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDW  338 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~APEv~~~~~-y~~~~Di  338 (358)
                                                                          ..+.+||+.|+|||++.+.. ++.++|+
T Consensus       175 ----------------------------------------------------~~~~~g~~~y~apE~~~~~~~~~~~~Di  202 (348)
T d2gfsa1         175 ----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDI  202 (348)
T ss_dssp             ----------------------------------------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHH
T ss_pred             ----------------------------------------------------cccccccccccCchhhcCCccCCcccch
Confidence                                                                11347999999999988765 6899999


Q ss_pred             hhhhHHHHhhcccccccc
Q 018275          339 LAYWNETLSCNYLSDIML  356 (358)
Q Consensus       339 wSlGvil~e~l~~~~~~~  356 (358)
                      |||||++|+|+++..+|.
T Consensus       203 wSlGv~l~~ll~g~~pF~  220 (348)
T d2gfsa1         203 WSVGCIMAELLTGRTLFP  220 (348)
T ss_dssp             HHHHHHHHHHHHSSCSCC
T ss_pred             hhhhHHHHHHHhCCCCCC
Confidence            999999999999987764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-37  Score=292.34  Aligned_cols=194  Identities=23%  Similarity=0.337  Sum_probs=160.1

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhc-----------CcceEEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-----------SHCIVKLYYS  174 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------h~~iv~l~~~  174 (358)
                      ++|++++.||+|+||+||+|.+..+|+.||||++++...    ..+.+.+|+.+++.++           |+|||+++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            569999999999999999999999999999999986532    2345677888887775           5789999888


Q ss_pred             ee--cCCEEEEEEeecCCCCH-HHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEcCCC-----
Q 018275          175 FQ--DAEYLYLIMEYLPGGDV-MTLL--MREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNG-----  243 (358)
Q Consensus       175 ~~--~~~~~~lV~E~~~~g~L-~~~l--~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~iiHrDikp~NILl~~~~-----  243 (358)
                      +.  .....+++|+++..+.. ....  .....+++..++.++.|++.||.|||+ .||+||||||+|||++.++     
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            75  44667788877755433 2222  234678999999999999999999998 8999999999999998765     


Q ss_pred             -cEEEEecCCCccCCCCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhhccccccccCCCCCc
Q 018275          244 -HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI  322 (358)
Q Consensus       244 -~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~gt~~Y~  322 (358)
                       .++++|||.|......                                                    ..+.+||+.|+
T Consensus       169 ~~~kl~dfg~s~~~~~~----------------------------------------------------~~~~~gt~~y~  196 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH----------------------------------------------------YTNSIQTREYR  196 (362)
T ss_dssp             EEEEECCCTTCEETTBC----------------------------------------------------CCSCCSCGGGC
T ss_pred             ceeeEeecccccccccc----------------------------------------------------ccccccccccc
Confidence             4999999998754311                                                    11447999999


Q ss_pred             hhhhhcCCCCCccchhhhhhHHHHhhccccccc
Q 018275          323 APEVLLKKGYGMECDWLAYWNETLSCNYLSDIM  355 (358)
Q Consensus       323 APEv~~~~~y~~~~DiwSlGvil~e~l~~~~~~  355 (358)
                      |||++.+.+|+.++|+||+||++++|+++..+|
T Consensus       197 aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF  229 (362)
T d1q8ya_         197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLF  229 (362)
T ss_dssp             CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence            999999999999999999999999999988765

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=1.9e-27  Score=204.45  Aligned_cols=137  Identities=15%  Similarity=0.152  Sum_probs=106.0

Q ss_pred             ceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh---------------chhhHHHHHHHHHHHHHhcCcceEEEE
Q 018275          108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML---------------SRGQVEHVRAERNLLAEVASHCIVKLY  172 (358)
Q Consensus       108 ~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~---------------~~~~~~~~~~E~~il~~l~h~~iv~l~  172 (358)
                      +.+.+.||+|+||+||+|.+ .+|+.||||+++.....               ..........|...+..+.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            45789999999999999987 46889999987643210               011223455688889999999998887


Q ss_pred             EEeecCCEEEEEEeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEcCCCcEEEEecCC
Q 018275          173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL  252 (358)
Q Consensus       173 ~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iiHrDikp~NILl~~~~~vkl~DFGl  252 (358)
                      ++..    .++||||+++..+..       ++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6542    269999998765433       3344556788999999999999999999999999999865 589999999


Q ss_pred             CccCC
Q 018275          253 CKPLD  257 (358)
Q Consensus       253 a~~~~  257 (358)
                      |+...
T Consensus       149 a~~~~  153 (191)
T d1zara2         149 SVEVG  153 (191)
T ss_dssp             CEETT
T ss_pred             cccCC
Confidence            97653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.57  E-value=2.9e-07  Score=80.23  Aligned_cols=140  Identities=11%  Similarity=0.061  Sum_probs=88.3

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcC-cceEEEEEEeecCCEEEEE
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYLYLI  184 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lV  184 (358)
                      ..|.+.+..+-++.+.||+..  .++..+++|.........   ...+.+|...+..+.. --+.+++.++.+++..++|
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv   88 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence            456666654445557899764  456678889876553222   2236678888877743 2356677777888899999


Q ss_pred             EeecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHH----------------------------------------------
Q 018275          185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLA----------------------------------------------  218 (358)
Q Consensus       185 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~a----------------------------------------------  218 (358)
                      |++++|.++........  ....   ++.++...                                              
T Consensus        89 ~~~l~G~~~~~~~~~~~--~~~~---~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYEDEQ--SPEK---IIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTTCS--CHHH---HHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEecccccccccccccc--cHHH---HHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            99999877754432110  0000   11111111                                              


Q ss_pred             -------HHHHHhC------CceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          219 -------IESIHKH------NYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       219 -------L~~LH~~------~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                             +..+...      .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                   1222221      289999999999999877778999998864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.11  E-value=3.1e-06  Score=78.58  Aligned_cols=80  Identities=18%  Similarity=0.181  Sum_probs=48.2

Q ss_pred             eeeEeeeeeEEEEEEEEecCCCEEEEEecchhhhh----chhhHHHHHHHHHHHHHhcC--c-ceEEEEEEeecCCEEEE
Q 018275          111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML----SRGQVEHVRAERNLLAEVAS--H-CIVKLYYSFQDAEYLYL  183 (358)
Q Consensus       111 ~~~IG~G~fG~Vy~~~~~~~~~~vaiK~i~~~~~~----~~~~~~~~~~E~~il~~l~h--~-~iv~l~~~~~~~~~~~l  183 (358)
                      .+.||.|....||++.+..+++.|++|.-......    -+....+...|..+|+.+.-  | .+++++.+.  +...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            45789999999999987777888999964321100    01123345568877776632  2 455565543  344579


Q ss_pred             EEeecCCCC
Q 018275          184 IMEYLPGGD  192 (358)
Q Consensus       184 V~E~~~~g~  192 (358)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=1.1e-05  Score=69.39  Aligned_cols=135  Identities=13%  Similarity=0.116  Sum_probs=80.8

Q ss_pred             Eeeee-eEEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcc--eEEEEEEeecCCEEEEEEeecCC
Q 018275          114 IGRGA-FGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYSFQDAEYLYLIMEYLPG  190 (358)
Q Consensus       114 IG~G~-fG~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~--iv~l~~~~~~~~~~~lV~E~~~~  190 (358)
                      +..|. -+.||+... .++..+++|.......      ..+..|..+++.+....  +.+++.+..+++..++||++++|
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            34444 367898653 4566788897654421      22667888887775443  55677777888889999999987


Q ss_pred             CCHHHH--------------Hhh-------cCCCC--HH-HHH----HHH---------------HHHHHHHHHHHhC--
Q 018275          191 GDVMTL--------------LMR-------EETLT--ET-VAR----FYI---------------AQSVLAIESIHKH--  225 (358)
Q Consensus       191 g~L~~~--------------l~~-------~~~~~--~~-~~~----~~~---------------~qi~~aL~~LH~~--  225 (358)
                      .++...              +..       ..++.  .. ...    .+.               ......+..+...  
T Consensus        91 ~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  170 (255)
T d1nd4a_          91 QDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP  170 (255)
T ss_dssp             EETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred             cccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCC
Confidence            654221              100       00000  00 000    000               0011223333322  


Q ss_pred             -----CceeCCCCCCCEEEcCCCcEEEEecCCCcc
Q 018275          226 -----NYIHRDIKPDNLLLDQNGHMKLSDFGLCKP  255 (358)
Q Consensus       226 -----~iiHrDikp~NILl~~~~~vkl~DFGla~~  255 (358)
                           .++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       171 ~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         171 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                 389999999999999877788999998864

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.23  E-value=0.0004  Score=62.01  Aligned_cols=67  Identities=7%  Similarity=0.177  Sum_probs=41.8

Q ss_pred             EEEEEEEEecCCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcce--EEEE-----EEeecCCEEEEEEeecCCC
Q 018275          120 GEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI--VKLY-----YSFQDAEYLYLIMEYLPGG  191 (358)
Q Consensus       120 G~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i--v~l~-----~~~~~~~~~~lV~E~~~~g  191 (358)
                      =.||++.. .+|..|++|+.+...    .....+..|...+..+....+  +...     ..+......+.++++++|.
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            47998764 568889999987642    123346678888877753322  1111     1123456788999999763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.36  E-value=0.0063  Score=53.32  Aligned_cols=30  Identities=27%  Similarity=0.310  Sum_probs=27.3

Q ss_pred             CCceeCCCCCCCEEEcCCCcEEEEecCCCc
Q 018275          225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK  254 (358)
Q Consensus       225 ~~iiHrDikp~NILl~~~~~vkl~DFGla~  254 (358)
                      .|+||+|+.++||+++.+...-|.||+.|.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            369999999999999988888999999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.33  E-value=0.0068  Score=55.12  Aligned_cols=77  Identities=19%  Similarity=0.307  Sum_probs=48.2

Q ss_pred             CCceeeeeEeeeeeEEEEEEEEec-------CCCEEEEEecchhhhhchhhHHHHHHHHHHHHHhcCcceE-EEEEEeec
Q 018275          106 DDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV-KLYYSFQD  177 (358)
Q Consensus       106 ~~~~~~~~IG~G~fG~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~l~~~~~~  177 (358)
                      +++++ +.|+-|--=.+|++....       ....|.+++.-..    ... ....+|..+++.+.-.+++ +++++|.+
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~  116 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETE-SHLVAESVIFTLLSERHLGPKLYGIFSG  116 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence            34444 466667777899887542       2356777776422    122 2355788888887655544 66666643


Q ss_pred             CCEEEEEEeecCCCC
Q 018275          178 AEYLYLIMEYLPGGD  192 (358)
Q Consensus       178 ~~~~~lV~E~~~~g~  192 (358)
                          .+||||++|..
T Consensus       117 ----g~I~efi~g~~  127 (395)
T d1nw1a_         117 ----GRLEEYIPSRP  127 (395)
T ss_dssp             ----EEEECCCCEEE
T ss_pred             ----ceEEEEecccc
Confidence                58999998743